data_1ulp_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ulp _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo . . . . . 0 N--CA 1.48 0.706 0 N-CA-C 110.068 -0.782 . . . . 0.0 110.068 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.526 ' CD1' ' O ' ' A' ' 144' ' ' VAL . 9.4 pt -93.64 -22.93 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.241 -0.912 . . . . 0.0 110.165 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.425 ' O ' HG21 ' A' ' 8' ' ' THR . . . 123.11 119.3 2.5 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -57.46 94.58 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.246 -1.149 . . . . 0.0 110.03 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.467 ' HA2' ' HA ' ' A' ' 143' ' ' ASP . . . 100.03 78.74 1.39 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.464 HG23 HG13 ' A' ' 4' ' ' ILE . 7.2 p -95.12 -170.53 2.21 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.286 -1.126 . . . . 0.0 110.336 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.592 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 5.5 m-30 58.62 14.52 3.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.396 -0.815 . . . . 0.0 110.322 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.562 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 26.8 p-10 -88.86 23.88 2.21 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.178 -0.951 . . . . 0.0 109.967 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.562 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.6 OUTLIER 161.36 -24.24 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.422 0.629 . . . . 0.0 109.444 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -158.51 153.56 24.7 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.429 ' HB3' ' CD1' ' A' ' 32' ' ' LEU . 45.6 Cg_endo -72.37 -3.13 12.81 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.96 1.505 . . . . 0.0 110.458 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.422 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 0.3 OUTLIER 60.13 -88.62 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.28 -0.887 . . . . 0.0 110.353 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.436 ' O ' ' C ' ' A' ' 16' ' ' TRP . . . -132.14 -21.33 0.97 Allowed Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.886 -1.15 . . . . 0.0 110.381 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.574 ' CZ2' HD11 ' A' ' 125' ' ' ILE . 56.1 m95 -41.51 121.87 1.79 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.09 -1.241 . . . . 0.0 110.565 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.533 ' O ' ' CG1' ' A' ' 47' ' ' VAL . 1.2 m -115.5 150.82 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.276 -0.89 . . . . 0.0 109.611 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.579 ' CB ' ' CD2' ' A' ' 25' ' ' LEU . . . -130.21 123.0 29.18 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.061 -1.025 . . . . 0.0 109.818 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.466 ' O ' HG11 ' A' ' 45' ' ' VAL . 23.4 p90 -108.68 157.26 18.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.51 -0.744 . . . . 0.0 110.486 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.495 ' O ' ' CG1' ' A' ' 45' ' ' VAL . . . 78.81 29.37 52.09 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.474 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 24.0 p -136.29 -160.96 1.11 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.219 -1.165 . . . . 0.0 110.466 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.455 ' O ' ' O ' ' A' ' 23' ' ' GLY . 15.0 t0 -99.46 131.96 45.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.368 -0.832 . . . . 0.0 110.318 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 22' ' ' ASP . . . 43.46 -166.18 0.02 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.3 -159.58 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.039 1.547 . . . . 0.0 110.46 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.579 ' CD2' ' CB ' ' A' ' 18' ' ' ALA . 7.9 mt -87.41 160.36 18.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.221 -0.925 . . . . 0.0 110.184 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -126.66 122.88 36.22 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.26 -0.9 . . . . 0.0 110.174 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.444 ' O ' ' C ' ' A' ' 28' ' ' SER . 2.2 p -119.51 -84.39 0.66 Allowed 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.373 -0.829 . . . . 0.0 109.801 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.455 ' O ' ' HB ' ' A' ' 29' ' ' THR . 36.5 m 37.09 55.84 1.27 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.644 -0.66 . . . . 0.0 110.972 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.455 ' HB ' ' O ' ' A' ' 28' ' ' SER . 13.0 t -177.56 -32.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.115 -0.99 . . . . 0.0 110.411 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' A' ' 9' ' ' PHE . . . 121.46 13.64 5.16 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -150.15 123.05 8.73 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -1.159 . . . . 0.0 110.14 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.429 ' CD1' ' HB3' ' A' ' 13' ' ' PRO . 0.9 OUTLIER -62.25 103.85 0.43 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -0.922 . . . . 0.0 109.841 179.788 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 36.6 m -107.99 103.5 12.74 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.14 -0.975 . . . . 0.0 110.864 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.477 ' O ' ' OG1' ' A' ' 138' ' ' THR . 17.5 m -89.87 141.74 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.234 -0.916 . . . . 0.0 109.218 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.466 ' HA ' ' OG1' ' A' ' 138' ' ' THR . . . -89.63 106.05 18.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.158 -0.964 . . . . 0.0 111.137 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.583 ' CG1' ' CZ2' ' A' ' 137' ' ' TRP . 94.2 t -84.48 121.22 74.98 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.235 -0.916 . . . . 0.0 109.191 178.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 21' ' ' THR . 46.9 Cg_endo -74.71 137.27 22.2 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.937 1.493 . . . . 0.0 111.043 -178.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.501 ' HA ' ' HA ' ' A' ' 136' ' ' ALA . . . -45.52 170.59 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.337 -0.852 . . . . 0.0 109.766 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 45.86 48.33 13.66 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.595 ' HB2' ' CZ3' ' A' ' 137' ' ' TRP . 0.6 OUTLIER -86.97 36.12 0.71 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.27 -1.136 . . . . 0.0 109.886 179.675 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.533 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . -89.08 -141.16 0.14 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.643 -0.661 . . . . 0.0 109.859 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.543 ' HG2' ' N ' ' A' ' 43' ' ' TYR . 14.7 pm0 39.88 -140.16 0.07 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.692 -0.63 . . . . 0.0 110.247 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.601 ' CD1' ' O ' ' A' ' 44' ' ' GLY . 5.3 p90 -27.59 -42.55 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.236 0 CA-C-O 121.278 0.561 . . . . 0.0 110.612 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.601 ' O ' ' CD1' ' A' ' 43' ' ' TYR . . . 88.48 136.42 5.5 Favored Glycine 0 N--CA 1.492 2.39 0 C-N-CA 120.257 -0.973 . . . . 0.0 110.998 177.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.516 ' CG2' ' OG ' ' A' ' 40' ' ' SER . 2.3 t -88.95 -177.2 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.426 -1.043 . . . . 0.0 108.489 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.464 ' HA2' ' HG ' ' A' ' 129' ' ' LEU . . . 167.67 175.88 37.88 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 118.819 -1.658 . . . . 0.0 110.838 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.533 ' CG1' ' O ' ' A' ' 17' ' ' VAL . 23.9 t -139.45 132.1 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.717 -0.872 . . . . 0.0 109.552 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.531 HG21 ' CG2' ' A' ' 17' ' ' VAL . 17.3 m -124.63 141.28 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.967 -1.083 . . . . 0.0 110.856 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.573 HD11 ' CG ' ' A' ' 16' ' ' TRP . 10.3 tp -128.23 100.6 5.9 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.374 -0.829 . . . . 0.0 110.131 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.527 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 0.1 OUTLIER -78.22 136.02 37.71 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.261 -0.9 . . . . 0.0 110.259 179.96 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 126.02 72.19 0.2 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.468 HG13 HG12 ' A' ' 54' ' ' ILE . 3.5 t -126.28 161.7 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.221 -1.164 . . . . 0.0 109.97 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -122.53 77.42 1.42 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.2 -0.938 . . . . 0.0 110.373 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.586 HG13 ' CD2' ' A' ' 112' ' ' TYR . 41.2 mm -119.13 151.08 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.248 -0.908 . . . . 0.0 110.07 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.524 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 1.6 pt-20 -150.22 133.19 16.1 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.182 -0.949 . . . . 0.0 110.461 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.524 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 11.7 pt-20 38.28 -153.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.69 -0.631 . . . . 0.0 110.842 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.467 ' N ' ' HG3' ' A' ' 56' ' ' GLU . . . -86.56 86.12 1.55 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.528 ' CG2' ' N ' ' A' ' 59' ' ' THR . 1.3 m -110.65 171.04 7.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.177 -1.19 . . . . 0.0 109.864 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.583 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 1.6 m -89.88 155.59 19.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 0.0 110.154 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.583 ' CG ' ' O ' ' A' ' 59' ' ' THR . 56.3 m-85 -159.91 177.04 11.19 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.355 -0.84 . . . . 0.0 110.132 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 62.8 m -149.91 112.22 4.68 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.312 -0.867 . . . . 0.0 110.126 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.6 tp -89.84 124.49 34.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.243 -0.911 . . . . 0.0 110.095 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' A' ' 102' ' ' VAL . 10.3 mtt180 -131.47 107.45 8.9 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.194 -0.941 . . . . 0.0 110.427 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.55 ' CZ ' HG23 ' A' ' 102' ' ' VAL . 4.6 p90 -147.07 151.61 37.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.288 -0.882 . . . . 0.0 110.125 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.52 ' CG2' ' HA ' ' A' ' 101' ' ' GLN . 0.2 OUTLIER -119.78 92.45 3.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.184 -0.948 . . . . 0.0 109.936 179.86 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.52 ' CB ' HD22 ' A' ' 95' ' ' LEU . . . -89.59 144.85 25.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 110.507 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.456 HG21 ' O ' ' A' ' 98' ' ' GLU . 99.9 m -150.33 116.74 5.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.403 -0.811 . . . . 0.0 110.215 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -103.24 138.73 39.64 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.23 -0.919 . . . . 0.0 110.028 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.1 p -47.65 -24.29 0.88 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.149 -0.969 . . . . 0.0 109.431 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.544 ' CG2' ' HB2' ' A' ' 137' ' ' TRP . 3.6 t -115.38 171.78 7.49 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.496 -0.752 . . . . 0.0 109.979 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.468 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 1.0 OUTLIER -86.16 69.69 10.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.158 -0.963 . . . . 0.0 109.445 179.192 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.529 ' CG2' ' HB2' ' A' ' 133' ' ' SER . 5.1 p -96.2 138.94 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.279 -0.888 . . . . 0.0 111.117 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 97.1 m -120.86 89.47 3.14 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.436 -0.79 . . . . 0.0 108.921 178.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.586 ' HA ' ' CD1' ' A' ' 132' ' ' PHE . 10.7 m -89.64 -147.88 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.22 -0.925 . . . . 0.0 110.587 -179.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.478 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 4.2 mtp180 -128.98 144.37 51.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 0.0 110.697 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.519 ' CB ' ' HG3' ' A' ' 93' ' ' PRO . . . -142.91 150.83 40.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.286 -0.884 . . . . 0.0 109.818 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.496 ' C ' ' CD1' ' A' ' 77' ' ' LEU . 2.7 pp 177.58 -159.59 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.237 -0.914 . . . . 0.0 110.479 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.571 HG11 ' CE2' ' A' ' 112' ' ' TYR . 6.1 t -149.36 168.64 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.396 -0.815 . . . . 0.0 109.335 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.497 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . -177.6 -178.94 47.57 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.265 -1.445 . . . . 0.0 110.088 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.484 ' CD ' ' N ' ' A' ' 81' ' ' ASN . 14.5 tp60 -107.93 138.12 44.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.415 -1.05 . . . . 0.0 110.302 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.541 ' ND2' ' NE2' ' A' ' 124' ' ' GLN . 1.2 m-80 -123.94 97.31 5.3 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 83' ' ' ALA . . . 132.23 33.71 0.4 Allowed Glycine 0 N--CA 1.484 1.866 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.577 ' HA ' ' CD2' ' A' ' 85' ' ' TYR . . . 60.41 143.58 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.191 -1.182 . . . . 0.0 110.124 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.468 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.9 Cg_endo -82.67 18.96 17.96 Favored 'Cis proline' 0 C--N 1.314 -1.261 0 C-N-CA 121.872 -2.136 . . . . 0.0 110.807 -0.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.577 ' CD2' ' HA ' ' A' ' 83' ' ' ALA . 89.3 m-85 57.53 -179.95 0.06 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.136 -0.978 . . . . 0.0 110.203 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 127.96 113.57 1.76 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.455 HG21 ' O ' ' A' ' 78' ' ' VAL . 0.8 OUTLIER -97.51 145.89 25.78 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.283 -1.128 . . . . 0.0 110.034 179.779 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.521 ' CG1' ' N ' ' A' ' 109' ' ' SER . 35.9 m -123.73 -17.98 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.193 -0.942 . . . . 0.0 110.384 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.577 HD12 ' CZ ' ' A' ' 106' ' ' PHE . 3.9 mp -103.38 135.27 45.31 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.205 -0.934 . . . . 0.0 111.046 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -150.97 83.55 1.33 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.451 -0.781 . . . . 0.0 109.951 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.5 p -137.9 -179.62 5.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.035 -1.041 . . . . 0.0 110.772 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.7 m -119.71 110.83 36.56 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.403 -0.811 . . . . 0.0 110.063 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.535 ' HG2' ' CG2' ' A' ' 74' ' ' VAL . 44.3 Cg_endo -71.58 94.0 0.68 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.04 1.548 . . . . 0.0 110.813 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.527 ' CB ' ' HD2' ' A' ' 100' ' ' ARG . . . -71.75 151.86 43.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.234 -0.916 . . . . 0.0 109.625 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.524 ' CD1' ' HG ' ' A' ' 139' ' ' LEU . 97.6 mt -143.77 162.82 35.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.05 -1.031 . . . . 0.0 110.493 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 70' ' ' THR . 0.3 OUTLIER 179.75 -179.08 0.43 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.39 -0.818 . . . . 0.0 110.018 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.95 -24.5 64.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.256 -0.902 . . . . 0.0 110.07 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.456 ' O ' HG21 ' A' ' 67' ' ' THR . 1.5 mt-10 -89.92 164.48 28.31 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.281 -0.887 . . . . 0.0 110.06 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.449 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 46.1 Cg_endo -73.0 136.77 25.43 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.008 1.53 . . . . 0.0 110.366 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.527 ' HD2' ' CB ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.6 80.42 1.57 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.17 -0.956 . . . . 0.0 110.188 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.52 ' HA ' ' CG2' ' A' ' 65' ' ' THR . 16.3 tt0 -68.73 154.73 41.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.299 -0.876 . . . . 0.0 110.195 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.55 HG23 ' CZ ' ' A' ' 64' ' ' TYR . 95.6 t -135.5 135.52 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.284 -0.885 . . . . 0.0 110.135 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.06 111.0 4.33 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.26 -0.9 . . . . 0.0 110.19 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -158.25 134.74 9.52 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.164 -0.96 . . . . 0.0 110.361 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 10.1 t -95.77 113.73 25.39 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.245 -0.909 . . . . 0.0 110.091 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.577 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 30.6 p90 -111.72 154.79 24.48 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.909 . . . . 0.0 110.286 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.417 ' O ' ' N ' ' A' ' 109' ' ' SER . 6.6 m -91.7 91.87 8.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.286 -0.884 . . . . 0.0 110.044 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.567 ' HB1' ' CD2' ' A' ' 60' ' ' TYR . . . -48.54 96.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.235 -0.915 . . . . 0.0 110.303 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.521 ' N ' ' CG1' ' A' ' 88' ' ' VAL . 16.1 p -85.99 49.96 1.88 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.256 -0.902 . . . . 0.0 110.124 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -156.23 -154.43 0.48 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.297 -0.877 . . . . 0.0 110.136 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.2 m -152.4 112.5 4.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.209 -0.932 . . . . 0.0 110.304 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.586 ' CD2' HG13 ' A' ' 54' ' ' ILE . 13.5 m-30 -107.03 93.16 8.65 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.277 -0.889 . . . . 0.0 109.9 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.471 ' HD2' ' OE1' ' A' ' 80' ' ' GLN . 45.3 Cg_endo -72.26 179.61 4.85 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.942 1.496 . . . . 0.0 110.41 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.245 -0.909 . . . . 0.0 110.206 -179.937 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.511 ' O ' ' HB2' ' A' ' 81' ' ' ASN . 2.2 pm0 . . . . . 0 N--CA 1.5 2.06 0 CA-C-O 121.515 0.674 . . . . 0.0 111.794 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -100.99 155.56 19.22 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.976 -1.249 . . . . 0.0 109.976 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.541 ' NE2' ' ND2' ' A' ' 81' ' ' ASN . 1.4 pt20 -150.55 -149.9 0.32 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.398 -1.06 . . . . 0.0 110.395 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.574 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 9.6 mt -118.37 138.62 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.588 -0.695 . . . . 0.0 109.136 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -115.42 122.24 45.21 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.205 -0.934 . . . . 0.0 111.169 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.477 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 4.6 m-85 -119.15 109.05 15.42 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 178.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . 0.473 ' O ' ' HB ' ' A' ' 74' ' ' VAL . 2.0 mt-30 -88.85 91.84 8.98 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.105 -0.997 . . . . 0.0 111.141 -178.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.525 HD23 ' CD2' ' A' ' 139' ' ' LEU . 15.5 mt -93.23 41.89 1.09 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.451 -0.78 . . . . 0.0 109.286 178.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.527 ' HA3' ' CA ' ' A' ' 44' ' ' GLY . . . -130.49 140.16 11.53 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.475 ' O ' ' CG ' ' A' ' 132' ' ' PHE . . . 71.4 61.7 3.79 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.586 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 38.4 m-85 -154.67 -78.32 0.1 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.243 -1.151 . . . . 0.0 110.182 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.576 ' O ' ' CZ3' ' A' ' 137' ' ' TRP . 1.3 t -89.67 119.57 30.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.123 -0.986 . . . . 0.0 110.116 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.401 ' O ' ' O ' ' A' ' 135' ' ' ASP . . . -62.44 -71.67 0.15 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.228 -0.92 . . . . 0.0 110.274 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.401 ' O ' ' O ' ' A' ' 134' ' ' ALA . 0.8 OUTLIER -53.82 -173.29 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.292 -0.88 . . . . 0.0 110.343 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.501 ' HA ' ' HA ' ' A' ' 38' ' ' ALA . . . -83.51 141.08 31.89 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.269 -0.894 . . . . 0.0 110.302 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.595 ' CZ3' ' HB2' ' A' ' 40' ' ' SER . 7.3 p90 -151.5 -164.19 1.93 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.323 -0.861 . . . . 0.0 109.964 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.527 ' O ' ' CB ' ' A' ' 68' ' ' ALA . 0.5 OUTLIER -160.4 173.47 15.57 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.0 -1.08 . . . . 0.0 111.106 -178.493 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.525 ' CD2' HD23 ' A' ' 129' ' ' LEU . 2.6 mp -129.64 129.37 44.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.447 -0.783 . . . . 0.0 109.576 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' CYS . . . . . . . . . . . . . 6.6 m -124.37 93.26 3.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.129 -0.982 . . . . 0.0 110.938 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.475 ' HA ' ' O ' ' A' ' 65' ' ' THR . 0.7 OUTLIER -89.86 -175.42 4.61 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.179 -0.951 . . . . 0.0 109.414 179.147 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.513 ' O ' ' CB ' ' A' ' 143' ' ' ASP . 1.1 p30 176.76 124.27 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.054 -1.029 . . . . 0.0 110.842 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.513 ' CB ' ' O ' ' A' ' 142' ' ' ASP . 0.3 OUTLIER 70.94 61.29 0.18 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.288 -0.882 . . . . 0.0 110.654 179.479 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.568 HG22 ' CE2' ' A' ' 9' ' ' PHE . 42.0 t -94.46 111.4 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -0.914 . . . . 0.0 109.73 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -120.46 163.56 17.74 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.233 -0.917 . . . . 0.0 110.47 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.526 HD12 ' CE2' ' A' ' 106' ' ' PHE . 14.0 tp -167.3 88.18 0.29 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.409 -0.807 . . . . 0.0 110.085 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.463 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 7.6 t70 -123.37 165.17 17.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.269 -0.895 . . . . 0.0 110.289 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.508 ' HB3' ' CE1' ' A' ' 60' ' ' TYR . 12.7 p . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 0.0 110.317 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo . . . . . 0 N--CA 1.479 0.673 0 N-CA-C 110.123 -0.76 . . . . 0.0 110.123 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.524 ' CG2' ' O ' ' A' ' 51' ' ' GLY . 13.1 pt -95.98 31.16 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.234 -0.916 . . . . 0.0 110.251 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 91.58 -29.32 7.38 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 51.67 66.98 1.04 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.252 -1.146 . . . . 0.0 110.24 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 143' ' ' ASP . . . -148.36 -179.99 24.75 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.476 ' CG2' ' HB2' ' A' ' 143' ' ' ASP . 0.8 OUTLIER -98.31 51.64 1.02 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.201 -1.176 . . . . 0.0 110.151 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.567 ' CE2' HG22 ' A' ' 144' ' ' VAL . 69.3 m-85 43.16 36.31 0.97 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.274 -0.891 . . . . 0.0 110.095 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.556 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 5.1 p30 -84.68 44.48 1.06 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.316 -0.865 . . . . 0.0 110.299 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.556 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 2.4 t70 161.58 78.42 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.336 0.589 . . . . 0.0 109.433 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.66 159.58 7.0 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.522 ' HB3' ' CD1' ' A' ' 32' ' ' LEU . 50.0 Cg_endo -75.75 4.71 4.89 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.016 1.535 . . . . 0.0 110.713 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 2.8 mm-40 65.12 -89.01 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.259 -0.901 . . . . 0.0 110.516 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.442 ' C ' ' CD1' ' A' ' 49' ' ' LEU . . . -139.63 6.99 3.01 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.57 ' CE2' HD21 ' A' ' 49' ' ' LEU . 46.0 m95 -69.52 126.0 28.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.108 -1.23 . . . . 0.0 110.179 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.569 ' CG2' ' CG2' ' A' ' 48' ' ' VAL . 0.9 OUTLIER -126.9 148.6 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.206 -0.934 . . . . 0.0 109.669 179.806 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.522 ' CB ' HD23 ' A' ' 25' ' ' LEU . . . -130.32 142.16 50.55 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.101 -0.999 . . . . 0.0 109.648 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.476 ' CD1' ' N ' ' A' ' 19' ' ' TYR . 23.2 p90 -131.71 164.01 26.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.292 -0.88 . . . . 0.0 110.766 -178.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.478 ' C ' ' CG2' ' A' ' 21' ' ' THR . . . 77.19 40.21 24.96 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.527 HG21 ' CG1' ' A' ' 45' ' ' VAL . 7.9 p -149.88 -143.79 0.14 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.129 -1.218 . . . . 0.0 110.489 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.465 ' O ' ' O ' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -117.29 129.94 56.22 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.244 -0.91 . . . . 0.0 110.355 -179.792 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 22' ' ' ASP . . . 52.21 174.48 0.03 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.38 -159.54 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.064 1.56 . . . . 0.0 110.518 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.582 ' CD2' ' CG1' ' A' ' 34' ' ' VAL . 24.4 mt -78.27 178.52 7.58 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.272 -0.893 . . . . 0.0 110.331 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -145.46 115.0 7.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.318 -0.864 . . . . 0.0 110.102 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.479 ' O ' ' N ' ' A' ' 29' ' ' THR . 1.1 p -119.65 -83.59 0.65 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.308 -0.87 . . . . 0.0 109.921 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 27' ' ' THR . 5.4 p 39.2 28.36 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.498 -0.751 . . . . 0.0 110.637 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.479 ' N ' ' O ' ' A' ' 27' ' ' THR . 8.5 t -153.43 -37.0 0.1 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.149 -0.969 . . . . 0.0 110.385 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.472 ' O ' ' HB2' ' A' ' 9' ' ' PHE . . . 133.97 -2.29 4.36 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -133.15 143.97 49.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.138 -1.213 . . . . 0.0 110.125 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.522 ' CD1' ' HB3' ' A' ' 13' ' ' PRO . 0.6 OUTLIER -83.96 112.31 20.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.24 -0.912 . . . . 0.0 110.055 179.87 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 34.1 m -114.86 116.55 28.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 110.554 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.582 ' CG1' ' CD2' ' A' ' 25' ' ' LEU . 33.2 m -101.1 144.63 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.324 -0.86 . . . . 0.0 109.812 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.503 ' HA ' ' OG1' ' A' ' 138' ' ' THR . . . -93.05 94.02 8.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.189 -0.944 . . . . 0.0 110.547 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.665 ' CG1' ' CZ2' ' A' ' 137' ' ' TRP . 41.9 t -86.23 132.49 43.14 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.377 -0.827 . . . . 0.0 110.099 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.507 ' HD2' HG11 ' A' ' 36' ' ' VAL . 40.0 Cg_endo -66.85 168.95 15.71 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.809 1.426 . . . . 0.0 110.586 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.522 ' N ' ' HA ' ' A' ' 136' ' ' ALA . . . -62.01 121.04 12.02 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.305 -0.872 . . . . 0.0 110.912 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.553 ' O ' ' N ' ' A' ' 41' ' ' ALA . . . 41.6 96.03 0.01 OUTLIER Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.47 ' OG ' ' HA2' ' A' ' 44' ' ' GLY . 0.4 OUTLIER -42.12 93.75 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.428 -1.043 . . . . 0.0 109.786 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' A' ' 39' ' ' GLY . . . -89.38 28.91 1.17 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.695 0.759 . . . . 0.0 110.565 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -128.92 -166.95 1.71 Allowed 'General case' 0 C--N 1.292 -1.904 0 O-C-N 121.773 -0.579 . . . . 0.0 109.779 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.473 ' CD1' ' O ' ' A' ' 44' ' ' GLY . 11.1 p90 -46.54 -24.13 0.48 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.16 -0.962 . . . . 0.0 109.797 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.473 ' O ' ' CD1' ' A' ' 43' ' ' TYR . . . 126.45 140.58 5.29 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.527 ' CG1' HG21 ' A' ' 21' ' ' THR . 19.9 t -89.39 173.65 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.124 -1.221 . . . . 0.0 109.205 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' A' ' 128' ' ' GLN . . . -178.22 -179.42 48.19 Favored Glycine 0 N--CA 1.487 2.098 0 C-N-CA 118.92 -1.61 . . . . 0.0 110.851 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.538 ' CG1' ' O ' ' A' ' 17' ' ' VAL . 21.4 t -150.39 128.48 2.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.569 ' CG2' ' CG2' ' A' ' 17' ' ' VAL . 30.5 m -119.38 132.68 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.018 -1.051 . . . . 0.0 111.106 -178.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.57 HD21 ' CE2' ' A' ' 16' ' ' TRP . 13.8 tp -124.22 91.27 3.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.559 -0.713 . . . . 0.0 110.01 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.439 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 0.1 OUTLIER -66.86 113.88 5.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 110.209 -179.908 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.524 ' O ' ' CG2' ' A' ' 4' ' ' ILE . . . 154.14 83.04 0.04 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.471 HG13 HG12 ' A' ' 54' ' ' ILE . 38.8 t -140.53 160.43 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.197 -1.178 . . . . 0.0 110.207 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.457 ' O ' HD12 ' A' ' 54' ' ' ILE . . . -129.85 90.78 3.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.203 -0.936 . . . . 0.0 110.396 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.622 ' CD1' ' CE1' ' A' ' 60' ' ' TYR . 33.5 mm -124.01 168.7 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.261 -0.899 . . . . 0.0 109.931 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.522 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 1.7 tt0 -162.71 127.72 3.2 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.122 -0.986 . . . . 0.0 110.653 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.522 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 13.1 pt-20 37.74 -152.89 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.635 -0.666 . . . . 0.0 110.984 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.469 ' HA2' ' O ' ' A' ' 108' ' ' ALA . . . -86.76 79.57 1.81 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.576 HG21 ' CE2' ' A' ' 60' ' ' TYR . 1.2 m -108.85 173.71 6.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.253 -1.145 . . . . 0.0 109.804 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.574 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 0.4 OUTLIER -89.8 156.23 18.64 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.287 -0.883 . . . . 0.0 110.281 -179.82 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.622 ' CE1' ' CD1' ' A' ' 54' ' ' ILE . 67.9 m-85 -158.94 167.83 28.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 110.323 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 85.5 m -143.19 115.49 8.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -0.893 . . . . 0.0 110.072 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 28.4 tp -89.76 122.55 32.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.261 -0.899 . . . . 0.0 110.05 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 102' ' ' VAL . 6.1 mtm180 -126.38 125.8 42.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.253 -0.904 . . . . 0.0 110.356 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.634 ' CZ ' ' CG2' ' A' ' 102' ' ' VAL . 5.3 p90 -167.89 151.71 6.2 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.248 -0.908 . . . . 0.0 110.145 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.487 ' CG2' ' HG2' ' A' ' 101' ' ' GLN . 93.6 m -119.65 99.58 6.74 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.242 -0.911 . . . . 0.0 110.063 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.451 ' HB3' HD23 ' A' ' 95' ' ' LEU . . . -100.34 145.59 27.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.327 -0.858 . . . . 0.0 110.364 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.45 ' OG1' ' HA ' ' A' ' 99' ' ' PRO . 43.8 m -148.09 115.92 6.39 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.255 -0.903 . . . . 0.0 110.303 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.463 ' HB3' HD11 ' A' ' 95' ' ' LEU . . . -101.66 141.02 35.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 109.971 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.11 -23.05 1.09 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.129 -0.982 . . . . 0.0 109.41 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.545 ' CG2' ' HB2' ' A' ' 137' ' ' TRP . 2.9 t -116.96 169.69 9.21 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.51 -0.743 . . . . 0.0 110.034 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.499 ' OD1' ' CB ' ' A' ' 96' ' ' THR . 77.0 m-20 -84.57 69.75 10.64 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.13 -0.981 . . . . 0.0 109.289 179.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.516 ' CG2' ' HB2' ' A' ' 133' ' ' SER . 4.8 p -94.47 140.05 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.874 . . . . 0.0 111.273 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 21.4 m -121.72 91.87 3.61 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.417 -0.802 . . . . 0.0 108.916 178.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.591 ' HA ' ' CG ' ' A' ' 132' ' ' PHE . 12.3 m -89.8 -147.56 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.21 -0.931 . . . . 0.0 110.774 -178.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.491 ' CA ' ' HD2' ' A' ' 93' ' ' PRO . 6.9 mtm180 -131.03 139.01 49.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.38 -0.825 . . . . 0.0 110.52 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.517 ' N ' ' HD3' ' A' ' 93' ' ' PRO . . . -138.63 154.52 48.66 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.336 -0.853 . . . . 0.0 109.687 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.578 ' CD1' ' N ' ' A' ' 78' ' ' VAL . 3.9 pp -179.84 -148.36 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.207 -0.933 . . . . 0.0 110.326 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.578 ' N ' ' CD1' ' A' ' 77' ' ' LEU . 3.0 t -150.76 167.68 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.269 -0.894 . . . . 0.0 109.495 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.526 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . -170.69 -171.27 35.86 Favored Glycine 0 N--CA 1.491 2.33 0 C-N-CA 119.277 -1.44 . . . . 0.0 110.338 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.508 ' O ' ' ND2' ' A' ' 81' ' ' ASN . 3.7 tt0 -100.25 -160.96 0.83 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.473 -1.016 . . . . 0.0 110.262 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 80' ' ' GLN . 25.8 m120 -158.18 80.31 0.83 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.235 -0.915 . . . . 0.0 110.229 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.571 ' O ' ' CZ ' ' A' ' 85' ' ' TYR . . . 167.52 -83.8 0.1 OUTLIER Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.425 ' CB ' ' O ' ' A' ' 82' ' ' GLY . . . 173.88 146.89 0.21 Allowed Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.176 -1.191 . . . . 0.0 110.205 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.469 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.4 Cg_endo -84.81 33.68 4.03 Favored 'Cis proline' 0 C--N 1.312 -1.355 0 C-N-CA 121.887 -2.131 . . . . 0.0 110.619 -0.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.571 ' CZ ' ' O ' ' A' ' 82' ' ' GLY . 21.2 m-85 64.14 137.17 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.187 -0.946 . . . . 0.0 110.2 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -153.02 121.4 1.16 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.447 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 2.0 p -96.83 147.78 23.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.203 -1.175 . . . . 0.0 110.261 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.584 ' CG1' ' CB ' ' A' ' 110' ' ' ALA . 33.5 m -119.79 -24.22 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.304 -0.873 . . . . 0.0 109.989 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.576 HD13 ' CE1' ' A' ' 106' ' ' PHE . 3.9 mp -105.76 146.39 29.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.313 -0.867 . . . . 0.0 110.729 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.451 ' O ' HG21 ' A' ' 91' ' ' THR . 23.4 t70 -151.17 81.74 1.31 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.23 -0.919 . . . . 0.0 110.13 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.451 HG21 ' O ' ' A' ' 90' ' ' ASP . 1.2 p -145.4 173.55 11.89 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.071 -1.018 . . . . 0.0 110.578 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 43.3 m -121.78 118.77 29.32 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.348 -0.845 . . . . 0.0 110.093 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.535 ' HG2' ' CG2' ' A' ' 74' ' ' VAL . 46.1 Cg_endo -71.96 146.82 48.1 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.884 1.465 . . . . 0.0 110.966 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.523 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -109.62 148.99 30.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.396 -0.815 . . . . 0.0 109.543 179.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.519 ' CD1' ' HG ' ' A' ' 139' ' ' LEU . 70.9 mt -140.13 172.43 12.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.085 -1.009 . . . . 0.0 110.609 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.499 ' CB ' ' OD1' ' A' ' 71' ' ' ASP . 0.1 OUTLIER 169.16 -179.15 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.467 -0.771 . . . . 0.0 109.888 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.4 ' N ' ' OG1' ' A' ' 96' ' ' THR . 0.1 OUTLIER -62.88 -12.7 26.74 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.223 -0.923 . . . . 0.0 109.734 179.765 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.532 ' CG ' ' HD2' ' A' ' 99' ' ' PRO . 33.9 tt0 -100.2 149.21 35.83 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.433 -0.792 . . . . 0.0 109.89 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.532 ' HD2' ' CG ' ' A' ' 98' ' ' GLU . 41.8 Cg_endo -68.71 131.25 22.32 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.877 1.462 . . . . 0.0 110.248 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.523 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 11.6 ttt-85 -119.66 92.22 3.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.243 -0.91 . . . . 0.0 110.5 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.487 ' HG2' ' CG2' ' A' ' 65' ' ' THR . 0.0 OUTLIER -71.49 160.84 32.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.329 -0.857 . . . . 0.0 109.771 179.629 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.634 ' CG2' ' CZ ' ' A' ' 64' ' ' TYR . 38.9 t -131.05 133.91 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.135 -0.978 . . . . 0.0 110.444 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.39 88.34 1.5 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.341 -0.85 . . . . 0.0 110.105 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -139.72 151.77 46.12 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.162 -0.962 . . . . 0.0 110.387 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.472 ' CG2' ' O ' ' A' ' 60' ' ' TYR . 90.6 m -111.3 137.23 49.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.325 -0.859 . . . . 0.0 110.15 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.576 ' CE1' HD13 ' A' ' 89' ' ' LEU . 51.3 p90 -132.5 156.61 46.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.271 -0.893 . . . . 0.0 110.217 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.6 m -90.29 88.29 7.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.292 -0.88 . . . . 0.0 110.102 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.575 ' HB2' ' CE2' ' A' ' 60' ' ' TYR . . . -47.26 104.22 0.05 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.894 . . . . 0.0 110.347 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 84.9 p -91.54 53.63 2.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.247 -0.908 . . . . 0.0 110.162 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.584 ' CB ' ' CG1' ' A' ' 88' ' ' VAL . . . -166.13 -156.34 0.25 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.239 -0.913 . . . . 0.0 110.316 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 12.3 m -146.18 117.1 7.72 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.305 -0.872 . . . . 0.0 110.287 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.578 ' CG ' ' HA3' ' A' ' 123' ' ' GLY . 20.7 m-30 -113.31 75.48 2.31 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.887 . . . . 0.0 109.994 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.481 ' O ' ' CB ' ' A' ' 122' ' ' GLU . 45.8 Cg_endo -72.39 136.93 27.28 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.932 1.491 . . . . 0.0 110.422 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.667 0 O-C-N 121.315 -0.866 . . . . 0.0 110.293 -179.954 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.481 ' CB ' ' O ' ' A' ' 113' ' ' PRO . 15.2 pm0 . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.578 ' HA3' ' CG ' ' A' ' 112' ' ' TYR . . . -140.21 159.02 26.08 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.519 ' HG2' ' N ' ' A' ' 125' ' ' ILE . 2.1 pm0 -150.5 -160.01 1.11 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.342 -1.093 . . . . 0.0 110.213 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.531 HG23 ' CH2' ' A' ' 16' ' ' TRP . 33.2 mt -118.38 142.45 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.37 -0.831 . . . . 0.0 109.522 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.468 ' O ' ' HA ' ' A' ' 76' ' ' ALA . . . -113.88 115.22 27.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.304 -0.872 . . . . 0.0 111.541 -178.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.522 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 4.5 m-85 -120.58 80.8 1.67 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . 0.474 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 2.9 mt-30 -87.96 115.06 25.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.112 -0.993 . . . . 0.0 111.636 -178.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.579 ' CD1' ' CD1' ' A' ' 139' ' ' LEU . 9.0 mt -98.77 49.66 0.97 Allowed 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 121.835 0.826 . . . . 0.0 108.856 178.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 132' ' ' PHE . . . -53.11 -173.45 0.04 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.45 ' HA2' ' HB3' ' A' ' 40' ' ' SER . . . -52.95 90.24 0.01 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.591 ' CG ' ' HA ' ' A' ' 74' ' ' VAL . 20.1 m-85 -114.87 -56.93 2.33 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.235 -1.156 . . . . 0.0 110.647 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.526 ' HB3' ' CE3' ' A' ' 137' ' ' TRP . 1.4 t -89.42 -177.36 5.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.259 -0.9 . . . . 0.0 110.373 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.455 ' N ' ' OG ' ' A' ' 133' ' ' SER . . . -106.59 -73.74 0.68 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.294 -0.879 . . . . 0.0 110.073 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.43 ' C ' ' HA ' ' A' ' 38' ' ' ALA . 17.3 m-20 -70.09 152.99 43.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.233 -0.917 . . . . 0.0 110.076 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.522 ' HA ' ' N ' ' A' ' 38' ' ' ALA . . . -43.29 120.79 1.99 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.281 -0.887 . . . . 0.0 110.134 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.665 ' CZ2' ' CG1' ' A' ' 36' ' ' VAL . 5.0 p90 -125.27 -169.59 2.02 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.176 -0.952 . . . . 0.0 110.258 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.503 ' OG1' ' HA ' ' A' ' 35' ' ' ALA 0.255 0.9 OUTLIER -159.33 168.65 25.85 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.384 -0.927 . . . . 0.0 110.41 -177.528 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.579 ' CD1' ' CD1' ' A' ' 129' ' ' LEU . 2.2 mp -124.85 125.84 44.61 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.378 -0.826 . . . . 0.0 109.629 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' CYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 22.2 m -122.98 99.5 6.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.117 -0.989 . . . . 0.0 110.76 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.461 ' HA ' ' O ' ' A' ' 65' ' ' THR . 1.5 mt -92.09 -177.17 4.61 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.302 -0.874 . . . . 0.0 109.308 179.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.462 ' O ' ' HB2' ' A' ' 143' ' ' ASP . 2.8 p-10 -169.77 26.09 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.107 -0.996 . . . . 0.0 110.438 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.493 ' O ' ' HA ' ' A' ' 64' ' ' TYR . 0.7 OUTLIER 172.54 130.75 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.317 -0.864 . . . . 0.0 109.87 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.567 HG22 ' CE2' ' A' ' 9' ' ' PHE . 1.3 t -150.48 115.9 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.117 -0.989 . . . . 0.0 109.761 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -140.35 154.44 46.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.252 -0.905 . . . . 0.0 110.495 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.433 ' CD1' ' HB3' ' A' ' 60' ' ' TYR . 61.0 tp -148.07 99.6 3.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.39 -0.819 . . . . 0.0 110.113 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.473 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 1.3 m-20 -102.69 -166.58 1.29 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.238 -0.914 . . . . 0.0 110.243 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.493 1.69 0 O-C-N 121.278 -0.889 . . . . 0.0 110.154 -179.929 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo . . . . . 0 N--CA 1.484 0.926 0 N-CA-C 110.645 -0.559 . . . . 0.0 110.645 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.46 ' O ' ' OE1' ' A' ' 14' ' ' GLU . 27.9 pt -97.11 42.78 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.16 -0.962 . . . . 0.0 109.928 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 6' ' ' GLU . . . 97.98 -16.84 59.64 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' A' ' 5' ' ' GLY . 3.3 tt0 42.5 30.73 0.23 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.316 -1.109 . . . . 0.0 110.193 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.416 ' C ' HG21 ' A' ' 8' ' ' THR . . . -159.86 -130.73 1.16 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.525 HG23 ' CA ' ' A' ' 143' ' ' ASP . 40.1 p -126.83 -172.39 2.63 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.273 -1.133 . . . . 0.0 110.443 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.573 ' CD2' ' HB2' ' A' ' 32' ' ' LEU . 5.8 m-30 -94.4 47.68 1.2 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.326 -0.859 . . . . 0.0 110.097 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.555 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 32.6 p30 -87.78 36.89 0.77 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.247 -0.908 . . . . 0.0 110.2 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.555 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.7 OUTLIER 161.46 37.47 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.678 -0.639 . . . . 0.0 109.686 -179.891 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 124.87 133.18 3.95 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.517 ' O ' ' N ' ' A' ' 15' ' ' GLY . 50.4 Cg_endo -80.43 41.14 1.08 Allowed 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.909 1.479 . . . . 0.0 111.136 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.46 ' OE1' ' O ' ' A' ' 4' ' ' ILE . 0.9 OUTLIER 45.88 -91.99 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.996 -1.065 . . . . 0.0 110.431 179.867 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 13' ' ' PRO . . . -149.07 10.35 1.01 Allowed Glycine 0 N--CA 1.493 2.459 0 C-N-CA 119.779 -1.2 . . . . 0.0 110.331 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.534 ' CG ' HD11 ' A' ' 49' ' ' LEU . 53.5 m95 -53.25 120.35 5.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.006 -1.291 . . . . 0.0 110.154 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.522 ' O ' ' CG1' ' A' ' 47' ' ' VAL . 0.9 OUTLIER -116.36 154.48 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.106 -0.996 . . . . 0.0 109.763 179.77 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.463 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . . . -137.53 139.77 40.69 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.433 -0.792 . . . . 0.0 109.008 179.018 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.576 ' CE2' ' O ' ' A' ' 46' ' ' GLY . 6.1 p90 -123.24 151.4 42.33 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.022 -1.049 . . . . 0.0 111.729 -178.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.577 ' HA2' ' CE1' ' A' ' 43' ' ' TYR . . . 133.59 -77.05 0.39 Allowed Glycine 0 N--CA 1.495 2.629 0 N-CA-C 108.899 -1.681 . . . . 0.0 108.899 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.576 HG21 ' CE2' ' A' ' 43' ' ' TYR . 5.5 p -150.81 19.57 0.8 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.213 -1.169 . . . . 0.0 110.08 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.463 ' O ' ' O ' ' A' ' 23' ' ' GLY . 1.3 p30 -107.44 112.3 25.02 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.301 -0.874 . . . . 0.0 110.09 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 22' ' ' ASP . . . -61.88 -132.49 0.01 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.455 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 46.1 Cg_endo -72.94 122.17 7.91 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.874 1.46 . . . . 0.0 110.215 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.59 ' CD1' ' CD1' ' A' ' 32' ' ' LEU . 8.1 mt -42.23 126.4 3.35 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.254 -0.904 . . . . 0.0 109.911 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 24' ' ' PRO . 11.8 m-20 -88.45 121.97 31.42 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.226 -0.921 . . . . 0.0 110.603 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.481 ' CG2' ' O ' ' A' ' 31' ' ' ALA . 3.0 p -119.96 -82.74 0.65 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.339 -0.851 . . . . 0.0 109.964 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.5 ' O ' ' CB ' ' A' ' 29' ' ' THR . 0.2 OUTLIER 58.28 46.38 15.7 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.247 -0.908 . . . . 0.0 110.662 179.581 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.5 ' CB ' ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER 169.78 -95.37 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.153 -0.967 . . . . 0.0 110.261 179.738 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 9' ' ' PHE . . . -158.39 21.93 0.35 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.481 ' O ' ' CG2' ' A' ' 27' ' ' THR . . . -135.02 162.06 33.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.306 -1.114 . . . . 0.0 110.157 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.59 ' CD1' ' CD1' ' A' ' 25' ' ' LEU . 0.5 OUTLIER -119.17 98.3 6.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.262 -0.899 . . . . 0.0 110.146 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.525 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 0.8 OUTLIER -98.09 113.21 25.03 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.287 -0.883 . . . . 0.0 111.594 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.527 ' CG1' HD21 ' A' ' 25' ' ' LEU . 16.6 m -89.55 147.83 4.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 178.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.454 ' O ' ' HB3' ' A' ' 22' ' ' ASP . . . -89.18 91.09 8.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.361 -0.837 . . . . 0.0 111.409 -178.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.641 ' CG1' ' CZ2' ' A' ' 137' ' ' TRP . 66.6 t -79.67 133.67 58.73 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.376 -0.828 . . . . 0.0 108.888 178.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.534 ' HG2' ' HA ' ' A' ' 40' ' ' SER . 38.4 Cg_endo -66.66 168.34 16.92 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.881 1.464 . . . . 0.0 111.573 -178.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.543 ' HA ' ' N ' ' A' ' 136' ' ' ALA . . . -55.34 124.39 16.94 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.526 -0.734 . . . . 0.0 111.367 -178.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.532 ' O ' ' C ' ' A' ' 40' ' ' SER . . . 39.73 26.08 0.08 OUTLIER Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.556 ' OG ' ' CG2' ' A' ' 45' ' ' VAL . 24.1 t 30.06 66.61 0.12 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.844 -0.797 . . . . 0.0 110.565 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.571 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . -89.06 145.05 25.72 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.659 -0.651 . . . . 0.0 109.661 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.571 ' HG2' ' O ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER 45.77 27.61 0.48 Allowed 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -178.893 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.577 ' CE1' ' HA2' ' A' ' 20' ' ' GLY . 0.1 OUTLIER -151.83 124.65 8.52 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 119.034 -1.066 . . . . 0.0 111.881 -178.19 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.53 ' HA2' ' CA ' ' A' ' 130' ' ' GLY . . . -90.32 95.63 2.11 Favored Glycine 0 C--N 1.296 -1.681 0 N-CA-C 106.615 -2.594 . . . . 0.0 106.615 177.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.576 ' O ' ' CB ' ' A' ' 129' ' ' LEU . 3.2 t -86.55 111.95 22.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 O-C-N 120.968 -1.313 . . . . 0.0 108.127 -178.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.576 ' O ' ' CE2' ' A' ' 19' ' ' TYR . . . -141.88 147.71 19.28 Favored Glycine 0 N--CA 1.484 1.895 0 C-N-CA 118.886 -1.626 . . . . 0.0 109.876 -178.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.522 ' CG1' ' O ' ' A' ' 17' ' ' VAL . 9.3 t -109.92 126.65 67.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.315 -1.109 . . . . 0.0 109.887 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.495 ' CG2' ' CG2' ' A' ' 17' ' ' VAL . 27.6 m -119.73 142.36 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.962 -1.086 . . . . 0.0 110.567 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.534 HD11 ' CG ' ' A' ' 16' ' ' TRP . 6.7 tp -126.04 95.17 4.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.369 -0.832 . . . . 0.0 109.918 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.527 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 0.7 OUTLIER -76.47 144.36 39.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.295 -0.878 . . . . 0.0 110.469 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 123.23 54.9 0.2 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.469 HG13 ' HB2' ' A' ' 112' ' ' TYR . 75.2 t -119.8 164.54 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.148 -1.207 . . . . 0.0 110.218 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' A' ' 112' ' ' TYR . . . -140.15 84.54 1.97 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.248 -0.908 . . . . 0.0 110.516 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.609 ' CD1' ' CZ ' ' A' ' 60' ' ' TYR . 47.5 mm -111.75 155.21 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.243 -0.911 . . . . 0.0 109.702 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.527 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 0.7 OUTLIER -145.24 132.07 20.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.097 -1.002 . . . . 0.0 110.56 -179.766 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 7.9 pt-20 38.39 -152.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.743 -0.598 . . . . 0.0 110.695 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.498 ' N ' ' HG3' ' A' ' 56' ' ' GLU . . . -88.98 116.99 4.78 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.523 ' CG2' ' CE2' ' A' ' 60' ' ' TYR . 0.9 OUTLIER -136.35 168.27 19.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.279 -1.13 . . . . 0.0 109.769 179.917 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 148' ' ' SER . 1.6 m -90.25 99.48 12.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.284 -0.885 . . . . 0.0 110.578 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.609 ' CZ ' ' CD1' ' A' ' 54' ' ' ILE . 59.9 m-85 -106.33 151.96 24.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.228 -0.92 . . . . 0.0 110.21 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.47 ' N ' HD13 ' A' ' 146' ' ' LEU . 92.9 m -125.3 109.77 13.2 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 110.028 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.465 ' O ' ' HA ' ' A' ' 103' ' ' THR . 14.2 tp -89.94 120.14 30.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.22 -0.925 . . . . 0.0 110.008 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.478 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 20.9 ttp180 -129.45 110.84 12.21 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.896 . . . . 0.0 110.257 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.496 ' CD1' ' C ' ' A' ' 64' ' ' TYR . 8.3 p90 -143.41 155.44 44.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.375 -0.828 . . . . 0.0 109.911 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 4.5 m -119.69 97.72 5.77 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.108 -0.995 . . . . 0.0 109.921 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.467 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -97.9 150.17 21.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.223 -0.923 . . . . 0.0 110.479 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 99.9 m -149.96 130.71 14.12 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.291 -0.88 . . . . 0.0 110.017 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.522 ' HB1' ' CB ' ' A' ' 95' ' ' LEU . . . -119.32 128.92 54.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.235 -0.915 . . . . 0.0 110.205 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.79 -9.23 26.62 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.257 -0.902 . . . . 0.0 110.102 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.542 HG22 ' CB ' ' A' ' 137' ' ' TRP . 6.0 t -114.33 19.53 16.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.238 -0.914 . . . . 0.0 110.095 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.461 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 4.9 t70 43.35 73.56 0.14 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.32 -0.862 . . . . 0.0 109.772 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.528 ' CG1' HD13 ' A' ' 95' ' ' LEU . 5.6 p -109.59 140.48 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.385 -0.822 . . . . 0.0 110.768 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 54.4 m -119.87 83.88 2.12 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.447 -0.783 . . . . 0.0 109.036 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.596 ' HA ' ' CD2' ' A' ' 132' ' ' PHE . 14.2 m -89.83 -139.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.221 -0.925 . . . . 0.0 110.759 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.471 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 0.4 OUTLIER -131.58 142.93 50.01 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.185 -0.947 . . . . 0.0 111.12 -179.075 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.512 ' N ' ' HD3' ' A' ' 93' ' ' PRO . . . -143.91 154.37 43.27 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.472 -0.768 . . . . 0.0 109.44 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.578 ' CD1' ' N ' ' A' ' 78' ' ' VAL . 4.2 pp -179.86 -152.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.116 -0.99 . . . . 0.0 110.5 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.578 ' N ' ' CD1' ' A' ' 77' ' ' LEU . 66.8 t -155.14 168.94 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.392 -0.818 . . . . 0.0 109.251 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.522 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . 173.37 179.37 43.99 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.205 -1.474 . . . . 0.0 110.312 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.476 ' HG2' ' O ' ' A' ' 122' ' ' GLU . 1.0 OUTLIER -72.74 -152.9 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.571 -0.958 . . . . 0.0 110.265 179.932 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.48 ' N ' ' O ' ' A' ' 122' ' ' GLU . 15.2 m120 -160.57 60.55 0.32 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.541 -0.725 . . . . 0.0 109.317 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.578 ' O ' ' CZ ' ' A' ' 85' ' ' TYR . . . 158.28 -125.97 1.62 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.443 ' HA ' ' CD1' ' A' ' 85' ' ' TYR . . . -125.2 153.2 71.73 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.174 -1.192 . . . . 0.0 110.122 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.479 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.5 Cg_endo -86.07 35.69 3.73 Favored 'Cis proline' 0 C--N 1.311 -1.418 0 C-N-CA 121.854 -2.144 . . . . 0.0 110.614 -0.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.578 ' CZ ' ' O ' ' A' ' 82' ' ' GLY . 76.6 m-85 58.98 148.89 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.178 -0.951 . . . . 0.0 110.226 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -173.19 115.57 0.57 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -110.65 143.63 40.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.238 -1.154 . . . . 0.0 110.376 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.501 HG22 ' CD1' ' A' ' 89' ' ' LEU . 34.6 m -124.43 -15.14 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.265 -0.897 . . . . 0.0 110.38 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.579 HD13 ' CE1' ' A' ' 106' ' ' PHE . 4.2 mp -108.33 137.39 46.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.209 -0.932 . . . . 0.0 111.002 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -151.15 81.27 1.32 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.4 -0.812 . . . . 0.0 109.901 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.5 p -137.76 179.52 6.38 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.994 -1.066 . . . . 0.0 110.699 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.7 m -119.89 115.28 33.48 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.378 -0.826 . . . . 0.0 110.059 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.512 ' HD3' ' N ' ' A' ' 76' ' ' ALA . 44.1 Cg_endo -72.18 92.81 0.73 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.93 1.489 . . . . 0.0 110.919 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.524 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -75.15 147.89 40.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.904 . . . . 0.0 109.568 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.528 HD13 ' CG1' ' A' ' 72' ' ' VAL . 71.1 mt -138.99 162.36 35.09 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.04 -1.038 . . . . 0.0 110.778 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 71' ' ' ASP . 0.3 OUTLIER -174.68 -179.22 1.44 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.438 -0.789 . . . . 0.0 110.088 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.56 -29.19 58.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.285 -0.884 . . . . 0.0 110.068 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.94 161.09 39.3 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.294 -0.879 . . . . 0.0 110.007 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.87 145.11 39.9 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.96 1.505 . . . . 0.0 110.487 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.524 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.85 94.34 4.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.29 -0.881 . . . . 0.0 110.037 179.811 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.434 ' HG3' ' OG1' ' A' ' 65' ' ' THR . 0.0 OUTLIER -84.23 95.07 8.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.385 -0.822 . . . . 0.0 110.198 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 25.2 t -89.54 134.4 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.348 -0.845 . . . . 0.0 110.066 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.52 ' O ' ' CG ' ' A' ' 104' ' ' GLU . 0.2 OUTLIER -150.15 130.72 13.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.327 -0.858 . . . . 0.0 110.163 -179.945 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.52 ' CG ' ' O ' ' A' ' 103' ' ' THR . 21.1 mt-10 -160.1 138.23 10.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.19 -0.944 . . . . 0.0 110.378 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 4.1 t -90.05 76.14 7.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.233 -0.917 . . . . 0.0 110.047 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.579 ' CE1' HD13 ' A' ' 89' ' ' LEU . 30.4 p90 -77.64 153.01 33.56 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.261 -0.9 . . . . 0.0 110.422 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.461 ' HA ' ' O ' ' A' ' 58' ' ' THR . 78.8 m -93.57 98.57 11.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.267 -0.895 . . . . 0.0 109.919 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.587 ' CB ' ' CD2' ' A' ' 60' ' ' TYR . . . -58.47 99.19 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -0.933 . . . . 0.0 110.239 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.416 ' N ' ' CG1' ' A' ' 88' ' ' VAL . 81.6 p -87.05 55.15 3.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.222 -0.924 . . . . 0.0 109.927 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -161.96 -151.42 0.21 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.268 -0.895 . . . . 0.0 110.353 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 31.6 m -157.13 122.43 4.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.319 -0.863 . . . . 0.0 110.398 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.568 ' CD2' HG13 ' A' ' 54' ' ' ILE . 14.3 m-30 -112.73 86.52 8.78 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.312 -0.867 . . . . 0.0 109.766 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.472 ' HG2' ' HA ' ' A' ' 122' ' ' GLU . 43.1 Cg_endo -70.5 163.84 37.4 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.941 1.495 . . . . 0.0 110.4 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.222 -0.924 . . . . 0.0 110.295 -179.775 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.48 ' O ' ' N ' ' A' ' 81' ' ' ASN . 0.4 OUTLIER . . . . . 0 N--CA 1.494 1.742 0 CA-C-O 121.198 0.523 . . . . 0.0 110.485 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.514 ' HA3' ' CB ' ' A' ' 112' ' ' TYR . . . -148.38 140.79 8.56 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.083 -1.607 . . . . 0.0 109.083 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.527 ' CB ' ' HA ' ' A' ' 50' ' ' ASN . 1.0 OUTLIER -150.34 -149.83 0.32 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.134 -1.215 . . . . 0.0 110.731 -179.325 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.479 ' O ' ' NE2' ' A' ' 124' ' ' GLN . 11.4 mt -118.22 150.98 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.481 -0.762 . . . . 0.0 109.409 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -130.13 124.19 32.13 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.271 -0.893 . . . . 0.0 110.801 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.501 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 5.4 m-85 -118.61 106.02 12.2 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . 0.527 ' O ' ' CD2' ' A' ' 129' ' ' LEU . 0.5 OUTLIER -89.58 129.19 36.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.187 -0.945 . . . . 0.0 112.109 -177.711 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.576 ' CB ' ' O ' ' A' ' 45' ' ' VAL . 0.4 OUTLIER -143.73 34.79 1.27 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 178.047 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.53 ' CA ' ' HA2' ' A' ' 44' ' ' GLY . . . -83.8 123.67 6.28 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.301 -1.519 . . . . 0.0 109.301 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 44.91 63.42 2.57 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.596 ' CD2' ' HA ' ' A' ' 74' ' ' VAL . 10.5 m-85 -115.61 -61.8 1.69 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.088 -1.242 . . . . 0.0 111.155 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.576 ' HB3' ' CE3' ' A' ' 137' ' ' TRP . 3.3 t -87.73 -161.25 0.69 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.949 -1.094 . . . . 0.0 110.527 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -119.79 -62.97 1.43 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.169 -0.957 . . . . 0.0 110.557 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -84.54 151.69 24.39 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.107 -0.996 . . . . 0.0 110.042 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.543 ' N ' ' HA ' ' A' ' 38' ' ' ALA . . . -48.59 127.91 14.2 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.331 -0.856 . . . . 0.0 110.543 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.641 ' CZ2' ' CG1' ' A' ' 36' ' ' VAL . 10.5 p90 -139.38 -173.18 3.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.204 -0.935 . . . . 0.0 110.489 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.521 ' CG2' ' N ' ' A' ' 139' ' ' LEU 0.254 0.8 OUTLIER -150.16 176.64 10.66 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.404 -0.81 . . . . 0.0 109.922 -177.799 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.525 ' CD2' HD12 ' A' ' 95' ' ' LEU . 1.9 mp -139.0 117.98 12.48 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.069 -1.019 . . . . 0.0 111.76 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' CYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 0.8 OUTLIER -101.45 116.25 32.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.653 -0.655 . . . . 0.0 110.834 178.7 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.487 ' O ' ' HB3' ' A' ' 142' ' ' ASP . 1.6 mt -110.42 178.85 4.25 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.258 -0.901 . . . . 0.0 109.508 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.487 ' HB3' ' O ' ' A' ' 141' ' ' LEU . 4.7 p-10 174.18 175.96 0.15 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.399 -0.813 . . . . 0.0 110.239 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.525 ' CA ' HG23 ' A' ' 8' ' ' THR . 5.1 t0 41.24 59.33 2.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.541 -0.725 . . . . 0.0 110.076 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 2.8 t -100.57 113.23 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.3 -0.875 . . . . 0.0 110.04 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -136.95 158.87 43.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.24 -0.913 . . . . 0.0 110.377 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.47 HD13 ' N ' ' A' ' 61' ' ' THR . 13.0 tp -167.39 122.09 1.03 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.36 -0.837 . . . . 0.0 110.06 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.453 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 1.5 t70 -139.22 -158.51 0.86 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.229 -0.919 . . . . 0.0 110.312 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' A' ' 59' ' ' THR . 75.0 p . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.27 -0.894 . . . . 0.0 110.196 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo . . . . . 0 N--CA 1.48 0.7 0 N-CA-C 110.104 -0.768 . . . . 0.0 110.104 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 14.3 pt -90.24 -32.45 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.238 -0.913 . . . . 0.0 110.163 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 169.16 147.82 5.57 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.42 19.57 2.74 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.277 -1.131 . . . . 0.0 110.194 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.497 ' O ' ' N ' ' A' ' 144' ' ' VAL . . . 161.75 -97.74 0.16 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.529 ' CB ' ' O ' ' A' ' 142' ' ' ASP . 17.1 p -92.07 147.31 23.05 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.23 -1.159 . . . . 0.0 109.95 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.578 ' CE2' ' HB2' ' A' ' 32' ' ' LEU . 21.8 m-85 -44.04 -40.77 5.02 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.312 -0.868 . . . . 0.0 109.408 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.553 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 12.0 t70 31.28 42.27 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.074 0.464 . . . . 0.0 111.299 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.553 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 1.7 t70 161.66 80.87 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.559 -0.713 . . . . 0.0 109.58 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 55.23 173.38 0.1 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.487 ' HB3' ' CD1' ' A' ' 32' ' ' LEU . 47.6 Cg_endo -73.56 -5.42 17.07 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 124.048 1.551 . . . . 0.0 110.519 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 0.5 OUTLIER 65.29 -87.1 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.215 -0.928 . . . . 0.0 110.282 -179.92 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.492 ' C ' ' CD1' ' A' ' 49' ' ' LEU . . . -140.92 6.23 2.58 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.581 ' CE2' HD21 ' A' ' 49' ' ' LEU . 55.0 m95 -71.34 82.6 0.77 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.178 -1.189 . . . . 0.0 110.406 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.6 ' CG2' ' CG2' ' A' ' 48' ' ' VAL . 1.0 OUTLIER -78.53 149.35 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.011 -1.055 . . . . 0.0 109.287 179.559 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.586 ' CB ' ' CG1' ' A' ' 34' ' ' VAL . . . -135.33 132.74 38.03 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.049 -1.032 . . . . 0.0 110.461 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.482 ' O ' ' CD2' ' A' ' 19' ' ' TYR . 11.8 p90 -122.07 115.46 22.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.526 -0.734 . . . . 0.0 110.006 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.522 ' HA3' ' CG1' ' A' ' 45' ' ' VAL . . . -152.96 27.55 0.81 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 20' ' ' GLY . 17.9 p 47.87 21.32 0.28 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.304 -1.115 . . . . 0.0 110.862 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.535 ' HB3' ' CB ' ' A' ' 35' ' ' ALA . 3.2 m-20 -125.15 43.12 3.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.898 -1.126 . . . . 0.0 110.261 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.41 152.07 17.32 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.415 ' O ' ' C ' ' A' ' 25' ' ' LEU . 46.6 Cg_endo -73.09 140.76 31.68 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.989 1.521 . . . . 0.0 110.428 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.518 ' CD1' HD13 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -42.41 156.64 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.316 -0.865 . . . . 0.0 110.219 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -145.12 148.76 33.98 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.262 -0.899 . . . . 0.0 110.261 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.456 ' O ' HG21 ' A' ' 29' ' ' THR . 0.8 OUTLIER -119.89 -74.14 0.62 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.266 -0.896 . . . . 0.0 110.236 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 27' ' ' THR . 2.5 t 43.14 36.05 0.91 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.229 -0.919 . . . . 0.0 110.232 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.456 HG21 ' O ' ' A' ' 27' ' ' THR . 14.9 t -172.65 -34.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.317 -0.864 . . . . 0.0 110.21 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.73 7.88 6.53 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.438 ' CB ' ' HB3' ' A' ' 142' ' ' ASP . . . -130.95 132.21 44.92 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.164 -1.197 . . . . 0.0 110.222 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.578 ' HB2' ' CE2' ' A' ' 9' ' ' PHE . 2.2 tp -74.03 109.06 7.23 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.233 -0.917 . . . . 0.0 110.066 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 9.5 m -111.12 103.36 11.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.151 -0.968 . . . . 0.0 110.774 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.586 ' CG1' ' CB ' ' A' ' 18' ' ' ALA . 25.4 m -89.7 169.44 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.894 . . . . 0.0 109.13 179.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.535 ' CB ' ' HB3' ' A' ' 22' ' ' ASP . . . -122.46 129.22 51.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.904 -1.122 . . . . 0.0 111.317 -179.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.655 ' CG1' ' CZ2' ' A' ' 137' ' ' TRP . 4.5 t -117.1 122.58 31.06 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.508 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 45.4 Cg_endo -74.5 152.65 43.7 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.804 1.423 . . . . 0.0 111.625 -178.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.524 ' HA ' ' CA ' ' A' ' 136' ' ' ALA . . . -42.07 131.39 3.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.32 -0.862 . . . . 0.0 109.892 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 38' ' ' ALA . . . 46.18 71.98 0.45 Allowed Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.558 -1.817 . . . . 0.0 108.558 -179.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.523 ' HB2' ' CG2' ' A' ' 45' ' ' VAL . 0.9 OUTLIER -84.6 34.92 0.54 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.319 -1.106 . . . . 0.0 110.778 -179.354 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.522 ' CB ' ' HA3' ' A' ' 131' ' ' GLY . . . -98.87 20.73 12.63 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.308 -0.87 . . . . 0.0 109.708 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.583 ' HG3' ' CD2' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -95.02 20.25 9.25 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.747 0.785 . . . . 0.0 109.882 179.771 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.584 ' CE1' HG21 ' A' ' 45' ' ' VAL . 24.4 p90 176.86 -29.35 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.497 ' N ' ' CD1' ' A' ' 43' ' ' TYR . . . 99.24 108.91 2.93 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 110.241 -1.143 . . . . 0.0 110.241 179.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.584 HG21 ' CE1' ' A' ' 43' ' ' TYR . 1.9 t -89.99 178.28 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.215 -1.167 . . . . 0.0 108.74 179.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.463 ' CA ' ' HA ' ' A' ' 128' ' ' GLN . . . 162.81 -173.96 39.1 Favored Glycine 0 N--CA 1.487 2.051 0 C-N-CA 118.867 -1.635 . . . . 0.0 110.823 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.519 ' CG1' ' O ' ' A' ' 17' ' ' VAL . 38.9 t -151.06 128.2 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.6 ' CG2' ' CG2' ' A' ' 17' ' ' VAL . 27.6 m -120.55 128.37 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.842 -1.161 . . . . 0.0 110.749 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.581 HD21 ' CE2' ' A' ' 16' ' ' TRP . 19.7 tp -119.29 105.2 11.09 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.367 -0.833 . . . . 0.0 110.3 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.481 ' HA ' ' HB3' ' A' ' 124' ' ' GLN . 0.2 OUTLIER -82.29 103.29 11.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.265 -0.897 . . . . 0.0 110.161 179.826 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.71 69.48 0.02 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.523 ' CG2' ' HA ' ' A' ' 124' ' ' GLN . 38.3 t -119.9 171.78 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.196 -1.179 . . . . 0.0 109.979 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.515 ' N ' ' CG1' ' A' ' 52' ' ' VAL . . . -137.6 78.46 1.69 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.122 -0.987 . . . . 0.0 110.783 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.629 ' CD1' ' CE1' ' A' ' 60' ' ' TYR . 28.2 mm -118.31 160.41 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.21 -0.931 . . . . 0.0 109.712 179.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.527 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 1.2 tt0 -154.46 131.77 11.15 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.026 -1.046 . . . . 0.0 110.82 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 10.8 pt-20 37.58 -154.4 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.726 -0.609 . . . . 0.0 110.981 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 108' ' ' ALA . . . -86.77 91.91 1.76 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.555 ' CG2' ' N ' ' A' ' 59' ' ' THR . 1.2 m -121.36 173.74 7.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.274 -1.133 . . . . 0.0 109.83 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.555 ' N ' ' CG2' ' A' ' 58' ' ' THR . 0.5 OUTLIER -89.72 152.66 21.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.278 -0.889 . . . . 0.0 110.28 -179.913 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.629 ' CE1' ' CD1' ' A' ' 54' ' ' ILE . 54.1 m-85 -156.79 165.33 36.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.286 -0.884 . . . . 0.0 110.344 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 96.2 m -142.78 112.95 7.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.314 -0.866 . . . . 0.0 109.982 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.3 tp -89.76 120.76 31.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 110.148 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.465 ' HA ' ' O ' ' A' ' 102' ' ' VAL . 32.5 ttp180 -130.12 119.48 23.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.339 -0.851 . . . . 0.0 110.119 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.544 ' CZ ' HG23 ' A' ' 102' ' ' VAL . 14.6 p90 -150.91 153.26 34.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.237 -0.915 . . . . 0.0 110.252 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 5.6 m -119.73 94.86 4.55 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.26 -0.9 . . . . 0.0 109.968 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.518 ' HB2' ' CD2' ' A' ' 95' ' ' LEU . . . -99.72 153.33 19.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.324 -0.86 . . . . 0.0 110.401 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.485 ' CA ' HD21 ' A' ' 95' ' ' LEU . 67.9 m -150.1 117.08 5.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.243 -0.911 . . . . 0.0 110.161 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -99.48 140.35 33.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.268 -0.895 . . . . 0.0 109.872 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.409 ' C ' ' O ' ' A' ' 68' ' ' ALA . 22.9 t -44.72 -26.27 0.37 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.185 -0.947 . . . . 0.0 109.282 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.533 HG23 ' CB ' ' A' ' 137' ' ' TRP . 5.0 t -116.99 -152.63 0.51 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.574 -0.704 . . . . 0.0 109.764 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.522 ' N ' HG22 ' A' ' 70' ' ' THR . 0.1 OUTLIER -116.03 62.17 0.71 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.276 -0.89 . . . . 0.0 109.324 179.043 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.537 ' CG2' ' HB2' ' A' ' 133' ' ' SER . 4.5 p -82.95 136.63 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.329 -0.857 . . . . 0.0 111.187 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.3 m -119.79 89.96 3.23 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.602 ' HA ' ' CG ' ' A' ' 132' ' ' PHE . 12.8 m -89.81 -150.39 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.279 -0.888 . . . . 0.0 110.811 -178.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.454 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 6.4 mtm180 -129.83 137.04 50.25 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.319 -0.863 . . . . 0.0 110.63 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.488 ' O ' ' HB3' ' A' ' 77' ' ' LEU . . . -134.24 157.67 45.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.408 -0.808 . . . . 0.0 109.746 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.488 ' HB3' ' O ' ' A' ' 76' ' ' ALA . 3.8 pp 178.66 -156.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.195 -0.94 . . . . 0.0 110.373 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.55 HG11 ' CE2' ' A' ' 112' ' ' TYR . 3.4 t -148.39 167.55 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.296 -0.877 . . . . 0.0 109.565 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.499 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . -178.78 -170.23 40.5 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.343 -1.408 . . . . 0.0 110.202 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.475 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 28.2 tt0 -111.15 118.5 36.13 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.441 -1.035 . . . . 0.0 110.297 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.501 ' CB ' ' OE2' ' A' ' 122' ' ' GLU . 2.5 m120 -85.49 94.51 9.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.221 -0.924 . . . . 0.0 110.166 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.581 ' O ' ' CZ ' ' A' ' 85' ' ' TYR . . . 164.69 -89.53 0.1 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.444 ' CB ' ' O ' ' A' ' 82' ' ' GLY . . . 173.04 144.19 0.17 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.229 -1.159 . . . . 0.0 110.15 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.48 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.6 Cg_endo -84.23 32.87 4.1 Favored 'Cis proline' 0 C--N 1.314 -1.28 0 C-N-CA 121.929 -2.113 . . . . 0.0 110.681 -0.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.581 ' CZ ' ' O ' ' A' ' 82' ' ' GLY . 19.4 m-85 64.76 157.47 0.09 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.16 -0.963 . . . . 0.0 110.246 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.461 ' O ' ' HA2' ' A' ' 79' ' ' GLY . . . -171.74 103.48 0.19 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.455 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 1.7 p -89.87 139.25 30.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.19 -1.182 . . . . 0.0 110.359 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.518 HG22 ' CD1' ' A' ' 89' ' ' LEU . 34.4 m -119.92 -16.79 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.337 -0.852 . . . . 0.0 109.979 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.56 HD13 ' CE1' ' A' ' 106' ' ' PHE . 4.2 mp -108.82 143.34 38.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.292 -0.88 . . . . 0.0 110.775 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -150.78 83.51 1.34 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.34 -0.85 . . . . 0.0 110.125 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.0 p -145.3 174.9 10.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.082 -1.011 . . . . 0.0 110.534 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.5 m -121.38 116.33 30.88 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.33 -0.856 . . . . 0.0 110.145 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.532 ' HG2' ' CG2' ' A' ' 74' ' ' VAL . 43.9 Cg_endo -71.15 124.77 10.79 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.898 1.473 . . . . 0.0 110.962 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.525 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -96.62 148.11 23.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.32 -0.862 . . . . 0.0 109.438 179.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.525 ' CD1' ' HG ' ' A' ' 139' ' ' LEU . 32.2 mt -136.2 166.51 23.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.001 -1.062 . . . . 0.0 110.726 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 70' ' ' THR . 0.2 OUTLIER -164.35 -178.81 5.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.482 -0.761 . . . . 0.0 109.975 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.42 -6.47 30.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.225 -0.922 . . . . 0.0 110.183 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.486 ' CB ' ' HD2' ' A' ' 99' ' ' PRO . 1.5 mt-10 -113.11 178.34 0.99 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.292 -0.88 . . . . 0.0 110.074 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.486 ' HD2' ' CB ' ' A' ' 98' ' ' GLU . 45.6 Cg_endo -72.68 128.03 12.99 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.0 1.527 . . . . 0.0 110.359 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.525 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.77 91.56 3.58 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.26 -0.9 . . . . 0.0 110.217 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.452 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 0.5 OUTLIER -75.78 157.19 33.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.302 -0.874 . . . . 0.0 110.138 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.544 HG23 ' CZ ' ' A' ' 64' ' ' TYR . 41.0 t -135.09 139.26 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.221 -0.924 . . . . 0.0 110.129 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.96 102.43 3.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.263 -0.898 . . . . 0.0 110.194 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -142.01 165.78 26.51 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.239 -0.913 . . . . 0.0 110.171 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.5 t -122.08 167.15 13.48 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.22 -0.925 . . . . 0.0 110.163 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.56 ' CE1' HD13 ' A' ' 89' ' ' LEU . 34.4 p90 -173.3 151.37 2.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.245 -0.909 . . . . 0.0 110.274 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 66.9 m -89.98 96.14 10.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.225 -0.922 . . . . 0.0 110.029 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.596 ' CB ' ' CD2' ' A' ' 60' ' ' TYR . . . -55.17 100.07 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.289 -0.882 . . . . 0.0 110.251 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.448 ' N ' HG13 ' A' ' 88' ' ' VAL . 54.5 p -89.08 52.45 2.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.258 -0.901 . . . . 0.0 110.179 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.488 ' HB1' ' CG1' ' A' ' 88' ' ' VAL . . . -159.22 -155.85 0.49 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.253 -0.904 . . . . 0.0 110.191 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 88.6 m -147.05 111.1 5.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.262 -0.899 . . . . 0.0 110.283 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.55 ' CE2' HG11 ' A' ' 78' ' ' VAL . 15.0 m-30 -111.43 77.04 1.58 Allowed Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.361 -0.837 . . . . 0.0 109.994 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.467 ' O ' ' HB2' ' A' ' 122' ' ' GLU . 44.8 Cg_endo -72.46 177.56 7.24 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.975 1.513 . . . . 0.0 110.419 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.243 -0.911 . . . . 0.0 110.264 -179.909 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.515 ' N ' ' OE1' ' A' ' 122' ' ' GLU . 6.4 pm0 . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.218 0.532 . . . . 0.0 110.187 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.527 ' HA3' ' CB ' ' A' ' 112' ' ' TYR . . . -138.12 154.6 22.91 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.523 ' HA ' ' CG2' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -150.25 -162.14 1.49 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -1.176 . . . . 0.0 110.518 -179.716 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.524 HG23 ' CH2' ' A' ' 16' ' ' TRP . 10.1 mt -118.86 144.25 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.486 -0.759 . . . . 0.0 109.503 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.475 ' O ' ' HA ' ' A' ' 76' ' ' ALA . . . -116.28 115.29 25.67 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.453 -0.779 . . . . 0.0 111.41 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.502 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 2.7 m-30 -118.09 75.52 1.01 Allowed 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . 0.463 ' HA ' ' CA ' ' A' ' 46' ' ' GLY . 25.6 mt-30 -88.21 122.72 32.08 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.278 -0.888 . . . . 0.0 112.512 -177.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.55 ' N ' ' CD2' ' A' ' 129' ' ' LEU . 0.6 OUTLIER -108.38 55.6 0.64 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.008 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.463 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -66.04 89.38 0.13 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 -178.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.522 ' HA3' ' CB ' ' A' ' 41' ' ' ALA . . . 39.7 86.04 0.01 OUTLIER Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.999 -1.241 . . . . 0.0 109.999 179.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.602 ' CG ' ' HA ' ' A' ' 74' ' ' VAL . 12.9 m-85 -111.94 -47.95 3.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.191 -1.182 . . . . 0.0 110.348 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.57 ' HB3' ' CE3' ' A' ' 137' ' ' TRP . 37.2 t -89.84 -174.47 4.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.214 -0.929 . . . . 0.0 110.235 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -98.11 -80.6 0.45 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -0.892 . . . . 0.0 110.391 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -63.17 155.81 27.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.211 -0.931 . . . . 0.0 110.425 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.524 ' CA ' ' HA ' ' A' ' 38' ' ' ALA . . . -50.4 128.42 19.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.246 -0.909 . . . . 0.0 110.193 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.655 ' CZ2' ' CG1' ' A' ' 36' ' ' VAL . 11.2 p90 -132.04 -165.03 1.53 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.287 -0.883 . . . . 0.0 110.216 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.528 ' O ' ' CB ' ' A' ' 68' ' ' ALA . 0.5 OUTLIER -160.38 -178.44 6.93 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.683 -178.831 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.525 ' HG ' ' CD1' ' A' ' 95' ' ' LEU . 2.3 mp -141.08 141.22 34.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.348 -0.845 . . . . 0.0 110.129 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' CYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 22.3 m -140.59 103.35 4.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.185 -0.947 . . . . 0.0 110.459 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.486 ' O ' ' HB3' ' A' ' 142' ' ' ASP . 1.0 OUTLIER -96.29 -177.95 4.14 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.2 -0.938 . . . . 0.0 109.926 179.58 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.529 ' O ' ' CB ' ' A' ' 8' ' ' THR . 3.2 p30 168.87 35.68 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.439 -0.788 . . . . 0.0 110.004 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.471 ' O ' ' HA ' ' A' ' 64' ' ' TYR . 3.3 t0 -169.69 43.29 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.32 -0.862 . . . . 0.0 109.676 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.497 ' N ' ' O ' ' A' ' 7' ' ' GLY . 3.5 t -89.7 126.46 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.39 -0.819 . . . . 0.0 110.353 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -149.11 148.32 29.53 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.336 -0.853 . . . . 0.0 110.094 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 47.5 tp -140.41 139.92 35.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.259 -0.901 . . . . 0.0 110.303 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.467 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -151.3 -177.83 6.29 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.281 -0.887 . . . . 0.0 110.031 179.9 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.666 0 O-C-N 121.224 -0.922 . . . . 0.0 110.205 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo . . . . . 0 N--CA 1.48 0.714 0 N-CA-C 110.043 -0.791 . . . . 0.0 110.043 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.517 HD13 ' CG1' ' A' ' 144' ' ' VAL . 8.2 pt -89.97 4.49 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.189 -0.944 . . . . 0.0 110.215 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 133.07 -166.43 23.7 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -137.14 76.84 1.61 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.23 -1.159 . . . . 0.0 110.203 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.425 ' C ' ' HA ' ' A' ' 143' ' ' ASP . . . 110.89 -133.13 11.36 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.524 ' CG2' ' O ' ' A' ' 142' ' ' ASP . 80.7 p -76.19 146.42 39.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.256 -1.143 . . . . 0.0 110.252 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.53 ' CE1' ' CD1' ' A' ' 16' ' ' TRP . 43.3 m-85 -42.95 -36.0 1.4 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.343 -0.848 . . . . 0.0 109.968 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.56 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 3.3 p-10 35.53 59.36 0.81 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.653 -0.654 . . . . 0.0 111.417 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.56 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 4.0 t0 162.03 -67.34 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.514 -0.742 . . . . 0.0 109.764 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.45 ' HA2' ' HB ' ' A' ' 27' ' ' THR . . . -174.56 -172.06 39.32 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.528 ' HD3' ' CG2' ' A' ' 27' ' ' THR . 47.3 Cg_endo -74.35 80.91 2.14 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 124.124 1.591 . . . . 0.0 110.384 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -35.8 -65.61 0.24 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.666 -0.646 . . . . 0.0 110.567 -179.853 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.489 ' C ' ' CD1' ' A' ' 49' ' ' LEU . . . -144.73 12.15 1.94 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.567 ' CE2' HD21 ' A' ' 49' ' ' LEU . 51.3 m95 -73.27 108.18 6.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.294 -1.121 . . . . 0.0 110.851 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.536 ' O ' ' CG1' ' A' ' 47' ' ' VAL . 1.4 m -109.0 151.38 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.317 -0.864 . . . . 0.0 109.133 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . . . -130.77 118.14 20.41 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.862 -1.149 . . . . 0.0 109.757 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.571 ' CE2' ' O ' ' A' ' 46' ' ' GLY . 7.4 p90 -107.02 173.63 6.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.513 -0.742 . . . . 0.0 110.861 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.541 ' HA2' ' CE1' ' A' ' 43' ' ' TYR . . . 90.69 -13.94 64.36 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.539 ' CG2' ' HD3' ' A' ' 37' ' ' PRO . 17.8 p -149.93 -141.44 0.11 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.27 -1.135 . . . . 0.0 110.236 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.533 ' CB ' ' HD3' ' A' ' 24' ' ' PRO . 19.4 t0 -89.29 174.47 7.81 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.357 -0.839 . . . . 0.0 109.658 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.585 ' N ' ' HD3' ' A' ' 24' ' ' PRO . . . -122.08 43.82 1.43 Allowed Glycine 0 N--CA 1.488 2.165 0 C-N-CA 119.513 -1.327 . . . . 0.0 110.765 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.585 ' HD3' ' N ' ' A' ' 23' ' ' GLY . 55.8 Cg_endo -80.19 41.12 1.07 Allowed 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 123.458 1.241 . . . . 0.0 110.685 179.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.584 ' CD2' ' CG1' ' A' ' 34' ' ' VAL . 17.4 mt -44.33 93.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.978 -1.076 . . . . 0.0 110.273 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 24' ' ' PRO . 36.0 t0 -74.67 115.82 14.67 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.278 -0.888 . . . . 0.0 109.333 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.528 ' CG2' ' HD3' ' A' ' 13' ' ' PRO . 2.1 p -119.38 -30.97 4.76 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.158 -0.964 . . . . 0.0 110.779 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.519 ' O ' ' CB ' ' A' ' 29' ' ' THR . 3.4 m -53.42 82.75 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.615 -0.678 . . . . 0.0 110.59 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.519 ' CB ' ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER 165.6 -33.14 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.215 -0.928 . . . . 0.0 109.806 -179.542 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.434 ' O ' ' HB3' ' A' ' 142' ' ' ASP . . . 127.51 7.36 4.83 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' A' ' 141' ' ' LEU . . . -150.57 154.95 38.49 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.039 -1.271 . . . . 0.0 110.662 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.494 ' O ' ' O ' ' A' ' 139' ' ' LEU . 2.0 tt -105.4 104.65 14.42 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.369 -0.832 . . . . 0.0 110.239 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.532 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 0.8 OUTLIER -97.65 113.86 25.69 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.223 -0.923 . . . . 0.0 111.449 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.584 ' CG1' ' CD2' ' A' ' 25' ' ' LEU . 18.7 m -89.76 148.8 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 178.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.29 111.0 21.72 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.39 -0.819 . . . . 0.0 111.309 -178.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.637 ' CG1' ' CZ2' ' A' ' 137' ' ' TRP . 55.7 t -105.29 133.36 20.2 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.477 -0.765 . . . . 0.0 109.303 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.539 ' HD3' ' CG2' ' A' ' 21' ' ' THR . 40.2 Cg_endo -67.2 171.84 10.88 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.81 1.426 . . . . 0.0 111.0 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.531 ' HA ' ' N ' ' A' ' 136' ' ' ALA . . . -57.86 129.26 41.08 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.441 -0.787 . . . . 0.0 111.06 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.574 ' O ' ' C ' ' A' ' 40' ' ' SER . . . 40.31 38.95 1.49 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.574 ' C ' ' O ' ' A' ' 39' ' ' GLY . 74.6 p 17.45 59.91 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 117.524 0.662 . . . . 0.0 111.733 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.481 ' O ' ' HB3' ' A' ' 42' ' ' GLN . . . -89.5 104.98 17.49 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.66 0.743 . . . . 0.0 110.52 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.481 ' HB3' ' O ' ' A' ' 41' ' ' ALA . 2.8 pt20 171.32 -169.47 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.842 -0.536 . . . . 0.0 109.709 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.541 ' CE1' ' HA2' ' A' ' 20' ' ' GLY . 3.1 p90 -44.2 -26.14 0.29 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.162 -0.961 . . . . 0.0 109.73 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.511 ' N ' ' CD1' ' A' ' 43' ' ' TYR . . . 123.68 127.73 3.25 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.53 ' CG1' HG22 ' A' ' 21' ' ' THR . 4.0 t -89.45 177.08 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.198 -1.178 . . . . 0.0 109.153 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.571 ' O ' ' CE2' ' A' ' 19' ' ' TYR . . . 165.45 137.63 2.24 Favored Glycine 0 N--CA 1.49 2.275 0 C-N-CA 119.047 -1.549 . . . . 0.0 110.849 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.536 ' CG1' ' O ' ' A' ' 17' ' ' VAL . 21.5 t -104.58 141.55 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.534 -0.98 . . . . 0.0 109.487 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.529 HG22 ' CG2' ' A' ' 17' ' ' VAL . 4.9 m -132.44 143.91 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 120.799 -1.188 . . . . 0.0 110.474 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.567 HD21 ' CE2' ' A' ' 16' ' ' TRP . 25.5 tp -136.72 113.05 9.9 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.313 -0.867 . . . . 0.0 110.09 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.535 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 4.4 t30 -88.9 132.33 34.73 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.204 -0.935 . . . . 0.0 110.561 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.46 ' O ' HG21 ' A' ' 4' ' ' ILE . . . 141.21 72.31 0.04 OUTLIER Glycine 0 N--CA 1.49 2.258 0 C-N-CA 119.826 -1.178 . . . . 0.0 110.204 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.483 HG13 HG12 ' A' ' 54' ' ' ILE . 5.7 t -119.9 173.28 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.025 -1.28 . . . . 0.0 110.009 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.529 ' O ' ' CD1' ' A' ' 54' ' ' ILE . . . -124.4 80.12 1.81 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.06 -1.025 . . . . 0.0 110.806 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.575 HD11 ' CZ ' ' A' ' 60' ' ' TYR . 4.9 mm -142.52 163.63 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.256 -0.902 . . . . 0.0 109.603 179.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.515 ' O ' ' HB3' ' A' ' 56' ' ' GLU . 36.8 tt0 -172.12 27.62 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.02 -1.05 . . . . 0.0 110.557 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.515 ' HB3' ' O ' ' A' ' 55' ' ' GLU . 3.3 pt-20 177.62 -165.52 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.649 -0.657 . . . . 0.0 110.111 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.483 ' N ' ' HG3' ' A' ' 56' ' ' GLU . . . -94.08 68.75 1.4 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.567 ' CG2' ' N ' ' A' ' 59' ' ' THR . 1.2 m -104.4 173.02 6.48 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.463 -1.022 . . . . 0.0 110.393 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.574 ' O ' ' CD2' ' A' ' 60' ' ' TYR . 0.4 OUTLIER -89.79 159.57 16.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.437 -0.789 . . . . 0.0 109.79 179.636 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.592 ' CD2' ' CB ' ' A' ' 108' ' ' ALA . 66.4 m-85 -159.5 -175.51 5.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.29 -0.881 . . . . 0.0 110.23 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 91.5 m -147.68 121.62 9.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.326 -0.859 . . . . 0.0 109.894 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.488 HD23 ' CD2' ' A' ' 89' ' ' LEU . 18.9 tp -89.56 120.43 30.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.205 -0.935 . . . . 0.0 110.15 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.494 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 2.6 ttt180 -124.26 137.57 54.49 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.338 -0.851 . . . . 0.0 109.97 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.633 ' CZ ' ' CG2' ' A' ' 102' ' ' VAL . 0.9 OUTLIER -178.46 142.94 0.25 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.302 -0.874 . . . . 0.0 109.732 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.47 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 96.0 m -119.19 97.86 5.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.187 -0.946 . . . . 0.0 109.892 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.521 ' HB1' ' CD2' ' A' ' 141' ' ' LEU . . . -99.62 149.22 23.5 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.425 -0.797 . . . . 0.0 110.32 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.448 ' OG1' ' HA ' ' A' ' 99' ' ' PRO . 95.4 m -149.79 102.28 3.13 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.321 -0.862 . . . . 0.0 110.197 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -90.01 133.1 35.01 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.289 -0.882 . . . . 0.0 110.008 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.421 ' C ' ' O ' ' A' ' 68' ' ' ALA . 19.2 p -43.99 -26.49 0.29 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.251 -0.906 . . . . 0.0 109.521 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.598 ' CG2' ' CB ' ' A' ' 137' ' ' TRP . 2.4 t -111.23 159.7 17.65 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.457 -0.777 . . . . 0.0 109.987 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 3.1 m-20 -78.75 79.52 5.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.142 -0.974 . . . . 0.0 109.424 179.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.548 ' CG2' ' HB2' ' A' ' 133' ' ' SER . 9.9 p -102.73 139.43 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.18 -0.95 . . . . 0.0 111.27 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 17.8 m -119.86 86.73 2.61 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.603 ' HA ' ' CD1' ' A' ' 132' ' ' PHE . 11.1 m -89.55 -142.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.273 -0.892 . . . . 0.0 110.674 -178.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.519 ' N ' HG22 ' A' ' 74' ' ' VAL . 30.1 mtm-85 -132.56 148.68 52.38 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.281 -0.887 . . . . 0.0 110.456 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.495 ' N ' ' HD3' ' A' ' 93' ' ' PRO . . . -148.25 154.75 40.47 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.238 -0.914 . . . . 0.0 109.826 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.493 ' CD1' ' CB ' ' A' ' 126' ' ' ALA . 3.9 pp 179.0 -156.42 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.253 -0.904 . . . . 0.0 110.467 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.519 HG22 ' CD2' ' A' ' 89' ' ' LEU . 3.9 t -149.41 165.48 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.352 -0.842 . . . . 0.0 109.535 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.551 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . -174.83 -163.64 28.33 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.408 -1.377 . . . . 0.0 110.255 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.518 ' CG ' ' N ' ' A' ' 86' ' ' GLY . 3.3 pt20 -119.84 143.38 47.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.383 -1.069 . . . . 0.0 110.461 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.475 ' HB2' ' HG2' ' A' ' 122' ' ' GLU . 3.6 m-20 -96.22 94.71 7.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.365 -0.834 . . . . 0.0 109.991 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.544 ' C ' ' CE1' ' A' ' 85' ' ' TYR . . . 137.49 149.43 5.57 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.622 ' N ' ' CE1' ' A' ' 85' ' ' TYR . . . -62.44 155.12 69.33 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.303 -1.116 . . . . 0.0 110.298 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.52 ' C ' ' CD2' ' A' ' 85' ' ' TYR . 50.5 Cg_endo -77.41 7.91 18.71 Favored 'Cis proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.636 -2.235 . . . . 0.0 110.803 -0.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.622 ' CE1' ' N ' ' A' ' 83' ' ' ALA . 11.4 m-85 69.94 166.0 0.28 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.306 -0.871 . . . . 0.0 110.161 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.518 ' N ' ' CG ' ' A' ' 80' ' ' GLN . . . 172.69 165.94 30.48 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.428 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 0.8 OUTLIER -143.31 149.1 37.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.274 -1.133 . . . . 0.0 110.239 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.519 ' CG2' HD11 ' A' ' 89' ' ' LEU . 30.3 m -122.14 -18.43 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.25 -0.906 . . . . 0.0 110.285 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.56 HD13 ' CD2' ' A' ' 106' ' ' PHE . 4.3 mp -111.93 143.02 43.6 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.178 -0.951 . . . . 0.0 110.984 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -151.11 88.59 1.46 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.339 -0.85 . . . . 0.0 110.183 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.4 p -153.29 176.96 11.39 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.049 -1.032 . . . . 0.0 110.656 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.2 m -119.89 120.05 30.66 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.348 -0.845 . . . . 0.0 110.072 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.534 ' HG2' ' CG2' ' A' ' 74' ' ' VAL . 46.1 Cg_endo -74.05 127.88 11.77 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.928 1.488 . . . . 0.0 111.076 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.516 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -95.11 149.68 21.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.318 -0.864 . . . . 0.0 109.3 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.533 ' CD1' ' CD2' ' A' ' 139' ' ' LEU . 43.5 mt -145.21 173.5 11.89 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.973 -1.079 . . . . 0.0 110.997 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.471 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 0.1 OUTLIER 169.15 -178.59 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.633 -0.667 . . . . 0.0 109.716 -179.874 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.32 -13.75 21.66 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.126 -0.984 . . . . 0.0 109.806 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.546 ' CG ' ' HD2' ' A' ' 99' ' ' PRO . 33.7 tt0 -95.74 149.56 36.22 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.444 -0.785 . . . . 0.0 109.866 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.546 ' HD2' ' CG ' ' A' ' 98' ' ' GLU . 41.5 Cg_endo -68.11 130.09 20.75 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.807 1.425 . . . . 0.0 110.169 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.516 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.83 91.92 3.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.267 -0.896 . . . . 0.0 110.624 -179.537 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.467 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 31.8 mt-30 -73.54 157.94 35.78 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.273 -0.892 . . . . 0.0 109.632 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.633 ' CG2' ' CZ ' ' A' ' 64' ' ' TYR . 60.4 t -131.29 133.03 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.143 -0.973 . . . . 0.0 110.518 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.49 87.73 1.46 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.406 -0.809 . . . . 0.0 110.009 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.416 ' O ' HG22 ' A' ' 61' ' ' THR . 56.8 mt-10 -125.83 -176.14 3.54 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.203 -0.935 . . . . 0.0 110.377 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 1.8 t -135.64 166.93 22.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.3 -0.875 . . . . 0.0 110.204 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.56 ' CD2' HD13 ' A' ' 89' ' ' LEU . 31.8 p90 -174.74 152.8 1.66 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.22 -0.925 . . . . 0.0 110.196 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.521 ' O ' ' N ' ' A' ' 109' ' ' SER . 4.8 m -89.7 94.95 10.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.192 -0.943 . . . . 0.0 109.97 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.592 ' CB ' ' CD2' ' A' ' 60' ' ' TYR . . . -50.76 89.54 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.301 -0.874 . . . . 0.0 110.014 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 107' ' ' THR . 10.3 p -85.65 53.27 2.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.27 -0.894 . . . . 0.0 109.996 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -157.79 -163.35 1.32 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.178 -0.951 . . . . 0.0 110.392 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.513 ' CG2' ' HA ' ' A' ' 55' ' ' GLU . 97.0 m -136.0 110.63 8.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.272 -0.892 . . . . 0.0 110.286 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.569 ' CG ' ' HA3' ' A' ' 123' ' ' GLY . 15.4 m-30 -109.07 70.75 0.43 Allowed Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.341 -0.849 . . . . 0.0 110.047 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.467 ' O ' ' HB2' ' A' ' 122' ' ' GLU . 46.4 Cg_endo -71.38 120.42 6.95 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 123.802 1.422 . . . . 0.0 110.401 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.275 -0.89 . . . . 0.0 110.218 -179.98 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.534 ' CG ' ' N ' ' A' ' 123' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 121.036 0.446 . . . . 0.0 110.06 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.569 ' HA3' ' CG ' ' A' ' 112' ' ' TYR . . . -149.86 147.3 17.41 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.535 ' CB ' ' HA ' ' A' ' 50' ' ' ASN . 1.8 pt20 -150.32 -162.56 1.58 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.328 -1.101 . . . . 0.0 110.421 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 13.0 mt -119.12 143.83 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.481 -0.762 . . . . 0.0 109.278 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.493 ' CB ' ' CD1' ' A' ' 77' ' ' LEU . . . -117.04 117.44 29.66 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.178 -0.951 . . . . 0.0 111.048 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.51 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 3.0 m-30 -116.97 102.75 9.62 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . 0.478 ' O ' ' CE2' ' A' ' 132' ' ' PHE . 6.6 mt-30 -88.98 107.77 19.21 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.108 -0.995 . . . . 0.0 111.132 -178.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.508 ' CD2' HG23 ' A' ' 74' ' ' VAL . 16.8 mt -106.35 43.53 1.14 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.5 -0.75 . . . . 0.0 109.035 178.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 131' ' ' GLY . . . -91.68 116.65 5.04 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.546 ' N ' ' OG ' ' A' ' 40' ' ' SER . . . 41.95 90.07 0.01 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.603 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 6.8 m-85 -139.98 -55.73 0.55 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.167 -1.196 . . . . 0.0 110.492 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.575 ' HB3' ' CZ3' ' A' ' 137' ' ' TRP . 1.2 t -88.95 -177.24 5.42 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.945 -1.097 . . . . 0.0 110.29 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.454 ' N ' ' OG ' ' A' ' 133' ' ' SER . . . -100.08 -75.22 0.58 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.226 -0.921 . . . . 0.0 110.393 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' A' ' 136' ' ' ALA . 83.9 m-20 -83.24 153.75 24.54 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.218 -0.927 . . . . 0.0 110.156 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.531 ' N ' ' HA ' ' A' ' 38' ' ' ALA . . . -40.95 142.3 0.5 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.363 -0.836 . . . . 0.0 110.452 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.637 ' CZ2' ' CG1' ' A' ' 36' ' ' VAL . 18.8 p90 -153.46 -159.9 1.05 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.281 -0.887 . . . . 0.0 110.654 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.523 ' O ' ' CB ' ' A' ' 68' ' ' ALA . 0.8 OUTLIER -160.1 176.12 12.16 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.371 -0.83 . . . . 0.0 109.63 -178.4 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.533 ' CD2' ' CD1' ' A' ' 95' ' ' LEU . 1.8 mp -136.66 117.33 13.95 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.905 -1.122 . . . . 0.0 111.89 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' CYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 0.8 OUTLIER -105.37 111.03 23.6 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.662 -0.649 . . . . 0.0 111.176 178.683 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.523 ' O ' ' CB ' ' A' ' 142' ' ' ASP . 1.4 mt -100.78 -179.73 4.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.914 . . . . 0.0 109.08 178.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.524 ' O ' ' CG2' ' A' ' 8' ' ' THR . 0.5 OUTLIER 166.19 64.88 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.327 -0.858 . . . . 0.0 110.073 179.912 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.513 ' CB ' ' O ' ' A' ' 142' ' ' ASP . 0.3 OUTLIER 165.79 42.8 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.374 -0.829 . . . . 0.0 108.962 -179.906 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.517 ' CG1' HD13 ' A' ' 4' ' ' ILE . 1.0 OUTLIER -89.15 120.02 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.542 -0.724 . . . . 0.0 110.593 -178.811 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -157.53 147.35 20.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.471 -0.768 . . . . 0.0 109.778 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.512 ' CD1' ' HB3' ' A' ' 60' ' ' TYR . 42.9 tp -144.07 146.83 33.08 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.254 -0.903 . . . . 0.0 110.342 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 7.1 t0 -177.88 152.12 0.74 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.214 -0.929 . . . . 0.0 110.296 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.521 ' HB3' ' CE1' ' A' ' 60' ' ' TYR . 22.5 p . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.286 -0.884 . . . . 0.0 110.174 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.451 ' HG2' ' O ' ' A' ' 51' ' ' GLY . 51.4 Cg_endo . . . . . 0 N--CA 1.482 0.824 0 N-CA-C 111.072 -0.395 . . . . 0.0 111.072 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.455 HG22 HD22 ' A' ' 49' ' ' LEU . 6.7 pt -145.09 11.74 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.968 -1.082 . . . . 0.0 110.221 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 115.07 148.47 9.47 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -89.73 20.8 3.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.234 -1.157 . . . . 0.0 110.24 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.436 ' C ' ' HA ' ' A' ' 143' ' ' ASP . . . 153.86 -125.41 1.74 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 143' ' ' ASP . 0.8 OUTLIER -57.62 132.91 54.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.229 -1.159 . . . . 0.0 110.154 -179.92 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.569 ' O ' ' CB ' ' A' ' 10' ' ' ASP . 11.8 m-85 -43.86 -27.24 0.33 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.32 -0.862 . . . . 0.0 109.527 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.569 ' CB ' ' O ' ' A' ' 9' ' ' PHE . 0.0 OUTLIER 80.34 -43.43 0.24 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 122.038 -0.413 . . . . 0.0 111.062 179.303 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.568 ' HB2' ' O ' ' A' ' 10' ' ' ASP . 9.4 t70 161.93 39.22 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.083 0 CA-C-O 121.904 0.859 . . . . 0.0 109.085 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -176.81 134.74 2.62 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.476 ' HB3' HD13 ' A' ' 32' ' ' LEU . 45.9 Cg_endo -72.86 -15.39 26.53 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.932 1.491 . . . . 0.0 110.43 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 0.3 OUTLIER 63.77 -87.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.237 -0.914 . . . . 0.0 110.184 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.525 ' O ' ' CG1' ' A' ' 17' ' ' VAL . . . -124.35 -14.8 3.52 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.58 ' CZ2' HD21 ' A' ' 49' ' ' LEU . 80.6 m95 -51.82 111.36 0.59 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.263 -1.139 . . . . 0.0 110.593 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.59 ' CG2' ' CG2' ' A' ' 48' ' ' VAL . 1.0 OUTLIER -112.56 148.01 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.142 -0.974 . . . . 0.0 109.528 179.433 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.579 ' CB ' ' CG1' ' A' ' 34' ' ' VAL . . . -129.76 154.02 47.62 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.052 -1.03 . . . . 0.0 109.817 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.571 ' CE2' ' O ' ' A' ' 46' ' ' GLY . 9.4 p90 -145.91 155.58 42.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.915 . . . . 0.0 110.936 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.495 ' C ' ' CG2' ' A' ' 21' ' ' THR . . . 161.83 -93.89 0.12 Allowed Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.016 -1.633 . . . . 0.0 109.016 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.538 ' CG2' ' HG3' ' A' ' 37' ' ' PRO . 11.6 p -151.21 18.19 0.75 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.183 -1.187 . . . . 0.0 110.715 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.57 ' CB ' ' CB ' ' A' ' 35' ' ' ALA . 0.4 OUTLIER -123.87 60.6 1.11 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.037 -1.039 . . . . 0.0 110.229 179.479 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 43.53 -161.7 0.06 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.431 ' O ' ' C ' ' A' ' 25' ' ' LEU . 46.0 Cg_endo -72.86 145.12 39.99 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.973 1.512 . . . . 0.0 110.378 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.531 ' CD2' ' HA ' ' A' ' 17' ' ' VAL . 0.8 OUTLIER -42.66 163.43 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.311 -0.868 . . . . 0.0 110.194 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.28 138.55 45.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.264 -0.898 . . . . 0.0 110.109 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.444 ' O ' ' HB2' ' A' ' 28' ' ' SER . 0.7 OUTLIER -119.85 -78.97 0.6 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.182 -0.949 . . . . 0.0 110.232 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.444 ' HB2' ' O ' ' A' ' 27' ' ' THR . 0.4 OUTLIER 61.43 -87.68 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.257 -0.902 . . . . 0.0 110.227 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.441 HG21 ' O ' ' A' ' 27' ' ' THR . 5.1 t -42.18 -29.99 0.27 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.275 -0.891 . . . . 0.0 110.276 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.461 ' HA2' ' HA ' ' A' ' 11' ' ' ASP . . . 125.39 -26.41 5.49 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.479 ' CB ' ' HB3' ' A' ' 142' ' ' ASP . . . -91.8 136.08 33.42 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.211 -1.17 . . . . 0.0 110.188 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.525 HD13 ' CD1' ' A' ' 25' ' ' LEU . 1.9 tp -68.05 106.25 2.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.163 -0.96 . . . . 0.0 109.806 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 8.9 m -113.86 102.75 10.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.219 -0.925 . . . . 0.0 110.97 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.579 ' CG1' ' CB ' ' A' ' 18' ' ' ALA . 24.0 m -89.76 164.19 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.244 -0.91 . . . . 0.0 108.997 178.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.57 ' CB ' ' CB ' ' A' ' 22' ' ' ASP . . . -112.07 132.14 55.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.942 -1.099 . . . . 0.0 111.139 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.643 ' CG1' ' CZ2' ' A' ' 137' ' ' TRP . 37.2 t -119.66 117.37 32.71 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.543 -0.723 . . . . 0.0 109.325 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.538 ' HG3' ' CG2' ' A' ' 21' ' ' THR . 44.2 Cg_endo -70.38 144.22 50.1 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.885 1.466 . . . . 0.0 111.236 -179.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.488 ' HA ' ' HA ' ' A' ' 136' ' ' ALA . . . -45.34 153.94 0.2 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.375 -0.828 . . . . 0.0 109.83 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 38' ' ' ALA . . . 45.22 59.39 4.61 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.575 ' HB2' ' CH2' ' A' ' 137' ' ' TRP . 0.6 OUTLIER -84.14 36.99 0.59 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.314 -1.109 . . . . 0.0 110.589 -179.625 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -92.44 19.73 6.92 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.96 0.886 . . . . 0.0 109.664 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.583 ' HG3' ' CD2' ' A' ' 43' ' ' TYR . 16.2 pt20 -73.23 -143.19 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.635 ' CD1' ' N ' ' A' ' 44' ' ' GLY . 6.8 p90 -42.05 -27.52 0.13 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.502 -0.749 . . . . 0.0 109.375 179.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.635 ' N ' ' CD1' ' A' ' 43' ' ' TYR . . . 117.66 113.51 2.64 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.472 ' HB ' ' O ' ' A' ' 129' ' ' LEU . 2.6 t -89.55 149.99 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.137 -1.214 . . . . 0.0 108.191 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.571 ' O ' ' CE2' ' A' ' 19' ' ' TYR . . . 179.3 166.97 35.99 Favored Glycine 0 N--CA 1.489 2.178 0 C-N-CA 118.582 -1.771 . . . . 0.0 111.083 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.529 ' CG1' ' O ' ' A' ' 17' ' ' VAL . 38.4 t -122.22 131.41 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.754 -0.851 . . . . 0.0 109.457 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.59 ' CG2' ' CG2' ' A' ' 17' ' ' VAL . 33.0 m -120.14 139.01 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.886 -1.134 . . . . 0.0 110.683 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.58 HD21 ' CZ2' ' A' ' 16' ' ' TRP . 7.7 tp -130.66 87.33 2.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.325 -0.859 . . . . 0.0 110.211 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.541 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 3.5 m120 -69.15 103.3 1.87 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.926 . . . . 0.0 110.276 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.451 ' O ' ' HG2' ' A' ' 3' ' ' PRO . . . 157.02 79.72 0.03 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.526 ' CG2' ' HA ' ' A' ' 124' ' ' GLN . 6.8 t -124.92 160.16 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.167 -1.196 . . . . 0.0 109.933 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.448 ' O ' HD12 ' A' ' 54' ' ' ILE . . . -119.63 89.94 3.23 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.173 -0.955 . . . . 0.0 110.855 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.57 HG13 ' CD2' ' A' ' 112' ' ' TYR . 27.4 mm -130.06 172.79 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.28 -0.887 . . . . 0.0 109.507 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.512 ' N ' HG23 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -177.79 131.51 0.15 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.913 -1.117 . . . . 0.0 111.354 -179.749 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.464 ' O ' ' O ' ' A' ' 108' ' ' ALA . 7.8 mm-40 52.96 -168.45 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.667 -0.646 . . . . 0.0 110.85 178.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.483 ' HA2' ' HA ' ' A' ' 109' ' ' SER . . . -87.24 61.57 4.24 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.357 -1.897 . . . . 0.0 108.357 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.6 HG21 ' CE2' ' A' ' 60' ' ' TYR . 1.0 OUTLIER -96.41 174.43 6.87 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.625 -0.927 . . . . 0.0 110.078 -179.323 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.571 ' O ' ' CD2' ' A' ' 60' ' ' TYR . 7.5 m -89.89 158.8 17.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.331 -0.856 . . . . 0.0 110.487 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.648 ' CD2' ' CB ' ' A' ' 108' ' ' ALA . 66.4 m-85 -159.31 119.81 3.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.381 -0.824 . . . . 0.0 109.917 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 68.9 m -89.91 110.65 21.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.175 -0.953 . . . . 0.0 110.29 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.451 HD21 HD22 ' A' ' 89' ' ' LEU . 17.5 tp -89.76 126.0 35.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.257 -0.902 . . . . 0.0 109.775 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.475 ' O ' ' O ' ' A' ' 143' ' ' ASP . 19.8 mtm105 -132.81 130.46 39.88 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.251 -0.906 . . . . 0.0 110.395 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.575 ' CZ ' ' CG2' ' A' ' 102' ' ' VAL . 5.7 p90 -166.0 149.61 7.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.398 -0.814 . . . . 0.0 109.809 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.522 ' N ' ' OD2' ' A' ' 143' ' ' ASP . 28.9 m -119.58 89.69 3.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.208 -0.932 . . . . 0.0 110.245 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.478 ' C ' ' CD2' ' A' ' 95' ' ' LEU . . . -89.9 149.26 22.7 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.355 -0.84 . . . . 0.0 110.18 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.469 ' OG1' ' HA ' ' A' ' 99' ' ' PRO . 98.8 m -150.19 129.77 13.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.364 -0.835 . . . . 0.0 110.217 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -114.36 142.32 46.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.312 -0.868 . . . . 0.0 109.915 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 68' ' ' ALA . 17.3 m -45.6 -25.64 0.49 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.064 -1.023 . . . . 0.0 109.102 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.555 ' CG2' ' HB2' ' A' ' 137' ' ' TRP . 4.8 t -119.03 -160.55 0.81 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.589 -0.695 . . . . 0.0 109.835 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 4.9 m-20 -107.77 67.98 0.7 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.336 -0.853 . . . . 0.0 109.179 178.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.573 HG22 ' CE2' ' A' ' 137' ' ' TRP . 3.8 p -88.04 135.64 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.33 -0.856 . . . . 0.0 111.374 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.438 ' O ' HG21 ' A' ' 73' ' ' THR . 7.4 m -121.92 91.42 3.51 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.586 ' HA ' ' CD1' ' A' ' 132' ' ' PHE . 5.3 m -89.56 -158.93 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.172 -0.955 . . . . 0.0 110.88 -178.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 14.4 mtm-85 -119.15 107.51 13.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.264 -0.897 . . . . 0.0 110.886 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.492 ' O ' ' HB3' ' A' ' 77' ' ' LEU . . . -112.1 160.59 17.39 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.156 -0.965 . . . . 0.0 109.797 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.492 ' HB3' ' O ' ' A' ' 76' ' ' ALA . 3.3 pp 177.71 -156.65 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.295 -0.878 . . . . 0.0 110.201 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.566 HG11 ' CE2' ' A' ' 112' ' ' TYR . 3.9 t -147.81 168.03 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.217 -0.927 . . . . 0.0 109.527 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.492 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . 177.39 -176.18 47.94 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.39 -1.386 . . . . 0.0 110.174 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.46 ' O ' ' OD1' ' A' ' 81' ' ' ASN . 1.5 tt0 -89.27 -159.16 0.55 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.423 -1.045 . . . . 0.0 110.222 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.469 ' HB2' ' HG2' ' A' ' 122' ' ' GLU . 4.7 m120 -168.12 83.95 0.19 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.352 -0.843 . . . . 0.0 110.166 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 83' ' ' ALA . . . 140.55 36.75 0.11 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.562 ' HA ' ' CD2' ' A' ' 85' ' ' TYR . . . 59.49 145.99 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.254 -1.145 . . . . 0.0 110.315 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.473 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.6 Cg_endo -81.79 21.27 11.78 Favored 'Cis proline' 0 C--N 1.314 -1.288 0 C-N-CA 121.755 -2.185 . . . . 0.0 110.869 -0.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.562 ' CD2' ' HA ' ' A' ' 83' ' ' ALA . 50.0 m-85 60.39 124.16 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.095 -1.003 . . . . 0.0 110.282 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -152.86 112.91 0.55 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.446 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 0.8 OUTLIER -98.09 147.21 24.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.247 -1.149 . . . . 0.0 110.396 -179.891 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.518 ' CG2' HD13 ' A' ' 89' ' ' LEU . 33.2 m -119.97 -20.73 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.299 -0.876 . . . . 0.0 109.966 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.581 HD12 ' CZ ' ' A' ' 106' ' ' PHE . 4.5 mp -105.36 143.86 32.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.312 -0.868 . . . . 0.0 110.764 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.463 ' O ' ' CG2' ' A' ' 91' ' ' THR . 10.1 m-20 -150.63 86.21 1.39 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.294 -0.879 . . . . 0.0 110.245 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.463 ' CG2' ' O ' ' A' ' 90' ' ' ASP . 1.8 p -159.98 177.98 10.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.167 -0.958 . . . . 0.0 110.476 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.507 ' CB ' ' O ' ' A' ' 74' ' ' VAL . 4.8 m -120.0 129.78 25.18 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.305 -0.872 . . . . 0.0 110.066 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.508 ' HG2' ' CG2' ' A' ' 74' ' ' VAL . 48.0 Cg_endo -72.19 78.61 1.85 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.906 1.477 . . . . 0.0 110.879 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.533 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -50.84 138.67 18.35 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.059 -1.026 . . . . 0.0 109.313 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.515 HD11 ' CG1' ' A' ' 72' ' ' VAL . 42.7 mt -130.12 176.3 8.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.93 -1.106 . . . . 0.0 110.862 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 70' ' ' THR . 0.2 OUTLIER -171.73 -178.66 2.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.493 -0.754 . . . . 0.0 109.786 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 9.8 p -70.25 -7.84 45.39 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.2 -0.938 . . . . 0.0 110.12 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.465 ' CB ' ' HD2' ' A' ' 99' ' ' PRO . 4.4 mt-10 -109.18 177.34 1.27 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.238 -0.914 . . . . 0.0 110.077 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.469 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 46.4 Cg_endo -72.6 132.99 19.7 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 124.035 1.545 . . . . 0.0 110.357 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.533 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.59 86.55 2.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.222 -0.924 . . . . 0.0 110.16 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.465 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 1.8 mt-30 -73.49 155.8 38.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.283 -0.885 . . . . 0.0 110.258 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.575 ' CG2' ' CZ ' ' A' ' 64' ' ' TYR . 23.0 t -134.76 138.34 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -0.906 . . . . 0.0 110.105 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.3 m -150.11 112.51 4.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.931 . . . . 0.0 110.245 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -156.91 133.03 9.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.233 -0.917 . . . . 0.0 110.306 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 11.2 m -95.53 94.18 7.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.283 -0.886 . . . . 0.0 110.164 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.581 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 33.8 p90 -94.23 153.57 17.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.27 -0.894 . . . . 0.0 110.281 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 97.3 m -89.72 99.36 12.38 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.175 -0.953 . . . . 0.0 109.811 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.648 ' CB ' ' CD2' ' A' ' 60' ' ' TYR . . . -58.72 104.58 0.23 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.28 -0.888 . . . . 0.0 110.497 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.483 ' HA ' ' HA2' ' A' ' 57' ' ' GLY . 11.1 p -91.11 53.7 2.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.393 -0.817 . . . . 0.0 110.047 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -164.28 -153.43 0.21 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.292 -0.88 . . . . 0.0 110.217 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . 14.4 m -150.85 112.55 4.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -0.898 . . . . 0.0 110.341 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.571 ' CG ' ' HA3' ' A' ' 123' ' ' GLY . 14.4 m-30 -110.81 78.2 1.53 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.289 -0.882 . . . . 0.0 110.171 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.47 ' HD2' ' HA ' ' A' ' 122' ' ' GLU . 44.2 Cg_endo -70.99 -174.0 1.03 Allowed 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.956 1.503 . . . . 0.0 110.347 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 0.0 110.239 -179.931 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.47 ' HA ' ' HD2' ' A' ' 113' ' ' PRO . 1.2 pt-20 . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.237 0.541 . . . . 0.0 110.133 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.571 ' HA3' ' CG ' ' A' ' 112' ' ' TYR . . . -137.28 154.76 22.54 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.541 ' CB ' ' HA ' ' A' ' 50' ' ' ASN . 1.7 pp0? -150.51 -160.55 1.18 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.151 -1.205 . . . . 0.0 110.623 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.547 HD11 ' CH2' ' A' ' 16' ' ' TRP . 13.8 mt -118.21 143.34 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.449 ' O ' ' HA ' ' A' ' 76' ' ' ALA . . . -119.31 123.59 44.58 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.234 -0.916 . . . . 0.0 111.198 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.484 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 11.3 m-85 -118.51 97.11 5.59 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 178.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . 0.44 ' O ' ' HB ' ' A' ' 74' ' ' VAL . 12.4 mm-40 -88.65 93.23 9.49 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.302 -0.874 . . . . 0.0 111.841 -177.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.498 HD12 ' CD1' ' A' ' 139' ' ' LEU . 15.1 mt -93.94 47.17 1.2 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -84.42 83.1 1.64 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -179.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 55.61 100.13 0.01 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.586 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 9.8 m-85 -139.39 -40.44 0.46 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.312 -1.111 . . . . 0.0 109.943 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.583 ' HB3' ' CE3' ' A' ' 137' ' ' TRP . 1.3 t -90.86 -176.98 4.83 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.276 -0.89 . . . . 0.0 110.152 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.46 ' N ' ' OG ' ' A' ' 133' ' ' SER . . . -89.05 -88.07 0.16 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.207 -0.933 . . . . 0.0 110.402 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.8 176.49 6.27 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.274 -0.891 . . . . 0.0 110.452 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.488 ' HA ' ' HA ' ' A' ' 38' ' ' ALA . . . -50.12 128.98 20.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.326 -0.859 . . . . 0.0 110.286 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.643 ' CZ2' ' CG1' ' A' ' 36' ' ' VAL . 4.4 p90 -134.92 -170.07 2.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.25 -0.906 . . . . 0.0 110.027 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.526 ' O ' ' CB ' ' A' ' 68' ' ' ALA . 0.5 OUTLIER -160.55 175.18 13.0 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.255 -0.978 . . . . 0.0 110.7 -178.759 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.525 ' HB2' ' CG2' ' A' ' 34' ' ' VAL . 2.4 mp -127.78 146.46 50.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.312 -0.867 . . . . 0.0 109.731 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' CYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 11.8 m -147.56 97.74 2.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.062 -1.024 . . . . 0.0 110.949 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.471 ' O ' ' HB3' ' A' ' 142' ' ' ASP . 0.5 OUTLIER -93.2 -177.07 4.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.168 -0.958 . . . . 0.0 109.222 179.012 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.479 ' HB3' ' CB ' ' A' ' 31' ' ' ALA . 0.8 OUTLIER 175.57 38.23 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.058 -1.027 . . . . 0.0 110.624 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.522 ' OD2' ' N ' ' A' ' 65' ' ' THR . 3.8 p-10 175.31 51.45 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.364 -0.835 . . . . 0.0 109.698 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 3.5 t -90.13 114.88 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.389 -0.819 . . . . 0.0 110.32 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -137.75 133.39 34.05 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.319 -0.863 . . . . 0.0 110.077 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.425 ' O ' ' HB2' ' A' ' 147' ' ' ASP . 39.4 tp -129.17 137.92 51.45 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.276 -0.89 . . . . 0.0 110.182 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.434 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 1.3 t70 -179.07 156.25 0.78 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.229 -0.919 . . . . 0.0 110.253 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.457 ' HA ' ' O ' ' A' ' 59' ' ' THR . 2.3 p . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.263 -0.898 . . . . 0.0 110.196 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo . . . . . 0 N--CA 1.48 0.699 0 N-CA-C 110.133 -0.757 . . . . 0.0 110.133 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.427 ' O ' ' CD ' ' A' ' 14' ' ' GLU . 8.2 pt -94.76 -13.03 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.203 -0.936 . . . . 0.0 110.139 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 144.09 -25.96 2.05 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.527 ' HA ' ' CB ' ' A' ' 145' ' ' ALA . 6.1 mt-10 54.52 68.77 0.81 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.274 -1.133 . . . . 0.0 110.26 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 170.11 -161.82 35.02 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.52 ' CG2' ' O ' ' A' ' 142' ' ' ASP . 15.2 p -90.54 -168.06 2.0 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.213 -1.169 . . . . 0.0 110.218 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.521 ' CE1' ' CD1' ' A' ' 16' ' ' TRP . 44.7 m-85 -103.29 49.67 0.82 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.9 . . . . 0.0 110.122 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.546 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 4.8 p30 -84.98 44.63 1.09 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.263 -0.898 . . . . 0.0 110.248 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.546 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 4.5 t0 161.75 78.66 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.264 0.554 . . . . 0.0 109.597 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 70.14 142.49 0.19 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.471 ' O ' ' HB2' ' A' ' 14' ' ' GLU . 48.7 Cg_endo -75.83 3.82 5.7 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.059 1.557 . . . . 0.0 110.666 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 0.1 OUTLIER 67.41 -84.78 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.262 -0.899 . . . . 0.0 110.301 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.432 ' C ' HD11 ' A' ' 49' ' ' LEU . . . -141.46 8.39 2.6 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.576 ' CD1' HD12 ' A' ' 49' ' ' LEU . 38.0 m95 -64.23 131.94 48.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.173 -1.192 . . . . 0.0 110.391 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.584 ' CG2' ' CG2' ' A' ' 48' ' ' VAL . 1.0 OUTLIER -133.5 153.9 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.255 -0.903 . . . . 0.0 109.82 179.692 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.448 ' CB ' HD23 ' A' ' 25' ' ' LEU . . . -139.13 139.41 37.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.333 -0.854 . . . . 0.0 109.348 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.565 ' CE2' ' O ' ' A' ' 46' ' ' GLY . 1.7 p90 -121.52 144.04 48.94 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.165 -0.959 . . . . 0.0 111.093 -178.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.592 ' HA2' ' CE1' ' A' ' 43' ' ' TYR . . . 116.24 82.97 1.0 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.642 ' CG2' ' CE2' ' A' ' 43' ' ' TYR . 1.6 p 52.04 18.26 0.8 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.495 -1.003 . . . . 0.0 110.688 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.535 ' HA ' ' CB ' ' A' ' 35' ' ' ALA . 5.4 p30 -114.91 93.07 4.15 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.113 -0.992 . . . . 0.0 109.939 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 22' ' ' ASP . . . -60.31 -121.67 0.01 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.85 145.85 41.34 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.826 1.435 . . . . 0.0 110.488 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.528 ' CD1' HD12 ' A' ' 32' ' ' LEU . 14.3 mt -76.32 102.87 6.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.255 -0.903 . . . . 0.0 110.069 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.469 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 24.4 t0 -43.53 110.24 0.19 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.207 -0.933 . . . . 0.0 109.933 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.448 HG22 ' O ' ' A' ' 25' ' ' LEU . 12.7 p -119.41 -61.15 1.66 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.073 -1.017 . . . . 0.0 110.563 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.469 ' O ' ' OG1' ' A' ' 29' ' ' THR . 68.9 m 43.75 38.61 2.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.156 -0.965 . . . . 0.0 109.921 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.469 ' OG1' ' O ' ' A' ' 28' ' ' SER . 13.9 p 48.75 80.01 0.07 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.374 -0.829 . . . . 0.0 110.314 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 175.54 -65.5 0.1 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.45 ' O ' ' O ' ' A' ' 26' ' ' ASP . . . -150.17 151.72 33.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.308 -1.113 . . . . 0.0 110.069 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.528 HD12 ' CD1' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -104.82 94.41 5.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.158 -0.964 . . . . 0.0 110.393 -179.908 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.532 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 0.8 OUTLIER -94.71 115.81 27.98 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.215 -0.928 . . . . 0.0 111.176 179.759 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.512 HG13 ' CD2' ' A' ' 25' ' ' LEU . 16.6 m -89.4 149.43 4.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.535 ' CB ' ' HA ' ' A' ' 22' ' ' ASP . . . -88.95 92.99 9.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.314 -0.866 . . . . 0.0 111.093 -178.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.668 ' CG1' ' CZ2' ' A' ' 137' ' ' TRP . 96.7 t -89.89 123.43 66.23 Favored Pre-proline 0 C--N 1.301 -1.508 0 O-C-N 121.489 -0.757 . . . . 0.0 109.373 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.524 ' HD2' ' CG2' ' A' ' 45' ' ' VAL . 40.0 Cg_endo -66.1 179.28 1.97 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.845 1.445 . . . . 0.0 112.048 -178.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.557 ' HA ' ' CA ' ' A' ' 136' ' ' ALA . . . -62.99 125.26 23.4 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.542 -0.724 . . . . 0.0 111.285 -179.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.531 ' O ' ' C ' ' A' ' 40' ' ' SER . . . 37.62 28.42 0.04 OUTLIER Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.531 ' C ' ' O ' ' A' ' 39' ' ' GLY . 11.0 t 28.64 53.88 0.08 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.984 -0.715 . . . . 0.0 110.435 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.641 ' O ' ' CG ' ' A' ' 42' ' ' GLN . . . -88.19 114.43 24.8 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.541 -0.725 . . . . 0.0 110.156 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.641 ' CG ' ' O ' ' A' ' 41' ' ' ALA . 1.1 pt20 84.19 30.4 0.06 Allowed 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.642 ' CE2' ' CG2' ' A' ' 21' ' ' THR . 0.1 OUTLIER -149.45 -33.37 0.2 Allowed 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 118.564 -1.254 . . . . 0.0 112.677 -177.888 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.532 ' HA2' ' CA ' ' A' ' 130' ' ' GLY . . . 52.81 79.88 0.08 OUTLIER Glycine 0 N--CA 1.483 1.794 0 N-CA-C 105.733 -2.947 . . . . 0.0 105.733 -176.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.524 ' CG2' ' HD2' ' A' ' 37' ' ' PRO . 3.8 t -87.64 129.31 39.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.422 -1.046 . . . . 0.0 109.001 -177.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.565 ' O ' ' CE2' ' A' ' 19' ' ' TYR . . . -155.44 156.46 27.0 Favored Glycine 0 N--CA 1.487 2.094 0 C-N-CA 119.018 -1.563 . . . . 0.0 110.172 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.526 ' CG1' ' O ' ' A' ' 17' ' ' VAL . 11.3 t -112.9 128.46 69.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.419 -1.048 . . . . 0.0 109.791 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.584 ' CG2' ' CG2' ' A' ' 17' ' ' VAL . 27.3 m -119.86 137.06 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.031 -1.043 . . . . 0.0 110.62 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.576 HD12 ' CD1' ' A' ' 16' ' ' TRP . 14.1 tp -131.27 97.4 4.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.341 -0.849 . . . . 0.0 110.197 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.523 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 45.2 m-80 -75.46 147.07 40.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.256 -0.903 . . . . 0.0 110.445 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 124.5 63.2 0.19 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.524 ' CG2' ' HA ' ' A' ' 124' ' ' GLN . 43.1 t -119.92 158.42 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.163 -1.198 . . . . 0.0 110.177 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -128.12 80.74 1.98 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.224 -0.923 . . . . 0.0 110.695 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.569 HD11 ' CZ ' ' A' ' 60' ' ' TYR . 34.7 mm -117.44 173.03 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.244 -0.91 . . . . 0.0 109.72 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.522 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 1.8 tp10 -166.92 131.58 2.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.966 -1.083 . . . . 0.0 110.785 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.522 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 8.1 pt-20 37.85 -153.9 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.664 -0.647 . . . . 0.0 110.922 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.469 ' HA2' ' O ' ' A' ' 108' ' ' ALA . . . -87.77 87.21 1.52 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.561 ' CG2' ' N ' ' A' ' 59' ' ' THR . 1.3 m -113.78 173.6 6.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.269 -1.136 . . . . 0.0 109.843 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.576 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 3.5 m -89.66 153.21 20.91 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.163 -0.961 . . . . 0.0 110.376 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.583 ' CE1' ' CB ' ' A' ' 148' ' ' SER . 56.9 m-85 -160.29 179.37 8.73 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.339 -0.85 . . . . 0.0 110.211 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 36.7 m -150.31 115.35 5.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.344 -0.848 . . . . 0.0 109.876 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.519 HD23 ' CD2' ' A' ' 89' ' ' LEU . 13.7 tp -89.45 119.68 30.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.162 -0.961 . . . . 0.0 110.18 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.491 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 6.4 mtm180 -126.37 137.8 53.49 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.45 -0.781 . . . . 0.0 109.693 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.531 ' CD1' ' C ' ' A' ' 64' ' ' TYR . 0.7 OUTLIER -178.3 143.63 0.29 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.288 -0.883 . . . . 0.0 109.676 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.466 ' HB ' ' OD1' ' A' ' 142' ' ' ASP . 69.9 m -119.14 99.49 6.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.244 -0.91 . . . . 0.0 109.962 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.462 ' C ' ' CD2' ' A' ' 95' ' ' LEU . . . -99.78 156.77 16.93 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.432 -0.793 . . . . 0.0 110.225 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.481 ' CA ' HD21 ' A' ' 95' ' ' LEU . 64.6 m -150.38 121.7 7.85 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.301 -0.875 . . . . 0.0 110.266 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.07 135.2 51.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.214 -0.928 . . . . 0.0 109.998 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.76 -9.12 25.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.206 -0.934 . . . . 0.0 109.972 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.6 ' CG2' ' CB ' ' A' ' 137' ' ' TRP . 5.0 t -118.37 19.39 13.42 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.326 -0.859 . . . . 0.0 110.214 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.46 ' OD2' ' O ' ' A' ' 71' ' ' ASP . 8.4 t70 43.01 61.1 2.25 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.321 -0.862 . . . . 0.0 109.611 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.564 HG13 ' CD1' ' A' ' 137' ' ' TRP . 6.5 p -89.97 139.3 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.387 -0.821 . . . . 0.0 110.95 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.8 m -120.58 85.95 2.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.393 -0.817 . . . . 0.0 109.283 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.574 ' HA ' ' CD1' ' A' ' 132' ' ' PHE . 4.6 m -89.94 -141.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.298 -0.877 . . . . 0.0 110.508 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.446 ' N ' ' CG2' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -132.32 119.42 20.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.254 -0.904 . . . . 0.0 110.617 -179.574 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.519 ' N ' ' HD3' ' A' ' 93' ' ' PRO . . . -122.63 163.64 19.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.217 -0.927 . . . . 0.0 109.663 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.483 ' HB3' ' O ' ' A' ' 76' ' ' ALA . 1.8 pp 174.69 -157.62 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.22 -0.925 . . . . 0.0 110.283 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.472 HG12 ' O ' ' A' ' 124' ' ' GLN . 4.0 t -144.2 169.45 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.344 -0.847 . . . . 0.0 109.181 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.502 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . 172.2 179.22 42.95 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 118.993 -1.575 . . . . 0.0 110.465 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.5 ' NE2' ' O ' ' A' ' 82' ' ' GLY . 11.6 tt0 -98.15 142.16 30.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.537 -0.978 . . . . 0.0 110.119 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.466 ' OD1' ' HG2' ' A' ' 124' ' ' GLN . 5.7 m120 -95.58 86.0 4.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.276 -0.89 . . . . 0.0 109.968 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.505 ' C ' ' CE1' ' A' ' 85' ' ' TYR . . . 124.68 142.85 6.0 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.619 ' N ' ' CE1' ' A' ' 85' ' ' TYR . . . -42.67 154.12 0.3 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.211 -1.17 . . . . 0.0 110.291 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.469 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.7 Cg_endo -79.38 12.25 20.34 Favored 'Cis proline' 0 C--N 1.312 -1.356 0 C-N-CA 121.673 -2.22 . . . . 0.0 110.896 -0.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.619 ' CE1' ' N ' ' A' ' 83' ' ' ALA . 31.9 m-85 61.79 150.4 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.105 -0.997 . . . . 0.0 110.261 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.443 ' O ' ' HA2' ' A' ' 79' ' ' GLY . . . -171.95 106.9 0.24 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.7 p -96.6 140.52 31.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.195 -1.179 . . . . 0.0 110.261 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.541 HG22 ' CE2' ' A' ' 106' ' ' PHE . 17.3 m -121.71 -15.91 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.274 -0.891 . . . . 0.0 110.177 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.537 ' CD1' ' CG2' ' A' ' 88' ' ' VAL . 4.4 mp -118.74 142.36 47.76 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.285 -0.884 . . . . 0.0 110.857 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.484 ' O ' ' CG2' ' A' ' 91' ' ' THR . 2.7 m-20 -150.62 85.65 1.38 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.342 -0.849 . . . . 0.0 110.203 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.484 ' CG2' ' O ' ' A' ' 90' ' ' ASP . 3.3 p -159.55 -172.32 3.66 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.16 -0.963 . . . . 0.0 110.412 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.447 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 72.1 m -121.75 138.34 28.41 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.324 -0.86 . . . . 0.0 110.207 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.542 ' CG ' HG21 ' A' ' 74' ' ' VAL . 49.4 Cg_endo -76.75 74.29 4.94 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.977 1.514 . . . . 0.0 110.623 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.523 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -49.62 127.37 15.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.121 -0.987 . . . . 0.0 109.557 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.514 HD13 ' CD2' ' A' ' 139' ' ' LEU . 20.8 mt -125.08 165.62 17.86 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.065 -1.022 . . . . 0.0 110.808 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.462 ' O ' HG21 ' A' ' 67' ' ' THR . 0.1 OUTLIER -157.93 -178.44 7.31 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.45 -0.781 . . . . 0.0 109.923 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.6 p -67.2 -29.17 68.76 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.151 -0.968 . . . . 0.0 110.38 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.491 ' CB ' ' HD2' ' A' ' 99' ' ' PRO . 2.6 mt-10 -91.41 179.78 1.33 Allowed Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.19 -0.944 . . . . 0.0 110.12 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.491 ' HD2' ' CB ' ' A' ' 98' ' ' GLU . 46.2 Cg_endo -73.75 130.47 14.69 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.896 1.472 . . . . 0.0 110.276 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.523 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 1.3 mtt-85 -119.83 92.65 3.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.145 -0.972 . . . . 0.0 110.498 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.452 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 1.0 OUTLIER -73.16 156.59 38.47 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.339 -0.851 . . . . 0.0 109.997 179.725 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.496 HG12 ' CE2' ' A' ' 64' ' ' TYR . 49.8 t -137.02 134.32 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.202 -0.936 . . . . 0.0 110.267 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.443 ' O ' ' CG ' ' A' ' 104' ' ' GLU . 0.2 OUTLIER -150.06 120.5 7.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.231 -0.918 . . . . 0.0 110.249 -179.891 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.443 ' CG ' ' O ' ' A' ' 103' ' ' THR . 14.3 mp0 -160.01 133.73 7.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.213 -0.93 . . . . 0.0 110.222 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 24.2 m -92.22 145.05 24.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.168 -0.957 . . . . 0.0 110.228 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.541 ' CE2' HG22 ' A' ' 88' ' ' VAL . 34.0 p90 -150.21 153.33 36.07 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.312 -0.867 . . . . 0.0 110.315 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.425 ' O ' ' N ' ' A' ' 109' ' ' SER . 22.6 m -90.03 92.62 9.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.247 -0.908 . . . . 0.0 109.917 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.581 ' CB ' ' CD2' ' A' ' 60' ' ' TYR . . . -48.23 96.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.296 -0.878 . . . . 0.0 110.354 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.445 ' HA ' ' HA2' ' A' ' 57' ' ' GLY . 70.0 p -85.24 49.48 1.76 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.268 -0.895 . . . . 0.0 110.145 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.464 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -154.05 -154.16 0.5 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.268 -0.895 . . . . 0.0 110.224 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 18.8 m -150.95 112.66 4.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.268 -0.895 . . . . 0.0 110.277 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.567 ' CD2' HG13 ' A' ' 54' ' ' ILE . 14.7 m-30 -109.91 101.52 47.34 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.32 -0.863 . . . . 0.0 110.152 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.497 ' HG2' ' HA ' ' A' ' 122' ' ' GLU . 42.4 Cg_endo -71.75 136.86 28.76 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.747 1.393 . . . . 0.0 110.019 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.301 -0.874 . . . . 0.0 110.916 -179.158 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.497 ' HA ' ' HG2' ' A' ' 113' ' ' PRO . 5.8 pm0 . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 121.238 0.542 . . . . 0.0 110.056 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.475 ' HA3' ' HB3' ' A' ' 112' ' ' TYR . . . -82.76 146.66 24.54 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.524 ' HA ' ' CG2' ' A' ' 52' ' ' VAL . 7.9 pt20 -150.72 -156.22 0.7 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.206 -1.173 . . . . 0.0 110.696 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.461 ' CG2' ' CE1' ' A' ' 127' ' ' PHE . 10.7 mt -117.82 137.7 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -114.41 124.95 53.21 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.296 -0.878 . . . . 0.0 111.26 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.489 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 4.4 m-85 -118.39 95.4 4.86 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . 0.561 ' O ' ' CE2' ' A' ' 132' ' ' PHE . 3.0 mp0 -88.38 90.91 8.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.512 -0.743 . . . . 0.0 112.39 -177.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.56 ' CD2' ' CG2' ' A' ' 74' ' ' VAL . 5.4 mt -100.95 45.65 0.97 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 177.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.57 ' O ' ' CD2' ' A' ' 132' ' ' PHE . . . -96.47 136.18 12.67 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 39' ' ' GLY . . . 38.25 73.33 0.15 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.574 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 9.8 m-85 -129.41 -80.27 0.56 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.073 -1.251 . . . . 0.0 110.967 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.499 ' O ' ' HA2' ' A' ' 39' ' ' GLY . 14.0 t -89.06 100.31 13.11 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.061 -1.024 . . . . 0.0 110.462 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -30.26 -50.45 0.12 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.967 -0.458 . . . . 0.0 111.75 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.466 ' O ' ' O ' ' A' ' 133' ' ' SER . 6.7 m-20 -73.04 159.6 33.38 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.004 -1.06 . . . . 0.0 110.038 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.557 ' CA ' ' HA ' ' A' ' 38' ' ' ALA . . . -80.57 146.88 31.04 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.358 -0.838 . . . . 0.0 110.355 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.668 ' CZ2' ' CG1' ' A' ' 36' ' ' VAL . 4.6 p90 -155.58 -166.8 2.33 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.222 -0.924 . . . . 0.0 111.012 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.505 ' CG2' ' SG ' ' A' ' 33' ' ' CYS 0.254 0.7 OUTLIER -149.5 169.07 21.76 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -178.236 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.532 ' O ' ' HA ' ' A' ' 33' ' ' CYS . 1.8 mp -133.02 116.91 16.97 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.826 -1.171 . . . . 0.0 111.82 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' CYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 0.8 OUTLIER -102.06 109.53 21.27 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.747 -0.596 . . . . 0.0 111.081 178.895 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.496 ' O ' ' CB ' ' A' ' 142' ' ' ASP . 1.5 mt -100.42 -179.0 3.98 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.294 -0.879 . . . . 0.0 108.679 178.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.52 ' O ' ' CG2' ' A' ' 8' ' ' THR . 1.8 p30 167.14 57.9 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.167 -0.958 . . . . 0.0 110.486 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.514 ' N ' ' HA ' ' A' ' 8' ' ' THR . 0.4 OUTLIER 167.35 44.62 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.263 -0.898 . . . . 0.0 109.664 179.838 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 1.9 t -89.92 114.09 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.434 -0.791 . . . . 0.0 110.205 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.527 ' CB ' ' HA ' ' A' ' 6' ' ' GLU . . . -145.8 155.17 42.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.315 -0.866 . . . . 0.0 110.168 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.52 ' CD2' HD13 ' A' ' 54' ' ' ILE . 10.2 tp -153.83 123.55 6.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.317 -0.864 . . . . 0.0 110.169 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.459 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 11.1 t0 -136.02 147.52 47.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.256 -0.903 . . . . 0.0 110.281 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.583 ' CB ' ' CE1' ' A' ' 60' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.333 -0.854 . . . . 0.0 110.205 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo . . . . . 0 N--CA 1.48 0.707 0 N-CA-C 110.03 -0.796 . . . . 0.0 110.03 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.521 ' CD1' ' O ' ' A' ' 144' ' ' VAL . 13.3 pt -92.04 -1.57 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.209 -0.932 . . . . 0.0 110.13 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 6' ' ' GLU . . . 75.82 43.54 22.53 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.434 ' HA ' ' HB3' ' A' ' 145' ' ' ALA . 0.8 OUTLIER 42.54 66.23 0.79 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.295 -1.121 . . . . 0.0 110.189 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.449 ' O ' ' CE1' ' A' ' 9' ' ' PHE . . . -67.82 89.69 0.2 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.468 ' O ' ' HB2' ' A' ' 9' ' ' PHE . 1.9 p -76.14 -1.29 25.41 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.238 -1.154 . . . . 0.0 110.101 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.567 ' CD1' ' HB3' ' A' ' 13' ' ' PRO . 6.3 m-30 60.32 81.42 0.18 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.33 -0.857 . . . . 0.0 110.321 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.543 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 21.0 t70 -142.26 12.22 1.97 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.225 -0.922 . . . . 0.0 110.168 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.543 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.8 OUTLIER 161.47 -24.26 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.678 -0.639 . . . . 0.0 109.609 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -161.23 86.66 0.11 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.567 ' HB3' ' CD1' ' A' ' 9' ' ' PHE . 49.6 Cg_endo -76.0 72.94 5.06 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.153 1.607 . . . . 0.0 110.963 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.446 ' C ' ' O ' ' A' ' 13' ' ' PRO . 25.6 mm-40 38.33 -92.0 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.491 -0.756 . . . . 0.0 110.782 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 13' ' ' PRO . . . -153.42 17.87 0.68 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.575 ' CE2' HD21 ' A' ' 49' ' ' LEU . 41.3 m95 -42.93 122.52 2.44 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -1.135 . . . . 0.0 110.4 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.575 ' CG2' ' CG2' ' A' ' 48' ' ' VAL . 1.9 m -119.28 153.2 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.177 -0.952 . . . . 0.0 109.865 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.47 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . . . -137.58 122.47 18.89 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.165 -0.959 . . . . 0.0 109.96 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.563 ' CZ ' ' O ' ' A' ' 46' ' ' GLY . 3.7 p90 -115.24 154.78 28.44 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.39 -0.819 . . . . 0.0 110.498 -179.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.465 ' O ' HG23 ' A' ' 45' ' ' VAL . . . 90.77 29.11 13.96 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.472 ' HB ' ' O ' ' A' ' 35' ' ' ALA . 14.2 p -146.15 -160.38 1.14 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.127 -1.219 . . . . 0.0 110.303 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.45 ' O ' ' O ' ' A' ' 23' ' ' GLY . 12.4 t0 -89.93 123.47 33.88 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 0.0 110.196 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 22' ' ' ASP . . . 43.94 -166.1 0.03 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.416 ' O ' ' O ' ' A' ' 25' ' ' LEU . 45.5 Cg_endo -73.18 162.74 39.86 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.066 1.561 . . . . 0.0 110.405 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.559 ' CD1' ' CD1' ' A' ' 32' ' ' LEU . 0.6 OUTLIER -59.37 -154.43 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.265 -0.897 . . . . 0.0 110.185 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -152.48 161.35 42.71 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.269 -0.894 . . . . 0.0 110.145 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.525 ' CG2' ' HG3' ' A' ' 13' ' ' PRO . 0.7 OUTLIER -125.22 -28.2 3.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.27 -0.894 . . . . 0.0 110.235 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.463 ' O ' ' OG1' ' A' ' 29' ' ' THR . 0.5 OUTLIER 48.48 23.48 0.61 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.216 -0.927 . . . . 0.0 110.152 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' A' ' 28' ' ' SER . 17.9 p 47.19 65.83 1.15 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.297 -0.877 . . . . 0.0 110.268 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.501 ' N ' ' HA ' ' A' ' 10' ' ' ASP . . . 169.85 -50.17 0.21 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 141' ' ' LEU . . . -150.04 141.51 23.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -1.117 . . . . 0.0 110.292 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.559 ' CD1' ' CD1' ' A' ' 25' ' ' LEU . 5.8 tt -79.96 110.87 15.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.215 -0.928 . . . . 0.0 109.921 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.486 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 88.7 m -118.43 129.2 55.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.141 -0.975 . . . . 0.0 110.708 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.522 ' CG2' ' HB2' ' A' ' 139' ' ' LEU . 17.9 m -98.83 153.06 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.301 -0.874 . . . . 0.0 109.692 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.485 ' HA ' ' OG1' ' A' ' 138' ' ' THR . . . -102.76 87.65 3.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.249 -0.907 . . . . 0.0 110.898 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.59 HG12 ' CZ2' ' A' ' 137' ' ' TRP . 57.5 t -75.98 132.14 74.67 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.161 -0.962 . . . . 0.0 109.386 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.524 ' CG ' ' OH ' ' A' ' 43' ' ' TYR . 47.8 Cg_endo -78.89 158.24 27.49 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.87 1.458 . . . . 0.0 111.114 -179.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.527 ' HA ' ' CA ' ' A' ' 136' ' ' ALA . . . -42.94 126.79 3.95 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.291 -0.881 . . . . 0.0 109.775 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 38' ' ' ALA . . . 47.92 86.67 0.01 OUTLIER Glycine 0 N--CA 1.485 1.963 0 N-CA-C 108.385 -1.886 . . . . 0.0 108.385 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.471 ' O ' HG22 ' A' ' 45' ' ' VAL . 0.8 OUTLIER -82.2 39.04 0.56 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.353 -1.086 . . . . 0.0 110.636 -179.453 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.492 ' CB ' ' HA3' ' A' ' 131' ' ' GLY . . . -105.25 20.23 19.24 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.17 -0.957 . . . . 0.0 109.756 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.572 ' HG3' ' CD2' ' A' ' 43' ' ' TYR . 17.6 pt20 -93.04 27.02 2.58 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 121.581 0.705 . . . . 0.0 109.5 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.628 ' CD1' ' N ' ' A' ' 43' ' ' TYR . 0.0 OUTLIER 159.55 6.24 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.203 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.725 179.357 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.453 ' HA2' ' HA2' ' A' ' 130' ' ' GLY . . . 67.6 100.77 0.03 OUTLIER Glycine 0 N--CA 1.487 2.042 0 O-C-N 120.502 -1.374 . . . . 0.0 109.83 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.472 ' HB ' ' O ' ' A' ' 129' ' ' LEU . 48.8 t -89.19 170.37 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.119 -1.224 . . . . 0.0 108.431 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.563 ' O ' ' CZ ' ' A' ' 19' ' ' TYR . . . 167.33 140.45 2.91 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 118.943 -1.598 . . . . 0.0 110.721 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.528 ' CG1' ' O ' ' A' ' 17' ' ' VAL . 21.3 t -105.94 132.2 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.505 -0.997 . . . . 0.0 109.605 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.575 ' CG2' ' CG2' ' A' ' 17' ' ' VAL . 35.6 m -126.9 141.03 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.923 -1.111 . . . . 0.0 110.572 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.575 HD21 ' CE2' ' A' ' 16' ' ' TRP . 14.2 tp -132.12 102.26 5.73 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.329 -0.857 . . . . 0.0 110.207 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.538 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 1.4 m-80 -80.08 122.79 27.22 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.289 -0.882 . . . . 0.0 110.424 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.423 ' O ' HG23 ' A' ' 4' ' ' ILE . . . 146.04 74.47 0.02 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.524 ' CG2' ' HA ' ' A' ' 124' ' ' GLN . 6.3 t -119.81 178.84 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.185 -1.185 . . . . 0.0 110.086 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.501 ' O ' ' CD1' ' A' ' 54' ' ' ILE . . . -132.84 84.01 2.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.174 -0.954 . . . . 0.0 110.441 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.591 ' CD1' ' CE1' ' A' ' 60' ' ' TYR . 5.6 mm -143.08 163.48 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.227 -0.92 . . . . 0.0 109.625 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.524 ' HA ' ' CB ' ' A' ' 111' ' ' THR . 8.1 tt0 -178.88 32.44 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.101 -0.999 . . . . 0.0 110.28 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 55' ' ' GLU . 2.0 tt0 179.78 -176.44 0.32 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.529 -0.732 . . . . 0.0 110.07 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.482 ' HA2' ' O ' ' A' ' 108' ' ' ALA . . . -93.41 67.07 1.7 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.255 -1.938 . . . . 0.0 108.255 178.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.589 HG21 ' CE2' ' A' ' 60' ' ' TYR . 1.0 OUTLIER -105.08 177.68 4.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.585 -0.95 . . . . 0.0 110.265 -179.036 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.584 ' N ' ' CG2' ' A' ' 58' ' ' THR . 0.6 OUTLIER -88.95 154.62 20.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.302 -0.874 . . . . 0.0 110.016 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.634 ' CD2' ' CB ' ' A' ' 108' ' ' ALA . 59.3 m-85 -155.98 124.37 5.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.346 -0.847 . . . . 0.0 110.061 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 28.9 m -94.1 115.23 27.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.204 -0.935 . . . . 0.0 110.108 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.523 HD23 ' CD2' ' A' ' 89' ' ' LEU . 19.4 tp -89.39 122.53 32.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.173 -0.954 . . . . 0.0 109.816 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.472 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 6.3 mtt180 -123.4 140.58 52.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.311 -0.868 . . . . 0.0 110.263 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.597 ' CZ ' ' CG2' ' A' ' 102' ' ' VAL . 1.6 p90 -178.28 147.53 0.43 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.41 -0.806 . . . . 0.0 109.629 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 47.6 m -119.37 91.04 3.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.115 -0.99 . . . . 0.0 110.407 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.526 ' CB ' HD22 ' A' ' 95' ' ' LEU . . . -90.06 147.65 23.52 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.366 -0.833 . . . . 0.0 110.069 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.462 HG21 ' O ' ' A' ' 96' ' ' THR . 40.7 m -146.84 131.9 18.26 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.27 -0.894 . . . . 0.0 110.442 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.531 ' HB1' ' CB ' ' A' ' 95' ' ' LEU . . . -123.85 136.57 54.46 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.35 -0.844 . . . . 0.0 109.906 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 64.5 m -65.17 -9.06 20.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.177 -0.952 . . . . 0.0 110.314 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.54 ' CG2' ' HB2' ' A' ' 137' ' ' TRP . 6.4 t -119.77 19.79 12.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.25 -0.906 . . . . 0.0 110.237 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 95' ' ' LEU . 13.2 t70 43.57 49.94 6.42 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.295 -0.878 . . . . 0.0 109.678 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.539 ' CG2' ' HB2' ' A' ' 133' ' ' SER . 8.8 p -75.47 145.64 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.429 -0.794 . . . . 0.0 110.662 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 89.7 m -119.94 86.06 2.49 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.39 -0.819 . . . . 0.0 109.339 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.583 ' HA ' ' CD1' ' A' ' 132' ' ' PHE . 15.0 m -89.5 -141.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.258 -0.901 . . . . 0.0 110.312 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.476 ' N ' HG22 ' A' ' 74' ' ' VAL . 16.0 mtm-85 -131.94 148.05 52.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.129 -0.982 . . . . 0.0 110.851 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.513 ' N ' ' HD3' ' A' ' 93' ' ' PRO . . . -148.34 155.35 41.17 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.336 -0.853 . . . . 0.0 109.998 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.585 ' CD1' ' CB ' ' A' ' 126' ' ' ALA . 2.1 pp 175.82 -160.52 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 0.0 110.294 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.521 HG22 ' CD2' ' A' ' 89' ' ' LEU . 4.3 t -147.78 167.98 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.303 -0.873 . . . . 0.0 109.597 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.512 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . 174.08 -175.76 46.54 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.33 -1.414 . . . . 0.0 110.314 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.463 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 3.5 tm0? -94.37 178.25 5.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.458 -1.025 . . . . 0.0 110.142 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.513 ' ND2' ' HG2' ' A' ' 124' ' ' GLN . 3.8 m-80 -146.53 87.75 1.73 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.248 -0.907 . . . . 0.0 110.155 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 83' ' ' ALA . . . 137.07 34.27 0.21 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.567 ' HA ' ' CD2' ' A' ' 85' ' ' TYR . . . 59.07 148.31 0.07 OUTLIER Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.133 -1.216 . . . . 0.0 110.407 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.456 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 52.4 Cg_endo -80.37 21.03 9.08 Favored 'Cis proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.761 -2.183 . . . . 0.0 111.103 -0.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.567 ' CD2' ' HA ' ' A' ' 83' ' ' ALA . 35.6 m-85 60.93 130.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.057 -1.027 . . . . 0.0 110.239 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.452 ' O ' ' HA2' ' A' ' 79' ' ' GLY . . . -151.44 99.05 0.19 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.3 p -91.16 134.15 34.78 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.287 -1.125 . . . . 0.0 110.187 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.554 HG22 ' CE1' ' A' ' 106' ' ' PHE . 32.1 m -120.24 -9.2 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.233 -0.917 . . . . 0.0 110.092 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.578 HD12 ' CZ ' ' A' ' 106' ' ' PHE . 4.2 mp -118.63 137.63 53.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.275 -0.89 . . . . 0.0 111.006 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -150.71 85.13 1.36 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.486 -0.759 . . . . 0.0 109.951 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 65.6 p -144.08 -174.28 4.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.053 -1.029 . . . . 0.0 110.698 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.2 m -119.69 116.88 32.96 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.364 -0.835 . . . . 0.0 109.947 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.537 ' HG2' ' CG2' ' A' ' 74' ' ' VAL . 44.6 Cg_endo -71.84 79.61 1.59 Allowed 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.923 1.486 . . . . 0.0 110.642 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.528 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -67.03 148.17 52.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.208 -0.932 . . . . 0.0 109.833 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.531 ' CB ' ' HB1' ' A' ' 68' ' ' ALA . 73.3 mt -134.08 176.97 8.11 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.187 -0.946 . . . . 0.0 110.475 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.462 ' O ' HG21 ' A' ' 67' ' ' THR . 0.3 OUTLIER -170.66 -179.14 2.81 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.275 -0.891 . . . . 0.0 110.14 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.63 -30.27 71.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.257 -0.902 . . . . 0.0 110.039 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.518 ' CB ' ' HD2' ' A' ' 99' ' ' PRO . 0.1 OUTLIER -93.1 179.72 1.23 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.278 -0.889 . . . . 0.0 110.042 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.518 ' HD2' ' CB ' ' A' ' 98' ' ' GLU . 44.3 Cg_endo -72.06 134.99 24.33 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.9 1.474 . . . . 0.0 110.287 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.528 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.73 85.81 2.45 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.283 -0.885 . . . . 0.0 110.25 -179.893 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.454 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 8.7 mt-30 -71.7 156.33 39.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.27 -0.894 . . . . 0.0 110.216 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.597 ' CG2' ' CZ ' ' A' ' 64' ' ' TYR . 40.7 t -139.66 138.92 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.24 -0.913 . . . . 0.0 110.166 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.07 116.34 6.53 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.252 -0.905 . . . . 0.0 110.131 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -140.88 131.87 26.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.253 -0.904 . . . . 0.0 110.245 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.4 m -89.82 65.42 6.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.181 -0.949 . . . . 0.0 110.225 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.61 ' CZ ' ' CB ' ' A' ' 60' ' ' TYR . 26.1 p90 -71.29 144.95 49.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 0.0 110.099 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.531 ' O ' ' N ' ' A' ' 109' ' ' SER . 3.5 m -89.35 92.76 9.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.17 -0.956 . . . . 0.0 109.699 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.634 ' CB ' ' CD2' ' A' ' 60' ' ' TYR . . . -45.23 92.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.37 -0.831 . . . . 0.0 110.156 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 107' ' ' THR . 81.2 p -89.45 54.68 2.99 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.332 -0.855 . . . . 0.0 109.61 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -163.34 -155.2 0.31 Allowed 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.465 -0.894 . . . . 0.0 110.678 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.524 ' CB ' ' HA ' ' A' ' 55' ' ' GLU . 4.5 m -148.14 118.58 7.4 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.294 -0.879 . . . . 0.0 110.587 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.577 ' CD2' HG13 ' A' ' 54' ' ' ILE . 15.8 m-30 -112.61 85.52 7.48 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.497 -0.752 . . . . 0.0 109.542 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.475 ' O ' ' HA ' ' A' ' 122' ' ' GLU . 43.4 Cg_endo -69.97 127.77 14.9 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 123.86 1.453 . . . . 0.0 110.49 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.318 -0.864 . . . . 0.0 110.395 -179.796 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.475 ' HA ' ' O ' ' A' ' 113' ' ' PRO . 0.9 OUTLIER . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 121.298 0.57 . . . . 0.0 110.663 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.576 ' HA3' ' CG ' ' A' ' 112' ' ' TYR . . . -106.51 155.55 16.51 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.538 ' CB ' ' HA ' ' A' ' 50' ' ' ASN . 1.1 pt20 -150.4 -160.15 1.13 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.168 -1.195 . . . . 0.0 110.719 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.463 ' CG2' ' CE1' ' A' ' 127' ' ' PHE . 18.3 mt -118.34 142.65 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.585 ' CB ' ' CD1' ' A' ' 77' ' ' LEU . . . -118.03 120.98 39.43 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.249 -0.907 . . . . 0.0 111.439 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.489 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 4.9 m-85 -118.79 100.79 7.62 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . 0.543 ' O ' ' CE2' ' A' ' 132' ' ' PHE . 32.1 mm-40 -89.47 103.15 15.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.127 -0.983 . . . . 0.0 112.313 -177.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.53 ' CD2' HG23 ' A' ' 74' ' ' VAL . 11.5 mt -100.68 41.04 1.2 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 177.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.453 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -67.61 85.68 0.15 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 -179.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.492 ' HA3' ' CB ' ' A' ' 41' ' ' ALA . . . 40.57 79.23 0.05 OUTLIER Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.583 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 10.5 m-85 -107.28 -42.64 4.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.171 -1.194 . . . . 0.0 110.183 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.604 ' HB3' ' CE3' ' A' ' 137' ' ' TRP . 1.2 t -89.81 -176.5 4.97 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.198 -0.938 . . . . 0.0 110.238 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.46 ' N ' ' OG ' ' A' ' 133' ' ' SER . . . -96.69 -92.23 0.23 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.122 -0.986 . . . . 0.0 110.855 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -63.63 170.75 3.03 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.187 -0.946 . . . . 0.0 110.637 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.527 ' CA ' ' HA ' ' A' ' 38' ' ' ALA . . . -52.92 136.53 34.37 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.392 -0.817 . . . . 0.0 110.397 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.604 ' CE3' ' HB3' ' A' ' 133' ' ' SER . 8.1 p90 -145.17 -167.55 2.71 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.314 -0.866 . . . . 0.0 110.336 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.538 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 0.5 OUTLIER -160.35 165.96 30.27 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.214 -0.929 . . . . 0.0 110.398 -178.729 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.522 ' HB2' ' CG2' ' A' ' 34' ' ' VAL . 2.4 mp -119.52 161.32 20.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.434 -0.791 . . . . 0.0 109.209 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' CYS . . . . . . . . . . . . . 1.9 m -150.58 94.44 2.1 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.069 -1.019 . . . . 0.0 111.209 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.488 ' O ' ' HB3' ' A' ' 142' ' ' ASP . 0.9 OUTLIER -95.14 -176.03 3.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.229 -0.919 . . . . 0.0 108.903 178.754 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.488 ' HB3' ' O ' ' A' ' 141' ' ' LEU . 0.5 OUTLIER 170.2 37.25 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.051 -1.031 . . . . 0.0 110.631 179.912 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.467 ' O ' ' O ' ' A' ' 63' ' ' ARG . 34.5 t0 179.35 48.75 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.184 -0.948 . . . . 0.0 110.056 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.521 ' O ' ' CD1' ' A' ' 4' ' ' ILE . 2.8 t -89.77 113.51 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.369 -0.832 . . . . 0.0 110.08 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.434 ' HB3' ' HA ' ' A' ' 6' ' ' GLU . . . -144.4 163.19 34.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.263 -0.898 . . . . 0.0 110.219 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.518 ' CD1' ' HB3' ' A' ' 60' ' ' TYR . 16.3 tp -145.99 128.87 16.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.27 -0.894 . . . . 0.0 110.218 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.581 ' O ' ' CD1' ' A' ' 60' ' ' TYR . 0.3 OUTLIER -135.75 -154.15 0.55 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.302 -0.874 . . . . 0.0 110.238 179.988 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 48.3 p . . . . . 0 N--CA 1.492 1.665 0 O-C-N 121.273 -0.892 . . . . 0.0 110.116 179.991 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo . . . . . 0 N--CA 1.48 0.69 0 N-CA-C 110.097 -0.77 . . . . 0.0 110.097 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.499 HD11 HG22 ' A' ' 4' ' ' ILE . 7.8 pt -120.52 -3.62 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.181 -0.95 . . . . 0.0 110.128 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 6' ' ' GLU . . . 97.52 139.17 10.54 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 5' ' ' GLY . 0.4 OUTLIER -42.76 -85.5 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.241 -1.152 . . . . 0.0 110.126 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.469 ' HA2' ' HA ' ' A' ' 143' ' ' ASP . . . -80.85 127.66 8.03 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.538 ' CG2' ' O ' ' A' ' 144' ' ' VAL . 16.3 p -107.0 163.89 12.6 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.147 -1.208 . . . . 0.0 110.64 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.604 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.1 m-30 65.89 9.79 6.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.452 -0.78 . . . . 0.0 110.229 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.552 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 4.0 p-10 -86.12 41.66 0.94 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.159 -0.963 . . . . 0.0 109.885 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.552 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 2.1 t70 161.3 -24.17 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 172.91 164.21 27.95 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.48 ' O ' ' C ' ' A' ' 14' ' ' GLU . 44.1 Cg_endo -71.17 81.56 1.16 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.011 1.532 . . . . 0.0 110.442 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.48 ' C ' ' O ' ' A' ' 13' ' ' PRO . 1.0 OUTLIER -31.42 -68.2 0.09 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.275 0.559 . . . . 0.0 111.163 -179.636 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.495 ' C ' ' CD1' ' A' ' 49' ' ' LEU . . . -152.47 14.05 0.71 Allowed Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.765 -1.207 . . . . 0.0 110.218 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.581 ' NE1' ' CD2' ' A' ' 49' ' ' LEU . 24.2 m95 -77.77 110.08 12.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.028 -1.278 . . . . 0.0 110.244 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.506 ' CG2' ' O ' ' A' ' 17' ' ' VAL . 2.2 m -100.64 125.67 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.238 -0.914 . . . . 0.0 110.068 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.574 ' CB ' ' CG1' ' A' ' 34' ' ' VAL . . . -104.17 119.32 38.69 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.156 -0.965 . . . . 0.0 110.093 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.588 ' CZ ' ' O ' ' A' ' 46' ' ' GLY . 6.2 p90 -112.42 148.05 35.16 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.298 -0.876 . . . . 0.0 110.458 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.537 ' CA ' ' OH ' ' A' ' 43' ' ' TYR . . . 96.82 34.62 5.66 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.481 ' CG2' ' C ' ' A' ' 20' ' ' GLY . 7.3 p -150.21 -147.31 0.22 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.137 -1.214 . . . . 0.0 110.407 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 23' ' ' GLY . 62.2 t0 -89.96 114.77 26.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.334 -0.854 . . . . 0.0 110.33 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 43.16 -155.52 0.16 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.32 157.32 49.94 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 124.031 1.543 . . . . 0.0 110.493 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.423 ' CD1' HD12 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -53.63 179.8 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.254 -0.904 . . . . 0.0 110.201 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -152.58 142.33 21.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.27 -0.894 . . . . 0.0 110.196 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.5 ' CG2' ' HA ' ' A' ' 32' ' ' LEU . 2.2 p -119.64 -79.97 0.61 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.295 -0.878 . . . . 0.0 110.031 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.42 ' OG ' ' C ' ' A' ' 27' ' ' THR . 1.6 p 40.44 27.46 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.384 -0.822 . . . . 0.0 110.645 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.454 ' N ' ' O ' ' A' ' 27' ' ' THR . 12.8 t -148.7 13.93 0.93 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.139 -0.976 . . . . 0.0 110.364 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 9' ' ' PHE . . . 75.48 7.86 83.3 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.462 ' HB2' ' O ' ' A' ' 141' ' ' LEU . . . -150.35 151.38 32.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.256 -1.144 . . . . 0.0 110.118 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.57 ' HB2' ' CG ' ' A' ' 9' ' ' PHE . 0.5 OUTLIER -79.85 114.56 18.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.123 -0.986 . . . . 0.0 109.822 179.829 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 67.0 m -120.93 118.27 29.46 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.184 -0.947 . . . . 0.0 110.745 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.574 ' CG1' ' CB ' ' A' ' 18' ' ' ALA . 15.3 m -99.52 135.38 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.35 -0.844 . . . . 0.0 109.494 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.466 ' HA ' ' OG1' ' A' ' 138' ' ' THR . . . -89.47 89.74 7.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.207 -0.933 . . . . 0.0 111.089 -179.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.591 HG13 ' CE2' ' A' ' 137' ' ' TRP . 53.1 t -69.87 134.53 87.89 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.245 -0.91 . . . . 0.0 109.416 179.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 21' ' ' THR . 47.2 Cg_endo -76.68 152.85 33.53 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.944 1.497 . . . . 0.0 111.325 -178.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.529 ' HA ' ' CA ' ' A' ' 136' ' ' ALA . . . -43.89 130.99 5.74 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.373 -0.83 . . . . 0.0 109.884 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 38' ' ' ALA . . . 45.24 78.18 0.08 OUTLIER Glycine 0 N--CA 1.487 2.041 0 N-CA-C 108.724 -1.75 . . . . 0.0 108.724 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.501 ' HB2' ' CG2' ' A' ' 45' ' ' VAL . 1.1 p -82.76 40.33 0.67 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.304 -1.115 . . . . 0.0 110.473 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.532 ' CB ' ' HA3' ' A' ' 131' ' ' GLY . . . -109.1 25.13 12.17 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.361 -0.837 . . . . 0.0 109.767 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.503 ' O ' ' HB3' ' A' ' 43' ' ' TYR . 16.3 pt20 -78.14 2.7 17.19 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.637 0.732 . . . . 0.0 110.542 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.537 ' OH ' ' CA ' ' A' ' 20' ' ' GLY . 2.5 p90 177.26 -32.52 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.508 ' O ' ' CE2' ' A' ' 43' ' ' TYR . . . 123.48 104.47 1.68 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 110.266 -1.133 . . . . 0.0 110.266 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.501 ' CG2' ' HB2' ' A' ' 40' ' ' SER . 39.8 t -89.7 177.27 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.066 -1.255 . . . . 0.0 108.502 178.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.588 ' O ' ' CZ ' ' A' ' 19' ' ' TYR . . . 160.55 140.11 2.81 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 118.491 -1.814 . . . . 0.0 111.66 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.523 ' O ' ' CG1' ' A' ' 48' ' ' VAL . 21.5 t -100.53 162.17 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.644 -0.915 . . . . 0.0 108.693 178.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.523 ' CG1' ' O ' ' A' ' 47' ' ' VAL . 15.6 m -157.25 157.61 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.841 -1.162 . . . . 0.0 110.71 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.581 ' CD2' ' NE1' ' A' ' 16' ' ' TRP . 13.8 tp -151.33 120.28 6.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.327 -0.858 . . . . 0.0 110.351 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.497 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 23.7 p30 -96.26 158.24 15.53 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.216 -0.927 . . . . 0.0 110.234 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.11 74.4 0.62 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.446 HG13 HG12 ' A' ' 54' ' ' ILE . 87.2 t -138.83 172.43 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.173 -1.193 . . . . 0.0 110.177 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.465 ' O ' HD12 ' A' ' 54' ' ' ILE . . . -139.5 101.19 4.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.173 -0.955 . . . . 0.0 110.409 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.65 ' CG1' ' CD2' ' A' ' 112' ' ' TYR . 45.0 mm -126.34 173.13 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.248 -0.907 . . . . 0.0 109.987 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.527 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -164.74 128.59 2.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.118 -0.989 . . . . 0.0 110.814 -179.923 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 8.3 pt-20 37.74 -153.31 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.673 -0.642 . . . . 0.0 110.999 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 108' ' ' ALA . . . -87.03 75.67 2.16 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.556 ' CG2' ' N ' ' A' ' 59' ' ' THR . 1.3 m -101.67 173.61 6.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.334 -1.098 . . . . 0.0 109.807 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.575 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 0.7 OUTLIER -89.96 153.27 20.73 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.235 -0.916 . . . . 0.0 110.559 -179.577 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.612 ' CD2' ' CB ' ' A' ' 108' ' ' ALA . 64.3 m-85 -159.96 123.12 3.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.311 -0.868 . . . . 0.0 110.01 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 30.6 m -89.88 115.35 27.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.161 -0.962 . . . . 0.0 110.167 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.2 tp -89.5 126.27 35.52 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.232 -0.918 . . . . 0.0 109.907 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.496 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 14.3 ttp85 -131.16 136.49 48.36 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.385 -0.822 . . . . 0.0 110.107 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.636 ' CZ ' ' CG2' ' A' ' 102' ' ' VAL . 0.6 OUTLIER -178.46 143.2 0.26 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.383 -0.823 . . . . 0.0 109.57 179.678 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.464 ' CG2' ' HA ' ' A' ' 101' ' ' GLN . 0.2 OUTLIER -119.26 93.35 4.05 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.149 -0.969 . . . . 0.0 110.434 -179.466 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.517 ' HB1' ' CD2' ' A' ' 141' ' ' LEU . . . -94.81 153.95 17.49 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.293 -0.879 . . . . 0.0 110.119 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.466 ' OG1' ' HA ' ' A' ' 99' ' ' PRO . 51.9 m -150.14 135.65 18.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.22 -0.925 . . . . 0.0 110.363 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' A' ' 138' ' ' THR . . . -126.14 140.06 52.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.282 -0.886 . . . . 0.0 110.013 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.9 m -71.2 -3.71 21.67 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.22 -0.925 . . . . 0.0 110.113 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.548 ' CG2' ' HB2' ' A' ' 137' ' ' TRP . 6.3 t -124.62 19.84 8.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 110.096 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.466 ' OD1' ' O ' ' A' ' 95' ' ' LEU . 14.9 t0 43.51 60.77 2.48 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.272 -0.892 . . . . 0.0 109.558 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.528 ' CG2' ' HB2' ' A' ' 133' ' ' SER . 5.5 p -87.07 140.96 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.463 -0.773 . . . . 0.0 110.87 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 23.2 m -119.86 87.88 2.83 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.483 -0.761 . . . . 0.0 109.107 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.578 ' HA ' ' CG ' ' A' ' 132' ' ' PHE . 19.2 m -89.73 -146.15 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -0.906 . . . . 0.0 110.382 -179.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -127.16 124.14 38.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.244 -0.91 . . . . 0.0 110.434 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.511 ' N ' ' HD3' ' A' ' 93' ' ' PRO . . . -126.99 158.67 36.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.309 -0.869 . . . . 0.0 109.666 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.503 ' HA ' ' HB3' ' A' ' 89' ' ' LEU . 3.4 pp 177.87 -157.33 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.19 -0.944 . . . . 0.0 110.475 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.526 ' CG2' HD11 ' A' ' 89' ' ' LEU . 9.8 t -143.56 -178.21 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.339 -0.851 . . . . 0.0 109.558 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.537 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . 161.56 -154.93 26.03 Favored Glycine 0 N--CA 1.49 2.274 0 C-N-CA 119.303 -1.427 . . . . 0.0 110.053 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.566 ' HB3' ' CD1' ' A' ' 112' ' ' TYR . 6.2 pt20 -135.21 158.36 44.56 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.469 -1.018 . . . . 0.0 110.356 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.468 ' HB2' ' HG2' ' A' ' 122' ' ' GLU . 2.4 m120 -107.23 97.22 7.01 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.315 -0.866 . . . . 0.0 110.038 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.542 ' C ' ' CE1' ' A' ' 85' ' ' TYR . . . 138.44 143.01 4.4 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.593 ' N ' ' CE1' ' A' ' 85' ' ' TYR . . . -65.95 155.7 86.08 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.262 -1.14 . . . . 0.0 110.222 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.533 ' C ' ' CD2' ' A' ' 85' ' ' TYR . 50.6 Cg_endo -77.48 8.94 17.83 Favored 'Cis proline' 0 C--N 1.313 -1.322 0 C-N-CA 121.637 -2.235 . . . . 0.0 110.905 0.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.593 ' CE1' ' N ' ' A' ' 83' ' ' ALA . 10.5 m-85 69.33 -171.23 0.18 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.231 -0.918 . . . . 0.0 110.214 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 153.46 107.27 0.31 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.464 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 4.1 p -96.05 167.84 10.98 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.211 -1.17 . . . . 0.0 110.391 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.554 ' CG1' ' N ' ' A' ' 109' ' ' SER . 5.4 m -135.5 -32.76 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.364 -0.835 . . . . 0.0 110.324 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.579 HD12 ' CZ ' ' A' ' 106' ' ' PHE . 4.3 mp -98.3 144.24 27.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -0.909 . . . . 0.0 110.859 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 17.4 p-10 -151.08 86.11 1.36 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.324 -0.86 . . . . 0.0 110.172 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.419 ' CG2' ' O ' ' A' ' 90' ' ' ASP . 2.4 p -157.52 -175.03 5.16 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.024 -1.047 . . . . 0.0 110.531 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.49 130.47 24.78 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.326 -0.858 . . . . 0.0 110.172 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.529 ' HG2' ' CG2' ' A' ' 74' ' ' VAL . 49.7 Cg_endo -75.44 80.58 2.49 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.961 1.506 . . . . 0.0 110.87 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.535 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -56.55 135.63 54.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.059 -1.025 . . . . 0.0 109.479 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.492 ' CD1' ' CD2' ' A' ' 139' ' ' LEU . 93.4 mt -125.16 176.22 6.87 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.032 -1.043 . . . . 0.0 110.691 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.467 HG23 ' HG3' ' A' ' 100' ' ' ARG . 0.3 OUTLIER -167.9 -178.92 3.97 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.43 -0.794 . . . . 0.0 110.039 179.922 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.4 -29.87 70.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.196 -0.94 . . . . 0.0 110.281 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.457 ' CB ' ' HD2' ' A' ' 99' ' ' PRO . 3.7 mt-10 -90.28 176.7 2.8 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.172 -0.955 . . . . 0.0 110.14 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.466 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 45.4 Cg_endo -72.19 134.44 23.05 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.956 1.503 . . . . 0.0 110.334 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.535 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.9 92.94 3.9 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.191 -0.943 . . . . 0.0 110.368 -179.868 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.464 ' HA ' ' CG2' ' A' ' 65' ' ' THR . 6.4 tp-100 -76.71 154.92 33.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.292 -0.88 . . . . 0.0 110.085 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.636 ' CG2' ' CZ ' ' A' ' 64' ' ' TYR . 32.2 t -131.72 134.47 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.232 -0.917 . . . . 0.0 110.194 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.25 115.61 5.45 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.275 -0.891 . . . . 0.0 110.138 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -159.88 131.19 5.95 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.207 -0.933 . . . . 0.0 110.32 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.6 m -89.97 105.25 17.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.261 -0.899 . . . . 0.0 110.06 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.579 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 34.4 p90 -106.83 154.28 21.25 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.275 -0.89 . . . . 0.0 110.447 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 58' ' ' THR . 33.0 m -91.29 89.8 7.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.28 -0.888 . . . . 0.0 109.691 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.612 ' CB ' ' CD2' ' A' ' 60' ' ' TYR . . . -41.94 101.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.329 -0.857 . . . . 0.0 110.452 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.554 ' N ' ' CG1' ' A' ' 88' ' ' VAL . 88.8 p -85.89 55.55 3.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.3 -0.875 . . . . 0.0 110.063 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.465 ' HB1' HG12 ' A' ' 88' ' ' VAL . . . -159.55 -154.96 0.43 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.282 -0.886 . . . . 0.0 110.131 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.432 ' C ' ' CD1' ' A' ' 112' ' ' TYR . 19.7 m -159.99 110.89 1.92 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.111 -0.993 . . . . 0.0 110.591 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.65 ' CD2' ' CG1' ' A' ' 54' ' ' ILE . 3.3 m-30 -112.99 106.72 54.92 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.188 -0.945 . . . . 0.0 109.84 179.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.63 -159.02 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.785 1.413 . . . . 0.0 110.094 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.106 -0.996 . . . . 0.0 110.322 -179.969 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 80' ' ' GLN . 1.4 pt-20 . . . . . 0 N--CA 1.494 1.769 0 CA-C-O 121.163 0.506 . . . . 0.0 110.303 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.534 ' CA ' ' HB3' ' A' ' 112' ' ' TYR . . . -130.15 131.81 6.73 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.497 ' CB ' ' HA ' ' A' ' 50' ' ' ASN . 1.5 pt20 -150.43 -174.23 4.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.145 -1.209 . . . . 0.0 110.78 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.443 HG23 ' CH2' ' A' ' 16' ' ' TRP . 8.8 mt -118.74 143.87 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.488 ' HB2' ' CD1' ' A' ' 77' ' ' LEU . . . -115.15 119.65 37.11 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.286 -0.884 . . . . 0.0 111.275 -179.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.437 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 2.6 m-30 -117.34 94.08 4.42 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -89.25 105.08 17.55 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.084 -1.01 . . . . 0.0 111.524 -178.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.544 ' CD2' HG22 ' A' ' 74' ' ' VAL . 14.8 mt -100.13 50.09 0.91 Allowed 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.469 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -69.51 84.12 0.27 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.019 -1.233 . . . . 0.0 110.019 -179.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.532 ' HA3' ' CB ' ' A' ' 41' ' ' ALA . . . 39.02 72.47 0.2 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.578 ' CG ' ' HA ' ' A' ' 74' ' ' VAL . 10.5 m-85 -97.89 -39.64 8.89 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.136 -1.214 . . . . 0.0 110.124 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.6 ' HB3' ' CE3' ' A' ' 137' ' ' TRP . 1.2 t -89.69 -176.08 4.86 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.239 -0.913 . . . . 0.0 109.915 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.451 ' N ' ' OG ' ' A' ' 133' ' ' SER . . . -93.9 -99.48 0.14 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.033 -1.042 . . . . 0.0 110.982 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -61.17 177.51 0.34 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.993 -1.067 . . . . 0.0 110.853 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.529 ' CA ' ' HA ' ' A' ' 38' ' ' ALA . . . -53.52 136.5 38.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.472 -0.767 . . . . 0.0 110.342 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.6 ' CE3' ' HB3' ' A' ' 133' ' ' SER . 5.7 p90 -145.5 -170.16 3.38 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.372 -0.83 . . . . 0.0 110.157 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.537 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 0.5 OUTLIER -160.34 159.91 31.76 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.244 -0.983 . . . . 0.0 110.812 -178.789 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.492 ' CD2' ' CD1' ' A' ' 95' ' ' LEU . 2.2 mp -119.34 160.37 22.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.423 -0.798 . . . . 0.0 109.303 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' CYS . . . . . . . . . . . . . 13.6 m -150.53 100.55 2.87 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.128 -0.982 . . . . 0.0 110.598 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.521 ' O ' ' CB ' ' A' ' 142' ' ' ASP . 0.9 OUTLIER -96.44 -176.75 3.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.3 -0.875 . . . . 0.0 109.446 179.321 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.573 ' O ' ' CB ' ' A' ' 143' ' ' ASP . 2.4 p30 166.72 61.52 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.324 -0.86 . . . . 0.0 110.042 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.573 ' CB ' ' O ' ' A' ' 142' ' ' ASP . 1.4 m-20 159.85 46.52 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.538 ' O ' ' CG2' ' A' ' 8' ' ' THR . 3.5 t -89.64 112.04 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.329 -0.857 . . . . 0.0 110.466 -179.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -135.3 151.93 51.01 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.223 -0.923 . . . . 0.0 110.187 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 58.8 tp -151.61 124.67 8.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.335 -0.853 . . . . 0.0 110.194 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.451 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 3.5 t0 -161.07 156.43 24.53 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.278 -0.889 . . . . 0.0 110.326 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 59' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.259 -0.901 . . . . 0.0 110.167 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo . . . . . 0 N--CA 1.48 0.695 0 N-CA-C 110.159 -0.746 . . . . 0.0 110.159 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.51 ' CD1' ' HB ' ' A' ' 144' ' ' VAL . 6.1 pt -89.9 -0.05 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.234 -0.916 . . . . 0.0 110.18 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 6' ' ' GLU . . . 119.69 -24.42 8.0 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.527 ' HG3' ' CB ' ' A' ' 145' ' ' ALA . 4.3 tt0 43.06 48.68 5.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.308 -1.113 . . . . 0.0 110.153 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 143' ' ' ASP . . . -134.81 159.17 23.83 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.463 ' HA ' ' HB2' ' A' ' 143' ' ' ASP . 1.2 p -51.29 -179.0 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.291 -1.123 . . . . 0.0 110.345 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.574 ' CZ ' HG22 ' A' ' 144' ' ' VAL . 3.2 m-30 -110.78 24.83 12.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.292 -0.88 . . . . 0.0 110.283 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.565 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 29.6 t70 -110.74 50.91 0.79 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.172 -0.955 . . . . 0.0 110.209 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.565 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.3 OUTLIER 161.61 66.49 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.572 -0.705 . . . . 0.0 109.927 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.08 94.39 0.67 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.476 ' O ' ' HB3' ' A' ' 14' ' ' GLU . 51.1 Cg_endo -81.8 46.19 2.16 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.113 1.586 . . . . 0.0 110.63 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.476 ' HB3' ' O ' ' A' ' 13' ' ' PRO . 12.7 tp10 56.85 -90.97 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.155 -0.966 . . . . 0.0 110.187 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.486 ' C ' ' CD1' ' A' ' 49' ' ' LEU . . . -154.61 31.73 0.69 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.637 ' CE2' ' CD2' ' A' ' 49' ' ' LEU . 61.3 m95 -69.3 84.45 0.38 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.283 -1.127 . . . . 0.0 110.297 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.568 ' CG2' ' CG2' ' A' ' 48' ' ' VAL . 1.3 m -89.64 148.05 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.149 -0.97 . . . . 0.0 109.804 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.532 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . . . -124.58 135.75 53.39 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.095 -1.003 . . . . 0.0 109.893 179.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.517 ' CE1' HG12 ' A' ' 48' ' ' VAL . 20.1 p90 -124.69 168.51 13.08 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.385 -0.822 . . . . 0.0 110.753 -178.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.495 ' C ' ' CG2' ' A' ' 21' ' ' THR . . . 68.71 42.68 78.9 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.495 ' CG2' ' C ' ' A' ' 20' ' ' GLY . 1.8 p -151.35 -147.55 0.23 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.088 -1.242 . . . . 0.0 110.245 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.419 ' O ' ' O ' ' A' ' 23' ' ' GLY . 1.1 t70 -108.86 117.31 33.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.308 -0.87 . . . . 0.0 110.165 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 22' ' ' ASP . . . 52.83 177.15 0.06 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.02 151.12 49.69 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.965 1.508 . . . . 0.0 110.447 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.462 HD12 ' O ' ' A' ' 16' ' ' TRP . 0.8 OUTLIER -49.02 161.86 0.13 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.333 -0.855 . . . . 0.0 110.228 179.945 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -121.34 132.29 54.69 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.241 -0.912 . . . . 0.0 110.046 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 31' ' ' ALA . 0.7 OUTLIER -120.33 -24.93 5.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.216 -0.927 . . . . 0.0 110.61 -179.797 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 27' ' ' THR . 0.6 OUTLIER -43.93 -25.81 0.23 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.134 -0.978 . . . . 0.0 110.176 -179.828 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.412 ' N ' ' O ' ' A' ' 27' ' ' THR . 6.2 t -62.97 -47.51 82.83 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.271 -0.893 . . . . 0.0 110.686 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.401 ' N ' ' CG2' ' A' ' 29' ' ' THR . . . 161.03 -20.64 0.21 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.856 -1.297 . . . . 0.0 109.856 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.471 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -150.12 -176.08 5.31 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.167 -1.196 . . . . 0.0 109.965 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.568 ' HB2' ' CD2' ' A' ' 9' ' ' PHE . 0.7 OUTLIER -87.51 94.9 9.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.108 -0.995 . . . . 0.0 109.949 179.801 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 89.4 m -110.54 106.68 16.05 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.149 -0.969 . . . . 0.0 110.748 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.499 ' O ' ' OG1' ' A' ' 138' ' ' THR . 22.4 m -89.72 138.79 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.292 -0.88 . . . . 0.0 109.178 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.467 ' O ' ' HB ' ' A' ' 21' ' ' THR . . . -89.0 93.15 9.5 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.141 -0.975 . . . . 0.0 111.337 -178.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.635 ' CG1' ' CZ2' ' A' ' 137' ' ' TRP . 75.3 t -70.53 135.3 86.26 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.341 -0.849 . . . . 0.0 109.372 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.502 ' HD2' HG11 ' A' ' 36' ' ' VAL . 41.4 Cg_endo -68.56 172.28 11.7 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.727 1.383 . . . . 0.0 111.542 -178.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.525 ' HA ' ' CA ' ' A' ' 136' ' ' ALA . . . -70.47 115.32 9.51 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.39 -0.819 . . . . 0.0 110.447 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.476 ' O ' ' N ' ' A' ' 41' ' ' ALA . . . 83.79 -40.63 2.9 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.561 ' CB ' ' HA2' ' A' ' 130' ' ' GLY . 1.5 m 38.3 30.48 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.542 -0.975 . . . . 0.0 110.146 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 39' ' ' GLY . . . -89.6 23.22 2.7 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.973 0.892 . . . . 0.0 110.08 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.589 ' O ' ' CG ' ' A' ' 43' ' ' TYR . 9.7 pm0 -108.67 126.9 53.49 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.589 ' CG ' ' O ' ' A' ' 42' ' ' GLN . 43.9 p90 39.45 27.88 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.515 -0.741 . . . . 0.0 109.927 -178.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 42' ' ' GLN . . . 51.17 173.84 0.02 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.602 ' N ' ' HA3' ' A' ' 130' ' ' GLY . 43.5 t -142.0 -179.07 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 179.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.524 ' HA2' ' O ' ' A' ' 127' ' ' PHE . . . 164.22 -163.39 36.0 Favored Glycine 0 N--CA 1.484 1.852 0 C-N-CA 117.345 -2.36 . . . . 0.0 112.734 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.532 ' HA ' ' HA ' ' A' ' 18' ' ' ALA . 38.5 t -150.98 132.09 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.568 ' CG2' ' CG2' ' A' ' 17' ' ' VAL . 35.7 m -119.51 138.93 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.917 -1.115 . . . . 0.0 110.833 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.637 ' CD2' ' CE2' ' A' ' 16' ' ' TRP . 20.1 tp -133.69 97.68 3.99 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.373 -0.829 . . . . 0.0 110.236 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.53 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 8.6 p30 -81.11 113.61 19.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.218 -0.926 . . . . 0.0 110.239 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.453 ' O ' HG21 ' A' ' 4' ' ' ILE . . . 154.89 64.25 0.01 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.516 ' CG2' ' HA ' ' A' ' 124' ' ' GLN . 3.2 t -119.95 -176.18 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.237 -1.155 . . . . 0.0 109.881 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -142.49 75.14 1.48 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.074 -1.016 . . . . 0.0 110.634 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.538 HG13 ' CD2' ' A' ' 112' ' ' TYR . 32.5 mm -113.78 162.29 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.098 -1.001 . . . . 0.0 109.971 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.526 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 18.4 tt0 -162.25 132.31 4.68 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.176 -0.952 . . . . 0.0 110.605 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.526 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 15.2 pt-20 38.13 -160.25 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.67 -0.644 . . . . 0.0 110.916 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 109' ' ' SER . . . -80.63 74.88 2.32 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.571 HG21 ' CE2' ' A' ' 60' ' ' TYR . 1.3 m -104.17 168.2 9.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.351 -1.087 . . . . 0.0 109.868 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.571 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 3.1 m -89.99 157.98 17.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.177 -0.952 . . . . 0.0 110.264 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.574 ' CD2' ' HB1' ' A' ' 108' ' ' ALA . 66.5 m-85 -158.95 173.79 15.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.225 -0.922 . . . . 0.0 110.37 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.515 ' OG1' ' CG2' ' A' ' 105' ' ' THR . 22.1 m -150.16 113.98 5.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.355 -0.841 . . . . 0.0 110.034 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.463 HD13 ' N ' ' A' ' 63' ' ' ARG . 10.3 tp -89.66 121.96 32.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.16 -0.963 . . . . 0.0 110.077 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.463 ' N ' HD13 ' A' ' 62' ' ' LEU . 9.5 ttt-85 -127.63 107.16 9.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 110.489 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.563 ' CE2' ' HB ' ' A' ' 102' ' ' VAL . 7.8 p90 -143.34 172.33 12.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.333 -0.854 . . . . 0.0 109.915 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 101' ' ' GLN . 5.0 m -131.27 94.91 3.66 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.171 -0.956 . . . . 0.0 110.226 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 100' ' ' ARG . . . -99.6 142.1 31.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -0.898 . . . . 0.0 110.398 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.453 ' OG1' ' HA ' ' A' ' 99' ' ' PRO . 93.3 m -150.37 101.86 3.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.403 -0.811 . . . . 0.0 110.048 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -89.81 144.07 26.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.192 -0.942 . . . . 0.0 110.105 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.4 m -60.59 -15.01 23.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.147 -0.971 . . . . 0.0 109.225 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.535 ' CG2' ' HB2' ' A' ' 137' ' ' TRP . 3.0 t -121.71 160.18 25.05 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.592 -0.693 . . . . 0.0 109.809 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -77.94 79.7 4.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.044 -1.035 . . . . 0.0 108.927 178.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.562 HG22 ' CE2' ' A' ' 137' ' ' TRP . 3.7 p -99.56 135.31 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.199 -0.938 . . . . 0.0 111.654 -178.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.403 HG21 ' HB2' ' A' ' 92' ' ' SER . 23.3 m -121.61 86.86 2.65 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.603 ' CG2' ' CD2' ' A' ' 129' ' ' LEU . 10.8 m -89.84 -149.71 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.283 -0.886 . . . . 0.0 111.172 -178.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -130.68 106.38 8.44 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.534 -0.729 . . . . 0.0 110.524 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.489 ' O ' ' HB3' ' A' ' 77' ' ' LEU . . . -110.39 158.22 18.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.378 -0.827 . . . . 0.0 109.586 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.531 ' CD1' ' HB1' ' A' ' 126' ' ' ALA . 3.7 pp 177.79 -158.04 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.279 -0.888 . . . . 0.0 110.376 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.567 HG13 ' CE2' ' A' ' 112' ' ' TYR . 4.3 t -147.19 171.6 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.39 -0.819 . . . . 0.0 109.488 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.492 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . 175.36 -171.66 44.76 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.353 -1.403 . . . . 0.0 110.242 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.426 ' O ' ' CG ' ' A' ' 81' ' ' ASN . 2.5 tt0 -94.08 -169.63 2.12 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.429 -1.042 . . . . 0.0 110.171 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 23.2 m120 -157.21 75.2 0.8 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.308 -0.87 . . . . 0.0 109.831 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 83' ' ' ALA . . . 144.5 38.57 0.06 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.467 ' O ' ' O ' ' A' ' 82' ' ' GLY . . . 58.96 150.91 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.232 -1.158 . . . . 0.0 110.305 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.472 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 52.1 Cg_endo -80.49 21.99 8.32 Favored 'Cis proline' 0 C--N 1.312 -1.343 0 C-N-CA 121.696 -2.21 . . . . 0.0 111.113 0.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.472 ' HB2' ' O ' ' A' ' 84' ' ' PRO . 43.5 m-85 60.49 123.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.01 -1.056 . . . . 0.0 110.317 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -154.86 110.77 0.46 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.8 p -89.89 142.53 27.61 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.208 -1.172 . . . . 0.0 110.333 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.502 ' CG2' HD13 ' A' ' 89' ' ' LEU . 28.8 m -119.97 -20.11 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.345 -0.847 . . . . 0.0 109.973 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.566 HD12 ' CZ ' ' A' ' 106' ' ' PHE . 4.7 mp -111.97 142.18 44.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.855 . . . . 0.0 110.652 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.412 ' O ' ' OD1' ' A' ' 90' ' ' ASP . 1.7 p30 -151.18 87.84 1.42 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.252 -0.905 . . . . 0.0 110.159 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.7 p -156.74 178.66 10.09 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.933 -1.104 . . . . 0.0 110.797 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.403 ' HB2' HG21 ' A' ' 73' ' ' THR . 81.5 p -119.79 127.81 26.2 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.377 -0.827 . . . . 0.0 109.886 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.536 ' CG ' HG21 ' A' ' 74' ' ' VAL . 48.9 Cg_endo -75.08 75.08 3.84 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.887 1.467 . . . . 0.0 111.192 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.521 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -52.45 124.83 14.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.922 -1.111 . . . . 0.0 109.094 179.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.527 HD12 ' CD2' ' A' ' 139' ' ' LEU . 38.2 mt -119.91 175.51 5.87 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.992 -1.068 . . . . 0.0 111.0 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -168.78 -178.54 3.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.521 -0.737 . . . . 0.0 109.806 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.2 p -70.26 -7.38 41.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.221 -0.924 . . . . 0.0 110.293 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.473 ' CG ' ' HD2' ' A' ' 99' ' ' PRO . 1.1 mt-10 -102.35 172.34 4.44 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.212 -0.93 . . . . 0.0 110.094 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.473 ' HD2' ' CG ' ' A' ' 98' ' ' GLU . 44.8 Cg_endo -72.5 129.0 14.16 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.014 1.534 . . . . 0.0 110.304 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.521 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.79 92.03 3.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.205 -0.934 . . . . 0.0 110.333 -179.81 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.466 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 0.0 OUTLIER -88.61 106.14 18.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.254 -0.904 . . . . 0.0 110.081 179.842 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.563 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 37.5 t -89.98 133.82 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.231 -0.918 . . . . 0.0 110.316 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.465 ' C ' ' CG ' ' A' ' 104' ' ' GLU . 8.3 m -150.24 112.03 4.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.286 -0.884 . . . . 0.0 110.042 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.465 ' CG ' ' C ' ' A' ' 103' ' ' THR . 32.0 mt-10 -150.7 156.13 40.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.184 -0.947 . . . . 0.0 110.354 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.515 ' CG2' ' OG1' ' A' ' 61' ' ' THR . 0.8 OUTLIER -106.33 134.78 48.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.331 -0.856 . . . . 0.0 110.095 179.863 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.566 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 55.4 p90 -136.65 157.63 46.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.215 -0.928 . . . . 0.0 110.305 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 86.4 m -89.98 91.36 8.54 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.278 -0.889 . . . . 0.0 110.041 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.574 ' HB1' ' CD2' ' A' ' 60' ' ' TYR . . . -57.36 117.08 3.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.253 -0.904 . . . . 0.0 110.381 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.459 ' HA ' ' HA2' ' A' ' 57' ' ' GLY . 11.0 p -100.21 54.93 0.9 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.227 -0.921 . . . . 0.0 110.099 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -166.38 -162.42 0.52 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.215 -0.928 . . . . 0.0 110.417 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 61.9 m -143.39 115.27 8.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.237 -0.914 . . . . 0.0 110.297 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.567 ' CE2' HG13 ' A' ' 78' ' ' VAL . 11.8 m-30 -114.84 80.97 6.97 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.266 -0.896 . . . . 0.0 110.08 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.469 ' HG2' ' HA ' ' A' ' 122' ' ' GLU . 45.7 Cg_endo -73.04 -162.37 0.13 Allowed 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 124.015 1.534 . . . . 0.0 110.446 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.275 -0.891 . . . . 0.0 110.29 -179.954 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.469 ' HA ' ' HG2' ' A' ' 113' ' ' PRO . 3.7 pm0 . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 121.197 0.522 . . . . 0.0 110.465 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.544 ' HA3' ' CD1' ' A' ' 112' ' ' TYR . . . -123.62 159.08 18.28 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.336 -1.505 . . . . 0.0 109.336 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.53 ' CB ' ' HA ' ' A' ' 50' ' ' ASN . 19.6 pt20 -150.34 -159.07 0.98 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.161 -1.199 . . . . 0.0 110.687 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.444 ' CG2' ' CE1' ' A' ' 127' ' ' PHE . 9.8 mt -118.95 147.08 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.529 -0.732 . . . . 0.0 109.388 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.531 ' HB1' ' CD1' ' A' ' 77' ' ' LEU . . . -120.35 118.85 31.46 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.322 -0.861 . . . . 0.0 111.314 -179.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.524 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 4.6 m-85 -119.57 73.35 0.95 Allowed 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . 0.517 ' HA ' ' HA3' ' A' ' 46' ' ' GLY . 34.1 mt-30 -87.9 106.01 17.82 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 122.52 1.152 . . . . 0.0 112.104 -177.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.603 ' CD2' ' CG2' ' A' ' 74' ' ' VAL . 10.3 mt -93.47 -111.22 0.11 Allowed 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.602 ' HA3' ' N ' ' A' ' 45' ' ' VAL . . . 50.75 111.81 0.01 OUTLIER Glycine 0 N--CA 1.493 2.442 0 O-C-N 120.743 -1.223 . . . . 0.0 111.138 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 40' ' ' SER . . . 72.91 66.88 1.94 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.583 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 5.0 m-85 -148.03 -52.01 0.18 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.234 -1.157 . . . . 0.0 110.182 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.528 ' HB2' ' CG2' ' A' ' 72' ' ' VAL . 1.6 t -89.36 -151.78 0.23 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.086 -1.009 . . . . 0.0 110.15 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -112.09 -88.82 0.52 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.147 -0.97 . . . . 0.0 110.321 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.407 ' O ' ' C ' ' A' ' 136' ' ' ALA . 6.1 m-20 -84.07 172.65 11.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.222 -0.924 . . . . 0.0 110.273 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.525 ' CA ' ' HA ' ' A' ' 38' ' ' ALA . . . -42.35 130.33 3.81 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.297 -0.877 . . . . 0.0 110.293 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.635 ' CZ2' ' CG1' ' A' ' 36' ' ' VAL . 9.7 p90 -142.97 -165.21 2.01 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.325 -0.859 . . . . 0.0 109.648 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.526 ' O ' ' CB ' ' A' ' 68' ' ' ALA . 0.5 OUTLIER -160.04 172.72 17.0 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.834 -1.166 . . . . 0.0 111.231 -178.284 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.527 ' CD2' HD12 ' A' ' 95' ' ' LEU . 2.2 mp -134.35 126.58 29.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.582 -0.699 . . . . 0.0 109.326 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' CYS . . . . . . . . . . . . . 7.2 m -114.07 96.09 5.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.154 -0.966 . . . . 0.0 110.807 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.459 ' HA ' ' O ' ' A' ' 65' ' ' THR . 2.1 mt -89.75 -166.65 1.64 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.357 -0.839 . . . . 0.0 109.357 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.57 ' HA ' ' CD2' ' A' ' 9' ' ' PHE . 22.0 p-10 -167.93 -151.31 0.11 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.964 -1.085 . . . . 0.0 110.626 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.476 ' C ' ' CG2' ' A' ' 144' ' ' VAL . 6.5 t0 -38.82 150.89 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.641 -0.662 . . . . 0.0 110.662 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.574 HG22 ' CZ ' ' A' ' 9' ' ' PHE . 3.0 t -150.15 132.47 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.357 -0.839 . . . . 0.0 109.955 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.527 ' CB ' ' HG3' ' A' ' 6' ' ' GLU . . . -127.91 146.35 50.66 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.187 -0.946 . . . . 0.0 110.413 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.462 HD13 ' HB3' ' A' ' 60' ' ' TYR . 22.8 tp -153.81 90.72 1.4 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.323 -0.861 . . . . 0.0 110.085 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.466 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 0.4 OUTLIER -107.07 -167.02 1.22 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.249 -0.907 . . . . 0.0 110.258 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.428 ' HB3' ' CE1' ' A' ' 60' ' ' TYR . 1.2 p . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.207 -0.933 . . . . 0.0 110.25 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo . . . . . 0 N--CA 1.48 0.69 0 N-CA-C 110.085 -0.775 . . . . 0.0 110.085 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.525 ' CG2' ' O ' ' A' ' 51' ' ' GLY . 20.7 pt -89.96 43.63 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.19 -0.944 . . . . 0.0 110.113 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 6' ' ' GLU . . . 56.83 61.28 7.68 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.46 ' O ' ' HA ' ' A' ' 145' ' ' ALA . 1.7 mp0 57.16 -88.62 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.292 -1.122 . . . . 0.0 110.193 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.469 ' O ' ' OG1' ' A' ' 8' ' ' THR . . . 159.22 -115.34 0.65 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.469 ' OG1' ' O ' ' A' ' 7' ' ' GLY . 4.1 p 45.46 97.49 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.39 -1.065 . . . . 0.0 110.165 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.584 ' CD2' ' HB2' ' A' ' 32' ' ' LEU . 78.2 m-85 -77.62 7.62 5.41 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.479 -0.763 . . . . 0.0 109.7 179.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.551 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 34.4 t0 -84.15 45.06 1.06 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.419 -0.801 . . . . 0.0 110.122 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.551 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.3 OUTLIER 161.6 36.83 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.572 -0.705 . . . . 0.0 109.879 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 118.29 112.01 2.52 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.527 ' HG3' ' CG2' ' A' ' 27' ' ' THR . 51.0 Cg_endo -77.07 8.91 2.97 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 O-C-N 123.834 1.439 . . . . 0.0 110.93 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.5 ' HB3' ' O ' ' A' ' 13' ' ' PRO . 30.1 tp10 61.34 -89.47 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.237 -0.914 . . . . 0.0 110.464 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -149.02 19.15 1.22 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.577 ' CG ' HD11 ' A' ' 49' ' ' LEU . 23.5 m95 -62.53 125.31 23.48 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.211 -1.17 . . . . 0.0 110.324 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.526 ' O ' ' CG1' ' A' ' 47' ' ' VAL . 0.2 OUTLIER -115.44 161.93 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.234 -0.916 . . . . 0.0 109.234 179.635 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.506 ' CB ' HG13 ' A' ' 34' ' ' VAL . . . -146.9 152.24 38.35 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.323 -0.861 . . . . 0.0 110.209 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.574 ' CE2' ' O ' ' A' ' 46' ' ' GLY . 11.8 p90 -138.61 114.02 9.62 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.296 -0.877 . . . . 0.0 110.274 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.533 ' HA3' ' CG1' ' A' ' 45' ' ' VAL . . . -173.0 49.97 0.16 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.475 ' OG1' ' O ' ' A' ' 20' ' ' GLY . 8.2 p 50.9 19.22 0.61 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.366 -1.079 . . . . 0.0 110.479 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.482 ' HB3' ' O ' ' A' ' 35' ' ' ALA . 1.8 p30 -102.59 38.01 1.8 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.133 -0.98 . . . . 0.0 110.197 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 44.46 -153.27 0.47 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.457 ' O ' ' O ' ' A' ' 25' ' ' LEU . 46.3 Cg_endo -73.54 125.92 10.48 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.933 1.491 . . . . 0.0 110.361 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' A' ' 24' ' ' PRO . 0.8 OUTLIER -42.87 166.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.227 -0.921 . . . . 0.0 110.11 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.448 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 0.5 OUTLIER -125.83 149.92 48.25 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.163 -0.96 . . . . 0.0 110.275 -179.815 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.527 ' CG2' ' HG3' ' A' ' 13' ' ' PRO . 0.7 OUTLIER -129.78 -43.78 1.22 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.249 -0.907 . . . . 0.0 110.251 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.463 ' HB3' ' O ' ' A' ' 27' ' ' THR . 4.5 t 56.35 36.28 27.26 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.31 -0.869 . . . . 0.0 110.303 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.451 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 33.2 p 42.53 33.21 0.42 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.299 -0.876 . . . . 0.0 110.3 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.511 ' CA ' ' HA ' ' A' ' 10' ' ' ASP . . . -140.51 -63.58 0.03 OUTLIER Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.467 ' HB3' ' HB3' ' A' ' 142' ' ' ASP . . . -150.11 148.78 29.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.308 -1.113 . . . . 0.0 110.101 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.584 ' HB2' ' CD2' ' A' ' 9' ' ' PHE . 1.8 tt -88.36 115.46 25.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.116 -0.99 . . . . 0.0 109.861 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 72.8 m -121.56 137.74 54.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.193 -0.942 . . . . 0.0 110.765 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.506 HG13 ' CB ' ' A' ' 18' ' ' ALA . 2.7 m -110.98 143.47 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.408 -0.807 . . . . 0.0 109.215 179.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.482 ' O ' ' HB3' ' A' ' 22' ' ' ASP . . . -89.43 90.04 8.13 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.167 -0.958 . . . . 0.0 111.46 -178.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.642 ' CG1' ' CZ2' ' A' ' 137' ' ' TRP . 87.2 t -72.52 119.14 73.39 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.043 -1.036 . . . . 0.0 109.182 178.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.46 ' HG3' ' OG1' ' A' ' 21' ' ' THR . 42.7 Cg_endo -68.12 151.1 77.51 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.951 1.501 . . . . 0.0 111.415 -178.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.526 ' HA ' ' CA ' ' A' ' 136' ' ' ALA . . . -43.11 144.24 0.67 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.498 -0.751 . . . . 0.0 110.042 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 38' ' ' ALA . . . 44.46 77.73 0.09 OUTLIER Glycine 0 N--CA 1.488 2.133 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.578 ' HB3' ' CH2' ' A' ' 137' ' ' TRP . 0.3 OUTLIER -87.33 25.98 1.3 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.223 -1.163 . . . . 0.0 110.386 -179.703 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.408 ' HB1' ' HA2' ' A' ' 131' ' ' GLY . . . -92.85 19.89 7.17 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 122.048 0.928 . . . . 0.0 109.606 179.374 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.574 ' HG3' ' CD2' ' A' ' 43' ' ' TYR . 25.7 pt20 -89.87 -131.34 0.09 Allowed 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.417 179.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.638 ' CD1' ' N ' ' A' ' 44' ' ' GLY . 12.4 p90 -37.51 -28.94 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.589 -0.695 . . . . 0.0 110.218 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.638 ' N ' ' CD1' ' A' ' 43' ' ' TYR . . . 105.45 111.3 3.59 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 179.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.533 ' CG1' ' HA3' ' A' ' 20' ' ' GLY . 2.1 t -89.91 171.18 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.176 -1.19 . . . . 0.0 108.541 178.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.574 ' O ' ' CE2' ' A' ' 19' ' ' TYR . . . 160.72 155.61 7.87 Favored Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.029 -1.557 . . . . 0.0 110.478 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.526 ' CG1' ' O ' ' A' ' 17' ' ' VAL . 48.6 t -120.5 133.48 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.473 -1.016 . . . . 0.0 109.656 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.472 ' O ' HG12 ' A' ' 17' ' ' VAL . 30.4 m -120.02 153.46 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.079 -1.013 . . . . 0.0 110.523 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.577 HD11 ' CG ' ' A' ' 16' ' ' TRP . 13.5 tp -140.51 87.64 2.14 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.304 -0.872 . . . . 0.0 110.197 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.489 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 23.6 m-20 -68.1 104.13 1.7 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.291 -0.881 . . . . 0.0 110.241 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.525 ' O ' ' CG2' ' A' ' 4' ' ' ILE . . . 154.39 74.22 0.01 OUTLIER Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.531 ' CG1' HG12 ' A' ' 54' ' ' ILE . 24.7 t -120.74 172.44 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.277 -1.131 . . . . 0.0 109.939 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.526 ' N ' ' CG1' ' A' ' 52' ' ' VAL . . . -134.27 77.57 1.71 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.09 -1.006 . . . . 0.0 110.941 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.563 HD11 ' CZ ' ' A' ' 60' ' ' TYR . 24.9 mm -118.82 165.2 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.191 -0.943 . . . . 0.0 109.599 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.52 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 0.3 OUTLIER -158.88 126.79 5.07 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.989 -1.07 . . . . 0.0 110.888 -179.722 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.52 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 17.2 pt-20 37.29 -154.98 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.65 -0.656 . . . . 0.0 110.99 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 108' ' ' ALA . . . -81.4 81.67 1.62 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.571 HG21 ' CE2' ' A' ' 60' ' ' TYR . 1.2 m -112.44 172.34 6.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.209 -1.171 . . . . 0.0 109.943 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.57 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 0.4 OUTLIER -89.98 154.3 19.94 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.316 -0.865 . . . . 0.0 110.213 -179.894 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.588 ' CD2' ' CB ' ' A' ' 108' ' ' ALA . 59.9 m-85 -159.69 173.47 16.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.293 -0.879 . . . . 0.0 110.238 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 27.4 m -150.11 114.52 5.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.282 -0.886 . . . . 0.0 110.081 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 14.1 tp -89.62 120.83 31.25 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.211 -0.931 . . . . 0.0 109.902 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.475 ' HA ' ' O ' ' A' ' 102' ' ' VAL . 6.5 ttt180 -131.49 128.5 39.5 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.228 -0.92 . . . . 0.0 110.405 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.537 ' CZ ' HG23 ' A' ' 102' ' ' VAL . 6.9 p90 -165.09 156.02 14.32 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.409 -0.807 . . . . 0.0 109.964 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.471 ' HB ' ' OD1' ' A' ' 142' ' ' ASP . 32.2 m -119.76 99.79 6.85 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.17 -0.956 . . . . 0.0 109.919 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.508 ' CB ' HD23 ' A' ' 95' ' ' LEU . . . -100.79 154.51 18.57 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.264 -0.897 . . . . 0.0 110.473 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.6 m -150.34 136.84 18.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.362 -0.836 . . . . 0.0 110.145 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.52 ' N ' ' HB3' ' A' ' 95' ' ' LEU . . . -129.39 127.33 40.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.234 -0.916 . . . . 0.0 109.993 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 68' ' ' ALA . 0.6 OUTLIER -43.13 -26.84 0.18 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.246 -0.909 . . . . 0.0 109.66 179.809 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.583 ' CG2' ' CB ' ' A' ' 137' ' ' TRP . 3.5 t -110.5 164.08 13.06 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.482 -0.761 . . . . 0.0 109.928 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -82.79 72.04 9.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.168 -0.958 . . . . 0.0 109.038 178.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.575 HG22 ' CE2' ' A' ' 137' ' ' TRP . 4.0 p -93.54 136.38 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.326 -0.859 . . . . 0.0 111.384 -178.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.541 ' O ' ' CD1' ' A' ' 132' ' ' PHE . 13.5 m -119.98 87.85 2.82 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.608 ' HA ' ' CG ' ' A' ' 132' ' ' PHE . 11.5 m -89.5 -153.18 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.249 -0.907 . . . . 0.0 110.761 -178.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.463 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 0.3 OUTLIER -127.99 135.29 49.72 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.369 -0.832 . . . . 0.0 110.476 -179.207 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.481 ' O ' ' HB3' ' A' ' 77' ' ' LEU . . . -136.83 154.89 50.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.299 -0.875 . . . . 0.0 109.979 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.571 ' CD1' ' N ' ' A' ' 78' ' ' VAL . 4.0 pp 179.2 -149.22 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.363 -0.836 . . . . 0.0 110.099 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.571 ' N ' ' CD1' ' A' ' 77' ' ' LEU . 4.7 t -147.86 177.67 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.28 -0.887 . . . . 0.0 109.365 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.533 ' C ' ' CZ ' ' A' ' 112' ' ' TYR . . . -177.69 -176.55 45.81 Favored Glycine 0 N--CA 1.489 2.186 0 C-N-CA 119.22 -1.466 . . . . 0.0 110.16 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.495 ' HA ' ' CD1' ' A' ' 112' ' ' TYR . 5.0 tt0 -98.0 -151.93 0.39 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.404 -1.056 . . . . 0.0 110.193 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.47 ' N ' ' O ' ' A' ' 122' ' ' GLU . 10.0 m120 -161.15 61.6 0.28 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.411 -0.806 . . . . 0.0 109.681 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 83' ' ' ALA . . . 159.97 128.4 0.97 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.196 -1.561 . . . . 0.0 109.196 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.628 ' N ' ' CE1' ' A' ' 85' ' ' TYR . . . -41.73 151.34 0.32 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.319 -1.106 . . . . 0.0 110.377 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.488 ' C ' ' CD2' ' A' ' 85' ' ' TYR . 50.9 Cg_endo -79.14 10.04 22.91 Favored 'Cis proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.632 -2.237 . . . . 0.0 110.775 -0.081 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.628 ' CE1' ' N ' ' A' ' 83' ' ' ALA . 12.5 m-85 68.0 156.53 0.12 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.241 -0.912 . . . . 0.0 110.169 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -171.6 125.84 1.23 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.98 152.44 19.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.242 -1.152 . . . . 0.0 110.209 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.467 ' HB ' ' HA ' ' A' ' 108' ' ' ALA . 16.0 m -123.23 -24.94 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.287 -0.883 . . . . 0.0 110.2 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.567 HD12 ' CZ ' ' A' ' 106' ' ' PHE . 4.2 mp -108.96 144.79 36.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.232 -0.917 . . . . 0.0 110.911 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.424 ' O ' ' CG ' ' A' ' 90' ' ' ASP . 40.2 p-10 -151.45 80.91 1.3 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.352 -0.843 . . . . 0.0 110.063 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 44.3 p -144.01 171.74 13.84 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.959 -1.088 . . . . 0.0 110.742 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.96 115.02 33.51 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.385 -0.822 . . . . 0.0 110.021 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.537 ' HG2' ' CG2' ' A' ' 74' ' ' VAL . 43.7 Cg_endo -70.16 155.19 65.19 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.951 1.501 . . . . 0.0 110.998 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.519 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -129.92 145.39 51.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.407 -0.808 . . . . 0.0 109.573 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.527 ' CD1' ' HG ' ' A' ' 139' ' ' LEU . 39.6 mt -134.19 173.0 12.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.07 -1.019 . . . . 0.0 110.673 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.468 ' O ' ' O ' ' A' ' 68' ' ' ALA . 6.0 t -171.85 -154.87 0.09 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.401 -0.812 . . . . 0.0 109.918 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.44 28.41 1.48 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.206 -0.934 . . . . 0.0 110.143 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.95 173.81 3.99 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.315 -0.866 . . . . 0.0 109.968 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.56 130.62 16.25 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.953 1.501 . . . . 0.0 110.364 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.519 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.61 87.43 2.74 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.226 -0.921 . . . . 0.0 110.042 -179.98 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.453 ' HG2' ' OG1' ' A' ' 65' ' ' THR . 0.9 OUTLIER -68.31 151.68 46.55 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.359 -0.838 . . . . 0.0 110.245 -179.903 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.537 HG23 ' CZ ' ' A' ' 64' ' ' TYR . 65.1 t -131.49 136.31 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.228 -0.92 . . . . 0.0 110.009 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.464 ' O ' ' HG3' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -150.13 104.04 3.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.271 -0.893 . . . . 0.0 110.173 -179.937 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' A' ' 103' ' ' THR . 6.7 mt-10 -145.53 132.9 20.64 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.286 -0.884 . . . . 0.0 110.166 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.45 ' O ' ' HB3' ' A' ' 106' ' ' PHE . 0.2 OUTLIER -89.92 169.82 10.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.287 -0.883 . . . . 0.0 110.12 179.918 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.572 ' CZ ' ' HB2' ' A' ' 60' ' ' TYR . 42.1 p90 -177.38 150.49 0.71 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -0.923 . . . . 0.0 110.288 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.5 m -91.47 92.39 8.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.234 -0.917 . . . . 0.0 110.061 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.588 ' CB ' ' CD2' ' A' ' 60' ' ' TYR . . . -50.86 113.83 1.01 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.887 . . . . 0.0 110.227 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 17.1 p -96.52 51.4 1.17 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.213 -0.93 . . . . 0.0 110.191 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.402 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -162.99 -166.57 1.31 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.218 -0.926 . . . . 0.0 110.18 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.446 HG21 ' HD3' ' A' ' 113' ' ' PRO . 11.2 m -134.39 112.27 10.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.218 -0.926 . . . . 0.0 110.307 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.568 ' CE2' HG13 ' A' ' 78' ' ' VAL . 17.9 m-30 -113.02 71.42 1.34 Allowed Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.339 -0.85 . . . . 0.0 110.001 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.462 ' HD2' ' HA ' ' A' ' 122' ' ' GLU . 44.0 Cg_endo -72.13 -167.6 0.33 Allowed 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.932 1.49 . . . . 0.0 110.374 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.202 -0.936 . . . . 0.0 110.279 -179.895 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.471 ' O ' ' HG2' ' A' ' 80' ' ' GLN . 5.4 pt-20 . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 121.244 0.545 . . . . 0.0 110.484 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.53 ' HA3' ' CB ' ' A' ' 112' ' ' TYR . . . -148.21 156.1 26.74 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.351 -1.499 . . . . 0.0 109.351 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.517 ' HA ' ' CG2' ' A' ' 52' ' ' VAL . 1.0 OUTLIER -150.52 -158.68 0.94 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.171 -1.193 . . . . 0.0 110.72 -179.644 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.551 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 11.4 mt -118.24 150.37 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.473 -0.767 . . . . 0.0 109.132 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.447 ' N ' HG21 ' A' ' 125' ' ' ILE . . . -127.89 122.63 33.0 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.292 -0.88 . . . . 0.0 111.033 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.468 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 4.9 m-85 -118.73 101.77 8.34 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . 0.431 ' C ' HD21 ' A' ' 129' ' ' LEU . 0.0 OUTLIER -88.97 101.51 14.15 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.252 -0.905 . . . . 0.0 111.956 -177.596 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.527 ' CD2' HG23 ' A' ' 74' ' ' VAL . 8.8 mt -104.6 42.65 1.18 Allowed 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 178.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -97.45 87.3 0.87 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.575 ' O ' ' CG ' ' A' ' 132' ' ' PHE . . . 84.53 107.95 0.61 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.608 ' CG ' ' HA ' ' A' ' 74' ' ' VAL . 7.0 m-85 -167.31 -62.19 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.331 -1.099 . . . . 0.0 110.102 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.585 ' HB3' ' CE3' ' A' ' 137' ' ' TRP . 1.3 t -89.52 -178.84 5.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.076 -1.015 . . . . 0.0 109.912 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.426 ' N ' ' OG ' ' A' ' 133' ' ' SER . . . -100.62 -95.31 0.27 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.127 -0.983 . . . . 0.0 110.7 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -55.68 153.74 7.69 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.094 -1.004 . . . . 0.0 110.574 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.526 ' CA ' ' HA ' ' A' ' 38' ' ' ALA . . . -47.7 121.94 4.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.372 -0.83 . . . . 0.0 110.167 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.642 ' CZ2' ' CG1' ' A' ' 36' ' ' VAL . 22.2 p90 -125.7 -157.58 0.8 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.287 -0.883 . . . . 0.0 110.044 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.543 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 0.5 OUTLIER -160.33 169.53 22.95 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.104 -0.997 . . . . 0.0 110.62 -178.844 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.527 ' HG ' ' CD1' ' A' ' 95' ' ' LEU . 2.4 mp -121.8 159.5 26.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.334 -0.854 . . . . 0.0 109.322 179.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' CYS . . . . . . . . . . . . . 2.0 m -150.61 92.22 1.82 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.041 -1.037 . . . . 0.0 110.931 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.497 ' O ' ' CB ' ' A' ' 142' ' ' ASP . 1.2 mt -90.01 -178.36 5.43 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.227 -0.92 . . . . 0.0 109.316 179.068 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.52 ' O ' ' CB ' ' A' ' 143' ' ' ASP . 2.0 p30 167.19 47.88 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.276 -0.89 . . . . 0.0 110.423 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.52 ' CB ' ' O ' ' A' ' 142' ' ' ASP . 0.4 OUTLIER 166.64 40.41 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.26 -0.9 . . . . 0.0 109.84 179.961 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.497 ' CG2' ' HB2' ' A' ' 64' ' ' TYR . 25.9 t -89.26 111.55 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.302 -0.874 . . . . 0.0 110.259 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 6' ' ' GLU . . . -137.33 165.47 26.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.337 -0.852 . . . . 0.0 110.237 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.467 ' CD2' HD13 ' A' ' 54' ' ' ILE . 10.5 tp -151.8 139.58 19.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.249 -0.907 . . . . 0.0 110.181 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.457 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -155.06 152.89 30.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.188 -0.945 . . . . 0.0 110.268 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.479 ' HB3' ' CE1' ' A' ' 60' ' ' TYR . 3.0 p . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.291 -0.881 . . . . 0.0 110.191 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo . . . . . 0 N--CA 1.483 0.897 0 N-CA-C 110.579 -0.585 . . . . 0.0 110.579 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.417 HG13 ' O ' ' A' ' 4' ' ' ILE . 11.4 pt -113.46 32.33 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.223 -0.923 . . . . 0.0 110.096 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.526 ' O ' ' CG ' ' A' ' 6' ' ' GLU . . . 95.44 -31.52 7.04 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.526 ' CG ' ' O ' ' A' ' 5' ' ' GLY . 9.0 pt-20 38.32 35.89 0.11 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.671 -0.899 . . . . 0.0 110.522 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 143' ' ' ASP . . . -136.16 -160.92 8.97 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.521 ' CB ' ' O ' ' A' ' 142' ' ' ASP . 40.4 p -105.53 51.53 0.75 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.294 -1.121 . . . . 0.0 110.322 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.485 ' CE1' ' CD1' ' A' ' 16' ' ' TRP . 16.5 m-85 42.71 28.87 0.14 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.306 -0.871 . . . . 0.0 110.228 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.554 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 4.5 p-10 -86.22 52.25 2.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.271 -0.893 . . . . 0.0 110.062 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.554 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 1.0 OUTLIER 161.7 37.05 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.68 -0.637 . . . . 0.0 109.901 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.99 148.43 12.11 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.495 ' O ' ' HB3' ' A' ' 14' ' ' GLU . 49.6 Cg_endo -76.12 6.6 3.76 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 124.035 1.545 . . . . 0.0 110.902 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.495 ' HB3' ' O ' ' A' ' 13' ' ' PRO . 2.6 tm-20 59.26 -89.27 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.206 -0.934 . . . . 0.0 110.406 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.464 ' O ' HD13 ' A' ' 49' ' ' LEU . . . -144.22 30.66 1.87 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.569 ' CE2' HD23 ' A' ' 49' ' ' LEU . 52.7 m95 -85.93 124.72 32.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.215 -1.168 . . . . 0.0 110.554 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.548 ' O ' ' CG1' ' A' ' 47' ' ' VAL . 0.2 OUTLIER -114.2 160.94 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.309 -0.87 . . . . 0.0 108.884 179.44 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.491 ' N ' HG21 ' A' ' 17' ' ' VAL . . . -147.12 126.1 12.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.112 -0.993 . . . . 0.0 110.297 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.511 ' CZ ' ' C ' ' A' ' 46' ' ' GLY . 17.5 p90 -104.94 170.59 7.78 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.486 -0.759 . . . . 0.0 110.26 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.518 ' HA3' ' CG1' ' A' ' 45' ' ' VAL . . . 115.44 35.09 1.34 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' A' ' 20' ' ' GLY . 12.1 p 51.13 17.75 0.5 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.682 -0.893 . . . . 0.0 111.005 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.542 ' HB3' ' CB ' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -152.68 77.6 1.18 Allowed 'General case' 0 C--N 1.306 -1.291 0 O-C-N 120.975 -1.078 . . . . 0.0 109.049 179.265 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.593 ' N ' ' CD ' ' A' ' 24' ' ' PRO . . . -118.54 43.97 1.5 Allowed Glycine 0 N--CA 1.489 2.171 0 C-N-CA 119.451 -1.357 . . . . 0.0 110.72 -179.108 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 23' ' ' GLY . 50.5 Cg_endo -75.39 76.62 3.49 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.668 1.352 . . . . 0.0 109.649 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.553 ' CD2' ' CG1' ' A' ' 34' ' ' VAL . 14.8 mt -68.16 84.6 0.24 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.182 -0.949 . . . . 0.0 110.46 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.469 ' O ' ' O ' ' A' ' 31' ' ' ALA . 0.2 OUTLIER -74.81 113.12 11.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.165 -0.959 . . . . 0.0 109.085 179.314 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.417 ' O ' ' C ' ' A' ' 28' ' ' SER . 1.4 p -119.6 -29.08 5.15 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.061 -1.024 . . . . 0.0 111.196 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 27' ' ' THR . 33.2 p -45.04 -27.92 0.63 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.948 -1.095 . . . . 0.0 108.619 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.41 ' N ' ' C ' ' A' ' 27' ' ' THR . 5.5 t -70.4 -45.78 65.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.868 -0.52 . . . . 0.0 110.751 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 138.04 3.42 1.97 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.55 ' CB ' ' HB3' ' A' ' 142' ' ' ASP . . . -150.38 130.91 13.89 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.98 -1.306 . . . . 0.0 110.021 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.474 ' CD1' ' HB3' ' A' ' 13' ' ' PRO . 0.9 OUTLIER -67.23 110.33 3.45 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.996 -1.065 . . . . 0.0 109.543 179.754 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.452 ' O ' ' O ' ' A' ' 24' ' ' PRO . 2.9 m -109.39 106.59 16.43 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.091 -1.006 . . . . 0.0 111.164 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.553 ' CG1' ' CD2' ' A' ' 25' ' ' LEU . 36.0 m -89.81 173.6 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.542 ' CB ' ' HB3' ' A' ' 22' ' ' ASP . . . -122.75 152.78 40.28 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.574 -1.329 . . . . 0.0 111.685 -178.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.473 ' HB ' ' O ' ' A' ' 137' ' ' TRP . 10.6 t -137.88 111.28 8.74 Favored Pre-proline 0 C--N 1.303 -1.446 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.437 ' O ' ' O ' ' A' ' 38' ' ' ALA . 44.3 Cg_endo -73.75 141.99 31.47 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.011 1.532 . . . . 0.0 111.185 -178.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.486 ' HA ' ' HA ' ' A' ' 136' ' ' ALA . . . -42.35 164.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.504 -0.747 . . . . 0.0 109.834 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 51.22 50.12 41.34 Favored Glycine 0 N--CA 1.485 1.949 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.598 ' HB3' ' CZ3' ' A' ' 137' ' ' TRP . 1.6 t -86.88 35.92 0.7 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.228 -1.16 . . . . 0.0 109.803 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.533 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . -87.44 -139.87 0.1 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.475 -0.766 . . . . 0.0 109.414 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.536 ' HG2' ' N ' ' A' ' 43' ' ' TYR . 0.0 OUTLIER 42.03 -142.29 0.09 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.476 -0.765 . . . . 0.0 110.066 -179.491 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.583 ' CE1' ' O ' ' A' ' 44' ' ' GLY . 5.8 p90 -31.39 -39.27 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.198 0 CA-C-O 121.354 0.597 . . . . 0.0 110.292 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.583 ' O ' ' CE1' ' A' ' 43' ' ' TYR . . . 88.82 137.32 6.01 Favored Glycine 0 N--CA 1.49 2.283 0 C-N-CA 120.227 -0.987 . . . . 0.0 111.128 177.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.529 ' CG2' ' OG ' ' A' ' 40' ' ' SER . 4.0 t -89.75 167.91 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.511 ' C ' ' CZ ' ' A' ' 19' ' ' TYR . . . 168.11 162.19 19.54 Favored Glycine 0 N--CA 1.49 2.298 0 C-N-CA 118.51 -1.805 . . . . 0.0 111.056 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.548 ' CG1' ' O ' ' A' ' 17' ' ' VAL . 44.6 t -114.54 157.69 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.74 -0.859 . . . . 0.0 109.793 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.479 ' N ' HG11 ' A' ' 47' ' ' VAL . 3.7 m -143.5 150.55 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.076 -1.015 . . . . 0.0 110.08 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.569 HD23 ' CE2' ' A' ' 16' ' ' TRP . 19.4 tp -138.47 89.89 2.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.199 -0.938 . . . . 0.0 110.417 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.519 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 40.9 t30 -73.04 132.79 43.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.294 -0.879 . . . . 0.0 110.151 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 124.0 60.52 0.19 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.519 ' CG2' ' HA ' ' A' ' 124' ' ' GLN . 40.3 t -119.94 172.07 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.233 -1.157 . . . . 0.0 110.101 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.516 ' N ' ' CG1' ' A' ' 52' ' ' VAL . . . -137.88 102.01 4.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.235 -0.915 . . . . 0.0 110.389 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.564 ' HB ' ' CG ' ' A' ' 112' ' ' TYR . 42.3 mm -131.65 49.59 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.291 -0.881 . . . . 0.0 109.936 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.542 ' HA ' ' HA ' ' A' ' 111' ' ' THR . 0.3 OUTLIER -72.16 139.95 48.54 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.408 -0.807 . . . . 0.0 111.072 -179.571 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.539 ' HB3' ' O ' ' A' ' 55' ' ' GLU . 6.6 tm-20 73.12 178.12 0.24 Allowed 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 121.968 0.89 . . . . 0.0 111.907 178.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.537 ' HA2' ' O ' ' A' ' 108' ' ' ALA . . . -103.04 89.54 0.72 Allowed Glycine 0 N--CA 1.487 2.047 0 N-CA-C 107.764 -2.135 . . . . 0.0 107.764 178.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.609 HG21 ' CE1' ' A' ' 60' ' ' TYR . 0.4 OUTLIER -120.19 -165.53 1.2 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.41 -1.053 . . . . 0.0 110.641 -178.486 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.571 ' N ' ' CG2' ' A' ' 58' ' ' THR . 8.2 m -103.49 86.3 2.62 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.413 -0.804 . . . . 0.0 110.372 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.662 ' CD1' ' CB ' ' A' ' 108' ' ' ALA . 96.1 m-85 -85.84 116.19 23.93 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.147 -0.971 . . . . 0.0 109.905 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 38.9 m -89.89 114.76 26.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.211 -0.931 . . . . 0.0 110.154 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.41 HD23 ' CD2' ' A' ' 89' ' ' LEU . 18.2 tp -89.71 121.47 31.9 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.185 -0.947 . . . . 0.0 110.002 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.468 ' O ' ' O ' ' A' ' 143' ' ' ASP . 48.3 mtp180 -122.67 121.73 37.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.297 -0.877 . . . . 0.0 110.142 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.536 ' CD1' ' C ' ' A' ' 64' ' ' TYR . 0.7 OUTLIER -159.57 141.57 13.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.285 -0.884 . . . . 0.0 109.906 179.784 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 101' ' ' GLN . 89.9 m -119.18 97.04 5.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.279 -0.888 . . . . 0.0 109.674 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.494 ' C ' ' CD2' ' A' ' 95' ' ' LEU . . . -97.14 154.02 17.62 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.476 -0.765 . . . . 0.0 110.554 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.485 ' CG2' ' O ' ' A' ' 98' ' ' GLU . 96.9 m -150.34 122.02 8.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.369 -0.832 . . . . 0.0 110.101 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -108.3 142.9 37.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.244 -0.91 . . . . 0.0 109.945 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.12 -22.01 2.26 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.154 -0.966 . . . . 0.0 109.138 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.555 ' CG2' ' HB2' ' A' ' 137' ' ' TRP . 3.4 t -119.27 166.92 12.39 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.563 -0.71 . . . . 0.0 109.835 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.429 ' N ' ' OD1' ' A' ' 71' ' ' ASP . 0.9 OUTLIER -82.38 73.54 9.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.047 -1.033 . . . . 0.0 109.114 178.925 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.538 ' CG2' ' HB2' ' A' ' 133' ' ' SER . 5.4 p -98.06 145.04 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.303 -0.873 . . . . 0.0 111.348 -178.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.46 HG23 ' HB3' ' A' ' 92' ' ' SER . 19.8 m -128.69 91.12 3.17 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 178.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.586 ' HA ' ' CG ' ' A' ' 132' ' ' PHE . 3.3 m -89.67 -148.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.203 -0.935 . . . . 0.0 110.766 -178.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.97 118.3 28.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.194 -0.941 . . . . 0.0 110.82 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.528 ' N ' ' HD3' ' A' ' 93' ' ' PRO . . . -122.98 147.92 46.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.204 -0.935 . . . . 0.0 109.681 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.58 ' CD1' ' N ' ' A' ' 78' ' ' VAL . 3.5 pp 178.92 -148.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.296 -0.878 . . . . 0.0 110.08 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.58 ' N ' ' CD1' ' A' ' 77' ' ' LEU . 2.5 t -147.85 171.07 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.194 -0.941 . . . . 0.0 108.902 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.498 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . -172.24 -178.5 42.48 Favored Glycine 0 N--CA 1.489 2.183 0 C-N-CA 119.169 -1.491 . . . . 0.0 110.183 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.422 ' O ' ' OD1' ' A' ' 81' ' ' ASN . 8.1 tt0 -92.28 -148.99 0.24 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.49 -1.006 . . . . 0.0 110.192 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.473 ' HB2' ' HG2' ' A' ' 122' ' ' GLU . 5.8 m120 -164.38 64.22 0.14 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.523 -0.736 . . . . 0.0 109.574 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.433 ' O ' ' C ' ' A' ' 83' ' ' ALA . . . 134.91 147.25 5.5 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.629 ' N ' ' CE1' ' A' ' 85' ' ' TYR . . . -41.25 151.62 0.28 Allowed Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.33 -1.1 . . . . 0.0 110.375 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.474 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.3 Cg_endo -80.16 12.48 23.23 Favored 'Cis proline' 0 C--N 1.312 -1.353 0 C-N-CA 121.659 -2.226 . . . . 0.0 110.884 -0.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.629 ' CE1' ' N ' ' A' ' 83' ' ' ALA . 26.4 m-85 63.2 150.63 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.16 -0.963 . . . . 0.0 110.194 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 175.97 131.49 1.47 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.59 155.15 21.79 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.299 -1.118 . . . . 0.0 110.104 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.569 HG23 ' CE2' ' A' ' 112' ' ' TYR . 33.2 m -125.4 -22.0 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.257 -0.902 . . . . 0.0 110.447 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.571 HD12 ' CZ ' ' A' ' 106' ' ' PHE . 3.7 mp -111.72 144.16 41.46 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.111 -0.993 . . . . 0.0 111.023 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -150.98 85.83 1.36 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.434 -0.791 . . . . 0.0 110.206 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.6 p -155.04 -177.31 6.44 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.053 -1.029 . . . . 0.0 110.581 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.46 ' HB3' HG23 ' A' ' 73' ' ' THR . 3.7 m -123.64 134.16 25.1 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.346 -0.847 . . . . 0.0 109.978 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.535 ' CG ' HG21 ' A' ' 74' ' ' VAL . 51.6 Cg_endo -78.31 79.81 3.19 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.871 1.458 . . . . 0.0 110.877 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.527 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -49.26 134.51 18.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.939 -1.101 . . . . 0.0 109.159 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.494 ' CD2' ' C ' ' A' ' 66' ' ' ALA . 27.6 mt -131.44 170.64 14.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.052 -1.03 . . . . 0.0 110.89 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.478 ' CG2' ' HG3' ' A' ' 100' ' ' ARG . 0.2 OUTLIER -170.99 -178.69 2.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.445 -0.784 . . . . 0.0 109.942 179.972 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.84 -6.37 26.58 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.278 -0.888 . . . . 0.0 110.244 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.485 ' O ' ' CG2' ' A' ' 67' ' ' THR . 0.6 OUTLIER -110.52 174.58 2.3 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.243 -0.911 . . . . 0.0 110.1 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.471 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 45.0 Cg_endo -72.31 128.02 13.28 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.026 1.54 . . . . 0.0 110.294 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.527 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 1.2 mtt-85 -119.76 92.17 3.72 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.152 -0.968 . . . . 0.0 110.4 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.47 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 38.9 tt0 -75.1 154.11 37.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.364 -0.835 . . . . 0.0 109.978 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.432 ' HB ' ' O ' ' A' ' 64' ' ' TYR . 74.4 t -139.5 133.72 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.166 -0.958 . . . . 0.0 110.354 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.443 HG21 ' HG2' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -150.15 118.99 6.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.283 -0.886 . . . . 0.0 110.083 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -140.6 153.13 45.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.204 -0.935 . . . . 0.0 110.361 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.518 HG23 ' CG2' ' A' ' 59' ' ' THR . 8.4 m -109.5 70.79 0.74 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.289 -0.882 . . . . 0.0 110.116 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.571 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 40.0 p90 -84.82 146.62 27.24 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.306 -0.871 . . . . 0.0 110.144 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 58' ' ' THR . 5.6 m -89.94 102.65 15.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -0.93 . . . . 0.0 109.987 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.662 ' CB ' ' CD1' ' A' ' 60' ' ' TYR . . . -70.04 95.78 0.99 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.155 -0.966 . . . . 0.0 110.388 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.533 ' HA ' ' HA2' ' A' ' 57' ' ' GLY . 8.2 p -85.88 59.63 5.75 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.675 -0.64 . . . . 0.0 109.512 179.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -155.27 -156.24 0.64 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.12 -0.987 . . . . 0.0 110.835 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . 46.6 m -147.42 108.05 4.14 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.373 -0.829 . . . . 0.0 110.87 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.58 ' CE2' HG13 ' A' ' 78' ' ' VAL . 16.4 m-30 -110.04 74.17 0.77 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.396 -0.815 . . . . 0.0 109.642 179.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.471 ' O ' ' HB2' ' A' ' 122' ' ' GLU . 43.7 Cg_endo -71.65 -159.08 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.908 1.478 . . . . 0.0 110.41 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.271 -0.893 . . . . 0.0 110.247 -179.824 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.473 ' HG2' ' HB2' ' A' ' 81' ' ' ASN . 22.5 pm0 . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 121.107 0.479 . . . . 0.0 110.219 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.514 ' HA3' ' CB ' ' A' ' 112' ' ' TYR . . . -151.36 150.8 22.79 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.519 ' CB ' ' HA ' ' A' ' 50' ' ' ASN . 3.0 pt20 -150.35 -153.34 0.48 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.269 -1.136 . . . . 0.0 110.394 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.435 ' CG2' ' CE1' ' A' ' 127' ' ' PHE . 7.5 mt -118.45 144.86 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.419 -0.801 . . . . 0.0 109.379 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -122.11 121.1 36.14 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.228 -0.92 . . . . 0.0 111.04 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.475 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 5.1 m-85 -119.42 97.19 5.53 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . 0.479 ' O ' ' HB ' ' A' ' 74' ' ' VAL . 2.5 mt-30 -88.95 89.1 7.84 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.245 -0.91 . . . . 0.0 111.149 -178.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.525 HD12 ' CD2' ' A' ' 139' ' ' LEU . 16.0 mt -87.61 51.55 2.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.571 -0.705 . . . . 0.0 109.274 178.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.53 ' O ' ' CD2' ' A' ' 132' ' ' PHE . . . -127.68 151.0 18.42 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 51.81 63.55 4.65 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.586 ' CG ' ' HA ' ' A' ' 74' ' ' VAL . 15.5 m-85 -148.06 -78.79 0.15 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.243 -1.151 . . . . 0.0 110.25 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.591 ' HB3' ' CD2' ' A' ' 137' ' ' TRP . 2.3 t -89.59 144.58 25.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.058 -1.026 . . . . 0.0 110.055 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -81.87 -84.45 0.11 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.289 -0.882 . . . . 0.0 110.357 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -42.54 154.92 0.05 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.247 -0.908 . . . . 0.0 110.293 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.486 ' HA ' ' HA ' ' A' ' 38' ' ' ALA . . . -57.59 124.28 18.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.279 -0.888 . . . . 0.0 110.214 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.598 ' CZ3' ' HB3' ' A' ' 40' ' ' SER . 6.0 p90 -131.23 -167.49 1.86 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.279 -0.888 . . . . 0.0 110.236 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.542 ' CG2' ' N ' ' A' ' 139' ' ' LEU . 0.8 OUTLIER -160.81 178.75 9.12 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.31 -0.956 . . . . 0.0 110.532 -178.255 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.542 ' N ' ' CG2' ' A' ' 138' ' ' THR . 2.2 mp -133.96 155.6 49.65 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.388 -0.82 . . . . 0.0 110.062 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' CYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 33' ' ' CYS . 11.1 m -150.12 97.88 2.62 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.173 -0.954 . . . . 0.0 110.724 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.491 ' O ' ' HB3' ' A' ' 142' ' ' ASP . 1.1 mt -89.62 -177.09 5.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.299 -0.876 . . . . 0.0 109.518 179.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.55 ' HB3' ' CB ' ' A' ' 31' ' ' ALA . 0.6 OUTLIER 172.33 44.21 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.186 -0.946 . . . . 0.0 110.999 179.926 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.489 ' HB2' ' O ' ' A' ' 142' ' ' ASP . 5.8 t0 171.85 69.81 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.309 -0.87 . . . . 0.0 109.592 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 1.9 t -106.64 122.28 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.129 -0.982 . . . . 0.0 110.412 -179.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -151.81 150.93 30.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.344 -0.847 . . . . 0.0 110.067 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.522 ' CD2' HD12 ' A' ' 54' ' ' ILE . 22.3 tp -138.49 158.83 43.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.288 -0.882 . . . . 0.0 110.29 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.505 ' N ' ' HG ' ' A' ' 146' ' ' LEU . 0.4 OUTLIER -163.25 -157.33 0.42 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.213 -0.929 . . . . 0.0 110.278 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.679 0 O-C-N 121.215 -0.928 . . . . 0.0 110.136 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo . . . . . 0 N--CA 1.48 0.712 0 N-CA-C 110.01 -0.804 . . . . 0.0 110.01 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.459 HD13 ' O ' ' A' ' 144' ' ' VAL . 5.0 pt -94.5 -8.78 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.197 -0.939 . . . . 0.0 110.167 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 69.75 156.24 1.39 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -72.23 83.12 1.02 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.223 -1.163 . . . . 0.0 110.152 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -86.76 127.41 8.38 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.454 ' O ' ' HB2' ' A' ' 9' ' ' PHE . 2.1 p -77.31 2.87 14.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.222 -1.164 . . . . 0.0 110.236 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.57 ' CD2' ' HB2' ' A' ' 32' ' ' LEU . 3.3 m-85 56.41 16.7 2.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.253 -0.904 . . . . 0.0 110.204 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.547 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 18.3 p-10 -98.41 14.03 29.53 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.234 -0.916 . . . . 0.0 110.391 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.547 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 2.2 t70 161.68 80.63 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.79 -0.569 . . . . 0.0 109.544 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.22 82.49 1.65 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.459 ' O ' ' HB3' ' A' ' 14' ' ' GLU . 51.2 Cg_endo -81.31 43.14 1.47 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.073 1.565 . . . . 0.0 110.668 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.459 ' HB3' ' O ' ' A' ' 13' ' ' PRO . 36.2 tp10 56.9 -91.27 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.137 -0.977 . . . . 0.0 110.206 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.485 ' C ' ' CD1' ' A' ' 49' ' ' LEU . . . -152.75 32.63 0.82 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.577 ' CE2' HD21 ' A' ' 49' ' ' LEU . 59.5 m95 -71.19 86.71 0.78 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.23 -1.159 . . . . 0.0 110.267 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.565 ' CG2' ' CG2' ' A' ' 48' ' ' VAL . 1.4 m -82.26 147.92 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.224 -0.922 . . . . 0.0 109.781 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.589 ' CB ' ' CG1' ' A' ' 34' ' ' VAL . . . -134.12 119.51 18.97 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.178 -0.951 . . . . 0.0 109.978 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.542 ' CZ ' ' C ' ' A' ' 46' ' ' GLY . 16.9 p90 -108.56 138.03 45.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.469 -0.77 . . . . 0.0 110.411 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.532 ' HA3' ' CG1' ' A' ' 45' ' ' VAL . . . 160.82 45.48 0.02 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.467 ' OG1' ' O ' ' A' ' 20' ' ' GLY . 9.6 p 50.84 19.16 0.59 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.442 -1.034 . . . . 0.0 110.733 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.535 ' HB2' ' CB ' ' A' ' 35' ' ' ALA . 3.0 p30 -97.88 38.51 1.29 Allowed 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.069 -1.019 . . . . 0.0 110.031 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 45.94 -156.54 0.45 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.436 ' O ' ' C ' ' A' ' 25' ' ' LEU . 46.5 Cg_endo -73.72 125.63 10.16 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 123.939 1.494 . . . . 0.0 110.35 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.464 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -42.26 133.02 3.26 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.277 -0.889 . . . . 0.0 110.015 179.887 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.07 116.23 28.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.144 -0.972 . . . . 0.0 110.054 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.535 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.9 OUTLIER -119.88 -28.71 5.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.167 -0.958 . . . . 0.0 110.34 -179.76 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.445 ' O ' ' HB ' ' A' ' 29' ' ' THR . 0.3 OUTLIER -48.91 83.13 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.838 -0.539 . . . . 0.0 111.254 -179.957 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.535 ' N ' ' O ' ' A' ' 27' ' ' THR . 0.8 OUTLIER 175.97 -28.93 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.017 -1.052 . . . . 0.0 110.309 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.519 ' HA2' ' CB ' ' A' ' 10' ' ' ASP . . . 133.73 -7.05 4.87 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.706 -1.357 . . . . 0.0 109.706 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.466 ' HA ' ' HB3' ' A' ' 9' ' ' PHE . . . -150.3 172.46 15.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.149 -1.207 . . . . 0.0 110.329 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.57 ' HB2' ' CD2' ' A' ' 9' ' ' PHE . 0.6 OUTLIER -103.97 94.73 5.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.274 -0.891 . . . . 0.0 109.769 179.736 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.483 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 65.5 m -100.09 115.61 30.17 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.295 -0.878 . . . . 0.0 111.002 -179.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.589 ' CG1' ' CB ' ' A' ' 18' ' ' ALA . 15.1 m -96.11 157.17 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.319 -0.863 . . . . 0.0 109.231 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.535 ' CB ' ' HB2' ' A' ' 22' ' ' ASP . . . -102.26 89.23 3.51 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.269 -0.894 . . . . 0.0 111.635 -178.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.581 HG13 ' CE2' ' A' ' 137' ' ' TRP . 76.3 t -74.71 119.21 75.58 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 120.976 -1.077 . . . . 0.0 109.192 178.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.426 ' O ' ' C ' ' A' ' 38' ' ' ALA . 42.7 Cg_endo -69.17 144.79 58.4 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.865 1.455 . . . . 0.0 111.226 -179.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.501 ' HA ' ' HA ' ' A' ' 136' ' ' ALA . . . -42.11 147.83 0.22 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.462 -0.774 . . . . 0.0 110.109 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.459 ' O ' ' OE1' ' A' ' 42' ' ' GLN . . . 44.52 70.64 0.56 Allowed Glycine 0 N--CA 1.488 2.132 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.575 ' HB2' ' CH2' ' A' ' 137' ' ' TRP . 0.5 OUTLIER -87.01 29.72 0.8 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.31 -1.112 . . . . 0.0 110.44 -179.636 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.417 ' HB3' ' HA3' ' A' ' 131' ' ' GLY . . . -91.38 19.99 5.61 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.926 0.869 . . . . 0.0 109.739 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.594 ' HG3' ' CD2' ' A' ' 43' ' ' TYR . 0.5 OUTLIER -84.44 -135.65 0.05 Allowed 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.527 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.646 ' CD1' ' N ' ' A' ' 44' ' ' GLY . 8.3 p90 -38.9 -27.39 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.379 -0.826 . . . . 0.0 110.417 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.646 ' N ' ' CD1' ' A' ' 43' ' ' TYR . . . 111.04 106.92 2.96 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.533 HG22 ' CB ' ' A' ' 40' ' ' SER . 2.9 t -90.09 153.83 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.231 -1.159 . . . . 0.0 108.73 179.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.542 ' C ' ' CZ ' ' A' ' 19' ' ' TYR . . . 176.75 169.51 38.16 Favored Glycine 0 N--CA 1.49 2.26 0 C-N-CA 119.221 -1.466 . . . . 0.0 110.218 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.53 ' CG1' ' O ' ' A' ' 17' ' ' VAL . 48.8 t -128.19 144.03 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.412 -1.052 . . . . 0.0 109.901 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.565 ' CG2' ' CG2' ' A' ' 17' ' ' VAL . 34.0 m -135.55 147.69 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.039 -1.038 . . . . 0.0 110.419 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.577 HD21 ' CE2' ' A' ' 16' ' ' TRP . 22.8 tp -135.82 109.85 8.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.251 -0.906 . . . . 0.0 110.308 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.493 ' ND2' ' O ' ' A' ' 50' ' ' ASN . 2.4 p-10 -84.33 121.71 27.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.224 -0.922 . . . . 0.0 110.269 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 139.92 79.43 0.06 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.522 HG13 ' CB ' ' A' ' 112' ' ' TYR . 54.0 t -131.36 150.44 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.197 -1.178 . . . . 0.0 110.198 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.51 ' N ' HG11 ' A' ' 52' ' ' VAL . . . -117.34 92.58 3.89 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.224 -0.922 . . . . 0.0 110.238 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.544 ' HB ' ' CD1' ' A' ' 112' ' ' TYR . 14.6 mm -136.37 169.33 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.237 -0.914 . . . . 0.0 110.065 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.507 ' HA ' ' HA ' ' A' ' 111' ' ' THR . 2.2 pt-20 179.05 139.54 0.1 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.24 -0.912 . . . . 0.0 110.361 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.499 ' HB3' ' O ' ' A' ' 55' ' ' GLU . 3.9 tt0 64.23 -179.67 0.17 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.512 -0.742 . . . . 0.0 110.759 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.494 ' HA2' ' HA ' ' A' ' 109' ' ' SER . . . -92.42 70.98 1.63 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.624 -1.791 . . . . 0.0 108.624 179.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.594 HG21 ' CE2' ' A' ' 60' ' ' TYR . 1.0 OUTLIER -105.9 176.81 5.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.532 -0.981 . . . . 0.0 110.087 -179.281 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.577 ' N ' ' CG2' ' A' ' 58' ' ' THR . 0.7 OUTLIER -89.57 156.4 18.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.304 -0.872 . . . . 0.0 110.436 -179.69 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.618 ' CD2' ' CB ' ' A' ' 108' ' ' ALA . 68.2 m-85 -156.45 118.08 3.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.448 -0.782 . . . . 0.0 109.625 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 104' ' ' GLU . 10.0 m -89.94 112.03 23.29 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.209 -0.932 . . . . 0.0 110.646 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 21.7 tp -90.21 140.0 30.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.346 -0.846 . . . . 0.0 109.66 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.465 ' O ' ' O ' ' A' ' 143' ' ' ASP . 27.1 mtt180 -136.92 105.68 5.87 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.146 -0.971 . . . . 0.0 110.722 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.528 ' CD1' ' C ' ' A' ' 64' ' ' TYR . 3.5 p90 -140.18 151.67 45.42 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.33 -0.856 . . . . 0.0 109.676 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 4.2 m -119.62 92.04 3.69 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.095 -1.003 . . . . 0.0 110.114 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' A' ' 140' ' ' CYS . . . -89.44 145.51 25.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.302 -0.874 . . . . 0.0 110.17 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.458 ' OG1' ' HA ' ' A' ' 99' ' ' PRO . 53.4 m -150.72 104.87 3.23 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.316 -0.865 . . . . 0.0 110.492 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -95.93 132.38 41.29 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.165 -0.96 . . . . 0.0 109.854 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 68' ' ' ALA . 20.0 m -43.54 -26.78 0.24 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.219 -0.926 . . . . 0.0 109.435 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.535 HG23 ' CB ' ' A' ' 137' ' ' TRP . 3.0 t -112.74 167.63 10.33 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.563 -0.711 . . . . 0.0 109.838 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.468 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 32.9 t0 -84.29 69.36 10.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.104 -0.997 . . . . 0.0 109.224 178.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.586 ' CG2' ' CB ' ' A' ' 133' ' ' SER . 3.8 p -92.0 140.08 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.331 -0.856 . . . . 0.0 111.318 -178.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.474 ' O ' ' CD1' ' A' ' 132' ' ' PHE . 98.3 m -126.46 91.94 3.46 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.582 ' HA ' ' CG ' ' A' ' 132' ' ' PHE . 3.2 m -89.79 -159.34 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.18 -0.95 . . . . 0.0 110.715 -178.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -119.16 106.61 12.54 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.284 -0.885 . . . . 0.0 110.394 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.485 ' O ' ' HB3' ' A' ' 77' ' ' LEU . . . -113.08 165.14 12.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.906 . . . . 0.0 110.194 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.502 ' HA ' ' HB3' ' A' ' 89' ' ' LEU . 3.1 pp 176.93 -159.7 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.363 -0.836 . . . . 0.0 110.12 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.508 HG22 ' CD2' ' A' ' 89' ' ' LEU . 3.4 t -149.26 155.61 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.26 -0.9 . . . . 0.0 109.718 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.575 ' O ' ' CE2' ' A' ' 112' ' ' TYR . . . -172.43 -178.2 42.41 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.429 -1.367 . . . . 0.0 110.258 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 111' ' ' THR . 0.0 OUTLIER -93.42 128.34 39.44 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.434 -1.039 . . . . 0.0 110.697 -179.726 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.489 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 1.4 m-80 -96.64 75.49 2.8 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.192 -0.943 . . . . 0.0 109.557 179.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.579 ' O ' ' CE1' ' A' ' 85' ' ' TYR . . . -166.07 -90.48 0.08 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 175.84 136.49 0.19 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.345 -1.091 . . . . 0.0 109.923 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.535 ' C ' ' CD2' ' A' ' 85' ' ' TYR . 52.3 Cg_endo -83.84 33.2 3.61 Favored 'Cis proline' 0 C--N 1.314 -1.271 0 C-N-CA 122.096 -2.044 . . . . 0.0 110.84 -0.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.579 ' CE1' ' O ' ' A' ' 82' ' ' GLY . 18.7 m-85 65.24 166.03 0.17 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.229 -0.919 . . . . 0.0 110.449 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.496 ' O ' ' CA ' ' A' ' 79' ' ' GLY . . . -163.4 171.11 39.02 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.57 133.67 21.52 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.099 -1.236 . . . . 0.0 110.507 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.582 ' CG2' ' CD1' ' A' ' 89' ' ' LEU . 12.4 m -119.8 -10.49 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.326 -0.859 . . . . 0.0 109.732 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.582 ' CD1' ' CG2' ' A' ' 88' ' ' VAL . 4.5 mp -123.5 143.49 50.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.418 -0.801 . . . . 0.0 110.816 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.443 ' O ' HG21 ' A' ' 91' ' ' THR . 0.7 OUTLIER -150.62 83.69 1.35 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.283 -0.886 . . . . 0.0 110.223 179.713 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.443 HG21 ' O ' ' A' ' 90' ' ' ASP . 1.1 p -160.06 -176.71 5.82 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.125 -0.984 . . . . 0.0 110.509 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.425 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 0.1 OUTLIER -119.93 131.24 24.48 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.321 -0.862 . . . . 0.0 110.079 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.527 ' CG ' HG21 ' A' ' 74' ' ' VAL . 48.6 Cg_endo -73.11 77.6 2.37 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.97 1.511 . . . . 0.0 110.912 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.532 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -48.63 135.26 14.91 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.975 -1.078 . . . . 0.0 109.148 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.472 ' CD1' ' HG ' ' A' ' 139' ' ' LEU . 36.4 mt -130.85 176.79 7.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.997 -1.064 . . . . 0.0 110.872 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 68' ' ' ALA . 0.2 OUTLIER -177.89 -178.8 0.72 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.49 -0.756 . . . . 0.0 109.918 -179.955 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.63 -22.44 63.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.226 -0.921 . . . . 0.0 110.287 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -90.07 169.86 11.5 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.29 -0.881 . . . . 0.0 110.078 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.458 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 45.0 Cg_endo -72.55 130.44 16.02 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 123.956 1.503 . . . . 0.0 110.276 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.532 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.69 92.2 3.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.154 -0.966 . . . . 0.0 110.35 -179.865 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.461 ' HG3' ' OG1' ' A' ' 65' ' ' THR . 38.3 tt0 -85.76 99.3 11.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.289 -0.882 . . . . 0.0 110.104 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.493 HG23 ' NH1' ' A' ' 100' ' ' ARG . 72.6 t -89.62 133.77 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 0.0 110.256 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.507 ' O ' ' CG ' ' A' ' 104' ' ' GLU . 49.5 m -147.51 135.72 21.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.357 -0.839 . . . . 0.0 110.084 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.507 ' CG ' ' O ' ' A' ' 103' ' ' THR . 17.9 mt-10 -160.16 -177.33 6.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.169 -0.957 . . . . 0.0 110.267 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.461 HG21 ' OG1' ' A' ' 61' ' ' THR . 0.0 OUTLIER -133.62 91.54 2.86 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.285 -0.885 . . . . 0.0 110.162 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.564 ' CE2' HG22 ' A' ' 88' ' ' VAL . 36.4 p90 -92.44 155.48 17.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.286 -0.884 . . . . 0.0 110.254 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 109' ' ' SER . 38.7 m -89.56 92.78 9.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.178 -0.951 . . . . 0.0 109.777 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.618 ' CB ' ' CD2' ' A' ' 60' ' ' TYR . . . -47.39 91.67 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.27 -0.894 . . . . 0.0 110.455 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 107' ' ' THR . 8.9 p -85.78 57.28 4.38 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.349 -0.844 . . . . 0.0 109.621 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.524 ' HB1' ' CG1' ' A' ' 88' ' ' VAL . . . -166.98 -156.34 0.22 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.115 -0.991 . . . . 0.0 110.868 -179.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.507 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . 35.5 m -148.0 111.57 5.01 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.539 -0.726 . . . . 0.0 110.024 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.578 ' CD2' ' HA3' ' A' ' 123' ' ' GLY . 4.2 m-85 -104.87 92.3 5.08 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.361 -0.837 . . . . 0.0 109.943 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.485 ' HG2' ' HA ' ' A' ' 122' ' ' GLU . 43.4 Cg_endo -71.73 160.9 46.79 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.798 1.42 . . . . 0.0 110.389 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.67 0 O-C-N 121.144 -0.972 . . . . 0.0 110.376 -179.695 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.489 ' O ' ' HB2' ' A' ' 81' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.229 0.537 . . . . 0.0 110.455 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.578 ' HA3' ' CD2' ' A' ' 112' ' ' TYR . . . -89.5 149.0 20.32 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.495 ' HA ' ' CG2' ' A' ' 52' ' ' VAL . 2.8 pt20 -150.37 -163.84 1.87 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.094 -1.239 . . . . 0.0 110.948 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.487 ' CG2' ' CE2' ' A' ' 127' ' ' PHE . 9.5 mt -118.57 144.37 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.579 -0.7 . . . . 0.0 109.186 179.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.435 ' N ' HG21 ' A' ' 125' ' ' ILE . . . -121.25 129.14 53.01 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.315 -0.866 . . . . 0.0 110.67 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.487 ' CE2' ' CG2' ' A' ' 125' ' ' ILE . 14.3 m-85 -118.78 105.0 11.1 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -89.03 85.37 6.68 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.376 -0.828 . . . . 0.0 111.923 -177.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.577 ' CD2' ' CG2' ' A' ' 74' ' ' VAL . 14.6 mt -91.13 45.11 1.22 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -98.37 89.45 0.95 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 -179.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.579 ' O ' ' CG ' ' A' ' 132' ' ' PHE . . . 81.08 107.87 0.32 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 110.029 -1.229 . . . . 0.0 110.029 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.582 ' CG ' ' HA ' ' A' ' 74' ' ' VAL . 8.4 m-85 -167.78 -67.1 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.366 -1.079 . . . . 0.0 109.849 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.586 ' CB ' ' CG2' ' A' ' 72' ' ' VAL . 1.3 t -89.68 160.79 16.42 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.143 -0.973 . . . . 0.0 109.893 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.405 ' O ' ' C ' ' A' ' 135' ' ' ASP . . . -88.3 -94.1 0.1 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.179 -0.95 . . . . 0.0 110.606 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 134' ' ' ALA . 9.5 m-20 -43.99 153.4 0.14 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.16 -0.963 . . . . 0.0 110.511 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.501 ' HA ' ' HA ' ' A' ' 38' ' ' ALA . . . -52.97 126.33 20.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.309 -0.869 . . . . 0.0 110.149 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.584 ' CD1' ' N ' ' A' ' 138' ' ' THR . 9.7 p90 -131.07 -161.15 1.1 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.257 -0.902 . . . . 0.0 110.181 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.584 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 0.8 OUTLIER -160.42 177.74 10.27 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.157 -0.964 . . . . 0.0 110.427 -178.084 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.541 ' N ' ' CG2' ' A' ' 138' ' ' THR . 2.2 mp -134.02 125.85 28.99 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.365 -0.834 . . . . 0.0 109.892 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' CYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 59.9 m -120.12 104.13 9.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.16 -0.963 . . . . 0.0 110.993 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.494 ' O ' ' HB3' ' A' ' 142' ' ' ASP . 1.0 OUTLIER -102.11 -178.63 3.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.259 -0.9 . . . . 0.0 109.805 179.301 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.494 ' HB3' ' O ' ' A' ' 141' ' ' LEU . 4.5 p-10 173.59 167.35 0.18 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.458 -0.776 . . . . 0.0 110.316 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.465 ' O ' ' O ' ' A' ' 63' ' ' ARG . 13.9 t70 41.74 64.54 1.04 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.341 -0.849 . . . . 0.0 110.364 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.476 HG22 ' CZ ' ' A' ' 9' ' ' PHE . 4.9 t -99.1 113.2 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.252 -0.905 . . . . 0.0 110.053 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -129.8 171.33 12.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -0.934 . . . . 0.0 110.404 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.517 ' CD2' HD13 ' A' ' 54' ' ' ILE . 60.8 tp -162.49 120.75 2.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.275 -0.891 . . . . 0.0 110.159 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.532 ' O ' ' CD1' ' A' ' 60' ' ' TYR . 0.5 OUTLIER -125.24 -152.42 0.52 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.274 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 72.5 p . . . . . 0 N--CA 1.492 1.647 0 O-C-N 121.303 -0.873 . . . . 0.0 110.158 -179.951 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo . . . . . 0 N--CA 1.483 0.859 0 N-CA-C 110.515 -0.61 . . . . 0.0 110.515 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.44 HG13 ' O ' ' A' ' 4' ' ' ILE . 10.7 pt -117.72 32.67 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.227 -0.921 . . . . 0.0 110.113 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 7' ' ' GLY . . . 81.49 44.45 7.92 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.514 ' HG2' ' CB ' ' A' ' 145' ' ' ALA . 4.1 mt-10 -41.93 94.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.337 -1.096 . . . . 0.0 110.337 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 5' ' ' GLY . . . 152.48 -149.9 21.63 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.437 ' HA ' ' C ' ' A' ' 142' ' ' ASP . 70.4 p -92.71 163.49 13.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.27 -1.136 . . . . 0.0 110.233 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -87.61 35.47 0.72 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.256 -0.903 . . . . 0.0 110.189 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.543 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 13.8 t0 -86.22 57.13 4.31 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.275 -0.891 . . . . 0.0 110.133 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.543 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.9 OUTLIER 161.69 36.84 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.628 -0.67 . . . . 0.0 110.073 -179.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.26 140.28 9.2 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.501 ' HB3' ' CD1' ' A' ' 32' ' ' LEU . 49.8 Cg_endo -77.13 6.6 4.18 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.104 1.581 . . . . 0.0 110.637 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 0.7 OUTLIER 65.57 -85.79 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.205 -0.934 . . . . 0.0 110.413 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.426 ' C ' HD13 ' A' ' 49' ' ' LEU . . . -147.88 13.88 1.33 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.578 ' CE2' HD21 ' A' ' 49' ' ' LEU . 30.5 m95 -66.68 135.0 53.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.163 -1.198 . . . . 0.0 110.367 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.575 ' CG2' ' CG2' ' A' ' 48' ' ' VAL . 1.2 m -129.76 156.54 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.0 110.052 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.456 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . . . -139.1 130.87 27.54 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.474 -0.767 . . . . 0.0 108.959 179.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.578 ' CE2' ' O ' ' A' ' 46' ' ' GLY . 9.3 p90 -121.62 158.8 27.83 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.098 -1.001 . . . . 0.0 111.73 -178.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.586 ' HA2' ' CE1' ' A' ' 43' ' ' TYR . . . 75.27 36.38 45.36 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.586 ' CG2' ' CG1' ' A' ' 45' ' ' VAL . 15.0 p -128.29 -160.69 1.04 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.089 -1.242 . . . . 0.0 110.5 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -98.42 39.19 1.26 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.37 -0.831 . . . . 0.0 110.249 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 133.89 175.31 13.86 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.455 ' O ' ' O ' ' A' ' 25' ' ' LEU . 46.8 Cg_endo -73.34 138.45 27.41 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.018 1.536 . . . . 0.0 110.563 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.511 ' CD1' HD12 ' A' ' 32' ' ' LEU . 0.8 OUTLIER -42.2 165.09 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.416 -0.802 . . . . 0.0 110.142 179.844 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -150.62 150.45 31.18 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.19 -0.944 . . . . 0.0 110.297 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.52 ' CG2' ' HA ' ' A' ' 32' ' ' LEU . 0.8 OUTLIER -119.94 -76.98 0.57 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.272 -0.893 . . . . 0.0 110.058 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.448 ' HB3' ' O ' ' A' ' 27' ' ' THR . 25.6 t 55.53 -88.28 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.252 -0.905 . . . . 0.0 110.605 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.445 ' N ' ' O ' ' A' ' 27' ' ' THR . 9.6 t -40.5 -27.62 0.05 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.398 -0.814 . . . . 0.0 110.573 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 28' ' ' SER . . . 132.13 -42.75 1.35 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.457 ' HB2' ' HB3' ' A' ' 140' ' ' CYS . . . -89.82 144.75 25.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.297 -1.119 . . . . 0.0 109.876 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.52 ' HA ' ' CG2' ' A' ' 27' ' ' THR . 0.5 OUTLIER -79.33 95.37 5.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.226 -0.921 . . . . 0.0 110.469 -179.786 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.515 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 0.8 OUTLIER -93.99 115.83 28.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.28 -0.887 . . . . 0.0 111.093 179.563 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.479 ' O ' ' OG1' ' A' ' 138' ' ' THR . 15.9 m -89.31 142.12 13.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.51 76.63 8.18 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.379 -0.826 . . . . 0.0 110.777 -178.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.662 ' CG1' ' CZ2' ' A' ' 137' ' ' TRP . 95.6 t -68.97 125.11 91.66 Favored Pre-proline 0 C--N 1.302 -1.463 0 O-C-N 121.443 -0.785 . . . . 0.0 109.08 179.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.496 ' HD3' ' HA ' ' A' ' 21' ' ' THR . 38.7 Cg_endo -65.82 175.64 4.35 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.966 1.508 . . . . 0.0 112.107 -178.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.534 ' HA ' ' N ' ' A' ' 136' ' ' ALA . . . -53.94 121.64 8.43 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.566 -0.709 . . . . 0.0 111.412 -178.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 134' ' ' ALA . . . 37.73 27.86 0.03 OUTLIER Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 38' ' ' ALA . 22.4 m 33.16 61.34 0.42 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.74 -0.859 . . . . 0.0 110.103 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.546 ' O ' ' CG ' ' A' ' 42' ' ' GLN . . . -88.54 133.94 34.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.45 -0.781 . . . . 0.0 110.444 -178.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.546 ' CG ' ' O ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER 59.49 30.03 19.66 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.192 0.52 . . . . 0.0 109.766 -179.454 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.586 ' CE1' ' HA2' ' A' ' 20' ' ' GLY . 0.1 OUTLIER -161.94 82.37 0.57 Allowed 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 118.776 -1.17 . . . . 0.0 111.707 -178.587 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.543 ' HA2' ' CA ' ' A' ' 130' ' ' GLY . . . -50.33 99.26 0.03 OUTLIER Glycine 0 N--CA 1.482 1.761 0 N-CA-C 107.091 -2.404 . . . . 0.0 107.091 178.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.586 ' CG1' ' CG2' ' A' ' 21' ' ' THR . 3.1 t -87.2 111.8 22.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 120.976 -1.308 . . . . 0.0 108.812 -178.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.578 ' O ' ' CE2' ' A' ' 19' ' ' TYR . . . -136.78 141.78 12.82 Favored Glycine 0 N--CA 1.486 1.98 0 C-N-CA 118.959 -1.591 . . . . 0.0 110.507 -178.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.518 ' CG1' ' O ' ' A' ' 17' ' ' VAL . 17.0 t -106.21 125.49 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.39 -1.065 . . . . 0.0 109.433 179.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.575 ' CG2' ' CG2' ' A' ' 17' ' ' VAL . 35.6 m -119.94 145.22 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.001 -1.062 . . . . 0.0 110.83 -179.225 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.578 HD21 ' CE2' ' A' ' 16' ' ' TRP . 10.4 tp -135.23 97.19 3.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.412 -0.805 . . . . 0.0 109.955 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.523 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 3.1 m120 -73.94 129.65 38.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.226 -0.921 . . . . 0.0 110.355 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 146.69 58.23 0.02 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.524 ' CG2' ' HA ' ' A' ' 124' ' ' GLN . 71.3 t -123.2 170.79 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.092 -1.24 . . . . 0.0 110.148 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 112' ' ' TYR . . . -146.91 92.31 2.12 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.198 -0.939 . . . . 0.0 110.572 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.566 HG13 ' CD2' ' A' ' 112' ' ' TYR . 48.6 mm -124.3 156.68 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.244 -0.91 . . . . 0.0 109.793 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.522 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 1.1 tt0 -145.19 130.43 18.56 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.034 -1.041 . . . . 0.0 110.572 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.522 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 10.4 pt-20 38.11 -154.72 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.691 -0.631 . . . . 0.0 110.758 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 108' ' ' ALA . . . -83.44 85.91 1.52 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.573 HG21 ' CE2' ' A' ' 60' ' ' TYR . 1.2 m -110.59 173.68 6.22 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.248 -1.148 . . . . 0.0 109.821 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.567 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 0.6 OUTLIER -89.88 151.29 21.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.196 -0.94 . . . . 0.0 110.354 -179.881 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.573 ' CD2' ' CB ' ' A' ' 108' ' ' ALA . 56.9 m-85 -160.2 178.17 9.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.265 -0.897 . . . . 0.0 110.287 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 75.5 m -150.19 119.81 6.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.437 -0.789 . . . . 0.0 109.746 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' A' ' 103' ' ' THR . 17.7 tp -89.48 119.97 30.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.13 -0.981 . . . . 0.0 110.12 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.507 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 10.2 ttp180 -124.4 138.68 54.34 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.373 -0.829 . . . . 0.0 109.806 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.536 ' CD1' ' C ' ' A' ' 64' ' ' TYR . 0.8 OUTLIER -178.74 142.2 0.21 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.37 -0.831 . . . . 0.0 109.677 179.892 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 4.3 m -119.22 94.5 4.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.066 -1.021 . . . . 0.0 110.009 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.511 ' CB ' HD23 ' A' ' 95' ' ' LEU . . . -97.12 156.16 16.51 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.377 -0.827 . . . . 0.0 110.412 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.456 HG22 ' O ' ' A' ' 98' ' ' GLU . 54.9 m -149.63 119.98 7.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.316 -0.865 . . . . 0.0 110.126 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -108.2 131.3 54.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.246 -0.909 . . . . 0.0 110.043 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 11.3 t -65.62 -9.23 25.21 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.212 -0.93 . . . . 0.0 110.104 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.548 ' CG2' ' CB ' ' A' ' 137' ' ' TRP . 6.0 t -116.0 19.54 14.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -0.895 . . . . 0.0 110.266 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.48 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 9.6 t0 42.76 66.49 0.76 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.291 -0.88 . . . . 0.0 109.69 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.526 ' CG1' HD11 ' A' ' 95' ' ' LEU . 5.8 p -97.84 141.87 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.407 -0.808 . . . . 0.0 110.826 -179.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 19.5 m -119.76 82.56 1.9 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.377 -0.827 . . . . 0.0 109.163 179.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.588 ' HA ' ' CD2' ' A' ' 132' ' ' PHE . 17.7 m -90.0 -140.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.243 -0.911 . . . . 0.0 110.739 -179.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.521 ' N ' HG21 ' A' ' 74' ' ' VAL . 7.5 mtm180 -130.43 145.01 51.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.19 -0.944 . . . . 0.0 110.828 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.541 ' N ' ' HD3' ' A' ' 93' ' ' PRO . . . -150.5 153.42 35.82 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.417 -0.802 . . . . 0.0 109.479 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.573 ' CD1' ' N ' ' A' ' 78' ' ' VAL . 3.9 pp 179.86 -147.59 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.136 -0.977 . . . . 0.0 110.4 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.573 ' N ' ' CD1' ' A' ' 77' ' ' LEU . 5.0 t -149.92 164.97 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.359 -0.838 . . . . 0.0 109.114 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.494 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . -171.81 -175.56 40.15 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 118.958 -1.591 . . . . 0.0 110.693 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.467 ' HG3' ' O ' ' A' ' 122' ' ' GLU . 1.3 tt0 -90.88 -151.63 0.26 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.639 -0.918 . . . . 0.0 110.272 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.511 ' HB2' ' HG2' ' A' ' 122' ' ' GLU . 47.9 m-80 -161.81 83.57 0.59 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.434 -0.791 . . . . 0.0 109.582 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 83' ' ' ALA . . . 122.54 136.67 4.93 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.63 ' N ' ' CE1' ' A' ' 85' ' ' TYR . . . -40.45 150.82 0.26 Allowed Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.333 -1.098 . . . . 0.0 110.447 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.482 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.6 Cg_endo -80.07 12.07 23.64 Favored 'Cis proline' 0 C--N 1.313 -1.334 0 C-N-CA 121.711 -2.204 . . . . 0.0 110.938 -0.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.63 ' CE1' ' N ' ' A' ' 83' ' ' ALA . 27.2 m-85 63.6 163.65 0.12 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.187 -0.946 . . . . 0.0 110.282 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 176.4 131.9 1.55 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.455 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 0.7 OUTLIER -117.73 153.31 33.6 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.227 -1.161 . . . . 0.0 110.282 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.543 HG23 ' CE2' ' A' ' 112' ' ' TYR . 31.3 m -124.88 -24.45 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.32 -0.863 . . . . 0.0 110.305 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.584 ' CD1' ' CZ ' ' A' ' 106' ' ' PHE . 3.8 mp -104.79 144.29 31.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.204 -0.935 . . . . 0.0 110.952 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.438 ' O ' HG21 ' A' ' 91' ' ' THR . 12.9 p-10 -151.5 76.66 1.22 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.348 -0.845 . . . . 0.0 109.974 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.438 HG21 ' O ' ' A' ' 90' ' ' ASP . 67.1 p -142.71 -178.72 5.93 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.978 -1.076 . . . . 0.0 110.756 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.94 128.03 26.07 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.457 -0.777 . . . . 0.0 110.07 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.541 ' HD3' ' N ' ' A' ' 76' ' ' ALA . 46.4 Cg_endo -72.5 78.2 2.03 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.95 1.5 . . . . 0.0 111.038 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.535 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -56.43 139.64 48.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.057 -1.027 . . . . 0.0 109.223 179.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.575 ' CD1' ' CD2' ' A' ' 139' ' ' LEU . 44.4 mt -135.61 160.15 39.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.007 -1.058 . . . . 0.0 110.907 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -158.59 -179.02 7.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.476 -0.765 . . . . 0.0 109.926 179.949 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.81 -27.65 69.32 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -0.933 . . . . 0.0 110.118 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.457 ' HB3' ' HD2' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -90.51 176.65 2.8 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.184 -0.948 . . . . 0.0 110.018 179.824 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.457 ' HD2' ' HB3' ' A' ' 98' ' ' GLU . 44.9 Cg_endo -72.08 135.61 25.5 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.928 1.488 . . . . 0.0 110.381 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.535 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.84 93.49 4.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.228 -0.92 . . . . 0.0 110.208 179.985 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -87.61 97.25 10.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.371 -0.831 . . . . 0.0 110.359 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.531 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 40.2 t -89.55 134.03 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.347 -0.846 . . . . 0.0 110.216 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -150.25 133.81 16.58 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.219 -0.925 . . . . 0.0 110.211 179.902 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -160.26 135.62 8.09 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.909 . . . . 0.0 110.245 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.427 HG21 ' O ' ' A' ' 60' ' ' TYR . 85.3 m -90.03 125.87 35.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.224 -0.922 . . . . 0.0 110.053 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.584 ' CZ ' ' CD1' ' A' ' 89' ' ' LEU . 28.2 p90 -132.31 156.03 47.3 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.185 -0.947 . . . . 0.0 110.354 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.2 m -90.06 94.92 9.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.224 -0.923 . . . . 0.0 109.897 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.573 ' CB ' ' CD2' ' A' ' 60' ' ' TYR . . . -53.02 107.5 0.23 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.252 -0.905 . . . . 0.0 110.329 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.449 ' HA ' ' HA2' ' A' ' 57' ' ' GLY . 24.6 p -94.06 53.26 1.74 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.264 -0.898 . . . . 0.0 110.017 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -162.09 -153.55 0.28 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.297 -0.877 . . . . 0.0 110.278 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 5.2 m -147.27 118.38 7.74 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.283 -0.886 . . . . 0.0 110.172 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.566 ' CD2' HG13 ' A' ' 54' ' ' ILE . 20.3 m-30 -113.23 70.21 1.36 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.303 -0.873 . . . . 0.0 109.971 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.469 ' O ' ' HB2' ' A' ' 122' ' ' GLU . 46.3 Cg_endo -72.39 -159.06 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.035 1.545 . . . . 0.0 110.436 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.228 -0.92 . . . . 0.0 110.206 -179.944 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.511 ' HG2' ' HB2' ' A' ' 81' ' ' ASN . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 121.012 0.434 . . . . 0.0 109.878 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.563 ' HA3' ' CG ' ' A' ' 112' ' ' TYR . . . -144.37 149.09 21.13 Favored Glycine 0 N--CA 1.491 2.321 0 C-N-CA 119.56 -1.305 . . . . 0.0 109.889 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.524 ' HA ' ' CG2' ' A' ' 52' ' ' VAL . 19.4 pt20 -150.51 -153.11 0.47 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.314 -1.11 . . . . 0.0 110.085 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.478 HD12 HG22 ' A' ' 125' ' ' ILE . 14.2 mt -118.18 139.23 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.487 -0.758 . . . . 0.0 109.359 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -117.12 123.62 47.2 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.291 -0.88 . . . . 0.0 110.933 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.471 ' CE1' ' CG2' ' A' ' 125' ' ' ILE . 4.5 m-85 -118.84 103.18 9.39 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . 0.529 ' O ' ' CD2' ' A' ' 129' ' ' LEU . 2.0 mt-30 -89.11 129.87 35.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.203 -0.935 . . . . 0.0 111.714 -177.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.544 ' CB ' ' O ' ' A' ' 45' ' ' VAL . 0.8 OUTLIER -141.53 34.08 1.64 Allowed 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.441 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.543 ' CA ' ' HA2' ' A' ' 44' ' ' GLY . . . -82.23 118.96 4.74 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.454 ' HA2' ' O ' ' A' ' 39' ' ' GLY . . . 42.56 69.99 0.54 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.588 ' CD2' ' HA ' ' A' ' 74' ' ' VAL . 11.2 m-85 -117.35 -61.81 1.65 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.109 -1.23 . . . . 0.0 111.006 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.516 ' HB2' ' CG2' ' A' ' 72' ' ' VAL . 1.3 t -88.36 -176.46 5.35 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.02 -1.05 . . . . 0.0 110.693 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -92.53 -82.03 0.33 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.276 -0.89 . . . . 0.0 110.225 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -70.25 177.77 3.15 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.147 -0.971 . . . . 0.0 109.765 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.534 ' N ' ' HA ' ' A' ' 38' ' ' ALA . . . -75.2 138.81 42.21 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.297 -0.877 . . . . 0.0 110.736 -179.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.662 ' CZ2' ' CG1' ' A' ' 36' ' ' VAL . 9.0 p90 -140.99 -171.41 3.25 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.263 -0.898 . . . . 0.0 110.682 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.479 ' OG1' ' O ' ' A' ' 34' ' ' VAL 0.251 0.8 OUTLIER -149.25 171.34 16.65 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.536 -0.727 . . . . 0.0 109.702 -177.986 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.575 ' CD2' ' CD1' ' A' ' 95' ' ' LEU . 1.7 mp -139.47 117.91 12.11 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.998 -1.064 . . . . 0.0 112.11 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' CYS . . . . . 0.457 ' HB3' ' HB2' ' A' ' 31' ' ' ALA . 0.8 OUTLIER -103.4 110.11 22.0 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.646 -0.659 . . . . 0.0 110.64 178.186 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.491 ' O ' ' CB ' ' A' ' 142' ' ' ASP . 1.3 mt -97.28 -178.5 4.19 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.277 -0.89 . . . . 0.0 108.974 178.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 143' ' ' ASP . 0.5 OUTLIER 169.31 61.12 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.145 -0.972 . . . . 0.0 110.407 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.53 ' CB ' ' O ' ' A' ' 142' ' ' ASP . 0.5 OUTLIER 166.35 43.26 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.388 -0.82 . . . . 0.0 109.344 179.852 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 1.5 t -89.45 114.33 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.373 -0.83 . . . . 0.0 110.281 -179.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.514 ' CB ' ' HG2' ' A' ' 6' ' ' GLU . . . -151.84 148.45 27.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.413 -0.804 . . . . 0.0 110.081 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.447 HD22 HD13 ' A' ' 54' ' ' ILE . 38.8 tp -146.54 123.57 11.41 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.341 -0.849 . . . . 0.0 110.099 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.449 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -140.66 157.57 45.25 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.235 -0.916 . . . . 0.0 110.373 -179.938 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 59' ' ' THR . 24.4 p . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.282 -0.886 . . . . 0.0 110.136 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo . . . . . 0 N--CA 1.479 0.649 0 N-CA-C 110.09 -0.773 . . . . 0.0 110.09 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.473 HG23 HD22 ' A' ' 49' ' ' LEU . 10.0 pt -96.38 -28.93 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.183 -0.948 . . . . 0.0 110.181 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.51 ' O ' ' N ' ' A' ' 7' ' ' GLY . . . 99.4 106.47 2.71 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.454 ' HB2' ' HB3' ' A' ' 145' ' ' ALA . 0.6 OUTLIER -45.01 93.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.231 -1.158 . . . . 0.0 110.069 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 5' ' ' GLY . . . -139.55 177.84 20.12 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.512 ' O ' ' HB2' ' A' ' 9' ' ' PHE . 29.4 p -129.52 20.35 5.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.386 -1.067 . . . . 0.0 109.818 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.58 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.2 m-30 70.71 -78.96 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.812 -0.555 . . . . 0.0 110.671 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.555 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 1.4 p30 40.02 27.87 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.095 -1.003 . . . . 0.0 110.505 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.555 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 1.9 t70 161.13 -57.84 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.54 0.686 . . . . 0.0 109.235 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 9' ' ' PHE . . . -133.67 127.13 4.53 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.57 ' HA ' ' CD1' ' A' ' 9' ' ' PHE . 52.4 Cg_endo -81.82 29.85 0.53 Allowed 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.819 1.431 . . . . 0.0 111.16 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 0.2 OUTLIER 62.23 -89.35 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.997 -1.065 . . . . 0.0 110.326 179.923 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -149.73 22.19 1.16 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.643 ' CE2' ' CD2' ' A' ' 49' ' ' LEU . 40.0 m95 -61.69 142.56 57.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.276 -1.132 . . . . 0.0 110.381 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.527 ' CG2' HG22 ' A' ' 48' ' ' VAL . 0.8 OUTLIER -132.87 140.87 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.232 -0.918 . . . . 0.0 109.222 179.15 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.518 ' CB ' HG13 ' A' ' 34' ' ' VAL . . . -125.15 114.75 19.43 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.97 -1.081 . . . . 0.0 110.235 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.411 ' O ' HG11 ' A' ' 45' ' ' VAL . 40.0 p90 -100.93 150.53 22.77 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.691 -0.631 . . . . 0.0 109.924 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.57 ' O ' ' OG1' ' A' ' 21' ' ' THR . . . 112.58 87.2 1.64 Allowed Glycine 0 N--CA 1.483 1.802 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.57 ' OG1' ' O ' ' A' ' 20' ' ' GLY . 1.4 p 75.24 -139.81 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.116 0 O-C-N 122.064 -0.668 . . . . 0.0 110.333 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.523 ' O ' ' CB ' ' A' ' 35' ' ' ALA . 2.5 m-20 -88.72 116.84 27.27 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.884 -1.135 . . . . 0.0 110.075 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.557 ' N ' ' CD ' ' A' ' 24' ' ' PRO . . . -119.61 49.24 0.88 Allowed Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.557 ' CD ' ' N ' ' A' ' 23' ' ' GLY . 43.4 Cg_endo -69.89 82.17 0.8 Allowed 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 124.024 1.539 . . . . 0.0 109.677 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.525 ' HB3' ' CD1' ' A' ' 32' ' ' LEU . 40.8 mt -50.93 88.52 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.44 -0.787 . . . . 0.0 110.422 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 24' ' ' PRO . 0.3 OUTLIER -91.22 120.95 32.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -0.885 . . . . 0.0 109.442 179.626 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.449 HG22 ' HB3' ' A' ' 9' ' ' PHE . 1.2 p -119.54 -27.39 5.54 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.076 -1.015 . . . . 0.0 110.889 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 27' ' ' THR . 74.4 m -43.46 -28.08 0.33 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.186 -0.946 . . . . 0.0 109.192 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.417 ' CG2' ' N ' ' A' ' 30' ' ' GLY . 6.3 t -67.78 -47.89 67.87 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.629 -0.669 . . . . 0.0 110.482 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.417 ' N ' ' CG2' ' A' ' 29' ' ' THR . . . 164.93 -25.94 0.18 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.527 ' CB ' ' HB3' ' A' ' 140' ' ' CYS . . . -150.54 159.67 44.33 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.295 -1.121 . . . . 0.0 110.218 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.525 ' CD1' ' HB3' ' A' ' 25' ' ' LEU . 0.6 OUTLIER -72.71 102.0 3.22 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.314 -0.866 . . . . 0.0 110.328 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.543 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 0.8 OUTLIER -98.84 119.76 38.14 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.167 -0.958 . . . . 0.0 111.913 -179.915 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.518 HG13 ' CB ' ' A' ' 18' ' ' ALA . 17.2 m -96.92 150.11 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' A' ' 22' ' ' ASP . . . -89.95 121.75 32.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.054 -1.029 . . . . 0.0 111.781 -178.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.643 ' CG1' ' CZ2' ' A' ' 137' ' ' TRP . 66.5 t -119.56 125.8 27.29 Favored Pre-proline 0 C--N 1.303 -1.452 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 178.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.475 ' HG3' HG23 ' A' ' 21' ' ' THR . 44.8 Cg_endo -71.59 147.39 51.42 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 123.811 1.427 . . . . 0.0 110.929 -178.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.522 ' HA ' ' N ' ' A' ' 136' ' ' ALA . . . -43.03 123.97 3.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.364 -0.835 . . . . 0.0 109.277 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 134' ' ' ALA . . . 61.39 78.8 0.15 Allowed Glycine 0 N--CA 1.486 1.968 0 N-CA-C 108.0 -2.04 . . . . 0.0 108.0 -178.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.575 ' HB3' ' CH2' ' A' ' 137' ' ' TRP . 2.4 p -85.28 53.63 2.82 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.542 -0.975 . . . . 0.0 110.076 -179.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.566 ' O ' ' O ' ' A' ' 42' ' ' GLN . . . -88.83 -147.49 0.16 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.69 -0.631 . . . . 0.0 110.024 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.701 ' O ' ' CD2' ' A' ' 43' ' ' TYR . 5.8 pt20 38.94 102.98 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 CA-C-O 121.761 0.791 . . . . 0.0 110.522 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.701 ' CD2' ' O ' ' A' ' 42' ' ' GLN . 0.0 OUTLIER 77.7 -20.95 0.35 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.729 -1.232 . . . . 0.0 110.275 -178.797 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.584 ' O ' ' CD1' ' A' ' 43' ' ' TYR . . . 57.71 141.95 0.01 OUTLIER Glycine 0 N--CA 1.492 2.398 0 O-C-N 120.952 -1.092 . . . . 0.0 111.196 178.155 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.55 ' CG2' ' HB2' ' A' ' 40' ' ' SER . 2.5 t -93.35 -172.66 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.306 -1.114 . . . . 0.0 108.762 179.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 127' ' ' PHE . . . 172.13 -175.4 45.41 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 118.635 -1.745 . . . . 0.0 111.464 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.526 ' CG1' ' O ' ' A' ' 17' ' ' VAL . 35.5 t -150.6 133.75 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.527 HG22 ' CG2' ' A' ' 17' ' ' VAL . 22.5 m -123.66 138.5 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 120.81 -1.181 . . . . 0.0 110.99 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.643 ' CD2' ' CE2' ' A' ' 16' ' ' TRP . 5.2 tp -132.03 98.87 4.55 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.326 -0.859 . . . . 0.0 110.202 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.521 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 3.4 p-10 -73.46 98.88 2.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 0.0 110.091 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.448 ' O ' HG21 ' A' ' 4' ' ' ILE . . . 172.7 77.57 0.05 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.498 ' CG2' ' HA ' ' A' ' 124' ' ' GLN . 12.4 t -134.93 169.17 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.215 -1.168 . . . . 0.0 109.937 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -136.46 79.7 1.78 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.107 -0.995 . . . . 0.0 110.671 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.554 HG13 ' CD2' ' A' ' 112' ' ' TYR . 36.0 mm -115.63 158.91 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.209 -0.932 . . . . 0.0 109.934 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.53 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 3.8 tt0 -152.04 124.25 8.18 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.116 -0.99 . . . . 0.0 110.438 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.53 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 11.5 pt-20 37.73 -152.93 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.669 -0.645 . . . . 0.0 110.789 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.461 ' N ' ' HG3' ' A' ' 56' ' ' GLU . . . -82.03 99.95 2.07 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.58 HG21 ' CE2' ' A' ' 60' ' ' TYR . 1.2 m -132.46 174.16 10.55 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.33 -1.1 . . . . 0.0 109.855 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.568 ' N ' ' CG2' ' A' ' 58' ' ' THR . 1.3 m -89.72 152.97 21.06 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.226 -0.921 . . . . 0.0 110.191 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.582 ' CD2' ' HB1' ' A' ' 108' ' ' ALA . 57.9 m-85 -158.6 158.61 34.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.255 -0.903 . . . . 0.0 110.28 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 87.8 m -132.37 117.3 17.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.317 -0.865 . . . . 0.0 109.971 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 20.1 tp -89.73 121.49 31.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.188 -0.945 . . . . 0.0 110.156 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.478 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 9.5 ttp180 -125.78 131.84 52.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 110.12 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.638 ' CZ ' ' CG2' ' A' ' 102' ' ' VAL . 2.7 p90 -169.8 146.64 3.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.221 -0.924 . . . . 0.0 109.975 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.461 ' OG1' ' HG3' ' A' ' 101' ' ' GLN . 3.4 m -119.49 101.33 7.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.199 -0.938 . . . . 0.0 109.745 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.483 ' HB1' ' CD2' ' A' ' 141' ' ' LEU . . . -104.83 150.79 24.52 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.356 -0.84 . . . . 0.0 110.497 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.457 ' OG1' ' HA ' ' A' ' 99' ' ' PRO . 86.0 m -150.43 106.48 3.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.32 -0.863 . . . . 0.0 110.161 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.472 ' O ' ' O ' ' A' ' 96' ' ' THR . . . -95.73 127.04 41.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.206 -0.934 . . . . 0.0 109.951 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 68' ' ' ALA . 39.9 t -42.56 -26.95 0.14 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.284 -0.885 . . . . 0.0 109.843 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.557 ' CG2' ' CB ' ' A' ' 137' ' ' TRP . 2.6 t -108.5 159.95 16.28 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.356 -0.84 . . . . 0.0 110.056 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.462 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 60.4 t0 -78.31 78.63 4.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.121 -0.987 . . . . 0.0 109.215 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.547 ' CG2' ' CB ' ' A' ' 133' ' ' SER . 4.4 p -106.64 145.72 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.186 -0.946 . . . . 0.0 111.239 -178.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.476 ' O ' ' CD1' ' A' ' 132' ' ' PHE . 98.2 m -126.02 91.35 3.36 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.585 ' HA ' ' CG ' ' A' ' 132' ' ' PHE . 15.4 m -89.77 -152.11 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.196 -0.94 . . . . 0.0 110.833 -178.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.466 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 8.2 mtm180 -129.21 136.34 50.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.332 -0.855 . . . . 0.0 110.647 -179.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.477 ' O ' ' HB3' ' A' ' 77' ' ' LEU . . . -135.67 153.56 51.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.388 -0.82 . . . . 0.0 109.648 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.574 ' CD1' ' N ' ' A' ' 78' ' ' VAL . 4.0 pp -179.74 -150.02 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.243 -0.911 . . . . 0.0 110.377 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.574 ' N ' ' CD1' ' A' ' 77' ' ' LEU . 3.5 t -150.87 170.54 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.29 -0.881 . . . . 0.0 109.616 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.575 ' O ' ' CE1' ' A' ' 112' ' ' TYR . . . -174.83 -162.43 26.3 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.404 -1.379 . . . . 0.0 110.256 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.514 ' OE1' ' N ' ' A' ' 82' ' ' GLY . 3.5 tm0? -120.9 128.21 52.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.448 -1.031 . . . . 0.0 110.655 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.518 ' OD1' ' NE2' ' A' ' 124' ' ' GLN . 4.5 m120 -83.46 67.64 9.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.4 -0.812 . . . . 0.0 109.813 179.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.514 ' N ' ' OE1' ' A' ' 80' ' ' GLN . . . 166.7 141.36 3.13 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.618 ' N ' ' CE1' ' A' ' 85' ' ' TYR . . . -61.97 156.06 59.63 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.245 -1.15 . . . . 0.0 110.134 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.52 ' C ' ' CD2' ' A' ' 85' ' ' TYR . 49.9 Cg_endo -77.22 8.15 17.63 Favored 'Cis proline' 0 C--N 1.312 -1.377 0 C-N-CA 121.692 -2.212 . . . . 0.0 110.904 0.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.618 ' CE1' ' N ' ' A' ' 83' ' ' ALA . 11.7 m-85 70.15 158.19 0.17 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.26 -0.9 . . . . 0.0 110.196 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -177.68 114.27 0.46 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.456 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 1.6 p -89.92 147.15 23.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.243 -1.151 . . . . 0.0 110.329 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.455 ' HB ' ' HA ' ' A' ' 108' ' ' ALA . 16.4 m -119.96 -24.0 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.29 -0.881 . . . . 0.0 110.016 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.575 HD13 ' CE2' ' A' ' 106' ' ' PHE . 4.2 mp -105.74 145.22 31.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 110.792 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -151.19 78.23 1.28 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.326 -0.859 . . . . 0.0 109.996 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.0 p -140.22 170.63 15.48 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.028 -1.045 . . . . 0.0 110.686 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.2 m -120.09 115.62 33.02 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.383 -0.823 . . . . 0.0 110.087 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.54 ' HG2' ' CG2' ' A' ' 74' ' ' VAL . 45.2 Cg_endo -70.68 128.76 15.61 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.901 1.474 . . . . 0.0 111.057 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.511 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -94.25 148.12 22.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.32 -0.862 . . . . 0.0 109.407 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.569 ' CD1' ' CD2' ' A' ' 139' ' ' LEU . 77.1 mt -141.15 157.39 45.33 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.019 -1.051 . . . . 0.0 110.807 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 68' ' ' ALA . 6.0 t -164.47 -156.58 0.33 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.407 -0.808 . . . . 0.0 109.902 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.11 34.05 0.79 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.177 -0.952 . . . . 0.0 110.244 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.403 ' HG2' ' HD2' ' A' ' 99' ' ' PRO . 0.1 OUTLIER -150.16 168.02 11.83 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.304 -0.872 . . . . 0.0 110.068 179.899 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.457 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 45.5 Cg_endo -72.41 127.74 12.9 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.005 1.529 . . . . 0.0 110.313 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.511 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 1.2 ttm180 -119.46 91.83 3.64 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.179 -0.951 . . . . 0.0 110.152 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.461 ' HG3' ' OG1' ' A' ' 65' ' ' THR . 0.0 OUTLIER -73.89 147.12 43.49 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.341 -0.85 . . . . 0.0 109.963 179.93 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.638 ' CG2' ' CZ ' ' A' ' 64' ' ' TYR . 19.6 t -124.03 135.17 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.227 -0.92 . . . . 0.0 110.296 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.18 96.66 2.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.283 -0.886 . . . . 0.0 110.196 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -142.39 160.09 40.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.216 -0.927 . . . . 0.0 110.256 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 1.2 t -114.97 170.74 8.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.251 -0.906 . . . . 0.0 110.164 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.575 ' CE2' HD13 ' A' ' 89' ' ' LEU . 41.7 p90 -173.06 153.89 2.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.248 -0.907 . . . . 0.0 110.289 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' A' ' 58' ' ' THR . 16.4 m -89.92 90.37 8.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.884 . . . . 0.0 109.993 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.582 ' HB1' ' CD2' ' A' ' 60' ' ' TYR . . . -54.15 113.49 1.26 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.296 -0.878 . . . . 0.0 110.393 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 68.7 p -97.33 54.79 1.23 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.224 -0.922 . . . . 0.0 109.993 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.439 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -165.14 -159.0 0.41 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.3 -0.875 . . . . 0.0 110.236 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.428 HG21 ' HA ' ' A' ' 55' ' ' GLU . 13.6 m -147.77 117.9 7.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.223 -0.923 . . . . 0.0 110.342 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.575 ' CE1' ' O ' ' A' ' 79' ' ' GLY . 17.4 m-30 -115.9 80.39 8.82 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.29 -0.881 . . . . 0.0 109.841 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.469 ' HG2' ' HA ' ' A' ' 122' ' ' GLU . 44.5 Cg_endo -72.32 -164.56 0.18 Allowed 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.92 1.484 . . . . 0.0 110.51 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.209 -0.932 . . . . 0.0 110.25 -179.956 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.516 ' HG2' ' N ' ' A' ' 123' ' ' GLY . 4.9 pm0 . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.017 0.437 . . . . 0.0 110.408 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.516 ' N ' ' HG2' ' A' ' 122' ' ' GLU . . . -145.82 158.26 27.62 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.521 ' CB ' ' HA ' ' A' ' 50' ' ' ASN . 3.3 pt20 -150.23 -161.0 1.25 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.071 -1.252 . . . . 0.0 110.748 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.473 ' CG2' ' CE1' ' A' ' 127' ' ' PHE . 30.4 mt -118.97 148.63 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.49 -0.756 . . . . 0.0 109.413 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.443 ' HB2' ' HG ' ' A' ' 77' ' ' LEU . . . -117.36 120.13 37.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.35 -0.844 . . . . 0.0 111.426 -179.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.5 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 5.3 m-85 -125.14 77.47 1.63 Allowed 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . 0.466 ' HA ' ' CA ' ' A' ' 46' ' ' GLY . 8.4 mt-30 -87.47 121.19 29.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.135 -0.978 . . . . 0.0 111.706 -177.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.528 ' CD2' HG23 ' A' ' 74' ' ' VAL . 6.4 mt -105.24 49.19 0.81 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.49 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -91.34 137.71 13.95 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.579 ' O ' ' CD1' ' A' ' 132' ' ' PHE . . . 41.96 93.23 0.01 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.585 ' CG ' ' HA ' ' A' ' 74' ' ' VAL . 13.0 m-85 -154.86 -74.97 0.11 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -1.168 . . . . 0.0 110.353 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.579 ' HB3' ' CE3' ' A' ' 137' ' ' TRP . 1.4 t -89.5 166.49 13.64 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.026 -1.046 . . . . 0.0 110.26 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -101.85 -59.41 1.71 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.18 -0.95 . . . . 0.0 110.552 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.425 ' C ' ' HA ' ' A' ' 38' ' ' ALA . 15.8 m-20 -73.09 152.45 41.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.189 -0.944 . . . . 0.0 110.261 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.522 ' N ' ' HA ' ' A' ' 38' ' ' ALA . . . -49.2 133.58 18.92 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.19 -0.944 . . . . 0.0 109.925 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.643 ' CZ2' ' CG1' ' A' ' 36' ' ' VAL . 6.2 p90 -147.25 -173.6 4.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.123 -0.985 . . . . 0.0 110.944 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.53 ' CG2' ' N ' ' A' ' 139' ' ' LEU 0.25 0.8 OUTLIER -154.09 178.75 9.61 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.538 -0.726 . . . . 0.0 109.369 -178.372 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.569 ' CD2' ' CD1' ' A' ' 95' ' ' LEU . 1.6 mp -138.16 115.93 11.47 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.846 -1.159 . . . . 0.0 112.195 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' CYS . . . . . 0.527 ' HB3' ' CB ' ' A' ' 31' ' ' ALA . 0.8 OUTLIER -103.51 107.44 18.29 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.71 -0.619 . . . . 0.0 110.929 178.351 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.497 ' O ' ' CB ' ' A' ' 142' ' ' ASP . 3.9 mt -94.42 179.92 5.12 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.246 -0.909 . . . . 0.0 108.961 178.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.511 ' N ' ' OD1' ' A' ' 142' ' ' ASP . 2.0 p30 168.31 61.15 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.044 -1.035 . . . . 0.0 110.578 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.511 ' CB ' ' O ' ' A' ' 142' ' ' ASP . 0.5 OUTLIER 164.92 45.63 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.444 -0.785 . . . . 0.0 109.355 179.773 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.511 HG22 ' CZ ' ' A' ' 9' ' ' PHE . 1.1 t -89.46 115.66 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.309 -0.87 . . . . 0.0 110.316 -179.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.454 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . . . -144.45 155.37 43.7 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.431 -0.793 . . . . 0.0 110.151 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 39.4 tp -148.98 141.71 24.53 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.332 -0.855 . . . . 0.0 110.177 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.47 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 0.5 OUTLIER -151.4 176.85 10.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.237 -0.915 . . . . 0.0 110.246 -179.914 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.577 ' HB3' ' CE1' ' A' ' 60' ' ' TYR . 6.2 p . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.153 -0.967 . . . . 0.0 110.249 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo . . . . . 0 N--CA 1.481 0.76 0 N-CA-C 110.06 -0.785 . . . . 0.0 110.06 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.515 ' CG2' ' O ' ' A' ' 51' ' ' GLY . 27.7 pt -89.8 -34.36 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.195 -0.94 . . . . 0.0 110.09 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.508 ' N ' HG13 ' A' ' 4' ' ' ILE . . . -172.31 -119.93 0.54 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.429 ' HB2' ' O ' ' A' ' 5' ' ' GLY . 1.9 tt0 178.47 31.58 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.217 -1.166 . . . . 0.0 110.242 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.449 ' O ' ' HA ' ' A' ' 143' ' ' ASP . . . 156.32 -116.74 0.74 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.537 ' CG2' ' O ' ' A' ' 142' ' ' ASP . 3.8 p -108.03 168.28 9.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -1.151 . . . . 0.0 110.034 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.518 ' O ' ' N ' ' A' ' 11' ' ' ASP . 14.7 m-85 -70.05 -33.92 72.57 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.239 -0.913 . . . . 0.0 109.199 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.57 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 20.0 t70 37.01 27.7 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.734 -0.604 . . . . 0.0 111.384 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.57 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.9 OUTLIER 161.31 -66.55 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.313 -0.867 . . . . 0.0 110.184 179.728 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.476 ' O ' ' HB3' ' A' ' 9' ' ' PHE . . . -122.46 145.67 16.52 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.523 ' HB3' ' CD1' ' A' ' 32' ' ' LEU . 49.5 Cg_endo -76.02 4.95 4.82 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 O-C-N 124.093 1.575 . . . . 0.0 110.814 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.461 ' CB ' ' O ' ' A' ' 13' ' ' PRO . 1.5 mm-40 67.39 -84.77 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.199 -0.938 . . . . 0.0 110.378 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.488 ' C ' ' CD1' ' A' ' 49' ' ' LEU . . . -137.84 4.35 3.26 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.584 ' CE2' HD21 ' A' ' 49' ' ' LEU . 51.8 m95 -61.75 87.97 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.133 -1.216 . . . . 0.0 110.095 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.519 ' O ' ' CG1' ' A' ' 47' ' ' VAL . 1.2 m -93.01 162.88 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.228 -0.92 . . . . 0.0 109.976 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.459 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . . . -142.67 129.79 20.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.391 -0.818 . . . . 0.0 109.286 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.57 ' CE2' ' O ' ' A' ' 46' ' ' GLY . 10.6 p90 -118.26 157.14 27.59 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.141 -0.974 . . . . 0.0 111.363 -178.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.516 ' HA2' ' CE2' ' A' ' 43' ' ' TYR . . . 74.97 41.44 32.7 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.593 ' CG2' ' CG1' ' A' ' 45' ' ' VAL . 17.2 p -128.11 -154.09 0.61 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.147 -1.208 . . . . 0.0 110.469 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -100.76 38.11 1.59 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.389 -0.819 . . . . 0.0 110.127 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 124.93 -174.89 17.26 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.465 ' O ' ' O ' ' A' ' 25' ' ' LEU . 46.9 Cg_endo -73.47 134.7 21.03 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.046 1.551 . . . . 0.0 110.615 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.53 ' CD1' HD13 ' A' ' 32' ' ' LEU . 0.8 OUTLIER -49.14 -179.98 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.236 -0.915 . . . . 0.0 110.168 179.899 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -155.67 158.51 38.42 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.138 -0.976 . . . . 0.0 110.233 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.509 ' O ' ' CG2' ' A' ' 29' ' ' THR . 0.9 OUTLIER -119.92 -75.12 0.59 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.328 -0.857 . . . . 0.0 110.039 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 27' ' ' THR . 1.0 OUTLIER 40.53 27.53 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.445 -0.784 . . . . 0.0 110.624 179.843 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.509 ' CG2' ' O ' ' A' ' 27' ' ' THR . 9.4 t -164.48 23.75 0.06 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.17 -0.956 . . . . 0.0 110.357 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.505 ' HA2' ' N ' ' A' ' 11' ' ' ASP . . . 60.36 17.93 48.42 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.463 ' O ' HG21 ' A' ' 27' ' ' THR . . . -142.57 153.93 43.98 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.369 -1.077 . . . . 0.0 110.088 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.53 HD13 ' CD1' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -91.89 95.37 9.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.92 . . . . 0.0 110.162 179.996 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 7.4 m -101.27 99.48 9.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.302 -0.874 . . . . 0.0 110.428 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.464 HG13 ' HB3' ' A' ' 25' ' ' LEU . 20.3 m -89.82 145.67 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.257 -0.902 . . . . 0.0 109.624 179.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.499 ' HA ' ' OG1' ' A' ' 138' ' ' THR . . . -91.43 99.2 12.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.164 -0.96 . . . . 0.0 110.751 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.666 ' CG1' ' CZ2' ' A' ' 137' ' ' TRP . 62.9 t -84.94 129.35 56.67 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.263 -0.898 . . . . 0.0 109.46 179.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.49 ' HD2' HG23 ' A' ' 45' ' ' VAL . 38.5 Cg_endo -65.56 178.48 2.14 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 121.704 1.602 . . . . 0.0 112.508 -178.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.526 ' HA ' ' CA ' ' A' ' 136' ' ' ALA . . . -61.27 117.16 5.25 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.519 0.676 . . . . 0.0 111.51 -178.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 134' ' ' ALA . . . 37.22 26.93 0.02 OUTLIER Glycine 0 N--CA 1.493 2.494 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.516 ' N ' ' O ' ' A' ' 38' ' ' ALA . 12.6 t 36.84 73.86 0.09 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.405 -1.056 . . . . 0.0 109.859 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.578 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . -87.77 115.0 24.92 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.669 -0.812 . . . . 0.0 109.977 -179.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.578 ' HG2' ' O ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER 67.37 10.51 7.79 Favored 'General case' 0 N--CA 1.504 2.26 0 CA-C-O 121.399 0.619 . . . . 0.0 109.965 -179.247 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.53 ' O ' ' N ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -132.32 76.02 1.67 Allowed 'General case' 0 C--N 1.289 -2.044 0 C-N-CA 119.551 -0.86 . . . . 0.0 111.719 -178.162 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.438 ' HA2' ' HA3' ' A' ' 130' ' ' GLY . . . -48.8 98.52 0.02 OUTLIER Glycine 0 N--CA 1.484 1.843 0 N-CA-C 107.362 -2.295 . . . . 0.0 107.362 178.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.593 ' CG1' ' CG2' ' A' ' 21' ' ' THR . 2.7 t -86.89 113.7 24.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.185 -1.185 . . . . 0.0 108.693 -178.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.57 ' O ' ' CE2' ' A' ' 19' ' ' TYR . . . -133.35 141.2 12.54 Favored Glycine 0 N--CA 1.487 2.095 0 C-N-CA 119.299 -1.429 . . . . 0.0 110.491 -178.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.519 ' CG1' ' O ' ' A' ' 17' ' ' VAL . 15.8 t -105.79 123.39 60.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 121.519 -0.989 . . . . 0.0 109.483 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.425 HG21 ' O ' ' A' ' 48' ' ' VAL . 35.1 m -119.69 140.28 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.003 -1.061 . . . . 0.0 110.72 -179.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.584 HD21 ' CE2' ' A' ' 16' ' ' TRP . 20.7 tp -130.91 98.67 4.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.338 -0.851 . . . . 0.0 110.191 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.516 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 19.4 p30 -77.02 138.22 39.46 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.206 -0.934 . . . . 0.0 110.223 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.515 ' O ' ' CG2' ' A' ' 4' ' ' ILE . . . 134.15 76.08 0.09 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.504 ' CG1' ' N ' ' A' ' 53' ' ' ALA . 41.5 t -135.51 171.57 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.192 -1.181 . . . . 0.0 110.148 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.504 ' N ' ' CG1' ' A' ' 52' ' ' VAL . . . -139.59 81.84 1.85 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.105 -0.997 . . . . 0.0 110.665 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.571 HD11 ' CE2' ' A' ' 60' ' ' TYR . 30.1 mm -119.48 159.86 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.301 -0.874 . . . . 0.0 109.774 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.527 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 6.3 tt0 -152.8 131.75 12.54 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.006 -1.059 . . . . 0.0 110.762 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 19.5 pt-20 37.8 -154.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.64 -0.662 . . . . 0.0 111.022 179.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 109' ' ' SER . . . -84.58 83.47 1.63 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.561 HG21 ' CE2' ' A' ' 60' ' ' TYR . 1.2 m -112.05 170.58 8.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -1.166 . . . . 0.0 109.781 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.567 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 0.7 OUTLIER -89.88 154.12 20.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.234 -0.916 . . . . 0.0 110.311 -179.902 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.571 ' CE2' HD11 ' A' ' 54' ' ' ILE . 61.8 m-85 -158.95 -179.62 8.21 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.257 -0.902 . . . . 0.0 110.112 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.413 ' O ' HD13 ' A' ' 146' ' ' LEU . 94.6 m -150.01 111.28 4.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.276 -0.89 . . . . 0.0 110.065 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.453 ' O ' ' HA ' ' A' ' 103' ' ' THR . 20.4 tp -89.7 121.3 31.74 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.183 -0.948 . . . . 0.0 110.201 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.492 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 26.5 ttp180 -127.67 138.11 52.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.324 -0.86 . . . . 0.0 109.894 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.513 ' CE2' ' HB ' ' A' ' 102' ' ' VAL . 6.3 p90 -174.9 151.29 1.35 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.278 -0.889 . . . . 0.0 109.821 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.483 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 78.1 m -119.39 91.03 3.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.149 -0.969 . . . . 0.0 110.092 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.475 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -89.79 143.1 27.08 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.387 -0.821 . . . . 0.0 110.423 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.458 ' OG1' ' HA ' ' A' ' 99' ' ' PRO . 99.4 m -143.84 116.2 8.53 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.281 -0.887 . . . . 0.0 110.205 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.52 ' HB1' ' CD2' ' A' ' 95' ' ' LEU . . . -109.14 126.48 53.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.3 -0.875 . . . . 0.0 109.874 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.433 ' C ' ' O ' ' A' ' 68' ' ' ALA . 0.4 OUTLIER -43.98 -26.41 0.28 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.234 -0.916 . . . . 0.0 109.573 179.709 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.529 ' CG2' ' CB ' ' A' ' 137' ' ' TRP . 2.7 t -110.41 169.87 8.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.543 -0.723 . . . . 0.0 110.01 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.452 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 12.5 t70 -87.16 51.85 2.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.177 -0.952 . . . . 0.0 108.988 178.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.579 HG22 ' CE2' ' A' ' 137' ' ' TRP . 4.0 p -66.62 135.33 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.519 -0.738 . . . . 0.0 111.353 -178.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 92.2 m -119.86 79.89 1.51 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.583 ' HA ' ' CD1' ' A' ' 132' ' ' PHE . 7.5 m -89.68 -142.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.317 -0.864 . . . . 0.0 110.443 -178.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.523 ' N ' HG22 ' A' ' 74' ' ' VAL . 0.7 OUTLIER -130.27 145.88 51.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.164 -0.96 . . . . 0.0 110.718 -179.453 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.521 ' CB ' ' HG3' ' A' ' 93' ' ' PRO . . . -146.19 150.42 35.81 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.333 -0.854 . . . . 0.0 109.594 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.489 ' C ' ' CD1' ' A' ' 77' ' ' LEU . 1.3 pp 175.6 -158.81 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.258 -0.901 . . . . 0.0 110.489 -179.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.466 HG12 ' O ' ' A' ' 124' ' ' GLN . 5.4 t -145.65 167.63 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.415 -0.803 . . . . 0.0 109.299 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.498 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . -178.02 -171.41 41.37 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.168 -1.491 . . . . 0.0 110.444 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.468 ' HA ' ' OE1' ' A' ' 80' ' ' GLN . 26.6 tp60 -114.22 102.14 9.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.493 -1.004 . . . . 0.0 110.212 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 0.8 OUTLIER -63.08 95.57 0.08 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.152 -0.968 . . . . 0.0 110.234 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.536 ' C ' ' CE1' ' A' ' 85' ' ' TYR . . . 119.87 130.43 4.0 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.627 ' N ' ' CE1' ' A' ' 85' ' ' TYR . . . -42.99 153.46 0.34 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.294 -1.121 . . . . 0.0 110.196 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.461 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.1 Cg_endo -78.09 11.85 16.16 Favored 'Cis proline' 0 C--N 1.312 -1.352 0 C-N-CA 121.648 -2.23 . . . . 0.0 111.066 0.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.627 ' CE1' ' N ' ' A' ' 83' ' ' ALA . 37.1 m-85 61.24 -158.87 0.33 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.098 -1.001 . . . . 0.0 110.197 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 135.9 101.53 0.64 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.8 p -89.84 139.69 30.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.276 -1.131 . . . . 0.0 110.236 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.526 HG22 ' CD1' ' A' ' 89' ' ' LEU . 22.9 m -120.08 -16.77 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.252 -0.905 . . . . 0.0 110.148 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.579 HD12 ' CZ ' ' A' ' 106' ' ' PHE . 4.2 mp -118.85 139.59 51.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.296 -0.878 . . . . 0.0 110.978 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.461 ' O ' HG21 ' A' ' 91' ' ' THR . 32.1 t70 -151.12 85.17 1.33 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.425 -0.797 . . . . 0.0 109.969 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.461 HG21 ' O ' ' A' ' 90' ' ' ASP . 2.8 p -142.76 -175.59 4.55 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.997 -1.064 . . . . 0.0 110.854 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.53 112.35 35.66 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.444 -0.785 . . . . 0.0 109.905 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.53 ' HG2' ' CG2' ' A' ' 74' ' ' VAL . 43.4 Cg_endo -70.77 92.62 0.61 Allowed 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 124.023 1.539 . . . . 0.0 111.109 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.522 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -84.64 129.45 34.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.229 -0.919 . . . . 0.0 109.373 179.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.52 ' CD2' ' HB1' ' A' ' 68' ' ' ALA . 7.5 mp -119.69 -178.53 3.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.046 -1.034 . . . . 0.0 111.083 -179.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -179.99 -178.59 0.43 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.561 -0.712 . . . . 0.0 109.846 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.93 -12.3 17.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.206 -0.934 . . . . 0.0 110.148 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -99.99 158.83 31.34 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.263 -0.898 . . . . 0.0 110.11 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.458 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 44.3 Cg_endo -72.65 140.12 32.11 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.962 1.506 . . . . 0.0 110.348 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.522 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 32.0 ttm-85 -119.91 94.11 4.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.215 -0.928 . . . . 0.0 110.38 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.458 ' HG2' ' OG1' ' A' ' 65' ' ' THR . 17.0 mt-30 -84.98 92.98 8.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.398 -0.813 . . . . 0.0 109.666 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.513 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 38.9 t -89.12 133.6 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.289 -0.882 . . . . 0.0 110.434 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -150.39 130.26 13.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.404 -0.81 . . . . 0.0 110.028 179.96 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -159.19 139.39 12.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.168 -0.957 . . . . 0.0 110.416 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 88.0 m -94.7 106.65 18.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.305 -0.872 . . . . 0.0 110.123 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.579 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 38.7 p90 -113.24 157.18 22.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.275 -0.891 . . . . 0.0 110.324 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 26.2 m -89.97 90.17 8.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.292 -0.88 . . . . 0.0 110.016 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.548 ' CB ' ' CD2' ' A' ' 60' ' ' TYR . . . -45.88 105.44 0.06 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.258 -0.901 . . . . 0.0 110.348 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.494 ' N ' HG13 ' A' ' 88' ' ' VAL . 79.4 p -91.84 51.4 1.83 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.232 -0.917 . . . . 0.0 110.237 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.507 ' HB1' ' CG1' ' A' ' 88' ' ' VAL . . . -159.46 -155.26 0.45 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.259 -0.901 . . . . 0.0 110.242 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 18.7 m -144.91 113.4 6.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.273 -0.892 . . . . 0.0 110.215 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.554 ' CG ' ' HA3' ' A' ' 123' ' ' GLY . 18.0 m-30 -111.2 86.25 6.15 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.288 -0.882 . . . . 0.0 110.101 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.466 ' HD2' ' OE1' ' A' ' 80' ' ' GLN . 44.6 Cg_endo -72.28 140.16 33.33 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.938 1.494 . . . . 0.0 110.333 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.21 -0.931 . . . . 0.0 110.266 -179.911 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.483 ' CD ' ' N ' ' A' ' 122' ' ' GLU . 3.2 pm0 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.23 0.538 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.554 ' HA3' ' CG ' ' A' ' 112' ' ' TYR . . . -89.48 150.55 21.31 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.516 ' CB ' ' HA ' ' A' ' 50' ' ' ASN . 1.2 pp0? -150.31 -157.75 0.85 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.315 -1.109 . . . . 0.0 110.399 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.431 ' CG2' ' CH2' ' A' ' 16' ' ' TRP . 17.0 mt -118.43 141.55 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.526 -0.734 . . . . 0.0 109.309 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.414 ' HB2' ' CD1' ' A' ' 77' ' ' LEU . . . -117.62 122.8 44.57 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.302 -0.874 . . . . 0.0 111.098 -179.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.473 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 4.1 m-85 -118.73 101.51 8.15 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . 0.597 ' O ' ' CE2' ' A' ' 132' ' ' PHE . 0.4 OUTLIER -89.17 85.41 6.64 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.101 -0.999 . . . . 0.0 112.09 -177.738 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.521 ' CD2' HG23 ' A' ' 74' ' ' VAL . 0.6 OUTLIER -93.38 48.23 1.3 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.325 -0.86 . . . . 0.0 108.887 178.053 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.442 ' O ' ' CD2' ' A' ' 132' ' ' PHE . . . -108.27 135.63 12.96 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.864 -1.16 . . . . 0.0 110.753 -178.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 130' ' ' GLY . . . 39.14 55.22 2.43 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 179.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.597 ' CE2' ' O ' ' A' ' 128' ' ' GLN . 8.0 m-85 -118.46 -58.02 2.01 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.089 -1.242 . . . . 0.0 110.719 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.531 ' HB2' ' CG2' ' A' ' 72' ' ' VAL . 1.3 t -88.74 -179.71 6.06 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.921 -1.112 . . . . 0.0 110.283 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -100.69 -74.25 0.62 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.245 -0.909 . . . . 0.0 110.249 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -72.65 174.42 7.6 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.209 -0.932 . . . . 0.0 110.07 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.526 ' CA ' ' HA ' ' A' ' 38' ' ' ALA . . . -70.38 127.94 34.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.274 -0.891 . . . . 0.0 110.286 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.666 ' CZ2' ' CG1' ' A' ' 36' ' ' VAL . 6.1 p90 -132.27 -161.97 1.19 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.267 -0.895 . . . . 0.0 110.138 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.499 ' OG1' ' HA ' ' A' ' 35' ' ' ALA . 0.8 OUTLIER -160.26 166.18 30.04 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.138 -1.025 . . . . 0.0 110.57 -177.775 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.418 HD21 HD12 ' A' ' 129' ' ' LEU . 2.2 mp -124.15 127.51 47.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.461 -0.775 . . . . 0.0 109.282 179.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' CYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 52.9 m -125.27 95.75 4.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.072 -1.017 . . . . 0.0 110.9 -179.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.486 ' O ' ' HB3' ' A' ' 142' ' ' ASP . 0.9 OUTLIER -89.86 -177.69 5.29 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.21 -0.931 . . . . 0.0 109.218 179.033 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.537 ' O ' ' CG2' ' A' ' 8' ' ' THR . 0.6 OUTLIER 169.37 48.15 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.252 -0.905 . . . . 0.0 110.235 -179.96 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 142' ' ' ASP . 11.3 t0 177.05 46.3 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.441 -0.787 . . . . 0.0 109.148 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.492 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 1.0 OUTLIER -89.21 124.74 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.478 -0.764 . . . . 0.0 110.305 -178.981 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -158.52 152.71 24.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.386 -0.821 . . . . 0.0 110.075 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.427 ' O ' ' HB2' ' A' ' 147' ' ' ASP . 23.1 tp -149.93 153.36 36.5 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.267 -0.895 . . . . 0.0 110.218 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.427 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 34.0 t70 -176.5 152.56 1.07 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.241 -0.912 . . . . 0.0 110.273 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.445 ' HA ' ' O ' ' A' ' 59' ' ' THR . 78.7 p . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.268 -0.895 . . . . 0.0 110.205 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo . . . . . 0 N--CA 1.484 0.914 0 N-CA-C 110.486 -0.621 . . . . 0.0 110.486 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 6.4 pt -107.71 31.0 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -0.901 . . . . 0.0 110.068 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.451 ' O ' ' HB3' ' A' ' 6' ' ' GLU . . . 81.08 -169.52 51.88 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.467 ' HA ' ' O ' ' A' ' 144' ' ' VAL . 9.0 pt-20 176.29 65.54 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.102 -1.234 . . . . 0.0 110.358 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.53 ' O ' ' CG2' ' A' ' 8' ' ' THR . . . 164.52 -64.55 0.23 Allowed Glycine 0 N--CA 1.488 2.164 0 C-N-CA 119.689 -1.243 . . . . 0.0 110.002 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.53 ' CG2' ' O ' ' A' ' 7' ' ' GLY . 73.6 p -156.41 -154.44 0.48 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.216 -1.167 . . . . 0.0 110.302 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.538 ' CZ ' HG22 ' A' ' 144' ' ' VAL . 33.0 m-85 -135.29 42.58 2.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -0.874 . . . . 0.0 110.263 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.55 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 26.7 t0 -88.14 49.01 1.72 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.202 -0.936 . . . . 0.0 110.247 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.55 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.5 OUTLIER 161.66 80.43 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.675 -0.641 . . . . 0.0 109.735 -179.963 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 11' ' ' ASP . . . 62.83 127.3 0.01 OUTLIER Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.52 ' O ' ' N ' ' A' ' 15' ' ' GLY . 50.2 Cg_endo -80.89 42.09 1.27 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 O-C-N 123.839 1.442 . . . . 0.0 110.987 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.434 ' HA ' ' OE1' ' A' ' 14' ' ' GLU . 4.7 mm-40 46.72 -92.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.003 -1.061 . . . . 0.0 110.288 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.523 ' O ' ' CG1' ' A' ' 17' ' ' VAL . . . -140.61 -0.06 1.85 Allowed Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.818 -1.182 . . . . 0.0 110.469 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.57 ' CH2' HG23 ' A' ' 125' ' ' ILE . 46.6 m95 -53.54 88.63 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.004 -1.292 . . . . 0.0 110.402 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.576 ' CG2' ' CG2' ' A' ' 48' ' ' VAL . 1.0 OUTLIER -87.81 150.67 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.035 -1.04 . . . . 0.0 109.627 179.558 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.569 ' CB ' ' CG1' ' A' ' 34' ' ' VAL . . . -131.29 158.38 40.79 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.174 -0.954 . . . . 0.0 109.831 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.639 ' CD1' ' N ' ' A' ' 19' ' ' TYR . 3.5 p90 -150.5 166.21 30.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.31 -0.869 . . . . 0.0 110.5 -178.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.516 ' C ' ' CG2' ' A' ' 21' ' ' THR . . . 161.04 -96.78 0.15 Allowed Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.014 -1.634 . . . . 0.0 109.014 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.52 HG22 ' NE2' ' A' ' 42' ' ' GLN . 6.5 p -153.91 18.39 0.51 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.115 -1.227 . . . . 0.0 111.224 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.596 ' CB ' ' CB ' ' A' ' 35' ' ' ALA . 0.8 OUTLIER -137.36 -179.95 6.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.664 -1.272 . . . . 0.0 110.607 179.743 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 22' ' ' ASP . . . -42.22 164.59 0.02 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 25' ' ' LEU . 45.5 Cg_endo -72.48 160.87 45.71 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.102 1.58 . . . . 0.0 110.409 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.511 ' CD1' HD13 ' A' ' 32' ' ' LEU . 0.7 OUTLIER -41.8 151.2 0.09 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.306 -0.871 . . . . 0.0 110.394 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.466 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 79.7 m-20 -124.43 137.11 54.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.317 -0.864 . . . . 0.0 109.829 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.537 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.8 OUTLIER -119.95 -26.76 5.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.099 -1.001 . . . . 0.0 110.55 -179.705 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.514 ' O ' ' CB ' ' A' ' 29' ' ' THR . 12.0 m -49.75 82.96 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.788 -0.57 . . . . 0.0 111.248 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.537 ' N ' ' O ' ' A' ' 27' ' ' THR . 0.0 OUTLIER 166.62 -31.77 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.229 -0.919 . . . . 0.0 109.948 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 128.37 0.32 6.32 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -150.46 161.17 43.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.137 -1.214 . . . . 0.0 110.214 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.511 HD13 ' CD1' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -104.08 99.37 9.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.178 -0.951 . . . . 0.0 110.134 179.911 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 0.8 OUTLIER -96.09 117.0 29.84 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.197 -0.94 . . . . 0.0 111.61 -179.773 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.569 ' CG1' ' CB ' ' A' ' 18' ' ' ALA . 30.2 m -89.43 149.97 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.596 ' CB ' ' CB ' ' A' ' 22' ' ' ASP . . . -89.83 126.32 35.65 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.016 -1.052 . . . . 0.0 111.529 -178.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.65 ' CG1' ' CZ2' ' A' ' 137' ' ' TRP . 48.7 t -126.73 119.63 22.78 Favored Pre-proline 0 C--N 1.303 -1.455 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.239 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.476 ' HG2' ' HA ' ' A' ' 40' ' ' SER . 39.7 Cg_endo -66.23 -177.74 0.93 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.753 1.397 . . . . 0.0 111.324 -179.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.537 ' HA ' ' N ' ' A' ' 136' ' ' ALA . . . -56.14 126.66 27.05 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.436 -0.79 . . . . 0.0 111.157 -179.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.501 ' O ' ' C ' ' A' ' 40' ' ' SER . . . 40.33 28.05 0.17 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.541 ' OG ' ' CG2' ' A' ' 45' ' ' VAL . 15.0 t 31.68 60.01 0.3 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.819 -0.812 . . . . 0.0 110.593 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.48 ' O ' ' HB3' ' A' ' 42' ' ' GLN . . . -88.72 95.21 10.18 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.278 -0.889 . . . . 0.0 109.864 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.558 ' NE2' ' CG2' ' A' ' 45' ' ' VAL . 2.0 pt20 179.83 -150.27 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 121.308 0.575 . . . . 0.0 109.822 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.524 ' CD1' ' HG3' ' A' ' 42' ' ' GLN . 16.0 p90 -61.41 -12.72 15.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.331 -0.856 . . . . 0.0 109.898 179.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.417 ' O ' ' CE2' ' A' ' 43' ' ' TYR . . . 109.75 129.14 5.69 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.558 ' CG2' ' NE2' ' A' ' 42' ' ' GLN . 9.4 t -89.29 170.45 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.173 -1.193 . . . . 0.0 108.572 179.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.519 ' CA ' ' O ' ' A' ' 127' ' ' PHE . . . 169.76 -174.02 43.97 Favored Glycine 0 N--CA 1.487 2.052 0 C-N-CA 118.997 -1.573 . . . . 0.0 110.559 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.533 ' CG2' HG13 ' A' ' 34' ' ' VAL . 41.4 t -150.39 129.08 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.602 -0.94 . . . . 0.0 108.781 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.576 ' CG2' ' CG2' ' A' ' 17' ' ' VAL . 32.9 m -119.97 135.68 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.081 -1.012 . . . . 0.0 110.987 -179.038 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.564 HD21 ' CE2' ' A' ' 16' ' ' TRP . 21.3 tp -128.67 96.71 4.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.393 -0.817 . . . . 0.0 110.24 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.519 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 12.9 p30 -75.13 134.94 41.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.909 . . . . 0.0 110.186 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 136.38 76.85 0.08 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.528 ' CG2' ' HA ' ' A' ' 124' ' ' GLN . 18.1 t -139.37 167.26 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -1.173 . . . . 0.0 110.023 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.413 ' N ' HG11 ' A' ' 52' ' ' VAL . . . -137.75 83.82 2.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.195 -0.941 . . . . 0.0 110.488 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.63 ' CD1' ' CE1' ' A' ' 60' ' ' TYR . 43.2 mm -115.92 158.78 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.227 -0.92 . . . . 0.0 109.918 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.512 ' N ' HG21 ' A' ' 54' ' ' ILE . 7.9 tp10 -151.78 134.34 15.43 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.208 -0.933 . . . . 0.0 110.366 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.565 ' CG ' ' N ' ' A' ' 57' ' ' GLY . 1.1 pt-20 37.03 -157.01 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.698 -0.626 . . . . 0.0 110.73 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.565 ' N ' ' CG ' ' A' ' 56' ' ' GLU . . . -84.04 90.68 1.61 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.576 HG21 ' CE2' ' A' ' 60' ' ' TYR . 1.2 m -118.73 173.86 6.62 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.306 -1.114 . . . . 0.0 109.79 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.572 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 0.6 OUTLIER -89.82 153.85 20.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.268 -0.895 . . . . 0.0 110.494 -179.758 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.63 ' CE1' ' CD1' ' A' ' 54' ' ' ILE . 59.2 m-85 -159.88 121.79 3.29 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.271 -0.893 . . . . 0.0 110.218 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 89.2 m -90.87 114.74 27.25 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.213 -0.929 . . . . 0.0 109.983 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.0 tp -89.55 120.85 31.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.209 -0.932 . . . . 0.0 109.945 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.49 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 12.7 ttp180 -125.59 130.17 51.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.309 -0.87 . . . . 0.0 110.227 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.598 ' CZ ' ' CG2' ' A' ' 102' ' ' VAL . 0.8 OUTLIER -170.33 142.98 2.26 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.294 -0.879 . . . . 0.0 109.821 179.756 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.457 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 16.9 m -119.16 97.63 5.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.289 -0.882 . . . . 0.0 110.079 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.49 ' HB1' ' CD2' ' A' ' 141' ' ' LEU . . . -98.98 149.38 23.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.382 -0.824 . . . . 0.0 110.328 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.462 ' OG1' ' HA ' ' A' ' 99' ' ' PRO . 90.3 m -150.52 102.22 3.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -0.884 . . . . 0.0 110.198 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.47 ' O ' ' O ' ' A' ' 96' ' ' THR . . . -89.82 131.24 35.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.233 -0.917 . . . . 0.0 109.977 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.45 ' C ' ' O ' ' A' ' 68' ' ' ALA . 1.2 p -42.72 -27.17 0.16 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.298 -0.876 . . . . 0.0 109.522 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.599 ' CG2' ' CB ' ' A' ' 137' ' ' TRP . 1.7 t -109.87 161.34 15.56 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.559 -0.713 . . . . 0.0 109.836 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.462 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 0.3 OUTLIER -80.19 76.69 6.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.056 -1.027 . . . . 0.0 109.25 179.05 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.573 HG22 ' CE2' ' A' ' 137' ' ' TRP . 4.3 p -99.75 135.62 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.27 -0.894 . . . . 0.0 111.292 -178.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 89.6 m -121.09 87.13 2.7 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.583 ' HA ' ' CD1' ' A' ' 132' ' ' PHE . 5.1 m -89.7 -149.18 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.246 -0.909 . . . . 0.0 110.764 -178.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -128.43 121.32 28.73 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.262 -0.898 . . . . 0.0 110.656 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.496 ' O ' ' HB3' ' A' ' 77' ' ' LEU . . . -119.03 161.36 20.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.217 -0.927 . . . . 0.0 109.643 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.505 ' HA ' ' HB3' ' A' ' 89' ' ' LEU . 3.5 pp 177.15 -158.83 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.128 -0.982 . . . . 0.0 110.463 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.524 HG11 ' CE2' ' A' ' 112' ' ' TYR . 19.5 t -149.54 165.0 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.433 -0.792 . . . . 0.0 109.266 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.542 ' C ' ' CE1' ' A' ' 112' ' ' TYR . . . -172.81 -166.75 31.79 Favored Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.056 -1.545 . . . . 0.0 110.587 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.484 ' O ' ' HG3' ' A' ' 80' ' ' GLN . 4.7 tp60 -114.34 85.93 2.33 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.508 -0.995 . . . . 0.0 110.391 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 2.1 m-80 -66.0 100.13 0.56 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.066 -1.022 . . . . 0.0 109.308 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.575 ' O ' ' CZ ' ' A' ' 85' ' ' TYR . . . 152.0 -87.67 0.14 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.432 ' CB ' ' O ' ' A' ' 82' ' ' GLY . . . 173.24 145.68 0.19 Allowed Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.189 -1.183 . . . . 0.0 110.192 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.511 ' C ' ' CD2' ' A' ' 85' ' ' TYR . 51.0 Cg_endo -84.56 32.8 4.41 Favored 'Cis proline' 0 C--N 1.313 -1.314 0 C-N-CA 121.9 -2.125 . . . . 0.0 110.663 -0.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.575 ' CZ ' ' O ' ' A' ' 82' ' ' GLY . 17.6 m-85 64.47 -172.67 0.18 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.165 -0.959 . . . . 0.0 110.402 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 140.03 99.38 0.41 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.46 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 1.4 p -89.8 143.59 26.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.25 -1.147 . . . . 0.0 110.367 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.524 ' CG1' ' N ' ' A' ' 109' ' ' SER . 27.0 m -123.93 -16.95 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.313 -0.867 . . . . 0.0 110.332 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.573 HD12 ' CZ ' ' A' ' 106' ' ' PHE . 4.1 mp -105.36 139.87 39.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.204 -0.935 . . . . 0.0 110.924 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.503 ' O ' ' CG2' ' A' ' 91' ' ' THR . 1.6 m-20 -150.68 94.29 2.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.379 -0.826 . . . . 0.0 110.194 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.503 ' CG2' ' O ' ' A' ' 90' ' ' ASP . 3.9 p -160.07 -175.09 4.88 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.162 -0.962 . . . . 0.0 110.44 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.4 p -125.35 128.87 24.63 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.285 -0.885 . . . . 0.0 110.143 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.542 ' HG2' ' CG2' ' A' ' 74' ' ' VAL . 50.2 Cg_endo -74.14 77.02 2.89 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.883 1.465 . . . . 0.0 110.983 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.529 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -50.47 136.45 20.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.996 -1.065 . . . . 0.0 109.348 179.351 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.589 ' CD1' ' CD2' ' A' ' 139' ' ' LEU . 35.4 mt -135.63 168.12 19.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.991 -1.068 . . . . 0.0 110.891 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.47 ' O ' ' O ' ' A' ' 68' ' ' ALA . 6.7 t -165.8 -153.18 0.17 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.444 -0.785 . . . . 0.0 109.914 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.94 -28.19 24.45 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.103 -0.998 . . . . 0.0 110.391 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.458 ' HB3' ' HD2' ' A' ' 99' ' ' PRO . 0.6 OUTLIER -89.77 176.5 3.04 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.238 -0.914 . . . . 0.0 110.06 179.974 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.462 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 45.4 Cg_endo -72.09 134.03 22.48 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 123.979 1.515 . . . . 0.0 110.327 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.529 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.53 84.03 2.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.18 -0.95 . . . . 0.0 110.22 -179.87 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.451 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 17.6 mt-30 -69.02 155.98 39.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.32 -0.862 . . . . 0.0 110.124 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.598 ' CG2' ' CZ ' ' A' ' 64' ' ' TYR . 58.6 t -133.43 133.71 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.25 -0.906 . . . . 0.0 110.111 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.33 111.51 4.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.25 -0.906 . . . . 0.0 110.109 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -153.59 151.59 29.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.159 -0.963 . . . . 0.0 110.356 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -108.39 122.09 46.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.283 -0.886 . . . . 0.0 110.063 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.573 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 41.4 p90 -127.93 153.32 46.82 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.236 -0.915 . . . . 0.0 110.299 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 58' ' ' THR . 3.6 m -89.93 94.24 9.73 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.276 -0.89 . . . . 0.0 110.063 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.617 ' CB ' ' CD2' ' A' ' 60' ' ' TYR . . . -53.64 99.42 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.244 -0.91 . . . . 0.0 110.309 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.524 ' N ' ' CG1' ' A' ' 88' ' ' VAL . 54.3 p -85.93 55.66 3.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.18 -0.95 . . . . 0.0 109.945 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.403 ' HB1' HG12 ' A' ' 88' ' ' VAL . . . -160.29 -151.31 0.24 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.315 -0.866 . . . . 0.0 110.298 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 46.2 m -158.14 116.42 3.05 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.323 -0.861 . . . . 0.0 110.414 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.575 ' CD2' ' CG1' ' A' ' 54' ' ' ILE . 12.7 m-30 -112.22 109.87 53.97 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.302 -0.874 . . . . 0.0 109.784 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.483 ' HD2' ' OE1' ' A' ' 80' ' ' GLN . 47.7 Cg_endo -75.48 96.2 1.03 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.849 1.447 . . . . 0.0 110.539 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.245 -0.91 . . . . 0.0 110.127 179.935 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.483 ' CB ' ' HG2' ' A' ' 113' ' ' PRO . 5.0 pt-20 . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 121.177 0.513 . . . . 0.0 110.357 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.572 ' HA3' ' CG ' ' A' ' 112' ' ' TYR . . . -90.59 148.09 19.38 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.528 ' HA ' ' CG2' ' A' ' 52' ' ' VAL . 3.3 pt20 -150.31 -155.66 0.65 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.289 -1.124 . . . . 0.0 110.491 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.57 HG23 ' CH2' ' A' ' 16' ' ' TRP . 7.6 mt -118.22 141.26 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.538 -0.726 . . . . 0.0 109.256 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.41 ' N ' HG21 ' A' ' 125' ' ' ILE . . . -117.6 121.75 41.77 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.36 -0.837 . . . . 0.0 111.291 -179.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.519 ' O ' ' CA ' ' A' ' 46' ' ' GLY . 4.4 m-85 -118.99 91.2 3.5 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 178.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -88.57 93.92 9.71 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.944 -1.097 . . . . 0.0 112.449 -177.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.531 HD21 ' CG2' ' A' ' 74' ' ' VAL . 12.9 mt -90.87 44.16 1.18 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 177.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 131' ' ' GLY . . . -82.29 115.54 4.04 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 -179.048 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 39' ' ' GLY . . . 40.36 93.1 0.01 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.583 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 8.9 m-85 -143.55 -52.59 0.35 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.099 -1.236 . . . . 0.0 110.704 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.533 ' HB2' ' CG2' ' A' ' 72' ' ' VAL . 1.3 t -89.26 175.3 7.4 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.973 -1.079 . . . . 0.0 110.399 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -80.93 -88.13 0.08 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.257 -0.902 . . . . 0.0 110.033 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 135' ' ' ASP . 3.9 m-20 -67.27 -173.41 0.28 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -0.909 . . . . 0.0 109.774 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.537 ' N ' ' HA ' ' A' ' 38' ' ' ALA . . . -78.94 149.33 32.37 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.229 -0.919 . . . . 0.0 110.248 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.65 ' CZ2' ' CG1' ' A' ' 36' ' ' VAL . 15.1 p90 -151.8 -160.0 1.09 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.152 -0.967 . . . . 0.0 111.162 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.514 ' CG2' ' N ' ' A' ' 139' ' ' LEU . 0.8 OUTLIER -159.65 178.53 9.74 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -178.596 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.589 ' CD2' ' CD1' ' A' ' 95' ' ' LEU . 1.7 mp -139.91 115.54 10.09 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.766 -1.209 . . . . 0.0 112.082 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' CYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 0.8 OUTLIER -103.34 104.35 14.45 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.727 -0.608 . . . . 0.0 110.662 178.492 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.512 ' O ' ' CB ' ' A' ' 142' ' ' ASP . 1.4 mt -90.22 -178.67 5.45 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.217 -0.927 . . . . 0.0 109.305 179.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.545 ' O ' ' CB ' ' A' ' 143' ' ' ASP . 2.3 p30 166.9 68.24 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.263 -0.898 . . . . 0.0 110.172 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.545 ' CB ' ' O ' ' A' ' 142' ' ' ASP . 0.4 OUTLIER 161.89 42.79 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.879 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.538 HG22 ' CZ ' ' A' ' 9' ' ' PHE . 1.5 t -89.4 115.93 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.418 -0.801 . . . . 0.0 110.684 -178.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -148.26 139.84 23.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.463 -0.773 . . . . 0.0 109.912 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.403 HD23 HD13 ' A' ' 54' ' ' ILE . 28.6 tp -129.93 152.7 49.12 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.305 -0.872 . . . . 0.0 110.332 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.45 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -161.83 -175.78 4.87 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.248 -0.907 . . . . 0.0 110.149 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 148' ' ' SER . 9.3 p . . . . . 0 N--CA 1.493 1.676 0 O-C-N 121.2 -0.937 . . . . 0.0 110.174 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo . . . . . 0 N--CA 1.483 0.873 0 N-CA-C 110.616 -0.571 . . . . 0.0 110.616 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.407 ' O ' HG13 ' A' ' 4' ' ' ILE . 32.7 pt -107.36 40.41 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.183 -0.948 . . . . 0.0 109.979 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' A' ' 7' ' ' GLY . . . 103.78 -45.48 1.32 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.445 ' HA ' ' HB3' ' A' ' 145' ' ' ALA . 44.4 mt-10 41.67 28.08 0.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.354 -1.086 . . . . 0.0 110.306 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.452 ' O ' ' HA ' ' A' ' 143' ' ' ASP . . . -158.85 -166.28 17.58 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 34.0 p -72.59 165.81 23.96 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.307 -1.113 . . . . 0.0 110.377 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.582 ' CG ' ' HA ' ' A' ' 142' ' ' ASP . 3.1 m-30 -93.7 56.57 2.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.336 -0.852 . . . . 0.0 110.135 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.537 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 16.0 t0 -114.39 52.35 0.84 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.183 -0.948 . . . . 0.0 110.202 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.537 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 2.2 t70 161.76 78.14 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.753 -0.592 . . . . 0.0 109.657 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.02 133.51 0.33 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.473 ' O ' ' HB2' ' A' ' 14' ' ' GLU . 50.2 Cg_endo -77.3 5.82 4.81 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.943 1.496 . . . . 0.0 110.635 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 0.8 OUTLIER 66.44 -85.72 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.158 -0.964 . . . . 0.0 110.184 -179.853 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.494 ' C ' ' CD1' ' A' ' 49' ' ' LEU . . . -142.71 8.3 2.26 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.575 ' CD1' HD23 ' A' ' 49' ' ' LEU . 45.9 m95 -72.92 93.03 1.68 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.127 -1.22 . . . . 0.0 110.343 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.521 ' O ' ' CG1' ' A' ' 47' ' ' VAL . 1.5 m -95.49 152.23 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.148 -0.97 . . . . 0.0 109.895 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.589 ' CB ' ' CG1' ' A' ' 34' ' ' VAL . . . -129.96 127.54 40.27 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.164 -0.96 . . . . 0.0 109.725 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.57 ' CZ ' ' O ' ' A' ' 46' ' ' GLY . 10.9 p90 -121.17 158.34 28.19 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.291 -0.881 . . . . 0.0 110.739 -178.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.516 ' CA ' ' OH ' ' A' ' 43' ' ' TYR . . . 90.57 35.01 7.55 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 179.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.5 ' CG2' ' C ' ' A' ' 20' ' ' GLY . 5.4 p -150.89 -154.94 0.58 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.98 -1.306 . . . . 0.0 110.499 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.46 ' O ' ' O ' ' A' ' 23' ' ' GLY . 8.2 t0 -94.87 132.01 40.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.353 -0.842 . . . . 0.0 110.363 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 22' ' ' ASP . . . 44.41 -168.1 0.02 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.58 -159.85 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.062 1.559 . . . . 0.0 110.484 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.512 HD11 ' CD1' ' A' ' 32' ' ' LEU . 0.4 OUTLIER -101.21 161.39 13.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.258 -0.901 . . . . 0.0 110.222 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -116.86 140.04 49.91 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.205 -0.935 . . . . 0.0 110.008 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 31' ' ' ALA . 0.7 OUTLIER -128.24 -22.69 3.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.144 -0.973 . . . . 0.0 111.212 -179.55 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.2 -17.87 0.28 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.26 -0.9 . . . . 0.0 111.173 -179.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.6 t -72.1 6.37 2.21 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.049 -1.032 . . . . 0.0 111.519 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.55 -12.28 67.81 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.468 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -150.97 167.99 25.92 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.481 -1.011 . . . . 0.0 109.503 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.512 ' CD1' HD11 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -87.04 90.92 8.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.967 -1.083 . . . . 0.0 110.163 179.906 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 0.8 OUTLIER -99.45 111.78 24.09 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.387 -0.821 . . . . 0.0 111.507 179.987 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.589 ' CG1' ' CB ' ' A' ' 18' ' ' ALA . 15.7 m -89.86 146.11 6.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.483 ' O ' ' HB ' ' A' ' 21' ' ' THR . . . -88.55 72.44 8.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.541 -0.725 . . . . 0.0 110.982 -178.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.642 ' CG1' ' CZ2' ' A' ' 137' ' ' TRP . 56.3 t -58.66 134.07 86.15 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.322 -0.861 . . . . 0.0 109.564 179.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.491 ' HG2' ' HA ' ' A' ' 40' ' ' SER . 39.5 Cg_endo -67.48 176.47 4.88 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.951 1.501 . . . . 0.0 111.501 -179.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.527 ' HA ' ' N ' ' A' ' 136' ' ' ALA . . . -60.9 126.23 26.6 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.509 -0.744 . . . . 0.0 111.463 -178.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.534 ' O ' ' C ' ' A' ' 40' ' ' SER . . . 39.0 26.83 0.05 OUTLIER Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.534 ' C ' ' O ' ' A' ' 39' ' ' GLY . 9.6 t 27.08 59.21 0.09 Allowed 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.886 -0.773 . . . . 0.0 110.9 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.495 ' O ' ' HB3' ' A' ' 42' ' ' GLN . . . -88.36 100.8 13.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.231 -0.918 . . . . 0.0 110.201 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.495 ' HB3' ' O ' ' A' ' 41' ' ' ALA . 0.9 OUTLIER 174.41 -158.78 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.912 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.516 ' CE2' ' O ' ' A' ' 44' ' ' GLY . 8.9 p90 -50.32 -24.0 2.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.096 -1.002 . . . . 0.0 109.726 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.516 ' O ' ' CE2' ' A' ' 43' ' ' TYR . . . 119.82 129.29 3.82 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.533 ' CG2' ' OG ' ' A' ' 40' ' ' SER . 6.2 t -89.58 177.05 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.265 -1.138 . . . . 0.0 109.001 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.57 ' O ' ' CZ ' ' A' ' 19' ' ' TYR . . . 166.15 149.32 5.88 Favored Glycine 0 N--CA 1.488 2.153 0 C-N-CA 119.166 -1.492 . . . . 0.0 110.552 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.521 ' CG1' ' O ' ' A' ' 17' ' ' VAL . 43.8 t -116.24 144.18 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.552 -0.969 . . . . 0.0 109.449 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.467 ' O ' HG23 ' A' ' 17' ' ' VAL . 29.0 m -138.56 153.96 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.834 -1.166 . . . . 0.0 111.004 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.575 HD23 ' CD1' ' A' ' 16' ' ' TRP . 14.8 tp -140.89 99.66 3.65 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.446 -0.784 . . . . 0.0 109.929 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.524 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 8.6 t30 -78.11 133.34 37.87 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.248 -0.907 . . . . 0.0 110.542 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 139.34 55.32 0.05 OUTLIER Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.52 HG13 ' CB ' ' A' ' 112' ' ' TYR . 53.3 t -120.04 161.11 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.092 -1.24 . . . . 0.0 110.278 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' A' ' 112' ' ' TYR . . . -130.83 96.8 4.16 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.186 -0.946 . . . . 0.0 110.65 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.639 ' CD1' ' CE1' ' A' ' 60' ' ' TYR . 50.6 mm -131.65 160.51 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.268 -0.895 . . . . 0.0 109.786 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.536 ' N ' HG21 ' A' ' 54' ' ' ILE . 13.2 pt-20 -149.02 130.58 14.88 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.087 -1.008 . . . . 0.0 110.432 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.528 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 10.8 pt-20 38.14 -152.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.646 -0.659 . . . . 0.0 110.85 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.474 ' N ' ' HG3' ' A' ' 56' ' ' GLU . . . -85.28 108.43 3.2 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.578 HG21 ' CE2' ' A' ' 60' ' ' TYR . 1.1 m -136.75 174.63 10.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.238 -1.154 . . . . 0.0 109.714 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.574 ' N ' ' CG2' ' A' ' 58' ' ' THR . 0.5 OUTLIER -89.83 145.44 25.16 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.256 -0.903 . . . . 0.0 110.261 -179.922 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.639 ' CE1' ' CD1' ' A' ' 54' ' ' ILE . 58.5 m-85 -154.41 154.67 33.64 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.313 -0.867 . . . . 0.0 110.271 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 85.3 m -124.1 114.0 19.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.354 -0.841 . . . . 0.0 110.066 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.51 HD21 ' CD2' ' A' ' 89' ' ' LEU . 18.2 tp -89.69 121.81 32.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -0.914 . . . . 0.0 110.105 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.483 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 8.1 mtt85 -127.33 138.25 52.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.318 -0.864 . . . . 0.0 110.287 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.63 ' CZ ' ' CG2' ' A' ' 102' ' ' VAL . 2.8 p90 -177.92 152.69 0.77 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.395 -0.816 . . . . 0.0 109.796 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.462 ' HB ' ' OD2' ' A' ' 142' ' ' ASP . 0.2 OUTLIER -119.28 102.8 8.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.121 -0.987 . . . . 0.0 110.105 -179.947 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.483 ' C ' ' CD2' ' A' ' 95' ' ' LEU . . . -102.3 141.66 34.78 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.308 -0.87 . . . . 0.0 110.05 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.466 ' OG1' ' HA ' ' A' ' 99' ' ' PRO . 35.0 m -150.14 107.41 3.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.294 -0.879 . . . . 0.0 110.18 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.518 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -98.3 131.68 44.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.281 -0.887 . . . . 0.0 110.169 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 68' ' ' ALA . 0.9 OUTLIER -44.47 -26.23 0.33 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.188 -0.945 . . . . 0.0 109.467 179.528 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.581 ' CG2' ' CB ' ' A' ' 137' ' ' TRP . 1.9 t -110.28 165.27 11.9 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.453 -0.78 . . . . 0.0 109.856 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.455 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 4.8 t0 -84.15 68.97 10.31 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.146 -0.971 . . . . 0.0 109.321 179.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.55 HG22 ' CE2' ' A' ' 137' ' ' TRP . 6.1 p -86.89 134.36 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.327 -0.858 . . . . 0.0 111.248 -179.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 23.3 m -120.58 85.26 2.36 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.587 ' HA ' ' CD1' ' A' ' 132' ' ' PHE . 3.0 m -89.63 -157.95 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.25 -0.906 . . . . 0.0 110.72 -178.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -120.23 104.06 9.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.357 -0.839 . . . . 0.0 110.278 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.495 ' O ' ' HB3' ' A' ' 77' ' ' LEU . . . -99.9 163.75 12.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.21 -0.931 . . . . 0.0 109.851 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.555 ' CD1' ' CB ' ' A' ' 126' ' ' ALA . 2.0 pp 173.32 -161.1 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.285 -0.884 . . . . 0.0 110.132 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.484 HG21 ' CD2' ' A' ' 89' ' ' LEU . 3.6 t -146.31 168.91 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.275 -0.89 . . . . 0.0 109.58 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.548 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . 175.09 -160.45 29.3 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.416 -1.373 . . . . 0.0 109.934 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.501 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 4.7 pt20 -125.08 137.12 54.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.275 -1.132 . . . . 0.0 110.642 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -86.62 93.82 9.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.366 -0.834 . . . . 0.0 109.964 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.58 ' O ' ' CD2' ' A' ' 85' ' ' TYR . . . 148.18 -177.39 26.46 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.271 -1.531 . . . . 0.0 109.271 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.568 ' HA ' ' CD1' ' A' ' 85' ' ' TYR . . . -99.61 152.18 37.71 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.275 -1.133 . . . . 0.0 110.231 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.48 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.7 Cg_endo -83.02 30.09 4.69 Favored 'Cis proline' 0 C--N 1.312 -1.349 0 C-N-CA 121.795 -2.169 . . . . 0.0 111.021 -0.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.58 ' CD2' ' O ' ' A' ' 82' ' ' GLY . 57.2 m-85 60.37 -175.6 0.11 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.138 -0.976 . . . . 0.0 110.26 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.45 ' O ' ' HG2' ' A' ' 80' ' ' GLN . . . 161.95 126.67 0.83 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.0 p -120.16 146.2 46.22 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.21 -1.17 . . . . 0.0 110.099 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.525 ' CG2' HD13 ' A' ' 89' ' ' LEU . 28.9 m -125.65 -16.41 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.259 -0.901 . . . . 0.0 110.559 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.565 HD12 ' CZ ' ' A' ' 106' ' ' PHE . 4.3 mp -110.88 140.93 44.93 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.118 -0.989 . . . . 0.0 111.18 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.51 ' O ' ' CG2' ' A' ' 91' ' ' THR . 38.9 p30 -150.9 93.4 1.94 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.411 -0.806 . . . . 0.0 110.161 179.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.51 ' CG2' ' O ' ' A' ' 90' ' ' ASP . 16.3 p -159.02 -175.96 5.58 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.026 -1.046 . . . . 0.0 110.67 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.428 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 29.0 m -120.0 135.04 24.07 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.312 -0.868 . . . . 0.0 110.075 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.53 ' CG ' HG21 ' A' ' 74' ' ' VAL . 49.5 Cg_endo -87.46 67.91 3.82 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.968 1.509 . . . . 0.0 111.063 -179.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.513 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -45.59 121.91 3.33 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.95 -1.094 . . . . 0.0 109.271 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.544 ' CD1' ' CD2' ' A' ' 139' ' ' LEU . 15.1 mt -119.87 175.32 5.95 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.086 -1.009 . . . . 0.0 110.901 -179.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 179.26 -178.87 0.37 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.499 -0.751 . . . . 0.0 109.953 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.94 -14.07 20.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.21 -0.931 . . . . 0.0 110.197 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.419 ' HG2' ' HD2' ' A' ' 99' ' ' PRO . 1.7 mt-10 -96.66 157.46 35.24 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.283 -0.886 . . . . 0.0 110.145 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.466 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 45.5 Cg_endo -72.51 137.42 27.84 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.971 1.511 . . . . 0.0 110.367 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.513 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.82 93.05 3.93 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.201 -0.937 . . . . 0.0 110.351 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.451 ' HG2' HG22 ' A' ' 65' ' ' THR . 0.0 OUTLIER -74.04 143.39 45.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.912 . . . . 0.0 109.818 179.633 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.63 ' CG2' ' CZ ' ' A' ' 64' ' ' TYR . 47.5 t -121.16 132.35 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.137 -0.977 . . . . 0.0 110.407 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.454 HG21 ' HD3' ' A' ' 63' ' ' ARG . 0.2 OUTLIER -150.86 94.11 2.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.412 -0.805 . . . . 0.0 110.098 179.919 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -139.95 157.99 44.79 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.132 -0.98 . . . . 0.0 110.447 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -114.8 97.0 6.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.305 -0.872 . . . . 0.0 110.048 179.944 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.565 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 36.0 p90 -96.58 155.9 16.57 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.264 -0.898 . . . . 0.0 110.334 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.7 m -90.6 101.92 14.66 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.334 -0.854 . . . . 0.0 110.004 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.584 ' CB ' ' CD2' ' A' ' 60' ' ' TYR . . . -64.89 102.48 0.6 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.233 -0.917 . . . . 0.0 110.355 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.458 ' HA ' ' HA2' ' A' ' 57' ' ' GLY . 2.9 p -93.95 52.37 1.64 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.258 -0.901 . . . . 0.0 110.023 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.509 ' HB1' ' CG1' ' A' ' 88' ' ' VAL . . . -156.91 -158.4 0.77 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.207 -0.933 . . . . 0.0 110.417 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.465 ' O ' ' HD3' ' A' ' 113' ' ' PRO . 69.9 m -137.74 111.22 8.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.238 -0.914 . . . . 0.0 110.261 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.589 ' CD2' HG13 ' A' ' 54' ' ' ILE . 15.1 m-30 -106.9 78.03 0.55 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.322 -0.862 . . . . 0.0 110.001 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 111' ' ' THR . 44.3 Cg_endo -71.36 124.95 10.84 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.836 1.44 . . . . 0.0 110.418 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.276 -0.89 . . . . 0.0 110.33 -179.85 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' A' ' 80' ' ' GLN . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.546 ' HA3' ' CB ' ' A' ' 112' ' ' TYR . . . -125.11 139.14 11.44 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.524 ' CB ' ' HA ' ' A' ' 50' ' ' ASN . 3.2 pt20 -150.39 -160.63 1.2 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.298 -1.119 . . . . 0.0 110.419 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.488 ' CG2' ' CE1' ' A' ' 127' ' ' PHE . 15.4 mt -118.5 135.06 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.506 -0.746 . . . . 0.0 109.131 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.555 ' CB ' ' CD1' ' A' ' 77' ' ' LEU . . . -112.6 123.46 50.35 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.285 -0.884 . . . . 0.0 111.082 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.503 ' O ' ' CA ' ' A' ' 46' ' ' GLY . 4.4 m-85 -119.18 107.16 13.1 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . 0.47 ' O ' ' HB ' ' A' ' 74' ' ' VAL . 10.5 mm-40 -89.48 97.25 11.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.155 -0.966 . . . . 0.0 111.431 -178.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.481 ' HB2' ' HB ' ' A' ' 45' ' ' VAL . 24.1 mt -97.13 41.92 1.1 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.355 -0.84 . . . . 0.0 109.191 178.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 131' ' ' GLY . . . -88.65 116.56 4.66 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -179.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.46 ' HA2' ' O ' ' A' ' 39' ' ' GLY . . . 39.74 92.59 0.01 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.587 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 7.2 m-85 -143.96 -54.42 0.36 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.112 -1.228 . . . . 0.0 110.516 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.565 ' HB3' ' CE3' ' A' ' 137' ' ' TRP . 1.3 t -89.05 175.15 7.51 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.967 -1.083 . . . . 0.0 110.157 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.2 -91.96 0.08 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.209 -0.932 . . . . 0.0 110.348 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.38 170.32 13.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.162 -0.961 . . . . 0.0 110.122 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.527 ' N ' ' HA ' ' A' ' 38' ' ' ALA . . . -55.55 133.04 50.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.237 -0.914 . . . . 0.0 110.144 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.642 ' CZ2' ' CG1' ' A' ' 36' ' ' VAL . 16.5 p90 -136.23 -161.67 1.19 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.197 -0.939 . . . . 0.0 110.65 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.523 ' CG2' ' N ' ' A' ' 139' ' ' LEU 0.258 0.9 OUTLIER -156.86 176.76 12.32 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.405 -0.809 . . . . 0.0 110.028 -177.78 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.544 ' CD2' ' CD1' ' A' ' 95' ' ' LEU . 1.8 mp -145.43 119.42 9.37 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.097 -1.002 . . . . 0.0 112.04 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' CYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 0.8 OUTLIER -99.71 111.68 23.99 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.577 -0.702 . . . . 0.0 110.387 178.349 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.507 ' O ' ' HB3' ' A' ' 142' ' ' ASP . 5.5 mt -103.57 173.89 6.11 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.233 -0.917 . . . . 0.0 109.687 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.582 ' HA ' ' CG ' ' A' ' 9' ' ' PHE . 3.0 p-10 172.09 -177.81 0.06 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.426 -0.796 . . . . 0.0 110.166 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.452 ' HA ' ' O ' ' A' ' 7' ' ' GLY . 19.3 t0 42.07 59.62 2.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.339 -0.85 . . . . 0.0 109.856 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.57 HG22 ' CE1' ' A' ' 9' ' ' PHE . 1.9 t -100.89 114.45 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.32 -0.863 . . . . 0.0 110.113 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.445 ' HB3' ' HA ' ' A' ' 6' ' ' GLU . . . -144.6 156.25 44.04 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.317 -0.864 . . . . 0.0 110.447 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 35.5 tp -154.58 125.55 7.18 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.321 -0.862 . . . . 0.0 110.094 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.467 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 6.9 m-20 -125.26 179.12 5.22 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.265 -0.897 . . . . 0.0 110.302 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.486 ' HB3' ' CE1' ' A' ' 60' ' ' TYR . 10.9 p . . . . . 0 N--CA 1.493 1.689 0 O-C-N 121.268 -0.895 . . . . 0.0 110.209 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo . . . . . 0 N--CA 1.48 0.679 0 N-CA-C 110.089 -0.774 . . . . 0.0 110.089 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.492 ' CG1' ' N ' ' A' ' 5' ' ' GLY . 9.4 pt -90.19 -42.78 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.17 -0.956 . . . . 0.0 110.2 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.499 ' O ' ' N ' ' A' ' 7' ' ' GLY . . . 137.38 74.42 0.06 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.521 ' CB ' ' HB1' ' A' ' 145' ' ' ALA . 5.8 pt-20 -42.75 94.95 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.3 -1.118 . . . . 0.0 110.247 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 5' ' ' GLY . . . -172.55 143.94 7.65 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.517 ' CG2' ' HB3' ' A' ' 143' ' ' ASP . 76.8 p -54.79 167.2 0.39 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.344 -1.092 . . . . 0.0 110.161 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.57 ' CD2' ' HA ' ' A' ' 142' ' ' ASP . 22.9 m-85 -91.28 55.54 2.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.243 -0.91 . . . . 0.0 110.131 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.561 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 3.3 p-10 -101.77 38.59 1.6 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.164 -0.96 . . . . 0.0 110.316 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.561 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 1.5 m-20 161.42 79.19 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.637 -0.664 . . . . 0.0 109.723 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 63.69 94.86 0.02 OUTLIER Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.536 ' O ' ' N ' ' A' ' 15' ' ' GLY . 45.1 Cg_endo -72.65 78.6 2.02 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.071 1.564 . . . . 0.0 110.627 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.446 ' HG3' ' HB ' ' A' ' 4' ' ' ILE . 6.9 mm-40 42.25 -91.4 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.35 -0.844 . . . . 0.0 110.627 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 13' ' ' PRO . . . -158.96 24.63 0.34 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.575 ' CE2' ' CD2' ' A' ' 49' ' ' LEU . 41.5 m95 -56.12 87.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.283 -1.128 . . . . 0.0 110.255 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.59 ' CG2' ' CG2' ' A' ' 48' ' ' VAL . 0.9 OUTLIER -91.28 146.91 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.049 -1.032 . . . . 0.0 109.647 179.743 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.485 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . . . -130.14 135.58 48.36 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.125 -0.985 . . . . 0.0 109.781 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.463 ' O ' HG11 ' A' ' 45' ' ' VAL . 19.7 p90 -124.3 167.69 13.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.424 -0.797 . . . . 0.0 110.668 -178.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.527 ' CA ' ' OH ' ' A' ' 43' ' ' TYR . . . 75.28 43.79 24.44 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.52 HG21 ' CG1' ' A' ' 45' ' ' VAL . 6.0 p -150.69 -157.23 0.79 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.125 -1.22 . . . . 0.0 110.367 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -93.87 75.92 4.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.32 -0.863 . . . . 0.0 110.23 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.74 -172.09 43.93 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.22 163.62 37.52 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.989 1.521 . . . . 0.0 110.465 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.528 ' CB ' HG11 ' A' ' 34' ' ' VAL . 0.7 OUTLIER -68.17 -169.73 0.15 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.283 -0.885 . . . . 0.0 110.24 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -162.4 150.93 14.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.232 -0.918 . . . . 0.0 110.293 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.511 ' CG2' ' O ' ' A' ' 31' ' ' ALA . 0.8 OUTLIER -119.81 -77.48 0.58 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.327 -0.858 . . . . 0.0 110.046 179.933 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 27' ' ' THR . 1.3 m 40.64 27.77 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.431 -0.793 . . . . 0.0 110.476 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.467 ' CG2' ' O ' ' A' ' 27' ' ' THR . 9.2 t -164.52 30.76 0.07 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.153 -0.967 . . . . 0.0 110.279 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.529 ' HA2' ' CA ' ' A' ' 10' ' ' ASP . . . 53.1 28.38 33.36 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.511 ' O ' ' CG2' ' A' ' 27' ' ' THR . . . -150.13 161.46 42.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.309 -1.113 . . . . 0.0 110.313 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.558 ' HB2' ' CD2' ' A' ' 9' ' ' PHE . 0.8 OUTLIER -105.4 98.04 7.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.89 . . . . 0.0 109.562 179.817 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 64.9 m -107.59 116.35 31.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.244 -0.91 . . . . 0.0 111.01 -179.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.528 HG11 ' CB ' ' A' ' 25' ' ' LEU . 20.3 m -104.03 140.92 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.42 -0.8 . . . . 0.0 109.175 179.213 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.478 ' O ' ' HB ' ' A' ' 21' ' ' THR . . . -88.96 89.5 8.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.064 -1.023 . . . . 0.0 110.69 -179.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.597 ' CG1' ' CZ2' ' A' ' 137' ' ' TRP . 43.8 t -71.62 135.79 83.54 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.263 -0.898 . . . . 0.0 109.775 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.481 ' HG3' ' OE1' ' A' ' 42' ' ' GLN . 40.0 Cg_endo -67.74 -174.06 0.55 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.091 1.574 . . . . 0.0 111.652 -179.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.539 ' HA ' ' CA ' ' A' ' 136' ' ' ALA . . . -72.45 118.77 15.76 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.537 -0.727 . . . . 0.0 111.874 -178.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.565 ' O ' ' C ' ' A' ' 40' ' ' SER . . . 52.98 15.25 3.25 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 178.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.578 ' OG ' ' CH2' ' A' ' 137' ' ' TRP . 49.3 m 25.16 46.73 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.278 0 CA-C-N 118.268 1.034 . . . . 0.0 110.831 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.508 ' N ' ' O ' ' A' ' 39' ' ' GLY . . . -89.09 26.66 1.54 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.475 -0.766 . . . . 0.0 111.167 -178.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.481 ' OE1' ' HG3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -91.98 -153.1 0.32 Allowed 'General case' 0 C--N 1.29 -1.992 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.461 179.183 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.563 ' CE1' ' O ' ' A' ' 44' ' ' GLY . 25.0 p90 -56.57 -16.25 5.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.035 -1.041 . . . . 0.0 109.931 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.563 ' O ' ' CE1' ' A' ' 43' ' ' TYR . . . 123.67 122.64 2.73 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.527 ' CG2' ' HB3' ' A' ' 40' ' ' SER . 5.2 t -90.04 179.23 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.144 -1.209 . . . . 0.0 109.21 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.449 ' CA ' ' HA ' ' A' ' 128' ' ' GLN . . . 164.0 -175.29 40.15 Favored Glycine 0 N--CA 1.489 2.225 0 C-N-CA 119.097 -1.525 . . . . 0.0 110.772 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.532 ' CG1' ' O ' ' A' ' 17' ' ' VAL . 21.8 t -151.04 131.47 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.722 -0.869 . . . . 0.0 108.701 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.59 ' CG2' ' CG2' ' A' ' 17' ' ' VAL . 29.3 m -119.83 131.51 72.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.948 -1.095 . . . . 0.0 110.797 -179.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.575 ' CD2' ' CE2' ' A' ' 16' ' ' TRP . 21.0 tp -131.91 103.91 6.57 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.377 -0.827 . . . . 0.0 110.365 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.526 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 35.7 p30 -78.73 152.41 31.55 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.253 -0.904 . . . . 0.0 110.285 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 125.33 64.45 0.18 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.465 HG13 HG12 ' A' ' 54' ' ' ILE . 89.2 t -131.0 172.62 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.155 -1.203 . . . . 0.0 110.134 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 112' ' ' TYR . . . -150.28 85.78 1.4 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.18 -0.95 . . . . 0.0 110.567 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.637 ' CG1' ' CD2' ' A' ' 112' ' ' TYR . 42.4 mm -111.11 159.97 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.244 -0.91 . . . . 0.0 109.912 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.523 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 72.5 mt-10 -149.52 120.54 7.7 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.119 -0.988 . . . . 0.0 110.471 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.523 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 11.7 pt-20 37.52 -152.0 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.618 -0.676 . . . . 0.0 110.779 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.464 ' N ' ' HG3' ' A' ' 56' ' ' GLU . . . -79.4 114.27 3.84 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.591 HG21 ' CE2' ' A' ' 60' ' ' TYR . 1.2 m -144.22 171.76 13.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.267 -1.137 . . . . 0.0 109.772 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.574 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 0.5 OUTLIER -89.8 158.17 17.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.278 -0.889 . . . . 0.0 110.106 179.866 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.631 ' CE1' ' CD1' ' A' ' 54' ' ' ILE . 68.4 m-85 -159.2 171.22 20.29 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.249 -0.907 . . . . 0.0 110.244 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.469 ' OG1' ' CG2' ' A' ' 105' ' ' THR . 25.7 m -150.11 117.28 6.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.317 -0.864 . . . . 0.0 110.211 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 27.5 tp -89.74 122.49 32.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.205 -0.934 . . . . 0.0 110.022 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.51 ' NH2' ' OD2' ' A' ' 143' ' ' ASP . 1.0 OUTLIER -124.92 104.06 8.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.226 -0.921 . . . . 0.0 110.349 -179.757 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.619 ' CZ ' ' CG2' ' A' ' 102' ' ' VAL . 3.0 p90 -150.54 151.78 33.16 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.281 -0.887 . . . . 0.0 110.012 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 101' ' ' GLN . 29.4 m -119.88 97.62 5.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.221 -0.925 . . . . 0.0 110.251 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.522 ' HB1' ' CD2' ' A' ' 141' ' ' LEU . . . -99.65 145.96 27.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 0.0 110.403 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.463 ' OG1' ' HA ' ' A' ' 99' ' ' PRO . 98.9 m -150.32 117.32 5.93 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.302 -0.874 . . . . 0.0 110.08 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.522 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -107.53 133.41 52.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.184 -0.948 . . . . 0.0 110.115 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 68' ' ' ALA . 1.5 m -45.79 -25.71 0.55 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.167 -0.958 . . . . 0.0 109.399 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.558 ' CG2' ' CB ' ' A' ' 137' ' ' TRP . 1.8 t -110.27 169.26 8.85 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.484 -0.76 . . . . 0.0 109.86 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.462 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 2.2 m-20 -86.15 62.34 7.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.179 -0.951 . . . . 0.0 109.181 179.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.569 HG22 ' CE2' ' A' ' 137' ' ' TRP . 3.3 p -86.16 136.58 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.35 -0.844 . . . . 0.0 111.203 -179.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 67.0 m -122.95 92.08 3.63 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.583 ' HA ' ' CG ' ' A' ' 132' ' ' PHE . 4.3 m -89.97 -153.07 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.158 -0.964 . . . . 0.0 110.628 -178.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.481 ' N ' HG21 ' A' ' 74' ' ' VAL . 5.0 mtm180 -127.7 128.73 45.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.313 -0.867 . . . . 0.0 110.577 -179.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.479 ' O ' ' HB3' ' A' ' 77' ' ' LEU . . . -131.22 155.41 47.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.335 -0.853 . . . . 0.0 109.786 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.484 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 3.8 pp 178.55 -154.46 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.272 -0.892 . . . . 0.0 110.281 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.545 HG13 ' CE2' ' A' ' 112' ' ' TYR . 4.3 t -146.87 171.92 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.289 -0.882 . . . . 0.0 109.357 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.5 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . 178.78 -176.3 47.89 Favored Glycine 0 N--CA 1.49 2.258 0 C-N-CA 119.363 -1.399 . . . . 0.0 110.056 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.477 ' O ' ' HG3' ' A' ' 80' ' ' GLN . 5.1 tp60 -112.64 86.85 2.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.393 -1.063 . . . . 0.0 110.21 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.472 ' N ' ' O ' ' A' ' 122' ' ' GLU . 3.6 m-80 -64.68 97.39 0.21 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.135 -0.978 . . . . 0.0 109.681 179.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.585 ' O ' ' CZ ' ' A' ' 85' ' ' TYR . . . 149.13 -88.69 0.14 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 178.83 146.67 0.37 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.187 -1.184 . . . . 0.0 110.054 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.495 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.5 Cg_endo -85.44 36.06 3.21 Favored 'Cis proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.921 -2.116 . . . . 0.0 110.616 -0.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.585 ' CZ ' ' O ' ' A' ' 82' ' ' GLY . 98.9 m-85 59.17 -168.91 0.14 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.263 -0.898 . . . . 0.0 110.399 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.425 ' O ' ' OH ' ' A' ' 112' ' ' TYR . . . 135.77 110.54 1.07 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -89.76 140.5 29.53 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.22 -1.165 . . . . 0.0 110.389 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.523 ' CG2' ' HB ' ' A' ' 78' ' ' VAL . 30.6 m -119.78 -17.98 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.409 -0.807 . . . . 0.0 109.746 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.576 HD12 ' CZ ' ' A' ' 106' ' ' PHE . 4.4 mp -121.55 143.26 49.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.401 -0.812 . . . . 0.0 110.784 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.402 ' C ' HG21 ' A' ' 91' ' ' THR . 1.9 p30 -151.15 78.88 1.3 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.886 . . . . 0.0 110.074 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.402 HG21 ' C ' ' A' ' 90' ' ' ASP . 36.3 p -147.04 174.05 11.9 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.039 -1.038 . . . . 0.0 110.708 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.422 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 1.3 m -119.81 120.31 30.56 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.395 -0.815 . . . . 0.0 109.848 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.53 ' HG2' ' CG2' ' A' ' 74' ' ' VAL . 43.6 Cg_endo -70.61 117.49 5.17 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.928 1.489 . . . . 0.0 111.125 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.526 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -86.18 138.96 31.49 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.896 . . . . 0.0 109.339 179.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.52 ' CD1' ' HG ' ' A' ' 139' ' ' LEU . 72.4 mt -130.66 169.46 15.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.033 -1.042 . . . . 0.0 110.883 -179.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.404 ' O ' HG21 ' A' ' 67' ' ' THR . 0.2 OUTLIER -178.34 -178.75 0.64 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.488 -0.757 . . . . 0.0 109.938 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.61 -23.72 67.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.887 . . . . 0.0 110.17 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.466 ' HB3' ' HD2' ' A' ' 99' ' ' PRO . 4.3 mt-10 -89.8 165.17 25.95 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.292 -0.88 . . . . 0.0 110.178 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.466 ' HD2' ' HB3' ' A' ' 98' ' ' GLU . 45.1 Cg_endo -72.45 133.18 20.31 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.946 1.498 . . . . 0.0 110.29 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.526 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.79 81.05 1.67 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.206 -0.934 . . . . 0.0 110.289 -179.927 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.471 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 0.0 OUTLIER -68.12 158.22 33.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.25 -0.906 . . . . 0.0 110.015 179.827 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.619 ' CG2' ' CZ ' ' A' ' 64' ' ' TYR . 65.3 t -133.67 132.38 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.174 -0.954 . . . . 0.0 110.434 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -150.57 89.21 1.54 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.405 -0.809 . . . . 0.0 110.035 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' ' 61' ' ' THR . 1.2 mm-40 -141.38 168.78 18.97 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.155 -0.966 . . . . 0.0 110.273 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.472 ' CG2' ' O ' ' A' ' 60' ' ' TYR . 0.6 OUTLIER -121.98 -179.51 4.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.309 -0.869 . . . . 0.0 110.172 -179.992 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.626 ' CZ ' ' CB ' ' A' ' 60' ' ' TYR . 53.7 p90 -177.96 155.47 0.98 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.217 -0.927 . . . . 0.0 110.259 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 58' ' ' THR . 99.3 m -91.25 95.79 10.22 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.223 -0.923 . . . . 0.0 110.132 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.575 ' HB1' ' CD2' ' A' ' 60' ' ' TYR . . . -65.72 113.67 4.44 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -0.918 . . . . 0.0 110.44 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 109' ' ' SER . 5.8 p -98.42 55.87 1.12 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.208 -0.933 . . . . 0.0 109.958 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.433 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -158.19 -160.62 0.92 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.256 -0.902 . . . . 0.0 110.455 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.458 HG21 ' O ' ' A' ' 54' ' ' ILE . 10.5 m -152.54 118.17 5.35 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.347 -0.845 . . . . 0.0 110.34 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.637 ' CD2' ' CG1' ' A' ' 54' ' ' ILE . 11.2 m-30 -113.08 94.17 28.94 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.256 -0.903 . . . . 0.0 109.85 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.461 ' O ' ' HB2' ' A' ' 122' ' ' GLU . 45.7 Cg_endo -72.94 139.72 30.55 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.022 1.538 . . . . 0.0 110.51 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.242 -0.911 . . . . 0.0 110.246 179.95 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.472 ' O ' ' N ' ' A' ' 81' ' ' ASN . 14.7 pt-20 . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 121.201 0.524 . . . . 0.0 110.405 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 80' ' ' GLN . . . -99.69 144.85 17.21 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.526 ' CB ' ' HA ' ' A' ' 50' ' ' ASN . 2.1 pt20 -150.49 -153.82 0.51 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.208 -1.172 . . . . 0.0 110.597 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.466 HG23 ' CH2' ' A' ' 16' ' ' TRP . 21.6 mt -118.63 142.2 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.515 -0.74 . . . . 0.0 109.297 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 76' ' ' ALA . . . -113.64 115.87 28.58 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.395 -0.816 . . . . 0.0 111.774 -178.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.495 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 4.5 m-85 -119.75 74.28 1.01 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.135 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . 0.449 ' HA ' ' CA ' ' A' ' 46' ' ' GLY . 2.3 mt-30 -87.26 126.54 34.89 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.207 -0.933 . . . . 0.0 112.146 -177.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.522 ' CD2' HG22 ' A' ' 74' ' ' VAL . 1.4 mt -112.77 55.38 0.69 Allowed 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 131' ' ' GLY . . . -73.28 85.3 0.6 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 39' ' ' GLY . . . 58.44 114.61 0.01 OUTLIER Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.583 ' CG ' ' HA ' ' A' ' 74' ' ' VAL . 10.3 m-85 -147.4 -57.16 0.25 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -1.148 . . . . 0.0 110.206 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.538 ' HB3' ' CE3' ' A' ' 137' ' ' TRP . 5.9 t -89.69 173.79 8.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.149 -0.969 . . . . 0.0 110.187 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -74.84 -93.73 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.213 -0.93 . . . . 0.0 110.208 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.33 -167.84 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.081 -1.012 . . . . 0.0 109.937 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.539 ' CA ' ' HA ' ' A' ' 38' ' ' ALA . . . -77.58 150.07 34.76 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.214 -0.929 . . . . 0.0 110.375 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.597 ' CZ2' ' CG1' ' A' ' 36' ' ' VAL . 24.3 p90 -148.49 -154.81 0.58 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.315 -0.866 . . . . 0.0 110.11 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.522 ' O ' ' CB ' ' A' ' 68' ' ' ALA . 1.0 OUTLIER -160.43 163.17 33.26 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.922 -1.111 . . . . 0.0 111.296 -178.21 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.52 ' HG ' ' CD1' ' A' ' 95' ' ' LEU . 2.1 mp -126.52 125.74 42.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.429 -0.794 . . . . 0.0 109.56 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' CYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 41.1 m -121.01 99.45 6.5 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.107 -0.995 . . . . 0.0 110.713 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.522 ' CD2' ' HB1' ' A' ' 66' ' ' ALA . 2.2 mt -89.64 -154.67 0.33 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.317 -0.864 . . . . 0.0 109.479 179.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.57 ' HA ' ' CD2' ' A' ' 9' ' ' PHE . 39.7 p-10 -177.78 -151.49 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.187 -0.946 . . . . 0.0 110.03 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.517 ' HB3' ' CG2' ' A' ' 8' ' ' THR . 23.6 p-10 -40.56 115.05 0.52 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.526 -0.734 . . . . 0.0 109.785 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.468 HG22 ' O ' ' A' ' 142' ' ' ASP . 43.0 t -128.85 125.09 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.284 -0.885 . . . . 0.0 110.244 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.521 ' HB1' ' CB ' ' A' ' 6' ' ' GLU . . . -136.89 178.82 6.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.292 -0.88 . . . . 0.0 110.658 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.449 HD11 ' O ' ' A' ' 61' ' ' THR . 14.4 tp -158.93 118.7 3.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.384 -0.823 . . . . 0.0 109.947 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.467 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 49.3 m-20 -113.15 141.05 47.38 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.228 -0.92 . . . . 0.0 110.415 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.572 ' OG ' ' CE1' ' A' ' 60' ' ' TYR . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.321 -0.862 . . . . 0.0 110.224 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo . . . . . 0 N--CA 1.48 0.728 0 N-CA-C 110.053 -0.787 . . . . 0.0 110.053 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.453 HD13 ' HB ' ' A' ' 144' ' ' VAL . 9.5 pt -89.88 34.91 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.151 -0.968 . . . . 0.0 110.166 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.42 ' O ' ' C ' ' A' ' 6' ' ' GLU . . . 89.62 -34.14 4.14 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.458 ' HG3' ' CB ' ' A' ' 145' ' ' ALA . 30.4 tt0 42.86 41.47 2.57 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.34 -1.094 . . . . 0.0 110.172 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 143' ' ' ASP . . . -126.26 169.93 18.15 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.432 ' O ' ' C ' ' A' ' 9' ' ' PHE . 12.7 p -83.7 42.51 0.85 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.275 -1.132 . . . . 0.0 110.522 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.584 ' CG ' ' HB3' ' A' ' 13' ' ' PRO . 15.7 m-30 41.29 32.54 0.21 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.27 -0.894 . . . . 0.0 110.381 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.539 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 35.4 p-10 -89.35 46.4 1.37 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.167 -0.958 . . . . 0.0 110.316 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.539 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.3 OUTLIER 161.52 -22.56 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.798 -0.564 . . . . 0.0 109.75 179.962 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 167.58 110.74 0.23 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.584 ' HB3' ' CG ' ' A' ' 9' ' ' PHE . 49.9 Cg_endo -76.59 72.75 5.48 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.984 1.518 . . . . 0.0 110.778 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.497 ' HG3' ' N ' ' A' ' 15' ' ' GLY . 12.8 tp10 41.32 -92.1 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.293 -0.879 . . . . 0.0 110.509 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 13' ' ' PRO . . . -157.71 43.24 0.51 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.577 ' CD1' HD23 ' A' ' 49' ' ' LEU . 37.9 m95 -66.47 127.88 34.01 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.32 -1.106 . . . . 0.0 110.288 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.58 ' CG2' ' CG2' ' A' ' 48' ' ' VAL . 1.3 m -122.32 154.73 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.135 -0.978 . . . . 0.0 109.689 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.463 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . . . -137.1 154.83 50.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.303 -0.873 . . . . 0.0 109.526 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.577 ' CE1' ' O ' ' A' ' 46' ' ' GLY . 0.6 OUTLIER -139.47 138.67 36.62 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.06 -1.025 . . . . 0.0 111.13 -178.752 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.581 ' HA2' ' CE1' ' A' ' 43' ' ' TYR . . . 121.26 84.3 0.77 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.641 ' CG2' ' CE2' ' A' ' 43' ' ' TYR . 1.7 p 53.15 17.6 1.0 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.508 -0.995 . . . . 0.0 110.955 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.538 ' HA ' ' CB ' ' A' ' 35' ' ' ALA . 5.9 p30 -101.89 111.36 23.59 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.083 -1.011 . . . . 0.0 110.284 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 22' ' ' ASP . . . -59.94 -152.91 0.02 OUTLIER Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.022 -1.631 . . . . 0.0 109.022 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.455 ' O ' ' C ' ' A' ' 25' ' ' LEU . 47.0 Cg_endo -74.4 95.63 0.94 Allowed 'Trans proline' 0 C--N 1.303 -1.86 0 O-C-N 123.814 1.429 . . . . 0.0 110.307 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.526 HD11 ' CD1' ' A' ' 32' ' ' LEU . 0.8 OUTLIER -40.65 150.39 0.07 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.354 -0.841 . . . . 0.0 109.771 179.808 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -146.6 159.77 43.03 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.98 -1.075 . . . . 0.0 110.757 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.524 ' CG2' ' HB3' ' A' ' 9' ' ' PHE . 3.7 p -119.63 -55.86 2.08 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.321 -0.862 . . . . 0.0 110.161 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 50.57 -89.58 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.275 -0.891 . . . . 0.0 110.228 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.514 ' N ' ' O ' ' A' ' 27' ' ' THR . 15.2 t -55.71 -17.19 5.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.243 -0.911 . . . . 0.0 110.161 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' A' ' 9' ' ' PHE . . . 111.65 32.55 2.46 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' A' ' 141' ' ' LEU . . . -140.52 109.97 6.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.272 -1.134 . . . . 0.0 110.274 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.526 ' CD1' HD11 ' A' ' 25' ' ' LEU . 0.6 OUTLIER -67.17 94.31 0.35 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.266 -0.896 . . . . 0.0 109.991 179.912 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 59.0 m -99.4 133.09 44.2 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.31 -0.869 . . . . 0.0 110.574 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.468 ' O ' ' OG1' ' A' ' 138' ' ' THR . 6.2 m -121.62 167.28 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.571 -0.705 . . . . 0.0 109.4 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.538 ' CB ' ' HA ' ' A' ' 22' ' ' ASP . . . -103.15 128.46 50.08 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.126 -0.984 . . . . 0.0 111.887 -178.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.658 ' CG1' ' CZ2' ' A' ' 137' ' ' TRP . 90.3 t -117.5 121.47 32.01 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.163 -0.961 . . . . 0.0 108.991 178.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.49 ' HD3' ' OG1' ' A' ' 21' ' ' THR . 38.2 Cg_endo -64.25 173.99 4.6 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.856 1.45 . . . . 0.0 112.196 -178.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.544 ' HA ' ' CA ' ' A' ' 136' ' ' ALA . . . -53.31 122.28 9.27 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.514 0.673 . . . . 0.0 111.456 -178.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.513 ' O ' ' C ' ' A' ' 40' ' ' SER . . . 37.89 27.17 0.03 OUTLIER Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.565 ' CB ' HG22 ' A' ' 45' ' ' VAL . 31.3 t 32.77 46.39 0.08 Allowed 'General case' 0 N--CA 1.498 1.934 0 CA-C-N 118.045 0.923 . . . . 0.0 110.15 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.644 ' O ' ' CG ' ' A' ' 42' ' ' GLN . . . -89.51 119.02 29.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.594 -0.692 . . . . 0.0 110.127 -179.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.644 ' CG ' ' O ' ' A' ' 41' ' ' ALA . 0.5 OUTLIER 84.1 28.64 0.08 Allowed 'General case' 0 N--CA 1.508 2.433 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -179.492 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.641 ' CE2' ' CG2' ' A' ' 21' ' ' THR . 0.1 OUTLIER -146.4 -33.27 0.32 Allowed 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 118.757 -1.177 . . . . 0.0 112.335 -177.878 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 43' ' ' TYR . . . 52.26 75.28 0.23 Allowed Glycine 0 N--CA 1.482 1.758 0 N-CA-C 105.849 -2.9 . . . . 0.0 105.849 -177.011 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.565 HG22 ' CB ' ' A' ' 40' ' ' SER . 2.6 t -85.68 160.76 3.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.513 -0.992 . . . . 0.0 109.186 -177.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.577 ' O ' ' CE1' ' A' ' 19' ' ' TYR . . . 176.68 164.66 30.98 Favored Glycine 0 N--CA 1.488 2.102 0 C-N-CA 119.357 -1.402 . . . . 0.0 110.08 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.525 ' CG1' ' O ' ' A' ' 17' ' ' VAL . 17.8 t -124.59 125.53 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.473 -1.016 . . . . 0.0 109.626 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.58 ' CG2' ' CG2' ' A' ' 17' ' ' VAL . 33.8 m -119.73 139.89 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.007 -1.058 . . . . 0.0 110.842 -179.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.577 HD23 ' CD1' ' A' ' 16' ' ' TRP . 18.4 tp -132.08 99.25 4.66 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.318 -0.864 . . . . 0.0 110.086 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.527 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 10.6 p30 -73.38 121.52 20.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.245 -0.909 . . . . 0.0 110.429 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.449 ' O ' ' CG2' ' A' ' 4' ' ' ILE . . . 150.54 65.85 0.01 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.864 -1.295 . . . . 0.0 109.864 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.514 ' CG2' ' HA ' ' A' ' 124' ' ' GLN . 53.1 t -122.61 169.68 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.137 -1.213 . . . . 0.0 110.073 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.472 ' N ' ' CG1' ' A' ' 52' ' ' VAL . . . -141.41 88.63 2.16 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.151 -0.968 . . . . 0.0 110.613 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.526 HG21 ' N ' ' A' ' 55' ' ' GLU . 36.1 mm -122.14 163.0 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.292 -0.88 . . . . 0.0 109.718 179.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.526 ' N ' HG21 ' A' ' 54' ' ' ILE . 2.0 tt0 -150.25 127.05 11.02 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.044 -1.035 . . . . 0.0 110.778 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.52 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 13.6 pt-20 37.56 -157.86 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.642 -0.661 . . . . 0.0 111.093 179.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' A' ' 109' ' ' SER . . . -79.04 82.84 1.32 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.559 HG21 ' CE2' ' A' ' 60' ' ' TYR . 1.3 m -110.16 170.46 8.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.266 -1.137 . . . . 0.0 109.779 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.576 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 6.5 m -89.87 154.58 19.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.175 -0.953 . . . . 0.0 110.33 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.576 ' CG ' ' O ' ' A' ' 59' ' ' THR . 60.3 m-85 -159.77 173.06 16.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.332 -0.855 . . . . 0.0 110.225 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 27.4 m -150.14 116.01 5.6 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.3 -0.875 . . . . 0.0 110.036 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.466 ' O ' ' HA ' ' A' ' 103' ' ' THR . 38.3 tp -89.78 122.6 33.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.265 -0.897 . . . . 0.0 110.057 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.508 ' HG2' ' CG2' ' A' ' 103' ' ' THR . 16.1 mtt180 -131.81 106.46 8.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.332 -0.855 . . . . 0.0 110.233 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.496 ' CD1' ' C ' ' A' ' 64' ' ' TYR . 10.0 p90 -143.04 159.62 41.92 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.246 -0.908 . . . . 0.0 110.236 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 1.3 m -119.96 102.35 8.49 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.179 -0.951 . . . . 0.0 109.866 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.457 ' HB2' HD23 ' A' ' 95' ' ' LEU . . . -104.83 149.47 25.63 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.273 -0.892 . . . . 0.0 110.699 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.47 ' O ' ' HB2' ' A' ' 140' ' ' CYS . 93.5 m -150.22 126.01 10.4 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.444 -0.785 . . . . 0.0 110.025 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -114.32 136.96 52.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.211 -0.931 . . . . 0.0 109.999 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' ' 68' ' ' ALA . 0.4 OUTLIER -44.03 -26.57 0.3 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.189 -0.944 . . . . 0.0 109.344 179.528 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.567 ' CG2' ' CB ' ' A' ' 137' ' ' TRP . 2.7 t -114.07 169.39 9.04 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.51 -0.744 . . . . 0.0 109.824 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.463 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 33.7 p-10 -85.07 66.02 9.53 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.137 -0.977 . . . . 0.0 109.201 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.547 HG22 ' CE2' ' A' ' 137' ' ' TRP . 4.0 p -89.39 140.36 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -0.885 . . . . 0.0 111.483 -178.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.436 ' O ' HG21 ' A' ' 73' ' ' THR . 16.8 m -127.72 87.21 2.58 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.586 ' HA ' ' CD1' ' A' ' 132' ' ' PHE . 2.8 m -89.78 -140.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.238 -0.914 . . . . 0.0 110.483 -178.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.517 ' N ' ' CG2' ' A' ' 74' ' ' VAL . 7.0 mtm180 -127.74 149.07 50.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.169 -0.957 . . . . 0.0 110.767 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.486 ' O ' ' HB3' ' A' ' 77' ' ' LEU . . . -150.11 152.47 34.81 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.399 -0.813 . . . . 0.0 109.421 179.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.585 ' CD1' ' N ' ' A' ' 78' ' ' VAL . 3.9 pp 179.87 -147.15 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.181 -0.949 . . . . 0.0 110.294 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.585 ' N ' ' CD1' ' A' ' 77' ' ' LEU . 6.8 t -151.29 169.59 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.215 -0.928 . . . . 0.0 109.431 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.543 ' C ' ' CE1' ' A' ' 112' ' ' TYR . . . -172.42 -173.59 39.14 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.236 -1.459 . . . . 0.0 110.252 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.499 ' HG3' ' HA ' ' A' ' 85' ' ' TYR . 4.3 pt20 -115.88 108.0 15.73 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.466 -1.02 . . . . 0.0 110.163 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.448 ' HB2' ' HG2' ' A' ' 122' ' ' GLU . 6.2 m-20 -66.61 92.97 0.22 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.193 -0.942 . . . . 0.0 110.236 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.538 ' C ' ' CE1' ' A' ' 85' ' ' TYR . . . 142.8 144.23 4.27 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.654 -1.379 . . . . 0.0 109.654 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.618 ' N ' ' CE1' ' A' ' 85' ' ' TYR . . . -62.7 157.02 61.45 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.226 -1.161 . . . . 0.0 110.27 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.517 ' C ' ' CD2' ' A' ' 85' ' ' TYR . 50.6 Cg_endo -77.38 8.54 17.89 Favored 'Cis proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.647 -2.23 . . . . 0.0 110.876 -0.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.618 ' CE1' ' N ' ' A' ' 83' ' ' ALA . 11.6 m-85 69.83 161.34 0.21 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.241 -0.912 . . . . 0.0 110.262 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.498 ' N ' ' CG ' ' A' ' 80' ' ' GLN . . . 166.76 106.6 0.19 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.463 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 1.0 OUTLIER -89.55 152.38 21.45 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.121 -1.223 . . . . 0.0 110.464 -179.787 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.491 HG22 ' CD1' ' A' ' 89' ' ' LEU . 33.2 m -119.72 -24.92 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.35 -0.844 . . . . 0.0 109.8 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.575 HD13 ' CE1' ' A' ' 106' ' ' PHE . 3.6 mp -99.16 141.8 31.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.285 -0.884 . . . . 0.0 110.73 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 45.5 p-10 -151.34 73.92 1.11 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.393 -0.817 . . . . 0.0 110.032 179.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 41.5 p -135.35 176.03 9.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.051 -1.031 . . . . 0.0 110.643 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.4 m -122.01 121.33 28.05 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.385 -0.822 . . . . 0.0 109.949 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.487 ' HG2' HG21 ' A' ' 74' ' ' VAL . 44.7 Cg_endo -70.92 155.38 62.2 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.919 1.484 . . . . 0.0 110.898 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.519 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -122.26 137.47 54.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.449 -0.782 . . . . 0.0 109.463 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.487 HD13 ' CG1' ' A' ' 72' ' ' VAL . 93.0 mt -131.96 169.03 16.88 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.104 -0.997 . . . . 0.0 110.625 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.468 ' O ' ' O ' ' A' ' 68' ' ' ALA . 5.9 t -174.65 -155.08 0.06 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.428 -0.795 . . . . 0.0 110.0 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.7 24.33 2.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.261 -0.899 . . . . 0.0 110.128 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.487 ' CG ' ' HD2' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -147.57 172.03 5.65 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.35 -0.844 . . . . 0.0 110.012 179.882 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.487 ' HD2' ' CG ' ' A' ' 98' ' ' GLU . 45.2 Cg_endo -72.82 127.45 12.28 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.979 1.515 . . . . 0.0 110.443 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.519 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 6.6 mtt-85 -119.51 93.1 3.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.261 -0.9 . . . . 0.0 109.867 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -78.06 102.71 7.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.448 -0.783 . . . . 0.0 110.569 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 50.2 t -89.41 134.13 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.241 -0.912 . . . . 0.0 109.805 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.508 ' CG2' ' HG2' ' A' ' 63' ' ' ARG . 0.2 OUTLIER -147.05 133.09 19.22 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.16 -0.963 . . . . 0.0 110.247 -179.884 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -160.25 134.72 7.5 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.259 -0.901 . . . . 0.0 110.333 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 25.2 m -90.68 143.82 26.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.281 -0.887 . . . . 0.0 110.125 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.575 ' CE1' HD13 ' A' ' 89' ' ' LEU . 41.7 p90 -154.48 159.85 41.25 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.234 -0.916 . . . . 0.0 110.259 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 58' ' ' THR . 80.2 m -97.02 89.04 4.68 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.201 -0.937 . . . . 0.0 110.054 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.547 ' HB1' ' CD2' ' A' ' 60' ' ' TYR . . . -45.63 106.39 0.08 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -0.892 . . . . 0.0 110.296 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.46 ' HA ' ' HA2' ' A' ' 57' ' ' GLY . 5.2 p -90.29 54.29 2.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.282 -0.886 . . . . 0.0 110.278 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.411 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -164.67 -158.39 0.41 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.895 . . . . 0.0 110.229 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.467 ' CG2' ' HD3' ' A' ' 113' ' ' PRO . 19.9 m -145.04 118.94 9.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.246 -0.909 . . . . 0.0 110.264 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.583 ' CG ' ' HA3' ' A' ' 123' ' ' GLY . 19.2 m-30 -115.79 63.62 2.2 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.361 -0.837 . . . . 0.0 110.073 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.471 ' O ' ' HA ' ' A' ' 122' ' ' GLU . 45.3 Cg_endo -71.67 147.44 51.05 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.852 1.448 . . . . 0.0 110.608 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.197 -0.94 . . . . 0.0 110.246 179.952 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.49 ' O ' ' HA ' ' A' ' 80' ' ' GLN . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.024 0.44 . . . . 0.0 110.039 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.583 ' HA3' ' CG ' ' A' ' 112' ' ' TYR . . . -145.02 158.67 27.71 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.859 -1.297 . . . . 0.0 109.859 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.527 ' CB ' ' HA ' ' A' ' 50' ' ' ASN . 1.1 pp0? -150.38 -158.12 0.88 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.415 -1.05 . . . . 0.0 110.262 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.576 HG23 ' CH2' ' A' ' 16' ' ' TRP . 6.2 mt -118.18 139.49 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.523 -0.736 . . . . 0.0 109.208 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -117.6 122.56 43.95 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.243 -0.911 . . . . 0.0 110.886 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.482 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 3.0 m-30 -116.76 103.39 10.29 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . 0.583 ' O ' ' CE2' ' A' ' 132' ' ' PHE . 11.0 mm100 -89.08 89.12 7.83 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.323 -0.861 . . . . 0.0 112.511 -177.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.579 ' CD2' ' CG2' ' A' ' 74' ' ' VAL . 27.0 mt -94.73 44.98 1.11 Allowed 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 177.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.552 ' O ' ' CD2' ' A' ' 132' ' ' PHE . . . -99.06 127.89 9.39 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 120.117 -1.04 . . . . 0.0 110.737 -178.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.469 ' HA2' ' O ' ' A' ' 39' ' ' GLY . . . 37.14 68.8 0.32 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.586 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 9.4 m-85 -123.29 -57.52 1.67 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.028 -1.278 . . . . 0.0 110.82 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.529 ' HB2' ' CG2' ' A' ' 72' ' ' VAL . 1.3 t -88.54 -177.52 5.61 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.904 -1.122 . . . . 0.0 110.415 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -93.69 -84.76 0.3 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.248 -0.908 . . . . 0.0 110.246 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.08 179.49 1.51 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.165 -0.959 . . . . 0.0 109.999 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.544 ' CA ' ' HA ' ' A' ' 38' ' ' ALA . . . -75.0 129.9 38.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.299 -0.876 . . . . 0.0 110.656 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.658 ' CZ2' ' CG1' ' A' ' 36' ' ' VAL . 6.8 p90 -133.32 -158.93 0.92 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.336 -0.853 . . . . 0.0 109.859 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.524 ' O ' ' CB ' ' A' ' 68' ' ' ALA . 0.3 OUTLIER -160.37 171.68 18.67 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.048 -1.033 . . . . 0.0 110.48 -178.638 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.52 ' CD1' HD11 ' A' ' 129' ' ' LEU . 2.4 mp -122.26 157.39 31.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.405 -0.809 . . . . 0.0 109.639 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' CYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 67' ' ' THR . 8.5 m -150.27 91.14 1.73 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.081 -1.012 . . . . 0.0 110.657 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.472 ' O ' ' HB3' ' A' ' 142' ' ' ASP . 1.0 OUTLIER -90.0 -156.33 0.41 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.926 . . . . 0.0 109.259 179.275 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.58 ' O ' ' CG ' ' A' ' 9' ' ' PHE . 1.9 p-10 175.94 -48.53 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.007 -1.058 . . . . 0.0 110.522 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.494 ' O ' ' HA ' ' A' ' 64' ' ' TYR . 22.6 t70 -119.25 137.73 53.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -0.937 . . . . 0.0 110.208 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.548 HG22 ' CZ ' ' A' ' 9' ' ' PHE . 3.0 t -150.39 113.18 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.213 -0.93 . . . . 0.0 110.115 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.458 ' CB ' ' HG3' ' A' ' 6' ' ' GLU . . . -126.46 153.55 44.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.302 -0.874 . . . . 0.0 110.282 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.461 HD12 ' HB3' ' A' ' 60' ' ' TYR . 29.7 tp -159.71 96.65 1.27 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.34 -0.85 . . . . 0.0 110.03 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.469 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 32.3 t70 -121.95 164.36 17.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.228 -0.92 . . . . 0.0 110.259 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.568 ' HB3' ' CE1' ' A' ' 60' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.226 -0.921 . . . . 0.0 110.255 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo . . . . . 0 N--CA 1.483 0.875 0 N-CA-C 110.427 -0.643 . . . . 0.0 110.427 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.525 HD11 ' CD1' ' A' ' 125' ' ' ILE . 9.1 pt -107.92 42.8 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 110.254 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.52 ' N ' ' CG ' ' A' ' 14' ' ' GLU . . . 73.93 40.54 43.63 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.487 ' HA ' ' O ' ' A' ' 144' ' ' VAL . 22.0 tt0 -42.03 94.03 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.33 -1.1 . . . . 0.0 110.434 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 5' ' ' GLY . . . 163.48 -154.76 25.82 Favored Glycine 0 N--CA 1.49 2.27 0 C-N-CA 119.647 -1.264 . . . . 0.0 110.164 179.77 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.54 ' HA ' ' CA ' ' A' ' 142' ' ' ASP . 62.0 p -105.99 38.15 2.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.416 -1.049 . . . . 0.0 110.604 -179.594 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.552 ' CZ ' HG22 ' A' ' 144' ' ' VAL . 25.4 m-85 42.75 80.78 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.209 -0.932 . . . . 0.0 110.179 179.779 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.548 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 2.6 p30 -108.48 23.23 14.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.202 -0.936 . . . . 0.0 110.415 -179.843 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.548 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.8 OUTLIER 161.51 80.48 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.601 -0.687 . . . . 0.0 109.822 179.991 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.41 101.54 0.08 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.864 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.526 ' O ' ' N ' ' A' ' 15' ' ' GLY . 45.0 Cg_endo -73.27 78.46 2.27 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.038 1.547 . . . . 0.0 110.667 -179.801 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.52 ' CG ' ' N ' ' A' ' 5' ' ' GLY . 5.0 mm-40 39.45 -91.21 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.467 -0.77 . . . . 0.0 111.066 179.675 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.538 ' O ' ' CG1' ' A' ' 17' ' ' VAL . . . -148.24 12.56 1.23 Allowed Glycine 0 N--CA 1.493 2.478 0 C-N-CA 119.618 -1.277 . . . . 0.0 110.386 -179.535 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.574 ' CD1' HD21 ' A' ' 49' ' ' LEU . 36.8 m95 -40.62 128.82 2.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.23 -1.159 . . . . 0.0 110.786 179.832 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.538 ' CG1' ' O ' ' A' ' 15' ' ' GLY . 1.4 m -128.08 148.03 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.16 -0.962 . . . . 0.0 109.696 179.305 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.488 ' CB ' HG13 ' A' ' 34' ' ' VAL . . . -130.32 117.27 19.53 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.027 -1.045 . . . . 0.0 109.821 179.552 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.576 ' CE2' ' O ' ' A' ' 46' ' ' GLY . 29.3 p90 -106.76 172.8 6.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.471 -0.768 . . . . 0.0 110.709 -179.241 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.515 ' O ' ' CG1' ' A' ' 45' ' ' VAL . . . 68.07 27.17 73.77 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 179.589 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.586 ' CG2' ' CG1' ' A' ' 45' ' ' VAL . 30.9 p -132.32 -164.17 1.43 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.066 -1.255 . . . . 0.0 110.514 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -89.99 39.46 0.96 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.275 -0.891 . . . . 0.0 110.42 -179.75 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 126.26 -168.01 18.51 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 179.827 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.48 -159.09 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.112 1.585 . . . . 0.0 110.579 -179.877 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.571 ' CD1' ' CD1' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -115.81 156.86 25.3 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.339 -0.851 . . . . 0.0 110.104 -179.998 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -121.21 141.14 51.14 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.203 -0.935 . . . . 0.0 110.137 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.523 ' CG2' ' HA ' ' A' ' 32' ' ' LEU . 0.7 OUTLIER -126.36 -24.3 3.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.114 -0.991 . . . . 0.0 110.874 -179.694 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.435 ' C ' ' O ' ' A' ' 27' ' ' THR . 3.5 t -41.06 -36.69 0.73 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.263 -0.898 . . . . 0.0 110.538 -179.618 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.7 t -53.2 -49.78 66.01 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.259 -0.9 . . . . 0.0 110.706 -179.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 166.99 -25.46 0.14 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.925 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.461 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -146.92 169.01 20.06 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -1.128 . . . . 0.0 109.593 179.838 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.571 ' CD1' ' CD1' ' A' ' 25' ' ' LEU . 0.6 OUTLIER -78.42 92.26 4.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.011 -1.056 . . . . 0.0 110.502 -179.837 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 0.8 OUTLIER -100.22 110.78 23.04 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.417 -0.802 . . . . 0.0 111.447 179.517 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.488 HG13 ' CB ' ' A' ' 18' ' ' ALA . 15.6 m -89.53 143.71 10.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.001 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.467 ' HA ' ' OG1' ' A' ' 138' ' ' THR . . . -88.63 83.13 6.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.472 -0.767 . . . . 0.0 110.916 -178.59 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.588 HG12 ' CZ2' ' A' ' 137' ' ' TRP . 40.9 t -69.34 128.59 92.32 Favored Pre-proline 0 N--CA 1.487 1.421 0 O-C-N 121.307 -0.87 . . . . 0.0 109.112 179.064 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 21' ' ' THR . 42.8 Cg_endo -70.26 146.77 58.01 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.936 1.493 . . . . 0.0 111.157 -178.951 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.51 ' HA ' ' N ' ' A' ' 136' ' ' ALA . . . -41.57 136.42 1.85 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.512 -0.742 . . . . 0.0 110.229 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 38' ' ' ALA . . . 45.51 92.99 0.01 OUTLIER Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.845 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.568 ' OG ' ' CH2' ' A' ' 137' ' ' TRP . 25.9 m -87.36 33.76 0.69 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.164 -1.198 . . . . 0.0 110.108 179.991 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -91.58 19.95 5.84 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.933 0.873 . . . . 0.0 110.155 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.575 ' OE1' ' CE2' ' A' ' 43' ' ' TYR . 17.8 pt20 -85.69 -143.46 0.1 Allowed 'General case' 0 C--N 1.292 -1.898 0 O-C-N 121.804 -0.56 . . . . 0.0 109.721 179.49 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.575 ' CE2' ' OE1' ' A' ' 42' ' ' GLN . 5.5 p90 -41.54 -27.15 0.09 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.463 -0.773 . . . . 0.0 109.97 179.838 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.571 ' N ' ' CD1' ' A' ' 43' ' ' TYR . . . 115.14 113.49 2.93 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.448 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.586 ' CG1' ' CG2' ' A' ' 21' ' ' THR . 2.0 t -96.37 160.5 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.183 -1.187 . . . . 0.0 108.841 179.384 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.576 ' O ' ' CE2' ' A' ' 19' ' ' TYR . . . 177.56 152.66 10.24 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.271 -1.442 . . . . 0.0 110.329 -179.74 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.517 ' CG1' ' O ' ' A' ' 17' ' ' VAL . 22.9 t -113.46 134.79 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.374 -1.074 . . . . 0.0 109.796 179.479 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.523 HG22 ' CG2' ' A' ' 17' ' ' VAL . 8.6 m -130.13 151.16 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.035 -1.041 . . . . 0.0 110.46 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.574 HD21 ' CD1' ' A' ' 16' ' ' TRP . 19.9 tp -149.71 114.5 5.34 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.275 -0.89 . . . . 0.0 110.388 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.527 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 21.4 t30 -79.72 124.63 28.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.269 -0.894 . . . . 0.0 110.306 179.749 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.509 ' O ' ' CG2' ' A' ' 4' ' ' ILE . . . 155.23 67.99 0.01 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.468 ' CG2' ' HA ' ' A' ' 124' ' ' GLN . 43.0 t -130.44 171.89 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.216 -1.167 . . . . 0.0 110.106 179.844 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' A' ' 112' ' ' TYR . . . -145.04 87.47 1.83 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.102 -0.999 . . . . 0.0 110.718 -179.76 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.581 HG13 ' CD2' ' A' ' 112' ' ' TYR . 36.7 mm -120.51 159.55 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.226 -0.921 . . . . 0.0 109.893 179.418 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.521 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 0.4 OUTLIER -147.68 121.54 9.34 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.161 -0.962 . . . . 0.0 110.437 -179.868 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.521 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 9.4 pt-20 37.57 -151.65 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.654 -0.654 . . . . 0.0 110.797 179.705 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.463 ' N ' ' HG3' ' A' ' 56' ' ' GLU . . . -81.15 94.41 1.59 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.574 HG21 ' CE2' ' A' ' 60' ' ' TYR . 1.2 m -124.74 174.29 7.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.257 -1.143 . . . . 0.0 109.824 179.968 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.572 ' N ' ' CG2' ' A' ' 58' ' ' THR . 0.6 OUTLIER -89.63 151.66 21.78 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.269 -0.894 . . . . 0.0 110.137 -179.969 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.594 ' CD2' ' CB ' ' A' ' 108' ' ' ALA . 54.6 m-85 -159.29 174.4 14.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.223 -0.923 . . . . 0.0 110.575 -179.987 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 94.8 m -149.98 121.23 7.82 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.439 -0.788 . . . . 0.0 109.685 179.69 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 18.7 tp -89.56 120.44 30.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.208 -0.932 . . . . 0.0 110.279 -179.691 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.516 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 3.3 ttt180 -121.03 138.24 54.26 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.326 -0.859 . . . . 0.0 109.803 179.673 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.54 ' CZ ' HG22 ' A' ' 102' ' ' VAL . 0.6 OUTLIER -178.52 142.2 0.23 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.228 -0.92 . . . . 0.0 110.033 179.922 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 5.8 m -119.37 94.36 4.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.225 -0.922 . . . . 0.0 110.06 -179.839 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.53 ' HB2' ' CD2' ' A' ' 95' ' ' LEU . . . -95.91 155.95 16.54 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.345 -0.847 . . . . 0.0 110.153 -179.829 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.462 HG22 ' O ' ' A' ' 98' ' ' GLU . 44.3 m -148.38 117.59 6.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.261 -0.9 . . . . 0.0 110.27 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -102.87 129.8 49.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.297 -0.877 . . . . 0.0 109.942 179.783 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 82.7 p -65.5 -9.05 22.75 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.175 -0.953 . . . . 0.0 110.092 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.531 HG22 ' CB ' ' A' ' 137' ' ' TRP . 7.4 t -116.97 19.9 14.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.871 . . . . 0.0 110.166 -179.912 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.466 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 4.7 t70 43.05 92.35 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.3 -0.875 . . . . 0.0 109.851 -179.754 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.524 ' CG1' HD11 ' A' ' 95' ' ' LEU . 12.1 p -131.36 161.31 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -0.918 . . . . 0.0 110.953 -179.337 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.517 ' N ' HG21 ' A' ' 72' ' ' VAL . 23.2 m -128.68 89.11 2.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.37 -0.831 . . . . 0.0 109.219 179.248 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.582 ' HA ' ' CD1' ' A' ' 132' ' ' PHE . 17.4 m -89.74 -140.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.911 . . . . 0.0 110.655 -179.199 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.511 ' N ' HG22 ' A' ' 74' ' ' VAL . 19.3 mtm-85 -133.1 146.55 51.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.902 . . . . 0.0 110.597 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.531 ' N ' ' HD3' ' A' ' 93' ' ' PRO . . . -150.02 152.21 34.51 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.348 -0.845 . . . . 0.0 109.712 179.731 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.572 ' CD1' ' N ' ' A' ' 78' ' ' VAL . 3.7 pp 179.49 -146.97 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.241 -0.912 . . . . 0.0 110.218 -179.587 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.572 ' N ' ' CD1' ' A' ' 77' ' ' LEU . 3.5 t -148.22 177.59 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.921 . . . . 0.0 109.544 179.904 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.512 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . -179.49 -175.87 46.67 Favored Glycine 0 N--CA 1.489 2.204 0 C-N-CA 119.384 -1.389 . . . . 0.0 110.14 179.988 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.469 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 3.0 tt0 -93.98 -153.76 0.38 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.422 -1.046 . . . . 0.0 110.107 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.472 ' HB2' ' HG2' ' A' ' 122' ' ' GLU . 9.7 m120 -154.44 72.46 0.87 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.361 -0.837 . . . . 0.0 109.702 179.894 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.478 ' C ' ' CE1' ' A' ' 85' ' ' TYR . . . 131.57 144.08 5.33 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -179.688 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.628 ' N ' ' CE1' ' A' ' 85' ' ' TYR . . . -41.93 152.27 0.31 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.28 -1.13 . . . . 0.0 110.321 -179.868 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.472 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.6 Cg_endo -80.04 12.57 22.55 Favored 'Cis proline' 0 C--N 1.312 -1.343 0 C-N-CA 121.651 -2.229 . . . . 0.0 110.896 -0.067 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.628 ' CE1' ' N ' ' A' ' 83' ' ' ALA . 29.1 m-85 62.53 146.8 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.139 -0.975 . . . . 0.0 110.233 -179.816 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -172.5 128.13 1.5 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.463 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 0.8 OUTLIER -105.55 153.76 21.31 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.236 -1.155 . . . . 0.0 110.208 179.984 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.47 ' HB ' ' HA ' ' A' ' 108' ' ' ALA . 15.5 m -124.98 -24.69 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.302 -0.873 . . . . 0.0 110.331 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.572 HD12 ' CZ ' ' A' ' 106' ' ' PHE . 3.8 mp -105.72 145.29 31.29 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.17 -0.957 . . . . 0.0 111.082 179.883 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -151.76 76.09 1.18 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.371 -0.831 . . . . 0.0 109.947 179.474 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 82.1 p -135.62 178.52 6.98 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.98 -1.075 . . . . 0.0 110.869 -179.504 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.97 117.8 32.04 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.435 -0.791 . . . . 0.0 110.079 179.941 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.531 ' HD3' ' N ' ' A' ' 76' ' ' ALA . 47.4 Cg_endo -73.74 105.56 2.03 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.93 1.49 . . . . 0.0 110.981 -179.697 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.53 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -77.83 151.32 33.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.156 -0.965 . . . . 0.0 109.428 179.171 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.579 ' CD1' ' CD2' ' A' ' 139' ' ' LEU . 64.2 mt -138.99 162.83 33.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.994 -1.067 . . . . 0.0 110.817 -179.548 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -161.9 -178.93 6.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.455 -0.778 . . . . 0.0 109.907 179.894 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.7 p -64.64 -30.79 71.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.272 -0.892 . . . . 0.0 110.126 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.527 ' CB ' ' HD2' ' A' ' 99' ' ' PRO . 0.1 OUTLIER -90.1 179.94 1.38 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.333 -0.854 . . . . 0.0 109.978 179.822 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.527 ' HD2' ' CB ' ' A' ' 98' ' ' GLU . 44.6 Cg_endo -71.88 132.07 19.37 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.925 1.487 . . . . 0.0 110.313 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.53 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.84 92.43 3.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.234 -0.916 . . . . 0.0 110.402 -179.841 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 1.5 tt0 -76.99 156.76 31.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.296 -0.878 . . . . 0.0 110.113 179.861 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.54 HG22 ' CZ ' ' A' ' 64' ' ' TYR . 52.5 t -138.71 134.15 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.205 -0.935 . . . . 0.0 110.219 -179.992 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 21.6 m -150.06 113.46 4.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.319 -0.863 . . . . 0.0 110.181 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -146.48 138.3 24.75 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.295 -0.878 . . . . 0.0 110.244 -179.949 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.03 159.28 16.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.27 -0.894 . . . . 0.0 110.085 179.952 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.572 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 48.8 p90 -167.77 151.27 6.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.23 -0.919 . . . . 0.0 110.279 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 58' ' ' THR . 3.1 m -89.89 90.71 8.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.209 -0.932 . . . . 0.0 110.012 179.787 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.594 ' CB ' ' CD2' ' A' ' 60' ' ' TYR . . . -52.41 116.26 2.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.244 -0.91 . . . . 0.0 110.314 -179.828 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 55.4 p -99.4 54.83 0.97 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.262 -0.899 . . . . 0.0 110.082 179.836 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -165.06 -160.15 0.47 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.261 -0.9 . . . . 0.0 110.37 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.455 HG23 ' HD3' ' A' ' 113' ' ' PRO . 85.1 m -144.0 116.69 8.7 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.267 -0.896 . . . . 0.0 110.264 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.581 ' CD2' HG13 ' A' ' 54' ' ' ILE . 20.4 m-30 -114.49 73.43 2.8 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.251 -0.905 . . . . 0.0 110.043 179.92 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.462 ' O ' ' HB2' ' A' ' 122' ' ' GLU . 43.9 Cg_endo -70.47 -163.18 0.11 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.998 1.525 . . . . 0.0 110.465 -179.962 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.669 0 O-C-N 121.237 -0.914 . . . . 0.0 110.223 -179.873 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.519 ' N ' ' OE1' ' A' ' 122' ' ' GLU . 22.5 pm0 . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 121.215 0.531 . . . . 0.0 110.264 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.512 ' HA3' ' CB ' ' A' ' 112' ' ' TYR . . . -147.45 157.84 27.52 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.527 ' CB ' ' HA ' ' A' ' 50' ' ' ASN . 2.4 pt20 -150.43 -157.55 0.83 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.276 -1.132 . . . . 0.0 110.6 -179.58 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.525 ' CD1' HD11 ' A' ' 4' ' ' ILE . 12.4 mt -118.45 142.92 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.464 -0.773 . . . . 0.0 109.068 179.382 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -121.32 123.56 42.46 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.258 -0.901 . . . . 0.0 111.032 -179.351 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.478 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 4.9 m-85 -118.59 109.38 16.09 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 178.446 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . 0.476 ' O ' ' CE2' ' A' ' 132' ' ' PHE . 1.3 mm100 -88.65 102.53 15.06 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.231 -0.918 . . . . 0.0 111.901 -177.497 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.479 ' HG ' ' HA2' ' A' ' 46' ' ' GLY . 13.9 mt -107.42 45.06 1.02 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 178.289 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -95.57 78.1 0.82 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.453 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.576 ' O ' ' CG ' ' A' ' 132' ' ' PHE . . . 78.61 110.3 0.2 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.747 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.582 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 26.0 m-85 -161.57 -49.02 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.22 -1.165 . . . . 0.0 110.355 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.586 ' HB3' ' CE3' ' A' ' 137' ' ' TRP . 1.0 OUTLIER -89.43 -140.13 0.14 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.046 -1.034 . . . . 0.0 110.1 179.888 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -133.95 -83.37 0.45 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.17 -0.956 . . . . 0.0 110.364 -179.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.434 ' O ' ' C ' ' A' ' 136' ' ' ALA . 1.1 m-20 -81.53 162.87 23.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.192 -0.942 . . . . 0.0 110.283 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.51 ' N ' ' HA ' ' A' ' 38' ' ' ALA . . . -41.21 123.35 2.04 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.333 -0.854 . . . . 0.0 110.263 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.588 ' CZ2' HG12 ' A' ' 36' ' ' VAL . 11.4 p90 -137.22 -173.15 3.38 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.174 -0.953 . . . . 0.0 110.619 -179.93 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.471 ' CG2' ' N ' ' A' ' 139' ' ' LEU . 0.8 OUTLIER -151.07 174.19 13.48 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.432 -0.792 . . . . 0.0 110.073 -178.024 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.579 ' CD2' ' CD1' ' A' ' 95' ' ' LEU . 1.7 mp -139.82 119.38 13.12 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.153 -0.967 . . . . 0.0 112.059 -179.679 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' CYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 0.8 OUTLIER -103.27 108.37 19.56 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.618 -0.676 . . . . 0.0 110.878 178.132 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.521 ' O ' ' CB ' ' A' ' 142' ' ' ASP . 1.4 mt -94.55 -178.93 4.72 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.285 -0.885 . . . . 0.0 108.792 178.513 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.54 ' CA ' ' HA ' ' A' ' 8' ' ' THR . 0.4 OUTLIER 168.29 55.38 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.063 -1.023 . . . . 0.0 110.98 -179.963 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.524 ' HB2' ' O ' ' A' ' 142' ' ' ASP . 10.9 t70 172.91 46.81 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.469 -0.769 . . . . 0.0 109.132 179.56 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.552 HG22 ' CZ ' ' A' ' 9' ' ' PHE . 1.3 t -91.71 112.93 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.16 -0.962 . . . . 0.0 110.646 -179.043 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -149.43 147.17 27.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.488 -0.758 . . . . 0.0 110.041 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.424 ' CD2' HD13 ' A' ' 54' ' ' ILE . 10.8 tp -141.49 125.2 16.9 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.388 -0.82 . . . . 0.0 110.237 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.471 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -133.81 174.33 10.57 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.197 -0.94 . . . . 0.0 110.207 179.977 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 57.5 p . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.207 -0.933 . . . . 0.0 110.32 -179.989 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.457 ' HB2' ' O ' ' A' ' 51' ' ' GLY . 51.1 Cg_endo . . . . . 0 N--CA 1.481 0.755 0 N-CA-C 111.115 -0.379 . . . . 0.0 111.115 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.451 ' CG1' ' N ' ' A' ' 5' ' ' GLY . 6.1 pt -138.78 -37.01 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.997 -1.065 . . . . 0.0 110.118 179.906 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.451 ' N ' ' CG1' ' A' ' 4' ' ' ILE . . . 161.36 126.59 0.83 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -73.52 81.99 1.48 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.258 -1.142 . . . . 0.0 110.192 179.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 144' ' ' VAL . . . 114.59 -123.37 5.99 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.524 ' CG2' ' O ' ' A' ' 142' ' ' ASP . 15.6 p -80.5 179.04 7.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.29 -1.123 . . . . 0.0 110.136 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.567 ' CE2' ' HB2' ' A' ' 32' ' ' LEU . 23.0 m-85 -68.57 -35.78 77.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.306 -0.871 . . . . 0.0 109.579 179.735 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.551 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 23.2 t0 38.09 42.74 0.5 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.645 -0.659 . . . . 0.0 110.705 179.308 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.551 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 4.3 t0 161.9 71.07 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 121.508 0.671 . . . . 0.0 109.545 179.871 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 11' ' ' ASP . . . 43.95 -168.5 0.02 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.485 ' O ' ' C ' ' A' ' 14' ' ' GLU . 51.1 Cg_endo -74.43 81.47 2.05 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.121 1.59 . . . . 0.0 110.337 179.947 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.485 ' C ' ' O ' ' A' ' 13' ' ' PRO . 0.2 OUTLIER -31.77 -67.51 0.1 Allowed 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.292 0.568 . . . . 0.0 111.183 -179.614 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.5 ' C ' ' CD1' ' A' ' 49' ' ' LEU . . . -145.75 10.24 1.64 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.579 ' CH2' HG23 ' A' ' 125' ' ' ILE . 66.4 m95 -78.06 88.95 4.18 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.149 -1.207 . . . . 0.0 110.257 -179.863 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.592 ' CG2' ' CG2' ' A' ' 48' ' ' VAL . 0.8 OUTLIER -85.18 144.88 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.093 -1.004 . . . . 0.0 109.44 179.802 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.528 ' CB ' HG13 ' A' ' 34' ' ' VAL . . . -128.64 128.81 44.88 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.025 -1.047 . . . . 0.0 109.93 179.554 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.486 ' O ' HG11 ' A' ' 45' ' ' VAL . 23.4 p90 -113.24 145.49 40.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.451 -0.781 . . . . 0.0 110.397 -179.302 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.499 ' C ' ' CG2' ' A' ' 21' ' ' THR . . . 156.77 -91.03 0.12 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.528 ' CG2' ' HG3' ' A' ' 37' ' ' PRO . 5.5 p -151.96 18.92 0.68 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.254 -1.145 . . . . 0.0 110.051 179.675 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.468 ' HB3' ' O ' ' A' ' 35' ' ' ALA . 2.0 p30 -102.76 147.72 26.5 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.28 -0.887 . . . . 0.0 110.197 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.68 -138.13 0.15 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.801 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.417 ' O ' ' C ' ' A' ' 25' ' ' LEU . 46.2 Cg_endo -73.62 133.46 18.82 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.044 1.549 . . . . 0.0 110.346 179.865 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.507 ' CD1' ' O ' ' A' ' 16' ' ' TRP . 7.8 mt -42.53 113.52 0.47 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.254 -0.904 . . . . 0.0 110.083 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.472 ' HB3' ' HB2' ' A' ' 33' ' ' CYS . 29.5 t70 -66.4 101.37 0.74 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.23 -0.919 . . . . 0.0 110.188 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.473 ' OG1' ' HD3' ' A' ' 13' ' ' PRO . 1.5 p -119.23 -81.32 0.63 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.296 -0.877 . . . . 0.0 109.955 -179.911 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.456 ' O ' ' HB ' ' A' ' 29' ' ' THR . 22.5 p 42.16 36.23 0.68 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.254 -0.903 . . . . 0.0 110.442 179.811 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.456 ' HB ' ' O ' ' A' ' 28' ' ' SER . 12.2 t -177.97 -31.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.3 -0.875 . . . . 0.0 110.194 179.914 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.444 ' O ' ' HB2' ' A' ' 9' ' ' PHE . . . 126.35 2.19 7.04 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.946 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.47 ' HA ' ' HB3' ' A' ' 142' ' ' ASP . . . -111.29 109.83 20.03 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.212 -1.169 . . . . 0.0 110.24 179.992 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.567 ' HB2' ' CE2' ' A' ' 9' ' ' PHE . 1.0 OUTLIER -68.51 102.37 1.44 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.281 -0.887 . . . . 0.0 109.966 179.943 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.472 ' HB2' ' HB3' ' A' ' 26' ' ' ASP . 34.2 m -108.19 103.61 12.84 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.319 -0.863 . . . . 0.0 110.514 -179.687 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.528 HG13 ' CB ' ' A' ' 18' ' ' ALA . 19.5 m -89.71 155.51 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.262 -0.899 . . . . 0.0 109.762 179.621 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.484 ' HA ' ' OG1' ' A' ' 138' ' ' THR . . . -103.87 101.26 11.06 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.249 -0.907 . . . . 0.0 111.346 -179.111 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.574 HG12 ' CZ2' ' A' ' 137' ' ' TRP . 91.4 t -84.41 123.07 75.25 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.168 -0.958 . . . . 0.0 109.009 178.794 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.528 ' HG3' ' CG2' ' A' ' 21' ' ' THR . 43.2 Cg_endo -67.85 147.33 74.62 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.87 1.458 . . . . 0.0 111.347 -178.866 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.517 ' HA ' ' CA ' ' A' ' 136' ' ' ALA . . . -47.37 116.47 1.43 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.312 -0.868 . . . . 0.0 109.817 179.659 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.1 71.91 1.16 Allowed Glycine 0 N--CA 1.486 1.99 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 -179.51 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.579 ' HB3' ' CH2' ' A' ' 137' ' ' TRP . 0.4 OUTLIER -84.89 43.96 1.03 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.324 -1.103 . . . . 0.0 109.807 -179.987 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.526 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . -88.5 -139.46 0.12 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.491 -0.755 . . . . 0.0 110.029 179.871 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.553 ' HG2' ' N ' ' A' ' 43' ' ' TYR . 0.0 OUTLIER 42.79 -140.98 0.14 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.543 -0.723 . . . . 0.0 110.346 -179.479 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.599 ' CD1' ' O ' ' A' ' 44' ' ' GLY . 8.3 p90 -28.96 -39.51 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.175 0 CA-C-O 121.143 0.497 . . . . 0.0 110.929 -179.136 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.599 ' O ' ' CD1' ' A' ' 43' ' ' TYR . . . 89.76 132.96 4.93 Favored Glycine 0 N--CA 1.493 2.441 0 C-N-CA 120.041 -1.076 . . . . 0.0 110.674 178.22 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.542 ' CG2' ' HB2' ' A' ' 40' ' ' SER . 2.6 t -89.85 179.52 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.364 -1.08 . . . . 0.0 108.908 179.238 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 128' ' ' GLN . . . 173.57 -177.58 45.86 Favored Glycine 0 N--CA 1.488 2.118 0 C-N-CA 119.024 -1.56 . . . . 0.0 110.668 -179.886 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.531 ' CG1' ' O ' ' A' ' 17' ' ' VAL . 21.6 t -150.65 132.43 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.737 -0.861 . . . . 0.0 108.768 179.779 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.592 ' CG2' ' CG2' ' A' ' 17' ' ' VAL . 31.1 m -119.66 131.7 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.976 -1.077 . . . . 0.0 110.69 -179.383 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.574 HD21 ' CZ2' ' A' ' 16' ' ' TRP . 30.0 tp -124.06 90.76 3.32 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.439 -0.788 . . . . 0.0 110.353 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.535 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 22.0 p30 -75.2 145.84 41.71 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.271 -0.893 . . . . 0.0 110.237 179.881 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 3' ' ' PRO . . . 122.19 63.48 0.22 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.969 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.49 ' CG1' ' N ' ' A' ' 53' ' ' ALA . 53.5 t -121.96 171.9 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.235 -1.156 . . . . 0.0 109.968 179.807 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.49 ' N ' ' CG1' ' A' ' 52' ' ' VAL . . . -141.88 77.91 1.61 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.072 -1.017 . . . . 0.0 110.804 -179.742 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.593 ' CD1' ' CE1' ' A' ' 60' ' ' TYR . 35.6 mm -112.34 159.24 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.177 -0.952 . . . . 0.0 109.622 179.343 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.527 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 0.6 OUTLIER -153.48 132.25 12.34 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.04 -1.037 . . . . 0.0 110.836 -179.634 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 19.4 pt-20 37.72 -155.49 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.67 -0.644 . . . . 0.0 110.994 179.488 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 109' ' ' SER . . . -85.95 80.92 1.75 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.776 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.559 ' CG2' ' N ' ' A' ' 59' ' ' THR . 1.2 m -105.72 173.88 6.12 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.268 -1.137 . . . . 0.0 109.73 179.76 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.559 ' N ' ' CG2' ' A' ' 58' ' ' THR . 0.6 OUTLIER -89.7 154.78 19.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.144 -0.972 . . . . 0.0 110.411 -179.731 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.593 ' CE1' ' CD1' ' A' ' 54' ' ' ILE . 55.8 m-85 -159.87 178.5 9.69 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.32 -0.862 . . . . 0.0 110.3 179.905 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 104' ' ' GLU . 32.8 m -150.13 123.61 9.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.337 -0.852 . . . . 0.0 109.925 179.8 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.6 tp -89.44 118.63 29.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.186 -0.946 . . . . 0.0 110.067 -179.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.494 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 2.1 tpt180 -127.97 114.47 17.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.31 -0.869 . . . . 0.0 110.204 -179.761 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.64 ' CZ ' ' CG2' ' A' ' 102' ' ' VAL . 0.4 OUTLIER -157.99 141.19 15.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.155 -0.966 . . . . 0.0 110.037 179.591 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.516 ' CG2' ' HG2' ' A' ' 101' ' ' GLN . 18.7 m -119.42 98.91 6.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.916 . . . . 0.0 109.976 -179.834 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.522 ' HB1' ' CD2' ' A' ' 141' ' ' LEU . . . -103.51 152.35 21.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.335 -0.853 . . . . 0.0 110.368 -179.669 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.457 ' OG1' ' HA ' ' A' ' 99' ' ' PRO . 98.1 m -150.2 108.32 3.74 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.235 -0.915 . . . . 0.0 110.289 179.922 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -92.84 136.05 33.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.238 -0.914 . . . . 0.0 109.975 179.836 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 68' ' ' ALA . 12.2 t -44.93 -26.14 0.39 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.082 -1.011 . . . . 0.0 109.343 179.57 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.529 ' CG2' ' HB2' ' A' ' 137' ' ' TRP . 3.2 t -113.71 -179.69 3.71 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.527 -0.733 . . . . 0.0 109.806 179.708 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.453 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 37.5 t0 -94.4 69.48 3.63 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.16 -0.962 . . . . 0.0 109.545 179.253 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.582 ' CG2' ' CB ' ' A' ' 133' ' ' SER . 4.7 p -92.1 147.34 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.259 -0.901 . . . . 0.0 111.045 -179.278 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.5 m -128.6 89.45 2.89 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.078 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.581 ' HA ' ' CD1' ' A' ' 132' ' ' PHE . 10.7 m -89.64 -151.2 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.228 -0.92 . . . . 0.0 110.49 -179.116 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.465 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 34.9 mtm-85 -128.05 137.6 52.24 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.206 -0.934 . . . . 0.0 110.761 -179.295 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.521 ' CB ' ' HG3' ' A' ' 93' ' ' PRO . . . -139.28 155.38 47.77 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.356 -0.84 . . . . 0.0 109.881 179.455 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.489 ' C ' ' CD1' ' A' ' 77' ' ' LEU . 1.3 pp 175.23 -157.4 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.327 -0.858 . . . . 0.0 109.982 -179.601 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.536 HG13 ' CE2' ' A' ' 112' ' ' TYR . 4.9 t -147.85 168.54 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.204 -0.935 . . . . 0.0 109.41 179.762 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.493 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . -177.8 176.78 48.2 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.339 -1.41 . . . . 0.0 109.906 -179.882 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.486 ' NE2' ' C ' ' A' ' 81' ' ' ASN . 13.6 tp60 -107.31 135.43 48.83 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.31 -1.112 . . . . 0.0 110.534 179.931 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.538 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 2.4 m120 -123.26 96.77 5.12 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 122.072 0.939 . . . . 0.0 108.894 178.644 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 83' ' ' ALA . . . 132.9 34.21 0.35 Allowed Glycine 0 N--CA 1.484 1.861 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.214 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.545 ' HA ' ' CD2' ' A' ' 85' ' ' TYR . . . 60.15 143.94 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.264 -1.139 . . . . 0.0 110.235 -179.861 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.466 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.5 Cg_endo -82.22 18.45 17.86 Favored 'Cis proline' 0 C--N 1.313 -1.303 0 C-N-CA 121.868 -2.138 . . . . 0.0 110.869 -0.139 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.545 ' CD2' ' HA ' ' A' ' 83' ' ' ALA . 94.1 m-85 57.28 170.26 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.152 -0.967 . . . . 0.0 110.439 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 136.6 117.93 1.7 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.425 HG23 ' O ' ' A' ' 78' ' ' VAL . 0.8 OUTLIER -97.78 145.69 26.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.195 -1.179 . . . . 0.0 110.185 179.863 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.46 ' HB ' ' HA ' ' A' ' 108' ' ' ALA . 29.4 m -123.98 -17.45 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.265 -0.897 . . . . 0.0 110.359 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.576 HD12 ' CZ ' ' A' ' 106' ' ' PHE . 4.0 mp -108.5 136.96 47.25 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.189 -0.945 . . . . 0.0 111.009 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -150.97 82.2 1.33 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.457 -0.777 . . . . 0.0 109.836 179.601 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.2 p -140.06 178.5 7.23 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.033 -1.042 . . . . 0.0 110.741 -179.598 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.7 m -119.81 111.97 35.51 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.456 -0.777 . . . . 0.0 109.863 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.532 ' HG2' ' CG2' ' A' ' 74' ' ' VAL . 43.6 Cg_endo -70.1 99.57 0.79 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.957 1.503 . . . . 0.0 110.866 -179.764 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.518 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -76.23 153.21 36.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 0.0 109.687 179.504 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.523 ' CD1' ' HG ' ' A' ' 139' ' ' LEU . 72.7 mt -142.54 168.83 18.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.118 -0.989 . . . . 0.0 110.492 -179.751 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 70' ' ' THR . 0.3 OUTLIER -177.22 -178.82 0.82 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.411 -0.805 . . . . 0.0 110.038 -179.966 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.7 -8.23 26.38 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.228 -0.92 . . . . 0.0 110.148 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.447 ' O ' HG22 ' A' ' 67' ' ' THR . 11.3 mt-10 -106.17 168.22 8.51 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.907 . . . . 0.0 110.097 179.87 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.457 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 46.4 Cg_endo -72.83 130.26 15.46 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.046 1.55 . . . . 0.0 110.363 179.993 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.518 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 3.1 ttm-85 -119.91 92.42 3.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.176 -0.953 . . . . 0.0 110.251 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.516 ' HG2' ' CG2' ' A' ' 65' ' ' THR . 1.7 mt-30 -75.11 153.23 38.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.33 -0.856 . . . . 0.0 109.975 179.845 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.64 ' CG2' ' CZ ' ' A' ' 64' ' ' TYR . 39.4 t -130.35 133.56 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.18 -0.95 . . . . 0.0 110.387 -179.945 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.526 ' O ' ' CG ' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -150.35 124.35 9.33 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.356 -0.84 . . . . 0.0 110.065 -179.987 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.526 ' CG ' ' O ' ' A' ' 103' ' ' THR . 35.3 mt-10 -157.56 154.53 28.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.256 -0.902 . . . . 0.0 110.315 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.2 m -117.39 114.67 23.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.261 -0.899 . . . . 0.0 110.042 179.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.576 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 35.4 p90 -127.27 155.42 43.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.195 -0.94 . . . . 0.0 110.342 -179.782 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.413 ' O ' ' C ' ' A' ' 108' ' ' ALA . 21.0 m -93.12 89.04 6.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.296 -0.878 . . . . 0.0 109.977 179.7 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.589 ' CB ' ' CD2' ' A' ' 60' ' ' TYR . . . -42.61 100.06 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.245 -0.909 . . . . 0.0 110.346 -179.855 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.463 ' HA ' ' HA2' ' A' ' 57' ' ' GLY . 43.2 p -88.81 51.87 2.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.262 -0.899 . . . . 0.0 110.144 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.434 ' HB1' HG12 ' A' ' 88' ' ' VAL . . . -159.18 -152.81 0.33 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.264 -0.898 . . . . 0.0 110.301 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.452 HG22 ' HA ' ' A' ' 55' ' ' GLU . 25.1 m -153.5 119.07 5.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.886 . . . . 0.0 110.204 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.575 ' CD2' HG13 ' A' ' 54' ' ' ILE . 17.8 m-30 -113.95 89.7 17.28 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.303 -0.873 . . . . 0.0 109.942 179.829 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.473 ' O ' ' HB2' ' A' ' 122' ' ' GLU . 44.9 Cg_endo -71.84 -158.69 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.028 1.541 . . . . 0.0 110.406 -179.928 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.422 ' HA ' ' CD ' ' A' ' 122' ' ' GLU . . . . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.221 -0.925 . . . . 0.0 110.244 -179.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.538 ' O ' ' HB2' ' A' ' 81' ' ' ASN . 6.6 pt-20 . . . . . 0 N--CA 1.497 1.907 0 CA-C-O 121.108 0.48 . . . . 0.0 111.133 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -106.01 158.94 15.4 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 -179.429 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.535 ' CB ' ' HA ' ' A' ' 50' ' ' ASN . 17.1 pt20 -150.63 -151.76 0.41 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.366 -1.079 . . . . 0.0 110.621 -179.806 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.579 HG23 ' CH2' ' A' ' 16' ' ' TRP . 23.9 mt -118.56 146.51 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.616 -0.677 . . . . 0.0 109.425 179.665 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.472 ' CB ' HD13 ' A' ' 77' ' ' LEU . . . -116.15 114.87 25.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.336 -0.853 . . . . 0.0 111.744 -178.879 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.504 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 4.0 m-85 -119.81 75.69 1.1 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.247 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . 0.454 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 12.9 mt-30 -88.42 123.27 32.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.196 -0.94 . . . . 0.0 111.902 -177.754 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.514 ' CD2' HG23 ' A' ' 74' ' ' VAL . 3.6 mt -107.76 51.77 0.73 Allowed 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.746 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -96.1 130.75 10.38 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.627 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.577 ' O ' ' CD1' ' A' ' 132' ' ' PHE . . . 51.14 93.81 0.01 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.581 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 9.5 m-85 -158.86 -78.23 0.07 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.281 -1.129 . . . . 0.0 110.419 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.591 ' HB3' ' CE3' ' A' ' 137' ' ' TRP . 1.3 t -89.66 168.39 12.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.096 -1.003 . . . . 0.0 110.339 -179.812 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -98.26 -91.56 0.26 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.274 -0.892 . . . . 0.0 110.316 -179.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -46.65 158.05 0.13 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.081 -1.012 . . . . 0.0 110.35 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.517 ' CA ' ' HA ' ' A' ' 38' ' ' ALA . . . -54.48 128.66 32.93 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.313 -0.867 . . . . 0.0 110.333 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.591 ' CE3' ' HB3' ' A' ' 133' ' ' SER . 8.9 p90 -135.24 -163.35 1.37 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.306 -0.871 . . . . 0.0 110.009 179.674 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.589 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 0.8 OUTLIER -160.95 176.5 11.34 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.195 -1.002 . . . . 0.0 110.696 -178.382 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.523 ' HG ' ' CD1' ' A' ' 95' ' ' LEU . 2.1 mp -133.52 126.04 30.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.464 -0.773 . . . . 0.0 109.605 179.172 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 140' ' ' CYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 33.4 m -121.94 98.77 6.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.032 -1.043 . . . . 0.0 110.91 -179.536 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.522 ' CD2' ' HB1' ' A' ' 66' ' ' ALA . 2.2 mt -89.8 -179.91 5.85 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -0.927 . . . . 0.0 109.318 179.067 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.524 ' O ' ' CG2' ' A' ' 8' ' ' THR . 2.7 p30 168.03 41.08 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.289 -0.882 . . . . 0.0 110.104 179.908 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.477 ' O ' ' HA ' ' A' ' 64' ' ' TYR . 0.3 OUTLIER -174.98 52.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.289 -0.882 . . . . 0.0 109.659 -179.877 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.561 HG22 ' CE1' ' A' ' 9' ' ' PHE . 1.4 t -89.2 121.27 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.349 -0.845 . . . . 0.0 109.917 -179.44 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -144.41 140.87 29.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.329 -0.857 . . . . 0.0 110.293 -179.631 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 13.6 tp -148.08 123.82 10.54 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.376 -0.828 . . . . 0.0 110.072 179.839 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.468 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 7.3 t0 -136.15 -177.31 4.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.179 -0.951 . . . . 0.0 110.295 -179.893 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.3 p . . . . . 0 N--CA 1.492 1.666 0 O-C-N 121.253 -0.904 . . . . 0.0 110.129 179.958 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo . . . . . 0 N--CA 1.479 0.675 0 N-CA-C 110.115 -0.763 . . . . 0.0 110.115 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.489 ' CG2' ' O ' ' A' ' 51' ' ' GLY . 9.1 pt -95.51 19.49 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.278 -0.889 . . . . 0.0 110.097 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' A' ' 7' ' ' GLY . . . 79.94 70.39 1.33 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.965 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.427 ' HA ' ' HB3' ' A' ' 145' ' ' ALA . 82.6 mt-10 -42.42 94.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.31 -1.112 . . . . 0.0 110.198 -179.945 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 5' ' ' GLY . . . 173.99 -159.1 28.36 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.987 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.521 ' CG2' ' O ' ' A' ' 142' ' ' ASP . 11.9 p -98.34 -154.91 0.47 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.367 -1.078 . . . . 0.0 110.268 -179.851 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.523 ' CE1' ' CD1' ' A' ' 16' ' ' TRP . 64.6 m-85 -120.56 44.21 2.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.305 -0.872 . . . . 0.0 110.176 179.959 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.559 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 49.5 t0 -97.84 61.7 1.57 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.234 -0.916 . . . . 0.0 110.126 -179.973 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.559 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 2.5 t0 161.83 -23.72 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.745 -0.597 . . . . 0.0 109.652 -179.973 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 176.21 133.98 1.87 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.505 ' O ' ' HB3' ' A' ' 14' ' ' GLU . 48.9 Cg_endo -78.02 6.15 4.83 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.906 1.477 . . . . 0.0 110.533 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.505 ' HB3' ' O ' ' A' ' 13' ' ' PRO . 5.6 tp10 60.66 -89.03 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.356 -0.84 . . . . 0.0 110.386 -179.793 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.484 ' C ' ' CD1' ' A' ' 49' ' ' LEU . . . -148.09 25.44 1.43 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -179.859 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.568 ' CD1' HD23 ' A' ' 49' ' ' LEU . 57.1 m95 -72.12 86.39 1.05 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.166 -1.197 . . . . 0.0 110.354 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.589 ' CG2' ' CG2' ' A' ' 48' ' ' VAL . 1.1 m -87.42 153.32 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.205 -0.934 . . . . 0.0 109.92 179.942 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . . . -136.84 133.63 36.06 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.268 -0.895 . . . . 0.0 109.456 179.437 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.572 ' CZ ' ' O ' ' A' ' 46' ' ' GLY . 6.1 p90 -120.38 161.11 21.74 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.283 -0.886 . . . . 0.0 111.122 -178.635 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.573 ' HA2' ' CE1' ' A' ' 43' ' ' TYR . . . 72.96 49.15 17.82 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.88 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.53 HG21 ' CG1' ' A' ' 45' ' ' VAL . 11.5 p -148.12 -153.52 0.5 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.254 -1.145 . . . . 0.0 110.404 -179.956 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -89.87 44.02 1.18 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.326 -0.859 . . . . 0.0 110.079 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.56 -144.28 16.29 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.889 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.99 -159.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.973 1.512 . . . . 0.0 110.367 179.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 17' ' ' VAL . 0.3 OUTLIER -111.51 -173.12 2.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.184 -0.947 . . . . 0.0 110.037 179.809 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -132.03 159.9 37.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.163 -0.96 . . . . 0.0 110.19 -179.88 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.464 HG23 ' HD3' ' A' ' 13' ' ' PRO . 0.7 OUTLIER -133.62 -34.57 1.03 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.254 -0.904 . . . . 0.0 110.258 -179.911 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.441 ' O ' ' OG1' ' A' ' 29' ' ' THR . 73.6 m 51.28 30.41 5.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.23 -0.919 . . . . 0.0 110.221 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.453 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 5.4 p 42.8 55.04 4.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.28 -0.888 . . . . 0.0 110.2 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.516 ' N ' ' HA ' ' A' ' 10' ' ' ASP . . . -169.55 -54.86 0.03 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.464 ' HB2' ' O ' ' A' ' 141' ' ' LEU . . . -149.88 149.91 31.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.211 -1.17 . . . . 0.0 110.32 -179.902 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.494 ' CD1' ' HB3' ' A' ' 13' ' ' PRO . 1.1 tp -79.97 103.15 9.66 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.243 -0.911 . . . . 0.0 109.822 179.739 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.441 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 23.2 m -109.6 105.85 15.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.212 -0.93 . . . . 0.0 110.778 -179.503 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.495 ' O ' ' OG1' ' A' ' 138' ' ' THR . 18.0 m -91.09 140.12 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.241 -0.912 . . . . 0.0 109.122 179.08 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.471 ' O ' ' HB ' ' A' ' 21' ' ' THR . . . -89.18 98.33 11.71 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.102 -0.999 . . . . 0.0 111.032 -179.052 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.664 ' CG1' ' CZ2' ' A' ' 137' ' ' TRP . 48.3 t -83.72 130.09 56.98 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.267 -0.896 . . . . 0.0 109.617 179.168 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 21' ' ' THR . 43.6 Cg_endo -70.73 -179.25 3.2 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.815 1.429 . . . . 0.0 110.538 -179.742 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.577 ' HA ' ' N ' ' A' ' 136' ' ' ALA . . . -42.79 166.67 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.25 -0.906 . . . . 0.0 110.137 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.595 ' O ' ' N ' ' A' ' 41' ' ' ALA . . . -35.68 108.12 0.05 OUTLIER Glycine 0 N--CA 1.495 2.62 0 N-CA-C 109.169 -1.573 . . . . 0.0 109.169 179.798 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.554 ' O ' ' CA ' ' A' ' 131' ' ' GLY . 0.4 OUTLIER -39.36 89.9 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.979 0.895 . . . . 0.0 110.263 -178.899 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.595 ' N ' ' O ' ' A' ' 39' ' ' GLY . . . -114.79 23.84 12.28 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 121.952 0.882 . . . . 0.0 109.673 -179.465 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.543 ' CG ' ' O ' ' A' ' 42' ' ' GLN . 0.9 OUTLIER 177.04 34.3 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.241 -179.891 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.573 ' CE1' ' HA2' ' A' ' 20' ' ' GLY . 0.1 OUTLIER -158.79 -28.19 0.07 Allowed 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 118.548 -1.261 . . . . 0.0 112.389 -177.806 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 43' ' ' TYR . . . 53.43 84.47 0.03 OUTLIER Glycine 0 N--CA 1.483 1.829 0 N-CA-C 105.285 -3.126 . . . . 0.0 105.285 -176.766 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.53 ' CG1' HG21 ' A' ' 21' ' ' THR . 3.0 t -86.61 143.08 12.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.301 -1.117 . . . . 0.0 109.665 -176.751 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.572 ' O ' ' CZ ' ' A' ' 19' ' ' TYR . . . -166.26 147.35 12.01 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.289 -1.434 . . . . 0.0 110.785 -179.058 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.519 ' CG1' ' O ' ' A' ' 17' ' ' VAL . 19.7 t -111.7 129.69 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.576 -0.955 . . . . 0.0 109.668 179.659 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.589 ' CG2' ' CG2' ' A' ' 17' ' ' VAL . 27.3 m -120.69 145.02 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.743 -1.223 . . . . 0.0 110.656 -179.624 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.568 HD23 ' CD1' ' A' ' 16' ' ' TRP . 15.9 tp -144.45 117.38 8.81 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.262 -0.899 . . . . 0.0 110.34 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.532 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 5.2 p-10 -90.44 148.19 22.94 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.208 -0.932 . . . . 0.0 110.49 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.489 ' O ' ' CG2' ' A' ' 4' ' ' ILE . . . 126.44 78.62 0.29 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.837 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.531 HG13 ' CG1' ' A' ' 54' ' ' ILE . 3.7 t -132.79 158.45 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.181 -1.188 . . . . 0.0 110.135 179.781 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -105.71 61.21 0.66 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.167 -0.958 . . . . 0.0 110.472 -179.885 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.571 HD11 ' CZ ' ' A' ' 60' ' ' TYR . 6.3 mm -123.63 151.42 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.194 -0.941 . . . . 0.0 109.846 179.731 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.514 ' HA ' ' CG2' ' A' ' 111' ' ' THR . 4.4 pt-20 -174.97 34.07 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.106 -0.996 . . . . 0.0 110.376 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.497 ' HB2' ' O ' ' A' ' 55' ' ' GLU . 1.3 tt0 179.88 -174.66 0.26 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.426 -0.796 . . . . 0.0 110.256 -179.797 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.486 ' HA2' ' O ' ' A' ' 108' ' ' ALA . . . -94.27 68.01 1.4 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 108.239 -1.944 . . . . 0.0 108.239 178.956 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.581 ' CG2' ' N ' ' A' ' 59' ' ' THR . 1.0 OUTLIER -109.02 176.17 5.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.503 -0.998 . . . . 0.0 110.367 -178.963 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.582 ' O ' ' CD2' ' A' ' 60' ' ' TYR . 0.4 OUTLIER -89.73 158.62 17.46 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.415 -0.803 . . . . 0.0 110.23 -179.941 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.585 ' CE2' ' HB2' ' A' ' 108' ' ' ALA . 68.2 m-85 -156.14 -176.75 6.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.443 -0.786 . . . . 0.0 109.834 179.906 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 26.6 m -150.11 113.42 4.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.196 -0.94 . . . . 0.0 110.187 179.889 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.518 HD23 ' CD2' ' A' ' 89' ' ' LEU . 18.0 tp -89.71 120.86 31.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 110.032 179.821 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.471 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 19.5 mtp-105 -128.4 130.73 48.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.282 -0.887 . . . . 0.0 110.099 179.961 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.541 ' CE2' ' HB ' ' A' ' 102' ' ' VAL . 8.7 p90 -165.48 152.77 10.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.262 -0.899 . . . . 0.0 109.923 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 25.6 m -119.67 93.95 4.24 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.097 -1.002 . . . . 0.0 109.968 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.509 ' CB ' HD23 ' A' ' 95' ' ' LEU . . . -96.33 154.54 17.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.274 -0.891 . . . . 0.0 110.939 -179.482 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 50.9 m -149.69 134.94 18.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.562 -0.711 . . . . 0.0 109.39 179.263 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.516 ' N ' ' HB3' ' A' ' 95' ' ' LEU . . . -120.86 133.94 55.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.064 -1.023 . . . . 0.0 110.282 -179.685 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 68' ' ' ALA . 11.6 t -43.83 -26.17 0.24 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.27 -0.894 . . . . 0.0 109.547 179.546 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.547 ' CG2' ' HB2' ' A' ' 137' ' ' TRP . 5.7 t -115.21 -167.15 1.2 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.436 -0.79 . . . . 0.0 109.824 179.703 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.43 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 34.4 t0 -102.93 47.0 0.9 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.274 -0.891 . . . . 0.0 109.371 179.125 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.526 ' CG1' HD13 ' A' ' 95' ' ' LEU . 1.9 p -63.46 171.53 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.429 -0.794 . . . . 0.0 110.824 -179.227 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.459 HG23 ' O ' ' A' ' 73' ' ' THR . 11.9 m -160.33 83.81 0.7 Allowed 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.67 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.57 ' HA ' ' CG ' ' A' ' 132' ' ' PHE . 2.4 m -89.9 -160.05 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.265 -0.897 . . . . 0.0 110.547 -178.616 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.439 ' HG2' ' OG ' ' A' ' 92' ' ' SER . 20.8 mtm-85 -121.28 112.97 19.27 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.256 -0.902 . . . . 0.0 110.328 -179.613 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.516 ' CB ' ' HD3' ' A' ' 93' ' ' PRO . . . -115.7 157.15 24.7 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.145 -0.972 . . . . 0.0 110.097 179.849 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.57 ' CD1' ' N ' ' A' ' 78' ' ' VAL . 3.8 pp 178.73 -147.3 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.409 -0.807 . . . . 0.0 109.851 -179.828 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.57 ' N ' ' CD1' ' A' ' 77' ' ' LEU . 3.1 t -151.92 172.57 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.115 -0.991 . . . . 0.0 109.563 179.773 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.48 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . 176.07 172.7 41.08 Favored Glycine 0 N--CA 1.49 2.276 0 C-N-CA 119.36 -1.4 . . . . 0.0 110.138 179.892 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.483 ' NE2' ' C ' ' A' ' 81' ' ' ASN . 15.1 tp60 -93.04 137.72 32.14 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.4 -1.059 . . . . 0.0 110.355 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.517 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 3.6 m120 -123.3 96.4 4.98 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.839 0.828 . . . . 0.0 109.02 178.943 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 83' ' ' ALA . . . 132.31 34.4 0.37 Allowed Glycine 0 N--CA 1.484 1.878 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.523 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.564 ' HA ' ' CD2' ' A' ' 85' ' ' TYR . . . 60.41 142.95 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.282 -1.128 . . . . 0.0 110.14 -179.86 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.474 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.3 Cg_endo -82.28 18.6 17.7 Favored 'Cis proline' 0 C--N 1.314 -1.255 0 C-N-CA 121.938 -2.109 . . . . 0.0 110.813 -0.159 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.564 ' CD2' ' HA ' ' A' ' 83' ' ' ALA . 75.7 m-85 58.91 170.02 0.06 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.153 -0.967 . . . . 0.0 110.342 -179.911 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 142.33 114.64 1.06 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.451 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 1.1 p -91.26 147.83 22.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.188 -1.183 . . . . 0.0 110.299 -179.963 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.559 HG22 ' CE1' ' A' ' 106' ' ' PHE . 15.6 m -123.12 -21.81 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.299 -0.876 . . . . 0.0 110.266 179.98 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.535 HD12 ' CE2' ' A' ' 106' ' ' PHE . 3.9 mp -104.94 146.76 28.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.239 -0.913 . . . . 0.0 110.7 179.735 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.517 ' O ' ' CG2' ' A' ' 91' ' ' THR . 8.9 t0 -151.03 89.04 1.49 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.324 -0.86 . . . . 0.0 110.142 179.727 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.517 ' CG2' ' O ' ' A' ' 90' ' ' ASP . 6.5 p -160.0 -178.98 7.4 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.123 -0.986 . . . . 0.0 110.584 -179.862 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.529 ' CB ' ' O ' ' A' ' 74' ' ' VAL . 3.5 m -129.08 129.49 23.38 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.329 -0.857 . . . . 0.0 110.07 179.927 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.516 ' HD3' ' CB ' ' A' ' 76' ' ' ALA . 46.9 Cg_endo -72.28 91.44 0.76 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.935 1.492 . . . . 0.0 110.994 -179.719 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.522 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -70.48 125.14 25.96 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.073 -1.017 . . . . 0.0 109.002 178.972 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.532 ' CD1' ' HG ' ' A' ' 139' ' ' LEU . 29.4 mt -119.83 170.48 9.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.113 -0.992 . . . . 0.0 110.846 -179.023 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.458 ' O ' ' O ' ' A' ' 68' ' ' ALA . 6.1 t -169.36 -151.18 0.09 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.394 -0.816 . . . . 0.0 109.735 179.886 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.423 ' N ' HG22 ' A' ' 96' ' ' THR . 0.5 OUTLIER -93.41 25.51 3.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.046 -1.034 . . . . 0.0 110.043 179.8 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -145.84 171.99 5.83 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.34 -0.85 . . . . 0.0 109.959 179.847 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.57 130.83 16.51 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 124.005 1.529 . . . . 0.0 110.379 -179.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.522 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 1.7 mtt180 -119.7 93.2 3.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.254 -0.904 . . . . 0.0 110.006 179.915 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -82.99 95.24 7.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.448 -0.783 . . . . 0.0 110.45 -179.767 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.541 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 73.6 t -89.47 133.51 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.277 -0.89 . . . . 0.0 110.013 179.836 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 53.5 m -150.21 139.54 21.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.227 -0.921 . . . . 0.0 110.328 -179.948 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.456 ' CG ' ' O ' ' A' ' 103' ' ' THR . 21.3 mt-10 -160.2 160.94 33.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.244 -0.91 . . . . 0.0 110.257 179.881 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.43 HG21 ' O ' ' A' ' 105' ' ' THR . 3.1 t -111.5 128.06 55.9 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.229 -0.919 . . . . 0.0 110.114 179.894 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.559 ' CE1' HG22 ' A' ' 88' ' ' VAL . 22.4 p90 -136.38 157.27 47.19 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.246 -0.909 . . . . 0.0 110.269 -179.916 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.534 ' O ' ' N ' ' A' ' 109' ' ' SER . 3.6 m -89.49 93.9 9.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.163 -0.96 . . . . 0.0 109.732 179.603 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.585 ' HB2' ' CE2' ' A' ' 60' ' ' TYR . . . -49.68 89.99 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.353 -0.842 . . . . 0.0 110.084 -179.932 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.534 ' N ' ' O ' ' A' ' 107' ' ' THR . 79.8 p -85.99 53.96 2.97 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.315 -0.866 . . . . 0.0 109.76 179.888 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -159.28 -156.75 0.54 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.244 -0.91 . . . . 0.0 110.393 -179.769 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.514 ' CG2' ' HA ' ' A' ' 55' ' ' GLU . 3.4 m -149.8 113.45 5.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.256 -0.902 . . . . 0.0 110.457 -179.896 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.489 ' CE2' HG13 ' A' ' 78' ' ' VAL . 11.9 m-30 -109.85 85.91 4.39 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.366 -0.834 . . . . 0.0 109.571 179.535 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.47 ' HD2' ' OE1' ' A' ' 80' ' ' GLN . 45.4 Cg_endo -72.19 -165.83 0.23 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.892 1.469 . . . . 0.0 110.517 -179.757 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.307 -0.871 . . . . 0.0 110.24 -179.993 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.517 ' O ' ' HB2' ' A' ' 81' ' ' ASN . 0.5 OUTLIER . . . . . 0 N--CA 1.5 2.033 0 CA-C-O 121.325 0.583 . . . . 0.0 111.903 . . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.484 ' HA3' ' CB ' ' A' ' 112' ' ' TYR . . . -85.54 149.21 23.39 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -179.378 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.532 ' CB ' ' HA ' ' A' ' 50' ' ' ASN . 6.8 pt20 -150.78 -157.59 0.83 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.358 -1.084 . . . . 0.0 110.651 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.443 ' CG2' ' CE1' ' A' ' 127' ' ' PHE . 5.5 mt -118.54 146.97 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 179.294 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -121.5 122.62 40.12 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.325 -179.183 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.511 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 5.0 m-85 -118.59 98.54 6.29 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.185 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . 0.478 ' O ' ' HB ' ' A' ' 74' ' ' VAL . 10.5 mm-40 -88.75 84.13 6.69 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.262 -0.899 . . . . 0.0 112.368 -177.154 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.502 ' N ' ' O ' ' A' ' 45' ' ' VAL . 7.0 mt -85.2 45.99 1.24 Allowed 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.515 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' A' ' 132' ' ' PHE . . . -64.2 -170.5 2.02 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 -179.396 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.554 ' CA ' ' O ' ' A' ' 40' ' ' SER . . . -51.81 89.49 0.01 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.905 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.57 ' CG ' ' HA ' ' A' ' 74' ' ' VAL . 9.7 m-85 -118.35 -49.53 2.47 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.113 -1.228 . . . . 0.0 110.693 -179.361 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.524 ' HB2' ' CG2' ' A' ' 72' ' ' VAL . 1.3 t -88.53 175.83 7.41 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.997 -1.065 . . . . 0.0 110.233 -179.71 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -97.25 -52.94 3.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.322 -0.862 . . . . 0.0 110.309 -179.744 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -98.82 174.11 6.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.228 -0.92 . . . . 0.0 109.984 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.577 ' N ' ' HA ' ' A' ' 38' ' ' ALA . . . -57.59 125.6 23.63 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.151 -0.968 . . . . 0.0 110.047 -179.756 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.664 ' CZ2' ' CG1' ' A' ' 36' ' ' VAL . 6.6 p90 -132.18 -168.48 2.05 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.063 -1.023 . . . . 0.0 109.803 179.659 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.495 ' OG1' ' O ' ' A' ' 34' ' ' VAL . 0.5 OUTLIER -155.76 172.46 18.28 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.805 -1.185 . . . . 0.0 111.331 -177.819 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.532 ' HG ' ' CD1' ' A' ' 95' ' ' LEU . 2.4 mp -130.47 128.81 42.0 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.548 -0.72 . . . . 0.0 109.506 179.497 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 140' ' ' CYS . . . . . . . . . . . . . 15.9 m -127.63 100.7 6.09 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.091 -1.006 . . . . 0.0 110.771 -179.535 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.485 ' O ' ' HB3' ' A' ' 142' ' ' ASP . 0.7 OUTLIER -95.96 -177.93 4.18 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.29 -0.881 . . . . 0.0 109.325 179.189 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.524 ' O ' ' CB ' ' A' ' 143' ' ' ASP . 0.6 OUTLIER 171.11 49.89 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.184 -0.947 . . . . 0.0 110.411 -179.996 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.524 ' CB ' ' O ' ' A' ' 142' ' ' ASP . 0.4 OUTLIER 166.23 55.43 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.37 -0.831 . . . . 0.0 109.614 179.849 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 2.1 t -96.32 118.72 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.303 -0.873 . . . . 0.0 110.274 -179.474 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.427 ' HB3' ' HA ' ' A' ' 6' ' ' GLU . . . -145.2 155.55 43.33 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.318 -0.864 . . . . 0.0 110.189 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.426 HD22 HD12 ' A' ' 54' ' ' ILE . 14.1 tp -147.9 143.39 27.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.922 . . . . 0.0 110.188 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.459 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 5.0 t0 -172.3 151.15 2.49 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.2 -0.937 . . . . 0.0 110.311 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.471 ' HA ' ' O ' ' A' ' 59' ' ' THR . 9.7 p . . . . . 0 N--CA 1.492 1.653 0 O-C-N 121.281 -0.887 . . . . 0.0 110.197 179.998 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo . . . . . 0 N--CA 1.48 0.72 0 N-CA-C 110.072 -0.78 . . . . 0.0 110.072 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.483 ' CD1' HG13 ' A' ' 144' ' ' VAL . 13.8 pt -95.39 23.97 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.195 -0.941 . . . . 0.0 110.17 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 94.23 -23.8 29.99 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.917 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.53 ' CG ' ' CB ' ' A' ' 145' ' ' ALA . 1.4 tt0 44.7 74.07 0.14 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.273 -1.134 . . . . 0.0 110.212 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -163.26 -164.01 17.31 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.961 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.515 ' CG2' ' O ' ' A' ' 142' ' ' ASP . 26.1 p -117.57 33.92 5.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.259 -1.142 . . . . 0.0 110.323 -179.975 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.552 ' CZ ' HG22 ' A' ' 144' ' ' VAL . 13.6 m-85 60.25 48.24 8.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -0.934 . . . . 0.0 110.146 179.938 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.557 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 32.2 t70 -90.13 32.21 0.94 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.223 -0.923 . . . . 0.0 110.333 -179.911 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.557 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.4 OUTLIER 161.55 37.77 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.572 -0.705 . . . . 0.0 109.974 179.983 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.24 136.07 4.36 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.47 ' O ' ' CB ' ' A' ' 14' ' ' GLU . 48.3 Cg_endo -74.69 1.66 7.31 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.962 1.506 . . . . 0.0 110.609 179.955 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.47 ' CB ' ' O ' ' A' ' 13' ' ' PRO . 0.1 OUTLIER 68.15 -84.04 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.265 -0.897 . . . . 0.0 110.274 -179.872 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.493 ' C ' ' CD1' ' A' ' 49' ' ' LEU . . . -137.39 5.54 3.52 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.921 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.575 ' CE2' HD21 ' A' ' 49' ' ' LEU . 56.0 m95 -65.5 105.25 1.15 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.188 -1.183 . . . . 0.0 110.249 -179.898 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.587 ' CG2' ' CG2' ' A' ' 48' ' ' VAL . 1.0 OUTLIER -113.41 151.72 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.173 -0.955 . . . . 0.0 109.783 179.784 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.523 ' CB ' HG13 ' A' ' 34' ' ' VAL . . . -133.73 136.97 44.96 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.192 -0.942 . . . . 0.0 109.679 179.359 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.466 ' O ' HG11 ' A' ' 45' ' ' VAL . 26.8 p90 -128.17 148.64 50.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.417 -0.802 . . . . 0.0 110.665 -178.902 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.437 ' C ' HG21 ' A' ' 21' ' ' THR . . . 94.3 24.61 18.58 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 179.464 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.582 ' CG2' ' CG1' ' A' ' 45' ' ' VAL . 28.1 p -134.88 -148.6 0.32 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.033 -1.275 . . . . 0.0 110.494 179.904 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.454 ' O ' ' O ' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -116.84 136.43 52.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.342 -0.849 . . . . 0.0 110.383 -179.806 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 22' ' ' ASP . . . 52.07 174.46 0.03 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.766 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.52 -159.32 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.08 1.569 . . . . 0.0 110.42 179.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.523 ' CD1' ' O ' ' A' ' 16' ' ' TRP . 17.3 mt -93.05 145.3 24.49 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.215 -0.928 . . . . 0.0 110.237 179.987 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -97.59 119.41 36.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.243 -0.911 . . . . 0.0 109.827 179.709 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 31' ' ' ALA . 0.8 OUTLIER -119.65 -44.56 2.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.127 -0.983 . . . . 0.0 110.503 -179.58 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.483 ' O ' ' OG1' ' A' ' 29' ' ' THR . 8.1 t 43.76 36.04 1.21 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.186 -0.946 . . . . 0.0 109.874 -179.831 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.483 ' OG1' ' O ' ' A' ' 28' ' ' SER . 4.3 p 54.11 59.94 3.92 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.457 -0.777 . . . . 0.0 110.057 -179.731 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 8' ' ' THR . . . -159.24 -71.12 0.02 OUTLIER Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.467 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -150.74 160.17 44.03 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.25 -1.147 . . . . 0.0 110.451 -179.899 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.468 ' O ' ' HA ' ' A' ' 140' ' ' CYS . 0.6 OUTLIER -88.71 111.8 22.39 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.276 -0.89 . . . . 0.0 109.842 179.568 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 53.4 m -119.58 106.36 12.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.221 -0.924 . . . . 0.0 110.61 -179.642 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.523 HG13 ' CB ' ' A' ' 18' ' ' ALA . 18.2 m -89.87 145.58 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.207 -0.933 . . . . 0.0 109.715 179.535 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.496 ' HA ' ' OG1' ' A' ' 138' ' ' THR . . . -95.52 91.69 6.29 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.338 -0.851 . . . . 0.0 111.113 -179.268 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.633 ' CG1' ' CZ2' ' A' ' 137' ' ' TRP . 58.8 t -71.54 130.85 86.86 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.168 -0.958 . . . . 0.0 109.307 179.076 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 21' ' ' THR . 43.1 Cg_endo -71.24 155.12 61.29 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.933 1.491 . . . . 0.0 111.164 -178.945 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.56 ' HA ' ' CA ' ' A' ' 136' ' ' ALA . . . -43.05 111.1 0.23 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.37 -0.832 . . . . 0.0 110.345 -179.839 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 134' ' ' ALA . . . 58.67 117.6 0.01 OUTLIER Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.981 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.572 ' OG ' ' CH2' ' A' ' 137' ' ' TRP . 58.6 m -85.55 49.0 1.67 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.27 -1.135 . . . . 0.0 109.553 179.668 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.526 ' O ' ' HB3' ' A' ' 42' ' ' GLN . . . -89.72 103.89 16.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.497 -0.752 . . . . 0.0 110.217 -179.741 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.526 ' HB3' ' O ' ' A' ' 41' ' ' ALA . 0.8 OUTLIER 168.18 -152.17 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -179.757 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.409 ' C ' ' O ' ' A' ' 42' ' ' GLN . 7.4 p90 -43.13 -26.43 0.16 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.091 -1.006 . . . . 0.0 109.564 179.174 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 42' ' ' GLN . . . 107.59 129.39 6.1 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.35 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.582 ' CG1' ' CG2' ' A' ' 21' ' ' THR . 3.0 t -89.88 177.89 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.132 -1.217 . . . . 0.0 108.46 179.144 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.467 ' HA2' ' HA ' ' A' ' 128' ' ' GLN . . . 169.4 -177.29 43.09 Favored Glycine 0 N--CA 1.489 2.182 0 C-N-CA 118.748 -1.692 . . . . 0.0 111.075 -179.894 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.528 ' CG1' ' O ' ' A' ' 17' ' ' VAL . 18.3 t -150.95 126.84 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.803 -0.822 . . . . 0.0 108.83 179.862 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.587 ' CG2' ' CG2' ' A' ' 17' ' ' VAL . 29.0 m -119.82 133.67 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.027 -1.046 . . . . 0.0 110.907 -179.159 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.575 HD21 ' CE2' ' A' ' 16' ' ' TRP . 30.7 tp -122.97 90.64 3.33 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.397 -0.815 . . . . 0.0 110.074 179.787 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.468 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 8.1 p30 -73.57 113.5 10.75 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.236 -0.915 . . . . 0.0 110.247 -179.909 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.456 ' O ' HG21 ' A' ' 4' ' ' ILE . . . 153.95 65.86 0.01 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.908 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.529 ' CG2' ' HA ' ' A' ' 124' ' ' GLN . 97.2 t -120.04 173.07 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.164 -1.197 . . . . 0.0 109.982 179.787 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.437 ' N ' ' CG1' ' A' ' 52' ' ' VAL . . . -143.43 97.74 3.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.072 -1.017 . . . . 0.0 110.652 -179.786 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.589 HD11 ' CZ ' ' A' ' 60' ' ' TYR . 11.6 mm -137.79 159.87 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.292 -0.88 . . . . 0.0 109.818 179.603 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.474 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -147.82 135.34 20.76 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.108 -0.995 . . . . 0.0 110.683 -179.774 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.565 ' CG ' ' N ' ' A' ' 57' ' ' GLY . 0.9 OUTLIER 34.23 -155.08 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.342 0.592 . . . . 0.0 111.243 179.759 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.565 ' N ' ' CG ' ' A' ' 56' ' ' GLU . . . -83.39 81.39 1.75 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.837 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.567 HG21 ' CE2' ' A' ' 60' ' ' TYR . 1.2 m -109.13 171.26 7.54 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.305 -1.115 . . . . 0.0 109.826 179.876 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.519 ' N ' ' CG2' ' A' ' 58' ' ' THR . 1.0 OUTLIER -89.91 150.21 22.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.257 -0.902 . . . . 0.0 110.181 -179.941 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.598 ' CD2' ' CB ' ' A' ' 108' ' ' ALA . 64.9 m-85 -154.69 171.74 19.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.233 -0.917 . . . . 0.0 110.225 179.895 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.466 ' OG1' HG22 ' A' ' 105' ' ' THR . 17.9 m -142.73 114.51 8.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.304 -0.872 . . . . 0.0 110.086 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.422 HD21 HD22 ' A' ' 89' ' ' LEU . 17.1 tp -89.71 121.19 31.64 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.177 -0.952 . . . . 0.0 109.965 179.894 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.479 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 2.2 ttt180 -129.29 127.8 41.89 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -0.878 . . . . 0.0 110.314 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.539 ' CE1' HG22 ' A' ' 102' ' ' VAL . 2.1 p90 -165.12 149.6 8.94 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.336 -0.853 . . . . 0.0 109.888 179.807 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 51.6 m -119.44 95.7 4.9 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.183 -0.948 . . . . 0.0 110.117 -179.965 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.452 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -93.92 151.93 19.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.358 -0.839 . . . . 0.0 110.339 -179.801 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.479 ' CG2' ' O ' ' A' ' 98' ' ' GLU . 57.1 m -149.76 121.16 7.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.278 -0.889 . . . . 0.0 110.261 179.97 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.498 ' HB1' ' CB ' ' A' ' 95' ' ' LEU . . . -114.89 132.01 56.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.314 -0.866 . . . . 0.0 109.852 179.752 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.9 p -47.69 -23.99 0.83 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.074 -1.016 . . . . 0.0 109.343 179.497 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.539 ' CG2' ' HB2' ' A' ' 137' ' ' TRP . 2.5 t -113.84 170.2 8.44 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.49 -0.756 . . . . 0.0 110.067 179.904 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.478 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 15.7 t70 -86.75 66.02 9.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.179 -0.951 . . . . 0.0 109.119 178.86 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.57 HG22 ' CE2' ' A' ' 137' ' ' TRP . 3.5 p -85.23 137.25 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.319 -0.863 . . . . 0.0 111.341 -178.871 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.409 ' O ' ' CD1' ' A' ' 132' ' ' PHE . 89.6 m -122.81 86.02 2.51 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.85 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.589 ' HA ' ' CD1' ' A' ' 132' ' ' PHE . 4.8 m -89.33 -153.28 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.287 -0.883 . . . . 0.0 110.444 -179.068 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.447 ' N ' HG21 ' A' ' 74' ' ' VAL . 2.4 mtp180 -125.94 133.16 51.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.207 -0.933 . . . . 0.0 110.627 -179.431 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.489 ' O ' ' HB3' ' A' ' 77' ' ' LEU . . . -137.32 155.72 49.09 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.346 -0.846 . . . . 0.0 110.079 179.691 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.572 ' CD1' ' N ' ' A' ' 78' ' ' VAL . 3.9 pp 179.18 -147.77 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.354 -0.841 . . . . 0.0 110.033 -179.724 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.576 HG11 ' CE2' ' A' ' 112' ' ' TYR . 3.8 t -151.65 166.43 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.147 -0.971 . . . . 0.0 109.321 179.77 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.513 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . -171.67 -174.53 39.33 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.11 -1.519 . . . . 0.0 110.631 -179.81 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.502 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 4.0 pt20 -114.78 150.8 34.84 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.545 -0.973 . . . . 0.0 110.065 179.793 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.465 ' OD1' ' HG2' ' A' ' 122' ' ' GLU . 18.6 m120 -106.31 92.47 4.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.207 -0.933 . . . . 0.0 110.396 -179.952 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.538 ' C ' ' CE1' ' A' ' 85' ' ' TYR . . . 135.54 130.18 2.92 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.869 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.582 ' HA ' ' CD2' ' A' ' 85' ' ' TYR . . . -42.12 155.32 0.25 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.38 -1.071 . . . . 0.0 110.317 -179.951 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.477 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 50.8 Cg_endo -78.78 11.75 18.72 Favored 'Cis proline' 0 C--N 1.312 -1.352 0 C-N-CA 121.636 -2.235 . . . . 0.0 110.93 -0.049 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.582 ' CD2' ' HA ' ' A' ' 83' ' ' ALA . 39.3 m-85 60.88 157.71 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.125 -0.985 . . . . 0.0 110.17 -179.739 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.459 ' O ' ' HG2' ' A' ' 80' ' ' GLN . . . 167.78 113.46 0.28 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.464 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 1.2 p -89.84 155.52 19.1 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.232 -1.158 . . . . 0.0 110.299 -179.853 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.51 HG22 ' CD1' ' A' ' 89' ' ' LEU . 35.3 m -119.82 -24.22 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.886 . . . . 0.0 109.899 179.837 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.571 HD12 ' CZ ' ' A' ' 106' ' ' PHE . 4.0 mp -104.59 144.39 31.76 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.351 -0.843 . . . . 0.0 110.667 179.684 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -151.04 76.33 1.23 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.324 -0.86 . . . . 0.0 110.195 179.805 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -144.85 176.38 9.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.052 -1.03 . . . . 0.0 110.508 -179.832 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 66.2 m -124.39 126.08 25.54 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.318 -0.864 . . . . 0.0 110.045 179.907 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.525 ' HG2' ' CG2' ' A' ' 74' ' ' VAL . 45.4 Cg_endo -71.73 127.66 13.34 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.876 1.461 . . . . 0.0 110.749 -179.805 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.515 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -105.19 128.49 53.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.321 -0.862 . . . . 0.0 109.838 179.58 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.525 HD13 ' CG1' ' A' ' 72' ' ' VAL . 57.4 mt -119.91 178.95 4.41 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.186 -0.946 . . . . 0.0 110.467 -179.711 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -159.24 -79.64 0.06 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.265 -0.897 . . . . 0.0 110.335 -179.848 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -158.75 -37.66 0.06 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.271 -0.893 . . . . 0.0 110.061 179.952 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.525 ' CB ' ' HD2' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -89.88 -177.72 0.85 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.341 -0.849 . . . . 0.0 109.786 179.748 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.525 ' HD2' ' CB ' ' A' ' 98' ' ' GLU . 44.2 Cg_endo -71.61 128.63 14.58 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.748 1.394 . . . . 0.0 110.272 179.915 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.515 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 8.0 ttm-85 -119.68 92.03 3.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.185 -0.947 . . . . 0.0 110.36 -179.803 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 1.9 pt20 -70.23 159.03 34.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.327 -0.858 . . . . 0.0 110.045 179.796 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.539 HG22 ' CE1' ' A' ' 64' ' ' TYR . 98.7 t -135.12 139.34 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.208 -0.932 . . . . 0.0 110.165 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.463 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 0.2 OUTLIER -150.21 117.1 5.89 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.238 -0.914 . . . . 0.0 110.154 179.976 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 103' ' ' THR . 17.7 mm-40 -155.28 134.86 12.6 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.206 -0.934 . . . . 0.0 110.288 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.466 HG22 ' OG1' ' A' ' 61' ' ' THR . 0.7 OUTLIER -102.18 119.24 38.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.271 -0.893 . . . . 0.0 110.106 179.939 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.571 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 35.0 p90 -125.91 157.91 36.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.233 -0.917 . . . . 0.0 110.285 -179.943 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 19.3 m -89.93 98.57 11.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.3 -0.875 . . . . 0.0 109.997 179.786 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.598 ' CB ' ' CD2' ' A' ' 60' ' ' TYR . . . -59.3 107.78 0.61 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.253 -0.905 . . . . 0.0 110.411 -179.726 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.453 ' HA ' ' HA2' ' A' ' 57' ' ' GLY . 3.3 p -94.8 54.27 1.72 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.258 -0.901 . . . . 0.0 110.005 179.67 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.43 ' HB1' ' CG1' ' A' ' 88' ' ' VAL . . . -160.57 -152.38 0.28 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.214 -0.929 . . . . 0.0 110.431 -179.81 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.516 ' CG2' ' HD3' ' A' ' 113' ' ' PRO . 84.1 m -151.89 111.46 3.97 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.325 -0.859 . . . . 0.0 110.312 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.576 ' CE2' HG11 ' A' ' 78' ' ' VAL . 17.3 m-30 -111.02 69.66 0.66 Allowed Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.265 -0.897 . . . . 0.0 110.16 179.791 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.516 ' HD3' ' CG2' ' A' ' 111' ' ' THR . 45.8 Cg_endo -71.3 117.21 5.04 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.889 1.468 . . . . 0.0 110.361 179.949 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.261 -0.899 . . . . 0.0 110.231 -179.951 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.543 ' CG ' ' N ' ' A' ' 123' ' ' GLY . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.117 0.485 . . . . 0.0 109.999 . . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.543 ' N ' ' CG ' ' A' ' 122' ' ' GLU . . . -166.44 156.31 28.11 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.814 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.529 ' HA ' ' CG2' ' A' ' 52' ' ' VAL . 3.6 pt20 -150.08 -161.23 1.3 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.38 -1.07 . . . . 0.0 110.313 -179.727 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.457 ' HB ' ' HB3' ' A' ' 49' ' ' LEU . 17.5 mt -118.49 149.83 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.528 -0.732 . . . . 0.0 109.552 179.772 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.533 ' O ' ' CD1' ' A' ' 127' ' ' PHE . . . -114.97 133.92 55.62 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.78 0.8 . . . . 0.0 111.179 -179.228 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.533 ' CD1' ' O ' ' A' ' 126' ' ' ALA . 8.5 m-85 -146.8 73.9 1.33 Allowed 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.062 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . 0.467 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 40.2 mt-30 -87.55 125.44 34.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.303 -0.873 . . . . 0.0 111.841 -177.773 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.52 ' O ' ' CB ' ' A' ' 40' ' ' SER . 2.9 mt -113.95 54.34 0.76 Allowed 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.871 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -106.54 104.33 2.18 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 -179.36 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 77.21 74.46 0.98 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.781 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.589 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 6.5 m-85 -143.93 -71.77 0.29 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.196 -1.179 . . . . 0.0 110.243 179.859 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.6 ' HB3' ' CE3' ' A' ' 137' ' ' TRP . 1.3 t -89.13 156.45 18.8 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.055 -1.028 . . . . 0.0 110.103 179.825 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -80.23 -92.31 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.225 -0.922 . . . . 0.0 110.874 -179.34 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.448 ' O ' ' O ' ' A' ' 134' ' ' ALA . 12.6 m-20 -52.28 -172.35 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.165 -0.959 . . . . 0.0 110.679 -179.494 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.56 ' CA ' ' HA ' ' A' ' 38' ' ' ALA . . . -76.55 139.44 40.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.363 -0.835 . . . . 0.0 110.386 -179.799 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.633 ' CZ2' ' CG1' ' A' ' 36' ' ' VAL . 9.1 p90 -145.82 -166.34 2.43 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.296 -0.877 . . . . 0.0 110.058 179.672 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.504 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 0.8 OUTLIER -160.38 170.47 20.96 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.034 -1.041 . . . . 0.0 110.735 -178.068 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' A' ' 33' ' ' CYS . 2.2 mp -129.28 126.26 38.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.469 -0.769 . . . . 0.0 109.444 179.14 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 140' ' ' CYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 27.9 m -121.81 102.73 8.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.141 -0.974 . . . . 0.0 110.892 -179.443 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.508 ' O ' ' CB ' ' A' ' 142' ' ' ASP . 1.2 mt -95.26 -177.94 4.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.301 -0.875 . . . . 0.0 109.355 179.093 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.515 ' O ' ' CG2' ' A' ' 8' ' ' THR . 2.8 p30 168.5 52.96 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.244 -0.91 . . . . 0.0 110.301 179.954 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.49 ' CB ' ' O ' ' A' ' 142' ' ' ASP . 0.3 OUTLIER 167.27 53.06 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.223 -0.923 . . . . 0.0 109.71 179.947 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.552 HG22 ' CZ ' ' A' ' 9' ' ' PHE . 2.2 t -95.71 114.17 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.28 -0.887 . . . . 0.0 110.189 -179.599 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.53 ' CB ' ' CG ' ' A' ' 6' ' ' GLU . . . -146.11 164.75 31.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.897 . . . . 0.0 110.262 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.514 ' CD2' HD12 ' A' ' 54' ' ' ILE . 6.7 tp -145.21 148.23 33.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.323 -0.861 . . . . 0.0 110.234 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.468 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 0.5 OUTLIER -134.22 -173.97 3.42 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.196 -0.94 . . . . 0.0 110.23 -179.982 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 78.5 p . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.237 -0.915 . . . . 0.0 110.224 -179.974 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.523 ' CG ' ' HA ' ' A' ' 52' ' ' VAL . 53.8 Cg_endo . . . . . 0 N--CA 1.483 0.869 0 N-CA-C 111.134 -0.372 . . . . 0.0 111.134 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.483 HG13 ' N ' ' A' ' 5' ' ' GLY . 7.8 pt -146.15 -37.52 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.989 -1.07 . . . . 0.0 109.811 179.715 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.511 ' O ' ' N ' ' A' ' 7' ' ' GLY . . . 55.71 163.18 0.02 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 179.574 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.527 ' HG3' ' CB ' ' A' ' 145' ' ' ALA . 63.3 mt-10 -51.69 88.75 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.302 -1.116 . . . . 0.0 110.11 179.85 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 5' ' ' GLY . . . -78.63 -32.41 41.71 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.953 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.477 ' OG1' ' O ' ' A' ' 7' ' ' GLY . 11.2 p 50.57 18.93 0.51 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.427 -1.043 . . . . 0.0 110.467 -179.794 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.58 ' CG ' ' HB2' ' A' ' 32' ' ' LEU . 24.3 m-85 36.85 46.64 0.51 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.56 -0.712 . . . . 0.0 110.813 179.563 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.558 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 3.2 p-10 -100.25 43.46 1.06 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.244 -0.91 . . . . 0.0 110.281 -179.998 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.558 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.6 OUTLIER 161.57 -24.97 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.722 -0.612 . . . . 0.0 109.52 179.951 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -177.64 151.12 10.54 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.498 ' HB3' ' CD1' ' A' ' 32' ' ' LEU . 46.3 Cg_endo -73.64 0.01 8.74 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.014 1.534 . . . . 0.0 110.552 -179.987 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 0.5 OUTLIER 62.07 -89.55 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.255 -0.903 . . . . 0.0 110.135 -179.791 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.46 ' O ' HG12 ' A' ' 17' ' ' VAL . . . -122.68 -15.89 3.87 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.579 ' CE2' HD21 ' A' ' 49' ' ' LEU . 82.4 m95 -54.05 140.68 30.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.254 -1.145 . . . . 0.0 110.782 -179.758 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.523 ' O ' ' CG1' ' A' ' 47' ' ' VAL . 1.2 m -146.08 157.95 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.324 -0.86 . . . . 0.0 109.455 179.425 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . . . -134.26 163.2 30.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.235 -0.916 . . . . 0.0 109.49 179.303 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.511 ' CZ ' ' C ' ' A' ' 46' ' ' GLY . 3.5 p90 -150.04 147.9 28.38 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.93 -1.106 . . . . 0.0 111.625 -178.519 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.582 ' HA2' ' CE1' ' A' ' 43' ' ' TYR . . . 132.09 -81.75 0.32 Allowed Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.763 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.586 HG21 ' CE2' ' A' ' 43' ' ' TYR . 12.1 p -149.69 23.95 0.88 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.171 -1.194 . . . . 0.0 110.319 -179.899 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.48 ' O ' ' C ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -107.63 27.43 9.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 110.35 179.845 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.48 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 36.87 -137.43 0.53 Allowed Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.749 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.78 -158.88 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.974 1.513 . . . . 0.0 110.106 179.514 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.524 ' CD1' ' O ' ' A' ' 16' ' ' TRP . 61.1 mt -111.26 123.69 50.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.122 -0.986 . . . . 0.0 110.263 179.923 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.02 105.63 12.39 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.196 -0.94 . . . . 0.0 109.911 179.871 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.543 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.8 OUTLIER -119.56 -27.4 5.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.185 -0.947 . . . . 0.0 110.488 -179.653 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.484 ' O ' ' CB ' ' A' ' 29' ' ' THR . 8.0 t -48.48 82.91 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.758 -0.589 . . . . 0.0 111.233 -179.863 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.543 ' N ' ' O ' ' A' ' 27' ' ' THR . 0.0 OUTLIER 167.91 -31.71 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.254 -0.904 . . . . 0.0 109.856 -179.918 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' A' ' 10' ' ' ASP . . . 127.17 -0.07 7.0 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.907 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.534 ' CB ' ' HB3' ' A' ' 142' ' ' ASP . . . -150.75 134.98 16.93 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.15 -1.206 . . . . 0.0 110.535 -179.907 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.58 ' HB2' ' CG ' ' A' ' 9' ' ' PHE . 3.2 tt -76.27 138.6 40.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.181 -0.949 . . . . 0.0 109.293 179.205 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 66.6 m -141.82 118.43 10.99 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.069 -1.02 . . . . 0.0 110.838 -179.552 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.493 ' O ' ' OG1' ' A' ' 138' ' ' THR . 17.2 m -102.1 142.06 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.485 -0.759 . . . . 0.0 109.274 179.306 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.461 ' O ' ' HB3' ' A' ' 22' ' ' ASP . . . -88.44 102.79 15.24 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.129 -0.982 . . . . 0.0 110.781 -179.211 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.648 ' CG1' ' CZ2' ' A' ' 137' ' ' TRP . 49.1 t -83.91 125.23 73.48 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.417 -0.802 . . . . 0.0 109.596 179.471 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.491 ' HG2' ' HA ' ' A' ' 40' ' ' SER . 40.4 Cg_endo -66.42 -178.57 1.21 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.878 1.462 . . . . 0.0 111.741 -178.965 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.535 ' HA ' ' N ' ' A' ' 136' ' ' ALA . . . -60.5 120.92 10.87 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.452 -0.78 . . . . 0.0 111.296 -178.983 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.519 ' O ' ' C ' ' A' ' 40' ' ' SER . . . 39.22 26.73 0.06 OUTLIER Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 179.588 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.551 ' OG ' ' CH2' ' A' ' 137' ' ' TRP . 45.6 m 28.43 44.68 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 CA-C-N 117.863 0.831 . . . . 0.0 110.65 -179.998 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.631 ' O ' ' CG ' ' A' ' 42' ' ' GLN . . . -89.07 126.58 35.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.474 -0.766 . . . . 0.0 110.158 -179.278 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.631 ' CG ' ' O ' ' A' ' 41' ' ' ALA . 0.4 OUTLIER 83.17 28.54 0.1 Allowed 'General case' 0 N--CA 1.508 2.443 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -179.365 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.586 ' CE2' HG21 ' A' ' 21' ' ' THR . 0.1 OUTLIER -156.31 -31.05 0.09 Allowed 'General case' 0 C--N 1.293 -1.865 0 C-N-CA 118.648 -1.221 . . . . 0.0 112.314 -177.767 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.538 ' HA2' ' CA ' ' A' ' 130' ' ' GLY . . . 53.2 80.01 0.08 OUTLIER Glycine 0 N--CA 1.479 1.556 0 N-CA-C 105.922 -2.871 . . . . 0.0 105.922 -177.015 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.477 ' O ' ' HB2' ' A' ' 129' ' ' LEU . 4.2 t -86.95 133.9 28.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.358 -1.084 . . . . 0.0 108.893 -177.955 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.511 ' C ' ' CZ ' ' A' ' 19' ' ' TYR . . . -157.13 163.74 32.5 Favored Glycine 0 N--CA 1.487 2.089 0 C-N-CA 118.755 -1.688 . . . . 0.0 110.65 -178.973 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.523 ' CG1' ' O ' ' A' ' 17' ' ' VAL . 15.3 t -123.87 123.31 66.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.648 -0.913 . . . . 0.0 109.536 179.639 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.7 m -119.79 140.48 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.916 -1.115 . . . . 0.0 111.018 -179.002 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.579 HD21 ' CE2' ' A' ' 16' ' ' TRP . 15.0 tp -118.98 97.7 5.82 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.46 -0.775 . . . . 0.0 109.743 179.449 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.481 ' HA ' ' HB3' ' A' ' 124' ' ' GLN . 2.3 t-20 -78.16 113.73 16.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.28 -0.887 . . . . 0.0 110.405 -179.782 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.472 ' O ' ' HG2' ' A' ' 3' ' ' PRO . . . 146.22 73.98 0.02 OUTLIER Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 179.748 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.523 ' HA ' ' CG ' ' A' ' 3' ' ' PRO . 96.5 t -133.81 154.45 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.216 -1.167 . . . . 0.0 110.067 179.653 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.462 ' O ' HD11 ' A' ' 54' ' ' ILE . . . -128.73 105.19 8.09 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.218 -0.926 . . . . 0.0 110.501 -179.744 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.633 ' CG1' ' CD2' ' A' ' 112' ' ' TYR . 50.7 mm -131.78 166.45 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.318 -0.864 . . . . 0.0 109.74 179.58 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.526 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 0.2 OUTLIER -154.22 130.01 10.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.054 -1.029 . . . . 0.0 110.795 -179.726 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.526 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 11.0 pt-20 37.55 -156.5 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.773 -0.579 . . . . 0.0 110.915 179.525 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.47 ' HA2' ' O ' ' A' ' 108' ' ' ALA . . . -86.63 73.59 2.47 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.915 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.563 ' CG2' ' N ' ' A' ' 59' ' ' THR . 1.2 m -95.65 173.62 7.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.312 -1.11 . . . . 0.0 109.854 179.875 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.573 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 0.8 OUTLIER -89.63 155.9 18.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.205 -0.935 . . . . 0.0 110.391 -179.74 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.59 ' CD2' ' CB ' ' A' ' 108' ' ' ALA . 56.9 m-85 -160.41 -175.21 4.89 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.333 -0.854 . . . . 0.0 110.194 179.902 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 26.9 m -150.16 114.43 5.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.341 -0.85 . . . . 0.0 109.945 179.737 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.526 HD21 ' CD2' ' A' ' 89' ' ' LEU . 14.0 tp -89.53 119.69 30.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.208 -0.932 . . . . 0.0 110.065 -179.937 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.497 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 0.0 OUTLIER -128.23 128.92 45.59 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.352 -0.842 . . . . 0.0 110.206 -179.8 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.541 ' CD1' ' C ' ' A' ' 64' ' ' TYR . 0.8 OUTLIER -172.61 144.38 1.43 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.22 -0.925 . . . . 0.0 109.849 179.731 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.517 ' CG2' ' HG2' ' A' ' 101' ' ' GLN . 4.6 m -119.22 92.93 3.92 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.225 -0.922 . . . . 0.0 109.957 -179.815 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.524 ' CB ' HD22 ' A' ' 95' ' ' LEU . . . -90.8 149.29 22.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.38 -0.825 . . . . 0.0 110.373 -179.747 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.453 ' OG1' ' HA ' ' A' ' 99' ' ' PRO . 99.7 m -150.25 107.15 3.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.34 -0.85 . . . . 0.0 110.265 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -97.11 133.36 41.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.246 -0.909 . . . . 0.0 110.032 179.738 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.407 ' C ' ' O ' ' A' ' 68' ' ' ALA . 19.2 t -45.35 -26.18 0.5 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.131 -0.981 . . . . 0.0 109.234 179.557 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.524 HG23 ' CB ' ' A' ' 137' ' ' TRP . 2.1 t -112.43 171.15 7.69 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.592 -0.693 . . . . 0.0 109.858 179.723 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 49.0 t0 -86.58 61.13 6.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.106 -0.996 . . . . 0.0 109.115 178.937 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.561 HG13 ' CD1' ' A' ' 137' ' ' TRP . 2.7 p -84.78 136.76 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.381 -0.824 . . . . 0.0 111.357 -178.912 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 19.9 m -125.78 86.91 2.6 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.711 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.597 ' CG2' ' CD2' ' A' ' 129' ' ' LEU . 3.0 m -90.5 -140.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.134 -0.979 . . . . 0.0 110.663 -178.73 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.484 ' N ' ' CG2' ' A' ' 74' ' ' VAL . 9.4 mtm180 -123.44 144.96 49.17 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.194 -0.941 . . . . 0.0 110.81 -179.633 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.483 ' O ' ' HB3' ' A' ' 77' ' ' LEU . . . -150.34 148.49 28.88 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.388 -0.82 . . . . 0.0 109.365 179.421 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.492 ' C ' ' CD1' ' A' ' 77' ' ' LEU . 1.3 pp 175.37 -159.39 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.123 -0.986 . . . . 0.0 110.674 -179.551 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.516 ' HB ' ' CG2' ' A' ' 88' ' ' VAL . 6.3 t -143.7 170.44 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.375 -0.828 . . . . 0.0 109.39 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.537 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . 176.02 -173.45 46.27 Favored Glycine 0 N--CA 1.491 2.325 0 C-N-CA 119.18 -1.486 . . . . 0.0 110.534 -179.92 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.529 ' CG ' ' O ' ' A' ' 122' ' ' GLU . 31.5 tt0 -105.39 159.39 15.95 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.58 -0.953 . . . . 0.0 110.129 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.463 ' HB2' ' HG2' ' A' ' 122' ' ' GLU . 4.2 m120 -112.18 94.13 4.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.26 -0.9 . . . . 0.0 109.984 179.761 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.542 ' C ' ' CE1' ' A' ' 85' ' ' TYR . . . 120.3 131.83 4.19 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.815 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.596 ' N ' ' CE1' ' A' ' 85' ' ' TYR . . . -42.08 152.71 0.31 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.327 -1.102 . . . . 0.0 110.232 -179.903 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.465 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.6 Cg_endo -79.1 12.43 18.8 Favored 'Cis proline' 0 C--N 1.313 -1.332 0 C-N-CA 121.657 -2.226 . . . . 0.0 111.017 -0.021 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.596 ' CE1' ' N ' ' A' ' 83' ' ' ALA . 37.9 m-85 60.85 170.54 0.1 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.099 -1.0 . . . . 0.0 110.273 -179.81 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.41 ' O ' ' HA2' ' A' ' 79' ' ' GLY . . . 176.63 108.28 0.22 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.46 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 2.5 p -98.17 147.83 24.2 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.214 -1.168 . . . . 0.0 110.346 -179.934 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.516 ' CG2' ' HB ' ' A' ' 78' ' ' VAL . 7.8 m -122.64 -22.82 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.329 -0.857 . . . . 0.0 110.168 179.874 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.566 HD13 ' CZ ' ' A' ' 106' ' ' PHE . 4.5 mp -115.51 143.74 44.87 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.288 -0.882 . . . . 0.0 110.74 179.94 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -151.08 79.24 1.31 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.329 -0.857 . . . . 0.0 110.187 179.56 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.9 p -151.59 -173.56 4.55 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.007 -1.058 . . . . 0.0 110.544 -179.865 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.98 134.18 23.97 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.361 -0.837 . . . . 0.0 110.037 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.525 ' HG2' HG21 ' A' ' 74' ' ' VAL . 50.0 Cg_endo -75.14 75.83 3.64 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.962 1.506 . . . . 0.0 110.808 -179.697 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.531 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -49.55 134.66 19.34 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.971 -1.081 . . . . 0.0 109.265 179.416 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.524 HD22 ' CB ' ' A' ' 66' ' ' ALA . 34.6 mt -131.91 164.65 25.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.032 -1.042 . . . . 0.0 110.819 -179.396 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -165.35 -178.71 5.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.488 -0.758 . . . . 0.0 109.933 179.864 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.8 p -67.58 -22.21 65.39 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.224 -0.923 . . . . 0.0 110.257 -179.981 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.28 170.56 8.5 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.216 -0.927 . . . . 0.0 110.116 179.906 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.453 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 45.8 Cg_endo -72.34 132.38 19.18 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.993 1.523 . . . . 0.0 110.39 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.531 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -119.83 92.61 3.82 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.206 -0.934 . . . . 0.0 110.36 -179.967 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.517 ' HG2' ' CG2' ' A' ' 65' ' ' THR . 0.1 OUTLIER -75.75 152.37 37.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.392 -0.817 . . . . 0.0 110.083 179.962 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.533 ' CG2' ' CZ ' ' A' ' 64' ' ' TYR . 91.6 t -132.04 133.19 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.22 -0.925 . . . . 0.0 110.246 179.942 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.523 ' O ' ' CG ' ' A' ' 104' ' ' GLU . 0.2 OUTLIER -150.38 116.77 5.73 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.317 -0.864 . . . . 0.0 110.158 -179.962 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.523 ' CG ' ' O ' ' A' ' 103' ' ' THR . 23.7 mt-10 -160.33 129.97 5.15 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.16 -0.963 . . . . 0.0 110.348 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 47.5 m -89.91 107.47 19.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.21 -0.931 . . . . 0.0 110.108 179.766 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.566 ' CZ ' HD13 ' A' ' 89' ' ' LEU . 36.7 p90 -110.2 155.9 21.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.242 -0.911 . . . . 0.0 110.4 -179.78 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.448 HG23 ' O ' ' A' ' 107' ' ' THR . 5.2 m -90.01 89.07 7.54 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.287 -0.883 . . . . 0.0 109.953 179.735 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.59 ' CB ' ' CD2' ' A' ' 60' ' ' TYR . . . -42.71 98.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.28 -0.888 . . . . 0.0 110.278 -179.747 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.492 ' N ' HG11 ' A' ' 88' ' ' VAL . 14.2 p -87.22 53.99 3.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.239 -0.913 . . . . 0.0 110.088 179.883 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.419 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -154.19 -155.33 0.58 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.261 -0.899 . . . . 0.0 110.333 -179.943 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.453 ' C ' ' CD1' ' A' ' 112' ' ' TYR . 27.5 m -159.52 110.58 2.0 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.895 . . . . 0.0 110.531 -179.9 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.633 ' CD2' ' CG1' ' A' ' 54' ' ' ILE . 5.8 m-30 -113.71 94.73 34.16 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.298 -0.877 . . . . 0.0 109.66 179.401 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.472 ' HD2' ' HA ' ' A' ' 122' ' ' GLU . 51.3 Cg_endo -80.66 33.04 0.51 Allowed 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.825 1.434 . . . . 0.0 111.717 -179.697 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 113' ' ' PRO . . . . . . . . 0 N--CA 1.498 1.953 0 O-C-N 121.606 -0.684 . . . . 0.0 111.156 179.432 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.529 ' O ' ' CG ' ' A' ' 80' ' ' GLN . 23.9 pm0 . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 120.994 0.426 . . . . 0.0 109.923 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.57 ' HA3' ' CG ' ' A' ' 112' ' ' TYR . . . -168.57 143.29 7.99 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.758 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.512 ' HA ' ' CG2' ' A' ' 52' ' ' VAL . 1.7 pt20 -150.56 -159.5 1.04 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.336 -1.096 . . . . 0.0 110.248 -179.808 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.563 HG23 ' CZ3' ' A' ' 16' ' ' TRP . 10.4 mt -118.32 146.35 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.45 -0.781 . . . . 0.0 109.114 179.246 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.505 ' N ' HG21 ' A' ' 125' ' ' ILE . . . -121.98 120.5 34.58 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.281 -0.887 . . . . 0.0 111.144 -179.302 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.5 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 3.4 m-30 -116.79 97.98 6.27 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 178.266 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . 0.574 ' O ' ' CE2' ' A' ' 132' ' ' PHE . 2.3 mm-40 -88.37 92.56 9.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.332 -0.855 . . . . 0.0 112.702 -176.783 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.597 ' CD2' ' CG2' ' A' ' 74' ' ' VAL . 5.2 mt -99.61 42.65 1.09 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.447 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.538 ' CA ' ' HA2' ' A' ' 44' ' ' GLY . . . -97.56 125.7 8.6 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 110.509 -1.037 . . . . 0.0 110.509 -178.775 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.476 ' HA2' ' O ' ' A' ' 39' ' ' GLY . . . 39.79 64.03 1.13 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 179.304 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.591 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 9.2 m-85 -117.98 -61.65 1.65 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.048 -1.266 . . . . 0.0 110.75 179.813 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.527 ' HB2' ' CG2' ' A' ' 72' ' ' VAL . 1.3 t -88.4 178.78 6.47 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.043 -1.036 . . . . 0.0 110.376 -179.661 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -86.71 -89.05 0.12 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.338 -0.851 . . . . 0.0 110.278 -179.763 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -63.61 179.99 0.42 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.246 -0.909 . . . . 0.0 110.078 179.903 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.535 ' N ' ' HA ' ' A' ' 38' ' ' ALA . . . -77.16 136.18 38.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.282 -0.886 . . . . 0.0 110.47 -179.656 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.648 ' CZ2' ' CG1' ' A' ' 36' ' ' VAL . 8.4 p90 -135.56 -156.09 0.69 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.372 -0.83 . . . . 0.0 109.756 179.38 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.529 ' O ' ' CB ' ' A' ' 68' ' ' ALA . 0.6 OUTLIER -160.34 172.2 17.75 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.875 -1.13 . . . . 0.0 111.039 -178.548 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.498 ' HG ' ' CD1' ' A' ' 95' ' ' LEU . 2.3 mp -132.23 127.99 36.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.498 -0.751 . . . . 0.0 109.253 179.272 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 140' ' ' CYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 4.9 m -123.96 96.51 4.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.067 -1.021 . . . . 0.0 111.134 -179.35 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.483 ' O ' ' HB3' ' A' ' 142' ' ' ASP . 0.9 OUTLIER -89.74 -176.14 4.87 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.267 -0.895 . . . . 0.0 108.88 178.774 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.534 ' HB3' ' CB ' ' A' ' 31' ' ' ALA . 0.5 OUTLIER 170.6 43.96 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.929 -1.107 . . . . 0.0 111.003 179.98 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.492 ' HB2' ' O ' ' A' ' 142' ' ' ASP . 11.3 t70 174.01 61.47 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.36 -0.838 . . . . 0.0 109.505 179.63 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.497 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 1.1 t -95.17 114.68 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.096 -1.003 . . . . 0.0 110.308 -179.399 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.527 ' CB ' ' HG3' ' A' ' 6' ' ' GLU . . . -138.27 145.29 41.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.339 -0.851 . . . . 0.0 110.229 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.442 HD22 HD12 ' A' ' 54' ' ' ILE . 6.7 tp -153.47 129.57 10.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.238 -0.914 . . . . 0.0 110.219 179.969 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.46 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 1.5 t0 -160.04 155.06 24.68 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.24 -0.912 . . . . 0.0 110.267 179.963 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.464 ' HA ' ' O ' ' A' ' 59' ' ' THR . 1.7 t . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.258 -0.901 . . . . 0.0 110.248 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.226 0.536 . . . . 0.0 110.184 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 p -116.63 133.24 23.05 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.254 -0.903 . . . . 0.0 110.244 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -76.41 -156.45 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.938 1.494 . . . . 0.0 110.068 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.526 ' CD1' ' O ' ' A' ' 144' ' ' VAL . 9.4 pt -93.64 -22.93 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.241 -0.912 . . . . 0.0 110.165 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.425 ' O ' HG21 ' A' ' 8' ' ' THR . . . 123.11 119.3 2.5 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -57.46 94.58 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.246 -1.149 . . . . 0.0 110.03 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.467 ' HA2' ' HA ' ' A' ' 143' ' ' ASP . . . 100.03 78.74 1.39 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.464 HG23 HG13 ' A' ' 4' ' ' ILE . 7.2 p -95.12 -170.53 2.21 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.286 -1.126 . . . . 0.0 110.336 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.592 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 5.5 m-30 58.62 14.52 3.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.396 -0.815 . . . . 0.0 110.322 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.562 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 26.8 p-10 -88.86 23.88 2.21 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.178 -0.951 . . . . 0.0 109.967 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.562 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.6 OUTLIER 161.36 -24.24 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.422 0.629 . . . . 0.0 109.444 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -158.51 153.56 24.7 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.429 ' HB3' ' CD1' ' A' ' 32' ' ' LEU . 45.6 Cg_endo -72.37 -3.13 12.81 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.96 1.505 . . . . 0.0 110.458 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.422 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 0.3 OUTLIER 60.13 -88.62 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.28 -0.887 . . . . 0.0 110.353 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.436 ' O ' ' C ' ' A' ' 16' ' ' TRP . . . -132.14 -21.33 0.97 Allowed Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.886 -1.15 . . . . 0.0 110.381 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.574 ' CZ2' HD11 ' A' ' 125' ' ' ILE . 56.1 m95 -41.51 121.87 1.79 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.09 -1.241 . . . . 0.0 110.565 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.533 ' O ' ' CG1' ' A' ' 47' ' ' VAL . 1.2 m -115.5 150.82 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.276 -0.89 . . . . 0.0 109.611 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.579 ' CB ' ' CD2' ' A' ' 25' ' ' LEU . . . -130.21 123.0 29.18 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.061 -1.025 . . . . 0.0 109.818 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.466 ' O ' HG11 ' A' ' 45' ' ' VAL . 23.4 p90 -108.68 157.26 18.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.51 -0.744 . . . . 0.0 110.486 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.495 ' O ' ' CG1' ' A' ' 45' ' ' VAL . . . 78.81 29.37 52.09 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.474 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 24.0 p -136.29 -160.96 1.11 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.219 -1.165 . . . . 0.0 110.466 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.455 ' O ' ' O ' ' A' ' 23' ' ' GLY . 15.0 t0 -99.46 131.96 45.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.368 -0.832 . . . . 0.0 110.318 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 22' ' ' ASP . . . 43.46 -166.18 0.02 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.3 -159.58 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.039 1.547 . . . . 0.0 110.46 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.579 ' CD2' ' CB ' ' A' ' 18' ' ' ALA . 7.9 mt -87.41 160.36 18.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.221 -0.925 . . . . 0.0 110.184 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -126.66 122.88 36.22 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.26 -0.9 . . . . 0.0 110.174 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.444 ' O ' ' C ' ' A' ' 28' ' ' SER . 2.2 p -119.51 -84.39 0.66 Allowed 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.373 -0.829 . . . . 0.0 109.801 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.455 ' O ' ' HB ' ' A' ' 29' ' ' THR . 36.5 m 37.09 55.84 1.27 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.644 -0.66 . . . . 0.0 110.972 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.455 ' HB ' ' O ' ' A' ' 28' ' ' SER . 13.0 t -177.56 -32.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.115 -0.99 . . . . 0.0 110.411 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' A' ' 9' ' ' PHE . . . 121.46 13.64 5.16 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -150.15 123.05 8.73 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -1.159 . . . . 0.0 110.14 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.429 ' CD1' ' HB3' ' A' ' 13' ' ' PRO . 0.9 OUTLIER -62.25 103.85 0.43 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -0.922 . . . . 0.0 109.841 179.788 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 36.6 m -107.99 103.5 12.74 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.14 -0.975 . . . . 0.0 110.864 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.477 ' O ' ' OG1' ' A' ' 138' ' ' THR . 17.5 m -89.87 141.74 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.234 -0.916 . . . . 0.0 109.218 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.466 ' HA ' ' OG1' ' A' ' 138' ' ' THR . . . -89.63 106.05 18.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.158 -0.964 . . . . 0.0 111.137 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.583 ' CG1' ' CZ2' ' A' ' 137' ' ' TRP . 94.2 t -84.48 121.22 74.98 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.235 -0.916 . . . . 0.0 109.191 178.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 21' ' ' THR . 46.9 Cg_endo -74.71 137.27 22.2 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.937 1.493 . . . . 0.0 111.043 -178.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.501 ' HA ' ' HA ' ' A' ' 136' ' ' ALA . . . -45.52 170.59 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.337 -0.852 . . . . 0.0 109.766 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 45.86 48.33 13.66 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.595 ' HB2' ' CZ3' ' A' ' 137' ' ' TRP . 0.6 OUTLIER -86.97 36.12 0.71 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.27 -1.136 . . . . 0.0 109.886 179.675 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.533 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . -89.08 -141.16 0.14 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.643 -0.661 . . . . 0.0 109.859 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.543 ' HG2' ' N ' ' A' ' 43' ' ' TYR . 14.7 pm0 39.88 -140.16 0.07 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.692 -0.63 . . . . 0.0 110.247 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.601 ' CD1' ' O ' ' A' ' 44' ' ' GLY . 5.3 p90 -27.59 -42.55 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.236 0 CA-C-O 121.278 0.561 . . . . 0.0 110.612 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.601 ' O ' ' CD1' ' A' ' 43' ' ' TYR . . . 88.48 136.42 5.5 Favored Glycine 0 N--CA 1.492 2.39 0 C-N-CA 120.257 -0.973 . . . . 0.0 110.998 177.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.516 ' CG2' ' OG ' ' A' ' 40' ' ' SER . 2.3 t -88.95 -177.2 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.426 -1.043 . . . . 0.0 108.489 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.464 ' HA2' ' HG ' ' A' ' 129' ' ' LEU . . . 167.67 175.88 37.88 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 118.819 -1.658 . . . . 0.0 110.838 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.533 ' CG1' ' O ' ' A' ' 17' ' ' VAL . 23.9 t -139.45 132.1 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.717 -0.872 . . . . 0.0 109.552 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.531 HG21 ' CG2' ' A' ' 17' ' ' VAL . 17.3 m -124.63 141.28 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.967 -1.083 . . . . 0.0 110.856 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.573 HD11 ' CG ' ' A' ' 16' ' ' TRP . 10.3 tp -128.23 100.6 5.9 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.374 -0.829 . . . . 0.0 110.131 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.527 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 0.1 OUTLIER -78.22 136.02 37.71 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.261 -0.9 . . . . 0.0 110.259 179.96 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 126.02 72.19 0.2 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.468 HG13 HG12 ' A' ' 54' ' ' ILE . 3.5 t -126.28 161.7 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.221 -1.164 . . . . 0.0 109.97 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -122.53 77.42 1.42 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.2 -0.938 . . . . 0.0 110.373 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.586 HG13 ' CD2' ' A' ' 112' ' ' TYR . 41.2 mm -119.13 151.08 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.248 -0.908 . . . . 0.0 110.07 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.524 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 1.6 pt-20 -150.22 133.19 16.1 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.182 -0.949 . . . . 0.0 110.461 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.524 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 11.7 pt-20 38.28 -153.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.69 -0.631 . . . . 0.0 110.842 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.467 ' N ' ' HG3' ' A' ' 56' ' ' GLU . . . -86.56 86.12 1.55 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.528 ' CG2' ' N ' ' A' ' 59' ' ' THR . 1.3 m -110.65 171.04 7.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.177 -1.19 . . . . 0.0 109.864 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.583 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 1.6 m -89.88 155.59 19.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 0.0 110.154 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.583 ' CG ' ' O ' ' A' ' 59' ' ' THR . 56.3 m-85 -159.91 177.04 11.19 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.355 -0.84 . . . . 0.0 110.132 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 62.8 m -149.91 112.22 4.68 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.312 -0.867 . . . . 0.0 110.126 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.6 tp -89.84 124.49 34.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.243 -0.911 . . . . 0.0 110.095 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' A' ' 102' ' ' VAL . 10.3 mtt180 -131.47 107.45 8.9 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.194 -0.941 . . . . 0.0 110.427 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.55 ' CZ ' HG23 ' A' ' 102' ' ' VAL . 4.6 p90 -147.07 151.61 37.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.288 -0.882 . . . . 0.0 110.125 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.52 ' CG2' ' HA ' ' A' ' 101' ' ' GLN . 0.2 OUTLIER -119.78 92.45 3.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.184 -0.948 . . . . 0.0 109.936 179.86 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.52 ' CB ' HD22 ' A' ' 95' ' ' LEU . . . -89.59 144.85 25.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 110.507 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.456 HG21 ' O ' ' A' ' 98' ' ' GLU . 99.9 m -150.33 116.74 5.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.403 -0.811 . . . . 0.0 110.215 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -103.24 138.73 39.64 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.23 -0.919 . . . . 0.0 110.028 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.1 p -47.65 -24.29 0.88 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.149 -0.969 . . . . 0.0 109.431 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.544 ' CG2' ' HB2' ' A' ' 137' ' ' TRP . 3.6 t -115.38 171.78 7.49 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.496 -0.752 . . . . 0.0 109.979 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.468 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 1.0 OUTLIER -86.16 69.69 10.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.158 -0.963 . . . . 0.0 109.445 179.192 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.529 ' CG2' ' HB2' ' A' ' 133' ' ' SER . 5.1 p -96.2 138.94 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.279 -0.888 . . . . 0.0 111.117 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 97.1 m -120.86 89.47 3.14 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.436 -0.79 . . . . 0.0 108.921 178.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.586 ' HA ' ' CD1' ' A' ' 132' ' ' PHE . 10.7 m -89.64 -147.88 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.22 -0.925 . . . . 0.0 110.587 -179.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.478 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 4.2 mtp180 -128.98 144.37 51.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 0.0 110.697 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.519 ' CB ' ' HG3' ' A' ' 93' ' ' PRO . . . -142.91 150.83 40.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.286 -0.884 . . . . 0.0 109.818 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.496 ' C ' ' CD1' ' A' ' 77' ' ' LEU . 2.7 pp 177.58 -159.59 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.237 -0.914 . . . . 0.0 110.479 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.571 HG11 ' CE2' ' A' ' 112' ' ' TYR . 6.1 t -149.36 168.64 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.396 -0.815 . . . . 0.0 109.335 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.497 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . -177.6 -178.94 47.57 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.265 -1.445 . . . . 0.0 110.088 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.484 ' CD ' ' N ' ' A' ' 81' ' ' ASN . 14.5 tp60 -107.93 138.12 44.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.415 -1.05 . . . . 0.0 110.302 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.541 ' ND2' ' NE2' ' A' ' 124' ' ' GLN . 1.2 m-80 -123.94 97.31 5.3 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.633 ' CA ' ' HD2' ' A' ' 121' ' ' PRO . . . 132.23 33.71 0.4 Allowed Glycine 0 N--CA 1.484 1.866 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.577 ' HA ' ' CD2' ' A' ' 85' ' ' TYR . . . 60.41 143.58 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.191 -1.182 . . . . 0.0 110.124 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.468 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.9 Cg_endo -82.67 18.96 17.96 Favored 'Cis proline' 0 C--N 1.314 -1.261 0 C-N-CA 121.872 -2.136 . . . . 0.0 110.807 -0.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.577 ' CD2' ' HA ' ' A' ' 83' ' ' ALA . 89.3 m-85 57.53 -179.95 0.06 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.136 -0.978 . . . . 0.0 110.203 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 127.96 113.57 1.76 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.455 HG21 ' O ' ' A' ' 78' ' ' VAL . 0.8 OUTLIER -97.51 145.89 25.78 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.283 -1.128 . . . . 0.0 110.034 179.779 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.521 ' CG1' ' N ' ' A' ' 109' ' ' SER . 35.9 m -123.73 -17.98 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.193 -0.942 . . . . 0.0 110.384 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.577 HD12 ' CZ ' ' A' ' 106' ' ' PHE . 3.9 mp -103.38 135.27 45.31 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.205 -0.934 . . . . 0.0 111.046 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -150.97 83.55 1.33 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.451 -0.781 . . . . 0.0 109.951 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.5 p -137.9 -179.62 5.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.035 -1.041 . . . . 0.0 110.772 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.7 m -119.71 110.83 36.56 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.403 -0.811 . . . . 0.0 110.063 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.535 ' HG2' ' CG2' ' A' ' 74' ' ' VAL . 44.3 Cg_endo -71.58 94.0 0.68 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.04 1.548 . . . . 0.0 110.813 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.527 ' CB ' ' HD2' ' A' ' 100' ' ' ARG . . . -71.75 151.86 43.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.234 -0.916 . . . . 0.0 109.625 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.524 ' CD1' ' HG ' ' A' ' 139' ' ' LEU . 97.6 mt -143.77 162.82 35.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.05 -1.031 . . . . 0.0 110.493 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 70' ' ' THR . 0.3 OUTLIER 179.75 -179.08 0.43 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.39 -0.818 . . . . 0.0 110.018 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.95 -24.5 64.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.256 -0.902 . . . . 0.0 110.07 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.456 ' O ' HG21 ' A' ' 67' ' ' THR . 1.5 mt-10 -89.92 164.48 28.31 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.281 -0.887 . . . . 0.0 110.06 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.449 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 46.1 Cg_endo -73.0 136.77 25.43 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.008 1.53 . . . . 0.0 110.366 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.527 ' HD2' ' CB ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.6 80.42 1.57 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.17 -0.956 . . . . 0.0 110.188 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.52 ' HA ' ' CG2' ' A' ' 65' ' ' THR . 16.3 tt0 -68.73 154.73 41.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.299 -0.876 . . . . 0.0 110.195 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.55 HG23 ' CZ ' ' A' ' 64' ' ' TYR . 95.6 t -135.5 135.52 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.284 -0.885 . . . . 0.0 110.135 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.06 111.0 4.33 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.26 -0.9 . . . . 0.0 110.19 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -158.25 134.74 9.52 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.164 -0.96 . . . . 0.0 110.361 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 10.1 t -95.77 113.73 25.39 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.245 -0.909 . . . . 0.0 110.091 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.577 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 30.6 p90 -111.72 154.79 24.48 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.909 . . . . 0.0 110.286 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.417 ' O ' ' N ' ' A' ' 109' ' ' SER . 6.6 m -91.7 91.87 8.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.286 -0.884 . . . . 0.0 110.044 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.567 ' HB1' ' CD2' ' A' ' 60' ' ' TYR . . . -48.54 96.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.235 -0.915 . . . . 0.0 110.303 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.521 ' N ' ' CG1' ' A' ' 88' ' ' VAL . 16.1 p -85.99 49.96 1.88 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.256 -0.902 . . . . 0.0 110.124 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -156.23 -154.43 0.48 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.297 -0.877 . . . . 0.0 110.136 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.2 m -152.4 112.5 4.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.209 -0.932 . . . . 0.0 110.304 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.586 ' CD2' HG13 ' A' ' 54' ' ' ILE . 13.5 m-30 -107.03 93.16 8.65 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.277 -0.889 . . . . 0.0 109.9 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.471 ' HD2' ' OE1' ' A' ' 80' ' ' GLN . 45.3 Cg_endo -72.26 179.61 4.85 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.942 1.496 . . . . 0.0 110.41 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -129.62 63.62 1.51 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.245 -0.909 . . . . 0.0 110.206 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.463 ' O ' ' O ' ' A' ' 120' ' ' ASP . 2.8 t -121.93 100.48 43.13 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.279 -0.888 . . . . 0.0 110.155 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.92 81.7 1.62 Allowed 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.036 1.545 . . . . 0.0 110.449 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.524 ' CB ' ' HB2' ' A' ' 120' ' ' ASP . . . -122.7 166.51 14.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.27 -0.894 . . . . 0.0 110.213 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.47 -63.49 1.21 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.238 -0.914 . . . . 0.0 110.205 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -87.65 26.9 1.2 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.275 -0.891 . . . . 0.0 110.326 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.524 ' HB2' ' CB ' ' A' ' 117' ' ' ALA . 1.4 m-20 -150.04 72.52 9.44 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.177 -0.952 . . . . 0.0 110.255 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.633 ' HD2' ' CA ' ' A' ' 82' ' ' GLY . 44.5 Cg_endo -76.14 17.95 0.69 Allowed 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 124.032 1.543 . . . . 0.0 112.598 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.525 ' O ' ' O ' ' A' ' 121' ' ' PRO . 2.2 pm0 40.5 -173.31 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 CA-C-O 121.515 0.674 . . . . 0.0 111.794 178.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -100.99 155.56 19.22 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.976 -1.249 . . . . 0.0 109.976 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.541 ' NE2' ' ND2' ' A' ' 81' ' ' ASN . 1.4 pt20 -150.55 -149.9 0.32 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.398 -1.06 . . . . 0.0 110.395 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.574 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 9.6 mt -118.37 138.62 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.588 -0.695 . . . . 0.0 109.136 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -115.42 122.24 45.21 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.205 -0.934 . . . . 0.0 111.169 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.477 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 4.6 m-85 -119.15 109.05 15.42 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 178.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.473 ' O ' ' HB ' ' A' ' 74' ' ' VAL . 2.0 mt-30 -88.85 91.84 8.98 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.105 -0.997 . . . . 0.0 111.141 -178.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.525 HD23 ' CD2' ' A' ' 139' ' ' LEU . 15.5 mt -93.23 41.89 1.09 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.451 -0.78 . . . . 0.0 109.286 178.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.527 ' HA3' ' CA ' ' A' ' 44' ' ' GLY . . . -130.49 140.16 11.53 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.475 ' O ' ' CG ' ' A' ' 132' ' ' PHE . . . 71.4 61.7 3.79 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.586 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 38.4 m-85 -154.67 -78.32 0.1 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.243 -1.151 . . . . 0.0 110.182 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.576 ' O ' ' CZ3' ' A' ' 137' ' ' TRP . 1.3 t -89.67 119.57 30.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.123 -0.986 . . . . 0.0 110.116 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.401 ' O ' ' O ' ' A' ' 135' ' ' ASP . . . -62.44 -71.67 0.15 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.228 -0.92 . . . . 0.0 110.274 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.401 ' O ' ' O ' ' A' ' 134' ' ' ALA . 0.8 OUTLIER -53.82 -173.29 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.292 -0.88 . . . . 0.0 110.343 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.501 ' HA ' ' HA ' ' A' ' 38' ' ' ALA . . . -83.51 141.08 31.89 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.269 -0.894 . . . . 0.0 110.302 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.595 ' CZ3' ' HB2' ' A' ' 40' ' ' SER . 7.3 p90 -151.5 -164.19 1.93 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.323 -0.861 . . . . 0.0 109.964 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.527 ' O ' ' CB ' ' A' ' 68' ' ' ALA . 0.5 OUTLIER -160.4 173.47 15.57 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.0 -1.08 . . . . 0.0 111.106 -178.493 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.525 ' CD2' HD23 ' A' ' 129' ' ' LEU . 2.6 mp -129.64 129.37 44.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.447 -0.783 . . . . 0.0 109.576 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' CYS . . . . . . . . . . . . . 6.6 m -124.37 93.26 3.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.129 -0.982 . . . . 0.0 110.938 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.475 ' HA ' ' O ' ' A' ' 65' ' ' THR . 0.7 OUTLIER -89.86 -175.42 4.61 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.179 -0.951 . . . . 0.0 109.414 179.147 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.513 ' O ' ' CB ' ' A' ' 143' ' ' ASP . 1.1 p30 176.76 124.27 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.054 -1.029 . . . . 0.0 110.842 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.513 ' CB ' ' O ' ' A' ' 142' ' ' ASP . 0.3 OUTLIER 70.94 61.29 0.18 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.288 -0.882 . . . . 0.0 110.654 179.479 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.568 HG22 ' CE2' ' A' ' 9' ' ' PHE . 42.0 t -94.46 111.4 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -0.914 . . . . 0.0 109.73 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -120.46 163.56 17.74 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.233 -0.917 . . . . 0.0 110.47 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.526 HD12 ' CE2' ' A' ' 106' ' ' PHE . 14.0 tp -167.3 88.18 0.29 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.409 -0.807 . . . . 0.0 110.085 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.463 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 7.6 t70 -123.37 165.17 17.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.269 -0.895 . . . . 0.0 110.289 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.508 ' HB3' ' CE1' ' A' ' 60' ' ' TYR . 12.7 p -95.43 119.9 34.73 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 0.0 110.317 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.458 ' HB3' ' O ' ' A' ' 148' ' ' SER . 2.4 tp10 58.44 118.91 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.321 -0.862 . . . . 0.0 110.331 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 9.4 p -149.03 166.16 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.262 -0.899 . . . . 0.0 110.127 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -48.41 165.95 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.26 -0.9 . . . . 0.0 110.225 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.3 pp . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.197 -179.983 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.431 ' O ' ' HB3' ' A' ' 53' ' ' ALA . . . . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.266 0.555 . . . . 0.0 110.227 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 55.21 59.26 10.4 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.267 -0.896 . . . . 0.0 110.217 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -75.78 -156.44 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.991 1.522 . . . . 0.0 110.123 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.524 ' CG2' ' O ' ' A' ' 51' ' ' GLY . 13.1 pt -95.98 31.16 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.234 -0.916 . . . . 0.0 110.251 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 91.58 -29.32 7.38 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 51.67 66.98 1.04 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.252 -1.146 . . . . 0.0 110.24 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 143' ' ' ASP . . . -148.36 -179.99 24.75 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.476 ' CG2' ' HB2' ' A' ' 143' ' ' ASP . 0.8 OUTLIER -98.31 51.64 1.02 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.201 -1.176 . . . . 0.0 110.151 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.567 ' CE2' HG22 ' A' ' 144' ' ' VAL . 69.3 m-85 43.16 36.31 0.97 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.274 -0.891 . . . . 0.0 110.095 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.556 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 5.1 p30 -84.68 44.48 1.06 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.316 -0.865 . . . . 0.0 110.299 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.556 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 2.4 t70 161.58 78.42 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.336 0.589 . . . . 0.0 109.433 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.66 159.58 7.0 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.522 ' HB3' ' CD1' ' A' ' 32' ' ' LEU . 50.0 Cg_endo -75.75 4.71 4.89 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.016 1.535 . . . . 0.0 110.713 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 2.8 mm-40 65.12 -89.01 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.259 -0.901 . . . . 0.0 110.516 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.442 ' C ' ' CD1' ' A' ' 49' ' ' LEU . . . -139.63 6.99 3.01 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.57 ' CE2' HD21 ' A' ' 49' ' ' LEU . 46.0 m95 -69.52 126.0 28.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.108 -1.23 . . . . 0.0 110.179 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.569 ' CG2' ' CG2' ' A' ' 48' ' ' VAL . 0.9 OUTLIER -126.9 148.6 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.206 -0.934 . . . . 0.0 109.669 179.806 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.522 ' CB ' HD23 ' A' ' 25' ' ' LEU . . . -130.32 142.16 50.55 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.101 -0.999 . . . . 0.0 109.648 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.476 ' CD1' ' N ' ' A' ' 19' ' ' TYR . 23.2 p90 -131.71 164.01 26.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.292 -0.88 . . . . 0.0 110.766 -178.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.478 ' C ' ' CG2' ' A' ' 21' ' ' THR . . . 77.19 40.21 24.96 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.527 HG21 ' CG1' ' A' ' 45' ' ' VAL . 7.9 p -149.88 -143.79 0.14 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.129 -1.218 . . . . 0.0 110.489 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.465 ' O ' ' O ' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -117.29 129.94 56.22 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.244 -0.91 . . . . 0.0 110.355 -179.792 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 22' ' ' ASP . . . 52.21 174.48 0.03 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.38 -159.54 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.064 1.56 . . . . 0.0 110.518 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.582 ' CD2' ' CG1' ' A' ' 34' ' ' VAL . 24.4 mt -78.27 178.52 7.58 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.272 -0.893 . . . . 0.0 110.331 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -145.46 115.0 7.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.318 -0.864 . . . . 0.0 110.102 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.479 ' O ' ' N ' ' A' ' 29' ' ' THR . 1.1 p -119.65 -83.59 0.65 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.308 -0.87 . . . . 0.0 109.921 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 27' ' ' THR . 5.4 p 39.2 28.36 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.498 -0.751 . . . . 0.0 110.637 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.479 ' N ' ' O ' ' A' ' 27' ' ' THR . 8.5 t -153.43 -37.0 0.1 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.149 -0.969 . . . . 0.0 110.385 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.472 ' O ' ' HB2' ' A' ' 9' ' ' PHE . . . 133.97 -2.29 4.36 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -133.15 143.97 49.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.138 -1.213 . . . . 0.0 110.125 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.522 ' CD1' ' HB3' ' A' ' 13' ' ' PRO . 0.6 OUTLIER -83.96 112.31 20.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.24 -0.912 . . . . 0.0 110.055 179.87 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 34.1 m -114.86 116.55 28.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 110.554 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.582 ' CG1' ' CD2' ' A' ' 25' ' ' LEU . 33.2 m -101.1 144.63 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.324 -0.86 . . . . 0.0 109.812 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.503 ' HA ' ' OG1' ' A' ' 138' ' ' THR . . . -93.05 94.02 8.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.189 -0.944 . . . . 0.0 110.547 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.665 ' CG1' ' CZ2' ' A' ' 137' ' ' TRP . 41.9 t -86.23 132.49 43.14 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.377 -0.827 . . . . 0.0 110.099 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.507 ' HD2' HG11 ' A' ' 36' ' ' VAL . 40.0 Cg_endo -66.85 168.95 15.71 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.809 1.426 . . . . 0.0 110.586 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.522 ' N ' ' HA ' ' A' ' 136' ' ' ALA . . . -62.01 121.04 12.02 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.305 -0.872 . . . . 0.0 110.912 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.553 ' O ' ' N ' ' A' ' 41' ' ' ALA . . . 41.6 96.03 0.01 OUTLIER Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.47 ' OG ' ' HA2' ' A' ' 44' ' ' GLY . 0.4 OUTLIER -42.12 93.75 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.428 -1.043 . . . . 0.0 109.786 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' A' ' 39' ' ' GLY . . . -89.38 28.91 1.17 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.695 0.759 . . . . 0.0 110.565 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -128.92 -166.95 1.71 Allowed 'General case' 0 C--N 1.292 -1.904 0 O-C-N 121.773 -0.579 . . . . 0.0 109.779 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.473 ' CD1' ' O ' ' A' ' 44' ' ' GLY . 11.1 p90 -46.54 -24.13 0.48 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.16 -0.962 . . . . 0.0 109.797 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.473 ' O ' ' CD1' ' A' ' 43' ' ' TYR . . . 126.45 140.58 5.29 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.527 ' CG1' HG21 ' A' ' 21' ' ' THR . 19.9 t -89.39 173.65 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.124 -1.221 . . . . 0.0 109.205 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' A' ' 128' ' ' GLN . . . -178.22 -179.42 48.19 Favored Glycine 0 N--CA 1.487 2.098 0 C-N-CA 118.92 -1.61 . . . . 0.0 110.851 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.538 ' CG1' ' O ' ' A' ' 17' ' ' VAL . 21.4 t -150.39 128.48 2.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.569 ' CG2' ' CG2' ' A' ' 17' ' ' VAL . 30.5 m -119.38 132.68 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.018 -1.051 . . . . 0.0 111.106 -178.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.57 HD21 ' CE2' ' A' ' 16' ' ' TRP . 13.8 tp -124.22 91.27 3.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.559 -0.713 . . . . 0.0 110.01 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.439 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 0.1 OUTLIER -66.86 113.88 5.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 110.209 -179.908 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.524 ' O ' ' CG2' ' A' ' 4' ' ' ILE . . . 154.14 83.04 0.04 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.471 HG13 HG12 ' A' ' 54' ' ' ILE . 38.8 t -140.53 160.43 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.197 -1.178 . . . . 0.0 110.207 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.457 ' O ' HD12 ' A' ' 54' ' ' ILE . . . -129.85 90.78 3.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.203 -0.936 . . . . 0.0 110.396 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.622 ' CD1' ' CE1' ' A' ' 60' ' ' TYR . 33.5 mm -124.01 168.7 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.261 -0.899 . . . . 0.0 109.931 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.522 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 1.7 tt0 -162.71 127.72 3.2 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.122 -0.986 . . . . 0.0 110.653 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.522 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 13.1 pt-20 37.74 -152.89 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.635 -0.666 . . . . 0.0 110.984 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.469 ' HA2' ' O ' ' A' ' 108' ' ' ALA . . . -86.76 79.57 1.81 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.576 HG21 ' CE2' ' A' ' 60' ' ' TYR . 1.2 m -108.85 173.71 6.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.253 -1.145 . . . . 0.0 109.804 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.574 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 0.4 OUTLIER -89.8 156.23 18.64 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.287 -0.883 . . . . 0.0 110.281 -179.82 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.622 ' CE1' ' CD1' ' A' ' 54' ' ' ILE . 67.9 m-85 -158.94 167.83 28.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 110.323 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 85.5 m -143.19 115.49 8.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -0.893 . . . . 0.0 110.072 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 28.4 tp -89.76 122.55 32.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.261 -0.899 . . . . 0.0 110.05 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 102' ' ' VAL . 6.1 mtm180 -126.38 125.8 42.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.253 -0.904 . . . . 0.0 110.356 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.634 ' CZ ' ' CG2' ' A' ' 102' ' ' VAL . 5.3 p90 -167.89 151.71 6.2 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.248 -0.908 . . . . 0.0 110.145 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.487 ' CG2' ' HG2' ' A' ' 101' ' ' GLN . 93.6 m -119.65 99.58 6.74 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.242 -0.911 . . . . 0.0 110.063 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.451 ' HB3' HD23 ' A' ' 95' ' ' LEU . . . -100.34 145.59 27.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.327 -0.858 . . . . 0.0 110.364 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.45 ' OG1' ' HA ' ' A' ' 99' ' ' PRO . 43.8 m -148.09 115.92 6.39 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.255 -0.903 . . . . 0.0 110.303 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.463 ' HB3' HD11 ' A' ' 95' ' ' LEU . . . -101.66 141.02 35.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 109.971 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.11 -23.05 1.09 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.129 -0.982 . . . . 0.0 109.41 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.545 ' CG2' ' HB2' ' A' ' 137' ' ' TRP . 2.9 t -116.96 169.69 9.21 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.51 -0.743 . . . . 0.0 110.034 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.499 ' OD1' ' CB ' ' A' ' 96' ' ' THR . 77.0 m-20 -84.57 69.75 10.64 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.13 -0.981 . . . . 0.0 109.289 179.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.516 ' CG2' ' HB2' ' A' ' 133' ' ' SER . 4.8 p -94.47 140.05 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.874 . . . . 0.0 111.273 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 21.4 m -121.72 91.87 3.61 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.417 -0.802 . . . . 0.0 108.916 178.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.591 ' HA ' ' CG ' ' A' ' 132' ' ' PHE . 12.3 m -89.8 -147.56 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.21 -0.931 . . . . 0.0 110.774 -178.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.491 ' CA ' ' HD2' ' A' ' 93' ' ' PRO . 6.9 mtm180 -131.03 139.01 49.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.38 -0.825 . . . . 0.0 110.52 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.517 ' N ' ' HD3' ' A' ' 93' ' ' PRO . . . -138.63 154.52 48.66 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.336 -0.853 . . . . 0.0 109.687 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.578 ' CD1' ' N ' ' A' ' 78' ' ' VAL . 3.9 pp -179.84 -148.36 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.207 -0.933 . . . . 0.0 110.326 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.578 ' N ' ' CD1' ' A' ' 77' ' ' LEU . 3.0 t -150.76 167.68 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.269 -0.894 . . . . 0.0 109.495 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.526 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . -170.69 -171.27 35.86 Favored Glycine 0 N--CA 1.491 2.33 0 C-N-CA 119.277 -1.44 . . . . 0.0 110.338 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.508 ' O ' ' ND2' ' A' ' 81' ' ' ASN . 3.7 tt0 -100.25 -160.96 0.83 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.473 -1.016 . . . . 0.0 110.262 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 80' ' ' GLN . 25.8 m120 -158.18 80.31 0.83 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.235 -0.915 . . . . 0.0 110.229 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.571 ' O ' ' CZ ' ' A' ' 85' ' ' TYR . . . 167.52 -83.8 0.1 OUTLIER Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.425 ' CB ' ' O ' ' A' ' 82' ' ' GLY . . . 173.88 146.89 0.21 Allowed Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.176 -1.191 . . . . 0.0 110.205 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.469 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.4 Cg_endo -84.81 33.68 4.03 Favored 'Cis proline' 0 C--N 1.312 -1.355 0 C-N-CA 121.887 -2.131 . . . . 0.0 110.619 -0.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.571 ' CZ ' ' O ' ' A' ' 82' ' ' GLY . 21.2 m-85 64.14 137.17 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.187 -0.946 . . . . 0.0 110.2 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -153.02 121.4 1.16 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.447 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 2.0 p -96.83 147.78 23.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.203 -1.175 . . . . 0.0 110.261 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.584 ' CG1' ' CB ' ' A' ' 110' ' ' ALA . 33.5 m -119.79 -24.22 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.304 -0.873 . . . . 0.0 109.989 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.576 HD13 ' CE1' ' A' ' 106' ' ' PHE . 3.9 mp -105.76 146.39 29.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.313 -0.867 . . . . 0.0 110.729 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.451 ' O ' HG21 ' A' ' 91' ' ' THR . 23.4 t70 -151.17 81.74 1.31 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.23 -0.919 . . . . 0.0 110.13 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.451 HG21 ' O ' ' A' ' 90' ' ' ASP . 1.2 p -145.4 173.55 11.89 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.071 -1.018 . . . . 0.0 110.578 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 43.3 m -121.78 118.77 29.32 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.348 -0.845 . . . . 0.0 110.093 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.535 ' HG2' ' CG2' ' A' ' 74' ' ' VAL . 46.1 Cg_endo -71.96 146.82 48.1 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.884 1.465 . . . . 0.0 110.966 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.523 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -109.62 148.99 30.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.396 -0.815 . . . . 0.0 109.543 179.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.519 ' CD1' ' HG ' ' A' ' 139' ' ' LEU . 70.9 mt -140.13 172.43 12.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.085 -1.009 . . . . 0.0 110.609 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.499 ' CB ' ' OD1' ' A' ' 71' ' ' ASP . 0.1 OUTLIER 169.16 -179.15 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.467 -0.771 . . . . 0.0 109.888 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.4 ' N ' ' OG1' ' A' ' 96' ' ' THR . 0.1 OUTLIER -62.88 -12.7 26.74 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.223 -0.923 . . . . 0.0 109.734 179.765 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.532 ' CG ' ' HD2' ' A' ' 99' ' ' PRO . 33.9 tt0 -100.2 149.21 35.83 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.433 -0.792 . . . . 0.0 109.89 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.532 ' HD2' ' CG ' ' A' ' 98' ' ' GLU . 41.8 Cg_endo -68.71 131.25 22.32 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.877 1.462 . . . . 0.0 110.248 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.523 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 11.6 ttt-85 -119.66 92.22 3.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.243 -0.91 . . . . 0.0 110.5 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.487 ' HG2' ' CG2' ' A' ' 65' ' ' THR . 0.0 OUTLIER -71.49 160.84 32.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.329 -0.857 . . . . 0.0 109.771 179.629 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.634 ' CG2' ' CZ ' ' A' ' 64' ' ' TYR . 38.9 t -131.05 133.91 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.135 -0.978 . . . . 0.0 110.444 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.39 88.34 1.5 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.341 -0.85 . . . . 0.0 110.105 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -139.72 151.77 46.12 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.162 -0.962 . . . . 0.0 110.387 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.472 ' CG2' ' O ' ' A' ' 60' ' ' TYR . 90.6 m -111.3 137.23 49.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.325 -0.859 . . . . 0.0 110.15 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.576 ' CE1' HD13 ' A' ' 89' ' ' LEU . 51.3 p90 -132.5 156.61 46.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.271 -0.893 . . . . 0.0 110.217 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.6 m -90.29 88.29 7.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.292 -0.88 . . . . 0.0 110.102 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.575 ' HB2' ' CE2' ' A' ' 60' ' ' TYR . . . -47.26 104.22 0.05 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.894 . . . . 0.0 110.347 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 84.9 p -91.54 53.63 2.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.247 -0.908 . . . . 0.0 110.162 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.584 ' CB ' ' CG1' ' A' ' 88' ' ' VAL . . . -166.13 -156.34 0.25 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.239 -0.913 . . . . 0.0 110.316 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 12.3 m -146.18 117.1 7.72 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.305 -0.872 . . . . 0.0 110.287 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.578 ' CG ' ' HA3' ' A' ' 123' ' ' GLY . 20.7 m-30 -113.31 75.48 2.31 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.887 . . . . 0.0 109.994 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.481 ' O ' ' CB ' ' A' ' 122' ' ' GLU . 45.8 Cg_endo -72.39 136.93 27.28 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.932 1.491 . . . . 0.0 110.422 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -84.4 45.39 1.12 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.315 -0.866 . . . . 0.0 110.293 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.503 ' O ' ' CB ' ' A' ' 120' ' ' ASP . 7.5 t -123.65 85.46 53.13 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.218 -0.926 . . . . 0.0 110.148 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.0 118.19 5.45 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.002 1.527 . . . . 0.0 110.41 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.461 ' HB1' ' HB2' ' A' ' 120' ' ' ASP . . . -147.81 -175.21 4.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.224 -0.922 . . . . 0.0 110.248 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.38 -8.94 36.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.255 -0.903 . . . . 0.0 110.249 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -152.99 17.23 0.57 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.255 -0.903 . . . . 0.0 110.257 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 120' ' ' ASP . 0.8 OUTLIER -109.01 96.75 21.68 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.244 -0.91 . . . . 0.0 110.119 179.913 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.548 ' HB3' ' HA3' ' A' ' 82' ' ' GLY . 44.0 Cg_endo -74.82 126.61 10.2 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.045 1.55 . . . . 0.0 110.736 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.481 ' CB ' ' O ' ' A' ' 113' ' ' PRO . 15.2 pm0 -105.74 -157.42 0.61 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.261 -0.899 . . . . 0.0 109.565 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.578 ' HA3' ' CG ' ' A' ' 112' ' ' TYR . . . -140.21 159.02 26.08 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.519 ' HG2' ' N ' ' A' ' 125' ' ' ILE . 2.1 pm0 -150.5 -160.01 1.11 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.342 -1.093 . . . . 0.0 110.213 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.531 HG23 ' CH2' ' A' ' 16' ' ' TRP . 33.2 mt -118.38 142.45 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.37 -0.831 . . . . 0.0 109.522 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.468 ' O ' ' HA ' ' A' ' 76' ' ' ALA . . . -113.88 115.22 27.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.304 -0.872 . . . . 0.0 111.541 -178.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.522 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 4.5 m-85 -120.58 80.8 1.67 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.474 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 2.9 mt-30 -87.96 115.06 25.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.112 -0.993 . . . . 0.0 111.636 -178.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.579 ' CD1' ' CD1' ' A' ' 139' ' ' LEU . 9.0 mt -98.77 49.66 0.97 Allowed 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 121.835 0.826 . . . . 0.0 108.856 178.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 132' ' ' PHE . . . -53.11 -173.45 0.04 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.45 ' HA2' ' HB3' ' A' ' 40' ' ' SER . . . -52.95 90.24 0.01 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.591 ' CG ' ' HA ' ' A' ' 74' ' ' VAL . 20.1 m-85 -114.87 -56.93 2.33 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.235 -1.156 . . . . 0.0 110.647 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.526 ' HB3' ' CE3' ' A' ' 137' ' ' TRP . 1.4 t -89.42 -177.36 5.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.259 -0.9 . . . . 0.0 110.373 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.455 ' N ' ' OG ' ' A' ' 133' ' ' SER . . . -106.59 -73.74 0.68 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.294 -0.879 . . . . 0.0 110.073 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.43 ' C ' ' HA ' ' A' ' 38' ' ' ALA . 17.3 m-20 -70.09 152.99 43.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.233 -0.917 . . . . 0.0 110.076 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.522 ' HA ' ' N ' ' A' ' 38' ' ' ALA . . . -43.29 120.79 1.99 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.281 -0.887 . . . . 0.0 110.134 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.665 ' CZ2' ' CG1' ' A' ' 36' ' ' VAL . 5.0 p90 -125.27 -169.59 2.02 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.176 -0.952 . . . . 0.0 110.258 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.503 ' OG1' ' HA ' ' A' ' 35' ' ' ALA 0.255 0.9 OUTLIER -159.33 168.65 25.85 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.384 -0.927 . . . . 0.0 110.41 -177.528 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.579 ' CD1' ' CD1' ' A' ' 129' ' ' LEU . 2.2 mp -124.85 125.84 44.61 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.378 -0.826 . . . . 0.0 109.629 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' CYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 22.2 m -122.98 99.5 6.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.117 -0.989 . . . . 0.0 110.76 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.461 ' HA ' ' O ' ' A' ' 65' ' ' THR . 1.5 mt -92.09 -177.17 4.61 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.302 -0.874 . . . . 0.0 109.308 179.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.462 ' O ' ' HB2' ' A' ' 143' ' ' ASP . 2.8 p-10 -169.77 26.09 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.107 -0.996 . . . . 0.0 110.438 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.493 ' O ' ' HA ' ' A' ' 64' ' ' TYR . 0.7 OUTLIER 172.54 130.75 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.317 -0.864 . . . . 0.0 109.87 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.567 HG22 ' CE2' ' A' ' 9' ' ' PHE . 1.3 t -150.48 115.9 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.117 -0.989 . . . . 0.0 109.761 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -140.35 154.44 46.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.252 -0.905 . . . . 0.0 110.495 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.433 ' CD1' ' HB3' ' A' ' 60' ' ' TYR . 61.0 tp -148.07 99.6 3.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.39 -0.819 . . . . 0.0 110.113 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.473 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 1.3 m-20 -102.69 -166.58 1.29 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.238 -0.914 . . . . 0.0 110.243 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.402 ' O ' ' CG1' ' A' ' 150' ' ' VAL . 1.5 p -128.21 -177.52 4.18 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.278 -0.889 . . . . 0.0 110.154 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -53.79 96.43 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.288 -0.883 . . . . 0.0 110.214 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.402 ' CG1' ' O ' ' A' ' 148' ' ' SER . 12.4 m -123.62 19.99 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.276 -0.89 . . . . 0.0 110.202 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.456 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 7.4 pt-20 -65.34 157.62 28.69 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.205 -0.934 . . . . 0.0 110.238 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.456 ' HB2' ' O ' ' A' ' 151' ' ' GLU . 1.2 tt . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.217 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.527 ' O ' ' CB ' ' A' ' 53' ' ' ALA . . . . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.232 0.539 . . . . 0.0 110.157 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.403 ' HB3' HG11 ' A' ' 52' ' ' VAL . 91.2 p -107.26 88.86 4.23 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.191 -0.943 . . . . 0.0 110.191 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 1' ' ' ALA . 47.0 Cg_endo -73.52 77.97 2.46 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.022 1.538 . . . . 0.0 110.645 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.46 ' O ' ' OE1' ' A' ' 14' ' ' GLU . 27.9 pt -97.11 42.78 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.16 -0.962 . . . . 0.0 109.928 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 6' ' ' GLU . . . 97.98 -16.84 59.64 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' A' ' 5' ' ' GLY . 3.3 tt0 42.5 30.73 0.23 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.316 -1.109 . . . . 0.0 110.193 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.416 ' C ' HG21 ' A' ' 8' ' ' THR . . . -159.86 -130.73 1.16 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.525 HG23 ' CA ' ' A' ' 143' ' ' ASP . 40.1 p -126.83 -172.39 2.63 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.273 -1.133 . . . . 0.0 110.443 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.573 ' CD2' ' HB2' ' A' ' 32' ' ' LEU . 5.8 m-30 -94.4 47.68 1.2 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.326 -0.859 . . . . 0.0 110.097 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.555 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 32.6 p30 -87.78 36.89 0.77 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.247 -0.908 . . . . 0.0 110.2 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.555 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.7 OUTLIER 161.46 37.47 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.678 -0.639 . . . . 0.0 109.686 -179.891 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 124.87 133.18 3.95 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.517 ' O ' ' N ' ' A' ' 15' ' ' GLY . 50.4 Cg_endo -80.43 41.14 1.08 Allowed 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.909 1.479 . . . . 0.0 111.136 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.46 ' OE1' ' O ' ' A' ' 4' ' ' ILE . 0.9 OUTLIER 45.88 -91.99 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.996 -1.065 . . . . 0.0 110.431 179.867 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 13' ' ' PRO . . . -149.07 10.35 1.01 Allowed Glycine 0 N--CA 1.493 2.459 0 C-N-CA 119.779 -1.2 . . . . 0.0 110.331 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.534 ' CG ' HD11 ' A' ' 49' ' ' LEU . 53.5 m95 -53.25 120.35 5.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.006 -1.291 . . . . 0.0 110.154 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.522 ' O ' ' CG1' ' A' ' 47' ' ' VAL . 0.9 OUTLIER -116.36 154.48 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.106 -0.996 . . . . 0.0 109.763 179.77 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.463 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . . . -137.53 139.77 40.69 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.433 -0.792 . . . . 0.0 109.008 179.018 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.576 ' CE2' ' O ' ' A' ' 46' ' ' GLY . 6.1 p90 -123.24 151.4 42.33 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.022 -1.049 . . . . 0.0 111.729 -178.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.577 ' HA2' ' CE1' ' A' ' 43' ' ' TYR . . . 133.59 -77.05 0.39 Allowed Glycine 0 N--CA 1.495 2.629 0 N-CA-C 108.899 -1.681 . . . . 0.0 108.899 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.576 HG21 ' CE2' ' A' ' 43' ' ' TYR . 5.5 p -150.81 19.57 0.8 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.213 -1.169 . . . . 0.0 110.08 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.463 ' O ' ' O ' ' A' ' 23' ' ' GLY . 1.3 p30 -107.44 112.3 25.02 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.301 -0.874 . . . . 0.0 110.09 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 22' ' ' ASP . . . -61.88 -132.49 0.01 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.455 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 46.1 Cg_endo -72.94 122.17 7.91 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.874 1.46 . . . . 0.0 110.215 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.59 ' CD1' ' CD1' ' A' ' 32' ' ' LEU . 8.1 mt -42.23 126.4 3.35 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.254 -0.904 . . . . 0.0 109.911 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 24' ' ' PRO . 11.8 m-20 -88.45 121.97 31.42 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.226 -0.921 . . . . 0.0 110.603 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.481 ' CG2' ' O ' ' A' ' 31' ' ' ALA . 3.0 p -119.96 -82.74 0.65 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.339 -0.851 . . . . 0.0 109.964 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.5 ' O ' ' CB ' ' A' ' 29' ' ' THR . 0.2 OUTLIER 58.28 46.38 15.7 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.247 -0.908 . . . . 0.0 110.662 179.581 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.5 ' CB ' ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER 169.78 -95.37 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.153 -0.967 . . . . 0.0 110.261 179.738 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 9' ' ' PHE . . . -158.39 21.93 0.35 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.481 ' O ' ' CG2' ' A' ' 27' ' ' THR . . . -135.02 162.06 33.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.306 -1.114 . . . . 0.0 110.157 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.59 ' CD1' ' CD1' ' A' ' 25' ' ' LEU . 0.5 OUTLIER -119.17 98.3 6.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.262 -0.899 . . . . 0.0 110.146 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.525 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 0.8 OUTLIER -98.09 113.21 25.03 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.287 -0.883 . . . . 0.0 111.594 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.527 ' CG1' HD21 ' A' ' 25' ' ' LEU . 16.6 m -89.55 147.83 4.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 178.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.454 ' O ' ' HB3' ' A' ' 22' ' ' ASP . . . -89.18 91.09 8.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.361 -0.837 . . . . 0.0 111.409 -178.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.641 ' CG1' ' CZ2' ' A' ' 137' ' ' TRP . 66.6 t -79.67 133.67 58.73 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.376 -0.828 . . . . 0.0 108.888 178.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.534 ' HG2' ' HA ' ' A' ' 40' ' ' SER . 38.4 Cg_endo -66.66 168.34 16.92 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.881 1.464 . . . . 0.0 111.573 -178.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.543 ' HA ' ' N ' ' A' ' 136' ' ' ALA . . . -55.34 124.39 16.94 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.526 -0.734 . . . . 0.0 111.367 -178.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.532 ' O ' ' C ' ' A' ' 40' ' ' SER . . . 39.73 26.08 0.08 OUTLIER Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.556 ' OG ' ' CG2' ' A' ' 45' ' ' VAL . 24.1 t 30.06 66.61 0.12 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.844 -0.797 . . . . 0.0 110.565 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.571 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . -89.06 145.05 25.72 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.659 -0.651 . . . . 0.0 109.661 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.571 ' HG2' ' O ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER 45.77 27.61 0.48 Allowed 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -178.893 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.577 ' CE1' ' HA2' ' A' ' 20' ' ' GLY . 0.1 OUTLIER -151.83 124.65 8.52 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 119.034 -1.066 . . . . 0.0 111.881 -178.19 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.53 ' HA2' ' CA ' ' A' ' 130' ' ' GLY . . . -90.32 95.63 2.11 Favored Glycine 0 C--N 1.296 -1.681 0 N-CA-C 106.615 -2.594 . . . . 0.0 106.615 177.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.576 ' O ' ' CB ' ' A' ' 129' ' ' LEU . 3.2 t -86.55 111.95 22.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 O-C-N 120.968 -1.313 . . . . 0.0 108.127 -178.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.576 ' O ' ' CE2' ' A' ' 19' ' ' TYR . . . -141.88 147.71 19.28 Favored Glycine 0 N--CA 1.484 1.895 0 C-N-CA 118.886 -1.626 . . . . 0.0 109.876 -178.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.522 ' CG1' ' O ' ' A' ' 17' ' ' VAL . 9.3 t -109.92 126.65 67.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.315 -1.109 . . . . 0.0 109.887 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.495 ' CG2' ' CG2' ' A' ' 17' ' ' VAL . 27.6 m -119.73 142.36 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.962 -1.086 . . . . 0.0 110.567 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.534 HD11 ' CG ' ' A' ' 16' ' ' TRP . 6.7 tp -126.04 95.17 4.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.369 -0.832 . . . . 0.0 109.918 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.527 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 0.7 OUTLIER -76.47 144.36 39.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.295 -0.878 . . . . 0.0 110.469 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 123.23 54.9 0.2 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.469 HG13 ' HB2' ' A' ' 112' ' ' TYR . 75.2 t -119.8 164.54 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.148 -1.207 . . . . 0.0 110.218 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 1' ' ' ALA . . . -140.15 84.54 1.97 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.248 -0.908 . . . . 0.0 110.516 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.609 ' CD1' ' CZ ' ' A' ' 60' ' ' TYR . 47.5 mm -111.75 155.21 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.243 -0.911 . . . . 0.0 109.702 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.527 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 0.7 OUTLIER -145.24 132.07 20.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.097 -1.002 . . . . 0.0 110.56 -179.766 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 7.9 pt-20 38.39 -152.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.743 -0.598 . . . . 0.0 110.695 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.498 ' N ' ' HG3' ' A' ' 56' ' ' GLU . . . -88.98 116.99 4.78 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.523 ' CG2' ' CE2' ' A' ' 60' ' ' TYR . 0.9 OUTLIER -136.35 168.27 19.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.279 -1.13 . . . . 0.0 109.769 179.917 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 148' ' ' SER . 1.6 m -90.25 99.48 12.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.284 -0.885 . . . . 0.0 110.578 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.609 ' CZ ' ' CD1' ' A' ' 54' ' ' ILE . 59.9 m-85 -106.33 151.96 24.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.228 -0.92 . . . . 0.0 110.21 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.47 ' N ' HD13 ' A' ' 146' ' ' LEU . 92.9 m -125.3 109.77 13.2 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 110.028 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.465 ' O ' ' HA ' ' A' ' 103' ' ' THR . 14.2 tp -89.94 120.14 30.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.22 -0.925 . . . . 0.0 110.008 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.478 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 20.9 ttp180 -129.45 110.84 12.21 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.896 . . . . 0.0 110.257 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.496 ' CD1' ' C ' ' A' ' 64' ' ' TYR . 8.3 p90 -143.41 155.44 44.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.375 -0.828 . . . . 0.0 109.911 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 4.5 m -119.69 97.72 5.77 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.108 -0.995 . . . . 0.0 109.921 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.467 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -97.9 150.17 21.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.223 -0.923 . . . . 0.0 110.479 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 99.9 m -149.96 130.71 14.12 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.291 -0.88 . . . . 0.0 110.017 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.522 ' HB1' ' CB ' ' A' ' 95' ' ' LEU . . . -119.32 128.92 54.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.235 -0.915 . . . . 0.0 110.205 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.79 -9.23 26.62 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.257 -0.902 . . . . 0.0 110.102 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.542 HG22 ' CB ' ' A' ' 137' ' ' TRP . 6.0 t -114.33 19.53 16.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.238 -0.914 . . . . 0.0 110.095 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.461 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 4.9 t70 43.35 73.56 0.14 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.32 -0.862 . . . . 0.0 109.772 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.528 ' CG1' HD13 ' A' ' 95' ' ' LEU . 5.6 p -109.59 140.48 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.385 -0.822 . . . . 0.0 110.768 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 54.4 m -119.87 83.88 2.12 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.447 -0.783 . . . . 0.0 109.036 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.596 ' HA ' ' CD2' ' A' ' 132' ' ' PHE . 14.2 m -89.83 -139.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.221 -0.925 . . . . 0.0 110.759 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.471 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 0.4 OUTLIER -131.58 142.93 50.01 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.185 -0.947 . . . . 0.0 111.12 -179.075 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.512 ' N ' ' HD3' ' A' ' 93' ' ' PRO . . . -143.91 154.37 43.27 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.472 -0.768 . . . . 0.0 109.44 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.578 ' CD1' ' N ' ' A' ' 78' ' ' VAL . 4.2 pp -179.86 -152.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.116 -0.99 . . . . 0.0 110.5 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.578 ' N ' ' CD1' ' A' ' 77' ' ' LEU . 66.8 t -155.14 168.94 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.392 -0.818 . . . . 0.0 109.251 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.522 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . 173.37 179.37 43.99 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.205 -1.474 . . . . 0.0 110.312 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.476 ' HG2' ' O ' ' A' ' 122' ' ' GLU . 1.0 OUTLIER -72.74 -152.9 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.571 -0.958 . . . . 0.0 110.265 179.932 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.529 ' O ' ' CB ' ' A' ' 121' ' ' PRO . 15.2 m120 -160.57 60.55 0.32 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.541 -0.725 . . . . 0.0 109.317 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.578 ' O ' ' CZ ' ' A' ' 85' ' ' TYR . . . 158.28 -125.97 1.62 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.443 ' HA ' ' CD1' ' A' ' 85' ' ' TYR . . . -125.2 153.2 71.73 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.174 -1.192 . . . . 0.0 110.122 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.479 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.5 Cg_endo -86.07 35.69 3.73 Favored 'Cis proline' 0 C--N 1.311 -1.418 0 C-N-CA 121.854 -2.144 . . . . 0.0 110.614 -0.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.578 ' CZ ' ' O ' ' A' ' 82' ' ' GLY . 76.6 m-85 58.98 148.89 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.178 -0.951 . . . . 0.0 110.226 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -173.19 115.57 0.57 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -110.65 143.63 40.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.238 -1.154 . . . . 0.0 110.376 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.501 HG22 ' CD1' ' A' ' 89' ' ' LEU . 34.6 m -124.43 -15.14 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.265 -0.897 . . . . 0.0 110.38 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.579 HD13 ' CE1' ' A' ' 106' ' ' PHE . 4.2 mp -108.33 137.39 46.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.209 -0.932 . . . . 0.0 111.002 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -151.15 81.27 1.32 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.4 -0.812 . . . . 0.0 109.901 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.5 p -137.76 179.52 6.38 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.994 -1.066 . . . . 0.0 110.699 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.7 m -119.89 115.28 33.48 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.378 -0.826 . . . . 0.0 110.059 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.512 ' HD3' ' N ' ' A' ' 76' ' ' ALA . 44.1 Cg_endo -72.18 92.81 0.73 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.93 1.489 . . . . 0.0 110.919 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.524 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -75.15 147.89 40.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.904 . . . . 0.0 109.568 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.528 HD13 ' CG1' ' A' ' 72' ' ' VAL . 71.1 mt -138.99 162.36 35.09 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.04 -1.038 . . . . 0.0 110.778 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 71' ' ' ASP . 0.3 OUTLIER -174.68 -179.22 1.44 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.438 -0.789 . . . . 0.0 110.088 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.56 -29.19 58.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.285 -0.884 . . . . 0.0 110.068 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.94 161.09 39.3 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.294 -0.879 . . . . 0.0 110.007 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.87 145.11 39.9 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.96 1.505 . . . . 0.0 110.487 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.524 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.85 94.34 4.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.29 -0.881 . . . . 0.0 110.037 179.811 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.434 ' HG3' ' OG1' ' A' ' 65' ' ' THR . 0.0 OUTLIER -84.23 95.07 8.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.385 -0.822 . . . . 0.0 110.198 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 25.2 t -89.54 134.4 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.348 -0.845 . . . . 0.0 110.066 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.52 ' O ' ' CG ' ' A' ' 104' ' ' GLU . 0.2 OUTLIER -150.15 130.72 13.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.327 -0.858 . . . . 0.0 110.163 -179.945 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.52 ' CG ' ' O ' ' A' ' 103' ' ' THR . 21.1 mt-10 -160.1 138.23 10.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.19 -0.944 . . . . 0.0 110.378 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 4.1 t -90.05 76.14 7.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.233 -0.917 . . . . 0.0 110.047 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.579 ' CE1' HD13 ' A' ' 89' ' ' LEU . 30.4 p90 -77.64 153.01 33.56 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.261 -0.9 . . . . 0.0 110.422 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.461 ' HA ' ' O ' ' A' ' 58' ' ' THR . 78.8 m -93.57 98.57 11.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.267 -0.895 . . . . 0.0 109.919 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.587 ' CB ' ' CD2' ' A' ' 60' ' ' TYR . . . -58.47 99.19 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -0.933 . . . . 0.0 110.239 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.416 ' N ' ' CG1' ' A' ' 88' ' ' VAL . 81.6 p -87.05 55.15 3.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.222 -0.924 . . . . 0.0 109.927 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -161.96 -151.42 0.21 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.268 -0.895 . . . . 0.0 110.353 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 31.6 m -157.13 122.43 4.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.319 -0.863 . . . . 0.0 110.398 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.568 ' CD2' HG13 ' A' ' 54' ' ' ILE . 14.3 m-30 -112.73 86.52 8.78 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.312 -0.867 . . . . 0.0 109.766 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.472 ' HG2' ' HA ' ' A' ' 122' ' ' GLU . 43.1 Cg_endo -70.5 163.84 37.4 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.941 1.495 . . . . 0.0 110.4 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -102.97 63.14 0.82 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.222 -0.924 . . . . 0.0 110.295 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.468 ' O ' ' O ' ' A' ' 120' ' ' ASP . 27.2 m -134.27 88.15 31.36 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.268 -0.895 . . . . 0.0 110.14 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.73 91.56 0.89 Allowed 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.965 1.508 . . . . 0.0 110.37 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.443 ' HB2' ' HB2' ' A' ' 120' ' ' ASP . . . -149.97 165.25 33.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.268 -0.895 . . . . 0.0 110.247 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.66 -64.3 0.94 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.248 -0.907 . . . . 0.0 110.208 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.415 ' O ' ' HD3' ' A' ' 121' ' ' PRO . 8.9 t0 -69.09 -31.46 70.22 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.305 -0.872 . . . . 0.0 110.09 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.468 ' O ' ' O ' ' A' ' 115' ' ' THR . 0.6 OUTLIER -107.24 95.32 12.97 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.283 -0.886 . . . . 0.0 110.206 179.96 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.529 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 48.2 Cg_endo -74.9 -164.44 0.23 Allowed 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.037 1.546 . . . . 0.0 110.496 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.48 ' O ' ' N ' ' A' ' 81' ' ' ASN . 0.4 OUTLIER -155.73 -151.11 0.33 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.171 -0.955 . . . . 0.0 110.485 179.899 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.514 ' HA3' ' CB ' ' A' ' 112' ' ' TYR . . . -148.38 140.79 8.56 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.083 -1.607 . . . . 0.0 109.083 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.527 ' CB ' ' HA ' ' A' ' 50' ' ' ASN . 1.0 OUTLIER -150.34 -149.83 0.32 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.134 -1.215 . . . . 0.0 110.731 -179.325 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.479 ' O ' ' NE2' ' A' ' 124' ' ' GLN . 11.4 mt -118.22 150.98 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.481 -0.762 . . . . 0.0 109.409 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -130.13 124.19 32.13 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.271 -0.893 . . . . 0.0 110.801 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.501 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 5.4 m-85 -118.61 106.02 12.2 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.527 ' O ' ' CD2' ' A' ' 129' ' ' LEU . 0.5 OUTLIER -89.58 129.19 36.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.187 -0.945 . . . . 0.0 112.109 -177.711 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.576 ' CB ' ' O ' ' A' ' 45' ' ' VAL . 0.4 OUTLIER -143.73 34.79 1.27 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 178.047 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.53 ' CA ' ' HA2' ' A' ' 44' ' ' GLY . . . -83.8 123.67 6.28 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.301 -1.519 . . . . 0.0 109.301 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 44.91 63.42 2.57 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.596 ' CD2' ' HA ' ' A' ' 74' ' ' VAL . 10.5 m-85 -115.61 -61.8 1.69 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.088 -1.242 . . . . 0.0 111.155 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.576 ' HB3' ' CE3' ' A' ' 137' ' ' TRP . 3.3 t -87.73 -161.25 0.69 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.949 -1.094 . . . . 0.0 110.527 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -119.79 -62.97 1.43 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.169 -0.957 . . . . 0.0 110.557 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -84.54 151.69 24.39 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.107 -0.996 . . . . 0.0 110.042 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.543 ' N ' ' HA ' ' A' ' 38' ' ' ALA . . . -48.59 127.91 14.2 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.331 -0.856 . . . . 0.0 110.543 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.641 ' CZ2' ' CG1' ' A' ' 36' ' ' VAL . 10.5 p90 -139.38 -173.18 3.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.204 -0.935 . . . . 0.0 110.489 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.521 ' CG2' ' N ' ' A' ' 139' ' ' LEU 0.254 0.8 OUTLIER -150.16 176.64 10.66 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.404 -0.81 . . . . 0.0 109.922 -177.799 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.525 ' CD2' HD12 ' A' ' 95' ' ' LEU . 1.9 mp -139.0 117.98 12.48 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.069 -1.019 . . . . 0.0 111.76 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' CYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 0.8 OUTLIER -101.45 116.25 32.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.653 -0.655 . . . . 0.0 110.834 178.7 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.487 ' O ' ' HB3' ' A' ' 142' ' ' ASP . 1.6 mt -110.42 178.85 4.25 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.258 -0.901 . . . . 0.0 109.508 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.487 ' HB3' ' O ' ' A' ' 141' ' ' LEU . 4.7 p-10 174.18 175.96 0.15 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.399 -0.813 . . . . 0.0 110.239 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.525 ' CA ' HG23 ' A' ' 8' ' ' THR . 5.1 t0 41.24 59.33 2.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.541 -0.725 . . . . 0.0 110.076 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 2.8 t -100.57 113.23 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.3 -0.875 . . . . 0.0 110.04 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -136.95 158.87 43.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.24 -0.913 . . . . 0.0 110.377 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.47 HD13 ' N ' ' A' ' 61' ' ' THR . 13.0 tp -167.39 122.09 1.03 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.36 -0.837 . . . . 0.0 110.06 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.453 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 1.5 t70 -139.22 -158.51 0.86 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.229 -0.919 . . . . 0.0 110.312 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' A' ' 59' ' ' THR . 75.0 p -136.05 128.96 31.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.27 -0.894 . . . . 0.0 110.196 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -68.93 174.11 4.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.279 -0.888 . . . . 0.0 110.206 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.508 ' O ' ' CG2' ' A' ' 150' ' ' VAL . 6.3 p -168.92 30.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.223 -0.923 . . . . 0.0 110.194 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 150' ' ' VAL . 1.0 OUTLIER -177.46 125.73 0.14 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.297 -0.877 . . . . 0.0 110.192 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.215 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.41 ' O ' ' CB ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.217 0.532 . . . . 0.0 110.197 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.41 ' CB ' ' O ' ' A' ' 1' ' ' ALA . 0.2 OUTLIER 174.89 85.79 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.241 -0.912 . . . . 0.0 110.224 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -76.02 -156.14 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.07 1.563 . . . . 0.0 110.104 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 14.3 pt -90.24 -32.45 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.238 -0.913 . . . . 0.0 110.163 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 169.16 147.82 5.57 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.42 19.57 2.74 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.277 -1.131 . . . . 0.0 110.194 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.497 ' O ' ' N ' ' A' ' 144' ' ' VAL . . . 161.75 -97.74 0.16 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.529 ' CB ' ' O ' ' A' ' 142' ' ' ASP . 17.1 p -92.07 147.31 23.05 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.23 -1.159 . . . . 0.0 109.95 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.578 ' CE2' ' HB2' ' A' ' 32' ' ' LEU . 21.8 m-85 -44.04 -40.77 5.02 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.312 -0.868 . . . . 0.0 109.408 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.553 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 12.0 t70 31.28 42.27 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.074 0.464 . . . . 0.0 111.299 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.553 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 1.7 t70 161.66 80.87 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.559 -0.713 . . . . 0.0 109.58 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 55.23 173.38 0.1 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.487 ' HB3' ' CD1' ' A' ' 32' ' ' LEU . 47.6 Cg_endo -73.56 -5.42 17.07 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 124.048 1.551 . . . . 0.0 110.519 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 0.5 OUTLIER 65.29 -87.1 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.215 -0.928 . . . . 0.0 110.282 -179.92 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.492 ' C ' ' CD1' ' A' ' 49' ' ' LEU . . . -140.92 6.23 2.58 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.581 ' CE2' HD21 ' A' ' 49' ' ' LEU . 55.0 m95 -71.34 82.6 0.77 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.178 -1.189 . . . . 0.0 110.406 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.6 ' CG2' ' CG2' ' A' ' 48' ' ' VAL . 1.0 OUTLIER -78.53 149.35 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.011 -1.055 . . . . 0.0 109.287 179.559 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.586 ' CB ' ' CG1' ' A' ' 34' ' ' VAL . . . -135.33 132.74 38.03 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.049 -1.032 . . . . 0.0 110.461 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.482 ' O ' ' CD2' ' A' ' 19' ' ' TYR . 11.8 p90 -122.07 115.46 22.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.526 -0.734 . . . . 0.0 110.006 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.522 ' HA3' ' CG1' ' A' ' 45' ' ' VAL . . . -152.96 27.55 0.81 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 20' ' ' GLY . 17.9 p 47.87 21.32 0.28 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.304 -1.115 . . . . 0.0 110.862 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.535 ' HB3' ' CB ' ' A' ' 35' ' ' ALA . 3.2 m-20 -125.15 43.12 3.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.898 -1.126 . . . . 0.0 110.261 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.41 152.07 17.32 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.415 ' O ' ' C ' ' A' ' 25' ' ' LEU . 46.6 Cg_endo -73.09 140.76 31.68 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.989 1.521 . . . . 0.0 110.428 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.518 ' CD1' HD13 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -42.41 156.64 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.316 -0.865 . . . . 0.0 110.219 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -145.12 148.76 33.98 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.262 -0.899 . . . . 0.0 110.261 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.456 ' O ' HG21 ' A' ' 29' ' ' THR . 0.8 OUTLIER -119.89 -74.14 0.62 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.266 -0.896 . . . . 0.0 110.236 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 27' ' ' THR . 2.5 t 43.14 36.05 0.91 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.229 -0.919 . . . . 0.0 110.232 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.456 HG21 ' O ' ' A' ' 27' ' ' THR . 14.9 t -172.65 -34.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.317 -0.864 . . . . 0.0 110.21 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.73 7.88 6.53 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.438 ' CB ' ' HB3' ' A' ' 142' ' ' ASP . . . -130.95 132.21 44.92 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.164 -1.197 . . . . 0.0 110.222 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.578 ' HB2' ' CE2' ' A' ' 9' ' ' PHE . 2.2 tp -74.03 109.06 7.23 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.233 -0.917 . . . . 0.0 110.066 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 9.5 m -111.12 103.36 11.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.151 -0.968 . . . . 0.0 110.774 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.586 ' CG1' ' CB ' ' A' ' 18' ' ' ALA . 25.4 m -89.7 169.44 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.894 . . . . 0.0 109.13 179.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.535 ' CB ' ' HB3' ' A' ' 22' ' ' ASP . . . -122.46 129.22 51.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.904 -1.122 . . . . 0.0 111.317 -179.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.655 ' CG1' ' CZ2' ' A' ' 137' ' ' TRP . 4.5 t -117.1 122.58 31.06 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.508 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 45.4 Cg_endo -74.5 152.65 43.7 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.804 1.423 . . . . 0.0 111.625 -178.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.524 ' HA ' ' CA ' ' A' ' 136' ' ' ALA . . . -42.07 131.39 3.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.32 -0.862 . . . . 0.0 109.892 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 38' ' ' ALA . . . 46.18 71.98 0.45 Allowed Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.558 -1.817 . . . . 0.0 108.558 -179.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.523 ' HB2' ' CG2' ' A' ' 45' ' ' VAL . 0.9 OUTLIER -84.6 34.92 0.54 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.319 -1.106 . . . . 0.0 110.778 -179.354 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.522 ' CB ' ' HA3' ' A' ' 131' ' ' GLY . . . -98.87 20.73 12.63 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.308 -0.87 . . . . 0.0 109.708 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.583 ' HG3' ' CD2' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -95.02 20.25 9.25 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.747 0.785 . . . . 0.0 109.882 179.771 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.584 ' CE1' HG21 ' A' ' 45' ' ' VAL . 24.4 p90 176.86 -29.35 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.497 ' N ' ' CD1' ' A' ' 43' ' ' TYR . . . 99.24 108.91 2.93 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 110.241 -1.143 . . . . 0.0 110.241 179.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.584 HG21 ' CE1' ' A' ' 43' ' ' TYR . 1.9 t -89.99 178.28 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.215 -1.167 . . . . 0.0 108.74 179.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.463 ' CA ' ' HA ' ' A' ' 128' ' ' GLN . . . 162.81 -173.96 39.1 Favored Glycine 0 N--CA 1.487 2.051 0 C-N-CA 118.867 -1.635 . . . . 0.0 110.823 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.519 ' CG1' ' O ' ' A' ' 17' ' ' VAL . 38.9 t -151.06 128.2 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.6 ' CG2' ' CG2' ' A' ' 17' ' ' VAL . 27.6 m -120.55 128.37 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.842 -1.161 . . . . 0.0 110.749 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.581 HD21 ' CE2' ' A' ' 16' ' ' TRP . 19.7 tp -119.29 105.2 11.09 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.367 -0.833 . . . . 0.0 110.3 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.481 ' HA ' ' HB3' ' A' ' 124' ' ' GLN . 0.2 OUTLIER -82.29 103.29 11.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.265 -0.897 . . . . 0.0 110.161 179.826 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.71 69.48 0.02 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.523 ' CG2' ' HA ' ' A' ' 124' ' ' GLN . 38.3 t -119.9 171.78 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.196 -1.179 . . . . 0.0 109.979 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.515 ' N ' ' CG1' ' A' ' 52' ' ' VAL . . . -137.6 78.46 1.69 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.122 -0.987 . . . . 0.0 110.783 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.629 ' CD1' ' CE1' ' A' ' 60' ' ' TYR . 28.2 mm -118.31 160.41 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.21 -0.931 . . . . 0.0 109.712 179.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.527 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 1.2 tt0 -154.46 131.77 11.15 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.026 -1.046 . . . . 0.0 110.82 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 10.8 pt-20 37.58 -154.4 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.726 -0.609 . . . . 0.0 110.981 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 108' ' ' ALA . . . -86.77 91.91 1.76 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.555 ' CG2' ' N ' ' A' ' 59' ' ' THR . 1.2 m -121.36 173.74 7.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.274 -1.133 . . . . 0.0 109.83 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.555 ' N ' ' CG2' ' A' ' 58' ' ' THR . 0.5 OUTLIER -89.72 152.66 21.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.278 -0.889 . . . . 0.0 110.28 -179.913 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.629 ' CE1' ' CD1' ' A' ' 54' ' ' ILE . 54.1 m-85 -156.79 165.33 36.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.286 -0.884 . . . . 0.0 110.344 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 96.2 m -142.78 112.95 7.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.314 -0.866 . . . . 0.0 109.982 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.3 tp -89.76 120.76 31.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 110.148 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.465 ' HA ' ' O ' ' A' ' 102' ' ' VAL . 32.5 ttp180 -130.12 119.48 23.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.339 -0.851 . . . . 0.0 110.119 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.544 ' CZ ' HG23 ' A' ' 102' ' ' VAL . 14.6 p90 -150.91 153.26 34.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.237 -0.915 . . . . 0.0 110.252 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 5.6 m -119.73 94.86 4.55 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.26 -0.9 . . . . 0.0 109.968 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.518 ' HB2' ' CD2' ' A' ' 95' ' ' LEU . . . -99.72 153.33 19.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.324 -0.86 . . . . 0.0 110.401 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.485 ' CA ' HD21 ' A' ' 95' ' ' LEU . 67.9 m -150.1 117.08 5.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.243 -0.911 . . . . 0.0 110.161 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -99.48 140.35 33.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.268 -0.895 . . . . 0.0 109.872 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.409 ' C ' ' O ' ' A' ' 68' ' ' ALA . 22.9 t -44.72 -26.27 0.37 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.185 -0.947 . . . . 0.0 109.282 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.533 HG23 ' CB ' ' A' ' 137' ' ' TRP . 5.0 t -116.99 -152.63 0.51 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.574 -0.704 . . . . 0.0 109.764 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.522 ' N ' HG22 ' A' ' 70' ' ' THR . 0.1 OUTLIER -116.03 62.17 0.71 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.276 -0.89 . . . . 0.0 109.324 179.043 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.537 ' CG2' ' HB2' ' A' ' 133' ' ' SER . 4.5 p -82.95 136.63 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.329 -0.857 . . . . 0.0 111.187 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.3 m -119.79 89.96 3.23 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.602 ' HA ' ' CG ' ' A' ' 132' ' ' PHE . 12.8 m -89.81 -150.39 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.279 -0.888 . . . . 0.0 110.811 -178.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.454 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 6.4 mtm180 -129.83 137.04 50.25 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.319 -0.863 . . . . 0.0 110.63 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.488 ' O ' ' HB3' ' A' ' 77' ' ' LEU . . . -134.24 157.67 45.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.408 -0.808 . . . . 0.0 109.746 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.488 ' HB3' ' O ' ' A' ' 76' ' ' ALA . 3.8 pp 178.66 -156.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.195 -0.94 . . . . 0.0 110.373 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.55 HG11 ' CE2' ' A' ' 112' ' ' TYR . 3.4 t -148.39 167.55 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.296 -0.877 . . . . 0.0 109.565 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.499 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . -178.78 -170.23 40.5 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.343 -1.408 . . . . 0.0 110.202 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.475 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 28.2 tt0 -111.15 118.5 36.13 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.441 -1.035 . . . . 0.0 110.297 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.501 ' CB ' ' OE2' ' A' ' 122' ' ' GLU . 2.5 m120 -85.49 94.51 9.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.221 -0.924 . . . . 0.0 110.166 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.581 ' O ' ' CZ ' ' A' ' 85' ' ' TYR . . . 164.69 -89.53 0.1 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.444 ' CB ' ' O ' ' A' ' 82' ' ' GLY . . . 173.04 144.19 0.17 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.229 -1.159 . . . . 0.0 110.15 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.48 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.6 Cg_endo -84.23 32.87 4.1 Favored 'Cis proline' 0 C--N 1.314 -1.28 0 C-N-CA 121.929 -2.113 . . . . 0.0 110.681 -0.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.581 ' CZ ' ' O ' ' A' ' 82' ' ' GLY . 19.4 m-85 64.76 157.47 0.09 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.16 -0.963 . . . . 0.0 110.246 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.461 ' O ' ' HA2' ' A' ' 79' ' ' GLY . . . -171.74 103.48 0.19 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.455 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 1.7 p -89.87 139.25 30.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.19 -1.182 . . . . 0.0 110.359 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.518 HG22 ' CD1' ' A' ' 89' ' ' LEU . 34.4 m -119.92 -16.79 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.337 -0.852 . . . . 0.0 109.979 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.56 HD13 ' CE1' ' A' ' 106' ' ' PHE . 4.2 mp -108.82 143.34 38.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.292 -0.88 . . . . 0.0 110.775 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -150.78 83.51 1.34 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.34 -0.85 . . . . 0.0 110.125 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.0 p -145.3 174.9 10.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.082 -1.011 . . . . 0.0 110.534 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.5 m -121.38 116.33 30.88 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.33 -0.856 . . . . 0.0 110.145 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.532 ' HG2' ' CG2' ' A' ' 74' ' ' VAL . 43.9 Cg_endo -71.15 124.77 10.79 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.898 1.473 . . . . 0.0 110.962 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.525 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -96.62 148.11 23.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.32 -0.862 . . . . 0.0 109.438 179.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.525 ' CD1' ' HG ' ' A' ' 139' ' ' LEU . 32.2 mt -136.2 166.51 23.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.001 -1.062 . . . . 0.0 110.726 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 70' ' ' THR . 0.2 OUTLIER -164.35 -178.81 5.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.482 -0.761 . . . . 0.0 109.975 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.42 -6.47 30.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.225 -0.922 . . . . 0.0 110.183 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.486 ' CB ' ' HD2' ' A' ' 99' ' ' PRO . 1.5 mt-10 -113.11 178.34 0.99 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.292 -0.88 . . . . 0.0 110.074 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.486 ' HD2' ' CB ' ' A' ' 98' ' ' GLU . 45.6 Cg_endo -72.68 128.03 12.99 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.0 1.527 . . . . 0.0 110.359 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.525 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.77 91.56 3.58 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.26 -0.9 . . . . 0.0 110.217 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.452 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 0.5 OUTLIER -75.78 157.19 33.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.302 -0.874 . . . . 0.0 110.138 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.544 HG23 ' CZ ' ' A' ' 64' ' ' TYR . 41.0 t -135.09 139.26 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.221 -0.924 . . . . 0.0 110.129 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.96 102.43 3.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.263 -0.898 . . . . 0.0 110.194 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -142.01 165.78 26.51 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.239 -0.913 . . . . 0.0 110.171 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.5 t -122.08 167.15 13.48 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.22 -0.925 . . . . 0.0 110.163 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.56 ' CE1' HD13 ' A' ' 89' ' ' LEU . 34.4 p90 -173.3 151.37 2.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.245 -0.909 . . . . 0.0 110.274 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 66.9 m -89.98 96.14 10.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.225 -0.922 . . . . 0.0 110.029 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.596 ' CB ' ' CD2' ' A' ' 60' ' ' TYR . . . -55.17 100.07 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.289 -0.882 . . . . 0.0 110.251 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.448 ' N ' HG13 ' A' ' 88' ' ' VAL . 54.5 p -89.08 52.45 2.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.258 -0.901 . . . . 0.0 110.179 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.488 ' HB1' ' CG1' ' A' ' 88' ' ' VAL . . . -159.22 -155.85 0.49 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.253 -0.904 . . . . 0.0 110.191 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 88.6 m -147.05 111.1 5.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.262 -0.899 . . . . 0.0 110.283 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.55 ' CE2' HG11 ' A' ' 78' ' ' VAL . 15.0 m-30 -111.43 77.04 1.58 Allowed Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.361 -0.837 . . . . 0.0 109.994 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.467 ' O ' ' HB2' ' A' ' 122' ' ' GLU . 44.8 Cg_endo -72.46 177.56 7.24 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.975 1.513 . . . . 0.0 110.419 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.409 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -115.95 34.4 4.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.243 -0.911 . . . . 0.0 110.264 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 120' ' ' ASP . 1.4 m -108.24 89.49 5.85 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.21 -0.931 . . . . 0.0 110.168 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 46.2 Cg_endo -72.87 80.19 1.83 Allowed 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.968 1.51 . . . . 0.0 110.434 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.501 ' CB ' ' HB2' ' A' ' 120' ' ' ASP . . . -132.25 175.02 9.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.253 -0.904 . . . . 0.0 110.132 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.73 -59.8 3.04 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.245 -0.91 . . . . 0.0 110.186 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.88 12.6 5.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.255 -0.903 . . . . 0.0 110.288 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.501 ' HB2' ' CB ' ' A' ' 117' ' ' ALA . 41.0 m-20 -135.55 91.89 17.9 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.28 -0.887 . . . . 0.0 110.239 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.461 ' HB3' ' HA3' ' A' ' 82' ' ' GLY . 47.5 Cg_endo -73.64 172.12 16.4 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.999 1.526 . . . . 0.0 110.416 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.515 ' N ' ' OE1' ' A' ' 122' ' ' GLU . 6.4 pm0 -141.02 -163.88 1.63 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.233 -0.917 . . . . 0.0 110.187 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.527 ' HA3' ' CB ' ' A' ' 112' ' ' TYR . . . -138.12 154.6 22.91 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.523 ' HA ' ' CG2' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -150.25 -162.14 1.49 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -1.176 . . . . 0.0 110.518 -179.716 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.524 HG23 ' CH2' ' A' ' 16' ' ' TRP . 10.1 mt -118.86 144.25 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.486 -0.759 . . . . 0.0 109.503 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.475 ' O ' ' HA ' ' A' ' 76' ' ' ALA . . . -116.28 115.29 25.67 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.453 -0.779 . . . . 0.0 111.41 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.502 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 2.7 m-30 -118.09 75.52 1.01 Allowed 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.463 ' HA ' ' CA ' ' A' ' 46' ' ' GLY . 25.6 mt-30 -88.21 122.72 32.08 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.278 -0.888 . . . . 0.0 112.512 -177.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.55 ' N ' ' CD2' ' A' ' 129' ' ' LEU . 0.6 OUTLIER -108.38 55.6 0.64 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.008 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.463 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -66.04 89.38 0.13 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 -178.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.522 ' HA3' ' CB ' ' A' ' 41' ' ' ALA . . . 39.7 86.04 0.01 OUTLIER Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.999 -1.241 . . . . 0.0 109.999 179.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.602 ' CG ' ' HA ' ' A' ' 74' ' ' VAL . 12.9 m-85 -111.94 -47.95 3.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.191 -1.182 . . . . 0.0 110.348 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.57 ' HB3' ' CE3' ' A' ' 137' ' ' TRP . 37.2 t -89.84 -174.47 4.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.214 -0.929 . . . . 0.0 110.235 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -98.11 -80.6 0.45 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -0.892 . . . . 0.0 110.391 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -63.17 155.81 27.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.211 -0.931 . . . . 0.0 110.425 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.524 ' CA ' ' HA ' ' A' ' 38' ' ' ALA . . . -50.4 128.42 19.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.246 -0.909 . . . . 0.0 110.193 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.655 ' CZ2' ' CG1' ' A' ' 36' ' ' VAL . 11.2 p90 -132.04 -165.03 1.53 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.287 -0.883 . . . . 0.0 110.216 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.528 ' O ' ' CB ' ' A' ' 68' ' ' ALA . 0.5 OUTLIER -160.38 -178.44 6.93 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.683 -178.831 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.525 ' HG ' ' CD1' ' A' ' 95' ' ' LEU . 2.3 mp -141.08 141.22 34.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.348 -0.845 . . . . 0.0 110.129 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' CYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 22.3 m -140.59 103.35 4.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.185 -0.947 . . . . 0.0 110.459 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.486 ' O ' ' HB3' ' A' ' 142' ' ' ASP . 1.0 OUTLIER -96.29 -177.95 4.14 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.2 -0.938 . . . . 0.0 109.926 179.58 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.529 ' O ' ' CB ' ' A' ' 8' ' ' THR . 3.2 p30 168.87 35.68 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.439 -0.788 . . . . 0.0 110.004 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.471 ' O ' ' HA ' ' A' ' 64' ' ' TYR . 3.3 t0 -169.69 43.29 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.32 -0.862 . . . . 0.0 109.676 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.497 ' N ' ' O ' ' A' ' 7' ' ' GLY . 3.5 t -89.7 126.46 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.39 -0.819 . . . . 0.0 110.353 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -149.11 148.32 29.53 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.336 -0.853 . . . . 0.0 110.094 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 47.5 tp -140.41 139.92 35.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.259 -0.901 . . . . 0.0 110.303 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.467 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -151.3 -177.83 6.29 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.281 -0.887 . . . . 0.0 110.031 179.9 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -129.61 175.25 8.95 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.224 -0.922 . . . . 0.0 110.205 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.464 ' O ' ' HB ' ' A' ' 150' ' ' VAL . 0.0 OUTLIER -64.74 86.75 0.05 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.894 . . . . 0.0 110.266 -179.906 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.464 ' HB ' ' O ' ' A' ' 149' ' ' GLU . 14.2 p -178.28 127.66 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.237 -0.914 . . . . 0.0 110.218 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 150' ' ' VAL . 4.7 mm-40 55.62 -172.91 0.06 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.283 -0.885 . . . . 0.0 110.243 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 7.8 mt . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.191 -179.993 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.263 0.554 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.453 ' HB2' ' HD2' ' A' ' 3' ' ' PRO . 9.7 p -165.98 169.01 7.16 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.22 -0.925 . . . . 0.0 110.26 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.453 ' HD2' ' HB2' ' A' ' 2' ' ' SER . 49.5 Cg_endo -75.99 -156.17 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.043 1.549 . . . . 0.0 110.043 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.517 HD13 ' CG1' ' A' ' 144' ' ' VAL . 8.2 pt -89.97 4.49 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.189 -0.944 . . . . 0.0 110.215 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 133.07 -166.43 23.7 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -137.14 76.84 1.61 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.23 -1.159 . . . . 0.0 110.203 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.425 ' C ' ' HA ' ' A' ' 143' ' ' ASP . . . 110.89 -133.13 11.36 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.524 ' CG2' ' O ' ' A' ' 142' ' ' ASP . 80.7 p -76.19 146.42 39.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.256 -1.143 . . . . 0.0 110.252 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.53 ' CE1' ' CD1' ' A' ' 16' ' ' TRP . 43.3 m-85 -42.95 -36.0 1.4 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.343 -0.848 . . . . 0.0 109.968 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.56 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 3.3 p-10 35.53 59.36 0.81 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.653 -0.654 . . . . 0.0 111.417 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.56 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 4.0 t0 162.03 -67.34 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.514 -0.742 . . . . 0.0 109.764 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.45 ' HA2' ' HB ' ' A' ' 27' ' ' THR . . . -174.56 -172.06 39.32 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.528 ' HD3' ' CG2' ' A' ' 27' ' ' THR . 47.3 Cg_endo -74.35 80.91 2.14 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 124.124 1.591 . . . . 0.0 110.384 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -35.8 -65.61 0.24 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.666 -0.646 . . . . 0.0 110.567 -179.853 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.489 ' C ' ' CD1' ' A' ' 49' ' ' LEU . . . -144.73 12.15 1.94 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.567 ' CE2' HD21 ' A' ' 49' ' ' LEU . 51.3 m95 -73.27 108.18 6.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.294 -1.121 . . . . 0.0 110.851 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.536 ' O ' ' CG1' ' A' ' 47' ' ' VAL . 1.4 m -109.0 151.38 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.317 -0.864 . . . . 0.0 109.133 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . . . -130.77 118.14 20.41 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.862 -1.149 . . . . 0.0 109.757 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.571 ' CE2' ' O ' ' A' ' 46' ' ' GLY . 7.4 p90 -107.02 173.63 6.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.513 -0.742 . . . . 0.0 110.861 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.541 ' HA2' ' CE1' ' A' ' 43' ' ' TYR . . . 90.69 -13.94 64.36 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.539 ' CG2' ' HD3' ' A' ' 37' ' ' PRO . 17.8 p -149.93 -141.44 0.11 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.27 -1.135 . . . . 0.0 110.236 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.533 ' CB ' ' HD3' ' A' ' 24' ' ' PRO . 19.4 t0 -89.29 174.47 7.81 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.357 -0.839 . . . . 0.0 109.658 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.585 ' N ' ' HD3' ' A' ' 24' ' ' PRO . . . -122.08 43.82 1.43 Allowed Glycine 0 N--CA 1.488 2.165 0 C-N-CA 119.513 -1.327 . . . . 0.0 110.765 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.585 ' HD3' ' N ' ' A' ' 23' ' ' GLY . 55.8 Cg_endo -80.19 41.12 1.07 Allowed 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 123.458 1.241 . . . . 0.0 110.685 179.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.584 ' CD2' ' CG1' ' A' ' 34' ' ' VAL . 17.4 mt -44.33 93.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.978 -1.076 . . . . 0.0 110.273 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 24' ' ' PRO . 36.0 t0 -74.67 115.82 14.67 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.278 -0.888 . . . . 0.0 109.333 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.528 ' CG2' ' HD3' ' A' ' 13' ' ' PRO . 2.1 p -119.38 -30.97 4.76 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.158 -0.964 . . . . 0.0 110.779 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.519 ' O ' ' CB ' ' A' ' 29' ' ' THR . 3.4 m -53.42 82.75 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.615 -0.678 . . . . 0.0 110.59 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.519 ' CB ' ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER 165.6 -33.14 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.215 -0.928 . . . . 0.0 109.806 -179.542 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.434 ' O ' ' HB3' ' A' ' 142' ' ' ASP . . . 127.51 7.36 4.83 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' A' ' 141' ' ' LEU . . . -150.57 154.95 38.49 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.039 -1.271 . . . . 0.0 110.662 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.494 ' O ' ' O ' ' A' ' 139' ' ' LEU . 2.0 tt -105.4 104.65 14.42 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.369 -0.832 . . . . 0.0 110.239 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.532 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 0.8 OUTLIER -97.65 113.86 25.69 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.223 -0.923 . . . . 0.0 111.449 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.584 ' CG1' ' CD2' ' A' ' 25' ' ' LEU . 18.7 m -89.76 148.8 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 178.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.29 111.0 21.72 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.39 -0.819 . . . . 0.0 111.309 -178.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.637 ' CG1' ' CZ2' ' A' ' 137' ' ' TRP . 55.7 t -105.29 133.36 20.2 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.477 -0.765 . . . . 0.0 109.303 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.539 ' HD3' ' CG2' ' A' ' 21' ' ' THR . 40.2 Cg_endo -67.2 171.84 10.88 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.81 1.426 . . . . 0.0 111.0 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.531 ' HA ' ' N ' ' A' ' 136' ' ' ALA . . . -57.86 129.26 41.08 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.441 -0.787 . . . . 0.0 111.06 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.574 ' O ' ' C ' ' A' ' 40' ' ' SER . . . 40.31 38.95 1.49 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.574 ' C ' ' O ' ' A' ' 39' ' ' GLY . 74.6 p 17.45 59.91 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 117.524 0.662 . . . . 0.0 111.733 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.481 ' O ' ' HB3' ' A' ' 42' ' ' GLN . . . -89.5 104.98 17.49 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.66 0.743 . . . . 0.0 110.52 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.481 ' HB3' ' O ' ' A' ' 41' ' ' ALA . 2.8 pt20 171.32 -169.47 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.842 -0.536 . . . . 0.0 109.709 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.541 ' CE1' ' HA2' ' A' ' 20' ' ' GLY . 3.1 p90 -44.2 -26.14 0.29 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.162 -0.961 . . . . 0.0 109.73 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.511 ' N ' ' CD1' ' A' ' 43' ' ' TYR . . . 123.68 127.73 3.25 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.53 ' CG1' HG22 ' A' ' 21' ' ' THR . 4.0 t -89.45 177.08 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.198 -1.178 . . . . 0.0 109.153 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.571 ' O ' ' CE2' ' A' ' 19' ' ' TYR . . . 165.45 137.63 2.24 Favored Glycine 0 N--CA 1.49 2.275 0 C-N-CA 119.047 -1.549 . . . . 0.0 110.849 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.536 ' CG1' ' O ' ' A' ' 17' ' ' VAL . 21.5 t -104.58 141.55 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.534 -0.98 . . . . 0.0 109.487 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.529 HG22 ' CG2' ' A' ' 17' ' ' VAL . 4.9 m -132.44 143.91 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 120.799 -1.188 . . . . 0.0 110.474 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.567 HD21 ' CE2' ' A' ' 16' ' ' TRP . 25.5 tp -136.72 113.05 9.9 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.313 -0.867 . . . . 0.0 110.09 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.535 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 4.4 t30 -88.9 132.33 34.73 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.204 -0.935 . . . . 0.0 110.561 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.46 ' O ' HG21 ' A' ' 4' ' ' ILE . . . 141.21 72.31 0.04 OUTLIER Glycine 0 N--CA 1.49 2.258 0 C-N-CA 119.826 -1.178 . . . . 0.0 110.204 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.483 HG13 HG12 ' A' ' 54' ' ' ILE . 5.7 t -119.9 173.28 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.025 -1.28 . . . . 0.0 110.009 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.529 ' O ' ' CD1' ' A' ' 54' ' ' ILE . . . -124.4 80.12 1.81 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.06 -1.025 . . . . 0.0 110.806 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.575 HD11 ' CZ ' ' A' ' 60' ' ' TYR . 4.9 mm -142.52 163.63 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.256 -0.902 . . . . 0.0 109.603 179.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.515 ' O ' ' HB3' ' A' ' 56' ' ' GLU . 36.8 tt0 -172.12 27.62 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.02 -1.05 . . . . 0.0 110.557 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.515 ' HB3' ' O ' ' A' ' 55' ' ' GLU . 3.3 pt-20 177.62 -165.52 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.649 -0.657 . . . . 0.0 110.111 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.483 ' N ' ' HG3' ' A' ' 56' ' ' GLU . . . -94.08 68.75 1.4 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.567 ' CG2' ' N ' ' A' ' 59' ' ' THR . 1.2 m -104.4 173.02 6.48 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.463 -1.022 . . . . 0.0 110.393 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.574 ' O ' ' CD2' ' A' ' 60' ' ' TYR . 0.4 OUTLIER -89.79 159.57 16.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.437 -0.789 . . . . 0.0 109.79 179.636 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.592 ' CD2' ' CB ' ' A' ' 108' ' ' ALA . 66.4 m-85 -159.5 -175.51 5.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.29 -0.881 . . . . 0.0 110.23 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 91.5 m -147.68 121.62 9.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.326 -0.859 . . . . 0.0 109.894 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.488 HD23 ' CD2' ' A' ' 89' ' ' LEU . 18.9 tp -89.56 120.43 30.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.205 -0.935 . . . . 0.0 110.15 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.494 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 2.6 ttt180 -124.26 137.57 54.49 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.338 -0.851 . . . . 0.0 109.97 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.633 ' CZ ' ' CG2' ' A' ' 102' ' ' VAL . 0.9 OUTLIER -178.46 142.94 0.25 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.302 -0.874 . . . . 0.0 109.732 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.47 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 96.0 m -119.19 97.86 5.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.187 -0.946 . . . . 0.0 109.892 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.521 ' HB1' ' CD2' ' A' ' 141' ' ' LEU . . . -99.62 149.22 23.5 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.425 -0.797 . . . . 0.0 110.32 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.448 ' OG1' ' HA ' ' A' ' 99' ' ' PRO . 95.4 m -149.79 102.28 3.13 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.321 -0.862 . . . . 0.0 110.197 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -90.01 133.1 35.01 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.289 -0.882 . . . . 0.0 110.008 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.421 ' C ' ' O ' ' A' ' 68' ' ' ALA . 19.2 p -43.99 -26.49 0.29 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.251 -0.906 . . . . 0.0 109.521 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.598 ' CG2' ' CB ' ' A' ' 137' ' ' TRP . 2.4 t -111.23 159.7 17.65 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.457 -0.777 . . . . 0.0 109.987 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 3.1 m-20 -78.75 79.52 5.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.142 -0.974 . . . . 0.0 109.424 179.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.548 ' CG2' ' HB2' ' A' ' 133' ' ' SER . 9.9 p -102.73 139.43 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.18 -0.95 . . . . 0.0 111.27 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 17.8 m -119.86 86.73 2.61 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.603 ' HA ' ' CD1' ' A' ' 132' ' ' PHE . 11.1 m -89.55 -142.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.273 -0.892 . . . . 0.0 110.674 -178.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.519 ' N ' HG22 ' A' ' 74' ' ' VAL . 30.1 mtm-85 -132.56 148.68 52.38 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.281 -0.887 . . . . 0.0 110.456 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.495 ' N ' ' HD3' ' A' ' 93' ' ' PRO . . . -148.25 154.75 40.47 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.238 -0.914 . . . . 0.0 109.826 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.493 ' CD1' ' CB ' ' A' ' 126' ' ' ALA . 3.9 pp 179.0 -156.42 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.253 -0.904 . . . . 0.0 110.467 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.519 HG22 ' CD2' ' A' ' 89' ' ' LEU . 3.9 t -149.41 165.48 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.352 -0.842 . . . . 0.0 109.535 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.551 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . -174.83 -163.64 28.33 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.408 -1.377 . . . . 0.0 110.255 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.518 ' CG ' ' N ' ' A' ' 86' ' ' GLY . 3.3 pt20 -119.84 143.38 47.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.383 -1.069 . . . . 0.0 110.461 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.475 ' HB2' ' HG2' ' A' ' 122' ' ' GLU . 3.6 m-20 -96.22 94.71 7.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.365 -0.834 . . . . 0.0 109.991 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.544 ' C ' ' CE1' ' A' ' 85' ' ' TYR . . . 137.49 149.43 5.57 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.622 ' N ' ' CE1' ' A' ' 85' ' ' TYR . . . -62.44 155.12 69.33 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.303 -1.116 . . . . 0.0 110.298 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.52 ' C ' ' CD2' ' A' ' 85' ' ' TYR . 50.5 Cg_endo -77.41 7.91 18.71 Favored 'Cis proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.636 -2.235 . . . . 0.0 110.803 -0.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.622 ' CE1' ' N ' ' A' ' 83' ' ' ALA . 11.4 m-85 69.94 166.0 0.28 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.306 -0.871 . . . . 0.0 110.161 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.518 ' N ' ' CG ' ' A' ' 80' ' ' GLN . . . 172.69 165.94 30.48 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.428 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 0.8 OUTLIER -143.31 149.1 37.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.274 -1.133 . . . . 0.0 110.239 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.519 ' CG2' HD11 ' A' ' 89' ' ' LEU . 30.3 m -122.14 -18.43 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.25 -0.906 . . . . 0.0 110.285 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.56 HD13 ' CD2' ' A' ' 106' ' ' PHE . 4.3 mp -111.93 143.02 43.6 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.178 -0.951 . . . . 0.0 110.984 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -151.11 88.59 1.46 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.339 -0.85 . . . . 0.0 110.183 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.4 p -153.29 176.96 11.39 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.049 -1.032 . . . . 0.0 110.656 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.2 m -119.89 120.05 30.66 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.348 -0.845 . . . . 0.0 110.072 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.534 ' HG2' ' CG2' ' A' ' 74' ' ' VAL . 46.1 Cg_endo -74.05 127.88 11.77 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.928 1.488 . . . . 0.0 111.076 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.516 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -95.11 149.68 21.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.318 -0.864 . . . . 0.0 109.3 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.533 ' CD1' ' CD2' ' A' ' 139' ' ' LEU . 43.5 mt -145.21 173.5 11.89 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.973 -1.079 . . . . 0.0 110.997 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.471 ' CB ' ' O ' ' A' ' 95' ' ' LEU . 0.1 OUTLIER 169.15 -178.59 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.633 -0.667 . . . . 0.0 109.716 -179.874 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.32 -13.75 21.66 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.126 -0.984 . . . . 0.0 109.806 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.546 ' CG ' ' HD2' ' A' ' 99' ' ' PRO . 33.7 tt0 -95.74 149.56 36.22 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.444 -0.785 . . . . 0.0 109.866 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.546 ' HD2' ' CG ' ' A' ' 98' ' ' GLU . 41.5 Cg_endo -68.11 130.09 20.75 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.807 1.425 . . . . 0.0 110.169 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.516 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.83 91.92 3.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.267 -0.896 . . . . 0.0 110.624 -179.537 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.467 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 31.8 mt-30 -73.54 157.94 35.78 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.273 -0.892 . . . . 0.0 109.632 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.633 ' CG2' ' CZ ' ' A' ' 64' ' ' TYR . 60.4 t -131.29 133.03 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.143 -0.973 . . . . 0.0 110.518 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.49 87.73 1.46 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.406 -0.809 . . . . 0.0 110.009 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.416 ' O ' HG22 ' A' ' 61' ' ' THR . 56.8 mt-10 -125.83 -176.14 3.54 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.203 -0.935 . . . . 0.0 110.377 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 1.8 t -135.64 166.93 22.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.3 -0.875 . . . . 0.0 110.204 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.56 ' CD2' HD13 ' A' ' 89' ' ' LEU . 31.8 p90 -174.74 152.8 1.66 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.22 -0.925 . . . . 0.0 110.196 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.521 ' O ' ' N ' ' A' ' 109' ' ' SER . 4.8 m -89.7 94.95 10.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.192 -0.943 . . . . 0.0 109.97 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.592 ' CB ' ' CD2' ' A' ' 60' ' ' TYR . . . -50.76 89.54 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.301 -0.874 . . . . 0.0 110.014 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 107' ' ' THR . 10.3 p -85.65 53.27 2.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.27 -0.894 . . . . 0.0 109.996 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -157.79 -163.35 1.32 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.178 -0.951 . . . . 0.0 110.392 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.513 ' CG2' ' HA ' ' A' ' 55' ' ' GLU . 97.0 m -136.0 110.63 8.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.272 -0.892 . . . . 0.0 110.286 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.569 ' CG ' ' HA3' ' A' ' 123' ' ' GLY . 15.4 m-30 -109.07 70.75 0.43 Allowed Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.341 -0.849 . . . . 0.0 110.047 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.524 ' CG ' ' O ' ' A' ' 121' ' ' PRO . 46.4 Cg_endo -71.38 120.42 6.95 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 123.802 1.422 . . . . 0.0 110.401 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.459 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -66.39 -8.07 23.33 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.275 -0.89 . . . . 0.0 110.218 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.6 m -107.46 86.56 2.81 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.216 -0.928 . . . . 0.0 110.286 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 45.5 Cg_endo -72.65 151.69 52.55 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.001 1.527 . . . . 0.0 110.441 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.468 ' CB ' ' HB2' ' A' ' 120' ' ' ASP . . . -142.45 -165.88 2.14 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.267 -0.896 . . . . 0.0 110.289 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.58 -11.46 16.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.21 -0.931 . . . . 0.0 110.263 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -156.66 21.46 0.34 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.242 -0.911 . . . . 0.0 110.124 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.468 ' HB2' ' CB ' ' A' ' 117' ' ' ALA . 26.2 m-20 -112.86 102.53 54.79 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.25 -0.906 . . . . 0.0 110.251 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.524 ' O ' ' CG ' ' A' ' 113' ' ' PRO . 47.1 Cg_endo -73.28 135.04 21.92 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.022 1.538 . . . . 0.0 110.271 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.534 ' CG ' ' N ' ' A' ' 123' ' ' GLY . 0.2 OUTLIER -95.58 -143.25 0.26 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.21 -0.931 . . . . 0.0 110.06 179.904 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.569 ' HA3' ' CG ' ' A' ' 112' ' ' TYR . . . -149.86 147.3 17.41 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.535 ' CB ' ' HA ' ' A' ' 50' ' ' ASN . 1.8 pt20 -150.32 -162.56 1.58 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.328 -1.101 . . . . 0.0 110.421 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 13.0 mt -119.12 143.83 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.481 -0.762 . . . . 0.0 109.278 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.493 ' CB ' ' CD1' ' A' ' 77' ' ' LEU . . . -117.04 117.44 29.66 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.178 -0.951 . . . . 0.0 111.048 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.51 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 3.0 m-30 -116.97 102.75 9.62 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.478 ' O ' ' CE2' ' A' ' 132' ' ' PHE . 6.6 mt-30 -88.98 107.77 19.21 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.108 -0.995 . . . . 0.0 111.132 -178.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.508 ' CD2' HG23 ' A' ' 74' ' ' VAL . 16.8 mt -106.35 43.53 1.14 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.5 -0.75 . . . . 0.0 109.035 178.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 131' ' ' GLY . . . -91.68 116.65 5.04 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.546 ' N ' ' OG ' ' A' ' 40' ' ' SER . . . 41.95 90.07 0.01 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.603 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 6.8 m-85 -139.98 -55.73 0.55 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.167 -1.196 . . . . 0.0 110.492 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.575 ' HB3' ' CZ3' ' A' ' 137' ' ' TRP . 1.2 t -88.95 -177.24 5.42 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.945 -1.097 . . . . 0.0 110.29 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.454 ' N ' ' OG ' ' A' ' 133' ' ' SER . . . -100.08 -75.22 0.58 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.226 -0.921 . . . . 0.0 110.393 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' A' ' 136' ' ' ALA . 83.9 m-20 -83.24 153.75 24.54 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.218 -0.927 . . . . 0.0 110.156 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.531 ' N ' ' HA ' ' A' ' 38' ' ' ALA . . . -40.95 142.3 0.5 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.363 -0.836 . . . . 0.0 110.452 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.637 ' CZ2' ' CG1' ' A' ' 36' ' ' VAL . 18.8 p90 -153.46 -159.9 1.05 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.281 -0.887 . . . . 0.0 110.654 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.523 ' O ' ' CB ' ' A' ' 68' ' ' ALA . 0.8 OUTLIER -160.1 176.12 12.16 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.371 -0.83 . . . . 0.0 109.63 -178.4 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.533 ' CD2' ' CD1' ' A' ' 95' ' ' LEU . 1.8 mp -136.66 117.33 13.95 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.905 -1.122 . . . . 0.0 111.89 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' CYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 0.8 OUTLIER -105.37 111.03 23.6 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.662 -0.649 . . . . 0.0 111.176 178.683 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.523 ' O ' ' CB ' ' A' ' 142' ' ' ASP . 1.4 mt -100.78 -179.73 4.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.914 . . . . 0.0 109.08 178.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.524 ' O ' ' CG2' ' A' ' 8' ' ' THR . 0.5 OUTLIER 166.19 64.88 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.327 -0.858 . . . . 0.0 110.073 179.912 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.513 ' CB ' ' O ' ' A' ' 142' ' ' ASP . 0.3 OUTLIER 165.79 42.8 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.374 -0.829 . . . . 0.0 108.962 -179.906 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.517 ' CG1' HD13 ' A' ' 4' ' ' ILE . 1.0 OUTLIER -89.15 120.02 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.542 -0.724 . . . . 0.0 110.593 -178.811 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -157.53 147.35 20.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.471 -0.768 . . . . 0.0 109.778 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.512 ' CD1' ' HB3' ' A' ' 60' ' ' TYR . 42.9 tp -144.07 146.83 33.08 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.254 -0.903 . . . . 0.0 110.342 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 7.1 t0 -177.88 152.12 0.74 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.214 -0.929 . . . . 0.0 110.296 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.521 ' HB3' ' CE1' ' A' ' 60' ' ' TYR . 22.5 p -91.95 -176.02 4.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.286 -0.884 . . . . 0.0 110.174 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -52.91 169.51 0.09 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.226 -0.921 . . . . 0.0 110.143 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 11.4 p -47.48 146.04 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.229 -0.92 . . . . 0.0 110.218 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -168.71 61.15 0.06 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.286 -0.884 . . . . 0.0 110.218 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.207 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.425 ' O ' ' C ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.293 0.568 . . . . 0.0 110.175 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 1' ' ' ALA . 1.6 t -42.95 107.82 0.59 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.193 -0.942 . . . . 0.0 110.138 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.451 ' HG2' ' O ' ' A' ' 51' ' ' GLY . 51.4 Cg_endo -80.82 19.58 1.11 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.998 1.525 . . . . 0.0 111.072 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.455 HG22 HD22 ' A' ' 49' ' ' LEU . 6.7 pt -145.09 11.74 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.968 -1.082 . . . . 0.0 110.221 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 115.07 148.47 9.47 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -89.73 20.8 3.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.234 -1.157 . . . . 0.0 110.24 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.436 ' C ' ' HA ' ' A' ' 143' ' ' ASP . . . 153.86 -125.41 1.74 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 143' ' ' ASP . 0.8 OUTLIER -57.62 132.91 54.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.229 -1.159 . . . . 0.0 110.154 -179.92 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.569 ' O ' ' CB ' ' A' ' 10' ' ' ASP . 11.8 m-85 -43.86 -27.24 0.33 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.32 -0.862 . . . . 0.0 109.527 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.569 ' CB ' ' O ' ' A' ' 9' ' ' PHE . 0.0 OUTLIER 80.34 -43.43 0.24 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 122.038 -0.413 . . . . 0.0 111.062 179.303 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.568 ' HB2' ' O ' ' A' ' 10' ' ' ASP . 9.4 t70 161.93 39.22 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.083 0 CA-C-O 121.904 0.859 . . . . 0.0 109.085 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -176.81 134.74 2.62 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.476 ' HB3' HD13 ' A' ' 32' ' ' LEU . 45.9 Cg_endo -72.86 -15.39 26.53 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.932 1.491 . . . . 0.0 110.43 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 0.3 OUTLIER 63.77 -87.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.237 -0.914 . . . . 0.0 110.184 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.525 ' O ' ' CG1' ' A' ' 17' ' ' VAL . . . -124.35 -14.8 3.52 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.58 ' CZ2' HD21 ' A' ' 49' ' ' LEU . 80.6 m95 -51.82 111.36 0.59 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.263 -1.139 . . . . 0.0 110.593 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.59 ' CG2' ' CG2' ' A' ' 48' ' ' VAL . 1.0 OUTLIER -112.56 148.01 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.142 -0.974 . . . . 0.0 109.528 179.433 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.579 ' CB ' ' CG1' ' A' ' 34' ' ' VAL . . . -129.76 154.02 47.62 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.052 -1.03 . . . . 0.0 109.817 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.571 ' CE2' ' O ' ' A' ' 46' ' ' GLY . 9.4 p90 -145.91 155.58 42.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.915 . . . . 0.0 110.936 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.495 ' C ' ' CG2' ' A' ' 21' ' ' THR . . . 161.83 -93.89 0.12 Allowed Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.016 -1.633 . . . . 0.0 109.016 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.538 ' CG2' ' HG3' ' A' ' 37' ' ' PRO . 11.6 p -151.21 18.19 0.75 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.183 -1.187 . . . . 0.0 110.715 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.57 ' CB ' ' CB ' ' A' ' 35' ' ' ALA . 0.4 OUTLIER -123.87 60.6 1.11 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.037 -1.039 . . . . 0.0 110.229 179.479 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 43.53 -161.7 0.06 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.431 ' O ' ' C ' ' A' ' 25' ' ' LEU . 46.0 Cg_endo -72.86 145.12 39.99 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.973 1.512 . . . . 0.0 110.378 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.531 ' CD2' ' HA ' ' A' ' 17' ' ' VAL . 0.8 OUTLIER -42.66 163.43 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.311 -0.868 . . . . 0.0 110.194 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.28 138.55 45.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.264 -0.898 . . . . 0.0 110.109 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.444 ' O ' ' HB2' ' A' ' 28' ' ' SER . 0.7 OUTLIER -119.85 -78.97 0.6 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.182 -0.949 . . . . 0.0 110.232 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.444 ' HB2' ' O ' ' A' ' 27' ' ' THR . 0.4 OUTLIER 61.43 -87.68 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.257 -0.902 . . . . 0.0 110.227 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.441 HG21 ' O ' ' A' ' 27' ' ' THR . 5.1 t -42.18 -29.99 0.27 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.275 -0.891 . . . . 0.0 110.276 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.461 ' HA2' ' HA ' ' A' ' 11' ' ' ASP . . . 125.39 -26.41 5.49 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.479 ' CB ' ' HB3' ' A' ' 142' ' ' ASP . . . -91.8 136.08 33.42 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.211 -1.17 . . . . 0.0 110.188 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.525 HD13 ' CD1' ' A' ' 25' ' ' LEU . 1.9 tp -68.05 106.25 2.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.163 -0.96 . . . . 0.0 109.806 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 8.9 m -113.86 102.75 10.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.219 -0.925 . . . . 0.0 110.97 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.579 ' CG1' ' CB ' ' A' ' 18' ' ' ALA . 24.0 m -89.76 164.19 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.244 -0.91 . . . . 0.0 108.997 178.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.57 ' CB ' ' CB ' ' A' ' 22' ' ' ASP . . . -112.07 132.14 55.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.942 -1.099 . . . . 0.0 111.139 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.643 ' CG1' ' CZ2' ' A' ' 137' ' ' TRP . 37.2 t -119.66 117.37 32.71 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.543 -0.723 . . . . 0.0 109.325 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.538 ' HG3' ' CG2' ' A' ' 21' ' ' THR . 44.2 Cg_endo -70.38 144.22 50.1 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.885 1.466 . . . . 0.0 111.236 -179.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.488 ' HA ' ' HA ' ' A' ' 136' ' ' ALA . . . -45.34 153.94 0.2 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.375 -0.828 . . . . 0.0 109.83 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 38' ' ' ALA . . . 45.22 59.39 4.61 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.575 ' HB2' ' CH2' ' A' ' 137' ' ' TRP . 0.6 OUTLIER -84.14 36.99 0.59 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.314 -1.109 . . . . 0.0 110.589 -179.625 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -92.44 19.73 6.92 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.96 0.886 . . . . 0.0 109.664 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.583 ' HG3' ' CD2' ' A' ' 43' ' ' TYR . 16.2 pt20 -73.23 -143.19 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.635 ' CD1' ' N ' ' A' ' 44' ' ' GLY . 6.8 p90 -42.05 -27.52 0.13 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.502 -0.749 . . . . 0.0 109.375 179.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.635 ' N ' ' CD1' ' A' ' 43' ' ' TYR . . . 117.66 113.51 2.64 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.472 ' HB ' ' O ' ' A' ' 129' ' ' LEU . 2.6 t -89.55 149.99 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.137 -1.214 . . . . 0.0 108.191 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.571 ' O ' ' CE2' ' A' ' 19' ' ' TYR . . . 179.3 166.97 35.99 Favored Glycine 0 N--CA 1.489 2.178 0 C-N-CA 118.582 -1.771 . . . . 0.0 111.083 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.529 ' CG1' ' O ' ' A' ' 17' ' ' VAL . 38.4 t -122.22 131.41 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.754 -0.851 . . . . 0.0 109.457 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.59 ' CG2' ' CG2' ' A' ' 17' ' ' VAL . 33.0 m -120.14 139.01 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.886 -1.134 . . . . 0.0 110.683 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.58 HD21 ' CZ2' ' A' ' 16' ' ' TRP . 7.7 tp -130.66 87.33 2.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.325 -0.859 . . . . 0.0 110.211 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.541 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 3.5 m120 -69.15 103.3 1.87 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.926 . . . . 0.0 110.276 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.451 ' O ' ' HG2' ' A' ' 3' ' ' PRO . . . 157.02 79.72 0.03 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.526 ' CG2' ' HA ' ' A' ' 124' ' ' GLN . 6.8 t -124.92 160.16 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.167 -1.196 . . . . 0.0 109.933 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.448 ' O ' HD12 ' A' ' 54' ' ' ILE . . . -119.63 89.94 3.23 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.173 -0.955 . . . . 0.0 110.855 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.57 HG13 ' CD2' ' A' ' 112' ' ' TYR . 27.4 mm -130.06 172.79 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.28 -0.887 . . . . 0.0 109.507 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.512 ' N ' HG23 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -177.79 131.51 0.15 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.913 -1.117 . . . . 0.0 111.354 -179.749 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.464 ' O ' ' O ' ' A' ' 108' ' ' ALA . 7.8 mm-40 52.96 -168.45 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.667 -0.646 . . . . 0.0 110.85 178.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.483 ' HA2' ' HA ' ' A' ' 109' ' ' SER . . . -87.24 61.57 4.24 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.357 -1.897 . . . . 0.0 108.357 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.6 HG21 ' CE2' ' A' ' 60' ' ' TYR . 1.0 OUTLIER -96.41 174.43 6.87 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.625 -0.927 . . . . 0.0 110.078 -179.323 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.571 ' O ' ' CD2' ' A' ' 60' ' ' TYR . 7.5 m -89.89 158.8 17.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.331 -0.856 . . . . 0.0 110.487 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.648 ' CD2' ' CB ' ' A' ' 108' ' ' ALA . 66.4 m-85 -159.31 119.81 3.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.381 -0.824 . . . . 0.0 109.917 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 68.9 m -89.91 110.65 21.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.175 -0.953 . . . . 0.0 110.29 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.451 HD21 HD22 ' A' ' 89' ' ' LEU . 17.5 tp -89.76 126.0 35.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.257 -0.902 . . . . 0.0 109.775 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.475 ' O ' ' O ' ' A' ' 143' ' ' ASP . 19.8 mtm105 -132.81 130.46 39.88 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.251 -0.906 . . . . 0.0 110.395 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.575 ' CZ ' ' CG2' ' A' ' 102' ' ' VAL . 5.7 p90 -166.0 149.61 7.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.398 -0.814 . . . . 0.0 109.809 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.522 ' N ' ' OD2' ' A' ' 143' ' ' ASP . 28.9 m -119.58 89.69 3.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.208 -0.932 . . . . 0.0 110.245 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.478 ' C ' ' CD2' ' A' ' 95' ' ' LEU . . . -89.9 149.26 22.7 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.355 -0.84 . . . . 0.0 110.18 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.469 ' OG1' ' HA ' ' A' ' 99' ' ' PRO . 98.8 m -150.19 129.77 13.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.364 -0.835 . . . . 0.0 110.217 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -114.36 142.32 46.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.312 -0.868 . . . . 0.0 109.915 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 68' ' ' ALA . 17.3 m -45.6 -25.64 0.49 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.064 -1.023 . . . . 0.0 109.102 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.555 ' CG2' ' HB2' ' A' ' 137' ' ' TRP . 4.8 t -119.03 -160.55 0.81 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.589 -0.695 . . . . 0.0 109.835 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 4.9 m-20 -107.77 67.98 0.7 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.336 -0.853 . . . . 0.0 109.179 178.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.573 HG22 ' CE2' ' A' ' 137' ' ' TRP . 3.8 p -88.04 135.64 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.33 -0.856 . . . . 0.0 111.374 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.438 ' O ' HG21 ' A' ' 73' ' ' THR . 7.4 m -121.92 91.42 3.51 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.586 ' HA ' ' CD1' ' A' ' 132' ' ' PHE . 5.3 m -89.56 -158.93 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.172 -0.955 . . . . 0.0 110.88 -178.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 14.4 mtm-85 -119.15 107.51 13.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.264 -0.897 . . . . 0.0 110.886 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.492 ' O ' ' HB3' ' A' ' 77' ' ' LEU . . . -112.1 160.59 17.39 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.156 -0.965 . . . . 0.0 109.797 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.492 ' HB3' ' O ' ' A' ' 76' ' ' ALA . 3.3 pp 177.71 -156.65 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.295 -0.878 . . . . 0.0 110.201 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.566 HG11 ' CE2' ' A' ' 112' ' ' TYR . 3.9 t -147.81 168.03 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.217 -0.927 . . . . 0.0 109.527 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.492 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . 177.39 -176.18 47.94 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.39 -1.386 . . . . 0.0 110.174 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.46 ' O ' ' OD1' ' A' ' 81' ' ' ASN . 1.5 tt0 -89.27 -159.16 0.55 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.423 -1.045 . . . . 0.0 110.222 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.469 ' HB2' ' HG2' ' A' ' 122' ' ' GLU . 4.7 m120 -168.12 83.95 0.19 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.352 -0.843 . . . . 0.0 110.166 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.473 ' HA3' ' HB3' ' A' ' 121' ' ' PRO . . . 140.55 36.75 0.11 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.562 ' HA ' ' CD2' ' A' ' 85' ' ' TYR . . . 59.49 145.99 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.254 -1.145 . . . . 0.0 110.315 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.473 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.6 Cg_endo -81.79 21.27 11.78 Favored 'Cis proline' 0 C--N 1.314 -1.288 0 C-N-CA 121.755 -2.185 . . . . 0.0 110.869 -0.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.562 ' CD2' ' HA ' ' A' ' 83' ' ' ALA . 50.0 m-85 60.39 124.16 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.095 -1.003 . . . . 0.0 110.282 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -152.86 112.91 0.55 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.446 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 0.8 OUTLIER -98.09 147.21 24.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.247 -1.149 . . . . 0.0 110.396 -179.891 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.518 ' CG2' HD13 ' A' ' 89' ' ' LEU . 33.2 m -119.97 -20.73 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.299 -0.876 . . . . 0.0 109.966 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.581 HD12 ' CZ ' ' A' ' 106' ' ' PHE . 4.5 mp -105.36 143.86 32.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.312 -0.868 . . . . 0.0 110.764 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.463 ' O ' ' CG2' ' A' ' 91' ' ' THR . 10.1 m-20 -150.63 86.21 1.39 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.294 -0.879 . . . . 0.0 110.245 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.463 ' CG2' ' O ' ' A' ' 90' ' ' ASP . 1.8 p -159.98 177.98 10.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.167 -0.958 . . . . 0.0 110.476 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.507 ' CB ' ' O ' ' A' ' 74' ' ' VAL . 4.8 m -120.0 129.78 25.18 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.305 -0.872 . . . . 0.0 110.066 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.508 ' HG2' ' CG2' ' A' ' 74' ' ' VAL . 48.0 Cg_endo -72.19 78.61 1.85 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.906 1.477 . . . . 0.0 110.879 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.533 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -50.84 138.67 18.35 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.059 -1.026 . . . . 0.0 109.313 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.515 HD11 ' CG1' ' A' ' 72' ' ' VAL . 42.7 mt -130.12 176.3 8.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.93 -1.106 . . . . 0.0 110.862 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 70' ' ' THR . 0.2 OUTLIER -171.73 -178.66 2.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.493 -0.754 . . . . 0.0 109.786 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 9.8 p -70.25 -7.84 45.39 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.2 -0.938 . . . . 0.0 110.12 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.465 ' CB ' ' HD2' ' A' ' 99' ' ' PRO . 4.4 mt-10 -109.18 177.34 1.27 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.238 -0.914 . . . . 0.0 110.077 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.469 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 46.4 Cg_endo -72.6 132.99 19.7 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 124.035 1.545 . . . . 0.0 110.357 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.533 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.59 86.55 2.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.222 -0.924 . . . . 0.0 110.16 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.465 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 1.8 mt-30 -73.49 155.8 38.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.283 -0.885 . . . . 0.0 110.258 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.575 ' CG2' ' CZ ' ' A' ' 64' ' ' TYR . 23.0 t -134.76 138.34 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -0.906 . . . . 0.0 110.105 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.3 m -150.11 112.51 4.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.931 . . . . 0.0 110.245 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -156.91 133.03 9.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.233 -0.917 . . . . 0.0 110.306 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 11.2 m -95.53 94.18 7.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.283 -0.886 . . . . 0.0 110.164 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.581 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 33.8 p90 -94.23 153.57 17.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.27 -0.894 . . . . 0.0 110.281 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 97.3 m -89.72 99.36 12.38 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.175 -0.953 . . . . 0.0 109.811 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.648 ' CB ' ' CD2' ' A' ' 60' ' ' TYR . . . -58.72 104.58 0.23 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.28 -0.888 . . . . 0.0 110.497 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.483 ' HA ' ' HA2' ' A' ' 57' ' ' GLY . 11.1 p -91.11 53.7 2.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.393 -0.817 . . . . 0.0 110.047 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -164.28 -153.43 0.21 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.292 -0.88 . . . . 0.0 110.217 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . 14.4 m -150.85 112.55 4.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -0.898 . . . . 0.0 110.341 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.571 ' CG ' ' HA3' ' A' ' 123' ' ' GLY . 14.4 m-30 -110.81 78.2 1.53 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.289 -0.882 . . . . 0.0 110.171 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.47 ' HD2' ' HA ' ' A' ' 122' ' ' GLU . 44.2 Cg_endo -70.99 -174.0 1.03 Allowed 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.956 1.503 . . . . 0.0 110.347 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -133.75 43.88 2.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 0.0 110.239 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.468 ' CG2' ' O ' ' A' ' 115' ' ' THR . 8.5 t -139.87 93.74 9.34 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.286 -0.884 . . . . 0.0 110.162 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.99 117.44 5.12 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.059 1.557 . . . . 0.0 110.443 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.476 ' CB ' ' HB2' ' A' ' 120' ' ' ASP . . . -135.38 -174.6 3.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.241 -0.912 . . . . 0.0 110.143 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.02 -10.6 22.81 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.21 -0.931 . . . . 0.0 110.198 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.435 ' OD1' ' OD1' ' A' ' 120' ' ' ASP . 5.4 p30 -156.46 20.08 0.34 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.291 -0.88 . . . . 0.0 110.155 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.476 ' HB2' ' CB ' ' A' ' 117' ' ' ALA . 80.0 m-20 -116.51 89.01 26.04 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.213 -0.929 . . . . 0.0 110.246 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.473 ' HB3' ' HA3' ' A' ' 82' ' ' GLY . 46.7 Cg_endo -73.71 155.11 49.42 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.997 1.525 . . . . 0.0 110.401 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.47 ' HA ' ' HD2' ' A' ' 113' ' ' PRO . 1.2 pt-20 -122.09 -164.11 1.13 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.23 -0.919 . . . . 0.0 110.133 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.571 ' HA3' ' CG ' ' A' ' 112' ' ' TYR . . . -137.28 154.76 22.54 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.541 ' CB ' ' HA ' ' A' ' 50' ' ' ASN . 1.7 pp0? -150.51 -160.55 1.18 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.151 -1.205 . . . . 0.0 110.623 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.547 HD11 ' CH2' ' A' ' 16' ' ' TRP . 13.8 mt -118.21 143.34 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.449 ' O ' ' HA ' ' A' ' 76' ' ' ALA . . . -119.31 123.59 44.58 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.234 -0.916 . . . . 0.0 111.198 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.484 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 11.3 m-85 -118.51 97.11 5.59 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 178.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.44 ' O ' ' HB ' ' A' ' 74' ' ' VAL . 12.4 mm-40 -88.65 93.23 9.49 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.302 -0.874 . . . . 0.0 111.841 -177.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.498 HD12 ' CD1' ' A' ' 139' ' ' LEU . 15.1 mt -93.94 47.17 1.2 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -84.42 83.1 1.64 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -179.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 55.61 100.13 0.01 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.586 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 9.8 m-85 -139.39 -40.44 0.46 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.312 -1.111 . . . . 0.0 109.943 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.583 ' HB3' ' CE3' ' A' ' 137' ' ' TRP . 1.3 t -90.86 -176.98 4.83 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.276 -0.89 . . . . 0.0 110.152 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.46 ' N ' ' OG ' ' A' ' 133' ' ' SER . . . -89.05 -88.07 0.16 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.207 -0.933 . . . . 0.0 110.402 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.8 176.49 6.27 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.274 -0.891 . . . . 0.0 110.452 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.488 ' HA ' ' HA ' ' A' ' 38' ' ' ALA . . . -50.12 128.98 20.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.326 -0.859 . . . . 0.0 110.286 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.643 ' CZ2' ' CG1' ' A' ' 36' ' ' VAL . 4.4 p90 -134.92 -170.07 2.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.25 -0.906 . . . . 0.0 110.027 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.526 ' O ' ' CB ' ' A' ' 68' ' ' ALA . 0.5 OUTLIER -160.55 175.18 13.0 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.255 -0.978 . . . . 0.0 110.7 -178.759 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.525 ' HB2' ' CG2' ' A' ' 34' ' ' VAL . 2.4 mp -127.78 146.46 50.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.312 -0.867 . . . . 0.0 109.731 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' CYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 11.8 m -147.56 97.74 2.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.062 -1.024 . . . . 0.0 110.949 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.471 ' O ' ' HB3' ' A' ' 142' ' ' ASP . 0.5 OUTLIER -93.2 -177.07 4.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.168 -0.958 . . . . 0.0 109.222 179.012 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.479 ' HB3' ' CB ' ' A' ' 31' ' ' ALA . 0.8 OUTLIER 175.57 38.23 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.058 -1.027 . . . . 0.0 110.624 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.522 ' OD2' ' N ' ' A' ' 65' ' ' THR . 3.8 p-10 175.31 51.45 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.364 -0.835 . . . . 0.0 109.698 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 3.5 t -90.13 114.88 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.389 -0.819 . . . . 0.0 110.32 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -137.75 133.39 34.05 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.319 -0.863 . . . . 0.0 110.077 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.425 ' O ' ' HB2' ' A' ' 147' ' ' ASP . 39.4 tp -129.17 137.92 51.45 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.276 -0.89 . . . . 0.0 110.182 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.434 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 1.3 t70 -179.07 156.25 0.78 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.229 -0.919 . . . . 0.0 110.253 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.457 ' HA ' ' O ' ' A' ' 59' ' ' THR . 2.3 p -90.72 -171.91 3.2 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.263 -0.898 . . . . 0.0 110.196 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.452 ' OE1' HG11 ' A' ' 150' ' ' VAL . 0.9 OUTLIER -46.82 169.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.206 -0.934 . . . . 0.0 110.209 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.452 HG11 ' OE1' ' A' ' 149' ' ' GLU . 9.9 p -43.04 161.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -0.894 . . . . 0.0 110.263 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -117.24 166.03 12.75 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.233 -0.917 . . . . 0.0 110.187 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.4 tp . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.204 -179.987 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.414 ' O ' ' CB ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.246 0.546 . . . . 0.0 110.241 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.414 ' CB ' ' O ' ' A' ' 1' ' ' ALA . 0.5 OUTLIER 63.72 61.2 1.72 Allowed Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.278 -0.889 . . . . 0.0 110.228 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -76.22 -156.36 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.009 1.531 . . . . 0.0 110.133 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.427 ' O ' ' CD ' ' A' ' 14' ' ' GLU . 8.2 pt -94.76 -13.03 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.203 -0.936 . . . . 0.0 110.139 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 144.09 -25.96 2.05 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.527 ' HA ' ' CB ' ' A' ' 145' ' ' ALA . 6.1 mt-10 54.52 68.77 0.81 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.274 -1.133 . . . . 0.0 110.26 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 170.11 -161.82 35.02 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.52 ' CG2' ' O ' ' A' ' 142' ' ' ASP . 15.2 p -90.54 -168.06 2.0 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.213 -1.169 . . . . 0.0 110.218 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.521 ' CE1' ' CD1' ' A' ' 16' ' ' TRP . 44.7 m-85 -103.29 49.67 0.82 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.9 . . . . 0.0 110.122 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.546 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 4.8 p30 -84.98 44.63 1.09 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.263 -0.898 . . . . 0.0 110.248 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.546 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 4.5 t0 161.75 78.66 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.264 0.554 . . . . 0.0 109.597 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 70.14 142.49 0.19 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.471 ' O ' ' HB2' ' A' ' 14' ' ' GLU . 48.7 Cg_endo -75.83 3.82 5.7 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.059 1.557 . . . . 0.0 110.666 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 0.1 OUTLIER 67.41 -84.78 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.262 -0.899 . . . . 0.0 110.301 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.432 ' C ' HD11 ' A' ' 49' ' ' LEU . . . -141.46 8.39 2.6 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.576 ' CD1' HD12 ' A' ' 49' ' ' LEU . 38.0 m95 -64.23 131.94 48.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.173 -1.192 . . . . 0.0 110.391 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.584 ' CG2' ' CG2' ' A' ' 48' ' ' VAL . 1.0 OUTLIER -133.5 153.9 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.255 -0.903 . . . . 0.0 109.82 179.692 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.448 ' CB ' HD23 ' A' ' 25' ' ' LEU . . . -139.13 139.41 37.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.333 -0.854 . . . . 0.0 109.348 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.565 ' CE2' ' O ' ' A' ' 46' ' ' GLY . 1.7 p90 -121.52 144.04 48.94 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.165 -0.959 . . . . 0.0 111.093 -178.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.592 ' HA2' ' CE1' ' A' ' 43' ' ' TYR . . . 116.24 82.97 1.0 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.642 ' CG2' ' CE2' ' A' ' 43' ' ' TYR . 1.6 p 52.04 18.26 0.8 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.495 -1.003 . . . . 0.0 110.688 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.535 ' HA ' ' CB ' ' A' ' 35' ' ' ALA . 5.4 p30 -114.91 93.07 4.15 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.113 -0.992 . . . . 0.0 109.939 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 22' ' ' ASP . . . -60.31 -121.67 0.01 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.85 145.85 41.34 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.826 1.435 . . . . 0.0 110.488 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.528 ' CD1' HD12 ' A' ' 32' ' ' LEU . 14.3 mt -76.32 102.87 6.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.255 -0.903 . . . . 0.0 110.069 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.469 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 24.4 t0 -43.53 110.24 0.19 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.207 -0.933 . . . . 0.0 109.933 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.448 HG22 ' O ' ' A' ' 25' ' ' LEU . 12.7 p -119.41 -61.15 1.66 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.073 -1.017 . . . . 0.0 110.563 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.469 ' O ' ' OG1' ' A' ' 29' ' ' THR . 68.9 m 43.75 38.61 2.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.156 -0.965 . . . . 0.0 109.921 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.469 ' OG1' ' O ' ' A' ' 28' ' ' SER . 13.9 p 48.75 80.01 0.07 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.374 -0.829 . . . . 0.0 110.314 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 175.54 -65.5 0.1 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.45 ' O ' ' O ' ' A' ' 26' ' ' ASP . . . -150.17 151.72 33.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.308 -1.113 . . . . 0.0 110.069 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.528 HD12 ' CD1' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -104.82 94.41 5.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.158 -0.964 . . . . 0.0 110.393 -179.908 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.532 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 0.8 OUTLIER -94.71 115.81 27.98 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.215 -0.928 . . . . 0.0 111.176 179.759 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.512 HG13 ' CD2' ' A' ' 25' ' ' LEU . 16.6 m -89.4 149.43 4.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.535 ' CB ' ' HA ' ' A' ' 22' ' ' ASP . . . -88.95 92.99 9.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.314 -0.866 . . . . 0.0 111.093 -178.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.668 ' CG1' ' CZ2' ' A' ' 137' ' ' TRP . 96.7 t -89.89 123.43 66.23 Favored Pre-proline 0 C--N 1.301 -1.508 0 O-C-N 121.489 -0.757 . . . . 0.0 109.373 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.524 ' HD2' ' CG2' ' A' ' 45' ' ' VAL . 40.0 Cg_endo -66.1 179.28 1.97 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.845 1.445 . . . . 0.0 112.048 -178.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.557 ' HA ' ' CA ' ' A' ' 136' ' ' ALA . . . -62.99 125.26 23.4 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.542 -0.724 . . . . 0.0 111.285 -179.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.531 ' O ' ' C ' ' A' ' 40' ' ' SER . . . 37.62 28.42 0.04 OUTLIER Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.531 ' C ' ' O ' ' A' ' 39' ' ' GLY . 11.0 t 28.64 53.88 0.08 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.984 -0.715 . . . . 0.0 110.435 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.641 ' O ' ' CG ' ' A' ' 42' ' ' GLN . . . -88.19 114.43 24.8 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.541 -0.725 . . . . 0.0 110.156 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.641 ' CG ' ' O ' ' A' ' 41' ' ' ALA . 1.1 pt20 84.19 30.4 0.06 Allowed 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.642 ' CE2' ' CG2' ' A' ' 21' ' ' THR . 0.1 OUTLIER -149.45 -33.37 0.2 Allowed 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 118.564 -1.254 . . . . 0.0 112.677 -177.888 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.532 ' HA2' ' CA ' ' A' ' 130' ' ' GLY . . . 52.81 79.88 0.08 OUTLIER Glycine 0 N--CA 1.483 1.794 0 N-CA-C 105.733 -2.947 . . . . 0.0 105.733 -176.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.524 ' CG2' ' HD2' ' A' ' 37' ' ' PRO . 3.8 t -87.64 129.31 39.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.422 -1.046 . . . . 0.0 109.001 -177.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.565 ' O ' ' CE2' ' A' ' 19' ' ' TYR . . . -155.44 156.46 27.0 Favored Glycine 0 N--CA 1.487 2.094 0 C-N-CA 119.018 -1.563 . . . . 0.0 110.172 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.526 ' CG1' ' O ' ' A' ' 17' ' ' VAL . 11.3 t -112.9 128.46 69.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.419 -1.048 . . . . 0.0 109.791 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.584 ' CG2' ' CG2' ' A' ' 17' ' ' VAL . 27.3 m -119.86 137.06 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.031 -1.043 . . . . 0.0 110.62 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.576 HD12 ' CD1' ' A' ' 16' ' ' TRP . 14.1 tp -131.27 97.4 4.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.341 -0.849 . . . . 0.0 110.197 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.523 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 45.2 m-80 -75.46 147.07 40.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.256 -0.903 . . . . 0.0 110.445 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 124.5 63.2 0.19 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.524 ' CG2' ' HA ' ' A' ' 124' ' ' GLN . 43.1 t -119.92 158.42 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.163 -1.198 . . . . 0.0 110.177 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -128.12 80.74 1.98 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.224 -0.923 . . . . 0.0 110.695 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.569 HD11 ' CZ ' ' A' ' 60' ' ' TYR . 34.7 mm -117.44 173.03 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.244 -0.91 . . . . 0.0 109.72 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.522 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 1.8 tp10 -166.92 131.58 2.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.966 -1.083 . . . . 0.0 110.785 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.522 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 8.1 pt-20 37.85 -153.9 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.664 -0.647 . . . . 0.0 110.922 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.469 ' HA2' ' O ' ' A' ' 108' ' ' ALA . . . -87.77 87.21 1.52 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.561 ' CG2' ' N ' ' A' ' 59' ' ' THR . 1.3 m -113.78 173.6 6.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.269 -1.136 . . . . 0.0 109.843 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.576 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 3.5 m -89.66 153.21 20.91 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.163 -0.961 . . . . 0.0 110.376 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.583 ' CE1' ' CB ' ' A' ' 148' ' ' SER . 56.9 m-85 -160.29 179.37 8.73 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.339 -0.85 . . . . 0.0 110.211 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 36.7 m -150.31 115.35 5.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.344 -0.848 . . . . 0.0 109.876 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.519 HD23 ' CD2' ' A' ' 89' ' ' LEU . 13.7 tp -89.45 119.68 30.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.162 -0.961 . . . . 0.0 110.18 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.491 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 6.4 mtm180 -126.37 137.8 53.49 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.45 -0.781 . . . . 0.0 109.693 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.531 ' CD1' ' C ' ' A' ' 64' ' ' TYR . 0.7 OUTLIER -178.3 143.63 0.29 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.288 -0.883 . . . . 0.0 109.676 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.466 ' HB ' ' OD1' ' A' ' 142' ' ' ASP . 69.9 m -119.14 99.49 6.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.244 -0.91 . . . . 0.0 109.962 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.462 ' C ' ' CD2' ' A' ' 95' ' ' LEU . . . -99.78 156.77 16.93 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.432 -0.793 . . . . 0.0 110.225 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.481 ' CA ' HD21 ' A' ' 95' ' ' LEU . 64.6 m -150.38 121.7 7.85 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.301 -0.875 . . . . 0.0 110.266 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.07 135.2 51.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.214 -0.928 . . . . 0.0 109.998 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.76 -9.12 25.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.206 -0.934 . . . . 0.0 109.972 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.6 ' CG2' ' CB ' ' A' ' 137' ' ' TRP . 5.0 t -118.37 19.39 13.42 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.326 -0.859 . . . . 0.0 110.214 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.46 ' OD2' ' O ' ' A' ' 71' ' ' ASP . 8.4 t70 43.01 61.1 2.25 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.321 -0.862 . . . . 0.0 109.611 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.564 HG13 ' CD1' ' A' ' 137' ' ' TRP . 6.5 p -89.97 139.3 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.387 -0.821 . . . . 0.0 110.95 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.8 m -120.58 85.95 2.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.393 -0.817 . . . . 0.0 109.283 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.574 ' HA ' ' CD1' ' A' ' 132' ' ' PHE . 4.6 m -89.94 -141.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.298 -0.877 . . . . 0.0 110.508 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.446 ' N ' ' CG2' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -132.32 119.42 20.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.254 -0.904 . . . . 0.0 110.617 -179.574 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.519 ' N ' ' HD3' ' A' ' 93' ' ' PRO . . . -122.63 163.64 19.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.217 -0.927 . . . . 0.0 109.663 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.483 ' HB3' ' O ' ' A' ' 76' ' ' ALA . 1.8 pp 174.69 -157.62 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.22 -0.925 . . . . 0.0 110.283 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.472 HG12 ' O ' ' A' ' 124' ' ' GLN . 4.0 t -144.2 169.45 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.344 -0.847 . . . . 0.0 109.181 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.502 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . 172.2 179.22 42.95 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 118.993 -1.575 . . . . 0.0 110.465 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.5 ' NE2' ' O ' ' A' ' 82' ' ' GLY . 11.6 tt0 -98.15 142.16 30.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.537 -0.978 . . . . 0.0 110.119 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.533 ' O ' ' CB ' ' A' ' 121' ' ' PRO . 5.7 m120 -95.58 86.0 4.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.276 -0.89 . . . . 0.0 109.968 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.505 ' C ' ' CE1' ' A' ' 85' ' ' TYR . . . 124.68 142.85 6.0 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.619 ' N ' ' CE1' ' A' ' 85' ' ' TYR . . . -42.67 154.12 0.3 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.211 -1.17 . . . . 0.0 110.291 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.469 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.7 Cg_endo -79.38 12.25 20.34 Favored 'Cis proline' 0 C--N 1.312 -1.356 0 C-N-CA 121.673 -2.22 . . . . 0.0 110.896 -0.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.619 ' CE1' ' N ' ' A' ' 83' ' ' ALA . 31.9 m-85 61.79 150.4 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.105 -0.997 . . . . 0.0 110.261 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.443 ' O ' ' HA2' ' A' ' 79' ' ' GLY . . . -171.95 106.9 0.24 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.7 p -96.6 140.52 31.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.195 -1.179 . . . . 0.0 110.261 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.541 HG22 ' CE2' ' A' ' 106' ' ' PHE . 17.3 m -121.71 -15.91 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.274 -0.891 . . . . 0.0 110.177 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.537 ' CD1' ' CG2' ' A' ' 88' ' ' VAL . 4.4 mp -118.74 142.36 47.76 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.285 -0.884 . . . . 0.0 110.857 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.484 ' O ' ' CG2' ' A' ' 91' ' ' THR . 2.7 m-20 -150.62 85.65 1.38 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.342 -0.849 . . . . 0.0 110.203 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.484 ' CG2' ' O ' ' A' ' 90' ' ' ASP . 3.3 p -159.55 -172.32 3.66 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.16 -0.963 . . . . 0.0 110.412 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.447 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 72.1 m -121.75 138.34 28.41 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.324 -0.86 . . . . 0.0 110.207 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.542 ' CG ' HG21 ' A' ' 74' ' ' VAL . 49.4 Cg_endo -76.75 74.29 4.94 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.977 1.514 . . . . 0.0 110.623 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.523 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -49.62 127.37 15.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.121 -0.987 . . . . 0.0 109.557 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.514 HD13 ' CD2' ' A' ' 139' ' ' LEU . 20.8 mt -125.08 165.62 17.86 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.065 -1.022 . . . . 0.0 110.808 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.462 ' O ' HG21 ' A' ' 67' ' ' THR . 0.1 OUTLIER -157.93 -178.44 7.31 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.45 -0.781 . . . . 0.0 109.923 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.6 p -67.2 -29.17 68.76 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.151 -0.968 . . . . 0.0 110.38 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.491 ' CB ' ' HD2' ' A' ' 99' ' ' PRO . 2.6 mt-10 -91.41 179.78 1.33 Allowed Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.19 -0.944 . . . . 0.0 110.12 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.491 ' HD2' ' CB ' ' A' ' 98' ' ' GLU . 46.2 Cg_endo -73.75 130.47 14.69 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.896 1.472 . . . . 0.0 110.276 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.523 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 1.3 mtt-85 -119.83 92.65 3.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.145 -0.972 . . . . 0.0 110.498 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.452 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 1.0 OUTLIER -73.16 156.59 38.47 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.339 -0.851 . . . . 0.0 109.997 179.725 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.496 HG12 ' CE2' ' A' ' 64' ' ' TYR . 49.8 t -137.02 134.32 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.202 -0.936 . . . . 0.0 110.267 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.443 ' O ' ' CG ' ' A' ' 104' ' ' GLU . 0.2 OUTLIER -150.06 120.5 7.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.231 -0.918 . . . . 0.0 110.249 -179.891 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.443 ' CG ' ' O ' ' A' ' 103' ' ' THR . 14.3 mp0 -160.01 133.73 7.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.213 -0.93 . . . . 0.0 110.222 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 24.2 m -92.22 145.05 24.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.168 -0.957 . . . . 0.0 110.228 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.541 ' CE2' HG22 ' A' ' 88' ' ' VAL . 34.0 p90 -150.21 153.33 36.07 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.312 -0.867 . . . . 0.0 110.315 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.425 ' O ' ' N ' ' A' ' 109' ' ' SER . 22.6 m -90.03 92.62 9.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.247 -0.908 . . . . 0.0 109.917 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.581 ' CB ' ' CD2' ' A' ' 60' ' ' TYR . . . -48.23 96.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.296 -0.878 . . . . 0.0 110.354 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.445 ' HA ' ' HA2' ' A' ' 57' ' ' GLY . 70.0 p -85.24 49.48 1.76 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.268 -0.895 . . . . 0.0 110.145 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.464 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -154.05 -154.16 0.5 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.268 -0.895 . . . . 0.0 110.224 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 18.8 m -150.95 112.66 4.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.268 -0.895 . . . . 0.0 110.277 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.567 ' CD2' HG13 ' A' ' 54' ' ' ILE . 14.7 m-30 -109.91 101.52 47.34 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.32 -0.863 . . . . 0.0 110.152 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.497 ' HG2' ' HA ' ' A' ' 122' ' ' GLU . 42.4 Cg_endo -71.75 136.86 28.76 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.747 1.393 . . . . 0.0 110.019 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -43.84 -84.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.301 -0.874 . . . . 0.0 110.916 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.91 153.86 42.91 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.217 -0.927 . . . . 0.0 110.671 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.532 ' CB ' ' O ' ' A' ' 120' ' ' ASP . 48.0 Cg_endo -74.57 178.96 6.42 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.131 1.595 . . . . 0.0 110.427 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.435 ' HB1' ' HB2' ' A' ' 120' ' ' ASP . . . -150.15 -161.36 1.32 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.243 -0.911 . . . . 0.0 110.028 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -46.58 -24.41 0.53 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.17 -0.956 . . . . 0.0 109.952 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -161.95 23.02 0.11 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.344 -0.847 . . . . 0.0 110.066 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.532 ' O ' ' CB ' ' A' ' 116' ' ' PRO . 1.1 m-20 -105.76 128.38 26.59 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.297 -0.877 . . . . 0.0 110.113 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.533 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 50.7 Cg_endo -76.56 -170.05 0.82 Allowed 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.896 1.471 . . . . 0.0 110.66 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.497 ' HA ' ' HG2' ' A' ' 113' ' ' PRO . 5.8 pm0 -153.08 132.8 13.12 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.341 -0.849 . . . . 0.0 110.056 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.475 ' HA3' ' HB3' ' A' ' 112' ' ' TYR . . . -82.76 146.66 24.54 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.524 ' HA ' ' CG2' ' A' ' 52' ' ' VAL . 7.9 pt20 -150.72 -156.22 0.7 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.206 -1.173 . . . . 0.0 110.696 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.461 ' CG2' ' CE1' ' A' ' 127' ' ' PHE . 10.7 mt -117.82 137.7 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -114.41 124.95 53.21 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.296 -0.878 . . . . 0.0 111.26 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.489 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 4.4 m-85 -118.39 95.4 4.86 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.561 ' O ' ' CE2' ' A' ' 132' ' ' PHE . 3.0 mp0 -88.38 90.91 8.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.512 -0.743 . . . . 0.0 112.39 -177.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.56 ' CD2' ' CG2' ' A' ' 74' ' ' VAL . 5.4 mt -100.95 45.65 0.97 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 177.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.57 ' O ' ' CD2' ' A' ' 132' ' ' PHE . . . -96.47 136.18 12.67 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 39' ' ' GLY . . . 38.25 73.33 0.15 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.574 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 9.8 m-85 -129.41 -80.27 0.56 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.073 -1.251 . . . . 0.0 110.967 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.499 ' O ' ' HA2' ' A' ' 39' ' ' GLY . 14.0 t -89.06 100.31 13.11 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.061 -1.024 . . . . 0.0 110.462 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -30.26 -50.45 0.12 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.967 -0.458 . . . . 0.0 111.75 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.466 ' O ' ' O ' ' A' ' 133' ' ' SER . 6.7 m-20 -73.04 159.6 33.38 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.004 -1.06 . . . . 0.0 110.038 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.557 ' CA ' ' HA ' ' A' ' 38' ' ' ALA . . . -80.57 146.88 31.04 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.358 -0.838 . . . . 0.0 110.355 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.668 ' CZ2' ' CG1' ' A' ' 36' ' ' VAL . 4.6 p90 -155.58 -166.8 2.33 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.222 -0.924 . . . . 0.0 111.012 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.505 ' CG2' ' SG ' ' A' ' 33' ' ' CYS 0.254 0.7 OUTLIER -149.5 169.07 21.76 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -178.236 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.532 ' O ' ' HA ' ' A' ' 33' ' ' CYS . 1.8 mp -133.02 116.91 16.97 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.826 -1.171 . . . . 0.0 111.82 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' CYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 0.8 OUTLIER -102.06 109.53 21.27 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.747 -0.596 . . . . 0.0 111.081 178.895 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.496 ' O ' ' CB ' ' A' ' 142' ' ' ASP . 1.5 mt -100.42 -179.0 3.98 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.294 -0.879 . . . . 0.0 108.679 178.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.52 ' O ' ' CG2' ' A' ' 8' ' ' THR . 1.8 p30 167.14 57.9 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.167 -0.958 . . . . 0.0 110.486 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.514 ' N ' ' HA ' ' A' ' 8' ' ' THR . 0.4 OUTLIER 167.35 44.62 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.263 -0.898 . . . . 0.0 109.664 179.838 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 1.9 t -89.92 114.09 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.434 -0.791 . . . . 0.0 110.205 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.527 ' CB ' ' HA ' ' A' ' 6' ' ' GLU . . . -145.8 155.17 42.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.315 -0.866 . . . . 0.0 110.168 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.52 ' CD2' HD13 ' A' ' 54' ' ' ILE . 10.2 tp -153.83 123.55 6.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.317 -0.864 . . . . 0.0 110.169 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.459 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 11.1 t0 -136.02 147.52 47.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.256 -0.903 . . . . 0.0 110.281 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.583 ' CB ' ' CE1' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -107.1 112.95 26.11 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.333 -0.854 . . . . 0.0 110.205 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.436 ' HG3' ' HB ' ' A' ' 59' ' ' THR . 0.4 OUTLIER -73.93 87.38 1.81 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -0.896 . . . . 0.0 110.201 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.462 ' CG1' ' OG ' ' A' ' 148' ' ' SER . 3.9 p -159.37 170.42 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.255 -0.903 . . . . 0.0 110.275 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.457 ' N ' ' CG2' ' A' ' 150' ' ' VAL . 38.3 tt0 -87.25 74.97 9.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.276 -0.89 . . . . 0.0 110.218 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.498 ' CD1' ' O ' ' A' ' 152' ' ' LEU . 1.1 pp . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.219 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.436 ' HB1' ' HB1' ' A' ' 114' ' ' ALA . . . . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.259 0.552 . . . . 0.0 110.192 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -128.41 136.4 29.03 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.246 -0.909 . . . . 0.0 110.142 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -76.21 -156.25 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.97 1.51 . . . . 0.0 110.03 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.521 ' CD1' ' O ' ' A' ' 144' ' ' VAL . 13.3 pt -92.04 -1.57 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.209 -0.932 . . . . 0.0 110.13 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 6' ' ' GLU . . . 75.82 43.54 22.53 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.434 ' HA ' ' HB3' ' A' ' 145' ' ' ALA . 0.8 OUTLIER 42.54 66.23 0.79 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.295 -1.121 . . . . 0.0 110.189 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.449 ' O ' ' CE1' ' A' ' 9' ' ' PHE . . . -67.82 89.69 0.2 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.468 ' O ' ' HB2' ' A' ' 9' ' ' PHE . 1.9 p -76.14 -1.29 25.41 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.238 -1.154 . . . . 0.0 110.101 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.567 ' CD1' ' HB3' ' A' ' 13' ' ' PRO . 6.3 m-30 60.32 81.42 0.18 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.33 -0.857 . . . . 0.0 110.321 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.543 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 21.0 t70 -142.26 12.22 1.97 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.225 -0.922 . . . . 0.0 110.168 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.543 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.8 OUTLIER 161.47 -24.26 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.678 -0.639 . . . . 0.0 109.609 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -161.23 86.66 0.11 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.567 ' HB3' ' CD1' ' A' ' 9' ' ' PHE . 49.6 Cg_endo -76.0 72.94 5.06 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.153 1.607 . . . . 0.0 110.963 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.446 ' C ' ' O ' ' A' ' 13' ' ' PRO . 25.6 mm-40 38.33 -92.0 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.491 -0.756 . . . . 0.0 110.782 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 13' ' ' PRO . . . -153.42 17.87 0.68 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.575 ' CE2' HD21 ' A' ' 49' ' ' LEU . 41.3 m95 -42.93 122.52 2.44 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -1.135 . . . . 0.0 110.4 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.575 ' CG2' ' CG2' ' A' ' 48' ' ' VAL . 1.9 m -119.28 153.2 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.177 -0.952 . . . . 0.0 109.865 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.47 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . . . -137.58 122.47 18.89 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.165 -0.959 . . . . 0.0 109.96 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.563 ' CZ ' ' O ' ' A' ' 46' ' ' GLY . 3.7 p90 -115.24 154.78 28.44 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.39 -0.819 . . . . 0.0 110.498 -179.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.465 ' O ' HG23 ' A' ' 45' ' ' VAL . . . 90.77 29.11 13.96 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.472 ' HB ' ' O ' ' A' ' 35' ' ' ALA . 14.2 p -146.15 -160.38 1.14 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.127 -1.219 . . . . 0.0 110.303 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.45 ' O ' ' O ' ' A' ' 23' ' ' GLY . 12.4 t0 -89.93 123.47 33.88 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 0.0 110.196 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 22' ' ' ASP . . . 43.94 -166.1 0.03 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.416 ' O ' ' O ' ' A' ' 25' ' ' LEU . 45.5 Cg_endo -73.18 162.74 39.86 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.066 1.561 . . . . 0.0 110.405 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.559 ' CD1' ' CD1' ' A' ' 32' ' ' LEU . 0.6 OUTLIER -59.37 -154.43 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.265 -0.897 . . . . 0.0 110.185 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -152.48 161.35 42.71 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.269 -0.894 . . . . 0.0 110.145 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.525 ' CG2' ' HG3' ' A' ' 13' ' ' PRO . 0.7 OUTLIER -125.22 -28.2 3.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.27 -0.894 . . . . 0.0 110.235 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.463 ' O ' ' OG1' ' A' ' 29' ' ' THR . 0.5 OUTLIER 48.48 23.48 0.61 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.216 -0.927 . . . . 0.0 110.152 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' A' ' 28' ' ' SER . 17.9 p 47.19 65.83 1.15 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.297 -0.877 . . . . 0.0 110.268 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.501 ' N ' ' HA ' ' A' ' 10' ' ' ASP . . . 169.85 -50.17 0.21 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 141' ' ' LEU . . . -150.04 141.51 23.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -1.117 . . . . 0.0 110.292 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.559 ' CD1' ' CD1' ' A' ' 25' ' ' LEU . 5.8 tt -79.96 110.87 15.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.215 -0.928 . . . . 0.0 109.921 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.486 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 88.7 m -118.43 129.2 55.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.141 -0.975 . . . . 0.0 110.708 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.522 ' CG2' ' HB2' ' A' ' 139' ' ' LEU . 17.9 m -98.83 153.06 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.301 -0.874 . . . . 0.0 109.692 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.485 ' HA ' ' OG1' ' A' ' 138' ' ' THR . . . -102.76 87.65 3.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.249 -0.907 . . . . 0.0 110.898 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.59 HG12 ' CZ2' ' A' ' 137' ' ' TRP . 57.5 t -75.98 132.14 74.67 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.161 -0.962 . . . . 0.0 109.386 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.524 ' CG ' ' OH ' ' A' ' 43' ' ' TYR . 47.8 Cg_endo -78.89 158.24 27.49 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.87 1.458 . . . . 0.0 111.114 -179.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.527 ' HA ' ' CA ' ' A' ' 136' ' ' ALA . . . -42.94 126.79 3.95 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.291 -0.881 . . . . 0.0 109.775 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 38' ' ' ALA . . . 47.92 86.67 0.01 OUTLIER Glycine 0 N--CA 1.485 1.963 0 N-CA-C 108.385 -1.886 . . . . 0.0 108.385 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.471 ' O ' HG22 ' A' ' 45' ' ' VAL . 0.8 OUTLIER -82.2 39.04 0.56 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.353 -1.086 . . . . 0.0 110.636 -179.453 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.492 ' CB ' ' HA3' ' A' ' 131' ' ' GLY . . . -105.25 20.23 19.24 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.17 -0.957 . . . . 0.0 109.756 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.572 ' HG3' ' CD2' ' A' ' 43' ' ' TYR . 17.6 pt20 -93.04 27.02 2.58 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 121.581 0.705 . . . . 0.0 109.5 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.628 ' CD1' ' N ' ' A' ' 43' ' ' TYR . 0.0 OUTLIER 159.55 6.24 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.203 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.725 179.357 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.453 ' HA2' ' HA2' ' A' ' 130' ' ' GLY . . . 67.6 100.77 0.03 OUTLIER Glycine 0 N--CA 1.487 2.042 0 O-C-N 120.502 -1.374 . . . . 0.0 109.83 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.472 ' HB ' ' O ' ' A' ' 129' ' ' LEU . 48.8 t -89.19 170.37 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.119 -1.224 . . . . 0.0 108.431 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.563 ' O ' ' CZ ' ' A' ' 19' ' ' TYR . . . 167.33 140.45 2.91 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 118.943 -1.598 . . . . 0.0 110.721 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.528 ' CG1' ' O ' ' A' ' 17' ' ' VAL . 21.3 t -105.94 132.2 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.505 -0.997 . . . . 0.0 109.605 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.575 ' CG2' ' CG2' ' A' ' 17' ' ' VAL . 35.6 m -126.9 141.03 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.923 -1.111 . . . . 0.0 110.572 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.575 HD21 ' CE2' ' A' ' 16' ' ' TRP . 14.2 tp -132.12 102.26 5.73 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.329 -0.857 . . . . 0.0 110.207 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.538 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 1.4 m-80 -80.08 122.79 27.22 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.289 -0.882 . . . . 0.0 110.424 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.423 ' O ' HG23 ' A' ' 4' ' ' ILE . . . 146.04 74.47 0.02 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.524 ' CG2' ' HA ' ' A' ' 124' ' ' GLN . 6.3 t -119.81 178.84 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.185 -1.185 . . . . 0.0 110.086 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.501 ' O ' ' CD1' ' A' ' 54' ' ' ILE . . . -132.84 84.01 2.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.174 -0.954 . . . . 0.0 110.441 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.591 ' CD1' ' CE1' ' A' ' 60' ' ' TYR . 5.6 mm -143.08 163.48 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.227 -0.92 . . . . 0.0 109.625 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.524 ' HA ' ' CB ' ' A' ' 111' ' ' THR . 8.1 tt0 -178.88 32.44 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.101 -0.999 . . . . 0.0 110.28 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 55' ' ' GLU . 2.0 tt0 179.78 -176.44 0.32 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.529 -0.732 . . . . 0.0 110.07 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.482 ' HA2' ' O ' ' A' ' 108' ' ' ALA . . . -93.41 67.07 1.7 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.255 -1.938 . . . . 0.0 108.255 178.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.589 HG21 ' CE2' ' A' ' 60' ' ' TYR . 1.0 OUTLIER -105.08 177.68 4.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.585 -0.95 . . . . 0.0 110.265 -179.036 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.584 ' N ' ' CG2' ' A' ' 58' ' ' THR . 0.6 OUTLIER -88.95 154.62 20.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.302 -0.874 . . . . 0.0 110.016 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.634 ' CD2' ' CB ' ' A' ' 108' ' ' ALA . 59.3 m-85 -155.98 124.37 5.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.346 -0.847 . . . . 0.0 110.061 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 28.9 m -94.1 115.23 27.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.204 -0.935 . . . . 0.0 110.108 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.523 HD23 ' CD2' ' A' ' 89' ' ' LEU . 19.4 tp -89.39 122.53 32.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.173 -0.954 . . . . 0.0 109.816 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.472 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 6.3 mtt180 -123.4 140.58 52.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.311 -0.868 . . . . 0.0 110.263 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.597 ' CZ ' ' CG2' ' A' ' 102' ' ' VAL . 1.6 p90 -178.28 147.53 0.43 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.41 -0.806 . . . . 0.0 109.629 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 47.6 m -119.37 91.04 3.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.115 -0.99 . . . . 0.0 110.407 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.526 ' CB ' HD22 ' A' ' 95' ' ' LEU . . . -90.06 147.65 23.52 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.366 -0.833 . . . . 0.0 110.069 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.462 HG21 ' O ' ' A' ' 96' ' ' THR . 40.7 m -146.84 131.9 18.26 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.27 -0.894 . . . . 0.0 110.442 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.531 ' HB1' ' CB ' ' A' ' 95' ' ' LEU . . . -123.85 136.57 54.46 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.35 -0.844 . . . . 0.0 109.906 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 64.5 m -65.17 -9.06 20.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.177 -0.952 . . . . 0.0 110.314 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.54 ' CG2' ' HB2' ' A' ' 137' ' ' TRP . 6.4 t -119.77 19.79 12.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.25 -0.906 . . . . 0.0 110.237 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 95' ' ' LEU . 13.2 t70 43.57 49.94 6.42 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.295 -0.878 . . . . 0.0 109.678 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.539 ' CG2' ' HB2' ' A' ' 133' ' ' SER . 8.8 p -75.47 145.64 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.429 -0.794 . . . . 0.0 110.662 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 89.7 m -119.94 86.06 2.49 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.39 -0.819 . . . . 0.0 109.339 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.583 ' HA ' ' CD1' ' A' ' 132' ' ' PHE . 15.0 m -89.5 -141.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.258 -0.901 . . . . 0.0 110.312 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.476 ' N ' HG22 ' A' ' 74' ' ' VAL . 16.0 mtm-85 -131.94 148.05 52.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.129 -0.982 . . . . 0.0 110.851 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.513 ' N ' ' HD3' ' A' ' 93' ' ' PRO . . . -148.34 155.35 41.17 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.336 -0.853 . . . . 0.0 109.998 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.585 ' CD1' ' CB ' ' A' ' 126' ' ' ALA . 2.1 pp 175.82 -160.52 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 0.0 110.294 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.521 HG22 ' CD2' ' A' ' 89' ' ' LEU . 4.3 t -147.78 167.98 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.303 -0.873 . . . . 0.0 109.597 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.512 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . 174.08 -175.76 46.54 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.33 -1.414 . . . . 0.0 110.314 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.513 ' NE2' ' HB2' ' A' ' 121' ' ' PRO . 3.5 tm0? -94.37 178.25 5.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.458 -1.025 . . . . 0.0 110.142 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.513 ' ND2' ' HG2' ' A' ' 124' ' ' GLN . 3.8 m-80 -146.53 87.75 1.73 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.248 -0.907 . . . . 0.0 110.155 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.495 ' HA3' ' HB3' ' A' ' 121' ' ' PRO . . . 137.07 34.27 0.21 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.567 ' HA ' ' CD2' ' A' ' 85' ' ' TYR . . . 59.07 148.31 0.07 OUTLIER Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.133 -1.216 . . . . 0.0 110.407 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.456 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 52.4 Cg_endo -80.37 21.03 9.08 Favored 'Cis proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.761 -2.183 . . . . 0.0 111.103 -0.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.567 ' CD2' ' HA ' ' A' ' 83' ' ' ALA . 35.6 m-85 60.93 130.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.057 -1.027 . . . . 0.0 110.239 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.452 ' O ' ' HA2' ' A' ' 79' ' ' GLY . . . -151.44 99.05 0.19 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.3 p -91.16 134.15 34.78 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.287 -1.125 . . . . 0.0 110.187 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.554 HG22 ' CE1' ' A' ' 106' ' ' PHE . 32.1 m -120.24 -9.2 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.233 -0.917 . . . . 0.0 110.092 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.578 HD12 ' CZ ' ' A' ' 106' ' ' PHE . 4.2 mp -118.63 137.63 53.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.275 -0.89 . . . . 0.0 111.006 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -150.71 85.13 1.36 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.486 -0.759 . . . . 0.0 109.951 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 65.6 p -144.08 -174.28 4.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.053 -1.029 . . . . 0.0 110.698 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.2 m -119.69 116.88 32.96 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.364 -0.835 . . . . 0.0 109.947 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.537 ' HG2' ' CG2' ' A' ' 74' ' ' VAL . 44.6 Cg_endo -71.84 79.61 1.59 Allowed 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.923 1.486 . . . . 0.0 110.642 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.528 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -67.03 148.17 52.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.208 -0.932 . . . . 0.0 109.833 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.531 ' CB ' ' HB1' ' A' ' 68' ' ' ALA . 73.3 mt -134.08 176.97 8.11 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.187 -0.946 . . . . 0.0 110.475 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.462 ' O ' HG21 ' A' ' 67' ' ' THR . 0.3 OUTLIER -170.66 -179.14 2.81 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.275 -0.891 . . . . 0.0 110.14 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.63 -30.27 71.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.257 -0.902 . . . . 0.0 110.039 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.518 ' CB ' ' HD2' ' A' ' 99' ' ' PRO . 0.1 OUTLIER -93.1 179.72 1.23 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.278 -0.889 . . . . 0.0 110.042 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.518 ' HD2' ' CB ' ' A' ' 98' ' ' GLU . 44.3 Cg_endo -72.06 134.99 24.33 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.9 1.474 . . . . 0.0 110.287 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.528 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.73 85.81 2.45 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.283 -0.885 . . . . 0.0 110.25 -179.893 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.454 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 8.7 mt-30 -71.7 156.33 39.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.27 -0.894 . . . . 0.0 110.216 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.597 ' CG2' ' CZ ' ' A' ' 64' ' ' TYR . 40.7 t -139.66 138.92 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.24 -0.913 . . . . 0.0 110.166 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.07 116.34 6.53 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.252 -0.905 . . . . 0.0 110.131 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -140.88 131.87 26.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.253 -0.904 . . . . 0.0 110.245 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.4 m -89.82 65.42 6.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.181 -0.949 . . . . 0.0 110.225 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.61 ' CZ ' ' CB ' ' A' ' 60' ' ' TYR . 26.1 p90 -71.29 144.95 49.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 0.0 110.099 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.531 ' O ' ' N ' ' A' ' 109' ' ' SER . 3.5 m -89.35 92.76 9.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.17 -0.956 . . . . 0.0 109.699 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.634 ' CB ' ' CD2' ' A' ' 60' ' ' TYR . . . -45.23 92.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.37 -0.831 . . . . 0.0 110.156 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 107' ' ' THR . 81.2 p -89.45 54.68 2.99 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.332 -0.855 . . . . 0.0 109.61 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -163.34 -155.2 0.31 Allowed 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.465 -0.894 . . . . 0.0 110.678 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.524 ' CB ' ' HA ' ' A' ' 55' ' ' GLU . 4.5 m -148.14 118.58 7.4 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.294 -0.879 . . . . 0.0 110.587 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.577 ' CD2' HG13 ' A' ' 54' ' ' ILE . 15.8 m-30 -112.61 85.52 7.48 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.497 -0.752 . . . . 0.0 109.542 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.475 ' O ' ' HA ' ' A' ' 122' ' ' GLU . 43.4 Cg_endo -69.97 127.77 14.9 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 123.86 1.453 . . . . 0.0 110.49 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.436 ' HB1' ' HB1' ' A' ' 1' ' ' ALA . . . -85.12 55.65 3.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.318 -0.864 . . . . 0.0 110.395 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.519 ' O ' ' CB ' ' A' ' 120' ' ' ASP . 5.7 m -136.21 74.7 54.83 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.212 -0.93 . . . . 0.0 110.046 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.425 ' HB3' ' CD ' ' A' ' 122' ' ' GLU . 44.8 Cg_endo -72.06 81.27 1.44 Allowed 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 124.036 1.545 . . . . 0.0 110.387 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -122.98 -172.69 2.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.341 -0.85 . . . . 0.0 110.116 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -53.12 -56.48 15.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.233 -0.917 . . . . 0.0 110.19 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -110.99 40.11 2.11 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.235 -0.916 . . . . 0.0 110.318 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.519 ' CB ' ' O ' ' A' ' 115' ' ' THR . 72.2 m-20 -139.63 99.28 7.75 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.209 -0.932 . . . . 0.0 110.15 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.513 ' HB2' ' NE2' ' A' ' 80' ' ' GLN . 48.8 Cg_endo -74.38 -176.94 2.98 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 124.001 1.527 . . . . 0.0 110.35 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.475 ' HA ' ' O ' ' A' ' 113' ' ' PRO . 0.9 OUTLIER -162.37 169.73 20.03 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.204 -0.935 . . . . 0.0 110.663 179.738 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.576 ' HA3' ' CG ' ' A' ' 112' ' ' TYR . . . -106.51 155.55 16.51 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.538 ' CB ' ' HA ' ' A' ' 50' ' ' ASN . 1.1 pt20 -150.4 -160.15 1.13 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.168 -1.195 . . . . 0.0 110.719 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.463 ' CG2' ' CE1' ' A' ' 127' ' ' PHE . 18.3 mt -118.34 142.65 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.585 ' CB ' ' CD1' ' A' ' 77' ' ' LEU . . . -118.03 120.98 39.43 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.249 -0.907 . . . . 0.0 111.439 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.489 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 4.9 m-85 -118.79 100.79 7.62 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.543 ' O ' ' CE2' ' A' ' 132' ' ' PHE . 32.1 mm-40 -89.47 103.15 15.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.127 -0.983 . . . . 0.0 112.313 -177.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.53 ' CD2' HG23 ' A' ' 74' ' ' VAL . 11.5 mt -100.68 41.04 1.2 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 177.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.453 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -67.61 85.68 0.15 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 -179.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.492 ' HA3' ' CB ' ' A' ' 41' ' ' ALA . . . 40.57 79.23 0.05 OUTLIER Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.583 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 10.5 m-85 -107.28 -42.64 4.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.171 -1.194 . . . . 0.0 110.183 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.604 ' HB3' ' CE3' ' A' ' 137' ' ' TRP . 1.2 t -89.81 -176.5 4.97 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.198 -0.938 . . . . 0.0 110.238 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.46 ' N ' ' OG ' ' A' ' 133' ' ' SER . . . -96.69 -92.23 0.23 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.122 -0.986 . . . . 0.0 110.855 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -63.63 170.75 3.03 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.187 -0.946 . . . . 0.0 110.637 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.527 ' CA ' ' HA ' ' A' ' 38' ' ' ALA . . . -52.92 136.53 34.37 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.392 -0.817 . . . . 0.0 110.397 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.604 ' CE3' ' HB3' ' A' ' 133' ' ' SER . 8.1 p90 -145.17 -167.55 2.71 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.314 -0.866 . . . . 0.0 110.336 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.538 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 0.5 OUTLIER -160.35 165.96 30.27 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.214 -0.929 . . . . 0.0 110.398 -178.729 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.522 ' HB2' ' CG2' ' A' ' 34' ' ' VAL . 2.4 mp -119.52 161.32 20.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.434 -0.791 . . . . 0.0 109.209 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' CYS . . . . . . . . . . . . . 1.9 m -150.58 94.44 2.1 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.069 -1.019 . . . . 0.0 111.209 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.488 ' O ' ' HB3' ' A' ' 142' ' ' ASP . 0.9 OUTLIER -95.14 -176.03 3.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.229 -0.919 . . . . 0.0 108.903 178.754 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.488 ' HB3' ' O ' ' A' ' 141' ' ' LEU . 0.5 OUTLIER 170.2 37.25 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.051 -1.031 . . . . 0.0 110.631 179.912 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.467 ' O ' ' O ' ' A' ' 63' ' ' ARG . 34.5 t0 179.35 48.75 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.184 -0.948 . . . . 0.0 110.056 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.521 ' O ' ' CD1' ' A' ' 4' ' ' ILE . 2.8 t -89.77 113.51 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.369 -0.832 . . . . 0.0 110.08 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.434 ' HB3' ' HA ' ' A' ' 6' ' ' GLU . . . -144.4 163.19 34.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.263 -0.898 . . . . 0.0 110.219 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.518 ' CD1' ' HB3' ' A' ' 60' ' ' TYR . 16.3 tp -145.99 128.87 16.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.27 -0.894 . . . . 0.0 110.218 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.581 ' O ' ' CD1' ' A' ' 60' ' ' TYR . 0.3 OUTLIER -135.75 -154.15 0.55 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.302 -0.874 . . . . 0.0 110.238 179.988 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 149' ' ' GLU . 48.3 p -140.25 169.24 18.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.273 -0.892 . . . . 0.0 110.116 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.509 ' O ' ' CG ' ' A' ' 149' ' ' GLU . 21.1 pt-20 -43.28 121.36 2.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.201 -0.937 . . . . 0.0 110.175 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 8.7 p -103.53 177.17 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.22 -0.925 . . . . 0.0 110.266 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -64.21 -167.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.262 -0.899 . . . . 0.0 110.263 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.452 HD21 ' N ' ' A' ' 152' ' ' LEU . 1.7 mm? . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.179 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.459 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.242 0.544 . . . . 0.0 110.183 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 1' ' ' ALA . 0.1 OUTLIER 55.12 166.47 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.259 -0.901 . . . . 0.0 110.162 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.446 ' HD2' ' OG ' ' A' ' 2' ' ' SER . 48.9 Cg_endo -76.0 -156.38 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.016 1.535 . . . . 0.0 110.097 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.499 HD11 HG22 ' A' ' 4' ' ' ILE . 7.8 pt -120.52 -3.62 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.181 -0.95 . . . . 0.0 110.128 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 6' ' ' GLU . . . 97.52 139.17 10.54 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 5' ' ' GLY . 0.4 OUTLIER -42.76 -85.5 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.241 -1.152 . . . . 0.0 110.126 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.469 ' HA2' ' HA ' ' A' ' 143' ' ' ASP . . . -80.85 127.66 8.03 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.538 ' CG2' ' O ' ' A' ' 144' ' ' VAL . 16.3 p -107.0 163.89 12.6 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.147 -1.208 . . . . 0.0 110.64 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.604 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.1 m-30 65.89 9.79 6.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.452 -0.78 . . . . 0.0 110.229 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.552 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 4.0 p-10 -86.12 41.66 0.94 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.159 -0.963 . . . . 0.0 109.885 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.552 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 2.1 t70 161.3 -24.17 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 172.91 164.21 27.95 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.48 ' O ' ' C ' ' A' ' 14' ' ' GLU . 44.1 Cg_endo -71.17 81.56 1.16 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.011 1.532 . . . . 0.0 110.442 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.48 ' C ' ' O ' ' A' ' 13' ' ' PRO . 1.0 OUTLIER -31.42 -68.2 0.09 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.275 0.559 . . . . 0.0 111.163 -179.636 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.495 ' C ' ' CD1' ' A' ' 49' ' ' LEU . . . -152.47 14.05 0.71 Allowed Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.765 -1.207 . . . . 0.0 110.218 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.581 ' NE1' ' CD2' ' A' ' 49' ' ' LEU . 24.2 m95 -77.77 110.08 12.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.028 -1.278 . . . . 0.0 110.244 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.506 ' CG2' ' O ' ' A' ' 17' ' ' VAL . 2.2 m -100.64 125.67 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.238 -0.914 . . . . 0.0 110.068 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.574 ' CB ' ' CG1' ' A' ' 34' ' ' VAL . . . -104.17 119.32 38.69 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.156 -0.965 . . . . 0.0 110.093 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.588 ' CZ ' ' O ' ' A' ' 46' ' ' GLY . 6.2 p90 -112.42 148.05 35.16 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.298 -0.876 . . . . 0.0 110.458 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.537 ' CA ' ' OH ' ' A' ' 43' ' ' TYR . . . 96.82 34.62 5.66 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.481 ' CG2' ' C ' ' A' ' 20' ' ' GLY . 7.3 p -150.21 -147.31 0.22 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.137 -1.214 . . . . 0.0 110.407 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 23' ' ' GLY . 62.2 t0 -89.96 114.77 26.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.334 -0.854 . . . . 0.0 110.33 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 43.16 -155.52 0.16 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.32 157.32 49.94 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 124.031 1.543 . . . . 0.0 110.493 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.423 ' CD1' HD12 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -53.63 179.8 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.254 -0.904 . . . . 0.0 110.201 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -152.58 142.33 21.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.27 -0.894 . . . . 0.0 110.196 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.5 ' CG2' ' HA ' ' A' ' 32' ' ' LEU . 2.2 p -119.64 -79.97 0.61 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.295 -0.878 . . . . 0.0 110.031 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.42 ' OG ' ' C ' ' A' ' 27' ' ' THR . 1.6 p 40.44 27.46 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.384 -0.822 . . . . 0.0 110.645 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.454 ' N ' ' O ' ' A' ' 27' ' ' THR . 12.8 t -148.7 13.93 0.93 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.139 -0.976 . . . . 0.0 110.364 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 9' ' ' PHE . . . 75.48 7.86 83.3 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.462 ' HB2' ' O ' ' A' ' 141' ' ' LEU . . . -150.35 151.38 32.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.256 -1.144 . . . . 0.0 110.118 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.57 ' HB2' ' CG ' ' A' ' 9' ' ' PHE . 0.5 OUTLIER -79.85 114.56 18.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.123 -0.986 . . . . 0.0 109.822 179.829 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 67.0 m -120.93 118.27 29.46 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.184 -0.947 . . . . 0.0 110.745 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.574 ' CG1' ' CB ' ' A' ' 18' ' ' ALA . 15.3 m -99.52 135.38 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.35 -0.844 . . . . 0.0 109.494 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.466 ' HA ' ' OG1' ' A' ' 138' ' ' THR . . . -89.47 89.74 7.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.207 -0.933 . . . . 0.0 111.089 -179.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.591 HG13 ' CE2' ' A' ' 137' ' ' TRP . 53.1 t -69.87 134.53 87.89 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.245 -0.91 . . . . 0.0 109.416 179.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 21' ' ' THR . 47.2 Cg_endo -76.68 152.85 33.53 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.944 1.497 . . . . 0.0 111.325 -178.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.529 ' HA ' ' CA ' ' A' ' 136' ' ' ALA . . . -43.89 130.99 5.74 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.373 -0.83 . . . . 0.0 109.884 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 38' ' ' ALA . . . 45.24 78.18 0.08 OUTLIER Glycine 0 N--CA 1.487 2.041 0 N-CA-C 108.724 -1.75 . . . . 0.0 108.724 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.501 ' HB2' ' CG2' ' A' ' 45' ' ' VAL . 1.1 p -82.76 40.33 0.67 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.304 -1.115 . . . . 0.0 110.473 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.532 ' CB ' ' HA3' ' A' ' 131' ' ' GLY . . . -109.1 25.13 12.17 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.361 -0.837 . . . . 0.0 109.767 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.503 ' O ' ' HB3' ' A' ' 43' ' ' TYR . 16.3 pt20 -78.14 2.7 17.19 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.637 0.732 . . . . 0.0 110.542 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.537 ' OH ' ' CA ' ' A' ' 20' ' ' GLY . 2.5 p90 177.26 -32.52 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.508 ' O ' ' CE2' ' A' ' 43' ' ' TYR . . . 123.48 104.47 1.68 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 110.266 -1.133 . . . . 0.0 110.266 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.501 ' CG2' ' HB2' ' A' ' 40' ' ' SER . 39.8 t -89.7 177.27 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.066 -1.255 . . . . 0.0 108.502 178.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.588 ' O ' ' CZ ' ' A' ' 19' ' ' TYR . . . 160.55 140.11 2.81 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 118.491 -1.814 . . . . 0.0 111.66 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.523 ' O ' ' CG1' ' A' ' 48' ' ' VAL . 21.5 t -100.53 162.17 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.644 -0.915 . . . . 0.0 108.693 178.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.523 ' CG1' ' O ' ' A' ' 47' ' ' VAL . 15.6 m -157.25 157.61 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.841 -1.162 . . . . 0.0 110.71 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.581 ' CD2' ' NE1' ' A' ' 16' ' ' TRP . 13.8 tp -151.33 120.28 6.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.327 -0.858 . . . . 0.0 110.351 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.497 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 23.7 p30 -96.26 158.24 15.53 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.216 -0.927 . . . . 0.0 110.234 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.11 74.4 0.62 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.446 HG13 HG12 ' A' ' 54' ' ' ILE . 87.2 t -138.83 172.43 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.173 -1.193 . . . . 0.0 110.177 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.465 ' O ' HD12 ' A' ' 54' ' ' ILE . . . -139.5 101.19 4.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.173 -0.955 . . . . 0.0 110.409 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.65 ' CG1' ' CD2' ' A' ' 112' ' ' TYR . 45.0 mm -126.34 173.13 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.248 -0.907 . . . . 0.0 109.987 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.527 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -164.74 128.59 2.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.118 -0.989 . . . . 0.0 110.814 -179.923 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 8.3 pt-20 37.74 -153.31 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.673 -0.642 . . . . 0.0 110.999 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 108' ' ' ALA . . . -87.03 75.67 2.16 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.556 ' CG2' ' N ' ' A' ' 59' ' ' THR . 1.3 m -101.67 173.61 6.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.334 -1.098 . . . . 0.0 109.807 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.575 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 0.7 OUTLIER -89.96 153.27 20.73 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.235 -0.916 . . . . 0.0 110.559 -179.577 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.612 ' CD2' ' CB ' ' A' ' 108' ' ' ALA . 64.3 m-85 -159.96 123.12 3.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.311 -0.868 . . . . 0.0 110.01 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 30.6 m -89.88 115.35 27.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.161 -0.962 . . . . 0.0 110.167 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.2 tp -89.5 126.27 35.52 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.232 -0.918 . . . . 0.0 109.907 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.496 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 14.3 ttp85 -131.16 136.49 48.36 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.385 -0.822 . . . . 0.0 110.107 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.636 ' CZ ' ' CG2' ' A' ' 102' ' ' VAL . 0.6 OUTLIER -178.46 143.2 0.26 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.383 -0.823 . . . . 0.0 109.57 179.678 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.464 ' CG2' ' HA ' ' A' ' 101' ' ' GLN . 0.2 OUTLIER -119.26 93.35 4.05 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.149 -0.969 . . . . 0.0 110.434 -179.466 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.517 ' HB1' ' CD2' ' A' ' 141' ' ' LEU . . . -94.81 153.95 17.49 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.293 -0.879 . . . . 0.0 110.119 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.466 ' OG1' ' HA ' ' A' ' 99' ' ' PRO . 51.9 m -150.14 135.65 18.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.22 -0.925 . . . . 0.0 110.363 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' A' ' 138' ' ' THR . . . -126.14 140.06 52.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.282 -0.886 . . . . 0.0 110.013 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.9 m -71.2 -3.71 21.67 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.22 -0.925 . . . . 0.0 110.113 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.548 ' CG2' ' HB2' ' A' ' 137' ' ' TRP . 6.3 t -124.62 19.84 8.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 110.096 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.466 ' OD1' ' O ' ' A' ' 95' ' ' LEU . 14.9 t0 43.51 60.77 2.48 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.272 -0.892 . . . . 0.0 109.558 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.528 ' CG2' ' HB2' ' A' ' 133' ' ' SER . 5.5 p -87.07 140.96 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.463 -0.773 . . . . 0.0 110.87 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 23.2 m -119.86 87.88 2.83 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.483 -0.761 . . . . 0.0 109.107 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.578 ' HA ' ' CG ' ' A' ' 132' ' ' PHE . 19.2 m -89.73 -146.15 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -0.906 . . . . 0.0 110.382 -179.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -127.16 124.14 38.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.244 -0.91 . . . . 0.0 110.434 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.511 ' N ' ' HD3' ' A' ' 93' ' ' PRO . . . -126.99 158.67 36.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.309 -0.869 . . . . 0.0 109.666 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.503 ' HA ' ' HB3' ' A' ' 89' ' ' LEU . 3.4 pp 177.87 -157.33 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.19 -0.944 . . . . 0.0 110.475 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.526 ' CG2' HD11 ' A' ' 89' ' ' LEU . 9.8 t -143.56 -178.21 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.339 -0.851 . . . . 0.0 109.558 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.537 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . 161.56 -154.93 26.03 Favored Glycine 0 N--CA 1.49 2.274 0 C-N-CA 119.303 -1.427 . . . . 0.0 110.053 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.566 ' HB3' ' CD1' ' A' ' 112' ' ' TYR . 6.2 pt20 -135.21 158.36 44.56 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.469 -1.018 . . . . 0.0 110.356 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.468 ' HB2' ' HG2' ' A' ' 122' ' ' GLU . 2.4 m120 -107.23 97.22 7.01 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.315 -0.866 . . . . 0.0 110.038 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.542 ' C ' ' CE1' ' A' ' 85' ' ' TYR . . . 138.44 143.01 4.4 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.593 ' N ' ' CE1' ' A' ' 85' ' ' TYR . . . -65.95 155.7 86.08 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.262 -1.14 . . . . 0.0 110.222 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.533 ' C ' ' CD2' ' A' ' 85' ' ' TYR . 50.6 Cg_endo -77.48 8.94 17.83 Favored 'Cis proline' 0 C--N 1.313 -1.322 0 C-N-CA 121.637 -2.235 . . . . 0.0 110.905 0.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.593 ' CE1' ' N ' ' A' ' 83' ' ' ALA . 10.5 m-85 69.33 -171.23 0.18 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.231 -0.918 . . . . 0.0 110.214 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 153.46 107.27 0.31 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.464 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 4.1 p -96.05 167.84 10.98 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.211 -1.17 . . . . 0.0 110.391 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.554 ' CG1' ' N ' ' A' ' 109' ' ' SER . 5.4 m -135.5 -32.76 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.364 -0.835 . . . . 0.0 110.324 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.579 HD12 ' CZ ' ' A' ' 106' ' ' PHE . 4.3 mp -98.3 144.24 27.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -0.909 . . . . 0.0 110.859 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 17.4 p-10 -151.08 86.11 1.36 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.324 -0.86 . . . . 0.0 110.172 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.419 ' CG2' ' O ' ' A' ' 90' ' ' ASP . 2.4 p -157.52 -175.03 5.16 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.024 -1.047 . . . . 0.0 110.531 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.49 130.47 24.78 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.326 -0.858 . . . . 0.0 110.172 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.529 ' HG2' ' CG2' ' A' ' 74' ' ' VAL . 49.7 Cg_endo -75.44 80.58 2.49 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.961 1.506 . . . . 0.0 110.87 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.535 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -56.55 135.63 54.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.059 -1.025 . . . . 0.0 109.479 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.492 ' CD1' ' CD2' ' A' ' 139' ' ' LEU . 93.4 mt -125.16 176.22 6.87 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.032 -1.043 . . . . 0.0 110.691 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.467 HG23 ' HG3' ' A' ' 100' ' ' ARG . 0.3 OUTLIER -167.9 -178.92 3.97 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.43 -0.794 . . . . 0.0 110.039 179.922 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.4 -29.87 70.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.196 -0.94 . . . . 0.0 110.281 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.457 ' CB ' ' HD2' ' A' ' 99' ' ' PRO . 3.7 mt-10 -90.28 176.7 2.8 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.172 -0.955 . . . . 0.0 110.14 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.466 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 45.4 Cg_endo -72.19 134.44 23.05 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.956 1.503 . . . . 0.0 110.334 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.535 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.9 92.94 3.9 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.191 -0.943 . . . . 0.0 110.368 -179.868 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.464 ' HA ' ' CG2' ' A' ' 65' ' ' THR . 6.4 tp-100 -76.71 154.92 33.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.292 -0.88 . . . . 0.0 110.085 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.636 ' CG2' ' CZ ' ' A' ' 64' ' ' TYR . 32.2 t -131.72 134.47 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.232 -0.917 . . . . 0.0 110.194 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.25 115.61 5.45 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.275 -0.891 . . . . 0.0 110.138 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -159.88 131.19 5.95 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.207 -0.933 . . . . 0.0 110.32 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.6 m -89.97 105.25 17.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.261 -0.899 . . . . 0.0 110.06 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.579 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 34.4 p90 -106.83 154.28 21.25 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.275 -0.89 . . . . 0.0 110.447 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 58' ' ' THR . 33.0 m -91.29 89.8 7.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.28 -0.888 . . . . 0.0 109.691 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.612 ' CB ' ' CD2' ' A' ' 60' ' ' TYR . . . -41.94 101.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.329 -0.857 . . . . 0.0 110.452 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.554 ' N ' ' CG1' ' A' ' 88' ' ' VAL . 88.8 p -85.89 55.55 3.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.3 -0.875 . . . . 0.0 110.063 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.465 ' HB1' HG12 ' A' ' 88' ' ' VAL . . . -159.55 -154.96 0.43 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.282 -0.886 . . . . 0.0 110.131 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.432 ' C ' ' CD1' ' A' ' 112' ' ' TYR . 19.7 m -159.99 110.89 1.92 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.111 -0.993 . . . . 0.0 110.591 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.65 ' CD2' ' CG1' ' A' ' 54' ' ' ILE . 3.3 m-30 -112.99 106.72 54.92 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.188 -0.945 . . . . 0.0 109.84 179.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.469 ' HG2' ' O ' ' A' ' 121' ' ' PRO . 46.4 Cg_endo -72.63 -159.02 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.785 1.413 . . . . 0.0 110.094 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -124.96 27.14 6.82 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.106 -0.996 . . . . 0.0 110.322 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.84 102.59 3.22 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.214 -0.928 . . . . 0.0 110.096 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.45 ' HA ' ' O ' ' A' ' 120' ' ' ASP . 47.2 Cg_endo -74.1 77.53 2.76 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.045 1.55 . . . . 0.0 110.588 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.524 ' CB ' ' HB2' ' A' ' 120' ' ' ASP . . . -96.59 -178.21 4.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.227 -0.921 . . . . 0.0 110.112 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -49.84 -58.89 4.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.239 -0.913 . . . . 0.0 110.223 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -101.18 26.82 6.67 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.275 -0.891 . . . . 0.0 110.354 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.524 ' HB2' ' CB ' ' A' ' 117' ' ' ALA . 28.6 m-20 -133.81 96.4 16.45 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.235 -0.916 . . . . 0.0 110.28 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.525 ' HB3' ' CA ' ' A' ' 82' ' ' GLY . 47.0 Cg_endo -73.85 164.25 35.08 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.011 1.532 . . . . 0.0 110.406 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 80' ' ' GLN . 1.4 pt-20 -112.78 -157.5 0.62 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.176 -0.953 . . . . 0.0 110.303 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.534 ' CA ' ' HB3' ' A' ' 112' ' ' TYR . . . -130.15 131.81 6.73 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.497 ' CB ' ' HA ' ' A' ' 50' ' ' ASN . 1.5 pt20 -150.43 -174.23 4.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.145 -1.209 . . . . 0.0 110.78 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.443 HG23 ' CH2' ' A' ' 16' ' ' TRP . 8.8 mt -118.74 143.87 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.488 ' HB2' ' CD1' ' A' ' 77' ' ' LEU . . . -115.15 119.65 37.11 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.286 -0.884 . . . . 0.0 111.275 -179.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.437 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 2.6 m-30 -117.34 94.08 4.42 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -89.25 105.08 17.55 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.084 -1.01 . . . . 0.0 111.524 -178.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.544 ' CD2' HG22 ' A' ' 74' ' ' VAL . 14.8 mt -100.13 50.09 0.91 Allowed 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.469 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -69.51 84.12 0.27 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.019 -1.233 . . . . 0.0 110.019 -179.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.532 ' HA3' ' CB ' ' A' ' 41' ' ' ALA . . . 39.02 72.47 0.2 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.578 ' CG ' ' HA ' ' A' ' 74' ' ' VAL . 10.5 m-85 -97.89 -39.64 8.89 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.136 -1.214 . . . . 0.0 110.124 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.6 ' HB3' ' CE3' ' A' ' 137' ' ' TRP . 1.2 t -89.69 -176.08 4.86 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.239 -0.913 . . . . 0.0 109.915 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.451 ' N ' ' OG ' ' A' ' 133' ' ' SER . . . -93.9 -99.48 0.14 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.033 -1.042 . . . . 0.0 110.982 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -61.17 177.51 0.34 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.993 -1.067 . . . . 0.0 110.853 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.529 ' CA ' ' HA ' ' A' ' 38' ' ' ALA . . . -53.52 136.5 38.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.472 -0.767 . . . . 0.0 110.342 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.6 ' CE3' ' HB3' ' A' ' 133' ' ' SER . 5.7 p90 -145.5 -170.16 3.38 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.372 -0.83 . . . . 0.0 110.157 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.537 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 0.5 OUTLIER -160.34 159.91 31.76 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.244 -0.983 . . . . 0.0 110.812 -178.789 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.492 ' CD2' ' CD1' ' A' ' 95' ' ' LEU . 2.2 mp -119.34 160.37 22.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.423 -0.798 . . . . 0.0 109.303 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' CYS . . . . . . . . . . . . . 13.6 m -150.53 100.55 2.87 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.128 -0.982 . . . . 0.0 110.598 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.521 ' O ' ' CB ' ' A' ' 142' ' ' ASP . 0.9 OUTLIER -96.44 -176.75 3.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.3 -0.875 . . . . 0.0 109.446 179.321 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.573 ' O ' ' CB ' ' A' ' 143' ' ' ASP . 2.4 p30 166.72 61.52 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.324 -0.86 . . . . 0.0 110.042 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.573 ' CB ' ' O ' ' A' ' 142' ' ' ASP . 1.4 m-20 159.85 46.52 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.538 ' O ' ' CG2' ' A' ' 8' ' ' THR . 3.5 t -89.64 112.04 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.329 -0.857 . . . . 0.0 110.466 -179.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -135.3 151.93 51.01 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.223 -0.923 . . . . 0.0 110.187 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 58.8 tp -151.61 124.67 8.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.335 -0.853 . . . . 0.0 110.194 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.451 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 3.5 t0 -161.07 156.43 24.53 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.278 -0.889 . . . . 0.0 110.326 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.514 ' OG ' ' N ' ' A' ' 149' ' ' GLU . 0.1 OUTLIER -99.48 -172.84 2.33 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.259 -0.901 . . . . 0.0 110.167 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.514 ' N ' ' OG ' ' A' ' 148' ' ' SER . 0.9 OUTLIER -121.46 111.34 17.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.188 -0.945 . . . . 0.0 110.32 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.453 ' HB ' ' O ' ' A' ' 149' ' ' GLU . 3.1 p 178.74 154.3 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.296 -0.878 . . . . 0.0 110.209 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.443 ' N ' HG21 ' A' ' 150' ' ' VAL . 34.4 mt-10 -105.21 -147.5 0.39 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.272 -0.892 . . . . 0.0 110.182 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.2 tp . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.266 -179.971 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.222 0.534 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.4 t -169.88 81.74 0.62 Allowed Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.294 -0.879 . . . . 0.0 110.117 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -76.13 -156.46 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.072 1.564 . . . . 0.0 110.159 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.51 ' CD1' ' HB ' ' A' ' 144' ' ' VAL . 6.1 pt -89.9 -0.05 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.234 -0.916 . . . . 0.0 110.18 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 6' ' ' GLU . . . 119.69 -24.42 8.0 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.527 ' HG3' ' CB ' ' A' ' 145' ' ' ALA . 4.3 tt0 43.06 48.68 5.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.308 -1.113 . . . . 0.0 110.153 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 143' ' ' ASP . . . -134.81 159.17 23.83 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.463 ' HA ' ' HB2' ' A' ' 143' ' ' ASP . 1.2 p -51.29 -179.0 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.291 -1.123 . . . . 0.0 110.345 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.574 ' CZ ' HG22 ' A' ' 144' ' ' VAL . 3.2 m-30 -110.78 24.83 12.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.292 -0.88 . . . . 0.0 110.283 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.565 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 29.6 t70 -110.74 50.91 0.79 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.172 -0.955 . . . . 0.0 110.209 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.565 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.3 OUTLIER 161.61 66.49 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.572 -0.705 . . . . 0.0 109.927 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.08 94.39 0.67 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.476 ' O ' ' HB3' ' A' ' 14' ' ' GLU . 51.1 Cg_endo -81.8 46.19 2.16 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.113 1.586 . . . . 0.0 110.63 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.476 ' HB3' ' O ' ' A' ' 13' ' ' PRO . 12.7 tp10 56.85 -90.97 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.155 -0.966 . . . . 0.0 110.187 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.486 ' C ' ' CD1' ' A' ' 49' ' ' LEU . . . -154.61 31.73 0.69 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.637 ' CE2' ' CD2' ' A' ' 49' ' ' LEU . 61.3 m95 -69.3 84.45 0.38 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.283 -1.127 . . . . 0.0 110.297 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.568 ' CG2' ' CG2' ' A' ' 48' ' ' VAL . 1.3 m -89.64 148.05 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.149 -0.97 . . . . 0.0 109.804 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.532 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . . . -124.58 135.75 53.39 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.095 -1.003 . . . . 0.0 109.893 179.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.517 ' CE1' HG12 ' A' ' 48' ' ' VAL . 20.1 p90 -124.69 168.51 13.08 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.385 -0.822 . . . . 0.0 110.753 -178.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.495 ' C ' ' CG2' ' A' ' 21' ' ' THR . . . 68.71 42.68 78.9 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.495 ' CG2' ' C ' ' A' ' 20' ' ' GLY . 1.8 p -151.35 -147.55 0.23 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.088 -1.242 . . . . 0.0 110.245 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.419 ' O ' ' O ' ' A' ' 23' ' ' GLY . 1.1 t70 -108.86 117.31 33.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.308 -0.87 . . . . 0.0 110.165 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 22' ' ' ASP . . . 52.83 177.15 0.06 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.02 151.12 49.69 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.965 1.508 . . . . 0.0 110.447 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.462 HD12 ' O ' ' A' ' 16' ' ' TRP . 0.8 OUTLIER -49.02 161.86 0.13 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.333 -0.855 . . . . 0.0 110.228 179.945 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -121.34 132.29 54.69 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.241 -0.912 . . . . 0.0 110.046 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 31' ' ' ALA . 0.7 OUTLIER -120.33 -24.93 5.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.216 -0.927 . . . . 0.0 110.61 -179.797 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 27' ' ' THR . 0.6 OUTLIER -43.93 -25.81 0.23 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.134 -0.978 . . . . 0.0 110.176 -179.828 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.412 ' N ' ' O ' ' A' ' 27' ' ' THR . 6.2 t -62.97 -47.51 82.83 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.271 -0.893 . . . . 0.0 110.686 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.401 ' N ' ' CG2' ' A' ' 29' ' ' THR . . . 161.03 -20.64 0.21 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.856 -1.297 . . . . 0.0 109.856 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.471 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -150.12 -176.08 5.31 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.167 -1.196 . . . . 0.0 109.965 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.568 ' HB2' ' CD2' ' A' ' 9' ' ' PHE . 0.7 OUTLIER -87.51 94.9 9.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.108 -0.995 . . . . 0.0 109.949 179.801 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 89.4 m -110.54 106.68 16.05 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.149 -0.969 . . . . 0.0 110.748 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.499 ' O ' ' OG1' ' A' ' 138' ' ' THR . 22.4 m -89.72 138.79 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.292 -0.88 . . . . 0.0 109.178 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.467 ' O ' ' HB ' ' A' ' 21' ' ' THR . . . -89.0 93.15 9.5 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.141 -0.975 . . . . 0.0 111.337 -178.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.635 ' CG1' ' CZ2' ' A' ' 137' ' ' TRP . 75.3 t -70.53 135.3 86.26 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.341 -0.849 . . . . 0.0 109.372 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.502 ' HD2' HG11 ' A' ' 36' ' ' VAL . 41.4 Cg_endo -68.56 172.28 11.7 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.727 1.383 . . . . 0.0 111.542 -178.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.525 ' HA ' ' CA ' ' A' ' 136' ' ' ALA . . . -70.47 115.32 9.51 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.39 -0.819 . . . . 0.0 110.447 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.476 ' O ' ' N ' ' A' ' 41' ' ' ALA . . . 83.79 -40.63 2.9 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.561 ' CB ' ' HA2' ' A' ' 130' ' ' GLY . 1.5 m 38.3 30.48 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.542 -0.975 . . . . 0.0 110.146 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 39' ' ' GLY . . . -89.6 23.22 2.7 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.973 0.892 . . . . 0.0 110.08 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.589 ' O ' ' CG ' ' A' ' 43' ' ' TYR . 9.7 pm0 -108.67 126.9 53.49 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.589 ' CG ' ' O ' ' A' ' 42' ' ' GLN . 43.9 p90 39.45 27.88 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.515 -0.741 . . . . 0.0 109.927 -178.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 42' ' ' GLN . . . 51.17 173.84 0.02 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.602 ' N ' ' HA3' ' A' ' 130' ' ' GLY . 43.5 t -142.0 -179.07 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 179.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.524 ' HA2' ' O ' ' A' ' 127' ' ' PHE . . . 164.22 -163.39 36.0 Favored Glycine 0 N--CA 1.484 1.852 0 C-N-CA 117.345 -2.36 . . . . 0.0 112.734 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.532 ' HA ' ' HA ' ' A' ' 18' ' ' ALA . 38.5 t -150.98 132.09 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.568 ' CG2' ' CG2' ' A' ' 17' ' ' VAL . 35.7 m -119.51 138.93 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.917 -1.115 . . . . 0.0 110.833 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.637 ' CD2' ' CE2' ' A' ' 16' ' ' TRP . 20.1 tp -133.69 97.68 3.99 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.373 -0.829 . . . . 0.0 110.236 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.53 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 8.6 p30 -81.11 113.61 19.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.218 -0.926 . . . . 0.0 110.239 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.453 ' O ' HG21 ' A' ' 4' ' ' ILE . . . 154.89 64.25 0.01 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.516 ' CG2' ' HA ' ' A' ' 124' ' ' GLN . 3.2 t -119.95 -176.18 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.237 -1.155 . . . . 0.0 109.881 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -142.49 75.14 1.48 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.074 -1.016 . . . . 0.0 110.634 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.538 HG13 ' CD2' ' A' ' 112' ' ' TYR . 32.5 mm -113.78 162.29 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.098 -1.001 . . . . 0.0 109.971 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.526 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 18.4 tt0 -162.25 132.31 4.68 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.176 -0.952 . . . . 0.0 110.605 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.526 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 15.2 pt-20 38.13 -160.25 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.67 -0.644 . . . . 0.0 110.916 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 109' ' ' SER . . . -80.63 74.88 2.32 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.571 HG21 ' CE2' ' A' ' 60' ' ' TYR . 1.3 m -104.17 168.2 9.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.351 -1.087 . . . . 0.0 109.868 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.571 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 3.1 m -89.99 157.98 17.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.177 -0.952 . . . . 0.0 110.264 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.574 ' CD2' ' HB1' ' A' ' 108' ' ' ALA . 66.5 m-85 -158.95 173.79 15.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.225 -0.922 . . . . 0.0 110.37 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.515 ' OG1' ' CG2' ' A' ' 105' ' ' THR . 22.1 m -150.16 113.98 5.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.355 -0.841 . . . . 0.0 110.034 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.463 HD13 ' N ' ' A' ' 63' ' ' ARG . 10.3 tp -89.66 121.96 32.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.16 -0.963 . . . . 0.0 110.077 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.463 ' N ' HD13 ' A' ' 62' ' ' LEU . 9.5 ttt-85 -127.63 107.16 9.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 110.489 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.563 ' CE2' ' HB ' ' A' ' 102' ' ' VAL . 7.8 p90 -143.34 172.33 12.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.333 -0.854 . . . . 0.0 109.915 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 101' ' ' GLN . 5.0 m -131.27 94.91 3.66 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.171 -0.956 . . . . 0.0 110.226 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 100' ' ' ARG . . . -99.6 142.1 31.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -0.898 . . . . 0.0 110.398 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.453 ' OG1' ' HA ' ' A' ' 99' ' ' PRO . 93.3 m -150.37 101.86 3.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.403 -0.811 . . . . 0.0 110.048 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -89.81 144.07 26.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.192 -0.942 . . . . 0.0 110.105 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.4 m -60.59 -15.01 23.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.147 -0.971 . . . . 0.0 109.225 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.535 ' CG2' ' HB2' ' A' ' 137' ' ' TRP . 3.0 t -121.71 160.18 25.05 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.592 -0.693 . . . . 0.0 109.809 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -77.94 79.7 4.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.044 -1.035 . . . . 0.0 108.927 178.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.562 HG22 ' CE2' ' A' ' 137' ' ' TRP . 3.7 p -99.56 135.31 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.199 -0.938 . . . . 0.0 111.654 -178.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.403 HG21 ' HB2' ' A' ' 92' ' ' SER . 23.3 m -121.61 86.86 2.65 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.603 ' CG2' ' CD2' ' A' ' 129' ' ' LEU . 10.8 m -89.84 -149.71 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.283 -0.886 . . . . 0.0 111.172 -178.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -130.68 106.38 8.44 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.534 -0.729 . . . . 0.0 110.524 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.489 ' O ' ' HB3' ' A' ' 77' ' ' LEU . . . -110.39 158.22 18.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.378 -0.827 . . . . 0.0 109.586 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.531 ' CD1' ' HB1' ' A' ' 126' ' ' ALA . 3.7 pp 177.79 -158.04 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.279 -0.888 . . . . 0.0 110.376 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.567 HG13 ' CE2' ' A' ' 112' ' ' TYR . 4.3 t -147.19 171.6 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.39 -0.819 . . . . 0.0 109.488 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.492 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . 175.36 -171.66 44.76 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.353 -1.403 . . . . 0.0 110.242 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.426 ' O ' ' CG ' ' A' ' 81' ' ' ASN . 2.5 tt0 -94.08 -169.63 2.12 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.429 -1.042 . . . . 0.0 110.171 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 23.2 m120 -157.21 75.2 0.8 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.308 -0.87 . . . . 0.0 109.831 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.526 ' HA3' ' CB ' ' A' ' 121' ' ' PRO . . . 144.5 38.57 0.06 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.467 ' O ' ' O ' ' A' ' 82' ' ' GLY . . . 58.96 150.91 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.232 -1.158 . . . . 0.0 110.305 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.472 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 52.1 Cg_endo -80.49 21.99 8.32 Favored 'Cis proline' 0 C--N 1.312 -1.343 0 C-N-CA 121.696 -2.21 . . . . 0.0 111.113 0.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.472 ' HB2' ' O ' ' A' ' 84' ' ' PRO . 43.5 m-85 60.49 123.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.01 -1.056 . . . . 0.0 110.317 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -154.86 110.77 0.46 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.8 p -89.89 142.53 27.61 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.208 -1.172 . . . . 0.0 110.333 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.502 ' CG2' HD13 ' A' ' 89' ' ' LEU . 28.8 m -119.97 -20.11 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.345 -0.847 . . . . 0.0 109.973 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.566 HD12 ' CZ ' ' A' ' 106' ' ' PHE . 4.7 mp -111.97 142.18 44.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.855 . . . . 0.0 110.652 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.412 ' O ' ' OD1' ' A' ' 90' ' ' ASP . 1.7 p30 -151.18 87.84 1.42 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.252 -0.905 . . . . 0.0 110.159 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.7 p -156.74 178.66 10.09 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.933 -1.104 . . . . 0.0 110.797 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.403 ' HB2' HG21 ' A' ' 73' ' ' THR . 81.5 p -119.79 127.81 26.2 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.377 -0.827 . . . . 0.0 109.886 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.536 ' CG ' HG21 ' A' ' 74' ' ' VAL . 48.9 Cg_endo -75.08 75.08 3.84 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.887 1.467 . . . . 0.0 111.192 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.521 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -52.45 124.83 14.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.922 -1.111 . . . . 0.0 109.094 179.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.527 HD12 ' CD2' ' A' ' 139' ' ' LEU . 38.2 mt -119.91 175.51 5.87 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.992 -1.068 . . . . 0.0 111.0 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -168.78 -178.54 3.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.521 -0.737 . . . . 0.0 109.806 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.2 p -70.26 -7.38 41.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.221 -0.924 . . . . 0.0 110.293 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.473 ' CG ' ' HD2' ' A' ' 99' ' ' PRO . 1.1 mt-10 -102.35 172.34 4.44 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.212 -0.93 . . . . 0.0 110.094 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.473 ' HD2' ' CG ' ' A' ' 98' ' ' GLU . 44.8 Cg_endo -72.5 129.0 14.16 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.014 1.534 . . . . 0.0 110.304 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.521 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.79 92.03 3.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.205 -0.934 . . . . 0.0 110.333 -179.81 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.466 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 0.0 OUTLIER -88.61 106.14 18.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.254 -0.904 . . . . 0.0 110.081 179.842 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.563 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 37.5 t -89.98 133.82 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.231 -0.918 . . . . 0.0 110.316 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.465 ' C ' ' CG ' ' A' ' 104' ' ' GLU . 8.3 m -150.24 112.03 4.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.286 -0.884 . . . . 0.0 110.042 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.465 ' CG ' ' C ' ' A' ' 103' ' ' THR . 32.0 mt-10 -150.7 156.13 40.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.184 -0.947 . . . . 0.0 110.354 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.515 ' CG2' ' OG1' ' A' ' 61' ' ' THR . 0.8 OUTLIER -106.33 134.78 48.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.331 -0.856 . . . . 0.0 110.095 179.863 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.566 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 55.4 p90 -136.65 157.63 46.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.215 -0.928 . . . . 0.0 110.305 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 86.4 m -89.98 91.36 8.54 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.278 -0.889 . . . . 0.0 110.041 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.574 ' HB1' ' CD2' ' A' ' 60' ' ' TYR . . . -57.36 117.08 3.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.253 -0.904 . . . . 0.0 110.381 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.459 ' HA ' ' HA2' ' A' ' 57' ' ' GLY . 11.0 p -100.21 54.93 0.9 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.227 -0.921 . . . . 0.0 110.099 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -166.38 -162.42 0.52 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.215 -0.928 . . . . 0.0 110.417 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 61.9 m -143.39 115.27 8.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.237 -0.914 . . . . 0.0 110.297 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.567 ' CE2' HG13 ' A' ' 78' ' ' VAL . 11.8 m-30 -114.84 80.97 6.97 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.266 -0.896 . . . . 0.0 110.08 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.469 ' HG2' ' HA ' ' A' ' 122' ' ' GLU . 45.7 Cg_endo -73.04 -162.37 0.13 Allowed 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 124.015 1.534 . . . . 0.0 110.446 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.441 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -142.69 25.0 1.85 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.275 -0.891 . . . . 0.0 110.29 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.448 ' O ' ' O ' ' A' ' 120' ' ' ASP . 1.3 m -108.92 83.13 2.03 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.197 -0.939 . . . . 0.0 110.172 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 46.3 Cg_endo -73.2 78.88 2.17 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.994 1.523 . . . . 0.0 110.506 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -101.37 -167.92 1.49 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.253 -0.904 . . . . 0.0 110.179 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.7 -53.2 58.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.235 -0.916 . . . . 0.0 110.218 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.49 41.13 2.38 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.268 -0.895 . . . . 0.0 110.253 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.448 ' O ' ' O ' ' A' ' 115' ' ' THR . 52.3 m-20 -148.98 86.75 5.59 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.223 -0.923 . . . . 0.0 110.229 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.526 ' CB ' ' HA3' ' A' ' 82' ' ' GLY . 45.8 Cg_endo -73.04 -158.96 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.966 1.509 . . . . 0.0 110.44 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.469 ' HA ' ' HG2' ' A' ' 113' ' ' PRO . 3.7 pm0 -160.68 -170.0 2.61 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.149 -0.97 . . . . 0.0 110.465 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.544 ' HA3' ' CD1' ' A' ' 112' ' ' TYR . . . -123.62 159.08 18.28 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.336 -1.505 . . . . 0.0 109.336 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.53 ' CB ' ' HA ' ' A' ' 50' ' ' ASN . 19.6 pt20 -150.34 -159.07 0.98 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.161 -1.199 . . . . 0.0 110.687 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.444 ' CG2' ' CE1' ' A' ' 127' ' ' PHE . 9.8 mt -118.95 147.08 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.529 -0.732 . . . . 0.0 109.388 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.531 ' HB1' ' CD1' ' A' ' 77' ' ' LEU . . . -120.35 118.85 31.46 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.322 -0.861 . . . . 0.0 111.314 -179.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.524 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 4.6 m-85 -119.57 73.35 0.95 Allowed 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.517 ' HA ' ' HA3' ' A' ' 46' ' ' GLY . 34.1 mt-30 -87.9 106.01 17.82 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 122.52 1.152 . . . . 0.0 112.104 -177.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.603 ' CD2' ' CG2' ' A' ' 74' ' ' VAL . 10.3 mt -93.47 -111.22 0.11 Allowed 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.602 ' HA3' ' N ' ' A' ' 45' ' ' VAL . . . 50.75 111.81 0.01 OUTLIER Glycine 0 N--CA 1.493 2.442 0 O-C-N 120.743 -1.223 . . . . 0.0 111.138 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 40' ' ' SER . . . 72.91 66.88 1.94 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.583 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 5.0 m-85 -148.03 -52.01 0.18 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.234 -1.157 . . . . 0.0 110.182 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.528 ' HB2' ' CG2' ' A' ' 72' ' ' VAL . 1.6 t -89.36 -151.78 0.23 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.086 -1.009 . . . . 0.0 110.15 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -112.09 -88.82 0.52 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.147 -0.97 . . . . 0.0 110.321 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.407 ' O ' ' C ' ' A' ' 136' ' ' ALA . 6.1 m-20 -84.07 172.65 11.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.222 -0.924 . . . . 0.0 110.273 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.525 ' CA ' ' HA ' ' A' ' 38' ' ' ALA . . . -42.35 130.33 3.81 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.297 -0.877 . . . . 0.0 110.293 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.635 ' CZ2' ' CG1' ' A' ' 36' ' ' VAL . 9.7 p90 -142.97 -165.21 2.01 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.325 -0.859 . . . . 0.0 109.648 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.526 ' O ' ' CB ' ' A' ' 68' ' ' ALA . 0.5 OUTLIER -160.04 172.72 17.0 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.834 -1.166 . . . . 0.0 111.231 -178.284 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.527 ' CD2' HD12 ' A' ' 95' ' ' LEU . 2.2 mp -134.35 126.58 29.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.582 -0.699 . . . . 0.0 109.326 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' CYS . . . . . . . . . . . . . 7.2 m -114.07 96.09 5.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.154 -0.966 . . . . 0.0 110.807 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.459 ' HA ' ' O ' ' A' ' 65' ' ' THR . 2.1 mt -89.75 -166.65 1.64 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.357 -0.839 . . . . 0.0 109.357 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.57 ' HA ' ' CD2' ' A' ' 9' ' ' PHE . 22.0 p-10 -167.93 -151.31 0.11 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.964 -1.085 . . . . 0.0 110.626 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.476 ' C ' ' CG2' ' A' ' 144' ' ' VAL . 6.5 t0 -38.82 150.89 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.641 -0.662 . . . . 0.0 110.662 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.574 HG22 ' CZ ' ' A' ' 9' ' ' PHE . 3.0 t -150.15 132.47 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.357 -0.839 . . . . 0.0 109.955 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.527 ' CB ' ' HG3' ' A' ' 6' ' ' GLU . . . -127.91 146.35 50.66 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.187 -0.946 . . . . 0.0 110.413 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.462 HD13 ' HB3' ' A' ' 60' ' ' TYR . 22.8 tp -153.81 90.72 1.4 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.323 -0.861 . . . . 0.0 110.085 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.466 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 0.4 OUTLIER -107.07 -167.02 1.22 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.249 -0.907 . . . . 0.0 110.258 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.428 ' HB3' ' CE1' ' A' ' 60' ' ' TYR . 1.2 p -138.77 105.9 5.47 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.207 -0.933 . . . . 0.0 110.25 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -114.61 155.74 25.97 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.262 -0.899 . . . . 0.0 110.226 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.42 ' O ' ' CG2' ' A' ' 150' ' ' VAL . 7.9 p -106.46 48.36 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.243 -0.91 . . . . 0.0 110.222 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -60.33 167.53 2.45 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.257 -0.902 . . . . 0.0 110.119 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.5 ' N ' HD11 ' A' ' 152' ' ' LEU . 6.4 mp . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.227 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.218 0.532 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.4 m -129.66 153.65 80.8 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.226 -0.922 . . . . 0.0 110.239 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -75.88 -156.06 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.005 1.529 . . . . 0.0 110.085 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.525 ' CG2' ' O ' ' A' ' 51' ' ' GLY . 20.7 pt -89.96 43.63 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.19 -0.944 . . . . 0.0 110.113 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 6' ' ' GLU . . . 56.83 61.28 7.68 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.46 ' O ' ' HA ' ' A' ' 145' ' ' ALA . 1.7 mp0 57.16 -88.62 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.292 -1.122 . . . . 0.0 110.193 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.469 ' O ' ' OG1' ' A' ' 8' ' ' THR . . . 159.22 -115.34 0.65 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.469 ' OG1' ' O ' ' A' ' 7' ' ' GLY . 4.1 p 45.46 97.49 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.39 -1.065 . . . . 0.0 110.165 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.584 ' CD2' ' HB2' ' A' ' 32' ' ' LEU . 78.2 m-85 -77.62 7.62 5.41 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.479 -0.763 . . . . 0.0 109.7 179.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.551 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 34.4 t0 -84.15 45.06 1.06 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.419 -0.801 . . . . 0.0 110.122 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.551 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.3 OUTLIER 161.6 36.83 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.572 -0.705 . . . . 0.0 109.879 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 118.29 112.01 2.52 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.527 ' HG3' ' CG2' ' A' ' 27' ' ' THR . 51.0 Cg_endo -77.07 8.91 2.97 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 O-C-N 123.834 1.439 . . . . 0.0 110.93 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.5 ' HB3' ' O ' ' A' ' 13' ' ' PRO . 30.1 tp10 61.34 -89.47 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.237 -0.914 . . . . 0.0 110.464 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -149.02 19.15 1.22 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.577 ' CG ' HD11 ' A' ' 49' ' ' LEU . 23.5 m95 -62.53 125.31 23.48 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.211 -1.17 . . . . 0.0 110.324 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.526 ' O ' ' CG1' ' A' ' 47' ' ' VAL . 0.2 OUTLIER -115.44 161.93 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.234 -0.916 . . . . 0.0 109.234 179.635 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.506 ' CB ' HG13 ' A' ' 34' ' ' VAL . . . -146.9 152.24 38.35 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.323 -0.861 . . . . 0.0 110.209 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.574 ' CE2' ' O ' ' A' ' 46' ' ' GLY . 11.8 p90 -138.61 114.02 9.62 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.296 -0.877 . . . . 0.0 110.274 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.533 ' HA3' ' CG1' ' A' ' 45' ' ' VAL . . . -173.0 49.97 0.16 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.475 ' OG1' ' O ' ' A' ' 20' ' ' GLY . 8.2 p 50.9 19.22 0.61 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.366 -1.079 . . . . 0.0 110.479 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.482 ' HB3' ' O ' ' A' ' 35' ' ' ALA . 1.8 p30 -102.59 38.01 1.8 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.133 -0.98 . . . . 0.0 110.197 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 44.46 -153.27 0.47 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.457 ' O ' ' O ' ' A' ' 25' ' ' LEU . 46.3 Cg_endo -73.54 125.92 10.48 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.933 1.491 . . . . 0.0 110.361 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' A' ' 24' ' ' PRO . 0.8 OUTLIER -42.87 166.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.227 -0.921 . . . . 0.0 110.11 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.448 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 0.5 OUTLIER -125.83 149.92 48.25 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.163 -0.96 . . . . 0.0 110.275 -179.815 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.527 ' CG2' ' HG3' ' A' ' 13' ' ' PRO . 0.7 OUTLIER -129.78 -43.78 1.22 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.249 -0.907 . . . . 0.0 110.251 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.463 ' HB3' ' O ' ' A' ' 27' ' ' THR . 4.5 t 56.35 36.28 27.26 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.31 -0.869 . . . . 0.0 110.303 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.451 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 33.2 p 42.53 33.21 0.42 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.299 -0.876 . . . . 0.0 110.3 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.511 ' CA ' ' HA ' ' A' ' 10' ' ' ASP . . . -140.51 -63.58 0.03 OUTLIER Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.467 ' HB3' ' HB3' ' A' ' 142' ' ' ASP . . . -150.11 148.78 29.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.308 -1.113 . . . . 0.0 110.101 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.584 ' HB2' ' CD2' ' A' ' 9' ' ' PHE . 1.8 tt -88.36 115.46 25.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.116 -0.99 . . . . 0.0 109.861 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 72.8 m -121.56 137.74 54.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.193 -0.942 . . . . 0.0 110.765 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.506 HG13 ' CB ' ' A' ' 18' ' ' ALA . 2.7 m -110.98 143.47 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.408 -0.807 . . . . 0.0 109.215 179.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.482 ' O ' ' HB3' ' A' ' 22' ' ' ASP . . . -89.43 90.04 8.13 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.167 -0.958 . . . . 0.0 111.46 -178.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.642 ' CG1' ' CZ2' ' A' ' 137' ' ' TRP . 87.2 t -72.52 119.14 73.39 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.043 -1.036 . . . . 0.0 109.182 178.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.46 ' HG3' ' OG1' ' A' ' 21' ' ' THR . 42.7 Cg_endo -68.12 151.1 77.51 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.951 1.501 . . . . 0.0 111.415 -178.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.526 ' HA ' ' CA ' ' A' ' 136' ' ' ALA . . . -43.11 144.24 0.67 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.498 -0.751 . . . . 0.0 110.042 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 38' ' ' ALA . . . 44.46 77.73 0.09 OUTLIER Glycine 0 N--CA 1.488 2.133 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.578 ' HB3' ' CH2' ' A' ' 137' ' ' TRP . 0.3 OUTLIER -87.33 25.98 1.3 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.223 -1.163 . . . . 0.0 110.386 -179.703 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.408 ' HB1' ' HA2' ' A' ' 131' ' ' GLY . . . -92.85 19.89 7.17 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 122.048 0.928 . . . . 0.0 109.606 179.374 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.574 ' HG3' ' CD2' ' A' ' 43' ' ' TYR . 25.7 pt20 -89.87 -131.34 0.09 Allowed 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.417 179.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.638 ' CD1' ' N ' ' A' ' 44' ' ' GLY . 12.4 p90 -37.51 -28.94 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.589 -0.695 . . . . 0.0 110.218 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.638 ' N ' ' CD1' ' A' ' 43' ' ' TYR . . . 105.45 111.3 3.59 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 179.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.533 ' CG1' ' HA3' ' A' ' 20' ' ' GLY . 2.1 t -89.91 171.18 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.176 -1.19 . . . . 0.0 108.541 178.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.574 ' O ' ' CE2' ' A' ' 19' ' ' TYR . . . 160.72 155.61 7.87 Favored Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.029 -1.557 . . . . 0.0 110.478 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.526 ' CG1' ' O ' ' A' ' 17' ' ' VAL . 48.6 t -120.5 133.48 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.473 -1.016 . . . . 0.0 109.656 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.472 ' O ' HG12 ' A' ' 17' ' ' VAL . 30.4 m -120.02 153.46 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.079 -1.013 . . . . 0.0 110.523 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.577 HD11 ' CG ' ' A' ' 16' ' ' TRP . 13.5 tp -140.51 87.64 2.14 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.304 -0.872 . . . . 0.0 110.197 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.489 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 23.6 m-20 -68.1 104.13 1.7 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.291 -0.881 . . . . 0.0 110.241 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.525 ' O ' ' CG2' ' A' ' 4' ' ' ILE . . . 154.39 74.22 0.01 OUTLIER Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.531 ' CG1' HG12 ' A' ' 54' ' ' ILE . 24.7 t -120.74 172.44 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.277 -1.131 . . . . 0.0 109.939 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.526 ' N ' ' CG1' ' A' ' 52' ' ' VAL . . . -134.27 77.57 1.71 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.09 -1.006 . . . . 0.0 110.941 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.563 HD11 ' CZ ' ' A' ' 60' ' ' TYR . 24.9 mm -118.82 165.2 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.191 -0.943 . . . . 0.0 109.599 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.52 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 0.3 OUTLIER -158.88 126.79 5.07 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.989 -1.07 . . . . 0.0 110.888 -179.722 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.52 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 17.2 pt-20 37.29 -154.98 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.65 -0.656 . . . . 0.0 110.99 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 108' ' ' ALA . . . -81.4 81.67 1.62 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.571 HG21 ' CE2' ' A' ' 60' ' ' TYR . 1.2 m -112.44 172.34 6.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.209 -1.171 . . . . 0.0 109.943 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.57 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 0.4 OUTLIER -89.98 154.3 19.94 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.316 -0.865 . . . . 0.0 110.213 -179.894 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.588 ' CD2' ' CB ' ' A' ' 108' ' ' ALA . 59.9 m-85 -159.69 173.47 16.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.293 -0.879 . . . . 0.0 110.238 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 27.4 m -150.11 114.52 5.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.282 -0.886 . . . . 0.0 110.081 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 14.1 tp -89.62 120.83 31.25 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.211 -0.931 . . . . 0.0 109.902 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.475 ' HA ' ' O ' ' A' ' 102' ' ' VAL . 6.5 ttt180 -131.49 128.5 39.5 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.228 -0.92 . . . . 0.0 110.405 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.537 ' CZ ' HG23 ' A' ' 102' ' ' VAL . 6.9 p90 -165.09 156.02 14.32 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.409 -0.807 . . . . 0.0 109.964 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.471 ' HB ' ' OD1' ' A' ' 142' ' ' ASP . 32.2 m -119.76 99.79 6.85 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.17 -0.956 . . . . 0.0 109.919 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.508 ' CB ' HD23 ' A' ' 95' ' ' LEU . . . -100.79 154.51 18.57 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.264 -0.897 . . . . 0.0 110.473 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.6 m -150.34 136.84 18.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.362 -0.836 . . . . 0.0 110.145 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.52 ' N ' ' HB3' ' A' ' 95' ' ' LEU . . . -129.39 127.33 40.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.234 -0.916 . . . . 0.0 109.993 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 68' ' ' ALA . 0.6 OUTLIER -43.13 -26.84 0.18 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.246 -0.909 . . . . 0.0 109.66 179.809 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.583 ' CG2' ' CB ' ' A' ' 137' ' ' TRP . 3.5 t -110.5 164.08 13.06 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.482 -0.761 . . . . 0.0 109.928 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -82.79 72.04 9.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.168 -0.958 . . . . 0.0 109.038 178.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.575 HG22 ' CE2' ' A' ' 137' ' ' TRP . 4.0 p -93.54 136.38 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.326 -0.859 . . . . 0.0 111.384 -178.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.541 ' O ' ' CD1' ' A' ' 132' ' ' PHE . 13.5 m -119.98 87.85 2.82 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.608 ' HA ' ' CG ' ' A' ' 132' ' ' PHE . 11.5 m -89.5 -153.18 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.249 -0.907 . . . . 0.0 110.761 -178.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.463 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 0.3 OUTLIER -127.99 135.29 49.72 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.369 -0.832 . . . . 0.0 110.476 -179.207 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.481 ' O ' ' HB3' ' A' ' 77' ' ' LEU . . . -136.83 154.89 50.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.299 -0.875 . . . . 0.0 109.979 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.571 ' CD1' ' N ' ' A' ' 78' ' ' VAL . 4.0 pp 179.2 -149.22 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.363 -0.836 . . . . 0.0 110.099 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.571 ' N ' ' CD1' ' A' ' 77' ' ' LEU . 4.7 t -147.86 177.67 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.28 -0.887 . . . . 0.0 109.365 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.533 ' C ' ' CZ ' ' A' ' 112' ' ' TYR . . . -177.69 -176.55 45.81 Favored Glycine 0 N--CA 1.489 2.186 0 C-N-CA 119.22 -1.466 . . . . 0.0 110.16 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.495 ' HA ' ' CD1' ' A' ' 112' ' ' TYR . 5.0 tt0 -98.0 -151.93 0.39 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.404 -1.056 . . . . 0.0 110.193 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.533 ' O ' ' CB ' ' A' ' 121' ' ' PRO . 10.0 m120 -161.15 61.6 0.28 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.411 -0.806 . . . . 0.0 109.681 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.471 ' HA3' ' HB3' ' A' ' 121' ' ' PRO . . . 159.97 128.4 0.97 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.196 -1.561 . . . . 0.0 109.196 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.628 ' N ' ' CE1' ' A' ' 85' ' ' TYR . . . -41.73 151.34 0.32 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.319 -1.106 . . . . 0.0 110.377 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.488 ' C ' ' CD2' ' A' ' 85' ' ' TYR . 50.9 Cg_endo -79.14 10.04 22.91 Favored 'Cis proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.632 -2.237 . . . . 0.0 110.775 -0.081 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.628 ' CE1' ' N ' ' A' ' 83' ' ' ALA . 12.5 m-85 68.0 156.53 0.12 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.241 -0.912 . . . . 0.0 110.169 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -171.6 125.84 1.23 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.98 152.44 19.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.242 -1.152 . . . . 0.0 110.209 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.467 ' HB ' ' HA ' ' A' ' 108' ' ' ALA . 16.0 m -123.23 -24.94 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.287 -0.883 . . . . 0.0 110.2 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.567 HD12 ' CZ ' ' A' ' 106' ' ' PHE . 4.2 mp -108.96 144.79 36.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.232 -0.917 . . . . 0.0 110.911 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.424 ' O ' ' CG ' ' A' ' 90' ' ' ASP . 40.2 p-10 -151.45 80.91 1.3 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.352 -0.843 . . . . 0.0 110.063 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 44.3 p -144.01 171.74 13.84 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.959 -1.088 . . . . 0.0 110.742 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.96 115.02 33.51 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.385 -0.822 . . . . 0.0 110.021 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.537 ' HG2' ' CG2' ' A' ' 74' ' ' VAL . 43.7 Cg_endo -70.16 155.19 65.19 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.951 1.501 . . . . 0.0 110.998 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.519 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -129.92 145.39 51.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.407 -0.808 . . . . 0.0 109.573 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.527 ' CD1' ' HG ' ' A' ' 139' ' ' LEU . 39.6 mt -134.19 173.0 12.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.07 -1.019 . . . . 0.0 110.673 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.468 ' O ' ' O ' ' A' ' 68' ' ' ALA . 6.0 t -171.85 -154.87 0.09 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.401 -0.812 . . . . 0.0 109.918 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.44 28.41 1.48 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.206 -0.934 . . . . 0.0 110.143 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.95 173.81 3.99 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.315 -0.866 . . . . 0.0 109.968 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.56 130.62 16.25 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.953 1.501 . . . . 0.0 110.364 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.519 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.61 87.43 2.74 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.226 -0.921 . . . . 0.0 110.042 -179.98 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.453 ' HG2' ' OG1' ' A' ' 65' ' ' THR . 0.9 OUTLIER -68.31 151.68 46.55 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.359 -0.838 . . . . 0.0 110.245 -179.903 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.537 HG23 ' CZ ' ' A' ' 64' ' ' TYR . 65.1 t -131.49 136.31 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.228 -0.92 . . . . 0.0 110.009 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.464 ' O ' ' HG3' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -150.13 104.04 3.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.271 -0.893 . . . . 0.0 110.173 -179.937 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' A' ' 103' ' ' THR . 6.7 mt-10 -145.53 132.9 20.64 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.286 -0.884 . . . . 0.0 110.166 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.45 ' O ' ' HB3' ' A' ' 106' ' ' PHE . 0.2 OUTLIER -89.92 169.82 10.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.287 -0.883 . . . . 0.0 110.12 179.918 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.572 ' CZ ' ' HB2' ' A' ' 60' ' ' TYR . 42.1 p90 -177.38 150.49 0.71 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -0.923 . . . . 0.0 110.288 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.5 m -91.47 92.39 8.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.234 -0.917 . . . . 0.0 110.061 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.588 ' CB ' ' CD2' ' A' ' 60' ' ' TYR . . . -50.86 113.83 1.01 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.887 . . . . 0.0 110.227 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 17.1 p -96.52 51.4 1.17 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.213 -0.93 . . . . 0.0 110.191 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.402 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -162.99 -166.57 1.31 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.218 -0.926 . . . . 0.0 110.18 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.446 HG21 ' HD3' ' A' ' 113' ' ' PRO . 11.2 m -134.39 112.27 10.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.218 -0.926 . . . . 0.0 110.307 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.568 ' CE2' HG13 ' A' ' 78' ' ' VAL . 17.9 m-30 -113.02 71.42 1.34 Allowed Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.339 -0.85 . . . . 0.0 110.001 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.462 ' HD2' ' HA ' ' A' ' 122' ' ' GLU . 44.0 Cg_endo -72.13 -167.6 0.33 Allowed 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.932 1.49 . . . . 0.0 110.374 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -135.51 63.69 1.6 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.202 -0.936 . . . . 0.0 110.279 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 120' ' ' ASP . 0.8 OUTLIER -150.08 85.57 5.47 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.29 -0.881 . . . . 0.0 110.159 179.91 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.63 80.74 1.67 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.039 1.547 . . . . 0.0 110.518 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.433 ' O ' ' HB1' ' A' ' 118' ' ' ALA . . . -118.27 46.62 1.76 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.273 -0.892 . . . . 0.0 110.163 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.433 ' HB1' ' O ' ' A' ' 117' ' ' ALA . . . 58.31 -88.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.232 -0.918 . . . . 0.0 110.247 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.417 ' N ' ' O ' ' A' ' 117' ' ' ALA . 33.2 t70 -57.62 -18.47 20.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.22 -0.925 . . . . 0.0 110.194 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 115' ' ' THR . 4.2 m-20 -116.13 93.21 38.13 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.252 -0.905 . . . . 0.0 110.203 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.533 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 47.3 Cg_endo -74.05 -167.5 0.39 Allowed 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 123.958 1.504 . . . . 0.0 110.449 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.471 ' O ' ' HG2' ' A' ' 80' ' ' GLN . 5.4 pt-20 -153.45 -150.63 0.34 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.201 -0.937 . . . . 0.0 110.484 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.53 ' HA3' ' CB ' ' A' ' 112' ' ' TYR . . . -148.21 156.1 26.74 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.351 -1.499 . . . . 0.0 109.351 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.517 ' HA ' ' CG2' ' A' ' 52' ' ' VAL . 1.0 OUTLIER -150.52 -158.68 0.94 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.171 -1.193 . . . . 0.0 110.72 -179.644 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.551 HD11 ' CZ2' ' A' ' 16' ' ' TRP . 11.4 mt -118.24 150.37 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.473 -0.767 . . . . 0.0 109.132 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.447 ' N ' HG21 ' A' ' 125' ' ' ILE . . . -127.89 122.63 33.0 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.292 -0.88 . . . . 0.0 111.033 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.468 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 4.9 m-85 -118.73 101.77 8.34 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.431 ' C ' HD21 ' A' ' 129' ' ' LEU . 0.0 OUTLIER -88.97 101.51 14.15 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.252 -0.905 . . . . 0.0 111.956 -177.596 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.527 ' CD2' HG23 ' A' ' 74' ' ' VAL . 8.8 mt -104.6 42.65 1.18 Allowed 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 178.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -97.45 87.3 0.87 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.575 ' O ' ' CG ' ' A' ' 132' ' ' PHE . . . 84.53 107.95 0.61 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.608 ' CG ' ' HA ' ' A' ' 74' ' ' VAL . 7.0 m-85 -167.31 -62.19 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.331 -1.099 . . . . 0.0 110.102 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.585 ' HB3' ' CE3' ' A' ' 137' ' ' TRP . 1.3 t -89.52 -178.84 5.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.076 -1.015 . . . . 0.0 109.912 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.426 ' N ' ' OG ' ' A' ' 133' ' ' SER . . . -100.62 -95.31 0.27 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.127 -0.983 . . . . 0.0 110.7 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -55.68 153.74 7.69 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.094 -1.004 . . . . 0.0 110.574 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.526 ' CA ' ' HA ' ' A' ' 38' ' ' ALA . . . -47.7 121.94 4.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.372 -0.83 . . . . 0.0 110.167 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.642 ' CZ2' ' CG1' ' A' ' 36' ' ' VAL . 22.2 p90 -125.7 -157.58 0.8 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.287 -0.883 . . . . 0.0 110.044 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.543 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 0.5 OUTLIER -160.33 169.53 22.95 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.104 -0.997 . . . . 0.0 110.62 -178.844 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.527 ' HG ' ' CD1' ' A' ' 95' ' ' LEU . 2.4 mp -121.8 159.5 26.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.334 -0.854 . . . . 0.0 109.322 179.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' CYS . . . . . . . . . . . . . 2.0 m -150.61 92.22 1.82 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.041 -1.037 . . . . 0.0 110.931 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.497 ' O ' ' CB ' ' A' ' 142' ' ' ASP . 1.2 mt -90.01 -178.36 5.43 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.227 -0.92 . . . . 0.0 109.316 179.068 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.52 ' O ' ' CB ' ' A' ' 143' ' ' ASP . 2.0 p30 167.19 47.88 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.276 -0.89 . . . . 0.0 110.423 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.52 ' CB ' ' O ' ' A' ' 142' ' ' ASP . 0.4 OUTLIER 166.64 40.41 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.26 -0.9 . . . . 0.0 109.84 179.961 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.497 ' CG2' ' HB2' ' A' ' 64' ' ' TYR . 25.9 t -89.26 111.55 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.302 -0.874 . . . . 0.0 110.259 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 6' ' ' GLU . . . -137.33 165.47 26.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.337 -0.852 . . . . 0.0 110.237 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.467 ' CD2' HD13 ' A' ' 54' ' ' ILE . 10.5 tp -151.8 139.58 19.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.249 -0.907 . . . . 0.0 110.181 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.457 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -155.06 152.89 30.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.188 -0.945 . . . . 0.0 110.268 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.479 ' HB3' ' CE1' ' A' ' 60' ' ' TYR . 3.0 p -101.65 119.94 39.55 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.291 -0.881 . . . . 0.0 110.191 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -102.96 -164.42 1.08 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.269 -0.894 . . . . 0.0 110.208 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 9.9 p -120.44 136.33 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.243 -0.91 . . . . 0.0 110.2 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -147.51 137.58 23.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.249 -0.907 . . . . 0.0 110.232 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.162 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.224 0.535 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 47.27 75.67 0.64 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.286 -0.883 . . . . 0.0 110.176 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.87 77.86 2.61 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.041 1.548 . . . . 0.0 110.579 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.417 HG13 ' O ' ' A' ' 4' ' ' ILE . 11.4 pt -113.46 32.33 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.223 -0.923 . . . . 0.0 110.096 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.526 ' O ' ' CG ' ' A' ' 6' ' ' GLU . . . 95.44 -31.52 7.04 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.526 ' CG ' ' O ' ' A' ' 5' ' ' GLY . 9.0 pt-20 38.32 35.89 0.11 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.671 -0.899 . . . . 0.0 110.522 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 143' ' ' ASP . . . -136.16 -160.92 8.97 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.521 ' CB ' ' O ' ' A' ' 142' ' ' ASP . 40.4 p -105.53 51.53 0.75 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.294 -1.121 . . . . 0.0 110.322 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.485 ' CE1' ' CD1' ' A' ' 16' ' ' TRP . 16.5 m-85 42.71 28.87 0.14 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.306 -0.871 . . . . 0.0 110.228 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.554 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 4.5 p-10 -86.22 52.25 2.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.271 -0.893 . . . . 0.0 110.062 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.554 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 1.0 OUTLIER 161.7 37.05 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.68 -0.637 . . . . 0.0 109.901 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.99 148.43 12.11 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.495 ' O ' ' HB3' ' A' ' 14' ' ' GLU . 49.6 Cg_endo -76.12 6.6 3.76 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 124.035 1.545 . . . . 0.0 110.902 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.495 ' HB3' ' O ' ' A' ' 13' ' ' PRO . 2.6 tm-20 59.26 -89.27 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.206 -0.934 . . . . 0.0 110.406 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.464 ' O ' HD13 ' A' ' 49' ' ' LEU . . . -144.22 30.66 1.87 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.569 ' CE2' HD23 ' A' ' 49' ' ' LEU . 52.7 m95 -85.93 124.72 32.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.215 -1.168 . . . . 0.0 110.554 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.548 ' O ' ' CG1' ' A' ' 47' ' ' VAL . 0.2 OUTLIER -114.2 160.94 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.309 -0.87 . . . . 0.0 108.884 179.44 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.491 ' N ' HG21 ' A' ' 17' ' ' VAL . . . -147.12 126.1 12.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.112 -0.993 . . . . 0.0 110.297 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.511 ' CZ ' ' C ' ' A' ' 46' ' ' GLY . 17.5 p90 -104.94 170.59 7.78 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.486 -0.759 . . . . 0.0 110.26 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.518 ' HA3' ' CG1' ' A' ' 45' ' ' VAL . . . 115.44 35.09 1.34 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' A' ' 20' ' ' GLY . 12.1 p 51.13 17.75 0.5 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.682 -0.893 . . . . 0.0 111.005 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.542 ' HB3' ' CB ' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -152.68 77.6 1.18 Allowed 'General case' 0 C--N 1.306 -1.291 0 O-C-N 120.975 -1.078 . . . . 0.0 109.049 179.265 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.593 ' N ' ' CD ' ' A' ' 24' ' ' PRO . . . -118.54 43.97 1.5 Allowed Glycine 0 N--CA 1.489 2.171 0 C-N-CA 119.451 -1.357 . . . . 0.0 110.72 -179.108 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 23' ' ' GLY . 50.5 Cg_endo -75.39 76.62 3.49 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.668 1.352 . . . . 0.0 109.649 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.553 ' CD2' ' CG1' ' A' ' 34' ' ' VAL . 14.8 mt -68.16 84.6 0.24 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.182 -0.949 . . . . 0.0 110.46 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.469 ' O ' ' O ' ' A' ' 31' ' ' ALA . 0.2 OUTLIER -74.81 113.12 11.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.165 -0.959 . . . . 0.0 109.085 179.314 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.417 ' O ' ' C ' ' A' ' 28' ' ' SER . 1.4 p -119.6 -29.08 5.15 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.061 -1.024 . . . . 0.0 111.196 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 27' ' ' THR . 33.2 p -45.04 -27.92 0.63 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.948 -1.095 . . . . 0.0 108.619 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.41 ' N ' ' C ' ' A' ' 27' ' ' THR . 5.5 t -70.4 -45.78 65.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.868 -0.52 . . . . 0.0 110.751 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 138.04 3.42 1.97 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.55 ' CB ' ' HB3' ' A' ' 142' ' ' ASP . . . -150.38 130.91 13.89 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.98 -1.306 . . . . 0.0 110.021 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.474 ' CD1' ' HB3' ' A' ' 13' ' ' PRO . 0.9 OUTLIER -67.23 110.33 3.45 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.996 -1.065 . . . . 0.0 109.543 179.754 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.452 ' O ' ' O ' ' A' ' 24' ' ' PRO . 2.9 m -109.39 106.59 16.43 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.091 -1.006 . . . . 0.0 111.164 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.553 ' CG1' ' CD2' ' A' ' 25' ' ' LEU . 36.0 m -89.81 173.6 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.542 ' CB ' ' HB3' ' A' ' 22' ' ' ASP . . . -122.75 152.78 40.28 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.574 -1.329 . . . . 0.0 111.685 -178.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.473 ' HB ' ' O ' ' A' ' 137' ' ' TRP . 10.6 t -137.88 111.28 8.74 Favored Pre-proline 0 C--N 1.303 -1.446 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.437 ' O ' ' O ' ' A' ' 38' ' ' ALA . 44.3 Cg_endo -73.75 141.99 31.47 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.011 1.532 . . . . 0.0 111.185 -178.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.486 ' HA ' ' HA ' ' A' ' 136' ' ' ALA . . . -42.35 164.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.504 -0.747 . . . . 0.0 109.834 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 51.22 50.12 41.34 Favored Glycine 0 N--CA 1.485 1.949 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.598 ' HB3' ' CZ3' ' A' ' 137' ' ' TRP . 1.6 t -86.88 35.92 0.7 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.228 -1.16 . . . . 0.0 109.803 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.533 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . -87.44 -139.87 0.1 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.475 -0.766 . . . . 0.0 109.414 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.536 ' HG2' ' N ' ' A' ' 43' ' ' TYR . 0.0 OUTLIER 42.03 -142.29 0.09 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.476 -0.765 . . . . 0.0 110.066 -179.491 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.583 ' CE1' ' O ' ' A' ' 44' ' ' GLY . 5.8 p90 -31.39 -39.27 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.198 0 CA-C-O 121.354 0.597 . . . . 0.0 110.292 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.583 ' O ' ' CE1' ' A' ' 43' ' ' TYR . . . 88.82 137.32 6.01 Favored Glycine 0 N--CA 1.49 2.283 0 C-N-CA 120.227 -0.987 . . . . 0.0 111.128 177.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.529 ' CG2' ' OG ' ' A' ' 40' ' ' SER . 4.0 t -89.75 167.91 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.511 ' C ' ' CZ ' ' A' ' 19' ' ' TYR . . . 168.11 162.19 19.54 Favored Glycine 0 N--CA 1.49 2.298 0 C-N-CA 118.51 -1.805 . . . . 0.0 111.056 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.548 ' CG1' ' O ' ' A' ' 17' ' ' VAL . 44.6 t -114.54 157.69 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.74 -0.859 . . . . 0.0 109.793 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.479 ' N ' HG11 ' A' ' 47' ' ' VAL . 3.7 m -143.5 150.55 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.076 -1.015 . . . . 0.0 110.08 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.569 HD23 ' CE2' ' A' ' 16' ' ' TRP . 19.4 tp -138.47 89.89 2.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.199 -0.938 . . . . 0.0 110.417 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.519 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 40.9 t30 -73.04 132.79 43.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.294 -0.879 . . . . 0.0 110.151 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 124.0 60.52 0.19 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.519 ' CG2' ' HA ' ' A' ' 124' ' ' GLN . 40.3 t -119.94 172.07 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.233 -1.157 . . . . 0.0 110.101 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.516 ' N ' ' CG1' ' A' ' 52' ' ' VAL . . . -137.88 102.01 4.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.235 -0.915 . . . . 0.0 110.389 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.564 ' HB ' ' CG ' ' A' ' 112' ' ' TYR . 42.3 mm -131.65 49.59 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.291 -0.881 . . . . 0.0 109.936 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.542 ' HA ' ' HA ' ' A' ' 111' ' ' THR . 0.3 OUTLIER -72.16 139.95 48.54 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.408 -0.807 . . . . 0.0 111.072 -179.571 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.539 ' HB3' ' O ' ' A' ' 55' ' ' GLU . 6.6 tm-20 73.12 178.12 0.24 Allowed 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 121.968 0.89 . . . . 0.0 111.907 178.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.537 ' HA2' ' O ' ' A' ' 108' ' ' ALA . . . -103.04 89.54 0.72 Allowed Glycine 0 N--CA 1.487 2.047 0 N-CA-C 107.764 -2.135 . . . . 0.0 107.764 178.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.609 HG21 ' CE1' ' A' ' 60' ' ' TYR . 0.4 OUTLIER -120.19 -165.53 1.2 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.41 -1.053 . . . . 0.0 110.641 -178.486 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.571 ' N ' ' CG2' ' A' ' 58' ' ' THR . 8.2 m -103.49 86.3 2.62 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.413 -0.804 . . . . 0.0 110.372 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.662 ' CD1' ' CB ' ' A' ' 108' ' ' ALA . 96.1 m-85 -85.84 116.19 23.93 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.147 -0.971 . . . . 0.0 109.905 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 38.9 m -89.89 114.76 26.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.211 -0.931 . . . . 0.0 110.154 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.41 HD23 ' CD2' ' A' ' 89' ' ' LEU . 18.2 tp -89.71 121.47 31.9 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.185 -0.947 . . . . 0.0 110.002 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.468 ' O ' ' O ' ' A' ' 143' ' ' ASP . 48.3 mtp180 -122.67 121.73 37.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.297 -0.877 . . . . 0.0 110.142 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.536 ' CD1' ' C ' ' A' ' 64' ' ' TYR . 0.7 OUTLIER -159.57 141.57 13.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.285 -0.884 . . . . 0.0 109.906 179.784 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 101' ' ' GLN . 89.9 m -119.18 97.04 5.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.279 -0.888 . . . . 0.0 109.674 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.494 ' C ' ' CD2' ' A' ' 95' ' ' LEU . . . -97.14 154.02 17.62 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.476 -0.765 . . . . 0.0 110.554 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.485 ' CG2' ' O ' ' A' ' 98' ' ' GLU . 96.9 m -150.34 122.02 8.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.369 -0.832 . . . . 0.0 110.101 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -108.3 142.9 37.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.244 -0.91 . . . . 0.0 109.945 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.12 -22.01 2.26 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.154 -0.966 . . . . 0.0 109.138 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.555 ' CG2' ' HB2' ' A' ' 137' ' ' TRP . 3.4 t -119.27 166.92 12.39 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.563 -0.71 . . . . 0.0 109.835 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.429 ' N ' ' OD1' ' A' ' 71' ' ' ASP . 0.9 OUTLIER -82.38 73.54 9.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.047 -1.033 . . . . 0.0 109.114 178.925 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.538 ' CG2' ' HB2' ' A' ' 133' ' ' SER . 5.4 p -98.06 145.04 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.303 -0.873 . . . . 0.0 111.348 -178.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.46 HG23 ' HB3' ' A' ' 92' ' ' SER . 19.8 m -128.69 91.12 3.17 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 178.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.586 ' HA ' ' CG ' ' A' ' 132' ' ' PHE . 3.3 m -89.67 -148.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.203 -0.935 . . . . 0.0 110.766 -178.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.97 118.3 28.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.194 -0.941 . . . . 0.0 110.82 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.528 ' N ' ' HD3' ' A' ' 93' ' ' PRO . . . -122.98 147.92 46.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.204 -0.935 . . . . 0.0 109.681 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.58 ' CD1' ' N ' ' A' ' 78' ' ' VAL . 3.5 pp 178.92 -148.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.296 -0.878 . . . . 0.0 110.08 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.58 ' N ' ' CD1' ' A' ' 77' ' ' LEU . 2.5 t -147.85 171.07 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.194 -0.941 . . . . 0.0 108.902 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.498 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . -172.24 -178.5 42.48 Favored Glycine 0 N--CA 1.489 2.183 0 C-N-CA 119.169 -1.491 . . . . 0.0 110.183 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.422 ' O ' ' OD1' ' A' ' 81' ' ' ASN . 8.1 tt0 -92.28 -148.99 0.24 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.49 -1.006 . . . . 0.0 110.192 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.473 ' HB2' ' HG2' ' A' ' 122' ' ' GLU . 5.8 m120 -164.38 64.22 0.14 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.523 -0.736 . . . . 0.0 109.574 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.477 ' HA3' ' HB3' ' A' ' 121' ' ' PRO . . . 134.91 147.25 5.5 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.629 ' N ' ' CE1' ' A' ' 85' ' ' TYR . . . -41.25 151.62 0.28 Allowed Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.33 -1.1 . . . . 0.0 110.375 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.474 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.3 Cg_endo -80.16 12.48 23.23 Favored 'Cis proline' 0 C--N 1.312 -1.353 0 C-N-CA 121.659 -2.226 . . . . 0.0 110.884 -0.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.629 ' CE1' ' N ' ' A' ' 83' ' ' ALA . 26.4 m-85 63.2 150.63 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.16 -0.963 . . . . 0.0 110.194 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 175.97 131.49 1.47 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.59 155.15 21.79 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.299 -1.118 . . . . 0.0 110.104 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.569 HG23 ' CE2' ' A' ' 112' ' ' TYR . 33.2 m -125.4 -22.0 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.257 -0.902 . . . . 0.0 110.447 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.571 HD12 ' CZ ' ' A' ' 106' ' ' PHE . 3.7 mp -111.72 144.16 41.46 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.111 -0.993 . . . . 0.0 111.023 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -150.98 85.83 1.36 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.434 -0.791 . . . . 0.0 110.206 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.6 p -155.04 -177.31 6.44 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.053 -1.029 . . . . 0.0 110.581 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.46 ' HB3' HG23 ' A' ' 73' ' ' THR . 3.7 m -123.64 134.16 25.1 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.346 -0.847 . . . . 0.0 109.978 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.535 ' CG ' HG21 ' A' ' 74' ' ' VAL . 51.6 Cg_endo -78.31 79.81 3.19 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.871 1.458 . . . . 0.0 110.877 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.527 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -49.26 134.51 18.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.939 -1.101 . . . . 0.0 109.159 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.494 ' CD2' ' C ' ' A' ' 66' ' ' ALA . 27.6 mt -131.44 170.64 14.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.052 -1.03 . . . . 0.0 110.89 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.478 ' CG2' ' HG3' ' A' ' 100' ' ' ARG . 0.2 OUTLIER -170.99 -178.69 2.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.445 -0.784 . . . . 0.0 109.942 179.972 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.84 -6.37 26.58 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.278 -0.888 . . . . 0.0 110.244 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.485 ' O ' ' CG2' ' A' ' 67' ' ' THR . 0.6 OUTLIER -110.52 174.58 2.3 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.243 -0.911 . . . . 0.0 110.1 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.471 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 45.0 Cg_endo -72.31 128.02 13.28 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.026 1.54 . . . . 0.0 110.294 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.527 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 1.2 mtt-85 -119.76 92.17 3.72 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.152 -0.968 . . . . 0.0 110.4 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.47 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 38.9 tt0 -75.1 154.11 37.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.364 -0.835 . . . . 0.0 109.978 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.432 ' HB ' ' O ' ' A' ' 64' ' ' TYR . 74.4 t -139.5 133.72 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.166 -0.958 . . . . 0.0 110.354 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.443 HG21 ' HG2' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -150.15 118.99 6.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.283 -0.886 . . . . 0.0 110.083 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -140.6 153.13 45.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.204 -0.935 . . . . 0.0 110.361 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.518 HG23 ' CG2' ' A' ' 59' ' ' THR . 8.4 m -109.5 70.79 0.74 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.289 -0.882 . . . . 0.0 110.116 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.571 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 40.0 p90 -84.82 146.62 27.24 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.306 -0.871 . . . . 0.0 110.144 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 58' ' ' THR . 5.6 m -89.94 102.65 15.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -0.93 . . . . 0.0 109.987 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.662 ' CB ' ' CD1' ' A' ' 60' ' ' TYR . . . -70.04 95.78 0.99 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.155 -0.966 . . . . 0.0 110.388 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.533 ' HA ' ' HA2' ' A' ' 57' ' ' GLY . 8.2 p -85.88 59.63 5.75 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.675 -0.64 . . . . 0.0 109.512 179.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -155.27 -156.24 0.64 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.12 -0.987 . . . . 0.0 110.835 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . 46.6 m -147.42 108.05 4.14 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.373 -0.829 . . . . 0.0 110.87 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.58 ' CE2' HG13 ' A' ' 78' ' ' VAL . 16.4 m-30 -110.04 74.17 0.77 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.396 -0.815 . . . . 0.0 109.642 179.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.471 ' O ' ' HB2' ' A' ' 122' ' ' GLU . 43.7 Cg_endo -71.65 -159.08 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.908 1.478 . . . . 0.0 110.41 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.455 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -145.79 36.56 1.06 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.271 -0.893 . . . . 0.0 110.247 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.528 ' O ' ' CB ' ' A' ' 120' ' ' ASP . 20.1 m -107.53 88.26 4.04 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.286 -0.883 . . . . 0.0 110.188 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 45.9 Cg_endo -72.9 110.35 3.01 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.97 1.51 . . . . 0.0 110.404 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.431 ' HB2' ' OD1' ' A' ' 120' ' ' ASP . . . -149.47 -170.17 3.57 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.236 -0.915 . . . . 0.0 110.219 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -75.16 -8.49 56.73 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.316 -0.865 . . . . 0.0 110.174 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -151.83 16.79 0.68 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.187 -0.946 . . . . 0.0 110.225 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.528 ' CB ' ' O ' ' A' ' 115' ' ' THR . 2.3 m-20 -114.72 90.33 21.73 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.227 -0.921 . . . . 0.0 110.131 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.477 ' HB3' ' HA3' ' A' ' 82' ' ' GLY . 46.5 Cg_endo -73.9 147.1 38.6 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.025 1.539 . . . . 0.0 110.478 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.473 ' HG2' ' HB2' ' A' ' 81' ' ' ASN . 22.5 pm0 -124.12 -154.75 0.63 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.172 -0.955 . . . . 0.0 110.219 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.514 ' HA3' ' CB ' ' A' ' 112' ' ' TYR . . . -151.36 150.8 22.79 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.519 ' CB ' ' HA ' ' A' ' 50' ' ' ASN . 3.0 pt20 -150.35 -153.34 0.48 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.269 -1.136 . . . . 0.0 110.394 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.435 ' CG2' ' CE1' ' A' ' 127' ' ' PHE . 7.5 mt -118.45 144.86 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.419 -0.801 . . . . 0.0 109.379 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -122.11 121.1 36.14 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.228 -0.92 . . . . 0.0 111.04 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.475 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 5.1 m-85 -119.42 97.19 5.53 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.479 ' O ' ' HB ' ' A' ' 74' ' ' VAL . 2.5 mt-30 -88.95 89.1 7.84 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.245 -0.91 . . . . 0.0 111.149 -178.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.525 HD12 ' CD2' ' A' ' 139' ' ' LEU . 16.0 mt -87.61 51.55 2.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.571 -0.705 . . . . 0.0 109.274 178.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.53 ' O ' ' CD2' ' A' ' 132' ' ' PHE . . . -127.68 151.0 18.42 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 51.81 63.55 4.65 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.586 ' CG ' ' HA ' ' A' ' 74' ' ' VAL . 15.5 m-85 -148.06 -78.79 0.15 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.243 -1.151 . . . . 0.0 110.25 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.591 ' HB3' ' CD2' ' A' ' 137' ' ' TRP . 2.3 t -89.59 144.58 25.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.058 -1.026 . . . . 0.0 110.055 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -81.87 -84.45 0.11 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.289 -0.882 . . . . 0.0 110.357 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -42.54 154.92 0.05 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.247 -0.908 . . . . 0.0 110.293 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.486 ' HA ' ' HA ' ' A' ' 38' ' ' ALA . . . -57.59 124.28 18.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.279 -0.888 . . . . 0.0 110.214 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.598 ' CZ3' ' HB3' ' A' ' 40' ' ' SER . 6.0 p90 -131.23 -167.49 1.86 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.279 -0.888 . . . . 0.0 110.236 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.542 ' CG2' ' N ' ' A' ' 139' ' ' LEU . 0.8 OUTLIER -160.81 178.75 9.12 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.31 -0.956 . . . . 0.0 110.532 -178.255 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.542 ' N ' ' CG2' ' A' ' 138' ' ' THR . 2.2 mp -133.96 155.6 49.65 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.388 -0.82 . . . . 0.0 110.062 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' CYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 33' ' ' CYS . 11.1 m -150.12 97.88 2.62 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.173 -0.954 . . . . 0.0 110.724 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.491 ' O ' ' HB3' ' A' ' 142' ' ' ASP . 1.1 mt -89.62 -177.09 5.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.299 -0.876 . . . . 0.0 109.518 179.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.55 ' HB3' ' CB ' ' A' ' 31' ' ' ALA . 0.6 OUTLIER 172.33 44.21 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.186 -0.946 . . . . 0.0 110.999 179.926 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.489 ' HB2' ' O ' ' A' ' 142' ' ' ASP . 5.8 t0 171.85 69.81 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.309 -0.87 . . . . 0.0 109.592 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 1.9 t -106.64 122.28 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.129 -0.982 . . . . 0.0 110.412 -179.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -151.81 150.93 30.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.344 -0.847 . . . . 0.0 110.067 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.522 ' CD2' HD12 ' A' ' 54' ' ' ILE . 22.3 tp -138.49 158.83 43.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.288 -0.882 . . . . 0.0 110.29 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.505 ' N ' ' HG ' ' A' ' 146' ' ' LEU . 0.4 OUTLIER -163.25 -157.33 0.42 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.213 -0.929 . . . . 0.0 110.278 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.411 ' O ' ' C ' ' A' ' 149' ' ' GLU . 0.1 OUTLIER -150.35 113.18 4.78 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.215 -0.928 . . . . 0.0 110.136 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 148' ' ' SER . 0.4 OUTLIER 42.97 71.94 0.2 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.267 -0.895 . . . . 0.0 110.226 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.424 HG12 ' HB3' ' A' ' 147' ' ' ASP . 33.9 m -117.56 40.99 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.256 -0.903 . . . . 0.0 110.236 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.424 ' O ' ' C ' ' A' ' 152' ' ' LEU . 92.0 mt-10 -120.63 -172.6 2.41 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.91 . . . . 0.0 110.218 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.424 ' C ' ' O ' ' A' ' 151' ' ' GLU . 1.7 mm? . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.229 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.448 ' O ' ' HB2' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.273 0.559 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.448 ' HB2' ' O ' ' A' ' 1' ' ' ALA . 0.9 OUTLIER -179.77 58.74 0.1 OUTLIER Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.219 -0.925 . . . . 0.0 110.229 179.997 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.414 ' HD3' ' N ' ' A' ' 2' ' ' SER . 49.2 Cg_endo -76.24 -156.32 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.008 1.53 . . . . 0.0 110.01 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.459 HD13 ' O ' ' A' ' 144' ' ' VAL . 5.0 pt -94.5 -8.78 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.197 -0.939 . . . . 0.0 110.167 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 69.75 156.24 1.39 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -72.23 83.12 1.02 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.223 -1.163 . . . . 0.0 110.152 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -86.76 127.41 8.38 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.454 ' O ' ' HB2' ' A' ' 9' ' ' PHE . 2.1 p -77.31 2.87 14.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.222 -1.164 . . . . 0.0 110.236 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.57 ' CD2' ' HB2' ' A' ' 32' ' ' LEU . 3.3 m-85 56.41 16.7 2.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.253 -0.904 . . . . 0.0 110.204 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.547 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 18.3 p-10 -98.41 14.03 29.53 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.234 -0.916 . . . . 0.0 110.391 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.547 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 2.2 t70 161.68 80.63 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.79 -0.569 . . . . 0.0 109.544 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.22 82.49 1.65 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.459 ' O ' ' HB3' ' A' ' 14' ' ' GLU . 51.2 Cg_endo -81.31 43.14 1.47 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.073 1.565 . . . . 0.0 110.668 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.459 ' HB3' ' O ' ' A' ' 13' ' ' PRO . 36.2 tp10 56.9 -91.27 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.137 -0.977 . . . . 0.0 110.206 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.485 ' C ' ' CD1' ' A' ' 49' ' ' LEU . . . -152.75 32.63 0.82 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.577 ' CE2' HD21 ' A' ' 49' ' ' LEU . 59.5 m95 -71.19 86.71 0.78 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.23 -1.159 . . . . 0.0 110.267 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.565 ' CG2' ' CG2' ' A' ' 48' ' ' VAL . 1.4 m -82.26 147.92 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.224 -0.922 . . . . 0.0 109.781 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.589 ' CB ' ' CG1' ' A' ' 34' ' ' VAL . . . -134.12 119.51 18.97 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.178 -0.951 . . . . 0.0 109.978 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.542 ' CZ ' ' C ' ' A' ' 46' ' ' GLY . 16.9 p90 -108.56 138.03 45.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.469 -0.77 . . . . 0.0 110.411 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.532 ' HA3' ' CG1' ' A' ' 45' ' ' VAL . . . 160.82 45.48 0.02 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.467 ' OG1' ' O ' ' A' ' 20' ' ' GLY . 9.6 p 50.84 19.16 0.59 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.442 -1.034 . . . . 0.0 110.733 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.535 ' HB2' ' CB ' ' A' ' 35' ' ' ALA . 3.0 p30 -97.88 38.51 1.29 Allowed 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.069 -1.019 . . . . 0.0 110.031 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 45.94 -156.54 0.45 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.436 ' O ' ' C ' ' A' ' 25' ' ' LEU . 46.5 Cg_endo -73.72 125.63 10.16 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 123.939 1.494 . . . . 0.0 110.35 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.464 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -42.26 133.02 3.26 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.277 -0.889 . . . . 0.0 110.015 179.887 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.07 116.23 28.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.144 -0.972 . . . . 0.0 110.054 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.535 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.9 OUTLIER -119.88 -28.71 5.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.167 -0.958 . . . . 0.0 110.34 -179.76 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.445 ' O ' ' HB ' ' A' ' 29' ' ' THR . 0.3 OUTLIER -48.91 83.13 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.838 -0.539 . . . . 0.0 111.254 -179.957 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.535 ' N ' ' O ' ' A' ' 27' ' ' THR . 0.8 OUTLIER 175.97 -28.93 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.017 -1.052 . . . . 0.0 110.309 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.519 ' HA2' ' CB ' ' A' ' 10' ' ' ASP . . . 133.73 -7.05 4.87 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.706 -1.357 . . . . 0.0 109.706 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.466 ' HA ' ' HB3' ' A' ' 9' ' ' PHE . . . -150.3 172.46 15.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.149 -1.207 . . . . 0.0 110.329 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.57 ' HB2' ' CD2' ' A' ' 9' ' ' PHE . 0.6 OUTLIER -103.97 94.73 5.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.274 -0.891 . . . . 0.0 109.769 179.736 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.483 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 65.5 m -100.09 115.61 30.17 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.295 -0.878 . . . . 0.0 111.002 -179.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.589 ' CG1' ' CB ' ' A' ' 18' ' ' ALA . 15.1 m -96.11 157.17 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.319 -0.863 . . . . 0.0 109.231 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.535 ' CB ' ' HB2' ' A' ' 22' ' ' ASP . . . -102.26 89.23 3.51 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.269 -0.894 . . . . 0.0 111.635 -178.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.581 HG13 ' CE2' ' A' ' 137' ' ' TRP . 76.3 t -74.71 119.21 75.58 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 120.976 -1.077 . . . . 0.0 109.192 178.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.426 ' O ' ' C ' ' A' ' 38' ' ' ALA . 42.7 Cg_endo -69.17 144.79 58.4 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.865 1.455 . . . . 0.0 111.226 -179.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.501 ' HA ' ' HA ' ' A' ' 136' ' ' ALA . . . -42.11 147.83 0.22 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.462 -0.774 . . . . 0.0 110.109 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.459 ' O ' ' OE1' ' A' ' 42' ' ' GLN . . . 44.52 70.64 0.56 Allowed Glycine 0 N--CA 1.488 2.132 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.575 ' HB2' ' CH2' ' A' ' 137' ' ' TRP . 0.5 OUTLIER -87.01 29.72 0.8 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.31 -1.112 . . . . 0.0 110.44 -179.636 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.417 ' HB3' ' HA3' ' A' ' 131' ' ' GLY . . . -91.38 19.99 5.61 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.926 0.869 . . . . 0.0 109.739 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.594 ' HG3' ' CD2' ' A' ' 43' ' ' TYR . 0.5 OUTLIER -84.44 -135.65 0.05 Allowed 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.527 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.646 ' CD1' ' N ' ' A' ' 44' ' ' GLY . 8.3 p90 -38.9 -27.39 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.379 -0.826 . . . . 0.0 110.417 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.646 ' N ' ' CD1' ' A' ' 43' ' ' TYR . . . 111.04 106.92 2.96 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.533 HG22 ' CB ' ' A' ' 40' ' ' SER . 2.9 t -90.09 153.83 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.231 -1.159 . . . . 0.0 108.73 179.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.542 ' C ' ' CZ ' ' A' ' 19' ' ' TYR . . . 176.75 169.51 38.16 Favored Glycine 0 N--CA 1.49 2.26 0 C-N-CA 119.221 -1.466 . . . . 0.0 110.218 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.53 ' CG1' ' O ' ' A' ' 17' ' ' VAL . 48.8 t -128.19 144.03 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.412 -1.052 . . . . 0.0 109.901 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.565 ' CG2' ' CG2' ' A' ' 17' ' ' VAL . 34.0 m -135.55 147.69 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.039 -1.038 . . . . 0.0 110.419 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.577 HD21 ' CE2' ' A' ' 16' ' ' TRP . 22.8 tp -135.82 109.85 8.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.251 -0.906 . . . . 0.0 110.308 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.493 ' ND2' ' O ' ' A' ' 50' ' ' ASN . 2.4 p-10 -84.33 121.71 27.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.224 -0.922 . . . . 0.0 110.269 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 139.92 79.43 0.06 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.522 HG13 ' CB ' ' A' ' 112' ' ' TYR . 54.0 t -131.36 150.44 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.197 -1.178 . . . . 0.0 110.198 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.51 ' N ' HG11 ' A' ' 52' ' ' VAL . . . -117.34 92.58 3.89 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.224 -0.922 . . . . 0.0 110.238 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.544 ' HB ' ' CD1' ' A' ' 112' ' ' TYR . 14.6 mm -136.37 169.33 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.237 -0.914 . . . . 0.0 110.065 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.507 ' HA ' ' HA ' ' A' ' 111' ' ' THR . 2.2 pt-20 179.05 139.54 0.1 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.24 -0.912 . . . . 0.0 110.361 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.499 ' HB3' ' O ' ' A' ' 55' ' ' GLU . 3.9 tt0 64.23 -179.67 0.17 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.512 -0.742 . . . . 0.0 110.759 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.494 ' HA2' ' HA ' ' A' ' 109' ' ' SER . . . -92.42 70.98 1.63 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.624 -1.791 . . . . 0.0 108.624 179.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.594 HG21 ' CE2' ' A' ' 60' ' ' TYR . 1.0 OUTLIER -105.9 176.81 5.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.532 -0.981 . . . . 0.0 110.087 -179.281 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.577 ' N ' ' CG2' ' A' ' 58' ' ' THR . 0.7 OUTLIER -89.57 156.4 18.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.304 -0.872 . . . . 0.0 110.436 -179.69 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.618 ' CD2' ' CB ' ' A' ' 108' ' ' ALA . 68.2 m-85 -156.45 118.08 3.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.448 -0.782 . . . . 0.0 109.625 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 104' ' ' GLU . 10.0 m -89.94 112.03 23.29 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.209 -0.932 . . . . 0.0 110.646 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 21.7 tp -90.21 140.0 30.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.346 -0.846 . . . . 0.0 109.66 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.465 ' O ' ' O ' ' A' ' 143' ' ' ASP . 27.1 mtt180 -136.92 105.68 5.87 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.146 -0.971 . . . . 0.0 110.722 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.528 ' CD1' ' C ' ' A' ' 64' ' ' TYR . 3.5 p90 -140.18 151.67 45.42 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.33 -0.856 . . . . 0.0 109.676 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 4.2 m -119.62 92.04 3.69 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.095 -1.003 . . . . 0.0 110.114 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' A' ' 140' ' ' CYS . . . -89.44 145.51 25.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.302 -0.874 . . . . 0.0 110.17 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.458 ' OG1' ' HA ' ' A' ' 99' ' ' PRO . 53.4 m -150.72 104.87 3.23 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.316 -0.865 . . . . 0.0 110.492 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -95.93 132.38 41.29 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.165 -0.96 . . . . 0.0 109.854 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 68' ' ' ALA . 20.0 m -43.54 -26.78 0.24 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.219 -0.926 . . . . 0.0 109.435 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.535 HG23 ' CB ' ' A' ' 137' ' ' TRP . 3.0 t -112.74 167.63 10.33 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.563 -0.711 . . . . 0.0 109.838 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.468 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 32.9 t0 -84.29 69.36 10.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.104 -0.997 . . . . 0.0 109.224 178.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.586 ' CG2' ' CB ' ' A' ' 133' ' ' SER . 3.8 p -92.0 140.08 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.331 -0.856 . . . . 0.0 111.318 -178.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.474 ' O ' ' CD1' ' A' ' 132' ' ' PHE . 98.3 m -126.46 91.94 3.46 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.582 ' HA ' ' CG ' ' A' ' 132' ' ' PHE . 3.2 m -89.79 -159.34 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.18 -0.95 . . . . 0.0 110.715 -178.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -119.16 106.61 12.54 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.284 -0.885 . . . . 0.0 110.394 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.485 ' O ' ' HB3' ' A' ' 77' ' ' LEU . . . -113.08 165.14 12.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.906 . . . . 0.0 110.194 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.502 ' HA ' ' HB3' ' A' ' 89' ' ' LEU . 3.1 pp 176.93 -159.7 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.363 -0.836 . . . . 0.0 110.12 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.508 HG22 ' CD2' ' A' ' 89' ' ' LEU . 3.4 t -149.26 155.61 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.26 -0.9 . . . . 0.0 109.718 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.575 ' O ' ' CE2' ' A' ' 112' ' ' TYR . . . -172.43 -178.2 42.41 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.429 -1.367 . . . . 0.0 110.258 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 111' ' ' THR . 0.0 OUTLIER -93.42 128.34 39.44 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.434 -1.039 . . . . 0.0 110.697 -179.726 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.489 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 1.4 m-80 -96.64 75.49 2.8 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.192 -0.943 . . . . 0.0 109.557 179.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.579 ' O ' ' CE1' ' A' ' 85' ' ' TYR . . . -166.07 -90.48 0.08 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 175.84 136.49 0.19 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.345 -1.091 . . . . 0.0 109.923 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.535 ' C ' ' CD2' ' A' ' 85' ' ' TYR . 52.3 Cg_endo -83.84 33.2 3.61 Favored 'Cis proline' 0 C--N 1.314 -1.271 0 C-N-CA 122.096 -2.044 . . . . 0.0 110.84 -0.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.579 ' CE1' ' O ' ' A' ' 82' ' ' GLY . 18.7 m-85 65.24 166.03 0.17 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.229 -0.919 . . . . 0.0 110.449 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.496 ' O ' ' CA ' ' A' ' 79' ' ' GLY . . . -163.4 171.11 39.02 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.57 133.67 21.52 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.099 -1.236 . . . . 0.0 110.507 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.582 ' CG2' ' CD1' ' A' ' 89' ' ' LEU . 12.4 m -119.8 -10.49 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.326 -0.859 . . . . 0.0 109.732 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.582 ' CD1' ' CG2' ' A' ' 88' ' ' VAL . 4.5 mp -123.5 143.49 50.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.418 -0.801 . . . . 0.0 110.816 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.443 ' O ' HG21 ' A' ' 91' ' ' THR . 0.7 OUTLIER -150.62 83.69 1.35 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.283 -0.886 . . . . 0.0 110.223 179.713 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.443 HG21 ' O ' ' A' ' 90' ' ' ASP . 1.1 p -160.06 -176.71 5.82 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.125 -0.984 . . . . 0.0 110.509 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.425 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 0.1 OUTLIER -119.93 131.24 24.48 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.321 -0.862 . . . . 0.0 110.079 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.527 ' CG ' HG21 ' A' ' 74' ' ' VAL . 48.6 Cg_endo -73.11 77.6 2.37 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.97 1.511 . . . . 0.0 110.912 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.532 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -48.63 135.26 14.91 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.975 -1.078 . . . . 0.0 109.148 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.472 ' CD1' ' HG ' ' A' ' 139' ' ' LEU . 36.4 mt -130.85 176.79 7.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.997 -1.064 . . . . 0.0 110.872 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 68' ' ' ALA . 0.2 OUTLIER -177.89 -178.8 0.72 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.49 -0.756 . . . . 0.0 109.918 -179.955 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.63 -22.44 63.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.226 -0.921 . . . . 0.0 110.287 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -90.07 169.86 11.5 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.29 -0.881 . . . . 0.0 110.078 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.458 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 45.0 Cg_endo -72.55 130.44 16.02 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 123.956 1.503 . . . . 0.0 110.276 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.532 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.69 92.2 3.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.154 -0.966 . . . . 0.0 110.35 -179.865 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.461 ' HG3' ' OG1' ' A' ' 65' ' ' THR . 38.3 tt0 -85.76 99.3 11.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.289 -0.882 . . . . 0.0 110.104 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.493 HG23 ' NH1' ' A' ' 100' ' ' ARG . 72.6 t -89.62 133.77 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 0.0 110.256 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.507 ' O ' ' CG ' ' A' ' 104' ' ' GLU . 49.5 m -147.51 135.72 21.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.357 -0.839 . . . . 0.0 110.084 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.507 ' CG ' ' O ' ' A' ' 103' ' ' THR . 17.9 mt-10 -160.16 -177.33 6.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.169 -0.957 . . . . 0.0 110.267 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.461 HG21 ' OG1' ' A' ' 61' ' ' THR . 0.0 OUTLIER -133.62 91.54 2.86 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.285 -0.885 . . . . 0.0 110.162 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.564 ' CE2' HG22 ' A' ' 88' ' ' VAL . 36.4 p90 -92.44 155.48 17.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.286 -0.884 . . . . 0.0 110.254 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 109' ' ' SER . 38.7 m -89.56 92.78 9.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.178 -0.951 . . . . 0.0 109.777 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.618 ' CB ' ' CD2' ' A' ' 60' ' ' TYR . . . -47.39 91.67 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.27 -0.894 . . . . 0.0 110.455 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 107' ' ' THR . 8.9 p -85.78 57.28 4.38 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.349 -0.844 . . . . 0.0 109.621 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.524 ' HB1' ' CG1' ' A' ' 88' ' ' VAL . . . -166.98 -156.34 0.22 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.115 -0.991 . . . . 0.0 110.868 -179.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.507 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . 35.5 m -148.0 111.57 5.01 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.539 -0.726 . . . . 0.0 110.024 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.578 ' CD2' ' HA3' ' A' ' 123' ' ' GLY . 4.2 m-85 -104.87 92.3 5.08 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.361 -0.837 . . . . 0.0 109.943 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.485 ' HG2' ' HA ' ' A' ' 122' ' ' GLU . 43.4 Cg_endo -71.73 160.9 46.79 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.798 1.42 . . . . 0.0 110.389 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -113.84 68.52 0.69 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.144 -0.972 . . . . 0.0 110.376 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.47 ' O ' ' O ' ' A' ' 120' ' ' ASP . 0.1 OUTLIER -149.1 113.6 3.6 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.263 -0.898 . . . . 0.0 110.215 179.9 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.412 ' HA ' ' OE1' ' A' ' 122' ' ' GLU . 48.5 Cg_endo -75.85 76.61 3.66 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.838 1.441 . . . . 0.0 110.353 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -147.76 158.13 43.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.192 -0.943 . . . . 0.0 110.281 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.25 -67.93 0.37 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.316 -0.865 . . . . 0.0 110.132 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -56.12 -36.34 68.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.277 -0.889 . . . . 0.0 109.974 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.47 ' O ' ' O ' ' A' ' 115' ' ' THR . 0.5 OUTLIER -117.14 87.99 25.43 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.324 -0.86 . . . . 0.0 109.969 179.821 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.542 ' CB ' ' HA3' ' A' ' 82' ' ' GLY . 47.7 Cg_endo -74.02 -159.17 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.09 1.574 . . . . 0.0 110.547 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.489 ' O ' ' HB2' ' A' ' 81' ' ' ASN . 0.1 OUTLIER -154.86 152.14 29.43 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.153 -0.967 . . . . 0.0 110.455 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.578 ' HA3' ' CD2' ' A' ' 112' ' ' TYR . . . -89.5 149.0 20.32 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.495 ' HA ' ' CG2' ' A' ' 52' ' ' VAL . 2.8 pt20 -150.37 -163.84 1.87 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.094 -1.239 . . . . 0.0 110.948 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.487 ' CG2' ' CE2' ' A' ' 127' ' ' PHE . 9.5 mt -118.57 144.37 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.579 -0.7 . . . . 0.0 109.186 179.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.435 ' N ' HG21 ' A' ' 125' ' ' ILE . . . -121.25 129.14 53.01 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.315 -0.866 . . . . 0.0 110.67 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.487 ' CE2' ' CG2' ' A' ' 125' ' ' ILE . 14.3 m-85 -118.78 105.0 11.1 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -89.03 85.37 6.68 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.376 -0.828 . . . . 0.0 111.923 -177.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.577 ' CD2' ' CG2' ' A' ' 74' ' ' VAL . 14.6 mt -91.13 45.11 1.22 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -98.37 89.45 0.95 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 -179.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.579 ' O ' ' CG ' ' A' ' 132' ' ' PHE . . . 81.08 107.87 0.32 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 110.029 -1.229 . . . . 0.0 110.029 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.582 ' CG ' ' HA ' ' A' ' 74' ' ' VAL . 8.4 m-85 -167.78 -67.1 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.366 -1.079 . . . . 0.0 109.849 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.586 ' CB ' ' CG2' ' A' ' 72' ' ' VAL . 1.3 t -89.68 160.79 16.42 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.143 -0.973 . . . . 0.0 109.893 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.405 ' O ' ' C ' ' A' ' 135' ' ' ASP . . . -88.3 -94.1 0.1 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.179 -0.95 . . . . 0.0 110.606 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 134' ' ' ALA . 9.5 m-20 -43.99 153.4 0.14 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.16 -0.963 . . . . 0.0 110.511 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.501 ' HA ' ' HA ' ' A' ' 38' ' ' ALA . . . -52.97 126.33 20.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.309 -0.869 . . . . 0.0 110.149 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.584 ' CD1' ' N ' ' A' ' 138' ' ' THR . 9.7 p90 -131.07 -161.15 1.1 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.257 -0.902 . . . . 0.0 110.181 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.584 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 0.8 OUTLIER -160.42 177.74 10.27 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.157 -0.964 . . . . 0.0 110.427 -178.084 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.541 ' N ' ' CG2' ' A' ' 138' ' ' THR . 2.2 mp -134.02 125.85 28.99 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.365 -0.834 . . . . 0.0 109.892 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' CYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 59.9 m -120.12 104.13 9.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.16 -0.963 . . . . 0.0 110.993 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.494 ' O ' ' HB3' ' A' ' 142' ' ' ASP . 1.0 OUTLIER -102.11 -178.63 3.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.259 -0.9 . . . . 0.0 109.805 179.301 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.494 ' HB3' ' O ' ' A' ' 141' ' ' LEU . 4.5 p-10 173.59 167.35 0.18 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.458 -0.776 . . . . 0.0 110.316 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.465 ' O ' ' O ' ' A' ' 63' ' ' ARG . 13.9 t70 41.74 64.54 1.04 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.341 -0.849 . . . . 0.0 110.364 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.476 HG22 ' CZ ' ' A' ' 9' ' ' PHE . 4.9 t -99.1 113.2 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.252 -0.905 . . . . 0.0 110.053 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -129.8 171.33 12.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -0.934 . . . . 0.0 110.404 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.517 ' CD2' HD13 ' A' ' 54' ' ' ILE . 60.8 tp -162.49 120.75 2.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.275 -0.891 . . . . 0.0 110.159 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.532 ' O ' ' CD1' ' A' ' 60' ' ' TYR . 0.5 OUTLIER -125.24 -152.42 0.52 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.274 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 72.5 p -149.31 95.32 2.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.303 -0.873 . . . . 0.0 110.158 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.05 -174.82 1.32 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.245 -0.91 . . . . 0.0 110.252 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.405 HG23 ' N ' ' A' ' 151' ' ' GLU . 12.1 p -130.2 171.2 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.26 -0.9 . . . . 0.0 110.243 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.405 ' N ' HG23 ' A' ' 150' ' ' VAL . 4.3 tm-20 -103.04 115.18 30.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.267 -0.896 . . . . 0.0 110.21 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.219 -179.967 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.461 ' O ' ' HD3' ' A' ' 3' ' ' PRO . . . . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.273 0.558 . . . . 0.0 110.237 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.443 ' OG ' HG22 ' A' ' 4' ' ' ILE . 13.5 t -106.66 90.25 4.9 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 0.0 110.179 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 1' ' ' ALA . 46.8 Cg_endo -73.3 79.25 2.14 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.023 1.539 . . . . 0.0 110.515 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.443 HG22 ' OG ' ' A' ' 2' ' ' SER . 10.7 pt -117.72 32.67 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.227 -0.921 . . . . 0.0 110.113 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 7' ' ' GLY . . . 81.49 44.45 7.92 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.514 ' HG2' ' CB ' ' A' ' 145' ' ' ALA . 4.1 mt-10 -41.93 94.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.337 -1.096 . . . . 0.0 110.337 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 5' ' ' GLY . . . 152.48 -149.9 21.63 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.437 ' HA ' ' C ' ' A' ' 142' ' ' ASP . 70.4 p -92.71 163.49 13.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.27 -1.136 . . . . 0.0 110.233 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -87.61 35.47 0.72 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.256 -0.903 . . . . 0.0 110.189 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.543 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 13.8 t0 -86.22 57.13 4.31 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.275 -0.891 . . . . 0.0 110.133 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.543 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.9 OUTLIER 161.69 36.84 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.628 -0.67 . . . . 0.0 110.073 -179.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.26 140.28 9.2 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.501 ' HB3' ' CD1' ' A' ' 32' ' ' LEU . 49.8 Cg_endo -77.13 6.6 4.18 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.104 1.581 . . . . 0.0 110.637 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 0.7 OUTLIER 65.57 -85.79 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.205 -0.934 . . . . 0.0 110.413 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.426 ' C ' HD13 ' A' ' 49' ' ' LEU . . . -147.88 13.88 1.33 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.578 ' CE2' HD21 ' A' ' 49' ' ' LEU . 30.5 m95 -66.68 135.0 53.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.163 -1.198 . . . . 0.0 110.367 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.575 ' CG2' ' CG2' ' A' ' 48' ' ' VAL . 1.2 m -129.76 156.54 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.0 110.052 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.456 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . . . -139.1 130.87 27.54 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.474 -0.767 . . . . 0.0 108.959 179.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.578 ' CE2' ' O ' ' A' ' 46' ' ' GLY . 9.3 p90 -121.62 158.8 27.83 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.098 -1.001 . . . . 0.0 111.73 -178.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.586 ' HA2' ' CE1' ' A' ' 43' ' ' TYR . . . 75.27 36.38 45.36 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.586 ' CG2' ' CG1' ' A' ' 45' ' ' VAL . 15.0 p -128.29 -160.69 1.04 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.089 -1.242 . . . . 0.0 110.5 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -98.42 39.19 1.26 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.37 -0.831 . . . . 0.0 110.249 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 133.89 175.31 13.86 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.455 ' O ' ' O ' ' A' ' 25' ' ' LEU . 46.8 Cg_endo -73.34 138.45 27.41 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.018 1.536 . . . . 0.0 110.563 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.511 ' CD1' HD12 ' A' ' 32' ' ' LEU . 0.8 OUTLIER -42.2 165.09 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.416 -0.802 . . . . 0.0 110.142 179.844 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -150.62 150.45 31.18 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.19 -0.944 . . . . 0.0 110.297 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.52 ' CG2' ' HA ' ' A' ' 32' ' ' LEU . 0.8 OUTLIER -119.94 -76.98 0.57 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.272 -0.893 . . . . 0.0 110.058 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.448 ' HB3' ' O ' ' A' ' 27' ' ' THR . 25.6 t 55.53 -88.28 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.252 -0.905 . . . . 0.0 110.605 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.445 ' N ' ' O ' ' A' ' 27' ' ' THR . 9.6 t -40.5 -27.62 0.05 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.398 -0.814 . . . . 0.0 110.573 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 28' ' ' SER . . . 132.13 -42.75 1.35 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.457 ' HB2' ' HB3' ' A' ' 140' ' ' CYS . . . -89.82 144.75 25.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.297 -1.119 . . . . 0.0 109.876 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.52 ' HA ' ' CG2' ' A' ' 27' ' ' THR . 0.5 OUTLIER -79.33 95.37 5.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.226 -0.921 . . . . 0.0 110.469 -179.786 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.515 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 0.8 OUTLIER -93.99 115.83 28.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.28 -0.887 . . . . 0.0 111.093 179.563 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.479 ' O ' ' OG1' ' A' ' 138' ' ' THR . 15.9 m -89.31 142.12 13.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.51 76.63 8.18 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.379 -0.826 . . . . 0.0 110.777 -178.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.662 ' CG1' ' CZ2' ' A' ' 137' ' ' TRP . 95.6 t -68.97 125.11 91.66 Favored Pre-proline 0 C--N 1.302 -1.463 0 O-C-N 121.443 -0.785 . . . . 0.0 109.08 179.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.496 ' HD3' ' HA ' ' A' ' 21' ' ' THR . 38.7 Cg_endo -65.82 175.64 4.35 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.966 1.508 . . . . 0.0 112.107 -178.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.534 ' HA ' ' N ' ' A' ' 136' ' ' ALA . . . -53.94 121.64 8.43 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.566 -0.709 . . . . 0.0 111.412 -178.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 134' ' ' ALA . . . 37.73 27.86 0.03 OUTLIER Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 38' ' ' ALA . 22.4 m 33.16 61.34 0.42 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.74 -0.859 . . . . 0.0 110.103 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.546 ' O ' ' CG ' ' A' ' 42' ' ' GLN . . . -88.54 133.94 34.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.45 -0.781 . . . . 0.0 110.444 -178.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.546 ' CG ' ' O ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER 59.49 30.03 19.66 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.192 0.52 . . . . 0.0 109.766 -179.454 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.586 ' CE1' ' HA2' ' A' ' 20' ' ' GLY . 0.1 OUTLIER -161.94 82.37 0.57 Allowed 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 118.776 -1.17 . . . . 0.0 111.707 -178.587 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.543 ' HA2' ' CA ' ' A' ' 130' ' ' GLY . . . -50.33 99.26 0.03 OUTLIER Glycine 0 N--CA 1.482 1.761 0 N-CA-C 107.091 -2.404 . . . . 0.0 107.091 178.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.586 ' CG1' ' CG2' ' A' ' 21' ' ' THR . 3.1 t -87.2 111.8 22.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 120.976 -1.308 . . . . 0.0 108.812 -178.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.578 ' O ' ' CE2' ' A' ' 19' ' ' TYR . . . -136.78 141.78 12.82 Favored Glycine 0 N--CA 1.486 1.98 0 C-N-CA 118.959 -1.591 . . . . 0.0 110.507 -178.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.518 ' CG1' ' O ' ' A' ' 17' ' ' VAL . 17.0 t -106.21 125.49 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.39 -1.065 . . . . 0.0 109.433 179.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.575 ' CG2' ' CG2' ' A' ' 17' ' ' VAL . 35.6 m -119.94 145.22 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.001 -1.062 . . . . 0.0 110.83 -179.225 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.578 HD21 ' CE2' ' A' ' 16' ' ' TRP . 10.4 tp -135.23 97.19 3.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.412 -0.805 . . . . 0.0 109.955 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.523 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 3.1 m120 -73.94 129.65 38.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.226 -0.921 . . . . 0.0 110.355 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 146.69 58.23 0.02 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.524 ' CG2' ' HA ' ' A' ' 124' ' ' GLN . 71.3 t -123.2 170.79 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.092 -1.24 . . . . 0.0 110.148 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 112' ' ' TYR . . . -146.91 92.31 2.12 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.198 -0.939 . . . . 0.0 110.572 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.566 HG13 ' CD2' ' A' ' 112' ' ' TYR . 48.6 mm -124.3 156.68 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.244 -0.91 . . . . 0.0 109.793 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.522 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 1.1 tt0 -145.19 130.43 18.56 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.034 -1.041 . . . . 0.0 110.572 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.522 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 10.4 pt-20 38.11 -154.72 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.691 -0.631 . . . . 0.0 110.758 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 108' ' ' ALA . . . -83.44 85.91 1.52 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.573 HG21 ' CE2' ' A' ' 60' ' ' TYR . 1.2 m -110.59 173.68 6.22 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.248 -1.148 . . . . 0.0 109.821 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.567 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 0.6 OUTLIER -89.88 151.29 21.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.196 -0.94 . . . . 0.0 110.354 -179.881 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.573 ' CD2' ' CB ' ' A' ' 108' ' ' ALA . 56.9 m-85 -160.2 178.17 9.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.265 -0.897 . . . . 0.0 110.287 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 75.5 m -150.19 119.81 6.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.437 -0.789 . . . . 0.0 109.746 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' A' ' 103' ' ' THR . 17.7 tp -89.48 119.97 30.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.13 -0.981 . . . . 0.0 110.12 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.507 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 10.2 ttp180 -124.4 138.68 54.34 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.373 -0.829 . . . . 0.0 109.806 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.536 ' CD1' ' C ' ' A' ' 64' ' ' TYR . 0.8 OUTLIER -178.74 142.2 0.21 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.37 -0.831 . . . . 0.0 109.677 179.892 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 4.3 m -119.22 94.5 4.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.066 -1.021 . . . . 0.0 110.009 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.511 ' CB ' HD23 ' A' ' 95' ' ' LEU . . . -97.12 156.16 16.51 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.377 -0.827 . . . . 0.0 110.412 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.456 HG22 ' O ' ' A' ' 98' ' ' GLU . 54.9 m -149.63 119.98 7.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.316 -0.865 . . . . 0.0 110.126 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -108.2 131.3 54.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.246 -0.909 . . . . 0.0 110.043 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 11.3 t -65.62 -9.23 25.21 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.212 -0.93 . . . . 0.0 110.104 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.548 ' CG2' ' CB ' ' A' ' 137' ' ' TRP . 6.0 t -116.0 19.54 14.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -0.895 . . . . 0.0 110.266 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.48 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 9.6 t0 42.76 66.49 0.76 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.291 -0.88 . . . . 0.0 109.69 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.526 ' CG1' HD11 ' A' ' 95' ' ' LEU . 5.8 p -97.84 141.87 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.407 -0.808 . . . . 0.0 110.826 -179.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 19.5 m -119.76 82.56 1.9 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.377 -0.827 . . . . 0.0 109.163 179.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.588 ' HA ' ' CD2' ' A' ' 132' ' ' PHE . 17.7 m -90.0 -140.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.243 -0.911 . . . . 0.0 110.739 -179.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.521 ' N ' HG21 ' A' ' 74' ' ' VAL . 7.5 mtm180 -130.43 145.01 51.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.19 -0.944 . . . . 0.0 110.828 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.541 ' N ' ' HD3' ' A' ' 93' ' ' PRO . . . -150.5 153.42 35.82 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.417 -0.802 . . . . 0.0 109.479 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.573 ' CD1' ' N ' ' A' ' 78' ' ' VAL . 3.9 pp 179.86 -147.59 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.136 -0.977 . . . . 0.0 110.4 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.573 ' N ' ' CD1' ' A' ' 77' ' ' LEU . 5.0 t -149.92 164.97 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.359 -0.838 . . . . 0.0 109.114 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.494 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . -171.81 -175.56 40.15 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 118.958 -1.591 . . . . 0.0 110.693 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.467 ' HG3' ' O ' ' A' ' 122' ' ' GLU . 1.3 tt0 -90.88 -151.63 0.26 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.639 -0.918 . . . . 0.0 110.272 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.511 ' HB2' ' HG2' ' A' ' 122' ' ' GLU . 47.9 m-80 -161.81 83.57 0.59 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.434 -0.791 . . . . 0.0 109.582 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.512 ' CA ' ' HB3' ' A' ' 121' ' ' PRO . . . 122.54 136.67 4.93 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.63 ' N ' ' CE1' ' A' ' 85' ' ' TYR . . . -40.45 150.82 0.26 Allowed Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.333 -1.098 . . . . 0.0 110.447 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.482 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.6 Cg_endo -80.07 12.07 23.64 Favored 'Cis proline' 0 C--N 1.313 -1.334 0 C-N-CA 121.711 -2.204 . . . . 0.0 110.938 -0.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.63 ' CE1' ' N ' ' A' ' 83' ' ' ALA . 27.2 m-85 63.6 163.65 0.12 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.187 -0.946 . . . . 0.0 110.282 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 176.4 131.9 1.55 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.455 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 0.7 OUTLIER -117.73 153.31 33.6 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.227 -1.161 . . . . 0.0 110.282 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.543 HG23 ' CE2' ' A' ' 112' ' ' TYR . 31.3 m -124.88 -24.45 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.32 -0.863 . . . . 0.0 110.305 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.584 ' CD1' ' CZ ' ' A' ' 106' ' ' PHE . 3.8 mp -104.79 144.29 31.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.204 -0.935 . . . . 0.0 110.952 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.438 ' O ' HG21 ' A' ' 91' ' ' THR . 12.9 p-10 -151.5 76.66 1.22 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.348 -0.845 . . . . 0.0 109.974 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.438 HG21 ' O ' ' A' ' 90' ' ' ASP . 67.1 p -142.71 -178.72 5.93 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.978 -1.076 . . . . 0.0 110.756 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.94 128.03 26.07 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.457 -0.777 . . . . 0.0 110.07 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.541 ' HD3' ' N ' ' A' ' 76' ' ' ALA . 46.4 Cg_endo -72.5 78.2 2.03 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.95 1.5 . . . . 0.0 111.038 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.535 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -56.43 139.64 48.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.057 -1.027 . . . . 0.0 109.223 179.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.575 ' CD1' ' CD2' ' A' ' 139' ' ' LEU . 44.4 mt -135.61 160.15 39.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.007 -1.058 . . . . 0.0 110.907 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -158.59 -179.02 7.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.476 -0.765 . . . . 0.0 109.926 179.949 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.81 -27.65 69.32 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -0.933 . . . . 0.0 110.118 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.457 ' HB3' ' HD2' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -90.51 176.65 2.8 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.184 -0.948 . . . . 0.0 110.018 179.824 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.457 ' HD2' ' HB3' ' A' ' 98' ' ' GLU . 44.9 Cg_endo -72.08 135.61 25.5 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.928 1.488 . . . . 0.0 110.381 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.535 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.84 93.49 4.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.228 -0.92 . . . . 0.0 110.208 179.985 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -87.61 97.25 10.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.371 -0.831 . . . . 0.0 110.359 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.531 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 40.2 t -89.55 134.03 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.347 -0.846 . . . . 0.0 110.216 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -150.25 133.81 16.58 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.219 -0.925 . . . . 0.0 110.211 179.902 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -160.26 135.62 8.09 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.909 . . . . 0.0 110.245 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.427 HG21 ' O ' ' A' ' 60' ' ' TYR . 85.3 m -90.03 125.87 35.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.224 -0.922 . . . . 0.0 110.053 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.584 ' CZ ' ' CD1' ' A' ' 89' ' ' LEU . 28.2 p90 -132.31 156.03 47.3 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.185 -0.947 . . . . 0.0 110.354 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.2 m -90.06 94.92 9.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.224 -0.923 . . . . 0.0 109.897 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.573 ' CB ' ' CD2' ' A' ' 60' ' ' TYR . . . -53.02 107.5 0.23 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.252 -0.905 . . . . 0.0 110.329 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.449 ' HA ' ' HA2' ' A' ' 57' ' ' GLY . 24.6 p -94.06 53.26 1.74 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.264 -0.898 . . . . 0.0 110.017 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -162.09 -153.55 0.28 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.297 -0.877 . . . . 0.0 110.278 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 5.2 m -147.27 118.38 7.74 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.283 -0.886 . . . . 0.0 110.172 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.566 ' CD2' HG13 ' A' ' 54' ' ' ILE . 20.3 m-30 -113.23 70.21 1.36 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.303 -0.873 . . . . 0.0 109.971 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.469 ' O ' ' HB2' ' A' ' 122' ' ' GLU . 46.3 Cg_endo -72.39 -159.06 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.035 1.545 . . . . 0.0 110.436 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -147.37 27.29 1.03 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.228 -0.92 . . . . 0.0 110.206 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.79 100.85 11.94 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.231 -0.918 . . . . 0.0 110.25 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.454 ' HA ' ' O ' ' A' ' 120' ' ' ASP . 47.6 Cg_endo -73.9 118.22 5.34 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.029 1.542 . . . . 0.0 110.444 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.44 ' CB ' ' HB2' ' A' ' 120' ' ' ASP . . . -123.59 -160.06 0.89 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.231 -0.918 . . . . 0.0 110.138 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.12 -16.98 5.92 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.26 -0.9 . . . . 0.0 110.191 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -169.87 28.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.3 -0.875 . . . . 0.0 110.146 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.454 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 0.7 OUTLIER -109.72 88.34 6.44 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.246 -0.909 . . . . 0.0 110.244 -179.957 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.512 ' HB3' ' CA ' ' A' ' 82' ' ' GLY . 46.2 Cg_endo -73.1 156.31 51.74 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.074 1.565 . . . . 0.0 110.266 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.511 ' HG2' ' HB2' ' A' ' 81' ' ' ASN . 0.8 OUTLIER -106.27 -163.02 0.89 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.131 -0.98 . . . . 0.0 109.878 179.802 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.563 ' HA3' ' CG ' ' A' ' 112' ' ' TYR . . . -144.37 149.09 21.13 Favored Glycine 0 N--CA 1.491 2.321 0 C-N-CA 119.56 -1.305 . . . . 0.0 109.889 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.524 ' HA ' ' CG2' ' A' ' 52' ' ' VAL . 19.4 pt20 -150.51 -153.11 0.47 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.314 -1.11 . . . . 0.0 110.085 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.478 HD12 HG22 ' A' ' 125' ' ' ILE . 14.2 mt -118.18 139.23 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.487 -0.758 . . . . 0.0 109.359 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -117.12 123.62 47.2 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.291 -0.88 . . . . 0.0 110.933 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.471 ' CE1' ' CG2' ' A' ' 125' ' ' ILE . 4.5 m-85 -118.84 103.18 9.39 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.529 ' O ' ' CD2' ' A' ' 129' ' ' LEU . 2.0 mt-30 -89.11 129.87 35.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.203 -0.935 . . . . 0.0 111.714 -177.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.544 ' CB ' ' O ' ' A' ' 45' ' ' VAL . 0.8 OUTLIER -141.53 34.08 1.64 Allowed 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.441 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.543 ' CA ' ' HA2' ' A' ' 44' ' ' GLY . . . -82.23 118.96 4.74 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.454 ' HA2' ' O ' ' A' ' 39' ' ' GLY . . . 42.56 69.99 0.54 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.588 ' CD2' ' HA ' ' A' ' 74' ' ' VAL . 11.2 m-85 -117.35 -61.81 1.65 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.109 -1.23 . . . . 0.0 111.006 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.516 ' HB2' ' CG2' ' A' ' 72' ' ' VAL . 1.3 t -88.36 -176.46 5.35 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.02 -1.05 . . . . 0.0 110.693 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -92.53 -82.03 0.33 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.276 -0.89 . . . . 0.0 110.225 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -70.25 177.77 3.15 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.147 -0.971 . . . . 0.0 109.765 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.534 ' N ' ' HA ' ' A' ' 38' ' ' ALA . . . -75.2 138.81 42.21 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.297 -0.877 . . . . 0.0 110.736 -179.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.662 ' CZ2' ' CG1' ' A' ' 36' ' ' VAL . 9.0 p90 -140.99 -171.41 3.25 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.263 -0.898 . . . . 0.0 110.682 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.479 ' OG1' ' O ' ' A' ' 34' ' ' VAL 0.251 0.8 OUTLIER -149.25 171.34 16.65 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.536 -0.727 . . . . 0.0 109.702 -177.986 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.575 ' CD2' ' CD1' ' A' ' 95' ' ' LEU . 1.7 mp -139.47 117.91 12.11 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.998 -1.064 . . . . 0.0 112.11 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' CYS . . . . . 0.457 ' HB3' ' HB2' ' A' ' 31' ' ' ALA . 0.8 OUTLIER -103.4 110.11 22.0 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.646 -0.659 . . . . 0.0 110.64 178.186 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.491 ' O ' ' CB ' ' A' ' 142' ' ' ASP . 1.3 mt -97.28 -178.5 4.19 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.277 -0.89 . . . . 0.0 108.974 178.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 143' ' ' ASP . 0.5 OUTLIER 169.31 61.12 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.145 -0.972 . . . . 0.0 110.407 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.53 ' CB ' ' O ' ' A' ' 142' ' ' ASP . 0.5 OUTLIER 166.35 43.26 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.388 -0.82 . . . . 0.0 109.344 179.852 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 1.5 t -89.45 114.33 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.373 -0.83 . . . . 0.0 110.281 -179.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.514 ' CB ' ' HG2' ' A' ' 6' ' ' GLU . . . -151.84 148.45 27.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.413 -0.804 . . . . 0.0 110.081 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.447 HD22 HD13 ' A' ' 54' ' ' ILE . 38.8 tp -146.54 123.57 11.41 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.341 -0.849 . . . . 0.0 110.099 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.449 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -140.66 157.57 45.25 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.235 -0.916 . . . . 0.0 110.373 -179.938 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 59' ' ' THR . 24.4 p -98.66 115.5 28.83 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.282 -0.886 . . . . 0.0 110.136 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.67 162.17 27.94 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.208 -0.933 . . . . 0.0 110.215 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 16.6 m -89.25 31.43 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.221 -0.924 . . . . 0.0 110.185 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -97.39 113.21 24.83 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.288 -0.882 . . . . 0.0 110.21 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.4 tp . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.199 -179.974 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.265 0.555 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' A' ' 2' ' ' SER . 2.8 t 179.06 66.9 0.12 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 0.0 110.184 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -75.94 -156.34 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.013 1.533 . . . . 0.0 110.09 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.473 HG23 HD22 ' A' ' 49' ' ' LEU . 10.0 pt -96.38 -28.93 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.183 -0.948 . . . . 0.0 110.181 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.51 ' O ' ' N ' ' A' ' 7' ' ' GLY . . . 99.4 106.47 2.71 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.454 ' HB2' ' HB3' ' A' ' 145' ' ' ALA . 0.6 OUTLIER -45.01 93.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.231 -1.158 . . . . 0.0 110.069 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 5' ' ' GLY . . . -139.55 177.84 20.12 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.512 ' O ' ' HB2' ' A' ' 9' ' ' PHE . 29.4 p -129.52 20.35 5.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.386 -1.067 . . . . 0.0 109.818 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.58 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.2 m-30 70.71 -78.96 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.812 -0.555 . . . . 0.0 110.671 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.555 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 1.4 p30 40.02 27.87 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.095 -1.003 . . . . 0.0 110.505 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.555 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 1.9 t70 161.13 -57.84 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.54 0.686 . . . . 0.0 109.235 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 9' ' ' PHE . . . -133.67 127.13 4.53 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.57 ' HA ' ' CD1' ' A' ' 9' ' ' PHE . 52.4 Cg_endo -81.82 29.85 0.53 Allowed 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.819 1.431 . . . . 0.0 111.16 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 0.2 OUTLIER 62.23 -89.35 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.997 -1.065 . . . . 0.0 110.326 179.923 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -149.73 22.19 1.16 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.643 ' CE2' ' CD2' ' A' ' 49' ' ' LEU . 40.0 m95 -61.69 142.56 57.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.276 -1.132 . . . . 0.0 110.381 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.527 ' CG2' HG22 ' A' ' 48' ' ' VAL . 0.8 OUTLIER -132.87 140.87 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.232 -0.918 . . . . 0.0 109.222 179.15 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.518 ' CB ' HG13 ' A' ' 34' ' ' VAL . . . -125.15 114.75 19.43 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.97 -1.081 . . . . 0.0 110.235 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.411 ' O ' HG11 ' A' ' 45' ' ' VAL . 40.0 p90 -100.93 150.53 22.77 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.691 -0.631 . . . . 0.0 109.924 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.57 ' O ' ' OG1' ' A' ' 21' ' ' THR . . . 112.58 87.2 1.64 Allowed Glycine 0 N--CA 1.483 1.802 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.57 ' OG1' ' O ' ' A' ' 20' ' ' GLY . 1.4 p 75.24 -139.81 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.116 0 O-C-N 122.064 -0.668 . . . . 0.0 110.333 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.523 ' O ' ' CB ' ' A' ' 35' ' ' ALA . 2.5 m-20 -88.72 116.84 27.27 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.884 -1.135 . . . . 0.0 110.075 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.557 ' N ' ' CD ' ' A' ' 24' ' ' PRO . . . -119.61 49.24 0.88 Allowed Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.557 ' CD ' ' N ' ' A' ' 23' ' ' GLY . 43.4 Cg_endo -69.89 82.17 0.8 Allowed 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 124.024 1.539 . . . . 0.0 109.677 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.525 ' HB3' ' CD1' ' A' ' 32' ' ' LEU . 40.8 mt -50.93 88.52 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.44 -0.787 . . . . 0.0 110.422 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 24' ' ' PRO . 0.3 OUTLIER -91.22 120.95 32.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -0.885 . . . . 0.0 109.442 179.626 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.449 HG22 ' HB3' ' A' ' 9' ' ' PHE . 1.2 p -119.54 -27.39 5.54 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.076 -1.015 . . . . 0.0 110.889 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 27' ' ' THR . 74.4 m -43.46 -28.08 0.33 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.186 -0.946 . . . . 0.0 109.192 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.417 ' CG2' ' N ' ' A' ' 30' ' ' GLY . 6.3 t -67.78 -47.89 67.87 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.629 -0.669 . . . . 0.0 110.482 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.417 ' N ' ' CG2' ' A' ' 29' ' ' THR . . . 164.93 -25.94 0.18 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.527 ' CB ' ' HB3' ' A' ' 140' ' ' CYS . . . -150.54 159.67 44.33 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.295 -1.121 . . . . 0.0 110.218 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.525 ' CD1' ' HB3' ' A' ' 25' ' ' LEU . 0.6 OUTLIER -72.71 102.0 3.22 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.314 -0.866 . . . . 0.0 110.328 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.543 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 0.8 OUTLIER -98.84 119.76 38.14 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.167 -0.958 . . . . 0.0 111.913 -179.915 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.518 HG13 ' CB ' ' A' ' 18' ' ' ALA . 17.2 m -96.92 150.11 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' A' ' 22' ' ' ASP . . . -89.95 121.75 32.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.054 -1.029 . . . . 0.0 111.781 -178.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.643 ' CG1' ' CZ2' ' A' ' 137' ' ' TRP . 66.5 t -119.56 125.8 27.29 Favored Pre-proline 0 C--N 1.303 -1.452 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 178.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.475 ' HG3' HG23 ' A' ' 21' ' ' THR . 44.8 Cg_endo -71.59 147.39 51.42 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 123.811 1.427 . . . . 0.0 110.929 -178.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.522 ' HA ' ' N ' ' A' ' 136' ' ' ALA . . . -43.03 123.97 3.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.364 -0.835 . . . . 0.0 109.277 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 134' ' ' ALA . . . 61.39 78.8 0.15 Allowed Glycine 0 N--CA 1.486 1.968 0 N-CA-C 108.0 -2.04 . . . . 0.0 108.0 -178.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.575 ' HB3' ' CH2' ' A' ' 137' ' ' TRP . 2.4 p -85.28 53.63 2.82 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.542 -0.975 . . . . 0.0 110.076 -179.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.566 ' O ' ' O ' ' A' ' 42' ' ' GLN . . . -88.83 -147.49 0.16 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.69 -0.631 . . . . 0.0 110.024 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.701 ' O ' ' CD2' ' A' ' 43' ' ' TYR . 5.8 pt20 38.94 102.98 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 CA-C-O 121.761 0.791 . . . . 0.0 110.522 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.701 ' CD2' ' O ' ' A' ' 42' ' ' GLN . 0.0 OUTLIER 77.7 -20.95 0.35 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.729 -1.232 . . . . 0.0 110.275 -178.797 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.584 ' O ' ' CD1' ' A' ' 43' ' ' TYR . . . 57.71 141.95 0.01 OUTLIER Glycine 0 N--CA 1.492 2.398 0 O-C-N 120.952 -1.092 . . . . 0.0 111.196 178.155 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.55 ' CG2' ' HB2' ' A' ' 40' ' ' SER . 2.5 t -93.35 -172.66 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.306 -1.114 . . . . 0.0 108.762 179.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 127' ' ' PHE . . . 172.13 -175.4 45.41 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 118.635 -1.745 . . . . 0.0 111.464 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.526 ' CG1' ' O ' ' A' ' 17' ' ' VAL . 35.5 t -150.6 133.75 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.527 HG22 ' CG2' ' A' ' 17' ' ' VAL . 22.5 m -123.66 138.5 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 120.81 -1.181 . . . . 0.0 110.99 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.643 ' CD2' ' CE2' ' A' ' 16' ' ' TRP . 5.2 tp -132.03 98.87 4.55 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.326 -0.859 . . . . 0.0 110.202 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.521 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 3.4 p-10 -73.46 98.88 2.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 0.0 110.091 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.448 ' O ' HG21 ' A' ' 4' ' ' ILE . . . 172.7 77.57 0.05 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.498 ' CG2' ' HA ' ' A' ' 124' ' ' GLN . 12.4 t -134.93 169.17 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.215 -1.168 . . . . 0.0 109.937 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -136.46 79.7 1.78 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.107 -0.995 . . . . 0.0 110.671 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.554 HG13 ' CD2' ' A' ' 112' ' ' TYR . 36.0 mm -115.63 158.91 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.209 -0.932 . . . . 0.0 109.934 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.53 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 3.8 tt0 -152.04 124.25 8.18 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.116 -0.99 . . . . 0.0 110.438 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.53 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 11.5 pt-20 37.73 -152.93 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.669 -0.645 . . . . 0.0 110.789 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.461 ' N ' ' HG3' ' A' ' 56' ' ' GLU . . . -82.03 99.95 2.07 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.58 HG21 ' CE2' ' A' ' 60' ' ' TYR . 1.2 m -132.46 174.16 10.55 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.33 -1.1 . . . . 0.0 109.855 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.568 ' N ' ' CG2' ' A' ' 58' ' ' THR . 1.3 m -89.72 152.97 21.06 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.226 -0.921 . . . . 0.0 110.191 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.582 ' CD2' ' HB1' ' A' ' 108' ' ' ALA . 57.9 m-85 -158.6 158.61 34.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.255 -0.903 . . . . 0.0 110.28 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 87.8 m -132.37 117.3 17.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.317 -0.865 . . . . 0.0 109.971 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 20.1 tp -89.73 121.49 31.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.188 -0.945 . . . . 0.0 110.156 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.478 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 9.5 ttp180 -125.78 131.84 52.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 110.12 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.638 ' CZ ' ' CG2' ' A' ' 102' ' ' VAL . 2.7 p90 -169.8 146.64 3.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.221 -0.924 . . . . 0.0 109.975 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.461 ' OG1' ' HG3' ' A' ' 101' ' ' GLN . 3.4 m -119.49 101.33 7.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.199 -0.938 . . . . 0.0 109.745 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.483 ' HB1' ' CD2' ' A' ' 141' ' ' LEU . . . -104.83 150.79 24.52 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.356 -0.84 . . . . 0.0 110.497 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.457 ' OG1' ' HA ' ' A' ' 99' ' ' PRO . 86.0 m -150.43 106.48 3.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.32 -0.863 . . . . 0.0 110.161 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.472 ' O ' ' O ' ' A' ' 96' ' ' THR . . . -95.73 127.04 41.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.206 -0.934 . . . . 0.0 109.951 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 68' ' ' ALA . 39.9 t -42.56 -26.95 0.14 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.284 -0.885 . . . . 0.0 109.843 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.557 ' CG2' ' CB ' ' A' ' 137' ' ' TRP . 2.6 t -108.5 159.95 16.28 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.356 -0.84 . . . . 0.0 110.056 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.462 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 60.4 t0 -78.31 78.63 4.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.121 -0.987 . . . . 0.0 109.215 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.547 ' CG2' ' CB ' ' A' ' 133' ' ' SER . 4.4 p -106.64 145.72 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.186 -0.946 . . . . 0.0 111.239 -178.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.476 ' O ' ' CD1' ' A' ' 132' ' ' PHE . 98.2 m -126.02 91.35 3.36 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.585 ' HA ' ' CG ' ' A' ' 132' ' ' PHE . 15.4 m -89.77 -152.11 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.196 -0.94 . . . . 0.0 110.833 -178.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.466 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 8.2 mtm180 -129.21 136.34 50.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.332 -0.855 . . . . 0.0 110.647 -179.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.477 ' O ' ' HB3' ' A' ' 77' ' ' LEU . . . -135.67 153.56 51.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.388 -0.82 . . . . 0.0 109.648 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.574 ' CD1' ' N ' ' A' ' 78' ' ' VAL . 4.0 pp -179.74 -150.02 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.243 -0.911 . . . . 0.0 110.377 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.574 ' N ' ' CD1' ' A' ' 77' ' ' LEU . 3.5 t -150.87 170.54 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.29 -0.881 . . . . 0.0 109.616 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.575 ' O ' ' CE1' ' A' ' 112' ' ' TYR . . . -174.83 -162.43 26.3 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.404 -1.379 . . . . 0.0 110.256 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.514 ' OE1' ' N ' ' A' ' 82' ' ' GLY . 3.5 tm0? -120.9 128.21 52.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.448 -1.031 . . . . 0.0 110.655 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.518 ' OD1' ' NE2' ' A' ' 124' ' ' GLN . 4.5 m120 -83.46 67.64 9.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.4 -0.812 . . . . 0.0 109.813 179.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.523 ' HA3' ' CB ' ' A' ' 121' ' ' PRO . . . 166.7 141.36 3.13 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.618 ' N ' ' CE1' ' A' ' 85' ' ' TYR . . . -61.97 156.06 59.63 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.245 -1.15 . . . . 0.0 110.134 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.52 ' C ' ' CD2' ' A' ' 85' ' ' TYR . 49.9 Cg_endo -77.22 8.15 17.63 Favored 'Cis proline' 0 C--N 1.312 -1.377 0 C-N-CA 121.692 -2.212 . . . . 0.0 110.904 0.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.618 ' CE1' ' N ' ' A' ' 83' ' ' ALA . 11.7 m-85 70.15 158.19 0.17 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.26 -0.9 . . . . 0.0 110.196 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -177.68 114.27 0.46 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.456 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 1.6 p -89.92 147.15 23.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.243 -1.151 . . . . 0.0 110.329 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.455 ' HB ' ' HA ' ' A' ' 108' ' ' ALA . 16.4 m -119.96 -24.0 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.29 -0.881 . . . . 0.0 110.016 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.575 HD13 ' CE2' ' A' ' 106' ' ' PHE . 4.2 mp -105.74 145.22 31.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 110.792 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -151.19 78.23 1.28 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.326 -0.859 . . . . 0.0 109.996 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.0 p -140.22 170.63 15.48 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.028 -1.045 . . . . 0.0 110.686 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.2 m -120.09 115.62 33.02 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.383 -0.823 . . . . 0.0 110.087 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.54 ' HG2' ' CG2' ' A' ' 74' ' ' VAL . 45.2 Cg_endo -70.68 128.76 15.61 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.901 1.474 . . . . 0.0 111.057 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.511 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -94.25 148.12 22.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.32 -0.862 . . . . 0.0 109.407 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.569 ' CD1' ' CD2' ' A' ' 139' ' ' LEU . 77.1 mt -141.15 157.39 45.33 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.019 -1.051 . . . . 0.0 110.807 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 68' ' ' ALA . 6.0 t -164.47 -156.58 0.33 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.407 -0.808 . . . . 0.0 109.902 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.11 34.05 0.79 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.177 -0.952 . . . . 0.0 110.244 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.403 ' HG2' ' HD2' ' A' ' 99' ' ' PRO . 0.1 OUTLIER -150.16 168.02 11.83 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.304 -0.872 . . . . 0.0 110.068 179.899 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.457 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 45.5 Cg_endo -72.41 127.74 12.9 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.005 1.529 . . . . 0.0 110.313 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.511 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 1.2 ttm180 -119.46 91.83 3.64 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.179 -0.951 . . . . 0.0 110.152 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.461 ' HG3' ' OG1' ' A' ' 65' ' ' THR . 0.0 OUTLIER -73.89 147.12 43.49 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.341 -0.85 . . . . 0.0 109.963 179.93 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.638 ' CG2' ' CZ ' ' A' ' 64' ' ' TYR . 19.6 t -124.03 135.17 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.227 -0.92 . . . . 0.0 110.296 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.18 96.66 2.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.283 -0.886 . . . . 0.0 110.196 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -142.39 160.09 40.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.216 -0.927 . . . . 0.0 110.256 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 1.2 t -114.97 170.74 8.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.251 -0.906 . . . . 0.0 110.164 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.575 ' CE2' HD13 ' A' ' 89' ' ' LEU . 41.7 p90 -173.06 153.89 2.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.248 -0.907 . . . . 0.0 110.289 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' A' ' 58' ' ' THR . 16.4 m -89.92 90.37 8.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.884 . . . . 0.0 109.993 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.582 ' HB1' ' CD2' ' A' ' 60' ' ' TYR . . . -54.15 113.49 1.26 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.296 -0.878 . . . . 0.0 110.393 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 68.7 p -97.33 54.79 1.23 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.224 -0.922 . . . . 0.0 109.993 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.439 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -165.14 -159.0 0.41 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.3 -0.875 . . . . 0.0 110.236 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.428 HG21 ' HA ' ' A' ' 55' ' ' GLU . 13.6 m -147.77 117.9 7.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.223 -0.923 . . . . 0.0 110.342 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.575 ' CE1' ' O ' ' A' ' 79' ' ' GLY . 17.4 m-30 -115.9 80.39 8.82 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.29 -0.881 . . . . 0.0 109.841 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.469 ' HG2' ' HA ' ' A' ' 122' ' ' GLU . 44.5 Cg_endo -72.32 -164.56 0.18 Allowed 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.92 1.484 . . . . 0.0 110.51 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -141.48 47.46 1.68 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.209 -0.932 . . . . 0.0 110.25 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.465 ' O ' ' O ' ' A' ' 120' ' ' ASP . 0.3 OUTLIER -128.17 72.24 79.55 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 0.0 110.184 -179.972 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.45 ' HA ' ' O ' ' A' ' 120' ' ' ASP . 45.8 Cg_endo -72.89 121.57 7.44 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.071 1.563 . . . . 0.0 110.458 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -144.78 -160.07 1.08 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.244 -0.91 . . . . 0.0 110.189 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -75.1 -9.45 58.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.301 -0.874 . . . . 0.0 110.237 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.433 ' OD1' ' OD1' ' A' ' 120' ' ' ASP . 4.7 p30 -155.19 18.84 0.42 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.219 -0.925 . . . . 0.0 110.181 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.465 ' O ' ' O ' ' A' ' 115' ' ' THR . 3.5 m-20 -132.71 90.15 33.42 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.251 -0.906 . . . . 0.0 110.23 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.523 ' CB ' ' HA3' ' A' ' 82' ' ' GLY . 45.7 Cg_endo -72.89 -159.07 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.018 1.536 . . . . 0.0 110.391 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.516 ' HG2' ' N ' ' A' ' 123' ' ' GLY . 4.9 pm0 -163.42 -137.78 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.179 -0.951 . . . . 0.0 110.408 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.516 ' N ' ' HG2' ' A' ' 122' ' ' GLU . . . -145.82 158.26 27.62 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.521 ' CB ' ' HA ' ' A' ' 50' ' ' ASN . 3.3 pt20 -150.23 -161.0 1.25 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.071 -1.252 . . . . 0.0 110.748 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.473 ' CG2' ' CE1' ' A' ' 127' ' ' PHE . 30.4 mt -118.97 148.63 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.49 -0.756 . . . . 0.0 109.413 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.443 ' HB2' ' HG ' ' A' ' 77' ' ' LEU . . . -117.36 120.13 37.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.35 -0.844 . . . . 0.0 111.426 -179.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.5 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 5.3 m-85 -125.14 77.47 1.63 Allowed 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.466 ' HA ' ' CA ' ' A' ' 46' ' ' GLY . 8.4 mt-30 -87.47 121.19 29.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.135 -0.978 . . . . 0.0 111.706 -177.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.528 ' CD2' HG23 ' A' ' 74' ' ' VAL . 6.4 mt -105.24 49.19 0.81 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.49 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -91.34 137.71 13.95 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.579 ' O ' ' CD1' ' A' ' 132' ' ' PHE . . . 41.96 93.23 0.01 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.585 ' CG ' ' HA ' ' A' ' 74' ' ' VAL . 13.0 m-85 -154.86 -74.97 0.11 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -1.168 . . . . 0.0 110.353 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.579 ' HB3' ' CE3' ' A' ' 137' ' ' TRP . 1.4 t -89.5 166.49 13.64 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.026 -1.046 . . . . 0.0 110.26 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -101.85 -59.41 1.71 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.18 -0.95 . . . . 0.0 110.552 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.425 ' C ' ' HA ' ' A' ' 38' ' ' ALA . 15.8 m-20 -73.09 152.45 41.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.189 -0.944 . . . . 0.0 110.261 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.522 ' N ' ' HA ' ' A' ' 38' ' ' ALA . . . -49.2 133.58 18.92 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.19 -0.944 . . . . 0.0 109.925 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.643 ' CZ2' ' CG1' ' A' ' 36' ' ' VAL . 6.2 p90 -147.25 -173.6 4.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.123 -0.985 . . . . 0.0 110.944 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.53 ' CG2' ' N ' ' A' ' 139' ' ' LEU 0.25 0.8 OUTLIER -154.09 178.75 9.61 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.538 -0.726 . . . . 0.0 109.369 -178.372 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.569 ' CD2' ' CD1' ' A' ' 95' ' ' LEU . 1.6 mp -138.16 115.93 11.47 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.846 -1.159 . . . . 0.0 112.195 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' CYS . . . . . 0.527 ' HB3' ' CB ' ' A' ' 31' ' ' ALA . 0.8 OUTLIER -103.51 107.44 18.29 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.71 -0.619 . . . . 0.0 110.929 178.351 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.497 ' O ' ' CB ' ' A' ' 142' ' ' ASP . 3.9 mt -94.42 179.92 5.12 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.246 -0.909 . . . . 0.0 108.961 178.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.511 ' N ' ' OD1' ' A' ' 142' ' ' ASP . 2.0 p30 168.31 61.15 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.044 -1.035 . . . . 0.0 110.578 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.511 ' CB ' ' O ' ' A' ' 142' ' ' ASP . 0.5 OUTLIER 164.92 45.63 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.444 -0.785 . . . . 0.0 109.355 179.773 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.511 HG22 ' CZ ' ' A' ' 9' ' ' PHE . 1.1 t -89.46 115.66 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.309 -0.87 . . . . 0.0 110.316 -179.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.454 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . . . -144.45 155.37 43.7 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.431 -0.793 . . . . 0.0 110.151 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 39.4 tp -148.98 141.71 24.53 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.332 -0.855 . . . . 0.0 110.177 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.47 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 0.5 OUTLIER -151.4 176.85 10.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.237 -0.915 . . . . 0.0 110.246 -179.914 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.577 ' HB3' ' CE1' ' A' ' 60' ' ' TYR . 6.2 p -135.13 177.88 7.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.153 -0.967 . . . . 0.0 110.249 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -106.98 142.55 36.42 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.332 -0.855 . . . . 0.0 110.185 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 7.9 p -125.68 30.02 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.266 -0.896 . . . . 0.0 110.205 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 61.03 -162.86 0.27 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.286 -0.884 . . . . 0.0 110.2 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.2 mt . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 117.999 -1.0 . . . . 0.0 110.199 -179.988 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.241 0.544 . . . . 0.0 110.238 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -165.09 137.41 3.49 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.281 -0.887 . . . . 0.0 110.216 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -75.7 -155.73 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.984 1.518 . . . . 0.0 110.06 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.515 ' CG2' ' O ' ' A' ' 51' ' ' GLY . 27.7 pt -89.8 -34.36 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.195 -0.94 . . . . 0.0 110.09 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.508 ' N ' HG13 ' A' ' 4' ' ' ILE . . . -172.31 -119.93 0.54 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.429 ' HB2' ' O ' ' A' ' 5' ' ' GLY . 1.9 tt0 178.47 31.58 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.217 -1.166 . . . . 0.0 110.242 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.449 ' O ' ' HA ' ' A' ' 143' ' ' ASP . . . 156.32 -116.74 0.74 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.537 ' CG2' ' O ' ' A' ' 142' ' ' ASP . 3.8 p -108.03 168.28 9.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -1.151 . . . . 0.0 110.034 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.518 ' O ' ' N ' ' A' ' 11' ' ' ASP . 14.7 m-85 -70.05 -33.92 72.57 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.239 -0.913 . . . . 0.0 109.199 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.57 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 20.0 t70 37.01 27.7 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.734 -0.604 . . . . 0.0 111.384 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.57 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.9 OUTLIER 161.31 -66.55 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.313 -0.867 . . . . 0.0 110.184 179.728 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.476 ' O ' ' HB3' ' A' ' 9' ' ' PHE . . . -122.46 145.67 16.52 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.523 ' HB3' ' CD1' ' A' ' 32' ' ' LEU . 49.5 Cg_endo -76.02 4.95 4.82 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 O-C-N 124.093 1.575 . . . . 0.0 110.814 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.461 ' CB ' ' O ' ' A' ' 13' ' ' PRO . 1.5 mm-40 67.39 -84.77 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.199 -0.938 . . . . 0.0 110.378 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.488 ' C ' ' CD1' ' A' ' 49' ' ' LEU . . . -137.84 4.35 3.26 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.584 ' CE2' HD21 ' A' ' 49' ' ' LEU . 51.8 m95 -61.75 87.97 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.133 -1.216 . . . . 0.0 110.095 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.519 ' O ' ' CG1' ' A' ' 47' ' ' VAL . 1.2 m -93.01 162.88 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.228 -0.92 . . . . 0.0 109.976 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.459 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . . . -142.67 129.79 20.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.391 -0.818 . . . . 0.0 109.286 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.57 ' CE2' ' O ' ' A' ' 46' ' ' GLY . 10.6 p90 -118.26 157.14 27.59 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.141 -0.974 . . . . 0.0 111.363 -178.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.516 ' HA2' ' CE2' ' A' ' 43' ' ' TYR . . . 74.97 41.44 32.7 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.593 ' CG2' ' CG1' ' A' ' 45' ' ' VAL . 17.2 p -128.11 -154.09 0.61 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.147 -1.208 . . . . 0.0 110.469 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -100.76 38.11 1.59 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.389 -0.819 . . . . 0.0 110.127 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 124.93 -174.89 17.26 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.465 ' O ' ' O ' ' A' ' 25' ' ' LEU . 46.9 Cg_endo -73.47 134.7 21.03 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.046 1.551 . . . . 0.0 110.615 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.53 ' CD1' HD13 ' A' ' 32' ' ' LEU . 0.8 OUTLIER -49.14 -179.98 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.236 -0.915 . . . . 0.0 110.168 179.899 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -155.67 158.51 38.42 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.138 -0.976 . . . . 0.0 110.233 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.509 ' O ' ' CG2' ' A' ' 29' ' ' THR . 0.9 OUTLIER -119.92 -75.12 0.59 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.328 -0.857 . . . . 0.0 110.039 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 27' ' ' THR . 1.0 OUTLIER 40.53 27.53 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.445 -0.784 . . . . 0.0 110.624 179.843 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.509 ' CG2' ' O ' ' A' ' 27' ' ' THR . 9.4 t -164.48 23.75 0.06 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.17 -0.956 . . . . 0.0 110.357 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.505 ' HA2' ' N ' ' A' ' 11' ' ' ASP . . . 60.36 17.93 48.42 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.463 ' O ' HG21 ' A' ' 27' ' ' THR . . . -142.57 153.93 43.98 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.369 -1.077 . . . . 0.0 110.088 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.53 HD13 ' CD1' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -91.89 95.37 9.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.92 . . . . 0.0 110.162 179.996 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 7.4 m -101.27 99.48 9.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.302 -0.874 . . . . 0.0 110.428 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.464 HG13 ' HB3' ' A' ' 25' ' ' LEU . 20.3 m -89.82 145.67 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.257 -0.902 . . . . 0.0 109.624 179.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.499 ' HA ' ' OG1' ' A' ' 138' ' ' THR . . . -91.43 99.2 12.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.164 -0.96 . . . . 0.0 110.751 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.666 ' CG1' ' CZ2' ' A' ' 137' ' ' TRP . 62.9 t -84.94 129.35 56.67 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.263 -0.898 . . . . 0.0 109.46 179.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.49 ' HD2' HG23 ' A' ' 45' ' ' VAL . 38.5 Cg_endo -65.56 178.48 2.14 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 121.704 1.602 . . . . 0.0 112.508 -178.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.526 ' HA ' ' CA ' ' A' ' 136' ' ' ALA . . . -61.27 117.16 5.25 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.519 0.676 . . . . 0.0 111.51 -178.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 134' ' ' ALA . . . 37.22 26.93 0.02 OUTLIER Glycine 0 N--CA 1.493 2.494 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.516 ' N ' ' O ' ' A' ' 38' ' ' ALA . 12.6 t 36.84 73.86 0.09 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.405 -1.056 . . . . 0.0 109.859 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.578 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . -87.77 115.0 24.92 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.669 -0.812 . . . . 0.0 109.977 -179.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.578 ' HG2' ' O ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER 67.37 10.51 7.79 Favored 'General case' 0 N--CA 1.504 2.26 0 CA-C-O 121.399 0.619 . . . . 0.0 109.965 -179.247 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.53 ' O ' ' N ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -132.32 76.02 1.67 Allowed 'General case' 0 C--N 1.289 -2.044 0 C-N-CA 119.551 -0.86 . . . . 0.0 111.719 -178.162 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.438 ' HA2' ' HA3' ' A' ' 130' ' ' GLY . . . -48.8 98.52 0.02 OUTLIER Glycine 0 N--CA 1.484 1.843 0 N-CA-C 107.362 -2.295 . . . . 0.0 107.362 178.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.593 ' CG1' ' CG2' ' A' ' 21' ' ' THR . 2.7 t -86.89 113.7 24.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.185 -1.185 . . . . 0.0 108.693 -178.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.57 ' O ' ' CE2' ' A' ' 19' ' ' TYR . . . -133.35 141.2 12.54 Favored Glycine 0 N--CA 1.487 2.095 0 C-N-CA 119.299 -1.429 . . . . 0.0 110.491 -178.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.519 ' CG1' ' O ' ' A' ' 17' ' ' VAL . 15.8 t -105.79 123.39 60.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 121.519 -0.989 . . . . 0.0 109.483 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.425 HG21 ' O ' ' A' ' 48' ' ' VAL . 35.1 m -119.69 140.28 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.003 -1.061 . . . . 0.0 110.72 -179.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.584 HD21 ' CE2' ' A' ' 16' ' ' TRP . 20.7 tp -130.91 98.67 4.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.338 -0.851 . . . . 0.0 110.191 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.516 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 19.4 p30 -77.02 138.22 39.46 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.206 -0.934 . . . . 0.0 110.223 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.515 ' O ' ' CG2' ' A' ' 4' ' ' ILE . . . 134.15 76.08 0.09 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.504 ' CG1' ' N ' ' A' ' 53' ' ' ALA . 41.5 t -135.51 171.57 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.192 -1.181 . . . . 0.0 110.148 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.504 ' N ' ' CG1' ' A' ' 52' ' ' VAL . . . -139.59 81.84 1.85 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.105 -0.997 . . . . 0.0 110.665 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.571 HD11 ' CE2' ' A' ' 60' ' ' TYR . 30.1 mm -119.48 159.86 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.301 -0.874 . . . . 0.0 109.774 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.527 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 6.3 tt0 -152.8 131.75 12.54 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.006 -1.059 . . . . 0.0 110.762 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 19.5 pt-20 37.8 -154.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.64 -0.662 . . . . 0.0 111.022 179.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 109' ' ' SER . . . -84.58 83.47 1.63 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.561 HG21 ' CE2' ' A' ' 60' ' ' TYR . 1.2 m -112.05 170.58 8.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -1.166 . . . . 0.0 109.781 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.567 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 0.7 OUTLIER -89.88 154.12 20.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.234 -0.916 . . . . 0.0 110.311 -179.902 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.571 ' CE2' HD11 ' A' ' 54' ' ' ILE . 61.8 m-85 -158.95 -179.62 8.21 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.257 -0.902 . . . . 0.0 110.112 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.413 ' O ' HD13 ' A' ' 146' ' ' LEU . 94.6 m -150.01 111.28 4.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.276 -0.89 . . . . 0.0 110.065 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.453 ' O ' ' HA ' ' A' ' 103' ' ' THR . 20.4 tp -89.7 121.3 31.74 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.183 -0.948 . . . . 0.0 110.201 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.492 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 26.5 ttp180 -127.67 138.11 52.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.324 -0.86 . . . . 0.0 109.894 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.513 ' CE2' ' HB ' ' A' ' 102' ' ' VAL . 6.3 p90 -174.9 151.29 1.35 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.278 -0.889 . . . . 0.0 109.821 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.483 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 78.1 m -119.39 91.03 3.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.149 -0.969 . . . . 0.0 110.092 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.475 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -89.79 143.1 27.08 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.387 -0.821 . . . . 0.0 110.423 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.458 ' OG1' ' HA ' ' A' ' 99' ' ' PRO . 99.4 m -143.84 116.2 8.53 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.281 -0.887 . . . . 0.0 110.205 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.52 ' HB1' ' CD2' ' A' ' 95' ' ' LEU . . . -109.14 126.48 53.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.3 -0.875 . . . . 0.0 109.874 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.433 ' C ' ' O ' ' A' ' 68' ' ' ALA . 0.4 OUTLIER -43.98 -26.41 0.28 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.234 -0.916 . . . . 0.0 109.573 179.709 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.529 ' CG2' ' CB ' ' A' ' 137' ' ' TRP . 2.7 t -110.41 169.87 8.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.543 -0.723 . . . . 0.0 110.01 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.452 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 12.5 t70 -87.16 51.85 2.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.177 -0.952 . . . . 0.0 108.988 178.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.579 HG22 ' CE2' ' A' ' 137' ' ' TRP . 4.0 p -66.62 135.33 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.519 -0.738 . . . . 0.0 111.353 -178.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 92.2 m -119.86 79.89 1.51 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.583 ' HA ' ' CD1' ' A' ' 132' ' ' PHE . 7.5 m -89.68 -142.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.317 -0.864 . . . . 0.0 110.443 -178.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.523 ' N ' HG22 ' A' ' 74' ' ' VAL . 0.7 OUTLIER -130.27 145.88 51.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.164 -0.96 . . . . 0.0 110.718 -179.453 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.521 ' CB ' ' HG3' ' A' ' 93' ' ' PRO . . . -146.19 150.42 35.81 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.333 -0.854 . . . . 0.0 109.594 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.489 ' C ' ' CD1' ' A' ' 77' ' ' LEU . 1.3 pp 175.6 -158.81 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.258 -0.901 . . . . 0.0 110.489 -179.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.466 HG12 ' O ' ' A' ' 124' ' ' GLN . 5.4 t -145.65 167.63 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.415 -0.803 . . . . 0.0 109.299 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.498 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . -178.02 -171.41 41.37 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.168 -1.491 . . . . 0.0 110.444 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.484 ' NE2' ' HB2' ' A' ' 121' ' ' PRO . 26.6 tp60 -114.22 102.14 9.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.493 -1.004 . . . . 0.0 110.212 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 0.8 OUTLIER -63.08 95.57 0.08 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.152 -0.968 . . . . 0.0 110.234 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.536 ' C ' ' CE1' ' A' ' 85' ' ' TYR . . . 119.87 130.43 4.0 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.627 ' N ' ' CE1' ' A' ' 85' ' ' TYR . . . -42.99 153.46 0.34 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.294 -1.121 . . . . 0.0 110.196 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.461 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.1 Cg_endo -78.09 11.85 16.16 Favored 'Cis proline' 0 C--N 1.312 -1.352 0 C-N-CA 121.648 -2.23 . . . . 0.0 111.066 0.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.627 ' CE1' ' N ' ' A' ' 83' ' ' ALA . 37.1 m-85 61.24 -158.87 0.33 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.098 -1.001 . . . . 0.0 110.197 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 135.9 101.53 0.64 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.8 p -89.84 139.69 30.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.276 -1.131 . . . . 0.0 110.236 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.526 HG22 ' CD1' ' A' ' 89' ' ' LEU . 22.9 m -120.08 -16.77 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.252 -0.905 . . . . 0.0 110.148 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.579 HD12 ' CZ ' ' A' ' 106' ' ' PHE . 4.2 mp -118.85 139.59 51.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.296 -0.878 . . . . 0.0 110.978 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.461 ' O ' HG21 ' A' ' 91' ' ' THR . 32.1 t70 -151.12 85.17 1.33 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.425 -0.797 . . . . 0.0 109.969 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.461 HG21 ' O ' ' A' ' 90' ' ' ASP . 2.8 p -142.76 -175.59 4.55 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.997 -1.064 . . . . 0.0 110.854 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.53 112.35 35.66 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.444 -0.785 . . . . 0.0 109.905 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.53 ' HG2' ' CG2' ' A' ' 74' ' ' VAL . 43.4 Cg_endo -70.77 92.62 0.61 Allowed 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 124.023 1.539 . . . . 0.0 111.109 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.522 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -84.64 129.45 34.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.229 -0.919 . . . . 0.0 109.373 179.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.52 ' CD2' ' HB1' ' A' ' 68' ' ' ALA . 7.5 mp -119.69 -178.53 3.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.046 -1.034 . . . . 0.0 111.083 -179.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -179.99 -178.59 0.43 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.561 -0.712 . . . . 0.0 109.846 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.93 -12.3 17.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.206 -0.934 . . . . 0.0 110.148 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -99.99 158.83 31.34 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.263 -0.898 . . . . 0.0 110.11 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.458 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 44.3 Cg_endo -72.65 140.12 32.11 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.962 1.506 . . . . 0.0 110.348 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.522 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 32.0 ttm-85 -119.91 94.11 4.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.215 -0.928 . . . . 0.0 110.38 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.458 ' HG2' ' OG1' ' A' ' 65' ' ' THR . 17.0 mt-30 -84.98 92.98 8.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.398 -0.813 . . . . 0.0 109.666 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.513 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 38.9 t -89.12 133.6 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.289 -0.882 . . . . 0.0 110.434 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -150.39 130.26 13.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.404 -0.81 . . . . 0.0 110.028 179.96 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -159.19 139.39 12.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.168 -0.957 . . . . 0.0 110.416 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 88.0 m -94.7 106.65 18.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.305 -0.872 . . . . 0.0 110.123 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.579 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 38.7 p90 -113.24 157.18 22.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.275 -0.891 . . . . 0.0 110.324 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 26.2 m -89.97 90.17 8.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.292 -0.88 . . . . 0.0 110.016 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.548 ' CB ' ' CD2' ' A' ' 60' ' ' TYR . . . -45.88 105.44 0.06 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.258 -0.901 . . . . 0.0 110.348 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.494 ' N ' HG13 ' A' ' 88' ' ' VAL . 79.4 p -91.84 51.4 1.83 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.232 -0.917 . . . . 0.0 110.237 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.507 ' HB1' ' CG1' ' A' ' 88' ' ' VAL . . . -159.46 -155.26 0.45 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.259 -0.901 . . . . 0.0 110.242 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 18.7 m -144.91 113.4 6.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.273 -0.892 . . . . 0.0 110.215 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.554 ' CG ' ' HA3' ' A' ' 123' ' ' GLY . 18.0 m-30 -111.2 86.25 6.15 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.288 -0.882 . . . . 0.0 110.101 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.466 ' HD2' ' OE1' ' A' ' 80' ' ' GLN . 44.6 Cg_endo -72.28 140.16 33.33 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.938 1.494 . . . . 0.0 110.333 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -85.65 55.95 3.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.21 -0.931 . . . . 0.0 110.266 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.47 HG23 ' CB ' ' A' ' 120' ' ' ASP . 90.6 m -134.47 102.55 11.6 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.278 -0.889 . . . . 0.0 110.207 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -81.35 43.04 1.45 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 124.056 1.556 . . . . 0.0 110.749 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.421 ' HB2' ' HB2' ' A' ' 120' ' ' ASP . . . -100.9 157.2 16.91 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.108 -0.995 . . . . 0.0 110.229 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.22 -54.53 45.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.225 -0.922 . . . . 0.0 110.181 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -72.6 -4.23 29.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.274 -0.891 . . . . 0.0 110.191 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.47 ' CB ' HG23 ' A' ' 115' ' ' THR . 4.3 m-20 -137.52 106.49 8.43 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.313 -0.867 . . . . 0.0 110.172 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.484 ' HB2' ' NE2' ' A' ' 80' ' ' GLN . 46.7 Cg_endo -73.4 -167.41 0.36 Allowed 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.061 1.558 . . . . 0.0 110.456 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.483 ' CD ' ' N ' ' A' ' 122' ' ' GLU . 3.2 pm0 -166.83 149.53 6.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.234 -0.916 . . . . 0.0 110.177 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.554 ' HA3' ' CG ' ' A' ' 112' ' ' TYR . . . -89.48 150.55 21.31 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.516 ' CB ' ' HA ' ' A' ' 50' ' ' ASN . 1.2 pp0? -150.31 -157.75 0.85 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.315 -1.109 . . . . 0.0 110.399 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.431 ' CG2' ' CH2' ' A' ' 16' ' ' TRP . 17.0 mt -118.43 141.55 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.526 -0.734 . . . . 0.0 109.309 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.414 ' HB2' ' CD1' ' A' ' 77' ' ' LEU . . . -117.62 122.8 44.57 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.302 -0.874 . . . . 0.0 111.098 -179.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.473 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 4.1 m-85 -118.73 101.51 8.15 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.597 ' O ' ' CE2' ' A' ' 132' ' ' PHE . 0.4 OUTLIER -89.17 85.41 6.64 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.101 -0.999 . . . . 0.0 112.09 -177.738 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.521 ' CD2' HG23 ' A' ' 74' ' ' VAL . 0.6 OUTLIER -93.38 48.23 1.3 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.325 -0.86 . . . . 0.0 108.887 178.053 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.442 ' O ' ' CD2' ' A' ' 132' ' ' PHE . . . -108.27 135.63 12.96 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.864 -1.16 . . . . 0.0 110.753 -178.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 130' ' ' GLY . . . 39.14 55.22 2.43 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 179.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.597 ' CE2' ' O ' ' A' ' 128' ' ' GLN . 8.0 m-85 -118.46 -58.02 2.01 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.089 -1.242 . . . . 0.0 110.719 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.531 ' HB2' ' CG2' ' A' ' 72' ' ' VAL . 1.3 t -88.74 -179.71 6.06 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.921 -1.112 . . . . 0.0 110.283 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -100.69 -74.25 0.62 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.245 -0.909 . . . . 0.0 110.249 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -72.65 174.42 7.6 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.209 -0.932 . . . . 0.0 110.07 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.526 ' CA ' ' HA ' ' A' ' 38' ' ' ALA . . . -70.38 127.94 34.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.274 -0.891 . . . . 0.0 110.286 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.666 ' CZ2' ' CG1' ' A' ' 36' ' ' VAL . 6.1 p90 -132.27 -161.97 1.19 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.267 -0.895 . . . . 0.0 110.138 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.499 ' OG1' ' HA ' ' A' ' 35' ' ' ALA . 0.8 OUTLIER -160.26 166.18 30.04 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.138 -1.025 . . . . 0.0 110.57 -177.775 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.418 HD21 HD12 ' A' ' 129' ' ' LEU . 2.2 mp -124.15 127.51 47.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.461 -0.775 . . . . 0.0 109.282 179.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' CYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 52.9 m -125.27 95.75 4.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.072 -1.017 . . . . 0.0 110.9 -179.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.486 ' O ' ' HB3' ' A' ' 142' ' ' ASP . 0.9 OUTLIER -89.86 -177.69 5.29 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.21 -0.931 . . . . 0.0 109.218 179.033 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.537 ' O ' ' CG2' ' A' ' 8' ' ' THR . 0.6 OUTLIER 169.37 48.15 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.252 -0.905 . . . . 0.0 110.235 -179.96 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 142' ' ' ASP . 11.3 t0 177.05 46.3 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.441 -0.787 . . . . 0.0 109.148 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.492 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 1.0 OUTLIER -89.21 124.74 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.478 -0.764 . . . . 0.0 110.305 -178.981 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -158.52 152.71 24.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.386 -0.821 . . . . 0.0 110.075 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.427 ' O ' ' HB2' ' A' ' 147' ' ' ASP . 23.1 tp -149.93 153.36 36.5 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.267 -0.895 . . . . 0.0 110.218 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.427 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 34.0 t70 -176.5 152.56 1.07 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.241 -0.912 . . . . 0.0 110.273 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.445 ' HA ' ' O ' ' A' ' 59' ' ' THR . 78.7 p -91.67 130.98 37.38 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.268 -0.895 . . . . 0.0 110.205 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.7 141.34 56.95 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.202 -0.936 . . . . 0.0 110.186 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.437 ' O ' ' CG2' ' A' ' 150' ' ' VAL . 20.2 m -111.37 67.57 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.231 -0.918 . . . . 0.0 110.207 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 52.15 -165.16 0.06 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.275 -0.891 . . . . 0.0 110.153 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.8 mp . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.25 -180.0 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.432 ' C ' ' HD3' ' A' ' 3' ' ' PRO . . . . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.179 0.514 . . . . 0.0 110.207 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.524 ' CB ' ' HA ' ' A' ' 52' ' ' VAL . 58.2 p -109.27 74.86 0.67 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.211 -0.93 . . . . 0.0 110.312 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.432 ' HD3' ' C ' ' A' ' 1' ' ' ALA . 46.2 Cg_endo -73.44 78.59 2.31 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.952 1.501 . . . . 0.0 110.486 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 6.4 pt -107.71 31.0 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -0.901 . . . . 0.0 110.068 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.451 ' O ' ' HB3' ' A' ' 6' ' ' GLU . . . 81.08 -169.52 51.88 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.467 ' HA ' ' O ' ' A' ' 144' ' ' VAL . 9.0 pt-20 176.29 65.54 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.102 -1.234 . . . . 0.0 110.358 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.53 ' O ' ' CG2' ' A' ' 8' ' ' THR . . . 164.52 -64.55 0.23 Allowed Glycine 0 N--CA 1.488 2.164 0 C-N-CA 119.689 -1.243 . . . . 0.0 110.002 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.53 ' CG2' ' O ' ' A' ' 7' ' ' GLY . 73.6 p -156.41 -154.44 0.48 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.216 -1.167 . . . . 0.0 110.302 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.538 ' CZ ' HG22 ' A' ' 144' ' ' VAL . 33.0 m-85 -135.29 42.58 2.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -0.874 . . . . 0.0 110.263 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.55 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 26.7 t0 -88.14 49.01 1.72 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.202 -0.936 . . . . 0.0 110.247 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.55 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.5 OUTLIER 161.66 80.43 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.675 -0.641 . . . . 0.0 109.735 -179.963 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 11' ' ' ASP . . . 62.83 127.3 0.01 OUTLIER Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.52 ' O ' ' N ' ' A' ' 15' ' ' GLY . 50.2 Cg_endo -80.89 42.09 1.27 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 O-C-N 123.839 1.442 . . . . 0.0 110.987 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.434 ' HA ' ' OE1' ' A' ' 14' ' ' GLU . 4.7 mm-40 46.72 -92.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.003 -1.061 . . . . 0.0 110.288 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.523 ' O ' ' CG1' ' A' ' 17' ' ' VAL . . . -140.61 -0.06 1.85 Allowed Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.818 -1.182 . . . . 0.0 110.469 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.57 ' CH2' HG23 ' A' ' 125' ' ' ILE . 46.6 m95 -53.54 88.63 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.004 -1.292 . . . . 0.0 110.402 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.576 ' CG2' ' CG2' ' A' ' 48' ' ' VAL . 1.0 OUTLIER -87.81 150.67 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.035 -1.04 . . . . 0.0 109.627 179.558 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.569 ' CB ' ' CG1' ' A' ' 34' ' ' VAL . . . -131.29 158.38 40.79 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.174 -0.954 . . . . 0.0 109.831 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.639 ' CD1' ' N ' ' A' ' 19' ' ' TYR . 3.5 p90 -150.5 166.21 30.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.31 -0.869 . . . . 0.0 110.5 -178.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.516 ' C ' ' CG2' ' A' ' 21' ' ' THR . . . 161.04 -96.78 0.15 Allowed Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.014 -1.634 . . . . 0.0 109.014 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.52 HG22 ' NE2' ' A' ' 42' ' ' GLN . 6.5 p -153.91 18.39 0.51 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.115 -1.227 . . . . 0.0 111.224 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.596 ' CB ' ' CB ' ' A' ' 35' ' ' ALA . 0.8 OUTLIER -137.36 -179.95 6.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.664 -1.272 . . . . 0.0 110.607 179.743 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 22' ' ' ASP . . . -42.22 164.59 0.02 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 25' ' ' LEU . 45.5 Cg_endo -72.48 160.87 45.71 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.102 1.58 . . . . 0.0 110.409 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.511 ' CD1' HD13 ' A' ' 32' ' ' LEU . 0.7 OUTLIER -41.8 151.2 0.09 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.306 -0.871 . . . . 0.0 110.394 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.466 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 79.7 m-20 -124.43 137.11 54.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.317 -0.864 . . . . 0.0 109.829 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.537 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.8 OUTLIER -119.95 -26.76 5.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.099 -1.001 . . . . 0.0 110.55 -179.705 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.514 ' O ' ' CB ' ' A' ' 29' ' ' THR . 12.0 m -49.75 82.96 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.788 -0.57 . . . . 0.0 111.248 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.537 ' N ' ' O ' ' A' ' 27' ' ' THR . 0.0 OUTLIER 166.62 -31.77 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.229 -0.919 . . . . 0.0 109.948 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 128.37 0.32 6.32 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -150.46 161.17 43.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.137 -1.214 . . . . 0.0 110.214 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.511 HD13 ' CD1' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -104.08 99.37 9.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.178 -0.951 . . . . 0.0 110.134 179.911 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 0.8 OUTLIER -96.09 117.0 29.84 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.197 -0.94 . . . . 0.0 111.61 -179.773 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.569 ' CG1' ' CB ' ' A' ' 18' ' ' ALA . 30.2 m -89.43 149.97 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.596 ' CB ' ' CB ' ' A' ' 22' ' ' ASP . . . -89.83 126.32 35.65 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.016 -1.052 . . . . 0.0 111.529 -178.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.65 ' CG1' ' CZ2' ' A' ' 137' ' ' TRP . 48.7 t -126.73 119.63 22.78 Favored Pre-proline 0 C--N 1.303 -1.455 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.239 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.476 ' HG2' ' HA ' ' A' ' 40' ' ' SER . 39.7 Cg_endo -66.23 -177.74 0.93 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.753 1.397 . . . . 0.0 111.324 -179.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.537 ' HA ' ' N ' ' A' ' 136' ' ' ALA . . . -56.14 126.66 27.05 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.436 -0.79 . . . . 0.0 111.157 -179.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.501 ' O ' ' C ' ' A' ' 40' ' ' SER . . . 40.33 28.05 0.17 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.541 ' OG ' ' CG2' ' A' ' 45' ' ' VAL . 15.0 t 31.68 60.01 0.3 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.819 -0.812 . . . . 0.0 110.593 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.48 ' O ' ' HB3' ' A' ' 42' ' ' GLN . . . -88.72 95.21 10.18 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.278 -0.889 . . . . 0.0 109.864 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.558 ' NE2' ' CG2' ' A' ' 45' ' ' VAL . 2.0 pt20 179.83 -150.27 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 121.308 0.575 . . . . 0.0 109.822 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.524 ' CD1' ' HG3' ' A' ' 42' ' ' GLN . 16.0 p90 -61.41 -12.72 15.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.331 -0.856 . . . . 0.0 109.898 179.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.417 ' O ' ' CE2' ' A' ' 43' ' ' TYR . . . 109.75 129.14 5.69 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.558 ' CG2' ' NE2' ' A' ' 42' ' ' GLN . 9.4 t -89.29 170.45 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.173 -1.193 . . . . 0.0 108.572 179.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.519 ' CA ' ' O ' ' A' ' 127' ' ' PHE . . . 169.76 -174.02 43.97 Favored Glycine 0 N--CA 1.487 2.052 0 C-N-CA 118.997 -1.573 . . . . 0.0 110.559 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.533 ' CG2' HG13 ' A' ' 34' ' ' VAL . 41.4 t -150.39 129.08 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.602 -0.94 . . . . 0.0 108.781 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.576 ' CG2' ' CG2' ' A' ' 17' ' ' VAL . 32.9 m -119.97 135.68 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.081 -1.012 . . . . 0.0 110.987 -179.038 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.564 HD21 ' CE2' ' A' ' 16' ' ' TRP . 21.3 tp -128.67 96.71 4.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.393 -0.817 . . . . 0.0 110.24 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.519 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 12.9 p30 -75.13 134.94 41.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.909 . . . . 0.0 110.186 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 136.38 76.85 0.08 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.528 ' CG2' ' HA ' ' A' ' 124' ' ' GLN . 18.1 t -139.37 167.26 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -1.173 . . . . 0.0 110.023 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.413 ' N ' HG11 ' A' ' 52' ' ' VAL . . . -137.75 83.82 2.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.195 -0.941 . . . . 0.0 110.488 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.63 ' CD1' ' CE1' ' A' ' 60' ' ' TYR . 43.2 mm -115.92 158.78 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.227 -0.92 . . . . 0.0 109.918 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.512 ' N ' HG21 ' A' ' 54' ' ' ILE . 7.9 tp10 -151.78 134.34 15.43 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.208 -0.933 . . . . 0.0 110.366 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.565 ' CG ' ' N ' ' A' ' 57' ' ' GLY . 1.1 pt-20 37.03 -157.01 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.698 -0.626 . . . . 0.0 110.73 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.565 ' N ' ' CG ' ' A' ' 56' ' ' GLU . . . -84.04 90.68 1.61 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.576 HG21 ' CE2' ' A' ' 60' ' ' TYR . 1.2 m -118.73 173.86 6.62 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.306 -1.114 . . . . 0.0 109.79 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.572 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 0.6 OUTLIER -89.82 153.85 20.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.268 -0.895 . . . . 0.0 110.494 -179.758 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.63 ' CE1' ' CD1' ' A' ' 54' ' ' ILE . 59.2 m-85 -159.88 121.79 3.29 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.271 -0.893 . . . . 0.0 110.218 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 89.2 m -90.87 114.74 27.25 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.213 -0.929 . . . . 0.0 109.983 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.0 tp -89.55 120.85 31.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.209 -0.932 . . . . 0.0 109.945 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.49 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 12.7 ttp180 -125.59 130.17 51.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.309 -0.87 . . . . 0.0 110.227 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.598 ' CZ ' ' CG2' ' A' ' 102' ' ' VAL . 0.8 OUTLIER -170.33 142.98 2.26 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.294 -0.879 . . . . 0.0 109.821 179.756 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.457 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 16.9 m -119.16 97.63 5.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.289 -0.882 . . . . 0.0 110.079 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.49 ' HB1' ' CD2' ' A' ' 141' ' ' LEU . . . -98.98 149.38 23.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.382 -0.824 . . . . 0.0 110.328 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.462 ' OG1' ' HA ' ' A' ' 99' ' ' PRO . 90.3 m -150.52 102.22 3.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -0.884 . . . . 0.0 110.198 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.47 ' O ' ' O ' ' A' ' 96' ' ' THR . . . -89.82 131.24 35.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.233 -0.917 . . . . 0.0 109.977 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.45 ' C ' ' O ' ' A' ' 68' ' ' ALA . 1.2 p -42.72 -27.17 0.16 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.298 -0.876 . . . . 0.0 109.522 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.599 ' CG2' ' CB ' ' A' ' 137' ' ' TRP . 1.7 t -109.87 161.34 15.56 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.559 -0.713 . . . . 0.0 109.836 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.462 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 0.3 OUTLIER -80.19 76.69 6.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.056 -1.027 . . . . 0.0 109.25 179.05 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.573 HG22 ' CE2' ' A' ' 137' ' ' TRP . 4.3 p -99.75 135.62 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.27 -0.894 . . . . 0.0 111.292 -178.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 89.6 m -121.09 87.13 2.7 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.583 ' HA ' ' CD1' ' A' ' 132' ' ' PHE . 5.1 m -89.7 -149.18 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.246 -0.909 . . . . 0.0 110.764 -178.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -128.43 121.32 28.73 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.262 -0.898 . . . . 0.0 110.656 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.496 ' O ' ' HB3' ' A' ' 77' ' ' LEU . . . -119.03 161.36 20.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.217 -0.927 . . . . 0.0 109.643 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.505 ' HA ' ' HB3' ' A' ' 89' ' ' LEU . 3.5 pp 177.15 -158.83 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.128 -0.982 . . . . 0.0 110.463 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.524 HG11 ' CE2' ' A' ' 112' ' ' TYR . 19.5 t -149.54 165.0 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.433 -0.792 . . . . 0.0 109.266 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.542 ' C ' ' CE1' ' A' ' 112' ' ' TYR . . . -172.81 -166.75 31.79 Favored Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.056 -1.545 . . . . 0.0 110.587 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.484 ' O ' ' HG3' ' A' ' 80' ' ' GLN . 4.7 tp60 -114.34 85.93 2.33 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.508 -0.995 . . . . 0.0 110.391 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.491 ' O ' ' HG2' ' A' ' 121' ' ' PRO . 2.1 m-80 -66.0 100.13 0.56 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.066 -1.022 . . . . 0.0 109.308 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.575 ' O ' ' CZ ' ' A' ' 85' ' ' TYR . . . 152.0 -87.67 0.14 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.432 ' CB ' ' O ' ' A' ' 82' ' ' GLY . . . 173.24 145.68 0.19 Allowed Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.189 -1.183 . . . . 0.0 110.192 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.511 ' C ' ' CD2' ' A' ' 85' ' ' TYR . 51.0 Cg_endo -84.56 32.8 4.41 Favored 'Cis proline' 0 C--N 1.313 -1.314 0 C-N-CA 121.9 -2.125 . . . . 0.0 110.663 -0.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.575 ' CZ ' ' O ' ' A' ' 82' ' ' GLY . 17.6 m-85 64.47 -172.67 0.18 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.165 -0.959 . . . . 0.0 110.402 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 140.03 99.38 0.41 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.46 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 1.4 p -89.8 143.59 26.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.25 -1.147 . . . . 0.0 110.367 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.524 ' CG1' ' N ' ' A' ' 109' ' ' SER . 27.0 m -123.93 -16.95 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.313 -0.867 . . . . 0.0 110.332 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.573 HD12 ' CZ ' ' A' ' 106' ' ' PHE . 4.1 mp -105.36 139.87 39.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.204 -0.935 . . . . 0.0 110.924 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.503 ' O ' ' CG2' ' A' ' 91' ' ' THR . 1.6 m-20 -150.68 94.29 2.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.379 -0.826 . . . . 0.0 110.194 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.503 ' CG2' ' O ' ' A' ' 90' ' ' ASP . 3.9 p -160.07 -175.09 4.88 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.162 -0.962 . . . . 0.0 110.44 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.4 p -125.35 128.87 24.63 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.285 -0.885 . . . . 0.0 110.143 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.542 ' HG2' ' CG2' ' A' ' 74' ' ' VAL . 50.2 Cg_endo -74.14 77.02 2.89 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.883 1.465 . . . . 0.0 110.983 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.529 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -50.47 136.45 20.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.996 -1.065 . . . . 0.0 109.348 179.351 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.589 ' CD1' ' CD2' ' A' ' 139' ' ' LEU . 35.4 mt -135.63 168.12 19.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.991 -1.068 . . . . 0.0 110.891 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.47 ' O ' ' O ' ' A' ' 68' ' ' ALA . 6.7 t -165.8 -153.18 0.17 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.444 -0.785 . . . . 0.0 109.914 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.94 -28.19 24.45 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.103 -0.998 . . . . 0.0 110.391 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.458 ' HB3' ' HD2' ' A' ' 99' ' ' PRO . 0.6 OUTLIER -89.77 176.5 3.04 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.238 -0.914 . . . . 0.0 110.06 179.974 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.462 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 45.4 Cg_endo -72.09 134.03 22.48 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 123.979 1.515 . . . . 0.0 110.327 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.529 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.53 84.03 2.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.18 -0.95 . . . . 0.0 110.22 -179.87 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.451 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 17.6 mt-30 -69.02 155.98 39.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.32 -0.862 . . . . 0.0 110.124 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.598 ' CG2' ' CZ ' ' A' ' 64' ' ' TYR . 58.6 t -133.43 133.71 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.25 -0.906 . . . . 0.0 110.111 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.33 111.51 4.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.25 -0.906 . . . . 0.0 110.109 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -153.59 151.59 29.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.159 -0.963 . . . . 0.0 110.356 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -108.39 122.09 46.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.283 -0.886 . . . . 0.0 110.063 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.573 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 41.4 p90 -127.93 153.32 46.82 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.236 -0.915 . . . . 0.0 110.299 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 58' ' ' THR . 3.6 m -89.93 94.24 9.73 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.276 -0.89 . . . . 0.0 110.063 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.617 ' CB ' ' CD2' ' A' ' 60' ' ' TYR . . . -53.64 99.42 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.244 -0.91 . . . . 0.0 110.309 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.524 ' N ' ' CG1' ' A' ' 88' ' ' VAL . 54.3 p -85.93 55.66 3.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.18 -0.95 . . . . 0.0 109.945 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.403 ' HB1' HG12 ' A' ' 88' ' ' VAL . . . -160.29 -151.31 0.24 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.315 -0.866 . . . . 0.0 110.298 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 46.2 m -158.14 116.42 3.05 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.323 -0.861 . . . . 0.0 110.414 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.575 ' CD2' ' CG1' ' A' ' 54' ' ' ILE . 12.7 m-30 -112.22 109.87 53.97 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.302 -0.874 . . . . 0.0 109.784 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.483 ' HD2' ' OE1' ' A' ' 80' ' ' GLN . 47.7 Cg_endo -75.48 96.2 1.03 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.849 1.447 . . . . 0.0 110.539 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -46.75 -24.06 0.51 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.245 -0.91 . . . . 0.0 110.127 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 58.5 p -98.38 117.91 64.11 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.279 -0.888 . . . . 0.0 110.183 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.4 ' N ' ' OE1' ' A' ' 122' ' ' GLU . 45.7 Cg_endo -72.97 -161.59 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.9 1.474 . . . . 0.0 110.413 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -147.88 -172.29 4.02 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.255 -0.903 . . . . 0.0 110.211 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -82.24 -9.36 59.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.26 -0.9 . . . . 0.0 110.188 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -155.02 18.82 0.44 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.282 -0.886 . . . . 0.0 110.137 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.406 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 6.7 m-20 -147.78 132.86 9.08 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.315 -0.866 . . . . 0.0 110.137 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.536 ' HG2' ' CA ' ' A' ' 82' ' ' GLY . 42.2 Cg_endo -85.82 -154.76 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.928 1.488 . . . . 0.0 110.258 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.483 ' CB ' ' HG2' ' A' ' 113' ' ' PRO . 5.0 pt-20 -149.21 -156.35 0.71 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.987 -1.07 . . . . 0.0 110.357 -179.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.572 ' HA3' ' CG ' ' A' ' 112' ' ' TYR . . . -90.59 148.09 19.38 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.528 ' HA ' ' CG2' ' A' ' 52' ' ' VAL . 3.3 pt20 -150.31 -155.66 0.65 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.289 -1.124 . . . . 0.0 110.491 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.57 HG23 ' CH2' ' A' ' 16' ' ' TRP . 7.6 mt -118.22 141.26 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.538 -0.726 . . . . 0.0 109.256 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.41 ' N ' HG21 ' A' ' 125' ' ' ILE . . . -117.6 121.75 41.77 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.36 -0.837 . . . . 0.0 111.291 -179.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.519 ' O ' ' CA ' ' A' ' 46' ' ' GLY . 4.4 m-85 -118.99 91.2 3.5 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 178.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -88.57 93.92 9.71 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.944 -1.097 . . . . 0.0 112.449 -177.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.531 HD21 ' CG2' ' A' ' 74' ' ' VAL . 12.9 mt -90.87 44.16 1.18 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 177.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 131' ' ' GLY . . . -82.29 115.54 4.04 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 -179.048 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 39' ' ' GLY . . . 40.36 93.1 0.01 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.583 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 8.9 m-85 -143.55 -52.59 0.35 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.099 -1.236 . . . . 0.0 110.704 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.533 ' HB2' ' CG2' ' A' ' 72' ' ' VAL . 1.3 t -89.26 175.3 7.4 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.973 -1.079 . . . . 0.0 110.399 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -80.93 -88.13 0.08 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.257 -0.902 . . . . 0.0 110.033 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 135' ' ' ASP . 3.9 m-20 -67.27 -173.41 0.28 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -0.909 . . . . 0.0 109.774 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.537 ' N ' ' HA ' ' A' ' 38' ' ' ALA . . . -78.94 149.33 32.37 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.229 -0.919 . . . . 0.0 110.248 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.65 ' CZ2' ' CG1' ' A' ' 36' ' ' VAL . 15.1 p90 -151.8 -160.0 1.09 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.152 -0.967 . . . . 0.0 111.162 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.514 ' CG2' ' N ' ' A' ' 139' ' ' LEU . 0.8 OUTLIER -159.65 178.53 9.74 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -178.596 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.589 ' CD2' ' CD1' ' A' ' 95' ' ' LEU . 1.7 mp -139.91 115.54 10.09 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.766 -1.209 . . . . 0.0 112.082 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' CYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 0.8 OUTLIER -103.34 104.35 14.45 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.727 -0.608 . . . . 0.0 110.662 178.492 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.512 ' O ' ' CB ' ' A' ' 142' ' ' ASP . 1.4 mt -90.22 -178.67 5.45 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.217 -0.927 . . . . 0.0 109.305 179.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.545 ' O ' ' CB ' ' A' ' 143' ' ' ASP . 2.3 p30 166.9 68.24 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.263 -0.898 . . . . 0.0 110.172 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.545 ' CB ' ' O ' ' A' ' 142' ' ' ASP . 0.4 OUTLIER 161.89 42.79 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.879 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.538 HG22 ' CZ ' ' A' ' 9' ' ' PHE . 1.5 t -89.4 115.93 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.418 -0.801 . . . . 0.0 110.684 -178.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -148.26 139.84 23.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.463 -0.773 . . . . 0.0 109.912 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.403 HD23 HD13 ' A' ' 54' ' ' ILE . 28.6 tp -129.93 152.7 49.12 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.305 -0.872 . . . . 0.0 110.332 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.45 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -161.83 -175.78 4.87 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.248 -0.907 . . . . 0.0 110.149 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 148' ' ' SER . 9.3 p -128.48 108.39 10.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.2 -0.937 . . . . 0.0 110.174 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.457 ' OE1' ' HB2' ' A' ' 151' ' ' GLU . 0.2 OUTLIER -93.3 165.43 12.8 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.292 -0.88 . . . . 0.0 110.173 179.94 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.503 ' CG1' ' O ' ' A' ' 150' ' ' VAL . 13.9 p -125.62 81.3 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.215 -0.928 . . . . 0.0 110.254 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.457 ' HB2' ' OE1' ' A' ' 149' ' ' GLU . 2.2 tt0 -112.1 135.07 53.22 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.265 -0.897 . . . . 0.0 110.165 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 117.969 -1.015 . . . . 0.0 110.184 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.516 ' HB2' ' CB ' ' A' ' 53' ' ' ALA . . . . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.172 0.51 . . . . 0.0 110.195 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.466 ' OG ' ' HA ' ' A' ' 52' ' ' VAL . 0.5 OUTLIER -111.53 74.0 1.14 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.287 -0.883 . . . . 0.0 110.164 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.424 ' HD3' ' C ' ' A' ' 1' ' ' ALA . 47.2 Cg_endo -73.9 77.8 2.63 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.025 1.539 . . . . 0.0 110.616 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.407 ' O ' HG13 ' A' ' 4' ' ' ILE . 32.7 pt -107.36 40.41 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.183 -0.948 . . . . 0.0 109.979 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' A' ' 7' ' ' GLY . . . 103.78 -45.48 1.32 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.445 ' HA ' ' HB3' ' A' ' 145' ' ' ALA . 44.4 mt-10 41.67 28.08 0.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.354 -1.086 . . . . 0.0 110.306 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.452 ' O ' ' HA ' ' A' ' 143' ' ' ASP . . . -158.85 -166.28 17.58 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 34.0 p -72.59 165.81 23.96 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.307 -1.113 . . . . 0.0 110.377 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.582 ' CG ' ' HA ' ' A' ' 142' ' ' ASP . 3.1 m-30 -93.7 56.57 2.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.336 -0.852 . . . . 0.0 110.135 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.537 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 16.0 t0 -114.39 52.35 0.84 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.183 -0.948 . . . . 0.0 110.202 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.537 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 2.2 t70 161.76 78.14 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.753 -0.592 . . . . 0.0 109.657 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.02 133.51 0.33 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.473 ' O ' ' HB2' ' A' ' 14' ' ' GLU . 50.2 Cg_endo -77.3 5.82 4.81 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.943 1.496 . . . . 0.0 110.635 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 0.8 OUTLIER 66.44 -85.72 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.158 -0.964 . . . . 0.0 110.184 -179.853 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.494 ' C ' ' CD1' ' A' ' 49' ' ' LEU . . . -142.71 8.3 2.26 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.575 ' CD1' HD23 ' A' ' 49' ' ' LEU . 45.9 m95 -72.92 93.03 1.68 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.127 -1.22 . . . . 0.0 110.343 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.521 ' O ' ' CG1' ' A' ' 47' ' ' VAL . 1.5 m -95.49 152.23 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.148 -0.97 . . . . 0.0 109.895 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.589 ' CB ' ' CG1' ' A' ' 34' ' ' VAL . . . -129.96 127.54 40.27 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.164 -0.96 . . . . 0.0 109.725 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.57 ' CZ ' ' O ' ' A' ' 46' ' ' GLY . 10.9 p90 -121.17 158.34 28.19 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.291 -0.881 . . . . 0.0 110.739 -178.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.516 ' CA ' ' OH ' ' A' ' 43' ' ' TYR . . . 90.57 35.01 7.55 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 179.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.5 ' CG2' ' C ' ' A' ' 20' ' ' GLY . 5.4 p -150.89 -154.94 0.58 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.98 -1.306 . . . . 0.0 110.499 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.46 ' O ' ' O ' ' A' ' 23' ' ' GLY . 8.2 t0 -94.87 132.01 40.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.353 -0.842 . . . . 0.0 110.363 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 22' ' ' ASP . . . 44.41 -168.1 0.02 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.58 -159.85 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.062 1.559 . . . . 0.0 110.484 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.512 HD11 ' CD1' ' A' ' 32' ' ' LEU . 0.4 OUTLIER -101.21 161.39 13.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.258 -0.901 . . . . 0.0 110.222 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -116.86 140.04 49.91 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.205 -0.935 . . . . 0.0 110.008 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 31' ' ' ALA . 0.7 OUTLIER -128.24 -22.69 3.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.144 -0.973 . . . . 0.0 111.212 -179.55 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.2 -17.87 0.28 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.26 -0.9 . . . . 0.0 111.173 -179.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.6 t -72.1 6.37 2.21 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.049 -1.032 . . . . 0.0 111.519 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.55 -12.28 67.81 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.468 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -150.97 167.99 25.92 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.481 -1.011 . . . . 0.0 109.503 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.512 ' CD1' HD11 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -87.04 90.92 8.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.967 -1.083 . . . . 0.0 110.163 179.906 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 0.8 OUTLIER -99.45 111.78 24.09 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.387 -0.821 . . . . 0.0 111.507 179.987 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.589 ' CG1' ' CB ' ' A' ' 18' ' ' ALA . 15.7 m -89.86 146.11 6.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.483 ' O ' ' HB ' ' A' ' 21' ' ' THR . . . -88.55 72.44 8.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.541 -0.725 . . . . 0.0 110.982 -178.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.642 ' CG1' ' CZ2' ' A' ' 137' ' ' TRP . 56.3 t -58.66 134.07 86.15 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.322 -0.861 . . . . 0.0 109.564 179.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.491 ' HG2' ' HA ' ' A' ' 40' ' ' SER . 39.5 Cg_endo -67.48 176.47 4.88 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.951 1.501 . . . . 0.0 111.501 -179.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.527 ' HA ' ' N ' ' A' ' 136' ' ' ALA . . . -60.9 126.23 26.6 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.509 -0.744 . . . . 0.0 111.463 -178.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.534 ' O ' ' C ' ' A' ' 40' ' ' SER . . . 39.0 26.83 0.05 OUTLIER Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.534 ' C ' ' O ' ' A' ' 39' ' ' GLY . 9.6 t 27.08 59.21 0.09 Allowed 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.886 -0.773 . . . . 0.0 110.9 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.495 ' O ' ' HB3' ' A' ' 42' ' ' GLN . . . -88.36 100.8 13.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.231 -0.918 . . . . 0.0 110.201 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.495 ' HB3' ' O ' ' A' ' 41' ' ' ALA . 0.9 OUTLIER 174.41 -158.78 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.912 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.516 ' CE2' ' O ' ' A' ' 44' ' ' GLY . 8.9 p90 -50.32 -24.0 2.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.096 -1.002 . . . . 0.0 109.726 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.516 ' O ' ' CE2' ' A' ' 43' ' ' TYR . . . 119.82 129.29 3.82 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.533 ' CG2' ' OG ' ' A' ' 40' ' ' SER . 6.2 t -89.58 177.05 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.265 -1.138 . . . . 0.0 109.001 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.57 ' O ' ' CZ ' ' A' ' 19' ' ' TYR . . . 166.15 149.32 5.88 Favored Glycine 0 N--CA 1.488 2.153 0 C-N-CA 119.166 -1.492 . . . . 0.0 110.552 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.521 ' CG1' ' O ' ' A' ' 17' ' ' VAL . 43.8 t -116.24 144.18 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.552 -0.969 . . . . 0.0 109.449 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.467 ' O ' HG23 ' A' ' 17' ' ' VAL . 29.0 m -138.56 153.96 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.834 -1.166 . . . . 0.0 111.004 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.575 HD23 ' CD1' ' A' ' 16' ' ' TRP . 14.8 tp -140.89 99.66 3.65 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.446 -0.784 . . . . 0.0 109.929 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.524 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 8.6 t30 -78.11 133.34 37.87 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.248 -0.907 . . . . 0.0 110.542 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 139.34 55.32 0.05 OUTLIER Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.52 HG13 ' CB ' ' A' ' 112' ' ' TYR . 53.3 t -120.04 161.11 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.092 -1.24 . . . . 0.0 110.278 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.516 ' CB ' ' HB2' ' A' ' 1' ' ' ALA . . . -130.83 96.8 4.16 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.186 -0.946 . . . . 0.0 110.65 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.639 ' CD1' ' CE1' ' A' ' 60' ' ' TYR . 50.6 mm -131.65 160.51 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.268 -0.895 . . . . 0.0 109.786 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.536 ' N ' HG21 ' A' ' 54' ' ' ILE . 13.2 pt-20 -149.02 130.58 14.88 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.087 -1.008 . . . . 0.0 110.432 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.528 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 10.8 pt-20 38.14 -152.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.646 -0.659 . . . . 0.0 110.85 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.474 ' N ' ' HG3' ' A' ' 56' ' ' GLU . . . -85.28 108.43 3.2 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.578 HG21 ' CE2' ' A' ' 60' ' ' TYR . 1.1 m -136.75 174.63 10.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.238 -1.154 . . . . 0.0 109.714 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.574 ' N ' ' CG2' ' A' ' 58' ' ' THR . 0.5 OUTLIER -89.83 145.44 25.16 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.256 -0.903 . . . . 0.0 110.261 -179.922 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.639 ' CE1' ' CD1' ' A' ' 54' ' ' ILE . 58.5 m-85 -154.41 154.67 33.64 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.313 -0.867 . . . . 0.0 110.271 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 85.3 m -124.1 114.0 19.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.354 -0.841 . . . . 0.0 110.066 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.51 HD21 ' CD2' ' A' ' 89' ' ' LEU . 18.2 tp -89.69 121.81 32.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -0.914 . . . . 0.0 110.105 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.483 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 8.1 mtt85 -127.33 138.25 52.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.318 -0.864 . . . . 0.0 110.287 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.63 ' CZ ' ' CG2' ' A' ' 102' ' ' VAL . 2.8 p90 -177.92 152.69 0.77 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.395 -0.816 . . . . 0.0 109.796 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.462 ' HB ' ' OD2' ' A' ' 142' ' ' ASP . 0.2 OUTLIER -119.28 102.8 8.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.121 -0.987 . . . . 0.0 110.105 -179.947 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.483 ' C ' ' CD2' ' A' ' 95' ' ' LEU . . . -102.3 141.66 34.78 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.308 -0.87 . . . . 0.0 110.05 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.466 ' OG1' ' HA ' ' A' ' 99' ' ' PRO . 35.0 m -150.14 107.41 3.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.294 -0.879 . . . . 0.0 110.18 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.518 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -98.3 131.68 44.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.281 -0.887 . . . . 0.0 110.169 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 68' ' ' ALA . 0.9 OUTLIER -44.47 -26.23 0.33 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.188 -0.945 . . . . 0.0 109.467 179.528 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.581 ' CG2' ' CB ' ' A' ' 137' ' ' TRP . 1.9 t -110.28 165.27 11.9 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.453 -0.78 . . . . 0.0 109.856 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.455 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 4.8 t0 -84.15 68.97 10.31 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.146 -0.971 . . . . 0.0 109.321 179.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.55 HG22 ' CE2' ' A' ' 137' ' ' TRP . 6.1 p -86.89 134.36 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.327 -0.858 . . . . 0.0 111.248 -179.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 23.3 m -120.58 85.26 2.36 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.587 ' HA ' ' CD1' ' A' ' 132' ' ' PHE . 3.0 m -89.63 -157.95 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.25 -0.906 . . . . 0.0 110.72 -178.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -120.23 104.06 9.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.357 -0.839 . . . . 0.0 110.278 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.495 ' O ' ' HB3' ' A' ' 77' ' ' LEU . . . -99.9 163.75 12.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.21 -0.931 . . . . 0.0 109.851 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.555 ' CD1' ' CB ' ' A' ' 126' ' ' ALA . 2.0 pp 173.32 -161.1 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.285 -0.884 . . . . 0.0 110.132 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.484 HG21 ' CD2' ' A' ' 89' ' ' LEU . 3.6 t -146.31 168.91 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.275 -0.89 . . . . 0.0 109.58 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.548 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . 175.09 -160.45 29.3 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.416 -1.373 . . . . 0.0 109.934 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.501 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 4.7 pt20 -125.08 137.12 54.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.275 -1.132 . . . . 0.0 110.642 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -86.62 93.82 9.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.366 -0.834 . . . . 0.0 109.964 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.58 ' O ' ' CD2' ' A' ' 85' ' ' TYR . . . 148.18 -177.39 26.46 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.271 -1.531 . . . . 0.0 109.271 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.568 ' HA ' ' CD1' ' A' ' 85' ' ' TYR . . . -99.61 152.18 37.71 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.275 -1.133 . . . . 0.0 110.231 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.48 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.7 Cg_endo -83.02 30.09 4.69 Favored 'Cis proline' 0 C--N 1.312 -1.349 0 C-N-CA 121.795 -2.169 . . . . 0.0 111.021 -0.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.58 ' CD2' ' O ' ' A' ' 82' ' ' GLY . 57.2 m-85 60.37 -175.6 0.11 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.138 -0.976 . . . . 0.0 110.26 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.45 ' O ' ' HG2' ' A' ' 80' ' ' GLN . . . 161.95 126.67 0.83 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.0 p -120.16 146.2 46.22 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.21 -1.17 . . . . 0.0 110.099 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.525 ' CG2' HD13 ' A' ' 89' ' ' LEU . 28.9 m -125.65 -16.41 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.259 -0.901 . . . . 0.0 110.559 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.565 HD12 ' CZ ' ' A' ' 106' ' ' PHE . 4.3 mp -110.88 140.93 44.93 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.118 -0.989 . . . . 0.0 111.18 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.51 ' O ' ' CG2' ' A' ' 91' ' ' THR . 38.9 p30 -150.9 93.4 1.94 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.411 -0.806 . . . . 0.0 110.161 179.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.51 ' CG2' ' O ' ' A' ' 90' ' ' ASP . 16.3 p -159.02 -175.96 5.58 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.026 -1.046 . . . . 0.0 110.67 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.428 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 29.0 m -120.0 135.04 24.07 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.312 -0.868 . . . . 0.0 110.075 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.53 ' CG ' HG21 ' A' ' 74' ' ' VAL . 49.5 Cg_endo -87.46 67.91 3.82 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.968 1.509 . . . . 0.0 111.063 -179.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.513 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -45.59 121.91 3.33 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.95 -1.094 . . . . 0.0 109.271 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.544 ' CD1' ' CD2' ' A' ' 139' ' ' LEU . 15.1 mt -119.87 175.32 5.95 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.086 -1.009 . . . . 0.0 110.901 -179.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 179.26 -178.87 0.37 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.499 -0.751 . . . . 0.0 109.953 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.94 -14.07 20.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.21 -0.931 . . . . 0.0 110.197 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.419 ' HG2' ' HD2' ' A' ' 99' ' ' PRO . 1.7 mt-10 -96.66 157.46 35.24 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.283 -0.886 . . . . 0.0 110.145 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.466 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 45.5 Cg_endo -72.51 137.42 27.84 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.971 1.511 . . . . 0.0 110.367 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.513 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.82 93.05 3.93 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.201 -0.937 . . . . 0.0 110.351 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.451 ' HG2' HG22 ' A' ' 65' ' ' THR . 0.0 OUTLIER -74.04 143.39 45.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.912 . . . . 0.0 109.818 179.633 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.63 ' CG2' ' CZ ' ' A' ' 64' ' ' TYR . 47.5 t -121.16 132.35 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.137 -0.977 . . . . 0.0 110.407 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.454 HG21 ' HD3' ' A' ' 63' ' ' ARG . 0.2 OUTLIER -150.86 94.11 2.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.412 -0.805 . . . . 0.0 110.098 179.919 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -139.95 157.99 44.79 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.132 -0.98 . . . . 0.0 110.447 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -114.8 97.0 6.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.305 -0.872 . . . . 0.0 110.048 179.944 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.565 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 36.0 p90 -96.58 155.9 16.57 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.264 -0.898 . . . . 0.0 110.334 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.7 m -90.6 101.92 14.66 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.334 -0.854 . . . . 0.0 110.004 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.584 ' CB ' ' CD2' ' A' ' 60' ' ' TYR . . . -64.89 102.48 0.6 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.233 -0.917 . . . . 0.0 110.355 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.458 ' HA ' ' HA2' ' A' ' 57' ' ' GLY . 2.9 p -93.95 52.37 1.64 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.258 -0.901 . . . . 0.0 110.023 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.509 ' HB1' ' CG1' ' A' ' 88' ' ' VAL . . . -156.91 -158.4 0.77 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.207 -0.933 . . . . 0.0 110.417 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.465 ' O ' ' HD3' ' A' ' 113' ' ' PRO . 69.9 m -137.74 111.22 8.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.238 -0.914 . . . . 0.0 110.261 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.589 ' CD2' HG13 ' A' ' 54' ' ' ILE . 15.1 m-30 -106.9 78.03 0.55 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.322 -0.862 . . . . 0.0 110.001 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.473 ' CG ' ' O ' ' A' ' 121' ' ' PRO . 44.3 Cg_endo -71.36 124.95 10.84 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.836 1.44 . . . . 0.0 110.418 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.468 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -63.61 -10.29 17.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.276 -0.89 . . . . 0.0 110.33 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.33 106.56 23.93 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.211 -0.93 . . . . 0.0 110.208 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 46.4 Cg_endo -73.07 82.47 1.55 Allowed 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.969 1.51 . . . . 0.0 110.41 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.526 ' CB ' ' HB2' ' A' ' 120' ' ' ASP . . . -96.36 138.32 34.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.267 -0.895 . . . . 0.0 110.149 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -50.1 -43.39 51.53 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.192 -0.942 . . . . 0.0 110.222 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -82.92 -19.3 37.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.18 -0.95 . . . . 0.0 110.282 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.526 ' HB2' ' CB ' ' A' ' 117' ' ' ALA . 30.5 m-20 -116.7 120.58 34.13 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.198 -0.939 . . . . 0.0 110.241 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.493 ' HB3' ' HA3' ' A' ' 82' ' ' GLY . 46.4 Cg_endo -73.32 139.46 29.07 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.888 1.467 . . . . 0.0 110.418 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' A' ' 80' ' ' GLN . 0.5 OUTLIER -90.96 -175.33 4.3 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.22 -0.925 . . . . 0.0 109.728 179.609 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.546 ' HA3' ' CB ' ' A' ' 112' ' ' TYR . . . -125.11 139.14 11.44 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.524 ' CB ' ' HA ' ' A' ' 50' ' ' ASN . 3.2 pt20 -150.39 -160.63 1.2 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.298 -1.119 . . . . 0.0 110.419 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.488 ' CG2' ' CE1' ' A' ' 127' ' ' PHE . 15.4 mt -118.5 135.06 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.506 -0.746 . . . . 0.0 109.131 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.555 ' CB ' ' CD1' ' A' ' 77' ' ' LEU . . . -112.6 123.46 50.35 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.285 -0.884 . . . . 0.0 111.082 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.503 ' O ' ' CA ' ' A' ' 46' ' ' GLY . 4.4 m-85 -119.18 107.16 13.1 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.47 ' O ' ' HB ' ' A' ' 74' ' ' VAL . 10.5 mm-40 -89.48 97.25 11.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.155 -0.966 . . . . 0.0 111.431 -178.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.481 ' HB2' ' HB ' ' A' ' 45' ' ' VAL . 24.1 mt -97.13 41.92 1.1 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.355 -0.84 . . . . 0.0 109.191 178.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 131' ' ' GLY . . . -88.65 116.56 4.66 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -179.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.46 ' HA2' ' O ' ' A' ' 39' ' ' GLY . . . 39.74 92.59 0.01 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.587 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 7.2 m-85 -143.96 -54.42 0.36 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.112 -1.228 . . . . 0.0 110.516 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.565 ' HB3' ' CE3' ' A' ' 137' ' ' TRP . 1.3 t -89.05 175.15 7.51 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.967 -1.083 . . . . 0.0 110.157 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.2 -91.96 0.08 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.209 -0.932 . . . . 0.0 110.348 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.38 170.32 13.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.162 -0.961 . . . . 0.0 110.122 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.527 ' N ' ' HA ' ' A' ' 38' ' ' ALA . . . -55.55 133.04 50.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.237 -0.914 . . . . 0.0 110.144 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.642 ' CZ2' ' CG1' ' A' ' 36' ' ' VAL . 16.5 p90 -136.23 -161.67 1.19 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.197 -0.939 . . . . 0.0 110.65 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.523 ' CG2' ' N ' ' A' ' 139' ' ' LEU 0.258 0.9 OUTLIER -156.86 176.76 12.32 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.405 -0.809 . . . . 0.0 110.028 -177.78 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.544 ' CD2' ' CD1' ' A' ' 95' ' ' LEU . 1.8 mp -145.43 119.42 9.37 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.097 -1.002 . . . . 0.0 112.04 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' CYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 0.8 OUTLIER -99.71 111.68 23.99 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.577 -0.702 . . . . 0.0 110.387 178.349 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.507 ' O ' ' HB3' ' A' ' 142' ' ' ASP . 5.5 mt -103.57 173.89 6.11 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.233 -0.917 . . . . 0.0 109.687 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.582 ' HA ' ' CG ' ' A' ' 9' ' ' PHE . 3.0 p-10 172.09 -177.81 0.06 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.426 -0.796 . . . . 0.0 110.166 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.452 ' HA ' ' O ' ' A' ' 7' ' ' GLY . 19.3 t0 42.07 59.62 2.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.339 -0.85 . . . . 0.0 109.856 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.57 HG22 ' CE1' ' A' ' 9' ' ' PHE . 1.9 t -100.89 114.45 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.32 -0.863 . . . . 0.0 110.113 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.445 ' HB3' ' HA ' ' A' ' 6' ' ' GLU . . . -144.6 156.25 44.04 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.317 -0.864 . . . . 0.0 110.447 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 35.5 tp -154.58 125.55 7.18 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.321 -0.862 . . . . 0.0 110.094 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.467 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 6.9 m-20 -125.26 179.12 5.22 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.265 -0.897 . . . . 0.0 110.302 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.486 ' HB3' ' CE1' ' A' ' 60' ' ' TYR . 10.9 p -141.24 102.17 4.17 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.268 -0.895 . . . . 0.0 110.209 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 148' ' ' SER . 7.2 tm-20 42.84 90.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.24 -0.913 . . . . 0.0 110.208 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.45 ' O ' ' O ' ' A' ' 151' ' ' GLU . 12.9 p -87.1 48.96 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.217 -0.927 . . . . 0.0 110.283 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.45 ' O ' ' O ' ' A' ' 150' ' ' VAL . 3.8 tt0 57.38 112.57 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.233 -0.917 . . . . 0.0 110.259 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.7 pp . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.167 -179.992 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.448 ' O ' ' HB2' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.255 0.55 . . . . 0.0 110.181 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.448 ' HB2' ' O ' ' A' ' 1' ' ' ALA . 26.9 t 178.67 107.61 0.15 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.281 -0.887 . . . . 0.0 110.192 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -75.98 -156.47 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.961 1.506 . . . . 0.0 110.089 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.492 ' CG1' ' N ' ' A' ' 5' ' ' GLY . 9.4 pt -90.19 -42.78 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.17 -0.956 . . . . 0.0 110.2 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.499 ' O ' ' N ' ' A' ' 7' ' ' GLY . . . 137.38 74.42 0.06 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.521 ' CB ' ' HB1' ' A' ' 145' ' ' ALA . 5.8 pt-20 -42.75 94.95 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.3 -1.118 . . . . 0.0 110.247 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 5' ' ' GLY . . . -172.55 143.94 7.65 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.517 ' CG2' ' HB3' ' A' ' 143' ' ' ASP . 76.8 p -54.79 167.2 0.39 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.344 -1.092 . . . . 0.0 110.161 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.57 ' CD2' ' HA ' ' A' ' 142' ' ' ASP . 22.9 m-85 -91.28 55.54 2.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.243 -0.91 . . . . 0.0 110.131 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.561 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 3.3 p-10 -101.77 38.59 1.6 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.164 -0.96 . . . . 0.0 110.316 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.561 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 1.5 m-20 161.42 79.19 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.637 -0.664 . . . . 0.0 109.723 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 63.69 94.86 0.02 OUTLIER Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.536 ' O ' ' N ' ' A' ' 15' ' ' GLY . 45.1 Cg_endo -72.65 78.6 2.02 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.071 1.564 . . . . 0.0 110.627 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.446 ' HG3' ' HB ' ' A' ' 4' ' ' ILE . 6.9 mm-40 42.25 -91.4 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.35 -0.844 . . . . 0.0 110.627 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 13' ' ' PRO . . . -158.96 24.63 0.34 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.575 ' CE2' ' CD2' ' A' ' 49' ' ' LEU . 41.5 m95 -56.12 87.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.283 -1.128 . . . . 0.0 110.255 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.59 ' CG2' ' CG2' ' A' ' 48' ' ' VAL . 0.9 OUTLIER -91.28 146.91 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.049 -1.032 . . . . 0.0 109.647 179.743 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.485 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . . . -130.14 135.58 48.36 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.125 -0.985 . . . . 0.0 109.781 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.463 ' O ' HG11 ' A' ' 45' ' ' VAL . 19.7 p90 -124.3 167.69 13.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.424 -0.797 . . . . 0.0 110.668 -178.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.527 ' CA ' ' OH ' ' A' ' 43' ' ' TYR . . . 75.28 43.79 24.44 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.52 HG21 ' CG1' ' A' ' 45' ' ' VAL . 6.0 p -150.69 -157.23 0.79 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.125 -1.22 . . . . 0.0 110.367 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -93.87 75.92 4.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.32 -0.863 . . . . 0.0 110.23 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.74 -172.09 43.93 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.22 163.62 37.52 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.989 1.521 . . . . 0.0 110.465 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.528 ' CB ' HG11 ' A' ' 34' ' ' VAL . 0.7 OUTLIER -68.17 -169.73 0.15 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.283 -0.885 . . . . 0.0 110.24 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -162.4 150.93 14.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.232 -0.918 . . . . 0.0 110.293 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.511 ' CG2' ' O ' ' A' ' 31' ' ' ALA . 0.8 OUTLIER -119.81 -77.48 0.58 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.327 -0.858 . . . . 0.0 110.046 179.933 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 27' ' ' THR . 1.3 m 40.64 27.77 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.431 -0.793 . . . . 0.0 110.476 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.467 ' CG2' ' O ' ' A' ' 27' ' ' THR . 9.2 t -164.52 30.76 0.07 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.153 -0.967 . . . . 0.0 110.279 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.529 ' HA2' ' CA ' ' A' ' 10' ' ' ASP . . . 53.1 28.38 33.36 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.511 ' O ' ' CG2' ' A' ' 27' ' ' THR . . . -150.13 161.46 42.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.309 -1.113 . . . . 0.0 110.313 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.558 ' HB2' ' CD2' ' A' ' 9' ' ' PHE . 0.8 OUTLIER -105.4 98.04 7.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.89 . . . . 0.0 109.562 179.817 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 64.9 m -107.59 116.35 31.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.244 -0.91 . . . . 0.0 111.01 -179.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.528 HG11 ' CB ' ' A' ' 25' ' ' LEU . 20.3 m -104.03 140.92 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.42 -0.8 . . . . 0.0 109.175 179.213 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.478 ' O ' ' HB ' ' A' ' 21' ' ' THR . . . -88.96 89.5 8.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.064 -1.023 . . . . 0.0 110.69 -179.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.597 ' CG1' ' CZ2' ' A' ' 137' ' ' TRP . 43.8 t -71.62 135.79 83.54 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.263 -0.898 . . . . 0.0 109.775 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.481 ' HG3' ' OE1' ' A' ' 42' ' ' GLN . 40.0 Cg_endo -67.74 -174.06 0.55 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.091 1.574 . . . . 0.0 111.652 -179.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.539 ' HA ' ' CA ' ' A' ' 136' ' ' ALA . . . -72.45 118.77 15.76 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.537 -0.727 . . . . 0.0 111.874 -178.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.565 ' O ' ' C ' ' A' ' 40' ' ' SER . . . 52.98 15.25 3.25 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 178.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.578 ' OG ' ' CH2' ' A' ' 137' ' ' TRP . 49.3 m 25.16 46.73 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.278 0 CA-C-N 118.268 1.034 . . . . 0.0 110.831 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.508 ' N ' ' O ' ' A' ' 39' ' ' GLY . . . -89.09 26.66 1.54 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.475 -0.766 . . . . 0.0 111.167 -178.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.481 ' OE1' ' HG3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -91.98 -153.1 0.32 Allowed 'General case' 0 C--N 1.29 -1.992 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.461 179.183 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.563 ' CE1' ' O ' ' A' ' 44' ' ' GLY . 25.0 p90 -56.57 -16.25 5.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.035 -1.041 . . . . 0.0 109.931 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.563 ' O ' ' CE1' ' A' ' 43' ' ' TYR . . . 123.67 122.64 2.73 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.527 ' CG2' ' HB3' ' A' ' 40' ' ' SER . 5.2 t -90.04 179.23 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.144 -1.209 . . . . 0.0 109.21 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.449 ' CA ' ' HA ' ' A' ' 128' ' ' GLN . . . 164.0 -175.29 40.15 Favored Glycine 0 N--CA 1.489 2.225 0 C-N-CA 119.097 -1.525 . . . . 0.0 110.772 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.532 ' CG1' ' O ' ' A' ' 17' ' ' VAL . 21.8 t -151.04 131.47 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.722 -0.869 . . . . 0.0 108.701 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.59 ' CG2' ' CG2' ' A' ' 17' ' ' VAL . 29.3 m -119.83 131.51 72.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.948 -1.095 . . . . 0.0 110.797 -179.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.575 ' CD2' ' CE2' ' A' ' 16' ' ' TRP . 21.0 tp -131.91 103.91 6.57 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.377 -0.827 . . . . 0.0 110.365 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.526 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 35.7 p30 -78.73 152.41 31.55 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.253 -0.904 . . . . 0.0 110.285 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 125.33 64.45 0.18 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.465 HG13 HG12 ' A' ' 54' ' ' ILE . 89.2 t -131.0 172.62 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.155 -1.203 . . . . 0.0 110.134 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 112' ' ' TYR . . . -150.28 85.78 1.4 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.18 -0.95 . . . . 0.0 110.567 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.637 ' CG1' ' CD2' ' A' ' 112' ' ' TYR . 42.4 mm -111.11 159.97 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.244 -0.91 . . . . 0.0 109.912 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.523 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 72.5 mt-10 -149.52 120.54 7.7 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.119 -0.988 . . . . 0.0 110.471 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.523 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 11.7 pt-20 37.52 -152.0 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.618 -0.676 . . . . 0.0 110.779 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.464 ' N ' ' HG3' ' A' ' 56' ' ' GLU . . . -79.4 114.27 3.84 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.591 HG21 ' CE2' ' A' ' 60' ' ' TYR . 1.2 m -144.22 171.76 13.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.267 -1.137 . . . . 0.0 109.772 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.574 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 0.5 OUTLIER -89.8 158.17 17.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.278 -0.889 . . . . 0.0 110.106 179.866 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.631 ' CE1' ' CD1' ' A' ' 54' ' ' ILE . 68.4 m-85 -159.2 171.22 20.29 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.249 -0.907 . . . . 0.0 110.244 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.469 ' OG1' ' CG2' ' A' ' 105' ' ' THR . 25.7 m -150.11 117.28 6.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.317 -0.864 . . . . 0.0 110.211 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 27.5 tp -89.74 122.49 32.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.205 -0.934 . . . . 0.0 110.022 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.51 ' NH2' ' OD2' ' A' ' 143' ' ' ASP . 1.0 OUTLIER -124.92 104.06 8.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.226 -0.921 . . . . 0.0 110.349 -179.757 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.619 ' CZ ' ' CG2' ' A' ' 102' ' ' VAL . 3.0 p90 -150.54 151.78 33.16 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.281 -0.887 . . . . 0.0 110.012 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 101' ' ' GLN . 29.4 m -119.88 97.62 5.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.221 -0.925 . . . . 0.0 110.251 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.522 ' HB1' ' CD2' ' A' ' 141' ' ' LEU . . . -99.65 145.96 27.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 0.0 110.403 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.463 ' OG1' ' HA ' ' A' ' 99' ' ' PRO . 98.9 m -150.32 117.32 5.93 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.302 -0.874 . . . . 0.0 110.08 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.522 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -107.53 133.41 52.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.184 -0.948 . . . . 0.0 110.115 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 68' ' ' ALA . 1.5 m -45.79 -25.71 0.55 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.167 -0.958 . . . . 0.0 109.399 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.558 ' CG2' ' CB ' ' A' ' 137' ' ' TRP . 1.8 t -110.27 169.26 8.85 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.484 -0.76 . . . . 0.0 109.86 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.462 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 2.2 m-20 -86.15 62.34 7.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.179 -0.951 . . . . 0.0 109.181 179.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.569 HG22 ' CE2' ' A' ' 137' ' ' TRP . 3.3 p -86.16 136.58 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.35 -0.844 . . . . 0.0 111.203 -179.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 67.0 m -122.95 92.08 3.63 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.583 ' HA ' ' CG ' ' A' ' 132' ' ' PHE . 4.3 m -89.97 -153.07 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.158 -0.964 . . . . 0.0 110.628 -178.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.481 ' N ' HG21 ' A' ' 74' ' ' VAL . 5.0 mtm180 -127.7 128.73 45.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.313 -0.867 . . . . 0.0 110.577 -179.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.479 ' O ' ' HB3' ' A' ' 77' ' ' LEU . . . -131.22 155.41 47.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.335 -0.853 . . . . 0.0 109.786 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.484 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 3.8 pp 178.55 -154.46 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.272 -0.892 . . . . 0.0 110.281 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.545 HG13 ' CE2' ' A' ' 112' ' ' TYR . 4.3 t -146.87 171.92 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.289 -0.882 . . . . 0.0 109.357 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.5 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . 178.78 -176.3 47.89 Favored Glycine 0 N--CA 1.49 2.258 0 C-N-CA 119.363 -1.399 . . . . 0.0 110.056 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.477 ' O ' ' HG3' ' A' ' 80' ' ' GLN . 5.1 tp60 -112.64 86.85 2.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.393 -1.063 . . . . 0.0 110.21 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.481 ' O ' ' HG2' ' A' ' 121' ' ' PRO . 3.6 m-80 -64.68 97.39 0.21 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.135 -0.978 . . . . 0.0 109.681 179.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.585 ' O ' ' CZ ' ' A' ' 85' ' ' TYR . . . 149.13 -88.69 0.14 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 178.83 146.67 0.37 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.187 -1.184 . . . . 0.0 110.054 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.495 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.5 Cg_endo -85.44 36.06 3.21 Favored 'Cis proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.921 -2.116 . . . . 0.0 110.616 -0.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.585 ' CZ ' ' O ' ' A' ' 82' ' ' GLY . 98.9 m-85 59.17 -168.91 0.14 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.263 -0.898 . . . . 0.0 110.399 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.425 ' O ' ' OH ' ' A' ' 112' ' ' TYR . . . 135.77 110.54 1.07 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -89.76 140.5 29.53 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.22 -1.165 . . . . 0.0 110.389 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.523 ' CG2' ' HB ' ' A' ' 78' ' ' VAL . 30.6 m -119.78 -17.98 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.409 -0.807 . . . . 0.0 109.746 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.576 HD12 ' CZ ' ' A' ' 106' ' ' PHE . 4.4 mp -121.55 143.26 49.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.401 -0.812 . . . . 0.0 110.784 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.402 ' C ' HG21 ' A' ' 91' ' ' THR . 1.9 p30 -151.15 78.88 1.3 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.886 . . . . 0.0 110.074 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.402 HG21 ' C ' ' A' ' 90' ' ' ASP . 36.3 p -147.04 174.05 11.9 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.039 -1.038 . . . . 0.0 110.708 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.422 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 1.3 m -119.81 120.31 30.56 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.395 -0.815 . . . . 0.0 109.848 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.53 ' HG2' ' CG2' ' A' ' 74' ' ' VAL . 43.6 Cg_endo -70.61 117.49 5.17 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.928 1.489 . . . . 0.0 111.125 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.526 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -86.18 138.96 31.49 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.896 . . . . 0.0 109.339 179.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.52 ' CD1' ' HG ' ' A' ' 139' ' ' LEU . 72.4 mt -130.66 169.46 15.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.033 -1.042 . . . . 0.0 110.883 -179.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.404 ' O ' HG21 ' A' ' 67' ' ' THR . 0.2 OUTLIER -178.34 -178.75 0.64 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.488 -0.757 . . . . 0.0 109.938 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.61 -23.72 67.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.887 . . . . 0.0 110.17 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.466 ' HB3' ' HD2' ' A' ' 99' ' ' PRO . 4.3 mt-10 -89.8 165.17 25.95 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.292 -0.88 . . . . 0.0 110.178 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.466 ' HD2' ' HB3' ' A' ' 98' ' ' GLU . 45.1 Cg_endo -72.45 133.18 20.31 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.946 1.498 . . . . 0.0 110.29 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.526 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.79 81.05 1.67 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.206 -0.934 . . . . 0.0 110.289 -179.927 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.471 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 0.0 OUTLIER -68.12 158.22 33.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.25 -0.906 . . . . 0.0 110.015 179.827 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.619 ' CG2' ' CZ ' ' A' ' 64' ' ' TYR . 65.3 t -133.67 132.38 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.174 -0.954 . . . . 0.0 110.434 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -150.57 89.21 1.54 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.405 -0.809 . . . . 0.0 110.035 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' ' 61' ' ' THR . 1.2 mm-40 -141.38 168.78 18.97 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.155 -0.966 . . . . 0.0 110.273 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.472 ' CG2' ' O ' ' A' ' 60' ' ' TYR . 0.6 OUTLIER -121.98 -179.51 4.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.309 -0.869 . . . . 0.0 110.172 -179.992 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.626 ' CZ ' ' CB ' ' A' ' 60' ' ' TYR . 53.7 p90 -177.96 155.47 0.98 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.217 -0.927 . . . . 0.0 110.259 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 58' ' ' THR . 99.3 m -91.25 95.79 10.22 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.223 -0.923 . . . . 0.0 110.132 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.575 ' HB1' ' CD2' ' A' ' 60' ' ' TYR . . . -65.72 113.67 4.44 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -0.918 . . . . 0.0 110.44 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 109' ' ' SER . 5.8 p -98.42 55.87 1.12 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.208 -0.933 . . . . 0.0 109.958 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.433 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -158.19 -160.62 0.92 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.256 -0.902 . . . . 0.0 110.455 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.458 HG21 ' O ' ' A' ' 54' ' ' ILE . 10.5 m -152.54 118.17 5.35 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.347 -0.845 . . . . 0.0 110.34 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.637 ' CD2' ' CG1' ' A' ' 54' ' ' ILE . 11.2 m-30 -113.08 94.17 28.94 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.256 -0.903 . . . . 0.0 109.85 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.461 ' O ' ' HB2' ' A' ' 122' ' ' GLU . 45.7 Cg_endo -72.94 139.72 30.55 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.022 1.538 . . . . 0.0 110.51 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.98 0.47 21.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.242 -0.911 . . . . 0.0 110.246 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -122.0 136.27 26.1 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.245 -0.909 . . . . 0.0 110.2 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.02 171.16 18.12 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.967 1.509 . . . . 0.0 110.406 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -90.57 49.37 1.66 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.272 -0.893 . . . . 0.0 110.281 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 119' ' ' ASP . . . 61.64 12.3 4.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.199 -0.938 . . . . 0.0 110.209 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 118' ' ' ALA . 2.1 t70 177.3 -28.61 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.35 -0.844 . . . . 0.0 110.312 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.426 ' HB3' ' HD2' ' A' ' 121' ' ' PRO . 7.6 m-20 -89.77 174.56 4.66 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.182 -0.949 . . . . 0.0 110.235 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.539 ' HG2' ' CA ' ' A' ' 82' ' ' GLY . 42.4 Cg_endo -88.7 -155.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 124.126 1.593 . . . . 0.0 110.331 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.472 ' O ' ' N ' ' A' ' 81' ' ' ASN . 14.7 pt-20 -145.92 -156.37 0.7 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.052 -1.03 . . . . 0.0 110.405 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 80' ' ' GLN . . . -99.69 144.85 17.21 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.526 ' CB ' ' HA ' ' A' ' 50' ' ' ASN . 2.1 pt20 -150.49 -153.82 0.51 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.208 -1.172 . . . . 0.0 110.597 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.466 HG23 ' CH2' ' A' ' 16' ' ' TRP . 21.6 mt -118.63 142.2 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.515 -0.74 . . . . 0.0 109.297 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 76' ' ' ALA . . . -113.64 115.87 28.58 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.395 -0.816 . . . . 0.0 111.774 -178.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.495 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 4.5 m-85 -119.75 74.28 1.01 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.135 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.449 ' HA ' ' CA ' ' A' ' 46' ' ' GLY . 2.3 mt-30 -87.26 126.54 34.89 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.207 -0.933 . . . . 0.0 112.146 -177.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.522 ' CD2' HG22 ' A' ' 74' ' ' VAL . 1.4 mt -112.77 55.38 0.69 Allowed 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 131' ' ' GLY . . . -73.28 85.3 0.6 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 39' ' ' GLY . . . 58.44 114.61 0.01 OUTLIER Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.583 ' CG ' ' HA ' ' A' ' 74' ' ' VAL . 10.3 m-85 -147.4 -57.16 0.25 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -1.148 . . . . 0.0 110.206 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.538 ' HB3' ' CE3' ' A' ' 137' ' ' TRP . 5.9 t -89.69 173.79 8.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.149 -0.969 . . . . 0.0 110.187 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -74.84 -93.73 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.213 -0.93 . . . . 0.0 110.208 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.33 -167.84 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.081 -1.012 . . . . 0.0 109.937 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.539 ' CA ' ' HA ' ' A' ' 38' ' ' ALA . . . -77.58 150.07 34.76 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.214 -0.929 . . . . 0.0 110.375 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.597 ' CZ2' ' CG1' ' A' ' 36' ' ' VAL . 24.3 p90 -148.49 -154.81 0.58 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.315 -0.866 . . . . 0.0 110.11 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.522 ' O ' ' CB ' ' A' ' 68' ' ' ALA . 1.0 OUTLIER -160.43 163.17 33.26 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.922 -1.111 . . . . 0.0 111.296 -178.21 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.52 ' HG ' ' CD1' ' A' ' 95' ' ' LEU . 2.1 mp -126.52 125.74 42.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.429 -0.794 . . . . 0.0 109.56 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' CYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 41.1 m -121.01 99.45 6.5 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.107 -0.995 . . . . 0.0 110.713 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.522 ' CD2' ' HB1' ' A' ' 66' ' ' ALA . 2.2 mt -89.64 -154.67 0.33 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.317 -0.864 . . . . 0.0 109.479 179.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.57 ' HA ' ' CD2' ' A' ' 9' ' ' PHE . 39.7 p-10 -177.78 -151.49 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.187 -0.946 . . . . 0.0 110.03 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.517 ' HB3' ' CG2' ' A' ' 8' ' ' THR . 23.6 p-10 -40.56 115.05 0.52 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.526 -0.734 . . . . 0.0 109.785 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.468 HG22 ' O ' ' A' ' 142' ' ' ASP . 43.0 t -128.85 125.09 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.284 -0.885 . . . . 0.0 110.244 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.521 ' HB1' ' CB ' ' A' ' 6' ' ' GLU . . . -136.89 178.82 6.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.292 -0.88 . . . . 0.0 110.658 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.449 HD11 ' O ' ' A' ' 61' ' ' THR . 14.4 tp -158.93 118.7 3.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.384 -0.823 . . . . 0.0 109.947 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.467 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 49.3 m-20 -113.15 141.05 47.38 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.228 -0.92 . . . . 0.0 110.415 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.572 ' OG ' ' CE1' ' A' ' 60' ' ' TYR . 0.8 OUTLIER -114.7 -160.54 0.74 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.321 -0.862 . . . . 0.0 110.224 179.935 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -114.4 101.67 9.37 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.307 -0.87 . . . . 0.0 110.2 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.456 ' O ' HG12 ' A' ' 150' ' ' VAL . 14.7 p -124.74 126.46 71.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.225 -0.922 . . . . 0.0 110.264 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -104.28 29.94 5.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -0.933 . . . . 0.0 110.269 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.209 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.261 0.553 . . . . 0.0 110.195 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.3 m -144.98 140.83 16.58 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.266 -0.896 . . . . 0.0 110.178 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -76.28 -156.35 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.002 1.528 . . . . 0.0 110.053 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.453 HD13 ' HB ' ' A' ' 144' ' ' VAL . 9.5 pt -89.88 34.91 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.151 -0.968 . . . . 0.0 110.166 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.42 ' O ' ' C ' ' A' ' 6' ' ' GLU . . . 89.62 -34.14 4.14 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.458 ' HG3' ' CB ' ' A' ' 145' ' ' ALA . 30.4 tt0 42.86 41.47 2.57 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.34 -1.094 . . . . 0.0 110.172 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 143' ' ' ASP . . . -126.26 169.93 18.15 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.432 ' O ' ' C ' ' A' ' 9' ' ' PHE . 12.7 p -83.7 42.51 0.85 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.275 -1.132 . . . . 0.0 110.522 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.584 ' CG ' ' HB3' ' A' ' 13' ' ' PRO . 15.7 m-30 41.29 32.54 0.21 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.27 -0.894 . . . . 0.0 110.381 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.539 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 35.4 p-10 -89.35 46.4 1.37 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.167 -0.958 . . . . 0.0 110.316 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.539 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.3 OUTLIER 161.52 -22.56 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.798 -0.564 . . . . 0.0 109.75 179.962 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 167.58 110.74 0.23 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.584 ' HB3' ' CG ' ' A' ' 9' ' ' PHE . 49.9 Cg_endo -76.59 72.75 5.48 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.984 1.518 . . . . 0.0 110.778 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.497 ' HG3' ' N ' ' A' ' 15' ' ' GLY . 12.8 tp10 41.32 -92.1 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.293 -0.879 . . . . 0.0 110.509 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 13' ' ' PRO . . . -157.71 43.24 0.51 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.577 ' CD1' HD23 ' A' ' 49' ' ' LEU . 37.9 m95 -66.47 127.88 34.01 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.32 -1.106 . . . . 0.0 110.288 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.58 ' CG2' ' CG2' ' A' ' 48' ' ' VAL . 1.3 m -122.32 154.73 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.135 -0.978 . . . . 0.0 109.689 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.463 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . . . -137.1 154.83 50.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.303 -0.873 . . . . 0.0 109.526 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.577 ' CE1' ' O ' ' A' ' 46' ' ' GLY . 0.6 OUTLIER -139.47 138.67 36.62 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.06 -1.025 . . . . 0.0 111.13 -178.752 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.581 ' HA2' ' CE1' ' A' ' 43' ' ' TYR . . . 121.26 84.3 0.77 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.641 ' CG2' ' CE2' ' A' ' 43' ' ' TYR . 1.7 p 53.15 17.6 1.0 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.508 -0.995 . . . . 0.0 110.955 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.538 ' HA ' ' CB ' ' A' ' 35' ' ' ALA . 5.9 p30 -101.89 111.36 23.59 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.083 -1.011 . . . . 0.0 110.284 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 22' ' ' ASP . . . -59.94 -152.91 0.02 OUTLIER Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.022 -1.631 . . . . 0.0 109.022 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.455 ' O ' ' C ' ' A' ' 25' ' ' LEU . 47.0 Cg_endo -74.4 95.63 0.94 Allowed 'Trans proline' 0 C--N 1.303 -1.86 0 O-C-N 123.814 1.429 . . . . 0.0 110.307 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.526 HD11 ' CD1' ' A' ' 32' ' ' LEU . 0.8 OUTLIER -40.65 150.39 0.07 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.354 -0.841 . . . . 0.0 109.771 179.808 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -146.6 159.77 43.03 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.98 -1.075 . . . . 0.0 110.757 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.524 ' CG2' ' HB3' ' A' ' 9' ' ' PHE . 3.7 p -119.63 -55.86 2.08 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.321 -0.862 . . . . 0.0 110.161 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 50.57 -89.58 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.275 -0.891 . . . . 0.0 110.228 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.514 ' N ' ' O ' ' A' ' 27' ' ' THR . 15.2 t -55.71 -17.19 5.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.243 -0.911 . . . . 0.0 110.161 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' A' ' 9' ' ' PHE . . . 111.65 32.55 2.46 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' A' ' 141' ' ' LEU . . . -140.52 109.97 6.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.272 -1.134 . . . . 0.0 110.274 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.526 ' CD1' HD11 ' A' ' 25' ' ' LEU . 0.6 OUTLIER -67.17 94.31 0.35 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.266 -0.896 . . . . 0.0 109.991 179.912 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 59.0 m -99.4 133.09 44.2 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.31 -0.869 . . . . 0.0 110.574 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.468 ' O ' ' OG1' ' A' ' 138' ' ' THR . 6.2 m -121.62 167.28 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.571 -0.705 . . . . 0.0 109.4 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.538 ' CB ' ' HA ' ' A' ' 22' ' ' ASP . . . -103.15 128.46 50.08 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.126 -0.984 . . . . 0.0 111.887 -178.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.658 ' CG1' ' CZ2' ' A' ' 137' ' ' TRP . 90.3 t -117.5 121.47 32.01 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.163 -0.961 . . . . 0.0 108.991 178.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.49 ' HD3' ' OG1' ' A' ' 21' ' ' THR . 38.2 Cg_endo -64.25 173.99 4.6 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.856 1.45 . . . . 0.0 112.196 -178.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.544 ' HA ' ' CA ' ' A' ' 136' ' ' ALA . . . -53.31 122.28 9.27 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.514 0.673 . . . . 0.0 111.456 -178.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.513 ' O ' ' C ' ' A' ' 40' ' ' SER . . . 37.89 27.17 0.03 OUTLIER Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.565 ' CB ' HG22 ' A' ' 45' ' ' VAL . 31.3 t 32.77 46.39 0.08 Allowed 'General case' 0 N--CA 1.498 1.934 0 CA-C-N 118.045 0.923 . . . . 0.0 110.15 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.644 ' O ' ' CG ' ' A' ' 42' ' ' GLN . . . -89.51 119.02 29.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.594 -0.692 . . . . 0.0 110.127 -179.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.644 ' CG ' ' O ' ' A' ' 41' ' ' ALA . 0.5 OUTLIER 84.1 28.64 0.08 Allowed 'General case' 0 N--CA 1.508 2.433 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -179.492 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.641 ' CE2' ' CG2' ' A' ' 21' ' ' THR . 0.1 OUTLIER -146.4 -33.27 0.32 Allowed 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 118.757 -1.177 . . . . 0.0 112.335 -177.878 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 43' ' ' TYR . . . 52.26 75.28 0.23 Allowed Glycine 0 N--CA 1.482 1.758 0 N-CA-C 105.849 -2.9 . . . . 0.0 105.849 -177.011 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.565 HG22 ' CB ' ' A' ' 40' ' ' SER . 2.6 t -85.68 160.76 3.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.513 -0.992 . . . . 0.0 109.186 -177.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.577 ' O ' ' CE1' ' A' ' 19' ' ' TYR . . . 176.68 164.66 30.98 Favored Glycine 0 N--CA 1.488 2.102 0 C-N-CA 119.357 -1.402 . . . . 0.0 110.08 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.525 ' CG1' ' O ' ' A' ' 17' ' ' VAL . 17.8 t -124.59 125.53 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.473 -1.016 . . . . 0.0 109.626 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.58 ' CG2' ' CG2' ' A' ' 17' ' ' VAL . 33.8 m -119.73 139.89 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.007 -1.058 . . . . 0.0 110.842 -179.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.577 HD23 ' CD1' ' A' ' 16' ' ' TRP . 18.4 tp -132.08 99.25 4.66 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.318 -0.864 . . . . 0.0 110.086 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.527 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 10.6 p30 -73.38 121.52 20.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.245 -0.909 . . . . 0.0 110.429 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.449 ' O ' ' CG2' ' A' ' 4' ' ' ILE . . . 150.54 65.85 0.01 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.864 -1.295 . . . . 0.0 109.864 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.514 ' CG2' ' HA ' ' A' ' 124' ' ' GLN . 53.1 t -122.61 169.68 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.137 -1.213 . . . . 0.0 110.073 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.472 ' N ' ' CG1' ' A' ' 52' ' ' VAL . . . -141.41 88.63 2.16 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.151 -0.968 . . . . 0.0 110.613 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.526 HG21 ' N ' ' A' ' 55' ' ' GLU . 36.1 mm -122.14 163.0 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.292 -0.88 . . . . 0.0 109.718 179.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.526 ' N ' HG21 ' A' ' 54' ' ' ILE . 2.0 tt0 -150.25 127.05 11.02 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.044 -1.035 . . . . 0.0 110.778 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.52 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 13.6 pt-20 37.56 -157.86 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.642 -0.661 . . . . 0.0 111.093 179.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' A' ' 109' ' ' SER . . . -79.04 82.84 1.32 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.559 HG21 ' CE2' ' A' ' 60' ' ' TYR . 1.3 m -110.16 170.46 8.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.266 -1.137 . . . . 0.0 109.779 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.576 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 6.5 m -89.87 154.58 19.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.175 -0.953 . . . . 0.0 110.33 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.576 ' CG ' ' O ' ' A' ' 59' ' ' THR . 60.3 m-85 -159.77 173.06 16.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.332 -0.855 . . . . 0.0 110.225 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 27.4 m -150.14 116.01 5.6 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.3 -0.875 . . . . 0.0 110.036 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.466 ' O ' ' HA ' ' A' ' 103' ' ' THR . 38.3 tp -89.78 122.6 33.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.265 -0.897 . . . . 0.0 110.057 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.508 ' HG2' ' CG2' ' A' ' 103' ' ' THR . 16.1 mtt180 -131.81 106.46 8.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.332 -0.855 . . . . 0.0 110.233 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.496 ' CD1' ' C ' ' A' ' 64' ' ' TYR . 10.0 p90 -143.04 159.62 41.92 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.246 -0.908 . . . . 0.0 110.236 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 1.3 m -119.96 102.35 8.49 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.179 -0.951 . . . . 0.0 109.866 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.457 ' HB2' HD23 ' A' ' 95' ' ' LEU . . . -104.83 149.47 25.63 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.273 -0.892 . . . . 0.0 110.699 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.47 ' O ' ' HB2' ' A' ' 140' ' ' CYS . 93.5 m -150.22 126.01 10.4 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.444 -0.785 . . . . 0.0 110.025 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -114.32 136.96 52.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.211 -0.931 . . . . 0.0 109.999 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' ' 68' ' ' ALA . 0.4 OUTLIER -44.03 -26.57 0.3 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.189 -0.944 . . . . 0.0 109.344 179.528 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.567 ' CG2' ' CB ' ' A' ' 137' ' ' TRP . 2.7 t -114.07 169.39 9.04 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.51 -0.744 . . . . 0.0 109.824 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.463 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 33.7 p-10 -85.07 66.02 9.53 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.137 -0.977 . . . . 0.0 109.201 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.547 HG22 ' CE2' ' A' ' 137' ' ' TRP . 4.0 p -89.39 140.36 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -0.885 . . . . 0.0 111.483 -178.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.436 ' O ' HG21 ' A' ' 73' ' ' THR . 16.8 m -127.72 87.21 2.58 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.586 ' HA ' ' CD1' ' A' ' 132' ' ' PHE . 2.8 m -89.78 -140.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.238 -0.914 . . . . 0.0 110.483 -178.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.517 ' N ' ' CG2' ' A' ' 74' ' ' VAL . 7.0 mtm180 -127.74 149.07 50.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.169 -0.957 . . . . 0.0 110.767 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.486 ' O ' ' HB3' ' A' ' 77' ' ' LEU . . . -150.11 152.47 34.81 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.399 -0.813 . . . . 0.0 109.421 179.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.585 ' CD1' ' N ' ' A' ' 78' ' ' VAL . 3.9 pp 179.87 -147.15 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.181 -0.949 . . . . 0.0 110.294 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.585 ' N ' ' CD1' ' A' ' 77' ' ' LEU . 6.8 t -151.29 169.59 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.215 -0.928 . . . . 0.0 109.431 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.543 ' C ' ' CE1' ' A' ' 112' ' ' TYR . . . -172.42 -173.59 39.14 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.236 -1.459 . . . . 0.0 110.252 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.499 ' HG3' ' HA ' ' A' ' 85' ' ' TYR . 4.3 pt20 -115.88 108.0 15.73 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.466 -1.02 . . . . 0.0 110.163 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.448 ' HB2' ' HG2' ' A' ' 122' ' ' GLU . 6.2 m-20 -66.61 92.97 0.22 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.193 -0.942 . . . . 0.0 110.236 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.538 ' C ' ' CE1' ' A' ' 85' ' ' TYR . . . 142.8 144.23 4.27 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.654 -1.379 . . . . 0.0 109.654 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.618 ' N ' ' CE1' ' A' ' 85' ' ' TYR . . . -62.7 157.02 61.45 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.226 -1.161 . . . . 0.0 110.27 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.517 ' C ' ' CD2' ' A' ' 85' ' ' TYR . 50.6 Cg_endo -77.38 8.54 17.89 Favored 'Cis proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.647 -2.23 . . . . 0.0 110.876 -0.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.618 ' CE1' ' N ' ' A' ' 83' ' ' ALA . 11.6 m-85 69.83 161.34 0.21 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.241 -0.912 . . . . 0.0 110.262 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.498 ' N ' ' CG ' ' A' ' 80' ' ' GLN . . . 166.76 106.6 0.19 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.463 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 1.0 OUTLIER -89.55 152.38 21.45 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.121 -1.223 . . . . 0.0 110.464 -179.787 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.491 HG22 ' CD1' ' A' ' 89' ' ' LEU . 33.2 m -119.72 -24.92 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.35 -0.844 . . . . 0.0 109.8 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.575 HD13 ' CE1' ' A' ' 106' ' ' PHE . 3.6 mp -99.16 141.8 31.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.285 -0.884 . . . . 0.0 110.73 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 45.5 p-10 -151.34 73.92 1.11 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.393 -0.817 . . . . 0.0 110.032 179.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 41.5 p -135.35 176.03 9.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.051 -1.031 . . . . 0.0 110.643 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.4 m -122.01 121.33 28.05 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.385 -0.822 . . . . 0.0 109.949 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.487 ' HG2' HG21 ' A' ' 74' ' ' VAL . 44.7 Cg_endo -70.92 155.38 62.2 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.919 1.484 . . . . 0.0 110.898 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.519 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -122.26 137.47 54.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.449 -0.782 . . . . 0.0 109.463 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.487 HD13 ' CG1' ' A' ' 72' ' ' VAL . 93.0 mt -131.96 169.03 16.88 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.104 -0.997 . . . . 0.0 110.625 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.468 ' O ' ' O ' ' A' ' 68' ' ' ALA . 5.9 t -174.65 -155.08 0.06 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.428 -0.795 . . . . 0.0 110.0 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.7 24.33 2.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.261 -0.899 . . . . 0.0 110.128 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.487 ' CG ' ' HD2' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -147.57 172.03 5.65 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.35 -0.844 . . . . 0.0 110.012 179.882 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.487 ' HD2' ' CG ' ' A' ' 98' ' ' GLU . 45.2 Cg_endo -72.82 127.45 12.28 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.979 1.515 . . . . 0.0 110.443 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.519 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 6.6 mtt-85 -119.51 93.1 3.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.261 -0.9 . . . . 0.0 109.867 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -78.06 102.71 7.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.448 -0.783 . . . . 0.0 110.569 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 50.2 t -89.41 134.13 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.241 -0.912 . . . . 0.0 109.805 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.508 ' CG2' ' HG2' ' A' ' 63' ' ' ARG . 0.2 OUTLIER -147.05 133.09 19.22 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.16 -0.963 . . . . 0.0 110.247 -179.884 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -160.25 134.72 7.5 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.259 -0.901 . . . . 0.0 110.333 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 25.2 m -90.68 143.82 26.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.281 -0.887 . . . . 0.0 110.125 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.575 ' CE1' HD13 ' A' ' 89' ' ' LEU . 41.7 p90 -154.48 159.85 41.25 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.234 -0.916 . . . . 0.0 110.259 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 58' ' ' THR . 80.2 m -97.02 89.04 4.68 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.201 -0.937 . . . . 0.0 110.054 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.547 ' HB1' ' CD2' ' A' ' 60' ' ' TYR . . . -45.63 106.39 0.08 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -0.892 . . . . 0.0 110.296 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.46 ' HA ' ' HA2' ' A' ' 57' ' ' GLY . 5.2 p -90.29 54.29 2.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.282 -0.886 . . . . 0.0 110.278 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.411 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -164.67 -158.39 0.41 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.895 . . . . 0.0 110.229 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.467 ' CG2' ' HD3' ' A' ' 113' ' ' PRO . 19.9 m -145.04 118.94 9.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.246 -0.909 . . . . 0.0 110.264 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.583 ' CG ' ' HA3' ' A' ' 123' ' ' GLY . 19.2 m-30 -115.79 63.62 2.2 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.361 -0.837 . . . . 0.0 110.073 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.471 ' O ' ' HA ' ' A' ' 122' ' ' GLU . 45.3 Cg_endo -71.67 147.44 51.05 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.852 1.448 . . . . 0.0 110.608 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.448 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -78.17 4.04 13.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.197 -0.94 . . . . 0.0 110.246 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 70.7 p -92.46 107.95 27.57 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.232 -0.917 . . . . 0.0 110.201 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.448 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 46.7 Cg_endo -73.33 106.49 2.18 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.965 1.508 . . . . 0.0 110.526 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.532 ' CB ' ' HB2' ' A' ' 120' ' ' ASP . . . -150.49 157.15 42.69 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.269 -0.894 . . . . 0.0 110.214 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -52.91 -68.22 0.19 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.206 -0.934 . . . . 0.0 110.262 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -76.79 -2.61 34.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.187 -0.946 . . . . 0.0 110.337 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.532 ' HB2' ' CB ' ' A' ' 117' ' ' ALA . 6.4 m-20 -128.12 72.58 79.5 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.195 -0.94 . . . . 0.0 110.202 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.487 ' HB3' ' HA3' ' A' ' 82' ' ' GLY . 47.7 Cg_endo -73.15 161.68 42.57 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.091 1.574 . . . . 0.0 110.331 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.49 ' O ' ' HA ' ' A' ' 80' ' ' GLN . 0.4 OUTLIER -104.48 -166.83 1.28 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.154 -0.966 . . . . 0.0 110.039 179.811 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.583 ' HA3' ' CG ' ' A' ' 112' ' ' TYR . . . -145.02 158.67 27.71 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.859 -1.297 . . . . 0.0 109.859 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.527 ' CB ' ' HA ' ' A' ' 50' ' ' ASN . 1.1 pp0? -150.38 -158.12 0.88 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.415 -1.05 . . . . 0.0 110.262 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.576 HG23 ' CH2' ' A' ' 16' ' ' TRP . 6.2 mt -118.18 139.49 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.523 -0.736 . . . . 0.0 109.208 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -117.6 122.56 43.95 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.243 -0.911 . . . . 0.0 110.886 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.482 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 3.0 m-30 -116.76 103.39 10.29 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.583 ' O ' ' CE2' ' A' ' 132' ' ' PHE . 11.0 mm100 -89.08 89.12 7.83 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.323 -0.861 . . . . 0.0 112.511 -177.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.579 ' CD2' ' CG2' ' A' ' 74' ' ' VAL . 27.0 mt -94.73 44.98 1.11 Allowed 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 177.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.552 ' O ' ' CD2' ' A' ' 132' ' ' PHE . . . -99.06 127.89 9.39 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 120.117 -1.04 . . . . 0.0 110.737 -178.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.469 ' HA2' ' O ' ' A' ' 39' ' ' GLY . . . 37.14 68.8 0.32 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.586 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 9.4 m-85 -123.29 -57.52 1.67 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.028 -1.278 . . . . 0.0 110.82 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.529 ' HB2' ' CG2' ' A' ' 72' ' ' VAL . 1.3 t -88.54 -177.52 5.61 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.904 -1.122 . . . . 0.0 110.415 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -93.69 -84.76 0.3 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.248 -0.908 . . . . 0.0 110.246 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.08 179.49 1.51 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.165 -0.959 . . . . 0.0 109.999 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.544 ' CA ' ' HA ' ' A' ' 38' ' ' ALA . . . -75.0 129.9 38.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.299 -0.876 . . . . 0.0 110.656 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.658 ' CZ2' ' CG1' ' A' ' 36' ' ' VAL . 6.8 p90 -133.32 -158.93 0.92 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.336 -0.853 . . . . 0.0 109.859 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.524 ' O ' ' CB ' ' A' ' 68' ' ' ALA . 0.3 OUTLIER -160.37 171.68 18.67 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.048 -1.033 . . . . 0.0 110.48 -178.638 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.52 ' CD1' HD11 ' A' ' 129' ' ' LEU . 2.4 mp -122.26 157.39 31.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.405 -0.809 . . . . 0.0 109.639 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' CYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 67' ' ' THR . 8.5 m -150.27 91.14 1.73 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.081 -1.012 . . . . 0.0 110.657 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.472 ' O ' ' HB3' ' A' ' 142' ' ' ASP . 1.0 OUTLIER -90.0 -156.33 0.41 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.926 . . . . 0.0 109.259 179.275 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.58 ' O ' ' CG ' ' A' ' 9' ' ' PHE . 1.9 p-10 175.94 -48.53 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.007 -1.058 . . . . 0.0 110.522 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.494 ' O ' ' HA ' ' A' ' 64' ' ' TYR . 22.6 t70 -119.25 137.73 53.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -0.937 . . . . 0.0 110.208 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.548 HG22 ' CZ ' ' A' ' 9' ' ' PHE . 3.0 t -150.39 113.18 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.213 -0.93 . . . . 0.0 110.115 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.458 ' CB ' ' HG3' ' A' ' 6' ' ' GLU . . . -126.46 153.55 44.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.302 -0.874 . . . . 0.0 110.282 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.461 HD12 ' HB3' ' A' ' 60' ' ' TYR . 29.7 tp -159.71 96.65 1.27 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.34 -0.85 . . . . 0.0 110.03 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.469 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 32.3 t70 -121.95 164.36 17.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.228 -0.92 . . . . 0.0 110.259 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.568 ' HB3' ' CE1' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -111.39 111.36 22.34 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.226 -0.921 . . . . 0.0 110.255 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.447 ' O ' ' O ' ' A' ' 148' ' ' SER . 1.0 OUTLIER 54.52 107.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.315 -0.866 . . . . 0.0 110.236 179.96 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 23.9 m -66.09 -175.84 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.261 -0.899 . . . . 0.0 110.245 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 61.51 34.49 17.94 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.304 -0.872 . . . . 0.0 110.213 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.152 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.415 ' C ' ' HD3' ' A' ' 3' ' ' PRO . . . . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.246 0.546 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.555 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 4.2 t 44.87 49.53 6.11 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.265 -0.897 . . . . 0.0 110.192 -179.998 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 2' ' ' SER . 45.6 Cg_endo -72.79 81.05 1.67 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.993 1.523 . . . . 0.0 110.427 179.985 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.525 HD11 ' CD1' ' A' ' 125' ' ' ILE . 9.1 pt -107.92 42.8 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 110.254 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.52 ' N ' ' CG ' ' A' ' 14' ' ' GLU . . . 73.93 40.54 43.63 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.487 ' HA ' ' O ' ' A' ' 144' ' ' VAL . 22.0 tt0 -42.03 94.03 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.33 -1.1 . . . . 0.0 110.434 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 5' ' ' GLY . . . 163.48 -154.76 25.82 Favored Glycine 0 N--CA 1.49 2.27 0 C-N-CA 119.647 -1.264 . . . . 0.0 110.164 179.77 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.54 ' HA ' ' CA ' ' A' ' 142' ' ' ASP . 62.0 p -105.99 38.15 2.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.416 -1.049 . . . . 0.0 110.604 -179.594 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.552 ' CZ ' HG22 ' A' ' 144' ' ' VAL . 25.4 m-85 42.75 80.78 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.209 -0.932 . . . . 0.0 110.179 179.779 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.548 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 2.6 p30 -108.48 23.23 14.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.202 -0.936 . . . . 0.0 110.415 -179.843 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.548 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.8 OUTLIER 161.51 80.48 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.601 -0.687 . . . . 0.0 109.822 179.991 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.41 101.54 0.08 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.864 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.526 ' O ' ' N ' ' A' ' 15' ' ' GLY . 45.0 Cg_endo -73.27 78.46 2.27 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.038 1.547 . . . . 0.0 110.667 -179.801 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.52 ' CG ' ' N ' ' A' ' 5' ' ' GLY . 5.0 mm-40 39.45 -91.21 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.467 -0.77 . . . . 0.0 111.066 179.675 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.538 ' O ' ' CG1' ' A' ' 17' ' ' VAL . . . -148.24 12.56 1.23 Allowed Glycine 0 N--CA 1.493 2.478 0 C-N-CA 119.618 -1.277 . . . . 0.0 110.386 -179.535 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.574 ' CD1' HD21 ' A' ' 49' ' ' LEU . 36.8 m95 -40.62 128.82 2.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.23 -1.159 . . . . 0.0 110.786 179.832 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.538 ' CG1' ' O ' ' A' ' 15' ' ' GLY . 1.4 m -128.08 148.03 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.16 -0.962 . . . . 0.0 109.696 179.305 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.488 ' CB ' HG13 ' A' ' 34' ' ' VAL . . . -130.32 117.27 19.53 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.027 -1.045 . . . . 0.0 109.821 179.552 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.576 ' CE2' ' O ' ' A' ' 46' ' ' GLY . 29.3 p90 -106.76 172.8 6.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.471 -0.768 . . . . 0.0 110.709 -179.241 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.515 ' O ' ' CG1' ' A' ' 45' ' ' VAL . . . 68.07 27.17 73.77 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 179.589 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.586 ' CG2' ' CG1' ' A' ' 45' ' ' VAL . 30.9 p -132.32 -164.17 1.43 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.066 -1.255 . . . . 0.0 110.514 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -89.99 39.46 0.96 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.275 -0.891 . . . . 0.0 110.42 -179.75 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 126.26 -168.01 18.51 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 179.827 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.48 -159.09 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.112 1.585 . . . . 0.0 110.579 -179.877 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.571 ' CD1' ' CD1' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -115.81 156.86 25.3 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.339 -0.851 . . . . 0.0 110.104 -179.998 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -121.21 141.14 51.14 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.203 -0.935 . . . . 0.0 110.137 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.523 ' CG2' ' HA ' ' A' ' 32' ' ' LEU . 0.7 OUTLIER -126.36 -24.3 3.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.114 -0.991 . . . . 0.0 110.874 -179.694 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.435 ' C ' ' O ' ' A' ' 27' ' ' THR . 3.5 t -41.06 -36.69 0.73 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.263 -0.898 . . . . 0.0 110.538 -179.618 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.7 t -53.2 -49.78 66.01 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.259 -0.9 . . . . 0.0 110.706 -179.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 166.99 -25.46 0.14 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.925 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.461 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -146.92 169.01 20.06 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -1.128 . . . . 0.0 109.593 179.838 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.571 ' CD1' ' CD1' ' A' ' 25' ' ' LEU . 0.6 OUTLIER -78.42 92.26 4.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.011 -1.056 . . . . 0.0 110.502 -179.837 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 0.8 OUTLIER -100.22 110.78 23.04 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.417 -0.802 . . . . 0.0 111.447 179.517 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.488 HG13 ' CB ' ' A' ' 18' ' ' ALA . 15.6 m -89.53 143.71 10.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.001 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.467 ' HA ' ' OG1' ' A' ' 138' ' ' THR . . . -88.63 83.13 6.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.472 -0.767 . . . . 0.0 110.916 -178.59 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.588 HG12 ' CZ2' ' A' ' 137' ' ' TRP . 40.9 t -69.34 128.59 92.32 Favored Pre-proline 0 N--CA 1.487 1.421 0 O-C-N 121.307 -0.87 . . . . 0.0 109.112 179.064 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 21' ' ' THR . 42.8 Cg_endo -70.26 146.77 58.01 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.936 1.493 . . . . 0.0 111.157 -178.951 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.51 ' HA ' ' N ' ' A' ' 136' ' ' ALA . . . -41.57 136.42 1.85 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.512 -0.742 . . . . 0.0 110.229 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 38' ' ' ALA . . . 45.51 92.99 0.01 OUTLIER Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.845 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.568 ' OG ' ' CH2' ' A' ' 137' ' ' TRP . 25.9 m -87.36 33.76 0.69 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.164 -1.198 . . . . 0.0 110.108 179.991 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -91.58 19.95 5.84 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.933 0.873 . . . . 0.0 110.155 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.575 ' OE1' ' CE2' ' A' ' 43' ' ' TYR . 17.8 pt20 -85.69 -143.46 0.1 Allowed 'General case' 0 C--N 1.292 -1.898 0 O-C-N 121.804 -0.56 . . . . 0.0 109.721 179.49 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.575 ' CE2' ' OE1' ' A' ' 42' ' ' GLN . 5.5 p90 -41.54 -27.15 0.09 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.463 -0.773 . . . . 0.0 109.97 179.838 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.571 ' N ' ' CD1' ' A' ' 43' ' ' TYR . . . 115.14 113.49 2.93 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.448 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.586 ' CG1' ' CG2' ' A' ' 21' ' ' THR . 2.0 t -96.37 160.5 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.183 -1.187 . . . . 0.0 108.841 179.384 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.576 ' O ' ' CE2' ' A' ' 19' ' ' TYR . . . 177.56 152.66 10.24 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.271 -1.442 . . . . 0.0 110.329 -179.74 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.517 ' CG1' ' O ' ' A' ' 17' ' ' VAL . 22.9 t -113.46 134.79 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.374 -1.074 . . . . 0.0 109.796 179.479 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.523 HG22 ' CG2' ' A' ' 17' ' ' VAL . 8.6 m -130.13 151.16 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.035 -1.041 . . . . 0.0 110.46 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.574 HD21 ' CD1' ' A' ' 16' ' ' TRP . 19.9 tp -149.71 114.5 5.34 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.275 -0.89 . . . . 0.0 110.388 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.527 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 21.4 t30 -79.72 124.63 28.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.269 -0.894 . . . . 0.0 110.306 179.749 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.509 ' O ' ' CG2' ' A' ' 4' ' ' ILE . . . 155.23 67.99 0.01 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.468 ' CG2' ' HA ' ' A' ' 124' ' ' GLN . 43.0 t -130.44 171.89 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.216 -1.167 . . . . 0.0 110.106 179.844 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' A' ' 112' ' ' TYR . . . -145.04 87.47 1.83 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.102 -0.999 . . . . 0.0 110.718 -179.76 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.581 HG13 ' CD2' ' A' ' 112' ' ' TYR . 36.7 mm -120.51 159.55 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.226 -0.921 . . . . 0.0 109.893 179.418 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.521 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 0.4 OUTLIER -147.68 121.54 9.34 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.161 -0.962 . . . . 0.0 110.437 -179.868 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.521 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 9.4 pt-20 37.57 -151.65 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.654 -0.654 . . . . 0.0 110.797 179.705 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.463 ' N ' ' HG3' ' A' ' 56' ' ' GLU . . . -81.15 94.41 1.59 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.574 HG21 ' CE2' ' A' ' 60' ' ' TYR . 1.2 m -124.74 174.29 7.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.257 -1.143 . . . . 0.0 109.824 179.968 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.572 ' N ' ' CG2' ' A' ' 58' ' ' THR . 0.6 OUTLIER -89.63 151.66 21.78 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.269 -0.894 . . . . 0.0 110.137 -179.969 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.594 ' CD2' ' CB ' ' A' ' 108' ' ' ALA . 54.6 m-85 -159.29 174.4 14.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.223 -0.923 . . . . 0.0 110.575 -179.987 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 94.8 m -149.98 121.23 7.82 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.439 -0.788 . . . . 0.0 109.685 179.69 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 18.7 tp -89.56 120.44 30.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.208 -0.932 . . . . 0.0 110.279 -179.691 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.516 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 3.3 ttt180 -121.03 138.24 54.26 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.326 -0.859 . . . . 0.0 109.803 179.673 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.54 ' CZ ' HG22 ' A' ' 102' ' ' VAL . 0.6 OUTLIER -178.52 142.2 0.23 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.228 -0.92 . . . . 0.0 110.033 179.922 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 5.8 m -119.37 94.36 4.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.225 -0.922 . . . . 0.0 110.06 -179.839 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.53 ' HB2' ' CD2' ' A' ' 95' ' ' LEU . . . -95.91 155.95 16.54 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.345 -0.847 . . . . 0.0 110.153 -179.829 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.462 HG22 ' O ' ' A' ' 98' ' ' GLU . 44.3 m -148.38 117.59 6.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.261 -0.9 . . . . 0.0 110.27 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -102.87 129.8 49.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.297 -0.877 . . . . 0.0 109.942 179.783 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 82.7 p -65.5 -9.05 22.75 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.175 -0.953 . . . . 0.0 110.092 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.531 HG22 ' CB ' ' A' ' 137' ' ' TRP . 7.4 t -116.97 19.9 14.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.871 . . . . 0.0 110.166 -179.912 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.466 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 4.7 t70 43.05 92.35 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.3 -0.875 . . . . 0.0 109.851 -179.754 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.524 ' CG1' HD11 ' A' ' 95' ' ' LEU . 12.1 p -131.36 161.31 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -0.918 . . . . 0.0 110.953 -179.337 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.517 ' N ' HG21 ' A' ' 72' ' ' VAL . 23.2 m -128.68 89.11 2.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.37 -0.831 . . . . 0.0 109.219 179.248 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.582 ' HA ' ' CD1' ' A' ' 132' ' ' PHE . 17.4 m -89.74 -140.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.911 . . . . 0.0 110.655 -179.199 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.511 ' N ' HG22 ' A' ' 74' ' ' VAL . 19.3 mtm-85 -133.1 146.55 51.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.902 . . . . 0.0 110.597 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.531 ' N ' ' HD3' ' A' ' 93' ' ' PRO . . . -150.02 152.21 34.51 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.348 -0.845 . . . . 0.0 109.712 179.731 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.572 ' CD1' ' N ' ' A' ' 78' ' ' VAL . 3.7 pp 179.49 -146.97 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.241 -0.912 . . . . 0.0 110.218 -179.587 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.572 ' N ' ' CD1' ' A' ' 77' ' ' LEU . 3.5 t -148.22 177.59 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.921 . . . . 0.0 109.544 179.904 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.512 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . -179.49 -175.87 46.67 Favored Glycine 0 N--CA 1.489 2.204 0 C-N-CA 119.384 -1.389 . . . . 0.0 110.14 179.988 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.469 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 3.0 tt0 -93.98 -153.76 0.38 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.422 -1.046 . . . . 0.0 110.107 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.532 ' O ' ' CB ' ' A' ' 121' ' ' PRO . 9.7 m120 -154.44 72.46 0.87 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.361 -0.837 . . . . 0.0 109.702 179.894 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.478 ' C ' ' CE1' ' A' ' 85' ' ' TYR . . . 131.57 144.08 5.33 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -179.688 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.628 ' N ' ' CE1' ' A' ' 85' ' ' TYR . . . -41.93 152.27 0.31 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.28 -1.13 . . . . 0.0 110.321 -179.868 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.472 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.6 Cg_endo -80.04 12.57 22.55 Favored 'Cis proline' 0 C--N 1.312 -1.343 0 C-N-CA 121.651 -2.229 . . . . 0.0 110.896 -0.067 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.628 ' CE1' ' N ' ' A' ' 83' ' ' ALA . 29.1 m-85 62.53 146.8 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.139 -0.975 . . . . 0.0 110.233 -179.816 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -172.5 128.13 1.5 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.463 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 0.8 OUTLIER -105.55 153.76 21.31 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.236 -1.155 . . . . 0.0 110.208 179.984 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.47 ' HB ' ' HA ' ' A' ' 108' ' ' ALA . 15.5 m -124.98 -24.69 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.302 -0.873 . . . . 0.0 110.331 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.572 HD12 ' CZ ' ' A' ' 106' ' ' PHE . 3.8 mp -105.72 145.29 31.29 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.17 -0.957 . . . . 0.0 111.082 179.883 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -151.76 76.09 1.18 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.371 -0.831 . . . . 0.0 109.947 179.474 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 82.1 p -135.62 178.52 6.98 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.98 -1.075 . . . . 0.0 110.869 -179.504 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.97 117.8 32.04 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.435 -0.791 . . . . 0.0 110.079 179.941 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.531 ' HD3' ' N ' ' A' ' 76' ' ' ALA . 47.4 Cg_endo -73.74 105.56 2.03 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.93 1.49 . . . . 0.0 110.981 -179.697 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.53 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -77.83 151.32 33.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.156 -0.965 . . . . 0.0 109.428 179.171 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.579 ' CD1' ' CD2' ' A' ' 139' ' ' LEU . 64.2 mt -138.99 162.83 33.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.994 -1.067 . . . . 0.0 110.817 -179.548 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -161.9 -178.93 6.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.455 -0.778 . . . . 0.0 109.907 179.894 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.7 p -64.64 -30.79 71.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.272 -0.892 . . . . 0.0 110.126 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.527 ' CB ' ' HD2' ' A' ' 99' ' ' PRO . 0.1 OUTLIER -90.1 179.94 1.38 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.333 -0.854 . . . . 0.0 109.978 179.822 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.527 ' HD2' ' CB ' ' A' ' 98' ' ' GLU . 44.6 Cg_endo -71.88 132.07 19.37 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.925 1.487 . . . . 0.0 110.313 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.53 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.84 92.43 3.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.234 -0.916 . . . . 0.0 110.402 -179.841 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 1.5 tt0 -76.99 156.76 31.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.296 -0.878 . . . . 0.0 110.113 179.861 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.54 HG22 ' CZ ' ' A' ' 64' ' ' TYR . 52.5 t -138.71 134.15 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.205 -0.935 . . . . 0.0 110.219 -179.992 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 21.6 m -150.06 113.46 4.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.319 -0.863 . . . . 0.0 110.181 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -146.48 138.3 24.75 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.295 -0.878 . . . . 0.0 110.244 -179.949 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.03 159.28 16.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.27 -0.894 . . . . 0.0 110.085 179.952 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.572 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 48.8 p90 -167.77 151.27 6.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.23 -0.919 . . . . 0.0 110.279 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 58' ' ' THR . 3.1 m -89.89 90.71 8.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.209 -0.932 . . . . 0.0 110.012 179.787 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.594 ' CB ' ' CD2' ' A' ' 60' ' ' TYR . . . -52.41 116.26 2.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.244 -0.91 . . . . 0.0 110.314 -179.828 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 55.4 p -99.4 54.83 0.97 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.262 -0.899 . . . . 0.0 110.082 179.836 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -165.06 -160.15 0.47 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.261 -0.9 . . . . 0.0 110.37 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.455 HG23 ' HD3' ' A' ' 113' ' ' PRO . 85.1 m -144.0 116.69 8.7 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.267 -0.896 . . . . 0.0 110.264 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.581 ' CD2' HG13 ' A' ' 54' ' ' ILE . 20.4 m-30 -114.49 73.43 2.8 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.251 -0.905 . . . . 0.0 110.043 179.92 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.462 ' O ' ' HB2' ' A' ' 122' ' ' GLU . 43.9 Cg_endo -70.47 -163.18 0.11 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.998 1.525 . . . . 0.0 110.465 -179.962 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.465 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -131.95 21.39 4.54 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.237 -0.914 . . . . 0.0 110.223 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 20.2 p -100.97 100.82 13.85 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.208 -0.933 . . . . 0.0 110.124 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 45.8 Cg_endo -72.92 79.21 2.02 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.985 1.518 . . . . 0.0 110.381 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -117.64 176.43 5.18 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.259 -0.901 . . . . 0.0 110.178 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -74.41 -58.75 3.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.215 -0.928 . . . . 0.0 110.222 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -85.02 -0.26 53.81 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 110.311 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 120' ' ' ASP . 1.8 m-20 -130.71 86.7 51.84 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.268 -0.895 . . . . 0.0 110.248 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.532 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 48.6 Cg_endo -75.21 -167.47 0.43 Allowed 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.981 1.516 . . . . 0.0 110.32 179.959 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.519 ' N ' ' OE1' ' A' ' 122' ' ' GLU . 22.5 pm0 -140.63 -145.78 0.18 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.144 -0.973 . . . . 0.0 110.264 179.768 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.512 ' HA3' ' CB ' ' A' ' 112' ' ' TYR . . . -147.45 157.84 27.52 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.527 ' CB ' ' HA ' ' A' ' 50' ' ' ASN . 2.4 pt20 -150.43 -157.55 0.83 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.276 -1.132 . . . . 0.0 110.6 -179.58 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.525 ' CD1' HD11 ' A' ' 4' ' ' ILE . 12.4 mt -118.45 142.92 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.464 -0.773 . . . . 0.0 109.068 179.382 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -121.32 123.56 42.46 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.258 -0.901 . . . . 0.0 111.032 -179.351 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.478 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 4.9 m-85 -118.59 109.38 16.09 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 178.446 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.476 ' O ' ' CE2' ' A' ' 132' ' ' PHE . 1.3 mm100 -88.65 102.53 15.06 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.231 -0.918 . . . . 0.0 111.901 -177.497 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.479 ' HG ' ' HA2' ' A' ' 46' ' ' GLY . 13.9 mt -107.42 45.06 1.02 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 178.289 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -95.57 78.1 0.82 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.453 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.576 ' O ' ' CG ' ' A' ' 132' ' ' PHE . . . 78.61 110.3 0.2 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.747 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.582 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 26.0 m-85 -161.57 -49.02 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.22 -1.165 . . . . 0.0 110.355 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.586 ' HB3' ' CE3' ' A' ' 137' ' ' TRP . 1.0 OUTLIER -89.43 -140.13 0.14 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.046 -1.034 . . . . 0.0 110.1 179.888 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -133.95 -83.37 0.45 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.17 -0.956 . . . . 0.0 110.364 -179.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.434 ' O ' ' C ' ' A' ' 136' ' ' ALA . 1.1 m-20 -81.53 162.87 23.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.192 -0.942 . . . . 0.0 110.283 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.51 ' N ' ' HA ' ' A' ' 38' ' ' ALA . . . -41.21 123.35 2.04 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.333 -0.854 . . . . 0.0 110.263 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.588 ' CZ2' HG12 ' A' ' 36' ' ' VAL . 11.4 p90 -137.22 -173.15 3.38 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.174 -0.953 . . . . 0.0 110.619 -179.93 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.471 ' CG2' ' N ' ' A' ' 139' ' ' LEU . 0.8 OUTLIER -151.07 174.19 13.48 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.432 -0.792 . . . . 0.0 110.073 -178.024 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.579 ' CD2' ' CD1' ' A' ' 95' ' ' LEU . 1.7 mp -139.82 119.38 13.12 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.153 -0.967 . . . . 0.0 112.059 -179.679 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' CYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 0.8 OUTLIER -103.27 108.37 19.56 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.618 -0.676 . . . . 0.0 110.878 178.132 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.521 ' O ' ' CB ' ' A' ' 142' ' ' ASP . 1.4 mt -94.55 -178.93 4.72 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.285 -0.885 . . . . 0.0 108.792 178.513 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.54 ' CA ' ' HA ' ' A' ' 8' ' ' THR . 0.4 OUTLIER 168.29 55.38 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.063 -1.023 . . . . 0.0 110.98 -179.963 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.524 ' HB2' ' O ' ' A' ' 142' ' ' ASP . 10.9 t70 172.91 46.81 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.469 -0.769 . . . . 0.0 109.132 179.56 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.552 HG22 ' CZ ' ' A' ' 9' ' ' PHE . 1.3 t -91.71 112.93 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.16 -0.962 . . . . 0.0 110.646 -179.043 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -149.43 147.17 27.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.488 -0.758 . . . . 0.0 110.041 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.45 ' HB3' ' OG ' ' A' ' 2' ' ' SER . 10.8 tp -141.49 125.2 16.9 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.388 -0.82 . . . . 0.0 110.237 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.471 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -133.81 174.33 10.57 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.197 -0.94 . . . . 0.0 110.207 179.977 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 149' ' ' GLU . 57.5 p -119.98 141.72 49.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.207 -0.933 . . . . 0.0 110.32 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 148' ' ' SER . 15.1 tt0 42.64 93.87 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.238 -0.914 . . . . 0.0 110.306 179.964 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 7.3 p -141.79 22.01 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.267 -0.896 . . . . 0.0 110.165 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -109.83 91.26 3.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.913 . . . . 0.0 110.283 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.439 ' N ' ' CD2' ' A' ' 152' ' ' LEU . 4.2 mm? . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.189 -179.984 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' A' ' 146' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.277 0.561 . . . . 0.0 110.213 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.447 ' HB2' ' O ' ' A' ' 1' ' ' ALA . 7.8 t -177.81 109.5 0.22 Allowed Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.32 -0.862 . . . . 0.0 110.068 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.457 ' HB2' ' O ' ' A' ' 51' ' ' GLY . 51.1 Cg_endo -80.97 19.58 1.12 Allowed 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.986 1.519 . . . . 0.0 111.115 -179.832 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.451 ' CG1' ' N ' ' A' ' 5' ' ' GLY . 6.1 pt -138.78 -37.01 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.997 -1.065 . . . . 0.0 110.118 179.906 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.451 ' N ' ' CG1' ' A' ' 4' ' ' ILE . . . 161.36 126.59 0.83 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -73.52 81.99 1.48 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.258 -1.142 . . . . 0.0 110.192 179.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 144' ' ' VAL . . . 114.59 -123.37 5.99 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.524 ' CG2' ' O ' ' A' ' 142' ' ' ASP . 15.6 p -80.5 179.04 7.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.29 -1.123 . . . . 0.0 110.136 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.567 ' CE2' ' HB2' ' A' ' 32' ' ' LEU . 23.0 m-85 -68.57 -35.78 77.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.306 -0.871 . . . . 0.0 109.579 179.735 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.551 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 23.2 t0 38.09 42.74 0.5 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.645 -0.659 . . . . 0.0 110.705 179.308 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.551 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 4.3 t0 161.9 71.07 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 121.508 0.671 . . . . 0.0 109.545 179.871 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 11' ' ' ASP . . . 43.95 -168.5 0.02 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.485 ' O ' ' C ' ' A' ' 14' ' ' GLU . 51.1 Cg_endo -74.43 81.47 2.05 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.121 1.59 . . . . 0.0 110.337 179.947 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.485 ' C ' ' O ' ' A' ' 13' ' ' PRO . 0.2 OUTLIER -31.77 -67.51 0.1 Allowed 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.292 0.568 . . . . 0.0 111.183 -179.614 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.5 ' C ' ' CD1' ' A' ' 49' ' ' LEU . . . -145.75 10.24 1.64 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.579 ' CH2' HG23 ' A' ' 125' ' ' ILE . 66.4 m95 -78.06 88.95 4.18 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.149 -1.207 . . . . 0.0 110.257 -179.863 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.592 ' CG2' ' CG2' ' A' ' 48' ' ' VAL . 0.8 OUTLIER -85.18 144.88 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.093 -1.004 . . . . 0.0 109.44 179.802 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.528 ' CB ' HG13 ' A' ' 34' ' ' VAL . . . -128.64 128.81 44.88 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.025 -1.047 . . . . 0.0 109.93 179.554 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.486 ' O ' HG11 ' A' ' 45' ' ' VAL . 23.4 p90 -113.24 145.49 40.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.451 -0.781 . . . . 0.0 110.397 -179.302 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.499 ' C ' ' CG2' ' A' ' 21' ' ' THR . . . 156.77 -91.03 0.12 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.528 ' CG2' ' HG3' ' A' ' 37' ' ' PRO . 5.5 p -151.96 18.92 0.68 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.254 -1.145 . . . . 0.0 110.051 179.675 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.468 ' HB3' ' O ' ' A' ' 35' ' ' ALA . 2.0 p30 -102.76 147.72 26.5 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.28 -0.887 . . . . 0.0 110.197 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.68 -138.13 0.15 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.801 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.417 ' O ' ' C ' ' A' ' 25' ' ' LEU . 46.2 Cg_endo -73.62 133.46 18.82 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.044 1.549 . . . . 0.0 110.346 179.865 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.507 ' CD1' ' O ' ' A' ' 16' ' ' TRP . 7.8 mt -42.53 113.52 0.47 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.254 -0.904 . . . . 0.0 110.083 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.472 ' HB3' ' HB2' ' A' ' 33' ' ' CYS . 29.5 t70 -66.4 101.37 0.74 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.23 -0.919 . . . . 0.0 110.188 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.473 ' OG1' ' HD3' ' A' ' 13' ' ' PRO . 1.5 p -119.23 -81.32 0.63 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.296 -0.877 . . . . 0.0 109.955 -179.911 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.456 ' O ' ' HB ' ' A' ' 29' ' ' THR . 22.5 p 42.16 36.23 0.68 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.254 -0.903 . . . . 0.0 110.442 179.811 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.456 ' HB ' ' O ' ' A' ' 28' ' ' SER . 12.2 t -177.97 -31.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.3 -0.875 . . . . 0.0 110.194 179.914 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.444 ' O ' ' HB2' ' A' ' 9' ' ' PHE . . . 126.35 2.19 7.04 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.946 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.47 ' HA ' ' HB3' ' A' ' 142' ' ' ASP . . . -111.29 109.83 20.03 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.212 -1.169 . . . . 0.0 110.24 179.992 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.567 ' HB2' ' CE2' ' A' ' 9' ' ' PHE . 1.0 OUTLIER -68.51 102.37 1.44 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.281 -0.887 . . . . 0.0 109.966 179.943 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.472 ' HB2' ' HB3' ' A' ' 26' ' ' ASP . 34.2 m -108.19 103.61 12.84 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.319 -0.863 . . . . 0.0 110.514 -179.687 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.528 HG13 ' CB ' ' A' ' 18' ' ' ALA . 19.5 m -89.71 155.51 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.262 -0.899 . . . . 0.0 109.762 179.621 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.484 ' HA ' ' OG1' ' A' ' 138' ' ' THR . . . -103.87 101.26 11.06 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.249 -0.907 . . . . 0.0 111.346 -179.111 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.574 HG12 ' CZ2' ' A' ' 137' ' ' TRP . 91.4 t -84.41 123.07 75.25 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.168 -0.958 . . . . 0.0 109.009 178.794 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.528 ' HG3' ' CG2' ' A' ' 21' ' ' THR . 43.2 Cg_endo -67.85 147.33 74.62 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.87 1.458 . . . . 0.0 111.347 -178.866 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.517 ' HA ' ' CA ' ' A' ' 136' ' ' ALA . . . -47.37 116.47 1.43 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.312 -0.868 . . . . 0.0 109.817 179.659 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.1 71.91 1.16 Allowed Glycine 0 N--CA 1.486 1.99 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 -179.51 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.579 ' HB3' ' CH2' ' A' ' 137' ' ' TRP . 0.4 OUTLIER -84.89 43.96 1.03 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.324 -1.103 . . . . 0.0 109.807 -179.987 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.526 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . -88.5 -139.46 0.12 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.491 -0.755 . . . . 0.0 110.029 179.871 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.553 ' HG2' ' N ' ' A' ' 43' ' ' TYR . 0.0 OUTLIER 42.79 -140.98 0.14 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.543 -0.723 . . . . 0.0 110.346 -179.479 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.599 ' CD1' ' O ' ' A' ' 44' ' ' GLY . 8.3 p90 -28.96 -39.51 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.175 0 CA-C-O 121.143 0.497 . . . . 0.0 110.929 -179.136 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.599 ' O ' ' CD1' ' A' ' 43' ' ' TYR . . . 89.76 132.96 4.93 Favored Glycine 0 N--CA 1.493 2.441 0 C-N-CA 120.041 -1.076 . . . . 0.0 110.674 178.22 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.542 ' CG2' ' HB2' ' A' ' 40' ' ' SER . 2.6 t -89.85 179.52 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.364 -1.08 . . . . 0.0 108.908 179.238 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 128' ' ' GLN . . . 173.57 -177.58 45.86 Favored Glycine 0 N--CA 1.488 2.118 0 C-N-CA 119.024 -1.56 . . . . 0.0 110.668 -179.886 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.531 ' CG1' ' O ' ' A' ' 17' ' ' VAL . 21.6 t -150.65 132.43 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.737 -0.861 . . . . 0.0 108.768 179.779 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.592 ' CG2' ' CG2' ' A' ' 17' ' ' VAL . 31.1 m -119.66 131.7 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.976 -1.077 . . . . 0.0 110.69 -179.383 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.574 HD21 ' CZ2' ' A' ' 16' ' ' TRP . 30.0 tp -124.06 90.76 3.32 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.439 -0.788 . . . . 0.0 110.353 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.535 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 22.0 p30 -75.2 145.84 41.71 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.271 -0.893 . . . . 0.0 110.237 179.881 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 3' ' ' PRO . . . 122.19 63.48 0.22 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.969 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.49 ' CG1' ' N ' ' A' ' 53' ' ' ALA . 53.5 t -121.96 171.9 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.235 -1.156 . . . . 0.0 109.968 179.807 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.49 ' N ' ' CG1' ' A' ' 52' ' ' VAL . . . -141.88 77.91 1.61 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.072 -1.017 . . . . 0.0 110.804 -179.742 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.593 ' CD1' ' CE1' ' A' ' 60' ' ' TYR . 35.6 mm -112.34 159.24 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.177 -0.952 . . . . 0.0 109.622 179.343 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.527 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 0.6 OUTLIER -153.48 132.25 12.34 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.04 -1.037 . . . . 0.0 110.836 -179.634 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 19.4 pt-20 37.72 -155.49 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.67 -0.644 . . . . 0.0 110.994 179.488 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 109' ' ' SER . . . -85.95 80.92 1.75 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.776 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.559 ' CG2' ' N ' ' A' ' 59' ' ' THR . 1.2 m -105.72 173.88 6.12 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.268 -1.137 . . . . 0.0 109.73 179.76 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.559 ' N ' ' CG2' ' A' ' 58' ' ' THR . 0.6 OUTLIER -89.7 154.78 19.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.144 -0.972 . . . . 0.0 110.411 -179.731 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.593 ' CE1' ' CD1' ' A' ' 54' ' ' ILE . 55.8 m-85 -159.87 178.5 9.69 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.32 -0.862 . . . . 0.0 110.3 179.905 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 104' ' ' GLU . 32.8 m -150.13 123.61 9.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.337 -0.852 . . . . 0.0 109.925 179.8 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.6 tp -89.44 118.63 29.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.186 -0.946 . . . . 0.0 110.067 -179.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.494 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 2.1 tpt180 -127.97 114.47 17.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.31 -0.869 . . . . 0.0 110.204 -179.761 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.64 ' CZ ' ' CG2' ' A' ' 102' ' ' VAL . 0.4 OUTLIER -157.99 141.19 15.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.155 -0.966 . . . . 0.0 110.037 179.591 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.516 ' CG2' ' HG2' ' A' ' 101' ' ' GLN . 18.7 m -119.42 98.91 6.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.916 . . . . 0.0 109.976 -179.834 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.522 ' HB1' ' CD2' ' A' ' 141' ' ' LEU . . . -103.51 152.35 21.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.335 -0.853 . . . . 0.0 110.368 -179.669 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.457 ' OG1' ' HA ' ' A' ' 99' ' ' PRO . 98.1 m -150.2 108.32 3.74 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.235 -0.915 . . . . 0.0 110.289 179.922 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -92.84 136.05 33.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.238 -0.914 . . . . 0.0 109.975 179.836 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 68' ' ' ALA . 12.2 t -44.93 -26.14 0.39 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.082 -1.011 . . . . 0.0 109.343 179.57 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.529 ' CG2' ' HB2' ' A' ' 137' ' ' TRP . 3.2 t -113.71 -179.69 3.71 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.527 -0.733 . . . . 0.0 109.806 179.708 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.453 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 37.5 t0 -94.4 69.48 3.63 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.16 -0.962 . . . . 0.0 109.545 179.253 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.582 ' CG2' ' CB ' ' A' ' 133' ' ' SER . 4.7 p -92.1 147.34 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.259 -0.901 . . . . 0.0 111.045 -179.278 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.5 m -128.6 89.45 2.89 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.078 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.581 ' HA ' ' CD1' ' A' ' 132' ' ' PHE . 10.7 m -89.64 -151.2 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.228 -0.92 . . . . 0.0 110.49 -179.116 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.465 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 34.9 mtm-85 -128.05 137.6 52.24 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.206 -0.934 . . . . 0.0 110.761 -179.295 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.521 ' CB ' ' HG3' ' A' ' 93' ' ' PRO . . . -139.28 155.38 47.77 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.356 -0.84 . . . . 0.0 109.881 179.455 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.489 ' C ' ' CD1' ' A' ' 77' ' ' LEU . 1.3 pp 175.23 -157.4 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.327 -0.858 . . . . 0.0 109.982 -179.601 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.536 HG13 ' CE2' ' A' ' 112' ' ' TYR . 4.9 t -147.85 168.54 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.204 -0.935 . . . . 0.0 109.41 179.762 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.493 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . -177.8 176.78 48.2 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.339 -1.41 . . . . 0.0 109.906 -179.882 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.486 ' NE2' ' C ' ' A' ' 81' ' ' ASN . 13.6 tp60 -107.31 135.43 48.83 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.31 -1.112 . . . . 0.0 110.534 179.931 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.538 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 2.4 m120 -123.26 96.77 5.12 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 122.072 0.939 . . . . 0.0 108.894 178.644 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.642 ' CA ' ' HD2' ' A' ' 121' ' ' PRO . . . 132.9 34.21 0.35 Allowed Glycine 0 N--CA 1.484 1.861 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.214 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.545 ' HA ' ' CD2' ' A' ' 85' ' ' TYR . . . 60.15 143.94 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.264 -1.139 . . . . 0.0 110.235 -179.861 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.466 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.5 Cg_endo -82.22 18.45 17.86 Favored 'Cis proline' 0 C--N 1.313 -1.303 0 C-N-CA 121.868 -2.138 . . . . 0.0 110.869 -0.139 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.545 ' CD2' ' HA ' ' A' ' 83' ' ' ALA . 94.1 m-85 57.28 170.26 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.152 -0.967 . . . . 0.0 110.439 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 136.6 117.93 1.7 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.425 HG23 ' O ' ' A' ' 78' ' ' VAL . 0.8 OUTLIER -97.78 145.69 26.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.195 -1.179 . . . . 0.0 110.185 179.863 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.46 ' HB ' ' HA ' ' A' ' 108' ' ' ALA . 29.4 m -123.98 -17.45 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.265 -0.897 . . . . 0.0 110.359 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.576 HD12 ' CZ ' ' A' ' 106' ' ' PHE . 4.0 mp -108.5 136.96 47.25 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.189 -0.945 . . . . 0.0 111.009 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -150.97 82.2 1.33 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.457 -0.777 . . . . 0.0 109.836 179.601 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.2 p -140.06 178.5 7.23 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.033 -1.042 . . . . 0.0 110.741 -179.598 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.7 m -119.81 111.97 35.51 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.456 -0.777 . . . . 0.0 109.863 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.532 ' HG2' ' CG2' ' A' ' 74' ' ' VAL . 43.6 Cg_endo -70.1 99.57 0.79 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.957 1.503 . . . . 0.0 110.866 -179.764 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.518 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -76.23 153.21 36.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 0.0 109.687 179.504 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.523 ' CD1' ' HG ' ' A' ' 139' ' ' LEU . 72.7 mt -142.54 168.83 18.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.118 -0.989 . . . . 0.0 110.492 -179.751 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 70' ' ' THR . 0.3 OUTLIER -177.22 -178.82 0.82 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.411 -0.805 . . . . 0.0 110.038 -179.966 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.7 -8.23 26.38 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.228 -0.92 . . . . 0.0 110.148 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.447 ' O ' HG22 ' A' ' 67' ' ' THR . 11.3 mt-10 -106.17 168.22 8.51 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.907 . . . . 0.0 110.097 179.87 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.457 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 46.4 Cg_endo -72.83 130.26 15.46 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.046 1.55 . . . . 0.0 110.363 179.993 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.518 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 3.1 ttm-85 -119.91 92.42 3.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.176 -0.953 . . . . 0.0 110.251 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.516 ' HG2' ' CG2' ' A' ' 65' ' ' THR . 1.7 mt-30 -75.11 153.23 38.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.33 -0.856 . . . . 0.0 109.975 179.845 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.64 ' CG2' ' CZ ' ' A' ' 64' ' ' TYR . 39.4 t -130.35 133.56 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.18 -0.95 . . . . 0.0 110.387 -179.945 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.526 ' O ' ' CG ' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -150.35 124.35 9.33 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.356 -0.84 . . . . 0.0 110.065 -179.987 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.526 ' CG ' ' O ' ' A' ' 103' ' ' THR . 35.3 mt-10 -157.56 154.53 28.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.256 -0.902 . . . . 0.0 110.315 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.2 m -117.39 114.67 23.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.261 -0.899 . . . . 0.0 110.042 179.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.576 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 35.4 p90 -127.27 155.42 43.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.195 -0.94 . . . . 0.0 110.342 -179.782 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.413 ' O ' ' C ' ' A' ' 108' ' ' ALA . 21.0 m -93.12 89.04 6.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.296 -0.878 . . . . 0.0 109.977 179.7 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.589 ' CB ' ' CD2' ' A' ' 60' ' ' TYR . . . -42.61 100.06 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.245 -0.909 . . . . 0.0 110.346 -179.855 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.463 ' HA ' ' HA2' ' A' ' 57' ' ' GLY . 43.2 p -88.81 51.87 2.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.262 -0.899 . . . . 0.0 110.144 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.434 ' HB1' HG12 ' A' ' 88' ' ' VAL . . . -159.18 -152.81 0.33 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.264 -0.898 . . . . 0.0 110.301 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.452 HG22 ' HA ' ' A' ' 55' ' ' GLU . 25.1 m -153.5 119.07 5.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.886 . . . . 0.0 110.204 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.575 ' CD2' HG13 ' A' ' 54' ' ' ILE . 17.8 m-30 -113.95 89.7 17.28 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.303 -0.873 . . . . 0.0 109.942 179.829 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.473 ' O ' ' HB2' ' A' ' 122' ' ' GLU . 44.9 Cg_endo -71.84 -158.69 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.028 1.541 . . . . 0.0 110.406 -179.928 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.422 ' HA ' ' CD ' ' A' ' 122' ' ' GLU . . . -153.94 36.89 0.44 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.221 -0.925 . . . . 0.0 110.244 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.448 ' O ' ' O ' ' A' ' 120' ' ' ASP . 7.2 m -106.6 95.0 11.03 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.307 -0.87 . . . . 0.0 110.203 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.464 ' HA ' ' O ' ' A' ' 120' ' ' ASP . 46.4 Cg_endo -73.16 128.37 12.93 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.014 1.534 . . . . 0.0 110.465 -179.945 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.422 ' CB ' ' HB2' ' A' ' 120' ' ' ASP . . . -150.05 -163.55 1.81 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.272 -0.892 . . . . 0.0 110.193 179.895 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.73 -11.75 48.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.229 -0.919 . . . . 0.0 110.194 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -160.3 21.98 0.16 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.201 -0.937 . . . . 0.0 110.148 179.941 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.464 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 79.9 m-20 -122.82 69.83 37.01 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.272 -0.893 . . . . 0.0 110.206 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.642 ' HD2' ' CA ' ' A' ' 82' ' ' GLY . 44.0 Cg_endo -76.48 18.06 0.73 Allowed 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 124.067 1.561 . . . . 0.0 112.505 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.538 ' O ' ' HB2' ' A' ' 81' ' ' ASN . 6.6 pt-20 40.72 -170.33 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.623 -0.673 . . . . 0.0 111.133 178.922 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -106.01 158.94 15.4 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 -179.429 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.535 ' CB ' ' HA ' ' A' ' 50' ' ' ASN . 17.1 pt20 -150.63 -151.76 0.41 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.366 -1.079 . . . . 0.0 110.621 -179.806 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.579 HG23 ' CH2' ' A' ' 16' ' ' TRP . 23.9 mt -118.56 146.51 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.616 -0.677 . . . . 0.0 109.425 179.665 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.472 ' CB ' HD13 ' A' ' 77' ' ' LEU . . . -116.15 114.87 25.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.336 -0.853 . . . . 0.0 111.744 -178.879 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.504 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 4.0 m-85 -119.81 75.69 1.1 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.247 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.454 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 12.9 mt-30 -88.42 123.27 32.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.196 -0.94 . . . . 0.0 111.902 -177.754 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.514 ' CD2' HG23 ' A' ' 74' ' ' VAL . 3.6 mt -107.76 51.77 0.73 Allowed 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.746 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -96.1 130.75 10.38 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.627 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.577 ' O ' ' CD1' ' A' ' 132' ' ' PHE . . . 51.14 93.81 0.01 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.581 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 9.5 m-85 -158.86 -78.23 0.07 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.281 -1.129 . . . . 0.0 110.419 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.591 ' HB3' ' CE3' ' A' ' 137' ' ' TRP . 1.3 t -89.66 168.39 12.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.096 -1.003 . . . . 0.0 110.339 -179.812 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -98.26 -91.56 0.26 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.274 -0.892 . . . . 0.0 110.316 -179.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -46.65 158.05 0.13 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.081 -1.012 . . . . 0.0 110.35 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.517 ' CA ' ' HA ' ' A' ' 38' ' ' ALA . . . -54.48 128.66 32.93 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.313 -0.867 . . . . 0.0 110.333 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.591 ' CE3' ' HB3' ' A' ' 133' ' ' SER . 8.9 p90 -135.24 -163.35 1.37 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.306 -0.871 . . . . 0.0 110.009 179.674 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.589 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 0.8 OUTLIER -160.95 176.5 11.34 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.195 -1.002 . . . . 0.0 110.696 -178.382 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.523 ' HG ' ' CD1' ' A' ' 95' ' ' LEU . 2.1 mp -133.52 126.04 30.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.464 -0.773 . . . . 0.0 109.605 179.172 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' CYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 33.4 m -121.94 98.77 6.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.032 -1.043 . . . . 0.0 110.91 -179.536 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.522 ' CD2' ' HB1' ' A' ' 66' ' ' ALA . 2.2 mt -89.8 -179.91 5.85 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -0.927 . . . . 0.0 109.318 179.067 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.524 ' O ' ' CG2' ' A' ' 8' ' ' THR . 2.7 p30 168.03 41.08 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.289 -0.882 . . . . 0.0 110.104 179.908 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.477 ' O ' ' HA ' ' A' ' 64' ' ' TYR . 0.3 OUTLIER -174.98 52.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.289 -0.882 . . . . 0.0 109.659 -179.877 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.561 HG22 ' CE1' ' A' ' 9' ' ' PHE . 1.4 t -89.2 121.27 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.349 -0.845 . . . . 0.0 109.917 -179.44 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -144.41 140.87 29.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.329 -0.857 . . . . 0.0 110.293 -179.631 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' A' ' 1' ' ' ALA . 13.6 tp -148.08 123.82 10.54 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.376 -0.828 . . . . 0.0 110.072 179.839 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.468 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 7.3 t0 -136.15 -177.31 4.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.179 -0.951 . . . . 0.0 110.295 -179.893 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.3 p -134.53 173.7 11.37 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.253 -0.904 . . . . 0.0 110.129 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.458 ' O ' ' HB ' ' A' ' 150' ' ' VAL . 0.0 OUTLIER -104.44 45.81 0.94 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.215 -0.928 . . . . 0.0 110.237 179.995 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.458 ' HB ' ' O ' ' A' ' 149' ' ' GLU . 6.2 p -179.6 139.81 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.247 -0.908 . . . . 0.0 110.222 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 150' ' ' VAL . 78.1 mt-10 -43.97 161.8 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.244 -0.91 . . . . 0.0 110.214 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.482 ' C ' ' CD1' ' A' ' 152' ' ' LEU . 2.9 tm? . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.231 -179.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.232 0.539 . . . . 0.0 110.208 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.6 m -113.31 85.5 8.65 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.275 -0.89 . . . . 0.0 110.223 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -76.48 -156.59 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.987 1.52 . . . . 0.0 110.115 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.489 ' CG2' ' O ' ' A' ' 51' ' ' GLY . 9.1 pt -95.51 19.49 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.278 -0.889 . . . . 0.0 110.097 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' A' ' 7' ' ' GLY . . . 79.94 70.39 1.33 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.965 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.427 ' HA ' ' HB3' ' A' ' 145' ' ' ALA . 82.6 mt-10 -42.42 94.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.31 -1.112 . . . . 0.0 110.198 -179.945 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 5' ' ' GLY . . . 173.99 -159.1 28.36 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.987 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.521 ' CG2' ' O ' ' A' ' 142' ' ' ASP . 11.9 p -98.34 -154.91 0.47 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.367 -1.078 . . . . 0.0 110.268 -179.851 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.523 ' CE1' ' CD1' ' A' ' 16' ' ' TRP . 64.6 m-85 -120.56 44.21 2.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.305 -0.872 . . . . 0.0 110.176 179.959 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.559 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 49.5 t0 -97.84 61.7 1.57 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.234 -0.916 . . . . 0.0 110.126 -179.973 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.559 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 2.5 t0 161.83 -23.72 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.745 -0.597 . . . . 0.0 109.652 -179.973 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 176.21 133.98 1.87 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.505 ' O ' ' HB3' ' A' ' 14' ' ' GLU . 48.9 Cg_endo -78.02 6.15 4.83 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.906 1.477 . . . . 0.0 110.533 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.505 ' HB3' ' O ' ' A' ' 13' ' ' PRO . 5.6 tp10 60.66 -89.03 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.356 -0.84 . . . . 0.0 110.386 -179.793 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.484 ' C ' ' CD1' ' A' ' 49' ' ' LEU . . . -148.09 25.44 1.43 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -179.859 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.568 ' CD1' HD23 ' A' ' 49' ' ' LEU . 57.1 m95 -72.12 86.39 1.05 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.166 -1.197 . . . . 0.0 110.354 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.589 ' CG2' ' CG2' ' A' ' 48' ' ' VAL . 1.1 m -87.42 153.32 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.205 -0.934 . . . . 0.0 109.92 179.942 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . . . -136.84 133.63 36.06 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.268 -0.895 . . . . 0.0 109.456 179.437 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.572 ' CZ ' ' O ' ' A' ' 46' ' ' GLY . 6.1 p90 -120.38 161.11 21.74 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.283 -0.886 . . . . 0.0 111.122 -178.635 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.573 ' HA2' ' CE1' ' A' ' 43' ' ' TYR . . . 72.96 49.15 17.82 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.88 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.53 HG21 ' CG1' ' A' ' 45' ' ' VAL . 11.5 p -148.12 -153.52 0.5 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.254 -1.145 . . . . 0.0 110.404 -179.956 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -89.87 44.02 1.18 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.326 -0.859 . . . . 0.0 110.079 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.56 -144.28 16.29 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.889 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.99 -159.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.973 1.512 . . . . 0.0 110.367 179.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 17' ' ' VAL . 0.3 OUTLIER -111.51 -173.12 2.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.184 -0.947 . . . . 0.0 110.037 179.809 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -132.03 159.9 37.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.163 -0.96 . . . . 0.0 110.19 -179.88 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.464 HG23 ' HD3' ' A' ' 13' ' ' PRO . 0.7 OUTLIER -133.62 -34.57 1.03 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.254 -0.904 . . . . 0.0 110.258 -179.911 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.441 ' O ' ' OG1' ' A' ' 29' ' ' THR . 73.6 m 51.28 30.41 5.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.23 -0.919 . . . . 0.0 110.221 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.453 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 5.4 p 42.8 55.04 4.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.28 -0.888 . . . . 0.0 110.2 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.516 ' N ' ' HA ' ' A' ' 10' ' ' ASP . . . -169.55 -54.86 0.03 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.464 ' HB2' ' O ' ' A' ' 141' ' ' LEU . . . -149.88 149.91 31.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.211 -1.17 . . . . 0.0 110.32 -179.902 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.494 ' CD1' ' HB3' ' A' ' 13' ' ' PRO . 1.1 tp -79.97 103.15 9.66 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.243 -0.911 . . . . 0.0 109.822 179.739 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.441 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 23.2 m -109.6 105.85 15.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.212 -0.93 . . . . 0.0 110.778 -179.503 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.495 ' O ' ' OG1' ' A' ' 138' ' ' THR . 18.0 m -91.09 140.12 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.241 -0.912 . . . . 0.0 109.122 179.08 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.471 ' O ' ' HB ' ' A' ' 21' ' ' THR . . . -89.18 98.33 11.71 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.102 -0.999 . . . . 0.0 111.032 -179.052 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.664 ' CG1' ' CZ2' ' A' ' 137' ' ' TRP . 48.3 t -83.72 130.09 56.98 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.267 -0.896 . . . . 0.0 109.617 179.168 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 21' ' ' THR . 43.6 Cg_endo -70.73 -179.25 3.2 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.815 1.429 . . . . 0.0 110.538 -179.742 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.577 ' HA ' ' N ' ' A' ' 136' ' ' ALA . . . -42.79 166.67 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.25 -0.906 . . . . 0.0 110.137 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.595 ' O ' ' N ' ' A' ' 41' ' ' ALA . . . -35.68 108.12 0.05 OUTLIER Glycine 0 N--CA 1.495 2.62 0 N-CA-C 109.169 -1.573 . . . . 0.0 109.169 179.798 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.554 ' O ' ' CA ' ' A' ' 131' ' ' GLY . 0.4 OUTLIER -39.36 89.9 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.979 0.895 . . . . 0.0 110.263 -178.899 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.595 ' N ' ' O ' ' A' ' 39' ' ' GLY . . . -114.79 23.84 12.28 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 121.952 0.882 . . . . 0.0 109.673 -179.465 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.543 ' CG ' ' O ' ' A' ' 42' ' ' GLN . 0.9 OUTLIER 177.04 34.3 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.241 -179.891 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.573 ' CE1' ' HA2' ' A' ' 20' ' ' GLY . 0.1 OUTLIER -158.79 -28.19 0.07 Allowed 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 118.548 -1.261 . . . . 0.0 112.389 -177.806 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 43' ' ' TYR . . . 53.43 84.47 0.03 OUTLIER Glycine 0 N--CA 1.483 1.829 0 N-CA-C 105.285 -3.126 . . . . 0.0 105.285 -176.766 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.53 ' CG1' HG21 ' A' ' 21' ' ' THR . 3.0 t -86.61 143.08 12.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.301 -1.117 . . . . 0.0 109.665 -176.751 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.572 ' O ' ' CZ ' ' A' ' 19' ' ' TYR . . . -166.26 147.35 12.01 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.289 -1.434 . . . . 0.0 110.785 -179.058 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.519 ' CG1' ' O ' ' A' ' 17' ' ' VAL . 19.7 t -111.7 129.69 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.576 -0.955 . . . . 0.0 109.668 179.659 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.589 ' CG2' ' CG2' ' A' ' 17' ' ' VAL . 27.3 m -120.69 145.02 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.743 -1.223 . . . . 0.0 110.656 -179.624 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.568 HD23 ' CD1' ' A' ' 16' ' ' TRP . 15.9 tp -144.45 117.38 8.81 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.262 -0.899 . . . . 0.0 110.34 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.532 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 5.2 p-10 -90.44 148.19 22.94 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.208 -0.932 . . . . 0.0 110.49 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.489 ' O ' ' CG2' ' A' ' 4' ' ' ILE . . . 126.44 78.62 0.29 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.837 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.531 HG13 ' CG1' ' A' ' 54' ' ' ILE . 3.7 t -132.79 158.45 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.181 -1.188 . . . . 0.0 110.135 179.781 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -105.71 61.21 0.66 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.167 -0.958 . . . . 0.0 110.472 -179.885 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.571 HD11 ' CZ ' ' A' ' 60' ' ' TYR . 6.3 mm -123.63 151.42 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.194 -0.941 . . . . 0.0 109.846 179.731 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.514 ' HA ' ' CG2' ' A' ' 111' ' ' THR . 4.4 pt-20 -174.97 34.07 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.106 -0.996 . . . . 0.0 110.376 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.497 ' HB2' ' O ' ' A' ' 55' ' ' GLU . 1.3 tt0 179.88 -174.66 0.26 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.426 -0.796 . . . . 0.0 110.256 -179.797 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.486 ' HA2' ' O ' ' A' ' 108' ' ' ALA . . . -94.27 68.01 1.4 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 108.239 -1.944 . . . . 0.0 108.239 178.956 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.581 ' CG2' ' N ' ' A' ' 59' ' ' THR . 1.0 OUTLIER -109.02 176.17 5.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.503 -0.998 . . . . 0.0 110.367 -178.963 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.582 ' O ' ' CD2' ' A' ' 60' ' ' TYR . 0.4 OUTLIER -89.73 158.62 17.46 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.415 -0.803 . . . . 0.0 110.23 -179.941 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.585 ' CE2' ' HB2' ' A' ' 108' ' ' ALA . 68.2 m-85 -156.14 -176.75 6.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.443 -0.786 . . . . 0.0 109.834 179.906 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 26.6 m -150.11 113.42 4.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.196 -0.94 . . . . 0.0 110.187 179.889 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.518 HD23 ' CD2' ' A' ' 89' ' ' LEU . 18.0 tp -89.71 120.86 31.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 110.032 179.821 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.471 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 19.5 mtp-105 -128.4 130.73 48.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.282 -0.887 . . . . 0.0 110.099 179.961 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.541 ' CE2' ' HB ' ' A' ' 102' ' ' VAL . 8.7 p90 -165.48 152.77 10.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.262 -0.899 . . . . 0.0 109.923 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 25.6 m -119.67 93.95 4.24 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.097 -1.002 . . . . 0.0 109.968 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.509 ' CB ' HD23 ' A' ' 95' ' ' LEU . . . -96.33 154.54 17.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.274 -0.891 . . . . 0.0 110.939 -179.482 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 50.9 m -149.69 134.94 18.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.562 -0.711 . . . . 0.0 109.39 179.263 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.516 ' N ' ' HB3' ' A' ' 95' ' ' LEU . . . -120.86 133.94 55.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.064 -1.023 . . . . 0.0 110.282 -179.685 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 68' ' ' ALA . 11.6 t -43.83 -26.17 0.24 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.27 -0.894 . . . . 0.0 109.547 179.546 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.547 ' CG2' ' HB2' ' A' ' 137' ' ' TRP . 5.7 t -115.21 -167.15 1.2 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.436 -0.79 . . . . 0.0 109.824 179.703 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.43 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 34.4 t0 -102.93 47.0 0.9 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.274 -0.891 . . . . 0.0 109.371 179.125 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.526 ' CG1' HD13 ' A' ' 95' ' ' LEU . 1.9 p -63.46 171.53 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.429 -0.794 . . . . 0.0 110.824 -179.227 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.459 HG23 ' O ' ' A' ' 73' ' ' THR . 11.9 m -160.33 83.81 0.7 Allowed 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.67 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.57 ' HA ' ' CG ' ' A' ' 132' ' ' PHE . 2.4 m -89.9 -160.05 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.265 -0.897 . . . . 0.0 110.547 -178.616 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.439 ' HG2' ' OG ' ' A' ' 92' ' ' SER . 20.8 mtm-85 -121.28 112.97 19.27 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.256 -0.902 . . . . 0.0 110.328 -179.613 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.516 ' CB ' ' HD3' ' A' ' 93' ' ' PRO . . . -115.7 157.15 24.7 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.145 -0.972 . . . . 0.0 110.097 179.849 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.57 ' CD1' ' N ' ' A' ' 78' ' ' VAL . 3.8 pp 178.73 -147.3 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.409 -0.807 . . . . 0.0 109.851 -179.828 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.57 ' N ' ' CD1' ' A' ' 77' ' ' LEU . 3.1 t -151.92 172.57 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.115 -0.991 . . . . 0.0 109.563 179.773 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.48 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . 176.07 172.7 41.08 Favored Glycine 0 N--CA 1.49 2.276 0 C-N-CA 119.36 -1.4 . . . . 0.0 110.138 179.892 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.483 ' NE2' ' C ' ' A' ' 81' ' ' ASN . 15.1 tp60 -93.04 137.72 32.14 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.4 -1.059 . . . . 0.0 110.355 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.517 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 3.6 m120 -123.3 96.4 4.98 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.839 0.828 . . . . 0.0 109.02 178.943 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.632 ' CA ' ' HD2' ' A' ' 121' ' ' PRO . . . 132.31 34.4 0.37 Allowed Glycine 0 N--CA 1.484 1.878 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.523 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.564 ' HA ' ' CD2' ' A' ' 85' ' ' TYR . . . 60.41 142.95 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.282 -1.128 . . . . 0.0 110.14 -179.86 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.474 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.3 Cg_endo -82.28 18.6 17.7 Favored 'Cis proline' 0 C--N 1.314 -1.255 0 C-N-CA 121.938 -2.109 . . . . 0.0 110.813 -0.159 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.564 ' CD2' ' HA ' ' A' ' 83' ' ' ALA . 75.7 m-85 58.91 170.02 0.06 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.153 -0.967 . . . . 0.0 110.342 -179.911 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 142.33 114.64 1.06 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.451 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 1.1 p -91.26 147.83 22.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.188 -1.183 . . . . 0.0 110.299 -179.963 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.559 HG22 ' CE1' ' A' ' 106' ' ' PHE . 15.6 m -123.12 -21.81 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.299 -0.876 . . . . 0.0 110.266 179.98 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.535 HD12 ' CE2' ' A' ' 106' ' ' PHE . 3.9 mp -104.94 146.76 28.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.239 -0.913 . . . . 0.0 110.7 179.735 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.517 ' O ' ' CG2' ' A' ' 91' ' ' THR . 8.9 t0 -151.03 89.04 1.49 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.324 -0.86 . . . . 0.0 110.142 179.727 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.517 ' CG2' ' O ' ' A' ' 90' ' ' ASP . 6.5 p -160.0 -178.98 7.4 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.123 -0.986 . . . . 0.0 110.584 -179.862 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.529 ' CB ' ' O ' ' A' ' 74' ' ' VAL . 3.5 m -129.08 129.49 23.38 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.329 -0.857 . . . . 0.0 110.07 179.927 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.516 ' HD3' ' CB ' ' A' ' 76' ' ' ALA . 46.9 Cg_endo -72.28 91.44 0.76 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.935 1.492 . . . . 0.0 110.994 -179.719 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.522 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -70.48 125.14 25.96 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.073 -1.017 . . . . 0.0 109.002 178.972 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.532 ' CD1' ' HG ' ' A' ' 139' ' ' LEU . 29.4 mt -119.83 170.48 9.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.113 -0.992 . . . . 0.0 110.846 -179.023 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.458 ' O ' ' O ' ' A' ' 68' ' ' ALA . 6.1 t -169.36 -151.18 0.09 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.394 -0.816 . . . . 0.0 109.735 179.886 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.423 ' N ' HG22 ' A' ' 96' ' ' THR . 0.5 OUTLIER -93.41 25.51 3.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.046 -1.034 . . . . 0.0 110.043 179.8 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -145.84 171.99 5.83 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.34 -0.85 . . . . 0.0 109.959 179.847 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.57 130.83 16.51 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 124.005 1.529 . . . . 0.0 110.379 -179.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.522 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 1.7 mtt180 -119.7 93.2 3.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.254 -0.904 . . . . 0.0 110.006 179.915 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -82.99 95.24 7.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.448 -0.783 . . . . 0.0 110.45 -179.767 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.541 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 73.6 t -89.47 133.51 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.277 -0.89 . . . . 0.0 110.013 179.836 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 53.5 m -150.21 139.54 21.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.227 -0.921 . . . . 0.0 110.328 -179.948 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.456 ' CG ' ' O ' ' A' ' 103' ' ' THR . 21.3 mt-10 -160.2 160.94 33.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.244 -0.91 . . . . 0.0 110.257 179.881 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.43 HG21 ' O ' ' A' ' 105' ' ' THR . 3.1 t -111.5 128.06 55.9 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.229 -0.919 . . . . 0.0 110.114 179.894 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.559 ' CE1' HG22 ' A' ' 88' ' ' VAL . 22.4 p90 -136.38 157.27 47.19 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.246 -0.909 . . . . 0.0 110.269 -179.916 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.534 ' O ' ' N ' ' A' ' 109' ' ' SER . 3.6 m -89.49 93.9 9.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.163 -0.96 . . . . 0.0 109.732 179.603 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.585 ' HB2' ' CE2' ' A' ' 60' ' ' TYR . . . -49.68 89.99 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.353 -0.842 . . . . 0.0 110.084 -179.932 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.534 ' N ' ' O ' ' A' ' 107' ' ' THR . 79.8 p -85.99 53.96 2.97 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.315 -0.866 . . . . 0.0 109.76 179.888 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -159.28 -156.75 0.54 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.244 -0.91 . . . . 0.0 110.393 -179.769 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.514 ' CG2' ' HA ' ' A' ' 55' ' ' GLU . 3.4 m -149.8 113.45 5.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.256 -0.902 . . . . 0.0 110.457 -179.896 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.489 ' CE2' HG13 ' A' ' 78' ' ' VAL . 11.9 m-30 -109.85 85.91 4.39 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.366 -0.834 . . . . 0.0 109.571 179.535 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.47 ' HD2' ' OE1' ' A' ' 80' ' ' GLN . 45.4 Cg_endo -72.19 -165.83 0.23 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.892 1.469 . . . . 0.0 110.517 -179.757 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -147.63 50.27 1.07 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.307 -0.871 . . . . 0.0 110.24 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 6.8 m -121.66 96.11 47.56 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 0.0 110.143 -179.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 120' ' ' ASP . 46.3 Cg_endo -73.3 123.81 9.01 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.052 1.554 . . . . 0.0 110.477 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.498 ' CB ' ' HB2' ' A' ' 120' ' ' ASP . . . -132.75 -163.35 1.33 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.201 -0.937 . . . . 0.0 110.189 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.64 -15.72 8.44 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.259 -0.901 . . . . 0.0 110.234 179.932 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -166.91 26.97 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.247 -0.908 . . . . 0.0 110.123 179.959 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.498 ' HB2' ' CB ' ' A' ' 117' ' ' ALA . 1.2 m-20 -114.41 83.72 8.86 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.259 -0.901 . . . . 0.0 110.276 -179.931 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.632 ' HD2' ' CA ' ' A' ' 82' ' ' GLY . 43.2 Cg_endo -78.44 17.58 1.06 Allowed 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.96 1.505 . . . . 0.0 112.372 179.929 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.517 ' O ' ' HB2' ' A' ' 81' ' ' ASN . 0.5 OUTLIER 38.29 -168.95 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.325 0.583 . . . . 0.0 111.903 178.625 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.484 ' HA3' ' CB ' ' A' ' 112' ' ' TYR . . . -85.54 149.21 23.39 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -179.378 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.532 ' CB ' ' HA ' ' A' ' 50' ' ' ASN . 6.8 pt20 -150.78 -157.59 0.83 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.358 -1.084 . . . . 0.0 110.651 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.443 ' CG2' ' CE1' ' A' ' 127' ' ' PHE . 5.5 mt -118.54 146.97 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 179.294 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -121.5 122.62 40.12 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.325 -179.183 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.511 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 5.0 m-85 -118.59 98.54 6.29 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.185 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.478 ' O ' ' HB ' ' A' ' 74' ' ' VAL . 10.5 mm-40 -88.75 84.13 6.69 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.262 -0.899 . . . . 0.0 112.368 -177.154 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.502 ' N ' ' O ' ' A' ' 45' ' ' VAL . 7.0 mt -85.2 45.99 1.24 Allowed 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.515 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' A' ' 132' ' ' PHE . . . -64.2 -170.5 2.02 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 -179.396 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.554 ' CA ' ' O ' ' A' ' 40' ' ' SER . . . -51.81 89.49 0.01 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.905 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.57 ' CG ' ' HA ' ' A' ' 74' ' ' VAL . 9.7 m-85 -118.35 -49.53 2.47 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.113 -1.228 . . . . 0.0 110.693 -179.361 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.524 ' HB2' ' CG2' ' A' ' 72' ' ' VAL . 1.3 t -88.53 175.83 7.41 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.997 -1.065 . . . . 0.0 110.233 -179.71 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -97.25 -52.94 3.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.322 -0.862 . . . . 0.0 110.309 -179.744 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -98.82 174.11 6.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.228 -0.92 . . . . 0.0 109.984 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.577 ' N ' ' HA ' ' A' ' 38' ' ' ALA . . . -57.59 125.6 23.63 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.151 -0.968 . . . . 0.0 110.047 -179.756 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.664 ' CZ2' ' CG1' ' A' ' 36' ' ' VAL . 6.6 p90 -132.18 -168.48 2.05 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.063 -1.023 . . . . 0.0 109.803 179.659 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.495 ' OG1' ' O ' ' A' ' 34' ' ' VAL . 0.5 OUTLIER -155.76 172.46 18.28 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.805 -1.185 . . . . 0.0 111.331 -177.819 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.532 ' HG ' ' CD1' ' A' ' 95' ' ' LEU . 2.4 mp -130.47 128.81 42.0 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.548 -0.72 . . . . 0.0 109.506 179.497 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' CYS . . . . . . . . . . . . . 15.9 m -127.63 100.7 6.09 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.091 -1.006 . . . . 0.0 110.771 -179.535 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.485 ' O ' ' HB3' ' A' ' 142' ' ' ASP . 0.7 OUTLIER -95.96 -177.93 4.18 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.29 -0.881 . . . . 0.0 109.325 179.189 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.524 ' O ' ' CB ' ' A' ' 143' ' ' ASP . 0.6 OUTLIER 171.11 49.89 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.184 -0.947 . . . . 0.0 110.411 -179.996 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.524 ' CB ' ' O ' ' A' ' 142' ' ' ASP . 0.4 OUTLIER 166.23 55.43 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.37 -0.831 . . . . 0.0 109.614 179.849 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 2.1 t -96.32 118.72 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.303 -0.873 . . . . 0.0 110.274 -179.474 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.427 ' HB3' ' HA ' ' A' ' 6' ' ' GLU . . . -145.2 155.55 43.33 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.318 -0.864 . . . . 0.0 110.189 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.426 HD22 HD12 ' A' ' 54' ' ' ILE . 14.1 tp -147.9 143.39 27.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.922 . . . . 0.0 110.188 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.459 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 5.0 t0 -172.3 151.15 2.49 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.2 -0.937 . . . . 0.0 110.311 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.471 ' HA ' ' O ' ' A' ' 59' ' ' THR . 9.7 p -94.11 153.12 18.29 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.281 -0.887 . . . . 0.0 110.197 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -115.98 -144.77 0.39 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.243 -0.91 . . . . 0.0 110.28 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 12.2 p -155.55 43.89 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.281 -0.887 . . . . 0.0 110.168 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -140.76 26.03 2.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.306 -0.872 . . . . 0.0 110.192 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.555 ' N ' HD11 ' A' ' 152' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.361 -179.981 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.441 ' O ' ' HD3' ' A' ' 3' ' ' PRO . . . . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.234 0.54 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.3 m -51.76 107.8 0.91 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.267 -0.896 . . . . 0.0 110.217 179.961 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' A' ' 1' ' ' ALA . 48.8 Cg_endo -75.97 -156.44 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.027 1.541 . . . . 0.0 110.072 -179.985 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.483 ' CD1' HG13 ' A' ' 144' ' ' VAL . 13.8 pt -95.39 23.97 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.195 -0.941 . . . . 0.0 110.17 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 94.23 -23.8 29.99 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.917 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.53 ' CG ' ' CB ' ' A' ' 145' ' ' ALA . 1.4 tt0 44.7 74.07 0.14 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.273 -1.134 . . . . 0.0 110.212 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -163.26 -164.01 17.31 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.961 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.515 ' CG2' ' O ' ' A' ' 142' ' ' ASP . 26.1 p -117.57 33.92 5.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.259 -1.142 . . . . 0.0 110.323 -179.975 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.552 ' CZ ' HG22 ' A' ' 144' ' ' VAL . 13.6 m-85 60.25 48.24 8.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -0.934 . . . . 0.0 110.146 179.938 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.557 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 32.2 t70 -90.13 32.21 0.94 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.223 -0.923 . . . . 0.0 110.333 -179.911 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.557 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.4 OUTLIER 161.55 37.77 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.572 -0.705 . . . . 0.0 109.974 179.983 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.24 136.07 4.36 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.47 ' O ' ' CB ' ' A' ' 14' ' ' GLU . 48.3 Cg_endo -74.69 1.66 7.31 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.962 1.506 . . . . 0.0 110.609 179.955 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.47 ' CB ' ' O ' ' A' ' 13' ' ' PRO . 0.1 OUTLIER 68.15 -84.04 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.265 -0.897 . . . . 0.0 110.274 -179.872 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.493 ' C ' ' CD1' ' A' ' 49' ' ' LEU . . . -137.39 5.54 3.52 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.921 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.575 ' CE2' HD21 ' A' ' 49' ' ' LEU . 56.0 m95 -65.5 105.25 1.15 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.188 -1.183 . . . . 0.0 110.249 -179.898 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.587 ' CG2' ' CG2' ' A' ' 48' ' ' VAL . 1.0 OUTLIER -113.41 151.72 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.173 -0.955 . . . . 0.0 109.783 179.784 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.523 ' CB ' HG13 ' A' ' 34' ' ' VAL . . . -133.73 136.97 44.96 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.192 -0.942 . . . . 0.0 109.679 179.359 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.466 ' O ' HG11 ' A' ' 45' ' ' VAL . 26.8 p90 -128.17 148.64 50.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.417 -0.802 . . . . 0.0 110.665 -178.902 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.437 ' C ' HG21 ' A' ' 21' ' ' THR . . . 94.3 24.61 18.58 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 179.464 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.582 ' CG2' ' CG1' ' A' ' 45' ' ' VAL . 28.1 p -134.88 -148.6 0.32 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.033 -1.275 . . . . 0.0 110.494 179.904 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.454 ' O ' ' O ' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -116.84 136.43 52.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.342 -0.849 . . . . 0.0 110.383 -179.806 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 22' ' ' ASP . . . 52.07 174.46 0.03 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.766 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.52 -159.32 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.08 1.569 . . . . 0.0 110.42 179.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.523 ' CD1' ' O ' ' A' ' 16' ' ' TRP . 17.3 mt -93.05 145.3 24.49 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.215 -0.928 . . . . 0.0 110.237 179.987 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -97.59 119.41 36.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.243 -0.911 . . . . 0.0 109.827 179.709 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 31' ' ' ALA . 0.8 OUTLIER -119.65 -44.56 2.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.127 -0.983 . . . . 0.0 110.503 -179.58 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.483 ' O ' ' OG1' ' A' ' 29' ' ' THR . 8.1 t 43.76 36.04 1.21 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.186 -0.946 . . . . 0.0 109.874 -179.831 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.483 ' OG1' ' O ' ' A' ' 28' ' ' SER . 4.3 p 54.11 59.94 3.92 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.457 -0.777 . . . . 0.0 110.057 -179.731 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 8' ' ' THR . . . -159.24 -71.12 0.02 OUTLIER Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.467 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -150.74 160.17 44.03 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.25 -1.147 . . . . 0.0 110.451 -179.899 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.468 ' O ' ' HA ' ' A' ' 140' ' ' CYS . 0.6 OUTLIER -88.71 111.8 22.39 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.276 -0.89 . . . . 0.0 109.842 179.568 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 53.4 m -119.58 106.36 12.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.221 -0.924 . . . . 0.0 110.61 -179.642 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.523 HG13 ' CB ' ' A' ' 18' ' ' ALA . 18.2 m -89.87 145.58 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.207 -0.933 . . . . 0.0 109.715 179.535 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.496 ' HA ' ' OG1' ' A' ' 138' ' ' THR . . . -95.52 91.69 6.29 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.338 -0.851 . . . . 0.0 111.113 -179.268 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.633 ' CG1' ' CZ2' ' A' ' 137' ' ' TRP . 58.8 t -71.54 130.85 86.86 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.168 -0.958 . . . . 0.0 109.307 179.076 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 21' ' ' THR . 43.1 Cg_endo -71.24 155.12 61.29 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.933 1.491 . . . . 0.0 111.164 -178.945 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.56 ' HA ' ' CA ' ' A' ' 136' ' ' ALA . . . -43.05 111.1 0.23 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.37 -0.832 . . . . 0.0 110.345 -179.839 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 134' ' ' ALA . . . 58.67 117.6 0.01 OUTLIER Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.981 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.572 ' OG ' ' CH2' ' A' ' 137' ' ' TRP . 58.6 m -85.55 49.0 1.67 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.27 -1.135 . . . . 0.0 109.553 179.668 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.526 ' O ' ' HB3' ' A' ' 42' ' ' GLN . . . -89.72 103.89 16.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.497 -0.752 . . . . 0.0 110.217 -179.741 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.526 ' HB3' ' O ' ' A' ' 41' ' ' ALA . 0.8 OUTLIER 168.18 -152.17 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -179.757 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.409 ' C ' ' O ' ' A' ' 42' ' ' GLN . 7.4 p90 -43.13 -26.43 0.16 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.091 -1.006 . . . . 0.0 109.564 179.174 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 42' ' ' GLN . . . 107.59 129.39 6.1 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.35 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.582 ' CG1' ' CG2' ' A' ' 21' ' ' THR . 3.0 t -89.88 177.89 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.132 -1.217 . . . . 0.0 108.46 179.144 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.467 ' HA2' ' HA ' ' A' ' 128' ' ' GLN . . . 169.4 -177.29 43.09 Favored Glycine 0 N--CA 1.489 2.182 0 C-N-CA 118.748 -1.692 . . . . 0.0 111.075 -179.894 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.528 ' CG1' ' O ' ' A' ' 17' ' ' VAL . 18.3 t -150.95 126.84 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.803 -0.822 . . . . 0.0 108.83 179.862 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.587 ' CG2' ' CG2' ' A' ' 17' ' ' VAL . 29.0 m -119.82 133.67 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.027 -1.046 . . . . 0.0 110.907 -179.159 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.575 HD21 ' CE2' ' A' ' 16' ' ' TRP . 30.7 tp -122.97 90.64 3.33 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.397 -0.815 . . . . 0.0 110.074 179.787 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.468 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 8.1 p30 -73.57 113.5 10.75 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.236 -0.915 . . . . 0.0 110.247 -179.909 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.456 ' O ' HG21 ' A' ' 4' ' ' ILE . . . 153.95 65.86 0.01 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.908 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.529 ' CG2' ' HA ' ' A' ' 124' ' ' GLN . 97.2 t -120.04 173.07 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.164 -1.197 . . . . 0.0 109.982 179.787 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.437 ' N ' ' CG1' ' A' ' 52' ' ' VAL . . . -143.43 97.74 3.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.072 -1.017 . . . . 0.0 110.652 -179.786 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.589 HD11 ' CZ ' ' A' ' 60' ' ' TYR . 11.6 mm -137.79 159.87 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.292 -0.88 . . . . 0.0 109.818 179.603 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.474 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -147.82 135.34 20.76 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.108 -0.995 . . . . 0.0 110.683 -179.774 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.565 ' CG ' ' N ' ' A' ' 57' ' ' GLY . 0.9 OUTLIER 34.23 -155.08 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.342 0.592 . . . . 0.0 111.243 179.759 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.565 ' N ' ' CG ' ' A' ' 56' ' ' GLU . . . -83.39 81.39 1.75 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.837 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.567 HG21 ' CE2' ' A' ' 60' ' ' TYR . 1.2 m -109.13 171.26 7.54 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.305 -1.115 . . . . 0.0 109.826 179.876 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.519 ' N ' ' CG2' ' A' ' 58' ' ' THR . 1.0 OUTLIER -89.91 150.21 22.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.257 -0.902 . . . . 0.0 110.181 -179.941 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.598 ' CD2' ' CB ' ' A' ' 108' ' ' ALA . 64.9 m-85 -154.69 171.74 19.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.233 -0.917 . . . . 0.0 110.225 179.895 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.466 ' OG1' HG22 ' A' ' 105' ' ' THR . 17.9 m -142.73 114.51 8.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.304 -0.872 . . . . 0.0 110.086 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.422 HD21 HD22 ' A' ' 89' ' ' LEU . 17.1 tp -89.71 121.19 31.64 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.177 -0.952 . . . . 0.0 109.965 179.894 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.479 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 2.2 ttt180 -129.29 127.8 41.89 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -0.878 . . . . 0.0 110.314 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.539 ' CE1' HG22 ' A' ' 102' ' ' VAL . 2.1 p90 -165.12 149.6 8.94 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.336 -0.853 . . . . 0.0 109.888 179.807 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 51.6 m -119.44 95.7 4.9 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.183 -0.948 . . . . 0.0 110.117 -179.965 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.452 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -93.92 151.93 19.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.358 -0.839 . . . . 0.0 110.339 -179.801 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.479 ' CG2' ' O ' ' A' ' 98' ' ' GLU . 57.1 m -149.76 121.16 7.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.278 -0.889 . . . . 0.0 110.261 179.97 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.498 ' HB1' ' CB ' ' A' ' 95' ' ' LEU . . . -114.89 132.01 56.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.314 -0.866 . . . . 0.0 109.852 179.752 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.9 p -47.69 -23.99 0.83 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.074 -1.016 . . . . 0.0 109.343 179.497 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.539 ' CG2' ' HB2' ' A' ' 137' ' ' TRP . 2.5 t -113.84 170.2 8.44 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.49 -0.756 . . . . 0.0 110.067 179.904 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.478 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 15.7 t70 -86.75 66.02 9.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.179 -0.951 . . . . 0.0 109.119 178.86 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.57 HG22 ' CE2' ' A' ' 137' ' ' TRP . 3.5 p -85.23 137.25 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.319 -0.863 . . . . 0.0 111.341 -178.871 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.409 ' O ' ' CD1' ' A' ' 132' ' ' PHE . 89.6 m -122.81 86.02 2.51 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.85 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.589 ' HA ' ' CD1' ' A' ' 132' ' ' PHE . 4.8 m -89.33 -153.28 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.287 -0.883 . . . . 0.0 110.444 -179.068 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.447 ' N ' HG21 ' A' ' 74' ' ' VAL . 2.4 mtp180 -125.94 133.16 51.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.207 -0.933 . . . . 0.0 110.627 -179.431 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.489 ' O ' ' HB3' ' A' ' 77' ' ' LEU . . . -137.32 155.72 49.09 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.346 -0.846 . . . . 0.0 110.079 179.691 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.572 ' CD1' ' N ' ' A' ' 78' ' ' VAL . 3.9 pp 179.18 -147.77 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.354 -0.841 . . . . 0.0 110.033 -179.724 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.576 HG11 ' CE2' ' A' ' 112' ' ' TYR . 3.8 t -151.65 166.43 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.147 -0.971 . . . . 0.0 109.321 179.77 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.513 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . -171.67 -174.53 39.33 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.11 -1.519 . . . . 0.0 110.631 -179.81 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.502 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 4.0 pt20 -114.78 150.8 34.84 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.545 -0.973 . . . . 0.0 110.065 179.793 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.465 ' OD1' ' HG2' ' A' ' 122' ' ' GLU . 18.6 m120 -106.31 92.47 4.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.207 -0.933 . . . . 0.0 110.396 -179.952 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.538 ' C ' ' CE1' ' A' ' 85' ' ' TYR . . . 135.54 130.18 2.92 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.869 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.582 ' HA ' ' CD2' ' A' ' 85' ' ' TYR . . . -42.12 155.32 0.25 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.38 -1.071 . . . . 0.0 110.317 -179.951 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.477 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 50.8 Cg_endo -78.78 11.75 18.72 Favored 'Cis proline' 0 C--N 1.312 -1.352 0 C-N-CA 121.636 -2.235 . . . . 0.0 110.93 -0.049 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.582 ' CD2' ' HA ' ' A' ' 83' ' ' ALA . 39.3 m-85 60.88 157.71 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.125 -0.985 . . . . 0.0 110.17 -179.739 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.459 ' O ' ' HG2' ' A' ' 80' ' ' GLN . . . 167.78 113.46 0.28 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.464 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 1.2 p -89.84 155.52 19.1 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.232 -1.158 . . . . 0.0 110.299 -179.853 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.51 HG22 ' CD1' ' A' ' 89' ' ' LEU . 35.3 m -119.82 -24.22 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.886 . . . . 0.0 109.899 179.837 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.571 HD12 ' CZ ' ' A' ' 106' ' ' PHE . 4.0 mp -104.59 144.39 31.76 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.351 -0.843 . . . . 0.0 110.667 179.684 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -151.04 76.33 1.23 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.324 -0.86 . . . . 0.0 110.195 179.805 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -144.85 176.38 9.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.052 -1.03 . . . . 0.0 110.508 -179.832 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 66.2 m -124.39 126.08 25.54 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.318 -0.864 . . . . 0.0 110.045 179.907 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.525 ' HG2' ' CG2' ' A' ' 74' ' ' VAL . 45.4 Cg_endo -71.73 127.66 13.34 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.876 1.461 . . . . 0.0 110.749 -179.805 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.515 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -105.19 128.49 53.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.321 -0.862 . . . . 0.0 109.838 179.58 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.525 HD13 ' CG1' ' A' ' 72' ' ' VAL . 57.4 mt -119.91 178.95 4.41 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.186 -0.946 . . . . 0.0 110.467 -179.711 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -159.24 -79.64 0.06 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.265 -0.897 . . . . 0.0 110.335 -179.848 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -158.75 -37.66 0.06 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.271 -0.893 . . . . 0.0 110.061 179.952 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.525 ' CB ' ' HD2' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -89.88 -177.72 0.85 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.341 -0.849 . . . . 0.0 109.786 179.748 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.525 ' HD2' ' CB ' ' A' ' 98' ' ' GLU . 44.2 Cg_endo -71.61 128.63 14.58 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.748 1.394 . . . . 0.0 110.272 179.915 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.515 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 8.0 ttm-85 -119.68 92.03 3.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.185 -0.947 . . . . 0.0 110.36 -179.803 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 1.9 pt20 -70.23 159.03 34.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.327 -0.858 . . . . 0.0 110.045 179.796 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.539 HG22 ' CE1' ' A' ' 64' ' ' TYR . 98.7 t -135.12 139.34 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.208 -0.932 . . . . 0.0 110.165 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.463 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 0.2 OUTLIER -150.21 117.1 5.89 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.238 -0.914 . . . . 0.0 110.154 179.976 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 103' ' ' THR . 17.7 mm-40 -155.28 134.86 12.6 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.206 -0.934 . . . . 0.0 110.288 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.466 HG22 ' OG1' ' A' ' 61' ' ' THR . 0.7 OUTLIER -102.18 119.24 38.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.271 -0.893 . . . . 0.0 110.106 179.939 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.571 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 35.0 p90 -125.91 157.91 36.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.233 -0.917 . . . . 0.0 110.285 -179.943 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 19.3 m -89.93 98.57 11.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.3 -0.875 . . . . 0.0 109.997 179.786 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.598 ' CB ' ' CD2' ' A' ' 60' ' ' TYR . . . -59.3 107.78 0.61 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.253 -0.905 . . . . 0.0 110.411 -179.726 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.453 ' HA ' ' HA2' ' A' ' 57' ' ' GLY . 3.3 p -94.8 54.27 1.72 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.258 -0.901 . . . . 0.0 110.005 179.67 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.43 ' HB1' ' CG1' ' A' ' 88' ' ' VAL . . . -160.57 -152.38 0.28 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.214 -0.929 . . . . 0.0 110.431 -179.81 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.516 ' CG2' ' HD3' ' A' ' 113' ' ' PRO . 84.1 m -151.89 111.46 3.97 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.325 -0.859 . . . . 0.0 110.312 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.576 ' CE2' HG11 ' A' ' 78' ' ' VAL . 17.3 m-30 -111.02 69.66 0.66 Allowed Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.265 -0.897 . . . . 0.0 110.16 179.791 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.527 ' CG ' ' O ' ' A' ' 121' ' ' PRO . 45.8 Cg_endo -71.3 117.21 5.04 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.889 1.468 . . . . 0.0 110.361 179.949 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.461 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -60.33 -13.41 12.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.261 -0.899 . . . . 0.0 110.231 -179.951 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.514 ' CG2' ' O ' ' A' ' 115' ' ' THR . 9.7 t -96.93 105.18 22.03 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.216 -0.928 . . . . 0.0 110.211 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 46.7 Cg_endo -73.32 113.6 3.82 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.006 1.53 . . . . 0.0 110.39 179.935 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.519 ' CB ' ' HB2' ' A' ' 120' ' ' ASP . . . -120.42 47.4 1.78 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.264 -0.898 . . . . 0.0 110.194 -179.998 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.45 ' HB1' ' O ' ' A' ' 117' ' ' ALA . . . 55.87 -89.02 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.291 -0.881 . . . . 0.0 110.202 -179.989 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.453 ' N ' ' O ' ' A' ' 117' ' ' ALA . 2.6 p30 -62.22 -11.98 17.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.241 -0.912 . . . . 0.0 110.213 -179.954 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.519 ' HB2' ' CB ' ' A' ' 117' ' ' ALA . 5.8 m-20 -108.77 103.99 53.29 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 110.243 179.954 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.527 ' O ' ' CG ' ' A' ' 113' ' ' PRO . 47.6 Cg_endo -73.46 146.8 40.15 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.983 1.517 . . . . 0.0 110.409 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.543 ' CG ' ' N ' ' A' ' 123' ' ' GLY . 0.7 OUTLIER -97.2 -142.75 0.29 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.256 -0.902 . . . . 0.0 109.999 179.843 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.543 ' N ' ' CG ' ' A' ' 122' ' ' GLU . . . -166.44 156.31 28.11 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.814 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.529 ' HA ' ' CG2' ' A' ' 52' ' ' VAL . 3.6 pt20 -150.08 -161.23 1.3 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.38 -1.07 . . . . 0.0 110.313 -179.727 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.457 ' HB ' ' HB3' ' A' ' 49' ' ' LEU . 17.5 mt -118.49 149.83 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.528 -0.732 . . . . 0.0 109.552 179.772 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.533 ' O ' ' CD1' ' A' ' 127' ' ' PHE . . . -114.97 133.92 55.62 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.78 0.8 . . . . 0.0 111.179 -179.228 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.533 ' CD1' ' O ' ' A' ' 126' ' ' ALA . 8.5 m-85 -146.8 73.9 1.33 Allowed 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.062 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.467 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 40.2 mt-30 -87.55 125.44 34.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.303 -0.873 . . . . 0.0 111.841 -177.773 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.52 ' O ' ' CB ' ' A' ' 40' ' ' SER . 2.9 mt -113.95 54.34 0.76 Allowed 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.871 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -106.54 104.33 2.18 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 -179.36 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 77.21 74.46 0.98 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.781 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.589 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 6.5 m-85 -143.93 -71.77 0.29 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.196 -1.179 . . . . 0.0 110.243 179.859 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.6 ' HB3' ' CE3' ' A' ' 137' ' ' TRP . 1.3 t -89.13 156.45 18.8 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.055 -1.028 . . . . 0.0 110.103 179.825 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -80.23 -92.31 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.225 -0.922 . . . . 0.0 110.874 -179.34 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.448 ' O ' ' O ' ' A' ' 134' ' ' ALA . 12.6 m-20 -52.28 -172.35 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.165 -0.959 . . . . 0.0 110.679 -179.494 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.56 ' CA ' ' HA ' ' A' ' 38' ' ' ALA . . . -76.55 139.44 40.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.363 -0.835 . . . . 0.0 110.386 -179.799 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.633 ' CZ2' ' CG1' ' A' ' 36' ' ' VAL . 9.1 p90 -145.82 -166.34 2.43 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.296 -0.877 . . . . 0.0 110.058 179.672 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.504 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 0.8 OUTLIER -160.38 170.47 20.96 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.034 -1.041 . . . . 0.0 110.735 -178.068 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' A' ' 33' ' ' CYS . 2.2 mp -129.28 126.26 38.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.469 -0.769 . . . . 0.0 109.444 179.14 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' CYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 27.9 m -121.81 102.73 8.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.141 -0.974 . . . . 0.0 110.892 -179.443 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.508 ' O ' ' CB ' ' A' ' 142' ' ' ASP . 1.2 mt -95.26 -177.94 4.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.301 -0.875 . . . . 0.0 109.355 179.093 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.515 ' O ' ' CG2' ' A' ' 8' ' ' THR . 2.8 p30 168.5 52.96 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.244 -0.91 . . . . 0.0 110.301 179.954 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.49 ' CB ' ' O ' ' A' ' 142' ' ' ASP . 0.3 OUTLIER 167.27 53.06 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.223 -0.923 . . . . 0.0 109.71 179.947 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.552 HG22 ' CZ ' ' A' ' 9' ' ' PHE . 2.2 t -95.71 114.17 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.28 -0.887 . . . . 0.0 110.189 -179.599 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.53 ' CB ' ' CG ' ' A' ' 6' ' ' GLU . . . -146.11 164.75 31.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.897 . . . . 0.0 110.262 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.514 ' CD2' HD12 ' A' ' 54' ' ' ILE . 6.7 tp -145.21 148.23 33.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.323 -0.861 . . . . 0.0 110.234 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.516 ' HB3' ' CG1' ' A' ' 150' ' ' VAL . 0.5 OUTLIER -134.22 -173.97 3.42 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.196 -0.94 . . . . 0.0 110.23 -179.982 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 78.5 p -137.5 102.72 4.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.237 -0.915 . . . . 0.0 110.224 -179.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 48.97 65.2 1.44 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.241 -0.912 . . . . 0.0 110.221 179.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.516 ' CG1' ' HB3' ' A' ' 147' ' ' ASP . 14.5 p -160.63 52.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.184 -0.947 . . . . 0.0 110.173 179.905 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -54.68 173.31 0.08 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.295 -0.878 . . . . 0.0 110.207 -179.98 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.214 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.271 0.558 . . . . 0.0 110.233 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.6 t 47.86 90.86 0.07 OUTLIER Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.232 -0.918 . . . . 0.0 110.224 179.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.523 ' CG ' ' HA ' ' A' ' 52' ' ' VAL . 53.8 Cg_endo -80.43 19.1 1.12 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.998 1.525 . . . . 0.0 111.134 179.982 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.483 HG13 ' N ' ' A' ' 5' ' ' GLY . 7.8 pt -146.15 -37.52 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.989 -1.07 . . . . 0.0 109.811 179.715 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.511 ' O ' ' N ' ' A' ' 7' ' ' GLY . . . 55.71 163.18 0.02 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 179.574 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.527 ' HG3' ' CB ' ' A' ' 145' ' ' ALA . 63.3 mt-10 -51.69 88.75 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.302 -1.116 . . . . 0.0 110.11 179.85 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 5' ' ' GLY . . . -78.63 -32.41 41.71 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.953 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.477 ' OG1' ' O ' ' A' ' 7' ' ' GLY . 11.2 p 50.57 18.93 0.51 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.427 -1.043 . . . . 0.0 110.467 -179.794 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.58 ' CG ' ' HB2' ' A' ' 32' ' ' LEU . 24.3 m-85 36.85 46.64 0.51 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.56 -0.712 . . . . 0.0 110.813 179.563 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.558 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 3.2 p-10 -100.25 43.46 1.06 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.244 -0.91 . . . . 0.0 110.281 -179.998 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.558 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.6 OUTLIER 161.57 -24.97 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.722 -0.612 . . . . 0.0 109.52 179.951 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -177.64 151.12 10.54 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.498 ' HB3' ' CD1' ' A' ' 32' ' ' LEU . 46.3 Cg_endo -73.64 0.01 8.74 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.014 1.534 . . . . 0.0 110.552 -179.987 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 0.5 OUTLIER 62.07 -89.55 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.255 -0.903 . . . . 0.0 110.135 -179.791 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.46 ' O ' HG12 ' A' ' 17' ' ' VAL . . . -122.68 -15.89 3.87 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.579 ' CE2' HD21 ' A' ' 49' ' ' LEU . 82.4 m95 -54.05 140.68 30.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.254 -1.145 . . . . 0.0 110.782 -179.758 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.523 ' O ' ' CG1' ' A' ' 47' ' ' VAL . 1.2 m -146.08 157.95 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.324 -0.86 . . . . 0.0 109.455 179.425 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . . . -134.26 163.2 30.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.235 -0.916 . . . . 0.0 109.49 179.303 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.511 ' CZ ' ' C ' ' A' ' 46' ' ' GLY . 3.5 p90 -150.04 147.9 28.38 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.93 -1.106 . . . . 0.0 111.625 -178.519 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.582 ' HA2' ' CE1' ' A' ' 43' ' ' TYR . . . 132.09 -81.75 0.32 Allowed Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.763 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.586 HG21 ' CE2' ' A' ' 43' ' ' TYR . 12.1 p -149.69 23.95 0.88 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.171 -1.194 . . . . 0.0 110.319 -179.899 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.48 ' O ' ' C ' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -107.63 27.43 9.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 110.35 179.845 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.48 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 36.87 -137.43 0.53 Allowed Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.749 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.78 -158.88 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.974 1.513 . . . . 0.0 110.106 179.514 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.524 ' CD1' ' O ' ' A' ' 16' ' ' TRP . 61.1 mt -111.26 123.69 50.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.122 -0.986 . . . . 0.0 110.263 179.923 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.02 105.63 12.39 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.196 -0.94 . . . . 0.0 109.911 179.871 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.543 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.8 OUTLIER -119.56 -27.4 5.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.185 -0.947 . . . . 0.0 110.488 -179.653 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.484 ' O ' ' CB ' ' A' ' 29' ' ' THR . 8.0 t -48.48 82.91 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.758 -0.589 . . . . 0.0 111.233 -179.863 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.543 ' N ' ' O ' ' A' ' 27' ' ' THR . 0.0 OUTLIER 167.91 -31.71 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.254 -0.904 . . . . 0.0 109.856 -179.918 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' A' ' 10' ' ' ASP . . . 127.17 -0.07 7.0 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.907 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.534 ' CB ' ' HB3' ' A' ' 142' ' ' ASP . . . -150.75 134.98 16.93 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.15 -1.206 . . . . 0.0 110.535 -179.907 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.58 ' HB2' ' CG ' ' A' ' 9' ' ' PHE . 3.2 tt -76.27 138.6 40.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.181 -0.949 . . . . 0.0 109.293 179.205 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 66.6 m -141.82 118.43 10.99 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.069 -1.02 . . . . 0.0 110.838 -179.552 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.493 ' O ' ' OG1' ' A' ' 138' ' ' THR . 17.2 m -102.1 142.06 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.485 -0.759 . . . . 0.0 109.274 179.306 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.461 ' O ' ' HB3' ' A' ' 22' ' ' ASP . . . -88.44 102.79 15.24 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.129 -0.982 . . . . 0.0 110.781 -179.211 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.648 ' CG1' ' CZ2' ' A' ' 137' ' ' TRP . 49.1 t -83.91 125.23 73.48 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.417 -0.802 . . . . 0.0 109.596 179.471 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.491 ' HG2' ' HA ' ' A' ' 40' ' ' SER . 40.4 Cg_endo -66.42 -178.57 1.21 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.878 1.462 . . . . 0.0 111.741 -178.965 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.535 ' HA ' ' N ' ' A' ' 136' ' ' ALA . . . -60.5 120.92 10.87 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.452 -0.78 . . . . 0.0 111.296 -178.983 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.519 ' O ' ' C ' ' A' ' 40' ' ' SER . . . 39.22 26.73 0.06 OUTLIER Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 179.588 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.551 ' OG ' ' CH2' ' A' ' 137' ' ' TRP . 45.6 m 28.43 44.68 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 CA-C-N 117.863 0.831 . . . . 0.0 110.65 -179.998 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.631 ' O ' ' CG ' ' A' ' 42' ' ' GLN . . . -89.07 126.58 35.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.474 -0.766 . . . . 0.0 110.158 -179.278 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.631 ' CG ' ' O ' ' A' ' 41' ' ' ALA . 0.4 OUTLIER 83.17 28.54 0.1 Allowed 'General case' 0 N--CA 1.508 2.443 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -179.365 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.586 ' CE2' HG21 ' A' ' 21' ' ' THR . 0.1 OUTLIER -156.31 -31.05 0.09 Allowed 'General case' 0 C--N 1.293 -1.865 0 C-N-CA 118.648 -1.221 . . . . 0.0 112.314 -177.767 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.538 ' HA2' ' CA ' ' A' ' 130' ' ' GLY . . . 53.2 80.01 0.08 OUTLIER Glycine 0 N--CA 1.479 1.556 0 N-CA-C 105.922 -2.871 . . . . 0.0 105.922 -177.015 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.477 ' O ' ' HB2' ' A' ' 129' ' ' LEU . 4.2 t -86.95 133.9 28.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.358 -1.084 . . . . 0.0 108.893 -177.955 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.511 ' C ' ' CZ ' ' A' ' 19' ' ' TYR . . . -157.13 163.74 32.5 Favored Glycine 0 N--CA 1.487 2.089 0 C-N-CA 118.755 -1.688 . . . . 0.0 110.65 -178.973 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.523 ' CG1' ' O ' ' A' ' 17' ' ' VAL . 15.3 t -123.87 123.31 66.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.648 -0.913 . . . . 0.0 109.536 179.639 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.7 m -119.79 140.48 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.916 -1.115 . . . . 0.0 111.018 -179.002 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.579 HD21 ' CE2' ' A' ' 16' ' ' TRP . 15.0 tp -118.98 97.7 5.82 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.46 -0.775 . . . . 0.0 109.743 179.449 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.481 ' HA ' ' HB3' ' A' ' 124' ' ' GLN . 2.3 t-20 -78.16 113.73 16.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.28 -0.887 . . . . 0.0 110.405 -179.782 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.472 ' O ' ' HG2' ' A' ' 3' ' ' PRO . . . 146.22 73.98 0.02 OUTLIER Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 179.748 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.523 ' HA ' ' CG ' ' A' ' 3' ' ' PRO . 96.5 t -133.81 154.45 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.216 -1.167 . . . . 0.0 110.067 179.653 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.462 ' O ' HD11 ' A' ' 54' ' ' ILE . . . -128.73 105.19 8.09 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.218 -0.926 . . . . 0.0 110.501 -179.744 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.633 ' CG1' ' CD2' ' A' ' 112' ' ' TYR . 50.7 mm -131.78 166.45 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.318 -0.864 . . . . 0.0 109.74 179.58 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.526 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 0.2 OUTLIER -154.22 130.01 10.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.054 -1.029 . . . . 0.0 110.795 -179.726 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.526 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 11.0 pt-20 37.55 -156.5 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.773 -0.579 . . . . 0.0 110.915 179.525 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.47 ' HA2' ' O ' ' A' ' 108' ' ' ALA . . . -86.63 73.59 2.47 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.915 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.563 ' CG2' ' N ' ' A' ' 59' ' ' THR . 1.2 m -95.65 173.62 7.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.312 -1.11 . . . . 0.0 109.854 179.875 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.573 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 0.8 OUTLIER -89.63 155.9 18.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.205 -0.935 . . . . 0.0 110.391 -179.74 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.59 ' CD2' ' CB ' ' A' ' 108' ' ' ALA . 56.9 m-85 -160.41 -175.21 4.89 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.333 -0.854 . . . . 0.0 110.194 179.902 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 26.9 m -150.16 114.43 5.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.341 -0.85 . . . . 0.0 109.945 179.737 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.526 HD21 ' CD2' ' A' ' 89' ' ' LEU . 14.0 tp -89.53 119.69 30.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.208 -0.932 . . . . 0.0 110.065 -179.937 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.497 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 0.0 OUTLIER -128.23 128.92 45.59 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.352 -0.842 . . . . 0.0 110.206 -179.8 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.541 ' CD1' ' C ' ' A' ' 64' ' ' TYR . 0.8 OUTLIER -172.61 144.38 1.43 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.22 -0.925 . . . . 0.0 109.849 179.731 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.517 ' CG2' ' HG2' ' A' ' 101' ' ' GLN . 4.6 m -119.22 92.93 3.92 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.225 -0.922 . . . . 0.0 109.957 -179.815 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.524 ' CB ' HD22 ' A' ' 95' ' ' LEU . . . -90.8 149.29 22.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.38 -0.825 . . . . 0.0 110.373 -179.747 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.453 ' OG1' ' HA ' ' A' ' 99' ' ' PRO . 99.7 m -150.25 107.15 3.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.34 -0.85 . . . . 0.0 110.265 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -97.11 133.36 41.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.246 -0.909 . . . . 0.0 110.032 179.738 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.407 ' C ' ' O ' ' A' ' 68' ' ' ALA . 19.2 t -45.35 -26.18 0.5 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.131 -0.981 . . . . 0.0 109.234 179.557 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.524 HG23 ' CB ' ' A' ' 137' ' ' TRP . 2.1 t -112.43 171.15 7.69 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.592 -0.693 . . . . 0.0 109.858 179.723 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 49.0 t0 -86.58 61.13 6.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.106 -0.996 . . . . 0.0 109.115 178.937 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.561 HG13 ' CD1' ' A' ' 137' ' ' TRP . 2.7 p -84.78 136.76 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.381 -0.824 . . . . 0.0 111.357 -178.912 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 19.9 m -125.78 86.91 2.6 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.711 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.597 ' CG2' ' CD2' ' A' ' 129' ' ' LEU . 3.0 m -90.5 -140.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.134 -0.979 . . . . 0.0 110.663 -178.73 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.484 ' N ' ' CG2' ' A' ' 74' ' ' VAL . 9.4 mtm180 -123.44 144.96 49.17 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.194 -0.941 . . . . 0.0 110.81 -179.633 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.483 ' O ' ' HB3' ' A' ' 77' ' ' LEU . . . -150.34 148.49 28.88 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.388 -0.82 . . . . 0.0 109.365 179.421 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.492 ' C ' ' CD1' ' A' ' 77' ' ' LEU . 1.3 pp 175.37 -159.39 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.123 -0.986 . . . . 0.0 110.674 -179.551 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.516 ' HB ' ' CG2' ' A' ' 88' ' ' VAL . 6.3 t -143.7 170.44 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.375 -0.828 . . . . 0.0 109.39 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.537 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . 176.02 -173.45 46.27 Favored Glycine 0 N--CA 1.491 2.325 0 C-N-CA 119.18 -1.486 . . . . 0.0 110.534 -179.92 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.529 ' CG ' ' O ' ' A' ' 122' ' ' GLU . 31.5 tt0 -105.39 159.39 15.95 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.58 -0.953 . . . . 0.0 110.129 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.463 ' HB2' ' HG2' ' A' ' 122' ' ' GLU . 4.2 m120 -112.18 94.13 4.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.26 -0.9 . . . . 0.0 109.984 179.761 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.542 ' C ' ' CE1' ' A' ' 85' ' ' TYR . . . 120.3 131.83 4.19 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.815 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.596 ' N ' ' CE1' ' A' ' 85' ' ' TYR . . . -42.08 152.71 0.31 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.327 -1.102 . . . . 0.0 110.232 -179.903 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.465 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.6 Cg_endo -79.1 12.43 18.8 Favored 'Cis proline' 0 C--N 1.313 -1.332 0 C-N-CA 121.657 -2.226 . . . . 0.0 111.017 -0.021 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.596 ' CE1' ' N ' ' A' ' 83' ' ' ALA . 37.9 m-85 60.85 170.54 0.1 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.099 -1.0 . . . . 0.0 110.273 -179.81 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.41 ' O ' ' HA2' ' A' ' 79' ' ' GLY . . . 176.63 108.28 0.22 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.46 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 2.5 p -98.17 147.83 24.2 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.214 -1.168 . . . . 0.0 110.346 -179.934 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.516 ' CG2' ' HB ' ' A' ' 78' ' ' VAL . 7.8 m -122.64 -22.82 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.329 -0.857 . . . . 0.0 110.168 179.874 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.566 HD13 ' CZ ' ' A' ' 106' ' ' PHE . 4.5 mp -115.51 143.74 44.87 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.288 -0.882 . . . . 0.0 110.74 179.94 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -151.08 79.24 1.31 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.329 -0.857 . . . . 0.0 110.187 179.56 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.9 p -151.59 -173.56 4.55 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.007 -1.058 . . . . 0.0 110.544 -179.865 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.98 134.18 23.97 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.361 -0.837 . . . . 0.0 110.037 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.525 ' HG2' HG21 ' A' ' 74' ' ' VAL . 50.0 Cg_endo -75.14 75.83 3.64 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.962 1.506 . . . . 0.0 110.808 -179.697 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.531 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -49.55 134.66 19.34 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.971 -1.081 . . . . 0.0 109.265 179.416 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.524 HD22 ' CB ' ' A' ' 66' ' ' ALA . 34.6 mt -131.91 164.65 25.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.032 -1.042 . . . . 0.0 110.819 -179.396 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -165.35 -178.71 5.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.488 -0.758 . . . . 0.0 109.933 179.864 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.8 p -67.58 -22.21 65.39 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.224 -0.923 . . . . 0.0 110.257 -179.981 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.28 170.56 8.5 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.216 -0.927 . . . . 0.0 110.116 179.906 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.453 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 45.8 Cg_endo -72.34 132.38 19.18 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.993 1.523 . . . . 0.0 110.39 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.531 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -119.83 92.61 3.82 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.206 -0.934 . . . . 0.0 110.36 -179.967 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.517 ' HG2' ' CG2' ' A' ' 65' ' ' THR . 0.1 OUTLIER -75.75 152.37 37.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.392 -0.817 . . . . 0.0 110.083 179.962 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.533 ' CG2' ' CZ ' ' A' ' 64' ' ' TYR . 91.6 t -132.04 133.19 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.22 -0.925 . . . . 0.0 110.246 179.942 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.523 ' O ' ' CG ' ' A' ' 104' ' ' GLU . 0.2 OUTLIER -150.38 116.77 5.73 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.317 -0.864 . . . . 0.0 110.158 -179.962 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.523 ' CG ' ' O ' ' A' ' 103' ' ' THR . 23.7 mt-10 -160.33 129.97 5.15 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.16 -0.963 . . . . 0.0 110.348 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 47.5 m -89.91 107.47 19.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.21 -0.931 . . . . 0.0 110.108 179.766 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.566 ' CZ ' HD13 ' A' ' 89' ' ' LEU . 36.7 p90 -110.2 155.9 21.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.242 -0.911 . . . . 0.0 110.4 -179.78 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.448 HG23 ' O ' ' A' ' 107' ' ' THR . 5.2 m -90.01 89.07 7.54 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.287 -0.883 . . . . 0.0 109.953 179.735 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.59 ' CB ' ' CD2' ' A' ' 60' ' ' TYR . . . -42.71 98.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.28 -0.888 . . . . 0.0 110.278 -179.747 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.492 ' N ' HG11 ' A' ' 88' ' ' VAL . 14.2 p -87.22 53.99 3.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.239 -0.913 . . . . 0.0 110.088 179.883 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.419 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -154.19 -155.33 0.58 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.261 -0.899 . . . . 0.0 110.333 -179.943 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.453 ' C ' ' CD1' ' A' ' 112' ' ' TYR . 27.5 m -159.52 110.58 2.0 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.895 . . . . 0.0 110.531 -179.9 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.633 ' CD2' ' CG1' ' A' ' 54' ' ' ILE . 5.8 m-30 -113.71 94.73 34.16 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.298 -0.877 . . . . 0.0 109.66 179.401 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.472 ' HD2' ' HA ' ' A' ' 122' ' ' GLU . 51.3 Cg_endo -80.66 33.04 0.51 Allowed 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.825 1.434 . . . . 0.0 111.717 -179.697 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 113' ' ' PRO . . . 33.55 48.86 0.21 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.606 -0.684 . . . . 0.0 111.156 179.432 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.463 ' O ' ' OE1' ' A' ' 122' ' ' GLU . 3.0 p -119.02 98.33 50.94 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.171 -0.956 . . . . 0.0 110.38 -179.859 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -75.58 76.15 3.72 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.06 1.558 . . . . 0.0 110.39 179.911 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -150.12 169.64 20.8 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.216 -0.928 . . . . 0.0 110.334 -179.995 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.67 -62.35 1.45 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.253 -0.904 . . . . 0.0 110.095 179.955 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.461 ' O ' ' HD3' ' A' ' 121' ' ' PRO . 14.4 p-10 -67.78 -29.13 68.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.301 -0.874 . . . . 0.0 110.09 179.922 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.46 ' O ' ' O ' ' A' ' 115' ' ' THR . 77.5 m-20 -105.17 95.72 9.98 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.285 -0.884 . . . . 0.0 110.11 179.824 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.517 ' HG2' ' NE2' ' A' ' 80' ' ' GLN . 48.5 Cg_endo -74.26 152.94 45.36 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.957 1.504 . . . . 0.0 110.684 -179.837 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.529 ' O ' ' CG ' ' A' ' 80' ' ' GLN . 23.9 pm0 -121.26 -135.52 0.31 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.26 -0.9 . . . . 0.0 109.923 179.645 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.57 ' HA3' ' CG ' ' A' ' 112' ' ' TYR . . . -168.57 143.29 7.99 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.758 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.512 ' HA ' ' CG2' ' A' ' 52' ' ' VAL . 1.7 pt20 -150.56 -159.5 1.04 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.336 -1.096 . . . . 0.0 110.248 -179.808 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.563 HG23 ' CZ3' ' A' ' 16' ' ' TRP . 10.4 mt -118.32 146.35 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.45 -0.781 . . . . 0.0 109.114 179.246 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.505 ' N ' HG21 ' A' ' 125' ' ' ILE . . . -121.98 120.5 34.58 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.281 -0.887 . . . . 0.0 111.144 -179.302 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.5 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 3.4 m-30 -116.79 97.98 6.27 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 178.266 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.574 ' O ' ' CE2' ' A' ' 132' ' ' PHE . 2.3 mm-40 -88.37 92.56 9.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.332 -0.855 . . . . 0.0 112.702 -176.783 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.597 ' CD2' ' CG2' ' A' ' 74' ' ' VAL . 5.2 mt -99.61 42.65 1.09 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.447 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.538 ' CA ' ' HA2' ' A' ' 44' ' ' GLY . . . -97.56 125.7 8.6 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 110.509 -1.037 . . . . 0.0 110.509 -178.775 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.476 ' HA2' ' O ' ' A' ' 39' ' ' GLY . . . 39.79 64.03 1.13 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 179.304 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.591 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 9.2 m-85 -117.98 -61.65 1.65 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.048 -1.266 . . . . 0.0 110.75 179.813 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.527 ' HB2' ' CG2' ' A' ' 72' ' ' VAL . 1.3 t -88.4 178.78 6.47 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.043 -1.036 . . . . 0.0 110.376 -179.661 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -86.71 -89.05 0.12 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.338 -0.851 . . . . 0.0 110.278 -179.763 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -63.61 179.99 0.42 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.246 -0.909 . . . . 0.0 110.078 179.903 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.535 ' N ' ' HA ' ' A' ' 38' ' ' ALA . . . -77.16 136.18 38.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.282 -0.886 . . . . 0.0 110.47 -179.656 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.648 ' CZ2' ' CG1' ' A' ' 36' ' ' VAL . 8.4 p90 -135.56 -156.09 0.69 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.372 -0.83 . . . . 0.0 109.756 179.38 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.529 ' O ' ' CB ' ' A' ' 68' ' ' ALA . 0.6 OUTLIER -160.34 172.2 17.75 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.875 -1.13 . . . . 0.0 111.039 -178.548 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.498 ' HG ' ' CD1' ' A' ' 95' ' ' LEU . 2.3 mp -132.23 127.99 36.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.498 -0.751 . . . . 0.0 109.253 179.272 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 140' ' ' CYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 4.9 m -123.96 96.51 4.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.067 -1.021 . . . . 0.0 111.134 -179.35 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.483 ' O ' ' HB3' ' A' ' 142' ' ' ASP . 0.9 OUTLIER -89.74 -176.14 4.87 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.267 -0.895 . . . . 0.0 108.88 178.774 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.534 ' HB3' ' CB ' ' A' ' 31' ' ' ALA . 0.5 OUTLIER 170.6 43.96 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.929 -1.107 . . . . 0.0 111.003 179.98 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.492 ' HB2' ' O ' ' A' ' 142' ' ' ASP . 11.3 t70 174.01 61.47 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.36 -0.838 . . . . 0.0 109.505 179.63 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.497 ' HA ' ' O ' ' A' ' 63' ' ' ARG . 1.1 t -95.17 114.68 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.096 -1.003 . . . . 0.0 110.308 -179.399 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.527 ' CB ' ' HG3' ' A' ' 6' ' ' GLU . . . -138.27 145.29 41.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.339 -0.851 . . . . 0.0 110.229 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.442 HD22 HD12 ' A' ' 54' ' ' ILE . 6.7 tp -153.47 129.57 10.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.238 -0.914 . . . . 0.0 110.219 179.969 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.46 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 1.5 t0 -160.04 155.06 24.68 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.24 -0.912 . . . . 0.0 110.267 179.963 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.464 ' HA ' ' O ' ' A' ' 59' ' ' THR . 1.7 t -91.28 151.4 20.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.258 -0.901 . . . . 0.0 110.248 179.966 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.23 46.42 0.99 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.278 -0.889 . . . . 0.0 110.202 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 11.8 p -142.03 21.72 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.285 -0.884 . . . . 0.0 110.194 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -169.46 -170.72 1.12 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.258 -0.901 . . . . 0.0 110.173 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.1 mp . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.187 -179.955 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo . . . . . 0 N--CA 1.48 0.706 0 N-CA-C 110.068 -0.782 . . . . 0.0 110.068 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 1.006 HD11 ' O ' ' A' ' 144' ' ' VAL . 9.4 pt -93.64 -22.93 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.241 -0.912 . . . . 0.0 110.165 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 123.11 119.3 2.5 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -57.46 94.58 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.246 -1.149 . . . . 0.0 110.03 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.481 ' HA2' ' HA ' ' A' ' 143' ' ' ASP . . . 100.03 78.74 1.39 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.426 ' O ' ' HB2' ' A' ' 9' ' ' PHE . 7.2 p -95.12 -170.53 2.21 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.286 -1.126 . . . . 0.0 110.336 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.592 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 5.5 m-30 58.62 14.52 3.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.396 -0.815 . . . . 0.0 110.322 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.562 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 26.8 p-10 -88.86 23.88 2.21 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.178 -0.951 . . . . 0.0 109.967 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.562 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.6 OUTLIER 161.36 -24.24 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.422 0.629 . . . . 0.0 109.444 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -158.51 153.56 24.7 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.703 ' HB3' HD12 ' A' ' 32' ' ' LEU . 45.6 Cg_endo -72.37 -3.13 12.81 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.96 1.505 . . . . 0.0 110.458 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 0.3 OUTLIER 60.13 -88.62 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.28 -0.887 . . . . 0.0 110.353 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.436 ' O ' ' C ' ' A' ' 16' ' ' TRP . . . -132.14 -21.33 0.97 Allowed Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.886 -1.15 . . . . 0.0 110.381 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.969 ' CE2' HD22 ' A' ' 49' ' ' LEU . 56.1 m95 -41.51 121.87 1.79 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.09 -1.241 . . . . 0.0 110.565 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.73 ' O ' HG13 ' A' ' 47' ' ' VAL . 1.2 m -115.5 150.82 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.276 -0.89 . . . . 0.0 109.611 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.893 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . . . -130.21 123.0 29.18 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.061 -1.025 . . . . 0.0 109.818 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.777 ' HE2' HG13 ' A' ' 48' ' ' VAL . 23.4 p90 -108.68 157.26 18.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.51 -0.744 . . . . 0.0 110.486 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.648 ' O ' HG13 ' A' ' 45' ' ' VAL . . . 78.81 29.37 52.09 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.716 HG22 HG11 ' A' ' 45' ' ' VAL . 24.0 p -136.29 -160.96 1.11 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.219 -1.165 . . . . 0.0 110.466 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.455 ' O ' ' O ' ' A' ' 23' ' ' GLY . 15.0 t0 -99.46 131.96 45.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.368 -0.832 . . . . 0.0 110.318 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 22' ' ' ASP . . . 43.46 -166.18 0.02 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.3 -159.58 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.039 1.547 . . . . 0.0 110.46 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.893 ' CD2' ' HB3' ' A' ' 18' ' ' ALA . 7.9 mt -87.41 160.36 18.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.221 -0.925 . . . . 0.0 110.184 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -126.66 122.88 36.22 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.26 -0.9 . . . . 0.0 110.174 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.629 HG22 ' HA ' ' A' ' 32' ' ' LEU . 2.2 p -119.51 -84.39 0.66 Allowed 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.373 -0.829 . . . . 0.0 109.801 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.461 ' O ' ' HB ' ' A' ' 29' ' ' THR . 36.5 m 37.09 55.84 1.27 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.644 -0.66 . . . . 0.0 110.972 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.461 ' HB ' ' O ' ' A' ' 28' ' ' SER . 13.0 t -177.56 -32.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.115 -0.99 . . . . 0.0 110.411 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 9' ' ' PHE . . . 121.46 13.64 5.16 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -150.15 123.05 8.73 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -1.159 . . . . 0.0 110.14 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.703 HD12 ' HB3' ' A' ' 13' ' ' PRO . 0.9 OUTLIER -62.25 103.85 0.43 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -0.922 . . . . 0.0 109.841 179.788 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.51 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 36.6 m -107.99 103.5 12.74 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.14 -0.975 . . . . 0.0 110.864 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.77 HG12 HD22 ' A' ' 25' ' ' LEU . 17.5 m -89.87 141.74 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.234 -0.916 . . . . 0.0 109.218 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.487 ' HA ' ' OG1' ' A' ' 138' ' ' THR . . . -89.63 106.05 18.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.158 -0.964 . . . . 0.0 111.137 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.045 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 94.2 t -84.48 121.22 74.98 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.235 -0.916 . . . . 0.0 109.191 178.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 21' ' ' THR . 46.9 Cg_endo -74.71 137.27 22.2 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.937 1.493 . . . . 0.0 111.043 -178.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.932 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -45.52 170.59 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.337 -0.852 . . . . 0.0 109.766 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 45.86 48.33 13.66 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.825 ' OG ' HG21 ' A' ' 45' ' ' VAL . 0.6 OUTLIER -86.97 36.12 0.71 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.27 -1.136 . . . . 0.0 109.886 179.675 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.531 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . -89.08 -141.16 0.14 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.643 -0.661 . . . . 0.0 109.859 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.55 ' HG2' ' N ' ' A' ' 43' ' ' TYR . 14.7 pm0 39.88 -140.16 0.07 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.692 -0.63 . . . . 0.0 110.247 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.659 ' OH ' HG22 ' A' ' 45' ' ' VAL . 5.3 p90 -27.59 -42.55 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.236 0 CA-C-O 121.278 0.561 . . . . 0.0 110.612 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.601 ' O ' ' CD1' ' A' ' 43' ' ' TYR . . . 88.48 136.42 5.5 Favored Glycine 0 N--CA 1.492 2.39 0 C-N-CA 120.257 -0.973 . . . . 0.0 110.998 177.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.825 HG21 ' OG ' ' A' ' 40' ' ' SER . 2.3 t -88.95 -177.2 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.426 -1.043 . . . . 0.0 108.489 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.52 ' H ' HG12 ' A' ' 45' ' ' VAL . . . 167.67 175.88 37.88 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 118.819 -1.658 . . . . 0.0 110.838 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.73 HG13 ' O ' ' A' ' 17' ' ' VAL . 23.9 t -139.45 132.1 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.717 -0.872 . . . . 0.0 109.552 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.777 HG13 ' HE2' ' A' ' 19' ' ' TYR . 17.3 m -124.63 141.28 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.967 -1.083 . . . . 0.0 110.856 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.969 HD22 ' CE2' ' A' ' 16' ' ' TRP . 10.3 tp -128.23 100.6 5.9 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.374 -0.829 . . . . 0.0 110.131 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.531 ' ND2' ' OE1' ' A' ' 124' ' ' GLN . 1.2 m-20 -78.22 136.02 37.71 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.261 -0.9 . . . . 0.0 110.259 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 126.02 72.19 0.2 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.524 HG12 HG12 ' A' ' 54' ' ' ILE . 3.5 t -126.28 161.7 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.221 -1.164 . . . . 0.0 109.97 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -122.53 77.42 1.42 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.2 -0.938 . . . . 0.0 110.373 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.605 HG13 ' CD2' ' A' ' 112' ' ' TYR . 41.2 mm -119.13 151.08 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.248 -0.908 . . . . 0.0 110.07 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.664 ' HA ' HG23 ' A' ' 111' ' ' THR . 1.6 pt-20 -150.22 133.19 16.1 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.182 -0.949 . . . . 0.0 110.461 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.524 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 11.7 pt-20 38.28 -153.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.69 -0.631 . . . . 0.0 110.842 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' A' ' 109' ' ' SER . . . -86.56 86.12 1.55 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.556 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.3 m -110.65 171.04 7.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.177 -1.19 . . . . 0.0 109.864 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.583 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 1.6 m -89.88 155.59 19.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 0.0 110.154 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.605 ' HB3' HD11 ' A' ' 146' ' ' LEU . 56.3 m-85 -159.91 177.04 11.19 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.355 -0.84 . . . . 0.0 110.132 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 62.8 m -149.91 112.22 4.68 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.312 -0.867 . . . . 0.0 110.126 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.6 tp -89.84 124.49 34.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.243 -0.911 . . . . 0.0 110.095 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.495 ' HA ' ' O ' ' A' ' 102' ' ' VAL . 10.3 mtt180 -131.47 107.45 8.9 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.194 -0.941 . . . . 0.0 110.427 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.997 ' CZ ' HG21 ' A' ' 102' ' ' VAL . 4.6 p90 -147.07 151.61 37.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.288 -0.882 . . . . 0.0 110.125 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.879 HG23 ' CA ' ' A' ' 101' ' ' GLN . 0.2 OUTLIER -119.78 92.45 3.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.184 -0.948 . . . . 0.0 109.936 179.86 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.793 ' HB1' HD21 ' A' ' 95' ' ' LEU . . . -89.59 144.85 25.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 110.507 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.601 HG23 ' O ' ' A' ' 98' ' ' GLU . 99.9 m -150.33 116.74 5.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.403 -0.811 . . . . 0.0 110.215 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -103.24 138.73 39.64 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.23 -0.919 . . . . 0.0 110.028 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.1 p -47.65 -24.29 0.88 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.149 -0.969 . . . . 0.0 109.431 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.692 HG22 ' HB2' ' A' ' 137' ' ' TRP . 3.6 t -115.38 171.78 7.49 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.496 -0.752 . . . . 0.0 109.979 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.507 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 1.0 OUTLIER -86.16 69.69 10.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.158 -0.963 . . . . 0.0 109.445 179.192 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.605 HG23 ' CB ' ' A' ' 133' ' ' SER . 5.1 p -96.2 138.94 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.279 -0.888 . . . . 0.0 111.117 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 97.1 m -120.86 89.47 3.14 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.436 -0.79 . . . . 0.0 108.921 178.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.594 ' HA ' ' CD1' ' A' ' 132' ' ' PHE . 10.7 m -89.64 -147.88 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.22 -0.925 . . . . 0.0 110.587 -179.082 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.542 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 4.2 mtp180 -128.98 144.37 51.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 0.0 110.697 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.855 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -142.91 150.83 40.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.286 -0.884 . . . . 0.0 109.818 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.858 HD11 ' HB3' ' A' ' 126' ' ' ALA . 2.7 pp 177.58 -159.59 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.237 -0.914 . . . . 0.0 110.479 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.903 HG23 HD22 ' A' ' 89' ' ' LEU . 6.1 t -149.36 168.64 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.396 -0.815 . . . . 0.0 109.335 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.489 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . -177.6 -178.94 47.57 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.265 -1.445 . . . . 0.0 110.088 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.489 ' OE1' ' HD2' ' A' ' 113' ' ' PRO . 14.5 tp60 -107.93 138.12 44.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.415 -1.05 . . . . 0.0 110.302 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.507 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 0.9 OUTLIER -123.94 97.31 5.3 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.952 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.556 ' O ' ' HB3' ' A' ' 83' ' ' ALA . . . 132.23 33.71 0.4 Allowed Glycine 0 N--CA 1.484 1.866 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 82' ' ' GLY . . . 60.41 143.58 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.191 -1.182 . . . . 0.0 110.124 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.457 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.9 Cg_endo -82.67 18.96 17.96 Favored 'Cis proline' 0 C--N 1.314 -1.261 0 C-N-CA 121.872 -2.136 . . . . 0.0 110.807 -0.174 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.545 ' CD2' ' HA ' ' A' ' 83' ' ' ALA . 89.3 m-85 57.53 -179.95 0.06 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.136 -0.978 . . . . 0.0 110.203 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 127.96 113.57 1.76 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.514 HG22 ' O ' ' A' ' 78' ' ' VAL . 0.8 OUTLIER -97.51 145.89 25.78 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.283 -1.128 . . . . 0.0 110.034 179.779 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 1.028 HG23 HD12 ' A' ' 89' ' ' LEU . 35.9 m -123.73 -17.98 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.193 -0.942 . . . . 0.0 110.384 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 1.028 HD12 HG23 ' A' ' 88' ' ' VAL . 3.9 mp -103.38 135.27 45.31 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.205 -0.934 . . . . 0.0 111.046 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -150.97 83.55 1.33 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.451 -0.781 . . . . 0.0 109.951 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.5 p -137.9 -179.62 5.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.035 -1.041 . . . . 0.0 110.772 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.404 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 1.7 m -119.71 110.83 36.56 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.403 -0.811 . . . . 0.0 110.063 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.855 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 44.3 Cg_endo -71.58 94.0 0.68 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.04 1.548 . . . . 0.0 110.813 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.794 ' HB3' ' HD2' ' A' ' 100' ' ' ARG . . . -71.75 151.86 43.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.234 -0.916 . . . . 0.0 109.625 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.793 HD21 ' HB1' ' A' ' 66' ' ' ALA . 97.6 mt -143.77 162.82 35.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.05 -1.031 . . . . 0.0 110.493 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 70' ' ' THR . 0.3 OUTLIER 179.75 -179.08 0.43 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.39 -0.818 . . . . 0.0 110.018 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.95 -24.5 64.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.256 -0.902 . . . . 0.0 110.07 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.601 ' O ' HG23 ' A' ' 67' ' ' THR . 1.5 mt-10 -89.92 164.48 28.31 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.281 -0.887 . . . . 0.0 110.06 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.482 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 46.1 Cg_endo -73.0 136.77 25.43 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.008 1.53 . . . . 0.0 110.366 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.794 ' HD2' ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.6 80.42 1.57 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.17 -0.956 . . . . 0.0 110.188 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.879 ' CA ' HG23 ' A' ' 65' ' ' THR . 16.3 tt0 -68.73 154.73 41.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.299 -0.876 . . . . 0.0 110.195 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.997 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 95.6 t -135.5 135.52 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.284 -0.885 . . . . 0.0 110.135 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.06 111.0 4.33 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.26 -0.9 . . . . 0.0 110.19 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -158.25 134.74 9.52 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.164 -0.96 . . . . 0.0 110.361 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.667 HG23 ' O ' ' A' ' 105' ' ' THR . 10.1 t -95.77 113.73 25.39 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.245 -0.909 . . . . 0.0 110.091 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.967 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 30.6 p90 -111.72 154.79 24.48 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.909 . . . . 0.0 110.286 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.476 HG22 ' O ' ' A' ' 107' ' ' THR . 6.6 m -91.7 91.87 8.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.286 -0.884 . . . . 0.0 110.044 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.593 ' HB1' ' CG2' ' A' ' 54' ' ' ILE . . . -48.54 96.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.235 -0.915 . . . . 0.0 110.303 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.521 ' N ' ' CG1' ' A' ' 88' ' ' VAL . 16.1 p -85.99 49.96 1.88 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.256 -0.902 . . . . 0.0 110.124 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -156.23 -154.43 0.48 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.297 -0.877 . . . . 0.0 110.136 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.664 HG23 ' HA ' ' A' ' 55' ' ' GLU . 14.2 m -152.4 112.5 4.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.209 -0.932 . . . . 0.0 110.304 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.605 ' CD2' HG13 ' A' ' 54' ' ' ILE . 13.5 m-30 -107.03 93.16 8.65 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.277 -0.889 . . . . 0.0 109.9 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.489 ' HD2' ' OE1' ' A' ' 80' ' ' GLN . 45.3 Cg_endo -72.26 179.61 4.85 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.942 1.496 . . . . 0.0 110.41 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.245 -0.909 . . . . 0.0 110.206 -179.937 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.507 ' O ' ' HB2' ' A' ' 81' ' ' ASN . 2.2 pm0 . . . . . 0 N--CA 1.5 2.06 0 CA-C-O 121.515 0.674 . . . . 0.0 111.794 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -100.99 155.56 19.22 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.976 -1.249 . . . . 0.0 109.976 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.531 ' OE1' ' ND2' ' A' ' 50' ' ' ASN . 1.4 pt20 -150.55 -149.9 0.32 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.398 -1.06 . . . . 0.0 110.395 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.739 HG21 ' CH2' ' A' ' 16' ' ' TRP . 9.6 mt -118.37 138.62 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.588 -0.695 . . . . 0.0 109.136 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.858 ' HB3' HD11 ' A' ' 77' ' ' LEU . . . -115.42 122.24 45.21 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.205 -0.934 . . . . 0.0 111.169 -179.123 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.477 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 4.6 m-85 -119.15 109.05 15.42 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 178.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLN . . . . . 0.485 ' O ' ' HB ' ' A' ' 74' ' ' VAL . 2.0 mt-30 -88.85 91.84 8.98 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.105 -0.997 . . . . 0.0 111.141 -178.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.958 HD13 HD13 ' A' ' 139' ' ' LEU . 15.5 mt -93.23 41.89 1.09 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.451 -0.78 . . . . 0.0 109.286 178.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.548 ' HA3' ' CA ' ' A' ' 44' ' ' GLY . . . -130.49 140.16 11.53 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.475 ' O ' ' CG ' ' A' ' 132' ' ' PHE . . . 71.4 61.7 3.79 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.594 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 38.4 m-85 -154.67 -78.32 0.1 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.243 -1.151 . . . . 0.0 110.182 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.605 ' CB ' HG23 ' A' ' 72' ' ' VAL . 1.3 t -89.67 119.57 30.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.123 -0.986 . . . . 0.0 110.116 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.401 ' O ' ' O ' ' A' ' 135' ' ' ASP . . . -62.44 -71.67 0.15 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.228 -0.92 . . . . 0.0 110.274 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.401 ' O ' ' O ' ' A' ' 134' ' ' ALA . 0.8 OUTLIER -53.82 -173.29 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.292 -0.88 . . . . 0.0 110.343 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.932 ' HB2' ' HB2' ' A' ' 38' ' ' ALA . . . -83.51 141.08 31.89 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.269 -0.894 . . . . 0.0 110.302 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 1.045 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 7.3 p90 -151.5 -164.19 1.93 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.323 -0.861 . . . . 0.0 109.964 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.527 ' O ' ' CB ' ' A' ' 68' ' ' ALA . 0.5 OUTLIER -160.4 173.47 15.57 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.0 -1.08 . . . . 0.0 111.106 -178.493 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.958 HD13 HD13 ' A' ' 129' ' ' LEU . 2.6 mp -129.64 129.37 44.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.447 -0.783 . . . . 0.0 109.576 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' CYS . . . . . . . . . . . . . 6.6 m -124.37 93.26 3.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.129 -0.982 . . . . 0.0 110.938 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.644 HD23 ' HB2' ' A' ' 66' ' ' ALA . 0.7 OUTLIER -89.86 -175.42 4.61 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.179 -0.951 . . . . 0.0 109.414 179.147 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.513 ' O ' ' CB ' ' A' ' 143' ' ' ASP . 1.1 p30 176.76 124.27 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.054 -1.029 . . . . 0.0 110.842 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.513 ' CB ' ' O ' ' A' ' 142' ' ' ASP . 0.3 OUTLIER 70.94 61.29 0.18 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.288 -0.882 . . . . 0.0 110.654 179.479 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 1.006 ' O ' HD11 ' A' ' 4' ' ' ILE . 42.0 t -94.46 111.4 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -0.914 . . . . 0.0 109.73 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -120.46 163.56 17.74 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.233 -0.917 . . . . 0.0 110.47 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.605 HD11 ' HB3' ' A' ' 60' ' ' TYR . 14.0 tp -167.3 88.18 0.29 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.409 -0.807 . . . . 0.0 110.085 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.495 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 7.6 t70 -123.37 165.17 17.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.269 -0.895 . . . . 0.0 110.289 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.513 ' HB3' ' CE1' ' A' ' 60' ' ' TYR . 12.7 p . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 0.0 110.317 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo . . . . . 0 N--CA 1.479 0.673 0 N-CA-C 110.123 -0.76 . . . . 0.0 110.123 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.627 HG22 ' O ' ' A' ' 51' ' ' GLY . 13.1 pt -95.98 31.16 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.234 -0.916 . . . . 0.0 110.251 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 91.58 -29.32 7.38 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.723 ' OE1' ' HB1' ' A' ' 145' ' ' ALA . 3.9 mt-10 51.67 66.98 1.04 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.252 -1.146 . . . . 0.0 110.24 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 143' ' ' ASP . . . -148.36 -179.99 24.75 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.862 HG22 ' HB2' ' A' ' 143' ' ' ASP . 0.8 OUTLIER -98.31 51.64 1.02 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.201 -1.176 . . . . 0.0 110.151 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.559 ' CE2' ' CG2' ' A' ' 144' ' ' VAL . 69.3 m-85 43.16 36.31 0.97 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.274 -0.891 . . . . 0.0 110.095 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.556 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 5.1 p30 -84.68 44.48 1.06 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.316 -0.865 . . . . 0.0 110.299 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.556 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 2.4 t70 161.58 78.42 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.336 0.589 . . . . 0.0 109.433 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.66 159.58 7.0 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.894 ' HB3' HD12 ' A' ' 32' ' ' LEU . 50.0 Cg_endo -75.75 4.71 4.89 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.016 1.535 . . . . 0.0 110.713 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 2.8 mm-40 65.12 -89.01 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.259 -0.901 . . . . 0.0 110.516 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.592 ' C ' HD12 ' A' ' 49' ' ' LEU . . . -139.63 6.99 3.01 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.95 ' CE2' HD22 ' A' ' 49' ' ' LEU . 46.0 m95 -69.52 126.0 28.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.108 -1.23 . . . . 0.0 110.179 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.719 ' HA ' HD11 ' A' ' 25' ' ' LEU . 0.9 OUTLIER -126.9 148.6 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.206 -0.934 . . . . 0.0 109.669 179.806 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.626 ' CB ' HD21 ' A' ' 25' ' ' LEU . . . -130.32 142.16 50.55 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.101 -0.999 . . . . 0.0 109.648 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.558 ' HE1' HG13 ' A' ' 48' ' ' VAL . 23.2 p90 -131.71 164.01 26.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.292 -0.88 . . . . 0.0 110.766 -178.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.483 ' HA2' ' OH ' ' A' ' 43' ' ' TYR . . . 77.19 40.21 24.96 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.553 HG22 ' CG1' ' A' ' 45' ' ' VAL . 7.9 p -149.88 -143.79 0.14 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.129 -1.218 . . . . 0.0 110.489 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.465 ' O ' ' O ' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -117.29 129.94 56.22 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.244 -0.91 . . . . 0.0 110.355 -179.792 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 22' ' ' ASP . . . 52.21 174.48 0.03 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.38 -159.54 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.064 1.56 . . . . 0.0 110.518 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.983 ' CD2' HG12 ' A' ' 34' ' ' VAL . 24.4 mt -78.27 178.52 7.58 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.272 -0.893 . . . . 0.0 110.331 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -145.46 115.0 7.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.318 -0.864 . . . . 0.0 110.102 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.479 ' O ' ' N ' ' A' ' 29' ' ' THR . 1.1 p -119.65 -83.59 0.65 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.308 -0.87 . . . . 0.0 109.921 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 27' ' ' THR . 5.4 p 39.2 28.36 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.498 -0.751 . . . . 0.0 110.637 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.479 ' N ' ' O ' ' A' ' 27' ' ' THR . 8.5 t -153.43 -37.0 0.1 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.149 -0.969 . . . . 0.0 110.385 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.493 ' O ' ' HB2' ' A' ' 9' ' ' PHE . . . 133.97 -2.29 4.36 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.598 ' HB1' ' O ' ' A' ' 141' ' ' LEU . . . -133.15 143.97 49.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.138 -1.213 . . . . 0.0 110.125 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.894 HD12 ' HB3' ' A' ' 13' ' ' PRO . 0.6 OUTLIER -83.96 112.31 20.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.24 -0.912 . . . . 0.0 110.055 179.87 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.51 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 34.1 m -114.86 116.55 28.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 110.554 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.983 HG12 ' CD2' ' A' ' 25' ' ' LEU . 33.2 m -101.1 144.63 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.324 -0.86 . . . . 0.0 109.812 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.532 ' HA ' ' OG1' ' A' ' 138' ' ' THR . . . -93.05 94.02 8.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.189 -0.944 . . . . 0.0 110.547 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.087 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 41.9 t -86.23 132.49 43.14 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.377 -0.827 . . . . 0.0 110.099 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.415 ' C ' ' HA ' ' A' ' 136' ' ' ALA . 40.0 Cg_endo -66.85 168.95 15.71 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.809 1.426 . . . . 0.0 110.586 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.499 ' O ' ' O ' ' A' ' 39' ' ' GLY . . . -62.01 121.04 12.02 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.305 -0.872 . . . . 0.0 110.912 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.553 ' O ' ' N ' ' A' ' 41' ' ' ALA . . . 41.6 96.03 0.01 OUTLIER Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.666 ' HB2' HG23 ' A' ' 45' ' ' VAL . 0.4 OUTLIER -42.12 93.75 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.428 -1.043 . . . . 0.0 109.786 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' A' ' 39' ' ' GLY . . . -89.38 28.91 1.17 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.695 0.759 . . . . 0.0 110.565 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -128.92 -166.95 1.71 Allowed 'General case' 0 C--N 1.292 -1.904 0 O-C-N 121.773 -0.579 . . . . 0.0 109.779 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.483 ' OH ' ' HA2' ' A' ' 20' ' ' GLY . 11.1 p90 -46.54 -24.13 0.48 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.16 -0.962 . . . . 0.0 109.797 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.473 ' O ' ' CD1' ' A' ' 43' ' ' TYR . . . 126.45 140.58 5.29 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.666 HG23 ' HB2' ' A' ' 40' ' ' SER . 19.9 t -89.39 173.65 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.124 -1.221 . . . . 0.0 109.205 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.562 ' HA2' ' HA ' ' A' ' 128' ' ' GLN . . . -178.22 -179.42 48.19 Favored Glycine 0 N--CA 1.487 2.098 0 C-N-CA 118.92 -1.61 . . . . 0.0 110.851 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.701 HG13 ' O ' ' A' ' 17' ' ' VAL . 21.4 t -150.39 128.48 2.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.594 ' CG2' HG22 ' A' ' 17' ' ' VAL . 30.5 m -119.38 132.68 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.018 -1.051 . . . . 0.0 111.106 -178.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 1.065 HD23 HD12 ' A' ' 125' ' ' ILE . 13.8 tp -124.22 91.27 3.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.559 -0.713 . . . . 0.0 110.01 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.44 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 0.7 OUTLIER -66.86 113.88 5.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 110.209 -179.908 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.627 ' O ' HG22 ' A' ' 4' ' ' ILE . . . 154.14 83.04 0.04 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.579 HG11 ' HD2' ' A' ' 112' ' ' TYR . 38.8 t -140.53 160.43 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.197 -1.178 . . . . 0.0 110.207 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.434 ' O ' HD13 ' A' ' 54' ' ' ILE . . . -129.85 90.78 3.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.203 -0.936 . . . . 0.0 110.396 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.743 HD11 HD21 ' A' ' 146' ' ' LEU . 33.5 mm -124.01 168.7 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.261 -0.899 . . . . 0.0 109.931 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.574 ' HA ' HG23 ' A' ' 111' ' ' THR . 1.7 tt0 -162.71 127.72 3.2 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.122 -0.986 . . . . 0.0 110.653 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.522 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 13.1 pt-20 37.74 -152.89 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.635 -0.666 . . . . 0.0 110.984 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 108' ' ' ALA . . . -86.76 79.57 1.81 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.625 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.2 m -108.85 173.71 6.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.253 -1.145 . . . . 0.0 109.804 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.574 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 0.4 OUTLIER -89.8 156.23 18.64 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.287 -0.883 . . . . 0.0 110.281 -179.82 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.829 ' HB3' HD11 ' A' ' 146' ' ' LEU . 67.9 m-85 -158.94 167.83 28.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 110.323 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 85.5 m -143.19 115.49 8.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -0.893 . . . . 0.0 110.072 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 28.4 tp -89.76 122.55 32.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.261 -0.899 . . . . 0.0 110.05 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.475 ' HA ' ' O ' ' A' ' 102' ' ' VAL . 6.1 mtm180 -126.38 125.8 42.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.253 -0.904 . . . . 0.0 110.356 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 1.184 ' CZ ' HG21 ' A' ' 102' ' ' VAL . 5.3 p90 -167.89 151.71 6.2 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.248 -0.908 . . . . 0.0 110.145 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.5 ' CG2' ' HG2' ' A' ' 101' ' ' GLN . 93.6 m -119.65 99.58 6.74 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.242 -0.911 . . . . 0.0 110.063 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.621 ' CB ' HD21 ' A' ' 95' ' ' LEU . . . -100.34 145.59 27.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.327 -0.858 . . . . 0.0 110.364 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.483 ' OG1' ' HA ' ' A' ' 99' ' ' PRO . 43.8 m -148.09 115.92 6.39 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.255 -0.903 . . . . 0.0 110.303 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.443 ' HB2' HD13 ' A' ' 95' ' ' LEU . . . -101.66 141.02 35.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 109.971 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.11 -23.05 1.09 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.129 -0.982 . . . . 0.0 109.41 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.684 HG22 ' HB2' ' A' ' 137' ' ' TRP . 2.9 t -116.96 169.69 9.21 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.51 -0.743 . . . . 0.0 110.034 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.509 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 77.0 m-20 -84.57 69.75 10.64 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.13 -0.981 . . . . 0.0 109.289 179.019 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.624 HG23 ' CB ' ' A' ' 133' ' ' SER . 4.8 p -94.47 140.05 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.874 . . . . 0.0 111.273 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 21.4 m -121.72 91.87 3.61 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.417 -0.802 . . . . 0.0 108.916 178.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.588 HG12 ' CD2' ' A' ' 132' ' ' PHE . 12.3 m -89.8 -147.56 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.21 -0.931 . . . . 0.0 110.774 -178.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.519 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 6.9 mtm180 -131.03 139.01 49.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.38 -0.825 . . . . 0.0 110.52 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.694 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -138.63 154.52 48.66 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.336 -0.853 . . . . 0.0 109.687 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.901 HD12 ' N ' ' A' ' 78' ' ' VAL . 3.9 pp -179.84 -148.36 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.207 -0.933 . . . . 0.0 110.326 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.901 ' N ' HD12 ' A' ' 77' ' ' LEU . 3.0 t -150.76 167.68 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.269 -0.894 . . . . 0.0 109.495 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.517 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . -170.69 -171.27 35.86 Favored Glycine 0 N--CA 1.491 2.33 0 C-N-CA 119.277 -1.44 . . . . 0.0 110.338 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.534 ' HA ' ' O ' ' A' ' 122' ' ' GLU . 3.7 tt0 -100.25 -160.96 0.83 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.473 -1.016 . . . . 0.0 110.262 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 80' ' ' GLN . 25.8 m120 -158.18 80.31 0.83 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.235 -0.915 . . . . 0.0 110.229 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.638 ' O ' ' HB2' ' A' ' 83' ' ' ALA . . . 167.52 -83.8 0.1 OUTLIER Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.638 ' HB2' ' O ' ' A' ' 82' ' ' GLY . . . 173.88 146.89 0.21 Allowed Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.176 -1.191 . . . . 0.0 110.205 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.456 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.4 Cg_endo -84.81 33.68 4.03 Favored 'Cis proline' 0 C--N 1.312 -1.355 0 C-N-CA 121.887 -2.131 . . . . 0.0 110.619 -0.216 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.571 ' CZ ' ' O ' ' A' ' 82' ' ' GLY . 21.2 m-85 64.14 137.17 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.187 -0.946 . . . . 0.0 110.2 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -153.02 121.4 1.16 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.462 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 2.0 p -96.83 147.78 23.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.203 -1.175 . . . . 0.0 110.261 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.986 HG23 HD12 ' A' ' 89' ' ' LEU . 33.5 m -119.79 -24.22 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.304 -0.873 . . . . 0.0 109.989 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.986 HD12 HG23 ' A' ' 88' ' ' VAL . 3.9 mp -105.76 146.39 29.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.313 -0.867 . . . . 0.0 110.729 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -151.17 81.74 1.31 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.23 -0.919 . . . . 0.0 110.13 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.2 p -145.4 173.55 11.89 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.071 -1.018 . . . . 0.0 110.578 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.463 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 43.3 m -121.78 118.77 29.32 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.348 -0.845 . . . . 0.0 110.093 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.694 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 46.1 Cg_endo -71.96 146.82 48.1 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.884 1.465 . . . . 0.0 110.966 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 1.032 ' HB3' ' NE ' ' A' ' 100' ' ' ARG . . . -109.62 148.99 30.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.396 -0.815 . . . . 0.0 109.543 179.314 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.622 ' C ' HG22 ' A' ' 96' ' ' THR . 70.9 mt -140.13 172.43 12.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.085 -1.009 . . . . 0.0 110.609 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.622 HG22 ' C ' ' A' ' 95' ' ' LEU . 0.1 OUTLIER 169.16 -179.15 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.467 -0.771 . . . . 0.0 109.888 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.4 ' N ' ' OG1' ' A' ' 96' ' ' THR . 0.1 OUTLIER -62.88 -12.7 26.74 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.223 -0.923 . . . . 0.0 109.734 179.765 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.526 ' CG ' ' HD2' ' A' ' 99' ' ' PRO . 33.9 tt0 -100.2 149.21 35.83 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.433 -0.792 . . . . 0.0 109.89 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.526 ' HD2' ' CG ' ' A' ' 98' ' ' GLU . 41.8 Cg_endo -68.71 131.25 22.32 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.877 1.462 . . . . 0.0 110.248 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 1.032 ' NE ' ' HB3' ' A' ' 94' ' ' ALA . 11.6 ttt-85 -119.66 92.22 3.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.243 -0.91 . . . . 0.0 110.5 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.5 ' HG2' ' CG2' ' A' ' 65' ' ' THR . 4.6 mt-30 -71.49 160.84 32.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.329 -0.857 . . . . 0.0 109.771 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 1.184 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 38.9 t -131.05 133.91 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.135 -0.978 . . . . 0.0 110.444 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.39 88.34 1.5 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.341 -0.85 . . . . 0.0 110.105 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -139.72 151.77 46.12 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.162 -0.962 . . . . 0.0 110.387 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.816 HG23 ' O ' ' A' ' 60' ' ' TYR . 90.6 m -111.3 137.23 49.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.325 -0.859 . . . . 0.0 110.15 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.944 ' CE1' HD11 ' A' ' 89' ' ' LEU . 51.3 p90 -132.5 156.61 46.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.271 -0.893 . . . . 0.0 110.217 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.542 HG22 ' O ' ' A' ' 107' ' ' THR . 7.6 m -90.29 88.29 7.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.292 -0.88 . . . . 0.0 110.102 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.603 ' HB3' ' CE2' ' A' ' 60' ' ' TYR . . . -47.26 104.22 0.05 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.894 . . . . 0.0 110.347 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 84.9 p -91.54 53.63 2.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.247 -0.908 . . . . 0.0 110.162 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.726 ' HB3' ' CG1' ' A' ' 88' ' ' VAL . . . -166.13 -156.34 0.25 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.239 -0.913 . . . . 0.0 110.316 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.574 HG23 ' HA ' ' A' ' 55' ' ' GLU . 12.3 m -146.18 117.1 7.72 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.305 -0.872 . . . . 0.0 110.287 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.594 ' CG ' ' HA3' ' A' ' 123' ' ' GLY . 20.7 m-30 -113.31 75.48 2.31 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.887 . . . . 0.0 109.994 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.481 ' O ' ' CB ' ' A' ' 122' ' ' GLU . 45.8 Cg_endo -72.39 136.93 27.28 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.932 1.491 . . . . 0.0 110.422 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.667 0 O-C-N 121.315 -0.866 . . . . 0.0 110.293 -179.954 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.534 ' O ' ' HA ' ' A' ' 80' ' ' GLN . 15.2 pm0 . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.594 ' HA3' ' CG ' ' A' ' 112' ' ' TYR . . . -140.21 159.02 26.08 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.545 ' O ' HG13 ' A' ' 78' ' ' VAL . 2.1 pm0 -150.5 -160.01 1.11 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.342 -1.093 . . . . 0.0 110.213 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 1.065 HD12 HD23 ' A' ' 49' ' ' LEU . 33.2 mt -118.38 142.45 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.37 -0.831 . . . . 0.0 109.522 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.524 ' HB3' ' HG ' ' A' ' 77' ' ' LEU . . . -113.88 115.22 27.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.304 -0.872 . . . . 0.0 111.541 -178.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.572 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 4.5 m-85 -120.58 80.8 1.67 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLN . . . . . 0.562 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 2.9 mt-30 -87.96 115.06 25.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.112 -0.993 . . . . 0.0 111.636 -178.169 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 1.063 ' CD1' HD13 ' A' ' 139' ' ' LEU . 9.0 mt -98.77 49.66 0.97 Allowed 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 121.835 0.826 . . . . 0.0 108.856 178.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 132' ' ' PHE . . . -53.11 -173.45 0.04 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.434 ' HA2' ' HB3' ' A' ' 40' ' ' SER . . . -52.95 90.24 0.01 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.588 ' CD2' HG12 ' A' ' 74' ' ' VAL . 20.1 m-85 -114.87 -56.93 2.33 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.235 -1.156 . . . . 0.0 110.647 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.624 ' CB ' HG23 ' A' ' 72' ' ' VAL . 1.4 t -89.42 -177.36 5.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.259 -0.9 . . . . 0.0 110.373 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.455 ' N ' ' OG ' ' A' ' 133' ' ' SER . . . -106.59 -73.74 0.68 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.294 -0.879 . . . . 0.0 110.073 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.425 ' O ' ' C ' ' A' ' 136' ' ' ALA . 17.3 m-20 -70.09 152.99 43.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.233 -0.917 . . . . 0.0 110.076 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.484 ' HA ' ' N ' ' A' ' 38' ' ' ALA . . . -43.29 120.79 1.99 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.281 -0.887 . . . . 0.0 110.134 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 1.087 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 5.0 p90 -125.27 -169.59 2.02 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.176 -0.952 . . . . 0.0 110.258 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.532 ' OG1' ' HA ' ' A' ' 35' ' ' ALA 0.255 0.9 OUTLIER -159.33 168.65 25.85 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.384 -0.927 . . . . 0.0 110.41 -177.528 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 1.063 HD13 ' CD1' ' A' ' 129' ' ' LEU . 2.2 mp -124.85 125.84 44.61 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.378 -0.826 . . . . 0.0 109.629 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' CYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 22.2 m -122.98 99.5 6.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.117 -0.989 . . . . 0.0 110.76 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.598 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 1.5 mt -92.09 -177.17 4.61 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.302 -0.874 . . . . 0.0 109.308 179.18 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.669 ' O ' HG22 ' A' ' 8' ' ' THR . 2.8 p-10 -169.77 26.09 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.107 -0.996 . . . . 0.0 110.438 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.862 ' HB2' HG22 ' A' ' 8' ' ' THR . 0.7 OUTLIER 172.54 130.75 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.317 -0.864 . . . . 0.0 109.87 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.82 HG11 ' HZ2' ' A' ' 16' ' ' TRP . 1.3 t -150.48 115.9 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.117 -0.989 . . . . 0.0 109.761 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.723 ' HB1' ' OE1' ' A' ' 6' ' ' GLU . . . -140.35 154.44 46.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.252 -0.905 . . . . 0.0 110.495 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.829 HD11 ' HB3' ' A' ' 60' ' ' TYR . 61.0 tp -148.07 99.6 3.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.39 -0.819 . . . . 0.0 110.113 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.481 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 1.3 m-20 -102.69 -166.58 1.29 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.238 -0.914 . . . . 0.0 110.243 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.493 1.69 0 O-C-N 121.278 -0.889 . . . . 0.0 110.154 -179.929 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo . . . . . 0 N--CA 1.484 0.926 0 N-CA-C 110.645 -0.559 . . . . 0.0 110.645 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.489 HD11 HG12 ' A' ' 144' ' ' VAL . 27.9 pt -97.11 42.78 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.16 -0.962 . . . . 0.0 109.928 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 6' ' ' GLU . . . 97.98 -16.84 59.64 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' A' ' 5' ' ' GLY . 3.3 tt0 42.5 30.73 0.23 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.316 -1.109 . . . . 0.0 110.193 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 143' ' ' ASP . . . -159.86 -130.73 1.16 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.953 HG22 ' CA ' ' A' ' 143' ' ' ASP . 40.1 p -126.83 -172.39 2.63 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.273 -1.133 . . . . 0.0 110.443 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.597 ' CD2' ' HB2' ' A' ' 32' ' ' LEU . 5.8 m-30 -94.4 47.68 1.2 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.326 -0.859 . . . . 0.0 110.097 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.555 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 32.6 p30 -87.78 36.89 0.77 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.247 -0.908 . . . . 0.0 110.2 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.555 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.7 OUTLIER 161.46 37.47 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.678 -0.639 . . . . 0.0 109.686 -179.891 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 124.87 133.18 3.95 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.773 ' HB3' HD12 ' A' ' 32' ' ' LEU . 50.4 Cg_endo -80.43 41.14 1.08 Allowed 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.909 1.479 . . . . 0.0 111.136 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.46 ' OE1' ' O ' ' A' ' 4' ' ' ILE . 0.9 OUTLIER 45.88 -91.99 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.996 -1.065 . . . . 0.0 110.431 179.867 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 13' ' ' PRO . . . -149.07 10.35 1.01 Allowed Glycine 0 N--CA 1.493 2.459 0 C-N-CA 119.779 -1.2 . . . . 0.0 110.331 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.591 ' CH2' HG21 ' A' ' 125' ' ' ILE . 53.5 m95 -53.25 120.35 5.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.006 -1.291 . . . . 0.0 110.154 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.671 ' O ' HG13 ' A' ' 47' ' ' VAL . 0.9 OUTLIER -116.36 154.48 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.106 -0.996 . . . . 0.0 109.763 179.77 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.423 ' HB3' ' OD1' ' A' ' 22' ' ' ASP . . . -137.53 139.77 40.69 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.433 -0.792 . . . . 0.0 109.008 179.018 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.601 ' HE2' HG13 ' A' ' 48' ' ' VAL . 6.1 p90 -123.24 151.4 42.33 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.022 -1.049 . . . . 0.0 111.729 -178.191 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.577 ' HA2' ' CE1' ' A' ' 43' ' ' TYR . . . 133.59 -77.05 0.39 Allowed Glycine 0 N--CA 1.495 2.629 0 N-CA-C 108.899 -1.681 . . . . 0.0 108.899 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.583 HG22 ' CE2' ' A' ' 43' ' ' TYR . 5.5 p -150.81 19.57 0.8 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.213 -1.169 . . . . 0.0 110.08 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.601 ' HA ' ' HB3' ' A' ' 35' ' ' ALA . 1.3 p30 -107.44 112.3 25.02 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.301 -0.874 . . . . 0.0 110.09 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 22' ' ' ASP . . . -61.88 -132.49 0.01 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.455 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 46.1 Cg_endo -72.94 122.17 7.91 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.874 1.46 . . . . 0.0 110.215 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 1.102 ' CD1' HD11 ' A' ' 32' ' ' LEU . 8.1 mt -42.23 126.4 3.35 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.254 -0.904 . . . . 0.0 109.911 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 24' ' ' PRO . 11.8 m-20 -88.45 121.97 31.42 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.226 -0.921 . . . . 0.0 110.603 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.966 HG22 ' O ' ' A' ' 31' ' ' ALA . 3.0 p -119.96 -82.74 0.65 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.339 -0.851 . . . . 0.0 109.964 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.692 ' C ' HG22 ' A' ' 29' ' ' THR . 0.2 OUTLIER 58.28 46.38 15.7 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.247 -0.908 . . . . 0.0 110.662 179.581 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.832 HG22 ' O ' ' A' ' 27' ' ' THR . 0.0 OUTLIER 169.78 -95.37 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.153 -0.967 . . . . 0.0 110.261 179.738 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.516 ' H ' HG23 ' A' ' 29' ' ' THR . . . -158.39 21.93 0.35 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.966 ' O ' HG22 ' A' ' 27' ' ' THR . . . -135.02 162.06 33.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.306 -1.114 . . . . 0.0 110.157 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.102 HD11 ' CD1' ' A' ' 25' ' ' LEU . 0.5 OUTLIER -119.17 98.3 6.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.262 -0.899 . . . . 0.0 110.146 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.556 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 0.8 OUTLIER -98.09 113.21 25.03 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.287 -0.883 . . . . 0.0 111.594 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.95 HG12 HD22 ' A' ' 25' ' ' LEU . 16.6 m -89.55 147.83 4.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 178.169 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.601 ' HB3' ' HA ' ' A' ' 22' ' ' ASP . . . -89.18 91.09 8.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.361 -0.837 . . . . 0.0 111.409 -178.353 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.079 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 66.6 t -79.67 133.67 58.73 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.376 -0.828 . . . . 0.0 108.888 178.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.819 ' HD2' HG21 ' A' ' 45' ' ' VAL . 38.4 Cg_endo -66.66 168.34 16.92 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.881 1.464 . . . . 0.0 111.573 -178.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.523 ' HA ' ' N ' ' A' ' 136' ' ' ALA . . . -55.34 124.39 16.94 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.526 -0.734 . . . . 0.0 111.367 -178.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.532 ' O ' ' C ' ' A' ' 40' ' ' SER . . . 39.73 26.08 0.08 OUTLIER Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.943 ' OG ' HG23 ' A' ' 45' ' ' VAL . 24.1 t 30.06 66.61 0.12 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.844 -0.797 . . . . 0.0 110.565 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.575 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . -89.06 145.05 25.72 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.659 -0.651 . . . . 0.0 109.661 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.575 ' HG2' ' O ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER 45.77 27.61 0.48 Allowed 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -178.893 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.583 ' CE2' HG22 ' A' ' 21' ' ' THR . 0.1 OUTLIER -151.83 124.65 8.52 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 119.034 -1.066 . . . . 0.0 111.881 -178.19 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.536 ' HA2' ' CA ' ' A' ' 130' ' ' GLY . . . -90.32 95.63 2.11 Favored Glycine 0 C--N 1.296 -1.681 0 N-CA-C 106.615 -2.594 . . . . 0.0 106.615 177.239 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.943 HG23 ' OG ' ' A' ' 40' ' ' SER . 3.2 t -86.55 111.95 22.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 O-C-N 120.968 -1.313 . . . . 0.0 108.127 -178.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.576 ' O ' ' CE2' ' A' ' 19' ' ' TYR . . . -141.88 147.71 19.28 Favored Glycine 0 N--CA 1.484 1.895 0 C-N-CA 118.886 -1.626 . . . . 0.0 109.876 -178.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.671 HG13 ' O ' ' A' ' 17' ' ' VAL . 9.3 t -109.92 126.65 67.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.315 -1.109 . . . . 0.0 109.887 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.601 HG13 ' HE2' ' A' ' 19' ' ' TYR . 27.6 m -119.73 142.36 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.962 -1.086 . . . . 0.0 110.567 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.555 HD13 ' CD1' ' A' ' 16' ' ' TRP . 6.7 tp -126.04 95.17 4.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.369 -0.832 . . . . 0.0 109.918 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.518 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 0.7 OUTLIER -76.47 144.36 39.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.295 -0.878 . . . . 0.0 110.469 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 123.23 54.9 0.2 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.615 HG11 ' HD2' ' A' ' 112' ' ' TYR . 75.2 t -119.8 164.54 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.148 -1.207 . . . . 0.0 110.218 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.491 ' HA ' ' O ' ' A' ' 112' ' ' TYR . . . -140.15 84.54 1.97 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.248 -0.908 . . . . 0.0 110.516 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.623 HG23 ' CE2' ' A' ' 60' ' ' TYR . 47.5 mm -111.75 155.21 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.243 -0.911 . . . . 0.0 109.702 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.541 ' HG3' HG23 ' A' ' 111' ' ' THR . 0.7 OUTLIER -145.24 132.07 20.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.097 -1.002 . . . . 0.0 110.56 -179.766 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 7.9 pt-20 38.39 -152.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.743 -0.598 . . . . 0.0 110.695 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.494 ' N ' ' HG3' ' A' ' 56' ' ' GLU . . . -88.98 116.99 4.78 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.523 ' CG2' ' CE2' ' A' ' 60' ' ' TYR . 0.9 OUTLIER -136.35 168.27 19.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.279 -1.13 . . . . 0.0 109.769 179.917 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.498 ' O ' ' HA ' ' A' ' 148' ' ' SER . 1.6 m -90.25 99.48 12.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.284 -0.885 . . . . 0.0 110.578 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.907 ' HB3' HD11 ' A' ' 146' ' ' LEU . 59.9 m-85 -106.33 151.96 24.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.228 -0.92 . . . . 0.0 110.21 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.431 ' C ' HD12 ' A' ' 146' ' ' LEU . 92.9 m -125.3 109.77 13.2 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 110.028 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 103' ' ' THR . 14.2 tp -89.94 120.14 30.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.22 -0.925 . . . . 0.0 110.008 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.596 ' HB2' HG23 ' A' ' 103' ' ' THR . 20.9 ttp180 -129.45 110.84 12.21 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.896 . . . . 0.0 110.257 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.496 ' C ' ' CD1' ' A' ' 64' ' ' TYR . 8.3 p90 -143.41 155.44 44.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.375 -0.828 . . . . 0.0 109.911 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.504 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 4.5 m -119.69 97.72 5.77 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.108 -0.995 . . . . 0.0 109.921 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.58 ' CB ' HD21 ' A' ' 95' ' ' LEU . . . -97.9 150.17 21.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.223 -0.923 . . . . 0.0 110.479 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.43 HG23 ' O ' ' A' ' 96' ' ' THR . 99.9 m -149.96 130.71 14.12 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.291 -0.88 . . . . 0.0 110.017 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.511 ' CB ' HG12 ' A' ' 72' ' ' VAL . . . -119.32 128.92 54.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.235 -0.915 . . . . 0.0 110.205 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.79 -9.23 26.62 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.257 -0.902 . . . . 0.0 110.102 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.674 HG21 ' CB ' ' A' ' 137' ' ' TRP . 6.0 t -114.33 19.53 16.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.238 -0.914 . . . . 0.0 110.095 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.501 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 4.9 t70 43.35 73.56 0.14 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.32 -0.862 . . . . 0.0 109.772 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.682 ' CG1' HD12 ' A' ' 95' ' ' LEU . 5.6 p -109.59 140.48 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.385 -0.822 . . . . 0.0 110.768 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 54.4 m -119.87 83.88 2.12 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.447 -0.783 . . . . 0.0 109.036 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.728 HG21 ' CD2' ' A' ' 129' ' ' LEU . 14.2 m -89.83 -139.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.221 -0.925 . . . . 0.0 110.759 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.567 ' N ' HG23 ' A' ' 74' ' ' VAL . 0.4 OUTLIER -131.58 142.93 50.01 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.185 -0.947 . . . . 0.0 111.12 -179.075 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.85 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -143.91 154.37 43.27 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.472 -0.768 . . . . 0.0 109.44 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.804 HD12 ' N ' ' A' ' 78' ' ' VAL . 4.2 pp -179.86 -152.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.116 -0.99 . . . . 0.0 110.5 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.867 HG23 HD22 ' A' ' 89' ' ' LEU . 66.8 t -155.14 168.94 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.392 -0.818 . . . . 0.0 109.251 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.515 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . 173.37 179.37 43.99 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.205 -1.474 . . . . 0.0 110.312 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.472 ' HG2' ' O ' ' A' ' 122' ' ' GLU . 1.0 OUTLIER -72.74 -152.9 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.571 -0.958 . . . . 0.0 110.265 179.932 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.48 ' N ' ' O ' ' A' ' 122' ' ' GLU . 15.2 m120 -160.57 60.55 0.32 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.541 -0.725 . . . . 0.0 109.317 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.578 ' O ' ' CZ ' ' A' ' 85' ' ' TYR . . . 158.28 -125.97 1.62 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.457 ' HA ' ' N ' ' A' ' 85' ' ' TYR . . . -125.2 153.2 71.73 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.174 -1.192 . . . . 0.0 110.122 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.472 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.5 Cg_endo -86.07 35.69 3.73 Favored 'Cis proline' 0 C--N 1.311 -1.418 0 C-N-CA 121.854 -2.144 . . . . 0.0 110.614 -0.448 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.578 ' CZ ' ' O ' ' A' ' 82' ' ' GLY . 76.6 m-85 58.98 148.89 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.178 -0.951 . . . . 0.0 110.226 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -173.19 115.57 0.57 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -110.65 143.63 40.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.238 -1.154 . . . . 0.0 110.376 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 1.046 HG23 HD12 ' A' ' 89' ' ' LEU . 34.6 m -124.43 -15.14 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.265 -0.897 . . . . 0.0 110.38 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 1.046 HD12 HG23 ' A' ' 88' ' ' VAL . 4.2 mp -108.33 137.39 46.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.209 -0.932 . . . . 0.0 111.002 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -151.15 81.27 1.32 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.4 -0.812 . . . . 0.0 109.901 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.5 p -137.76 179.52 6.38 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.994 -1.066 . . . . 0.0 110.699 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.7 m -119.89 115.28 33.48 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.378 -0.826 . . . . 0.0 110.059 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.85 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 44.1 Cg_endo -72.18 92.81 0.73 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.93 1.489 . . . . 0.0 110.919 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.524 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -75.15 147.89 40.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.904 . . . . 0.0 109.568 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.682 HD12 ' CG1' ' A' ' 72' ' ' VAL . 71.1 mt -138.99 162.36 35.09 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.04 -1.038 . . . . 0.0 110.778 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.43 ' O ' HG23 ' A' ' 67' ' ' THR . 0.3 OUTLIER -174.68 -179.22 1.44 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.438 -0.789 . . . . 0.0 110.088 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.56 -29.19 58.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.285 -0.884 . . . . 0.0 110.068 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.94 161.09 39.3 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.294 -0.879 . . . . 0.0 110.007 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.87 145.11 39.9 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.96 1.505 . . . . 0.0 110.487 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.524 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.85 94.34 4.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.29 -0.881 . . . . 0.0 110.037 179.811 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.459 HE21 ' HB2' ' A' ' 101' ' ' GLN . 0.0 OUTLIER -84.23 95.07 8.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.385 -0.822 . . . . 0.0 110.198 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 25.2 t -89.54 134.4 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.348 -0.845 . . . . 0.0 110.066 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.596 HG23 ' HB2' ' A' ' 63' ' ' ARG . 0.2 OUTLIER -150.15 130.72 13.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.327 -0.858 . . . . 0.0 110.163 -179.945 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.52 ' CG ' ' O ' ' A' ' 103' ' ' THR . 21.1 mt-10 -160.1 138.23 10.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.19 -0.944 . . . . 0.0 110.378 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 105' ' ' THR . 4.1 t -90.05 76.14 7.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.233 -0.917 . . . . 0.0 110.047 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.845 ' CE1' HD11 ' A' ' 89' ' ' LEU . 30.4 p90 -77.64 153.01 33.56 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.261 -0.9 . . . . 0.0 110.422 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 58' ' ' THR . 78.8 m -93.57 98.57 11.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.267 -0.895 . . . . 0.0 109.919 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.643 ' HB3' ' CE2' ' A' ' 60' ' ' TYR . . . -58.47 99.19 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -0.933 . . . . 0.0 110.239 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.416 ' N ' ' CG1' ' A' ' 88' ' ' VAL . 81.6 p -87.05 55.15 3.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.222 -0.924 . . . . 0.0 109.927 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -161.96 -151.42 0.21 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.268 -0.895 . . . . 0.0 110.353 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.541 HG23 ' HG3' ' A' ' 55' ' ' GLU . 31.6 m -157.13 122.43 4.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.319 -0.863 . . . . 0.0 110.398 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.615 ' HD2' HG11 ' A' ' 52' ' ' VAL . 14.3 m-30 -112.73 86.52 8.78 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.312 -0.867 . . . . 0.0 109.766 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.472 ' HG2' ' HA ' ' A' ' 122' ' ' GLU . 43.1 Cg_endo -70.5 163.84 37.4 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.941 1.495 . . . . 0.0 110.4 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.222 -0.924 . . . . 0.0 110.295 -179.775 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.48 ' O ' ' N ' ' A' ' 81' ' ' ASN . 0.4 OUTLIER . . . . . 0 N--CA 1.494 1.742 0 CA-C-O 121.198 0.523 . . . . 0.0 110.485 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.514 ' HA3' ' CB ' ' A' ' 112' ' ' TYR . . . -148.38 140.79 8.56 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.083 -1.607 . . . . 0.0 109.083 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.526 ' O ' HG13 ' A' ' 78' ' ' VAL . 1.0 OUTLIER -150.34 -149.83 0.32 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.134 -1.215 . . . . 0.0 110.731 -179.325 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.591 HG21 ' CH2' ' A' ' 16' ' ' TRP . 11.4 mt -118.22 150.98 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.481 -0.762 . . . . 0.0 109.409 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.413 ' HB3' HD11 ' A' ' 77' ' ' LEU . . . -130.13 124.19 32.13 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.271 -0.893 . . . . 0.0 110.801 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.501 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 5.4 m-85 -118.61 106.02 12.2 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLN . . . . . 1.049 ' O ' HD23 ' A' ' 129' ' ' LEU . 4.4 mt-30 -89.58 129.19 36.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.187 -0.945 . . . . 0.0 112.109 -177.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 1.049 HD23 ' O ' ' A' ' 128' ' ' GLN . 0.4 OUTLIER -143.73 34.79 1.27 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 178.047 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.536 ' CA ' ' HA2' ' A' ' 44' ' ' GLY . . . -83.8 123.67 6.28 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.301 -1.519 . . . . 0.0 109.301 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 44.91 63.42 2.57 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.594 ' CD2' ' HA ' ' A' ' 74' ' ' VAL . 10.5 m-85 -115.61 -61.8 1.69 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.088 -1.242 . . . . 0.0 111.155 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.592 ' HB3' ' CE3' ' A' ' 137' ' ' TRP . 3.3 t -87.73 -161.25 0.69 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.949 -1.094 . . . . 0.0 110.527 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -119.79 -62.97 1.43 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.169 -0.957 . . . . 0.0 110.557 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -84.54 151.69 24.39 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.107 -0.996 . . . . 0.0 110.042 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.523 ' N ' ' HA ' ' A' ' 38' ' ' ALA . . . -48.59 127.91 14.2 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.331 -0.856 . . . . 0.0 110.543 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 1.079 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 10.5 p90 -139.38 -173.18 3.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.204 -0.935 . . . . 0.0 110.489 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.528 ' C ' HD12 ' A' ' 139' ' ' LEU 0.254 0.8 OUTLIER -150.16 176.64 10.66 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.404 -0.81 . . . . 0.0 109.922 -177.799 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.556 ' O ' ' HA ' ' A' ' 33' ' ' CYS . 1.9 mp -139.0 117.98 12.48 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.069 -1.019 . . . . 0.0 111.76 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' CYS . . . . . 0.511 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 0.8 OUTLIER -101.45 116.25 32.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.653 -0.655 . . . . 0.0 110.834 178.7 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.504 ' HA ' ' O ' ' A' ' 65' ' ' THR . 1.6 mt -110.42 178.85 4.25 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.258 -0.901 . . . . 0.0 109.508 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.477 ' HB3' ' O ' ' A' ' 141' ' ' LEU . 4.7 p-10 174.18 175.96 0.15 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.399 -0.813 . . . . 0.0 110.239 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.953 ' CA ' HG22 ' A' ' 8' ' ' THR . 5.1 t0 41.24 59.33 2.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.541 -0.725 . . . . 0.0 110.076 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.535 HG21 ' HZ ' ' A' ' 9' ' ' PHE . 2.8 t -100.57 113.23 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.3 -0.875 . . . . 0.0 110.04 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -136.95 158.87 43.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.24 -0.913 . . . . 0.0 110.377 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.907 HD11 ' HB3' ' A' ' 60' ' ' TYR . 13.0 tp -167.39 122.09 1.03 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.36 -0.837 . . . . 0.0 110.06 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.463 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 1.5 t70 -139.22 -158.51 0.86 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.229 -0.919 . . . . 0.0 110.312 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' A' ' 59' ' ' THR . 75.0 p . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.27 -0.894 . . . . 0.0 110.196 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo . . . . . 0 N--CA 1.48 0.7 0 N-CA-C 110.104 -0.768 . . . . 0.0 110.104 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.41 HG13 ' N ' ' A' ' 5' ' ' GLY . 14.3 pt -90.24 -32.45 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.238 -0.913 . . . . 0.0 110.163 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.41 ' N ' HG13 ' A' ' 4' ' ' ILE . . . 169.16 147.82 5.57 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.42 19.57 2.74 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.277 -1.131 . . . . 0.0 110.194 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 143' ' ' ASP . . . 161.75 -97.74 0.16 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.657 HG22 ' O ' ' A' ' 142' ' ' ASP . 17.1 p -92.07 147.31 23.05 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.23 -1.159 . . . . 0.0 109.95 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.603 ' CE2' ' HB2' ' A' ' 32' ' ' LEU . 21.8 m-85 -44.04 -40.77 5.02 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.312 -0.868 . . . . 0.0 109.408 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.553 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 12.0 t70 31.28 42.27 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.074 0.464 . . . . 0.0 111.299 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.553 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 1.7 t70 161.66 80.87 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.559 -0.713 . . . . 0.0 109.58 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 55.23 173.38 0.1 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.861 ' HB3' HD12 ' A' ' 32' ' ' LEU . 47.6 Cg_endo -73.56 -5.42 17.07 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 124.048 1.551 . . . . 0.0 110.519 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 0.5 OUTLIER 65.29 -87.1 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.215 -0.928 . . . . 0.0 110.282 -179.92 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.74 ' C ' HD13 ' A' ' 49' ' ' LEU . . . -140.92 6.23 2.58 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.808 ' HH2' HG21 ' A' ' 125' ' ' ILE . 55.0 m95 -71.34 82.6 0.77 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.178 -1.189 . . . . 0.0 110.406 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.744 ' O ' HG13 ' A' ' 47' ' ' VAL . 1.0 OUTLIER -78.53 149.35 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.011 -1.055 . . . . 0.0 109.287 179.559 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.611 ' CB ' HG12 ' A' ' 34' ' ' VAL . . . -135.33 132.74 38.03 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.049 -1.032 . . . . 0.0 110.461 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.602 ' HE1' HG13 ' A' ' 48' ' ' VAL . 11.8 p90 -122.07 115.46 22.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.526 -0.734 . . . . 0.0 110.006 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.917 ' CA ' HG13 ' A' ' 45' ' ' VAL . . . -152.96 27.55 0.81 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.9 p 47.87 21.32 0.28 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.304 -1.115 . . . . 0.0 110.862 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.559 ' HB3' ' CB ' ' A' ' 35' ' ' ALA . 3.2 m-20 -125.15 43.12 3.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.898 -1.126 . . . . 0.0 110.261 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.41 152.07 17.32 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.415 ' O ' ' C ' ' A' ' 25' ' ' LEU . 46.6 Cg_endo -73.09 140.76 31.68 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.989 1.521 . . . . 0.0 110.428 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.743 HD13 HD11 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -42.41 156.64 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.316 -0.865 . . . . 0.0 110.219 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -145.12 148.76 33.98 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.262 -0.899 . . . . 0.0 110.261 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.646 ' O ' HG22 ' A' ' 29' ' ' THR . 0.8 OUTLIER -119.89 -74.14 0.62 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.266 -0.896 . . . . 0.0 110.236 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 27' ' ' THR . 2.5 t 43.14 36.05 0.91 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.229 -0.919 . . . . 0.0 110.232 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.646 HG22 ' O ' ' A' ' 27' ' ' THR . 14.9 t -172.65 -34.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.317 -0.864 . . . . 0.0 110.21 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.44 ' N ' HG23 ' A' ' 29' ' ' THR . . . 123.73 7.88 6.53 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.453 ' H ' HG23 ' A' ' 29' ' ' THR . . . -130.95 132.21 44.92 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.164 -1.197 . . . . 0.0 110.222 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.861 HD12 ' HB3' ' A' ' 13' ' ' PRO . 2.2 tp -74.03 109.06 7.23 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.233 -0.917 . . . . 0.0 110.066 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 9.5 m -111.12 103.36 11.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.151 -0.968 . . . . 0.0 110.774 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.611 HG12 ' CB ' ' A' ' 18' ' ' ALA . 25.4 m -89.7 169.44 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.894 . . . . 0.0 109.13 179.17 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.559 ' CB ' ' HB3' ' A' ' 22' ' ' ASP . . . -122.46 129.22 51.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.904 -1.122 . . . . 0.0 111.317 -179.237 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.139 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 4.5 t -117.1 122.58 31.06 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.508 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 45.4 Cg_endo -74.5 152.65 43.7 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.804 1.423 . . . . 0.0 111.625 -178.403 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.484 ' HA ' ' CA ' ' A' ' 136' ' ' ALA . . . -42.07 131.39 3.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.32 -0.862 . . . . 0.0 109.892 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 38' ' ' ALA . . . 46.18 71.98 0.45 Allowed Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.558 -1.817 . . . . 0.0 108.558 -179.345 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.926 ' OG ' HG12 ' A' ' 36' ' ' VAL . 0.9 OUTLIER -84.6 34.92 0.54 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.319 -1.106 . . . . 0.0 110.778 -179.354 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.95 ' HB2' ' HA3' ' A' ' 131' ' ' GLY . . . -98.87 20.73 12.63 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.308 -0.87 . . . . 0.0 109.708 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.642 HE21 ' HE2' ' A' ' 43' ' ' TYR . 0.5 OUTLIER -95.02 20.25 9.25 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.747 0.785 . . . . 0.0 109.882 179.771 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.702 ' CZ ' HG22 ' A' ' 45' ' ' VAL . 24.4 p90 176.86 -29.35 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.015 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.497 ' N ' ' CD1' ' A' ' 43' ' ' TYR . . . 99.24 108.91 2.93 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 110.241 -1.143 . . . . 0.0 110.241 179.095 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.917 HG13 ' CA ' ' A' ' 20' ' ' GLY . 1.9 t -89.99 178.28 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.215 -1.167 . . . . 0.0 108.74 179.114 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.509 ' CA ' ' HA ' ' A' ' 128' ' ' GLN . . . 162.81 -173.96 39.1 Favored Glycine 0 N--CA 1.487 2.051 0 C-N-CA 118.867 -1.635 . . . . 0.0 110.823 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.744 HG13 ' O ' ' A' ' 17' ' ' VAL . 38.9 t -151.06 128.2 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.625 ' O ' HG22 ' A' ' 17' ' ' VAL . 27.6 m -120.55 128.37 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.842 -1.161 . . . . 0.0 110.749 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.787 HD22 ' NE1' ' A' ' 16' ' ' TRP . 19.7 tp -119.29 105.2 11.09 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.367 -0.833 . . . . 0.0 110.3 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.512 ' HA ' ' HB3' ' A' ' 124' ' ' GLN . 0.2 OUTLIER -82.29 103.29 11.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.265 -0.897 . . . . 0.0 110.161 179.826 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.71 69.48 0.02 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.587 HG12 ' N ' ' A' ' 53' ' ' ALA . 38.3 t -119.9 171.78 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.196 -1.179 . . . . 0.0 109.979 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.587 ' N ' HG12 ' A' ' 52' ' ' VAL . . . -137.6 78.46 1.69 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.122 -0.987 . . . . 0.0 110.783 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.719 HD11 HD21 ' A' ' 146' ' ' LEU . 28.2 mm -118.31 160.41 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.21 -0.931 . . . . 0.0 109.712 179.286 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.527 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 1.2 tt0 -154.46 131.77 11.15 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.026 -1.046 . . . . 0.0 110.82 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 10.8 pt-20 37.58 -154.4 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.726 -0.609 . . . . 0.0 110.981 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 108' ' ' ALA . . . -86.77 91.91 1.76 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.555 ' CG2' ' N ' ' A' ' 59' ' ' THR . 1.2 m -121.36 173.74 7.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.274 -1.133 . . . . 0.0 109.83 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.555 ' N ' ' CG2' ' A' ' 58' ' ' THR . 0.5 OUTLIER -89.72 152.66 21.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.278 -0.889 . . . . 0.0 110.28 -179.913 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.629 ' CE1' ' CD1' ' A' ' 54' ' ' ILE . 54.1 m-85 -156.79 165.33 36.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.286 -0.884 . . . . 0.0 110.344 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 96.2 m -142.78 112.95 7.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.314 -0.866 . . . . 0.0 109.982 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.3 tp -89.76 120.76 31.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 110.148 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.491 ' HA ' ' O ' ' A' ' 102' ' ' VAL . 32.5 ttp180 -130.12 119.48 23.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.339 -0.851 . . . . 0.0 110.119 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.983 ' CZ ' HG21 ' A' ' 102' ' ' VAL . 14.6 p90 -150.91 153.26 34.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.237 -0.915 . . . . 0.0 110.252 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.492 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 5.6 m -119.73 94.86 4.55 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.26 -0.9 . . . . 0.0 109.968 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.832 ' HB2' HD23 ' A' ' 141' ' ' LEU . . . -99.72 153.33 19.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.324 -0.86 . . . . 0.0 110.401 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.691 HG23 ' O ' ' A' ' 98' ' ' GLU . 67.9 m -150.1 117.08 5.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.243 -0.911 . . . . 0.0 110.161 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -99.48 140.35 33.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.268 -0.895 . . . . 0.0 109.872 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.409 ' C ' ' O ' ' A' ' 68' ' ' ALA . 22.9 t -44.72 -26.27 0.37 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.185 -0.947 . . . . 0.0 109.282 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.738 HG22 ' HB2' ' A' ' 137' ' ' TRP . 5.0 t -116.99 -152.63 0.51 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.574 -0.704 . . . . 0.0 109.764 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.622 ' N ' HG23 ' A' ' 70' ' ' THR . 0.1 OUTLIER -116.03 62.17 0.71 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.276 -0.89 . . . . 0.0 109.324 179.043 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.818 HG23 ' HB2' ' A' ' 133' ' ' SER . 4.5 p -82.95 136.63 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.329 -0.857 . . . . 0.0 111.187 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.465 HG22 ' O ' ' A' ' 73' ' ' THR . 8.3 m -119.79 89.96 3.23 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.878 HG21 HD22 ' A' ' 129' ' ' LEU . 12.8 m -89.81 -150.39 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.279 -0.888 . . . . 0.0 110.811 -178.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.522 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 6.4 mtm180 -129.83 137.04 50.25 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.319 -0.863 . . . . 0.0 110.63 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.718 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -134.24 157.67 45.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.408 -0.808 . . . . 0.0 109.746 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.669 HD12 ' N ' ' A' ' 78' ' ' VAL . 3.8 pp 178.66 -156.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.195 -0.94 . . . . 0.0 110.373 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.86 ' CG2' HD22 ' A' ' 89' ' ' LEU . 3.4 t -148.39 167.55 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.296 -0.877 . . . . 0.0 109.565 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.49 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . -178.78 -170.23 40.5 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.343 -1.408 . . . . 0.0 110.202 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.52 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 28.2 tt0 -111.15 118.5 36.13 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.441 -1.035 . . . . 0.0 110.297 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.501 ' CB ' ' OE2' ' A' ' 122' ' ' GLU . 2.5 m120 -85.49 94.51 9.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.221 -0.924 . . . . 0.0 110.166 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.661 ' O ' ' HB2' ' A' ' 83' ' ' ALA . . . 164.69 -89.53 0.1 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.661 ' HB2' ' O ' ' A' ' 82' ' ' GLY . . . 173.04 144.19 0.17 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.229 -1.159 . . . . 0.0 110.15 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.467 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.6 Cg_endo -84.23 32.87 4.1 Favored 'Cis proline' 0 C--N 1.314 -1.28 0 C-N-CA 121.929 -2.113 . . . . 0.0 110.681 -0.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.581 ' CZ ' ' O ' ' A' ' 82' ' ' GLY . 19.4 m-85 64.76 157.47 0.09 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.16 -0.963 . . . . 0.0 110.246 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.472 ' O ' ' HA2' ' A' ' 79' ' ' GLY . . . -171.74 103.48 0.19 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.487 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 1.7 p -89.87 139.25 30.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.19 -1.182 . . . . 0.0 110.359 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 1.032 HG23 HD12 ' A' ' 89' ' ' LEU . 34.4 m -119.92 -16.79 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.337 -0.852 . . . . 0.0 109.979 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 1.032 HD12 HG23 ' A' ' 88' ' ' VAL . 4.2 mp -108.82 143.34 38.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.292 -0.88 . . . . 0.0 110.775 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -150.78 83.51 1.34 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.34 -0.85 . . . . 0.0 110.125 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.0 p -145.3 174.9 10.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.082 -1.011 . . . . 0.0 110.534 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.5 m -121.38 116.33 30.88 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.33 -0.856 . . . . 0.0 110.145 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.718 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 43.9 Cg_endo -71.15 124.77 10.79 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.898 1.473 . . . . 0.0 110.962 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 1.011 ' HB3' ' NH1' ' A' ' 100' ' ' ARG . . . -96.62 148.11 23.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.32 -0.862 . . . . 0.0 109.438 179.3 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.797 HD21 ' CB ' ' A' ' 66' ' ' ALA . 32.2 mt -136.2 166.51 23.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.001 -1.062 . . . . 0.0 110.726 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' A' ' 70' ' ' THR . 0.2 OUTLIER -164.35 -178.81 5.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.482 -0.761 . . . . 0.0 109.975 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.42 -6.47 30.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.225 -0.922 . . . . 0.0 110.183 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.691 ' O ' HG23 ' A' ' 67' ' ' THR . 1.5 mt-10 -113.11 178.34 0.99 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.292 -0.88 . . . . 0.0 110.074 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.495 ' HD2' ' CB ' ' A' ' 98' ' ' GLU . 45.6 Cg_endo -72.68 128.03 12.99 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.0 1.527 . . . . 0.0 110.359 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 1.011 ' NH1' ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.77 91.56 3.58 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.26 -0.9 . . . . 0.0 110.217 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.437 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 0.5 OUTLIER -75.78 157.19 33.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.302 -0.874 . . . . 0.0 110.138 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.983 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 41.0 t -135.09 139.26 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.221 -0.924 . . . . 0.0 110.129 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.96 102.43 3.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.263 -0.898 . . . . 0.0 110.194 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -142.01 165.78 26.51 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.239 -0.913 . . . . 0.0 110.171 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.5 t -122.08 167.15 13.48 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.22 -0.925 . . . . 0.0 110.163 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.881 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 34.4 p90 -173.3 151.37 2.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.245 -0.909 . . . . 0.0 110.274 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 66.9 m -89.98 96.14 10.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.225 -0.922 . . . . 0.0 110.029 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.598 ' HB3' ' CE2' ' A' ' 60' ' ' TYR . . . -55.17 100.07 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.289 -0.882 . . . . 0.0 110.251 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 54.5 p -89.08 52.45 2.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.258 -0.901 . . . . 0.0 110.179 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.43 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -159.22 -155.85 0.49 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.253 -0.904 . . . . 0.0 110.191 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.679 HG22 ' HD3' ' A' ' 113' ' ' PRO . 88.6 m -147.05 111.1 5.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.262 -0.899 . . . . 0.0 110.283 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.605 ' CE2' HG12 ' A' ' 78' ' ' VAL . 15.0 m-30 -111.43 77.04 1.58 Allowed Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.361 -0.837 . . . . 0.0 109.994 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.679 ' HD3' HG22 ' A' ' 111' ' ' THR . 44.8 Cg_endo -72.46 177.56 7.24 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.975 1.513 . . . . 0.0 110.419 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.243 -0.911 . . . . 0.0 110.264 -179.909 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.515 ' OE1' ' N ' ' A' ' 122' ' ' GLU . 6.4 pm0 . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.218 0.532 . . . . 0.0 110.187 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.526 ' HA3' ' CB ' ' A' ' 112' ' ' TYR . . . -138.12 154.6 22.91 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.574 ' HA ' ' CG2' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -150.25 -162.14 1.49 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -1.176 . . . . 0.0 110.518 -179.716 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.808 HG21 ' HH2' ' A' ' 16' ' ' TRP . 10.1 mt -118.86 144.25 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.486 -0.759 . . . . 0.0 109.503 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.51 ' O ' ' HA ' ' A' ' 76' ' ' ALA . . . -116.28 115.29 25.67 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.453 -0.779 . . . . 0.0 111.41 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.546 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 2.7 m-30 -118.09 75.52 1.01 Allowed 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLN . . . . . 0.861 ' C ' HD23 ' A' ' 129' ' ' LEU . 25.6 mt-30 -88.21 122.72 32.08 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.278 -0.888 . . . . 0.0 112.512 -177.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.878 HD22 HG21 ' A' ' 74' ' ' VAL . 0.6 OUTLIER -108.38 55.6 0.64 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.008 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.495 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -66.04 89.38 0.13 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 -178.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.95 ' HA3' ' HB2' ' A' ' 41' ' ' ALA . . . 39.7 86.04 0.01 OUTLIER Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.999 -1.241 . . . . 0.0 109.999 179.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.694 ' CD2' HG12 ' A' ' 74' ' ' VAL . 12.9 m-85 -111.94 -47.95 3.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.191 -1.182 . . . . 0.0 110.348 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.818 ' HB2' HG23 ' A' ' 72' ' ' VAL . 37.2 t -89.84 -174.47 4.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.214 -0.929 . . . . 0.0 110.235 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -98.11 -80.6 0.45 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -0.892 . . . . 0.0 110.391 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -63.17 155.81 27.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.211 -0.931 . . . . 0.0 110.425 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.484 ' CA ' ' HA ' ' A' ' 38' ' ' ALA . . . -50.4 128.42 19.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.246 -0.909 . . . . 0.0 110.193 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 1.139 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 11.2 p90 -132.04 -165.03 1.53 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.287 -0.883 . . . . 0.0 110.216 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.604 ' C ' HD12 ' A' ' 139' ' ' LEU . 0.5 OUTLIER -160.38 -178.44 6.93 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.683 -178.831 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.847 HD13 HD13 ' A' ' 129' ' ' LEU . 2.3 mp -141.08 141.22 34.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.348 -0.845 . . . . 0.0 110.129 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' CYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 22.3 m -140.59 103.35 4.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.185 -0.947 . . . . 0.0 110.459 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.832 HD23 ' HB2' ' A' ' 66' ' ' ALA . 1.0 OUTLIER -96.29 -177.95 4.14 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.2 -0.938 . . . . 0.0 109.926 179.58 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.657 ' O ' HG22 ' A' ' 8' ' ' THR . 3.2 p30 168.87 35.68 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.439 -0.788 . . . . 0.0 110.004 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.503 ' HA ' ' O ' ' A' ' 7' ' ' GLY . 3.3 t0 -169.69 43.29 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.32 -0.862 . . . . 0.0 109.676 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.639 HG11 ' HZ2' ' A' ' 16' ' ' TRP . 3.5 t -89.7 126.46 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.39 -0.819 . . . . 0.0 110.353 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -149.11 148.32 29.53 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.336 -0.853 . . . . 0.0 110.094 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.719 HD21 HD11 ' A' ' 54' ' ' ILE . 47.5 tp -140.41 139.92 35.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.259 -0.901 . . . . 0.0 110.303 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.483 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -151.3 -177.83 6.29 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.281 -0.887 . . . . 0.0 110.031 179.9 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.666 0 O-C-N 121.224 -0.922 . . . . 0.0 110.205 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo . . . . . 0 N--CA 1.48 0.714 0 N-CA-C 110.043 -0.791 . . . . 0.0 110.043 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.563 ' CD1' HG12 ' A' ' 144' ' ' VAL . 8.2 pt -89.97 4.49 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.189 -0.944 . . . . 0.0 110.215 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 133.07 -166.43 23.7 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -137.14 76.84 1.61 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.23 -1.159 . . . . 0.0 110.203 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.43 ' C ' ' HA ' ' A' ' 143' ' ' ASP . . . 110.89 -133.13 11.36 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' THR . . . . . 1.048 HG22 ' O ' ' A' ' 142' ' ' ASP . 80.7 p -76.19 146.42 39.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.256 -1.143 . . . . 0.0 110.252 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.53 ' CE1' ' CD1' ' A' ' 16' ' ' TRP . 43.3 m-85 -42.95 -36.0 1.4 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.343 -0.848 . . . . 0.0 109.968 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.56 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 3.3 p-10 35.53 59.36 0.81 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.653 -0.654 . . . . 0.0 111.417 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.56 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 4.0 t0 162.03 -67.34 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.514 -0.742 . . . . 0.0 109.764 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.469 ' HA2' ' HB ' ' A' ' 27' ' ' THR . . . -174.56 -172.06 39.32 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.761 ' HD3' HG21 ' A' ' 27' ' ' THR . 47.3 Cg_endo -74.35 80.91 2.14 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 124.124 1.591 . . . . 0.0 110.384 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -35.8 -65.61 0.24 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.666 -0.646 . . . . 0.0 110.567 -179.853 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.69 ' C ' HD13 ' A' ' 49' ' ' LEU . . . -144.73 12.15 1.94 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.86 ' NE1' HD22 ' A' ' 49' ' ' LEU . 51.3 m95 -73.27 108.18 6.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.294 -1.121 . . . . 0.0 110.851 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.773 ' O ' HG13 ' A' ' 47' ' ' VAL . 1.4 m -109.0 151.38 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.317 -0.864 . . . . 0.0 109.133 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.431 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . . . -130.77 118.14 20.41 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.862 -1.149 . . . . 0.0 109.757 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.571 ' CE2' ' O ' ' A' ' 46' ' ' GLY . 7.4 p90 -107.02 173.63 6.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.513 -0.742 . . . . 0.0 110.861 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.566 ' HA2' ' CE1' ' A' ' 43' ' ' TYR . . . 90.69 -13.94 64.36 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.783 HG23 HG13 ' A' ' 45' ' ' VAL . 17.8 p -149.93 -141.44 0.11 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.27 -1.135 . . . . 0.0 110.236 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.561 ' CB ' ' HD3' ' A' ' 24' ' ' PRO . 19.4 t0 -89.29 174.47 7.81 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.357 -0.839 . . . . 0.0 109.658 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.614 ' N ' ' HD3' ' A' ' 24' ' ' PRO . . . -122.08 43.82 1.43 Allowed Glycine 0 N--CA 1.488 2.165 0 C-N-CA 119.513 -1.327 . . . . 0.0 110.765 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.614 ' HD3' ' N ' ' A' ' 23' ' ' GLY . 55.8 Cg_endo -80.19 41.12 1.07 Allowed 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 123.458 1.241 . . . . 0.0 110.685 179.148 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 1.015 ' CD2' HG12 ' A' ' 34' ' ' VAL . 17.4 mt -44.33 93.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.978 -1.076 . . . . 0.0 110.273 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 24' ' ' PRO . 36.0 t0 -74.67 115.82 14.67 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.278 -0.888 . . . . 0.0 109.333 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.761 HG21 ' HD3' ' A' ' 13' ' ' PRO . 2.1 p -119.38 -30.97 4.76 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.158 -0.964 . . . . 0.0 110.779 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.7 ' C ' HG22 ' A' ' 29' ' ' THR . 3.4 m -53.42 82.75 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.615 -0.678 . . . . 0.0 110.59 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.7 HG22 ' C ' ' A' ' 28' ' ' SER . 0.0 OUTLIER 165.6 -33.14 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.215 -0.928 . . . . 0.0 109.806 -179.542 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.455 ' O ' ' HB3' ' A' ' 142' ' ' ASP . . . 127.51 7.36 4.83 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.497 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -150.57 154.95 38.49 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.039 -1.271 . . . . 0.0 110.662 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.78 HD11 HD13 ' A' ' 25' ' ' LEU . 2.0 tt -105.4 104.65 14.42 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.369 -0.832 . . . . 0.0 110.239 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.569 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 0.8 OUTLIER -97.65 113.86 25.69 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.223 -0.923 . . . . 0.0 111.449 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 1.015 HG12 ' CD2' ' A' ' 25' ' ' LEU . 18.7 m -89.76 148.8 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 178.489 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.423 ' HB2' ' HG2' ' A' ' 24' ' ' PRO . . . -89.29 111.0 21.72 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.39 -0.819 . . . . 0.0 111.309 -178.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.094 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 55.7 t -105.29 133.36 20.2 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.477 -0.765 . . . . 0.0 109.303 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.577 ' HD3' ' CG2' ' A' ' 21' ' ' THR . 40.2 Cg_endo -67.2 171.84 10.88 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.81 1.426 . . . . 0.0 111.0 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.509 ' HA ' ' N ' ' A' ' 136' ' ' ALA . . . -57.86 129.26 41.08 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.441 -0.787 . . . . 0.0 111.06 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.574 ' O ' ' C ' ' A' ' 40' ' ' SER . . . 40.31 38.95 1.49 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.574 ' C ' ' O ' ' A' ' 39' ' ' GLY . 74.6 p 17.45 59.91 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 117.524 0.662 . . . . 0.0 111.733 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.465 ' O ' ' HB3' ' A' ' 42' ' ' GLN . . . -89.5 104.98 17.49 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.66 0.743 . . . . 0.0 110.52 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.466 ' OE1' ' HG3' ' A' ' 37' ' ' PRO . 2.8 pt20 171.32 -169.47 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.842 -0.536 . . . . 0.0 109.709 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.566 ' CE1' ' HA2' ' A' ' 20' ' ' GLY . 3.1 p90 -44.2 -26.14 0.29 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.162 -0.961 . . . . 0.0 109.73 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.511 ' N ' ' CD1' ' A' ' 43' ' ' TYR . . . 123.68 127.73 3.25 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.783 HG13 HG23 ' A' ' 21' ' ' THR . 4.0 t -89.45 177.08 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.198 -1.178 . . . . 0.0 109.153 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.571 ' O ' ' CE2' ' A' ' 19' ' ' TYR . . . 165.45 137.63 2.24 Favored Glycine 0 N--CA 1.49 2.275 0 C-N-CA 119.047 -1.549 . . . . 0.0 110.849 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.773 HG13 ' O ' ' A' ' 17' ' ' VAL . 21.5 t -104.58 141.55 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.534 -0.98 . . . . 0.0 109.487 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.603 HG23 HG22 ' A' ' 17' ' ' VAL . 4.9 m -132.44 143.91 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 120.799 -1.188 . . . . 0.0 110.474 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.86 HD22 ' NE1' ' A' ' 16' ' ' TRP . 25.5 tp -136.72 113.05 9.9 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.313 -0.867 . . . . 0.0 110.09 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.519 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 4.4 t30 -88.9 132.33 34.73 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.204 -0.935 . . . . 0.0 110.561 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 141.21 72.31 0.04 OUTLIER Glycine 0 N--CA 1.49 2.258 0 C-N-CA 119.826 -1.178 . . . . 0.0 110.204 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 123' ' ' GLY . 5.7 t -119.9 173.28 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.025 -1.28 . . . . 0.0 110.009 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.971 ' O ' HD13 ' A' ' 54' ' ' ILE . . . -124.4 80.12 1.81 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.06 -1.025 . . . . 0.0 110.806 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.971 HD13 ' O ' ' A' ' 53' ' ' ALA . 4.9 mm -142.52 163.63 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.256 -0.902 . . . . 0.0 109.603 179.452 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.881 ' HA ' HG23 ' A' ' 111' ' ' THR . 36.8 tt0 -172.12 27.62 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.02 -1.05 . . . . 0.0 110.557 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.522 ' HB3' ' O ' ' A' ' 55' ' ' GLU . 3.3 pt-20 177.62 -165.52 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.649 -0.657 . . . . 0.0 110.111 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.497 ' N ' ' HG3' ' A' ' 56' ' ' GLU . . . -94.08 68.75 1.4 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.58 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.2 m -104.4 173.02 6.48 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.463 -1.022 . . . . 0.0 110.393 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.574 ' O ' ' CD2' ' A' ' 60' ' ' TYR . 0.4 OUTLIER -89.79 159.57 16.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.437 -0.789 . . . . 0.0 109.79 179.636 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.812 ' HB3' HD11 ' A' ' 146' ' ' LEU . 66.4 m-85 -159.5 -175.51 5.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.29 -0.881 . . . . 0.0 110.23 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.712 HG23 ' O ' ' A' ' 104' ' ' GLU . 91.5 m -147.68 121.62 9.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.326 -0.859 . . . . 0.0 109.894 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.635 HD22 HD23 ' A' ' 89' ' ' LEU . 18.9 tp -89.56 120.43 30.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.205 -0.935 . . . . 0.0 110.15 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.522 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 2.6 ttt180 -124.26 137.57 54.49 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.338 -0.851 . . . . 0.0 109.97 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 1.18 ' CZ ' HG21 ' A' ' 102' ' ' VAL . 0.9 OUTLIER -178.46 142.94 0.25 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.302 -0.874 . . . . 0.0 109.732 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.511 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 96.0 m -119.19 97.86 5.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.187 -0.946 . . . . 0.0 109.892 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.793 ' CB ' HD21 ' A' ' 95' ' ' LEU . . . -99.62 149.22 23.5 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.425 -0.797 . . . . 0.0 110.32 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.487 ' OG1' ' HA ' ' A' ' 99' ' ' PRO . 95.4 m -149.79 102.28 3.13 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.321 -0.862 . . . . 0.0 110.197 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -90.01 133.1 35.01 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.289 -0.882 . . . . 0.0 110.008 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.421 ' C ' ' O ' ' A' ' 68' ' ' ALA . 19.2 p -43.99 -26.49 0.29 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.251 -0.906 . . . . 0.0 109.521 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.598 ' CG2' ' CB ' ' A' ' 137' ' ' TRP . 2.4 t -111.23 159.7 17.65 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.457 -0.777 . . . . 0.0 109.987 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.501 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 3.1 m-20 -78.75 79.52 5.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.142 -0.974 . . . . 0.0 109.424 179.227 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.592 HG23 ' CB ' ' A' ' 133' ' ' SER . 9.9 p -102.73 139.43 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.18 -0.95 . . . . 0.0 111.27 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.418 HG22 ' O ' ' A' ' 73' ' ' THR . 17.8 m -119.86 86.73 2.61 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.691 HG11 HD22 ' A' ' 129' ' ' LEU . 11.1 m -89.55 -142.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.273 -0.892 . . . . 0.0 110.674 -178.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.548 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 30.1 mtm-85 -132.56 148.68 52.38 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.281 -0.887 . . . . 0.0 110.456 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.791 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -148.25 154.75 40.47 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.238 -0.914 . . . . 0.0 109.826 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.866 ' CD1' ' HB3' ' A' ' 126' ' ' ALA . 3.9 pp 179.0 -156.42 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.253 -0.904 . . . . 0.0 110.467 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.833 HG23 HD22 ' A' ' 89' ' ' LEU . 3.9 t -149.41 165.48 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.352 -0.842 . . . . 0.0 109.535 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.544 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . -174.83 -163.64 28.33 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.408 -1.377 . . . . 0.0 110.255 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.526 ' HG3' ' HA ' ' A' ' 85' ' ' TYR . 3.3 pt20 -119.84 143.38 47.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.383 -1.069 . . . . 0.0 110.461 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.482 ' HB2' ' HG2' ' A' ' 122' ' ' GLU . 3.6 m-20 -96.22 94.71 7.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.365 -0.834 . . . . 0.0 109.991 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.544 ' C ' ' CE1' ' A' ' 85' ' ' TYR . . . 137.49 149.43 5.57 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.622 ' N ' ' CE1' ' A' ' 85' ' ' TYR . . . -62.44 155.12 69.33 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.303 -1.116 . . . . 0.0 110.298 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.52 ' C ' ' CD2' ' A' ' 85' ' ' TYR . 50.5 Cg_endo -77.41 7.91 18.71 Favored 'Cis proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.636 -2.235 . . . . 0.0 110.803 -0.01 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.622 ' CE1' ' N ' ' A' ' 83' ' ' ALA . 11.4 m-85 69.94 166.0 0.28 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.306 -0.871 . . . . 0.0 110.161 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.518 ' N ' ' CG ' ' A' ' 80' ' ' GLN . . . 172.69 165.94 30.48 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.444 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 0.8 OUTLIER -143.31 149.1 37.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.274 -1.133 . . . . 0.0 110.239 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.951 HG23 HD12 ' A' ' 89' ' ' LEU . 30.3 m -122.14 -18.43 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.25 -0.906 . . . . 0.0 110.285 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.951 HD12 HG23 ' A' ' 88' ' ' VAL . 4.3 mp -111.93 143.02 43.6 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.178 -0.951 . . . . 0.0 110.984 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.507 ' O ' HG23 ' A' ' 91' ' ' THR . 11.2 m-20 -151.11 88.59 1.46 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.339 -0.85 . . . . 0.0 110.183 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.507 HG23 ' O ' ' A' ' 90' ' ' ASP . 6.4 p -153.29 176.96 11.39 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.049 -1.032 . . . . 0.0 110.656 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.2 m -119.89 120.05 30.66 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.348 -0.845 . . . . 0.0 110.072 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.791 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 46.1 Cg_endo -74.05 127.88 11.77 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.928 1.488 . . . . 0.0 111.076 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.593 ' HB3' ' NE ' ' A' ' 100' ' ' ARG . . . -95.11 149.68 21.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.318 -0.864 . . . . 0.0 109.3 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.793 HD21 ' CB ' ' A' ' 66' ' ' ALA . 43.5 mt -145.21 173.5 11.89 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.973 -1.079 . . . . 0.0 110.997 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.607 HG22 ' C ' ' A' ' 95' ' ' LEU . 0.1 OUTLIER 169.15 -178.59 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.633 -0.667 . . . . 0.0 109.716 -179.874 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.32 -13.75 21.66 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.126 -0.984 . . . . 0.0 109.806 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.541 ' CG ' ' HD2' ' A' ' 99' ' ' PRO . 33.7 tt0 -95.74 149.56 36.22 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.444 -0.785 . . . . 0.0 109.866 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.541 ' HD2' ' CG ' ' A' ' 98' ' ' GLU . 41.5 Cg_endo -68.11 130.09 20.75 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.807 1.425 . . . . 0.0 110.169 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.593 ' NE ' ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.83 91.92 3.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.267 -0.896 . . . . 0.0 110.624 -179.537 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.462 ' HG2' ' OG1' ' A' ' 65' ' ' THR . 31.8 mt-30 -73.54 157.94 35.78 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.273 -0.892 . . . . 0.0 109.632 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 1.18 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 60.4 t -131.29 133.03 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.143 -0.973 . . . . 0.0 110.518 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.49 87.73 1.46 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.406 -0.809 . . . . 0.0 110.009 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.712 ' O ' HG23 ' A' ' 61' ' ' THR . 56.8 mt-10 -125.83 -176.14 3.54 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.203 -0.935 . . . . 0.0 110.377 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 1.8 t -135.64 166.93 22.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.3 -0.875 . . . . 0.0 110.204 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.707 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 31.8 p90 -174.74 152.8 1.66 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.22 -0.925 . . . . 0.0 110.196 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.521 ' O ' ' N ' ' A' ' 109' ' ' SER . 4.8 m -89.7 94.95 10.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.192 -0.943 . . . . 0.0 109.97 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.685 ' HB1' HG21 ' A' ' 54' ' ' ILE . . . -50.76 89.54 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.301 -0.874 . . . . 0.0 110.014 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 107' ' ' THR . 10.3 p -85.65 53.27 2.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.27 -0.894 . . . . 0.0 109.996 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -157.79 -163.35 1.32 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.178 -0.951 . . . . 0.0 110.392 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.951 HG22 ' HD3' ' A' ' 113' ' ' PRO . 97.0 m -136.0 110.63 8.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.272 -0.892 . . . . 0.0 110.286 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.59 ' CG ' ' HA3' ' A' ' 123' ' ' GLY . 15.4 m-30 -109.07 70.75 0.43 Allowed Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.341 -0.849 . . . . 0.0 110.047 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.951 ' HD3' HG22 ' A' ' 111' ' ' THR . 46.4 Cg_endo -71.38 120.42 6.95 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 123.802 1.422 . . . . 0.0 110.401 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.275 -0.89 . . . . 0.0 110.218 -179.98 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.534 ' CG ' ' N ' ' A' ' 123' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 121.036 0.446 . . . . 0.0 110.06 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.6 ' O ' HG23 ' A' ' 52' ' ' VAL . . . -149.86 147.3 17.41 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.591 ' O ' HG13 ' A' ' 78' ' ' VAL . 1.8 pt20 -150.32 -162.56 1.58 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.328 -1.101 . . . . 0.0 110.421 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.543 HG21 ' CH2' ' A' ' 16' ' ' TRP . 13.0 mt -119.12 143.83 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.481 -0.762 . . . . 0.0 109.278 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.866 ' HB3' ' CD1' ' A' ' 77' ' ' LEU . . . -117.04 117.44 29.66 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.178 -0.951 . . . . 0.0 111.048 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.519 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 3.0 m-30 -116.97 102.75 9.62 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLN . . . . . 0.5 ' HB2' ' HB2' ' A' ' 75' ' ' ARG . 6.6 mt-30 -88.98 107.77 19.21 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.108 -0.995 . . . . 0.0 111.132 -178.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.691 HD22 HG11 ' A' ' 74' ' ' VAL . 16.8 mt -106.35 43.53 1.14 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.5 -0.75 . . . . 0.0 109.035 178.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 131' ' ' GLY . . . -91.68 116.65 5.04 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.546 ' N ' ' OG ' ' A' ' 40' ' ' SER . . . 41.95 90.07 0.01 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.613 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 6.8 m-85 -139.98 -55.73 0.55 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.167 -1.196 . . . . 0.0 110.492 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.592 ' CB ' HG23 ' A' ' 72' ' ' VAL . 1.2 t -88.95 -177.24 5.42 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.945 -1.097 . . . . 0.0 110.29 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.454 ' N ' ' OG ' ' A' ' 133' ' ' SER . . . -100.08 -75.22 0.58 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.226 -0.921 . . . . 0.0 110.393 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' A' ' 136' ' ' ALA . 83.9 m-20 -83.24 153.75 24.54 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.218 -0.927 . . . . 0.0 110.156 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.509 ' N ' ' HA ' ' A' ' 38' ' ' ALA . . . -40.95 142.3 0.5 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.363 -0.836 . . . . 0.0 110.452 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 1.094 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 18.8 p90 -153.46 -159.9 1.05 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.281 -0.887 . . . . 0.0 110.654 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.523 ' O ' ' CB ' ' A' ' 68' ' ' ALA . 0.8 OUTLIER -160.1 176.12 12.16 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.371 -0.83 . . . . 0.0 109.63 -178.4 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.569 ' O ' ' HA ' ' A' ' 33' ' ' CYS . 1.8 mp -136.66 117.33 13.95 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.905 -1.122 . . . . 0.0 111.89 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' CYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 0.8 OUTLIER -105.37 111.03 23.6 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.662 -0.649 . . . . 0.0 111.176 178.683 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.723 HD23 ' HB2' ' A' ' 66' ' ' ALA . 1.4 mt -100.78 -179.73 4.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.914 . . . . 0.0 109.08 178.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 1.048 ' O ' HG22 ' A' ' 8' ' ' THR . 0.5 OUTLIER 166.19 64.88 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.327 -0.858 . . . . 0.0 110.073 179.912 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.513 ' CB ' ' O ' ' A' ' 142' ' ' ASP . 0.3 OUTLIER 165.79 42.8 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.374 -0.829 . . . . 0.0 108.962 -179.906 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.692 HG11 ' HZ2' ' A' ' 16' ' ' TRP . 1.0 OUTLIER -89.15 120.02 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.542 -0.724 . . . . 0.0 110.593 -178.811 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -157.53 147.35 20.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.471 -0.768 . . . . 0.0 109.778 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.812 HD11 ' HB3' ' A' ' 60' ' ' TYR . 42.9 tp -144.07 146.83 33.08 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.254 -0.903 . . . . 0.0 110.342 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.482 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 7.1 t0 -177.88 152.12 0.74 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.214 -0.929 . . . . 0.0 110.296 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.527 ' HB2' ' CG2' ' A' ' 58' ' ' THR . 22.5 p . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.286 -0.884 . . . . 0.0 110.174 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.46 ' HG2' ' O ' ' A' ' 51' ' ' GLY . 51.4 Cg_endo . . . . . 0 N--CA 1.482 0.824 0 N-CA-C 111.072 -0.395 . . . . 0.0 111.072 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.639 ' CG2' HD21 ' A' ' 49' ' ' LEU . 6.7 pt -145.09 11.74 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.968 -1.082 . . . . 0.0 110.221 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 115.07 148.47 9.47 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -89.73 20.8 3.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.234 -1.157 . . . . 0.0 110.24 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.469 ' C ' ' HA ' ' A' ' 143' ' ' ASP . . . 153.86 -125.41 1.74 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.783 HG22 ' O ' ' A' ' 142' ' ' ASP . 0.8 OUTLIER -57.62 132.91 54.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.229 -1.159 . . . . 0.0 110.154 -179.92 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.569 ' O ' ' CB ' ' A' ' 10' ' ' ASP . 11.8 m-85 -43.86 -27.24 0.33 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.32 -0.862 . . . . 0.0 109.527 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.595 ' O ' ' HB2' ' A' ' 11' ' ' ASP . 0.0 OUTLIER 80.34 -43.43 0.24 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 122.038 -0.413 . . . . 0.0 111.062 179.303 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.595 ' HB2' ' O ' ' A' ' 10' ' ' ASP . 9.4 t70 161.93 39.22 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.083 0 CA-C-O 121.904 0.859 . . . . 0.0 109.085 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -176.81 134.74 2.62 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.618 ' HB3' HD12 ' A' ' 32' ' ' LEU . 45.9 Cg_endo -72.86 -15.39 26.53 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.932 1.491 . . . . 0.0 110.43 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 0.3 OUTLIER 63.77 -87.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.237 -0.914 . . . . 0.0 110.184 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.643 ' O ' HG13 ' A' ' 17' ' ' VAL . . . -124.35 -14.8 3.52 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 1.062 ' CE2' HD22 ' A' ' 49' ' ' LEU . 80.6 m95 -51.82 111.36 0.59 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.263 -1.139 . . . . 0.0 110.593 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.746 ' O ' HG13 ' A' ' 47' ' ' VAL . 1.0 OUTLIER -112.56 148.01 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.142 -0.974 . . . . 0.0 109.528 179.433 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.698 ' HB3' ' HB3' ' A' ' 25' ' ' LEU . . . -129.76 154.02 47.62 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.052 -1.03 . . . . 0.0 109.817 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.742 ' HE2' HG13 ' A' ' 48' ' ' VAL . 9.4 p90 -145.91 155.58 42.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.915 . . . . 0.0 110.936 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.649 ' HA3' HG13 ' A' ' 45' ' ' VAL . . . 161.83 -93.89 0.12 Allowed Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.016 -1.633 . . . . 0.0 109.016 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.558 ' CG2' ' HG3' ' A' ' 37' ' ' PRO . 11.6 p -151.21 18.19 0.75 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.183 -1.187 . . . . 0.0 110.715 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.941 ' CB ' ' HB3' ' A' ' 35' ' ' ALA . 0.4 OUTLIER -123.87 60.6 1.11 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.037 -1.039 . . . . 0.0 110.229 179.479 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 43.53 -161.7 0.06 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.431 ' O ' ' C ' ' A' ' 25' ' ' LEU . 46.0 Cg_endo -72.86 145.12 39.99 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.973 1.512 . . . . 0.0 110.378 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.729 HD13 HD11 ' A' ' 32' ' ' LEU . 0.8 OUTLIER -42.66 163.43 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.311 -0.868 . . . . 0.0 110.194 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.28 138.55 45.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.264 -0.898 . . . . 0.0 110.109 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.614 ' O ' HG22 ' A' ' 29' ' ' THR . 0.7 OUTLIER -119.85 -78.97 0.6 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.182 -0.949 . . . . 0.0 110.232 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.46 ' HB2' ' O ' ' A' ' 27' ' ' THR . 0.4 OUTLIER 61.43 -87.68 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.257 -0.902 . . . . 0.0 110.227 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.676 HG23 ' H ' ' A' ' 31' ' ' ALA . 5.1 t -42.18 -29.99 0.27 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.275 -0.891 . . . . 0.0 110.276 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' A' ' 11' ' ' ASP . . . 125.39 -26.41 5.49 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.676 ' H ' HG23 ' A' ' 29' ' ' THR . . . -91.8 136.08 33.42 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.211 -1.17 . . . . 0.0 110.188 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.729 HD11 HD13 ' A' ' 25' ' ' LEU . 1.9 tp -68.05 106.25 2.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.163 -0.96 . . . . 0.0 109.806 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 8.9 m -113.86 102.75 10.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.219 -0.925 . . . . 0.0 110.97 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.617 ' CG1' ' HB2' ' A' ' 18' ' ' ALA . 24.0 m -89.76 164.19 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.244 -0.91 . . . . 0.0 108.997 178.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.941 ' HB3' ' CB ' ' A' ' 22' ' ' ASP . . . -112.07 132.14 55.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.942 -1.099 . . . . 0.0 111.139 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.12 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 37.2 t -119.66 117.37 32.71 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.543 -0.723 . . . . 0.0 109.325 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.558 ' HG3' ' CG2' ' A' ' 21' ' ' THR . 44.2 Cg_endo -70.38 144.22 50.1 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.885 1.466 . . . . 0.0 111.236 -179.095 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.583 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -45.34 153.94 0.2 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.375 -0.828 . . . . 0.0 109.83 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 38' ' ' ALA . . . 45.22 59.39 4.61 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.724 ' OG ' HG21 ' A' ' 45' ' ' VAL . 0.6 OUTLIER -84.14 36.99 0.59 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.314 -1.109 . . . . 0.0 110.589 -179.625 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -92.44 19.73 6.92 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.96 0.886 . . . . 0.0 109.664 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.597 ' NE2' ' CE2' ' A' ' 43' ' ' TYR . 5.8 pt20 -73.23 -143.19 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.635 ' CD1' ' N ' ' A' ' 44' ' ' GLY . 6.8 p90 -42.05 -27.52 0.13 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.502 -0.749 . . . . 0.0 109.375 179.156 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.635 ' N ' ' CD1' ' A' ' 43' ' ' TYR . . . 117.66 113.51 2.64 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.724 HG21 ' OG ' ' A' ' 40' ' ' SER . 2.6 t -89.55 149.99 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.137 -1.214 . . . . 0.0 108.191 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.571 ' O ' ' CE2' ' A' ' 19' ' ' TYR . . . 179.3 166.97 35.99 Favored Glycine 0 N--CA 1.489 2.178 0 C-N-CA 118.582 -1.771 . . . . 0.0 111.083 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.746 HG13 ' O ' ' A' ' 17' ' ' VAL . 38.4 t -122.22 131.41 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.754 -0.851 . . . . 0.0 109.457 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.742 HG13 ' HE2' ' A' ' 19' ' ' TYR . 33.0 m -120.14 139.01 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.886 -1.134 . . . . 0.0 110.683 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 1.062 HD22 ' CE2' ' A' ' 16' ' ' TRP . 7.7 tp -130.66 87.33 2.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.325 -0.859 . . . . 0.0 110.211 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.552 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 3.5 m120 -69.15 103.3 1.87 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.926 . . . . 0.0 110.276 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.46 ' O ' ' HG2' ' A' ' 3' ' ' PRO . . . 157.02 79.72 0.03 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.66 HG23 ' HA ' ' A' ' 124' ' ' GLN . 6.8 t -124.92 160.16 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.167 -1.196 . . . . 0.0 109.933 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.616 ' O ' HD13 ' A' ' 54' ' ' ILE . . . -119.63 89.94 3.23 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.173 -0.955 . . . . 0.0 110.855 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.742 HD11 HD21 ' A' ' 146' ' ' LEU . 27.4 mm -130.06 172.79 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.28 -0.887 . . . . 0.0 109.507 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.585 ' N ' HG22 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -177.79 131.51 0.15 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.913 -1.117 . . . . 0.0 111.354 -179.749 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.464 ' O ' ' O ' ' A' ' 108' ' ' ALA . 7.8 mm-40 52.96 -168.45 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.667 -0.646 . . . . 0.0 110.85 178.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.502 ' HA2' ' HA ' ' A' ' 109' ' ' SER . . . -87.24 61.57 4.24 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.357 -1.897 . . . . 0.0 108.357 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.732 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.0 OUTLIER -96.41 174.43 6.87 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.625 -0.927 . . . . 0.0 110.078 -179.323 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.571 ' O ' ' CD2' ' A' ' 60' ' ' TYR . 7.5 m -89.89 158.8 17.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.331 -0.856 . . . . 0.0 110.487 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.732 ' CE2' HG22 ' A' ' 58' ' ' THR . 66.4 m-85 -159.31 119.81 3.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.381 -0.824 . . . . 0.0 109.917 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 68.9 m -89.91 110.65 21.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.175 -0.953 . . . . 0.0 110.29 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.417 HD22 ' CD2' ' A' ' 89' ' ' LEU . 17.5 tp -89.76 126.0 35.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.257 -0.902 . . . . 0.0 109.775 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.501 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 19.8 mtm105 -132.81 130.46 39.88 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.251 -0.906 . . . . 0.0 110.395 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 1.129 ' CZ ' HG21 ' A' ' 102' ' ' VAL . 5.7 p90 -166.0 149.61 7.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.398 -0.814 . . . . 0.0 109.809 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.688 HG23 ' HG2' ' A' ' 101' ' ' GLN . 28.9 m -119.58 89.69 3.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.208 -0.932 . . . . 0.0 110.245 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.734 ' CB ' HD21 ' A' ' 95' ' ' LEU . . . -89.9 149.26 22.7 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.355 -0.84 . . . . 0.0 110.18 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.768 HG23 ' O ' ' A' ' 98' ' ' GLU . 98.8 m -150.19 129.77 13.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.364 -0.835 . . . . 0.0 110.217 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -114.36 142.32 46.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.312 -0.868 . . . . 0.0 109.915 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 68' ' ' ALA . 17.3 m -45.6 -25.64 0.49 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.064 -1.023 . . . . 0.0 109.102 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.78 HG22 ' HB2' ' A' ' 137' ' ' TRP . 4.8 t -119.03 -160.55 0.81 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.589 -0.695 . . . . 0.0 109.835 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.503 ' N ' HG23 ' A' ' 70' ' ' THR . 4.9 m-20 -107.77 67.98 0.7 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.336 -0.853 . . . . 0.0 109.179 178.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.79 HG23 ' CB ' ' A' ' 133' ' ' SER . 3.8 p -88.04 135.64 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.33 -0.856 . . . . 0.0 111.374 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.432 HG22 ' O ' ' A' ' 73' ' ' THR . 7.4 m -121.92 91.42 3.51 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.918 HG11 HD22 ' A' ' 129' ' ' LEU . 5.3 m -89.56 -158.93 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.172 -0.955 . . . . 0.0 110.88 -178.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 14.4 mtm-85 -119.15 107.51 13.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.264 -0.897 . . . . 0.0 110.886 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.494 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -112.1 160.59 17.39 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.156 -0.965 . . . . 0.0 109.797 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.609 HD12 ' N ' ' A' ' 78' ' ' VAL . 3.3 pp 177.71 -156.65 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.295 -0.878 . . . . 0.0 110.201 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.826 HG23 HD22 ' A' ' 89' ' ' LEU . 3.9 t -147.81 168.03 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.217 -0.927 . . . . 0.0 109.527 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.488 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . 177.39 -176.18 47.94 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.39 -1.386 . . . . 0.0 110.174 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.496 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 1.5 tt0 -89.27 -159.16 0.55 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.423 -1.045 . . . . 0.0 110.222 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.501 ' HB2' ' HG2' ' A' ' 122' ' ' GLU . 4.7 m120 -168.12 83.95 0.19 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.352 -0.843 . . . . 0.0 110.166 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.534 ' O ' ' HB3' ' A' ' 83' ' ' ALA . . . 140.55 36.75 0.11 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.537 ' HA ' ' CD2' ' A' ' 85' ' ' TYR . . . 59.49 145.99 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.254 -1.145 . . . . 0.0 110.315 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.461 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.6 Cg_endo -81.79 21.27 11.78 Favored 'Cis proline' 0 C--N 1.314 -1.288 0 C-N-CA 121.755 -2.185 . . . . 0.0 110.869 -0.076 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.537 ' CD2' ' HA ' ' A' ' 83' ' ' ALA . 50.0 m-85 60.39 124.16 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.095 -1.003 . . . . 0.0 110.282 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -152.86 112.91 0.55 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.568 HG22 ' O ' ' A' ' 78' ' ' VAL . 0.8 OUTLIER -98.09 147.21 24.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.247 -1.149 . . . . 0.0 110.396 -179.891 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 1.063 HG23 HD12 ' A' ' 89' ' ' LEU . 33.2 m -119.97 -20.73 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.299 -0.876 . . . . 0.0 109.966 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 1.063 HD12 HG23 ' A' ' 88' ' ' VAL . 4.5 mp -105.36 143.86 32.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.312 -0.868 . . . . 0.0 110.764 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.732 ' O ' HG23 ' A' ' 91' ' ' THR . 10.1 m-20 -150.63 86.21 1.39 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.294 -0.879 . . . . 0.0 110.245 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.732 HG23 ' O ' ' A' ' 90' ' ' ASP . 1.8 p -159.98 177.98 10.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.167 -0.958 . . . . 0.0 110.476 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.507 ' CB ' ' O ' ' A' ' 74' ' ' VAL . 4.8 m -120.0 129.78 25.18 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.305 -0.872 . . . . 0.0 110.066 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.775 ' HG2' HG22 ' A' ' 74' ' ' VAL . 48.0 Cg_endo -72.19 78.61 1.85 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.906 1.477 . . . . 0.0 110.879 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.533 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -50.84 138.67 18.35 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.059 -1.026 . . . . 0.0 109.313 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.734 HD21 ' CB ' ' A' ' 66' ' ' ALA . 42.7 mt -130.12 176.3 8.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.93 -1.106 . . . . 0.0 110.862 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' A' ' 70' ' ' THR . 0.2 OUTLIER -171.73 -178.66 2.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.493 -0.754 . . . . 0.0 109.786 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 9.8 p -70.25 -7.84 45.39 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.2 -0.938 . . . . 0.0 110.12 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.768 ' O ' HG23 ' A' ' 67' ' ' THR . 4.4 mt-10 -109.18 177.34 1.27 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.238 -0.914 . . . . 0.0 110.077 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.504 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 46.4 Cg_endo -72.6 132.99 19.7 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 124.035 1.545 . . . . 0.0 110.357 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.533 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.59 86.55 2.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.222 -0.924 . . . . 0.0 110.16 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.688 ' HG2' HG23 ' A' ' 65' ' ' THR . 1.8 mt-30 -73.49 155.8 38.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.283 -0.885 . . . . 0.0 110.258 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 1.129 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 23.0 t -134.76 138.34 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -0.906 . . . . 0.0 110.105 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.3 m -150.11 112.51 4.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.931 . . . . 0.0 110.245 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -156.91 133.03 9.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.233 -0.917 . . . . 0.0 110.306 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.548 HG22 ' CG2' ' A' ' 59' ' ' THR . 11.2 m -95.53 94.18 7.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.283 -0.886 . . . . 0.0 110.164 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.585 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 33.8 p90 -94.23 153.57 17.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.27 -0.894 . . . . 0.0 110.281 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 97.3 m -89.72 99.36 12.38 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.175 -0.953 . . . . 0.0 109.811 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.648 ' CB ' ' CD2' ' A' ' 60' ' ' TYR . . . -58.72 104.58 0.23 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.28 -0.888 . . . . 0.0 110.497 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.502 ' HA ' ' HA2' ' A' ' 57' ' ' GLY . 11.1 p -91.11 53.7 2.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.393 -0.817 . . . . 0.0 110.047 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -164.28 -153.43 0.21 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.292 -0.88 . . . . 0.0 110.217 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.545 HG23 ' HA ' ' A' ' 55' ' ' GLU . 14.4 m -150.85 112.55 4.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -0.898 . . . . 0.0 110.341 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.611 ' CE2' HG12 ' A' ' 78' ' ' VAL . 14.4 m-30 -110.81 78.2 1.53 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.289 -0.882 . . . . 0.0 110.171 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.502 ' HD2' ' HA ' ' A' ' 122' ' ' GLU . 44.2 Cg_endo -70.99 -174.0 1.03 Allowed 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.956 1.503 . . . . 0.0 110.347 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 0.0 110.239 -179.931 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.502 ' HA ' ' HD2' ' A' ' 113' ' ' PRO . 1.2 pt-20 . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.237 0.541 . . . . 0.0 110.133 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.582 ' HA3' ' CG ' ' A' ' 112' ' ' TYR . . . -137.28 154.76 22.54 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.66 ' HA ' HG23 ' A' ' 52' ' ' VAL . 1.7 pp0? -150.51 -160.55 1.18 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.151 -1.205 . . . . 0.0 110.623 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.805 HG21 ' HH2' ' A' ' 16' ' ' TRP . 13.8 mt -118.21 143.34 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 76' ' ' ALA . . . -119.31 123.59 44.58 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.234 -0.916 . . . . 0.0 111.198 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.581 ' HE2' HG21 ' A' ' 125' ' ' ILE . 11.3 m-85 -118.51 97.11 5.59 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 178.32 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLN . . . . . 0.449 ' O ' ' HB ' ' A' ' 74' ' ' VAL . 12.4 mm-40 -88.65 93.23 9.49 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.302 -0.874 . . . . 0.0 111.841 -177.511 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 1.062 HD13 HD13 ' A' ' 139' ' ' LEU . 15.1 mt -93.94 47.17 1.2 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.111 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -84.42 83.1 1.64 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -179.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 55.61 100.13 0.01 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.594 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 9.8 m-85 -139.39 -40.44 0.46 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.312 -1.111 . . . . 0.0 109.943 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.79 ' CB ' HG23 ' A' ' 72' ' ' VAL . 1.3 t -90.86 -176.98 4.83 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.276 -0.89 . . . . 0.0 110.152 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.46 ' N ' ' OG ' ' A' ' 133' ' ' SER . . . -89.05 -88.07 0.16 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.207 -0.933 . . . . 0.0 110.402 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.8 176.49 6.27 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.274 -0.891 . . . . 0.0 110.452 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.583 ' HB2' ' HB2' ' A' ' 38' ' ' ALA . . . -50.12 128.98 20.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.326 -0.859 . . . . 0.0 110.286 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 1.12 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 4.4 p90 -134.92 -170.07 2.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.25 -0.906 . . . . 0.0 110.027 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.526 ' O ' ' CB ' ' A' ' 68' ' ' ALA . 0.5 OUTLIER -160.55 175.18 13.0 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.255 -0.978 . . . . 0.0 110.7 -178.759 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 1.062 HD13 HD13 ' A' ' 129' ' ' LEU . 2.4 mp -127.78 146.46 50.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.312 -0.867 . . . . 0.0 109.731 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' CYS . . . . . 0.517 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 11.8 m -147.56 97.74 2.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.062 -1.024 . . . . 0.0 110.949 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.584 HD12 HD23 ' A' ' 32' ' ' LEU . 0.5 OUTLIER -93.2 -177.07 4.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.168 -0.958 . . . . 0.0 109.222 179.012 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.783 ' O ' HG22 ' A' ' 8' ' ' THR . 0.8 OUTLIER 175.57 38.23 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.058 -1.027 . . . . 0.0 110.624 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.522 ' OD2' ' N ' ' A' ' 65' ' ' THR . 3.8 p-10 175.31 51.45 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.364 -0.835 . . . . 0.0 109.698 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.803 HG11 ' CZ2' ' A' ' 16' ' ' TRP . 3.5 t -90.13 114.88 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.389 -0.819 . . . . 0.0 110.32 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -137.75 133.39 34.05 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.319 -0.863 . . . . 0.0 110.077 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.742 HD21 HD11 ' A' ' 54' ' ' ILE . 39.4 tp -129.17 137.92 51.45 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.276 -0.89 . . . . 0.0 110.182 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.467 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 1.3 t70 -179.07 156.25 0.78 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.229 -0.919 . . . . 0.0 110.253 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.429 ' HB3' ' CG2' ' A' ' 58' ' ' THR . 2.3 p . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.263 -0.898 . . . . 0.0 110.196 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo . . . . . 0 N--CA 1.48 0.699 0 N-CA-C 110.133 -0.757 . . . . 0.0 110.133 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.427 ' O ' ' CD ' ' A' ' 14' ' ' GLU . 8.2 pt -94.76 -13.03 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.203 -0.936 . . . . 0.0 110.139 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 144.09 -25.96 2.05 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.558 ' HA ' ' CB ' ' A' ' 145' ' ' ALA . 6.1 mt-10 54.52 68.77 0.81 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.274 -1.133 . . . . 0.0 110.26 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 170.11 -161.82 35.02 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.781 HG22 ' O ' ' A' ' 142' ' ' ASP . 15.2 p -90.54 -168.06 2.0 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.213 -1.169 . . . . 0.0 110.218 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.521 ' CE1' ' CD1' ' A' ' 16' ' ' TRP . 44.7 m-85 -103.29 49.67 0.82 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.9 . . . . 0.0 110.122 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.546 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 4.8 p30 -84.98 44.63 1.09 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.263 -0.898 . . . . 0.0 110.248 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.546 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 4.5 t0 161.75 78.66 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.264 0.554 . . . . 0.0 109.597 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 70.14 142.49 0.19 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.482 ' O ' ' HB2' ' A' ' 14' ' ' GLU . 48.7 Cg_endo -75.83 3.82 5.7 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.059 1.557 . . . . 0.0 110.666 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 0.1 OUTLIER 67.41 -84.78 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.262 -0.899 . . . . 0.0 110.301 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.463 ' O ' HG13 ' A' ' 17' ' ' VAL . . . -141.46 8.39 2.6 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.92 ' CE2' HD22 ' A' ' 49' ' ' LEU . 38.0 m95 -64.23 131.94 48.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.173 -1.192 . . . . 0.0 110.391 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.702 ' O ' HG13 ' A' ' 47' ' ' VAL . 1.0 OUTLIER -133.5 153.9 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.255 -0.903 . . . . 0.0 109.82 179.692 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.422 ' HB3' HD21 ' A' ' 25' ' ' LEU . . . -139.13 139.41 37.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.333 -0.854 . . . . 0.0 109.348 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.565 ' CE2' ' O ' ' A' ' 46' ' ' GLY . 1.7 p90 -121.52 144.04 48.94 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.165 -0.959 . . . . 0.0 111.093 -178.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.595 ' HA2' ' CE1' ' A' ' 43' ' ' TYR . . . 116.24 82.97 1.0 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.642 ' CG2' ' CE2' ' A' ' 43' ' ' TYR . 1.6 p 52.04 18.26 0.8 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.495 -1.003 . . . . 0.0 110.688 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 1.015 ' HA ' ' HB3' ' A' ' 35' ' ' ALA . 5.4 p30 -114.91 93.07 4.15 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.113 -0.992 . . . . 0.0 109.939 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 22' ' ' ASP . . . -60.31 -121.67 0.01 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.85 145.85 41.34 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.826 1.435 . . . . 0.0 110.488 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 1.081 HD22 HG12 ' A' ' 34' ' ' VAL . 14.3 mt -76.32 102.87 6.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.255 -0.903 . . . . 0.0 110.069 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.503 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 24.4 t0 -43.53 110.24 0.19 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.207 -0.933 . . . . 0.0 109.933 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.831 HG23 ' O ' ' A' ' 25' ' ' LEU . 12.7 p -119.41 -61.15 1.66 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.073 -1.017 . . . . 0.0 110.563 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.43 ' O ' ' OG1' ' A' ' 29' ' ' THR . 68.9 m 43.75 38.61 2.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.156 -0.965 . . . . 0.0 109.921 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 28' ' ' SER . 13.9 p 48.75 80.01 0.07 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.374 -0.829 . . . . 0.0 110.314 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 175.54 -65.5 0.1 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -150.17 151.72 33.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.308 -1.113 . . . . 0.0 110.069 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.72 HD11 ' CD1' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -104.82 94.41 5.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.158 -0.964 . . . . 0.0 110.393 -179.908 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.565 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 0.8 OUTLIER -94.71 115.81 27.98 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.215 -0.928 . . . . 0.0 111.176 179.759 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 1.081 HG12 HD22 ' A' ' 25' ' ' LEU . 16.6 m -89.4 149.43 4.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 1.015 ' HB3' ' HA ' ' A' ' 22' ' ' ASP . . . -88.95 92.99 9.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.314 -0.866 . . . . 0.0 111.093 -178.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.973 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 96.7 t -89.89 123.43 66.23 Favored Pre-proline 0 C--N 1.301 -1.508 0 O-C-N 121.489 -0.757 . . . . 0.0 109.373 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.91 ' HD2' HG21 ' A' ' 45' ' ' VAL . 40.0 Cg_endo -66.1 179.28 1.97 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.845 1.445 . . . . 0.0 112.048 -178.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.545 ' HA ' ' CA ' ' A' ' 136' ' ' ALA . . . -62.99 125.26 23.4 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.542 -0.724 . . . . 0.0 111.285 -179.087 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.531 ' O ' ' C ' ' A' ' 40' ' ' SER . . . 37.62 28.42 0.04 OUTLIER Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.712 ' OG ' HG23 ' A' ' 45' ' ' VAL . 11.0 t 28.64 53.88 0.08 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.984 -0.715 . . . . 0.0 110.435 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.641 ' O ' ' CG ' ' A' ' 42' ' ' GLN . . . -88.19 114.43 24.8 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.541 -0.725 . . . . 0.0 110.156 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.641 ' CG ' ' O ' ' A' ' 41' ' ' ALA . 1.1 pt20 84.19 30.4 0.06 Allowed 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.642 ' CE2' ' CG2' ' A' ' 21' ' ' THR . 0.1 OUTLIER -149.45 -33.37 0.2 Allowed 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 118.564 -1.254 . . . . 0.0 112.677 -177.888 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.535 ' HA2' ' CA ' ' A' ' 130' ' ' GLY . . . 52.81 79.88 0.08 OUTLIER Glycine 0 N--CA 1.483 1.794 0 N-CA-C 105.733 -2.947 . . . . 0.0 105.733 -176.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.91 HG21 ' HD2' ' A' ' 37' ' ' PRO . 3.8 t -87.64 129.31 39.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.422 -1.046 . . . . 0.0 109.001 -177.631 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.565 ' O ' ' CE2' ' A' ' 19' ' ' TYR . . . -155.44 156.46 27.0 Favored Glycine 0 N--CA 1.487 2.094 0 C-N-CA 119.018 -1.563 . . . . 0.0 110.172 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.702 HG13 ' O ' ' A' ' 17' ' ' VAL . 11.3 t -112.9 128.46 69.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.419 -1.048 . . . . 0.0 109.791 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.584 ' CG2' ' CG2' ' A' ' 17' ' ' VAL . 27.3 m -119.86 137.06 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.031 -1.043 . . . . 0.0 110.62 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.92 HD22 ' CE2' ' A' ' 16' ' ' TRP . 14.1 tp -131.27 97.4 4.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.341 -0.849 . . . . 0.0 110.197 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.518 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 45.2 m-80 -75.46 147.07 40.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.256 -0.903 . . . . 0.0 110.445 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 124.5 63.2 0.19 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.66 HG11 ' HD2' ' A' ' 112' ' ' TYR . 43.1 t -119.92 158.42 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.163 -1.198 . . . . 0.0 110.177 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -128.12 80.74 1.98 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.224 -0.923 . . . . 0.0 110.695 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 1.082 HD11 HD21 ' A' ' 146' ' ' LEU . 34.7 mm -117.44 173.03 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.244 -0.91 . . . . 0.0 109.72 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.589 ' N ' HG22 ' A' ' 54' ' ' ILE . 1.8 tp10 -166.92 131.58 2.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.966 -1.083 . . . . 0.0 110.785 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.522 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 8.1 pt-20 37.85 -153.9 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.664 -0.647 . . . . 0.0 110.922 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' A' ' 109' ' ' SER . . . -87.77 87.21 1.52 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.561 ' CG2' ' N ' ' A' ' 59' ' ' THR . 1.3 m -113.78 173.6 6.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.269 -1.136 . . . . 0.0 109.843 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.576 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 3.5 m -89.66 153.21 20.91 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.163 -0.961 . . . . 0.0 110.376 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.61 ' HB3' HD11 ' A' ' 146' ' ' LEU . 56.9 m-85 -160.29 179.37 8.73 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.339 -0.85 . . . . 0.0 110.211 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 36.7 m -150.31 115.35 5.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.344 -0.848 . . . . 0.0 109.876 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.917 HD22 ' CD2' ' A' ' 89' ' ' LEU . 13.7 tp -89.45 119.68 30.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.162 -0.961 . . . . 0.0 110.18 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.517 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 6.4 mtm180 -126.37 137.8 53.49 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.45 -0.781 . . . . 0.0 109.693 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.721 ' CZ ' HG21 ' A' ' 102' ' ' VAL . 0.7 OUTLIER -178.3 143.63 0.29 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.288 -0.883 . . . . 0.0 109.676 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.542 HG23 ' N ' ' A' ' 101' ' ' GLN . 69.9 m -119.14 99.49 6.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.244 -0.91 . . . . 0.0 109.962 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.807 ' CB ' HD21 ' A' ' 95' ' ' LEU . . . -99.78 156.77 16.93 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.432 -0.793 . . . . 0.0 110.225 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.647 HG23 ' O ' ' A' ' 98' ' ' GLU . 64.6 m -150.38 121.7 7.85 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.301 -0.875 . . . . 0.0 110.266 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.456 ' CB ' HG12 ' A' ' 72' ' ' VAL . . . -110.07 135.2 51.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.214 -0.928 . . . . 0.0 109.998 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.76 -9.12 25.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.206 -0.934 . . . . 0.0 109.972 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.6 ' CG2' ' CB ' ' A' ' 137' ' ' TRP . 5.0 t -118.37 19.39 13.42 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.326 -0.859 . . . . 0.0 110.214 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.498 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 8.4 t70 43.01 61.1 2.25 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.321 -0.862 . . . . 0.0 109.611 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.901 HG23 ' HB2' ' A' ' 133' ' ' SER . 6.5 p -89.97 139.3 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.387 -0.821 . . . . 0.0 110.95 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.8 m -120.58 85.95 2.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.393 -0.817 . . . . 0.0 109.283 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 1.1 HG21 ' CD2' ' A' ' 129' ' ' LEU . 4.6 m -89.94 -141.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.298 -0.877 . . . . 0.0 110.508 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.688 ' N ' HG23 ' A' ' 74' ' ' VAL . 0.3 OUTLIER -132.32 119.42 20.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.254 -0.904 . . . . 0.0 110.617 -179.574 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.542 ' N ' ' HD3' ' A' ' 93' ' ' PRO . . . -122.63 163.64 19.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.217 -0.927 . . . . 0.0 109.663 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.681 ' CD1' ' HB3' ' A' ' 126' ' ' ALA . 1.8 pp 174.69 -157.62 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.22 -0.925 . . . . 0.0 110.283 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.742 HG23 HD22 ' A' ' 89' ' ' LEU . 4.0 t -144.2 169.45 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.344 -0.847 . . . . 0.0 109.181 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.498 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . 172.2 179.22 42.95 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 118.993 -1.575 . . . . 0.0 110.465 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.5 ' NE2' ' O ' ' A' ' 82' ' ' GLY . 11.6 tt0 -98.15 142.16 30.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.537 -0.978 . . . . 0.0 110.119 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.473 ' OD1' ' HG2' ' A' ' 124' ' ' GLN . 5.7 m120 -95.58 86.0 4.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.276 -0.89 . . . . 0.0 109.968 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.505 ' C ' ' CE1' ' A' ' 85' ' ' TYR . . . 124.68 142.85 6.0 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.619 ' N ' ' CE1' ' A' ' 85' ' ' TYR . . . -42.67 154.12 0.3 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.211 -1.17 . . . . 0.0 110.291 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.457 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.7 Cg_endo -79.38 12.25 20.34 Favored 'Cis proline' 0 C--N 1.312 -1.356 0 C-N-CA 121.673 -2.22 . . . . 0.0 110.896 -0.08 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.619 ' CE1' ' N ' ' A' ' 83' ' ' ALA . 31.9 m-85 61.79 150.4 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.105 -0.997 . . . . 0.0 110.261 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.457 ' O ' ' HA2' ' A' ' 79' ' ' GLY . . . -171.95 106.9 0.24 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.7 p -96.6 140.52 31.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.195 -1.179 . . . . 0.0 110.261 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 1.088 HG23 HD12 ' A' ' 89' ' ' LEU . 17.3 m -121.71 -15.91 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.274 -0.891 . . . . 0.0 110.177 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 1.088 HD12 HG23 ' A' ' 88' ' ' VAL . 4.4 mp -118.74 142.36 47.76 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.285 -0.884 . . . . 0.0 110.857 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.726 ' O ' HG23 ' A' ' 91' ' ' THR . 2.7 m-20 -150.62 85.65 1.38 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.342 -0.849 . . . . 0.0 110.203 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.726 HG23 ' O ' ' A' ' 90' ' ' ASP . 3.3 p -159.55 -172.32 3.66 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.16 -0.963 . . . . 0.0 110.412 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.436 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 72.1 m -121.75 138.34 28.41 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.324 -0.86 . . . . 0.0 110.207 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.713 ' HG2' HG22 ' A' ' 74' ' ' VAL . 49.4 Cg_endo -76.75 74.29 4.94 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.977 1.514 . . . . 0.0 110.623 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.523 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -49.62 127.37 15.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.121 -0.987 . . . . 0.0 109.557 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.807 HD21 ' CB ' ' A' ' 66' ' ' ALA . 20.8 mt -125.08 165.62 17.86 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.065 -1.022 . . . . 0.0 110.808 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.431 ' CG2' ' HG3' ' A' ' 100' ' ' ARG . 0.1 OUTLIER -157.93 -178.44 7.31 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.45 -0.781 . . . . 0.0 109.923 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.6 p -67.2 -29.17 68.76 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.151 -0.968 . . . . 0.0 110.38 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.647 ' O ' HG23 ' A' ' 67' ' ' THR . 2.6 mt-10 -91.41 179.78 1.33 Allowed Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.19 -0.944 . . . . 0.0 110.12 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.503 ' HD2' ' CB ' ' A' ' 98' ' ' GLU . 46.2 Cg_endo -73.75 130.47 14.69 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.896 1.472 . . . . 0.0 110.276 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.523 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 1.3 mtt-85 -119.83 92.65 3.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.145 -0.972 . . . . 0.0 110.498 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.542 ' N ' HG23 ' A' ' 65' ' ' THR . 3.8 tt0 -73.16 156.59 38.47 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.339 -0.851 . . . . 0.0 109.997 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.721 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 49.8 t -137.02 134.32 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.202 -0.936 . . . . 0.0 110.267 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.443 ' O ' ' CG ' ' A' ' 104' ' ' GLU . 0.2 OUTLIER -150.06 120.5 7.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.231 -0.918 . . . . 0.0 110.249 -179.891 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.443 ' CG ' ' O ' ' A' ' 103' ' ' THR . 14.3 mp0 -160.01 133.73 7.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.213 -0.93 . . . . 0.0 110.222 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.562 HG23 ' O ' ' A' ' 60' ' ' TYR . 24.2 m -92.22 145.05 24.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.168 -0.957 . . . . 0.0 110.228 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.415 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 34.0 p90 -150.21 153.33 36.07 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.312 -0.867 . . . . 0.0 110.315 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.425 ' O ' ' N ' ' A' ' 109' ' ' SER . 22.6 m -90.03 92.62 9.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.247 -0.908 . . . . 0.0 109.917 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.581 ' CB ' ' CD2' ' A' ' 60' ' ' TYR . . . -48.23 96.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.296 -0.878 . . . . 0.0 110.354 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.475 ' HA ' ' HA2' ' A' ' 57' ' ' GLY . 70.0 p -85.24 49.48 1.76 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.268 -0.895 . . . . 0.0 110.145 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.464 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -154.05 -154.16 0.5 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.268 -0.895 . . . . 0.0 110.224 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.524 HG23 ' HA ' ' A' ' 55' ' ' GLU . 18.8 m -150.95 112.66 4.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.268 -0.895 . . . . 0.0 110.277 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.713 ' OH ' HG13 ' A' ' 88' ' ' VAL . 14.7 m-30 -109.91 101.52 47.34 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.32 -0.863 . . . . 0.0 110.152 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.475 ' HG2' ' HA ' ' A' ' 122' ' ' GLU . 42.4 Cg_endo -71.75 136.86 28.76 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.747 1.393 . . . . 0.0 110.019 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.301 -0.874 . . . . 0.0 110.916 -179.158 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.475 ' HA ' ' HG2' ' A' ' 113' ' ' PRO . 5.8 pm0 . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 121.238 0.542 . . . . 0.0 110.056 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.495 ' HA2' ' HA ' ' A' ' 80' ' ' GLN . . . -82.76 146.66 24.54 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.562 ' HA ' ' CG2' ' A' ' 52' ' ' VAL . 7.9 pt20 -150.72 -156.22 0.7 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.206 -1.173 . . . . 0.0 110.696 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.461 ' CG2' ' CE1' ' A' ' 127' ' ' PHE . 10.7 mt -117.82 137.7 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.301 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.681 ' HB3' ' CD1' ' A' ' 77' ' ' LEU . . . -114.41 124.95 53.21 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.296 -0.878 . . . . 0.0 111.26 -179.098 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.493 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 4.4 m-85 -118.39 95.4 4.86 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.279 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLN . . . . . 0.561 ' O ' ' CE2' ' A' ' 132' ' ' PHE . 3.0 mp0 -88.38 90.91 8.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.512 -0.743 . . . . 0.0 112.39 -177.087 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 1.1 ' CD2' HG21 ' A' ' 74' ' ' VAL . 5.4 mt -100.95 45.65 0.97 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 177.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.57 ' O ' ' CD2' ' A' ' 132' ' ' PHE . . . -96.47 136.18 12.67 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' A' ' 39' ' ' GLY . . . 38.25 73.33 0.15 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.604 ' CE1' ' HA ' ' A' ' 74' ' ' VAL . 9.8 m-85 -129.41 -80.27 0.56 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.073 -1.251 . . . . 0.0 110.967 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.901 ' HB2' HG23 ' A' ' 72' ' ' VAL . 14.0 t -89.06 100.31 13.11 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.061 -1.024 . . . . 0.0 110.462 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -30.26 -50.45 0.12 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.967 -0.458 . . . . 0.0 111.75 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.466 ' O ' ' O ' ' A' ' 133' ' ' SER . 6.7 m-20 -73.04 159.6 33.38 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.004 -1.06 . . . . 0.0 110.038 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.545 ' CA ' ' HA ' ' A' ' 38' ' ' ALA . . . -80.57 146.88 31.04 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.358 -0.838 . . . . 0.0 110.355 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.973 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 4.6 p90 -155.58 -166.8 2.33 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.222 -0.924 . . . . 0.0 111.012 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.505 ' CG2' ' SG ' ' A' ' 33' ' ' CYS 0.254 0.7 OUTLIER -149.5 169.07 21.76 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -178.236 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.644 HD21 ' CD1' ' A' ' 95' ' ' LEU . 1.8 mp -133.02 116.91 16.97 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.826 -1.171 . . . . 0.0 111.82 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' CYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 0.8 OUTLIER -102.06 109.53 21.27 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.747 -0.596 . . . . 0.0 111.081 178.895 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.504 HD23 ' HB2' ' A' ' 66' ' ' ALA . 1.5 mt -100.42 -179.0 3.98 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.294 -0.879 . . . . 0.0 108.679 178.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.781 ' O ' HG22 ' A' ' 8' ' ' THR . 1.8 p30 167.14 57.9 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.167 -0.958 . . . . 0.0 110.486 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.521 ' CG ' HG22 ' A' ' 8' ' ' THR . 0.4 OUTLIER 167.35 44.62 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.263 -0.898 . . . . 0.0 109.664 179.838 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.865 HG11 ' HZ2' ' A' ' 16' ' ' TRP . 1.9 t -89.92 114.09 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.434 -0.791 . . . . 0.0 110.205 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.558 ' CB ' ' HA ' ' A' ' 6' ' ' GLU . . . -145.8 155.17 42.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.315 -0.866 . . . . 0.0 110.168 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 1.082 HD21 HD11 ' A' ' 54' ' ' ILE . 10.2 tp -153.83 123.55 6.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.317 -0.864 . . . . 0.0 110.169 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.486 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 11.1 t0 -136.02 147.52 47.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.256 -0.903 . . . . 0.0 110.281 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.59 ' HB3' ' CE1' ' A' ' 60' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.333 -0.854 . . . . 0.0 110.205 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.529 ' N ' ' HB2' ' A' ' 53' ' ' ALA . 49.3 Cg_endo . . . . . 0 N--CA 1.48 0.707 0 N-CA-C 110.03 -0.796 . . . . 0.0 110.03 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 1.049 HD11 ' O ' ' A' ' 144' ' ' VAL . 13.3 pt -92.04 -1.57 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.209 -0.932 . . . . 0.0 110.13 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 6' ' ' GLU . . . 75.82 43.54 22.53 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.512 ' HG3' ' HB1' ' A' ' 145' ' ' ALA . 0.8 OUTLIER 42.54 66.23 0.79 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.295 -1.121 . . . . 0.0 110.189 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.449 ' O ' ' CE1' ' A' ' 9' ' ' PHE . . . -67.82 89.69 0.2 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.454 ' O ' ' HB2' ' A' ' 9' ' ' PHE . 1.9 p -76.14 -1.29 25.41 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.238 -1.154 . . . . 0.0 110.101 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.597 ' CD1' ' HB3' ' A' ' 13' ' ' PRO . 6.3 m-30 60.32 81.42 0.18 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.33 -0.857 . . . . 0.0 110.321 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.543 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 21.0 t70 -142.26 12.22 1.97 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.225 -0.922 . . . . 0.0 110.168 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.543 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.8 OUTLIER 161.47 -24.26 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.678 -0.639 . . . . 0.0 109.609 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -161.23 86.66 0.11 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.597 ' HB3' ' CD1' ' A' ' 9' ' ' PHE . 49.6 Cg_endo -76.0 72.94 5.06 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.153 1.607 . . . . 0.0 110.963 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.452 ' HG3' ' HB ' ' A' ' 4' ' ' ILE . 25.6 mm-40 38.33 -92.0 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.491 -0.756 . . . . 0.0 110.782 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.561 ' O ' HG13 ' A' ' 17' ' ' VAL . . . -153.42 17.87 0.68 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.932 ' NE1' HD22 ' A' ' 49' ' ' LEU . 41.3 m95 -42.93 122.52 2.44 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -1.135 . . . . 0.0 110.4 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.737 ' O ' HG13 ' A' ' 47' ' ' VAL . 1.9 m -119.28 153.2 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.177 -0.952 . . . . 0.0 109.865 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.433 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . . . -137.58 122.47 18.89 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.165 -0.959 . . . . 0.0 109.96 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.563 ' CZ ' ' O ' ' A' ' 46' ' ' GLY . 3.7 p90 -115.24 154.78 28.44 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.39 -0.819 . . . . 0.0 110.498 -179.403 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.632 ' O ' HG22 ' A' ' 45' ' ' VAL . . . 90.77 29.11 13.96 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.484 ' HB ' ' O ' ' A' ' 35' ' ' ALA . 14.2 p -146.15 -160.38 1.14 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.127 -1.219 . . . . 0.0 110.303 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.45 ' O ' ' O ' ' A' ' 23' ' ' GLY . 12.4 t0 -89.93 123.47 33.88 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 0.0 110.196 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 22' ' ' ASP . . . 43.94 -166.1 0.03 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.416 ' O ' ' O ' ' A' ' 25' ' ' LEU . 45.5 Cg_endo -73.18 162.74 39.86 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.066 1.561 . . . . 0.0 110.405 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.828 HD13 HD11 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -59.37 -154.43 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.265 -0.897 . . . . 0.0 110.185 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -152.48 161.35 42.71 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.269 -0.894 . . . . 0.0 110.145 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.597 HG21 ' HD3' ' A' ' 13' ' ' PRO . 0.7 OUTLIER -125.22 -28.2 3.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.27 -0.894 . . . . 0.0 110.235 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.454 ' O ' ' OG1' ' A' ' 29' ' ' THR . 0.5 OUTLIER 48.48 23.48 0.61 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.216 -0.927 . . . . 0.0 110.152 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.454 ' OG1' ' O ' ' A' ' 28' ' ' SER . 17.9 p 47.19 65.83 1.15 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.297 -0.877 . . . . 0.0 110.268 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.526 ' N ' ' HA ' ' A' ' 10' ' ' ASP . . . 169.85 -50.17 0.21 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.451 ' HB1' ' O ' ' A' ' 141' ' ' LEU . . . -150.04 141.51 23.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -1.117 . . . . 0.0 110.292 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.828 HD11 HD13 ' A' ' 25' ' ' LEU . 5.8 tt -79.96 110.87 15.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.215 -0.928 . . . . 0.0 109.921 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 88.7 m -118.43 129.2 55.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.141 -0.975 . . . . 0.0 110.708 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.532 ' CG2' ' HB2' ' A' ' 139' ' ' LEU . 17.9 m -98.83 153.06 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.301 -0.874 . . . . 0.0 109.692 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.498 ' HA ' ' OG1' ' A' ' 138' ' ' THR . . . -102.76 87.65 3.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.249 -0.907 . . . . 0.0 110.898 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.101 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 57.5 t -75.98 132.14 74.67 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.161 -0.962 . . . . 0.0 109.386 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.524 ' CG ' ' OH ' ' A' ' 43' ' ' TYR . 47.8 Cg_endo -78.89 158.24 27.49 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.87 1.458 . . . . 0.0 111.114 -179.023 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.502 ' HA ' ' CA ' ' A' ' 136' ' ' ALA . . . -42.94 126.79 3.95 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.291 -0.881 . . . . 0.0 109.775 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 38' ' ' ALA . . . 47.92 86.67 0.01 OUTLIER Glycine 0 N--CA 1.485 1.963 0 N-CA-C 108.385 -1.886 . . . . 0.0 108.385 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.835 ' HB2' HG21 ' A' ' 45' ' ' VAL . 0.8 OUTLIER -82.2 39.04 0.56 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.353 -1.086 . . . . 0.0 110.636 -179.453 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.953 ' HB2' ' HA3' ' A' ' 131' ' ' GLY . . . -105.25 20.23 19.24 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.17 -0.957 . . . . 0.0 109.756 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.589 ' HG3' ' CD2' ' A' ' 43' ' ' TYR . 17.6 pt20 -93.04 27.02 2.58 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 121.581 0.705 . . . . 0.0 109.5 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.628 ' CD1' ' N ' ' A' ' 43' ' ' TYR . 0.0 OUTLIER 159.55 6.24 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.203 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.725 179.357 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.479 ' HA2' ' HA2' ' A' ' 130' ' ' GLY . . . 67.6 100.77 0.03 OUTLIER Glycine 0 N--CA 1.487 2.042 0 O-C-N 120.502 -1.374 . . . . 0.0 109.83 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.835 HG21 ' HB2' ' A' ' 40' ' ' SER . 48.8 t -89.19 170.37 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.119 -1.224 . . . . 0.0 108.431 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.563 ' O ' ' CZ ' ' A' ' 19' ' ' TYR . . . 167.33 140.45 2.91 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 118.943 -1.598 . . . . 0.0 110.721 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.737 HG13 ' O ' ' A' ' 17' ' ' VAL . 21.3 t -105.94 132.2 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.505 -0.997 . . . . 0.0 109.605 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.732 ' O ' HG22 ' A' ' 17' ' ' VAL . 35.6 m -126.9 141.03 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.923 -1.111 . . . . 0.0 110.572 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.932 HD22 ' NE1' ' A' ' 16' ' ' TRP . 14.2 tp -132.12 102.26 5.73 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.329 -0.857 . . . . 0.0 110.207 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.53 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 1.4 m-80 -80.08 122.79 27.22 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.289 -0.882 . . . . 0.0 110.424 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.549 ' O ' HG22 ' A' ' 4' ' ' ILE . . . 146.04 74.47 0.02 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.627 HG12 ' H ' ' A' ' 53' ' ' ALA . 6.3 t -119.81 178.84 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.185 -1.185 . . . . 0.0 110.086 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.887 ' O ' HD13 ' A' ' 54' ' ' ILE . . . -132.84 84.01 2.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.174 -0.954 . . . . 0.0 110.441 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.887 HD13 ' O ' ' A' ' 53' ' ' ALA . 5.6 mm -143.08 163.48 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.227 -0.92 . . . . 0.0 109.625 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.687 ' HG3' HG23 ' A' ' 111' ' ' THR . 8.1 tt0 -178.88 32.44 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.101 -0.999 . . . . 0.0 110.28 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 55' ' ' GLU . 2.0 tt0 179.78 -176.44 0.32 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.529 -0.732 . . . . 0.0 110.07 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.487 ' HA2' ' HA ' ' A' ' 109' ' ' SER . . . -93.41 67.07 1.7 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.255 -1.938 . . . . 0.0 108.255 178.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.716 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.0 OUTLIER -105.08 177.68 4.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.585 -0.95 . . . . 0.0 110.265 -179.036 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.584 ' N ' ' CG2' ' A' ' 58' ' ' THR . 0.6 OUTLIER -88.95 154.62 20.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.302 -0.874 . . . . 0.0 110.016 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.957 ' HB3' HD11 ' A' ' 146' ' ' LEU . 59.3 m-85 -155.98 124.37 5.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.346 -0.847 . . . . 0.0 110.061 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 28.9 m -94.1 115.23 27.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.204 -0.935 . . . . 0.0 110.108 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.668 HD22 ' CD2' ' A' ' 89' ' ' LEU . 19.4 tp -89.39 122.53 32.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.173 -0.954 . . . . 0.0 109.816 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.502 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 6.3 mtt180 -123.4 140.58 52.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.311 -0.868 . . . . 0.0 110.263 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.992 ' CZ ' HG21 ' A' ' 102' ' ' VAL . 1.6 p90 -178.28 147.53 0.43 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.41 -0.806 . . . . 0.0 109.629 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 47.6 m -119.37 91.04 3.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.115 -0.99 . . . . 0.0 110.407 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.603 ' CB ' HD21 ' A' ' 95' ' ' LEU . . . -90.06 147.65 23.52 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.366 -0.833 . . . . 0.0 110.069 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.5 ' OG1' ' HA ' ' A' ' 99' ' ' PRO . 40.7 m -146.84 131.9 18.26 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.27 -0.894 . . . . 0.0 110.442 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.598 ' CB ' HG12 ' A' ' 72' ' ' VAL . . . -123.85 136.57 54.46 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.35 -0.844 . . . . 0.0 109.906 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 64.5 m -65.17 -9.06 20.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.177 -0.952 . . . . 0.0 110.314 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.565 ' CG2' ' HB2' ' A' ' 137' ' ' TRP . 6.4 t -119.77 19.79 12.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.25 -0.906 . . . . 0.0 110.237 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.484 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 13.2 t70 43.57 49.94 6.42 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.295 -0.878 . . . . 0.0 109.678 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.762 ' CG1' HD12 ' A' ' 95' ' ' LEU . 8.8 p -75.47 145.64 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.429 -0.794 . . . . 0.0 110.662 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 89.7 m -119.94 86.06 2.49 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.39 -0.819 . . . . 0.0 109.339 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.711 HG12 ' HB2' ' A' ' 132' ' ' PHE . 15.0 m -89.5 -141.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.258 -0.901 . . . . 0.0 110.312 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.535 ' N ' HG23 ' A' ' 74' ' ' VAL . 16.0 mtm-85 -131.94 148.05 52.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.129 -0.982 . . . . 0.0 110.851 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.758 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -148.34 155.35 41.17 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.336 -0.853 . . . . 0.0 109.998 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.057 ' CD1' ' HB3' ' A' ' 126' ' ' ALA . 2.1 pp 175.82 -160.52 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 0.0 110.294 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.904 ' CG2' HD22 ' A' ' 89' ' ' LEU . 4.3 t -147.78 167.98 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.303 -0.873 . . . . 0.0 109.597 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.505 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . 174.08 -175.76 46.54 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.33 -1.414 . . . . 0.0 110.314 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.527 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 3.5 tm0? -94.37 178.25 5.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.458 -1.025 . . . . 0.0 110.142 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.472 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 3.7 m120 -146.53 87.75 1.73 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.248 -0.907 . . . . 0.0 110.155 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.512 ' O ' ' HB3' ' A' ' 83' ' ' ALA . . . 137.07 34.27 0.21 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.544 ' HA ' ' CD2' ' A' ' 85' ' ' TYR . . . 59.07 148.31 0.07 OUTLIER Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.133 -1.216 . . . . 0.0 110.407 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.453 ' O ' ' O ' ' A' ' 85' ' ' TYR . 52.4 Cg_endo -80.37 21.03 9.08 Favored 'Cis proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.761 -2.183 . . . . 0.0 111.103 -0.039 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.544 ' CD2' ' HA ' ' A' ' 83' ' ' ALA . 35.6 m-85 60.93 130.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.057 -1.027 . . . . 0.0 110.239 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.465 ' O ' ' HA2' ' A' ' 79' ' ' GLY . . . -151.44 99.05 0.19 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.3 p -91.16 134.15 34.78 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.287 -1.125 . . . . 0.0 110.187 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 1.109 HG23 HD12 ' A' ' 89' ' ' LEU . 32.1 m -120.24 -9.2 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.233 -0.917 . . . . 0.0 110.092 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 1.109 HD12 HG23 ' A' ' 88' ' ' VAL . 4.2 mp -118.63 137.63 53.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.275 -0.89 . . . . 0.0 111.006 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.405 ' C ' HG23 ' A' ' 91' ' ' THR . 12.0 p-10 -150.71 85.13 1.36 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.486 -0.759 . . . . 0.0 109.951 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.405 HG23 ' C ' ' A' ' 90' ' ' ASP . 65.6 p -144.08 -174.28 4.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.053 -1.029 . . . . 0.0 110.698 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.2 m -119.69 116.88 32.96 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.364 -0.835 . . . . 0.0 109.947 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.758 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 44.6 Cg_endo -71.84 79.61 1.59 Allowed 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.923 1.486 . . . . 0.0 110.642 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.805 ' HB3' HH11 ' A' ' 100' ' ' ARG . . . -67.03 148.17 52.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.208 -0.932 . . . . 0.0 109.833 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.762 HD12 ' CG1' ' A' ' 72' ' ' VAL . 73.3 mt -134.08 176.97 8.11 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.187 -0.946 . . . . 0.0 110.475 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.404 ' O ' HG23 ' A' ' 67' ' ' THR . 0.3 OUTLIER -170.66 -179.14 2.81 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.275 -0.891 . . . . 0.0 110.14 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.63 -30.27 71.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.257 -0.902 . . . . 0.0 110.039 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.525 ' CB ' ' HD2' ' A' ' 99' ' ' PRO . 0.1 OUTLIER -93.1 179.72 1.23 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.278 -0.889 . . . . 0.0 110.042 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.525 ' HD2' ' CB ' ' A' ' 98' ' ' GLU . 44.3 Cg_endo -72.06 134.99 24.33 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.9 1.474 . . . . 0.0 110.287 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.805 HH11 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.73 85.81 2.45 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.283 -0.885 . . . . 0.0 110.25 -179.893 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.413 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 8.7 mt-30 -71.7 156.33 39.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.27 -0.894 . . . . 0.0 110.216 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.992 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 40.7 t -139.66 138.92 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.24 -0.913 . . . . 0.0 110.166 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.07 116.34 6.53 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.252 -0.905 . . . . 0.0 110.131 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -140.88 131.87 26.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.253 -0.904 . . . . 0.0 110.245 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.527 HG22 HG22 ' A' ' 59' ' ' THR . 4.4 m -89.82 65.42 6.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.181 -0.949 . . . . 0.0 110.225 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.61 ' CZ ' ' CB ' ' A' ' 60' ' ' TYR . 26.1 p90 -71.29 144.95 49.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 0.0 110.099 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.531 ' O ' ' N ' ' A' ' 109' ' ' SER . 3.5 m -89.35 92.76 9.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.17 -0.956 . . . . 0.0 109.699 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.634 ' CB ' ' CD2' ' A' ' 60' ' ' TYR . . . -45.23 92.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.37 -0.831 . . . . 0.0 110.156 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 107' ' ' THR . 81.2 p -89.45 54.68 2.99 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.332 -0.855 . . . . 0.0 109.61 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -163.34 -155.2 0.31 Allowed 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.465 -0.894 . . . . 0.0 110.678 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.687 HG23 ' HG3' ' A' ' 55' ' ' GLU . 4.5 m -148.14 118.58 7.4 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.294 -0.879 . . . . 0.0 110.587 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.598 ' CD2' HG13 ' A' ' 54' ' ' ILE . 15.8 m-30 -112.61 85.52 7.48 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.497 -0.752 . . . . 0.0 109.542 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.677 ' HD3' HG22 ' A' ' 111' ' ' THR . 43.4 Cg_endo -69.97 127.77 14.9 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 123.86 1.453 . . . . 0.0 110.49 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.318 -0.864 . . . . 0.0 110.395 -179.796 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.487 ' HB2' ' O ' ' A' ' 113' ' ' PRO . 0.9 OUTLIER . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 121.298 0.57 . . . . 0.0 110.663 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.613 ' O ' HG23 ' A' ' 52' ' ' VAL . . . -106.51 155.55 16.51 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.552 ' HA ' ' CG2' ' A' ' 52' ' ' VAL . 1.1 pt20 -150.4 -160.15 1.13 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.168 -1.195 . . . . 0.0 110.719 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.819 HG21 ' HH2' ' A' ' 16' ' ' TRP . 18.3 mt -118.34 142.65 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 1.057 ' HB3' ' CD1' ' A' ' 77' ' ' LEU . . . -118.03 120.98 39.43 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.249 -0.907 . . . . 0.0 111.439 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.498 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 4.9 m-85 -118.79 100.79 7.62 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.202 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLN . . . . . 0.543 ' O ' ' CE2' ' A' ' 132' ' ' PHE . 32.1 mm-40 -89.47 103.15 15.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.127 -0.983 . . . . 0.0 112.313 -177.273 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.624 ' CD2' HG21 ' A' ' 74' ' ' VAL . 11.5 mt -100.68 41.04 1.2 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 177.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.479 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -67.61 85.68 0.15 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 -179.208 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.953 ' HA3' ' HB2' ' A' ' 41' ' ' ALA . . . 40.57 79.23 0.05 OUTLIER Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.711 ' HB2' HG12 ' A' ' 74' ' ' VAL . 10.5 m-85 -107.28 -42.64 4.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.171 -1.194 . . . . 0.0 110.183 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.703 ' HB2' HG23 ' A' ' 72' ' ' VAL . 1.2 t -89.81 -176.5 4.97 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.198 -0.938 . . . . 0.0 110.238 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.46 ' N ' ' OG ' ' A' ' 133' ' ' SER . . . -96.69 -92.23 0.23 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.122 -0.986 . . . . 0.0 110.855 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -63.63 170.75 3.03 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.187 -0.946 . . . . 0.0 110.637 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.502 ' CA ' ' HA ' ' A' ' 38' ' ' ALA . . . -52.92 136.53 34.37 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.392 -0.817 . . . . 0.0 110.397 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 1.101 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 8.1 p90 -145.17 -167.55 2.71 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.314 -0.866 . . . . 0.0 110.336 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.538 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 0.5 OUTLIER -160.35 165.96 30.27 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.214 -0.929 . . . . 0.0 110.398 -178.729 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.543 ' HG ' HD13 ' A' ' 95' ' ' LEU . 2.4 mp -119.52 161.32 20.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.434 -0.791 . . . . 0.0 109.209 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' CYS . . . . . . . . . . . . . 1.9 m -150.58 94.44 2.1 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.069 -1.019 . . . . 0.0 111.209 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.493 ' HA ' ' O ' ' A' ' 65' ' ' THR . 0.9 OUTLIER -95.14 -176.03 3.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.229 -0.919 . . . . 0.0 108.903 178.754 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.486 ' CB ' ' O ' ' A' ' 141' ' ' LEU . 0.5 OUTLIER 170.2 37.25 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.051 -1.031 . . . . 0.0 110.631 179.912 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.467 ' O ' ' O ' ' A' ' 63' ' ' ARG . 34.5 t0 179.35 48.75 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.184 -0.948 . . . . 0.0 110.056 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 1.049 ' O ' HD11 ' A' ' 4' ' ' ILE . 2.8 t -89.77 113.51 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.369 -0.832 . . . . 0.0 110.08 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.512 ' HB1' ' HG3' ' A' ' 6' ' ' GLU . . . -144.4 163.19 34.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.263 -0.898 . . . . 0.0 110.219 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.957 HD11 ' HB3' ' A' ' 60' ' ' TYR . 16.3 tp -145.99 128.87 16.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.27 -0.894 . . . . 0.0 110.218 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.581 ' O ' ' CD1' ' A' ' 60' ' ' TYR . 0.3 OUTLIER -135.75 -154.15 0.55 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.302 -0.874 . . . . 0.0 110.238 179.988 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 48.3 p . . . . . 0 N--CA 1.492 1.665 0 O-C-N 121.273 -0.892 . . . . 0.0 110.116 179.991 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo . . . . . 0 N--CA 1.48 0.69 0 N-CA-C 110.097 -0.77 . . . . 0.0 110.097 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.731 HD11 ' O ' ' A' ' 144' ' ' VAL . 7.8 pt -120.52 -3.62 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.181 -0.95 . . . . 0.0 110.128 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 6' ' ' GLU . . . 97.52 139.17 10.54 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 5' ' ' GLY . 0.4 OUTLIER -42.76 -85.5 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.241 -1.152 . . . . 0.0 110.126 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.5 ' HA2' ' HA ' ' A' ' 143' ' ' ASP . . . -80.85 127.66 8.03 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.69 HG21 ' HB ' ' A' ' 144' ' ' VAL . 16.3 p -107.0 163.89 12.6 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.147 -1.208 . . . . 0.0 110.64 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.604 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.1 m-30 65.89 9.79 6.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.452 -0.78 . . . . 0.0 110.229 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.552 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 4.0 p-10 -86.12 41.66 0.94 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.159 -0.963 . . . . 0.0 109.885 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.552 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 2.1 t70 161.3 -24.17 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 172.91 164.21 27.95 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.635 ' CB ' HD11 ' A' ' 25' ' ' LEU . 44.1 Cg_endo -71.17 81.56 1.16 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.011 1.532 . . . . 0.0 110.442 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.48 ' C ' ' O ' ' A' ' 13' ' ' PRO . 1.0 OUTLIER -31.42 -68.2 0.09 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.275 0.559 . . . . 0.0 111.163 -179.636 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.495 ' C ' ' CD1' ' A' ' 49' ' ' LEU . . . -152.47 14.05 0.71 Allowed Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.765 -1.207 . . . . 0.0 110.218 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 1.103 ' NE1' HD22 ' A' ' 49' ' ' LEU . 24.2 m95 -77.77 110.08 12.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.028 -1.278 . . . . 0.0 110.244 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.541 HG22 HG23 ' A' ' 48' ' ' VAL . 2.2 m -100.64 125.67 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.238 -0.914 . . . . 0.0 110.068 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.575 ' HB2' HG11 ' A' ' 34' ' ' VAL . . . -104.17 119.32 38.69 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.156 -0.965 . . . . 0.0 110.093 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.588 ' CZ ' ' O ' ' A' ' 46' ' ' GLY . 6.2 p90 -112.42 148.05 35.16 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.298 -0.876 . . . . 0.0 110.458 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.537 ' CA ' ' OH ' ' A' ' 43' ' ' TYR . . . 96.82 34.62 5.66 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.481 ' CG2' ' C ' ' A' ' 20' ' ' GLY . 7.3 p -150.21 -147.31 0.22 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.137 -1.214 . . . . 0.0 110.407 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 23' ' ' GLY . 62.2 t0 -89.96 114.77 26.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.334 -0.854 . . . . 0.0 110.33 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 43.16 -155.52 0.16 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.32 157.32 49.94 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 124.031 1.543 . . . . 0.0 110.493 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.639 HD23 ' H ' ' A' ' 25' ' ' LEU . 0.6 OUTLIER -53.63 179.8 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.254 -0.904 . . . . 0.0 110.201 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -152.58 142.33 21.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.27 -0.894 . . . . 0.0 110.196 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.78 HG22 ' HA ' ' A' ' 32' ' ' LEU . 2.2 p -119.64 -79.97 0.61 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.295 -0.878 . . . . 0.0 110.031 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.42 ' OG ' ' C ' ' A' ' 27' ' ' THR . 1.6 p 40.44 27.46 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.384 -0.822 . . . . 0.0 110.645 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.482 HG22 ' O ' ' A' ' 27' ' ' THR . 12.8 t -148.7 13.93 0.93 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.139 -0.976 . . . . 0.0 110.364 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 9' ' ' PHE . . . 75.48 7.86 83.3 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.643 ' HB1' ' O ' ' A' ' 141' ' ' LEU . . . -150.35 151.38 32.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.256 -1.144 . . . . 0.0 110.118 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.78 ' HA ' HG22 ' A' ' 27' ' ' THR . 0.5 OUTLIER -79.85 114.56 18.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.123 -0.986 . . . . 0.0 109.822 179.829 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 67.0 m -120.93 118.27 29.46 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.184 -0.947 . . . . 0.0 110.745 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.575 HG11 ' HB2' ' A' ' 18' ' ' ALA . 15.3 m -99.52 135.38 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.35 -0.844 . . . . 0.0 109.494 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.476 ' O ' ' HB ' ' A' ' 21' ' ' THR . . . -89.47 89.74 7.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.207 -0.933 . . . . 0.0 111.089 -179.086 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.141 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 53.1 t -69.87 134.53 87.89 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.245 -0.91 . . . . 0.0 109.416 179.175 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 21' ' ' THR . 47.2 Cg_endo -76.68 152.85 33.53 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.944 1.497 . . . . 0.0 111.325 -178.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.503 ' HA ' ' N ' ' A' ' 136' ' ' ALA . . . -43.89 130.99 5.74 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.373 -0.83 . . . . 0.0 109.884 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 38' ' ' ALA . . . 45.24 78.18 0.08 OUTLIER Glycine 0 N--CA 1.487 2.041 0 N-CA-C 108.724 -1.75 . . . . 0.0 108.724 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.883 ' HB2' HG21 ' A' ' 45' ' ' VAL . 1.1 p -82.76 40.33 0.67 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.304 -1.115 . . . . 0.0 110.473 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.966 ' HB2' ' HA3' ' A' ' 131' ' ' GLY . . . -109.1 25.13 12.17 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.361 -0.837 . . . . 0.0 109.767 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.51 ' O ' ' HB3' ' A' ' 43' ' ' TYR . 16.3 pt20 -78.14 2.7 17.19 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.637 0.732 . . . . 0.0 110.542 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.537 ' OH ' ' CA ' ' A' ' 20' ' ' GLY . 2.5 p90 177.26 -32.52 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.508 ' O ' ' CE2' ' A' ' 43' ' ' TYR . . . 123.48 104.47 1.68 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 110.266 -1.133 . . . . 0.0 110.266 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.883 HG21 ' HB2' ' A' ' 40' ' ' SER . 39.8 t -89.7 177.27 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.066 -1.255 . . . . 0.0 108.502 178.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.588 ' O ' ' CZ ' ' A' ' 19' ' ' TYR . . . 160.55 140.11 2.81 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 118.491 -1.814 . . . . 0.0 111.66 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.608 ' O ' HG13 ' A' ' 48' ' ' VAL . 21.5 t -100.53 162.17 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.644 -0.915 . . . . 0.0 108.693 178.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.608 HG13 ' O ' ' A' ' 47' ' ' VAL . 15.6 m -157.25 157.61 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.841 -1.162 . . . . 0.0 110.71 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 1.103 HD22 ' NE1' ' A' ' 16' ' ' TRP . 13.8 tp -151.33 120.28 6.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.327 -0.858 . . . . 0.0 110.351 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.483 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 23.7 p30 -96.26 158.24 15.53 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.216 -0.927 . . . . 0.0 110.234 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.11 74.4 0.62 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.594 HG12 ' N ' ' A' ' 53' ' ' ALA . 87.2 t -138.83 172.43 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.173 -1.193 . . . . 0.0 110.177 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.594 ' N ' HG12 ' A' ' 52' ' ' VAL . . . -139.5 101.19 4.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.173 -0.955 . . . . 0.0 110.409 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.65 ' CG1' ' CD2' ' A' ' 112' ' ' TYR . 45.0 mm -126.34 173.13 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.248 -0.907 . . . . 0.0 109.987 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.676 ' HA ' HG23 ' A' ' 111' ' ' THR . 0.0 OUTLIER -164.74 128.59 2.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.118 -0.989 . . . . 0.0 110.814 -179.923 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 8.3 pt-20 37.74 -153.31 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.673 -0.642 . . . . 0.0 110.999 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 108' ' ' ALA . . . -87.03 75.67 2.16 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.582 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.3 m -101.67 173.61 6.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.334 -1.098 . . . . 0.0 109.807 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.575 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 0.7 OUTLIER -89.96 153.27 20.73 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.235 -0.916 . . . . 0.0 110.559 -179.577 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.636 ' CD2' ' HB2' ' A' ' 108' ' ' ALA . 64.3 m-85 -159.96 123.12 3.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.311 -0.868 . . . . 0.0 110.01 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 30.6 m -89.88 115.35 27.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.161 -0.962 . . . . 0.0 110.167 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.423 HD22 ' CD2' ' A' ' 89' ' ' LEU . 15.2 tp -89.5 126.27 35.52 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.232 -0.918 . . . . 0.0 109.907 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.523 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 14.3 ttp85 -131.16 136.49 48.36 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.385 -0.822 . . . . 0.0 110.107 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 1.165 ' CZ ' HG21 ' A' ' 102' ' ' VAL . 0.6 OUTLIER -178.46 143.2 0.26 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.383 -0.823 . . . . 0.0 109.57 179.678 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.85 HG23 ' CA ' ' A' ' 101' ' ' GLN . 0.2 OUTLIER -119.26 93.35 4.05 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.149 -0.969 . . . . 0.0 110.434 -179.466 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.688 ' HB2' HD23 ' A' ' 141' ' ' LEU . . . -94.81 153.95 17.49 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.293 -0.879 . . . . 0.0 110.119 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.535 HG23 ' O ' ' A' ' 98' ' ' GLU . 51.9 m -150.14 135.65 18.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.22 -0.925 . . . . 0.0 110.363 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 138' ' ' THR . . . -126.14 140.06 52.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.282 -0.886 . . . . 0.0 110.013 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.9 m -71.2 -3.71 21.67 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.22 -0.925 . . . . 0.0 110.113 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.569 ' CG2' ' HB2' ' A' ' 137' ' ' TRP . 6.3 t -124.62 19.84 8.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 110.096 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.487 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 14.9 t0 43.51 60.77 2.48 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.272 -0.892 . . . . 0.0 109.558 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.742 HG23 ' HB2' ' A' ' 133' ' ' SER . 5.5 p -87.07 140.96 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.463 -0.773 . . . . 0.0 110.87 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 23.2 m -119.86 87.88 2.83 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.483 -0.761 . . . . 0.0 109.107 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.819 HG11 HD22 ' A' ' 129' ' ' LEU . 19.2 m -89.73 -146.15 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -0.906 . . . . 0.0 110.382 -179.24 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.414 ' N ' HG23 ' A' ' 74' ' ' VAL . 0.4 OUTLIER -127.16 124.14 38.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.244 -0.91 . . . . 0.0 110.434 -179.67 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.655 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -126.99 158.67 36.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.309 -0.869 . . . . 0.0 109.666 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.912 HD11 ' HB3' ' A' ' 126' ' ' ALA . 3.4 pp 177.87 -157.33 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.19 -0.944 . . . . 0.0 110.475 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.715 HG23 HD22 ' A' ' 89' ' ' LEU . 9.8 t -143.56 -178.21 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.339 -0.851 . . . . 0.0 109.558 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.631 ' H ' HG12 ' A' ' 78' ' ' VAL . . . 161.56 -154.93 26.03 Favored Glycine 0 N--CA 1.49 2.274 0 C-N-CA 119.303 -1.427 . . . . 0.0 110.053 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.571 ' HB3' ' CD1' ' A' ' 112' ' ' TYR . 5.7 pt20 -135.21 158.36 44.56 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.469 -1.018 . . . . 0.0 110.356 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.466 ' HB2' ' HG2' ' A' ' 122' ' ' GLU . 2.4 m120 -107.23 97.22 7.01 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.315 -0.866 . . . . 0.0 110.038 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.542 ' C ' ' CE1' ' A' ' 85' ' ' TYR . . . 138.44 143.01 4.4 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.593 ' N ' ' CE1' ' A' ' 85' ' ' TYR . . . -65.95 155.7 86.08 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.262 -1.14 . . . . 0.0 110.222 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.533 ' C ' ' CD2' ' A' ' 85' ' ' TYR . 50.6 Cg_endo -77.48 8.94 17.83 Favored 'Cis proline' 0 C--N 1.313 -1.322 0 C-N-CA 121.637 -2.235 . . . . 0.0 110.905 0.096 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.593 ' CE1' ' N ' ' A' ' 83' ' ' ALA . 10.5 m-85 69.33 -171.23 0.18 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.231 -0.918 . . . . 0.0 110.214 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 153.46 107.27 0.31 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.504 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 4.1 p -96.05 167.84 10.98 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.211 -1.17 . . . . 0.0 110.391 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.812 HG12 ' N ' ' A' ' 109' ' ' SER . 5.4 m -135.5 -32.76 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.364 -0.835 . . . . 0.0 110.324 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.715 HD22 HG23 ' A' ' 78' ' ' VAL . 4.3 mp -98.3 144.24 27.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -0.909 . . . . 0.0 110.859 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.651 ' O ' HG23 ' A' ' 91' ' ' THR . 17.4 p-10 -151.08 86.11 1.36 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.324 -0.86 . . . . 0.0 110.172 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.651 HG23 ' O ' ' A' ' 90' ' ' ASP . 2.4 p -157.52 -175.03 5.16 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.024 -1.047 . . . . 0.0 110.531 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.49 130.47 24.78 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.326 -0.858 . . . . 0.0 110.172 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.655 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 49.7 Cg_endo -75.44 80.58 2.49 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.961 1.506 . . . . 0.0 110.87 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.69 ' HB3' HH11 ' A' ' 100' ' ' ARG . . . -56.55 135.63 54.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.059 -1.025 . . . . 0.0 109.479 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.71 HD12 ' CG1' ' A' ' 72' ' ' VAL . 93.4 mt -125.16 176.22 6.87 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.032 -1.043 . . . . 0.0 110.691 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.52 HG22 ' HG3' ' A' ' 100' ' ' ARG . 0.3 OUTLIER -167.9 -178.92 3.97 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.43 -0.794 . . . . 0.0 110.039 179.922 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.4 -29.87 70.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.196 -0.94 . . . . 0.0 110.281 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.535 ' O ' HG23 ' A' ' 67' ' ' THR . 3.7 mt-10 -90.28 176.7 2.8 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.172 -0.955 . . . . 0.0 110.14 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.499 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 45.4 Cg_endo -72.19 134.44 23.05 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.956 1.503 . . . . 0.0 110.334 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.69 HH11 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.9 92.94 3.9 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.191 -0.943 . . . . 0.0 110.368 -179.868 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.85 ' CA ' HG23 ' A' ' 65' ' ' THR . 6.4 tp-100 -76.71 154.92 33.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.292 -0.88 . . . . 0.0 110.085 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 1.165 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 32.2 t -131.72 134.47 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.232 -0.917 . . . . 0.0 110.194 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.25 115.61 5.45 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.275 -0.891 . . . . 0.0 110.138 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -159.88 131.19 5.95 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.207 -0.933 . . . . 0.0 110.32 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.6 m -89.97 105.25 17.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.261 -0.899 . . . . 0.0 110.06 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.628 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 34.4 p90 -106.83 154.28 21.25 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.275 -0.89 . . . . 0.0 110.447 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 58' ' ' THR . 33.0 m -91.29 89.8 7.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.28 -0.888 . . . . 0.0 109.691 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.636 ' HB2' ' CD2' ' A' ' 60' ' ' TYR . . . -41.94 101.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.329 -0.857 . . . . 0.0 110.452 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.812 ' N ' HG12 ' A' ' 88' ' ' VAL . 88.8 p -85.89 55.55 3.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.3 -0.875 . . . . 0.0 110.063 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.457 ' CB ' HG13 ' A' ' 88' ' ' VAL . . . -159.55 -154.96 0.43 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.282 -0.886 . . . . 0.0 110.131 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.676 HG23 ' HA ' ' A' ' 55' ' ' GLU . 19.7 m -159.99 110.89 1.92 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.111 -0.993 . . . . 0.0 110.591 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.65 ' CD2' ' CG1' ' A' ' 54' ' ' ILE . 3.3 m-30 -112.99 106.72 54.92 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.188 -0.945 . . . . 0.0 109.84 179.203 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.63 -159.02 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.785 1.413 . . . . 0.0 110.094 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.106 -0.996 . . . . 0.0 110.322 -179.969 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.478 ' O ' ' HA ' ' A' ' 80' ' ' GLN . 1.4 pt-20 . . . . . 0 N--CA 1.494 1.769 0 CA-C-O 121.163 0.506 . . . . 0.0 110.303 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.546 ' CA ' ' HB3' ' A' ' 112' ' ' TYR . . . -130.15 131.81 6.73 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.483 ' CB ' ' HA ' ' A' ' 50' ' ' ASN . 4.9 pt20 -150.43 -174.23 4.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.145 -1.209 . . . . 0.0 110.78 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.764 HG21 ' HH2' ' A' ' 16' ' ' TRP . 8.8 mt -118.74 143.87 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.912 ' HB3' HD11 ' A' ' 77' ' ' LEU . . . -115.15 119.65 37.11 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.286 -0.884 . . . . 0.0 111.275 -179.231 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.446 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 2.6 m-30 -117.34 94.08 4.42 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -89.25 105.08 17.55 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.084 -1.01 . . . . 0.0 111.524 -178.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.819 HD22 HG11 ' A' ' 74' ' ' VAL . 14.8 mt -100.13 50.09 0.91 Allowed 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.373 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.497 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -69.51 84.12 0.27 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.019 -1.233 . . . . 0.0 110.019 -179.199 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.966 ' HA3' ' HB2' ' A' ' 41' ' ' ALA . . . 39.02 72.47 0.2 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.743 ' HB2' HG12 ' A' ' 74' ' ' VAL . 10.5 m-85 -97.89 -39.64 8.89 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.136 -1.214 . . . . 0.0 110.124 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.742 ' HB2' HG23 ' A' ' 72' ' ' VAL . 1.2 t -89.69 -176.08 4.86 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.239 -0.913 . . . . 0.0 109.915 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.451 ' N ' ' OG ' ' A' ' 133' ' ' SER . . . -93.9 -99.48 0.14 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.033 -1.042 . . . . 0.0 110.982 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -61.17 177.51 0.34 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.993 -1.067 . . . . 0.0 110.853 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.503 ' N ' ' HA ' ' A' ' 38' ' ' ALA . . . -53.52 136.5 38.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.472 -0.767 . . . . 0.0 110.342 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 1.141 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 5.7 p90 -145.5 -170.16 3.38 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.372 -0.83 . . . . 0.0 110.157 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.537 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 0.5 OUTLIER -160.34 159.91 31.76 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.244 -0.983 . . . . 0.0 110.812 -178.789 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.675 ' CD2' HD11 ' A' ' 95' ' ' LEU . 2.2 mp -119.34 160.37 22.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.423 -0.798 . . . . 0.0 109.303 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' CYS . . . . . . . . . . . . . 13.6 m -150.53 100.55 2.87 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.128 -0.982 . . . . 0.0 110.598 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.688 HD23 ' HB2' ' A' ' 66' ' ' ALA . 0.9 OUTLIER -96.44 -176.75 3.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.3 -0.875 . . . . 0.0 109.446 179.321 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.573 ' O ' ' CB ' ' A' ' 143' ' ' ASP . 2.4 p30 166.72 61.52 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.324 -0.86 . . . . 0.0 110.042 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.573 ' CB ' ' O ' ' A' ' 142' ' ' ASP . 1.4 m-20 159.85 46.52 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.839 HG11 ' HZ2' ' A' ' 16' ' ' TRP . 3.5 t -89.64 112.04 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.329 -0.857 . . . . 0.0 110.466 -179.261 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -135.3 151.93 51.01 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.223 -0.923 . . . . 0.0 110.187 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.507 HD23 HG13 ' A' ' 52' ' ' VAL . 58.8 tp -151.61 124.67 8.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.335 -0.853 . . . . 0.0 110.194 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.469 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 3.5 t0 -161.07 156.43 24.53 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.278 -0.889 . . . . 0.0 110.326 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 59' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.259 -0.901 . . . . 0.0 110.167 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo . . . . . 0 N--CA 1.48 0.695 0 N-CA-C 110.159 -0.746 . . . . 0.0 110.159 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.516 ' CD1' ' HB ' ' A' ' 144' ' ' VAL . 6.1 pt -89.9 -0.05 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.234 -0.916 . . . . 0.0 110.18 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 6' ' ' GLU . . . 119.69 -24.42 8.0 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.548 ' HG3' ' CB ' ' A' ' 145' ' ' ALA . 4.3 tt0 43.06 48.68 5.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.308 -1.113 . . . . 0.0 110.153 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 143' ' ' ASP . . . -134.81 159.17 23.83 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.444 ' HA ' ' HB2' ' A' ' 143' ' ' ASP . 1.2 p -51.29 -179.0 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.291 -1.123 . . . . 0.0 110.345 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.606 ' CD2' ' HA ' ' A' ' 142' ' ' ASP . 3.2 m-30 -110.78 24.83 12.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.292 -0.88 . . . . 0.0 110.283 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.565 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 29.6 t70 -110.74 50.91 0.79 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.172 -0.955 . . . . 0.0 110.209 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.565 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.3 OUTLIER 161.61 66.49 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.572 -0.705 . . . . 0.0 109.927 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.08 94.39 0.67 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.691 ' HG3' HG21 ' A' ' 27' ' ' THR . 51.1 Cg_endo -81.8 46.19 2.16 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.113 1.586 . . . . 0.0 110.63 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.477 ' HG3' ' N ' ' A' ' 15' ' ' GLY . 12.7 tp10 56.85 -90.97 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.155 -0.966 . . . . 0.0 110.187 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.725 ' C ' HD13 ' A' ' 49' ' ' LEU . . . -154.61 31.73 0.69 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.866 ' CE2' HD22 ' A' ' 49' ' ' LEU . 61.3 m95 -69.3 84.45 0.38 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.283 -1.127 . . . . 0.0 110.297 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.728 ' O ' HG13 ' A' ' 47' ' ' VAL . 1.3 m -89.64 148.05 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.149 -0.97 . . . . 0.0 109.804 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.534 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . . . -124.58 135.75 53.39 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.095 -1.003 . . . . 0.0 109.893 179.5 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.945 ' CE1' HG13 ' A' ' 48' ' ' VAL . 20.1 p90 -124.69 168.51 13.08 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.385 -0.822 . . . . 0.0 110.753 -178.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.602 ' O ' HG13 ' A' ' 45' ' ' VAL . . . 68.71 42.68 78.9 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.501 HG22 ' CG1' ' A' ' 45' ' ' VAL . 1.8 p -151.35 -147.55 0.23 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.088 -1.242 . . . . 0.0 110.245 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.419 ' O ' ' O ' ' A' ' 23' ' ' GLY . 1.1 t70 -108.86 117.31 33.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.308 -0.87 . . . . 0.0 110.165 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 22' ' ' ASP . . . 52.83 177.15 0.06 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.02 151.12 49.69 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.965 1.508 . . . . 0.0 110.447 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.701 HD23 ' H ' ' A' ' 25' ' ' LEU . 0.8 OUTLIER -49.02 161.86 0.13 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.333 -0.855 . . . . 0.0 110.228 179.945 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -121.34 132.29 54.69 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.241 -0.912 . . . . 0.0 110.046 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.691 HG21 ' HG3' ' A' ' 13' ' ' PRO . 0.7 OUTLIER -120.33 -24.93 5.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.216 -0.927 . . . . 0.0 110.61 -179.797 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 27' ' ' THR . 0.6 OUTLIER -43.93 -25.81 0.23 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.134 -0.978 . . . . 0.0 110.176 -179.828 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.592 HG23 ' N ' ' A' ' 30' ' ' GLY . 6.2 t -62.97 -47.51 82.83 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.271 -0.893 . . . . 0.0 110.686 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.592 ' N ' HG23 ' A' ' 29' ' ' THR . . . 161.03 -20.64 0.21 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.856 -1.297 . . . . 0.0 109.856 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.663 ' HB1' ' O ' ' A' ' 141' ' ' LEU . . . -150.12 -176.08 5.31 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.167 -1.196 . . . . 0.0 109.965 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.615 HD11 HD13 ' A' ' 25' ' ' LEU . 0.7 OUTLIER -87.51 94.9 9.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.108 -0.995 . . . . 0.0 109.949 179.801 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 89.4 m -110.54 106.68 16.05 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.149 -0.969 . . . . 0.0 110.748 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.537 HG12 ' HB3' ' A' ' 25' ' ' LEU . 22.4 m -89.72 138.79 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.292 -0.88 . . . . 0.0 109.178 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.475 ' O ' ' HB ' ' A' ' 21' ' ' THR . . . -89.0 93.15 9.5 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.141 -0.975 . . . . 0.0 111.337 -178.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.132 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 75.3 t -70.53 135.3 86.26 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.341 -0.849 . . . . 0.0 109.372 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.454 ' O ' ' OG ' ' A' ' 40' ' ' SER . 41.4 Cg_endo -68.56 172.28 11.7 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.727 1.383 . . . . 0.0 111.542 -178.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.504 ' HA ' ' N ' ' A' ' 136' ' ' ALA . . . -70.47 115.32 9.51 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.39 -0.819 . . . . 0.0 110.447 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.476 ' O ' ' N ' ' A' ' 41' ' ' ALA . . . 83.79 -40.63 2.9 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.753 ' HB3' HG21 ' A' ' 45' ' ' VAL . 1.5 m 38.3 30.48 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.542 -0.975 . . . . 0.0 110.146 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 39' ' ' GLY . . . -89.6 23.22 2.7 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.973 0.892 . . . . 0.0 110.08 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.589 ' O ' ' CG ' ' A' ' 43' ' ' TYR . 9.7 pm0 -108.67 126.9 53.49 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.589 ' CG ' ' O ' ' A' ' 42' ' ' GLN . 43.9 p90 39.45 27.88 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.515 -0.741 . . . . 0.0 109.927 -178.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 42' ' ' GLN . . . 51.17 173.84 0.02 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.753 HG21 ' HB3' ' A' ' 40' ' ' SER . 43.5 t -142.0 -179.07 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 179.447 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.578 ' H ' HG12 ' A' ' 45' ' ' VAL . . . 164.22 -163.39 36.0 Favored Glycine 0 N--CA 1.484 1.852 0 C-N-CA 117.345 -2.36 . . . . 0.0 112.734 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.728 HG13 ' O ' ' A' ' 17' ' ' VAL . 38.5 t -150.98 132.09 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.945 HG13 ' CE1' ' A' ' 19' ' ' TYR . 35.7 m -119.51 138.93 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.917 -1.115 . . . . 0.0 110.833 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.866 HD22 ' CE2' ' A' ' 16' ' ' TRP . 20.1 tp -133.69 97.68 3.99 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.373 -0.829 . . . . 0.0 110.236 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.51 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 8.6 p30 -81.11 113.61 19.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.218 -0.926 . . . . 0.0 110.239 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.413 ' O ' HG22 ' A' ' 4' ' ' ILE . . . 154.89 64.25 0.01 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.684 HG12 ' H ' ' A' ' 53' ' ' ALA . 3.2 t -119.95 -176.18 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.237 -1.155 . . . . 0.0 109.881 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.684 ' H ' HG12 ' A' ' 52' ' ' VAL . . . -142.49 75.14 1.48 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.074 -1.016 . . . . 0.0 110.634 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.638 ' CG2' ' HB1' ' A' ' 108' ' ' ALA . 32.5 mm -113.78 162.29 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.098 -1.001 . . . . 0.0 109.971 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.526 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 18.4 tt0 -162.25 132.31 4.68 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.176 -0.952 . . . . 0.0 110.605 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.526 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 15.2 pt-20 38.13 -160.25 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.67 -0.644 . . . . 0.0 110.916 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' A' ' 109' ' ' SER . . . -80.63 74.88 2.32 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.679 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.3 m -104.17 168.2 9.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.351 -1.087 . . . . 0.0 109.868 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.571 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 3.1 m -89.99 157.98 17.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.177 -0.952 . . . . 0.0 110.264 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.78 ' HB3' HD11 ' A' ' 146' ' ' LEU . 66.5 m-85 -158.95 173.79 15.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.225 -0.922 . . . . 0.0 110.37 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.839 ' OG1' HG22 ' A' ' 105' ' ' THR . 22.1 m -150.16 113.98 5.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.355 -0.841 . . . . 0.0 110.034 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.468 HD12 ' N ' ' A' ' 63' ' ' ARG . 10.3 tp -89.66 121.96 32.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.16 -0.963 . . . . 0.0 110.077 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.485 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 9.5 ttt-85 -127.63 107.16 9.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 110.489 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.603 ' OH ' HG21 ' A' ' 102' ' ' VAL . 7.8 p90 -143.34 172.33 12.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.333 -0.854 . . . . 0.0 109.915 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 5.0 m -131.27 94.91 3.66 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.171 -0.956 . . . . 0.0 110.226 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.689 ' CB ' HD21 ' A' ' 95' ' ' LEU . . . -99.6 142.1 31.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -0.898 . . . . 0.0 110.398 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.782 HG23 ' O ' ' A' ' 98' ' ' GLU . 93.3 m -150.37 101.86 3.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.403 -0.811 . . . . 0.0 110.048 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -89.81 144.07 26.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.192 -0.942 . . . . 0.0 110.105 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.4 m -60.59 -15.01 23.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.147 -0.971 . . . . 0.0 109.225 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.555 ' CG2' ' HB2' ' A' ' 137' ' ' TRP . 3.0 t -121.71 160.18 25.05 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.592 -0.693 . . . . 0.0 109.809 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -77.94 79.7 4.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.044 -1.035 . . . . 0.0 108.927 178.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.738 HG23 ' HB2' ' A' ' 133' ' ' SER . 3.7 p -99.56 135.31 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.199 -0.938 . . . . 0.0 111.654 -178.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 23.3 m -121.61 86.86 2.65 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.962 HG21 ' CD2' ' A' ' 129' ' ' LEU . 10.8 m -89.84 -149.71 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.283 -0.886 . . . . 0.0 111.172 -178.306 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.474 ' N ' HG23 ' A' ' 74' ' ' VAL . 0.4 OUTLIER -130.68 106.38 8.44 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.534 -0.729 . . . . 0.0 110.524 -179.583 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.48 ' O ' ' HB3' ' A' ' 77' ' ' LEU . . . -110.39 158.22 18.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.378 -0.827 . . . . 0.0 109.586 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.595 HD12 ' N ' ' A' ' 78' ' ' VAL . 3.7 pp 177.79 -158.04 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.279 -0.888 . . . . 0.0 110.376 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.85 ' CG2' HD22 ' A' ' 89' ' ' LEU . 4.3 t -147.19 171.6 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.39 -0.819 . . . . 0.0 109.488 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.489 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . 175.36 -171.66 44.76 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.353 -1.403 . . . . 0.0 110.242 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.426 ' O ' ' CG ' ' A' ' 81' ' ' ASN . 2.5 tt0 -94.08 -169.63 2.12 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.429 -1.042 . . . . 0.0 110.171 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 23.2 m120 -157.21 75.2 0.8 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.308 -0.87 . . . . 0.0 109.831 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.513 ' O ' ' HB3' ' A' ' 83' ' ' ALA . . . 144.5 38.57 0.06 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.513 ' HB3' ' O ' ' A' ' 82' ' ' GLY . . . 58.96 150.91 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.232 -1.158 . . . . 0.0 110.305 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.461 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 52.1 Cg_endo -80.49 21.99 8.32 Favored 'Cis proline' 0 C--N 1.312 -1.343 0 C-N-CA 121.696 -2.21 . . . . 0.0 111.113 0.094 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.464 ' N ' ' HA ' ' A' ' 83' ' ' ALA . 43.5 m-85 60.49 123.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.01 -1.056 . . . . 0.0 110.317 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -154.86 110.77 0.46 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.8 p -89.89 142.53 27.61 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.208 -1.172 . . . . 0.0 110.333 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 1.081 HG23 HD12 ' A' ' 89' ' ' LEU . 28.8 m -119.97 -20.11 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.345 -0.847 . . . . 0.0 109.973 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 1.081 HD12 HG23 ' A' ' 88' ' ' VAL . 4.7 mp -111.97 142.18 44.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.855 . . . . 0.0 110.652 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.634 ' O ' HG23 ' A' ' 91' ' ' THR . 1.7 p30 -151.18 87.84 1.42 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.252 -0.905 . . . . 0.0 110.159 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.634 HG23 ' O ' ' A' ' 90' ' ' ASP . 1.7 p -156.74 178.66 10.09 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.933 -1.104 . . . . 0.0 110.797 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 81.5 p -119.79 127.81 26.2 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.377 -0.827 . . . . 0.0 109.886 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.805 ' HG2' HG22 ' A' ' 74' ' ' VAL . 48.9 Cg_endo -75.08 75.08 3.84 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.887 1.467 . . . . 0.0 111.192 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.521 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -52.45 124.83 14.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.922 -1.111 . . . . 0.0 109.094 179.11 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.689 HD21 ' CB ' ' A' ' 66' ' ' ALA . 38.2 mt -119.91 175.51 5.87 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.992 -1.068 . . . . 0.0 111.0 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -168.78 -178.54 3.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.521 -0.737 . . . . 0.0 109.806 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.2 p -70.26 -7.38 41.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.221 -0.924 . . . . 0.0 110.293 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.782 ' O ' HG23 ' A' ' 67' ' ' THR . 1.1 mt-10 -102.35 172.34 4.44 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.212 -0.93 . . . . 0.0 110.094 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.5 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 44.8 Cg_endo -72.5 129.0 14.16 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.014 1.534 . . . . 0.0 110.304 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.521 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.79 92.03 3.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.205 -0.934 . . . . 0.0 110.333 -179.81 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.432 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 0.0 OUTLIER -88.61 106.14 18.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.254 -0.904 . . . . 0.0 110.081 179.842 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.603 HG21 ' OH ' ' A' ' 64' ' ' TYR . 37.5 t -89.98 133.82 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.231 -0.918 . . . . 0.0 110.316 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.465 ' C ' ' CG ' ' A' ' 104' ' ' GLU . 8.3 m -150.24 112.03 4.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.286 -0.884 . . . . 0.0 110.042 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.465 ' CG ' ' C ' ' A' ' 103' ' ' THR . 32.0 mt-10 -150.7 156.13 40.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.184 -0.947 . . . . 0.0 110.354 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.839 HG22 ' OG1' ' A' ' 61' ' ' THR . 0.8 OUTLIER -106.33 134.78 48.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.331 -0.856 . . . . 0.0 110.095 179.863 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.6 ' CE1' HD11 ' A' ' 89' ' ' LEU . 55.4 p90 -136.65 157.63 46.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.215 -0.928 . . . . 0.0 110.305 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 86.4 m -89.98 91.36 8.54 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.278 -0.889 . . . . 0.0 110.041 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.68 ' HB3' ' CE2' ' A' ' 60' ' ' TYR . . . -57.36 117.08 3.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.253 -0.904 . . . . 0.0 110.381 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.45 ' HA ' ' HA2' ' A' ' 57' ' ' GLY . 11.0 p -100.21 54.93 0.9 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.227 -0.921 . . . . 0.0 110.099 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -166.38 -162.42 0.52 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.215 -0.928 . . . . 0.0 110.417 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.497 HG22 ' HD3' ' A' ' 113' ' ' PRO . 61.9 m -143.39 115.27 8.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.237 -0.914 . . . . 0.0 110.297 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.633 ' OH ' HG13 ' A' ' 88' ' ' VAL . 11.8 m-30 -114.84 80.97 6.97 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.266 -0.896 . . . . 0.0 110.08 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.497 ' HD3' HG22 ' A' ' 111' ' ' THR . 45.7 Cg_endo -73.04 -162.37 0.13 Allowed 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 124.015 1.534 . . . . 0.0 110.446 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.275 -0.891 . . . . 0.0 110.29 -179.954 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.485 ' HA ' ' HD2' ' A' ' 113' ' ' PRO . 3.7 pm0 . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 121.197 0.522 . . . . 0.0 110.465 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.564 ' HA3' ' CD1' ' A' ' 112' ' ' TYR . . . -123.62 159.08 18.28 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.336 -1.505 . . . . 0.0 109.336 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.562 ' HA ' ' CG2' ' A' ' 52' ' ' VAL . 19.6 pt20 -150.34 -159.07 0.98 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.161 -1.199 . . . . 0.0 110.687 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.748 HG21 ' HH2' ' A' ' 16' ' ' TRP . 9.8 mt -118.95 147.08 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.529 -0.732 . . . . 0.0 109.388 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.507 ' HB3' ' CD1' ' A' ' 77' ' ' LEU . . . -120.35 118.85 31.46 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.322 -0.861 . . . . 0.0 111.314 -179.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.548 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 4.6 m-85 -119.57 73.35 0.95 Allowed 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLN . . . . . 0.547 ' HA ' ' HA3' ' A' ' 46' ' ' GLY . 34.1 mt-30 -87.9 106.01 17.82 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 122.52 1.152 . . . . 0.0 112.104 -177.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.962 ' CD2' HG21 ' A' ' 74' ' ' VAL . 10.3 mt -93.47 -111.22 0.11 Allowed 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.62 ' HA3' ' N ' ' A' ' 45' ' ' VAL . . . 50.75 111.81 0.01 OUTLIER Glycine 0 N--CA 1.493 2.442 0 O-C-N 120.743 -1.223 . . . . 0.0 111.138 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 40' ' ' SER . . . 72.91 66.88 1.94 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.588 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 5.0 m-85 -148.03 -52.01 0.18 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.234 -1.157 . . . . 0.0 110.182 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.738 ' HB2' HG23 ' A' ' 72' ' ' VAL . 1.6 t -89.36 -151.78 0.23 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.086 -1.009 . . . . 0.0 110.15 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -112.09 -88.82 0.52 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.147 -0.97 . . . . 0.0 110.321 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.407 ' O ' ' C ' ' A' ' 136' ' ' ALA . 6.1 m-20 -84.07 172.65 11.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.222 -0.924 . . . . 0.0 110.273 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.504 ' N ' ' HA ' ' A' ' 38' ' ' ALA . . . -42.35 130.33 3.81 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.297 -0.877 . . . . 0.0 110.293 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 1.132 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 9.7 p90 -142.97 -165.21 2.01 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.325 -0.859 . . . . 0.0 109.648 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.526 ' O ' ' CB ' ' A' ' 68' ' ' ALA . 0.5 OUTLIER -160.04 172.72 17.0 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.834 -1.166 . . . . 0.0 111.231 -178.284 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.609 HD13 HD13 ' A' ' 129' ' ' LEU . 2.2 mp -134.35 126.58 29.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.582 -0.699 . . . . 0.0 109.326 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' CYS . . . . . . . . . . . . . 7.2 m -114.07 96.09 5.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.154 -0.966 . . . . 0.0 110.807 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.663 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 2.1 mt -89.75 -166.65 1.64 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.357 -0.839 . . . . 0.0 109.357 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.606 ' HA ' ' CD2' ' A' ' 9' ' ' PHE . 22.0 p-10 -167.93 -151.31 0.11 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.964 -1.085 . . . . 0.0 110.626 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.476 ' C ' ' CG2' ' A' ' 144' ' ' VAL . 6.5 t0 -38.82 150.89 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.641 -0.662 . . . . 0.0 110.662 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 142' ' ' ASP . 3.0 t -150.15 132.47 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.357 -0.839 . . . . 0.0 109.955 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.548 ' CB ' ' HG3' ' A' ' 6' ' ' GLU . . . -127.91 146.35 50.66 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.187 -0.946 . . . . 0.0 110.413 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.78 HD11 ' HB3' ' A' ' 60' ' ' TYR . 22.8 tp -153.81 90.72 1.4 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.323 -0.861 . . . . 0.0 110.085 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.462 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 0.4 OUTLIER -107.07 -167.02 1.22 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.249 -0.907 . . . . 0.0 110.258 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.43 ' HB3' ' CE1' ' A' ' 60' ' ' TYR . 1.2 p . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.207 -0.933 . . . . 0.0 110.25 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo . . . . . 0 N--CA 1.48 0.69 0 N-CA-C 110.085 -0.775 . . . . 0.0 110.085 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.631 HG22 ' O ' ' A' ' 51' ' ' GLY . 20.7 pt -89.96 43.63 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.19 -0.944 . . . . 0.0 110.113 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 6' ' ' GLU . . . 56.83 61.28 7.68 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 5' ' ' GLY . 1.7 mp0 57.16 -88.62 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.292 -1.122 . . . . 0.0 110.193 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 8' ' ' THR . . . 159.22 -115.34 0.65 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 7' ' ' GLY . 4.1 p 45.46 97.49 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.39 -1.065 . . . . 0.0 110.165 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.603 ' CD2' ' HB2' ' A' ' 32' ' ' LEU . 78.2 m-85 -77.62 7.62 5.41 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.479 -0.763 . . . . 0.0 109.7 179.332 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.551 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 34.4 t0 -84.15 45.06 1.06 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.419 -0.801 . . . . 0.0 110.122 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.551 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.3 OUTLIER 161.6 36.83 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.572 -0.705 . . . . 0.0 109.879 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 118.29 112.01 2.52 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.906 ' HG3' HG21 ' A' ' 27' ' ' THR . 51.0 Cg_endo -77.07 8.91 2.97 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 O-C-N 123.834 1.439 . . . . 0.0 110.93 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.509 ' HB3' ' O ' ' A' ' 13' ' ' PRO . 30.1 tp10 61.34 -89.47 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.237 -0.914 . . . . 0.0 110.464 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -149.02 19.15 1.22 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.97 ' CE2' HD22 ' A' ' 49' ' ' LEU . 23.5 m95 -62.53 125.31 23.48 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.211 -1.17 . . . . 0.0 110.324 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.855 ' O ' HG13 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -115.44 161.93 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.234 -0.916 . . . . 0.0 109.234 179.635 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.474 ' HB1' HG11 ' A' ' 34' ' ' VAL . . . -146.9 152.24 38.35 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.323 -0.861 . . . . 0.0 110.209 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.638 ' HE2' HG13 ' A' ' 48' ' ' VAL . 11.8 p90 -138.61 114.02 9.62 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.296 -0.877 . . . . 0.0 110.274 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.854 ' HA3' HG13 ' A' ' 45' ' ' VAL . . . -173.0 49.97 0.16 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.445 ' OG1' ' HG3' ' A' ' 37' ' ' PRO . 8.2 p 50.9 19.22 0.61 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.366 -1.079 . . . . 0.0 110.479 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.634 ' CB ' ' HB3' ' A' ' 35' ' ' ALA . 1.8 p30 -102.59 38.01 1.8 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.133 -0.98 . . . . 0.0 110.197 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 44.46 -153.27 0.47 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.457 ' O ' ' O ' ' A' ' 25' ' ' LEU . 46.3 Cg_endo -73.54 125.92 10.48 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.933 1.491 . . . . 0.0 110.361 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.708 HD23 ' H ' ' A' ' 25' ' ' LEU . 0.8 OUTLIER -42.87 166.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.227 -0.921 . . . . 0.0 110.11 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.486 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 0.5 OUTLIER -125.83 149.92 48.25 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.163 -0.96 . . . . 0.0 110.275 -179.815 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.906 HG21 ' HG3' ' A' ' 13' ' ' PRO . 0.7 OUTLIER -129.78 -43.78 1.22 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.249 -0.907 . . . . 0.0 110.251 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.451 ' HB3' ' O ' ' A' ' 27' ' ' THR . 4.5 t 56.35 36.28 27.26 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.31 -0.869 . . . . 0.0 110.303 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.451 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 33.2 p 42.53 33.21 0.42 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.299 -0.876 . . . . 0.0 110.3 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.516 ' CA ' ' HA ' ' A' ' 10' ' ' ASP . . . -140.51 -63.58 0.03 OUTLIER Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.432 ' HB1' ' O ' ' A' ' 141' ' ' LEU . . . -150.11 148.78 29.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.308 -1.113 . . . . 0.0 110.101 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.701 HD12 ' HB3' ' A' ' 13' ' ' PRO . 1.8 tt -88.36 115.46 25.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.116 -0.99 . . . . 0.0 109.861 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 72.8 m -121.56 137.74 54.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.193 -0.942 . . . . 0.0 110.765 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.496 ' CG2' ' HB2' ' A' ' 139' ' ' LEU . 2.7 m -110.98 143.47 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.408 -0.807 . . . . 0.0 109.215 179.102 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.634 ' HB3' ' CB ' ' A' ' 22' ' ' ASP . . . -89.43 90.04 8.13 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.167 -0.958 . . . . 0.0 111.46 -178.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.154 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 87.2 t -72.52 119.14 73.39 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.043 -1.036 . . . . 0.0 109.182 178.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.445 ' HG3' ' OG1' ' A' ' 21' ' ' THR . 42.7 Cg_endo -68.12 151.1 77.51 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.951 1.501 . . . . 0.0 111.415 -178.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.577 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -43.11 144.24 0.67 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.498 -0.751 . . . . 0.0 110.042 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 38' ' ' ALA . . . 44.46 77.73 0.09 OUTLIER Glycine 0 N--CA 1.488 2.133 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.856 ' HB2' HG21 ' A' ' 45' ' ' VAL . 0.3 OUTLIER -87.33 25.98 1.3 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.223 -1.163 . . . . 0.0 110.386 -179.703 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.559 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . . . -92.85 19.89 7.17 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 122.048 0.928 . . . . 0.0 109.606 179.374 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.569 ' HG3' ' CD2' ' A' ' 43' ' ' TYR . 25.7 pt20 -89.87 -131.34 0.09 Allowed 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.417 179.373 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.638 ' CD1' ' N ' ' A' ' 44' ' ' GLY . 12.4 p90 -37.51 -28.94 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.589 -0.695 . . . . 0.0 110.218 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.638 ' N ' ' CD1' ' A' ' 43' ' ' TYR . . . 105.45 111.3 3.59 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 179.025 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.856 HG21 ' HB2' ' A' ' 40' ' ' SER . 2.1 t -89.91 171.18 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.176 -1.19 . . . . 0.0 108.541 178.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.574 ' O ' ' CE2' ' A' ' 19' ' ' TYR . . . 160.72 155.61 7.87 Favored Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.029 -1.557 . . . . 0.0 110.478 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.855 HG13 ' O ' ' A' ' 17' ' ' VAL . 48.6 t -120.5 133.48 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.473 -1.016 . . . . 0.0 109.656 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.638 HG13 ' HE2' ' A' ' 19' ' ' TYR . 30.4 m -120.02 153.46 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.079 -1.013 . . . . 0.0 110.523 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.97 HD22 ' CE2' ' A' ' 16' ' ' TRP . 13.5 tp -140.51 87.64 2.14 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.304 -0.872 . . . . 0.0 110.197 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.509 ' HA ' ' HB3' ' A' ' 124' ' ' GLN . 23.6 m-20 -68.1 104.13 1.7 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.291 -0.881 . . . . 0.0 110.241 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.631 ' O ' HG22 ' A' ' 4' ' ' ILE . . . 154.39 74.22 0.01 OUTLIER Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.735 HG23 ' HA ' ' A' ' 124' ' ' GLN . 24.7 t -120.74 172.44 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.277 -1.131 . . . . 0.0 109.939 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.578 ' N ' HG12 ' A' ' 52' ' ' VAL . . . -134.27 77.57 1.71 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.09 -1.006 . . . . 0.0 110.941 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 1.028 HD11 HD21 ' A' ' 146' ' ' LEU . 24.9 mm -118.82 165.2 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.191 -0.943 . . . . 0.0 109.599 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.52 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 0.3 OUTLIER -158.88 126.79 5.07 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.989 -1.07 . . . . 0.0 110.888 -179.722 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.52 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 17.2 pt-20 37.29 -154.98 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.65 -0.656 . . . . 0.0 110.99 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.467 ' HA2' ' O ' ' A' ' 108' ' ' ALA . . . -81.4 81.67 1.62 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.626 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.2 m -112.44 172.34 6.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.209 -1.171 . . . . 0.0 109.943 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.57 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 0.4 OUTLIER -89.98 154.3 19.94 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.316 -0.865 . . . . 0.0 110.213 -179.894 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.626 ' CE2' HG22 ' A' ' 58' ' ' THR . 59.9 m-85 -159.69 173.47 16.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.293 -0.879 . . . . 0.0 110.238 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 27.4 m -150.11 114.52 5.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.282 -0.886 . . . . 0.0 110.081 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 14.1 tp -89.62 120.83 31.25 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.211 -0.931 . . . . 0.0 109.902 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.498 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 6.5 ttt180 -131.49 128.5 39.5 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.228 -0.92 . . . . 0.0 110.405 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.962 ' HB2' HG22 ' A' ' 144' ' ' VAL . 6.9 p90 -165.09 156.02 14.32 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.409 -0.807 . . . . 0.0 109.964 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.48 ' HB ' ' OD1' ' A' ' 142' ' ' ASP . 32.2 m -119.76 99.79 6.85 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.17 -0.956 . . . . 0.0 109.919 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.515 ' HB2' HD23 ' A' ' 141' ' ' LEU . . . -100.79 154.51 18.57 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.264 -0.897 . . . . 0.0 110.473 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.647 HG23 ' O ' ' A' ' 98' ' ' GLU . 90.6 m -150.34 136.84 18.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.362 -0.836 . . . . 0.0 110.145 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.536 ' N ' ' HB3' ' A' ' 95' ' ' LEU . . . -129.39 127.33 40.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.234 -0.916 . . . . 0.0 109.993 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 68' ' ' ALA . 0.6 OUTLIER -43.13 -26.84 0.18 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.246 -0.909 . . . . 0.0 109.66 179.809 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.583 ' CG2' ' CB ' ' A' ' 137' ' ' TRP . 3.5 t -110.5 164.08 13.06 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.482 -0.761 . . . . 0.0 109.928 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -82.79 72.04 9.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.168 -0.958 . . . . 0.0 109.038 178.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.778 HG23 ' CB ' ' A' ' 133' ' ' SER . 4.0 p -93.54 136.38 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.326 -0.859 . . . . 0.0 111.384 -178.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.541 ' O ' ' CD1' ' A' ' 132' ' ' PHE . 13.5 m -119.98 87.85 2.82 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.701 HG11 HD22 ' A' ' 129' ' ' LEU . 11.5 m -89.5 -153.18 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.249 -0.907 . . . . 0.0 110.761 -178.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.528 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 0.3 OUTLIER -127.99 135.29 49.72 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.369 -0.832 . . . . 0.0 110.476 -179.207 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.685 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -136.83 154.89 50.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.299 -0.875 . . . . 0.0 109.979 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.892 HD12 ' N ' ' A' ' 78' ' ' VAL . 4.0 pp 179.2 -149.22 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.363 -0.836 . . . . 0.0 110.099 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.892 ' N ' HD12 ' A' ' 77' ' ' LEU . 4.7 t -147.86 177.67 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.28 -0.887 . . . . 0.0 109.365 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.533 ' C ' ' CZ ' ' A' ' 112' ' ' TYR . . . -177.69 -176.55 45.81 Favored Glycine 0 N--CA 1.489 2.186 0 C-N-CA 119.22 -1.466 . . . . 0.0 110.16 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' A' ' 122' ' ' GLU . 5.0 tt0 -98.0 -151.93 0.39 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.404 -1.056 . . . . 0.0 110.193 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.489 ' HB2' ' HG2' ' A' ' 122' ' ' GLU . 10.0 m120 -161.15 61.6 0.28 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.411 -0.806 . . . . 0.0 109.681 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 83' ' ' ALA . . . 159.97 128.4 0.97 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.196 -1.561 . . . . 0.0 109.196 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.628 ' N ' ' CE1' ' A' ' 85' ' ' TYR . . . -41.73 151.34 0.32 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.319 -1.106 . . . . 0.0 110.377 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.488 ' C ' ' CD2' ' A' ' 85' ' ' TYR . 50.9 Cg_endo -79.14 10.04 22.91 Favored 'Cis proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.632 -2.237 . . . . 0.0 110.775 -0.081 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.628 ' CE1' ' N ' ' A' ' 83' ' ' ALA . 12.5 m-85 68.0 156.53 0.12 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.241 -0.912 . . . . 0.0 110.169 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -171.6 125.84 1.23 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.98 152.44 19.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.242 -1.152 . . . . 0.0 110.209 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.678 HG23 HD12 ' A' ' 89' ' ' LEU . 16.0 m -123.23 -24.94 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.287 -0.883 . . . . 0.0 110.2 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.864 HD22 HG23 ' A' ' 78' ' ' VAL . 4.2 mp -108.96 144.79 36.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.232 -0.917 . . . . 0.0 110.911 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.424 ' O ' ' CG ' ' A' ' 90' ' ' ASP . 40.2 p-10 -151.45 80.91 1.3 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.352 -0.843 . . . . 0.0 110.063 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.403 HG23 ' C ' ' A' ' 90' ' ' ASP . 44.3 p -144.01 171.74 13.84 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.959 -1.088 . . . . 0.0 110.742 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.405 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 0.7 OUTLIER -119.96 115.02 33.51 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.385 -0.822 . . . . 0.0 110.021 179.879 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.685 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 43.7 Cg_endo -70.16 155.19 65.19 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.951 1.501 . . . . 0.0 110.998 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.777 ' O ' HD23 ' A' ' 95' ' ' LEU . . . -129.92 145.39 51.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.407 -0.808 . . . . 0.0 109.573 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.777 HD23 ' O ' ' A' ' 94' ' ' ALA . 39.6 mt -134.19 173.0 12.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.07 -1.019 . . . . 0.0 110.673 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.546 HG23 ' N ' ' A' ' 97' ' ' SER . 6.0 t -171.85 -154.87 0.09 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.401 -0.812 . . . . 0.0 109.918 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.546 ' N ' HG23 ' A' ' 96' ' ' THR . 0.3 OUTLIER -90.44 28.41 1.48 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.206 -0.934 . . . . 0.0 110.143 179.893 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.647 ' O ' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -149.95 173.81 3.99 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.315 -0.866 . . . . 0.0 109.968 179.873 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.56 130.62 16.25 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.953 1.501 . . . . 0.0 110.364 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.519 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.61 87.43 2.74 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.226 -0.921 . . . . 0.0 110.042 -179.98 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.444 ' HG2' ' OG1' ' A' ' 65' ' ' THR . 0.9 OUTLIER -68.31 151.68 46.55 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.359 -0.838 . . . . 0.0 110.245 -179.903 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.925 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 65.1 t -131.49 136.31 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.228 -0.92 . . . . 0.0 110.009 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.463 ' O ' ' HG3' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -150.13 104.04 3.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.271 -0.893 . . . . 0.0 110.173 -179.937 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.463 ' HG3' ' O ' ' A' ' 103' ' ' THR . 6.7 mt-10 -145.53 132.9 20.64 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.286 -0.884 . . . . 0.0 110.166 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.441 ' O ' ' HB3' ' A' ' 106' ' ' PHE . 0.2 OUTLIER -89.92 169.82 10.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.287 -0.883 . . . . 0.0 110.12 179.918 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.649 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 42.1 p90 -177.38 150.49 0.71 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -0.923 . . . . 0.0 110.288 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.5 m -91.47 92.39 8.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.234 -0.917 . . . . 0.0 110.061 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.611 ' HB3' ' CE2' ' A' ' 60' ' ' TYR . . . -50.86 113.83 1.01 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.887 . . . . 0.0 110.227 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.59 ' H ' HG12 ' A' ' 88' ' ' VAL . 17.1 p -96.52 51.4 1.17 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.213 -0.93 . . . . 0.0 110.191 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.402 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -162.99 -166.57 1.31 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.218 -0.926 . . . . 0.0 110.18 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.606 HG22 ' HD3' ' A' ' 113' ' ' PRO . 11.2 m -134.39 112.27 10.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.218 -0.926 . . . . 0.0 110.307 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.533 ' CZ ' ' C ' ' A' ' 79' ' ' GLY . 17.9 m-30 -113.02 71.42 1.34 Allowed Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.339 -0.85 . . . . 0.0 110.001 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.606 ' HD3' HG22 ' A' ' 111' ' ' THR . 44.0 Cg_endo -72.13 -167.6 0.33 Allowed 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.932 1.49 . . . . 0.0 110.374 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.202 -0.936 . . . . 0.0 110.279 -179.895 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.494 ' HA ' ' HD2' ' A' ' 113' ' ' PRO . 5.4 pt-20 . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 121.244 0.545 . . . . 0.0 110.484 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.531 ' HA3' ' CB ' ' A' ' 112' ' ' TYR . . . -148.21 156.1 26.74 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.351 -1.499 . . . . 0.0 109.351 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.735 ' HA ' HG23 ' A' ' 52' ' ' VAL . 1.0 OUTLIER -150.52 -158.68 0.94 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.171 -1.193 . . . . 0.0 110.72 -179.644 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.692 HG21 ' HH2' ' A' ' 16' ' ' TRP . 11.4 mt -118.24 150.37 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.473 -0.767 . . . . 0.0 109.132 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -127.89 122.63 33.0 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.292 -0.88 . . . . 0.0 111.033 -179.458 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.472 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 4.9 m-85 -118.73 101.77 8.34 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.501 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLN . . . . . 0.454 ' C ' HD23 ' A' ' 129' ' ' LEU . 8.8 mm-40 -88.97 101.51 14.15 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.252 -0.905 . . . . 0.0 111.956 -177.596 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.701 HD22 HG11 ' A' ' 74' ' ' VAL . 8.8 mt -104.6 42.65 1.18 Allowed 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 178.088 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -97.45 87.3 0.87 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.575 ' O ' ' CG ' ' A' ' 132' ' ' PHE . . . 84.53 107.95 0.61 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.586 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 7.0 m-85 -167.31 -62.19 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.331 -1.099 . . . . 0.0 110.102 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.778 ' CB ' HG23 ' A' ' 72' ' ' VAL . 1.3 t -89.52 -178.84 5.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.076 -1.015 . . . . 0.0 109.912 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.426 ' N ' ' OG ' ' A' ' 133' ' ' SER . . . -100.62 -95.31 0.27 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.127 -0.983 . . . . 0.0 110.7 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -55.68 153.74 7.69 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.094 -1.004 . . . . 0.0 110.574 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.577 ' HB2' ' HB2' ' A' ' 38' ' ' ALA . . . -47.7 121.94 4.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.372 -0.83 . . . . 0.0 110.167 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 1.154 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 22.2 p90 -125.7 -157.58 0.8 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.287 -0.883 . . . . 0.0 110.044 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.543 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 0.5 OUTLIER -160.33 169.53 22.95 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.104 -0.997 . . . . 0.0 110.62 -178.844 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.6 HD13 HD13 ' A' ' 129' ' ' LEU . 2.4 mp -121.8 159.5 26.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.334 -0.854 . . . . 0.0 109.322 179.367 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' CYS . . . . . . . . . . . . . 2.0 m -150.61 92.22 1.82 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.041 -1.037 . . . . 0.0 110.931 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.515 HD23 ' HB2' ' A' ' 66' ' ' ALA . 1.2 mt -90.01 -178.36 5.43 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.227 -0.92 . . . . 0.0 109.316 179.068 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.52 ' O ' ' CB ' ' A' ' 143' ' ' ASP . 2.0 p30 167.19 47.88 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.276 -0.89 . . . . 0.0 110.423 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.52 ' CB ' ' O ' ' A' ' 142' ' ' ASP . 0.4 OUTLIER 166.64 40.41 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.26 -0.9 . . . . 0.0 109.84 179.961 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.962 HG22 ' HB2' ' A' ' 64' ' ' TYR . 25.9 t -89.26 111.55 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.302 -0.874 . . . . 0.0 110.259 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.414 ' HA ' ' O ' ' A' ' 6' ' ' GLU . . . -137.33 165.47 26.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.337 -0.852 . . . . 0.0 110.237 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 1.028 HD21 HD11 ' A' ' 54' ' ' ILE . 10.5 tp -151.8 139.58 19.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.249 -0.907 . . . . 0.0 110.181 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.489 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -155.06 152.89 30.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.188 -0.945 . . . . 0.0 110.268 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.489 ' HB3' ' CE1' ' A' ' 60' ' ' TYR . 3.0 p . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.291 -0.881 . . . . 0.0 110.191 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo . . . . . 0 N--CA 1.483 0.897 0 N-CA-C 110.579 -0.585 . . . . 0.0 110.579 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.418 ' O ' HG13 ' A' ' 4' ' ' ILE . 11.4 pt -113.46 32.33 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.223 -0.923 . . . . 0.0 110.096 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.526 ' O ' ' CG ' ' A' ' 6' ' ' GLU . . . 95.44 -31.52 7.04 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.526 ' CG ' ' O ' ' A' ' 5' ' ' GLY . 9.0 pt-20 38.32 35.89 0.11 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.671 -0.899 . . . . 0.0 110.522 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' A' ' 143' ' ' ASP . . . -136.16 -160.92 8.97 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.81 HG22 ' HB2' ' A' ' 143' ' ' ASP . 40.4 p -105.53 51.53 0.75 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.294 -1.121 . . . . 0.0 110.322 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.485 ' CE1' ' CD1' ' A' ' 16' ' ' TRP . 16.5 m-85 42.71 28.87 0.14 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.306 -0.871 . . . . 0.0 110.228 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.554 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 4.5 p-10 -86.22 52.25 2.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.271 -0.893 . . . . 0.0 110.062 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.554 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 1.0 OUTLIER 161.7 37.05 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.68 -0.637 . . . . 0.0 109.901 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.99 148.43 12.11 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.568 ' HB3' HD12 ' A' ' 32' ' ' LEU . 49.6 Cg_endo -76.12 6.6 3.76 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 124.035 1.545 . . . . 0.0 110.902 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.501 ' HB3' ' O ' ' A' ' 13' ' ' PRO . 2.6 tm-20 59.26 -89.27 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.206 -0.934 . . . . 0.0 110.406 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.513 ' O ' HD12 ' A' ' 49' ' ' LEU . . . -144.22 30.66 1.87 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 1.002 ' CE2' HD22 ' A' ' 49' ' ' LEU . 52.7 m95 -85.93 124.72 32.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.215 -1.168 . . . . 0.0 110.554 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.854 ' O ' HG13 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -114.2 160.94 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.309 -0.87 . . . . 0.0 108.884 179.44 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.469 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . . . -147.12 126.1 12.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.112 -0.993 . . . . 0.0 110.297 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.626 ' HE2' HG13 ' A' ' 48' ' ' VAL . 17.5 p90 -104.94 170.59 7.78 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.486 -0.759 . . . . 0.0 110.26 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 1.064 ' HA3' HG13 ' A' ' 45' ' ' VAL . . . 115.44 35.09 1.34 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.1 p 51.13 17.75 0.5 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.682 -0.893 . . . . 0.0 111.005 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.702 ' HB3' ' HB3' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -152.68 77.6 1.18 Allowed 'General case' 0 C--N 1.306 -1.291 0 O-C-N 120.975 -1.078 . . . . 0.0 109.049 179.265 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.593 ' N ' ' CD ' ' A' ' 24' ' ' PRO . . . -118.54 43.97 1.5 Allowed Glycine 0 N--CA 1.489 2.171 0 C-N-CA 119.451 -1.357 . . . . 0.0 110.72 -179.108 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 23' ' ' GLY . 50.5 Cg_endo -75.39 76.62 3.49 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.668 1.352 . . . . 0.0 109.649 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 1.036 ' CD2' HG12 ' A' ' 34' ' ' VAL . 14.8 mt -68.16 84.6 0.24 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.182 -0.949 . . . . 0.0 110.46 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.469 ' O ' ' O ' ' A' ' 31' ' ' ALA . 0.2 OUTLIER -74.81 113.12 11.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.165 -0.959 . . . . 0.0 109.085 179.314 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.417 ' O ' ' C ' ' A' ' 28' ' ' SER . 1.4 p -119.6 -29.08 5.15 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.061 -1.024 . . . . 0.0 111.196 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 27' ' ' THR . 33.2 p -45.04 -27.92 0.63 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.948 -1.095 . . . . 0.0 108.619 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.613 HG23 ' H ' ' A' ' 31' ' ' ALA . 5.5 t -70.4 -45.78 65.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.868 -0.52 . . . . 0.0 110.751 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.574 ' N ' HG23 ' A' ' 29' ' ' THR . . . 138.04 3.42 1.97 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.613 ' H ' HG23 ' A' ' 29' ' ' THR . . . -150.38 130.91 13.89 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.98 -1.306 . . . . 0.0 110.021 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.797 HD11 HD13 ' A' ' 25' ' ' LEU . 0.9 OUTLIER -67.23 110.33 3.45 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.996 -1.065 . . . . 0.0 109.543 179.754 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.452 ' O ' ' O ' ' A' ' 24' ' ' PRO . 2.9 m -109.39 106.59 16.43 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.091 -1.006 . . . . 0.0 111.164 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 1.036 HG12 ' CD2' ' A' ' 25' ' ' LEU . 36.0 m -89.81 173.6 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.702 ' HB3' ' HB3' ' A' ' 22' ' ' ASP . . . -122.75 152.78 40.28 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.574 -1.329 . . . . 0.0 111.685 -178.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.886 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 10.6 t -137.88 111.28 8.74 Favored Pre-proline 0 C--N 1.303 -1.446 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.579 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.437 ' O ' ' O ' ' A' ' 38' ' ' ALA . 44.3 Cg_endo -73.75 141.99 31.47 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.011 1.532 . . . . 0.0 111.185 -178.355 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.83 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -42.35 164.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.504 -0.747 . . . . 0.0 109.834 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 51.22 50.12 41.34 Favored Glycine 0 N--CA 1.485 1.949 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.652 ' OG ' HG23 ' A' ' 45' ' ' VAL . 1.6 t -86.88 35.92 0.7 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.228 -1.16 . . . . 0.0 109.803 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.529 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . -87.44 -139.87 0.1 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.475 -0.766 . . . . 0.0 109.414 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.542 ' HG2' ' N ' ' A' ' 43' ' ' TYR . 0.0 OUTLIER 42.03 -142.29 0.09 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.476 -0.765 . . . . 0.0 110.066 -179.491 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.583 ' CE1' ' O ' ' A' ' 44' ' ' GLY . 5.8 p90 -31.39 -39.27 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.198 0 CA-C-O 121.354 0.597 . . . . 0.0 110.292 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.583 ' O ' ' CE1' ' A' ' 43' ' ' TYR . . . 88.82 137.32 6.01 Favored Glycine 0 N--CA 1.49 2.283 0 C-N-CA 120.227 -0.987 . . . . 0.0 111.128 177.66 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 1.064 HG13 ' HA3' ' A' ' 20' ' ' GLY . 4.0 t -89.75 167.91 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.616 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.511 ' C ' ' CZ ' ' A' ' 19' ' ' TYR . . . 168.11 162.19 19.54 Favored Glycine 0 N--CA 1.49 2.298 0 C-N-CA 118.51 -1.805 . . . . 0.0 111.056 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.854 HG13 ' O ' ' A' ' 17' ' ' VAL . 44.6 t -114.54 157.69 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.74 -0.859 . . . . 0.0 109.793 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.626 HG13 ' HE2' ' A' ' 19' ' ' TYR . 3.7 m -143.5 150.55 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.076 -1.015 . . . . 0.0 110.08 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 1.002 HD22 ' CE2' ' A' ' 16' ' ' TRP . 19.4 tp -138.47 89.89 2.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.199 -0.938 . . . . 0.0 110.417 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.526 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 40.9 t30 -73.04 132.79 43.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.294 -0.879 . . . . 0.0 110.151 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 124.0 60.52 0.19 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.576 HG12 ' N ' ' A' ' 53' ' ' ALA . 40.3 t -119.94 172.07 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.233 -1.157 . . . . 0.0 110.101 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.576 ' N ' HG12 ' A' ' 52' ' ' VAL . . . -137.88 102.01 4.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.235 -0.915 . . . . 0.0 110.389 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.909 HD11 HD21 ' A' ' 146' ' ' LEU . 42.3 mm -131.65 49.59 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.291 -0.881 . . . . 0.0 109.936 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.557 ' O ' ' HB3' ' A' ' 56' ' ' GLU . 0.3 OUTLIER -72.16 139.95 48.54 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.408 -0.807 . . . . 0.0 111.072 -179.571 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.557 ' HB3' ' O ' ' A' ' 55' ' ' GLU . 6.6 tm-20 73.12 178.12 0.24 Allowed 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 121.968 0.89 . . . . 0.0 111.907 178.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.565 ' HA2' ' HA ' ' A' ' 109' ' ' SER . . . -103.04 89.54 0.72 Allowed Glycine 0 N--CA 1.487 2.047 0 N-CA-C 107.764 -2.135 . . . . 0.0 107.764 178.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . 1.027 HG22 ' CE1' ' A' ' 60' ' ' TYR . 0.4 OUTLIER -120.19 -165.53 1.2 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.41 -1.053 . . . . 0.0 110.641 -178.486 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.768 ' N ' HG23 ' A' ' 58' ' ' THR . 8.2 m -103.49 86.3 2.62 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.413 -0.804 . . . . 0.0 110.372 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 1.027 ' CE1' HG22 ' A' ' 58' ' ' THR . 96.1 m-85 -85.84 116.19 23.93 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.147 -0.971 . . . . 0.0 109.905 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 38.9 m -89.89 114.76 26.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.211 -0.931 . . . . 0.0 110.154 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.446 HD22 ' CD2' ' A' ' 89' ' ' LEU . 18.2 tp -89.71 121.47 31.9 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.185 -0.947 . . . . 0.0 110.002 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.631 ' HG2' HG22 ' A' ' 103' ' ' THR . 48.3 mtp180 -122.67 121.73 37.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.297 -0.877 . . . . 0.0 110.142 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.538 ' CE2' HG11 ' A' ' 102' ' ' VAL . 0.7 OUTLIER -159.57 141.57 13.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.285 -0.884 . . . . 0.0 109.906 179.784 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.501 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 89.9 m -119.18 97.04 5.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.279 -0.888 . . . . 0.0 109.674 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.8 ' CB ' HD21 ' A' ' 95' ' ' LEU . . . -97.14 154.02 17.62 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.476 -0.765 . . . . 0.0 110.554 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.83 HG23 ' O ' ' A' ' 98' ' ' GLU . 96.9 m -150.34 122.02 8.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.369 -0.832 . . . . 0.0 110.101 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -108.3 142.9 37.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.244 -0.91 . . . . 0.0 109.945 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.12 -22.01 2.26 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.154 -0.966 . . . . 0.0 109.138 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.599 HG22 ' HB2' ' A' ' 137' ' ' TRP . 3.4 t -119.27 166.92 12.39 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.563 -0.71 . . . . 0.0 109.835 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.439 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 0.9 OUTLIER -82.38 73.54 9.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.047 -1.033 . . . . 0.0 109.114 178.925 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.714 HG23 ' HB2' ' A' ' 133' ' ' SER . 5.4 p -98.06 145.04 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.303 -0.873 . . . . 0.0 111.348 -178.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.534 HG22 ' HB3' ' A' ' 92' ' ' SER . 19.8 m -128.69 91.12 3.17 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 178.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.969 HG21 ' CD2' ' A' ' 129' ' ' LEU . 3.3 m -89.67 -148.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.203 -0.935 . . . . 0.0 110.766 -178.764 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.586 ' N ' HG23 ' A' ' 74' ' ' VAL . 0.1 OUTLIER -121.97 118.3 28.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.194 -0.941 . . . . 0.0 110.82 -179.437 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.686 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -122.98 147.92 46.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.204 -0.935 . . . . 0.0 109.681 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.728 HD12 ' N ' ' A' ' 78' ' ' VAL . 3.5 pp 178.92 -148.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.296 -0.878 . . . . 0.0 110.08 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.829 HG23 HD22 ' A' ' 89' ' ' LEU . 2.5 t -147.85 171.07 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.194 -0.941 . . . . 0.0 108.902 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.489 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . -172.24 -178.5 42.48 Favored Glycine 0 N--CA 1.489 2.183 0 C-N-CA 119.169 -1.491 . . . . 0.0 110.183 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.422 ' O ' ' OD1' ' A' ' 81' ' ' ASN . 8.1 tt0 -92.28 -148.99 0.24 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.49 -1.006 . . . . 0.0 110.192 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.481 ' HB3' ' OE2' ' A' ' 122' ' ' GLU . 5.8 m120 -164.38 64.22 0.14 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.523 -0.736 . . . . 0.0 109.574 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.433 ' O ' ' C ' ' A' ' 83' ' ' ALA . . . 134.91 147.25 5.5 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.629 ' N ' ' CE1' ' A' ' 85' ' ' TYR . . . -41.25 151.62 0.28 Allowed Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.33 -1.1 . . . . 0.0 110.375 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.46 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.3 Cg_endo -80.16 12.48 23.23 Favored 'Cis proline' 0 C--N 1.312 -1.353 0 C-N-CA 121.659 -2.226 . . . . 0.0 110.884 -0.07 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.629 ' CE1' ' N ' ' A' ' 83' ' ' ALA . 26.4 m-85 63.2 150.63 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.16 -0.963 . . . . 0.0 110.194 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 175.97 131.49 1.47 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.59 155.15 21.79 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.299 -1.118 . . . . 0.0 110.104 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.982 HG23 HD12 ' A' ' 89' ' ' LEU . 33.2 m -125.4 -22.0 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.257 -0.902 . . . . 0.0 110.447 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.982 HD12 HG23 ' A' ' 88' ' ' VAL . 3.7 mp -111.72 144.16 41.46 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.111 -0.993 . . . . 0.0 111.023 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.57 ' O ' HG23 ' A' ' 91' ' ' THR . 29.5 t0 -150.98 85.83 1.36 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.434 -0.791 . . . . 0.0 110.206 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.57 HG23 ' O ' ' A' ' 90' ' ' ASP . 2.6 p -155.04 -177.31 6.44 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.053 -1.029 . . . . 0.0 110.581 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.534 ' HB3' HG22 ' A' ' 73' ' ' THR . 3.7 m -123.64 134.16 25.1 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.346 -0.847 . . . . 0.0 109.978 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.789 ' HG2' HG22 ' A' ' 74' ' ' VAL . 51.6 Cg_endo -78.31 79.81 3.19 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.871 1.458 . . . . 0.0 110.877 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.527 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -49.26 134.51 18.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.939 -1.101 . . . . 0.0 109.159 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.8 HD21 ' CB ' ' A' ' 66' ' ' ALA . 27.6 mt -131.44 170.64 14.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.052 -1.03 . . . . 0.0 110.89 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.487 ' CG2' ' HG3' ' A' ' 100' ' ' ARG . 0.2 OUTLIER -170.99 -178.69 2.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.445 -0.784 . . . . 0.0 109.942 179.972 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.84 -6.37 26.58 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.278 -0.888 . . . . 0.0 110.244 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.83 ' O ' HG23 ' A' ' 67' ' ' THR . 0.6 OUTLIER -110.52 174.58 2.3 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.243 -0.911 . . . . 0.0 110.1 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.51 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 45.0 Cg_endo -72.31 128.02 13.28 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.026 1.54 . . . . 0.0 110.294 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.527 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 1.2 mtt-85 -119.76 92.17 3.72 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.152 -0.968 . . . . 0.0 110.4 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.455 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 38.9 tt0 -75.1 154.11 37.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.364 -0.835 . . . . 0.0 109.978 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.538 HG11 ' CE2' ' A' ' 64' ' ' TYR . 74.4 t -139.5 133.72 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.166 -0.958 . . . . 0.0 110.354 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.631 HG22 ' HG2' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -150.15 118.99 6.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.283 -0.886 . . . . 0.0 110.083 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -140.6 153.13 45.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.204 -0.935 . . . . 0.0 110.361 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.548 HG22 ' CG2' ' A' ' 59' ' ' THR . 8.4 m -109.5 70.79 0.74 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.289 -0.882 . . . . 0.0 110.116 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.879 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 40.0 p90 -84.82 146.62 27.24 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.306 -0.871 . . . . 0.0 110.144 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 58' ' ' THR . 5.6 m -89.94 102.65 15.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -0.93 . . . . 0.0 109.987 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 1.002 ' HB3' ' CD1' ' A' ' 60' ' ' TYR . . . -70.04 95.78 0.99 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.155 -0.966 . . . . 0.0 110.388 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.565 ' HA ' ' HA2' ' A' ' 57' ' ' GLY . 8.2 p -85.88 59.63 5.75 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.675 -0.64 . . . . 0.0 109.512 179.321 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.461 ' HB3' HG11 ' A' ' 88' ' ' VAL . . . -155.27 -156.24 0.64 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.12 -0.987 . . . . 0.0 110.835 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.974 HG22 ' HD3' ' A' ' 113' ' ' PRO . 46.6 m -147.42 108.05 4.14 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.373 -0.829 . . . . 0.0 110.87 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.584 ' CE2' HG12 ' A' ' 78' ' ' VAL . 16.4 m-30 -110.04 74.17 0.77 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.396 -0.815 . . . . 0.0 109.642 179.24 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.974 ' HD3' HG22 ' A' ' 111' ' ' THR . 43.7 Cg_endo -71.65 -159.08 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.908 1.478 . . . . 0.0 110.41 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.271 -0.893 . . . . 0.0 110.247 -179.824 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.481 ' OE2' ' HB3' ' A' ' 81' ' ' ASN . 22.5 pm0 . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 121.107 0.479 . . . . 0.0 110.219 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.514 ' HA3' ' CB ' ' A' ' 112' ' ' TYR . . . -151.36 150.8 22.79 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.569 ' HA ' ' CG2' ' A' ' 52' ' ' VAL . 3.0 pt20 -150.35 -153.34 0.48 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.269 -1.136 . . . . 0.0 110.394 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.449 ' HB ' ' HB3' ' A' ' 49' ' ' LEU . 7.5 mt -118.45 144.86 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.419 -0.801 . . . . 0.0 109.379 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.409 ' HB3' HD11 ' A' ' 77' ' ' LEU . . . -122.11 121.1 36.14 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.228 -0.92 . . . . 0.0 111.04 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.48 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 5.1 m-85 -119.42 97.19 5.53 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLN . . . . . 0.49 ' O ' ' HB ' ' A' ' 74' ' ' VAL . 2.5 mt-30 -88.95 89.1 7.84 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.245 -0.91 . . . . 0.0 111.149 -178.387 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.986 HD13 HD13 ' A' ' 139' ' ' LEU . 16.0 mt -87.61 51.55 2.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.571 -0.705 . . . . 0.0 109.274 178.738 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.53 ' O ' ' CD2' ' A' ' 132' ' ' PHE . . . -127.68 151.0 18.42 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 51.81 63.55 4.65 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.622 ' CE1' ' HA ' ' A' ' 74' ' ' VAL . 15.5 m-85 -148.06 -78.79 0.15 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.243 -1.151 . . . . 0.0 110.25 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.714 ' HB2' HG23 ' A' ' 72' ' ' VAL . 2.3 t -89.59 144.58 25.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.058 -1.026 . . . . 0.0 110.055 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -81.87 -84.45 0.11 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.289 -0.882 . . . . 0.0 110.357 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -42.54 154.92 0.05 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.247 -0.908 . . . . 0.0 110.293 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.83 ' HB2' ' HB2' ' A' ' 38' ' ' ALA . . . -57.59 124.28 18.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.279 -0.888 . . . . 0.0 110.214 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.886 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 6.0 p90 -131.23 -167.49 1.86 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.279 -0.888 . . . . 0.0 110.236 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.542 ' CG2' ' N ' ' A' ' 139' ' ' LEU . 0.8 OUTLIER -160.81 178.75 9.12 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.31 -0.956 . . . . 0.0 110.532 -178.255 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.986 HD13 HD13 ' A' ' 129' ' ' LEU . 2.2 mp -133.96 155.6 49.65 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.388 -0.82 . . . . 0.0 110.062 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' CYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 33' ' ' CYS . 11.1 m -150.12 97.88 2.62 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.173 -0.954 . . . . 0.0 110.724 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.518 HD23 ' HB2' ' A' ' 66' ' ' ALA . 1.1 mt -89.62 -177.09 5.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.299 -0.876 . . . . 0.0 109.518 179.288 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.567 ' HB3' ' CB ' ' A' ' 31' ' ' ALA . 0.6 OUTLIER 172.33 44.21 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.186 -0.946 . . . . 0.0 110.999 179.926 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.81 ' HB2' HG22 ' A' ' 8' ' ' THR . 5.8 t0 171.85 69.81 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.309 -0.87 . . . . 0.0 109.592 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.828 HG11 ' HZ2' ' A' ' 16' ' ' TRP . 1.9 t -106.64 122.28 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.129 -0.982 . . . . 0.0 110.412 -179.412 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -151.81 150.93 30.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.344 -0.847 . . . . 0.0 110.067 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.966 HD11 ' HB3' ' A' ' 60' ' ' TYR . 22.3 tp -138.49 158.83 43.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.288 -0.882 . . . . 0.0 110.29 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.512 ' N ' ' HG ' ' A' ' 146' ' ' LEU . 0.4 OUTLIER -163.25 -157.33 0.42 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.213 -0.929 . . . . 0.0 110.278 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.686 ' HB2' HG21 ' A' ' 58' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.679 0 O-C-N 121.215 -0.928 . . . . 0.0 110.136 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo . . . . . 0 N--CA 1.48 0.712 0 N-CA-C 110.01 -0.804 . . . . 0.0 110.01 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.0 pt -94.5 -8.78 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.197 -0.939 . . . . 0.0 110.167 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 69.75 156.24 1.39 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -72.23 83.12 1.02 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.223 -1.163 . . . . 0.0 110.152 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -86.76 127.41 8.38 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.457 ' O ' ' HB2' ' A' ' 9' ' ' PHE . 2.1 p -77.31 2.87 14.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.222 -1.164 . . . . 0.0 110.236 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.59 ' CD2' ' HB2' ' A' ' 32' ' ' LEU . 3.3 m-85 56.41 16.7 2.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.253 -0.904 . . . . 0.0 110.204 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.547 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 18.3 p-10 -98.41 14.03 29.53 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.234 -0.916 . . . . 0.0 110.391 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.547 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 2.2 t70 161.68 80.63 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.79 -0.569 . . . . 0.0 109.544 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.22 82.49 1.65 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.916 ' HG3' HG21 ' A' ' 27' ' ' THR . 51.2 Cg_endo -81.31 43.14 1.47 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.073 1.565 . . . . 0.0 110.668 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.455 ' HB3' ' O ' ' A' ' 13' ' ' PRO . 36.2 tp10 56.9 -91.27 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.137 -0.977 . . . . 0.0 110.206 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.502 ' C ' HD13 ' A' ' 49' ' ' LEU . . . -152.75 32.63 0.82 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.888 ' CE2' HD22 ' A' ' 49' ' ' LEU . 59.5 m95 -71.19 86.71 0.78 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.23 -1.159 . . . . 0.0 110.267 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.838 ' O ' HG13 ' A' ' 47' ' ' VAL . 1.4 m -82.26 147.92 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.224 -0.922 . . . . 0.0 109.781 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.589 ' CB ' ' CG1' ' A' ' 34' ' ' VAL . . . -134.12 119.51 18.97 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.178 -0.951 . . . . 0.0 109.978 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.668 ' HE2' HG13 ' A' ' 48' ' ' VAL . 16.9 p90 -108.56 138.03 45.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.469 -0.77 . . . . 0.0 110.411 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.92 ' HA3' HG13 ' A' ' 45' ' ' VAL . . . 160.82 45.48 0.02 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.515 HG23 ' OH ' ' A' ' 43' ' ' TYR . 9.6 p 50.84 19.16 0.59 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.442 -1.034 . . . . 0.0 110.733 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.925 ' HB2' ' HB3' ' A' ' 35' ' ' ALA . 3.0 p30 -97.88 38.51 1.29 Allowed 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.069 -1.019 . . . . 0.0 110.031 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 45.94 -156.54 0.45 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.436 ' O ' ' C ' ' A' ' 25' ' ' LEU . 46.5 Cg_endo -73.72 125.63 10.16 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 123.939 1.494 . . . . 0.0 110.35 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.718 HD23 ' H ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -42.26 133.02 3.26 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.277 -0.889 . . . . 0.0 110.015 179.887 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.07 116.23 28.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.144 -0.972 . . . . 0.0 110.054 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.916 HG21 ' HG3' ' A' ' 13' ' ' PRO . 0.9 OUTLIER -119.88 -28.71 5.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.167 -0.958 . . . . 0.0 110.34 -179.76 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.45 ' O ' ' HB ' ' A' ' 29' ' ' THR . 0.3 OUTLIER -48.91 83.13 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.838 -0.539 . . . . 0.0 111.254 -179.957 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.62 HG22 ' O ' ' A' ' 27' ' ' THR . 0.8 OUTLIER 175.97 -28.93 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.017 -1.052 . . . . 0.0 110.309 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.526 ' HA2' ' CB ' ' A' ' 10' ' ' ASP . . . 133.73 -7.05 4.87 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.706 -1.357 . . . . 0.0 109.706 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.548 ' HA ' ' HB3' ' A' ' 9' ' ' PHE . . . -150.3 172.46 15.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.149 -1.207 . . . . 0.0 110.329 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.684 HD12 ' CG2' ' A' ' 27' ' ' THR . 0.6 OUTLIER -103.97 94.73 5.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.274 -0.891 . . . . 0.0 109.769 179.736 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 65.5 m -100.09 115.61 30.17 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.295 -0.878 . . . . 0.0 111.002 -179.288 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.589 ' CG1' ' CB ' ' A' ' 18' ' ' ALA . 15.1 m -96.11 157.17 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.319 -0.863 . . . . 0.0 109.231 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.925 ' HB3' ' HB2' ' A' ' 22' ' ' ASP . . . -102.26 89.23 3.51 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.269 -0.894 . . . . 0.0 111.635 -178.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.037 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 76.3 t -74.71 119.21 75.58 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 120.976 -1.077 . . . . 0.0 109.192 178.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.426 ' O ' ' C ' ' A' ' 38' ' ' ALA . 42.7 Cg_endo -69.17 144.79 58.4 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.865 1.455 . . . . 0.0 111.226 -179.095 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.519 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -42.11 147.83 0.22 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.462 -0.774 . . . . 0.0 110.109 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.459 ' O ' ' OE1' ' A' ' 42' ' ' GLN . . . 44.52 70.64 0.56 Allowed Glycine 0 N--CA 1.488 2.132 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.987 ' OG ' HG21 ' A' ' 45' ' ' VAL . 0.5 OUTLIER -87.01 29.72 0.8 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.31 -1.112 . . . . 0.0 110.44 -179.636 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.501 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . . . -91.38 19.99 5.61 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.926 0.869 . . . . 0.0 109.739 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.614 ' HG3' ' CD2' ' A' ' 43' ' ' TYR . 0.5 OUTLIER -84.44 -135.65 0.05 Allowed 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.527 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.646 ' CD1' ' N ' ' A' ' 44' ' ' GLY . 8.3 p90 -38.9 -27.39 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.379 -0.826 . . . . 0.0 110.417 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.646 ' N ' ' CD1' ' A' ' 43' ' ' TYR . . . 111.04 106.92 2.96 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.987 HG21 ' OG ' ' A' ' 40' ' ' SER . 2.9 t -90.09 153.83 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.231 -1.159 . . . . 0.0 108.73 179.175 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.542 ' C ' ' CZ ' ' A' ' 19' ' ' TYR . . . 176.75 169.51 38.16 Favored Glycine 0 N--CA 1.49 2.26 0 C-N-CA 119.221 -1.466 . . . . 0.0 110.218 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.838 HG13 ' O ' ' A' ' 17' ' ' VAL . 48.8 t -128.19 144.03 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.412 -1.052 . . . . 0.0 109.901 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.674 ' O ' HG22 ' A' ' 17' ' ' VAL . 34.0 m -135.55 147.69 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.039 -1.038 . . . . 0.0 110.419 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.888 HD22 ' CE2' ' A' ' 16' ' ' TRP . 22.8 tp -135.82 109.85 8.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.251 -0.906 . . . . 0.0 110.308 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.509 ' HA ' ' HB3' ' A' ' 124' ' ' GLN . 2.4 p-10 -84.33 121.71 27.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.224 -0.922 . . . . 0.0 110.269 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 139.92 79.43 0.06 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.574 HG12 HG12 ' A' ' 54' ' ' ILE . 54.0 t -131.36 150.44 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.197 -1.178 . . . . 0.0 110.198 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -117.34 92.58 3.89 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.224 -0.922 . . . . 0.0 110.238 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.817 HD11 HD21 ' A' ' 146' ' ' LEU . 14.6 mm -136.37 169.33 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.237 -0.914 . . . . 0.0 110.065 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.513 ' O ' ' HB3' ' A' ' 56' ' ' GLU . 2.2 pt-20 179.05 139.54 0.1 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.24 -0.912 . . . . 0.0 110.361 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.513 ' HB3' ' O ' ' A' ' 55' ' ' GLU . 3.9 tt0 64.23 -179.67 0.17 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.512 -0.742 . . . . 0.0 110.759 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' A' ' 109' ' ' SER . . . -92.42 70.98 1.63 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.624 -1.791 . . . . 0.0 108.624 179.397 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.711 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.0 OUTLIER -105.9 176.81 5.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.532 -0.981 . . . . 0.0 110.087 -179.281 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.577 ' N ' ' CG2' ' A' ' 58' ' ' THR . 0.7 OUTLIER -89.57 156.4 18.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.304 -0.872 . . . . 0.0 110.436 -179.69 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.903 ' HB3' HD11 ' A' ' 146' ' ' LEU . 68.2 m-85 -156.45 118.08 3.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.448 -0.782 . . . . 0.0 109.625 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 104' ' ' GLU . 10.0 m -89.94 112.03 23.29 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.209 -0.932 . . . . 0.0 110.646 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 21.7 tp -90.21 140.0 30.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.346 -0.846 . . . . 0.0 109.66 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.771 ' HG2' HG23 ' A' ' 103' ' ' THR . 27.1 mtt180 -136.92 105.68 5.87 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.146 -0.971 . . . . 0.0 110.722 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.528 ' C ' ' CD1' ' A' ' 64' ' ' TYR . 3.5 p90 -140.18 151.67 45.42 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.33 -0.856 . . . . 0.0 109.676 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.523 HG22 ' O ' ' A' ' 65' ' ' THR . 4.2 m -119.62 92.04 3.69 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.095 -1.003 . . . . 0.0 110.114 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.883 ' HB1' HD21 ' A' ' 95' ' ' LEU . . . -89.44 145.51 25.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.302 -0.874 . . . . 0.0 110.17 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.653 HG23 ' O ' ' A' ' 98' ' ' GLU . 53.4 m -150.72 104.87 3.23 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.316 -0.865 . . . . 0.0 110.492 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.528 ' HB2' HD13 ' A' ' 95' ' ' LEU . . . -95.93 132.38 41.29 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.165 -0.96 . . . . 0.0 109.854 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 68' ' ' ALA . 20.0 m -43.54 -26.78 0.24 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.219 -0.926 . . . . 0.0 109.435 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.631 HG22 ' HB2' ' A' ' 137' ' ' TRP . 3.0 t -112.74 167.63 10.33 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.563 -0.711 . . . . 0.0 109.838 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.505 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 32.9 t0 -84.29 69.36 10.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.104 -0.997 . . . . 0.0 109.224 178.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.795 HG23 ' CB ' ' A' ' 133' ' ' SER . 3.8 p -92.0 140.08 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.331 -0.856 . . . . 0.0 111.318 -178.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.474 ' O ' ' CD1' ' A' ' 132' ' ' PHE . 98.3 m -126.46 91.94 3.46 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 1.021 HG21 ' CD2' ' A' ' 129' ' ' LEU . 3.2 m -89.79 -159.34 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.18 -0.95 . . . . 0.0 110.715 -178.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.437 ' N ' HG23 ' A' ' 74' ' ' VAL . 0.3 OUTLIER -119.16 106.61 12.54 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.284 -0.885 . . . . 0.0 110.394 -179.519 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.492 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -113.08 165.14 12.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.906 . . . . 0.0 110.194 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.556 ' HA ' ' HB3' ' A' ' 89' ' ' LEU . 3.1 pp 176.93 -159.7 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.363 -0.836 . . . . 0.0 110.12 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.784 ' CG2' HD22 ' A' ' 89' ' ' LEU . 3.4 t -149.26 155.61 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.26 -0.9 . . . . 0.0 109.718 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.575 ' O ' ' CE2' ' A' ' 112' ' ' TYR . . . -172.43 -178.2 42.41 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.429 -1.367 . . . . 0.0 110.258 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.484 ' HG2' ' O ' ' A' ' 111' ' ' THR . 0.0 OUTLIER -93.42 128.34 39.44 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.434 -1.039 . . . . 0.0 110.697 -179.726 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.499 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 1.4 m-80 -96.64 75.49 2.8 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.192 -0.943 . . . . 0.0 109.557 179.082 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.586 ' O ' ' HB2' ' A' ' 83' ' ' ALA . . . -166.07 -90.48 0.08 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.586 ' HB2' ' O ' ' A' ' 82' ' ' GLY . . . 175.84 136.49 0.19 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.345 -1.091 . . . . 0.0 109.923 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.535 ' C ' ' CD2' ' A' ' 85' ' ' TYR . 52.3 Cg_endo -83.84 33.2 3.61 Favored 'Cis proline' 0 C--N 1.314 -1.271 0 C-N-CA 122.096 -2.044 . . . . 0.0 110.84 -0.158 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.579 ' CE1' ' O ' ' A' ' 82' ' ' GLY . 18.7 m-85 65.24 166.03 0.17 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.229 -0.919 . . . . 0.0 110.449 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.496 ' O ' ' CA ' ' A' ' 79' ' ' GLY . . . -163.4 171.11 39.02 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.57 133.67 21.52 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.099 -1.236 . . . . 0.0 110.507 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 1.088 HG23 HD12 ' A' ' 89' ' ' LEU . 12.4 m -119.8 -10.49 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.326 -0.859 . . . . 0.0 109.732 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 1.088 HD12 HG23 ' A' ' 88' ' ' VAL . 4.5 mp -123.5 143.49 50.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.418 -0.801 . . . . 0.0 110.816 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.715 ' O ' HG23 ' A' ' 91' ' ' THR . 0.7 OUTLIER -150.62 83.69 1.35 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.283 -0.886 . . . . 0.0 110.223 179.713 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.715 HG23 ' O ' ' A' ' 90' ' ' ASP . 1.1 p -160.06 -176.71 5.82 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.125 -0.984 . . . . 0.0 110.509 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.431 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 0.1 OUTLIER -119.93 131.24 24.48 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.321 -0.862 . . . . 0.0 110.079 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.831 ' HG2' HG22 ' A' ' 74' ' ' VAL . 48.6 Cg_endo -73.11 77.6 2.37 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.97 1.511 . . . . 0.0 110.912 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.532 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -48.63 135.26 14.91 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.975 -1.078 . . . . 0.0 109.148 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.883 HD21 ' HB1' ' A' ' 66' ' ' ALA . 36.4 mt -130.85 176.79 7.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.997 -1.064 . . . . 0.0 110.872 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 68' ' ' ALA . 0.2 OUTLIER -177.89 -178.8 0.72 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.49 -0.756 . . . . 0.0 109.918 -179.955 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.63 -22.44 63.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.226 -0.921 . . . . 0.0 110.287 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.653 ' O ' HG23 ' A' ' 67' ' ' THR . 2.6 mt-10 -90.07 169.86 11.5 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.29 -0.881 . . . . 0.0 110.078 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.495 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 45.0 Cg_endo -72.55 130.44 16.02 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 123.956 1.503 . . . . 0.0 110.276 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.532 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.69 92.2 3.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.154 -0.966 . . . . 0.0 110.35 -179.865 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.453 ' HG3' ' OG1' ' A' ' 65' ' ' THR . 38.3 tt0 -85.76 99.3 11.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.289 -0.882 . . . . 0.0 110.104 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.426 ' HB ' ' CZ ' ' A' ' 64' ' ' TYR . 72.6 t -89.62 133.77 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 0.0 110.256 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.771 HG23 ' HG2' ' A' ' 63' ' ' ARG . 49.5 m -147.51 135.72 21.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.357 -0.839 . . . . 0.0 110.084 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.507 ' CG ' ' O ' ' A' ' 103' ' ' THR . 17.9 mt-10 -160.16 -177.33 6.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.169 -0.957 . . . . 0.0 110.267 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.491 HG23 HG23 ' A' ' 61' ' ' THR . 0.0 OUTLIER -133.62 91.54 2.86 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.285 -0.885 . . . . 0.0 110.162 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -92.44 155.48 17.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.286 -0.884 . . . . 0.0 110.254 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 109' ' ' SER . 38.7 m -89.56 92.78 9.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.178 -0.951 . . . . 0.0 109.777 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.618 ' CB ' ' CD2' ' A' ' 60' ' ' TYR . . . -47.39 91.67 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.27 -0.894 . . . . 0.0 110.455 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.523 ' HA ' ' HA2' ' A' ' 57' ' ' GLY . 8.9 p -85.78 57.28 4.38 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.349 -0.844 . . . . 0.0 109.621 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.645 ' HB3' ' HE1' ' A' ' 112' ' ' TYR . . . -166.98 -156.34 0.22 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.115 -0.991 . . . . 0.0 110.868 -179.561 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.497 ' O ' ' HD3' ' A' ' 113' ' ' PRO . 35.5 m -148.0 111.57 5.01 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.539 -0.726 . . . . 0.0 110.024 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.767 ' CE2' HG12 ' A' ' 78' ' ' VAL . 4.2 m-85 -104.87 92.3 5.08 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.361 -0.837 . . . . 0.0 109.943 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 111' ' ' THR . 43.4 Cg_endo -71.73 160.9 46.79 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.798 1.42 . . . . 0.0 110.389 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.67 0 O-C-N 121.144 -0.972 . . . . 0.0 110.376 -179.695 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.499 ' O ' ' HB2' ' A' ' 81' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.229 0.537 . . . . 0.0 110.455 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.59 ' HA3' ' CD2' ' A' ' 112' ' ' TYR . . . -89.5 149.0 20.32 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.537 ' HA ' ' CG2' ' A' ' 52' ' ' VAL . 2.8 pt20 -150.37 -163.84 1.87 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.094 -1.239 . . . . 0.0 110.948 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.604 HG21 ' HE2' ' A' ' 127' ' ' PHE . 9.5 mt -118.57 144.37 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.579 -0.7 . . . . 0.0 109.186 179.471 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -121.25 129.14 53.01 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.315 -0.866 . . . . 0.0 110.67 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.604 ' HE2' HG21 ' A' ' 125' ' ' ILE . 14.3 m-85 -118.78 105.0 11.1 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -89.03 85.37 6.68 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.376 -0.828 . . . . 0.0 111.923 -177.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 1.021 ' CD2' HG21 ' A' ' 74' ' ' VAL . 14.6 mt -91.13 45.11 1.22 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.047 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -98.37 89.45 0.95 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 -179.062 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.579 ' O ' ' CG ' ' A' ' 132' ' ' PHE . . . 81.08 107.87 0.32 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 110.029 -1.229 . . . . 0.0 110.029 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.63 ' CZ ' ' HA ' ' A' ' 74' ' ' VAL . 8.4 m-85 -167.78 -67.1 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.366 -1.079 . . . . 0.0 109.849 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.795 ' CB ' HG23 ' A' ' 72' ' ' VAL . 1.3 t -89.68 160.79 16.42 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.143 -0.973 . . . . 0.0 109.893 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.405 ' O ' ' C ' ' A' ' 135' ' ' ASP . . . -88.3 -94.1 0.1 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.179 -0.95 . . . . 0.0 110.606 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 134' ' ' ALA . 9.5 m-20 -43.99 153.4 0.14 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.16 -0.963 . . . . 0.0 110.511 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.519 ' HB2' ' HB2' ' A' ' 38' ' ' ALA . . . -52.97 126.33 20.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.309 -0.869 . . . . 0.0 110.149 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 1.037 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 9.7 p90 -131.07 -161.15 1.1 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.257 -0.902 . . . . 0.0 110.181 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.584 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 0.8 OUTLIER -160.42 177.74 10.27 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.157 -0.964 . . . . 0.0 110.427 -178.084 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.867 HD13 HD13 ' A' ' 129' ' ' LEU . 2.2 mp -134.02 125.85 28.99 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.365 -0.834 . . . . 0.0 109.892 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' CYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 59.9 m -120.12 104.13 9.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.16 -0.963 . . . . 0.0 110.993 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.508 ' HA ' ' O ' ' A' ' 65' ' ' THR . 1.0 OUTLIER -102.11 -178.63 3.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.259 -0.9 . . . . 0.0 109.805 179.301 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.484 ' HB3' ' O ' ' A' ' 141' ' ' LEU . 4.5 p-10 173.59 167.35 0.18 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.458 -0.776 . . . . 0.0 110.316 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.465 ' O ' ' O ' ' A' ' 63' ' ' ARG . 13.9 t70 41.74 64.54 1.04 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.341 -0.849 . . . . 0.0 110.364 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.622 HG11 ' HZ2' ' A' ' 16' ' ' TRP . 4.9 t -99.1 113.2 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.252 -0.905 . . . . 0.0 110.053 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -129.8 171.33 12.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -0.934 . . . . 0.0 110.404 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.903 HD11 ' HB3' ' A' ' 60' ' ' TYR . 60.8 tp -162.49 120.75 2.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.275 -0.891 . . . . 0.0 110.159 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.532 ' O ' ' CD1' ' A' ' 60' ' ' TYR . 0.5 OUTLIER -125.24 -152.42 0.52 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.274 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 72.5 p . . . . . 0 N--CA 1.492 1.647 0 O-C-N 121.303 -0.873 . . . . 0.0 110.158 -179.951 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo . . . . . 0 N--CA 1.483 0.859 0 N-CA-C 110.515 -0.61 . . . . 0.0 110.515 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.94 ' HB ' HD21 ' A' ' 49' ' ' LEU . 10.7 pt -117.72 32.67 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.227 -0.921 . . . . 0.0 110.113 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 7' ' ' GLY . . . 81.49 44.45 7.92 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.859 ' HG2' ' HB1' ' A' ' 145' ' ' ALA . 4.1 mt-10 -41.93 94.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.337 -1.096 . . . . 0.0 110.337 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 5' ' ' GLY . . . 152.48 -149.9 21.63 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.447 HG22 ' O ' ' A' ' 142' ' ' ASP . 70.4 p -92.71 163.49 13.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.27 -1.136 . . . . 0.0 110.233 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.459 ' CZ ' HG21 ' A' ' 144' ' ' VAL . 24.4 m-85 -87.61 35.47 0.72 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.256 -0.903 . . . . 0.0 110.189 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.543 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 13.8 t0 -86.22 57.13 4.31 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.275 -0.891 . . . . 0.0 110.133 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.543 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.9 OUTLIER 161.69 36.84 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.628 -0.67 . . . . 0.0 110.073 -179.999 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.26 140.28 9.2 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.7 ' HB3' HD12 ' A' ' 32' ' ' LEU . 49.8 Cg_endo -77.13 6.6 4.18 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.104 1.581 . . . . 0.0 110.637 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 0.7 OUTLIER 65.57 -85.79 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.205 -0.934 . . . . 0.0 110.413 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.52 ' C ' HD12 ' A' ' 49' ' ' LEU . . . -147.88 13.88 1.33 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 1.042 ' NE1' HD22 ' A' ' 49' ' ' LEU . 30.5 m95 -66.68 135.0 53.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.163 -1.198 . . . . 0.0 110.367 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.688 ' O ' HG13 ' A' ' 47' ' ' VAL . 1.2 m -129.76 156.54 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.0 110.052 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.413 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . . . -139.1 130.87 27.54 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.474 -0.767 . . . . 0.0 108.959 179.284 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.578 ' CE2' ' O ' ' A' ' 46' ' ' GLY . 9.3 p90 -121.62 158.8 27.83 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.098 -1.001 . . . . 0.0 111.73 -178.2 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.605 ' HA2' ' CE1' ' A' ' 43' ' ' TYR . . . 75.27 36.38 45.36 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . 1.078 HG22 HG13 ' A' ' 45' ' ' VAL . 15.0 p -128.29 -160.69 1.04 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.089 -1.242 . . . . 0.0 110.5 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -98.42 39.19 1.26 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.37 -0.831 . . . . 0.0 110.249 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 133.89 175.31 13.86 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.455 ' O ' ' O ' ' A' ' 25' ' ' LEU . 46.8 Cg_endo -73.34 138.45 27.41 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.018 1.536 . . . . 0.0 110.563 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.923 HD12 HD11 ' A' ' 32' ' ' LEU . 0.8 OUTLIER -42.2 165.09 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.416 -0.802 . . . . 0.0 110.142 179.844 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -150.62 150.45 31.18 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.19 -0.944 . . . . 0.0 110.297 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.499 HG22 ' HA ' ' A' ' 32' ' ' LEU . 0.8 OUTLIER -119.94 -76.98 0.57 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.272 -0.893 . . . . 0.0 110.058 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.446 ' O ' ' N ' ' A' ' 30' ' ' GLY . 25.6 t 55.53 -88.28 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.252 -0.905 . . . . 0.0 110.605 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.553 HG23 ' H ' ' A' ' 31' ' ' ALA . 9.6 t -40.5 -27.62 0.05 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.398 -0.814 . . . . 0.0 110.573 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 28' ' ' SER . . . 132.13 -42.75 1.35 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.553 ' H ' HG23 ' A' ' 29' ' ' THR . . . -89.82 144.75 25.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.297 -1.119 . . . . 0.0 109.876 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.923 HD11 HD12 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -79.33 95.37 5.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.226 -0.921 . . . . 0.0 110.469 -179.786 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 0.8 OUTLIER -93.99 115.83 28.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.28 -0.887 . . . . 0.0 111.093 179.563 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.42 ' H ' HG22 ' A' ' 34' ' ' VAL . 15.9 m -89.31 142.12 13.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.374 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.51 76.63 8.18 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.379 -0.826 . . . . 0.0 110.777 -178.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.058 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 95.6 t -68.97 125.11 91.66 Favored Pre-proline 0 C--N 1.302 -1.463 0 O-C-N 121.443 -0.785 . . . . 0.0 109.08 179.173 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.517 ' HD3' ' HA ' ' A' ' 21' ' ' THR . 38.7 Cg_endo -65.82 175.64 4.35 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.966 1.508 . . . . 0.0 112.107 -178.51 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.531 ' HA ' ' CA ' ' A' ' 136' ' ' ALA . . . -53.94 121.64 8.43 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.566 -0.709 . . . . 0.0 111.412 -178.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 134' ' ' ALA . . . 37.73 27.86 0.03 OUTLIER Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 38' ' ' ALA . 22.4 m 33.16 61.34 0.42 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.74 -0.859 . . . . 0.0 110.103 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.546 ' O ' ' CG ' ' A' ' 42' ' ' GLN . . . -88.54 133.94 34.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.45 -0.781 . . . . 0.0 110.444 -178.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.546 ' CG ' ' O ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER 59.49 30.03 19.66 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.192 0.52 . . . . 0.0 109.766 -179.454 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.61 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.1 OUTLIER -161.94 82.37 0.57 Allowed 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 118.776 -1.17 . . . . 0.0 111.707 -178.587 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.553 ' HA2' ' CA ' ' A' ' 130' ' ' GLY . . . -50.33 99.26 0.03 OUTLIER Glycine 0 N--CA 1.482 1.761 0 N-CA-C 107.091 -2.404 . . . . 0.0 107.091 178.119 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 1.078 HG13 HG22 ' A' ' 21' ' ' THR . 3.1 t -87.2 111.8 22.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 120.976 -1.308 . . . . 0.0 108.812 -178.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.578 ' O ' ' CE2' ' A' ' 19' ' ' TYR . . . -136.78 141.78 12.82 Favored Glycine 0 N--CA 1.486 1.98 0 C-N-CA 118.959 -1.591 . . . . 0.0 110.507 -178.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.688 HG13 ' O ' ' A' ' 17' ' ' VAL . 17.0 t -106.21 125.49 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.39 -1.065 . . . . 0.0 109.433 179.419 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.575 ' CG2' ' CG2' ' A' ' 17' ' ' VAL . 35.6 m -119.94 145.22 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.001 -1.062 . . . . 0.0 110.83 -179.225 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 1.042 HD22 ' NE1' ' A' ' 16' ' ' TRP . 10.4 tp -135.23 97.19 3.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.412 -0.805 . . . . 0.0 109.955 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.514 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 3.1 m120 -73.94 129.65 38.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.226 -0.921 . . . . 0.0 110.355 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 146.69 58.23 0.02 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.565 ' CG2' ' HA ' ' A' ' 124' ' ' GLN . 71.3 t -123.2 170.79 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.092 -1.24 . . . . 0.0 110.148 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.562 ' N ' HG12 ' A' ' 52' ' ' VAL . . . -146.91 92.31 2.12 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.198 -0.939 . . . . 0.0 110.572 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.86 HG21 ' HB1' ' A' ' 108' ' ' ALA . 48.6 mm -124.3 156.68 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.244 -0.91 . . . . 0.0 109.793 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.522 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 1.1 tt0 -145.19 130.43 18.56 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.034 -1.041 . . . . 0.0 110.572 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.522 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 10.4 pt-20 38.11 -154.72 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.691 -0.631 . . . . 0.0 110.758 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.461 ' HA2' ' HA ' ' A' ' 109' ' ' SER . . . -83.44 85.91 1.52 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.637 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.2 m -110.59 173.68 6.22 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.248 -1.148 . . . . 0.0 109.821 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.567 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 0.6 OUTLIER -89.88 151.29 21.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.196 -0.94 . . . . 0.0 110.354 -179.881 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.715 ' CE2' HG23 ' A' ' 54' ' ' ILE . 56.9 m-85 -160.2 178.17 9.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.265 -0.897 . . . . 0.0 110.287 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 75.5 m -150.19 119.81 6.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.437 -0.789 . . . . 0.0 109.746 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.685 HD22 ' CD2' ' A' ' 89' ' ' LEU . 17.7 tp -89.48 119.97 30.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.13 -0.981 . . . . 0.0 110.12 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.535 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 10.2 ttp180 -124.4 138.68 54.34 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.373 -0.829 . . . . 0.0 109.806 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.537 ' CE2' ' HB ' ' A' ' 102' ' ' VAL . 0.8 OUTLIER -178.74 142.2 0.21 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.37 -0.831 . . . . 0.0 109.677 179.892 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.517 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 4.3 m -119.22 94.5 4.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.066 -1.021 . . . . 0.0 110.009 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.72 ' CB ' HD21 ' A' ' 95' ' ' LEU . . . -97.12 156.16 16.51 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.377 -0.827 . . . . 0.0 110.412 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 54.9 m -149.63 119.98 7.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.316 -0.865 . . . . 0.0 110.126 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.453 ' CB ' HG12 ' A' ' 72' ' ' VAL . . . -108.2 131.3 54.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.246 -0.909 . . . . 0.0 110.043 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 11.3 t -65.62 -9.23 25.21 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.212 -0.93 . . . . 0.0 110.104 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.644 HG21 ' CB ' ' A' ' 137' ' ' TRP . 6.0 t -116.0 19.54 14.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -0.895 . . . . 0.0 110.266 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.509 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 9.6 t0 42.76 66.49 0.76 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.291 -0.88 . . . . 0.0 109.69 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.853 HG23 ' HB2' ' A' ' 133' ' ' SER . 5.8 p -97.84 141.87 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.407 -0.808 . . . . 0.0 110.826 -179.31 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.496 HG22 ' O ' ' A' ' 73' ' ' THR . 19.5 m -119.76 82.56 1.9 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.377 -0.827 . . . . 0.0 109.163 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.591 ' HA ' ' CD2' ' A' ' 132' ' ' PHE . 17.7 m -90.0 -140.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.243 -0.911 . . . . 0.0 110.739 -179.124 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.525 ' N ' HG23 ' A' ' 74' ' ' VAL . 7.5 mtm180 -130.43 145.01 51.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.19 -0.944 . . . . 0.0 110.828 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.577 ' N ' ' HD3' ' A' ' 93' ' ' PRO . . . -150.5 153.42 35.82 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.417 -0.802 . . . . 0.0 109.479 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.9 HD12 ' N ' ' A' ' 78' ' ' VAL . 3.9 pp 179.86 -147.59 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.136 -0.977 . . . . 0.0 110.4 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.9 ' N ' HD12 ' A' ' 77' ' ' LEU . 5.0 t -149.92 164.97 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.359 -0.838 . . . . 0.0 109.114 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.488 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . -171.81 -175.56 40.15 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 118.958 -1.591 . . . . 0.0 110.693 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.49 ' HA ' ' O ' ' A' ' 122' ' ' GLU . 1.3 tt0 -90.88 -151.63 0.26 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.639 -0.918 . . . . 0.0 110.272 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.519 ' HB2' ' HG2' ' A' ' 122' ' ' GLU . 14.5 m120 -161.81 83.57 0.59 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.434 -0.791 . . . . 0.0 109.582 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 83' ' ' ALA . . . 122.54 136.67 4.93 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.63 ' N ' ' CE1' ' A' ' 85' ' ' TYR . . . -40.45 150.82 0.26 Allowed Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.333 -1.098 . . . . 0.0 110.447 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.467 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.6 Cg_endo -80.07 12.07 23.64 Favored 'Cis proline' 0 C--N 1.313 -1.334 0 C-N-CA 121.711 -2.204 . . . . 0.0 110.938 -0.013 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.63 ' CE1' ' N ' ' A' ' 83' ' ' ALA . 27.2 m-85 63.6 163.65 0.12 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.187 -0.946 . . . . 0.0 110.282 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 176.4 131.9 1.55 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.471 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 0.7 OUTLIER -117.73 153.31 33.6 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.227 -1.161 . . . . 0.0 110.282 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 1.015 HG23 HD12 ' A' ' 89' ' ' LEU . 31.3 m -124.88 -24.45 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.32 -0.863 . . . . 0.0 110.305 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 1.015 HD12 HG23 ' A' ' 88' ' ' VAL . 3.8 mp -104.79 144.29 31.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.204 -0.935 . . . . 0.0 110.952 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -151.5 76.66 1.22 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.348 -0.845 . . . . 0.0 109.974 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 67.1 p -142.71 -178.72 5.93 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.978 -1.076 . . . . 0.0 110.756 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.94 128.03 26.07 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.457 -0.777 . . . . 0.0 110.07 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.577 ' HD3' ' N ' ' A' ' 76' ' ' ALA . 46.4 Cg_endo -72.5 78.2 2.03 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.95 1.5 . . . . 0.0 111.038 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.535 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -56.43 139.64 48.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.057 -1.027 . . . . 0.0 109.223 179.255 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.829 ' CD1' HD21 ' A' ' 139' ' ' LEU . 44.4 mt -135.61 160.15 39.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.007 -1.058 . . . . 0.0 110.907 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.698 HG22 ' HG3' ' A' ' 100' ' ' ARG . 0.2 OUTLIER -158.59 -179.02 7.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.476 -0.765 . . . . 0.0 109.926 179.949 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.81 -27.65 69.32 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -0.933 . . . . 0.0 110.118 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.465 ' CB ' ' HD2' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -90.51 176.65 2.8 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.184 -0.948 . . . . 0.0 110.018 179.824 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.465 ' HD2' ' CB ' ' A' ' 98' ' ' GLU . 44.9 Cg_endo -72.08 135.61 25.5 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.928 1.488 . . . . 0.0 110.381 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.698 ' HG3' HG22 ' A' ' 96' ' ' THR . 0.0 OUTLIER -119.84 93.49 4.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.228 -0.92 . . . . 0.0 110.208 179.985 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -87.61 97.25 10.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.371 -0.831 . . . . 0.0 110.359 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.537 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 40.2 t -89.55 134.03 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.347 -0.846 . . . . 0.0 110.216 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -150.25 133.81 16.58 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.219 -0.925 . . . . 0.0 110.211 179.902 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -160.26 135.62 8.09 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.909 . . . . 0.0 110.245 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.486 HG23 ' O ' ' A' ' 60' ' ' TYR . 85.3 m -90.03 125.87 35.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.224 -0.922 . . . . 0.0 110.053 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.953 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 28.2 p90 -132.31 156.03 47.3 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.185 -0.947 . . . . 0.0 110.354 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.2 m -90.06 94.92 9.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.224 -0.923 . . . . 0.0 109.897 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.86 ' HB1' HG21 ' A' ' 54' ' ' ILE . . . -53.02 107.5 0.23 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.252 -0.905 . . . . 0.0 110.329 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.461 ' HA ' ' HA2' ' A' ' 57' ' ' GLY . 24.6 p -94.06 53.26 1.74 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.264 -0.898 . . . . 0.0 110.017 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -162.09 -153.55 0.28 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.297 -0.877 . . . . 0.0 110.278 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.494 HG23 ' HA ' ' A' ' 55' ' ' GLU . 5.2 m -147.27 118.38 7.74 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.283 -0.886 . . . . 0.0 110.172 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.63 ' OH ' HG22 ' A' ' 88' ' ' VAL . 20.3 m-30 -113.23 70.21 1.36 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.303 -0.873 . . . . 0.0 109.971 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.493 ' HD3' HG22 ' A' ' 111' ' ' THR . 46.3 Cg_endo -72.39 -159.06 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.035 1.545 . . . . 0.0 110.436 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.228 -0.92 . . . . 0.0 110.206 -179.944 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.519 ' HG2' ' HB2' ' A' ' 81' ' ' ASN . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 121.012 0.434 . . . . 0.0 109.878 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.576 ' HA3' ' CG ' ' A' ' 112' ' ' TYR . . . -144.37 149.09 21.13 Favored Glycine 0 N--CA 1.491 2.321 0 C-N-CA 119.56 -1.305 . . . . 0.0 109.889 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.653 ' O ' HG13 ' A' ' 78' ' ' VAL . 19.4 pt20 -150.51 -153.11 0.47 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.314 -1.11 . . . . 0.0 110.085 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.78 HG21 ' CH2' ' A' ' 16' ' ' TRP . 14.2 mt -118.18 139.23 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.487 -0.758 . . . . 0.0 109.359 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -117.12 123.62 47.2 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.291 -0.88 . . . . 0.0 110.933 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.475 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 4.5 m-85 -118.84 103.18 9.39 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLN . . . . . 1.058 ' O ' HD23 ' A' ' 129' ' ' LEU . 2.0 mt-30 -89.11 129.87 35.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.203 -0.935 . . . . 0.0 111.714 -177.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 1.058 HD23 ' O ' ' A' ' 128' ' ' GLN . 0.8 OUTLIER -141.53 34.08 1.64 Allowed 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.441 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.553 ' CA ' ' HA2' ' A' ' 44' ' ' GLY . . . -82.23 118.96 4.74 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 39' ' ' GLY . . . 42.56 69.99 0.54 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.591 ' CD2' ' HA ' ' A' ' 74' ' ' VAL . 11.2 m-85 -117.35 -61.81 1.65 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.109 -1.23 . . . . 0.0 111.006 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.853 ' HB2' HG23 ' A' ' 72' ' ' VAL . 1.3 t -88.36 -176.46 5.35 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.02 -1.05 . . . . 0.0 110.693 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -92.53 -82.03 0.33 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.276 -0.89 . . . . 0.0 110.225 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -70.25 177.77 3.15 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.147 -0.971 . . . . 0.0 109.765 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.531 ' CA ' ' HA ' ' A' ' 38' ' ' ALA . . . -75.2 138.81 42.21 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.297 -0.877 . . . . 0.0 110.736 -179.507 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 1.058 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 9.0 p90 -140.99 -171.41 3.25 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.263 -0.898 . . . . 0.0 110.682 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.516 ' C ' HD12 ' A' ' 139' ' ' LEU 0.251 0.8 OUTLIER -149.25 171.34 16.65 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.536 -0.727 . . . . 0.0 109.702 -177.986 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.829 HD21 ' CD1' ' A' ' 95' ' ' LEU . 1.7 mp -139.47 117.91 12.11 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.998 -1.064 . . . . 0.0 112.11 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' CYS . . . . . 0.471 ' SG ' ' HB3' ' A' ' 31' ' ' ALA . 0.8 OUTLIER -103.4 110.11 22.0 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.646 -0.659 . . . . 0.0 110.64 178.186 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.569 HD23 ' HB2' ' A' ' 66' ' ' ALA . 1.3 mt -97.28 -178.5 4.19 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.277 -0.89 . . . . 0.0 108.974 178.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 143' ' ' ASP . 0.5 OUTLIER 169.31 61.12 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.145 -0.972 . . . . 0.0 110.407 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.53 ' CB ' ' O ' ' A' ' 142' ' ' ASP . 0.5 OUTLIER 166.35 43.26 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.388 -0.82 . . . . 0.0 109.344 179.852 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.795 HG11 ' HZ2' ' A' ' 16' ' ' TRP . 1.5 t -89.45 114.33 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.373 -0.83 . . . . 0.0 110.281 -179.244 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.859 ' HB1' ' HG2' ' A' ' 6' ' ' GLU . . . -151.84 148.45 27.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.413 -0.804 . . . . 0.0 110.081 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.835 HD21 HD11 ' A' ' 54' ' ' ILE . 38.8 tp -146.54 123.57 11.41 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.341 -0.849 . . . . 0.0 110.099 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.479 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -140.66 157.57 45.25 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.235 -0.916 . . . . 0.0 110.373 -179.938 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 59' ' ' THR . 24.4 p . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.282 -0.886 . . . . 0.0 110.136 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo . . . . . 0 N--CA 1.479 0.649 0 N-CA-C 110.09 -0.773 . . . . 0.0 110.09 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.0 pt -96.38 -28.93 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.183 -0.948 . . . . 0.0 110.181 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.51 ' O ' ' N ' ' A' ' 7' ' ' GLY . . . 99.4 106.47 2.71 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.617 ' HA ' ' HB2' ' A' ' 145' ' ' ALA . 0.6 OUTLIER -45.01 93.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.231 -1.158 . . . . 0.0 110.069 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 5' ' ' GLY . . . -139.55 177.84 20.12 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.671 HG22 ' HA ' ' A' ' 143' ' ' ASP . 29.4 p -129.52 20.35 5.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.386 -1.067 . . . . 0.0 109.818 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.643 ' HB3' HG21 ' A' ' 27' ' ' THR . 3.2 m-30 70.71 -78.96 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.812 -0.555 . . . . 0.0 110.671 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.555 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 1.4 p30 40.02 27.87 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.095 -1.003 . . . . 0.0 110.505 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.555 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 1.9 t70 161.13 -57.84 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.54 0.686 . . . . 0.0 109.235 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 9' ' ' PHE . . . -133.67 127.13 4.53 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.583 ' HA ' ' CD1' ' A' ' 9' ' ' PHE . 52.4 Cg_endo -81.82 29.85 0.53 Allowed 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.819 1.431 . . . . 0.0 111.16 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 0.2 OUTLIER 62.23 -89.35 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.997 -1.065 . . . . 0.0 110.326 179.923 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -149.73 22.19 1.16 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.84 ' HZ2' HG11 ' A' ' 144' ' ' VAL . 40.0 m95 -61.69 142.56 57.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.276 -1.132 . . . . 0.0 110.381 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.732 ' O ' HG13 ' A' ' 47' ' ' VAL . 0.8 OUTLIER -132.87 140.87 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.232 -0.918 . . . . 0.0 109.222 179.15 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.5 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . . . -125.15 114.75 19.43 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.97 -1.081 . . . . 0.0 110.235 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.887 ' HE2' HG13 ' A' ' 48' ' ' VAL . 40.0 p90 -100.93 150.53 22.77 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.691 -0.631 . . . . 0.0 109.924 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.777 ' C ' HG23 ' A' ' 21' ' ' THR . . . 112.58 87.2 1.64 Allowed Glycine 0 N--CA 1.483 1.802 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.777 HG23 ' C ' ' A' ' 20' ' ' GLY . 1.4 p 75.24 -139.81 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.116 0 O-C-N 122.064 -0.668 . . . . 0.0 110.333 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.96 ' O ' ' HB3' ' A' ' 35' ' ' ALA . 2.5 m-20 -88.72 116.84 27.27 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.884 -1.135 . . . . 0.0 110.075 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.557 ' N ' ' CD ' ' A' ' 24' ' ' PRO . . . -119.61 49.24 0.88 Allowed Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.557 ' CD ' ' N ' ' A' ' 23' ' ' GLY . 43.4 Cg_endo -69.89 82.17 0.8 Allowed 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 124.024 1.539 . . . . 0.0 109.677 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.784 HD13 HD11 ' A' ' 32' ' ' LEU . 40.8 mt -50.93 88.52 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.44 -0.787 . . . . 0.0 110.422 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 24' ' ' PRO . 0.3 OUTLIER -91.22 120.95 32.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -0.885 . . . . 0.0 109.442 179.626 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.643 HG21 ' HB3' ' A' ' 9' ' ' PHE . 1.2 p -119.54 -27.39 5.54 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.076 -1.015 . . . . 0.0 110.889 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 27' ' ' THR . 74.4 m -43.46 -28.08 0.33 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.186 -0.946 . . . . 0.0 109.192 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.606 HG23 ' N ' ' A' ' 30' ' ' GLY . 6.3 t -67.78 -47.89 67.87 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.629 -0.669 . . . . 0.0 110.482 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.606 ' N ' HG23 ' A' ' 29' ' ' THR . . . 164.93 -25.94 0.18 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.661 ' HB1' ' O ' ' A' ' 141' ' ' LEU . . . -150.54 159.67 44.33 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.295 -1.121 . . . . 0.0 110.218 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.784 HD11 HD13 ' A' ' 25' ' ' LEU . 0.6 OUTLIER -72.71 102.0 3.22 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.314 -0.866 . . . . 0.0 110.328 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.58 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 0.8 OUTLIER -98.84 119.76 38.14 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.167 -0.958 . . . . 0.0 111.913 -179.915 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.659 HG12 ' CD2' ' A' ' 25' ' ' LEU . 17.2 m -96.92 150.11 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.96 ' HB3' ' O ' ' A' ' 22' ' ' ASP . . . -89.95 121.75 32.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.054 -1.029 . . . . 0.0 111.781 -178.264 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.081 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 66.5 t -119.56 125.8 27.29 Favored Pre-proline 0 C--N 1.303 -1.452 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 178.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 38' ' ' ALA . 44.8 Cg_endo -71.59 147.39 51.42 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 123.811 1.427 . . . . 0.0 110.929 -178.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.489 ' HA ' ' N ' ' A' ' 136' ' ' ALA . . . -43.03 123.97 3.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.364 -0.835 . . . . 0.0 109.277 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 134' ' ' ALA . . . 61.39 78.8 0.15 Allowed Glycine 0 N--CA 1.486 1.968 0 N-CA-C 108.0 -2.04 . . . . 0.0 108.0 -178.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.667 ' HB2' HG21 ' A' ' 45' ' ' VAL . 2.4 p -85.28 53.63 2.82 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.542 -0.975 . . . . 0.0 110.076 -179.215 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.566 ' O ' ' O ' ' A' ' 42' ' ' GLN . . . -88.83 -147.49 0.16 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.69 -0.631 . . . . 0.0 110.024 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.701 ' O ' ' CD2' ' A' ' 43' ' ' TYR . 5.8 pt20 38.94 102.98 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 CA-C-O 121.761 0.791 . . . . 0.0 110.522 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.701 ' CD2' ' O ' ' A' ' 42' ' ' GLN . 0.0 OUTLIER 77.7 -20.95 0.35 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.729 -1.232 . . . . 0.0 110.275 -178.797 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.584 ' O ' ' CD1' ' A' ' 43' ' ' TYR . . . 57.71 141.95 0.01 OUTLIER Glycine 0 N--CA 1.492 2.398 0 O-C-N 120.952 -1.092 . . . . 0.0 111.196 178.155 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.76 HG13 ' HA3' ' A' ' 20' ' ' GLY . 2.5 t -93.35 -172.66 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.306 -1.114 . . . . 0.0 108.762 179.013 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.604 ' H ' HG12 ' A' ' 45' ' ' VAL . . . 172.13 -175.4 45.41 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 118.635 -1.745 . . . . 0.0 111.464 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.732 HG13 ' O ' ' A' ' 17' ' ' VAL . 35.5 t -150.6 133.75 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.887 HG13 ' HE2' ' A' ' 19' ' ' TYR . 22.5 m -123.66 138.5 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 120.81 -1.181 . . . . 0.0 110.99 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.643 ' CD2' ' CE2' ' A' ' 16' ' ' TRP . 5.2 tp -132.03 98.87 4.55 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.326 -0.859 . . . . 0.0 110.202 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.518 ' O ' ' ND2' ' A' ' 50' ' ' ASN . 3.4 p-10 -73.46 98.88 2.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 0.0 110.091 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 172.7 77.57 0.05 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.672 HG23 ' HA ' ' A' ' 124' ' ' GLN . 12.4 t -134.93 169.17 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.215 -1.168 . . . . 0.0 109.937 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.412 ' O ' HD13 ' A' ' 54' ' ' ILE . . . -136.46 79.7 1.78 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.107 -0.995 . . . . 0.0 110.671 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.836 HD11 HD21 ' A' ' 146' ' ' LEU . 36.0 mm -115.63 158.91 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.209 -0.932 . . . . 0.0 109.934 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.578 ' HA ' HG23 ' A' ' 111' ' ' THR . 3.8 tt0 -152.04 124.25 8.18 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.116 -0.99 . . . . 0.0 110.438 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.53 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 11.5 pt-20 37.73 -152.93 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.669 -0.645 . . . . 0.0 110.789 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.455 ' N ' ' HG3' ' A' ' 56' ' ' GLU . . . -82.03 99.95 2.07 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.651 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.2 m -132.46 174.16 10.55 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.33 -1.1 . . . . 0.0 109.855 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.568 ' N ' ' CG2' ' A' ' 58' ' ' THR . 1.3 m -89.72 152.97 21.06 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.226 -0.921 . . . . 0.0 110.191 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.651 ' CE2' HG22 ' A' ' 58' ' ' THR . 57.9 m-85 -158.6 158.61 34.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.255 -0.903 . . . . 0.0 110.28 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 87.8 m -132.37 117.3 17.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.317 -0.865 . . . . 0.0 109.971 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 20.1 tp -89.73 121.49 31.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.188 -0.945 . . . . 0.0 110.156 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.5 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 9.5 ttp180 -125.78 131.84 52.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 110.12 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 1.196 ' CZ ' HG21 ' A' ' 102' ' ' VAL . 2.7 p90 -169.8 146.64 3.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.221 -0.924 . . . . 0.0 109.975 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.503 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 3.4 m -119.49 101.33 7.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.199 -0.938 . . . . 0.0 109.745 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.659 ' CB ' HD21 ' A' ' 95' ' ' LEU . . . -104.83 150.79 24.52 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.356 -0.84 . . . . 0.0 110.497 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.756 HG23 ' O ' ' A' ' 98' ' ' GLU . 86.0 m -150.43 106.48 3.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.32 -0.863 . . . . 0.0 110.161 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.472 ' O ' ' O ' ' A' ' 96' ' ' THR . . . -95.73 127.04 41.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.206 -0.934 . . . . 0.0 109.951 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 68' ' ' ALA . 39.9 t -42.56 -26.95 0.14 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.284 -0.885 . . . . 0.0 109.843 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.557 ' CG2' ' CB ' ' A' ' 137' ' ' TRP . 2.6 t -108.5 159.95 16.28 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.356 -0.84 . . . . 0.0 110.056 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 60.4 t0 -78.31 78.63 4.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.121 -0.987 . . . . 0.0 109.215 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.702 HG23 ' CB ' ' A' ' 133' ' ' SER . 4.4 p -106.64 145.72 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.186 -0.946 . . . . 0.0 111.239 -178.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.476 ' O ' ' CD1' ' A' ' 132' ' ' PHE . 98.2 m -126.02 91.35 3.36 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.785 HG12 ' CD2' ' A' ' 132' ' ' PHE . 15.4 m -89.77 -152.11 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.196 -0.94 . . . . 0.0 110.833 -178.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.529 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 8.2 mtm180 -129.21 136.34 50.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.332 -0.855 . . . . 0.0 110.647 -179.173 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.691 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -135.67 153.56 51.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.388 -0.82 . . . . 0.0 109.648 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.891 HD12 ' N ' ' A' ' 78' ' ' VAL . 4.0 pp -179.74 -150.02 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.243 -0.911 . . . . 0.0 110.377 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.891 ' N ' HD12 ' A' ' 77' ' ' LEU . 3.5 t -150.87 170.54 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.29 -0.881 . . . . 0.0 109.616 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.575 ' O ' ' CE1' ' A' ' 112' ' ' TYR . . . -174.83 -162.43 26.3 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.404 -1.379 . . . . 0.0 110.256 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.544 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 3.5 tm0? -120.9 128.21 52.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.448 -1.031 . . . . 0.0 110.655 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.514 ' OD1' ' CG ' ' A' ' 124' ' ' GLN . 4.5 m120 -83.46 67.64 9.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.4 -0.812 . . . . 0.0 109.813 179.37 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.514 ' N ' ' OE1' ' A' ' 80' ' ' GLN . . . 166.7 141.36 3.13 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.618 ' N ' ' CE1' ' A' ' 85' ' ' TYR . . . -61.97 156.06 59.63 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.245 -1.15 . . . . 0.0 110.134 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.52 ' C ' ' CD2' ' A' ' 85' ' ' TYR . 49.9 Cg_endo -77.22 8.15 17.63 Favored 'Cis proline' 0 C--N 1.312 -1.377 0 C-N-CA 121.692 -2.212 . . . . 0.0 110.904 0.103 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.618 ' CE1' ' N ' ' A' ' 83' ' ' ALA . 11.7 m-85 70.15 158.19 0.17 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.26 -0.9 . . . . 0.0 110.196 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -177.68 114.27 0.46 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.471 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 1.6 p -89.92 147.15 23.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.243 -1.151 . . . . 0.0 110.329 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.794 HG23 HD12 ' A' ' 89' ' ' LEU . 16.4 m -119.96 -24.0 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.29 -0.881 . . . . 0.0 110.016 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.832 HD22 HG23 ' A' ' 78' ' ' VAL . 4.2 mp -105.74 145.22 31.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 110.792 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -151.19 78.23 1.28 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.326 -0.859 . . . . 0.0 109.996 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.0 p -140.22 170.63 15.48 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.028 -1.045 . . . . 0.0 110.686 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.403 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 1.2 m -120.09 115.62 33.02 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.383 -0.823 . . . . 0.0 110.087 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.691 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 45.2 Cg_endo -70.68 128.76 15.61 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.901 1.474 . . . . 0.0 111.057 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.511 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -94.25 148.12 22.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.32 -0.862 . . . . 0.0 109.407 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.792 ' CD1' HD21 ' A' ' 139' ' ' LEU . 77.1 mt -141.15 157.39 45.33 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.019 -1.051 . . . . 0.0 110.807 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.515 HG23 ' N ' ' A' ' 97' ' ' SER . 6.0 t -164.47 -156.58 0.33 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.407 -0.808 . . . . 0.0 109.902 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.515 ' N ' HG23 ' A' ' 96' ' ' THR . 0.1 OUTLIER -89.11 34.05 0.79 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.177 -0.952 . . . . 0.0 110.244 179.91 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.756 ' O ' HG23 ' A' ' 67' ' ' THR . 0.1 OUTLIER -150.16 168.02 11.83 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.304 -0.872 . . . . 0.0 110.068 179.899 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.476 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 45.5 Cg_endo -72.41 127.74 12.9 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.005 1.529 . . . . 0.0 110.313 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.511 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 1.2 ttm180 -119.46 91.83 3.64 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.179 -0.951 . . . . 0.0 110.152 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.479 ' HG3' ' OG1' ' A' ' 65' ' ' THR . 0.0 OUTLIER -73.89 147.12 43.49 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.341 -0.85 . . . . 0.0 109.963 179.93 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 1.196 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 19.6 t -124.03 135.17 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.227 -0.92 . . . . 0.0 110.296 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.408 ' C ' ' HG3' ' A' ' 104' ' ' GLU . 0.2 OUTLIER -150.18 96.66 2.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.283 -0.886 . . . . 0.0 110.196 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.408 ' HG3' ' C ' ' A' ' 103' ' ' THR . 43.0 mt-10 -142.39 160.09 40.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.216 -0.927 . . . . 0.0 110.256 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 1.2 t -114.97 170.74 8.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.251 -0.906 . . . . 0.0 110.164 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.788 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 41.7 p90 -173.06 153.89 2.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.248 -0.907 . . . . 0.0 110.289 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 58' ' ' THR . 16.4 m -89.92 90.37 8.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.884 . . . . 0.0 109.993 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.632 ' HB3' ' CE2' ' A' ' 60' ' ' TYR . . . -54.15 113.49 1.26 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.296 -0.878 . . . . 0.0 110.393 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 68.7 p -97.33 54.79 1.23 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.224 -0.922 . . . . 0.0 109.993 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.439 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -165.14 -159.0 0.41 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.3 -0.875 . . . . 0.0 110.236 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.578 HG23 ' HA ' ' A' ' 55' ' ' GLU . 13.6 m -147.77 117.9 7.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.223 -0.923 . . . . 0.0 110.342 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.577 ' CD2' HG13 ' A' ' 54' ' ' ILE . 17.4 m-30 -115.9 80.39 8.82 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.29 -0.881 . . . . 0.0 109.841 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.475 ' O ' ' HB2' ' A' ' 122' ' ' GLU . 44.5 Cg_endo -72.32 -164.56 0.18 Allowed 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.92 1.484 . . . . 0.0 110.51 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.209 -0.932 . . . . 0.0 110.25 -179.956 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.521 ' HG2' ' N ' ' A' ' 123' ' ' GLY . 4.9 pm0 . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.017 0.437 . . . . 0.0 110.408 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.544 ' HA2' ' HA ' ' A' ' 80' ' ' GLN . . . -145.82 158.26 27.62 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.672 ' HA ' HG23 ' A' ' 52' ' ' VAL . 9.7 pt20 -150.23 -161.0 1.25 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.071 -1.252 . . . . 0.0 110.748 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.693 HG21 ' HH2' ' A' ' 16' ' ' TRP . 30.4 mt -118.97 148.63 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.49 -0.756 . . . . 0.0 109.413 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.471 ' HB3' ' HG ' ' A' ' 77' ' ' LEU . . . -117.36 120.13 37.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.35 -0.844 . . . . 0.0 111.426 -179.108 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.544 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 5.3 m-85 -125.14 77.47 1.63 Allowed 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.665 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLN . . . . . 0.503 ' HA ' ' CA ' ' A' ' 46' ' ' GLY . 8.4 mt-30 -87.47 121.19 29.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.135 -0.978 . . . . 0.0 111.706 -177.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.833 HD13 HD13 ' A' ' 139' ' ' LEU . 6.4 mt -105.24 49.19 0.81 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.811 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.534 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -91.34 137.71 13.95 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.579 ' O ' ' CD1' ' A' ' 132' ' ' PHE . . . 41.96 93.23 0.01 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.785 ' CD2' HG12 ' A' ' 74' ' ' VAL . 13.0 m-85 -154.86 -74.97 0.11 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -1.168 . . . . 0.0 110.353 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.702 ' CB ' HG23 ' A' ' 72' ' ' VAL . 1.4 t -89.5 166.49 13.64 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.026 -1.046 . . . . 0.0 110.26 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -101.85 -59.41 1.71 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.18 -0.95 . . . . 0.0 110.552 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.422 ' C ' ' HA ' ' A' ' 38' ' ' ALA . 15.8 m-20 -73.09 152.45 41.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.189 -0.944 . . . . 0.0 110.261 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.489 ' N ' ' HA ' ' A' ' 38' ' ' ALA . . . -49.2 133.58 18.92 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.19 -0.944 . . . . 0.0 109.925 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 1.081 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 6.2 p90 -147.25 -173.6 4.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.123 -0.985 . . . . 0.0 110.944 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.53 ' CG2' ' N ' ' A' ' 139' ' ' LEU 0.25 0.8 OUTLIER -154.09 178.75 9.61 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.538 -0.726 . . . . 0.0 109.369 -178.372 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.833 HD13 HD13 ' A' ' 129' ' ' LEU . 1.6 mp -138.16 115.93 11.47 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.846 -1.159 . . . . 0.0 112.195 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' CYS . . . . . 0.632 ' HB3' ' HB3' ' A' ' 31' ' ' ALA . 0.8 OUTLIER -103.51 107.44 18.29 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.71 -0.619 . . . . 0.0 110.929 178.351 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.661 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 3.9 mt -94.42 179.92 5.12 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.246 -0.909 . . . . 0.0 108.961 178.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 142' ' ' ASP . 2.0 p30 168.31 61.15 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.044 -1.035 . . . . 0.0 110.578 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.671 ' HA ' HG22 ' A' ' 8' ' ' THR . 0.5 OUTLIER 164.92 45.63 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.444 -0.785 . . . . 0.0 109.355 179.773 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.84 HG11 ' HZ2' ' A' ' 16' ' ' TRP . 1.1 t -89.46 115.66 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.309 -0.87 . . . . 0.0 110.316 -179.122 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.617 ' HB2' ' HA ' ' A' ' 6' ' ' GLU . . . -144.45 155.37 43.7 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.431 -0.793 . . . . 0.0 110.151 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.836 HD21 HD11 ' A' ' 54' ' ' ILE . 39.4 tp -148.98 141.71 24.53 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.332 -0.855 . . . . 0.0 110.177 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.478 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 0.5 OUTLIER -151.4 176.85 10.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.237 -0.915 . . . . 0.0 110.246 -179.914 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.583 ' HB3' ' CE1' ' A' ' 60' ' ' TYR . 6.2 p . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.153 -0.967 . . . . 0.0 110.249 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo . . . . . 0 N--CA 1.481 0.76 0 N-CA-C 110.06 -0.785 . . . . 0.0 110.06 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.666 HG22 ' O ' ' A' ' 51' ' ' GLY . 27.7 pt -89.8 -34.36 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.195 -0.94 . . . . 0.0 110.09 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.528 ' N ' HG13 ' A' ' 4' ' ' ILE . . . -172.31 -119.93 0.54 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 5' ' ' GLY . 1.9 tt0 178.47 31.58 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.217 -1.166 . . . . 0.0 110.242 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.492 ' O ' ' HA ' ' A' ' 143' ' ' ASP . . . 156.32 -116.74 0.74 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.631 HG22 ' O ' ' A' ' 142' ' ' ASP . 3.8 p -108.03 168.28 9.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -1.151 . . . . 0.0 110.034 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.518 ' O ' ' N ' ' A' ' 11' ' ' ASP . 14.7 m-85 -70.05 -33.92 72.57 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.239 -0.913 . . . . 0.0 109.199 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.57 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 20.0 t70 37.01 27.7 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.734 -0.604 . . . . 0.0 111.384 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.57 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.9 OUTLIER 161.31 -66.55 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.313 -0.867 . . . . 0.0 110.184 179.728 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.47 ' O ' ' HB3' ' A' ' 9' ' ' PHE . . . -122.46 145.67 16.52 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.838 ' HB3' HD12 ' A' ' 32' ' ' LEU . 49.5 Cg_endo -76.02 4.95 4.82 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 O-C-N 124.093 1.575 . . . . 0.0 110.814 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.461 ' CB ' ' O ' ' A' ' 13' ' ' PRO . 1.5 mm-40 67.39 -84.77 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.199 -0.938 . . . . 0.0 110.378 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.803 ' O ' HG13 ' A' ' 17' ' ' VAL . . . -137.84 4.35 3.26 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.905 ' NE1' HD22 ' A' ' 49' ' ' LEU . 51.8 m95 -61.75 87.97 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.133 -1.216 . . . . 0.0 110.095 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.803 HG13 ' O ' ' A' ' 15' ' ' GLY . 1.2 m -93.01 162.88 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.228 -0.92 . . . . 0.0 109.976 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . . . -142.67 129.79 20.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.391 -0.818 . . . . 0.0 109.286 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.57 ' CE2' ' O ' ' A' ' 46' ' ' GLY . 10.6 p90 -118.26 157.14 27.59 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.141 -0.974 . . . . 0.0 111.363 -178.412 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.649 ' O ' HG22 ' A' ' 45' ' ' VAL . . . 74.97 41.44 32.7 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' THR . . . . . 1.078 HG22 ' CG1' ' A' ' 45' ' ' VAL . 17.2 p -128.11 -154.09 0.61 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.147 -1.208 . . . . 0.0 110.469 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -100.76 38.11 1.59 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.389 -0.819 . . . . 0.0 110.127 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 124.93 -174.89 17.26 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.465 ' O ' ' O ' ' A' ' 25' ' ' LEU . 46.9 Cg_endo -73.47 134.7 21.03 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.046 1.551 . . . . 0.0 110.615 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.826 ' CB ' HG12 ' A' ' 34' ' ' VAL . 0.8 OUTLIER -49.14 -179.98 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.236 -0.915 . . . . 0.0 110.168 179.899 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -155.67 158.51 38.42 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.138 -0.976 . . . . 0.0 110.233 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.965 ' O ' HG22 ' A' ' 29' ' ' THR . 0.9 OUTLIER -119.92 -75.12 0.59 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.328 -0.857 . . . . 0.0 110.039 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 27' ' ' THR . 1.0 OUTLIER 40.53 27.53 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.445 -0.784 . . . . 0.0 110.624 179.843 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.965 HG22 ' O ' ' A' ' 27' ' ' THR . 9.4 t -164.48 23.75 0.06 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.17 -0.956 . . . . 0.0 110.357 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.525 ' CA ' ' HA ' ' A' ' 10' ' ' ASP . . . 60.36 17.93 48.42 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.595 ' O ' HG22 ' A' ' 27' ' ' THR . . . -142.57 153.93 43.98 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.369 -1.077 . . . . 0.0 110.088 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.838 HD12 ' HB3' ' A' ' 13' ' ' PRO . 0.4 OUTLIER -91.89 95.37 9.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.92 . . . . 0.0 110.162 179.996 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 7.4 m -101.27 99.48 9.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.302 -0.874 . . . . 0.0 110.428 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.826 HG12 ' CB ' ' A' ' 25' ' ' LEU . 20.3 m -89.82 145.67 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.257 -0.902 . . . . 0.0 109.624 179.488 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.527 ' HA ' ' OG1' ' A' ' 138' ' ' THR . . . -91.43 99.2 12.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.164 -0.96 . . . . 0.0 110.751 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.995 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 62.9 t -84.94 129.35 56.67 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.263 -0.898 . . . . 0.0 109.46 179.311 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.509 ' HD3' ' HA ' ' A' ' 21' ' ' THR . 38.5 Cg_endo -65.56 178.48 2.14 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 121.704 1.602 . . . . 0.0 112.508 -178.376 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.528 ' HA ' ' CA ' ' A' ' 136' ' ' ALA . . . -61.27 117.16 5.25 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.519 0.676 . . . . 0.0 111.51 -178.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 134' ' ' ALA . . . 37.22 26.93 0.02 OUTLIER Glycine 0 N--CA 1.493 2.494 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.52 ' OG ' HG23 ' A' ' 45' ' ' VAL . 12.6 t 36.84 73.86 0.09 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.405 -1.056 . . . . 0.0 109.859 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.579 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . -87.77 115.0 24.92 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.669 -0.812 . . . . 0.0 109.977 -179.284 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.579 ' HG2' ' O ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER 67.37 10.51 7.79 Favored 'General case' 0 N--CA 1.504 2.26 0 CA-C-O 121.399 0.619 . . . . 0.0 109.965 -179.247 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.601 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.1 OUTLIER -132.32 76.02 1.67 Allowed 'General case' 0 C--N 1.289 -2.044 0 C-N-CA 119.551 -0.86 . . . . 0.0 111.719 -178.162 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.475 ' HA2' ' HA3' ' A' ' 130' ' ' GLY . . . -48.8 98.52 0.02 OUTLIER Glycine 0 N--CA 1.484 1.843 0 N-CA-C 107.362 -2.295 . . . . 0.0 107.362 178.295 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 1.078 ' CG1' HG22 ' A' ' 21' ' ' THR . 2.7 t -86.89 113.7 24.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.185 -1.185 . . . . 0.0 108.693 -178.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.57 ' O ' ' CE2' ' A' ' 19' ' ' TYR . . . -133.35 141.2 12.54 Favored Glycine 0 N--CA 1.487 2.095 0 C-N-CA 119.299 -1.429 . . . . 0.0 110.491 -178.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.709 HG13 ' O ' ' A' ' 17' ' ' VAL . 15.8 t -105.79 123.39 60.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 121.519 -0.989 . . . . 0.0 109.483 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.534 HG13 ' HE2' ' A' ' 19' ' ' TYR . 35.1 m -119.69 140.28 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.003 -1.061 . . . . 0.0 110.72 -179.224 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.905 HD22 ' NE1' ' A' ' 16' ' ' TRP . 20.7 tp -130.91 98.67 4.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.338 -0.851 . . . . 0.0 110.191 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.503 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 19.4 p30 -77.02 138.22 39.46 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.206 -0.934 . . . . 0.0 110.223 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.666 ' O ' HG22 ' A' ' 4' ' ' ILE . . . 134.15 76.08 0.09 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.582 HG12 ' N ' ' A' ' 53' ' ' ALA . 41.5 t -135.51 171.57 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.192 -1.181 . . . . 0.0 110.148 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.582 ' N ' HG12 ' A' ' 52' ' ' VAL . . . -139.59 81.84 1.85 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.105 -0.997 . . . . 0.0 110.665 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.634 HG21 ' HB1' ' A' ' 108' ' ' ALA . 30.1 mm -119.48 159.86 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.301 -0.874 . . . . 0.0 109.774 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.527 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 6.3 tt0 -152.8 131.75 12.54 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.006 -1.059 . . . . 0.0 110.762 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 19.5 pt-20 37.8 -154.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.64 -0.662 . . . . 0.0 111.022 179.556 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.473 ' HA2' ' HA ' ' A' ' 109' ' ' SER . . . -84.58 83.47 1.63 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.636 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.2 m -112.05 170.58 8.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -1.166 . . . . 0.0 109.781 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.567 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 0.7 OUTLIER -89.88 154.12 20.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.234 -0.916 . . . . 0.0 110.311 -179.902 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.636 ' CE2' HG22 ' A' ' 58' ' ' THR . 61.8 m-85 -158.95 -179.62 8.21 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.257 -0.902 . . . . 0.0 110.112 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.519 ' O ' HD12 ' A' ' 146' ' ' LEU . 94.6 m -150.01 111.28 4.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.276 -0.89 . . . . 0.0 110.065 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.643 HD22 ' CD2' ' A' ' 89' ' ' LEU . 20.4 tp -89.7 121.3 31.74 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.183 -0.948 . . . . 0.0 110.201 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.514 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 26.5 ttp180 -127.67 138.11 52.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.324 -0.86 . . . . 0.0 109.894 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.519 ' CE2' ' HB ' ' A' ' 102' ' ' VAL . 6.3 p90 -174.9 151.29 1.35 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.278 -0.889 . . . . 0.0 109.821 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.514 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 78.1 m -119.39 91.03 3.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.149 -0.969 . . . . 0.0 110.092 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.566 ' HB1' HD21 ' A' ' 95' ' ' LEU . . . -89.79 143.1 27.08 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.387 -0.821 . . . . 0.0 110.423 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.468 ' OG1' ' HA ' ' A' ' 99' ' ' PRO . 99.4 m -143.84 116.2 8.53 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.281 -0.887 . . . . 0.0 110.205 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.631 ' HB3' ' HB3' ' A' ' 95' ' ' LEU . . . -109.14 126.48 53.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.3 -0.875 . . . . 0.0 109.874 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.433 ' C ' ' O ' ' A' ' 68' ' ' ALA . 0.4 OUTLIER -43.98 -26.41 0.28 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.234 -0.916 . . . . 0.0 109.573 179.709 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.565 HG22 ' HB2' ' A' ' 137' ' ' TRP . 2.7 t -110.41 169.87 8.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.543 -0.723 . . . . 0.0 110.01 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.488 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 12.5 t70 -87.16 51.85 2.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.177 -0.952 . . . . 0.0 108.988 178.785 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.999 HG23 ' HB2' ' A' ' 133' ' ' SER . 4.0 p -66.62 135.33 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.519 -0.738 . . . . 0.0 111.353 -178.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 92.2 m -119.86 79.89 1.51 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.728 HG21 HD22 ' A' ' 129' ' ' LEU . 7.5 m -89.68 -142.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.317 -0.864 . . . . 0.0 110.443 -178.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.583 ' N ' HG23 ' A' ' 74' ' ' VAL . 0.7 OUTLIER -130.27 145.88 51.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.164 -0.96 . . . . 0.0 110.718 -179.453 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.87 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -146.19 150.42 35.81 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.333 -0.854 . . . . 0.0 109.594 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.015 HD11 ' HB3' ' A' ' 126' ' ' ALA . 1.3 pp 175.6 -158.81 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.258 -0.901 . . . . 0.0 110.489 -179.536 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.742 HG23 HD22 ' A' ' 89' ' ' LEU . 5.4 t -145.65 167.63 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.415 -0.803 . . . . 0.0 109.299 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.492 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . -178.02 -171.41 41.37 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.168 -1.491 . . . . 0.0 110.444 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.505 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 26.6 tp60 -114.22 102.14 9.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.493 -1.004 . . . . 0.0 110.212 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 6.6 m-20 -63.08 95.57 0.08 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.152 -0.968 . . . . 0.0 110.234 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.536 ' C ' ' CE1' ' A' ' 85' ' ' TYR . . . 119.87 130.43 4.0 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.627 ' N ' ' CE1' ' A' ' 85' ' ' TYR . . . -42.99 153.46 0.34 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.294 -1.121 . . . . 0.0 110.196 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.457 ' C ' ' HA ' ' A' ' 83' ' ' ALA . 51.1 Cg_endo -78.09 11.85 16.16 Favored 'Cis proline' 0 C--N 1.312 -1.352 0 C-N-CA 121.648 -2.23 . . . . 0.0 111.066 0.053 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.627 ' CE1' ' N ' ' A' ' 83' ' ' ALA . 37.1 m-85 61.24 -158.87 0.33 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.098 -1.001 . . . . 0.0 110.197 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 135.9 101.53 0.64 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.8 p -89.84 139.69 30.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.276 -1.131 . . . . 0.0 110.236 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 1.033 HG23 HD12 ' A' ' 89' ' ' LEU . 22.9 m -120.08 -16.77 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.252 -0.905 . . . . 0.0 110.148 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 1.033 HD12 HG23 ' A' ' 88' ' ' VAL . 4.2 mp -118.85 139.59 51.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.296 -0.878 . . . . 0.0 110.978 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -151.12 85.17 1.33 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.425 -0.797 . . . . 0.0 109.969 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.8 p -142.76 -175.59 4.55 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.997 -1.064 . . . . 0.0 110.854 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.53 112.35 35.66 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.444 -0.785 . . . . 0.0 109.905 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.87 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 43.4 Cg_endo -70.77 92.62 0.61 Allowed 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 124.023 1.539 . . . . 0.0 111.109 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.597 ' C ' HD12 ' A' ' 95' ' ' LEU . . . -84.64 129.45 34.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.229 -0.919 . . . . 0.0 109.373 179.113 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.631 ' HB3' ' HB3' ' A' ' 68' ' ' ALA . 7.5 mp -119.69 -178.53 3.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.046 -1.034 . . . . 0.0 111.083 -179.314 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -179.99 -178.59 0.43 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.561 -0.712 . . . . 0.0 109.846 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.93 -12.3 17.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.206 -0.934 . . . . 0.0 110.148 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -99.99 158.83 31.34 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.263 -0.898 . . . . 0.0 110.11 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.468 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 44.3 Cg_endo -72.65 140.12 32.11 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.962 1.506 . . . . 0.0 110.348 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.522 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 32.0 ttm-85 -119.91 94.11 4.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.215 -0.928 . . . . 0.0 110.38 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.481 ' HG2' ' OG1' ' A' ' 65' ' ' THR . 17.0 mt-30 -84.98 92.98 8.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.398 -0.813 . . . . 0.0 109.666 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.519 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 38.9 t -89.12 133.6 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.289 -0.882 . . . . 0.0 110.434 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -150.39 130.26 13.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.404 -0.81 . . . . 0.0 110.028 179.96 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -159.19 139.39 12.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.168 -0.957 . . . . 0.0 110.416 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.489 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 88.0 m -94.7 106.65 18.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.305 -0.872 . . . . 0.0 110.123 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.666 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 38.7 p90 -113.24 157.18 22.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.275 -0.891 . . . . 0.0 110.324 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 58' ' ' THR . 26.2 m -89.97 90.17 8.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.292 -0.88 . . . . 0.0 110.016 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.634 ' HB1' HG21 ' A' ' 54' ' ' ILE . . . -45.88 105.44 0.06 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.258 -0.901 . . . . 0.0 110.348 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.473 ' HA ' ' HA2' ' A' ' 57' ' ' GLY . 79.4 p -91.84 51.4 1.83 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.232 -0.917 . . . . 0.0 110.237 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.43 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -159.46 -155.26 0.45 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.259 -0.901 . . . . 0.0 110.242 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 18.7 m -144.91 113.4 6.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.273 -0.892 . . . . 0.0 110.215 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.568 ' CG ' ' HA3' ' A' ' 123' ' ' GLY . 18.0 m-30 -111.2 86.25 6.15 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.288 -0.882 . . . . 0.0 110.101 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.487 ' HD2' ' OE1' ' A' ' 80' ' ' GLN . 44.6 Cg_endo -72.28 140.16 33.33 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.938 1.494 . . . . 0.0 110.333 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.21 -0.931 . . . . 0.0 110.266 -179.911 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.483 ' N ' ' CD ' ' A' ' 122' ' ' GLU . 3.2 pm0 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.23 0.538 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.568 ' HA3' ' CG ' ' A' ' 112' ' ' TYR . . . -89.48 150.55 21.31 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.524 ' O ' HG13 ' A' ' 78' ' ' VAL . 1.2 pp0? -150.31 -157.75 0.85 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.315 -1.109 . . . . 0.0 110.399 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.881 HG21 ' CH2' ' A' ' 16' ' ' TRP . 17.0 mt -118.43 141.55 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.526 -0.734 . . . . 0.0 109.309 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 1.015 ' HB3' HD11 ' A' ' 77' ' ' LEU . . . -117.62 122.8 44.57 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.302 -0.874 . . . . 0.0 111.098 -179.28 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.479 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 4.1 m-85 -118.73 101.51 8.15 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.643 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLN . . . . . 0.597 ' O ' ' CE2' ' A' ' 132' ' ' PHE . 0.4 OUTLIER -89.17 85.41 6.64 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.101 -0.999 . . . . 0.0 112.09 -177.738 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 1.086 HD13 HD13 ' A' ' 139' ' ' LEU . 0.6 OUTLIER -93.38 48.23 1.3 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.325 -0.86 . . . . 0.0 108.887 178.053 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.475 ' HA3' ' HA2' ' A' ' 44' ' ' GLY . . . -108.27 135.63 12.96 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.864 -1.16 . . . . 0.0 110.753 -178.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 130' ' ' GLY . . . 39.14 55.22 2.43 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 179.382 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.602 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 8.0 m-85 -118.46 -58.02 2.01 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.089 -1.242 . . . . 0.0 110.719 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.999 ' HB2' HG23 ' A' ' 72' ' ' VAL . 1.3 t -88.74 -179.71 6.06 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.921 -1.112 . . . . 0.0 110.283 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -100.69 -74.25 0.62 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.245 -0.909 . . . . 0.0 110.249 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -72.65 174.42 7.6 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.209 -0.932 . . . . 0.0 110.07 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.528 ' CA ' ' HA ' ' A' ' 38' ' ' ALA . . . -70.38 127.94 34.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.274 -0.891 . . . . 0.0 110.286 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.995 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 6.1 p90 -132.27 -161.97 1.19 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.267 -0.895 . . . . 0.0 110.138 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.527 ' OG1' ' HA ' ' A' ' 35' ' ' ALA . 0.8 OUTLIER -160.26 166.18 30.04 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.138 -1.025 . . . . 0.0 110.57 -177.775 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 1.086 HD13 HD13 ' A' ' 129' ' ' LEU . 2.2 mp -124.15 127.51 47.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.461 -0.775 . . . . 0.0 109.282 179.168 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' CYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 52.9 m -125.27 95.75 4.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.072 -1.017 . . . . 0.0 110.9 -179.388 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.764 HD12 HD23 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -89.86 -177.69 5.29 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.21 -0.931 . . . . 0.0 109.218 179.033 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.631 ' O ' HG22 ' A' ' 8' ' ' THR . 0.6 OUTLIER 169.37 48.15 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.252 -0.905 . . . . 0.0 110.235 -179.96 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.492 ' HA ' ' O ' ' A' ' 7' ' ' GLY . 11.3 t0 177.05 46.3 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.441 -0.787 . . . . 0.0 109.148 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.663 HG11 ' HZ2' ' A' ' 16' ' ' TRP . 1.0 OUTLIER -89.21 124.74 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.478 -0.764 . . . . 0.0 110.305 -178.981 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -158.52 152.71 24.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.386 -0.821 . . . . 0.0 110.075 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.519 HD12 ' O ' ' A' ' 61' ' ' THR . 23.1 tp -149.93 153.36 36.5 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.267 -0.895 . . . . 0.0 110.218 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.456 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 34.0 t70 -176.5 152.56 1.07 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.241 -0.912 . . . . 0.0 110.273 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 59' ' ' THR . 78.7 p . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.268 -0.895 . . . . 0.0 110.205 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo . . . . . 0 N--CA 1.484 0.914 0 N-CA-C 110.486 -0.621 . . . . 0.0 110.486 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.579 ' HB ' HD21 ' A' ' 49' ' ' LEU . 6.4 pt -107.71 31.0 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -0.901 . . . . 0.0 110.068 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.436 ' O ' ' HB3' ' A' ' 6' ' ' GLU . . . 81.08 -169.52 51.88 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' A' ' 144' ' ' VAL . 9.0 pt-20 176.29 65.54 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.102 -1.234 . . . . 0.0 110.358 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.595 ' C ' HG23 ' A' ' 8' ' ' THR . . . 164.52 -64.55 0.23 Allowed Glycine 0 N--CA 1.488 2.164 0 C-N-CA 119.689 -1.243 . . . . 0.0 110.002 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.595 HG23 ' C ' ' A' ' 7' ' ' GLY . 73.6 p -156.41 -154.44 0.48 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.216 -1.167 . . . . 0.0 110.302 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.602 ' HZ ' HG21 ' A' ' 144' ' ' VAL . 33.0 m-85 -135.29 42.58 2.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -0.874 . . . . 0.0 110.263 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.55 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 26.7 t0 -88.14 49.01 1.72 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.202 -0.936 . . . . 0.0 110.247 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.55 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.5 OUTLIER 161.66 80.43 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.675 -0.641 . . . . 0.0 109.735 -179.963 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 11' ' ' ASP . . . 62.83 127.3 0.01 OUTLIER Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.52 ' O ' ' N ' ' A' ' 15' ' ' GLY . 50.2 Cg_endo -80.89 42.09 1.27 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 O-C-N 123.839 1.442 . . . . 0.0 110.987 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.441 ' HA ' ' OE1' ' A' ' 14' ' ' GLU . 4.7 mm-40 46.72 -92.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.003 -1.061 . . . . 0.0 110.288 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.705 ' O ' HG13 ' A' ' 17' ' ' VAL . . . -140.61 -0.06 1.85 Allowed Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.818 -1.182 . . . . 0.0 110.469 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.954 ' CH2' HG21 ' A' ' 125' ' ' ILE . 46.6 m95 -53.54 88.63 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.004 -1.292 . . . . 0.0 110.402 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.747 ' O ' HG13 ' A' ' 47' ' ' VAL . 1.0 OUTLIER -87.81 150.67 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.035 -1.04 . . . . 0.0 109.627 179.558 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.721 ' CB ' HG12 ' A' ' 34' ' ' VAL . . . -131.29 158.38 40.79 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.174 -0.954 . . . . 0.0 109.831 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.639 ' CD1' ' N ' ' A' ' 19' ' ' TYR . 3.5 p90 -150.5 166.21 30.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.31 -0.869 . . . . 0.0 110.5 -178.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.516 ' C ' ' CG2' ' A' ' 21' ' ' THR . . . 161.04 -96.78 0.15 Allowed Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.014 -1.634 . . . . 0.0 109.014 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.516 ' CG2' ' C ' ' A' ' 20' ' ' GLY . 6.5 p -153.91 18.39 0.51 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.115 -1.227 . . . . 0.0 111.224 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.699 ' CB ' ' HB1' ' A' ' 35' ' ' ALA . 0.8 OUTLIER -137.36 -179.95 6.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.664 -1.272 . . . . 0.0 110.607 179.743 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 22' ' ' ASP . . . -42.22 164.59 0.02 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 25' ' ' LEU . 45.5 Cg_endo -72.48 160.87 45.71 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.102 1.58 . . . . 0.0 110.409 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.719 HD23 ' H ' ' A' ' 25' ' ' LEU . 0.7 OUTLIER -41.8 151.2 0.09 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.306 -0.871 . . . . 0.0 110.394 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.508 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 79.7 m-20 -124.43 137.11 54.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.317 -0.864 . . . . 0.0 109.829 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.537 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.8 OUTLIER -119.95 -26.76 5.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.099 -1.001 . . . . 0.0 110.55 -179.705 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.684 ' C ' HG22 ' A' ' 29' ' ' THR . 12.0 m -49.75 82.96 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.788 -0.57 . . . . 0.0 111.248 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.684 HG22 ' C ' ' A' ' 28' ' ' SER . 0.0 OUTLIER 166.62 -31.77 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.229 -0.919 . . . . 0.0 109.948 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 128.37 0.32 6.32 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -150.46 161.17 43.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.137 -1.214 . . . . 0.0 110.214 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.544 HD23 ' O ' ' A' ' 32' ' ' LEU . 0.3 OUTLIER -104.08 99.37 9.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.178 -0.951 . . . . 0.0 110.134 179.911 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.585 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 0.8 OUTLIER -96.09 117.0 29.84 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.197 -0.94 . . . . 0.0 111.61 -179.773 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.721 HG12 ' CB ' ' A' ' 18' ' ' ALA . 30.2 m -89.43 149.97 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.122 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.699 ' HB1' ' CB ' ' A' ' 22' ' ' ASP . . . -89.83 126.32 35.65 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.016 -1.052 . . . . 0.0 111.529 -178.333 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.038 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 48.7 t -126.73 119.63 22.78 Favored Pre-proline 0 C--N 1.303 -1.455 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.239 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.496 ' HG2' ' HA ' ' A' ' 40' ' ' SER . 39.7 Cg_endo -66.23 -177.74 0.93 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.753 1.397 . . . . 0.0 111.324 -179.005 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.536 ' HA ' ' N ' ' A' ' 136' ' ' ALA . . . -56.14 126.66 27.05 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.436 -0.79 . . . . 0.0 111.157 -179.061 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.501 ' O ' ' C ' ' A' ' 40' ' ' SER . . . 40.33 28.05 0.17 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.948 ' OG ' HG23 ' A' ' 45' ' ' VAL . 15.0 t 31.68 60.01 0.3 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.819 -0.812 . . . . 0.0 110.593 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.478 ' O ' ' HB3' ' A' ' 42' ' ' GLN . . . -88.72 95.21 10.18 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.278 -0.889 . . . . 0.0 109.864 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.807 ' NE2' HG22 ' A' ' 45' ' ' VAL . 2.0 pt20 179.83 -150.27 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 121.308 0.575 . . . . 0.0 109.822 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.531 ' CD1' ' HG3' ' A' ' 42' ' ' GLN . 16.0 p90 -61.41 -12.72 15.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.331 -0.856 . . . . 0.0 109.898 179.597 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.417 ' O ' ' CE2' ' A' ' 43' ' ' TYR . . . 109.75 129.14 5.69 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.948 HG23 ' OG ' ' A' ' 40' ' ' SER . 9.4 t -89.29 170.45 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.173 -1.193 . . . . 0.0 108.572 179.362 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.519 ' CA ' ' O ' ' A' ' 127' ' ' PHE . . . 169.76 -174.02 43.97 Favored Glycine 0 N--CA 1.487 2.052 0 C-N-CA 118.997 -1.573 . . . . 0.0 110.559 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.747 HG13 ' O ' ' A' ' 17' ' ' VAL . 41.4 t -150.39 129.08 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.602 -0.94 . . . . 0.0 108.781 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.642 ' O ' HG22 ' A' ' 17' ' ' VAL . 32.9 m -119.97 135.68 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.081 -1.012 . . . . 0.0 110.987 -179.038 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.846 HD22 ' NE1' ' A' ' 16' ' ' TRP . 21.3 tp -128.67 96.71 4.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.393 -0.817 . . . . 0.0 110.24 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.512 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 12.9 p30 -75.13 134.94 41.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.909 . . . . 0.0 110.186 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 136.38 76.85 0.08 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.556 ' CG2' ' HA ' ' A' ' 124' ' ' GLN . 18.1 t -139.37 167.26 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -1.173 . . . . 0.0 110.023 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.413 ' N ' HG12 ' A' ' 52' ' ' VAL . . . -137.75 83.82 2.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.195 -0.941 . . . . 0.0 110.488 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.732 HG21 ' HB1' ' A' ' 108' ' ' ALA . 43.2 mm -115.92 158.78 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.227 -0.92 . . . . 0.0 109.918 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.493 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 7.9 tp10 -151.78 134.34 15.43 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.208 -0.933 . . . . 0.0 110.366 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.565 ' CG ' ' N ' ' A' ' 57' ' ' GLY . 1.1 pt-20 37.03 -157.01 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.698 -0.626 . . . . 0.0 110.73 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.565 ' N ' ' CG ' ' A' ' 56' ' ' GLU . . . -84.04 90.68 1.61 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.633 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.2 m -118.73 173.86 6.62 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.306 -1.114 . . . . 0.0 109.79 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.572 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 0.6 OUTLIER -89.82 153.85 20.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.268 -0.895 . . . . 0.0 110.494 -179.758 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.633 ' CE2' HG22 ' A' ' 58' ' ' THR . 59.2 m-85 -159.88 121.79 3.29 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.271 -0.893 . . . . 0.0 110.218 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 89.2 m -90.87 114.74 27.25 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.213 -0.929 . . . . 0.0 109.983 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.0 tp -89.55 120.85 31.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.209 -0.932 . . . . 0.0 109.945 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.522 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 12.7 ttp180 -125.59 130.17 51.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.309 -0.87 . . . . 0.0 110.227 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 1.122 ' CZ ' HG21 ' A' ' 102' ' ' VAL . 0.8 OUTLIER -170.33 142.98 2.26 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.294 -0.879 . . . . 0.0 109.821 179.756 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.496 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 16.9 m -119.16 97.63 5.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.289 -0.882 . . . . 0.0 110.079 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.697 ' CB ' HD21 ' A' ' 95' ' ' LEU . . . -98.98 149.38 23.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.382 -0.824 . . . . 0.0 110.328 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.749 HG23 ' O ' ' A' ' 98' ' ' GLU . 90.3 m -150.52 102.22 3.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -0.884 . . . . 0.0 110.198 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.47 ' O ' ' O ' ' A' ' 96' ' ' THR . . . -89.82 131.24 35.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.233 -0.917 . . . . 0.0 109.977 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.45 ' C ' ' O ' ' A' ' 68' ' ' ALA . 1.2 p -42.72 -27.17 0.16 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.298 -0.876 . . . . 0.0 109.522 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.599 ' CG2' ' CB ' ' A' ' 137' ' ' TRP . 1.7 t -109.87 161.34 15.56 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.559 -0.713 . . . . 0.0 109.836 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.19 76.69 6.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.056 -1.027 . . . . 0.0 109.25 179.05 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.791 HG23 ' CB ' ' A' ' 133' ' ' SER . 4.3 p -99.75 135.62 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.27 -0.894 . . . . 0.0 111.292 -178.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 89.6 m -121.09 87.13 2.7 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 1.113 HG21 HD23 ' A' ' 129' ' ' LEU . 5.1 m -89.7 -149.18 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.246 -0.909 . . . . 0.0 110.764 -178.705 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.482 ' N ' HG23 ' A' ' 74' ' ' VAL . 0.3 OUTLIER -128.43 121.32 28.73 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.262 -0.898 . . . . 0.0 110.656 -179.479 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.508 ' N ' ' HD3' ' A' ' 93' ' ' PRO . . . -119.03 161.36 20.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.217 -0.927 . . . . 0.0 109.643 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.75 ' CD1' ' HB3' ' A' ' 126' ' ' ALA . 3.5 pp 177.15 -158.83 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.128 -0.982 . . . . 0.0 110.463 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.898 HG23 HD22 ' A' ' 89' ' ' LEU . 19.5 t -149.54 165.0 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.433 -0.792 . . . . 0.0 109.266 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.542 ' C ' ' CE1' ' A' ' 112' ' ' TYR . . . -172.81 -166.75 31.79 Favored Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.056 -1.545 . . . . 0.0 110.587 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.54 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 4.7 tp60 -114.34 85.93 2.33 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.508 -0.995 . . . . 0.0 110.391 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 2.1 m-80 -66.0 100.13 0.56 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.066 -1.022 . . . . 0.0 109.308 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.636 ' O ' ' HB2' ' A' ' 83' ' ' ALA . . . 152.0 -87.67 0.14 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.466 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.636 ' HB2' ' O ' ' A' ' 82' ' ' GLY . . . 173.24 145.68 0.19 Allowed Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.189 -1.183 . . . . 0.0 110.192 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.511 ' C ' ' CD2' ' A' ' 85' ' ' TYR . 51.0 Cg_endo -84.56 32.8 4.41 Favored 'Cis proline' 0 C--N 1.313 -1.314 0 C-N-CA 121.9 -2.125 . . . . 0.0 110.663 -0.245 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.575 ' CZ ' ' O ' ' A' ' 82' ' ' GLY . 17.6 m-85 64.47 -172.67 0.18 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.165 -0.959 . . . . 0.0 110.402 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 140.03 99.38 0.41 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.483 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 1.4 p -89.8 143.59 26.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.25 -1.147 . . . . 0.0 110.367 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 1.037 HG23 HD12 ' A' ' 89' ' ' LEU . 27.0 m -123.93 -16.95 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.313 -0.867 . . . . 0.0 110.332 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 1.037 HD12 HG23 ' A' ' 88' ' ' VAL . 4.1 mp -105.36 139.87 39.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.204 -0.935 . . . . 0.0 110.924 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.733 ' O ' HG23 ' A' ' 91' ' ' THR . 1.6 m-20 -150.68 94.29 2.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.379 -0.826 . . . . 0.0 110.194 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.733 HG23 ' O ' ' A' ' 90' ' ' ASP . 3.9 p -160.07 -175.09 4.88 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.162 -0.962 . . . . 0.0 110.44 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.4 p -125.35 128.87 24.63 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.285 -0.885 . . . . 0.0 110.143 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.79 ' HG2' HG22 ' A' ' 74' ' ' VAL . 50.2 Cg_endo -74.14 77.02 2.89 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.883 1.465 . . . . 0.0 110.983 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.683 ' HB3' ' NH1' ' A' ' 100' ' ' ARG . . . -50.47 136.45 20.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.996 -1.065 . . . . 0.0 109.348 179.351 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.814 ' CD1' HD21 ' A' ' 139' ' ' LEU . 35.4 mt -135.63 168.12 19.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.991 -1.068 . . . . 0.0 110.891 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.762 HG23 ' H ' ' A' ' 98' ' ' GLU . 6.7 t -165.8 -153.18 0.17 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.444 -0.785 . . . . 0.0 109.914 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.529 ' N ' HG23 ' A' ' 96' ' ' THR . 0.1 OUTLIER -85.94 -28.19 24.45 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.103 -0.998 . . . . 0.0 110.391 -179.816 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.762 ' H ' HG23 ' A' ' 96' ' ' THR . 0.6 OUTLIER -89.77 176.5 3.04 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.238 -0.914 . . . . 0.0 110.06 179.974 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.507 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 45.4 Cg_endo -72.09 134.03 22.48 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 123.979 1.515 . . . . 0.0 110.327 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.683 ' NH1' ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.53 84.03 2.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.18 -0.95 . . . . 0.0 110.22 -179.87 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.455 ' HG2' ' OG1' ' A' ' 65' ' ' THR . 56.1 mt-30 -69.02 155.98 39.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.32 -0.862 . . . . 0.0 110.124 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 1.122 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 58.6 t -133.43 133.71 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.25 -0.906 . . . . 0.0 110.111 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.33 111.51 4.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.25 -0.906 . . . . 0.0 110.109 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -153.59 151.59 29.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.159 -0.963 . . . . 0.0 110.356 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -108.39 122.09 46.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.283 -0.886 . . . . 0.0 110.063 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.858 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 41.4 p90 -127.93 153.32 46.82 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.236 -0.915 . . . . 0.0 110.299 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 58' ' ' THR . 3.6 m -89.93 94.24 9.73 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.276 -0.89 . . . . 0.0 110.063 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.732 ' HB1' HG21 ' A' ' 54' ' ' ILE . . . -53.64 99.42 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.244 -0.91 . . . . 0.0 110.309 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.524 ' N ' ' CG1' ' A' ' 88' ' ' VAL . 54.3 p -85.93 55.66 3.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.18 -0.95 . . . . 0.0 109.945 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -160.29 -151.31 0.24 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.315 -0.866 . . . . 0.0 110.298 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.432 HG23 ' HA ' ' A' ' 55' ' ' GLU . 46.2 m -158.14 116.42 3.05 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.323 -0.861 . . . . 0.0 110.414 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.652 ' CE2' HG12 ' A' ' 78' ' ' VAL . 12.7 m-30 -112.22 109.87 53.97 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.302 -0.874 . . . . 0.0 109.784 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.516 ' HD2' ' OE1' ' A' ' 80' ' ' GLN . 47.7 Cg_endo -75.48 96.2 1.03 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.849 1.447 . . . . 0.0 110.539 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.245 -0.91 . . . . 0.0 110.127 179.935 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.487 ' O ' ' HB2' ' A' ' 81' ' ' ASN . 5.0 pt-20 . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 121.177 0.513 . . . . 0.0 110.357 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.582 ' HA3' ' CG ' ' A' ' 112' ' ' TYR . . . -90.59 148.09 19.38 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.592 ' O ' HG13 ' A' ' 78' ' ' VAL . 15.6 pt20 -150.31 -155.66 0.65 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.289 -1.124 . . . . 0.0 110.491 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.954 HG21 ' CH2' ' A' ' 16' ' ' TRP . 7.6 mt -118.22 141.26 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.538 -0.726 . . . . 0.0 109.256 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.75 ' HB3' ' CD1' ' A' ' 77' ' ' LEU . . . -117.6 121.75 41.77 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.36 -0.837 . . . . 0.0 111.291 -179.081 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.519 ' O ' ' CA ' ' A' ' 46' ' ' GLY . 4.4 m-85 -118.99 91.2 3.5 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 178.405 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -88.57 93.92 9.71 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.944 -1.097 . . . . 0.0 112.449 -177.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 1.113 HD23 HG21 ' A' ' 74' ' ' VAL . 12.9 mt -90.87 44.16 1.18 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 177.587 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 131' ' ' GLY . . . -82.29 115.54 4.04 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 -179.048 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.482 ' HA2' ' O ' ' A' ' 39' ' ' GLY . . . 40.36 93.1 0.01 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.586 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 8.9 m-85 -143.55 -52.59 0.35 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.099 -1.236 . . . . 0.0 110.704 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.791 ' CB ' HG23 ' A' ' 72' ' ' VAL . 1.3 t -89.26 175.3 7.4 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.973 -1.079 . . . . 0.0 110.399 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -80.93 -88.13 0.08 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.257 -0.902 . . . . 0.0 110.033 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 135' ' ' ASP . 3.9 m-20 -67.27 -173.41 0.28 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -0.909 . . . . 0.0 109.774 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.536 ' N ' ' HA ' ' A' ' 38' ' ' ALA . . . -78.94 149.33 32.37 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.229 -0.919 . . . . 0.0 110.248 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 1.038 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 15.1 p90 -151.8 -160.0 1.09 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.152 -0.967 . . . . 0.0 111.162 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.544 ' C ' HD12 ' A' ' 139' ' ' LEU . 0.8 OUTLIER -159.65 178.53 9.74 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -178.596 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.814 HD21 ' CD1' ' A' ' 95' ' ' LEU . 1.7 mp -139.91 115.54 10.09 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.766 -1.209 . . . . 0.0 112.082 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' CYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 0.8 OUTLIER -103.34 104.35 14.45 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.727 -0.608 . . . . 0.0 110.662 178.492 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.535 HD23 ' HB2' ' A' ' 66' ' ' ALA . 1.4 mt -90.22 -178.67 5.45 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.217 -0.927 . . . . 0.0 109.305 179.028 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.545 ' O ' ' CB ' ' A' ' 143' ' ' ASP . 2.3 p30 166.9 68.24 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.263 -0.898 . . . . 0.0 110.172 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.545 ' CB ' ' O ' ' A' ' 142' ' ' ASP . 0.4 OUTLIER 161.89 42.79 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.879 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.64 HG11 ' CZ2' ' A' ' 16' ' ' TRP . 1.5 t -89.4 115.93 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.418 -0.801 . . . . 0.0 110.684 -178.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.428 ' HB2' ' HA ' ' A' ' 6' ' ' GLU . . . -148.26 139.84 23.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.463 -0.773 . . . . 0.0 109.912 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.579 HD21 HD11 ' A' ' 54' ' ' ILE . 28.6 tp -129.93 152.7 49.12 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.305 -0.872 . . . . 0.0 110.332 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.464 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -161.83 -175.78 4.87 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.248 -0.907 . . . . 0.0 110.149 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.429 ' O ' ' OG ' ' A' ' 148' ' ' SER . 9.3 p . . . . . 0 N--CA 1.493 1.676 0 O-C-N 121.2 -0.937 . . . . 0.0 110.174 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo . . . . . 0 N--CA 1.483 0.873 0 N-CA-C 110.616 -0.571 . . . . 0.0 110.616 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.517 ' CD1' HG12 ' A' ' 144' ' ' VAL . 32.7 pt -107.36 40.41 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.183 -0.948 . . . . 0.0 109.979 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' A' ' 7' ' ' GLY . . . 103.78 -45.48 1.32 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.454 ' HA ' ' HB2' ' A' ' 145' ' ' ALA . 44.4 mt-10 41.67 28.08 0.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.354 -1.086 . . . . 0.0 110.306 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' A' ' 143' ' ' ASP . . . -158.85 -166.28 17.58 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 34.0 p -72.59 165.81 23.96 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.307 -1.113 . . . . 0.0 110.377 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.603 ' CZ ' HG21 ' A' ' 144' ' ' VAL . 3.1 m-30 -93.7 56.57 2.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.336 -0.852 . . . . 0.0 110.135 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.537 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 16.0 t0 -114.39 52.35 0.84 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.183 -0.948 . . . . 0.0 110.202 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.537 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 2.2 t70 161.76 78.14 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.753 -0.592 . . . . 0.0 109.657 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.02 133.51 0.33 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.611 ' HB3' HD12 ' A' ' 32' ' ' LEU . 50.2 Cg_endo -77.3 5.82 4.81 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.943 1.496 . . . . 0.0 110.635 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 0.8 OUTLIER 66.44 -85.72 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.158 -0.964 . . . . 0.0 110.184 -179.853 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.781 ' C ' HD13 ' A' ' 49' ' ' LEU . . . -142.71 8.3 2.26 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.857 ' CD1' HD22 ' A' ' 49' ' ' LEU . 45.9 m95 -72.92 93.03 1.68 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.127 -1.22 . . . . 0.0 110.343 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.821 ' O ' HG13 ' A' ' 47' ' ' VAL . 1.5 m -95.49 152.23 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.148 -0.97 . . . . 0.0 109.895 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.759 ' CB ' HG11 ' A' ' 34' ' ' VAL . . . -129.96 127.54 40.27 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.164 -0.96 . . . . 0.0 109.725 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.585 ' HE2' HG13 ' A' ' 48' ' ' VAL . 10.9 p90 -121.17 158.34 28.19 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.291 -0.881 . . . . 0.0 110.739 -178.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.516 ' CA ' ' OH ' ' A' ' 43' ' ' TYR . . . 90.57 35.01 7.55 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 179.383 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.5 ' CG2' ' C ' ' A' ' 20' ' ' GLY . 5.4 p -150.89 -154.94 0.58 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.98 -1.306 . . . . 0.0 110.499 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.46 ' O ' ' O ' ' A' ' 23' ' ' GLY . 8.2 t0 -94.87 132.01 40.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.353 -0.842 . . . . 0.0 110.363 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 22' ' ' ASP . . . 44.41 -168.1 0.02 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.58 -159.85 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.062 1.559 . . . . 0.0 110.484 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.933 HD13 HD11 ' A' ' 32' ' ' LEU . 0.4 OUTLIER -101.21 161.39 13.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.258 -0.901 . . . . 0.0 110.222 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -116.86 140.04 49.91 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.205 -0.935 . . . . 0.0 110.008 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.509 ' HA ' ' O ' ' A' ' 31' ' ' ALA . 0.7 OUTLIER -128.24 -22.69 3.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.144 -0.973 . . . . 0.0 111.212 -179.55 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.2 -17.87 0.28 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.26 -0.9 . . . . 0.0 111.173 -179.459 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.544 HG23 ' H ' ' A' ' 31' ' ' ALA . 2.6 t -72.1 6.37 2.21 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.049 -1.032 . . . . 0.0 111.519 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.55 -12.28 67.81 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.644 ' HB3' ' SG ' ' A' ' 140' ' ' CYS . . . -150.97 167.99 25.92 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.481 -1.011 . . . . 0.0 109.503 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.933 HD11 HD13 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -87.04 90.92 8.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.967 -1.083 . . . . 0.0 110.163 179.906 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.555 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 0.8 OUTLIER -99.45 111.78 24.09 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.387 -0.821 . . . . 0.0 111.507 179.987 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.759 HG11 ' CB ' ' A' ' 18' ' ' ALA . 15.7 m -89.86 146.11 6.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.153 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.496 ' O ' ' HB ' ' A' ' 21' ' ' THR . . . -88.55 72.44 8.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.541 -0.725 . . . . 0.0 110.982 -178.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.095 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 56.3 t -58.66 134.07 86.15 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.322 -0.861 . . . . 0.0 109.564 179.325 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.487 ' HG2' ' HA ' ' A' ' 40' ' ' SER . 39.5 Cg_endo -67.48 176.47 4.88 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.951 1.501 . . . . 0.0 111.501 -179.17 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.511 ' HA ' ' N ' ' A' ' 136' ' ' ALA . . . -60.9 126.23 26.6 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.509 -0.744 . . . . 0.0 111.463 -178.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.534 ' O ' ' C ' ' A' ' 40' ' ' SER . . . 39.0 26.83 0.05 OUTLIER Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.901 ' OG ' HG23 ' A' ' 45' ' ' VAL . 9.6 t 27.08 59.21 0.09 Allowed 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.886 -0.773 . . . . 0.0 110.9 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.485 ' O ' ' HB3' ' A' ' 42' ' ' GLN . . . -88.36 100.8 13.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.231 -0.918 . . . . 0.0 110.201 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.485 ' HB3' ' O ' ' A' ' 41' ' ' ALA . 2.2 pt20 174.41 -158.78 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.516 ' OH ' ' CA ' ' A' ' 20' ' ' GLY . 8.9 p90 -50.32 -24.0 2.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.096 -1.002 . . . . 0.0 109.726 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.516 ' O ' ' CE2' ' A' ' 43' ' ' TYR . . . 119.82 129.29 3.82 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.901 HG23 ' OG ' ' A' ' 40' ' ' SER . 6.2 t -89.58 177.05 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.265 -1.138 . . . . 0.0 109.001 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.57 ' O ' ' CZ ' ' A' ' 19' ' ' TYR . . . 166.15 149.32 5.88 Favored Glycine 0 N--CA 1.488 2.153 0 C-N-CA 119.166 -1.492 . . . . 0.0 110.552 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.821 HG13 ' O ' ' A' ' 17' ' ' VAL . 43.8 t -116.24 144.18 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.552 -0.969 . . . . 0.0 109.449 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.585 HG13 ' HE2' ' A' ' 19' ' ' TYR . 29.0 m -138.56 153.96 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.834 -1.166 . . . . 0.0 111.004 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.857 HD22 ' CD1' ' A' ' 16' ' ' TRP . 14.8 tp -140.89 99.66 3.65 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.446 -0.784 . . . . 0.0 109.929 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.513 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 8.6 t30 -78.11 133.34 37.87 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.248 -0.907 . . . . 0.0 110.542 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 139.34 55.32 0.05 OUTLIER Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.639 HG11 ' HD2' ' A' ' 112' ' ' TYR . 53.3 t -120.04 161.11 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.092 -1.24 . . . . 0.0 110.278 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 112' ' ' TYR . . . -130.83 96.8 4.16 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.186 -0.946 . . . . 0.0 110.65 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.758 HG21 ' HB1' ' A' ' 108' ' ' ALA . 50.6 mm -131.65 160.51 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.268 -0.895 . . . . 0.0 109.786 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.528 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 13.2 pt-20 -149.02 130.58 14.88 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.087 -1.008 . . . . 0.0 110.432 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.528 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 10.8 pt-20 38.14 -152.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.646 -0.659 . . . . 0.0 110.85 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.467 ' HA2' ' HA ' ' A' ' 109' ' ' SER . . . -85.28 108.43 3.2 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.671 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.1 m -136.75 174.63 10.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.238 -1.154 . . . . 0.0 109.714 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.574 ' N ' ' CG2' ' A' ' 58' ' ' THR . 0.5 OUTLIER -89.83 145.44 25.16 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.256 -0.903 . . . . 0.0 110.261 -179.922 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.819 ' HB3' HD11 ' A' ' 146' ' ' LEU . 58.5 m-85 -154.41 154.67 33.64 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.313 -0.867 . . . . 0.0 110.271 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 85.3 m -124.1 114.0 19.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.354 -0.841 . . . . 0.0 110.066 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.536 HD22 ' CD2' ' A' ' 89' ' ' LEU . 18.2 tp -89.69 121.81 32.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -0.914 . . . . 0.0 110.105 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.569 ' HD3' HG23 ' A' ' 103' ' ' THR . 8.1 mtt85 -127.33 138.25 52.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.318 -0.864 . . . . 0.0 110.287 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 1.163 ' CZ ' HG21 ' A' ' 102' ' ' VAL . 2.8 p90 -177.92 152.69 0.77 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.395 -0.816 . . . . 0.0 109.796 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.812 HG23 ' HG2' ' A' ' 101' ' ' GLN . 0.2 OUTLIER -119.28 102.8 8.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.121 -0.987 . . . . 0.0 110.105 -179.947 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.697 ' CB ' HD21 ' A' ' 95' ' ' LEU . . . -102.3 141.66 34.78 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.308 -0.87 . . . . 0.0 110.05 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.618 HG23 ' O ' ' A' ' 98' ' ' GLU . 35.0 m -150.14 107.41 3.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.294 -0.879 . . . . 0.0 110.18 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.518 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -98.3 131.68 44.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.281 -0.887 . . . . 0.0 110.169 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 68' ' ' ALA . 0.9 OUTLIER -44.47 -26.23 0.33 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.188 -0.945 . . . . 0.0 109.467 179.528 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.581 ' CG2' ' CB ' ' A' ' 137' ' ' TRP . 1.9 t -110.28 165.27 11.9 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.453 -0.78 . . . . 0.0 109.856 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.489 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 4.8 t0 -84.15 68.97 10.31 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.146 -0.971 . . . . 0.0 109.321 179.187 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.67 HG23 ' CB ' ' A' ' 133' ' ' SER . 6.1 p -86.89 134.36 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.327 -0.858 . . . . 0.0 111.248 -179.041 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 23.3 m -120.58 85.26 2.36 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.775 HG22 ' HG2' ' A' ' 93' ' ' PRO . 3.0 m -89.63 -157.95 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.25 -0.906 . . . . 0.0 110.72 -178.675 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.462 ' N ' HG23 ' A' ' 74' ' ' VAL . 0.4 OUTLIER -120.23 104.06 9.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.357 -0.839 . . . . 0.0 110.278 -179.629 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.67 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -99.9 163.75 12.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.21 -0.931 . . . . 0.0 109.851 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.076 ' CD1' ' HB3' ' A' ' 126' ' ' ALA . 2.0 pp 173.32 -161.1 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.285 -0.884 . . . . 0.0 110.132 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.906 ' CG2' HD22 ' A' ' 89' ' ' LEU . 3.6 t -146.31 168.91 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.275 -0.89 . . . . 0.0 109.58 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.54 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . 175.09 -160.45 29.3 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.416 -1.373 . . . . 0.0 109.934 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.535 ' HG3' ' HA ' ' A' ' 85' ' ' TYR . 4.7 pt20 -125.08 137.12 54.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.275 -1.132 . . . . 0.0 110.642 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -86.62 93.82 9.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.366 -0.834 . . . . 0.0 109.964 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.58 ' O ' ' CD2' ' A' ' 85' ' ' TYR . . . 148.18 -177.39 26.46 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.271 -1.531 . . . . 0.0 109.271 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.542 ' HA ' ' CD1' ' A' ' 85' ' ' TYR . . . -99.61 152.18 37.71 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.275 -1.133 . . . . 0.0 110.231 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.468 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.7 Cg_endo -83.02 30.09 4.69 Favored 'Cis proline' 0 C--N 1.312 -1.349 0 C-N-CA 121.795 -2.169 . . . . 0.0 111.021 -0.123 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.58 ' CD2' ' O ' ' A' ' 82' ' ' GLY . 57.2 m-85 60.37 -175.6 0.11 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.138 -0.976 . . . . 0.0 110.26 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.468 ' O ' ' HG2' ' A' ' 80' ' ' GLN . . . 161.95 126.67 0.83 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.0 p -120.16 146.2 46.22 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.21 -1.17 . . . . 0.0 110.099 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 1.061 HG23 HD12 ' A' ' 89' ' ' LEU . 28.9 m -125.65 -16.41 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.259 -0.901 . . . . 0.0 110.559 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 1.061 HD12 HG23 ' A' ' 88' ' ' VAL . 4.3 mp -110.88 140.93 44.93 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.118 -0.989 . . . . 0.0 111.18 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.693 ' O ' HG23 ' A' ' 91' ' ' THR . 38.9 p30 -150.9 93.4 1.94 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.411 -0.806 . . . . 0.0 110.161 179.579 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.693 HG23 ' O ' ' A' ' 90' ' ' ASP . 16.3 p -159.02 -175.96 5.58 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.026 -1.046 . . . . 0.0 110.67 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.476 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 29.0 m -120.0 135.04 24.07 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.312 -0.868 . . . . 0.0 110.075 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.775 ' HG2' HG22 ' A' ' 74' ' ' VAL . 49.5 Cg_endo -87.46 67.91 3.82 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.968 1.509 . . . . 0.0 111.063 -179.531 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.513 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -45.59 121.91 3.33 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.95 -1.094 . . . . 0.0 109.271 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.697 HD21 ' CB ' ' A' ' 66' ' ' ALA . 15.1 mt -119.87 175.32 5.95 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.086 -1.009 . . . . 0.0 110.901 -179.192 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.41 HG22 ' C ' ' A' ' 95' ' ' LEU . 0.2 OUTLIER 179.26 -178.87 0.37 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.499 -0.751 . . . . 0.0 109.953 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.94 -14.07 20.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.21 -0.931 . . . . 0.0 110.197 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.618 ' O ' HG23 ' A' ' 67' ' ' THR . 1.7 mt-10 -96.66 157.46 35.24 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.283 -0.886 . . . . 0.0 110.145 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.491 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 45.5 Cg_endo -72.51 137.42 27.84 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.971 1.511 . . . . 0.0 110.367 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.513 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.82 93.05 3.93 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.201 -0.937 . . . . 0.0 110.351 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.812 ' HG2' HG23 ' A' ' 65' ' ' THR . 0.0 OUTLIER -74.04 143.39 45.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.912 . . . . 0.0 109.818 179.633 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 1.163 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 47.5 t -121.16 132.35 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.137 -0.977 . . . . 0.0 110.407 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.569 HG23 ' HD3' ' A' ' 63' ' ' ARG . 0.2 OUTLIER -150.86 94.11 2.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.412 -0.805 . . . . 0.0 110.098 179.919 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -139.95 157.99 44.79 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.132 -0.98 . . . . 0.0 110.447 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -114.8 97.0 6.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.305 -0.872 . . . . 0.0 110.048 179.944 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.596 ' CE1' HD11 ' A' ' 89' ' ' LEU . 36.0 p90 -96.58 155.9 16.57 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.264 -0.898 . . . . 0.0 110.334 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.7 m -90.6 101.92 14.66 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.334 -0.854 . . . . 0.0 110.004 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.758 ' HB1' HG21 ' A' ' 54' ' ' ILE . . . -64.89 102.48 0.6 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.233 -0.917 . . . . 0.0 110.355 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.467 ' HA ' ' HA2' ' A' ' 57' ' ' GLY . 2.9 p -93.95 52.37 1.64 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.258 -0.901 . . . . 0.0 110.023 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -156.91 -158.4 0.77 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.207 -0.933 . . . . 0.0 110.417 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.542 HG22 ' HD3' ' A' ' 113' ' ' PRO . 69.9 m -137.74 111.22 8.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.238 -0.914 . . . . 0.0 110.261 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.639 ' HD2' HG11 ' A' ' 52' ' ' VAL . 15.1 m-30 -106.9 78.03 0.55 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.322 -0.862 . . . . 0.0 110.001 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.542 ' HD3' HG22 ' A' ' 111' ' ' THR . 44.3 Cg_endo -71.36 124.95 10.84 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.836 1.44 . . . . 0.0 110.418 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.276 -0.89 . . . . 0.0 110.33 -179.85 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.499 ' O ' ' HA ' ' A' ' 80' ' ' GLN . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.56 ' HA3' ' CB ' ' A' ' 112' ' ' TYR . . . -125.11 139.14 11.44 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.513 ' CB ' ' HA ' ' A' ' 50' ' ' ASN . 9.6 pt20 -150.39 -160.63 1.2 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.298 -1.119 . . . . 0.0 110.419 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.603 HG21 ' CH2' ' A' ' 16' ' ' TRP . 15.4 mt -118.5 135.06 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.506 -0.746 . . . . 0.0 109.131 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 1.076 ' HB3' ' CD1' ' A' ' 77' ' ' LEU . . . -112.6 123.46 50.35 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.285 -0.884 . . . . 0.0 111.082 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.504 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 4.4 m-85 -119.18 107.16 13.1 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.598 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLN . . . . . 0.48 ' O ' ' HB ' ' A' ' 74' ' ' VAL . 14.2 mm100 -89.48 97.25 11.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.155 -0.966 . . . . 0.0 111.431 -178.148 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.681 HD22 HG11 ' A' ' 74' ' ' VAL . 24.1 mt -97.13 41.92 1.1 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.355 -0.84 . . . . 0.0 109.191 178.781 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 131' ' ' GLY . . . -88.65 116.56 4.66 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -179.522 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 39' ' ' GLY . . . 39.74 92.59 0.01 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.581 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 7.2 m-85 -143.96 -54.42 0.36 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.112 -1.228 . . . . 0.0 110.516 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.67 ' CB ' HG23 ' A' ' 72' ' ' VAL . 1.3 t -89.05 175.15 7.51 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.967 -1.083 . . . . 0.0 110.157 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.2 -91.96 0.08 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.209 -0.932 . . . . 0.0 110.348 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.38 170.32 13.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.162 -0.961 . . . . 0.0 110.122 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.511 ' N ' ' HA ' ' A' ' 38' ' ' ALA . . . -55.55 133.04 50.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.237 -0.914 . . . . 0.0 110.144 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 1.095 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 16.5 p90 -136.23 -161.67 1.19 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.197 -0.939 . . . . 0.0 110.65 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.637 ' C ' HD12 ' A' ' 139' ' ' LEU 0.258 0.9 OUTLIER -156.86 176.76 12.32 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.405 -0.809 . . . . 0.0 110.028 -177.78 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.691 HD21 ' CD1' ' A' ' 95' ' ' LEU . 1.8 mp -145.43 119.42 9.37 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.097 -1.002 . . . . 0.0 112.04 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' CYS . . . . . 0.644 ' SG ' ' HB3' ' A' ' 31' ' ' ALA . 0.8 OUTLIER -99.71 111.68 23.99 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.577 -0.702 . . . . 0.0 110.387 178.349 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.495 ' O ' ' HB3' ' A' ' 142' ' ' ASP . 5.5 mt -103.57 173.89 6.11 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.233 -0.917 . . . . 0.0 109.687 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.563 ' HA ' ' CG ' ' A' ' 9' ' ' PHE . 3.0 p-10 172.09 -177.81 0.06 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.426 -0.796 . . . . 0.0 110.166 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.45 ' HA ' ' O ' ' A' ' 7' ' ' GLY . 19.3 t0 42.07 59.62 2.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.339 -0.85 . . . . 0.0 109.856 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.603 HG21 ' CZ ' ' A' ' 9' ' ' PHE . 1.9 t -100.89 114.45 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.32 -0.863 . . . . 0.0 110.113 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.454 ' HB2' ' HA ' ' A' ' 6' ' ' GLU . . . -144.6 156.25 44.04 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.317 -0.864 . . . . 0.0 110.447 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.819 HD11 ' HB3' ' A' ' 60' ' ' TYR . 35.5 tp -154.58 125.55 7.18 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.321 -0.862 . . . . 0.0 110.094 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.482 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 6.9 m-20 -125.26 179.12 5.22 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.265 -0.897 . . . . 0.0 110.302 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.502 ' HB3' ' CE1' ' A' ' 60' ' ' TYR . 10.9 p . . . . . 0 N--CA 1.493 1.689 0 O-C-N 121.268 -0.895 . . . . 0.0 110.209 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo . . . . . 0 N--CA 1.48 0.679 0 N-CA-C 110.089 -0.774 . . . . 0.0 110.089 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.843 HD11 ' O ' ' A' ' 144' ' ' VAL . 9.4 pt -90.19 -42.78 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.17 -0.956 . . . . 0.0 110.2 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.499 ' O ' ' N ' ' A' ' 7' ' ' GLY . . . 137.38 74.42 0.06 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.623 ' CB ' ' HB2' ' A' ' 145' ' ' ALA . 5.8 pt-20 -42.75 94.95 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.3 -1.118 . . . . 0.0 110.247 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 5' ' ' GLY . . . -172.55 143.94 7.65 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.524 ' CG2' ' HB3' ' A' ' 143' ' ' ASP . 76.8 p -54.79 167.2 0.39 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.344 -1.092 . . . . 0.0 110.161 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.596 ' CD2' ' HA ' ' A' ' 142' ' ' ASP . 22.9 m-85 -91.28 55.54 2.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.243 -0.91 . . . . 0.0 110.131 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.561 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 3.3 p-10 -101.77 38.59 1.6 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.164 -0.96 . . . . 0.0 110.316 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.561 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 1.5 m-20 161.42 79.19 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.637 -0.664 . . . . 0.0 109.723 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 63.69 94.86 0.02 OUTLIER Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.536 ' O ' ' N ' ' A' ' 15' ' ' GLY . 45.1 Cg_endo -72.65 78.6 2.02 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.071 1.564 . . . . 0.0 110.627 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.46 ' HG3' ' HB ' ' A' ' 4' ' ' ILE . 6.9 mm-40 42.25 -91.4 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.35 -0.844 . . . . 0.0 110.627 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.753 ' O ' HG13 ' A' ' 17' ' ' VAL . . . -158.96 24.63 0.34 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.967 ' CE2' HD22 ' A' ' 49' ' ' LEU . 41.5 m95 -56.12 87.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.283 -1.128 . . . . 0.0 110.255 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.753 HG13 ' O ' ' A' ' 15' ' ' GLY . 0.9 OUTLIER -91.28 146.91 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.049 -1.032 . . . . 0.0 109.647 179.743 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.455 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . . . -130.14 135.58 48.36 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.125 -0.985 . . . . 0.0 109.781 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.709 ' HE1' HG13 ' A' ' 48' ' ' VAL . 19.7 p90 -124.3 167.69 13.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.424 -0.797 . . . . 0.0 110.668 -178.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.527 ' CA ' ' OH ' ' A' ' 43' ' ' TYR . . . 75.28 43.79 24.44 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.517 HG22 ' CG1' ' A' ' 45' ' ' VAL . 6.0 p -150.69 -157.23 0.79 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.125 -1.22 . . . . 0.0 110.367 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -93.87 75.92 4.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.32 -0.863 . . . . 0.0 110.23 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.74 -172.09 43.93 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.22 163.62 37.52 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.989 1.521 . . . . 0.0 110.465 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.713 HD23 ' H ' ' A' ' 25' ' ' LEU . 0.7 OUTLIER -68.17 -169.73 0.15 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.283 -0.885 . . . . 0.0 110.24 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -162.4 150.93 14.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.232 -0.918 . . . . 0.0 110.293 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' THR . . . . . 1.0 HG22 ' O ' ' A' ' 31' ' ' ALA . 0.8 OUTLIER -119.81 -77.48 0.58 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.327 -0.858 . . . . 0.0 110.046 179.933 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 27' ' ' THR . 1.3 m 40.64 27.77 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.431 -0.793 . . . . 0.0 110.476 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.93 HG22 ' O ' ' A' ' 27' ' ' THR . 9.2 t -164.52 30.76 0.07 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.153 -0.967 . . . . 0.0 110.279 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.541 ' HA2' ' CA ' ' A' ' 10' ' ' ASP . . . 53.1 28.38 33.36 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 1.0 ' O ' HG22 ' A' ' 27' ' ' THR . . . -150.13 161.46 42.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.309 -1.113 . . . . 0.0 110.313 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.773 HD23 HD12 ' A' ' 141' ' ' LEU . 0.8 OUTLIER -105.4 98.04 7.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.89 . . . . 0.0 109.562 179.817 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.515 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 64.9 m -107.59 116.35 31.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.244 -0.91 . . . . 0.0 111.01 -179.231 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.523 HG12 ' CB ' ' A' ' 25' ' ' LEU . 20.3 m -104.03 140.92 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.42 -0.8 . . . . 0.0 109.175 179.213 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.49 ' O ' ' HB ' ' A' ' 21' ' ' THR . . . -88.96 89.5 8.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.064 -1.023 . . . . 0.0 110.69 -179.223 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.055 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 43.8 t -71.62 135.79 83.54 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.263 -0.898 . . . . 0.0 109.775 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.516 ' HG3' ' OE1' ' A' ' 42' ' ' GLN . 40.0 Cg_endo -67.74 -174.06 0.55 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.091 1.574 . . . . 0.0 111.652 -179.173 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.541 ' HA ' ' CA ' ' A' ' 136' ' ' ALA . . . -72.45 118.77 15.76 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.537 -0.727 . . . . 0.0 111.874 -178.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.565 ' O ' ' C ' ' A' ' 40' ' ' SER . . . 52.98 15.25 3.25 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 178.707 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.565 ' C ' ' O ' ' A' ' 39' ' ' GLY . 49.3 m 25.16 46.73 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.278 0 CA-C-N 118.268 1.034 . . . . 0.0 110.831 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.508 ' N ' ' O ' ' A' ' 39' ' ' GLY . . . -89.09 26.66 1.54 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.475 -0.766 . . . . 0.0 111.167 -178.476 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.516 ' OE1' ' HG3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -91.98 -153.1 0.32 Allowed 'General case' 0 C--N 1.29 -1.992 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.461 179.183 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.563 ' CE1' ' O ' ' A' ' 44' ' ' GLY . 25.0 p90 -56.57 -16.25 5.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.035 -1.041 . . . . 0.0 109.931 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.563 ' O ' ' CE1' ' A' ' 43' ' ' TYR . . . 123.67 122.64 2.73 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.532 HG12 ' H ' ' A' ' 46' ' ' GLY . 5.2 t -90.04 179.23 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.144 -1.209 . . . . 0.0 109.21 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.532 ' H ' HG12 ' A' ' 45' ' ' VAL . . . 164.0 -175.29 40.15 Favored Glycine 0 N--CA 1.489 2.225 0 C-N-CA 119.097 -1.525 . . . . 0.0 110.772 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.73 HG13 ' O ' ' A' ' 17' ' ' VAL . 21.8 t -151.04 131.47 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.722 -0.869 . . . . 0.0 108.701 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.709 HG13 ' HE1' ' A' ' 19' ' ' TYR . 29.3 m -119.83 131.51 72.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.948 -1.095 . . . . 0.0 110.797 -179.412 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.967 HD22 ' CE2' ' A' ' 16' ' ' TRP . 21.0 tp -131.91 103.91 6.57 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.377 -0.827 . . . . 0.0 110.365 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.513 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 35.7 p30 -78.73 152.41 31.55 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.253 -0.904 . . . . 0.0 110.285 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 125.33 64.45 0.18 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.589 HG12 ' N ' ' A' ' 53' ' ' ALA . 89.2 t -131.0 172.62 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.155 -1.203 . . . . 0.0 110.134 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.589 ' N ' HG12 ' A' ' 52' ' ' VAL . . . -150.28 85.78 1.4 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.18 -0.95 . . . . 0.0 110.567 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.637 ' CG1' ' CD2' ' A' ' 112' ' ' TYR . 42.4 mm -111.11 159.97 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.244 -0.91 . . . . 0.0 109.912 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.583 ' HA ' HG23 ' A' ' 111' ' ' THR . 72.5 mt-10 -149.52 120.54 7.7 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.119 -0.988 . . . . 0.0 110.471 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.523 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 11.7 pt-20 37.52 -152.0 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.618 -0.676 . . . . 0.0 110.779 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.461 ' N ' ' HG3' ' A' ' 56' ' ' GLU . . . -79.4 114.27 3.84 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.671 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.2 m -144.22 171.76 13.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.267 -1.137 . . . . 0.0 109.772 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.574 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 0.5 OUTLIER -89.8 158.17 17.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.278 -0.889 . . . . 0.0 110.106 179.866 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.867 ' O ' HG22 ' A' ' 105' ' ' THR . 68.4 m-85 -159.2 171.22 20.29 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.249 -0.907 . . . . 0.0 110.244 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.589 ' OG1' HG22 ' A' ' 105' ' ' THR . 25.7 m -150.11 117.28 6.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.317 -0.864 . . . . 0.0 110.211 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 27.5 tp -89.74 122.49 32.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.205 -0.934 . . . . 0.0 110.022 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.51 ' NH2' ' OD2' ' A' ' 143' ' ' ASP . 1.0 OUTLIER -124.92 104.06 8.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.226 -0.921 . . . . 0.0 110.349 -179.757 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 1.16 ' CZ ' HG21 ' A' ' 102' ' ' VAL . 3.0 p90 -150.54 151.78 33.16 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.281 -0.887 . . . . 0.0 110.012 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.508 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 29.4 m -119.88 97.62 5.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.221 -0.925 . . . . 0.0 110.251 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.758 ' CB ' HD21 ' A' ' 95' ' ' LEU . . . -99.65 145.96 27.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 0.0 110.403 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.685 HG23 ' O ' ' A' ' 98' ' ' GLU . 98.9 m -150.32 117.32 5.93 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.302 -0.874 . . . . 0.0 110.08 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.522 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -107.53 133.41 52.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.184 -0.948 . . . . 0.0 110.115 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 68' ' ' ALA . 1.5 m -45.79 -25.71 0.55 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.167 -0.958 . . . . 0.0 109.399 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.558 ' CG2' ' CB ' ' A' ' 137' ' ' TRP . 1.8 t -110.27 169.26 8.85 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.484 -0.76 . . . . 0.0 109.86 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.496 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 2.2 m-20 -86.15 62.34 7.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.179 -0.951 . . . . 0.0 109.181 179.064 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.947 HG21 ' CE2' ' A' ' 137' ' ' TRP . 3.3 p -86.16 136.58 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.35 -0.844 . . . . 0.0 111.203 -179.003 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 67.0 m -122.95 92.08 3.63 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.71 HG21 HD22 ' A' ' 129' ' ' LEU . 4.3 m -89.97 -153.07 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.158 -0.964 . . . . 0.0 110.628 -178.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.464 ' N ' HG23 ' A' ' 74' ' ' VAL . 5.0 mtm180 -127.7 128.73 45.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.313 -0.867 . . . . 0.0 110.577 -179.472 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.613 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -131.22 155.41 47.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.335 -0.853 . . . . 0.0 109.786 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.669 HD12 ' C ' ' A' ' 77' ' ' LEU . 3.8 pp 178.55 -154.46 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.272 -0.892 . . . . 0.0 110.281 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.732 HG23 HD22 ' A' ' 89' ' ' LEU . 4.3 t -146.87 171.92 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.289 -0.882 . . . . 0.0 109.357 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.494 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . 178.78 -176.3 47.89 Favored Glycine 0 N--CA 1.49 2.258 0 C-N-CA 119.363 -1.399 . . . . 0.0 110.056 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.625 ' NE2' ' HD2' ' A' ' 113' ' ' PRO . 1.8 tp-100 -112.64 86.85 2.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.393 -1.063 . . . . 0.0 110.21 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.472 ' N ' ' O ' ' A' ' 122' ' ' GLU . 3.6 m-80 -64.68 97.39 0.21 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.135 -0.978 . . . . 0.0 109.681 179.458 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.585 ' O ' ' CZ ' ' A' ' 85' ' ' TYR . . . 149.13 -88.69 0.14 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.513 ' HB2' ' O ' ' A' ' 82' ' ' GLY . . . 178.83 146.67 0.37 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.187 -1.184 . . . . 0.0 110.054 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.488 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.5 Cg_endo -85.44 36.06 3.21 Favored 'Cis proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.921 -2.116 . . . . 0.0 110.616 -0.303 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.585 ' CZ ' ' O ' ' A' ' 82' ' ' GLY . 98.9 m-85 59.17 -168.91 0.14 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.263 -0.898 . . . . 0.0 110.399 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 135.77 110.54 1.07 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -89.76 140.5 29.53 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.22 -1.165 . . . . 0.0 110.389 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.796 HG23 ' CD1' ' A' ' 89' ' ' LEU . 30.6 m -119.78 -17.98 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.409 -0.807 . . . . 0.0 109.746 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.866 HD11 ' CZ ' ' A' ' 106' ' ' PHE . 4.4 mp -121.55 143.26 49.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.401 -0.812 . . . . 0.0 110.784 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -151.15 78.88 1.3 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.886 . . . . 0.0 110.074 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 36.3 p -147.04 174.05 11.9 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.039 -1.038 . . . . 0.0 110.708 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.416 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 1.3 m -119.81 120.31 30.56 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.395 -0.815 . . . . 0.0 109.848 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.626 ' HG2' HG22 ' A' ' 74' ' ' VAL . 43.6 Cg_endo -70.61 117.49 5.17 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.928 1.489 . . . . 0.0 111.125 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.526 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -86.18 138.96 31.49 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.896 . . . . 0.0 109.339 179.173 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.826 HD13 ' HG ' ' A' ' 139' ' ' LEU . 72.4 mt -130.66 169.46 15.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.033 -1.042 . . . . 0.0 110.883 -179.405 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -178.34 -178.75 0.64 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.488 -0.757 . . . . 0.0 109.938 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.61 -23.72 67.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.887 . . . . 0.0 110.17 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.685 ' O ' HG23 ' A' ' 67' ' ' THR . 4.3 mt-10 -89.8 165.17 25.95 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.292 -0.88 . . . . 0.0 110.178 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.492 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 45.1 Cg_endo -72.45 133.18 20.31 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.946 1.498 . . . . 0.0 110.29 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.526 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.79 81.05 1.67 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.206 -0.934 . . . . 0.0 110.289 -179.927 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.45 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 0.0 OUTLIER -68.12 158.22 33.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.25 -0.906 . . . . 0.0 110.015 179.827 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 1.16 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 65.3 t -133.67 132.38 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.174 -0.954 . . . . 0.0 110.434 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -150.57 89.21 1.54 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.405 -0.809 . . . . 0.0 110.035 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' A' ' 61' ' ' THR . 1.2 mm-40 -141.38 168.78 18.97 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.155 -0.966 . . . . 0.0 110.273 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.867 HG22 ' O ' ' A' ' 60' ' ' TYR . 0.6 OUTLIER -121.98 -179.51 4.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.309 -0.869 . . . . 0.0 110.172 -179.992 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.866 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 53.7 p90 -177.96 155.47 0.98 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.217 -0.927 . . . . 0.0 110.259 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 58' ' ' THR . 99.3 m -91.25 95.79 10.22 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.223 -0.923 . . . . 0.0 110.132 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.776 ' HB3' ' CE2' ' A' ' 60' ' ' TYR . . . -65.72 113.67 4.44 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -0.918 . . . . 0.0 110.44 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.412 ' O ' ' OG ' ' A' ' 109' ' ' SER . 5.8 p -98.42 55.87 1.12 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.208 -0.933 . . . . 0.0 109.958 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.433 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -158.19 -160.62 0.92 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.256 -0.902 . . . . 0.0 110.455 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.583 HG23 ' HA ' ' A' ' 55' ' ' GLU . 10.5 m -152.54 118.17 5.35 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.347 -0.845 . . . . 0.0 110.34 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.637 ' CD2' ' CG1' ' A' ' 54' ' ' ILE . 11.2 m-30 -113.08 94.17 28.94 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.256 -0.903 . . . . 0.0 109.85 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.625 ' HD2' ' NE2' ' A' ' 80' ' ' GLN . 45.7 Cg_endo -72.94 139.72 30.55 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.022 1.538 . . . . 0.0 110.51 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.242 -0.911 . . . . 0.0 110.246 179.95 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' A' ' 113' ' ' PRO . 14.7 pt-20 . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 121.201 0.524 . . . . 0.0 110.405 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.542 ' HA2' ' HA ' ' A' ' 80' ' ' GLN . . . -99.69 144.85 17.21 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.513 ' CB ' ' HA ' ' A' ' 50' ' ' ASN . 10.2 pt20 -150.49 -153.82 0.51 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.208 -1.172 . . . . 0.0 110.597 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.751 HG21 ' HH2' ' A' ' 16' ' ' TRP . 21.6 mt -118.63 142.2 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.515 -0.74 . . . . 0.0 109.297 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.639 ' HB3' ' CD1' ' A' ' 77' ' ' LEU . . . -113.64 115.87 28.58 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.395 -0.816 . . . . 0.0 111.774 -178.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.539 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 4.5 m-85 -119.75 74.28 1.01 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.135 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLN . . . . . 0.928 ' C ' HD23 ' A' ' 129' ' ' LEU . 2.3 mt-30 -87.26 126.54 34.89 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.207 -0.933 . . . . 0.0 112.146 -177.305 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.928 HD23 ' C ' ' A' ' 128' ' ' GLN . 1.4 mt -112.77 55.38 0.69 Allowed 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.593 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 131' ' ' GLY . . . -73.28 85.3 0.6 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.499 ' HA2' ' O ' ' A' ' 39' ' ' GLY . . . 58.44 114.61 0.01 OUTLIER Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.639 ' CD2' HG12 ' A' ' 74' ' ' VAL . 10.3 m-85 -147.4 -57.16 0.25 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -1.148 . . . . 0.0 110.206 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.673 ' CB ' HG23 ' A' ' 72' ' ' VAL . 5.9 t -89.69 173.79 8.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.149 -0.969 . . . . 0.0 110.187 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -74.84 -93.73 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.213 -0.93 . . . . 0.0 110.208 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.33 -167.84 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.081 -1.012 . . . . 0.0 109.937 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.541 ' CA ' ' HA ' ' A' ' 38' ' ' ALA . . . -77.58 150.07 34.76 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.214 -0.929 . . . . 0.0 110.375 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 1.055 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 24.3 p90 -148.49 -154.81 0.58 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.315 -0.866 . . . . 0.0 110.11 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.522 ' O ' ' CB ' ' A' ' 68' ' ' ALA . 1.0 OUTLIER -160.43 163.17 33.26 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.922 -1.111 . . . . 0.0 111.296 -178.21 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.826 ' HG ' HD13 ' A' ' 95' ' ' LEU . 2.1 mp -126.52 125.74 42.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.429 -0.794 . . . . 0.0 109.56 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' CYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 41.1 m -121.01 99.45 6.5 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.107 -0.995 . . . . 0.0 110.713 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.773 HD12 HD23 ' A' ' 32' ' ' LEU . 2.2 mt -89.64 -154.67 0.33 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.317 -0.864 . . . . 0.0 109.479 179.366 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.92 ' O ' HG23 ' A' ' 144' ' ' VAL . 39.7 p-10 -177.78 -151.49 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.187 -0.946 . . . . 0.0 110.03 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.524 ' HB3' ' CG2' ' A' ' 8' ' ' THR . 23.6 p-10 -40.56 115.05 0.52 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.526 -0.734 . . . . 0.0 109.785 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.92 HG23 ' O ' ' A' ' 142' ' ' ASP . 43.0 t -128.85 125.09 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.284 -0.885 . . . . 0.0 110.244 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.623 ' HB2' ' CB ' ' A' ' 6' ' ' GLU . . . -136.89 178.82 6.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.292 -0.88 . . . . 0.0 110.658 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.553 HD12 ' O ' ' A' ' 61' ' ' THR . 14.4 tp -158.93 118.7 3.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.384 -0.823 . . . . 0.0 109.947 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.505 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 49.3 m-20 -113.15 141.05 47.38 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.228 -0.92 . . . . 0.0 110.415 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.573 ' HB3' ' CE1' ' A' ' 60' ' ' TYR . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.321 -0.862 . . . . 0.0 110.224 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo . . . . . 0 N--CA 1.48 0.728 0 N-CA-C 110.053 -0.787 . . . . 0.0 110.053 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.554 HG22 ' O ' ' A' ' 51' ' ' GLY . 9.5 pt -89.88 34.91 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.151 -0.968 . . . . 0.0 110.166 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.42 ' O ' ' C ' ' A' ' 6' ' ' GLU . . . 89.62 -34.14 4.14 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.59 ' HG3' ' HB2' ' A' ' 145' ' ' ALA . 30.4 tt0 42.86 41.47 2.57 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.34 -1.094 . . . . 0.0 110.172 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 143' ' ' ASP . . . -126.26 169.93 18.15 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 142' ' ' ASP . 12.7 p -83.7 42.51 0.85 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.275 -1.132 . . . . 0.0 110.522 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.77 ' HB3' HG21 ' A' ' 27' ' ' THR . 15.7 m-30 41.29 32.54 0.21 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.27 -0.894 . . . . 0.0 110.381 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.539 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 35.4 p-10 -89.35 46.4 1.37 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.167 -0.958 . . . . 0.0 110.316 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.539 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.3 OUTLIER 161.52 -22.56 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.798 -0.564 . . . . 0.0 109.75 179.962 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 167.58 110.74 0.23 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.81 ' HG3' HD12 ' A' ' 32' ' ' LEU . 49.9 Cg_endo -76.59 72.75 5.48 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.984 1.518 . . . . 0.0 110.778 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.519 ' HG3' HD11 ' A' ' 49' ' ' LEU . 12.8 tp10 41.32 -92.1 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.293 -0.879 . . . . 0.0 110.509 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.573 ' C ' HD13 ' A' ' 49' ' ' LEU . . . -157.71 43.24 0.51 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.945 ' NE1' HD22 ' A' ' 49' ' ' LEU . 37.9 m95 -66.47 127.88 34.01 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.32 -1.106 . . . . 0.0 110.288 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.724 HG22 ' O ' ' A' ' 48' ' ' VAL . 1.3 m -122.32 154.73 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.135 -0.978 . . . . 0.0 109.689 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.459 ' HB2' HG11 ' A' ' 34' ' ' VAL . . . -137.1 154.83 50.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.303 -0.873 . . . . 0.0 109.526 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.743 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.6 OUTLIER -139.47 138.67 36.62 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.06 -1.025 . . . . 0.0 111.13 -178.752 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.589 ' HA2' ' CE1' ' A' ' 43' ' ' TYR . . . 121.26 84.3 0.77 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.655 HG21 ' HB3' ' A' ' 37' ' ' PRO . 1.7 p 53.15 17.6 1.0 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.508 -0.995 . . . . 0.0 110.955 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 1.031 ' HA ' ' HB3' ' A' ' 35' ' ' ALA . 5.9 p30 -101.89 111.36 23.59 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.083 -1.011 . . . . 0.0 110.284 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 22' ' ' ASP . . . -59.94 -152.91 0.02 OUTLIER Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.022 -1.631 . . . . 0.0 109.022 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.455 ' O ' ' C ' ' A' ' 25' ' ' LEU . 47.0 Cg_endo -74.4 95.63 0.94 Allowed 'Trans proline' 0 C--N 1.303 -1.86 0 O-C-N 123.814 1.429 . . . . 0.0 110.307 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.716 HD23 ' H ' ' A' ' 25' ' ' LEU . 0.8 OUTLIER -40.65 150.39 0.07 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.354 -0.841 . . . . 0.0 109.771 179.808 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -146.6 159.77 43.03 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.98 -1.075 . . . . 0.0 110.757 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.77 HG21 ' HB3' ' A' ' 9' ' ' PHE . 3.7 p -119.63 -55.86 2.08 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.321 -0.862 . . . . 0.0 110.161 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 50.57 -89.58 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.275 -0.891 . . . . 0.0 110.228 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.514 ' N ' ' O ' ' A' ' 27' ' ' THR . 15.2 t -55.71 -17.19 5.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.243 -0.911 . . . . 0.0 110.161 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 9' ' ' PHE . . . 111.65 32.55 2.46 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.503 ' HA ' ' O ' ' A' ' 141' ' ' LEU . . . -140.52 109.97 6.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.272 -1.134 . . . . 0.0 110.274 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.81 HD12 ' HG3' ' A' ' 13' ' ' PRO . 0.6 OUTLIER -67.17 94.31 0.35 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.266 -0.896 . . . . 0.0 109.991 179.912 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.518 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 59.0 m -99.4 133.09 44.2 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.31 -0.869 . . . . 0.0 110.574 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.625 HG12 ' HB3' ' A' ' 25' ' ' LEU . 6.2 m -121.62 167.28 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.571 -0.705 . . . . 0.0 109.4 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 1.031 ' HB3' ' HA ' ' A' ' 22' ' ' ASP . . . -103.15 128.46 50.08 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.126 -0.984 . . . . 0.0 111.887 -178.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.999 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 90.3 t -117.5 121.47 32.01 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.163 -0.961 . . . . 0.0 108.991 178.627 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.655 ' HB3' HG21 ' A' ' 21' ' ' THR . 38.2 Cg_endo -64.25 173.99 4.6 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.856 1.45 . . . . 0.0 112.196 -178.505 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.54 ' HA ' ' CA ' ' A' ' 136' ' ' ALA . . . -53.31 122.28 9.27 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.514 0.673 . . . . 0.0 111.456 -178.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.513 ' O ' ' C ' ' A' ' 40' ' ' SER . . . 37.89 27.17 0.03 OUTLIER Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.972 ' OG ' HG23 ' A' ' 45' ' ' VAL . 31.3 t 32.77 46.39 0.08 Allowed 'General case' 0 N--CA 1.498 1.934 0 CA-C-N 118.045 0.923 . . . . 0.0 110.15 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.644 ' O ' ' CG ' ' A' ' 42' ' ' GLN . . . -89.51 119.02 29.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.594 -0.692 . . . . 0.0 110.127 -179.218 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.644 ' CG ' ' O ' ' A' ' 41' ' ' ALA . 0.5 OUTLIER 84.1 28.64 0.08 Allowed 'General case' 0 N--CA 1.508 2.433 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -179.492 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.641 ' CE2' ' CG2' ' A' ' 21' ' ' THR . 0.1 OUTLIER -146.4 -33.27 0.32 Allowed 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 118.757 -1.177 . . . . 0.0 112.335 -177.878 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 43' ' ' TYR . . . 52.26 75.28 0.23 Allowed Glycine 0 N--CA 1.482 1.758 0 N-CA-C 105.849 -2.9 . . . . 0.0 105.849 -177.011 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.972 HG23 ' OG ' ' A' ' 40' ' ' SER . 2.6 t -85.68 160.76 3.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.513 -0.992 . . . . 0.0 109.186 -177.409 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.577 ' O ' ' CE1' ' A' ' 19' ' ' TYR . . . 176.68 164.66 30.98 Favored Glycine 0 N--CA 1.488 2.102 0 C-N-CA 119.357 -1.402 . . . . 0.0 110.08 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.681 HG13 ' O ' ' A' ' 17' ' ' VAL . 17.8 t -124.59 125.53 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.473 -1.016 . . . . 0.0 109.626 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.724 ' O ' HG22 ' A' ' 17' ' ' VAL . 33.8 m -119.73 139.89 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.007 -1.058 . . . . 0.0 110.842 -179.233 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.945 HD22 ' NE1' ' A' ' 16' ' ' TRP . 18.4 tp -132.08 99.25 4.66 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.318 -0.864 . . . . 0.0 110.086 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.531 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 10.6 p30 -73.38 121.52 20.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.245 -0.909 . . . . 0.0 110.429 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.554 ' O ' HG22 ' A' ' 4' ' ' ILE . . . 150.54 65.85 0.01 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.864 -1.295 . . . . 0.0 109.864 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.656 HG23 ' HA ' ' A' ' 124' ' ' GLN . 53.1 t -122.61 169.68 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.137 -1.213 . . . . 0.0 110.073 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.562 ' N ' HG12 ' A' ' 52' ' ' VAL . . . -141.41 88.63 2.16 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.151 -0.968 . . . . 0.0 110.613 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.669 HG21 ' HB1' ' A' ' 108' ' ' ALA . 36.1 mm -122.14 163.0 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.292 -0.88 . . . . 0.0 109.718 179.572 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.524 ' HA ' HG23 ' A' ' 111' ' ' THR . 2.0 tt0 -150.25 127.05 11.02 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.044 -1.035 . . . . 0.0 110.778 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.52 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 13.6 pt-20 37.56 -157.86 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.642 -0.661 . . . . 0.0 111.093 179.576 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' A' ' 109' ' ' SER . . . -79.04 82.84 1.32 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.639 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.3 m -110.16 170.46 8.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.266 -1.137 . . . . 0.0 109.779 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.576 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 6.5 m -89.87 154.58 19.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.175 -0.953 . . . . 0.0 110.33 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.639 ' CE2' HG22 ' A' ' 58' ' ' THR . 60.3 m-85 -159.77 173.06 16.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.332 -0.855 . . . . 0.0 110.225 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 27.4 m -150.14 116.01 5.6 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.3 -0.875 . . . . 0.0 110.036 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 103' ' ' THR . 38.3 tp -89.78 122.6 33.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.265 -0.897 . . . . 0.0 110.057 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.584 ' HG2' HG23 ' A' ' 103' ' ' THR . 16.1 mtt180 -131.81 106.46 8.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.332 -0.855 . . . . 0.0 110.233 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.496 ' C ' ' CD1' ' A' ' 64' ' ' TYR . 10.0 p90 -143.04 159.62 41.92 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.246 -0.908 . . . . 0.0 110.236 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.504 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 1.3 m -119.96 102.35 8.49 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.179 -0.951 . . . . 0.0 109.866 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.708 ' CB ' HD21 ' A' ' 95' ' ' LEU . . . -104.83 149.47 25.63 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.273 -0.892 . . . . 0.0 110.699 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.498 HG23 ' O ' ' A' ' 98' ' ' GLU . 93.5 m -150.22 126.01 10.4 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.444 -0.785 . . . . 0.0 110.025 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -114.32 136.96 52.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.211 -0.931 . . . . 0.0 109.999 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' ' 68' ' ' ALA . 0.4 OUTLIER -44.03 -26.57 0.3 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.189 -0.944 . . . . 0.0 109.344 179.528 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.567 ' CG2' ' CB ' ' A' ' 137' ' ' TRP . 2.7 t -114.07 169.39 9.04 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.51 -0.744 . . . . 0.0 109.824 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.506 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 33.7 p-10 -85.07 66.02 9.53 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.137 -0.977 . . . . 0.0 109.201 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.964 HG23 ' HB2' ' A' ' 133' ' ' SER . 4.0 p -89.39 140.36 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -0.885 . . . . 0.0 111.483 -178.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.44 HG22 ' O ' ' A' ' 73' ' ' THR . 16.8 m -127.72 87.21 2.58 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.629 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 1.085 HG21 ' CD2' ' A' ' 129' ' ' LEU . 2.8 m -89.78 -140.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.238 -0.914 . . . . 0.0 110.483 -178.749 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.764 ' N ' HG23 ' A' ' 74' ' ' VAL . 7.0 mtm180 -127.74 149.07 50.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.169 -0.957 . . . . 0.0 110.767 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.592 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -150.11 152.47 34.81 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.399 -0.813 . . . . 0.0 109.421 179.465 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.909 HD12 ' N ' ' A' ' 78' ' ' VAL . 3.9 pp 179.87 -147.15 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.181 -0.949 . . . . 0.0 110.294 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.925 HG23 HD22 ' A' ' 89' ' ' LEU . 6.8 t -151.29 169.59 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.215 -0.928 . . . . 0.0 109.431 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.543 ' C ' ' CE1' ' A' ' 112' ' ' TYR . . . -172.42 -173.59 39.14 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.236 -1.459 . . . . 0.0 110.252 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.543 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 4.3 pt20 -115.88 108.0 15.73 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.466 -1.02 . . . . 0.0 110.163 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.477 ' HB2' ' HG2' ' A' ' 122' ' ' GLU . 6.2 m-20 -66.61 92.97 0.22 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.193 -0.942 . . . . 0.0 110.236 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.538 ' C ' ' CE1' ' A' ' 85' ' ' TYR . . . 142.8 144.23 4.27 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.654 -1.379 . . . . 0.0 109.654 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.618 ' N ' ' CE1' ' A' ' 85' ' ' TYR . . . -62.7 157.02 61.45 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.226 -1.161 . . . . 0.0 110.27 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.517 ' C ' ' CD2' ' A' ' 85' ' ' TYR . 50.6 Cg_endo -77.38 8.54 17.89 Favored 'Cis proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.647 -2.23 . . . . 0.0 110.876 -0.064 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.618 ' CE1' ' N ' ' A' ' 83' ' ' ALA . 11.6 m-85 69.83 161.34 0.21 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.241 -0.912 . . . . 0.0 110.262 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.498 ' N ' ' CG ' ' A' ' 80' ' ' GLN . . . 166.76 106.6 0.19 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.484 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 1.0 OUTLIER -89.55 152.38 21.45 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.121 -1.223 . . . . 0.0 110.464 -179.787 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 1.125 HG23 HD12 ' A' ' 89' ' ' LEU . 33.2 m -119.72 -24.92 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.35 -0.844 . . . . 0.0 109.8 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 1.125 HD12 HG23 ' A' ' 88' ' ' VAL . 3.6 mp -99.16 141.8 31.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.285 -0.884 . . . . 0.0 110.73 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 45.5 p-10 -151.34 73.92 1.11 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.393 -0.817 . . . . 0.0 110.032 179.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 41.5 p -135.35 176.03 9.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.051 -1.031 . . . . 0.0 110.643 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 1.4 m -122.01 121.33 28.05 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.385 -0.822 . . . . 0.0 109.949 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.592 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 44.7 Cg_endo -70.92 155.38 62.2 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.919 1.484 . . . . 0.0 110.898 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.519 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -122.26 137.47 54.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.449 -0.782 . . . . 0.0 109.463 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.708 HD21 ' CB ' ' A' ' 66' ' ' ALA . 93.0 mt -131.96 169.03 16.88 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.104 -0.997 . . . . 0.0 110.625 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.589 HG23 ' H ' ' A' ' 98' ' ' GLU . 5.9 t -174.65 -155.08 0.06 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.428 -0.795 . . . . 0.0 110.0 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.536 ' N ' HG23 ' A' ' 96' ' ' THR . 0.9 OUTLIER -89.7 24.33 2.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.261 -0.899 . . . . 0.0 110.128 179.956 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.589 ' H ' HG23 ' A' ' 96' ' ' THR . 0.0 OUTLIER -147.57 172.03 5.65 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.35 -0.844 . . . . 0.0 110.012 179.882 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.51 ' HD2' ' CG ' ' A' ' 98' ' ' GLU . 45.2 Cg_endo -72.82 127.45 12.28 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.979 1.515 . . . . 0.0 110.443 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.519 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 6.6 mtt-85 -119.51 93.1 3.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.261 -0.9 . . . . 0.0 109.867 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -78.06 102.71 7.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.448 -0.783 . . . . 0.0 110.569 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 50.2 t -89.41 134.13 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.241 -0.912 . . . . 0.0 109.805 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.584 HG23 ' HG2' ' A' ' 63' ' ' ARG . 0.2 OUTLIER -147.05 133.09 19.22 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.16 -0.963 . . . . 0.0 110.247 -179.884 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 103' ' ' THR . 1.8 mt-10 -160.25 134.72 7.5 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.259 -0.901 . . . . 0.0 110.333 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 25.2 m -90.68 143.82 26.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.281 -0.887 . . . . 0.0 110.125 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.913 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 41.7 p90 -154.48 159.85 41.25 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.234 -0.916 . . . . 0.0 110.259 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.489 ' HA ' ' O ' ' A' ' 58' ' ' THR . 80.2 m -97.02 89.04 4.68 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.201 -0.937 . . . . 0.0 110.054 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.669 ' HB1' HG21 ' A' ' 54' ' ' ILE . . . -45.63 106.39 0.08 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -0.892 . . . . 0.0 110.296 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.475 ' HA ' ' HA2' ' A' ' 57' ' ' GLY . 5.2 p -90.29 54.29 2.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.282 -0.886 . . . . 0.0 110.278 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.411 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -164.67 -158.39 0.41 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.895 . . . . 0.0 110.229 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.977 HG22 ' HD3' ' A' ' 113' ' ' PRO . 19.9 m -145.04 118.94 9.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.246 -0.909 . . . . 0.0 110.264 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.594 ' CG ' ' HA3' ' A' ' 123' ' ' GLY . 19.2 m-30 -115.79 63.62 2.2 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.361 -0.837 . . . . 0.0 110.073 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.977 ' HD3' HG22 ' A' ' 111' ' ' THR . 45.3 Cg_endo -71.67 147.44 51.05 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.852 1.448 . . . . 0.0 110.608 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.197 -0.94 . . . . 0.0 110.246 179.952 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.529 ' O ' ' HA ' ' A' ' 80' ' ' GLN . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.024 0.44 . . . . 0.0 110.039 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.594 ' HA3' ' CG ' ' A' ' 112' ' ' TYR . . . -145.02 158.67 27.71 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.859 -1.297 . . . . 0.0 109.859 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.656 ' HA ' HG23 ' A' ' 52' ' ' VAL . 1.1 pp0? -150.38 -158.12 0.88 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.415 -1.05 . . . . 0.0 110.262 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.882 HG21 ' CH2' ' A' ' 16' ' ' TRP . 6.2 mt -118.18 139.49 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.523 -0.736 . . . . 0.0 109.208 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -117.6 122.56 43.95 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.243 -0.911 . . . . 0.0 110.886 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.487 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 3.0 m-30 -116.76 103.39 10.29 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.659 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLN . . . . . 0.583 ' O ' ' CE2' ' A' ' 132' ' ' PHE . 11.0 mm100 -89.08 89.12 7.83 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.323 -0.861 . . . . 0.0 112.511 -177.283 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 1.085 ' CD2' HG21 ' A' ' 74' ' ' VAL . 27.0 mt -94.73 44.98 1.11 Allowed 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 177.387 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.552 ' O ' ' CD2' ' A' ' 132' ' ' PHE . . . -99.06 127.89 9.39 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 120.117 -1.04 . . . . 0.0 110.737 -178.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 39' ' ' GLY . . . 37.14 68.8 0.32 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.596 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 9.4 m-85 -123.29 -57.52 1.67 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.028 -1.278 . . . . 0.0 110.82 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.964 ' HB2' HG23 ' A' ' 72' ' ' VAL . 1.3 t -88.54 -177.52 5.61 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.904 -1.122 . . . . 0.0 110.415 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -93.69 -84.76 0.3 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.248 -0.908 . . . . 0.0 110.246 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.08 179.49 1.51 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.165 -0.959 . . . . 0.0 109.999 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.54 ' CA ' ' HA ' ' A' ' 38' ' ' ALA . . . -75.0 129.9 38.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.299 -0.876 . . . . 0.0 110.656 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.999 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 6.8 p90 -133.32 -158.93 0.92 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.336 -0.853 . . . . 0.0 109.859 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.524 ' O ' ' CB ' ' A' ' 68' ' ' ALA . 0.3 OUTLIER -160.37 171.68 18.67 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.048 -1.033 . . . . 0.0 110.48 -178.638 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.941 HD13 HD13 ' A' ' 129' ' ' LEU . 2.4 mp -122.26 157.39 31.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.405 -0.809 . . . . 0.0 109.639 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' CYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 67' ' ' THR . 8.5 m -150.27 91.14 1.73 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.081 -1.012 . . . . 0.0 110.657 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.504 ' HA ' ' O ' ' A' ' 65' ' ' THR . 1.0 OUTLIER -90.0 -156.33 0.41 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.926 . . . . 0.0 109.259 179.275 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.599 ' HA ' ' CD2' ' A' ' 9' ' ' PHE . 1.9 p-10 175.94 -48.53 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.007 -1.058 . . . . 0.0 110.522 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.492 ' O ' ' HA ' ' A' ' 64' ' ' TYR . 22.6 t70 -119.25 137.73 53.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -0.937 . . . . 0.0 110.208 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.492 ' O ' HD11 ' A' ' 4' ' ' ILE . 3.0 t -150.39 113.18 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.213 -0.93 . . . . 0.0 110.115 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.59 ' HB2' ' HG3' ' A' ' 6' ' ' GLU . . . -126.46 153.55 44.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.302 -0.874 . . . . 0.0 110.282 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.566 HD11 ' HB3' ' A' ' 60' ' ' TYR . 29.7 tp -159.71 96.65 1.27 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.34 -0.85 . . . . 0.0 110.03 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.492 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 32.3 t70 -121.95 164.36 17.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.228 -0.92 . . . . 0.0 110.259 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.56 ' HB3' ' CE1' ' A' ' 60' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.226 -0.921 . . . . 0.0 110.255 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo . . . . . 0 N--CA 1.483 0.875 0 N-CA-C 110.427 -0.643 . . . . 0.0 110.427 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.606 HD11 HG12 ' A' ' 144' ' ' VAL . 9.1 pt -107.92 42.8 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 110.254 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.543 ' N ' ' HG3' ' A' ' 14' ' ' GLU . . . 73.93 40.54 43.63 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' ' 144' ' ' VAL . 22.0 tt0 -42.03 94.03 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.33 -1.1 . . . . 0.0 110.434 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 5' ' ' GLY . . . 163.48 -154.76 25.82 Favored Glycine 0 N--CA 1.49 2.27 0 C-N-CA 119.647 -1.264 . . . . 0.0 110.164 179.77 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.732 HG22 ' O ' ' A' ' 142' ' ' ASP . 62.0 p -105.99 38.15 2.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.416 -1.049 . . . . 0.0 110.604 -179.594 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.551 ' HZ ' HG21 ' A' ' 144' ' ' VAL . 25.4 m-85 42.75 80.78 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.209 -0.932 . . . . 0.0 110.179 179.779 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.548 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 2.6 p30 -108.48 23.23 14.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.202 -0.936 . . . . 0.0 110.415 -179.843 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.548 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.8 OUTLIER 161.51 80.48 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.601 -0.687 . . . . 0.0 109.822 179.991 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.41 101.54 0.08 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.864 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.686 ' HG3' HD12 ' A' ' 32' ' ' LEU . 45.0 Cg_endo -73.27 78.46 2.27 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.038 1.547 . . . . 0.0 110.667 -179.801 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.543 ' HG3' ' N ' ' A' ' 5' ' ' GLY . 5.0 mm-40 39.45 -91.21 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.467 -0.77 . . . . 0.0 111.066 179.675 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.585 ' C ' HD13 ' A' ' 49' ' ' LEU . . . -148.24 12.56 1.23 Allowed Glycine 0 N--CA 1.493 2.478 0 C-N-CA 119.618 -1.277 . . . . 0.0 110.386 -179.535 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.913 ' N ' HD13 ' A' ' 49' ' ' LEU . 36.8 m95 -40.62 128.82 2.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.23 -1.159 . . . . 0.0 110.786 179.832 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.836 HG22 ' O ' ' A' ' 48' ' ' VAL . 1.4 m -128.08 148.03 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.16 -0.962 . . . . 0.0 109.696 179.305 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . . . -130.32 117.27 19.53 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.027 -1.045 . . . . 0.0 109.821 179.552 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.611 ' HE2' HG13 ' A' ' 48' ' ' VAL . 29.3 p90 -106.76 172.8 6.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.471 -0.768 . . . . 0.0 110.709 -179.241 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.859 ' O ' HG13 ' A' ' 45' ' ' VAL . . . 68.07 27.17 73.77 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 179.589 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.759 HG22 ' CG1' ' A' ' 45' ' ' VAL . 30.9 p -132.32 -164.17 1.43 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.066 -1.255 . . . . 0.0 110.514 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -89.99 39.46 0.96 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.275 -0.891 . . . . 0.0 110.42 -179.75 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 126.26 -168.01 18.51 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 179.827 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.48 -159.09 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.112 1.585 . . . . 0.0 110.579 -179.877 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 1.047 ' CD1' HD11 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -115.81 156.86 25.3 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.339 -0.851 . . . . 0.0 110.104 -179.998 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -121.21 141.14 51.14 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.203 -0.935 . . . . 0.0 110.137 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.482 ' CG2' ' HA ' ' A' ' 32' ' ' LEU . 0.7 OUTLIER -126.36 -24.3 3.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.114 -0.991 . . . . 0.0 110.874 -179.694 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.435 ' C ' ' O ' ' A' ' 27' ' ' THR . 3.5 t -41.06 -36.69 0.73 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.263 -0.898 . . . . 0.0 110.538 -179.618 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.568 HG23 ' H ' ' A' ' 30' ' ' GLY . 2.7 t -53.2 -49.78 66.01 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.259 -0.9 . . . . 0.0 110.706 -179.843 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.568 ' H ' HG23 ' A' ' 29' ' ' THR . . . 166.99 -25.46 0.14 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.925 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.64 ' HB3' ' SG ' ' A' ' 140' ' ' CYS . . . -146.92 169.01 20.06 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -1.128 . . . . 0.0 109.593 179.838 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.047 HD11 ' CD1' ' A' ' 25' ' ' LEU . 0.6 OUTLIER -78.42 92.26 4.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.011 -1.056 . . . . 0.0 110.502 -179.837 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.551 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 0.8 OUTLIER -100.22 110.78 23.04 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.417 -0.802 . . . . 0.0 111.447 179.517 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.864 HG12 ' HB3' ' A' ' 25' ' ' LEU . 15.6 m -89.53 143.71 10.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.001 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.477 ' HA ' ' OG1' ' A' ' 138' ' ' THR . . . -88.63 83.13 6.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.472 -0.767 . . . . 0.0 110.916 -178.59 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.057 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 40.9 t -69.34 128.59 92.32 Favored Pre-proline 0 N--CA 1.487 1.421 0 O-C-N 121.307 -0.87 . . . . 0.0 109.112 179.064 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 21' ' ' THR . 42.8 Cg_endo -70.26 146.77 58.01 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.936 1.493 . . . . 0.0 111.157 -178.951 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.472 ' HA ' ' N ' ' A' ' 136' ' ' ALA . . . -41.57 136.42 1.85 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.512 -0.742 . . . . 0.0 110.229 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 38' ' ' ALA . . . 45.51 92.99 0.01 OUTLIER Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.845 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.559 ' HB3' ' CG2' ' A' ' 45' ' ' VAL . 25.9 m -87.36 33.76 0.69 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.164 -1.198 . . . . 0.0 110.108 179.991 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -91.58 19.95 5.84 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.933 0.873 . . . . 0.0 110.155 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.725 ' NE2' ' CE2' ' A' ' 43' ' ' TYR . 7.9 pt20 -85.69 -143.46 0.1 Allowed 'General case' 0 C--N 1.292 -1.898 0 O-C-N 121.804 -0.56 . . . . 0.0 109.721 179.49 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.725 ' CE2' ' NE2' ' A' ' 42' ' ' GLN . 5.5 p90 -41.54 -27.15 0.09 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.463 -0.773 . . . . 0.0 109.97 179.838 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.571 ' N ' ' CD1' ' A' ' 43' ' ' TYR . . . 115.14 113.49 2.93 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.448 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.859 HG13 ' O ' ' A' ' 20' ' ' GLY . 2.0 t -96.37 160.5 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.183 -1.187 . . . . 0.0 108.841 179.384 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.576 ' O ' ' CE2' ' A' ' 19' ' ' TYR . . . 177.56 152.66 10.24 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.271 -1.442 . . . . 0.0 110.329 -179.74 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.757 HG13 ' O ' ' A' ' 17' ' ' VAL . 22.9 t -113.46 134.79 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.374 -1.074 . . . . 0.0 109.796 179.479 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.836 ' O ' HG22 ' A' ' 17' ' ' VAL . 8.6 m -130.13 151.16 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.035 -1.041 . . . . 0.0 110.46 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.913 HD13 ' N ' ' A' ' 16' ' ' TRP . 19.9 tp -149.71 114.5 5.34 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.275 -0.89 . . . . 0.0 110.388 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.523 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 21.4 t30 -79.72 124.63 28.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.269 -0.894 . . . . 0.0 110.306 179.749 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.509 ' O ' ' CG2' ' A' ' 4' ' ' ILE . . . 155.23 67.99 0.01 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.686 HG23 ' HA ' ' A' ' 124' ' ' GLN . 43.0 t -130.44 171.89 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.216 -1.167 . . . . 0.0 110.106 179.844 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.533 ' O ' HD13 ' A' ' 54' ' ' ILE . . . -145.04 87.47 1.83 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.102 -0.999 . . . . 0.0 110.718 -179.76 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.985 HD11 HD21 ' A' ' 146' ' ' LEU . 36.7 mm -120.51 159.55 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.226 -0.921 . . . . 0.0 109.893 179.418 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.521 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 0.4 OUTLIER -147.68 121.54 9.34 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.161 -0.962 . . . . 0.0 110.437 -179.868 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.521 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 9.4 pt-20 37.57 -151.65 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.654 -0.654 . . . . 0.0 110.797 179.705 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.459 ' N ' ' HG3' ' A' ' 56' ' ' GLU . . . -81.15 94.41 1.59 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.648 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.2 m -124.74 174.29 7.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.257 -1.143 . . . . 0.0 109.824 179.968 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.572 ' N ' ' CG2' ' A' ' 58' ' ' THR . 0.6 OUTLIER -89.63 151.66 21.78 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.269 -0.894 . . . . 0.0 110.137 -179.969 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.648 ' CE2' HG22 ' A' ' 58' ' ' THR . 54.6 m-85 -159.29 174.4 14.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.223 -0.923 . . . . 0.0 110.575 -179.987 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 94.8 m -149.98 121.23 7.82 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.439 -0.788 . . . . 0.0 109.685 179.69 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.544 ' HB2' HD21 ' A' ' 89' ' ' LEU . 18.7 tp -89.56 120.44 30.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.208 -0.932 . . . . 0.0 110.279 -179.691 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.539 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 3.3 ttt180 -121.03 138.24 54.26 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.326 -0.859 . . . . 0.0 109.803 179.673 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.843 ' CZ ' HG21 ' A' ' 102' ' ' VAL . 0.6 OUTLIER -178.52 142.2 0.23 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.228 -0.92 . . . . 0.0 110.033 179.922 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.504 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 5.8 m -119.37 94.36 4.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.225 -0.922 . . . . 0.0 110.06 -179.839 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.661 ' CB ' HD21 ' A' ' 95' ' ' LEU . . . -95.91 155.95 16.54 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.345 -0.847 . . . . 0.0 110.153 -179.829 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 44.3 m -148.38 117.59 6.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.261 -0.9 . . . . 0.0 110.27 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.677 ' CB ' HG12 ' A' ' 72' ' ' VAL . . . -102.87 129.8 49.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.297 -0.877 . . . . 0.0 109.942 179.783 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 82.7 p -65.5 -9.05 22.75 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.175 -0.953 . . . . 0.0 110.092 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.625 HG21 ' CB ' ' A' ' 137' ' ' TRP . 7.4 t -116.97 19.9 14.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.871 . . . . 0.0 110.166 -179.912 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.465 ' O ' ' O ' ' A' ' 70' ' ' THR . 4.7 t70 43.05 92.35 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.3 -0.875 . . . . 0.0 109.851 -179.754 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.759 HG13 HD12 ' A' ' 95' ' ' LEU . 12.1 p -131.36 161.31 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -0.918 . . . . 0.0 110.953 -179.337 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.4 ' N ' HG22 ' A' ' 72' ' ' VAL . 23.2 m -128.68 89.11 2.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.37 -0.831 . . . . 0.0 109.219 179.248 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.695 HG12 ' CB ' ' A' ' 132' ' ' PHE . 17.4 m -89.74 -140.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.911 . . . . 0.0 110.655 -179.199 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.542 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 19.3 mtm-85 -133.1 146.55 51.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.902 . . . . 0.0 110.597 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.829 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -150.02 152.21 34.51 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.348 -0.845 . . . . 0.0 109.712 179.731 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.889 HD12 ' N ' ' A' ' 78' ' ' VAL . 3.7 pp 179.49 -146.97 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.241 -0.912 . . . . 0.0 110.218 -179.587 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.889 ' N ' HD12 ' A' ' 77' ' ' LEU . 3.5 t -148.22 177.59 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.921 . . . . 0.0 109.544 179.904 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.523 ' H ' HG12 ' A' ' 78' ' ' VAL . . . -179.49 -175.87 46.67 Favored Glycine 0 N--CA 1.489 2.204 0 C-N-CA 119.384 -1.389 . . . . 0.0 110.14 179.988 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.552 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 3.0 tt0 -93.98 -153.76 0.38 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.422 -1.046 . . . . 0.0 110.107 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.479 ' HB3' ' OE2' ' A' ' 122' ' ' GLU . 9.7 m120 -154.44 72.46 0.87 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.361 -0.837 . . . . 0.0 109.702 179.894 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.478 ' C ' ' CE1' ' A' ' 85' ' ' TYR . . . 131.57 144.08 5.33 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -179.688 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.628 ' N ' ' CE1' ' A' ' 85' ' ' TYR . . . -41.93 152.27 0.31 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.28 -1.13 . . . . 0.0 110.321 -179.868 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.46 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.6 Cg_endo -80.04 12.57 22.55 Favored 'Cis proline' 0 C--N 1.312 -1.343 0 C-N-CA 121.651 -2.229 . . . . 0.0 110.896 -0.067 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.628 ' CE1' ' N ' ' A' ' 83' ' ' ALA . 29.1 m-85 62.53 146.8 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.139 -0.975 . . . . 0.0 110.233 -179.816 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -172.5 128.13 1.5 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.899 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.487 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 0.8 OUTLIER -105.55 153.76 21.31 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.236 -1.155 . . . . 0.0 110.208 179.984 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.72 HG23 HD12 ' A' ' 89' ' ' LEU . 15.5 m -124.98 -24.69 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.302 -0.873 . . . . 0.0 110.331 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.843 HD22 HG23 ' A' ' 78' ' ' VAL . 3.8 mp -105.72 145.29 31.29 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.17 -0.957 . . . . 0.0 111.082 179.883 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -151.76 76.09 1.18 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.371 -0.831 . . . . 0.0 109.947 179.474 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 82.1 p -135.62 178.52 6.98 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.98 -1.075 . . . . 0.0 110.869 -179.504 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.97 117.8 32.04 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.435 -0.791 . . . . 0.0 110.079 179.941 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.829 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 47.4 Cg_endo -73.74 105.56 2.03 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.93 1.49 . . . . 0.0 110.981 -179.697 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.53 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -77.83 151.32 33.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.156 -0.965 . . . . 0.0 109.428 179.171 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.864 ' CD1' HD21 ' A' ' 139' ' ' LEU . 64.2 mt -138.99 162.83 33.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.994 -1.067 . . . . 0.0 110.817 -179.548 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.49 HG22 ' HG3' ' A' ' 100' ' ' ARG . 0.2 OUTLIER -161.9 -178.93 6.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.455 -0.778 . . . . 0.0 109.907 179.894 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.7 p -64.64 -30.79 71.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.272 -0.892 . . . . 0.0 110.126 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.535 ' CB ' ' HD2' ' A' ' 99' ' ' PRO . 0.1 OUTLIER -90.1 179.94 1.38 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.333 -0.854 . . . . 0.0 109.978 179.822 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.535 ' HD2' ' CB ' ' A' ' 98' ' ' GLU . 44.6 Cg_endo -71.88 132.07 19.37 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.925 1.487 . . . . 0.0 110.313 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.53 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.84 92.43 3.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.234 -0.916 . . . . 0.0 110.402 -179.841 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.443 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 0.6 OUTLIER -76.99 156.76 31.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.296 -0.878 . . . . 0.0 110.113 179.861 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.843 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 52.5 t -138.71 134.15 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.205 -0.935 . . . . 0.0 110.219 -179.992 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 21.6 m -150.06 113.46 4.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.319 -0.863 . . . . 0.0 110.181 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -146.48 138.3 24.75 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.295 -0.878 . . . . 0.0 110.244 -179.949 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.03 159.28 16.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.27 -0.894 . . . . 0.0 110.085 179.952 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.803 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 48.8 p90 -167.77 151.27 6.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.23 -0.919 . . . . 0.0 110.279 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 58' ' ' THR . 3.1 m -89.89 90.71 8.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.209 -0.932 . . . . 0.0 110.012 179.787 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.7 ' HB1' HG21 ' A' ' 54' ' ' ILE . . . -52.41 116.26 2.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.244 -0.91 . . . . 0.0 110.314 -179.828 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.445 ' H ' HG12 ' A' ' 88' ' ' VAL . 55.4 p -99.4 54.83 0.97 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.262 -0.899 . . . . 0.0 110.082 179.836 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -165.06 -160.15 0.47 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.261 -0.9 . . . . 0.0 110.37 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.906 HG22 ' HD3' ' A' ' 113' ' ' PRO . 85.1 m -144.0 116.69 8.7 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.267 -0.896 . . . . 0.0 110.264 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.604 ' CD2' HG13 ' A' ' 54' ' ' ILE . 20.4 m-30 -114.49 73.43 2.8 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.251 -0.905 . . . . 0.0 110.043 179.92 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.906 ' HD3' HG22 ' A' ' 111' ' ' THR . 43.9 Cg_endo -70.47 -163.18 0.11 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.998 1.525 . . . . 0.0 110.465 -179.962 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.669 0 O-C-N 121.237 -0.914 . . . . 0.0 110.223 -179.873 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.519 ' OE1' ' N ' ' A' ' 122' ' ' GLU . 22.5 pm0 . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 121.215 0.531 . . . . 0.0 110.264 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.552 ' HA2' ' HA ' ' A' ' 80' ' ' GLN . . . -147.45 157.84 27.52 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.686 ' HA ' HG23 ' A' ' 52' ' ' VAL . 2.4 pt20 -150.43 -157.55 0.83 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.276 -1.132 . . . . 0.0 110.6 -179.58 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.606 HG21 ' CH2' ' A' ' 16' ' ' TRP . 12.4 mt -118.45 142.92 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.464 -0.773 . . . . 0.0 109.068 179.382 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.47 ' HB3' HD11 ' A' ' 77' ' ' LEU . . . -121.32 123.56 42.46 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.258 -0.901 . . . . 0.0 111.032 -179.351 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.481 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 4.9 m-85 -118.59 109.38 16.09 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 178.446 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 128' ' ' GLN . . . . . 0.501 ' HB2' ' HB2' ' A' ' 75' ' ' ARG . 1.3 mm100 -88.65 102.53 15.06 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.231 -0.918 . . . . 0.0 111.901 -177.497 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.495 ' HG ' ' HA2' ' A' ' 46' ' ' GLY . 13.9 mt -107.42 45.06 1.02 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 178.289 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -95.57 78.1 0.82 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.453 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.576 ' O ' ' CG ' ' A' ' 132' ' ' PHE . . . 78.61 110.3 0.2 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.747 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.695 ' CB ' HG12 ' A' ' 74' ' ' VAL . 26.0 m-85 -161.57 -49.02 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.22 -1.165 . . . . 0.0 110.355 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.624 ' HB2' HG21 ' A' ' 72' ' ' VAL . 1.0 OUTLIER -89.43 -140.13 0.14 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.046 -1.034 . . . . 0.0 110.1 179.888 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -133.95 -83.37 0.45 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.17 -0.956 . . . . 0.0 110.364 -179.917 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.434 ' O ' ' C ' ' A' ' 136' ' ' ALA . 1.1 m-20 -81.53 162.87 23.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.192 -0.942 . . . . 0.0 110.283 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.472 ' N ' ' HA ' ' A' ' 38' ' ' ALA . . . -41.21 123.35 2.04 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.333 -0.854 . . . . 0.0 110.263 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 1.057 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 11.4 p90 -137.22 -173.15 3.38 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.174 -0.953 . . . . 0.0 110.619 -179.93 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.521 ' C ' HD12 ' A' ' 139' ' ' LEU . 0.8 OUTLIER -151.07 174.19 13.48 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.432 -0.792 . . . . 0.0 110.073 -178.024 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.864 HD21 ' CD1' ' A' ' 95' ' ' LEU . 1.7 mp -139.82 119.38 13.12 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.153 -0.967 . . . . 0.0 112.059 -179.679 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 140' ' ' CYS . . . . . 0.64 ' SG ' ' HB3' ' A' ' 31' ' ' ALA . 0.8 OUTLIER -103.27 108.37 19.56 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.618 -0.676 . . . . 0.0 110.878 178.132 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.545 HD23 ' HB2' ' A' ' 66' ' ' ALA . 1.4 mt -94.55 -178.93 4.72 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.285 -0.885 . . . . 0.0 108.792 178.513 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.732 ' O ' HG22 ' A' ' 8' ' ' THR . 0.4 OUTLIER 168.29 55.38 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.063 -1.023 . . . . 0.0 110.98 -179.963 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.535 ' HB2' ' O ' ' A' ' 142' ' ' ASP . 10.9 t70 172.91 46.81 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.469 -0.769 . . . . 0.0 109.132 179.56 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.883 HG11 ' HZ2' ' A' ' 16' ' ' TRP . 1.3 t -91.71 112.93 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.16 -0.962 . . . . 0.0 110.646 -179.043 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.469 ' HB2' ' HG3' ' A' ' 6' ' ' GLU . . . -149.43 147.17 27.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.488 -0.758 . . . . 0.0 110.041 179.85 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.985 HD21 HD11 ' A' ' 54' ' ' ILE . 10.8 tp -141.49 125.2 16.9 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.388 -0.82 . . . . 0.0 110.237 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.49 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -133.81 174.33 10.57 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.197 -0.94 . . . . 0.0 110.207 179.977 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 57.5 p . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.207 -0.933 . . . . 0.0 110.32 -179.989 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.455 ' HB2' ' O ' ' A' ' 51' ' ' GLY . 51.1 Cg_endo . . . . . 0 N--CA 1.481 0.755 0 N-CA-C 111.115 -0.379 . . . . 0.0 111.115 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.477 HD12 ' CG1' ' A' ' 144' ' ' VAL . 6.1 pt -138.78 -37.01 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.997 -1.065 . . . . 0.0 110.118 179.906 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.451 ' N ' ' CG1' ' A' ' 4' ' ' ILE . . . 161.36 126.59 0.83 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -73.52 81.99 1.48 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.258 -1.142 . . . . 0.0 110.192 179.991 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 144' ' ' VAL . . . 114.59 -123.37 5.99 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.798 HG22 ' O ' ' A' ' 142' ' ' ASP . 15.6 p -80.5 179.04 7.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.29 -1.123 . . . . 0.0 110.136 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.687 ' CE1' HG21 ' A' ' 144' ' ' VAL . 23.0 m-85 -68.57 -35.78 77.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.306 -0.871 . . . . 0.0 109.579 179.735 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.552 ' O ' ' HB2' ' A' ' 11' ' ' ASP . 23.2 t0 38.09 42.74 0.5 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.645 -0.659 . . . . 0.0 110.705 179.308 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.552 ' HB2' ' O ' ' A' ' 10' ' ' ASP . 4.3 t0 161.9 71.07 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 121.508 0.671 . . . . 0.0 109.545 179.871 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.47 ' HA2' ' HB ' ' A' ' 27' ' ' THR . . . 43.95 -168.5 0.02 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.723 ' HB3' HD12 ' A' ' 32' ' ' LEU . 51.1 Cg_endo -74.43 81.47 2.05 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.121 1.59 . . . . 0.0 110.337 179.947 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.485 ' C ' ' O ' ' A' ' 13' ' ' PRO . 0.2 OUTLIER -31.77 -67.51 0.1 Allowed 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.292 0.568 . . . . 0.0 111.183 -179.614 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.5 ' C ' ' CD1' ' A' ' 49' ' ' LEU . . . -145.75 10.24 1.64 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.946 ' CE2' HD22 ' A' ' 49' ' ' LEU . 66.4 m95 -78.06 88.95 4.18 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.149 -1.207 . . . . 0.0 110.257 -179.863 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.719 ' O ' HG13 ' A' ' 47' ' ' VAL . 0.8 OUTLIER -85.18 144.88 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.093 -1.004 . . . . 0.0 109.44 179.802 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.454 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . . . -128.64 128.81 44.88 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.025 -1.047 . . . . 0.0 109.93 179.554 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.798 ' HE2' HG13 ' A' ' 48' ' ' VAL . 23.4 p90 -113.24 145.49 40.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.451 -0.781 . . . . 0.0 110.397 -179.302 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.615 ' HA3' HG13 ' A' ' 45' ' ' VAL . . . 156.77 -91.03 0.12 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.539 ' CG2' ' HG3' ' A' ' 37' ' ' PRO . 5.5 p -151.96 18.92 0.68 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.254 -1.145 . . . . 0.0 110.051 179.675 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.476 ' HB3' ' O ' ' A' ' 35' ' ' ALA . 2.0 p30 -102.76 147.72 26.5 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.28 -0.887 . . . . 0.0 110.197 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.68 -138.13 0.15 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.801 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.417 ' O ' ' C ' ' A' ' 25' ' ' LEU . 46.2 Cg_endo -73.62 133.46 18.82 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.044 1.549 . . . . 0.0 110.346 179.865 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.858 HD22 HD11 ' A' ' 32' ' ' LEU . 7.8 mt -42.53 113.52 0.47 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.254 -0.904 . . . . 0.0 110.083 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.487 ' HB3' ' HB2' ' A' ' 33' ' ' CYS . 29.5 t70 -66.4 101.37 0.74 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.23 -0.919 . . . . 0.0 110.188 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.694 ' O ' HG22 ' A' ' 29' ' ' THR . 1.5 p -119.23 -81.32 0.63 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.296 -0.877 . . . . 0.0 109.955 -179.911 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.462 ' O ' ' HB ' ' A' ' 29' ' ' THR . 22.5 p 42.16 36.23 0.68 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.254 -0.903 . . . . 0.0 110.442 179.811 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.694 HG22 ' O ' ' A' ' 27' ' ' THR . 12.2 t -177.97 -31.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.3 -0.875 . . . . 0.0 110.194 179.914 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 9' ' ' PHE . . . 126.35 2.19 7.04 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.946 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 141' ' ' LEU . . . -111.29 109.83 20.03 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.212 -1.169 . . . . 0.0 110.24 179.992 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.858 HD11 HD22 ' A' ' 25' ' ' LEU . 1.0 OUTLIER -68.51 102.37 1.44 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.281 -0.887 . . . . 0.0 109.966 179.943 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.51 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 34.2 m -108.19 103.61 12.84 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.319 -0.863 . . . . 0.0 110.514 -179.687 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.807 HG12 HD23 ' A' ' 25' ' ' LEU . 19.5 m -89.71 155.51 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.262 -0.899 . . . . 0.0 109.762 179.621 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.514 ' HA ' ' OG1' ' A' ' 138' ' ' THR . . . -103.87 101.26 11.06 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.249 -0.907 . . . . 0.0 111.346 -179.111 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.031 HG11 ' CE2' ' A' ' 137' ' ' TRP . 91.4 t -84.41 123.07 75.25 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.168 -0.958 . . . . 0.0 109.009 178.794 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.539 ' HG3' ' CG2' ' A' ' 21' ' ' THR . 43.2 Cg_endo -67.85 147.33 74.62 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.87 1.458 . . . . 0.0 111.347 -178.866 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.581 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -47.37 116.47 1.43 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.312 -0.868 . . . . 0.0 109.817 179.659 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.1 71.91 1.16 Allowed Glycine 0 N--CA 1.486 1.99 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 -179.51 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.755 ' HB2' HG21 ' A' ' 45' ' ' VAL . 0.4 OUTLIER -84.89 43.96 1.03 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.324 -1.103 . . . . 0.0 109.807 -179.987 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.522 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . -88.5 -139.46 0.12 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.491 -0.755 . . . . 0.0 110.029 179.871 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.561 ' HG2' ' N ' ' A' ' 43' ' ' TYR . 0.0 OUTLIER 42.79 -140.98 0.14 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.543 -0.723 . . . . 0.0 110.346 -179.479 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.73 ' OH ' HG22 ' A' ' 45' ' ' VAL . 8.3 p90 -28.96 -39.51 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.175 0 CA-C-O 121.143 0.497 . . . . 0.0 110.929 -179.136 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.599 ' O ' ' CD1' ' A' ' 43' ' ' TYR . . . 89.76 132.96 4.93 Favored Glycine 0 N--CA 1.493 2.441 0 C-N-CA 120.041 -1.076 . . . . 0.0 110.674 178.22 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.755 HG21 ' HB2' ' A' ' 40' ' ' SER . 2.6 t -89.85 179.52 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.364 -1.08 . . . . 0.0 108.908 179.238 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.532 ' HA2' ' HA ' ' A' ' 128' ' ' GLN . . . 173.57 -177.58 45.86 Favored Glycine 0 N--CA 1.488 2.118 0 C-N-CA 119.024 -1.56 . . . . 0.0 110.668 -179.886 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.719 HG13 ' O ' ' A' ' 17' ' ' VAL . 21.6 t -150.65 132.43 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.737 -0.861 . . . . 0.0 108.768 179.779 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.798 HG13 ' HE2' ' A' ' 19' ' ' TYR . 31.1 m -119.66 131.7 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.976 -1.077 . . . . 0.0 110.69 -179.383 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.946 HD22 ' CE2' ' A' ' 16' ' ' TRP . 30.0 tp -124.06 90.76 3.32 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.439 -0.788 . . . . 0.0 110.353 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.522 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 22.0 p30 -75.2 145.84 41.71 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.271 -0.893 . . . . 0.0 110.237 179.881 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.455 ' O ' ' HB2' ' A' ' 3' ' ' PRO . . . 122.19 63.48 0.22 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.969 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.594 HG12 ' N ' ' A' ' 53' ' ' ALA . 53.5 t -121.96 171.9 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.235 -1.156 . . . . 0.0 109.968 179.807 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.594 ' N ' HG12 ' A' ' 52' ' ' VAL . . . -141.88 77.91 1.61 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.072 -1.017 . . . . 0.0 110.804 -179.742 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.595 HG13 ' CD2' ' A' ' 112' ' ' TYR . 35.6 mm -112.34 159.24 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.177 -0.952 . . . . 0.0 109.622 179.343 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.534 ' HA ' HG23 ' A' ' 111' ' ' THR . 0.6 OUTLIER -153.48 132.25 12.34 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.04 -1.037 . . . . 0.0 110.836 -179.634 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 19.4 pt-20 37.72 -155.49 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.67 -0.644 . . . . 0.0 110.994 179.488 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' A' ' 109' ' ' SER . . . -85.95 80.92 1.75 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.776 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.569 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.2 m -105.72 173.88 6.12 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.268 -1.137 . . . . 0.0 109.73 179.76 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.559 ' N ' ' CG2' ' A' ' 58' ' ' THR . 0.6 OUTLIER -89.7 154.78 19.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.144 -0.972 . . . . 0.0 110.411 -179.731 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.608 ' CE2' ' HB3' ' A' ' 108' ' ' ALA . 55.8 m-85 -159.87 178.5 9.69 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.32 -0.862 . . . . 0.0 110.3 179.905 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 104' ' ' GLU . 32.8 m -150.13 123.61 9.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.337 -0.852 . . . . 0.0 109.925 179.8 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.6 tp -89.44 118.63 29.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.186 -0.946 . . . . 0.0 110.067 -179.948 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.524 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 2.1 tpt180 -127.97 114.47 17.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.31 -0.869 . . . . 0.0 110.204 -179.761 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 1.163 ' CZ ' HG21 ' A' ' 102' ' ' VAL . 0.4 OUTLIER -157.99 141.19 15.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.155 -0.966 . . . . 0.0 110.037 179.591 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.537 ' CG2' ' HG2' ' A' ' 101' ' ' GLN . 18.7 m -119.42 98.91 6.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.916 . . . . 0.0 109.976 -179.834 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.759 ' HB2' HD23 ' A' ' 141' ' ' LEU . . . -103.51 152.35 21.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.335 -0.853 . . . . 0.0 110.368 -179.669 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.71 HG23 ' O ' ' A' ' 98' ' ' GLU . 98.1 m -150.2 108.32 3.74 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.235 -0.915 . . . . 0.0 110.289 179.922 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -92.84 136.05 33.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.238 -0.914 . . . . 0.0 109.975 179.836 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 68' ' ' ALA . 12.2 t -44.93 -26.14 0.39 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.082 -1.011 . . . . 0.0 109.343 179.57 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.669 HG22 ' HB2' ' A' ' 137' ' ' TRP . 3.2 t -113.71 -179.69 3.71 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.527 -0.733 . . . . 0.0 109.806 179.708 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.499 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 37.5 t0 -94.4 69.48 3.63 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.16 -0.962 . . . . 0.0 109.545 179.253 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.828 HG23 ' CB ' ' A' ' 133' ' ' SER . 4.7 p -92.1 147.34 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.259 -0.901 . . . . 0.0 111.045 -179.278 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.54 HG22 ' O ' ' A' ' 73' ' ' THR . 3.5 m -128.6 89.45 2.89 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.078 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.779 HG21 HD22 ' A' ' 129' ' ' LEU . 10.7 m -89.64 -151.2 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.228 -0.92 . . . . 0.0 110.49 -179.116 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.527 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 34.9 mtm-85 -128.05 137.6 52.24 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.206 -0.934 . . . . 0.0 110.761 -179.295 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.805 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -139.28 155.38 47.77 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.356 -0.84 . . . . 0.0 109.881 179.455 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.922 ' CD1' ' HB3' ' A' ' 126' ' ' ALA . 1.3 pp 175.23 -157.4 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.327 -0.858 . . . . 0.0 109.982 -179.601 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.928 HG23 HD22 ' A' ' 89' ' ' LEU . 4.9 t -147.85 168.54 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.204 -0.935 . . . . 0.0 109.41 179.762 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.485 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . -177.8 176.78 48.2 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.339 -1.41 . . . . 0.0 109.906 -179.882 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.486 ' NE2' ' C ' ' A' ' 81' ' ' ASN . 13.6 tp60 -107.31 135.43 48.83 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.31 -1.112 . . . . 0.0 110.534 179.931 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.552 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 2.4 m120 -123.26 96.77 5.12 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 122.072 0.939 . . . . 0.0 108.894 178.644 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.528 ' O ' ' HB3' ' A' ' 83' ' ' ALA . . . 132.9 34.21 0.35 Allowed Glycine 0 N--CA 1.484 1.861 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.214 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 82' ' ' GLY . . . 60.15 143.94 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.264 -1.139 . . . . 0.0 110.235 -179.861 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.46 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.5 Cg_endo -82.22 18.45 17.86 Favored 'Cis proline' 0 C--N 1.313 -1.303 0 C-N-CA 121.868 -2.138 . . . . 0.0 110.869 -0.139 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.502 ' CD2' ' HA ' ' A' ' 83' ' ' ALA . 94.1 m-85 57.28 170.26 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.152 -0.967 . . . . 0.0 110.439 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 136.6 117.93 1.7 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.442 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 0.8 OUTLIER -97.78 145.69 26.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.195 -1.179 . . . . 0.0 110.185 179.863 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.96 HG23 HD12 ' A' ' 89' ' ' LEU . 29.4 m -123.98 -17.45 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.265 -0.897 . . . . 0.0 110.359 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.96 HD12 HG23 ' A' ' 88' ' ' VAL . 4.0 mp -108.5 136.96 47.25 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.189 -0.945 . . . . 0.0 111.009 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -150.97 82.2 1.33 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.457 -0.777 . . . . 0.0 109.836 179.601 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.2 p -140.06 178.5 7.23 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.033 -1.042 . . . . 0.0 110.741 -179.598 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.7 m -119.81 111.97 35.51 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.456 -0.777 . . . . 0.0 109.863 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.805 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 43.6 Cg_endo -70.1 99.57 0.79 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.957 1.503 . . . . 0.0 110.866 -179.764 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.518 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -76.23 153.21 36.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 0.0 109.687 179.504 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.712 HD21 ' CB ' ' A' ' 66' ' ' ALA . 72.7 mt -142.54 168.83 18.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.118 -0.989 . . . . 0.0 110.492 -179.751 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 70' ' ' THR . 0.3 OUTLIER -177.22 -178.82 0.82 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.411 -0.805 . . . . 0.0 110.038 -179.966 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.7 -8.23 26.38 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.228 -0.92 . . . . 0.0 110.148 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.71 ' O ' HG23 ' A' ' 67' ' ' THR . 11.3 mt-10 -106.17 168.22 8.51 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.907 . . . . 0.0 110.097 179.87 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.491 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 46.4 Cg_endo -72.83 130.26 15.46 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.046 1.55 . . . . 0.0 110.363 179.993 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.518 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 3.1 ttm-85 -119.91 92.42 3.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.176 -0.953 . . . . 0.0 110.251 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.537 ' HG2' ' CG2' ' A' ' 65' ' ' THR . 1.7 mt-30 -75.11 153.23 38.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.33 -0.856 . . . . 0.0 109.975 179.845 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 1.163 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 39.4 t -130.35 133.56 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.18 -0.95 . . . . 0.0 110.387 -179.945 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.526 ' O ' ' CG ' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -150.35 124.35 9.33 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.356 -0.84 . . . . 0.0 110.065 -179.987 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.526 ' CG ' ' O ' ' A' ' 103' ' ' THR . 35.3 mt-10 -157.56 154.53 28.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.256 -0.902 . . . . 0.0 110.315 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.2 m -117.39 114.67 23.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.261 -0.899 . . . . 0.0 110.042 179.898 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.959 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 35.4 p90 -127.27 155.42 43.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.195 -0.94 . . . . 0.0 110.342 -179.782 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.422 ' O ' HG22 ' A' ' 107' ' ' THR . 21.0 m -93.12 89.04 6.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.296 -0.878 . . . . 0.0 109.977 179.7 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.608 ' HB3' ' CE2' ' A' ' 60' ' ' TYR . . . -42.61 100.06 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.245 -0.909 . . . . 0.0 110.346 -179.855 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.47 ' H ' HG12 ' A' ' 88' ' ' VAL . 43.2 p -88.81 51.87 2.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.262 -0.899 . . . . 0.0 110.144 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.424 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -159.18 -152.81 0.33 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.264 -0.898 . . . . 0.0 110.301 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.534 HG23 ' HA ' ' A' ' 55' ' ' GLU . 25.1 m -153.5 119.07 5.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.886 . . . . 0.0 110.204 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.595 ' CD2' HG13 ' A' ' 54' ' ' ILE . 17.8 m-30 -113.95 89.7 17.28 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.303 -0.873 . . . . 0.0 109.942 179.829 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.484 ' HD2' ' OE1' ' A' ' 80' ' ' GLN . 44.9 Cg_endo -71.84 -158.69 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.028 1.541 . . . . 0.0 110.406 -179.928 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.431 ' HA ' ' CD ' ' A' ' 122' ' ' GLU . . . . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.221 -0.925 . . . . 0.0 110.244 -179.99 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.552 ' O ' ' HB2' ' A' ' 81' ' ' ASN . 6.6 pt-20 . . . . . 0 N--CA 1.497 1.907 0 CA-C-O 121.108 0.48 . . . . 0.0 111.133 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -106.01 158.94 15.4 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 -179.429 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.522 ' CB ' ' HA ' ' A' ' 50' ' ' ASN . 17.1 pt20 -150.63 -151.76 0.41 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.366 -1.079 . . . . 0.0 110.621 -179.806 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.877 HG21 ' CH2' ' A' ' 16' ' ' TRP . 23.9 mt -118.56 146.51 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.616 -0.677 . . . . 0.0 109.425 179.665 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.922 ' HB3' ' CD1' ' A' ' 77' ' ' LEU . . . -116.15 114.87 25.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.336 -0.853 . . . . 0.0 111.744 -178.879 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.548 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 4.0 m-85 -119.81 75.69 1.1 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.247 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 128' ' ' GLN . . . . . 0.741 ' C ' HD23 ' A' ' 129' ' ' LEU . 12.9 mt-30 -88.42 123.27 32.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.196 -0.94 . . . . 0.0 111.902 -177.754 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.993 HD13 HD13 ' A' ' 139' ' ' LEU . 3.6 mt -107.76 51.77 0.73 Allowed 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.746 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -96.1 130.75 10.38 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.627 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.577 ' O ' ' CD1' ' A' ' 132' ' ' PHE . . . 51.14 93.81 0.01 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.686 ' CD2' HG12 ' A' ' 74' ' ' VAL . 9.5 m-85 -158.86 -78.23 0.07 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.281 -1.129 . . . . 0.0 110.419 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.828 ' CB ' HG23 ' A' ' 72' ' ' VAL . 1.3 t -89.66 168.39 12.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.096 -1.003 . . . . 0.0 110.339 -179.812 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -98.26 -91.56 0.26 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.274 -0.892 . . . . 0.0 110.316 -179.917 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -46.65 158.05 0.13 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.081 -1.012 . . . . 0.0 110.35 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.581 ' HB2' ' HB2' ' A' ' 38' ' ' ALA . . . -54.48 128.66 32.93 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.313 -0.867 . . . . 0.0 110.333 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 1.031 ' CE2' HG11 ' A' ' 36' ' ' VAL . 8.9 p90 -135.24 -163.35 1.37 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.306 -0.871 . . . . 0.0 110.009 179.674 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.589 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 0.8 OUTLIER -160.95 176.5 11.34 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.195 -1.002 . . . . 0.0 110.696 -178.382 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.993 HD13 HD13 ' A' ' 129' ' ' LEU . 2.1 mp -133.52 126.04 30.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.464 -0.773 . . . . 0.0 109.605 179.172 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 140' ' ' CYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 33.4 m -121.94 98.77 6.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.032 -1.043 . . . . 0.0 110.91 -179.536 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.759 HD23 ' HB2' ' A' ' 66' ' ' ALA . 2.2 mt -89.8 -179.91 5.85 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -0.927 . . . . 0.0 109.318 179.067 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.798 ' O ' HG22 ' A' ' 8' ' ' THR . 2.7 p30 168.03 41.08 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.289 -0.882 . . . . 0.0 110.104 179.908 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.471 ' HA ' ' C ' ' A' ' 7' ' ' GLY . 0.3 OUTLIER -174.98 52.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.289 -0.882 . . . . 0.0 109.659 -179.877 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.687 HG21 ' CE1' ' A' ' 9' ' ' PHE . 1.4 t -89.2 121.27 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.349 -0.845 . . . . 0.0 109.917 -179.44 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.457 ' HB3' ' HB3' ' A' ' 63' ' ' ARG . . . -144.41 140.87 29.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.329 -0.857 . . . . 0.0 110.293 -179.631 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.482 HD21 HD11 ' A' ' 54' ' ' ILE . 13.6 tp -148.08 123.82 10.54 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.376 -0.828 . . . . 0.0 110.072 179.839 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.477 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 7.3 t0 -136.15 -177.31 4.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.179 -0.951 . . . . 0.0 110.295 -179.893 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.3 p . . . . . 0 N--CA 1.492 1.666 0 O-C-N 121.253 -0.904 . . . . 0.0 110.129 179.958 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo . . . . . 0 N--CA 1.479 0.675 0 N-CA-C 110.115 -0.763 . . . . 0.0 110.115 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.53 HG22 ' O ' ' A' ' 51' ' ' GLY . 9.1 pt -95.51 19.49 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.278 -0.889 . . . . 0.0 110.097 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' A' ' 7' ' ' GLY . . . 79.94 70.39 1.33 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.965 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.583 ' HG2' ' HB1' ' A' ' 145' ' ' ALA . 82.6 mt-10 -42.42 94.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.31 -1.112 . . . . 0.0 110.198 -179.945 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 5' ' ' GLY . . . 173.99 -159.1 28.36 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.987 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.739 HG22 ' O ' ' A' ' 142' ' ' ASP . 11.9 p -98.34 -154.91 0.47 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.367 -1.078 . . . . 0.0 110.268 -179.851 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.523 ' CE1' ' CD1' ' A' ' 16' ' ' TRP . 64.6 m-85 -120.56 44.21 2.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.305 -0.872 . . . . 0.0 110.176 179.959 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.559 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 49.5 t0 -97.84 61.7 1.57 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.234 -0.916 . . . . 0.0 110.126 -179.973 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.559 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 2.5 t0 161.83 -23.72 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.745 -0.597 . . . . 0.0 109.652 -179.973 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 176.21 133.98 1.87 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.724 ' HB3' HD12 ' A' ' 32' ' ' LEU . 48.9 Cg_endo -78.02 6.15 4.83 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.906 1.477 . . . . 0.0 110.533 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.512 ' HB3' ' O ' ' A' ' 13' ' ' PRO . 5.6 tp10 60.66 -89.03 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.356 -0.84 . . . . 0.0 110.386 -179.793 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.833 ' C ' HD13 ' A' ' 49' ' ' LEU . . . -148.09 25.44 1.43 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -179.859 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.834 ' HZ2' HG11 ' A' ' 144' ' ' VAL . 57.1 m95 -72.12 86.39 1.05 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.166 -1.197 . . . . 0.0 110.354 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.716 ' O ' HG13 ' A' ' 47' ' ' VAL . 1.1 m -87.42 153.32 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.205 -0.934 . . . . 0.0 109.92 179.942 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.403 ' CB ' HG22 ' A' ' 47' ' ' VAL . . . -136.84 133.63 36.06 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.268 -0.895 . . . . 0.0 109.456 179.437 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.6 ' HE2' HG13 ' A' ' 48' ' ' VAL . 6.1 p90 -120.38 161.11 21.74 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.283 -0.886 . . . . 0.0 111.122 -178.635 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.589 ' HA2' ' CE1' ' A' ' 43' ' ' TYR . . . 72.96 49.15 17.82 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.88 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.544 HG22 ' CG1' ' A' ' 45' ' ' VAL . 11.5 p -148.12 -153.52 0.5 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.254 -1.145 . . . . 0.0 110.404 -179.956 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -89.87 44.02 1.18 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.326 -0.859 . . . . 0.0 110.079 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.56 -144.28 16.29 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.889 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.99 -159.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.973 1.512 . . . . 0.0 110.367 179.944 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.638 ' CD1' HD11 ' A' ' 32' ' ' LEU . 0.3 OUTLIER -111.51 -173.12 2.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.184 -0.947 . . . . 0.0 110.037 179.809 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -132.03 159.9 37.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.163 -0.96 . . . . 0.0 110.19 -179.88 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.462 HG21 ' HD3' ' A' ' 13' ' ' PRO . 0.7 OUTLIER -133.62 -34.57 1.03 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.254 -0.904 . . . . 0.0 110.258 -179.911 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.44 ' O ' ' OG1' ' A' ' 29' ' ' THR . 73.6 m 51.28 30.41 5.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.23 -0.919 . . . . 0.0 110.221 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.453 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 5.4 p 42.8 55.04 4.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.28 -0.888 . . . . 0.0 110.2 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.508 ' N ' ' HA ' ' A' ' 10' ' ' ASP . . . -169.55 -54.86 0.03 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.611 ' HB1' ' O ' ' A' ' 141' ' ' LEU . . . -149.88 149.91 31.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.211 -1.17 . . . . 0.0 110.32 -179.902 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.724 HD12 ' HB3' ' A' ' 13' ' ' PRO . 1.1 tp -79.97 103.15 9.66 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.243 -0.911 . . . . 0.0 109.822 179.739 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.486 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 23.2 m -109.6 105.85 15.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.212 -0.93 . . . . 0.0 110.778 -179.503 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.545 HG12 ' HB3' ' A' ' 25' ' ' LEU . 18.0 m -91.09 140.12 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.241 -0.912 . . . . 0.0 109.122 179.08 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.483 ' O ' ' HB ' ' A' ' 21' ' ' THR . . . -89.18 98.33 11.71 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.102 -0.999 . . . . 0.0 111.032 -179.052 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.073 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 48.3 t -83.72 130.09 56.98 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.267 -0.896 . . . . 0.0 109.617 179.168 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 21' ' ' THR . 43.6 Cg_endo -70.73 -179.25 3.2 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.815 1.429 . . . . 0.0 110.538 -179.742 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.573 ' HA ' ' N ' ' A' ' 136' ' ' ALA . . . -42.79 166.67 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.25 -0.906 . . . . 0.0 110.137 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.595 ' O ' ' N ' ' A' ' 41' ' ' ALA . . . -35.68 108.12 0.05 OUTLIER Glycine 0 N--CA 1.495 2.62 0 N-CA-C 109.169 -1.573 . . . . 0.0 109.169 179.798 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.919 ' HB2' HG23 ' A' ' 45' ' ' VAL . 0.4 OUTLIER -39.36 89.9 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.979 0.895 . . . . 0.0 110.263 -178.899 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.595 ' N ' ' O ' ' A' ' 39' ' ' GLY . . . -114.79 23.84 12.28 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 121.952 0.882 . . . . 0.0 109.673 -179.465 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.543 ' O ' ' CG ' ' A' ' 42' ' ' GLN . 0.9 OUTLIER 177.04 34.3 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.241 -179.891 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.589 ' CE1' ' HA2' ' A' ' 20' ' ' GLY . 0.1 OUTLIER -158.79 -28.19 0.07 Allowed 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 118.548 -1.261 . . . . 0.0 112.389 -177.806 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 43' ' ' TYR . . . 53.43 84.47 0.03 OUTLIER Glycine 0 N--CA 1.483 1.829 0 N-CA-C 105.285 -3.126 . . . . 0.0 105.285 -176.766 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.919 HG23 ' HB2' ' A' ' 40' ' ' SER . 3.0 t -86.61 143.08 12.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.301 -1.117 . . . . 0.0 109.665 -176.751 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.572 ' O ' ' CZ ' ' A' ' 19' ' ' TYR . . . -166.26 147.35 12.01 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.289 -1.434 . . . . 0.0 110.785 -179.058 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.716 HG13 ' O ' ' A' ' 17' ' ' VAL . 19.7 t -111.7 129.69 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.576 -0.955 . . . . 0.0 109.668 179.659 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.6 HG13 ' HE2' ' A' ' 19' ' ' TYR . 27.3 m -120.69 145.02 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.743 -1.223 . . . . 0.0 110.656 -179.624 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.833 HD13 ' C ' ' A' ' 15' ' ' GLY . 15.9 tp -144.45 117.38 8.81 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.262 -0.899 . . . . 0.0 110.34 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.515 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 5.2 p-10 -90.44 148.19 22.94 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.208 -0.932 . . . . 0.0 110.49 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.53 ' O ' HG22 ' A' ' 4' ' ' ILE . . . 126.44 78.62 0.29 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.837 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.689 HG12 HG12 ' A' ' 54' ' ' ILE . 3.7 t -132.79 158.45 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.181 -1.188 . . . . 0.0 110.135 179.781 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -105.71 61.21 0.66 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.167 -0.958 . . . . 0.0 110.472 -179.885 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.928 HD11 HD21 ' A' ' 146' ' ' LEU . 6.3 mm -123.63 151.42 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.194 -0.941 . . . . 0.0 109.846 179.731 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.739 ' HA ' HG23 ' A' ' 111' ' ' THR . 4.4 pt-20 -174.97 34.07 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.106 -0.996 . . . . 0.0 110.376 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' A' ' 55' ' ' GLU . 1.3 tt0 179.88 -174.66 0.26 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.426 -0.796 . . . . 0.0 110.256 -179.797 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.494 ' HA2' ' HA ' ' A' ' 109' ' ' SER . . . -94.27 68.01 1.4 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 108.239 -1.944 . . . . 0.0 108.239 178.956 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.685 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.0 OUTLIER -109.02 176.17 5.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.503 -0.998 . . . . 0.0 110.367 -178.963 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.582 ' O ' ' CD2' ' A' ' 60' ' ' TYR . 0.4 OUTLIER -89.73 158.62 17.46 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.415 -0.803 . . . . 0.0 110.23 -179.941 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.685 ' CE2' HG22 ' A' ' 58' ' ' THR . 68.2 m-85 -156.14 -176.75 6.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.443 -0.786 . . . . 0.0 109.834 179.906 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 26.6 m -150.11 113.42 4.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.196 -0.94 . . . . 0.0 110.187 179.889 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.962 HD22 ' CD2' ' A' ' 89' ' ' LEU . 18.0 tp -89.71 120.86 31.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 110.032 179.821 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.799 ' HG2' HG23 ' A' ' 103' ' ' THR . 19.5 mtp-105 -128.4 130.73 48.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.282 -0.887 . . . . 0.0 110.099 179.961 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.548 ' CE2' ' HB ' ' A' ' 102' ' ' VAL . 8.7 p90 -165.48 152.77 10.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.262 -0.899 . . . . 0.0 109.923 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.504 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 25.6 m -119.67 93.95 4.24 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.097 -1.002 . . . . 0.0 109.968 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.551 ' HB2' HD23 ' A' ' 141' ' ' LEU . . . -96.33 154.54 17.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.274 -0.891 . . . . 0.0 110.939 -179.482 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.569 HG23 ' O ' ' A' ' 98' ' ' GLU . 50.9 m -149.69 134.94 18.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.562 -0.711 . . . . 0.0 109.39 179.263 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.534 ' N ' ' HB3' ' A' ' 95' ' ' LEU . . . -120.86 133.94 55.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.064 -1.023 . . . . 0.0 110.282 -179.685 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 68' ' ' ALA . 11.6 t -43.83 -26.17 0.24 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.27 -0.894 . . . . 0.0 109.547 179.546 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.73 HG22 ' HB2' ' A' ' 137' ' ' TRP . 5.7 t -115.21 -167.15 1.2 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.436 -0.79 . . . . 0.0 109.824 179.703 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.474 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 34.4 t0 -102.93 47.0 0.9 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.274 -0.891 . . . . 0.0 109.371 179.125 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.829 HG23 ' HB2' ' A' ' 133' ' ' SER . 1.9 p -63.46 171.53 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.429 -0.794 . . . . 0.0 110.824 -179.227 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.513 HG22 ' O ' ' A' ' 73' ' ' THR . 11.9 m -160.33 83.81 0.7 Allowed 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.67 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.997 HG21 ' CD2' ' A' ' 129' ' ' LEU . 2.4 m -89.9 -160.05 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.265 -0.897 . . . . 0.0 110.547 -178.616 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.465 ' N ' HG23 ' A' ' 74' ' ' VAL . 20.8 mtm-85 -121.28 112.97 19.27 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.256 -0.902 . . . . 0.0 110.328 -179.613 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.518 ' CB ' ' HD3' ' A' ' 93' ' ' PRO . . . -115.7 157.15 24.7 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.145 -0.972 . . . . 0.0 110.097 179.849 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.908 HD12 ' N ' ' A' ' 78' ' ' VAL . 3.8 pp 178.73 -147.3 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.409 -0.807 . . . . 0.0 109.851 -179.828 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.908 ' N ' HD12 ' A' ' 77' ' ' LEU . 3.1 t -151.92 172.57 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.115 -0.991 . . . . 0.0 109.563 179.773 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.494 ' HA2' ' HA ' ' A' ' 87' ' ' THR . . . 176.07 172.7 41.08 Favored Glycine 0 N--CA 1.49 2.276 0 C-N-CA 119.36 -1.4 . . . . 0.0 110.138 179.892 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.491 ' OE1' ' HD2' ' A' ' 113' ' ' PRO . 15.1 tp60 -93.04 137.72 32.14 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.4 -1.059 . . . . 0.0 110.355 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.532 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 3.6 m120 -123.3 96.4 4.98 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.839 0.828 . . . . 0.0 109.02 178.943 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.543 ' O ' ' HB3' ' A' ' 83' ' ' ALA . . . 132.31 34.4 0.37 Allowed Glycine 0 N--CA 1.484 1.878 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.523 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 82' ' ' GLY . . . 60.41 142.95 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.282 -1.128 . . . . 0.0 110.14 -179.86 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.463 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.3 Cg_endo -82.28 18.6 17.7 Favored 'Cis proline' 0 C--N 1.314 -1.255 0 C-N-CA 121.938 -2.109 . . . . 0.0 110.813 -0.159 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.541 ' CD2' ' HA ' ' A' ' 83' ' ' ALA . 75.7 m-85 58.91 170.02 0.06 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.153 -0.967 . . . . 0.0 110.342 -179.911 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 142.33 114.64 1.06 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.494 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 1.1 p -91.26 147.83 22.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.188 -1.183 . . . . 0.0 110.299 -179.963 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 1.032 HG23 HD12 ' A' ' 89' ' ' LEU . 15.6 m -123.12 -21.81 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.299 -0.876 . . . . 0.0 110.266 179.98 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 1.032 HD12 HG23 ' A' ' 88' ' ' VAL . 3.9 mp -104.94 146.76 28.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.239 -0.913 . . . . 0.0 110.7 179.735 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.733 ' O ' HG23 ' A' ' 91' ' ' THR . 8.9 t0 -151.03 89.04 1.49 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.324 -0.86 . . . . 0.0 110.142 179.727 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.733 HG23 ' O ' ' A' ' 90' ' ' ASP . 6.5 p -160.0 -178.98 7.4 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.123 -0.986 . . . . 0.0 110.584 -179.862 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.529 ' CB ' ' O ' ' A' ' 74' ' ' VAL . 3.5 m -129.08 129.49 23.38 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.329 -0.857 . . . . 0.0 110.07 179.927 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.844 ' HG2' HG22 ' A' ' 74' ' ' VAL . 46.9 Cg_endo -72.28 91.44 0.76 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.935 1.492 . . . . 0.0 110.994 -179.719 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.522 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -70.48 125.14 25.96 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.073 -1.017 . . . . 0.0 109.002 178.972 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.542 ' CD1' ' HG ' ' A' ' 139' ' ' LEU . 29.4 mt -119.83 170.48 9.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.113 -0.992 . . . . 0.0 110.846 -179.023 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.601 HG23 ' N ' ' A' ' 97' ' ' SER . 6.1 t -169.36 -151.18 0.09 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.394 -0.816 . . . . 0.0 109.735 179.886 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.601 ' N ' HG23 ' A' ' 96' ' ' THR . 0.5 OUTLIER -93.41 25.51 3.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.046 -1.034 . . . . 0.0 110.043 179.8 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.569 ' O ' HG23 ' A' ' 67' ' ' THR . 2.0 mt-10 -145.84 171.99 5.83 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.34 -0.85 . . . . 0.0 109.959 179.847 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.57 130.83 16.51 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 124.005 1.529 . . . . 0.0 110.379 -179.968 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.522 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 1.7 mtt180 -119.7 93.2 3.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.254 -0.904 . . . . 0.0 110.006 179.915 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -82.99 95.24 7.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.448 -0.783 . . . . 0.0 110.45 -179.767 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.548 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 73.6 t -89.47 133.51 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.277 -0.89 . . . . 0.0 110.013 179.836 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.799 HG23 ' HG2' ' A' ' 63' ' ' ARG . 53.5 m -150.21 139.54 21.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.227 -0.921 . . . . 0.0 110.328 -179.948 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.456 ' CG ' ' O ' ' A' ' 103' ' ' THR . 21.3 mt-10 -160.2 160.94 33.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.244 -0.91 . . . . 0.0 110.257 179.881 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.41 HG22 ' H ' ' A' ' 105' ' ' THR . 3.1 t -111.5 128.06 55.9 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.229 -0.919 . . . . 0.0 110.114 179.894 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.924 ' CE2' HD11 ' A' ' 89' ' ' LEU . 22.4 p90 -136.38 157.27 47.19 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.246 -0.909 . . . . 0.0 110.269 -179.916 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.534 ' O ' ' N ' ' A' ' 109' ' ' SER . 3.6 m -89.49 93.9 9.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.163 -0.96 . . . . 0.0 109.732 179.603 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.613 ' HB3' ' CE2' ' A' ' 60' ' ' TYR . . . -49.68 89.99 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.353 -0.842 . . . . 0.0 110.084 -179.932 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.534 ' N ' ' O ' ' A' ' 107' ' ' THR . 79.8 p -85.99 53.96 2.97 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.315 -0.866 . . . . 0.0 109.76 179.888 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -159.28 -156.75 0.54 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.244 -0.91 . . . . 0.0 110.393 -179.769 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.739 HG23 ' HA ' ' A' ' 55' ' ' GLU . 3.4 m -149.8 113.45 5.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.256 -0.902 . . . . 0.0 110.457 -179.896 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.751 ' OH ' HG13 ' A' ' 88' ' ' VAL . 11.9 m-30 -109.85 85.91 4.39 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.366 -0.834 . . . . 0.0 109.571 179.535 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.638 ' HD3' HG22 ' A' ' 111' ' ' THR . 45.4 Cg_endo -72.19 -165.83 0.23 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.892 1.469 . . . . 0.0 110.517 -179.757 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.307 -0.871 . . . . 0.0 110.24 -179.993 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.532 ' O ' ' HB2' ' A' ' 81' ' ' ASN . 0.5 OUTLIER . . . . . 0 N--CA 1.5 2.033 0 CA-C-O 121.325 0.583 . . . . 0.0 111.903 . . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.484 ' HA3' ' CB ' ' A' ' 112' ' ' TYR . . . -85.54 149.21 23.39 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -179.378 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.515 ' CB ' ' HA ' ' A' ' 50' ' ' ASN . 6.8 pt20 -150.78 -157.59 0.83 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.358 -1.084 . . . . 0.0 110.651 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.453 HG21 ' CH2' ' A' ' 16' ' ' TRP . 5.5 mt -118.54 146.97 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 179.294 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -121.5 122.62 40.12 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.325 -179.183 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.518 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 5.0 m-85 -118.59 98.54 6.29 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.185 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 128' ' ' GLN . . . . . 0.489 ' O ' ' HB ' ' A' ' 74' ' ' VAL . 10.5 mm-40 -88.75 84.13 6.69 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.262 -0.899 . . . . 0.0 112.368 -177.154 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 1.055 HD13 HD13 ' A' ' 139' ' ' LEU . 7.0 mt -85.2 45.99 1.24 Allowed 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.515 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' A' ' 132' ' ' PHE . . . -64.2 -170.5 2.02 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 -179.396 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.554 ' CA ' ' O ' ' A' ' 40' ' ' SER . . . -51.81 89.49 0.01 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.905 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.567 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 9.7 m-85 -118.35 -49.53 2.47 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.113 -1.228 . . . . 0.0 110.693 -179.361 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.829 ' HB2' HG23 ' A' ' 72' ' ' VAL . 1.3 t -88.53 175.83 7.41 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.997 -1.065 . . . . 0.0 110.233 -179.71 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -97.25 -52.94 3.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.322 -0.862 . . . . 0.0 110.309 -179.744 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -98.82 174.11 6.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.228 -0.92 . . . . 0.0 109.984 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.573 ' N ' ' HA ' ' A' ' 38' ' ' ALA . . . -57.59 125.6 23.63 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.151 -0.968 . . . . 0.0 110.047 -179.756 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 1.073 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 6.6 p90 -132.18 -168.48 2.05 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.063 -1.023 . . . . 0.0 109.803 179.659 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 68' ' ' ALA . 0.5 OUTLIER -155.76 172.46 18.28 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.805 -1.185 . . . . 0.0 111.331 -177.819 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 1.055 HD13 HD13 ' A' ' 129' ' ' LEU . 2.4 mp -130.47 128.81 42.0 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.548 -0.72 . . . . 0.0 109.506 179.497 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 140' ' ' CYS . . . . . . . . . . . . . 15.9 m -127.63 100.7 6.09 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.091 -1.006 . . . . 0.0 110.771 -179.535 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.611 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 0.7 OUTLIER -95.96 -177.93 4.18 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.29 -0.881 . . . . 0.0 109.325 179.189 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.739 ' O ' HG22 ' A' ' 8' ' ' THR . 0.6 OUTLIER 171.11 49.89 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.184 -0.947 . . . . 0.0 110.411 -179.996 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.677 ' CG ' HG22 ' A' ' 8' ' ' THR . 0.4 OUTLIER 166.23 55.43 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.37 -0.831 . . . . 0.0 109.614 179.849 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.834 HG11 ' HZ2' ' A' ' 16' ' ' TRP . 2.1 t -96.32 118.72 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.303 -0.873 . . . . 0.0 110.274 -179.474 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.583 ' HB1' ' HG2' ' A' ' 6' ' ' GLU . . . -145.2 155.55 43.33 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.318 -0.864 . . . . 0.0 110.189 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.928 HD21 HD11 ' A' ' 54' ' ' ILE . 14.1 tp -147.9 143.39 27.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.922 . . . . 0.0 110.188 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.493 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 5.0 t0 -172.3 151.15 2.49 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.2 -0.937 . . . . 0.0 110.311 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.433 ' HA ' ' O ' ' A' ' 59' ' ' THR . 9.7 p . . . . . 0 N--CA 1.492 1.653 0 O-C-N 121.281 -0.887 . . . . 0.0 110.197 179.998 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo . . . . . 0 N--CA 1.48 0.72 0 N-CA-C 110.072 -0.78 . . . . 0.0 110.072 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.633 HG22 ' O ' ' A' ' 51' ' ' GLY . 13.8 pt -95.39 23.97 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.195 -0.941 . . . . 0.0 110.17 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 94.23 -23.8 29.99 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.917 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.76 ' HG2' ' HB1' ' A' ' 145' ' ' ALA . 1.4 tt0 44.7 74.07 0.14 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.273 -1.134 . . . . 0.0 110.212 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -163.26 -164.01 17.31 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.961 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.572 HG22 ' O ' ' A' ' 142' ' ' ASP . 26.1 p -117.57 33.92 5.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.259 -1.142 . . . . 0.0 110.323 -179.975 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.552 ' HZ ' HG21 ' A' ' 144' ' ' VAL . 13.6 m-85 60.25 48.24 8.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -0.934 . . . . 0.0 110.146 179.938 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.557 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 32.2 t70 -90.13 32.21 0.94 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.223 -0.923 . . . . 0.0 110.333 -179.911 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.557 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.4 OUTLIER 161.55 37.77 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.572 -0.705 . . . . 0.0 109.974 179.983 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.24 136.07 4.36 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.774 ' HB3' HD12 ' A' ' 32' ' ' LEU . 48.3 Cg_endo -74.69 1.66 7.31 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.962 1.506 . . . . 0.0 110.609 179.955 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 0.1 OUTLIER 68.15 -84.04 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.265 -0.897 . . . . 0.0 110.274 -179.872 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.66 ' O ' HG13 ' A' ' 17' ' ' VAL . . . -137.39 5.54 3.52 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.921 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.884 ' CE2' HD22 ' A' ' 49' ' ' LEU . 56.0 m95 -65.5 105.25 1.15 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.188 -1.183 . . . . 0.0 110.249 -179.898 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.696 ' O ' HG13 ' A' ' 47' ' ' VAL . 1.0 OUTLIER -113.41 151.72 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.173 -0.955 . . . . 0.0 109.783 179.784 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 1.018 ' HB3' HD21 ' A' ' 25' ' ' LEU . . . -133.73 136.97 44.96 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.192 -0.942 . . . . 0.0 109.679 179.359 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.635 ' HE2' HG13 ' A' ' 48' ' ' VAL . 26.8 p90 -128.17 148.64 50.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.417 -0.802 . . . . 0.0 110.665 -178.902 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.3 24.61 18.58 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 179.464 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.704 HG22 HG11 ' A' ' 45' ' ' VAL . 28.1 p -134.88 -148.6 0.32 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.033 -1.275 . . . . 0.0 110.494 179.904 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.454 ' O ' ' O ' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -116.84 136.43 52.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.342 -0.849 . . . . 0.0 110.383 -179.806 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 22' ' ' ASP . . . 52.07 174.46 0.03 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.766 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.52 -159.32 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.08 1.569 . . . . 0.0 110.42 179.966 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 1.018 HD21 ' HB3' ' A' ' 18' ' ' ALA . 17.3 mt -93.05 145.3 24.49 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.215 -0.928 . . . . 0.0 110.237 179.987 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -97.59 119.41 36.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.243 -0.911 . . . . 0.0 109.827 179.709 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' A' ' 31' ' ' ALA . 0.8 OUTLIER -119.65 -44.56 2.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.127 -0.983 . . . . 0.0 110.503 -179.58 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.43 ' C ' ' O ' ' A' ' 27' ' ' THR . 8.1 t 43.76 36.04 1.21 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.186 -0.946 . . . . 0.0 109.874 -179.831 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 28' ' ' SER . 4.3 p 54.11 59.94 3.92 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.457 -0.777 . . . . 0.0 110.057 -179.731 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 8' ' ' THR . . . -159.24 -71.12 0.02 OUTLIER Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.624 ' HB1' ' O ' ' A' ' 141' ' ' LEU . . . -150.74 160.17 44.03 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.25 -1.147 . . . . 0.0 110.451 -179.899 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.774 HD12 ' HB3' ' A' ' 13' ' ' PRO . 0.6 OUTLIER -88.71 111.8 22.39 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.276 -0.89 . . . . 0.0 109.842 179.568 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 53.4 m -119.58 106.36 12.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.221 -0.924 . . . . 0.0 110.61 -179.642 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 1.006 HG12 HD22 ' A' ' 25' ' ' LEU . 18.2 m -89.87 145.58 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.207 -0.933 . . . . 0.0 109.715 179.535 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.527 ' HA ' ' OG1' ' A' ' 138' ' ' THR . . . -95.52 91.69 6.29 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.338 -0.851 . . . . 0.0 111.113 -179.268 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.126 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 58.8 t -71.54 130.85 86.86 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.168 -0.958 . . . . 0.0 109.307 179.076 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 21' ' ' THR . 43.1 Cg_endo -71.24 155.12 61.29 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.933 1.491 . . . . 0.0 111.164 -178.945 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.549 ' HA ' ' CA ' ' A' ' 136' ' ' ALA . . . -43.05 111.1 0.23 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.37 -0.832 . . . . 0.0 110.345 -179.839 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 134' ' ' ALA . . . 58.67 117.6 0.01 OUTLIER Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.981 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.597 ' HB3' HG23 ' A' ' 45' ' ' VAL . 58.6 m -85.55 49.0 1.67 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.27 -1.135 . . . . 0.0 109.553 179.668 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.513 ' O ' ' HB3' ' A' ' 42' ' ' GLN . . . -89.72 103.89 16.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.497 -0.752 . . . . 0.0 110.217 -179.741 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.513 ' HB3' ' O ' ' A' ' 41' ' ' ALA . 0.8 OUTLIER 168.18 -152.17 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -179.757 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.409 ' C ' ' O ' ' A' ' 42' ' ' GLN . 7.4 p90 -43.13 -26.43 0.16 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.091 -1.006 . . . . 0.0 109.564 179.174 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 42' ' ' GLN . . . 107.59 129.39 6.1 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.35 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.704 HG11 HG22 ' A' ' 21' ' ' THR . 3.0 t -89.88 177.89 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.132 -1.217 . . . . 0.0 108.46 179.144 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.556 ' HA2' ' HA ' ' A' ' 128' ' ' GLN . . . 169.4 -177.29 43.09 Favored Glycine 0 N--CA 1.489 2.182 0 C-N-CA 118.748 -1.692 . . . . 0.0 111.075 -179.894 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.696 HG13 ' O ' ' A' ' 17' ' ' VAL . 18.3 t -150.95 126.84 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.803 -0.822 . . . . 0.0 108.83 179.862 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.635 HG13 ' HE2' ' A' ' 19' ' ' TYR . 29.0 m -119.82 133.67 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.027 -1.046 . . . . 0.0 110.907 -179.159 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.884 HD22 ' CE2' ' A' ' 16' ' ' TRP . 30.7 tp -122.97 90.64 3.33 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.397 -0.815 . . . . 0.0 110.074 179.787 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.481 ' HA ' ' HB3' ' A' ' 124' ' ' GLN . 8.1 p30 -73.57 113.5 10.75 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.236 -0.915 . . . . 0.0 110.247 -179.909 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.633 ' O ' HG22 ' A' ' 4' ' ' ILE . . . 153.95 65.86 0.01 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.908 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.725 HG23 ' HA ' ' A' ' 124' ' ' GLN . 97.2 t -120.04 173.07 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.164 -1.197 . . . . 0.0 109.982 179.787 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.599 ' N ' HG12 ' A' ' 52' ' ' VAL . . . -143.43 97.74 3.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.072 -1.017 . . . . 0.0 110.652 -179.786 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.863 HG21 ' HB1' ' A' ' 108' ' ' ALA . 11.6 mm -137.79 159.87 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.292 -0.88 . . . . 0.0 109.818 179.603 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.475 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -147.82 135.34 20.76 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.108 -0.995 . . . . 0.0 110.683 -179.774 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.565 ' CG ' ' N ' ' A' ' 57' ' ' GLY . 0.9 OUTLIER 34.23 -155.08 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.342 0.592 . . . . 0.0 111.243 179.759 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.565 ' N ' ' CG ' ' A' ' 56' ' ' GLU . . . -83.39 81.39 1.75 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.837 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.681 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.2 m -109.13 171.26 7.54 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.305 -1.115 . . . . 0.0 109.826 179.876 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.519 ' N ' ' CG2' ' A' ' 58' ' ' THR . 1.0 OUTLIER -89.91 150.21 22.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.257 -0.902 . . . . 0.0 110.181 -179.941 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.823 ' CE2' HG23 ' A' ' 54' ' ' ILE . 64.9 m-85 -154.69 171.74 19.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.233 -0.917 . . . . 0.0 110.225 179.895 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.514 ' OG1' HG23 ' A' ' 105' ' ' THR . 17.9 m -142.73 114.51 8.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.304 -0.872 . . . . 0.0 110.086 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.1 tp -89.71 121.19 31.64 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.177 -0.952 . . . . 0.0 109.965 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.504 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 2.2 ttt180 -129.29 127.8 41.89 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -0.878 . . . . 0.0 110.314 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.964 ' CZ ' HG21 ' A' ' 102' ' ' VAL . 2.1 p90 -165.12 149.6 8.94 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.336 -0.853 . . . . 0.0 109.888 179.807 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 51.6 m -119.44 95.7 4.9 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.183 -0.948 . . . . 0.0 110.117 -179.965 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.501 ' HB2' HD23 ' A' ' 141' ' ' LEU . . . -93.92 151.93 19.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.358 -0.839 . . . . 0.0 110.339 -179.801 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.86 HG23 ' O ' ' A' ' 98' ' ' GLU . 57.1 m -149.76 121.16 7.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.278 -0.889 . . . . 0.0 110.261 179.97 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.469 ' O ' ' O ' ' A' ' 96' ' ' THR . . . -114.89 132.01 56.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.314 -0.866 . . . . 0.0 109.852 179.752 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.9 p -47.69 -23.99 0.83 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.074 -1.016 . . . . 0.0 109.343 179.497 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.592 HG22 ' HB2' ' A' ' 137' ' ' TRP . 2.5 t -113.84 170.2 8.44 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.49 -0.756 . . . . 0.0 110.067 179.904 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.43 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 15.7 t70 -86.75 66.02 9.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.179 -0.951 . . . . 0.0 109.119 178.86 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.776 HG23 ' CB ' ' A' ' 133' ' ' SER . 3.5 p -85.23 137.25 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.319 -0.863 . . . . 0.0 111.341 -178.871 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.409 ' O ' ' CD1' ' A' ' 132' ' ' PHE . 89.6 m -122.81 86.02 2.51 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.85 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.66 HG22 ' HG2' ' A' ' 93' ' ' PRO . 4.8 m -89.33 -153.28 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.287 -0.883 . . . . 0.0 110.444 -179.068 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.44 ' N ' HG23 ' A' ' 74' ' ' VAL . 2.4 mtp180 -125.94 133.16 51.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.207 -0.933 . . . . 0.0 110.627 -179.431 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.511 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -137.32 155.72 49.09 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.346 -0.846 . . . . 0.0 110.079 179.691 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.894 HD12 ' N ' ' A' ' 78' ' ' VAL . 3.9 pp 179.18 -147.77 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.354 -0.841 . . . . 0.0 110.033 -179.724 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.894 ' N ' HD12 ' A' ' 77' ' ' LEU . 3.8 t -151.65 166.43 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.147 -0.971 . . . . 0.0 109.321 179.77 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.507 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . -171.67 -174.53 39.33 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.11 -1.519 . . . . 0.0 110.631 -179.81 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.561 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 4.0 pt20 -114.78 150.8 34.84 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.545 -0.973 . . . . 0.0 110.065 179.793 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.487 ' OD1' ' HG2' ' A' ' 122' ' ' GLU . 18.6 m120 -106.31 92.47 4.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.207 -0.933 . . . . 0.0 110.396 -179.952 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.538 ' C ' ' CE1' ' A' ' 85' ' ' TYR . . . 135.54 130.18 2.92 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.869 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.581 ' N ' ' CZ ' ' A' ' 85' ' ' TYR . . . -42.12 155.32 0.25 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.38 -1.071 . . . . 0.0 110.317 -179.951 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.464 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 50.8 Cg_endo -78.78 11.75 18.72 Favored 'Cis proline' 0 C--N 1.312 -1.352 0 C-N-CA 121.636 -2.235 . . . . 0.0 110.93 -0.049 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.581 ' CZ ' ' N ' ' A' ' 83' ' ' ALA . 39.3 m-85 60.88 157.71 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.125 -0.985 . . . . 0.0 110.17 -179.739 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.47 ' O ' ' HG2' ' A' ' 80' ' ' GLN . . . 167.78 113.46 0.28 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.479 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 1.2 p -89.84 155.52 19.1 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.232 -1.158 . . . . 0.0 110.299 -179.853 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 1.068 HG23 HD12 ' A' ' 89' ' ' LEU . 35.3 m -119.82 -24.22 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.886 . . . . 0.0 109.899 179.837 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 1.068 HD12 HG23 ' A' ' 88' ' ' VAL . 4.0 mp -104.59 144.39 31.76 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.351 -0.843 . . . . 0.0 110.667 179.684 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -151.04 76.33 1.23 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.324 -0.86 . . . . 0.0 110.195 179.805 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -144.85 176.38 9.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.052 -1.03 . . . . 0.0 110.508 -179.832 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 66.2 m -124.39 126.08 25.54 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.318 -0.864 . . . . 0.0 110.045 179.907 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.66 ' HG2' HG22 ' A' ' 74' ' ' VAL . 45.4 Cg_endo -71.73 127.66 13.34 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.876 1.461 . . . . 0.0 110.749 -179.805 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.515 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -105.19 128.49 53.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.321 -0.862 . . . . 0.0 109.838 179.58 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.664 HD12 ' CG1' ' A' ' 72' ' ' VAL . 57.4 mt -119.91 178.95 4.41 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.186 -0.946 . . . . 0.0 110.467 -179.711 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.628 HG23 ' H ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -159.24 -79.64 0.06 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.265 -0.897 . . . . 0.0 110.335 -179.848 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.628 ' H ' HG23 ' A' ' 96' ' ' THR . 0.1 OUTLIER -158.75 -37.66 0.06 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.271 -0.893 . . . . 0.0 110.061 179.952 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.86 ' O ' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -89.88 -177.72 0.85 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.341 -0.849 . . . . 0.0 109.786 179.748 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.554 ' HD2' ' CG ' ' A' ' 98' ' ' GLU . 44.2 Cg_endo -71.61 128.63 14.58 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.748 1.394 . . . . 0.0 110.272 179.915 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.515 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 8.0 ttm-85 -119.68 92.03 3.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.185 -0.947 . . . . 0.0 110.36 -179.803 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 4.4 pt20 -70.23 159.03 34.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.327 -0.858 . . . . 0.0 110.045 179.796 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.964 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 98.7 t -135.12 139.34 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.208 -0.932 . . . . 0.0 110.165 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.447 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 0.2 OUTLIER -150.21 117.1 5.89 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.238 -0.914 . . . . 0.0 110.154 179.976 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.447 ' HG2' ' O ' ' A' ' 103' ' ' THR . 17.7 mm-40 -155.28 134.86 12.6 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.206 -0.934 . . . . 0.0 110.288 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.514 HG23 ' OG1' ' A' ' 61' ' ' THR . 0.7 OUTLIER -102.18 119.24 38.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.271 -0.893 . . . . 0.0 110.106 179.939 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.896 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 35.0 p90 -125.91 157.91 36.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.233 -0.917 . . . . 0.0 110.285 -179.943 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 19.3 m -89.93 98.57 11.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.3 -0.875 . . . . 0.0 109.997 179.786 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.863 ' HB1' HG21 ' A' ' 54' ' ' ILE . . . -59.3 107.78 0.61 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.253 -0.905 . . . . 0.0 110.411 -179.726 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.463 ' HA ' ' HA2' ' A' ' 57' ' ' GLY . 3.3 p -94.8 54.27 1.72 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.258 -0.901 . . . . 0.0 110.005 179.67 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.401 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -160.57 -152.38 0.28 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.214 -0.929 . . . . 0.0 110.431 -179.81 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 111' ' ' THR . . . . . 1.054 HG22 ' HD3' ' A' ' 113' ' ' PRO . 84.1 m -151.89 111.46 3.97 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.325 -0.859 . . . . 0.0 110.312 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.673 ' CE2' HG12 ' A' ' 78' ' ' VAL . 17.3 m-30 -111.02 69.66 0.66 Allowed Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.265 -0.897 . . . . 0.0 110.16 179.791 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 1.054 ' HD3' HG22 ' A' ' 111' ' ' THR . 45.8 Cg_endo -71.3 117.21 5.04 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.889 1.468 . . . . 0.0 110.361 179.949 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.261 -0.899 . . . . 0.0 110.231 -179.951 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.543 ' CG ' ' N ' ' A' ' 123' ' ' GLY . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.117 0.485 . . . . 0.0 109.999 . . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.561 ' HA2' ' HA ' ' A' ' 80' ' ' GLN . . . -166.44 156.31 28.11 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.814 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.725 ' HA ' HG23 ' A' ' 52' ' ' VAL . 3.6 pt20 -150.08 -161.23 1.3 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.38 -1.07 . . . . 0.0 110.313 -179.727 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.862 HG21 ' CH2' ' A' ' 16' ' ' TRP . 17.5 mt -118.49 149.83 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.528 -0.732 . . . . 0.0 109.552 179.772 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.761 ' HB3' ' HG ' ' A' ' 77' ' ' LEU . . . -114.97 133.92 55.62 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.78 0.8 . . . . 0.0 111.179 -179.228 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.533 ' CD1' ' O ' ' A' ' 126' ' ' ALA . 8.5 m-85 -146.8 73.9 1.33 Allowed 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.062 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 128' ' ' GLN . . . . . 0.893 ' C ' HD23 ' A' ' 129' ' ' LEU . 40.2 mt-30 -87.55 125.44 34.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.303 -0.873 . . . . 0.0 111.841 -177.773 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.893 HD23 ' C ' ' A' ' 128' ' ' GLN . 2.9 mt -113.95 54.34 0.76 Allowed 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.871 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -106.54 104.33 2.18 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 -179.36 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 77.21 74.46 0.98 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.781 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.611 ' CE1' ' HA ' ' A' ' 74' ' ' VAL . 6.5 m-85 -143.93 -71.77 0.29 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.196 -1.179 . . . . 0.0 110.243 179.859 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.776 ' CB ' HG23 ' A' ' 72' ' ' VAL . 1.3 t -89.13 156.45 18.8 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.055 -1.028 . . . . 0.0 110.103 179.825 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -80.23 -92.31 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.225 -0.922 . . . . 0.0 110.874 -179.34 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.448 ' O ' ' O ' ' A' ' 134' ' ' ALA . 12.6 m-20 -52.28 -172.35 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.165 -0.959 . . . . 0.0 110.679 -179.494 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.549 ' CA ' ' HA ' ' A' ' 38' ' ' ALA . . . -76.55 139.44 40.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.363 -0.835 . . . . 0.0 110.386 -179.799 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 1.126 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 9.1 p90 -145.82 -166.34 2.43 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.296 -0.877 . . . . 0.0 110.058 179.672 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.527 ' OG1' ' HA ' ' A' ' 35' ' ' ALA . 0.8 OUTLIER -160.38 170.47 20.96 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.034 -1.041 . . . . 0.0 110.735 -178.068 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.818 HD13 HD13 ' A' ' 129' ' ' LEU . 2.2 mp -129.28 126.26 38.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.469 -0.769 . . . . 0.0 109.444 179.14 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 140' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 27.9 m -121.81 102.73 8.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.141 -0.974 . . . . 0.0 110.892 -179.443 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.624 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 1.2 mt -95.26 -177.94 4.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.301 -0.875 . . . . 0.0 109.355 179.093 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.572 ' O ' HG22 ' A' ' 8' ' ' THR . 2.8 p30 168.5 52.96 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.244 -0.91 . . . . 0.0 110.301 179.954 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.523 ' CG ' HG22 ' A' ' 8' ' ' THR . 0.3 OUTLIER 167.27 53.06 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.223 -0.923 . . . . 0.0 109.71 179.947 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.864 HG11 ' HZ2' ' A' ' 16' ' ' TRP . 2.2 t -95.71 114.17 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.28 -0.887 . . . . 0.0 110.189 -179.599 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.76 ' HB1' ' HG2' ' A' ' 6' ' ' GLU . . . -146.11 164.75 31.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.897 . . . . 0.0 110.262 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.758 HD11 ' HB3' ' A' ' 60' ' ' TYR . 6.7 tp -145.21 148.23 33.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.323 -0.861 . . . . 0.0 110.234 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.477 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 0.5 OUTLIER -134.22 -173.97 3.42 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.196 -0.94 . . . . 0.0 110.23 -179.982 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 78.5 p . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.237 -0.915 . . . . 0.0 110.224 -179.974 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.563 ' CG ' ' HA ' ' A' ' 52' ' ' VAL . 53.8 Cg_endo . . . . . 0 N--CA 1.483 0.869 0 N-CA-C 111.134 -0.372 . . . . 0.0 111.134 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.505 HG13 ' N ' ' A' ' 5' ' ' GLY . 7.8 pt -146.15 -37.52 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.989 -1.07 . . . . 0.0 109.811 179.715 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.511 ' O ' ' N ' ' A' ' 7' ' ' GLY . . . 55.71 163.18 0.02 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 179.574 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.68 ' CG ' ' HB2' ' A' ' 145' ' ' ALA . 63.3 mt-10 -51.69 88.75 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.302 -1.116 . . . . 0.0 110.11 179.85 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 5' ' ' GLY . . . -78.63 -32.41 41.71 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.953 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.456 ' HA ' ' C ' ' A' ' 142' ' ' ASP . 11.2 p 50.57 18.93 0.51 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.427 -1.043 . . . . 0.0 110.467 -179.794 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.604 ' CG ' ' HB2' ' A' ' 32' ' ' LEU . 24.3 m-85 36.85 46.64 0.51 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.56 -0.712 . . . . 0.0 110.813 179.563 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.558 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 3.2 p-10 -100.25 43.46 1.06 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.244 -0.91 . . . . 0.0 110.281 -179.998 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.558 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.6 OUTLIER 161.57 -24.97 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.722 -0.612 . . . . 0.0 109.52 179.951 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -177.64 151.12 10.54 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.74 ' HB3' HD12 ' A' ' 32' ' ' LEU . 46.3 Cg_endo -73.64 0.01 8.74 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.014 1.534 . . . . 0.0 110.552 -179.987 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 0.5 OUTLIER 62.07 -89.55 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.255 -0.903 . . . . 0.0 110.135 -179.791 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.595 ' O ' HG13 ' A' ' 17' ' ' VAL . . . -122.68 -15.89 3.87 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.944 ' CH2' HG21 ' A' ' 125' ' ' ILE . 82.4 m95 -54.05 140.68 30.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.254 -1.145 . . . . 0.0 110.782 -179.758 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.938 ' HA ' HD11 ' A' ' 25' ' ' LEU . 1.2 m -146.08 157.95 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.324 -0.86 . . . . 0.0 109.455 179.425 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.452 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . . . -134.26 163.2 30.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.235 -0.916 . . . . 0.0 109.49 179.303 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.53 ' HE2' HG13 ' A' ' 48' ' ' VAL . 3.5 p90 -150.04 147.9 28.38 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.93 -1.106 . . . . 0.0 111.625 -178.519 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.587 ' HA2' ' CD1' ' A' ' 43' ' ' TYR . . . 132.09 -81.75 0.32 Allowed Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.763 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.617 HG22 ' CE2' ' A' ' 43' ' ' TYR . 12.1 p -149.69 23.95 0.88 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.171 -1.194 . . . . 0.0 110.319 -179.899 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.579 ' HA ' ' HB3' ' A' ' 35' ' ' ALA . 0.5 OUTLIER -107.63 27.43 9.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 110.35 179.845 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.48 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 36.87 -137.43 0.53 Allowed Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.749 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.78 -158.88 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.974 1.513 . . . . 0.0 110.106 179.514 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.938 HD11 ' HA ' ' A' ' 17' ' ' VAL . 61.1 mt -111.26 123.69 50.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.122 -0.986 . . . . 0.0 110.263 179.923 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.02 105.63 12.39 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.196 -0.94 . . . . 0.0 109.911 179.871 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.58 HG22 ' HB3' ' A' ' 9' ' ' PHE . 0.8 OUTLIER -119.56 -27.4 5.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.185 -0.947 . . . . 0.0 110.488 -179.653 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.645 ' C ' HG22 ' A' ' 29' ' ' THR . 8.0 t -48.48 82.91 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.758 -0.589 . . . . 0.0 111.233 -179.863 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.645 HG22 ' C ' ' A' ' 28' ' ' SER . 0.0 OUTLIER 167.91 -31.71 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.254 -0.904 . . . . 0.0 109.856 -179.918 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.434 ' HA2' ' HA ' ' A' ' 10' ' ' ASP . . . 127.17 -0.07 7.0 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.907 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.549 ' CB ' ' HB3' ' A' ' 142' ' ' ASP . . . -150.75 134.98 16.93 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.15 -1.206 . . . . 0.0 110.535 -179.907 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.74 HD12 ' HB3' ' A' ' 13' ' ' PRO . 3.2 tt -76.27 138.6 40.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.181 -0.949 . . . . 0.0 109.293 179.205 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 66.6 m -141.82 118.43 10.99 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.069 -1.02 . . . . 0.0 110.838 -179.552 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.544 HG12 ' CD2' ' A' ' 25' ' ' LEU . 17.2 m -102.1 142.06 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.485 -0.759 . . . . 0.0 109.274 179.306 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.579 ' HB3' ' HA ' ' A' ' 22' ' ' ASP . . . -88.44 102.79 15.24 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.129 -0.982 . . . . 0.0 110.781 -179.211 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.025 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 49.1 t -83.91 125.23 73.48 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.417 -0.802 . . . . 0.0 109.596 179.471 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.663 ' HD2' HG21 ' A' ' 45' ' ' VAL . 40.4 Cg_endo -66.42 -178.57 1.21 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.878 1.462 . . . . 0.0 111.741 -178.965 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.528 ' HA ' ' N ' ' A' ' 136' ' ' ALA . . . -60.5 120.92 10.87 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.452 -0.78 . . . . 0.0 111.296 -178.983 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.519 ' O ' ' C ' ' A' ' 40' ' ' SER . . . 39.22 26.73 0.06 OUTLIER Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 179.588 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.751 ' HB3' HG23 ' A' ' 45' ' ' VAL . 45.6 m 28.43 44.68 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 CA-C-N 117.863 0.831 . . . . 0.0 110.65 -179.998 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.631 ' O ' ' CG ' ' A' ' 42' ' ' GLN . . . -89.07 126.58 35.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.474 -0.766 . . . . 0.0 110.158 -179.278 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.631 ' CG ' ' O ' ' A' ' 41' ' ' ALA . 0.4 OUTLIER 83.17 28.54 0.1 Allowed 'General case' 0 N--CA 1.508 2.443 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -179.365 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.617 ' CE2' HG22 ' A' ' 21' ' ' THR . 0.1 OUTLIER -156.31 -31.05 0.09 Allowed 'General case' 0 C--N 1.293 -1.865 0 C-N-CA 118.648 -1.221 . . . . 0.0 112.314 -177.767 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.54 ' HA2' ' CA ' ' A' ' 130' ' ' GLY . . . 53.2 80.01 0.08 OUTLIER Glycine 0 N--CA 1.479 1.556 0 N-CA-C 105.922 -2.871 . . . . 0.0 105.922 -177.015 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.751 HG23 ' HB3' ' A' ' 40' ' ' SER . 4.2 t -86.95 133.9 28.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.358 -1.084 . . . . 0.0 108.893 -177.955 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.511 ' C ' ' CZ ' ' A' ' 19' ' ' TYR . . . -157.13 163.74 32.5 Favored Glycine 0 N--CA 1.487 2.089 0 C-N-CA 118.755 -1.688 . . . . 0.0 110.65 -178.973 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.652 HG13 ' O ' ' A' ' 17' ' ' VAL . 15.3 t -123.87 123.31 66.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.648 -0.913 . . . . 0.0 109.536 179.639 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.642 ' O ' HG22 ' A' ' 17' ' ' VAL . 32.7 m -119.79 140.48 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.916 -1.115 . . . . 0.0 111.018 -179.002 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.874 HD22 ' NE1' ' A' ' 16' ' ' TRP . 15.0 tp -118.98 97.7 5.82 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.46 -0.775 . . . . 0.0 109.743 179.449 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.526 ' HA ' ' HB3' ' A' ' 124' ' ' GLN . 38.9 t30 -78.16 113.73 16.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.28 -0.887 . . . . 0.0 110.405 -179.782 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.488 ' O ' ' HG2' ' A' ' 3' ' ' PRO . . . 146.22 73.98 0.02 OUTLIER Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 179.748 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.563 ' HA ' ' CG ' ' A' ' 3' ' ' PRO . 96.5 t -133.81 154.45 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.216 -1.167 . . . . 0.0 110.067 179.653 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.52 ' O ' HD13 ' A' ' 54' ' ' ILE . . . -128.73 105.19 8.09 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.218 -0.926 . . . . 0.0 110.501 -179.744 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.721 HD11 HD21 ' A' ' 146' ' ' LEU . 50.7 mm -131.78 166.45 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.318 -0.864 . . . . 0.0 109.74 179.58 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.526 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 0.2 OUTLIER -154.22 130.01 10.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.054 -1.029 . . . . 0.0 110.795 -179.726 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.526 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 11.0 pt-20 37.55 -156.5 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.773 -0.579 . . . . 0.0 110.915 179.525 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' A' ' 109' ' ' SER . . . -86.63 73.59 2.47 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.915 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.569 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.2 m -95.65 173.62 7.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.312 -1.11 . . . . 0.0 109.854 179.875 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.573 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 0.8 OUTLIER -89.63 155.9 18.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.205 -0.935 . . . . 0.0 110.391 -179.74 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.621 ' CE2' ' HB3' ' A' ' 108' ' ' ALA . 56.9 m-85 -160.41 -175.21 4.89 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.333 -0.854 . . . . 0.0 110.194 179.902 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 26.9 m -150.16 114.43 5.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.341 -0.85 . . . . 0.0 109.945 179.737 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.548 HD22 ' CD2' ' A' ' 89' ' ' LEU . 14.0 tp -89.53 119.69 30.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.208 -0.932 . . . . 0.0 110.065 -179.937 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.889 ' HD2' HG23 ' A' ' 103' ' ' THR . 0.0 OUTLIER -128.23 128.92 45.59 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.352 -0.842 . . . . 0.0 110.206 -179.8 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 1.073 ' CZ ' HG21 ' A' ' 102' ' ' VAL . 0.8 OUTLIER -172.61 144.38 1.43 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.22 -0.925 . . . . 0.0 109.849 179.731 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.542 HG23 ' CA ' ' A' ' 101' ' ' GLN . 4.6 m -119.22 92.93 3.92 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.225 -0.922 . . . . 0.0 109.957 -179.815 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.908 ' HB1' HD21 ' A' ' 95' ' ' LEU . . . -90.8 149.29 22.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.38 -0.825 . . . . 0.0 110.373 -179.747 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.644 HG23 ' O ' ' A' ' 98' ' ' GLU . 99.7 m -150.25 107.15 3.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.34 -0.85 . . . . 0.0 110.265 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -97.11 133.36 41.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.246 -0.909 . . . . 0.0 110.032 179.738 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.407 ' C ' ' O ' ' A' ' 68' ' ' ALA . 19.2 t -45.35 -26.18 0.5 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.131 -0.981 . . . . 0.0 109.234 179.557 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.561 HG22 ' HB2' ' A' ' 137' ' ' TRP . 2.1 t -112.43 171.15 7.69 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.592 -0.693 . . . . 0.0 109.858 179.723 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.507 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 49.0 t0 -86.58 61.13 6.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.106 -0.996 . . . . 0.0 109.115 178.937 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 1.047 HG23 ' HB2' ' A' ' 133' ' ' SER . 2.7 p -84.78 136.76 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.381 -0.824 . . . . 0.0 111.357 -178.912 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 19.9 m -125.78 86.91 2.6 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.711 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 1.115 HG21 ' CD2' ' A' ' 129' ' ' LEU . 3.0 m -90.5 -140.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.134 -0.979 . . . . 0.0 110.663 -178.73 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.793 ' N ' HG23 ' A' ' 74' ' ' VAL . 9.4 mtm180 -123.44 144.96 49.17 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.194 -0.941 . . . . 0.0 110.81 -179.633 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.541 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -150.34 148.49 28.88 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.388 -0.82 . . . . 0.0 109.365 179.421 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.862 HD11 ' HB3' ' A' ' 126' ' ' ALA . 1.3 pp 175.37 -159.39 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.123 -0.986 . . . . 0.0 110.674 -179.551 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.526 ' HB ' ' CG2' ' A' ' 88' ' ' VAL . 6.3 t -143.7 170.44 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.375 -0.828 . . . . 0.0 109.39 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.529 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . 176.02 -173.45 46.27 Favored Glycine 0 N--CA 1.491 2.325 0 C-N-CA 119.18 -1.486 . . . . 0.0 110.534 -179.92 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.537 ' HB3' ' HA ' ' A' ' 85' ' ' TYR . 31.5 tt0 -105.39 159.39 15.95 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.58 -0.953 . . . . 0.0 110.129 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.482 ' OD1' ' HG2' ' A' ' 124' ' ' GLN . 4.2 m120 -112.18 94.13 4.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.26 -0.9 . . . . 0.0 109.984 179.761 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.542 ' C ' ' CE1' ' A' ' 85' ' ' TYR . . . 120.3 131.83 4.19 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.815 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.596 ' N ' ' CE1' ' A' ' 85' ' ' TYR . . . -42.08 152.71 0.31 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.327 -1.102 . . . . 0.0 110.232 -179.903 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.455 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.6 Cg_endo -79.1 12.43 18.8 Favored 'Cis proline' 0 C--N 1.313 -1.332 0 C-N-CA 121.657 -2.226 . . . . 0.0 111.017 -0.021 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.596 ' CE1' ' N ' ' A' ' 83' ' ' ALA . 37.9 m-85 60.85 170.54 0.1 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.099 -1.0 . . . . 0.0 110.273 -179.81 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.421 ' O ' ' HA2' ' A' ' 79' ' ' GLY . . . 176.63 108.28 0.22 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.491 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 2.5 p -98.17 147.83 24.2 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.214 -1.168 . . . . 0.0 110.346 -179.934 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.794 HG12 ' N ' ' A' ' 109' ' ' SER . 7.8 m -122.64 -22.82 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.329 -0.857 . . . . 0.0 110.168 179.874 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.573 HD11 ' CZ ' ' A' ' 106' ' ' PHE . 4.5 mp -115.51 143.74 44.87 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.288 -0.882 . . . . 0.0 110.74 179.94 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.452 ' O ' HG23 ' A' ' 91' ' ' THR . 30.9 m-20 -151.08 79.24 1.31 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.329 -0.857 . . . . 0.0 110.187 179.56 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 90' ' ' ASP . 1.9 p -151.59 -173.56 4.55 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.007 -1.058 . . . . 0.0 110.544 -179.865 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.98 134.18 23.97 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.361 -0.837 . . . . 0.0 110.037 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.695 ' HG2' HG22 ' A' ' 74' ' ' VAL . 50.0 Cg_endo -75.14 75.83 3.64 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.962 1.506 . . . . 0.0 110.808 -179.697 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.531 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -49.55 134.66 19.34 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.971 -1.081 . . . . 0.0 109.265 179.416 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.908 HD21 ' HB1' ' A' ' 66' ' ' ALA . 34.6 mt -131.91 164.65 25.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.032 -1.042 . . . . 0.0 110.819 -179.396 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -165.35 -178.71 5.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.488 -0.758 . . . . 0.0 109.933 179.864 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.8 p -67.58 -22.21 65.39 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.224 -0.923 . . . . 0.0 110.257 -179.981 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.644 ' O ' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -93.28 170.56 8.5 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.216 -0.927 . . . . 0.0 110.116 179.906 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.497 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 45.8 Cg_endo -72.34 132.38 19.18 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.993 1.523 . . . . 0.0 110.39 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.531 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -119.83 92.61 3.82 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.206 -0.934 . . . . 0.0 110.36 -179.967 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.542 ' CA ' HG23 ' A' ' 65' ' ' THR . 0.1 OUTLIER -75.75 152.37 37.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.392 -0.817 . . . . 0.0 110.083 179.962 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 1.073 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 91.6 t -132.04 133.19 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.22 -0.925 . . . . 0.0 110.246 179.942 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.889 HG23 ' HD2' ' A' ' 63' ' ' ARG . 0.2 OUTLIER -150.38 116.77 5.73 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.317 -0.864 . . . . 0.0 110.158 -179.962 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.523 ' CG ' ' O ' ' A' ' 103' ' ' THR . 23.7 mt-10 -160.33 129.97 5.15 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.16 -0.963 . . . . 0.0 110.348 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.511 HG23 ' O ' ' A' ' 60' ' ' TYR . 47.5 m -89.91 107.47 19.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.21 -0.931 . . . . 0.0 110.108 179.766 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.573 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 36.7 p90 -110.2 155.9 21.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.242 -0.911 . . . . 0.0 110.4 -179.78 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.551 HG22 ' O ' ' A' ' 107' ' ' THR . 5.2 m -90.01 89.07 7.54 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.287 -0.883 . . . . 0.0 109.953 179.735 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.621 ' HB3' ' CE2' ' A' ' 60' ' ' TYR . . . -42.71 98.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.28 -0.888 . . . . 0.0 110.278 -179.747 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.794 ' N ' HG12 ' A' ' 88' ' ' VAL . 14.2 p -87.22 53.99 3.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.239 -0.913 . . . . 0.0 110.088 179.883 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.447 ' CB ' HG13 ' A' ' 88' ' ' VAL . . . -154.19 -155.33 0.58 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.261 -0.899 . . . . 0.0 110.333 -179.943 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.52 HG23 ' HA ' ' A' ' 55' ' ' GLU . 27.5 m -159.52 110.58 2.0 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.895 . . . . 0.0 110.531 -179.9 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.633 ' CD2' ' CG1' ' A' ' 54' ' ' ILE . 5.8 m-30 -113.71 94.73 34.16 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.298 -0.877 . . . . 0.0 109.66 179.401 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.493 ' HD2' ' HA ' ' A' ' 122' ' ' GLU . 51.3 Cg_endo -80.66 33.04 0.51 Allowed 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.825 1.434 . . . . 0.0 111.717 -179.697 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 113' ' ' PRO . . . . . . . . 0 N--CA 1.498 1.953 0 O-C-N 121.606 -0.684 . . . . 0.0 111.156 179.432 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.535 ' HG2' ' N ' ' A' ' 123' ' ' GLY . 23.9 pm0 . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 120.994 0.426 . . . . 0.0 109.923 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.584 ' HA3' ' CG ' ' A' ' 112' ' ' TYR . . . -168.57 143.29 7.99 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.758 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.542 ' HA ' ' CG2' ' A' ' 52' ' ' VAL . 1.7 pt20 -150.56 -159.5 1.04 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.336 -1.096 . . . . 0.0 110.248 -179.808 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.944 HG21 ' CH2' ' A' ' 16' ' ' TRP . 10.4 mt -118.32 146.35 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.45 -0.781 . . . . 0.0 109.114 179.246 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.862 ' HB3' HD11 ' A' ' 77' ' ' LEU . . . -121.98 120.5 34.58 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.281 -0.887 . . . . 0.0 111.144 -179.302 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.51 ' CE1' ' HB1' ' A' ' 76' ' ' ALA . 3.4 m-30 -116.79 97.98 6.27 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 178.266 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 128' ' ' GLN . . . . . 0.574 ' O ' ' CE2' ' A' ' 132' ' ' PHE . 2.3 mm-40 -88.37 92.56 9.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.332 -0.855 . . . . 0.0 112.702 -176.783 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 1.115 ' CD2' HG21 ' A' ' 74' ' ' VAL . 5.2 mt -99.61 42.65 1.09 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.447 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.54 ' CA ' ' HA2' ' A' ' 44' ' ' GLY . . . -97.56 125.7 8.6 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 110.509 -1.037 . . . . 0.0 110.509 -178.775 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 39' ' ' GLY . . . 39.79 64.03 1.13 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 179.304 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.597 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 9.2 m-85 -117.98 -61.65 1.65 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.048 -1.266 . . . . 0.0 110.75 179.813 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 133' ' ' SER . . . . . 1.047 ' HB2' HG23 ' A' ' 72' ' ' VAL . 1.3 t -88.4 178.78 6.47 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.043 -1.036 . . . . 0.0 110.376 -179.661 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -86.71 -89.05 0.12 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.338 -0.851 . . . . 0.0 110.278 -179.763 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -63.61 179.99 0.42 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.246 -0.909 . . . . 0.0 110.078 179.903 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.528 ' N ' ' HA ' ' A' ' 38' ' ' ALA . . . -77.16 136.18 38.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.282 -0.886 . . . . 0.0 110.47 -179.656 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 1.025 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 8.4 p90 -135.56 -156.09 0.69 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.372 -0.83 . . . . 0.0 109.756 179.38 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.529 ' O ' ' CB ' ' A' ' 68' ' ' ALA . 0.6 OUTLIER -160.34 172.2 17.75 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.875 -1.13 . . . . 0.0 111.039 -178.548 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.901 HD13 HD13 ' A' ' 129' ' ' LEU . 2.3 mp -132.23 127.99 36.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.498 -0.751 . . . . 0.0 109.253 179.272 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 140' ' ' CYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 4.9 m -123.96 96.51 4.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.067 -1.021 . . . . 0.0 111.134 -179.35 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.5 ' HA ' ' O ' ' A' ' 65' ' ' THR . 0.9 OUTLIER -89.74 -176.14 4.87 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.267 -0.895 . . . . 0.0 108.88 178.774 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.549 ' HB3' ' CB ' ' A' ' 31' ' ' ALA . 0.5 OUTLIER 170.6 43.96 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.929 -1.107 . . . . 0.0 111.003 179.98 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.504 ' HB2' ' O ' ' A' ' 142' ' ' ASP . 11.3 t70 174.01 61.47 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.36 -0.838 . . . . 0.0 109.505 179.63 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.807 HG11 ' CZ2' ' A' ' 16' ' ' TRP . 1.1 t -95.17 114.68 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.096 -1.003 . . . . 0.0 110.308 -179.399 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.68 ' HB2' ' CG ' ' A' ' 6' ' ' GLU . . . -138.27 145.29 41.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.339 -0.851 . . . . 0.0 110.229 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.721 HD21 HD11 ' A' ' 54' ' ' ILE . 6.7 tp -153.47 129.57 10.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.238 -0.914 . . . . 0.0 110.219 179.969 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.496 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 1.5 t0 -160.04 155.06 24.68 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.24 -0.912 . . . . 0.0 110.267 179.963 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.446 ' HA ' ' O ' ' A' ' 59' ' ' THR . 1.7 t . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.258 -0.901 . . . . 0.0 110.248 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.226 0.536 . . . . 0.0 110.184 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 p -116.63 133.24 23.05 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.254 -0.903 . . . . 0.0 110.244 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -76.41 -156.45 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.938 1.494 . . . . 0.0 110.068 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 1.006 HD11 ' O ' ' A' ' 144' ' ' VAL . 9.4 pt -93.64 -22.93 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.241 -0.912 . . . . 0.0 110.165 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 123.11 119.3 2.5 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -57.46 94.58 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.246 -1.149 . . . . 0.0 110.03 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.481 ' HA2' ' HA ' ' A' ' 143' ' ' ASP . . . 100.03 78.74 1.39 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.426 ' O ' ' HB2' ' A' ' 9' ' ' PHE . 7.2 p -95.12 -170.53 2.21 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.286 -1.126 . . . . 0.0 110.336 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.592 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 5.5 m-30 58.62 14.52 3.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.396 -0.815 . . . . 0.0 110.322 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.562 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 26.8 p-10 -88.86 23.88 2.21 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.178 -0.951 . . . . 0.0 109.967 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.562 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.6 OUTLIER 161.36 -24.24 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.422 0.629 . . . . 0.0 109.444 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -158.51 153.56 24.7 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.703 ' HB3' HD12 ' A' ' 32' ' ' LEU . 45.6 Cg_endo -72.37 -3.13 12.81 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.96 1.505 . . . . 0.0 110.458 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 0.3 OUTLIER 60.13 -88.62 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.28 -0.887 . . . . 0.0 110.353 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.436 ' O ' ' C ' ' A' ' 16' ' ' TRP . . . -132.14 -21.33 0.97 Allowed Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.886 -1.15 . . . . 0.0 110.381 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.969 ' CE2' HD22 ' A' ' 49' ' ' LEU . 56.1 m95 -41.51 121.87 1.79 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.09 -1.241 . . . . 0.0 110.565 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.73 ' O ' HG13 ' A' ' 47' ' ' VAL . 1.2 m -115.5 150.82 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.276 -0.89 . . . . 0.0 109.611 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.893 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . . . -130.21 123.0 29.18 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.061 -1.025 . . . . 0.0 109.818 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.777 ' HE2' HG13 ' A' ' 48' ' ' VAL . 23.4 p90 -108.68 157.26 18.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.51 -0.744 . . . . 0.0 110.486 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.648 ' O ' HG13 ' A' ' 45' ' ' VAL . . . 78.81 29.37 52.09 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.716 HG22 HG11 ' A' ' 45' ' ' VAL . 24.0 p -136.29 -160.96 1.11 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.219 -1.165 . . . . 0.0 110.466 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.455 ' O ' ' O ' ' A' ' 23' ' ' GLY . 15.0 t0 -99.46 131.96 45.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.368 -0.832 . . . . 0.0 110.318 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 22' ' ' ASP . . . 43.46 -166.18 0.02 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.3 -159.58 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.039 1.547 . . . . 0.0 110.46 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.893 ' CD2' ' HB3' ' A' ' 18' ' ' ALA . 7.9 mt -87.41 160.36 18.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.221 -0.925 . . . . 0.0 110.184 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -126.66 122.88 36.22 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.26 -0.9 . . . . 0.0 110.174 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.629 HG22 ' HA ' ' A' ' 32' ' ' LEU . 2.2 p -119.51 -84.39 0.66 Allowed 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.373 -0.829 . . . . 0.0 109.801 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.461 ' O ' ' HB ' ' A' ' 29' ' ' THR . 36.5 m 37.09 55.84 1.27 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.644 -0.66 . . . . 0.0 110.972 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.461 ' HB ' ' O ' ' A' ' 28' ' ' SER . 13.0 t -177.56 -32.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.115 -0.99 . . . . 0.0 110.411 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 9' ' ' PHE . . . 121.46 13.64 5.16 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -150.15 123.05 8.73 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -1.159 . . . . 0.0 110.14 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.703 HD12 ' HB3' ' A' ' 13' ' ' PRO . 0.9 OUTLIER -62.25 103.85 0.43 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -0.922 . . . . 0.0 109.841 179.788 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.51 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 36.6 m -107.99 103.5 12.74 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.14 -0.975 . . . . 0.0 110.864 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.77 HG12 HD22 ' A' ' 25' ' ' LEU . 17.5 m -89.87 141.74 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.234 -0.916 . . . . 0.0 109.218 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.487 ' HA ' ' OG1' ' A' ' 138' ' ' THR . . . -89.63 106.05 18.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.158 -0.964 . . . . 0.0 111.137 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.045 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 94.2 t -84.48 121.22 74.98 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.235 -0.916 . . . . 0.0 109.191 178.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 21' ' ' THR . 46.9 Cg_endo -74.71 137.27 22.2 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.937 1.493 . . . . 0.0 111.043 -178.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.932 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -45.52 170.59 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.337 -0.852 . . . . 0.0 109.766 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 45.86 48.33 13.66 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.825 ' OG ' HG21 ' A' ' 45' ' ' VAL . 0.6 OUTLIER -86.97 36.12 0.71 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.27 -1.136 . . . . 0.0 109.886 179.675 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.531 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . -89.08 -141.16 0.14 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.643 -0.661 . . . . 0.0 109.859 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.55 ' HG2' ' N ' ' A' ' 43' ' ' TYR . 14.7 pm0 39.88 -140.16 0.07 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.692 -0.63 . . . . 0.0 110.247 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.659 ' OH ' HG22 ' A' ' 45' ' ' VAL . 5.3 p90 -27.59 -42.55 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.236 0 CA-C-O 121.278 0.561 . . . . 0.0 110.612 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.601 ' O ' ' CD1' ' A' ' 43' ' ' TYR . . . 88.48 136.42 5.5 Favored Glycine 0 N--CA 1.492 2.39 0 C-N-CA 120.257 -0.973 . . . . 0.0 110.998 177.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.825 HG21 ' OG ' ' A' ' 40' ' ' SER . 2.3 t -88.95 -177.2 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.426 -1.043 . . . . 0.0 108.489 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.52 ' H ' HG12 ' A' ' 45' ' ' VAL . . . 167.67 175.88 37.88 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 118.819 -1.658 . . . . 0.0 110.838 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.73 HG13 ' O ' ' A' ' 17' ' ' VAL . 23.9 t -139.45 132.1 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.717 -0.872 . . . . 0.0 109.552 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.777 HG13 ' HE2' ' A' ' 19' ' ' TYR . 17.3 m -124.63 141.28 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.967 -1.083 . . . . 0.0 110.856 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.969 HD22 ' CE2' ' A' ' 16' ' ' TRP . 10.3 tp -128.23 100.6 5.9 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.374 -0.829 . . . . 0.0 110.131 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.531 ' ND2' ' OE1' ' A' ' 124' ' ' GLN . 1.2 m-20 -78.22 136.02 37.71 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.261 -0.9 . . . . 0.0 110.259 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 126.02 72.19 0.2 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.524 HG12 HG12 ' A' ' 54' ' ' ILE . 3.5 t -126.28 161.7 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.221 -1.164 . . . . 0.0 109.97 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -122.53 77.42 1.42 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.2 -0.938 . . . . 0.0 110.373 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.605 HG13 ' CD2' ' A' ' 112' ' ' TYR . 41.2 mm -119.13 151.08 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.248 -0.908 . . . . 0.0 110.07 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.664 ' HA ' HG23 ' A' ' 111' ' ' THR . 1.6 pt-20 -150.22 133.19 16.1 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.182 -0.949 . . . . 0.0 110.461 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.524 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 11.7 pt-20 38.28 -153.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.69 -0.631 . . . . 0.0 110.842 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' A' ' 109' ' ' SER . . . -86.56 86.12 1.55 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.556 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.3 m -110.65 171.04 7.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.177 -1.19 . . . . 0.0 109.864 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.583 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 1.6 m -89.88 155.59 19.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 0.0 110.154 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.605 ' HB3' HD11 ' A' ' 146' ' ' LEU . 56.3 m-85 -159.91 177.04 11.19 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.355 -0.84 . . . . 0.0 110.132 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 62.8 m -149.91 112.22 4.68 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.312 -0.867 . . . . 0.0 110.126 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.6 tp -89.84 124.49 34.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.243 -0.911 . . . . 0.0 110.095 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.495 ' HA ' ' O ' ' A' ' 102' ' ' VAL . 10.3 mtt180 -131.47 107.45 8.9 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.194 -0.941 . . . . 0.0 110.427 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.997 ' CZ ' HG21 ' A' ' 102' ' ' VAL . 4.6 p90 -147.07 151.61 37.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.288 -0.882 . . . . 0.0 110.125 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.879 HG23 ' CA ' ' A' ' 101' ' ' GLN . 0.2 OUTLIER -119.78 92.45 3.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.184 -0.948 . . . . 0.0 109.936 179.86 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.793 ' HB1' HD21 ' A' ' 95' ' ' LEU . . . -89.59 144.85 25.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 110.507 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.601 HG23 ' O ' ' A' ' 98' ' ' GLU . 99.9 m -150.33 116.74 5.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.403 -0.811 . . . . 0.0 110.215 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -103.24 138.73 39.64 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.23 -0.919 . . . . 0.0 110.028 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.1 p -47.65 -24.29 0.88 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.149 -0.969 . . . . 0.0 109.431 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.692 HG22 ' HB2' ' A' ' 137' ' ' TRP . 3.6 t -115.38 171.78 7.49 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.496 -0.752 . . . . 0.0 109.979 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.507 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 1.0 OUTLIER -86.16 69.69 10.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.158 -0.963 . . . . 0.0 109.445 179.192 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.605 HG23 ' CB ' ' A' ' 133' ' ' SER . 5.1 p -96.2 138.94 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.279 -0.888 . . . . 0.0 111.117 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 97.1 m -120.86 89.47 3.14 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.436 -0.79 . . . . 0.0 108.921 178.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.594 ' HA ' ' CD1' ' A' ' 132' ' ' PHE . 10.7 m -89.64 -147.88 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.22 -0.925 . . . . 0.0 110.587 -179.082 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.542 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 4.2 mtp180 -128.98 144.37 51.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 0.0 110.697 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.855 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -142.91 150.83 40.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.286 -0.884 . . . . 0.0 109.818 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.858 HD11 ' HB3' ' A' ' 126' ' ' ALA . 2.7 pp 177.58 -159.59 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.237 -0.914 . . . . 0.0 110.479 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.903 HG23 HD22 ' A' ' 89' ' ' LEU . 6.1 t -149.36 168.64 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.396 -0.815 . . . . 0.0 109.335 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.489 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . -177.6 -178.94 47.57 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.265 -1.445 . . . . 0.0 110.088 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.489 ' OE1' ' HD2' ' A' ' 113' ' ' PRO . 14.5 tp60 -107.93 138.12 44.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.415 -1.05 . . . . 0.0 110.302 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.507 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 0.9 OUTLIER -123.94 97.31 5.3 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.952 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.639 ' CA ' ' HD2' ' A' ' 121' ' ' PRO . . . 132.23 33.71 0.4 Allowed Glycine 0 N--CA 1.484 1.866 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 82' ' ' GLY . . . 60.41 143.58 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.191 -1.182 . . . . 0.0 110.124 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.457 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.9 Cg_endo -82.67 18.96 17.96 Favored 'Cis proline' 0 C--N 1.314 -1.261 0 C-N-CA 121.872 -2.136 . . . . 0.0 110.807 -0.174 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.545 ' CD2' ' HA ' ' A' ' 83' ' ' ALA . 89.3 m-85 57.53 -179.95 0.06 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.136 -0.978 . . . . 0.0 110.203 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 127.96 113.57 1.76 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.514 HG22 ' O ' ' A' ' 78' ' ' VAL . 0.8 OUTLIER -97.51 145.89 25.78 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.283 -1.128 . . . . 0.0 110.034 179.779 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 1.028 HG23 HD12 ' A' ' 89' ' ' LEU . 35.9 m -123.73 -17.98 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.193 -0.942 . . . . 0.0 110.384 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 1.028 HD12 HG23 ' A' ' 88' ' ' VAL . 3.9 mp -103.38 135.27 45.31 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.205 -0.934 . . . . 0.0 111.046 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -150.97 83.55 1.33 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.451 -0.781 . . . . 0.0 109.951 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.5 p -137.9 -179.62 5.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.035 -1.041 . . . . 0.0 110.772 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.404 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 1.7 m -119.71 110.83 36.56 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.403 -0.811 . . . . 0.0 110.063 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.855 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 44.3 Cg_endo -71.58 94.0 0.68 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.04 1.548 . . . . 0.0 110.813 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.794 ' HB3' ' HD2' ' A' ' 100' ' ' ARG . . . -71.75 151.86 43.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.234 -0.916 . . . . 0.0 109.625 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.793 HD21 ' HB1' ' A' ' 66' ' ' ALA . 97.6 mt -143.77 162.82 35.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.05 -1.031 . . . . 0.0 110.493 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 70' ' ' THR . 0.3 OUTLIER 179.75 -179.08 0.43 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.39 -0.818 . . . . 0.0 110.018 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.95 -24.5 64.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.256 -0.902 . . . . 0.0 110.07 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.601 ' O ' HG23 ' A' ' 67' ' ' THR . 1.5 mt-10 -89.92 164.48 28.31 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.281 -0.887 . . . . 0.0 110.06 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.482 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 46.1 Cg_endo -73.0 136.77 25.43 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.008 1.53 . . . . 0.0 110.366 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.794 ' HD2' ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.6 80.42 1.57 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.17 -0.956 . . . . 0.0 110.188 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.879 ' CA ' HG23 ' A' ' 65' ' ' THR . 16.3 tt0 -68.73 154.73 41.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.299 -0.876 . . . . 0.0 110.195 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.997 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 95.6 t -135.5 135.52 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.284 -0.885 . . . . 0.0 110.135 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.06 111.0 4.33 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.26 -0.9 . . . . 0.0 110.19 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -158.25 134.74 9.52 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.164 -0.96 . . . . 0.0 110.361 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.667 HG23 ' O ' ' A' ' 105' ' ' THR . 10.1 t -95.77 113.73 25.39 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.245 -0.909 . . . . 0.0 110.091 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.967 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 30.6 p90 -111.72 154.79 24.48 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.909 . . . . 0.0 110.286 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.476 HG22 ' O ' ' A' ' 107' ' ' THR . 6.6 m -91.7 91.87 8.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.286 -0.884 . . . . 0.0 110.044 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.593 ' HB1' ' CG2' ' A' ' 54' ' ' ILE . . . -48.54 96.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.235 -0.915 . . . . 0.0 110.303 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.521 ' N ' ' CG1' ' A' ' 88' ' ' VAL . 16.1 p -85.99 49.96 1.88 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.256 -0.902 . . . . 0.0 110.124 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -156.23 -154.43 0.48 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.297 -0.877 . . . . 0.0 110.136 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.664 HG23 ' HA ' ' A' ' 55' ' ' GLU . 14.2 m -152.4 112.5 4.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.209 -0.932 . . . . 0.0 110.304 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.605 ' CD2' HG13 ' A' ' 54' ' ' ILE . 13.5 m-30 -107.03 93.16 8.65 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.277 -0.889 . . . . 0.0 109.9 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.489 ' HD2' ' OE1' ' A' ' 80' ' ' GLN . 45.3 Cg_endo -72.26 179.61 4.85 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.942 1.496 . . . . 0.0 110.41 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -129.62 63.62 1.51 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.245 -0.909 . . . . 0.0 110.206 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.571 ' O ' HG23 ' A' ' 115' ' ' THR . 2.8 t -121.93 100.48 43.13 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.279 -0.888 . . . . 0.0 110.155 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.92 81.7 1.62 Allowed 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.036 1.545 . . . . 0.0 110.449 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.987 ' HB3' ' HB2' ' A' ' 120' ' ' ASP . . . -122.7 166.51 14.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.27 -0.894 . . . . 0.0 110.213 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.47 -63.49 1.21 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.238 -0.914 . . . . 0.0 110.205 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -87.65 26.9 1.2 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.275 -0.891 . . . . 0.0 110.326 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.987 ' HB2' ' HB3' ' A' ' 117' ' ' ALA . 1.4 m-20 -150.04 72.52 9.44 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.177 -0.952 . . . . 0.0 110.255 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.639 ' HD2' ' CA ' ' A' ' 82' ' ' GLY . 44.5 Cg_endo -76.14 17.95 0.69 Allowed 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 124.032 1.543 . . . . 0.0 112.598 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.525 ' O ' ' O ' ' A' ' 121' ' ' PRO . 2.2 pm0 40.5 -173.31 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 CA-C-O 121.515 0.674 . . . . 0.0 111.794 178.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -100.99 155.56 19.22 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.976 -1.249 . . . . 0.0 109.976 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.531 ' OE1' ' ND2' ' A' ' 50' ' ' ASN . 1.4 pt20 -150.55 -149.9 0.32 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.398 -1.06 . . . . 0.0 110.395 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.739 HG21 ' CH2' ' A' ' 16' ' ' TRP . 9.6 mt -118.37 138.62 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.588 -0.695 . . . . 0.0 109.136 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.858 ' HB3' HD11 ' A' ' 77' ' ' LEU . . . -115.42 122.24 45.21 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.205 -0.934 . . . . 0.0 111.169 -179.123 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.477 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 4.6 m-85 -119.15 109.05 15.42 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 178.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.485 ' O ' ' HB ' ' A' ' 74' ' ' VAL . 2.0 mt-30 -88.85 91.84 8.98 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.105 -0.997 . . . . 0.0 111.141 -178.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.958 HD13 HD13 ' A' ' 139' ' ' LEU . 15.5 mt -93.23 41.89 1.09 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.451 -0.78 . . . . 0.0 109.286 178.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.548 ' HA3' ' CA ' ' A' ' 44' ' ' GLY . . . -130.49 140.16 11.53 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.475 ' O ' ' CG ' ' A' ' 132' ' ' PHE . . . 71.4 61.7 3.79 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.594 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 38.4 m-85 -154.67 -78.32 0.1 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.243 -1.151 . . . . 0.0 110.182 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.605 ' CB ' HG23 ' A' ' 72' ' ' VAL . 1.3 t -89.67 119.57 30.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.123 -0.986 . . . . 0.0 110.116 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.401 ' O ' ' O ' ' A' ' 135' ' ' ASP . . . -62.44 -71.67 0.15 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.228 -0.92 . . . . 0.0 110.274 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.401 ' O ' ' O ' ' A' ' 134' ' ' ALA . 0.8 OUTLIER -53.82 -173.29 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.292 -0.88 . . . . 0.0 110.343 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.932 ' HB2' ' HB2' ' A' ' 38' ' ' ALA . . . -83.51 141.08 31.89 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.269 -0.894 . . . . 0.0 110.302 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 1.045 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 7.3 p90 -151.5 -164.19 1.93 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.323 -0.861 . . . . 0.0 109.964 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.527 ' O ' ' CB ' ' A' ' 68' ' ' ALA . 0.5 OUTLIER -160.4 173.47 15.57 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.0 -1.08 . . . . 0.0 111.106 -178.493 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.958 HD13 HD13 ' A' ' 129' ' ' LEU . 2.6 mp -129.64 129.37 44.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.447 -0.783 . . . . 0.0 109.576 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' CYS . . . . . . . . . . . . . 6.6 m -124.37 93.26 3.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.129 -0.982 . . . . 0.0 110.938 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.644 HD23 ' HB2' ' A' ' 66' ' ' ALA . 0.7 OUTLIER -89.86 -175.42 4.61 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.179 -0.951 . . . . 0.0 109.414 179.147 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.513 ' O ' ' CB ' ' A' ' 143' ' ' ASP . 1.1 p30 176.76 124.27 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.054 -1.029 . . . . 0.0 110.842 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.513 ' CB ' ' O ' ' A' ' 142' ' ' ASP . 0.3 OUTLIER 70.94 61.29 0.18 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.288 -0.882 . . . . 0.0 110.654 179.479 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 1.006 ' O ' HD11 ' A' ' 4' ' ' ILE . 42.0 t -94.46 111.4 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -0.914 . . . . 0.0 109.73 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -120.46 163.56 17.74 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.233 -0.917 . . . . 0.0 110.47 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.605 HD11 ' HB3' ' A' ' 60' ' ' TYR . 14.0 tp -167.3 88.18 0.29 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.409 -0.807 . . . . 0.0 110.085 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.495 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 7.6 t70 -123.37 165.17 17.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.269 -0.895 . . . . 0.0 110.289 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.513 ' HB3' ' CE1' ' A' ' 60' ' ' TYR . 12.7 p -95.43 119.9 34.73 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 0.0 110.317 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.46 ' HB3' ' O ' ' A' ' 148' ' ' SER . 2.4 tp10 58.44 118.91 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.321 -0.862 . . . . 0.0 110.331 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 9.4 p -149.03 166.16 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.262 -0.899 . . . . 0.0 110.127 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -48.41 165.95 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.26 -0.9 . . . . 0.0 110.225 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.3 pp . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.197 -179.983 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.836 ' HB3' ' HB1' ' A' ' 53' ' ' ALA . . . . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.266 0.555 . . . . 0.0 110.227 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.409 ' N ' ' HD3' ' A' ' 3' ' ' PRO . 0.4 OUTLIER 55.21 59.26 10.4 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.267 -0.896 . . . . 0.0 110.217 -179.938 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.409 ' HD3' ' N ' ' A' ' 2' ' ' SER . 49.4 Cg_endo -75.78 -156.44 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.991 1.522 . . . . 0.0 110.123 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.627 HG22 ' O ' ' A' ' 51' ' ' GLY . 13.1 pt -95.98 31.16 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.234 -0.916 . . . . 0.0 110.251 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 91.58 -29.32 7.38 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.723 ' OE1' ' HB1' ' A' ' 145' ' ' ALA . 3.9 mt-10 51.67 66.98 1.04 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.252 -1.146 . . . . 0.0 110.24 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 143' ' ' ASP . . . -148.36 -179.99 24.75 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.862 HG22 ' HB2' ' A' ' 143' ' ' ASP . 0.8 OUTLIER -98.31 51.64 1.02 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.201 -1.176 . . . . 0.0 110.151 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.559 ' CE2' ' CG2' ' A' ' 144' ' ' VAL . 69.3 m-85 43.16 36.31 0.97 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.274 -0.891 . . . . 0.0 110.095 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.556 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 5.1 p30 -84.68 44.48 1.06 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.316 -0.865 . . . . 0.0 110.299 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.556 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 2.4 t70 161.58 78.42 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.336 0.589 . . . . 0.0 109.433 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.66 159.58 7.0 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.894 ' HB3' HD12 ' A' ' 32' ' ' LEU . 50.0 Cg_endo -75.75 4.71 4.89 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.016 1.535 . . . . 0.0 110.713 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 2.8 mm-40 65.12 -89.01 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.259 -0.901 . . . . 0.0 110.516 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.592 ' C ' HD12 ' A' ' 49' ' ' LEU . . . -139.63 6.99 3.01 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.95 ' CE2' HD22 ' A' ' 49' ' ' LEU . 46.0 m95 -69.52 126.0 28.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.108 -1.23 . . . . 0.0 110.179 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.719 ' HA ' HD11 ' A' ' 25' ' ' LEU . 0.9 OUTLIER -126.9 148.6 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.206 -0.934 . . . . 0.0 109.669 179.806 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.626 ' CB ' HD21 ' A' ' 25' ' ' LEU . . . -130.32 142.16 50.55 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.101 -0.999 . . . . 0.0 109.648 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.558 ' HE1' HG13 ' A' ' 48' ' ' VAL . 23.2 p90 -131.71 164.01 26.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.292 -0.88 . . . . 0.0 110.766 -178.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.483 ' HA2' ' OH ' ' A' ' 43' ' ' TYR . . . 77.19 40.21 24.96 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.553 HG22 ' CG1' ' A' ' 45' ' ' VAL . 7.9 p -149.88 -143.79 0.14 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.129 -1.218 . . . . 0.0 110.489 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.465 ' O ' ' O ' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -117.29 129.94 56.22 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.244 -0.91 . . . . 0.0 110.355 -179.792 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 22' ' ' ASP . . . 52.21 174.48 0.03 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.38 -159.54 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.064 1.56 . . . . 0.0 110.518 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.983 ' CD2' HG12 ' A' ' 34' ' ' VAL . 24.4 mt -78.27 178.52 7.58 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.272 -0.893 . . . . 0.0 110.331 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -145.46 115.0 7.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.318 -0.864 . . . . 0.0 110.102 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.479 ' O ' ' N ' ' A' ' 29' ' ' THR . 1.1 p -119.65 -83.59 0.65 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.308 -0.87 . . . . 0.0 109.921 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 27' ' ' THR . 5.4 p 39.2 28.36 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.498 -0.751 . . . . 0.0 110.637 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.479 ' N ' ' O ' ' A' ' 27' ' ' THR . 8.5 t -153.43 -37.0 0.1 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.149 -0.969 . . . . 0.0 110.385 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.493 ' O ' ' HB2' ' A' ' 9' ' ' PHE . . . 133.97 -2.29 4.36 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.598 ' HB1' ' O ' ' A' ' 141' ' ' LEU . . . -133.15 143.97 49.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.138 -1.213 . . . . 0.0 110.125 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.894 HD12 ' HB3' ' A' ' 13' ' ' PRO . 0.6 OUTLIER -83.96 112.31 20.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.24 -0.912 . . . . 0.0 110.055 179.87 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.51 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 34.1 m -114.86 116.55 28.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 110.554 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.983 HG12 ' CD2' ' A' ' 25' ' ' LEU . 33.2 m -101.1 144.63 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.324 -0.86 . . . . 0.0 109.812 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.532 ' HA ' ' OG1' ' A' ' 138' ' ' THR . . . -93.05 94.02 8.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.189 -0.944 . . . . 0.0 110.547 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.087 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 41.9 t -86.23 132.49 43.14 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.377 -0.827 . . . . 0.0 110.099 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.415 ' C ' ' HA ' ' A' ' 136' ' ' ALA . 40.0 Cg_endo -66.85 168.95 15.71 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.809 1.426 . . . . 0.0 110.586 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.499 ' O ' ' O ' ' A' ' 39' ' ' GLY . . . -62.01 121.04 12.02 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.305 -0.872 . . . . 0.0 110.912 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.553 ' O ' ' N ' ' A' ' 41' ' ' ALA . . . 41.6 96.03 0.01 OUTLIER Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.666 ' HB2' HG23 ' A' ' 45' ' ' VAL . 0.4 OUTLIER -42.12 93.75 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.428 -1.043 . . . . 0.0 109.786 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' A' ' 39' ' ' GLY . . . -89.38 28.91 1.17 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.695 0.759 . . . . 0.0 110.565 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -128.92 -166.95 1.71 Allowed 'General case' 0 C--N 1.292 -1.904 0 O-C-N 121.773 -0.579 . . . . 0.0 109.779 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.483 ' OH ' ' HA2' ' A' ' 20' ' ' GLY . 11.1 p90 -46.54 -24.13 0.48 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.16 -0.962 . . . . 0.0 109.797 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.473 ' O ' ' CD1' ' A' ' 43' ' ' TYR . . . 126.45 140.58 5.29 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.666 HG23 ' HB2' ' A' ' 40' ' ' SER . 19.9 t -89.39 173.65 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.124 -1.221 . . . . 0.0 109.205 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.562 ' HA2' ' HA ' ' A' ' 128' ' ' GLN . . . -178.22 -179.42 48.19 Favored Glycine 0 N--CA 1.487 2.098 0 C-N-CA 118.92 -1.61 . . . . 0.0 110.851 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.701 HG13 ' O ' ' A' ' 17' ' ' VAL . 21.4 t -150.39 128.48 2.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.594 ' CG2' HG22 ' A' ' 17' ' ' VAL . 30.5 m -119.38 132.68 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.018 -1.051 . . . . 0.0 111.106 -178.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 1.065 HD23 HD12 ' A' ' 125' ' ' ILE . 13.8 tp -124.22 91.27 3.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.559 -0.713 . . . . 0.0 110.01 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.44 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 0.7 OUTLIER -66.86 113.88 5.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 110.209 -179.908 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.627 ' O ' HG22 ' A' ' 4' ' ' ILE . . . 154.14 83.04 0.04 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.579 HG11 ' HD2' ' A' ' 112' ' ' TYR . 38.8 t -140.53 160.43 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.197 -1.178 . . . . 0.0 110.207 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.836 ' HB1' ' HB3' ' A' ' 1' ' ' ALA . . . -129.85 90.78 3.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.203 -0.936 . . . . 0.0 110.396 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.743 HD11 HD21 ' A' ' 146' ' ' LEU . 33.5 mm -124.01 168.7 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.261 -0.899 . . . . 0.0 109.931 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.574 ' HA ' HG23 ' A' ' 111' ' ' THR . 1.7 tt0 -162.71 127.72 3.2 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.122 -0.986 . . . . 0.0 110.653 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.522 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 13.1 pt-20 37.74 -152.89 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.635 -0.666 . . . . 0.0 110.984 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 108' ' ' ALA . . . -86.76 79.57 1.81 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.625 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.2 m -108.85 173.71 6.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.253 -1.145 . . . . 0.0 109.804 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.574 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 0.4 OUTLIER -89.8 156.23 18.64 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.287 -0.883 . . . . 0.0 110.281 -179.82 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.829 ' HB3' HD11 ' A' ' 146' ' ' LEU . 67.9 m-85 -158.94 167.83 28.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 110.323 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 85.5 m -143.19 115.49 8.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -0.893 . . . . 0.0 110.072 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 28.4 tp -89.76 122.55 32.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.261 -0.899 . . . . 0.0 110.05 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.475 ' HA ' ' O ' ' A' ' 102' ' ' VAL . 6.1 mtm180 -126.38 125.8 42.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.253 -0.904 . . . . 0.0 110.356 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 1.184 ' CZ ' HG21 ' A' ' 102' ' ' VAL . 5.3 p90 -167.89 151.71 6.2 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.248 -0.908 . . . . 0.0 110.145 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.5 ' CG2' ' HG2' ' A' ' 101' ' ' GLN . 93.6 m -119.65 99.58 6.74 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.242 -0.911 . . . . 0.0 110.063 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.621 ' CB ' HD21 ' A' ' 95' ' ' LEU . . . -100.34 145.59 27.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.327 -0.858 . . . . 0.0 110.364 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.483 ' OG1' ' HA ' ' A' ' 99' ' ' PRO . 43.8 m -148.09 115.92 6.39 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.255 -0.903 . . . . 0.0 110.303 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.443 ' HB2' HD13 ' A' ' 95' ' ' LEU . . . -101.66 141.02 35.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 109.971 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.11 -23.05 1.09 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.129 -0.982 . . . . 0.0 109.41 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.684 HG22 ' HB2' ' A' ' 137' ' ' TRP . 2.9 t -116.96 169.69 9.21 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.51 -0.743 . . . . 0.0 110.034 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.509 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 77.0 m-20 -84.57 69.75 10.64 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.13 -0.981 . . . . 0.0 109.289 179.019 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.624 HG23 ' CB ' ' A' ' 133' ' ' SER . 4.8 p -94.47 140.05 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.874 . . . . 0.0 111.273 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 21.4 m -121.72 91.87 3.61 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.417 -0.802 . . . . 0.0 108.916 178.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.588 HG12 ' CD2' ' A' ' 132' ' ' PHE . 12.3 m -89.8 -147.56 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.21 -0.931 . . . . 0.0 110.774 -178.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.519 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 6.9 mtm180 -131.03 139.01 49.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.38 -0.825 . . . . 0.0 110.52 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.694 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -138.63 154.52 48.66 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.336 -0.853 . . . . 0.0 109.687 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.901 HD12 ' N ' ' A' ' 78' ' ' VAL . 3.9 pp -179.84 -148.36 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.207 -0.933 . . . . 0.0 110.326 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.901 ' N ' HD12 ' A' ' 77' ' ' LEU . 3.0 t -150.76 167.68 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.269 -0.894 . . . . 0.0 109.495 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.517 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . -170.69 -171.27 35.86 Favored Glycine 0 N--CA 1.491 2.33 0 C-N-CA 119.277 -1.44 . . . . 0.0 110.338 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.534 ' HA ' ' O ' ' A' ' 122' ' ' GLU . 3.7 tt0 -100.25 -160.96 0.83 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.473 -1.016 . . . . 0.0 110.262 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 80' ' ' GLN . 25.8 m120 -158.18 80.31 0.83 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.235 -0.915 . . . . 0.0 110.229 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.638 ' O ' ' HB2' ' A' ' 83' ' ' ALA . . . 167.52 -83.8 0.1 OUTLIER Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.638 ' HB2' ' O ' ' A' ' 82' ' ' GLY . . . 173.88 146.89 0.21 Allowed Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.176 -1.191 . . . . 0.0 110.205 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.456 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.4 Cg_endo -84.81 33.68 4.03 Favored 'Cis proline' 0 C--N 1.312 -1.355 0 C-N-CA 121.887 -2.131 . . . . 0.0 110.619 -0.216 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.571 ' CZ ' ' O ' ' A' ' 82' ' ' GLY . 21.2 m-85 64.14 137.17 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.187 -0.946 . . . . 0.0 110.2 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -153.02 121.4 1.16 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.462 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 2.0 p -96.83 147.78 23.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.203 -1.175 . . . . 0.0 110.261 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.986 HG23 HD12 ' A' ' 89' ' ' LEU . 33.5 m -119.79 -24.22 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.304 -0.873 . . . . 0.0 109.989 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.986 HD12 HG23 ' A' ' 88' ' ' VAL . 3.9 mp -105.76 146.39 29.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.313 -0.867 . . . . 0.0 110.729 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -151.17 81.74 1.31 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.23 -0.919 . . . . 0.0 110.13 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.2 p -145.4 173.55 11.89 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.071 -1.018 . . . . 0.0 110.578 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.463 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 43.3 m -121.78 118.77 29.32 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.348 -0.845 . . . . 0.0 110.093 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.694 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 46.1 Cg_endo -71.96 146.82 48.1 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.884 1.465 . . . . 0.0 110.966 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 1.032 ' HB3' ' NE ' ' A' ' 100' ' ' ARG . . . -109.62 148.99 30.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.396 -0.815 . . . . 0.0 109.543 179.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.622 ' C ' HG22 ' A' ' 96' ' ' THR . 70.9 mt -140.13 172.43 12.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.085 -1.009 . . . . 0.0 110.609 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.622 HG22 ' C ' ' A' ' 95' ' ' LEU . 0.1 OUTLIER 169.16 -179.15 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.467 -0.771 . . . . 0.0 109.888 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.4 ' N ' ' OG1' ' A' ' 96' ' ' THR . 0.1 OUTLIER -62.88 -12.7 26.74 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.223 -0.923 . . . . 0.0 109.734 179.765 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.526 ' CG ' ' HD2' ' A' ' 99' ' ' PRO . 33.9 tt0 -100.2 149.21 35.83 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.433 -0.792 . . . . 0.0 109.89 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.526 ' HD2' ' CG ' ' A' ' 98' ' ' GLU . 41.8 Cg_endo -68.71 131.25 22.32 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.877 1.462 . . . . 0.0 110.248 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 1.032 ' NE ' ' HB3' ' A' ' 94' ' ' ALA . 11.6 ttt-85 -119.66 92.22 3.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.243 -0.91 . . . . 0.0 110.5 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.5 ' HG2' ' CG2' ' A' ' 65' ' ' THR . 4.6 mt-30 -71.49 160.84 32.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.329 -0.857 . . . . 0.0 109.771 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 1.184 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 38.9 t -131.05 133.91 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.135 -0.978 . . . . 0.0 110.444 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.39 88.34 1.5 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.341 -0.85 . . . . 0.0 110.105 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -139.72 151.77 46.12 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.162 -0.962 . . . . 0.0 110.387 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.816 HG23 ' O ' ' A' ' 60' ' ' TYR . 90.6 m -111.3 137.23 49.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.325 -0.859 . . . . 0.0 110.15 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.944 ' CE1' HD11 ' A' ' 89' ' ' LEU . 51.3 p90 -132.5 156.61 46.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.271 -0.893 . . . . 0.0 110.217 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.542 HG22 ' O ' ' A' ' 107' ' ' THR . 7.6 m -90.29 88.29 7.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.292 -0.88 . . . . 0.0 110.102 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.603 ' HB3' ' CE2' ' A' ' 60' ' ' TYR . . . -47.26 104.22 0.05 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.894 . . . . 0.0 110.347 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 84.9 p -91.54 53.63 2.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.247 -0.908 . . . . 0.0 110.162 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.726 ' HB3' ' CG1' ' A' ' 88' ' ' VAL . . . -166.13 -156.34 0.25 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.239 -0.913 . . . . 0.0 110.316 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.574 HG23 ' HA ' ' A' ' 55' ' ' GLU . 12.3 m -146.18 117.1 7.72 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.305 -0.872 . . . . 0.0 110.287 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.594 ' CG ' ' HA3' ' A' ' 123' ' ' GLY . 20.7 m-30 -113.31 75.48 2.31 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.887 . . . . 0.0 109.994 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.665 ' HB2' HG22 ' A' ' 115' ' ' THR . 45.8 Cg_endo -72.39 136.93 27.28 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.932 1.491 . . . . 0.0 110.422 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -84.4 45.39 1.12 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.315 -0.866 . . . . 0.0 110.293 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.703 ' O ' HG23 ' A' ' 115' ' ' THR . 7.5 t -123.65 85.46 53.13 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.218 -0.926 . . . . 0.0 110.148 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.0 118.19 5.45 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.002 1.527 . . . . 0.0 110.41 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.754 ' HB3' ' CG ' ' A' ' 120' ' ' ASP . . . -147.81 -175.21 4.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.224 -0.922 . . . . 0.0 110.248 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.38 -8.94 36.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.255 -0.903 . . . . 0.0 110.249 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -152.99 17.23 0.57 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.255 -0.903 . . . . 0.0 110.257 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.754 ' CG ' ' HB3' ' A' ' 117' ' ' ALA . 0.8 OUTLIER -109.01 96.75 21.68 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.244 -0.91 . . . . 0.0 110.119 179.913 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.548 ' HB3' ' HA3' ' A' ' 82' ' ' GLY . 44.0 Cg_endo -74.82 126.61 10.2 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.045 1.55 . . . . 0.0 110.736 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.534 ' O ' ' HA ' ' A' ' 80' ' ' GLN . 15.2 pm0 -105.74 -157.42 0.61 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.261 -0.899 . . . . 0.0 109.565 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.594 ' HA3' ' CG ' ' A' ' 112' ' ' TYR . . . -140.21 159.02 26.08 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.545 ' O ' HG13 ' A' ' 78' ' ' VAL . 2.1 pm0 -150.5 -160.01 1.11 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.342 -1.093 . . . . 0.0 110.213 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 1.065 HD12 HD23 ' A' ' 49' ' ' LEU . 33.2 mt -118.38 142.45 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.37 -0.831 . . . . 0.0 109.522 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.524 ' HB3' ' HG ' ' A' ' 77' ' ' LEU . . . -113.88 115.22 27.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.304 -0.872 . . . . 0.0 111.541 -178.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.572 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 4.5 m-85 -120.58 80.8 1.67 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.562 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 2.9 mt-30 -87.96 115.06 25.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.112 -0.993 . . . . 0.0 111.636 -178.169 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 1.063 ' CD1' HD13 ' A' ' 139' ' ' LEU . 9.0 mt -98.77 49.66 0.97 Allowed 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 121.835 0.826 . . . . 0.0 108.856 178.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 132' ' ' PHE . . . -53.11 -173.45 0.04 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.434 ' HA2' ' HB3' ' A' ' 40' ' ' SER . . . -52.95 90.24 0.01 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.588 ' CD2' HG12 ' A' ' 74' ' ' VAL . 20.1 m-85 -114.87 -56.93 2.33 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.235 -1.156 . . . . 0.0 110.647 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.624 ' CB ' HG23 ' A' ' 72' ' ' VAL . 1.4 t -89.42 -177.36 5.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.259 -0.9 . . . . 0.0 110.373 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.455 ' N ' ' OG ' ' A' ' 133' ' ' SER . . . -106.59 -73.74 0.68 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.294 -0.879 . . . . 0.0 110.073 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.425 ' O ' ' C ' ' A' ' 136' ' ' ALA . 17.3 m-20 -70.09 152.99 43.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.233 -0.917 . . . . 0.0 110.076 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.484 ' HA ' ' N ' ' A' ' 38' ' ' ALA . . . -43.29 120.79 1.99 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.281 -0.887 . . . . 0.0 110.134 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 1.087 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 5.0 p90 -125.27 -169.59 2.02 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.176 -0.952 . . . . 0.0 110.258 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.532 ' OG1' ' HA ' ' A' ' 35' ' ' ALA 0.255 0.9 OUTLIER -159.33 168.65 25.85 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.384 -0.927 . . . . 0.0 110.41 -177.528 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 1.063 HD13 ' CD1' ' A' ' 129' ' ' LEU . 2.2 mp -124.85 125.84 44.61 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.378 -0.826 . . . . 0.0 109.629 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' CYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 22.2 m -122.98 99.5 6.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.117 -0.989 . . . . 0.0 110.76 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.598 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 1.5 mt -92.09 -177.17 4.61 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.302 -0.874 . . . . 0.0 109.308 179.18 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.669 ' O ' HG22 ' A' ' 8' ' ' THR . 2.8 p-10 -169.77 26.09 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.107 -0.996 . . . . 0.0 110.438 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.862 ' HB2' HG22 ' A' ' 8' ' ' THR . 0.7 OUTLIER 172.54 130.75 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.317 -0.864 . . . . 0.0 109.87 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.82 HG11 ' HZ2' ' A' ' 16' ' ' TRP . 1.3 t -150.48 115.9 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.117 -0.989 . . . . 0.0 109.761 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.723 ' HB1' ' OE1' ' A' ' 6' ' ' GLU . . . -140.35 154.44 46.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.252 -0.905 . . . . 0.0 110.495 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.829 HD11 ' HB3' ' A' ' 60' ' ' TYR . 61.0 tp -148.07 99.6 3.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.39 -0.819 . . . . 0.0 110.113 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.481 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 1.3 m-20 -102.69 -166.58 1.29 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.238 -0.914 . . . . 0.0 110.243 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.936 ' O ' HG13 ' A' ' 150' ' ' VAL . 1.5 p -128.21 -177.52 4.18 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.278 -0.889 . . . . 0.0 110.154 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -53.79 96.43 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.288 -0.883 . . . . 0.0 110.214 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.936 HG13 ' O ' ' A' ' 148' ' ' SER . 12.4 m -123.62 19.99 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.276 -0.89 . . . . 0.0 110.202 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 7.4 pt-20 -65.34 157.62 28.69 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.205 -0.934 . . . . 0.0 110.238 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.457 ' HB2' ' O ' ' A' ' 151' ' ' GLU . 1.2 tt . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.217 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.768 ' HB1' ' O ' ' A' ' 53' ' ' ALA . . . . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.232 0.539 . . . . 0.0 110.157 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.41 ' HB3' HG13 ' A' ' 52' ' ' VAL . 91.2 p -107.26 88.86 4.23 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.191 -0.943 . . . . 0.0 110.191 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.493 ' HD3' ' O ' ' A' ' 1' ' ' ALA . 47.0 Cg_endo -73.52 77.97 2.46 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.022 1.538 . . . . 0.0 110.645 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.489 HD11 HG12 ' A' ' 144' ' ' VAL . 27.9 pt -97.11 42.78 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.16 -0.962 . . . . 0.0 109.928 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 6' ' ' GLU . . . 97.98 -16.84 59.64 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' A' ' 5' ' ' GLY . 3.3 tt0 42.5 30.73 0.23 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.316 -1.109 . . . . 0.0 110.193 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 143' ' ' ASP . . . -159.86 -130.73 1.16 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.953 HG22 ' CA ' ' A' ' 143' ' ' ASP . 40.1 p -126.83 -172.39 2.63 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.273 -1.133 . . . . 0.0 110.443 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.597 ' CD2' ' HB2' ' A' ' 32' ' ' LEU . 5.8 m-30 -94.4 47.68 1.2 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.326 -0.859 . . . . 0.0 110.097 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.555 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 32.6 p30 -87.78 36.89 0.77 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.247 -0.908 . . . . 0.0 110.2 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.555 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.7 OUTLIER 161.46 37.47 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.678 -0.639 . . . . 0.0 109.686 -179.891 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 124.87 133.18 3.95 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.773 ' HB3' HD12 ' A' ' 32' ' ' LEU . 50.4 Cg_endo -80.43 41.14 1.08 Allowed 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.909 1.479 . . . . 0.0 111.136 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.46 ' OE1' ' O ' ' A' ' 4' ' ' ILE . 0.9 OUTLIER 45.88 -91.99 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.996 -1.065 . . . . 0.0 110.431 179.867 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 13' ' ' PRO . . . -149.07 10.35 1.01 Allowed Glycine 0 N--CA 1.493 2.459 0 C-N-CA 119.779 -1.2 . . . . 0.0 110.331 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.591 ' CH2' HG21 ' A' ' 125' ' ' ILE . 53.5 m95 -53.25 120.35 5.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.006 -1.291 . . . . 0.0 110.154 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.671 ' O ' HG13 ' A' ' 47' ' ' VAL . 0.9 OUTLIER -116.36 154.48 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.106 -0.996 . . . . 0.0 109.763 179.77 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.423 ' HB3' ' OD1' ' A' ' 22' ' ' ASP . . . -137.53 139.77 40.69 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.433 -0.792 . . . . 0.0 109.008 179.018 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.601 ' HE2' HG13 ' A' ' 48' ' ' VAL . 6.1 p90 -123.24 151.4 42.33 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.022 -1.049 . . . . 0.0 111.729 -178.191 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.577 ' HA2' ' CE1' ' A' ' 43' ' ' TYR . . . 133.59 -77.05 0.39 Allowed Glycine 0 N--CA 1.495 2.629 0 N-CA-C 108.899 -1.681 . . . . 0.0 108.899 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.583 HG22 ' CE2' ' A' ' 43' ' ' TYR . 5.5 p -150.81 19.57 0.8 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.213 -1.169 . . . . 0.0 110.08 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.601 ' HA ' ' HB3' ' A' ' 35' ' ' ALA . 1.3 p30 -107.44 112.3 25.02 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.301 -0.874 . . . . 0.0 110.09 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 22' ' ' ASP . . . -61.88 -132.49 0.01 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.455 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 46.1 Cg_endo -72.94 122.17 7.91 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.874 1.46 . . . . 0.0 110.215 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 1.102 ' CD1' HD11 ' A' ' 32' ' ' LEU . 8.1 mt -42.23 126.4 3.35 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.254 -0.904 . . . . 0.0 109.911 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 24' ' ' PRO . 11.8 m-20 -88.45 121.97 31.42 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.226 -0.921 . . . . 0.0 110.603 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.966 HG22 ' O ' ' A' ' 31' ' ' ALA . 3.0 p -119.96 -82.74 0.65 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.339 -0.851 . . . . 0.0 109.964 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.692 ' C ' HG22 ' A' ' 29' ' ' THR . 0.2 OUTLIER 58.28 46.38 15.7 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.247 -0.908 . . . . 0.0 110.662 179.581 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.832 HG22 ' O ' ' A' ' 27' ' ' THR . 0.0 OUTLIER 169.78 -95.37 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.153 -0.967 . . . . 0.0 110.261 179.738 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.516 ' H ' HG23 ' A' ' 29' ' ' THR . . . -158.39 21.93 0.35 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.966 ' O ' HG22 ' A' ' 27' ' ' THR . . . -135.02 162.06 33.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.306 -1.114 . . . . 0.0 110.157 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.102 HD11 ' CD1' ' A' ' 25' ' ' LEU . 0.5 OUTLIER -119.17 98.3 6.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.262 -0.899 . . . . 0.0 110.146 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.556 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 0.8 OUTLIER -98.09 113.21 25.03 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.287 -0.883 . . . . 0.0 111.594 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.95 HG12 HD22 ' A' ' 25' ' ' LEU . 16.6 m -89.55 147.83 4.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 178.169 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.601 ' HB3' ' HA ' ' A' ' 22' ' ' ASP . . . -89.18 91.09 8.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.361 -0.837 . . . . 0.0 111.409 -178.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.079 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 66.6 t -79.67 133.67 58.73 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.376 -0.828 . . . . 0.0 108.888 178.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.819 ' HD2' HG21 ' A' ' 45' ' ' VAL . 38.4 Cg_endo -66.66 168.34 16.92 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.881 1.464 . . . . 0.0 111.573 -178.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.523 ' HA ' ' N ' ' A' ' 136' ' ' ALA . . . -55.34 124.39 16.94 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.526 -0.734 . . . . 0.0 111.367 -178.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.532 ' O ' ' C ' ' A' ' 40' ' ' SER . . . 39.73 26.08 0.08 OUTLIER Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.943 ' OG ' HG23 ' A' ' 45' ' ' VAL . 24.1 t 30.06 66.61 0.12 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.844 -0.797 . . . . 0.0 110.565 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.575 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . -89.06 145.05 25.72 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.659 -0.651 . . . . 0.0 109.661 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.575 ' HG2' ' O ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER 45.77 27.61 0.48 Allowed 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -178.893 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.583 ' CE2' HG22 ' A' ' 21' ' ' THR . 0.1 OUTLIER -151.83 124.65 8.52 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 119.034 -1.066 . . . . 0.0 111.881 -178.19 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.536 ' HA2' ' CA ' ' A' ' 130' ' ' GLY . . . -90.32 95.63 2.11 Favored Glycine 0 C--N 1.296 -1.681 0 N-CA-C 106.615 -2.594 . . . . 0.0 106.615 177.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.943 HG23 ' OG ' ' A' ' 40' ' ' SER . 3.2 t -86.55 111.95 22.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 O-C-N 120.968 -1.313 . . . . 0.0 108.127 -178.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.576 ' O ' ' CE2' ' A' ' 19' ' ' TYR . . . -141.88 147.71 19.28 Favored Glycine 0 N--CA 1.484 1.895 0 C-N-CA 118.886 -1.626 . . . . 0.0 109.876 -178.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.671 HG13 ' O ' ' A' ' 17' ' ' VAL . 9.3 t -109.92 126.65 67.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.315 -1.109 . . . . 0.0 109.887 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.601 HG13 ' HE2' ' A' ' 19' ' ' TYR . 27.6 m -119.73 142.36 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.962 -1.086 . . . . 0.0 110.567 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.555 HD13 ' CD1' ' A' ' 16' ' ' TRP . 6.7 tp -126.04 95.17 4.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.369 -0.832 . . . . 0.0 109.918 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.518 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 0.7 OUTLIER -76.47 144.36 39.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.295 -0.878 . . . . 0.0 110.469 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 123.23 54.9 0.2 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.615 HG11 ' HD2' ' A' ' 112' ' ' TYR . 75.2 t -119.8 164.54 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.148 -1.207 . . . . 0.0 110.218 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.768 ' O ' ' HB1' ' A' ' 1' ' ' ALA . . . -140.15 84.54 1.97 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.248 -0.908 . . . . 0.0 110.516 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.623 HG23 ' CE2' ' A' ' 60' ' ' TYR . 47.5 mm -111.75 155.21 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.243 -0.911 . . . . 0.0 109.702 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.541 ' HG3' HG23 ' A' ' 111' ' ' THR . 0.7 OUTLIER -145.24 132.07 20.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.097 -1.002 . . . . 0.0 110.56 -179.766 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 7.9 pt-20 38.39 -152.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.743 -0.598 . . . . 0.0 110.695 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.494 ' N ' ' HG3' ' A' ' 56' ' ' GLU . . . -88.98 116.99 4.78 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.523 ' CG2' ' CE2' ' A' ' 60' ' ' TYR . 0.9 OUTLIER -136.35 168.27 19.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.279 -1.13 . . . . 0.0 109.769 179.917 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.498 ' O ' ' HA ' ' A' ' 148' ' ' SER . 1.6 m -90.25 99.48 12.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.284 -0.885 . . . . 0.0 110.578 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.907 ' HB3' HD11 ' A' ' 146' ' ' LEU . 59.9 m-85 -106.33 151.96 24.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.228 -0.92 . . . . 0.0 110.21 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.431 ' C ' HD12 ' A' ' 146' ' ' LEU . 92.9 m -125.3 109.77 13.2 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 110.028 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 103' ' ' THR . 14.2 tp -89.94 120.14 30.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.22 -0.925 . . . . 0.0 110.008 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.596 ' HB2' HG23 ' A' ' 103' ' ' THR . 20.9 ttp180 -129.45 110.84 12.21 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.896 . . . . 0.0 110.257 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.496 ' C ' ' CD1' ' A' ' 64' ' ' TYR . 8.3 p90 -143.41 155.44 44.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.375 -0.828 . . . . 0.0 109.911 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.504 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 4.5 m -119.69 97.72 5.77 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.108 -0.995 . . . . 0.0 109.921 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.58 ' CB ' HD21 ' A' ' 95' ' ' LEU . . . -97.9 150.17 21.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.223 -0.923 . . . . 0.0 110.479 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.43 HG23 ' O ' ' A' ' 96' ' ' THR . 99.9 m -149.96 130.71 14.12 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.291 -0.88 . . . . 0.0 110.017 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.511 ' CB ' HG12 ' A' ' 72' ' ' VAL . . . -119.32 128.92 54.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.235 -0.915 . . . . 0.0 110.205 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.79 -9.23 26.62 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.257 -0.902 . . . . 0.0 110.102 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.674 HG21 ' CB ' ' A' ' 137' ' ' TRP . 6.0 t -114.33 19.53 16.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.238 -0.914 . . . . 0.0 110.095 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.501 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 4.9 t70 43.35 73.56 0.14 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.32 -0.862 . . . . 0.0 109.772 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.682 ' CG1' HD12 ' A' ' 95' ' ' LEU . 5.6 p -109.59 140.48 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.385 -0.822 . . . . 0.0 110.768 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 54.4 m -119.87 83.88 2.12 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.447 -0.783 . . . . 0.0 109.036 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.728 HG21 ' CD2' ' A' ' 129' ' ' LEU . 14.2 m -89.83 -139.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.221 -0.925 . . . . 0.0 110.759 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.567 ' N ' HG23 ' A' ' 74' ' ' VAL . 0.4 OUTLIER -131.58 142.93 50.01 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.185 -0.947 . . . . 0.0 111.12 -179.075 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.85 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -143.91 154.37 43.27 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.472 -0.768 . . . . 0.0 109.44 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.804 HD12 ' N ' ' A' ' 78' ' ' VAL . 4.2 pp -179.86 -152.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.116 -0.99 . . . . 0.0 110.5 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.867 HG23 HD22 ' A' ' 89' ' ' LEU . 66.8 t -155.14 168.94 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.392 -0.818 . . . . 0.0 109.251 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.515 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . 173.37 179.37 43.99 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.205 -1.474 . . . . 0.0 110.312 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.472 ' HG2' ' O ' ' A' ' 122' ' ' GLU . 1.0 OUTLIER -72.74 -152.9 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.571 -0.958 . . . . 0.0 110.265 179.932 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.529 ' O ' ' CB ' ' A' ' 121' ' ' PRO . 15.2 m120 -160.57 60.55 0.32 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.541 -0.725 . . . . 0.0 109.317 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.578 ' O ' ' CZ ' ' A' ' 85' ' ' TYR . . . 158.28 -125.97 1.62 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.457 ' HA ' ' N ' ' A' ' 85' ' ' TYR . . . -125.2 153.2 71.73 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.174 -1.192 . . . . 0.0 110.122 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.472 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.5 Cg_endo -86.07 35.69 3.73 Favored 'Cis proline' 0 C--N 1.311 -1.418 0 C-N-CA 121.854 -2.144 . . . . 0.0 110.614 -0.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.578 ' CZ ' ' O ' ' A' ' 82' ' ' GLY . 76.6 m-85 58.98 148.89 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.178 -0.951 . . . . 0.0 110.226 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -173.19 115.57 0.57 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -110.65 143.63 40.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.238 -1.154 . . . . 0.0 110.376 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 1.046 HG23 HD12 ' A' ' 89' ' ' LEU . 34.6 m -124.43 -15.14 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.265 -0.897 . . . . 0.0 110.38 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 1.046 HD12 HG23 ' A' ' 88' ' ' VAL . 4.2 mp -108.33 137.39 46.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.209 -0.932 . . . . 0.0 111.002 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -151.15 81.27 1.32 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.4 -0.812 . . . . 0.0 109.901 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.5 p -137.76 179.52 6.38 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.994 -1.066 . . . . 0.0 110.699 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.7 m -119.89 115.28 33.48 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.378 -0.826 . . . . 0.0 110.059 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.85 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 44.1 Cg_endo -72.18 92.81 0.73 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.93 1.489 . . . . 0.0 110.919 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.524 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -75.15 147.89 40.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.904 . . . . 0.0 109.568 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.682 HD12 ' CG1' ' A' ' 72' ' ' VAL . 71.1 mt -138.99 162.36 35.09 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.04 -1.038 . . . . 0.0 110.778 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.43 ' O ' HG23 ' A' ' 67' ' ' THR . 0.3 OUTLIER -174.68 -179.22 1.44 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.438 -0.789 . . . . 0.0 110.088 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.56 -29.19 58.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.285 -0.884 . . . . 0.0 110.068 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.94 161.09 39.3 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.294 -0.879 . . . . 0.0 110.007 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.87 145.11 39.9 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.96 1.505 . . . . 0.0 110.487 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.524 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.85 94.34 4.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.29 -0.881 . . . . 0.0 110.037 179.811 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.459 HE21 ' HB2' ' A' ' 101' ' ' GLN . 0.0 OUTLIER -84.23 95.07 8.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.385 -0.822 . . . . 0.0 110.198 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 25.2 t -89.54 134.4 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.348 -0.845 . . . . 0.0 110.066 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.596 HG23 ' HB2' ' A' ' 63' ' ' ARG . 0.2 OUTLIER -150.15 130.72 13.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.327 -0.858 . . . . 0.0 110.163 -179.945 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.52 ' CG ' ' O ' ' A' ' 103' ' ' THR . 21.1 mt-10 -160.1 138.23 10.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.19 -0.944 . . . . 0.0 110.378 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 105' ' ' THR . 4.1 t -90.05 76.14 7.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.233 -0.917 . . . . 0.0 110.047 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.845 ' CE1' HD11 ' A' ' 89' ' ' LEU . 30.4 p90 -77.64 153.01 33.56 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.261 -0.9 . . . . 0.0 110.422 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 58' ' ' THR . 78.8 m -93.57 98.57 11.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.267 -0.895 . . . . 0.0 109.919 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.643 ' HB3' ' CE2' ' A' ' 60' ' ' TYR . . . -58.47 99.19 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -0.933 . . . . 0.0 110.239 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.416 ' N ' ' CG1' ' A' ' 88' ' ' VAL . 81.6 p -87.05 55.15 3.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.222 -0.924 . . . . 0.0 109.927 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -161.96 -151.42 0.21 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.268 -0.895 . . . . 0.0 110.353 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.541 HG23 ' HG3' ' A' ' 55' ' ' GLU . 31.6 m -157.13 122.43 4.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.319 -0.863 . . . . 0.0 110.398 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.615 ' HD2' HG11 ' A' ' 52' ' ' VAL . 14.3 m-30 -112.73 86.52 8.78 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.312 -0.867 . . . . 0.0 109.766 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.472 ' HG2' ' HA ' ' A' ' 122' ' ' GLU . 43.1 Cg_endo -70.5 163.84 37.4 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.941 1.495 . . . . 0.0 110.4 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -102.97 63.14 0.82 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.222 -0.924 . . . . 0.0 110.295 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.468 ' O ' ' O ' ' A' ' 120' ' ' ASP . 27.2 m -134.27 88.15 31.36 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.268 -0.895 . . . . 0.0 110.14 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.73 91.56 0.89 Allowed 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.965 1.508 . . . . 0.0 110.37 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.445 ' HB3' ' HB2' ' A' ' 120' ' ' ASP . . . -149.97 165.25 33.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.268 -0.895 . . . . 0.0 110.247 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.66 -64.3 0.94 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.248 -0.907 . . . . 0.0 110.208 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.445 ' O ' ' HD3' ' A' ' 121' ' ' PRO . 8.9 t0 -69.09 -31.46 70.22 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.305 -0.872 . . . . 0.0 110.09 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.468 ' O ' ' O ' ' A' ' 115' ' ' THR . 0.6 OUTLIER -107.24 95.32 12.97 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.283 -0.886 . . . . 0.0 110.206 179.96 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.529 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 48.2 Cg_endo -74.9 -164.44 0.23 Allowed 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.037 1.546 . . . . 0.0 110.496 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.48 ' O ' ' N ' ' A' ' 81' ' ' ASN . 0.4 OUTLIER -155.73 -151.11 0.33 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.171 -0.955 . . . . 0.0 110.485 179.899 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.514 ' HA3' ' CB ' ' A' ' 112' ' ' TYR . . . -148.38 140.79 8.56 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.083 -1.607 . . . . 0.0 109.083 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.526 ' O ' HG13 ' A' ' 78' ' ' VAL . 1.0 OUTLIER -150.34 -149.83 0.32 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.134 -1.215 . . . . 0.0 110.731 -179.325 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.591 HG21 ' CH2' ' A' ' 16' ' ' TRP . 11.4 mt -118.22 150.98 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.481 -0.762 . . . . 0.0 109.409 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.413 ' HB3' HD11 ' A' ' 77' ' ' LEU . . . -130.13 124.19 32.13 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.271 -0.893 . . . . 0.0 110.801 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.501 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 5.4 m-85 -118.61 106.02 12.2 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 1.049 ' O ' HD23 ' A' ' 129' ' ' LEU . 4.4 mt-30 -89.58 129.19 36.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.187 -0.945 . . . . 0.0 112.109 -177.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 1.049 HD23 ' O ' ' A' ' 128' ' ' GLN . 0.4 OUTLIER -143.73 34.79 1.27 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 178.047 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.536 ' CA ' ' HA2' ' A' ' 44' ' ' GLY . . . -83.8 123.67 6.28 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.301 -1.519 . . . . 0.0 109.301 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 44.91 63.42 2.57 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.594 ' CD2' ' HA ' ' A' ' 74' ' ' VAL . 10.5 m-85 -115.61 -61.8 1.69 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.088 -1.242 . . . . 0.0 111.155 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.592 ' HB3' ' CE3' ' A' ' 137' ' ' TRP . 3.3 t -87.73 -161.25 0.69 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.949 -1.094 . . . . 0.0 110.527 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -119.79 -62.97 1.43 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.169 -0.957 . . . . 0.0 110.557 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -84.54 151.69 24.39 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.107 -0.996 . . . . 0.0 110.042 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.523 ' N ' ' HA ' ' A' ' 38' ' ' ALA . . . -48.59 127.91 14.2 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.331 -0.856 . . . . 0.0 110.543 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 1.079 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 10.5 p90 -139.38 -173.18 3.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.204 -0.935 . . . . 0.0 110.489 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.528 ' C ' HD12 ' A' ' 139' ' ' LEU 0.254 0.8 OUTLIER -150.16 176.64 10.66 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.404 -0.81 . . . . 0.0 109.922 -177.799 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.556 ' O ' ' HA ' ' A' ' 33' ' ' CYS . 1.9 mp -139.0 117.98 12.48 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.069 -1.019 . . . . 0.0 111.76 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' CYS . . . . . 0.511 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 0.8 OUTLIER -101.45 116.25 32.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.653 -0.655 . . . . 0.0 110.834 178.7 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.504 ' HA ' ' O ' ' A' ' 65' ' ' THR . 1.6 mt -110.42 178.85 4.25 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.258 -0.901 . . . . 0.0 109.508 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.477 ' HB3' ' O ' ' A' ' 141' ' ' LEU . 4.7 p-10 174.18 175.96 0.15 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.399 -0.813 . . . . 0.0 110.239 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.953 ' CA ' HG22 ' A' ' 8' ' ' THR . 5.1 t0 41.24 59.33 2.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.541 -0.725 . . . . 0.0 110.076 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.535 HG21 ' HZ ' ' A' ' 9' ' ' PHE . 2.8 t -100.57 113.23 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.3 -0.875 . . . . 0.0 110.04 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -136.95 158.87 43.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.24 -0.913 . . . . 0.0 110.377 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.907 HD11 ' HB3' ' A' ' 60' ' ' TYR . 13.0 tp -167.39 122.09 1.03 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.36 -0.837 . . . . 0.0 110.06 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.463 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 1.5 t70 -139.22 -158.51 0.86 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.229 -0.919 . . . . 0.0 110.312 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' A' ' 59' ' ' THR . 75.0 p -136.05 128.96 31.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.27 -0.894 . . . . 0.0 110.196 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -68.93 174.11 4.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.279 -0.888 . . . . 0.0 110.206 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.764 HG22 ' O ' ' A' ' 150' ' ' VAL . 6.3 p -168.92 30.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.223 -0.923 . . . . 0.0 110.194 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.449 ' HB2' ' O ' ' A' ' 150' ' ' VAL . 1.0 OUTLIER -177.46 125.73 0.14 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.297 -0.877 . . . . 0.0 110.192 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.215 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.41 ' O ' ' CB ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.217 0.532 . . . . 0.0 110.197 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.41 ' CB ' ' O ' ' A' ' 1' ' ' ALA . 0.2 OUTLIER 174.89 85.79 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.241 -0.912 . . . . 0.0 110.224 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -76.02 -156.14 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.07 1.563 . . . . 0.0 110.104 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.41 HG13 ' N ' ' A' ' 5' ' ' GLY . 14.3 pt -90.24 -32.45 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.238 -0.913 . . . . 0.0 110.163 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.41 ' N ' HG13 ' A' ' 4' ' ' ILE . . . 169.16 147.82 5.57 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.42 19.57 2.74 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.277 -1.131 . . . . 0.0 110.194 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 143' ' ' ASP . . . 161.75 -97.74 0.16 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.657 HG22 ' O ' ' A' ' 142' ' ' ASP . 17.1 p -92.07 147.31 23.05 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.23 -1.159 . . . . 0.0 109.95 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.603 ' CE2' ' HB2' ' A' ' 32' ' ' LEU . 21.8 m-85 -44.04 -40.77 5.02 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.312 -0.868 . . . . 0.0 109.408 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.553 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 12.0 t70 31.28 42.27 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.074 0.464 . . . . 0.0 111.299 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.553 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 1.7 t70 161.66 80.87 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.559 -0.713 . . . . 0.0 109.58 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 55.23 173.38 0.1 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.861 ' HB3' HD12 ' A' ' 32' ' ' LEU . 47.6 Cg_endo -73.56 -5.42 17.07 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 124.048 1.551 . . . . 0.0 110.519 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 0.5 OUTLIER 65.29 -87.1 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.215 -0.928 . . . . 0.0 110.282 -179.92 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.74 ' C ' HD13 ' A' ' 49' ' ' LEU . . . -140.92 6.23 2.58 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.808 ' HH2' HG21 ' A' ' 125' ' ' ILE . 55.0 m95 -71.34 82.6 0.77 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.178 -1.189 . . . . 0.0 110.406 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.744 ' O ' HG13 ' A' ' 47' ' ' VAL . 1.0 OUTLIER -78.53 149.35 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.011 -1.055 . . . . 0.0 109.287 179.559 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.611 ' CB ' HG12 ' A' ' 34' ' ' VAL . . . -135.33 132.74 38.03 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.049 -1.032 . . . . 0.0 110.461 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.602 ' HE1' HG13 ' A' ' 48' ' ' VAL . 11.8 p90 -122.07 115.46 22.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.526 -0.734 . . . . 0.0 110.006 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.917 ' CA ' HG13 ' A' ' 45' ' ' VAL . . . -152.96 27.55 0.81 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.9 p 47.87 21.32 0.28 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.304 -1.115 . . . . 0.0 110.862 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.559 ' HB3' ' CB ' ' A' ' 35' ' ' ALA . 3.2 m-20 -125.15 43.12 3.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.898 -1.126 . . . . 0.0 110.261 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.41 152.07 17.32 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.415 ' O ' ' C ' ' A' ' 25' ' ' LEU . 46.6 Cg_endo -73.09 140.76 31.68 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.989 1.521 . . . . 0.0 110.428 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.743 HD13 HD11 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -42.41 156.64 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.316 -0.865 . . . . 0.0 110.219 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -145.12 148.76 33.98 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.262 -0.899 . . . . 0.0 110.261 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.646 ' O ' HG22 ' A' ' 29' ' ' THR . 0.8 OUTLIER -119.89 -74.14 0.62 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.266 -0.896 . . . . 0.0 110.236 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 27' ' ' THR . 2.5 t 43.14 36.05 0.91 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.229 -0.919 . . . . 0.0 110.232 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.646 HG22 ' O ' ' A' ' 27' ' ' THR . 14.9 t -172.65 -34.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.317 -0.864 . . . . 0.0 110.21 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.44 ' N ' HG23 ' A' ' 29' ' ' THR . . . 123.73 7.88 6.53 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.453 ' H ' HG23 ' A' ' 29' ' ' THR . . . -130.95 132.21 44.92 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.164 -1.197 . . . . 0.0 110.222 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.861 HD12 ' HB3' ' A' ' 13' ' ' PRO . 2.2 tp -74.03 109.06 7.23 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.233 -0.917 . . . . 0.0 110.066 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 9.5 m -111.12 103.36 11.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.151 -0.968 . . . . 0.0 110.774 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.611 HG12 ' CB ' ' A' ' 18' ' ' ALA . 25.4 m -89.7 169.44 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.894 . . . . 0.0 109.13 179.17 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.559 ' CB ' ' HB3' ' A' ' 22' ' ' ASP . . . -122.46 129.22 51.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.904 -1.122 . . . . 0.0 111.317 -179.237 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.139 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 4.5 t -117.1 122.58 31.06 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.508 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 45.4 Cg_endo -74.5 152.65 43.7 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.804 1.423 . . . . 0.0 111.625 -178.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.484 ' HA ' ' CA ' ' A' ' 136' ' ' ALA . . . -42.07 131.39 3.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.32 -0.862 . . . . 0.0 109.892 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 38' ' ' ALA . . . 46.18 71.98 0.45 Allowed Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.558 -1.817 . . . . 0.0 108.558 -179.345 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.926 ' OG ' HG12 ' A' ' 36' ' ' VAL . 0.9 OUTLIER -84.6 34.92 0.54 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.319 -1.106 . . . . 0.0 110.778 -179.354 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.95 ' HB2' ' HA3' ' A' ' 131' ' ' GLY . . . -98.87 20.73 12.63 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.308 -0.87 . . . . 0.0 109.708 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.642 HE21 ' HE2' ' A' ' 43' ' ' TYR . 0.5 OUTLIER -95.02 20.25 9.25 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.747 0.785 . . . . 0.0 109.882 179.771 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.702 ' CZ ' HG22 ' A' ' 45' ' ' VAL . 24.4 p90 176.86 -29.35 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.015 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.497 ' N ' ' CD1' ' A' ' 43' ' ' TYR . . . 99.24 108.91 2.93 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 110.241 -1.143 . . . . 0.0 110.241 179.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.917 HG13 ' CA ' ' A' ' 20' ' ' GLY . 1.9 t -89.99 178.28 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.215 -1.167 . . . . 0.0 108.74 179.114 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.509 ' CA ' ' HA ' ' A' ' 128' ' ' GLN . . . 162.81 -173.96 39.1 Favored Glycine 0 N--CA 1.487 2.051 0 C-N-CA 118.867 -1.635 . . . . 0.0 110.823 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.744 HG13 ' O ' ' A' ' 17' ' ' VAL . 38.9 t -151.06 128.2 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.625 ' O ' HG22 ' A' ' 17' ' ' VAL . 27.6 m -120.55 128.37 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.842 -1.161 . . . . 0.0 110.749 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.787 HD22 ' NE1' ' A' ' 16' ' ' TRP . 19.7 tp -119.29 105.2 11.09 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.367 -0.833 . . . . 0.0 110.3 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.512 ' HA ' ' HB3' ' A' ' 124' ' ' GLN . 0.2 OUTLIER -82.29 103.29 11.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.265 -0.897 . . . . 0.0 110.161 179.826 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.71 69.48 0.02 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.587 HG12 ' N ' ' A' ' 53' ' ' ALA . 38.3 t -119.9 171.78 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.196 -1.179 . . . . 0.0 109.979 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.587 ' N ' HG12 ' A' ' 52' ' ' VAL . . . -137.6 78.46 1.69 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.122 -0.987 . . . . 0.0 110.783 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.719 HD11 HD21 ' A' ' 146' ' ' LEU . 28.2 mm -118.31 160.41 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.21 -0.931 . . . . 0.0 109.712 179.286 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.527 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 1.2 tt0 -154.46 131.77 11.15 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.026 -1.046 . . . . 0.0 110.82 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 10.8 pt-20 37.58 -154.4 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.726 -0.609 . . . . 0.0 110.981 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 108' ' ' ALA . . . -86.77 91.91 1.76 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.555 ' CG2' ' N ' ' A' ' 59' ' ' THR . 1.2 m -121.36 173.74 7.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.274 -1.133 . . . . 0.0 109.83 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.555 ' N ' ' CG2' ' A' ' 58' ' ' THR . 0.5 OUTLIER -89.72 152.66 21.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.278 -0.889 . . . . 0.0 110.28 -179.913 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.629 ' CE1' ' CD1' ' A' ' 54' ' ' ILE . 54.1 m-85 -156.79 165.33 36.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.286 -0.884 . . . . 0.0 110.344 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 96.2 m -142.78 112.95 7.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.314 -0.866 . . . . 0.0 109.982 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.3 tp -89.76 120.76 31.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 110.148 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.491 ' HA ' ' O ' ' A' ' 102' ' ' VAL . 32.5 ttp180 -130.12 119.48 23.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.339 -0.851 . . . . 0.0 110.119 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.983 ' CZ ' HG21 ' A' ' 102' ' ' VAL . 14.6 p90 -150.91 153.26 34.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.237 -0.915 . . . . 0.0 110.252 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.492 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 5.6 m -119.73 94.86 4.55 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.26 -0.9 . . . . 0.0 109.968 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.832 ' HB2' HD23 ' A' ' 141' ' ' LEU . . . -99.72 153.33 19.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.324 -0.86 . . . . 0.0 110.401 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.691 HG23 ' O ' ' A' ' 98' ' ' GLU . 67.9 m -150.1 117.08 5.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.243 -0.911 . . . . 0.0 110.161 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -99.48 140.35 33.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.268 -0.895 . . . . 0.0 109.872 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.409 ' C ' ' O ' ' A' ' 68' ' ' ALA . 22.9 t -44.72 -26.27 0.37 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.185 -0.947 . . . . 0.0 109.282 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.738 HG22 ' HB2' ' A' ' 137' ' ' TRP . 5.0 t -116.99 -152.63 0.51 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.574 -0.704 . . . . 0.0 109.764 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.622 ' N ' HG23 ' A' ' 70' ' ' THR . 0.1 OUTLIER -116.03 62.17 0.71 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.276 -0.89 . . . . 0.0 109.324 179.043 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.818 HG23 ' HB2' ' A' ' 133' ' ' SER . 4.5 p -82.95 136.63 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.329 -0.857 . . . . 0.0 111.187 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.465 HG22 ' O ' ' A' ' 73' ' ' THR . 8.3 m -119.79 89.96 3.23 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.878 HG21 HD22 ' A' ' 129' ' ' LEU . 12.8 m -89.81 -150.39 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.279 -0.888 . . . . 0.0 110.811 -178.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.522 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 6.4 mtm180 -129.83 137.04 50.25 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.319 -0.863 . . . . 0.0 110.63 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.718 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -134.24 157.67 45.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.408 -0.808 . . . . 0.0 109.746 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.669 HD12 ' N ' ' A' ' 78' ' ' VAL . 3.8 pp 178.66 -156.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.195 -0.94 . . . . 0.0 110.373 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.86 ' CG2' HD22 ' A' ' 89' ' ' LEU . 3.4 t -148.39 167.55 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.296 -0.877 . . . . 0.0 109.565 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.49 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . -178.78 -170.23 40.5 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.343 -1.408 . . . . 0.0 110.202 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.52 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 28.2 tt0 -111.15 118.5 36.13 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.441 -1.035 . . . . 0.0 110.297 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.501 ' CB ' ' OE2' ' A' ' 122' ' ' GLU . 2.5 m120 -85.49 94.51 9.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.221 -0.924 . . . . 0.0 110.166 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.661 ' O ' ' HB2' ' A' ' 83' ' ' ALA . . . 164.69 -89.53 0.1 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.661 ' HB2' ' O ' ' A' ' 82' ' ' GLY . . . 173.04 144.19 0.17 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.229 -1.159 . . . . 0.0 110.15 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.467 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.6 Cg_endo -84.23 32.87 4.1 Favored 'Cis proline' 0 C--N 1.314 -1.28 0 C-N-CA 121.929 -2.113 . . . . 0.0 110.681 -0.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.581 ' CZ ' ' O ' ' A' ' 82' ' ' GLY . 19.4 m-85 64.76 157.47 0.09 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.16 -0.963 . . . . 0.0 110.246 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.472 ' O ' ' HA2' ' A' ' 79' ' ' GLY . . . -171.74 103.48 0.19 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.487 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 1.7 p -89.87 139.25 30.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.19 -1.182 . . . . 0.0 110.359 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 1.032 HG23 HD12 ' A' ' 89' ' ' LEU . 34.4 m -119.92 -16.79 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.337 -0.852 . . . . 0.0 109.979 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 1.032 HD12 HG23 ' A' ' 88' ' ' VAL . 4.2 mp -108.82 143.34 38.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.292 -0.88 . . . . 0.0 110.775 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -150.78 83.51 1.34 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.34 -0.85 . . . . 0.0 110.125 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.0 p -145.3 174.9 10.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.082 -1.011 . . . . 0.0 110.534 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.5 m -121.38 116.33 30.88 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.33 -0.856 . . . . 0.0 110.145 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.718 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 43.9 Cg_endo -71.15 124.77 10.79 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.898 1.473 . . . . 0.0 110.962 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 1.011 ' HB3' ' NH1' ' A' ' 100' ' ' ARG . . . -96.62 148.11 23.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.32 -0.862 . . . . 0.0 109.438 179.3 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.797 HD21 ' CB ' ' A' ' 66' ' ' ALA . 32.2 mt -136.2 166.51 23.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.001 -1.062 . . . . 0.0 110.726 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' A' ' 70' ' ' THR . 0.2 OUTLIER -164.35 -178.81 5.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.482 -0.761 . . . . 0.0 109.975 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.42 -6.47 30.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.225 -0.922 . . . . 0.0 110.183 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.691 ' O ' HG23 ' A' ' 67' ' ' THR . 1.5 mt-10 -113.11 178.34 0.99 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.292 -0.88 . . . . 0.0 110.074 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.495 ' HD2' ' CB ' ' A' ' 98' ' ' GLU . 45.6 Cg_endo -72.68 128.03 12.99 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.0 1.527 . . . . 0.0 110.359 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 1.011 ' NH1' ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.77 91.56 3.58 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.26 -0.9 . . . . 0.0 110.217 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.437 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 0.5 OUTLIER -75.78 157.19 33.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.302 -0.874 . . . . 0.0 110.138 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.983 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 41.0 t -135.09 139.26 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.221 -0.924 . . . . 0.0 110.129 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.96 102.43 3.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.263 -0.898 . . . . 0.0 110.194 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -142.01 165.78 26.51 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.239 -0.913 . . . . 0.0 110.171 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.5 t -122.08 167.15 13.48 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.22 -0.925 . . . . 0.0 110.163 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.881 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 34.4 p90 -173.3 151.37 2.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.245 -0.909 . . . . 0.0 110.274 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 66.9 m -89.98 96.14 10.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.225 -0.922 . . . . 0.0 110.029 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.598 ' HB3' ' CE2' ' A' ' 60' ' ' TYR . . . -55.17 100.07 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.289 -0.882 . . . . 0.0 110.251 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 54.5 p -89.08 52.45 2.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.258 -0.901 . . . . 0.0 110.179 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.43 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -159.22 -155.85 0.49 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.253 -0.904 . . . . 0.0 110.191 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.679 HG22 ' HD3' ' A' ' 113' ' ' PRO . 88.6 m -147.05 111.1 5.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.262 -0.899 . . . . 0.0 110.283 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.605 ' CE2' HG12 ' A' ' 78' ' ' VAL . 15.0 m-30 -111.43 77.04 1.58 Allowed Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.361 -0.837 . . . . 0.0 109.994 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.679 ' HD3' HG22 ' A' ' 111' ' ' THR . 44.8 Cg_endo -72.46 177.56 7.24 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.975 1.513 . . . . 0.0 110.419 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.444 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -115.95 34.4 4.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.243 -0.911 . . . . 0.0 110.264 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 120' ' ' ASP . 1.4 m -108.24 89.49 5.85 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.21 -0.931 . . . . 0.0 110.168 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 46.2 Cg_endo -72.87 80.19 1.83 Allowed 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.968 1.51 . . . . 0.0 110.434 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 1.02 ' HB3' ' HB2' ' A' ' 120' ' ' ASP . . . -132.25 175.02 9.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.253 -0.904 . . . . 0.0 110.132 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.73 -59.8 3.04 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.245 -0.91 . . . . 0.0 110.186 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.88 12.6 5.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.255 -0.903 . . . . 0.0 110.288 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 1.02 ' HB2' ' HB3' ' A' ' 117' ' ' ALA . 41.0 m-20 -135.55 91.89 17.9 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.28 -0.887 . . . . 0.0 110.239 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.501 ' HB3' ' HA3' ' A' ' 82' ' ' GLY . 47.5 Cg_endo -73.64 172.12 16.4 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.999 1.526 . . . . 0.0 110.416 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.515 ' OE1' ' N ' ' A' ' 122' ' ' GLU . 6.4 pm0 -141.02 -163.88 1.63 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.233 -0.917 . . . . 0.0 110.187 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.526 ' HA3' ' CB ' ' A' ' 112' ' ' TYR . . . -138.12 154.6 22.91 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.574 ' HA ' ' CG2' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -150.25 -162.14 1.49 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -1.176 . . . . 0.0 110.518 -179.716 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.808 HG21 ' HH2' ' A' ' 16' ' ' TRP . 10.1 mt -118.86 144.25 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.486 -0.759 . . . . 0.0 109.503 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.51 ' O ' ' HA ' ' A' ' 76' ' ' ALA . . . -116.28 115.29 25.67 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.453 -0.779 . . . . 0.0 111.41 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.546 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 2.7 m-30 -118.09 75.52 1.01 Allowed 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.861 ' C ' HD23 ' A' ' 129' ' ' LEU . 25.6 mt-30 -88.21 122.72 32.08 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.278 -0.888 . . . . 0.0 112.512 -177.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.878 HD22 HG21 ' A' ' 74' ' ' VAL . 0.6 OUTLIER -108.38 55.6 0.64 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.008 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.495 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -66.04 89.38 0.13 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 -178.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.95 ' HA3' ' HB2' ' A' ' 41' ' ' ALA . . . 39.7 86.04 0.01 OUTLIER Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.999 -1.241 . . . . 0.0 109.999 179.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.694 ' CD2' HG12 ' A' ' 74' ' ' VAL . 12.9 m-85 -111.94 -47.95 3.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.191 -1.182 . . . . 0.0 110.348 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.818 ' HB2' HG23 ' A' ' 72' ' ' VAL . 37.2 t -89.84 -174.47 4.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.214 -0.929 . . . . 0.0 110.235 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -98.11 -80.6 0.45 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -0.892 . . . . 0.0 110.391 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -63.17 155.81 27.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.211 -0.931 . . . . 0.0 110.425 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.484 ' CA ' ' HA ' ' A' ' 38' ' ' ALA . . . -50.4 128.42 19.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.246 -0.909 . . . . 0.0 110.193 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 1.139 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 11.2 p90 -132.04 -165.03 1.53 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.287 -0.883 . . . . 0.0 110.216 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.604 ' C ' HD12 ' A' ' 139' ' ' LEU . 0.5 OUTLIER -160.38 -178.44 6.93 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.683 -178.831 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.847 HD13 HD13 ' A' ' 129' ' ' LEU . 2.3 mp -141.08 141.22 34.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.348 -0.845 . . . . 0.0 110.129 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' CYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 22.3 m -140.59 103.35 4.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.185 -0.947 . . . . 0.0 110.459 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.832 HD23 ' HB2' ' A' ' 66' ' ' ALA . 1.0 OUTLIER -96.29 -177.95 4.14 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.2 -0.938 . . . . 0.0 109.926 179.58 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.657 ' O ' HG22 ' A' ' 8' ' ' THR . 3.2 p30 168.87 35.68 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.439 -0.788 . . . . 0.0 110.004 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.503 ' HA ' ' O ' ' A' ' 7' ' ' GLY . 3.3 t0 -169.69 43.29 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.32 -0.862 . . . . 0.0 109.676 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.639 HG11 ' HZ2' ' A' ' 16' ' ' TRP . 3.5 t -89.7 126.46 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.39 -0.819 . . . . 0.0 110.353 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -149.11 148.32 29.53 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.336 -0.853 . . . . 0.0 110.094 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.719 HD21 HD11 ' A' ' 54' ' ' ILE . 47.5 tp -140.41 139.92 35.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.259 -0.901 . . . . 0.0 110.303 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.483 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -151.3 -177.83 6.29 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.281 -0.887 . . . . 0.0 110.031 179.9 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -129.61 175.25 8.95 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.224 -0.922 . . . . 0.0 110.205 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.469 ' O ' ' HB ' ' A' ' 150' ' ' VAL . 0.0 OUTLIER -64.74 86.75 0.05 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.894 . . . . 0.0 110.266 -179.906 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.525 HG13 ' O ' ' A' ' 150' ' ' VAL . 14.2 p -178.28 127.66 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.237 -0.914 . . . . 0.0 110.218 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 150' ' ' VAL . 4.7 mm-40 55.62 -172.91 0.06 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.283 -0.885 . . . . 0.0 110.243 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 7.8 mt . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.191 -179.993 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.263 0.554 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.455 ' HB2' ' HD2' ' A' ' 3' ' ' PRO . 9.7 p -165.98 169.01 7.16 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.22 -0.925 . . . . 0.0 110.26 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' A' ' 2' ' ' SER . 49.5 Cg_endo -75.99 -156.17 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.043 1.549 . . . . 0.0 110.043 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.563 ' CD1' HG12 ' A' ' 144' ' ' VAL . 8.2 pt -89.97 4.49 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.189 -0.944 . . . . 0.0 110.215 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 133.07 -166.43 23.7 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -137.14 76.84 1.61 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.23 -1.159 . . . . 0.0 110.203 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.43 ' C ' ' HA ' ' A' ' 143' ' ' ASP . . . 110.89 -133.13 11.36 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . 1.048 HG22 ' O ' ' A' ' 142' ' ' ASP . 80.7 p -76.19 146.42 39.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.256 -1.143 . . . . 0.0 110.252 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.53 ' CE1' ' CD1' ' A' ' 16' ' ' TRP . 43.3 m-85 -42.95 -36.0 1.4 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.343 -0.848 . . . . 0.0 109.968 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.56 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 3.3 p-10 35.53 59.36 0.81 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.653 -0.654 . . . . 0.0 111.417 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.56 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 4.0 t0 162.03 -67.34 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.514 -0.742 . . . . 0.0 109.764 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.469 ' HA2' ' HB ' ' A' ' 27' ' ' THR . . . -174.56 -172.06 39.32 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.761 ' HD3' HG21 ' A' ' 27' ' ' THR . 47.3 Cg_endo -74.35 80.91 2.14 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 124.124 1.591 . . . . 0.0 110.384 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -35.8 -65.61 0.24 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.666 -0.646 . . . . 0.0 110.567 -179.853 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.69 ' C ' HD13 ' A' ' 49' ' ' LEU . . . -144.73 12.15 1.94 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.86 ' NE1' HD22 ' A' ' 49' ' ' LEU . 51.3 m95 -73.27 108.18 6.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.294 -1.121 . . . . 0.0 110.851 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.773 ' O ' HG13 ' A' ' 47' ' ' VAL . 1.4 m -109.0 151.38 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.317 -0.864 . . . . 0.0 109.133 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.431 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . . . -130.77 118.14 20.41 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.862 -1.149 . . . . 0.0 109.757 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.571 ' CE2' ' O ' ' A' ' 46' ' ' GLY . 7.4 p90 -107.02 173.63 6.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.513 -0.742 . . . . 0.0 110.861 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.566 ' HA2' ' CE1' ' A' ' 43' ' ' TYR . . . 90.69 -13.94 64.36 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.783 HG23 HG13 ' A' ' 45' ' ' VAL . 17.8 p -149.93 -141.44 0.11 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.27 -1.135 . . . . 0.0 110.236 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.561 ' CB ' ' HD3' ' A' ' 24' ' ' PRO . 19.4 t0 -89.29 174.47 7.81 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.357 -0.839 . . . . 0.0 109.658 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.614 ' N ' ' HD3' ' A' ' 24' ' ' PRO . . . -122.08 43.82 1.43 Allowed Glycine 0 N--CA 1.488 2.165 0 C-N-CA 119.513 -1.327 . . . . 0.0 110.765 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.614 ' HD3' ' N ' ' A' ' 23' ' ' GLY . 55.8 Cg_endo -80.19 41.12 1.07 Allowed 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 123.458 1.241 . . . . 0.0 110.685 179.148 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 1.015 ' CD2' HG12 ' A' ' 34' ' ' VAL . 17.4 mt -44.33 93.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.978 -1.076 . . . . 0.0 110.273 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 24' ' ' PRO . 36.0 t0 -74.67 115.82 14.67 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.278 -0.888 . . . . 0.0 109.333 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.761 HG21 ' HD3' ' A' ' 13' ' ' PRO . 2.1 p -119.38 -30.97 4.76 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.158 -0.964 . . . . 0.0 110.779 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.7 ' C ' HG22 ' A' ' 29' ' ' THR . 3.4 m -53.42 82.75 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.615 -0.678 . . . . 0.0 110.59 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.7 HG22 ' C ' ' A' ' 28' ' ' SER . 0.0 OUTLIER 165.6 -33.14 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.215 -0.928 . . . . 0.0 109.806 -179.542 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.455 ' O ' ' HB3' ' A' ' 142' ' ' ASP . . . 127.51 7.36 4.83 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.497 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -150.57 154.95 38.49 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.039 -1.271 . . . . 0.0 110.662 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.78 HD11 HD13 ' A' ' 25' ' ' LEU . 2.0 tt -105.4 104.65 14.42 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.369 -0.832 . . . . 0.0 110.239 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.569 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 0.8 OUTLIER -97.65 113.86 25.69 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.223 -0.923 . . . . 0.0 111.449 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 1.015 HG12 ' CD2' ' A' ' 25' ' ' LEU . 18.7 m -89.76 148.8 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 178.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.423 ' HB2' ' HG2' ' A' ' 24' ' ' PRO . . . -89.29 111.0 21.72 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.39 -0.819 . . . . 0.0 111.309 -178.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.094 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 55.7 t -105.29 133.36 20.2 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.477 -0.765 . . . . 0.0 109.303 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.577 ' HD3' ' CG2' ' A' ' 21' ' ' THR . 40.2 Cg_endo -67.2 171.84 10.88 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.81 1.426 . . . . 0.0 111.0 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.509 ' HA ' ' N ' ' A' ' 136' ' ' ALA . . . -57.86 129.26 41.08 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.441 -0.787 . . . . 0.0 111.06 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.574 ' O ' ' C ' ' A' ' 40' ' ' SER . . . 40.31 38.95 1.49 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.574 ' C ' ' O ' ' A' ' 39' ' ' GLY . 74.6 p 17.45 59.91 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 117.524 0.662 . . . . 0.0 111.733 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.465 ' O ' ' HB3' ' A' ' 42' ' ' GLN . . . -89.5 104.98 17.49 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.66 0.743 . . . . 0.0 110.52 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.466 ' OE1' ' HG3' ' A' ' 37' ' ' PRO . 2.8 pt20 171.32 -169.47 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.842 -0.536 . . . . 0.0 109.709 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.566 ' CE1' ' HA2' ' A' ' 20' ' ' GLY . 3.1 p90 -44.2 -26.14 0.29 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.162 -0.961 . . . . 0.0 109.73 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.511 ' N ' ' CD1' ' A' ' 43' ' ' TYR . . . 123.68 127.73 3.25 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.783 HG13 HG23 ' A' ' 21' ' ' THR . 4.0 t -89.45 177.08 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.198 -1.178 . . . . 0.0 109.153 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.571 ' O ' ' CE2' ' A' ' 19' ' ' TYR . . . 165.45 137.63 2.24 Favored Glycine 0 N--CA 1.49 2.275 0 C-N-CA 119.047 -1.549 . . . . 0.0 110.849 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.773 HG13 ' O ' ' A' ' 17' ' ' VAL . 21.5 t -104.58 141.55 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.534 -0.98 . . . . 0.0 109.487 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.603 HG23 HG22 ' A' ' 17' ' ' VAL . 4.9 m -132.44 143.91 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 120.799 -1.188 . . . . 0.0 110.474 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.86 HD22 ' NE1' ' A' ' 16' ' ' TRP . 25.5 tp -136.72 113.05 9.9 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.313 -0.867 . . . . 0.0 110.09 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.519 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 4.4 t30 -88.9 132.33 34.73 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.204 -0.935 . . . . 0.0 110.561 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 141.21 72.31 0.04 OUTLIER Glycine 0 N--CA 1.49 2.258 0 C-N-CA 119.826 -1.178 . . . . 0.0 110.204 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 123' ' ' GLY . 5.7 t -119.9 173.28 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.025 -1.28 . . . . 0.0 110.009 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.971 ' O ' HD13 ' A' ' 54' ' ' ILE . . . -124.4 80.12 1.81 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.06 -1.025 . . . . 0.0 110.806 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.971 HD13 ' O ' ' A' ' 53' ' ' ALA . 4.9 mm -142.52 163.63 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.256 -0.902 . . . . 0.0 109.603 179.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.881 ' HA ' HG23 ' A' ' 111' ' ' THR . 36.8 tt0 -172.12 27.62 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.02 -1.05 . . . . 0.0 110.557 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.522 ' HB3' ' O ' ' A' ' 55' ' ' GLU . 3.3 pt-20 177.62 -165.52 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.649 -0.657 . . . . 0.0 110.111 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.497 ' N ' ' HG3' ' A' ' 56' ' ' GLU . . . -94.08 68.75 1.4 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.58 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.2 m -104.4 173.02 6.48 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.463 -1.022 . . . . 0.0 110.393 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.574 ' O ' ' CD2' ' A' ' 60' ' ' TYR . 0.4 OUTLIER -89.79 159.57 16.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.437 -0.789 . . . . 0.0 109.79 179.636 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.812 ' HB3' HD11 ' A' ' 146' ' ' LEU . 66.4 m-85 -159.5 -175.51 5.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.29 -0.881 . . . . 0.0 110.23 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.712 HG23 ' O ' ' A' ' 104' ' ' GLU . 91.5 m -147.68 121.62 9.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.326 -0.859 . . . . 0.0 109.894 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.635 HD22 HD23 ' A' ' 89' ' ' LEU . 18.9 tp -89.56 120.43 30.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.205 -0.935 . . . . 0.0 110.15 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.522 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 2.6 ttt180 -124.26 137.57 54.49 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.338 -0.851 . . . . 0.0 109.97 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 1.18 ' CZ ' HG21 ' A' ' 102' ' ' VAL . 0.9 OUTLIER -178.46 142.94 0.25 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.302 -0.874 . . . . 0.0 109.732 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.511 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 96.0 m -119.19 97.86 5.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.187 -0.946 . . . . 0.0 109.892 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.793 ' CB ' HD21 ' A' ' 95' ' ' LEU . . . -99.62 149.22 23.5 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.425 -0.797 . . . . 0.0 110.32 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.487 ' OG1' ' HA ' ' A' ' 99' ' ' PRO . 95.4 m -149.79 102.28 3.13 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.321 -0.862 . . . . 0.0 110.197 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -90.01 133.1 35.01 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.289 -0.882 . . . . 0.0 110.008 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.421 ' C ' ' O ' ' A' ' 68' ' ' ALA . 19.2 p -43.99 -26.49 0.29 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.251 -0.906 . . . . 0.0 109.521 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.598 ' CG2' ' CB ' ' A' ' 137' ' ' TRP . 2.4 t -111.23 159.7 17.65 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.457 -0.777 . . . . 0.0 109.987 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.501 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 3.1 m-20 -78.75 79.52 5.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.142 -0.974 . . . . 0.0 109.424 179.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.592 HG23 ' CB ' ' A' ' 133' ' ' SER . 9.9 p -102.73 139.43 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.18 -0.95 . . . . 0.0 111.27 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.418 HG22 ' O ' ' A' ' 73' ' ' THR . 17.8 m -119.86 86.73 2.61 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.691 HG11 HD22 ' A' ' 129' ' ' LEU . 11.1 m -89.55 -142.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.273 -0.892 . . . . 0.0 110.674 -178.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.548 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 30.1 mtm-85 -132.56 148.68 52.38 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.281 -0.887 . . . . 0.0 110.456 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.791 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -148.25 154.75 40.47 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.238 -0.914 . . . . 0.0 109.826 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.866 ' CD1' ' HB3' ' A' ' 126' ' ' ALA . 3.9 pp 179.0 -156.42 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.253 -0.904 . . . . 0.0 110.467 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.833 HG23 HD22 ' A' ' 89' ' ' LEU . 3.9 t -149.41 165.48 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.352 -0.842 . . . . 0.0 109.535 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.544 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . -174.83 -163.64 28.33 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.408 -1.377 . . . . 0.0 110.255 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.526 ' HG3' ' HA ' ' A' ' 85' ' ' TYR . 3.3 pt20 -119.84 143.38 47.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.383 -1.069 . . . . 0.0 110.461 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.482 ' HB2' ' HG2' ' A' ' 122' ' ' GLU . 3.6 m-20 -96.22 94.71 7.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.365 -0.834 . . . . 0.0 109.991 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.544 ' C ' ' CE1' ' A' ' 85' ' ' TYR . . . 137.49 149.43 5.57 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.622 ' N ' ' CE1' ' A' ' 85' ' ' TYR . . . -62.44 155.12 69.33 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.303 -1.116 . . . . 0.0 110.298 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.52 ' C ' ' CD2' ' A' ' 85' ' ' TYR . 50.5 Cg_endo -77.41 7.91 18.71 Favored 'Cis proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.636 -2.235 . . . . 0.0 110.803 -0.01 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.622 ' CE1' ' N ' ' A' ' 83' ' ' ALA . 11.4 m-85 69.94 166.0 0.28 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.306 -0.871 . . . . 0.0 110.161 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.518 ' N ' ' CG ' ' A' ' 80' ' ' GLN . . . 172.69 165.94 30.48 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.444 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 0.8 OUTLIER -143.31 149.1 37.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.274 -1.133 . . . . 0.0 110.239 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.951 HG23 HD12 ' A' ' 89' ' ' LEU . 30.3 m -122.14 -18.43 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.25 -0.906 . . . . 0.0 110.285 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.951 HD12 HG23 ' A' ' 88' ' ' VAL . 4.3 mp -111.93 143.02 43.6 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.178 -0.951 . . . . 0.0 110.984 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.507 ' O ' HG23 ' A' ' 91' ' ' THR . 11.2 m-20 -151.11 88.59 1.46 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.339 -0.85 . . . . 0.0 110.183 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.507 HG23 ' O ' ' A' ' 90' ' ' ASP . 6.4 p -153.29 176.96 11.39 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.049 -1.032 . . . . 0.0 110.656 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.2 m -119.89 120.05 30.66 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.348 -0.845 . . . . 0.0 110.072 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.791 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 46.1 Cg_endo -74.05 127.88 11.77 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.928 1.488 . . . . 0.0 111.076 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.593 ' HB3' ' NE ' ' A' ' 100' ' ' ARG . . . -95.11 149.68 21.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.318 -0.864 . . . . 0.0 109.3 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.793 HD21 ' CB ' ' A' ' 66' ' ' ALA . 43.5 mt -145.21 173.5 11.89 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.973 -1.079 . . . . 0.0 110.997 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.607 HG22 ' C ' ' A' ' 95' ' ' LEU . 0.1 OUTLIER 169.15 -178.59 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.633 -0.667 . . . . 0.0 109.716 -179.874 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.32 -13.75 21.66 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.126 -0.984 . . . . 0.0 109.806 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.541 ' CG ' ' HD2' ' A' ' 99' ' ' PRO . 33.7 tt0 -95.74 149.56 36.22 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.444 -0.785 . . . . 0.0 109.866 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.541 ' HD2' ' CG ' ' A' ' 98' ' ' GLU . 41.5 Cg_endo -68.11 130.09 20.75 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.807 1.425 . . . . 0.0 110.169 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.593 ' NE ' ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.83 91.92 3.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.267 -0.896 . . . . 0.0 110.624 -179.537 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.462 ' HG2' ' OG1' ' A' ' 65' ' ' THR . 31.8 mt-30 -73.54 157.94 35.78 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.273 -0.892 . . . . 0.0 109.632 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 1.18 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 60.4 t -131.29 133.03 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.143 -0.973 . . . . 0.0 110.518 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.49 87.73 1.46 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.406 -0.809 . . . . 0.0 110.009 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.712 ' O ' HG23 ' A' ' 61' ' ' THR . 56.8 mt-10 -125.83 -176.14 3.54 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.203 -0.935 . . . . 0.0 110.377 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 1.8 t -135.64 166.93 22.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.3 -0.875 . . . . 0.0 110.204 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.707 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 31.8 p90 -174.74 152.8 1.66 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.22 -0.925 . . . . 0.0 110.196 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.521 ' O ' ' N ' ' A' ' 109' ' ' SER . 4.8 m -89.7 94.95 10.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.192 -0.943 . . . . 0.0 109.97 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.685 ' HB1' HG21 ' A' ' 54' ' ' ILE . . . -50.76 89.54 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.301 -0.874 . . . . 0.0 110.014 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 107' ' ' THR . 10.3 p -85.65 53.27 2.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.27 -0.894 . . . . 0.0 109.996 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -157.79 -163.35 1.32 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.178 -0.951 . . . . 0.0 110.392 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.951 HG22 ' HD3' ' A' ' 113' ' ' PRO . 97.0 m -136.0 110.63 8.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.272 -0.892 . . . . 0.0 110.286 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.59 ' CG ' ' HA3' ' A' ' 123' ' ' GLY . 15.4 m-30 -109.07 70.75 0.43 Allowed Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.341 -0.849 . . . . 0.0 110.047 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.951 ' HD3' HG22 ' A' ' 111' ' ' THR . 46.4 Cg_endo -71.38 120.42 6.95 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 123.802 1.422 . . . . 0.0 110.401 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.491 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -66.39 -8.07 23.33 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.275 -0.89 . . . . 0.0 110.218 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.6 m -107.46 86.56 2.81 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.216 -0.928 . . . . 0.0 110.286 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.491 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 45.5 Cg_endo -72.65 151.69 52.55 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.001 1.527 . . . . 0.0 110.441 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.703 ' HB3' ' HB2' ' A' ' 120' ' ' ASP . . . -142.45 -165.88 2.14 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.267 -0.896 . . . . 0.0 110.289 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.58 -11.46 16.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.21 -0.931 . . . . 0.0 110.263 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -156.66 21.46 0.34 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.242 -0.911 . . . . 0.0 110.124 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.703 ' HB2' ' HB3' ' A' ' 117' ' ' ALA . 26.2 m-20 -112.86 102.53 54.79 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.25 -0.906 . . . . 0.0 110.251 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.534 ' HB3' ' CA ' ' A' ' 82' ' ' GLY . 47.1 Cg_endo -73.28 135.04 21.92 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.022 1.538 . . . . 0.0 110.271 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.534 ' CG ' ' N ' ' A' ' 123' ' ' GLY . 0.2 OUTLIER -95.58 -143.25 0.26 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.21 -0.931 . . . . 0.0 110.06 179.904 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.6 ' O ' HG23 ' A' ' 52' ' ' VAL . . . -149.86 147.3 17.41 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.591 ' O ' HG13 ' A' ' 78' ' ' VAL . 1.8 pt20 -150.32 -162.56 1.58 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.328 -1.101 . . . . 0.0 110.421 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.543 HG21 ' CH2' ' A' ' 16' ' ' TRP . 13.0 mt -119.12 143.83 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.481 -0.762 . . . . 0.0 109.278 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.866 ' HB3' ' CD1' ' A' ' 77' ' ' LEU . . . -117.04 117.44 29.66 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.178 -0.951 . . . . 0.0 111.048 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.519 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 3.0 m-30 -116.97 102.75 9.62 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.5 ' HB2' ' HB2' ' A' ' 75' ' ' ARG . 6.6 mt-30 -88.98 107.77 19.21 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.108 -0.995 . . . . 0.0 111.132 -178.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.691 HD22 HG11 ' A' ' 74' ' ' VAL . 16.8 mt -106.35 43.53 1.14 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.5 -0.75 . . . . 0.0 109.035 178.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 131' ' ' GLY . . . -91.68 116.65 5.04 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.546 ' N ' ' OG ' ' A' ' 40' ' ' SER . . . 41.95 90.07 0.01 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.613 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 6.8 m-85 -139.98 -55.73 0.55 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.167 -1.196 . . . . 0.0 110.492 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.592 ' CB ' HG23 ' A' ' 72' ' ' VAL . 1.2 t -88.95 -177.24 5.42 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.945 -1.097 . . . . 0.0 110.29 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.454 ' N ' ' OG ' ' A' ' 133' ' ' SER . . . -100.08 -75.22 0.58 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.226 -0.921 . . . . 0.0 110.393 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' A' ' 136' ' ' ALA . 83.9 m-20 -83.24 153.75 24.54 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.218 -0.927 . . . . 0.0 110.156 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.509 ' N ' ' HA ' ' A' ' 38' ' ' ALA . . . -40.95 142.3 0.5 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.363 -0.836 . . . . 0.0 110.452 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 1.094 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 18.8 p90 -153.46 -159.9 1.05 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.281 -0.887 . . . . 0.0 110.654 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.523 ' O ' ' CB ' ' A' ' 68' ' ' ALA . 0.8 OUTLIER -160.1 176.12 12.16 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.371 -0.83 . . . . 0.0 109.63 -178.4 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.569 ' O ' ' HA ' ' A' ' 33' ' ' CYS . 1.8 mp -136.66 117.33 13.95 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.905 -1.122 . . . . 0.0 111.89 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' CYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 0.8 OUTLIER -105.37 111.03 23.6 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.662 -0.649 . . . . 0.0 111.176 178.683 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.723 HD23 ' HB2' ' A' ' 66' ' ' ALA . 1.4 mt -100.78 -179.73 4.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.914 . . . . 0.0 109.08 178.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 1.048 ' O ' HG22 ' A' ' 8' ' ' THR . 0.5 OUTLIER 166.19 64.88 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.327 -0.858 . . . . 0.0 110.073 179.912 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.513 ' CB ' ' O ' ' A' ' 142' ' ' ASP . 0.3 OUTLIER 165.79 42.8 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.374 -0.829 . . . . 0.0 108.962 -179.906 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.692 HG11 ' HZ2' ' A' ' 16' ' ' TRP . 1.0 OUTLIER -89.15 120.02 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.542 -0.724 . . . . 0.0 110.593 -178.811 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -157.53 147.35 20.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.471 -0.768 . . . . 0.0 109.778 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.812 HD11 ' HB3' ' A' ' 60' ' ' TYR . 42.9 tp -144.07 146.83 33.08 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.254 -0.903 . . . . 0.0 110.342 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.482 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 7.1 t0 -177.88 152.12 0.74 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.214 -0.929 . . . . 0.0 110.296 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.527 ' HB2' ' CG2' ' A' ' 58' ' ' THR . 22.5 p -91.95 -176.02 4.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.286 -0.884 . . . . 0.0 110.174 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -52.91 169.51 0.09 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.226 -0.921 . . . . 0.0 110.143 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 11.4 p -47.48 146.04 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.229 -0.92 . . . . 0.0 110.218 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -168.71 61.15 0.06 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.286 -0.884 . . . . 0.0 110.218 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.207 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.425 ' O ' ' C ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.293 0.568 . . . . 0.0 110.175 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 1' ' ' ALA . 1.6 t -42.95 107.82 0.59 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.193 -0.942 . . . . 0.0 110.138 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.46 ' HG2' ' O ' ' A' ' 51' ' ' GLY . 51.4 Cg_endo -80.82 19.58 1.11 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.998 1.525 . . . . 0.0 111.072 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.639 ' CG2' HD21 ' A' ' 49' ' ' LEU . 6.7 pt -145.09 11.74 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.968 -1.082 . . . . 0.0 110.221 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 115.07 148.47 9.47 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -89.73 20.8 3.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.234 -1.157 . . . . 0.0 110.24 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.469 ' C ' ' HA ' ' A' ' 143' ' ' ASP . . . 153.86 -125.41 1.74 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.783 HG22 ' O ' ' A' ' 142' ' ' ASP . 0.8 OUTLIER -57.62 132.91 54.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.229 -1.159 . . . . 0.0 110.154 -179.92 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.569 ' O ' ' CB ' ' A' ' 10' ' ' ASP . 11.8 m-85 -43.86 -27.24 0.33 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.32 -0.862 . . . . 0.0 109.527 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.595 ' O ' ' HB2' ' A' ' 11' ' ' ASP . 0.0 OUTLIER 80.34 -43.43 0.24 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 122.038 -0.413 . . . . 0.0 111.062 179.303 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.595 ' HB2' ' O ' ' A' ' 10' ' ' ASP . 9.4 t70 161.93 39.22 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.083 0 CA-C-O 121.904 0.859 . . . . 0.0 109.085 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -176.81 134.74 2.62 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.618 ' HB3' HD12 ' A' ' 32' ' ' LEU . 45.9 Cg_endo -72.86 -15.39 26.53 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.932 1.491 . . . . 0.0 110.43 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 0.3 OUTLIER 63.77 -87.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.237 -0.914 . . . . 0.0 110.184 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.643 ' O ' HG13 ' A' ' 17' ' ' VAL . . . -124.35 -14.8 3.52 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 1.062 ' CE2' HD22 ' A' ' 49' ' ' LEU . 80.6 m95 -51.82 111.36 0.59 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.263 -1.139 . . . . 0.0 110.593 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.746 ' O ' HG13 ' A' ' 47' ' ' VAL . 1.0 OUTLIER -112.56 148.01 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.142 -0.974 . . . . 0.0 109.528 179.433 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.698 ' HB3' ' HB3' ' A' ' 25' ' ' LEU . . . -129.76 154.02 47.62 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.052 -1.03 . . . . 0.0 109.817 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.742 ' HE2' HG13 ' A' ' 48' ' ' VAL . 9.4 p90 -145.91 155.58 42.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.915 . . . . 0.0 110.936 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.649 ' HA3' HG13 ' A' ' 45' ' ' VAL . . . 161.83 -93.89 0.12 Allowed Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.016 -1.633 . . . . 0.0 109.016 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.558 ' CG2' ' HG3' ' A' ' 37' ' ' PRO . 11.6 p -151.21 18.19 0.75 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.183 -1.187 . . . . 0.0 110.715 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.941 ' CB ' ' HB3' ' A' ' 35' ' ' ALA . 0.4 OUTLIER -123.87 60.6 1.11 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.037 -1.039 . . . . 0.0 110.229 179.479 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 43.53 -161.7 0.06 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.431 ' O ' ' C ' ' A' ' 25' ' ' LEU . 46.0 Cg_endo -72.86 145.12 39.99 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.973 1.512 . . . . 0.0 110.378 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.729 HD13 HD11 ' A' ' 32' ' ' LEU . 0.8 OUTLIER -42.66 163.43 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.311 -0.868 . . . . 0.0 110.194 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.28 138.55 45.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.264 -0.898 . . . . 0.0 110.109 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.614 ' O ' HG22 ' A' ' 29' ' ' THR . 0.7 OUTLIER -119.85 -78.97 0.6 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.182 -0.949 . . . . 0.0 110.232 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.46 ' HB2' ' O ' ' A' ' 27' ' ' THR . 0.4 OUTLIER 61.43 -87.68 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.257 -0.902 . . . . 0.0 110.227 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.676 HG23 ' H ' ' A' ' 31' ' ' ALA . 5.1 t -42.18 -29.99 0.27 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.275 -0.891 . . . . 0.0 110.276 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' A' ' 11' ' ' ASP . . . 125.39 -26.41 5.49 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.676 ' H ' HG23 ' A' ' 29' ' ' THR . . . -91.8 136.08 33.42 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.211 -1.17 . . . . 0.0 110.188 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.729 HD11 HD13 ' A' ' 25' ' ' LEU . 1.9 tp -68.05 106.25 2.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.163 -0.96 . . . . 0.0 109.806 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 8.9 m -113.86 102.75 10.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.219 -0.925 . . . . 0.0 110.97 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.617 ' CG1' ' HB2' ' A' ' 18' ' ' ALA . 24.0 m -89.76 164.19 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.244 -0.91 . . . . 0.0 108.997 178.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.941 ' HB3' ' CB ' ' A' ' 22' ' ' ASP . . . -112.07 132.14 55.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.942 -1.099 . . . . 0.0 111.139 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.12 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 37.2 t -119.66 117.37 32.71 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.543 -0.723 . . . . 0.0 109.325 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.558 ' HG3' ' CG2' ' A' ' 21' ' ' THR . 44.2 Cg_endo -70.38 144.22 50.1 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.885 1.466 . . . . 0.0 111.236 -179.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.583 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -45.34 153.94 0.2 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.375 -0.828 . . . . 0.0 109.83 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 38' ' ' ALA . . . 45.22 59.39 4.61 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.724 ' OG ' HG21 ' A' ' 45' ' ' VAL . 0.6 OUTLIER -84.14 36.99 0.59 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.314 -1.109 . . . . 0.0 110.589 -179.625 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -92.44 19.73 6.92 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.96 0.886 . . . . 0.0 109.664 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.597 ' NE2' ' CE2' ' A' ' 43' ' ' TYR . 5.8 pt20 -73.23 -143.19 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.635 ' CD1' ' N ' ' A' ' 44' ' ' GLY . 6.8 p90 -42.05 -27.52 0.13 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.502 -0.749 . . . . 0.0 109.375 179.156 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.635 ' N ' ' CD1' ' A' ' 43' ' ' TYR . . . 117.66 113.51 2.64 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.724 HG21 ' OG ' ' A' ' 40' ' ' SER . 2.6 t -89.55 149.99 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.137 -1.214 . . . . 0.0 108.191 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.571 ' O ' ' CE2' ' A' ' 19' ' ' TYR . . . 179.3 166.97 35.99 Favored Glycine 0 N--CA 1.489 2.178 0 C-N-CA 118.582 -1.771 . . . . 0.0 111.083 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.746 HG13 ' O ' ' A' ' 17' ' ' VAL . 38.4 t -122.22 131.41 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.754 -0.851 . . . . 0.0 109.457 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.742 HG13 ' HE2' ' A' ' 19' ' ' TYR . 33.0 m -120.14 139.01 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.886 -1.134 . . . . 0.0 110.683 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 1.062 HD22 ' CE2' ' A' ' 16' ' ' TRP . 7.7 tp -130.66 87.33 2.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.325 -0.859 . . . . 0.0 110.211 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.552 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 3.5 m120 -69.15 103.3 1.87 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.926 . . . . 0.0 110.276 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.46 ' O ' ' HG2' ' A' ' 3' ' ' PRO . . . 157.02 79.72 0.03 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.66 HG23 ' HA ' ' A' ' 124' ' ' GLN . 6.8 t -124.92 160.16 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.167 -1.196 . . . . 0.0 109.933 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.616 ' O ' HD13 ' A' ' 54' ' ' ILE . . . -119.63 89.94 3.23 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.173 -0.955 . . . . 0.0 110.855 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.742 HD11 HD21 ' A' ' 146' ' ' LEU . 27.4 mm -130.06 172.79 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.28 -0.887 . . . . 0.0 109.507 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.585 ' N ' HG22 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -177.79 131.51 0.15 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.913 -1.117 . . . . 0.0 111.354 -179.749 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.464 ' O ' ' O ' ' A' ' 108' ' ' ALA . 7.8 mm-40 52.96 -168.45 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.667 -0.646 . . . . 0.0 110.85 178.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.502 ' HA2' ' HA ' ' A' ' 109' ' ' SER . . . -87.24 61.57 4.24 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.357 -1.897 . . . . 0.0 108.357 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.732 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.0 OUTLIER -96.41 174.43 6.87 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.625 -0.927 . . . . 0.0 110.078 -179.323 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.571 ' O ' ' CD2' ' A' ' 60' ' ' TYR . 7.5 m -89.89 158.8 17.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.331 -0.856 . . . . 0.0 110.487 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.732 ' CE2' HG22 ' A' ' 58' ' ' THR . 66.4 m-85 -159.31 119.81 3.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.381 -0.824 . . . . 0.0 109.917 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 68.9 m -89.91 110.65 21.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.175 -0.953 . . . . 0.0 110.29 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.417 HD22 ' CD2' ' A' ' 89' ' ' LEU . 17.5 tp -89.76 126.0 35.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.257 -0.902 . . . . 0.0 109.775 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.501 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 19.8 mtm105 -132.81 130.46 39.88 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.251 -0.906 . . . . 0.0 110.395 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 1.129 ' CZ ' HG21 ' A' ' 102' ' ' VAL . 5.7 p90 -166.0 149.61 7.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.398 -0.814 . . . . 0.0 109.809 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.688 HG23 ' HG2' ' A' ' 101' ' ' GLN . 28.9 m -119.58 89.69 3.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.208 -0.932 . . . . 0.0 110.245 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.734 ' CB ' HD21 ' A' ' 95' ' ' LEU . . . -89.9 149.26 22.7 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.355 -0.84 . . . . 0.0 110.18 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.768 HG23 ' O ' ' A' ' 98' ' ' GLU . 98.8 m -150.19 129.77 13.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.364 -0.835 . . . . 0.0 110.217 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -114.36 142.32 46.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.312 -0.868 . . . . 0.0 109.915 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 68' ' ' ALA . 17.3 m -45.6 -25.64 0.49 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.064 -1.023 . . . . 0.0 109.102 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.78 HG22 ' HB2' ' A' ' 137' ' ' TRP . 4.8 t -119.03 -160.55 0.81 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.589 -0.695 . . . . 0.0 109.835 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.503 ' N ' HG23 ' A' ' 70' ' ' THR . 4.9 m-20 -107.77 67.98 0.7 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.336 -0.853 . . . . 0.0 109.179 178.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.79 HG23 ' CB ' ' A' ' 133' ' ' SER . 3.8 p -88.04 135.64 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.33 -0.856 . . . . 0.0 111.374 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.432 HG22 ' O ' ' A' ' 73' ' ' THR . 7.4 m -121.92 91.42 3.51 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.918 HG11 HD22 ' A' ' 129' ' ' LEU . 5.3 m -89.56 -158.93 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.172 -0.955 . . . . 0.0 110.88 -178.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 14.4 mtm-85 -119.15 107.51 13.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.264 -0.897 . . . . 0.0 110.886 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.494 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -112.1 160.59 17.39 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.156 -0.965 . . . . 0.0 109.797 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.609 HD12 ' N ' ' A' ' 78' ' ' VAL . 3.3 pp 177.71 -156.65 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.295 -0.878 . . . . 0.0 110.201 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.826 HG23 HD22 ' A' ' 89' ' ' LEU . 3.9 t -147.81 168.03 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.217 -0.927 . . . . 0.0 109.527 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.488 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . 177.39 -176.18 47.94 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.39 -1.386 . . . . 0.0 110.174 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.496 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 1.5 tt0 -89.27 -159.16 0.55 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.423 -1.045 . . . . 0.0 110.222 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.501 ' HB2' ' HG2' ' A' ' 122' ' ' GLU . 4.7 m120 -168.12 83.95 0.19 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.352 -0.843 . . . . 0.0 110.166 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.534 ' O ' ' HB3' ' A' ' 83' ' ' ALA . . . 140.55 36.75 0.11 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.537 ' HA ' ' CD2' ' A' ' 85' ' ' TYR . . . 59.49 145.99 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.254 -1.145 . . . . 0.0 110.315 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.461 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.6 Cg_endo -81.79 21.27 11.78 Favored 'Cis proline' 0 C--N 1.314 -1.288 0 C-N-CA 121.755 -2.185 . . . . 0.0 110.869 -0.076 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.537 ' CD2' ' HA ' ' A' ' 83' ' ' ALA . 50.0 m-85 60.39 124.16 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.095 -1.003 . . . . 0.0 110.282 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -152.86 112.91 0.55 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.568 HG22 ' O ' ' A' ' 78' ' ' VAL . 0.8 OUTLIER -98.09 147.21 24.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.247 -1.149 . . . . 0.0 110.396 -179.891 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 1.063 HG23 HD12 ' A' ' 89' ' ' LEU . 33.2 m -119.97 -20.73 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.299 -0.876 . . . . 0.0 109.966 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 1.063 HD12 HG23 ' A' ' 88' ' ' VAL . 4.5 mp -105.36 143.86 32.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.312 -0.868 . . . . 0.0 110.764 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.732 ' O ' HG23 ' A' ' 91' ' ' THR . 10.1 m-20 -150.63 86.21 1.39 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.294 -0.879 . . . . 0.0 110.245 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.732 HG23 ' O ' ' A' ' 90' ' ' ASP . 1.8 p -159.98 177.98 10.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.167 -0.958 . . . . 0.0 110.476 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.507 ' CB ' ' O ' ' A' ' 74' ' ' VAL . 4.8 m -120.0 129.78 25.18 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.305 -0.872 . . . . 0.0 110.066 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.775 ' HG2' HG22 ' A' ' 74' ' ' VAL . 48.0 Cg_endo -72.19 78.61 1.85 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.906 1.477 . . . . 0.0 110.879 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.533 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -50.84 138.67 18.35 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.059 -1.026 . . . . 0.0 109.313 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.734 HD21 ' CB ' ' A' ' 66' ' ' ALA . 42.7 mt -130.12 176.3 8.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.93 -1.106 . . . . 0.0 110.862 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' A' ' 70' ' ' THR . 0.2 OUTLIER -171.73 -178.66 2.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.493 -0.754 . . . . 0.0 109.786 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 9.8 p -70.25 -7.84 45.39 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.2 -0.938 . . . . 0.0 110.12 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.768 ' O ' HG23 ' A' ' 67' ' ' THR . 4.4 mt-10 -109.18 177.34 1.27 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.238 -0.914 . . . . 0.0 110.077 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.504 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 46.4 Cg_endo -72.6 132.99 19.7 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 124.035 1.545 . . . . 0.0 110.357 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.533 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.59 86.55 2.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.222 -0.924 . . . . 0.0 110.16 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.688 ' HG2' HG23 ' A' ' 65' ' ' THR . 1.8 mt-30 -73.49 155.8 38.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.283 -0.885 . . . . 0.0 110.258 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 1.129 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 23.0 t -134.76 138.34 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -0.906 . . . . 0.0 110.105 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.3 m -150.11 112.51 4.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.931 . . . . 0.0 110.245 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -156.91 133.03 9.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.233 -0.917 . . . . 0.0 110.306 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.548 HG22 ' CG2' ' A' ' 59' ' ' THR . 11.2 m -95.53 94.18 7.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.283 -0.886 . . . . 0.0 110.164 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.585 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 33.8 p90 -94.23 153.57 17.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.27 -0.894 . . . . 0.0 110.281 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 97.3 m -89.72 99.36 12.38 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.175 -0.953 . . . . 0.0 109.811 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.648 ' CB ' ' CD2' ' A' ' 60' ' ' TYR . . . -58.72 104.58 0.23 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.28 -0.888 . . . . 0.0 110.497 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.502 ' HA ' ' HA2' ' A' ' 57' ' ' GLY . 11.1 p -91.11 53.7 2.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.393 -0.817 . . . . 0.0 110.047 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -164.28 -153.43 0.21 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.292 -0.88 . . . . 0.0 110.217 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.545 HG23 ' HA ' ' A' ' 55' ' ' GLU . 14.4 m -150.85 112.55 4.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -0.898 . . . . 0.0 110.341 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.611 ' CE2' HG12 ' A' ' 78' ' ' VAL . 14.4 m-30 -110.81 78.2 1.53 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.289 -0.882 . . . . 0.0 110.171 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.502 ' HD2' ' HA ' ' A' ' 122' ' ' GLU . 44.2 Cg_endo -70.99 -174.0 1.03 Allowed 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.956 1.503 . . . . 0.0 110.347 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -133.75 43.88 2.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 0.0 110.239 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.726 ' O ' HG23 ' A' ' 115' ' ' THR . 8.5 t -139.87 93.74 9.34 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.286 -0.884 . . . . 0.0 110.162 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.99 117.44 5.12 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.059 1.557 . . . . 0.0 110.443 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.679 ' HB3' ' HB2' ' A' ' 120' ' ' ASP . . . -135.38 -174.6 3.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.241 -0.912 . . . . 0.0 110.143 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.02 -10.6 22.81 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.21 -0.931 . . . . 0.0 110.198 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.435 ' OD1' ' OD1' ' A' ' 120' ' ' ASP . 5.4 p30 -156.46 20.08 0.34 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.291 -0.88 . . . . 0.0 110.155 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.679 ' HB2' ' HB3' ' A' ' 117' ' ' ALA . 80.0 m-20 -116.51 89.01 26.04 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.213 -0.929 . . . . 0.0 110.246 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.479 ' HB3' ' HA3' ' A' ' 82' ' ' GLY . 46.7 Cg_endo -73.71 155.11 49.42 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.997 1.525 . . . . 0.0 110.401 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.502 ' HA ' ' HD2' ' A' ' 113' ' ' PRO . 1.2 pt-20 -122.09 -164.11 1.13 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.23 -0.919 . . . . 0.0 110.133 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.582 ' HA3' ' CG ' ' A' ' 112' ' ' TYR . . . -137.28 154.76 22.54 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.66 ' HA ' HG23 ' A' ' 52' ' ' VAL . 1.7 pp0? -150.51 -160.55 1.18 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.151 -1.205 . . . . 0.0 110.623 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.805 HG21 ' HH2' ' A' ' 16' ' ' TRP . 13.8 mt -118.21 143.34 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 76' ' ' ALA . . . -119.31 123.59 44.58 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.234 -0.916 . . . . 0.0 111.198 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.581 ' HE2' HG21 ' A' ' 125' ' ' ILE . 11.3 m-85 -118.51 97.11 5.59 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 178.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.449 ' O ' ' HB ' ' A' ' 74' ' ' VAL . 12.4 mm-40 -88.65 93.23 9.49 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.302 -0.874 . . . . 0.0 111.841 -177.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 1.062 HD13 HD13 ' A' ' 139' ' ' LEU . 15.1 mt -93.94 47.17 1.2 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.111 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -84.42 83.1 1.64 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -179.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 55.61 100.13 0.01 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.594 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 9.8 m-85 -139.39 -40.44 0.46 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.312 -1.111 . . . . 0.0 109.943 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.79 ' CB ' HG23 ' A' ' 72' ' ' VAL . 1.3 t -90.86 -176.98 4.83 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.276 -0.89 . . . . 0.0 110.152 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.46 ' N ' ' OG ' ' A' ' 133' ' ' SER . . . -89.05 -88.07 0.16 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.207 -0.933 . . . . 0.0 110.402 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.8 176.49 6.27 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.274 -0.891 . . . . 0.0 110.452 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.583 ' HB2' ' HB2' ' A' ' 38' ' ' ALA . . . -50.12 128.98 20.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.326 -0.859 . . . . 0.0 110.286 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 1.12 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 4.4 p90 -134.92 -170.07 2.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.25 -0.906 . . . . 0.0 110.027 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.526 ' O ' ' CB ' ' A' ' 68' ' ' ALA . 0.5 OUTLIER -160.55 175.18 13.0 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.255 -0.978 . . . . 0.0 110.7 -178.759 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 1.062 HD13 HD13 ' A' ' 129' ' ' LEU . 2.4 mp -127.78 146.46 50.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.312 -0.867 . . . . 0.0 109.731 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' CYS . . . . . 0.517 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 11.8 m -147.56 97.74 2.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.062 -1.024 . . . . 0.0 110.949 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.584 HD12 HD23 ' A' ' 32' ' ' LEU . 0.5 OUTLIER -93.2 -177.07 4.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.168 -0.958 . . . . 0.0 109.222 179.012 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.783 ' O ' HG22 ' A' ' 8' ' ' THR . 0.8 OUTLIER 175.57 38.23 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.058 -1.027 . . . . 0.0 110.624 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.522 ' OD2' ' N ' ' A' ' 65' ' ' THR . 3.8 p-10 175.31 51.45 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.364 -0.835 . . . . 0.0 109.698 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.803 HG11 ' CZ2' ' A' ' 16' ' ' TRP . 3.5 t -90.13 114.88 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.389 -0.819 . . . . 0.0 110.32 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -137.75 133.39 34.05 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.319 -0.863 . . . . 0.0 110.077 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.742 HD21 HD11 ' A' ' 54' ' ' ILE . 39.4 tp -129.17 137.92 51.45 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.276 -0.89 . . . . 0.0 110.182 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.467 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 1.3 t70 -179.07 156.25 0.78 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.229 -0.919 . . . . 0.0 110.253 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.429 ' HB3' ' CG2' ' A' ' 58' ' ' THR . 2.3 p -90.72 -171.91 3.2 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.263 -0.898 . . . . 0.0 110.196 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.516 ' OE1' HG12 ' A' ' 150' ' ' VAL . 0.9 OUTLIER -46.82 169.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.206 -0.934 . . . . 0.0 110.209 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.516 HG12 ' OE1' ' A' ' 149' ' ' GLU . 9.9 p -43.04 161.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -0.894 . . . . 0.0 110.263 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -117.24 166.03 12.75 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.233 -0.917 . . . . 0.0 110.187 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.4 tp . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.204 -179.987 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.414 ' O ' ' CB ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.246 0.546 . . . . 0.0 110.241 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.414 ' CB ' ' O ' ' A' ' 1' ' ' ALA . 0.5 OUTLIER 63.72 61.2 1.72 Allowed Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.278 -0.889 . . . . 0.0 110.228 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -76.22 -156.36 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.009 1.531 . . . . 0.0 110.133 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.427 ' O ' ' CD ' ' A' ' 14' ' ' GLU . 8.2 pt -94.76 -13.03 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.203 -0.936 . . . . 0.0 110.139 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 144.09 -25.96 2.05 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.558 ' HA ' ' CB ' ' A' ' 145' ' ' ALA . 6.1 mt-10 54.52 68.77 0.81 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.274 -1.133 . . . . 0.0 110.26 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 170.11 -161.82 35.02 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.781 HG22 ' O ' ' A' ' 142' ' ' ASP . 15.2 p -90.54 -168.06 2.0 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.213 -1.169 . . . . 0.0 110.218 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.521 ' CE1' ' CD1' ' A' ' 16' ' ' TRP . 44.7 m-85 -103.29 49.67 0.82 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.9 . . . . 0.0 110.122 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.546 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 4.8 p30 -84.98 44.63 1.09 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.263 -0.898 . . . . 0.0 110.248 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.546 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 4.5 t0 161.75 78.66 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.264 0.554 . . . . 0.0 109.597 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 70.14 142.49 0.19 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.482 ' O ' ' HB2' ' A' ' 14' ' ' GLU . 48.7 Cg_endo -75.83 3.82 5.7 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.059 1.557 . . . . 0.0 110.666 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 0.1 OUTLIER 67.41 -84.78 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.262 -0.899 . . . . 0.0 110.301 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.463 ' O ' HG13 ' A' ' 17' ' ' VAL . . . -141.46 8.39 2.6 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.92 ' CE2' HD22 ' A' ' 49' ' ' LEU . 38.0 m95 -64.23 131.94 48.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.173 -1.192 . . . . 0.0 110.391 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.702 ' O ' HG13 ' A' ' 47' ' ' VAL . 1.0 OUTLIER -133.5 153.9 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.255 -0.903 . . . . 0.0 109.82 179.692 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.422 ' HB3' HD21 ' A' ' 25' ' ' LEU . . . -139.13 139.41 37.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.333 -0.854 . . . . 0.0 109.348 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.565 ' CE2' ' O ' ' A' ' 46' ' ' GLY . 1.7 p90 -121.52 144.04 48.94 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.165 -0.959 . . . . 0.0 111.093 -178.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.595 ' HA2' ' CE1' ' A' ' 43' ' ' TYR . . . 116.24 82.97 1.0 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.642 ' CG2' ' CE2' ' A' ' 43' ' ' TYR . 1.6 p 52.04 18.26 0.8 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.495 -1.003 . . . . 0.0 110.688 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 1.015 ' HA ' ' HB3' ' A' ' 35' ' ' ALA . 5.4 p30 -114.91 93.07 4.15 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.113 -0.992 . . . . 0.0 109.939 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 22' ' ' ASP . . . -60.31 -121.67 0.01 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.85 145.85 41.34 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.826 1.435 . . . . 0.0 110.488 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 1.081 HD22 HG12 ' A' ' 34' ' ' VAL . 14.3 mt -76.32 102.87 6.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.255 -0.903 . . . . 0.0 110.069 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.503 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 24.4 t0 -43.53 110.24 0.19 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.207 -0.933 . . . . 0.0 109.933 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.831 HG23 ' O ' ' A' ' 25' ' ' LEU . 12.7 p -119.41 -61.15 1.66 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.073 -1.017 . . . . 0.0 110.563 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.43 ' O ' ' OG1' ' A' ' 29' ' ' THR . 68.9 m 43.75 38.61 2.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.156 -0.965 . . . . 0.0 109.921 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 28' ' ' SER . 13.9 p 48.75 80.01 0.07 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.374 -0.829 . . . . 0.0 110.314 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 175.54 -65.5 0.1 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -150.17 151.72 33.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.308 -1.113 . . . . 0.0 110.069 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.72 HD11 ' CD1' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -104.82 94.41 5.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.158 -0.964 . . . . 0.0 110.393 -179.908 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.565 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 0.8 OUTLIER -94.71 115.81 27.98 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.215 -0.928 . . . . 0.0 111.176 179.759 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 1.081 HG12 HD22 ' A' ' 25' ' ' LEU . 16.6 m -89.4 149.43 4.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 1.015 ' HB3' ' HA ' ' A' ' 22' ' ' ASP . . . -88.95 92.99 9.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.314 -0.866 . . . . 0.0 111.093 -178.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.973 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 96.7 t -89.89 123.43 66.23 Favored Pre-proline 0 C--N 1.301 -1.508 0 O-C-N 121.489 -0.757 . . . . 0.0 109.373 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.91 ' HD2' HG21 ' A' ' 45' ' ' VAL . 40.0 Cg_endo -66.1 179.28 1.97 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.845 1.445 . . . . 0.0 112.048 -178.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.545 ' HA ' ' CA ' ' A' ' 136' ' ' ALA . . . -62.99 125.26 23.4 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.542 -0.724 . . . . 0.0 111.285 -179.087 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.531 ' O ' ' C ' ' A' ' 40' ' ' SER . . . 37.62 28.42 0.04 OUTLIER Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.712 ' OG ' HG23 ' A' ' 45' ' ' VAL . 11.0 t 28.64 53.88 0.08 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.984 -0.715 . . . . 0.0 110.435 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.641 ' O ' ' CG ' ' A' ' 42' ' ' GLN . . . -88.19 114.43 24.8 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.541 -0.725 . . . . 0.0 110.156 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.641 ' CG ' ' O ' ' A' ' 41' ' ' ALA . 1.1 pt20 84.19 30.4 0.06 Allowed 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.642 ' CE2' ' CG2' ' A' ' 21' ' ' THR . 0.1 OUTLIER -149.45 -33.37 0.2 Allowed 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 118.564 -1.254 . . . . 0.0 112.677 -177.888 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.535 ' HA2' ' CA ' ' A' ' 130' ' ' GLY . . . 52.81 79.88 0.08 OUTLIER Glycine 0 N--CA 1.483 1.794 0 N-CA-C 105.733 -2.947 . . . . 0.0 105.733 -176.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.91 HG21 ' HD2' ' A' ' 37' ' ' PRO . 3.8 t -87.64 129.31 39.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.422 -1.046 . . . . 0.0 109.001 -177.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.565 ' O ' ' CE2' ' A' ' 19' ' ' TYR . . . -155.44 156.46 27.0 Favored Glycine 0 N--CA 1.487 2.094 0 C-N-CA 119.018 -1.563 . . . . 0.0 110.172 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.702 HG13 ' O ' ' A' ' 17' ' ' VAL . 11.3 t -112.9 128.46 69.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.419 -1.048 . . . . 0.0 109.791 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.584 ' CG2' ' CG2' ' A' ' 17' ' ' VAL . 27.3 m -119.86 137.06 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.031 -1.043 . . . . 0.0 110.62 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.92 HD22 ' CE2' ' A' ' 16' ' ' TRP . 14.1 tp -131.27 97.4 4.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.341 -0.849 . . . . 0.0 110.197 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.518 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 45.2 m-80 -75.46 147.07 40.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.256 -0.903 . . . . 0.0 110.445 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 124.5 63.2 0.19 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.66 HG11 ' HD2' ' A' ' 112' ' ' TYR . 43.1 t -119.92 158.42 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.163 -1.198 . . . . 0.0 110.177 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -128.12 80.74 1.98 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.224 -0.923 . . . . 0.0 110.695 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 1.082 HD11 HD21 ' A' ' 146' ' ' LEU . 34.7 mm -117.44 173.03 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.244 -0.91 . . . . 0.0 109.72 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.589 ' N ' HG22 ' A' ' 54' ' ' ILE . 1.8 tp10 -166.92 131.58 2.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.966 -1.083 . . . . 0.0 110.785 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.522 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 8.1 pt-20 37.85 -153.9 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.664 -0.647 . . . . 0.0 110.922 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' A' ' 109' ' ' SER . . . -87.77 87.21 1.52 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.561 ' CG2' ' N ' ' A' ' 59' ' ' THR . 1.3 m -113.78 173.6 6.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.269 -1.136 . . . . 0.0 109.843 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.576 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 3.5 m -89.66 153.21 20.91 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.163 -0.961 . . . . 0.0 110.376 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.61 ' HB3' HD11 ' A' ' 146' ' ' LEU . 56.9 m-85 -160.29 179.37 8.73 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.339 -0.85 . . . . 0.0 110.211 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 36.7 m -150.31 115.35 5.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.344 -0.848 . . . . 0.0 109.876 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.917 HD22 ' CD2' ' A' ' 89' ' ' LEU . 13.7 tp -89.45 119.68 30.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.162 -0.961 . . . . 0.0 110.18 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.517 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 6.4 mtm180 -126.37 137.8 53.49 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.45 -0.781 . . . . 0.0 109.693 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.721 ' CZ ' HG21 ' A' ' 102' ' ' VAL . 0.7 OUTLIER -178.3 143.63 0.29 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.288 -0.883 . . . . 0.0 109.676 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.542 HG23 ' N ' ' A' ' 101' ' ' GLN . 69.9 m -119.14 99.49 6.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.244 -0.91 . . . . 0.0 109.962 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.807 ' CB ' HD21 ' A' ' 95' ' ' LEU . . . -99.78 156.77 16.93 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.432 -0.793 . . . . 0.0 110.225 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.647 HG23 ' O ' ' A' ' 98' ' ' GLU . 64.6 m -150.38 121.7 7.85 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.301 -0.875 . . . . 0.0 110.266 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.456 ' CB ' HG12 ' A' ' 72' ' ' VAL . . . -110.07 135.2 51.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.214 -0.928 . . . . 0.0 109.998 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.76 -9.12 25.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.206 -0.934 . . . . 0.0 109.972 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.6 ' CG2' ' CB ' ' A' ' 137' ' ' TRP . 5.0 t -118.37 19.39 13.42 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.326 -0.859 . . . . 0.0 110.214 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.498 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 8.4 t70 43.01 61.1 2.25 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.321 -0.862 . . . . 0.0 109.611 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.901 HG23 ' HB2' ' A' ' 133' ' ' SER . 6.5 p -89.97 139.3 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.387 -0.821 . . . . 0.0 110.95 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.8 m -120.58 85.95 2.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.393 -0.817 . . . . 0.0 109.283 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 1.1 HG21 ' CD2' ' A' ' 129' ' ' LEU . 4.6 m -89.94 -141.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.298 -0.877 . . . . 0.0 110.508 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.688 ' N ' HG23 ' A' ' 74' ' ' VAL . 0.3 OUTLIER -132.32 119.42 20.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.254 -0.904 . . . . 0.0 110.617 -179.574 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.542 ' N ' ' HD3' ' A' ' 93' ' ' PRO . . . -122.63 163.64 19.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.217 -0.927 . . . . 0.0 109.663 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.681 ' CD1' ' HB3' ' A' ' 126' ' ' ALA . 1.8 pp 174.69 -157.62 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.22 -0.925 . . . . 0.0 110.283 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.742 HG23 HD22 ' A' ' 89' ' ' LEU . 4.0 t -144.2 169.45 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.344 -0.847 . . . . 0.0 109.181 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.498 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . 172.2 179.22 42.95 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 118.993 -1.575 . . . . 0.0 110.465 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.495 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 7.5 tt0 -98.15 142.16 30.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.537 -0.978 . . . . 0.0 110.119 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.533 ' O ' ' CB ' ' A' ' 121' ' ' PRO . 5.7 m120 -95.58 86.0 4.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.276 -0.89 . . . . 0.0 109.968 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.505 ' C ' ' CE1' ' A' ' 85' ' ' TYR . . . 124.68 142.85 6.0 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.619 ' N ' ' CE1' ' A' ' 85' ' ' TYR . . . -42.67 154.12 0.3 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.211 -1.17 . . . . 0.0 110.291 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.457 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.7 Cg_endo -79.38 12.25 20.34 Favored 'Cis proline' 0 C--N 1.312 -1.356 0 C-N-CA 121.673 -2.22 . . . . 0.0 110.896 -0.08 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.619 ' CE1' ' N ' ' A' ' 83' ' ' ALA . 31.9 m-85 61.79 150.4 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.105 -0.997 . . . . 0.0 110.261 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.457 ' O ' ' HA2' ' A' ' 79' ' ' GLY . . . -171.95 106.9 0.24 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.7 p -96.6 140.52 31.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.195 -1.179 . . . . 0.0 110.261 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 1.088 HG23 HD12 ' A' ' 89' ' ' LEU . 17.3 m -121.71 -15.91 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.274 -0.891 . . . . 0.0 110.177 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 1.088 HD12 HG23 ' A' ' 88' ' ' VAL . 4.4 mp -118.74 142.36 47.76 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.285 -0.884 . . . . 0.0 110.857 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.726 ' O ' HG23 ' A' ' 91' ' ' THR . 2.7 m-20 -150.62 85.65 1.38 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.342 -0.849 . . . . 0.0 110.203 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.726 HG23 ' O ' ' A' ' 90' ' ' ASP . 3.3 p -159.55 -172.32 3.66 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.16 -0.963 . . . . 0.0 110.412 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.436 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 72.1 m -121.75 138.34 28.41 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.324 -0.86 . . . . 0.0 110.207 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.713 ' HG2' HG22 ' A' ' 74' ' ' VAL . 49.4 Cg_endo -76.75 74.29 4.94 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.977 1.514 . . . . 0.0 110.623 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.523 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -49.62 127.37 15.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.121 -0.987 . . . . 0.0 109.557 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.807 HD21 ' CB ' ' A' ' 66' ' ' ALA . 20.8 mt -125.08 165.62 17.86 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.065 -1.022 . . . . 0.0 110.808 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.431 ' CG2' ' HG3' ' A' ' 100' ' ' ARG . 0.1 OUTLIER -157.93 -178.44 7.31 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.45 -0.781 . . . . 0.0 109.923 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.6 p -67.2 -29.17 68.76 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.151 -0.968 . . . . 0.0 110.38 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.647 ' O ' HG23 ' A' ' 67' ' ' THR . 2.6 mt-10 -91.41 179.78 1.33 Allowed Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.19 -0.944 . . . . 0.0 110.12 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.503 ' HD2' ' CB ' ' A' ' 98' ' ' GLU . 46.2 Cg_endo -73.75 130.47 14.69 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.896 1.472 . . . . 0.0 110.276 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.523 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 1.3 mtt-85 -119.83 92.65 3.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.145 -0.972 . . . . 0.0 110.498 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.542 ' N ' HG23 ' A' ' 65' ' ' THR . 3.8 tt0 -73.16 156.59 38.47 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.339 -0.851 . . . . 0.0 109.997 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.721 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 49.8 t -137.02 134.32 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.202 -0.936 . . . . 0.0 110.267 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.443 ' O ' ' CG ' ' A' ' 104' ' ' GLU . 0.2 OUTLIER -150.06 120.5 7.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.231 -0.918 . . . . 0.0 110.249 -179.891 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.443 ' CG ' ' O ' ' A' ' 103' ' ' THR . 14.3 mp0 -160.01 133.73 7.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.213 -0.93 . . . . 0.0 110.222 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.562 HG23 ' O ' ' A' ' 60' ' ' TYR . 24.2 m -92.22 145.05 24.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.168 -0.957 . . . . 0.0 110.228 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.415 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 34.0 p90 -150.21 153.33 36.07 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.312 -0.867 . . . . 0.0 110.315 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.425 ' O ' ' N ' ' A' ' 109' ' ' SER . 22.6 m -90.03 92.62 9.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.247 -0.908 . . . . 0.0 109.917 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.581 ' CB ' ' CD2' ' A' ' 60' ' ' TYR . . . -48.23 96.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.296 -0.878 . . . . 0.0 110.354 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.475 ' HA ' ' HA2' ' A' ' 57' ' ' GLY . 70.0 p -85.24 49.48 1.76 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.268 -0.895 . . . . 0.0 110.145 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.464 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -154.05 -154.16 0.5 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.268 -0.895 . . . . 0.0 110.224 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.524 HG23 ' HA ' ' A' ' 55' ' ' GLU . 18.8 m -150.95 112.66 4.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.268 -0.895 . . . . 0.0 110.277 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.713 ' OH ' HG13 ' A' ' 88' ' ' VAL . 14.7 m-30 -109.91 101.52 47.34 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.32 -0.863 . . . . 0.0 110.152 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.479 ' HG2' ' O ' ' A' ' 121' ' ' PRO . 42.4 Cg_endo -71.75 136.86 28.76 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.747 1.393 . . . . 0.0 110.019 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -43.84 -84.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.301 -0.874 . . . . 0.0 110.916 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.91 153.86 42.91 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.217 -0.927 . . . . 0.0 110.671 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.532 ' CB ' ' O ' ' A' ' 120' ' ' ASP . 48.0 Cg_endo -74.57 178.96 6.42 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.131 1.595 . . . . 0.0 110.427 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.551 ' HB3' ' HB2' ' A' ' 120' ' ' ASP . . . -150.15 -161.36 1.32 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.243 -0.911 . . . . 0.0 110.028 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -46.58 -24.41 0.53 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.17 -0.956 . . . . 0.0 109.952 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -161.95 23.02 0.11 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.344 -0.847 . . . . 0.0 110.066 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.551 ' HB2' ' HB3' ' A' ' 117' ' ' ALA . 1.1 m-20 -105.76 128.38 26.59 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.297 -0.877 . . . . 0.0 110.113 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.533 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 50.7 Cg_endo -76.56 -170.05 0.82 Allowed 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.896 1.471 . . . . 0.0 110.66 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.475 ' HA ' ' HG2' ' A' ' 113' ' ' PRO . 5.8 pm0 -153.08 132.8 13.12 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.341 -0.849 . . . . 0.0 110.056 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.495 ' HA2' ' HA ' ' A' ' 80' ' ' GLN . . . -82.76 146.66 24.54 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.562 ' HA ' ' CG2' ' A' ' 52' ' ' VAL . 7.9 pt20 -150.72 -156.22 0.7 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.206 -1.173 . . . . 0.0 110.696 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.461 ' CG2' ' CE1' ' A' ' 127' ' ' PHE . 10.7 mt -117.82 137.7 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.681 ' HB3' ' CD1' ' A' ' 77' ' ' LEU . . . -114.41 124.95 53.21 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.296 -0.878 . . . . 0.0 111.26 -179.098 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.493 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 4.4 m-85 -118.39 95.4 4.86 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.279 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.561 ' O ' ' CE2' ' A' ' 132' ' ' PHE . 3.0 mp0 -88.38 90.91 8.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.512 -0.743 . . . . 0.0 112.39 -177.087 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 1.1 ' CD2' HG21 ' A' ' 74' ' ' VAL . 5.4 mt -100.95 45.65 0.97 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 177.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.57 ' O ' ' CD2' ' A' ' 132' ' ' PHE . . . -96.47 136.18 12.67 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' A' ' 39' ' ' GLY . . . 38.25 73.33 0.15 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.604 ' CE1' ' HA ' ' A' ' 74' ' ' VAL . 9.8 m-85 -129.41 -80.27 0.56 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.073 -1.251 . . . . 0.0 110.967 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.901 ' HB2' HG23 ' A' ' 72' ' ' VAL . 14.0 t -89.06 100.31 13.11 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.061 -1.024 . . . . 0.0 110.462 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -30.26 -50.45 0.12 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.967 -0.458 . . . . 0.0 111.75 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.466 ' O ' ' O ' ' A' ' 133' ' ' SER . 6.7 m-20 -73.04 159.6 33.38 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.004 -1.06 . . . . 0.0 110.038 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.545 ' CA ' ' HA ' ' A' ' 38' ' ' ALA . . . -80.57 146.88 31.04 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.358 -0.838 . . . . 0.0 110.355 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.973 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 4.6 p90 -155.58 -166.8 2.33 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.222 -0.924 . . . . 0.0 111.012 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.505 ' CG2' ' SG ' ' A' ' 33' ' ' CYS 0.254 0.7 OUTLIER -149.5 169.07 21.76 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -178.236 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.644 HD21 ' CD1' ' A' ' 95' ' ' LEU . 1.8 mp -133.02 116.91 16.97 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.826 -1.171 . . . . 0.0 111.82 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' CYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 0.8 OUTLIER -102.06 109.53 21.27 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.747 -0.596 . . . . 0.0 111.081 178.895 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.504 HD23 ' HB2' ' A' ' 66' ' ' ALA . 1.5 mt -100.42 -179.0 3.98 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.294 -0.879 . . . . 0.0 108.679 178.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.781 ' O ' HG22 ' A' ' 8' ' ' THR . 1.8 p30 167.14 57.9 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.167 -0.958 . . . . 0.0 110.486 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.521 ' CG ' HG22 ' A' ' 8' ' ' THR . 0.4 OUTLIER 167.35 44.62 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.263 -0.898 . . . . 0.0 109.664 179.838 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.865 HG11 ' HZ2' ' A' ' 16' ' ' TRP . 1.9 t -89.92 114.09 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.434 -0.791 . . . . 0.0 110.205 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.558 ' CB ' ' HA ' ' A' ' 6' ' ' GLU . . . -145.8 155.17 42.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.315 -0.866 . . . . 0.0 110.168 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 1.082 HD21 HD11 ' A' ' 54' ' ' ILE . 10.2 tp -153.83 123.55 6.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.317 -0.864 . . . . 0.0 110.169 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.486 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 11.1 t0 -136.02 147.52 47.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.256 -0.903 . . . . 0.0 110.281 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.628 ' OG ' HG12 ' A' ' 150' ' ' VAL . 0.2 OUTLIER -107.1 112.95 26.11 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.333 -0.854 . . . . 0.0 110.205 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.468 ' HG3' ' HB ' ' A' ' 59' ' ' THR . 0.4 OUTLIER -73.93 87.38 1.81 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -0.896 . . . . 0.0 110.201 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.628 HG12 ' OG ' ' A' ' 148' ' ' SER . 3.9 p -159.37 170.42 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.255 -0.903 . . . . 0.0 110.275 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.577 ' N ' HG22 ' A' ' 150' ' ' VAL . 38.3 tt0 -87.25 74.97 9.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.276 -0.89 . . . . 0.0 110.218 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.744 ' O ' HD12 ' A' ' 152' ' ' LEU . 1.1 pp . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.219 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.259 0.552 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.641 ' C ' ' HB2' ' A' ' 53' ' ' ALA . 0.7 OUTLIER -128.41 136.4 29.03 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.246 -0.909 . . . . 0.0 110.142 -180.0 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.529 ' N ' ' HB2' ' A' ' 53' ' ' ALA . 49.3 Cg_endo -76.21 -156.25 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.97 1.51 . . . . 0.0 110.03 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 1.049 HD11 ' O ' ' A' ' 144' ' ' VAL . 13.3 pt -92.04 -1.57 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.209 -0.932 . . . . 0.0 110.13 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 6' ' ' GLU . . . 75.82 43.54 22.53 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.512 ' HG3' ' HB1' ' A' ' 145' ' ' ALA . 0.8 OUTLIER 42.54 66.23 0.79 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.295 -1.121 . . . . 0.0 110.189 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.449 ' O ' ' CE1' ' A' ' 9' ' ' PHE . . . -67.82 89.69 0.2 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.454 ' O ' ' HB2' ' A' ' 9' ' ' PHE . 1.9 p -76.14 -1.29 25.41 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.238 -1.154 . . . . 0.0 110.101 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.597 ' CD1' ' HB3' ' A' ' 13' ' ' PRO . 6.3 m-30 60.32 81.42 0.18 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.33 -0.857 . . . . 0.0 110.321 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.543 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 21.0 t70 -142.26 12.22 1.97 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.225 -0.922 . . . . 0.0 110.168 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.543 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.8 OUTLIER 161.47 -24.26 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.678 -0.639 . . . . 0.0 109.609 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -161.23 86.66 0.11 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.597 ' HB3' ' CD1' ' A' ' 9' ' ' PHE . 49.6 Cg_endo -76.0 72.94 5.06 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.153 1.607 . . . . 0.0 110.963 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.452 ' HG3' ' HB ' ' A' ' 4' ' ' ILE . 25.6 mm-40 38.33 -92.0 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.491 -0.756 . . . . 0.0 110.782 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.561 ' O ' HG13 ' A' ' 17' ' ' VAL . . . -153.42 17.87 0.68 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.932 ' NE1' HD22 ' A' ' 49' ' ' LEU . 41.3 m95 -42.93 122.52 2.44 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -1.135 . . . . 0.0 110.4 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.737 ' O ' HG13 ' A' ' 47' ' ' VAL . 1.9 m -119.28 153.2 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.177 -0.952 . . . . 0.0 109.865 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.433 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . . . -137.58 122.47 18.89 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.165 -0.959 . . . . 0.0 109.96 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.563 ' CZ ' ' O ' ' A' ' 46' ' ' GLY . 3.7 p90 -115.24 154.78 28.44 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.39 -0.819 . . . . 0.0 110.498 -179.403 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.632 ' O ' HG22 ' A' ' 45' ' ' VAL . . . 90.77 29.11 13.96 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.484 ' HB ' ' O ' ' A' ' 35' ' ' ALA . 14.2 p -146.15 -160.38 1.14 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.127 -1.219 . . . . 0.0 110.303 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.45 ' O ' ' O ' ' A' ' 23' ' ' GLY . 12.4 t0 -89.93 123.47 33.88 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 0.0 110.196 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 22' ' ' ASP . . . 43.94 -166.1 0.03 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.416 ' O ' ' O ' ' A' ' 25' ' ' LEU . 45.5 Cg_endo -73.18 162.74 39.86 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.066 1.561 . . . . 0.0 110.405 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.828 HD13 HD11 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -59.37 -154.43 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.265 -0.897 . . . . 0.0 110.185 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -152.48 161.35 42.71 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.269 -0.894 . . . . 0.0 110.145 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.597 HG21 ' HD3' ' A' ' 13' ' ' PRO . 0.7 OUTLIER -125.22 -28.2 3.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.27 -0.894 . . . . 0.0 110.235 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.454 ' O ' ' OG1' ' A' ' 29' ' ' THR . 0.5 OUTLIER 48.48 23.48 0.61 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.216 -0.927 . . . . 0.0 110.152 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.454 ' OG1' ' O ' ' A' ' 28' ' ' SER . 17.9 p 47.19 65.83 1.15 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.297 -0.877 . . . . 0.0 110.268 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.526 ' N ' ' HA ' ' A' ' 10' ' ' ASP . . . 169.85 -50.17 0.21 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.451 ' HB1' ' O ' ' A' ' 141' ' ' LEU . . . -150.04 141.51 23.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -1.117 . . . . 0.0 110.292 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.828 HD11 HD13 ' A' ' 25' ' ' LEU . 5.8 tt -79.96 110.87 15.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.215 -0.928 . . . . 0.0 109.921 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 88.7 m -118.43 129.2 55.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.141 -0.975 . . . . 0.0 110.708 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.532 ' CG2' ' HB2' ' A' ' 139' ' ' LEU . 17.9 m -98.83 153.06 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.301 -0.874 . . . . 0.0 109.692 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.498 ' HA ' ' OG1' ' A' ' 138' ' ' THR . . . -102.76 87.65 3.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.249 -0.907 . . . . 0.0 110.898 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.101 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 57.5 t -75.98 132.14 74.67 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.161 -0.962 . . . . 0.0 109.386 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.524 ' CG ' ' OH ' ' A' ' 43' ' ' TYR . 47.8 Cg_endo -78.89 158.24 27.49 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.87 1.458 . . . . 0.0 111.114 -179.023 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.502 ' HA ' ' CA ' ' A' ' 136' ' ' ALA . . . -42.94 126.79 3.95 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.291 -0.881 . . . . 0.0 109.775 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 38' ' ' ALA . . . 47.92 86.67 0.01 OUTLIER Glycine 0 N--CA 1.485 1.963 0 N-CA-C 108.385 -1.886 . . . . 0.0 108.385 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.835 ' HB2' HG21 ' A' ' 45' ' ' VAL . 0.8 OUTLIER -82.2 39.04 0.56 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.353 -1.086 . . . . 0.0 110.636 -179.453 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.953 ' HB2' ' HA3' ' A' ' 131' ' ' GLY . . . -105.25 20.23 19.24 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.17 -0.957 . . . . 0.0 109.756 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.589 ' HG3' ' CD2' ' A' ' 43' ' ' TYR . 17.6 pt20 -93.04 27.02 2.58 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 121.581 0.705 . . . . 0.0 109.5 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.628 ' CD1' ' N ' ' A' ' 43' ' ' TYR . 0.0 OUTLIER 159.55 6.24 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.203 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.725 179.357 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.479 ' HA2' ' HA2' ' A' ' 130' ' ' GLY . . . 67.6 100.77 0.03 OUTLIER Glycine 0 N--CA 1.487 2.042 0 O-C-N 120.502 -1.374 . . . . 0.0 109.83 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.835 HG21 ' HB2' ' A' ' 40' ' ' SER . 48.8 t -89.19 170.37 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.119 -1.224 . . . . 0.0 108.431 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.563 ' O ' ' CZ ' ' A' ' 19' ' ' TYR . . . 167.33 140.45 2.91 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 118.943 -1.598 . . . . 0.0 110.721 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.737 HG13 ' O ' ' A' ' 17' ' ' VAL . 21.3 t -105.94 132.2 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.505 -0.997 . . . . 0.0 109.605 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.732 ' O ' HG22 ' A' ' 17' ' ' VAL . 35.6 m -126.9 141.03 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.923 -1.111 . . . . 0.0 110.572 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.932 HD22 ' NE1' ' A' ' 16' ' ' TRP . 14.2 tp -132.12 102.26 5.73 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.329 -0.857 . . . . 0.0 110.207 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.53 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 1.4 m-80 -80.08 122.79 27.22 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.289 -0.882 . . . . 0.0 110.424 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.549 ' O ' HG22 ' A' ' 4' ' ' ILE . . . 146.04 74.47 0.02 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.627 HG12 ' H ' ' A' ' 53' ' ' ALA . 6.3 t -119.81 178.84 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.185 -1.185 . . . . 0.0 110.086 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.887 ' O ' HD13 ' A' ' 54' ' ' ILE . . . -132.84 84.01 2.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.174 -0.954 . . . . 0.0 110.441 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.887 HD13 ' O ' ' A' ' 53' ' ' ALA . 5.6 mm -143.08 163.48 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.227 -0.92 . . . . 0.0 109.625 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.687 ' HG3' HG23 ' A' ' 111' ' ' THR . 8.1 tt0 -178.88 32.44 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.101 -0.999 . . . . 0.0 110.28 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 55' ' ' GLU . 2.0 tt0 179.78 -176.44 0.32 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.529 -0.732 . . . . 0.0 110.07 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.487 ' HA2' ' HA ' ' A' ' 109' ' ' SER . . . -93.41 67.07 1.7 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.255 -1.938 . . . . 0.0 108.255 178.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.716 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.0 OUTLIER -105.08 177.68 4.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.585 -0.95 . . . . 0.0 110.265 -179.036 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.584 ' N ' ' CG2' ' A' ' 58' ' ' THR . 0.6 OUTLIER -88.95 154.62 20.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.302 -0.874 . . . . 0.0 110.016 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.957 ' HB3' HD11 ' A' ' 146' ' ' LEU . 59.3 m-85 -155.98 124.37 5.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.346 -0.847 . . . . 0.0 110.061 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 28.9 m -94.1 115.23 27.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.204 -0.935 . . . . 0.0 110.108 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.668 HD22 ' CD2' ' A' ' 89' ' ' LEU . 19.4 tp -89.39 122.53 32.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.173 -0.954 . . . . 0.0 109.816 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.502 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 6.3 mtt180 -123.4 140.58 52.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.311 -0.868 . . . . 0.0 110.263 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.992 ' CZ ' HG21 ' A' ' 102' ' ' VAL . 1.6 p90 -178.28 147.53 0.43 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.41 -0.806 . . . . 0.0 109.629 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 47.6 m -119.37 91.04 3.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.115 -0.99 . . . . 0.0 110.407 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.603 ' CB ' HD21 ' A' ' 95' ' ' LEU . . . -90.06 147.65 23.52 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.366 -0.833 . . . . 0.0 110.069 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.5 ' OG1' ' HA ' ' A' ' 99' ' ' PRO . 40.7 m -146.84 131.9 18.26 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.27 -0.894 . . . . 0.0 110.442 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.598 ' CB ' HG12 ' A' ' 72' ' ' VAL . . . -123.85 136.57 54.46 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.35 -0.844 . . . . 0.0 109.906 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 64.5 m -65.17 -9.06 20.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.177 -0.952 . . . . 0.0 110.314 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.565 ' CG2' ' HB2' ' A' ' 137' ' ' TRP . 6.4 t -119.77 19.79 12.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.25 -0.906 . . . . 0.0 110.237 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.484 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 13.2 t70 43.57 49.94 6.42 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.295 -0.878 . . . . 0.0 109.678 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.762 ' CG1' HD12 ' A' ' 95' ' ' LEU . 8.8 p -75.47 145.64 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.429 -0.794 . . . . 0.0 110.662 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 89.7 m -119.94 86.06 2.49 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.39 -0.819 . . . . 0.0 109.339 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.711 HG12 ' HB2' ' A' ' 132' ' ' PHE . 15.0 m -89.5 -141.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.258 -0.901 . . . . 0.0 110.312 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.535 ' N ' HG23 ' A' ' 74' ' ' VAL . 16.0 mtm-85 -131.94 148.05 52.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.129 -0.982 . . . . 0.0 110.851 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.758 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -148.34 155.35 41.17 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.336 -0.853 . . . . 0.0 109.998 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.057 ' CD1' ' HB3' ' A' ' 126' ' ' ALA . 2.1 pp 175.82 -160.52 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 0.0 110.294 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.904 ' CG2' HD22 ' A' ' 89' ' ' LEU . 4.3 t -147.78 167.98 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.303 -0.873 . . . . 0.0 109.597 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.505 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . 174.08 -175.76 46.54 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.33 -1.414 . . . . 0.0 110.314 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.531 ' NE2' ' HB2' ' A' ' 121' ' ' PRO . 3.5 tm0? -94.37 178.25 5.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.458 -1.025 . . . . 0.0 110.142 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.472 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 3.7 m120 -146.53 87.75 1.73 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.248 -0.907 . . . . 0.0 110.155 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.531 ' HA3' ' HB3' ' A' ' 121' ' ' PRO . . . 137.07 34.27 0.21 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.544 ' HA ' ' CD2' ' A' ' 85' ' ' TYR . . . 59.07 148.31 0.07 OUTLIER Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.133 -1.216 . . . . 0.0 110.407 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.453 ' O ' ' O ' ' A' ' 85' ' ' TYR . 52.4 Cg_endo -80.37 21.03 9.08 Favored 'Cis proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.761 -2.183 . . . . 0.0 111.103 -0.039 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.544 ' CD2' ' HA ' ' A' ' 83' ' ' ALA . 35.6 m-85 60.93 130.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.057 -1.027 . . . . 0.0 110.239 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.465 ' O ' ' HA2' ' A' ' 79' ' ' GLY . . . -151.44 99.05 0.19 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.3 p -91.16 134.15 34.78 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.287 -1.125 . . . . 0.0 110.187 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 1.109 HG23 HD12 ' A' ' 89' ' ' LEU . 32.1 m -120.24 -9.2 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.233 -0.917 . . . . 0.0 110.092 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 1.109 HD12 HG23 ' A' ' 88' ' ' VAL . 4.2 mp -118.63 137.63 53.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.275 -0.89 . . . . 0.0 111.006 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.405 ' C ' HG23 ' A' ' 91' ' ' THR . 12.0 p-10 -150.71 85.13 1.36 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.486 -0.759 . . . . 0.0 109.951 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.405 HG23 ' C ' ' A' ' 90' ' ' ASP . 65.6 p -144.08 -174.28 4.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.053 -1.029 . . . . 0.0 110.698 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.2 m -119.69 116.88 32.96 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.364 -0.835 . . . . 0.0 109.947 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.758 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 44.6 Cg_endo -71.84 79.61 1.59 Allowed 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.923 1.486 . . . . 0.0 110.642 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.805 ' HB3' HH11 ' A' ' 100' ' ' ARG . . . -67.03 148.17 52.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.208 -0.932 . . . . 0.0 109.833 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.762 HD12 ' CG1' ' A' ' 72' ' ' VAL . 73.3 mt -134.08 176.97 8.11 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.187 -0.946 . . . . 0.0 110.475 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.404 ' O ' HG23 ' A' ' 67' ' ' THR . 0.3 OUTLIER -170.66 -179.14 2.81 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.275 -0.891 . . . . 0.0 110.14 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.63 -30.27 71.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.257 -0.902 . . . . 0.0 110.039 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.525 ' CB ' ' HD2' ' A' ' 99' ' ' PRO . 0.1 OUTLIER -93.1 179.72 1.23 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.278 -0.889 . . . . 0.0 110.042 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.525 ' HD2' ' CB ' ' A' ' 98' ' ' GLU . 44.3 Cg_endo -72.06 134.99 24.33 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.9 1.474 . . . . 0.0 110.287 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.805 HH11 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.73 85.81 2.45 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.283 -0.885 . . . . 0.0 110.25 -179.893 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.413 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 8.7 mt-30 -71.7 156.33 39.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.27 -0.894 . . . . 0.0 110.216 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.992 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 40.7 t -139.66 138.92 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.24 -0.913 . . . . 0.0 110.166 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.07 116.34 6.53 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.252 -0.905 . . . . 0.0 110.131 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -140.88 131.87 26.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.253 -0.904 . . . . 0.0 110.245 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.527 HG22 HG22 ' A' ' 59' ' ' THR . 4.4 m -89.82 65.42 6.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.181 -0.949 . . . . 0.0 110.225 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.61 ' CZ ' ' CB ' ' A' ' 60' ' ' TYR . 26.1 p90 -71.29 144.95 49.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 0.0 110.099 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.531 ' O ' ' N ' ' A' ' 109' ' ' SER . 3.5 m -89.35 92.76 9.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.17 -0.956 . . . . 0.0 109.699 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.634 ' CB ' ' CD2' ' A' ' 60' ' ' TYR . . . -45.23 92.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.37 -0.831 . . . . 0.0 110.156 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 107' ' ' THR . 81.2 p -89.45 54.68 2.99 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.332 -0.855 . . . . 0.0 109.61 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -163.34 -155.2 0.31 Allowed 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.465 -0.894 . . . . 0.0 110.678 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.687 HG23 ' HG3' ' A' ' 55' ' ' GLU . 4.5 m -148.14 118.58 7.4 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.294 -0.879 . . . . 0.0 110.587 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.598 ' CD2' HG13 ' A' ' 54' ' ' ILE . 15.8 m-30 -112.61 85.52 7.48 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.497 -0.752 . . . . 0.0 109.542 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.677 ' HD3' HG22 ' A' ' 111' ' ' THR . 43.4 Cg_endo -69.97 127.77 14.9 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 123.86 1.453 . . . . 0.0 110.49 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -85.12 55.65 3.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.318 -0.864 . . . . 0.0 110.395 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.519 ' O ' ' CB ' ' A' ' 120' ' ' ASP . 5.7 m -136.21 74.7 54.83 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.212 -0.93 . . . . 0.0 110.046 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.429 ' HB3' ' CD ' ' A' ' 122' ' ' GLU . 44.8 Cg_endo -72.06 81.27 1.44 Allowed 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 124.036 1.545 . . . . 0.0 110.387 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.663 ' HB3' ' HB2' ' A' ' 120' ' ' ASP . . . -122.98 -172.69 2.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.341 -0.85 . . . . 0.0 110.116 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -53.12 -56.48 15.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.233 -0.917 . . . . 0.0 110.19 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -110.99 40.11 2.11 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.235 -0.916 . . . . 0.0 110.318 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.663 ' HB2' ' HB3' ' A' ' 117' ' ' ALA . 72.2 m-20 -139.63 99.28 7.75 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.209 -0.932 . . . . 0.0 110.15 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.531 ' HB3' ' HA3' ' A' ' 82' ' ' GLY . 48.8 Cg_endo -74.38 -176.94 2.98 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 124.001 1.527 . . . . 0.0 110.35 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.487 ' HB2' ' O ' ' A' ' 113' ' ' PRO . 0.9 OUTLIER -162.37 169.73 20.03 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.204 -0.935 . . . . 0.0 110.663 179.738 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.613 ' O ' HG23 ' A' ' 52' ' ' VAL . . . -106.51 155.55 16.51 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.552 ' HA ' ' CG2' ' A' ' 52' ' ' VAL . 1.1 pt20 -150.4 -160.15 1.13 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.168 -1.195 . . . . 0.0 110.719 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.819 HG21 ' HH2' ' A' ' 16' ' ' TRP . 18.3 mt -118.34 142.65 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 1.057 ' HB3' ' CD1' ' A' ' 77' ' ' LEU . . . -118.03 120.98 39.43 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.249 -0.907 . . . . 0.0 111.439 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.498 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 4.9 m-85 -118.79 100.79 7.62 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.202 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.543 ' O ' ' CE2' ' A' ' 132' ' ' PHE . 32.1 mm-40 -89.47 103.15 15.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.127 -0.983 . . . . 0.0 112.313 -177.273 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.624 ' CD2' HG21 ' A' ' 74' ' ' VAL . 11.5 mt -100.68 41.04 1.2 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 177.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.479 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -67.61 85.68 0.15 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 -179.208 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.953 ' HA3' ' HB2' ' A' ' 41' ' ' ALA . . . 40.57 79.23 0.05 OUTLIER Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.711 ' HB2' HG12 ' A' ' 74' ' ' VAL . 10.5 m-85 -107.28 -42.64 4.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.171 -1.194 . . . . 0.0 110.183 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.703 ' HB2' HG23 ' A' ' 72' ' ' VAL . 1.2 t -89.81 -176.5 4.97 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.198 -0.938 . . . . 0.0 110.238 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.46 ' N ' ' OG ' ' A' ' 133' ' ' SER . . . -96.69 -92.23 0.23 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.122 -0.986 . . . . 0.0 110.855 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -63.63 170.75 3.03 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.187 -0.946 . . . . 0.0 110.637 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.502 ' CA ' ' HA ' ' A' ' 38' ' ' ALA . . . -52.92 136.53 34.37 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.392 -0.817 . . . . 0.0 110.397 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 1.101 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 8.1 p90 -145.17 -167.55 2.71 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.314 -0.866 . . . . 0.0 110.336 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.538 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 0.5 OUTLIER -160.35 165.96 30.27 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.214 -0.929 . . . . 0.0 110.398 -178.729 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.543 ' HG ' HD13 ' A' ' 95' ' ' LEU . 2.4 mp -119.52 161.32 20.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.434 -0.791 . . . . 0.0 109.209 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' CYS . . . . . . . . . . . . . 1.9 m -150.58 94.44 2.1 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.069 -1.019 . . . . 0.0 111.209 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.493 ' HA ' ' O ' ' A' ' 65' ' ' THR . 0.9 OUTLIER -95.14 -176.03 3.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.229 -0.919 . . . . 0.0 108.903 178.754 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.486 ' CB ' ' O ' ' A' ' 141' ' ' LEU . 0.5 OUTLIER 170.2 37.25 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.051 -1.031 . . . . 0.0 110.631 179.912 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.467 ' O ' ' O ' ' A' ' 63' ' ' ARG . 34.5 t0 179.35 48.75 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.184 -0.948 . . . . 0.0 110.056 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 1.049 ' O ' HD11 ' A' ' 4' ' ' ILE . 2.8 t -89.77 113.51 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.369 -0.832 . . . . 0.0 110.08 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.512 ' HB1' ' HG3' ' A' ' 6' ' ' GLU . . . -144.4 163.19 34.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.263 -0.898 . . . . 0.0 110.219 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.957 HD11 ' HB3' ' A' ' 60' ' ' TYR . 16.3 tp -145.99 128.87 16.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.27 -0.894 . . . . 0.0 110.218 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.581 ' O ' ' CD1' ' A' ' 60' ' ' TYR . 0.3 OUTLIER -135.75 -154.15 0.55 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.302 -0.874 . . . . 0.0 110.238 179.988 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 149' ' ' GLU . 48.3 p -140.25 169.24 18.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.273 -0.892 . . . . 0.0 110.116 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.509 ' O ' ' CG ' ' A' ' 149' ' ' GLU . 21.1 pt-20 -43.28 121.36 2.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.201 -0.937 . . . . 0.0 110.175 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.581 HG22 ' H ' ' A' ' 151' ' ' GLU . 8.7 p -103.53 177.17 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.22 -0.925 . . . . 0.0 110.266 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.581 ' H ' HG22 ' A' ' 150' ' ' VAL . 1.6 mp0 -64.21 -167.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.262 -0.899 . . . . 0.0 110.263 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.426 ' HA ' HD13 ' A' ' 152' ' ' LEU . 1.7 mm? . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.179 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.459 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.242 0.544 . . . . 0.0 110.183 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 1' ' ' ALA . 0.1 OUTLIER 55.12 166.47 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.259 -0.901 . . . . 0.0 110.162 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.442 ' HD2' ' OG ' ' A' ' 2' ' ' SER . 48.9 Cg_endo -76.0 -156.38 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.016 1.535 . . . . 0.0 110.097 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.731 HD11 ' O ' ' A' ' 144' ' ' VAL . 7.8 pt -120.52 -3.62 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.181 -0.95 . . . . 0.0 110.128 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 6' ' ' GLU . . . 97.52 139.17 10.54 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 5' ' ' GLY . 0.4 OUTLIER -42.76 -85.5 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.241 -1.152 . . . . 0.0 110.126 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.5 ' HA2' ' HA ' ' A' ' 143' ' ' ASP . . . -80.85 127.66 8.03 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.69 HG21 ' HB ' ' A' ' 144' ' ' VAL . 16.3 p -107.0 163.89 12.6 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.147 -1.208 . . . . 0.0 110.64 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.604 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.1 m-30 65.89 9.79 6.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.452 -0.78 . . . . 0.0 110.229 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.552 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 4.0 p-10 -86.12 41.66 0.94 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.159 -0.963 . . . . 0.0 109.885 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.552 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 2.1 t70 161.3 -24.17 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 172.91 164.21 27.95 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.635 ' CB ' HD11 ' A' ' 25' ' ' LEU . 44.1 Cg_endo -71.17 81.56 1.16 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.011 1.532 . . . . 0.0 110.442 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.48 ' C ' ' O ' ' A' ' 13' ' ' PRO . 1.0 OUTLIER -31.42 -68.2 0.09 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.275 0.559 . . . . 0.0 111.163 -179.636 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.495 ' C ' ' CD1' ' A' ' 49' ' ' LEU . . . -152.47 14.05 0.71 Allowed Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.765 -1.207 . . . . 0.0 110.218 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 1.103 ' NE1' HD22 ' A' ' 49' ' ' LEU . 24.2 m95 -77.77 110.08 12.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.028 -1.278 . . . . 0.0 110.244 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.541 HG22 HG23 ' A' ' 48' ' ' VAL . 2.2 m -100.64 125.67 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.238 -0.914 . . . . 0.0 110.068 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.575 ' HB2' HG11 ' A' ' 34' ' ' VAL . . . -104.17 119.32 38.69 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.156 -0.965 . . . . 0.0 110.093 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.588 ' CZ ' ' O ' ' A' ' 46' ' ' GLY . 6.2 p90 -112.42 148.05 35.16 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.298 -0.876 . . . . 0.0 110.458 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.537 ' CA ' ' OH ' ' A' ' 43' ' ' TYR . . . 96.82 34.62 5.66 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.481 ' CG2' ' C ' ' A' ' 20' ' ' GLY . 7.3 p -150.21 -147.31 0.22 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.137 -1.214 . . . . 0.0 110.407 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 23' ' ' GLY . 62.2 t0 -89.96 114.77 26.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.334 -0.854 . . . . 0.0 110.33 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 43.16 -155.52 0.16 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.32 157.32 49.94 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 124.031 1.543 . . . . 0.0 110.493 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.639 HD23 ' H ' ' A' ' 25' ' ' LEU . 0.6 OUTLIER -53.63 179.8 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.254 -0.904 . . . . 0.0 110.201 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -152.58 142.33 21.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.27 -0.894 . . . . 0.0 110.196 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.78 HG22 ' HA ' ' A' ' 32' ' ' LEU . 2.2 p -119.64 -79.97 0.61 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.295 -0.878 . . . . 0.0 110.031 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.42 ' OG ' ' C ' ' A' ' 27' ' ' THR . 1.6 p 40.44 27.46 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.384 -0.822 . . . . 0.0 110.645 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.482 HG22 ' O ' ' A' ' 27' ' ' THR . 12.8 t -148.7 13.93 0.93 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.139 -0.976 . . . . 0.0 110.364 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 9' ' ' PHE . . . 75.48 7.86 83.3 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.643 ' HB1' ' O ' ' A' ' 141' ' ' LEU . . . -150.35 151.38 32.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.256 -1.144 . . . . 0.0 110.118 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.78 ' HA ' HG22 ' A' ' 27' ' ' THR . 0.5 OUTLIER -79.85 114.56 18.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.123 -0.986 . . . . 0.0 109.822 179.829 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 67.0 m -120.93 118.27 29.46 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.184 -0.947 . . . . 0.0 110.745 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.575 HG11 ' HB2' ' A' ' 18' ' ' ALA . 15.3 m -99.52 135.38 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.35 -0.844 . . . . 0.0 109.494 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.476 ' O ' ' HB ' ' A' ' 21' ' ' THR . . . -89.47 89.74 7.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.207 -0.933 . . . . 0.0 111.089 -179.086 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.141 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 53.1 t -69.87 134.53 87.89 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.245 -0.91 . . . . 0.0 109.416 179.175 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 21' ' ' THR . 47.2 Cg_endo -76.68 152.85 33.53 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.944 1.497 . . . . 0.0 111.325 -178.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.503 ' HA ' ' N ' ' A' ' 136' ' ' ALA . . . -43.89 130.99 5.74 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.373 -0.83 . . . . 0.0 109.884 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 38' ' ' ALA . . . 45.24 78.18 0.08 OUTLIER Glycine 0 N--CA 1.487 2.041 0 N-CA-C 108.724 -1.75 . . . . 0.0 108.724 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.883 ' HB2' HG21 ' A' ' 45' ' ' VAL . 1.1 p -82.76 40.33 0.67 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.304 -1.115 . . . . 0.0 110.473 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.966 ' HB2' ' HA3' ' A' ' 131' ' ' GLY . . . -109.1 25.13 12.17 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.361 -0.837 . . . . 0.0 109.767 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.51 ' O ' ' HB3' ' A' ' 43' ' ' TYR . 16.3 pt20 -78.14 2.7 17.19 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.637 0.732 . . . . 0.0 110.542 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.537 ' OH ' ' CA ' ' A' ' 20' ' ' GLY . 2.5 p90 177.26 -32.52 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.508 ' O ' ' CE2' ' A' ' 43' ' ' TYR . . . 123.48 104.47 1.68 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 110.266 -1.133 . . . . 0.0 110.266 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.883 HG21 ' HB2' ' A' ' 40' ' ' SER . 39.8 t -89.7 177.27 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.066 -1.255 . . . . 0.0 108.502 178.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.588 ' O ' ' CZ ' ' A' ' 19' ' ' TYR . . . 160.55 140.11 2.81 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 118.491 -1.814 . . . . 0.0 111.66 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.608 ' O ' HG13 ' A' ' 48' ' ' VAL . 21.5 t -100.53 162.17 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.644 -0.915 . . . . 0.0 108.693 178.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.608 HG13 ' O ' ' A' ' 47' ' ' VAL . 15.6 m -157.25 157.61 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.841 -1.162 . . . . 0.0 110.71 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 1.103 HD22 ' NE1' ' A' ' 16' ' ' TRP . 13.8 tp -151.33 120.28 6.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.327 -0.858 . . . . 0.0 110.351 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.483 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 23.7 p30 -96.26 158.24 15.53 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.216 -0.927 . . . . 0.0 110.234 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.11 74.4 0.62 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.594 HG12 ' N ' ' A' ' 53' ' ' ALA . 87.2 t -138.83 172.43 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.173 -1.193 . . . . 0.0 110.177 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.594 ' N ' HG12 ' A' ' 52' ' ' VAL . . . -139.5 101.19 4.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.173 -0.955 . . . . 0.0 110.409 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.65 ' CG1' ' CD2' ' A' ' 112' ' ' TYR . 45.0 mm -126.34 173.13 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.248 -0.907 . . . . 0.0 109.987 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.676 ' HA ' HG23 ' A' ' 111' ' ' THR . 0.0 OUTLIER -164.74 128.59 2.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.118 -0.989 . . . . 0.0 110.814 -179.923 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 8.3 pt-20 37.74 -153.31 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.673 -0.642 . . . . 0.0 110.999 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 108' ' ' ALA . . . -87.03 75.67 2.16 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.582 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.3 m -101.67 173.61 6.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.334 -1.098 . . . . 0.0 109.807 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.575 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 0.7 OUTLIER -89.96 153.27 20.73 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.235 -0.916 . . . . 0.0 110.559 -179.577 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.636 ' CD2' ' HB2' ' A' ' 108' ' ' ALA . 64.3 m-85 -159.96 123.12 3.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.311 -0.868 . . . . 0.0 110.01 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 30.6 m -89.88 115.35 27.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.161 -0.962 . . . . 0.0 110.167 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.423 HD22 ' CD2' ' A' ' 89' ' ' LEU . 15.2 tp -89.5 126.27 35.52 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.232 -0.918 . . . . 0.0 109.907 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.523 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 14.3 ttp85 -131.16 136.49 48.36 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.385 -0.822 . . . . 0.0 110.107 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 1.165 ' CZ ' HG21 ' A' ' 102' ' ' VAL . 0.6 OUTLIER -178.46 143.2 0.26 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.383 -0.823 . . . . 0.0 109.57 179.678 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.85 HG23 ' CA ' ' A' ' 101' ' ' GLN . 0.2 OUTLIER -119.26 93.35 4.05 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.149 -0.969 . . . . 0.0 110.434 -179.466 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.688 ' HB2' HD23 ' A' ' 141' ' ' LEU . . . -94.81 153.95 17.49 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.293 -0.879 . . . . 0.0 110.119 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.535 HG23 ' O ' ' A' ' 98' ' ' GLU . 51.9 m -150.14 135.65 18.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.22 -0.925 . . . . 0.0 110.363 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 138' ' ' THR . . . -126.14 140.06 52.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.282 -0.886 . . . . 0.0 110.013 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.9 m -71.2 -3.71 21.67 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.22 -0.925 . . . . 0.0 110.113 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.569 ' CG2' ' HB2' ' A' ' 137' ' ' TRP . 6.3 t -124.62 19.84 8.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 110.096 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.487 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 14.9 t0 43.51 60.77 2.48 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.272 -0.892 . . . . 0.0 109.558 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.742 HG23 ' HB2' ' A' ' 133' ' ' SER . 5.5 p -87.07 140.96 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.463 -0.773 . . . . 0.0 110.87 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 23.2 m -119.86 87.88 2.83 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.483 -0.761 . . . . 0.0 109.107 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.819 HG11 HD22 ' A' ' 129' ' ' LEU . 19.2 m -89.73 -146.15 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -0.906 . . . . 0.0 110.382 -179.24 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.414 ' N ' HG23 ' A' ' 74' ' ' VAL . 0.4 OUTLIER -127.16 124.14 38.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.244 -0.91 . . . . 0.0 110.434 -179.67 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.655 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -126.99 158.67 36.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.309 -0.869 . . . . 0.0 109.666 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.912 HD11 ' HB3' ' A' ' 126' ' ' ALA . 3.4 pp 177.87 -157.33 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.19 -0.944 . . . . 0.0 110.475 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.715 HG23 HD22 ' A' ' 89' ' ' LEU . 9.8 t -143.56 -178.21 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.339 -0.851 . . . . 0.0 109.558 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.631 ' H ' HG12 ' A' ' 78' ' ' VAL . . . 161.56 -154.93 26.03 Favored Glycine 0 N--CA 1.49 2.274 0 C-N-CA 119.303 -1.427 . . . . 0.0 110.053 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.571 ' HB3' ' CD1' ' A' ' 112' ' ' TYR . 5.7 pt20 -135.21 158.36 44.56 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.469 -1.018 . . . . 0.0 110.356 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.466 ' HB2' ' HG2' ' A' ' 122' ' ' GLU . 2.4 m120 -107.23 97.22 7.01 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.315 -0.866 . . . . 0.0 110.038 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.542 ' C ' ' CE1' ' A' ' 85' ' ' TYR . . . 138.44 143.01 4.4 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.593 ' N ' ' CE1' ' A' ' 85' ' ' TYR . . . -65.95 155.7 86.08 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.262 -1.14 . . . . 0.0 110.222 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.533 ' C ' ' CD2' ' A' ' 85' ' ' TYR . 50.6 Cg_endo -77.48 8.94 17.83 Favored 'Cis proline' 0 C--N 1.313 -1.322 0 C-N-CA 121.637 -2.235 . . . . 0.0 110.905 0.096 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.593 ' CE1' ' N ' ' A' ' 83' ' ' ALA . 10.5 m-85 69.33 -171.23 0.18 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.231 -0.918 . . . . 0.0 110.214 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 153.46 107.27 0.31 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.504 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 4.1 p -96.05 167.84 10.98 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.211 -1.17 . . . . 0.0 110.391 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.812 HG12 ' N ' ' A' ' 109' ' ' SER . 5.4 m -135.5 -32.76 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.364 -0.835 . . . . 0.0 110.324 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.715 HD22 HG23 ' A' ' 78' ' ' VAL . 4.3 mp -98.3 144.24 27.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -0.909 . . . . 0.0 110.859 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.651 ' O ' HG23 ' A' ' 91' ' ' THR . 17.4 p-10 -151.08 86.11 1.36 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.324 -0.86 . . . . 0.0 110.172 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.651 HG23 ' O ' ' A' ' 90' ' ' ASP . 2.4 p -157.52 -175.03 5.16 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.024 -1.047 . . . . 0.0 110.531 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.49 130.47 24.78 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.326 -0.858 . . . . 0.0 110.172 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.655 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 49.7 Cg_endo -75.44 80.58 2.49 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.961 1.506 . . . . 0.0 110.87 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.69 ' HB3' HH11 ' A' ' 100' ' ' ARG . . . -56.55 135.63 54.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.059 -1.025 . . . . 0.0 109.479 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.71 HD12 ' CG1' ' A' ' 72' ' ' VAL . 93.4 mt -125.16 176.22 6.87 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.032 -1.043 . . . . 0.0 110.691 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.52 HG22 ' HG3' ' A' ' 100' ' ' ARG . 0.3 OUTLIER -167.9 -178.92 3.97 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.43 -0.794 . . . . 0.0 110.039 179.922 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.4 -29.87 70.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.196 -0.94 . . . . 0.0 110.281 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.535 ' O ' HG23 ' A' ' 67' ' ' THR . 3.7 mt-10 -90.28 176.7 2.8 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.172 -0.955 . . . . 0.0 110.14 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.499 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 45.4 Cg_endo -72.19 134.44 23.05 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.956 1.503 . . . . 0.0 110.334 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.69 HH11 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.9 92.94 3.9 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.191 -0.943 . . . . 0.0 110.368 -179.868 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.85 ' CA ' HG23 ' A' ' 65' ' ' THR . 6.4 tp-100 -76.71 154.92 33.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.292 -0.88 . . . . 0.0 110.085 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 1.165 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 32.2 t -131.72 134.47 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.232 -0.917 . . . . 0.0 110.194 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.25 115.61 5.45 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.275 -0.891 . . . . 0.0 110.138 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -159.88 131.19 5.95 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.207 -0.933 . . . . 0.0 110.32 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.6 m -89.97 105.25 17.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.261 -0.899 . . . . 0.0 110.06 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.628 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 34.4 p90 -106.83 154.28 21.25 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.275 -0.89 . . . . 0.0 110.447 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 58' ' ' THR . 33.0 m -91.29 89.8 7.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.28 -0.888 . . . . 0.0 109.691 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.636 ' HB2' ' CD2' ' A' ' 60' ' ' TYR . . . -41.94 101.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.329 -0.857 . . . . 0.0 110.452 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.812 ' N ' HG12 ' A' ' 88' ' ' VAL . 88.8 p -85.89 55.55 3.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.3 -0.875 . . . . 0.0 110.063 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.457 ' CB ' HG13 ' A' ' 88' ' ' VAL . . . -159.55 -154.96 0.43 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.282 -0.886 . . . . 0.0 110.131 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.676 HG23 ' HA ' ' A' ' 55' ' ' GLU . 19.7 m -159.99 110.89 1.92 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.111 -0.993 . . . . 0.0 110.591 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.65 ' CD2' ' CG1' ' A' ' 54' ' ' ILE . 3.3 m-30 -112.99 106.72 54.92 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.188 -0.945 . . . . 0.0 109.84 179.203 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.48 ' HG2' ' O ' ' A' ' 121' ' ' PRO . 46.4 Cg_endo -72.63 -159.02 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.785 1.413 . . . . 0.0 110.094 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -124.96 27.14 6.82 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.106 -0.996 . . . . 0.0 110.322 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.84 102.59 3.22 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.214 -0.928 . . . . 0.0 110.096 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.523 ' HA ' ' O ' ' A' ' 120' ' ' ASP . 47.2 Cg_endo -74.1 77.53 2.76 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.045 1.55 . . . . 0.0 110.588 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.95 ' HB3' ' HB2' ' A' ' 120' ' ' ASP . . . -96.59 -178.21 4.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.227 -0.921 . . . . 0.0 110.112 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -49.84 -58.89 4.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.239 -0.913 . . . . 0.0 110.223 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -101.18 26.82 6.67 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.275 -0.891 . . . . 0.0 110.354 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.95 ' HB2' ' HB3' ' A' ' 117' ' ' ALA . 28.6 m-20 -133.81 96.4 16.45 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.235 -0.916 . . . . 0.0 110.28 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.537 ' HB3' ' CA ' ' A' ' 82' ' ' GLY . 47.0 Cg_endo -73.85 164.25 35.08 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.011 1.532 . . . . 0.0 110.406 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.478 ' O ' ' HA ' ' A' ' 80' ' ' GLN . 1.4 pt-20 -112.78 -157.5 0.62 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.176 -0.953 . . . . 0.0 110.303 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.546 ' CA ' ' HB3' ' A' ' 112' ' ' TYR . . . -130.15 131.81 6.73 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.483 ' CB ' ' HA ' ' A' ' 50' ' ' ASN . 4.9 pt20 -150.43 -174.23 4.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.145 -1.209 . . . . 0.0 110.78 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.764 HG21 ' HH2' ' A' ' 16' ' ' TRP . 8.8 mt -118.74 143.87 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.912 ' HB3' HD11 ' A' ' 77' ' ' LEU . . . -115.15 119.65 37.11 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.286 -0.884 . . . . 0.0 111.275 -179.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.446 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 2.6 m-30 -117.34 94.08 4.42 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -89.25 105.08 17.55 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.084 -1.01 . . . . 0.0 111.524 -178.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.819 HD22 HG11 ' A' ' 74' ' ' VAL . 14.8 mt -100.13 50.09 0.91 Allowed 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.497 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -69.51 84.12 0.27 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.019 -1.233 . . . . 0.0 110.019 -179.199 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.966 ' HA3' ' HB2' ' A' ' 41' ' ' ALA . . . 39.02 72.47 0.2 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.743 ' HB2' HG12 ' A' ' 74' ' ' VAL . 10.5 m-85 -97.89 -39.64 8.89 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.136 -1.214 . . . . 0.0 110.124 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.742 ' HB2' HG23 ' A' ' 72' ' ' VAL . 1.2 t -89.69 -176.08 4.86 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.239 -0.913 . . . . 0.0 109.915 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.451 ' N ' ' OG ' ' A' ' 133' ' ' SER . . . -93.9 -99.48 0.14 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.033 -1.042 . . . . 0.0 110.982 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -61.17 177.51 0.34 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.993 -1.067 . . . . 0.0 110.853 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.503 ' N ' ' HA ' ' A' ' 38' ' ' ALA . . . -53.52 136.5 38.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.472 -0.767 . . . . 0.0 110.342 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 1.141 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 5.7 p90 -145.5 -170.16 3.38 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.372 -0.83 . . . . 0.0 110.157 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.537 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 0.5 OUTLIER -160.34 159.91 31.76 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.244 -0.983 . . . . 0.0 110.812 -178.789 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.675 ' CD2' HD11 ' A' ' 95' ' ' LEU . 2.2 mp -119.34 160.37 22.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.423 -0.798 . . . . 0.0 109.303 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' CYS . . . . . . . . . . . . . 13.6 m -150.53 100.55 2.87 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.128 -0.982 . . . . 0.0 110.598 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.688 HD23 ' HB2' ' A' ' 66' ' ' ALA . 0.9 OUTLIER -96.44 -176.75 3.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.3 -0.875 . . . . 0.0 109.446 179.321 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.573 ' O ' ' CB ' ' A' ' 143' ' ' ASP . 2.4 p30 166.72 61.52 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.324 -0.86 . . . . 0.0 110.042 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.573 ' CB ' ' O ' ' A' ' 142' ' ' ASP . 1.4 m-20 159.85 46.52 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.839 HG11 ' HZ2' ' A' ' 16' ' ' TRP . 3.5 t -89.64 112.04 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.329 -0.857 . . . . 0.0 110.466 -179.261 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -135.3 151.93 51.01 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.223 -0.923 . . . . 0.0 110.187 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.507 HD23 HG13 ' A' ' 52' ' ' VAL . 58.8 tp -151.61 124.67 8.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.335 -0.853 . . . . 0.0 110.194 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.469 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 3.5 t0 -161.07 156.43 24.53 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.278 -0.889 . . . . 0.0 110.326 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.514 ' OG ' ' N ' ' A' ' 149' ' ' GLU . 0.1 OUTLIER -99.48 -172.84 2.33 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.259 -0.901 . . . . 0.0 110.167 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.514 ' N ' ' OG ' ' A' ' 148' ' ' SER . 0.9 OUTLIER -121.46 111.34 17.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.188 -0.945 . . . . 0.0 110.32 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.457 ' HB ' ' O ' ' A' ' 149' ' ' GLU . 3.1 p 178.74 154.3 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.296 -0.878 . . . . 0.0 110.209 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -105.21 -147.5 0.39 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.272 -0.892 . . . . 0.0 110.182 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.2 tp . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.266 -179.971 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.222 0.534 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.4 t -169.88 81.74 0.62 Allowed Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.294 -0.879 . . . . 0.0 110.117 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -76.13 -156.46 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.072 1.564 . . . . 0.0 110.159 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.516 ' CD1' ' HB ' ' A' ' 144' ' ' VAL . 6.1 pt -89.9 -0.05 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.234 -0.916 . . . . 0.0 110.18 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 6' ' ' GLU . . . 119.69 -24.42 8.0 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.548 ' HG3' ' CB ' ' A' ' 145' ' ' ALA . 4.3 tt0 43.06 48.68 5.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.308 -1.113 . . . . 0.0 110.153 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 143' ' ' ASP . . . -134.81 159.17 23.83 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.444 ' HA ' ' HB2' ' A' ' 143' ' ' ASP . 1.2 p -51.29 -179.0 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.291 -1.123 . . . . 0.0 110.345 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.606 ' CD2' ' HA ' ' A' ' 142' ' ' ASP . 3.2 m-30 -110.78 24.83 12.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.292 -0.88 . . . . 0.0 110.283 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.565 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 29.6 t70 -110.74 50.91 0.79 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.172 -0.955 . . . . 0.0 110.209 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.565 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.3 OUTLIER 161.61 66.49 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.572 -0.705 . . . . 0.0 109.927 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.08 94.39 0.67 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.691 ' HG3' HG21 ' A' ' 27' ' ' THR . 51.1 Cg_endo -81.8 46.19 2.16 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.113 1.586 . . . . 0.0 110.63 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.477 ' HG3' ' N ' ' A' ' 15' ' ' GLY . 12.7 tp10 56.85 -90.97 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.155 -0.966 . . . . 0.0 110.187 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.725 ' C ' HD13 ' A' ' 49' ' ' LEU . . . -154.61 31.73 0.69 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.866 ' CE2' HD22 ' A' ' 49' ' ' LEU . 61.3 m95 -69.3 84.45 0.38 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.283 -1.127 . . . . 0.0 110.297 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.728 ' O ' HG13 ' A' ' 47' ' ' VAL . 1.3 m -89.64 148.05 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.149 -0.97 . . . . 0.0 109.804 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.534 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . . . -124.58 135.75 53.39 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.095 -1.003 . . . . 0.0 109.893 179.5 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.945 ' CE1' HG13 ' A' ' 48' ' ' VAL . 20.1 p90 -124.69 168.51 13.08 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.385 -0.822 . . . . 0.0 110.753 -178.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.602 ' O ' HG13 ' A' ' 45' ' ' VAL . . . 68.71 42.68 78.9 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.501 HG22 ' CG1' ' A' ' 45' ' ' VAL . 1.8 p -151.35 -147.55 0.23 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.088 -1.242 . . . . 0.0 110.245 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.419 ' O ' ' O ' ' A' ' 23' ' ' GLY . 1.1 t70 -108.86 117.31 33.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.308 -0.87 . . . . 0.0 110.165 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 22' ' ' ASP . . . 52.83 177.15 0.06 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.02 151.12 49.69 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.965 1.508 . . . . 0.0 110.447 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.701 HD23 ' H ' ' A' ' 25' ' ' LEU . 0.8 OUTLIER -49.02 161.86 0.13 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.333 -0.855 . . . . 0.0 110.228 179.945 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -121.34 132.29 54.69 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.241 -0.912 . . . . 0.0 110.046 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.691 HG21 ' HG3' ' A' ' 13' ' ' PRO . 0.7 OUTLIER -120.33 -24.93 5.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.216 -0.927 . . . . 0.0 110.61 -179.797 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 27' ' ' THR . 0.6 OUTLIER -43.93 -25.81 0.23 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.134 -0.978 . . . . 0.0 110.176 -179.828 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.592 HG23 ' N ' ' A' ' 30' ' ' GLY . 6.2 t -62.97 -47.51 82.83 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.271 -0.893 . . . . 0.0 110.686 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.592 ' N ' HG23 ' A' ' 29' ' ' THR . . . 161.03 -20.64 0.21 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.856 -1.297 . . . . 0.0 109.856 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.663 ' HB1' ' O ' ' A' ' 141' ' ' LEU . . . -150.12 -176.08 5.31 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.167 -1.196 . . . . 0.0 109.965 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.615 HD11 HD13 ' A' ' 25' ' ' LEU . 0.7 OUTLIER -87.51 94.9 9.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.108 -0.995 . . . . 0.0 109.949 179.801 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 89.4 m -110.54 106.68 16.05 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.149 -0.969 . . . . 0.0 110.748 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.537 HG12 ' HB3' ' A' ' 25' ' ' LEU . 22.4 m -89.72 138.79 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.292 -0.88 . . . . 0.0 109.178 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.475 ' O ' ' HB ' ' A' ' 21' ' ' THR . . . -89.0 93.15 9.5 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.141 -0.975 . . . . 0.0 111.337 -178.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.132 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 75.3 t -70.53 135.3 86.26 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.341 -0.849 . . . . 0.0 109.372 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.454 ' O ' ' OG ' ' A' ' 40' ' ' SER . 41.4 Cg_endo -68.56 172.28 11.7 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.727 1.383 . . . . 0.0 111.542 -178.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.504 ' HA ' ' N ' ' A' ' 136' ' ' ALA . . . -70.47 115.32 9.51 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.39 -0.819 . . . . 0.0 110.447 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.476 ' O ' ' N ' ' A' ' 41' ' ' ALA . . . 83.79 -40.63 2.9 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.753 ' HB3' HG21 ' A' ' 45' ' ' VAL . 1.5 m 38.3 30.48 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.542 -0.975 . . . . 0.0 110.146 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 39' ' ' GLY . . . -89.6 23.22 2.7 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.973 0.892 . . . . 0.0 110.08 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.589 ' O ' ' CG ' ' A' ' 43' ' ' TYR . 9.7 pm0 -108.67 126.9 53.49 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.589 ' CG ' ' O ' ' A' ' 42' ' ' GLN . 43.9 p90 39.45 27.88 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.515 -0.741 . . . . 0.0 109.927 -178.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 42' ' ' GLN . . . 51.17 173.84 0.02 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.753 HG21 ' HB3' ' A' ' 40' ' ' SER . 43.5 t -142.0 -179.07 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 179.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.578 ' H ' HG12 ' A' ' 45' ' ' VAL . . . 164.22 -163.39 36.0 Favored Glycine 0 N--CA 1.484 1.852 0 C-N-CA 117.345 -2.36 . . . . 0.0 112.734 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.728 HG13 ' O ' ' A' ' 17' ' ' VAL . 38.5 t -150.98 132.09 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.945 HG13 ' CE1' ' A' ' 19' ' ' TYR . 35.7 m -119.51 138.93 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.917 -1.115 . . . . 0.0 110.833 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.866 HD22 ' CE2' ' A' ' 16' ' ' TRP . 20.1 tp -133.69 97.68 3.99 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.373 -0.829 . . . . 0.0 110.236 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.51 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 8.6 p30 -81.11 113.61 19.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.218 -0.926 . . . . 0.0 110.239 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.413 ' O ' HG22 ' A' ' 4' ' ' ILE . . . 154.89 64.25 0.01 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.684 HG12 ' H ' ' A' ' 53' ' ' ALA . 3.2 t -119.95 -176.18 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.237 -1.155 . . . . 0.0 109.881 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.684 ' H ' HG12 ' A' ' 52' ' ' VAL . . . -142.49 75.14 1.48 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.074 -1.016 . . . . 0.0 110.634 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.638 ' CG2' ' HB1' ' A' ' 108' ' ' ALA . 32.5 mm -113.78 162.29 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.098 -1.001 . . . . 0.0 109.971 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.526 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 18.4 tt0 -162.25 132.31 4.68 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.176 -0.952 . . . . 0.0 110.605 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.526 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 15.2 pt-20 38.13 -160.25 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.67 -0.644 . . . . 0.0 110.916 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' A' ' 109' ' ' SER . . . -80.63 74.88 2.32 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.679 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.3 m -104.17 168.2 9.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.351 -1.087 . . . . 0.0 109.868 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.571 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 3.1 m -89.99 157.98 17.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.177 -0.952 . . . . 0.0 110.264 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.78 ' HB3' HD11 ' A' ' 146' ' ' LEU . 66.5 m-85 -158.95 173.79 15.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.225 -0.922 . . . . 0.0 110.37 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.839 ' OG1' HG22 ' A' ' 105' ' ' THR . 22.1 m -150.16 113.98 5.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.355 -0.841 . . . . 0.0 110.034 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.468 HD12 ' N ' ' A' ' 63' ' ' ARG . 10.3 tp -89.66 121.96 32.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.16 -0.963 . . . . 0.0 110.077 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.485 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 9.5 ttt-85 -127.63 107.16 9.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 110.489 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.603 ' OH ' HG21 ' A' ' 102' ' ' VAL . 7.8 p90 -143.34 172.33 12.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.333 -0.854 . . . . 0.0 109.915 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 5.0 m -131.27 94.91 3.66 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.171 -0.956 . . . . 0.0 110.226 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.689 ' CB ' HD21 ' A' ' 95' ' ' LEU . . . -99.6 142.1 31.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -0.898 . . . . 0.0 110.398 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.782 HG23 ' O ' ' A' ' 98' ' ' GLU . 93.3 m -150.37 101.86 3.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.403 -0.811 . . . . 0.0 110.048 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -89.81 144.07 26.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.192 -0.942 . . . . 0.0 110.105 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.4 m -60.59 -15.01 23.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.147 -0.971 . . . . 0.0 109.225 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.555 ' CG2' ' HB2' ' A' ' 137' ' ' TRP . 3.0 t -121.71 160.18 25.05 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.592 -0.693 . . . . 0.0 109.809 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -77.94 79.7 4.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.044 -1.035 . . . . 0.0 108.927 178.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.738 HG23 ' HB2' ' A' ' 133' ' ' SER . 3.7 p -99.56 135.31 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.199 -0.938 . . . . 0.0 111.654 -178.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 23.3 m -121.61 86.86 2.65 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.962 HG21 ' CD2' ' A' ' 129' ' ' LEU . 10.8 m -89.84 -149.71 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.283 -0.886 . . . . 0.0 111.172 -178.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.474 ' N ' HG23 ' A' ' 74' ' ' VAL . 0.4 OUTLIER -130.68 106.38 8.44 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.534 -0.729 . . . . 0.0 110.524 -179.583 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.48 ' O ' ' HB3' ' A' ' 77' ' ' LEU . . . -110.39 158.22 18.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.378 -0.827 . . . . 0.0 109.586 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.595 HD12 ' N ' ' A' ' 78' ' ' VAL . 3.7 pp 177.79 -158.04 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.279 -0.888 . . . . 0.0 110.376 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.85 ' CG2' HD22 ' A' ' 89' ' ' LEU . 4.3 t -147.19 171.6 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.39 -0.819 . . . . 0.0 109.488 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.489 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . 175.36 -171.66 44.76 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.353 -1.403 . . . . 0.0 110.242 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.426 ' O ' ' CG ' ' A' ' 81' ' ' ASN . 2.5 tt0 -94.08 -169.63 2.12 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.429 -1.042 . . . . 0.0 110.171 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.487 ' O ' ' HB2' ' A' ' 121' ' ' PRO . 23.2 m120 -157.21 75.2 0.8 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.308 -0.87 . . . . 0.0 109.831 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.532 ' HA3' ' CB ' ' A' ' 121' ' ' PRO . . . 144.5 38.57 0.06 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.513 ' HB3' ' O ' ' A' ' 82' ' ' GLY . . . 58.96 150.91 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.232 -1.158 . . . . 0.0 110.305 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.461 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 52.1 Cg_endo -80.49 21.99 8.32 Favored 'Cis proline' 0 C--N 1.312 -1.343 0 C-N-CA 121.696 -2.21 . . . . 0.0 111.113 0.094 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.464 ' N ' ' HA ' ' A' ' 83' ' ' ALA . 43.5 m-85 60.49 123.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.01 -1.056 . . . . 0.0 110.317 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -154.86 110.77 0.46 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.8 p -89.89 142.53 27.61 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.208 -1.172 . . . . 0.0 110.333 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 1.081 HG23 HD12 ' A' ' 89' ' ' LEU . 28.8 m -119.97 -20.11 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.345 -0.847 . . . . 0.0 109.973 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 1.081 HD12 HG23 ' A' ' 88' ' ' VAL . 4.7 mp -111.97 142.18 44.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.855 . . . . 0.0 110.652 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.634 ' O ' HG23 ' A' ' 91' ' ' THR . 1.7 p30 -151.18 87.84 1.42 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.252 -0.905 . . . . 0.0 110.159 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.634 HG23 ' O ' ' A' ' 90' ' ' ASP . 1.7 p -156.74 178.66 10.09 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.933 -1.104 . . . . 0.0 110.797 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 81.5 p -119.79 127.81 26.2 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.377 -0.827 . . . . 0.0 109.886 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.805 ' HG2' HG22 ' A' ' 74' ' ' VAL . 48.9 Cg_endo -75.08 75.08 3.84 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.887 1.467 . . . . 0.0 111.192 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.521 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -52.45 124.83 14.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.922 -1.111 . . . . 0.0 109.094 179.11 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.689 HD21 ' CB ' ' A' ' 66' ' ' ALA . 38.2 mt -119.91 175.51 5.87 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.992 -1.068 . . . . 0.0 111.0 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -168.78 -178.54 3.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.521 -0.737 . . . . 0.0 109.806 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.2 p -70.26 -7.38 41.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.221 -0.924 . . . . 0.0 110.293 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.782 ' O ' HG23 ' A' ' 67' ' ' THR . 1.1 mt-10 -102.35 172.34 4.44 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.212 -0.93 . . . . 0.0 110.094 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.5 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 44.8 Cg_endo -72.5 129.0 14.16 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.014 1.534 . . . . 0.0 110.304 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.521 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.79 92.03 3.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.205 -0.934 . . . . 0.0 110.333 -179.81 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.432 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 0.0 OUTLIER -88.61 106.14 18.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.254 -0.904 . . . . 0.0 110.081 179.842 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.603 HG21 ' OH ' ' A' ' 64' ' ' TYR . 37.5 t -89.98 133.82 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.231 -0.918 . . . . 0.0 110.316 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.465 ' C ' ' CG ' ' A' ' 104' ' ' GLU . 8.3 m -150.24 112.03 4.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.286 -0.884 . . . . 0.0 110.042 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.465 ' CG ' ' C ' ' A' ' 103' ' ' THR . 32.0 mt-10 -150.7 156.13 40.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.184 -0.947 . . . . 0.0 110.354 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.839 HG22 ' OG1' ' A' ' 61' ' ' THR . 0.8 OUTLIER -106.33 134.78 48.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.331 -0.856 . . . . 0.0 110.095 179.863 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.6 ' CE1' HD11 ' A' ' 89' ' ' LEU . 55.4 p90 -136.65 157.63 46.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.215 -0.928 . . . . 0.0 110.305 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 86.4 m -89.98 91.36 8.54 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.278 -0.889 . . . . 0.0 110.041 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.68 ' HB3' ' CE2' ' A' ' 60' ' ' TYR . . . -57.36 117.08 3.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.253 -0.904 . . . . 0.0 110.381 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.45 ' HA ' ' HA2' ' A' ' 57' ' ' GLY . 11.0 p -100.21 54.93 0.9 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.227 -0.921 . . . . 0.0 110.099 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -166.38 -162.42 0.52 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.215 -0.928 . . . . 0.0 110.417 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.497 HG22 ' HD3' ' A' ' 113' ' ' PRO . 61.9 m -143.39 115.27 8.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.237 -0.914 . . . . 0.0 110.297 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.633 ' OH ' HG13 ' A' ' 88' ' ' VAL . 11.8 m-30 -114.84 80.97 6.97 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.266 -0.896 . . . . 0.0 110.08 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.497 ' HD3' HG22 ' A' ' 111' ' ' THR . 45.7 Cg_endo -73.04 -162.37 0.13 Allowed 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 124.015 1.534 . . . . 0.0 110.446 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.476 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -142.69 25.0 1.85 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.275 -0.891 . . . . 0.0 110.29 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.448 ' O ' ' O ' ' A' ' 120' ' ' ASP . 1.3 m -108.92 83.13 2.03 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.197 -0.939 . . . . 0.0 110.172 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 46.3 Cg_endo -73.2 78.88 2.17 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.994 1.523 . . . . 0.0 110.506 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.821 ' HB3' ' HB2' ' A' ' 120' ' ' ASP . . . -101.37 -167.92 1.49 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.253 -0.904 . . . . 0.0 110.179 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.7 -53.2 58.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.235 -0.916 . . . . 0.0 110.218 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.49 41.13 2.38 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.268 -0.895 . . . . 0.0 110.253 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.821 ' HB2' ' HB3' ' A' ' 117' ' ' ALA . 52.3 m-20 -148.98 86.75 5.59 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.223 -0.923 . . . . 0.0 110.229 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.532 ' CB ' ' HA3' ' A' ' 82' ' ' GLY . 45.8 Cg_endo -73.04 -158.96 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.966 1.509 . . . . 0.0 110.44 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.485 ' HA ' ' HD2' ' A' ' 113' ' ' PRO . 3.7 pm0 -160.68 -170.0 2.61 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.149 -0.97 . . . . 0.0 110.465 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.564 ' HA3' ' CD1' ' A' ' 112' ' ' TYR . . . -123.62 159.08 18.28 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.336 -1.505 . . . . 0.0 109.336 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.562 ' HA ' ' CG2' ' A' ' 52' ' ' VAL . 19.6 pt20 -150.34 -159.07 0.98 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.161 -1.199 . . . . 0.0 110.687 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.748 HG21 ' HH2' ' A' ' 16' ' ' TRP . 9.8 mt -118.95 147.08 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.529 -0.732 . . . . 0.0 109.388 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.507 ' HB3' ' CD1' ' A' ' 77' ' ' LEU . . . -120.35 118.85 31.46 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.322 -0.861 . . . . 0.0 111.314 -179.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.548 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 4.6 m-85 -119.57 73.35 0.95 Allowed 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.547 ' HA ' ' HA3' ' A' ' 46' ' ' GLY . 34.1 mt-30 -87.9 106.01 17.82 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 122.52 1.152 . . . . 0.0 112.104 -177.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.962 ' CD2' HG21 ' A' ' 74' ' ' VAL . 10.3 mt -93.47 -111.22 0.11 Allowed 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.62 ' HA3' ' N ' ' A' ' 45' ' ' VAL . . . 50.75 111.81 0.01 OUTLIER Glycine 0 N--CA 1.493 2.442 0 O-C-N 120.743 -1.223 . . . . 0.0 111.138 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 40' ' ' SER . . . 72.91 66.88 1.94 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.588 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 5.0 m-85 -148.03 -52.01 0.18 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.234 -1.157 . . . . 0.0 110.182 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.738 ' HB2' HG23 ' A' ' 72' ' ' VAL . 1.6 t -89.36 -151.78 0.23 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.086 -1.009 . . . . 0.0 110.15 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -112.09 -88.82 0.52 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.147 -0.97 . . . . 0.0 110.321 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.407 ' O ' ' C ' ' A' ' 136' ' ' ALA . 6.1 m-20 -84.07 172.65 11.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.222 -0.924 . . . . 0.0 110.273 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.504 ' N ' ' HA ' ' A' ' 38' ' ' ALA . . . -42.35 130.33 3.81 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.297 -0.877 . . . . 0.0 110.293 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 1.132 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 9.7 p90 -142.97 -165.21 2.01 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.325 -0.859 . . . . 0.0 109.648 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.526 ' O ' ' CB ' ' A' ' 68' ' ' ALA . 0.5 OUTLIER -160.04 172.72 17.0 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.834 -1.166 . . . . 0.0 111.231 -178.284 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.609 HD13 HD13 ' A' ' 129' ' ' LEU . 2.2 mp -134.35 126.58 29.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.582 -0.699 . . . . 0.0 109.326 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' CYS . . . . . . . . . . . . . 7.2 m -114.07 96.09 5.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.154 -0.966 . . . . 0.0 110.807 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.663 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 2.1 mt -89.75 -166.65 1.64 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.357 -0.839 . . . . 0.0 109.357 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.606 ' HA ' ' CD2' ' A' ' 9' ' ' PHE . 22.0 p-10 -167.93 -151.31 0.11 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.964 -1.085 . . . . 0.0 110.626 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.476 ' C ' ' CG2' ' A' ' 144' ' ' VAL . 6.5 t0 -38.82 150.89 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.641 -0.662 . . . . 0.0 110.662 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 142' ' ' ASP . 3.0 t -150.15 132.47 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.357 -0.839 . . . . 0.0 109.955 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.548 ' CB ' ' HG3' ' A' ' 6' ' ' GLU . . . -127.91 146.35 50.66 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.187 -0.946 . . . . 0.0 110.413 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.78 HD11 ' HB3' ' A' ' 60' ' ' TYR . 22.8 tp -153.81 90.72 1.4 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.323 -0.861 . . . . 0.0 110.085 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.462 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 0.4 OUTLIER -107.07 -167.02 1.22 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.249 -0.907 . . . . 0.0 110.258 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.43 ' HB3' ' CE1' ' A' ' 60' ' ' TYR . 1.2 p -138.77 105.9 5.47 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.207 -0.933 . . . . 0.0 110.25 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -114.61 155.74 25.97 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.262 -0.899 . . . . 0.0 110.226 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.673 HG22 ' O ' ' A' ' 150' ' ' VAL . 7.9 p -106.46 48.36 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.243 -0.91 . . . . 0.0 110.222 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -60.33 167.53 2.45 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.257 -0.902 . . . . 0.0 110.119 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.4 mp . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.227 179.983 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.218 0.532 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.4 m -129.66 153.65 80.8 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.226 -0.922 . . . . 0.0 110.239 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -75.88 -156.06 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.005 1.529 . . . . 0.0 110.085 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.631 HG22 ' O ' ' A' ' 51' ' ' GLY . 20.7 pt -89.96 43.63 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.19 -0.944 . . . . 0.0 110.113 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 6' ' ' GLU . . . 56.83 61.28 7.68 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 5' ' ' GLY . 1.7 mp0 57.16 -88.62 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.292 -1.122 . . . . 0.0 110.193 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 8' ' ' THR . . . 159.22 -115.34 0.65 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 7' ' ' GLY . 4.1 p 45.46 97.49 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.39 -1.065 . . . . 0.0 110.165 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.603 ' CD2' ' HB2' ' A' ' 32' ' ' LEU . 78.2 m-85 -77.62 7.62 5.41 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.479 -0.763 . . . . 0.0 109.7 179.332 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.551 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 34.4 t0 -84.15 45.06 1.06 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.419 -0.801 . . . . 0.0 110.122 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.551 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.3 OUTLIER 161.6 36.83 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.572 -0.705 . . . . 0.0 109.879 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 118.29 112.01 2.52 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.906 ' HG3' HG21 ' A' ' 27' ' ' THR . 51.0 Cg_endo -77.07 8.91 2.97 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 O-C-N 123.834 1.439 . . . . 0.0 110.93 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.509 ' HB3' ' O ' ' A' ' 13' ' ' PRO . 30.1 tp10 61.34 -89.47 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.237 -0.914 . . . . 0.0 110.464 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -149.02 19.15 1.22 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.97 ' CE2' HD22 ' A' ' 49' ' ' LEU . 23.5 m95 -62.53 125.31 23.48 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.211 -1.17 . . . . 0.0 110.324 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.855 ' O ' HG13 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -115.44 161.93 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.234 -0.916 . . . . 0.0 109.234 179.635 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.474 ' HB1' HG11 ' A' ' 34' ' ' VAL . . . -146.9 152.24 38.35 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.323 -0.861 . . . . 0.0 110.209 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.638 ' HE2' HG13 ' A' ' 48' ' ' VAL . 11.8 p90 -138.61 114.02 9.62 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.296 -0.877 . . . . 0.0 110.274 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.854 ' HA3' HG13 ' A' ' 45' ' ' VAL . . . -173.0 49.97 0.16 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.445 ' OG1' ' HG3' ' A' ' 37' ' ' PRO . 8.2 p 50.9 19.22 0.61 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.366 -1.079 . . . . 0.0 110.479 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.634 ' CB ' ' HB3' ' A' ' 35' ' ' ALA . 1.8 p30 -102.59 38.01 1.8 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.133 -0.98 . . . . 0.0 110.197 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 44.46 -153.27 0.47 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.457 ' O ' ' O ' ' A' ' 25' ' ' LEU . 46.3 Cg_endo -73.54 125.92 10.48 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.933 1.491 . . . . 0.0 110.361 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.708 HD23 ' H ' ' A' ' 25' ' ' LEU . 0.8 OUTLIER -42.87 166.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.227 -0.921 . . . . 0.0 110.11 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.486 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 0.5 OUTLIER -125.83 149.92 48.25 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.163 -0.96 . . . . 0.0 110.275 -179.815 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.906 HG21 ' HG3' ' A' ' 13' ' ' PRO . 0.7 OUTLIER -129.78 -43.78 1.22 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.249 -0.907 . . . . 0.0 110.251 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.451 ' HB3' ' O ' ' A' ' 27' ' ' THR . 4.5 t 56.35 36.28 27.26 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.31 -0.869 . . . . 0.0 110.303 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.451 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 33.2 p 42.53 33.21 0.42 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.299 -0.876 . . . . 0.0 110.3 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.516 ' CA ' ' HA ' ' A' ' 10' ' ' ASP . . . -140.51 -63.58 0.03 OUTLIER Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.432 ' HB1' ' O ' ' A' ' 141' ' ' LEU . . . -150.11 148.78 29.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.308 -1.113 . . . . 0.0 110.101 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.701 HD12 ' HB3' ' A' ' 13' ' ' PRO . 1.8 tt -88.36 115.46 25.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.116 -0.99 . . . . 0.0 109.861 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 72.8 m -121.56 137.74 54.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.193 -0.942 . . . . 0.0 110.765 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.496 ' CG2' ' HB2' ' A' ' 139' ' ' LEU . 2.7 m -110.98 143.47 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.408 -0.807 . . . . 0.0 109.215 179.102 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.634 ' HB3' ' CB ' ' A' ' 22' ' ' ASP . . . -89.43 90.04 8.13 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.167 -0.958 . . . . 0.0 111.46 -178.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.154 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 87.2 t -72.52 119.14 73.39 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.043 -1.036 . . . . 0.0 109.182 178.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.445 ' HG3' ' OG1' ' A' ' 21' ' ' THR . 42.7 Cg_endo -68.12 151.1 77.51 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.951 1.501 . . . . 0.0 111.415 -178.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.577 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -43.11 144.24 0.67 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.498 -0.751 . . . . 0.0 110.042 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 38' ' ' ALA . . . 44.46 77.73 0.09 OUTLIER Glycine 0 N--CA 1.488 2.133 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.856 ' HB2' HG21 ' A' ' 45' ' ' VAL . 0.3 OUTLIER -87.33 25.98 1.3 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.223 -1.163 . . . . 0.0 110.386 -179.703 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.559 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . . . -92.85 19.89 7.17 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 122.048 0.928 . . . . 0.0 109.606 179.374 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.569 ' HG3' ' CD2' ' A' ' 43' ' ' TYR . 25.7 pt20 -89.87 -131.34 0.09 Allowed 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.417 179.373 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.638 ' CD1' ' N ' ' A' ' 44' ' ' GLY . 12.4 p90 -37.51 -28.94 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.589 -0.695 . . . . 0.0 110.218 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.638 ' N ' ' CD1' ' A' ' 43' ' ' TYR . . . 105.45 111.3 3.59 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 179.025 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.856 HG21 ' HB2' ' A' ' 40' ' ' SER . 2.1 t -89.91 171.18 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.176 -1.19 . . . . 0.0 108.541 178.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.574 ' O ' ' CE2' ' A' ' 19' ' ' TYR . . . 160.72 155.61 7.87 Favored Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.029 -1.557 . . . . 0.0 110.478 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.855 HG13 ' O ' ' A' ' 17' ' ' VAL . 48.6 t -120.5 133.48 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.473 -1.016 . . . . 0.0 109.656 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.638 HG13 ' HE2' ' A' ' 19' ' ' TYR . 30.4 m -120.02 153.46 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.079 -1.013 . . . . 0.0 110.523 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.97 HD22 ' CE2' ' A' ' 16' ' ' TRP . 13.5 tp -140.51 87.64 2.14 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.304 -0.872 . . . . 0.0 110.197 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.509 ' HA ' ' HB3' ' A' ' 124' ' ' GLN . 23.6 m-20 -68.1 104.13 1.7 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.291 -0.881 . . . . 0.0 110.241 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.631 ' O ' HG22 ' A' ' 4' ' ' ILE . . . 154.39 74.22 0.01 OUTLIER Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.735 HG23 ' HA ' ' A' ' 124' ' ' GLN . 24.7 t -120.74 172.44 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.277 -1.131 . . . . 0.0 109.939 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.578 ' N ' HG12 ' A' ' 52' ' ' VAL . . . -134.27 77.57 1.71 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.09 -1.006 . . . . 0.0 110.941 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 1.028 HD11 HD21 ' A' ' 146' ' ' LEU . 24.9 mm -118.82 165.2 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.191 -0.943 . . . . 0.0 109.599 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.52 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 0.3 OUTLIER -158.88 126.79 5.07 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.989 -1.07 . . . . 0.0 110.888 -179.722 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.52 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 17.2 pt-20 37.29 -154.98 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.65 -0.656 . . . . 0.0 110.99 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.467 ' HA2' ' O ' ' A' ' 108' ' ' ALA . . . -81.4 81.67 1.62 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.626 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.2 m -112.44 172.34 6.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.209 -1.171 . . . . 0.0 109.943 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.57 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 0.4 OUTLIER -89.98 154.3 19.94 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.316 -0.865 . . . . 0.0 110.213 -179.894 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.626 ' CE2' HG22 ' A' ' 58' ' ' THR . 59.9 m-85 -159.69 173.47 16.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.293 -0.879 . . . . 0.0 110.238 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 27.4 m -150.11 114.52 5.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.282 -0.886 . . . . 0.0 110.081 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 14.1 tp -89.62 120.83 31.25 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.211 -0.931 . . . . 0.0 109.902 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.498 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 6.5 ttt180 -131.49 128.5 39.5 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.228 -0.92 . . . . 0.0 110.405 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.962 ' HB2' HG22 ' A' ' 144' ' ' VAL . 6.9 p90 -165.09 156.02 14.32 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.409 -0.807 . . . . 0.0 109.964 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.48 ' HB ' ' OD1' ' A' ' 142' ' ' ASP . 32.2 m -119.76 99.79 6.85 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.17 -0.956 . . . . 0.0 109.919 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.515 ' HB2' HD23 ' A' ' 141' ' ' LEU . . . -100.79 154.51 18.57 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.264 -0.897 . . . . 0.0 110.473 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.647 HG23 ' O ' ' A' ' 98' ' ' GLU . 90.6 m -150.34 136.84 18.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.362 -0.836 . . . . 0.0 110.145 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.536 ' N ' ' HB3' ' A' ' 95' ' ' LEU . . . -129.39 127.33 40.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.234 -0.916 . . . . 0.0 109.993 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 68' ' ' ALA . 0.6 OUTLIER -43.13 -26.84 0.18 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.246 -0.909 . . . . 0.0 109.66 179.809 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.583 ' CG2' ' CB ' ' A' ' 137' ' ' TRP . 3.5 t -110.5 164.08 13.06 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.482 -0.761 . . . . 0.0 109.928 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -82.79 72.04 9.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.168 -0.958 . . . . 0.0 109.038 178.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.778 HG23 ' CB ' ' A' ' 133' ' ' SER . 4.0 p -93.54 136.38 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.326 -0.859 . . . . 0.0 111.384 -178.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.541 ' O ' ' CD1' ' A' ' 132' ' ' PHE . 13.5 m -119.98 87.85 2.82 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.701 HG11 HD22 ' A' ' 129' ' ' LEU . 11.5 m -89.5 -153.18 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.249 -0.907 . . . . 0.0 110.761 -178.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.528 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 0.3 OUTLIER -127.99 135.29 49.72 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.369 -0.832 . . . . 0.0 110.476 -179.207 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.685 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -136.83 154.89 50.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.299 -0.875 . . . . 0.0 109.979 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.892 HD12 ' N ' ' A' ' 78' ' ' VAL . 4.0 pp 179.2 -149.22 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.363 -0.836 . . . . 0.0 110.099 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.892 ' N ' HD12 ' A' ' 77' ' ' LEU . 4.7 t -147.86 177.67 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.28 -0.887 . . . . 0.0 109.365 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.533 ' C ' ' CZ ' ' A' ' 112' ' ' TYR . . . -177.69 -176.55 45.81 Favored Glycine 0 N--CA 1.489 2.186 0 C-N-CA 119.22 -1.466 . . . . 0.0 110.16 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' A' ' 122' ' ' GLU . 5.0 tt0 -98.0 -151.93 0.39 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.404 -1.056 . . . . 0.0 110.193 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.533 ' O ' ' CB ' ' A' ' 121' ' ' PRO . 10.0 m120 -161.15 61.6 0.28 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.411 -0.806 . . . . 0.0 109.681 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.51 ' HA3' ' HB3' ' A' ' 121' ' ' PRO . . . 159.97 128.4 0.97 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.196 -1.561 . . . . 0.0 109.196 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.628 ' N ' ' CE1' ' A' ' 85' ' ' TYR . . . -41.73 151.34 0.32 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.319 -1.106 . . . . 0.0 110.377 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.488 ' C ' ' CD2' ' A' ' 85' ' ' TYR . 50.9 Cg_endo -79.14 10.04 22.91 Favored 'Cis proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.632 -2.237 . . . . 0.0 110.775 -0.081 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.628 ' CE1' ' N ' ' A' ' 83' ' ' ALA . 12.5 m-85 68.0 156.53 0.12 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.241 -0.912 . . . . 0.0 110.169 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -171.6 125.84 1.23 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.98 152.44 19.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.242 -1.152 . . . . 0.0 110.209 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.678 HG23 HD12 ' A' ' 89' ' ' LEU . 16.0 m -123.23 -24.94 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.287 -0.883 . . . . 0.0 110.2 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.864 HD22 HG23 ' A' ' 78' ' ' VAL . 4.2 mp -108.96 144.79 36.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.232 -0.917 . . . . 0.0 110.911 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.424 ' O ' ' CG ' ' A' ' 90' ' ' ASP . 40.2 p-10 -151.45 80.91 1.3 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.352 -0.843 . . . . 0.0 110.063 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.403 HG23 ' C ' ' A' ' 90' ' ' ASP . 44.3 p -144.01 171.74 13.84 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.959 -1.088 . . . . 0.0 110.742 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.405 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 0.7 OUTLIER -119.96 115.02 33.51 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.385 -0.822 . . . . 0.0 110.021 179.879 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.685 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 43.7 Cg_endo -70.16 155.19 65.19 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.951 1.501 . . . . 0.0 110.998 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.777 ' O ' HD23 ' A' ' 95' ' ' LEU . . . -129.92 145.39 51.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.407 -0.808 . . . . 0.0 109.573 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.777 HD23 ' O ' ' A' ' 94' ' ' ALA . 39.6 mt -134.19 173.0 12.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.07 -1.019 . . . . 0.0 110.673 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.546 HG23 ' N ' ' A' ' 97' ' ' SER . 6.0 t -171.85 -154.87 0.09 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.401 -0.812 . . . . 0.0 109.918 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.546 ' N ' HG23 ' A' ' 96' ' ' THR . 0.3 OUTLIER -90.44 28.41 1.48 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.206 -0.934 . . . . 0.0 110.143 179.893 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.647 ' O ' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -149.95 173.81 3.99 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.315 -0.866 . . . . 0.0 109.968 179.873 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.56 130.62 16.25 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.953 1.501 . . . . 0.0 110.364 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.519 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.61 87.43 2.74 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.226 -0.921 . . . . 0.0 110.042 -179.98 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.444 ' HG2' ' OG1' ' A' ' 65' ' ' THR . 0.9 OUTLIER -68.31 151.68 46.55 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.359 -0.838 . . . . 0.0 110.245 -179.903 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.925 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 65.1 t -131.49 136.31 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.228 -0.92 . . . . 0.0 110.009 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.463 ' O ' ' HG3' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -150.13 104.04 3.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.271 -0.893 . . . . 0.0 110.173 -179.937 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.463 ' HG3' ' O ' ' A' ' 103' ' ' THR . 6.7 mt-10 -145.53 132.9 20.64 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.286 -0.884 . . . . 0.0 110.166 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.441 ' O ' ' HB3' ' A' ' 106' ' ' PHE . 0.2 OUTLIER -89.92 169.82 10.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.287 -0.883 . . . . 0.0 110.12 179.918 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.649 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 42.1 p90 -177.38 150.49 0.71 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -0.923 . . . . 0.0 110.288 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.5 m -91.47 92.39 8.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.234 -0.917 . . . . 0.0 110.061 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.611 ' HB3' ' CE2' ' A' ' 60' ' ' TYR . . . -50.86 113.83 1.01 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.887 . . . . 0.0 110.227 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.59 ' H ' HG12 ' A' ' 88' ' ' VAL . 17.1 p -96.52 51.4 1.17 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.213 -0.93 . . . . 0.0 110.191 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.402 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -162.99 -166.57 1.31 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.218 -0.926 . . . . 0.0 110.18 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.606 HG22 ' HD3' ' A' ' 113' ' ' PRO . 11.2 m -134.39 112.27 10.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.218 -0.926 . . . . 0.0 110.307 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.533 ' CZ ' ' C ' ' A' ' 79' ' ' GLY . 17.9 m-30 -113.02 71.42 1.34 Allowed Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.339 -0.85 . . . . 0.0 110.001 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.606 ' HD3' HG22 ' A' ' 111' ' ' THR . 44.0 Cg_endo -72.13 -167.6 0.33 Allowed 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.932 1.49 . . . . 0.0 110.374 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -135.51 63.69 1.6 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.202 -0.936 . . . . 0.0 110.279 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 120' ' ' ASP . 0.8 OUTLIER -150.08 85.57 5.47 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.29 -0.881 . . . . 0.0 110.159 179.91 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.63 80.74 1.67 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.039 1.547 . . . . 0.0 110.518 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.68 ' HB3' ' HB2' ' A' ' 120' ' ' ASP . . . -118.27 46.62 1.76 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.273 -0.892 . . . . 0.0 110.163 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 117' ' ' ALA . . . 58.31 -88.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.232 -0.918 . . . . 0.0 110.247 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.417 ' N ' ' O ' ' A' ' 117' ' ' ALA . 33.2 t70 -57.62 -18.47 20.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.22 -0.925 . . . . 0.0 110.194 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.68 ' HB2' ' HB3' ' A' ' 117' ' ' ALA . 4.2 m-20 -116.13 93.21 38.13 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.252 -0.905 . . . . 0.0 110.203 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.533 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 47.3 Cg_endo -74.05 -167.5 0.39 Allowed 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 123.958 1.504 . . . . 0.0 110.449 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.494 ' HA ' ' HD2' ' A' ' 113' ' ' PRO . 5.4 pt-20 -153.45 -150.63 0.34 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.201 -0.937 . . . . 0.0 110.484 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.531 ' HA3' ' CB ' ' A' ' 112' ' ' TYR . . . -148.21 156.1 26.74 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.351 -1.499 . . . . 0.0 109.351 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.735 ' HA ' HG23 ' A' ' 52' ' ' VAL . 1.0 OUTLIER -150.52 -158.68 0.94 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.171 -1.193 . . . . 0.0 110.72 -179.644 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.692 HG21 ' HH2' ' A' ' 16' ' ' TRP . 11.4 mt -118.24 150.37 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.473 -0.767 . . . . 0.0 109.132 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -127.89 122.63 33.0 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.292 -0.88 . . . . 0.0 111.033 -179.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.472 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 4.9 m-85 -118.73 101.77 8.34 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.501 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.454 ' C ' HD23 ' A' ' 129' ' ' LEU . 8.8 mm-40 -88.97 101.51 14.15 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.252 -0.905 . . . . 0.0 111.956 -177.596 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.701 HD22 HG11 ' A' ' 74' ' ' VAL . 8.8 mt -104.6 42.65 1.18 Allowed 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 178.088 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -97.45 87.3 0.87 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.575 ' O ' ' CG ' ' A' ' 132' ' ' PHE . . . 84.53 107.95 0.61 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.586 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 7.0 m-85 -167.31 -62.19 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.331 -1.099 . . . . 0.0 110.102 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.778 ' CB ' HG23 ' A' ' 72' ' ' VAL . 1.3 t -89.52 -178.84 5.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.076 -1.015 . . . . 0.0 109.912 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.426 ' N ' ' OG ' ' A' ' 133' ' ' SER . . . -100.62 -95.31 0.27 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.127 -0.983 . . . . 0.0 110.7 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -55.68 153.74 7.69 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.094 -1.004 . . . . 0.0 110.574 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.577 ' HB2' ' HB2' ' A' ' 38' ' ' ALA . . . -47.7 121.94 4.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.372 -0.83 . . . . 0.0 110.167 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 1.154 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 22.2 p90 -125.7 -157.58 0.8 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.287 -0.883 . . . . 0.0 110.044 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.543 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 0.5 OUTLIER -160.33 169.53 22.95 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.104 -0.997 . . . . 0.0 110.62 -178.844 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.6 HD13 HD13 ' A' ' 129' ' ' LEU . 2.4 mp -121.8 159.5 26.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.334 -0.854 . . . . 0.0 109.322 179.367 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' CYS . . . . . . . . . . . . . 2.0 m -150.61 92.22 1.82 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.041 -1.037 . . . . 0.0 110.931 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.515 HD23 ' HB2' ' A' ' 66' ' ' ALA . 1.2 mt -90.01 -178.36 5.43 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.227 -0.92 . . . . 0.0 109.316 179.068 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.52 ' O ' ' CB ' ' A' ' 143' ' ' ASP . 2.0 p30 167.19 47.88 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.276 -0.89 . . . . 0.0 110.423 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.52 ' CB ' ' O ' ' A' ' 142' ' ' ASP . 0.4 OUTLIER 166.64 40.41 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.26 -0.9 . . . . 0.0 109.84 179.961 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.962 HG22 ' HB2' ' A' ' 64' ' ' TYR . 25.9 t -89.26 111.55 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.302 -0.874 . . . . 0.0 110.259 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.414 ' HA ' ' O ' ' A' ' 6' ' ' GLU . . . -137.33 165.47 26.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.337 -0.852 . . . . 0.0 110.237 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 1.028 HD21 HD11 ' A' ' 54' ' ' ILE . 10.5 tp -151.8 139.58 19.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.249 -0.907 . . . . 0.0 110.181 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.489 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -155.06 152.89 30.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.188 -0.945 . . . . 0.0 110.268 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.489 ' HB3' ' CE1' ' A' ' 60' ' ' TYR . 3.0 p -101.65 119.94 39.55 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.291 -0.881 . . . . 0.0 110.191 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -102.96 -164.42 1.08 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.269 -0.894 . . . . 0.0 110.208 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.417 HG13 ' O ' ' A' ' 150' ' ' VAL . 9.9 p -120.44 136.33 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.243 -0.91 . . . . 0.0 110.2 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -147.51 137.58 23.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.249 -0.907 . . . . 0.0 110.232 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.162 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.224 0.535 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.577 ' HB2' HD23 ' A' ' 146' ' ' LEU . 0.2 OUTLIER 47.27 75.67 0.64 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.286 -0.883 . . . . 0.0 110.176 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.87 77.86 2.61 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.041 1.548 . . . . 0.0 110.579 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.418 ' O ' HG13 ' A' ' 4' ' ' ILE . 11.4 pt -113.46 32.33 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.223 -0.923 . . . . 0.0 110.096 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.526 ' O ' ' CG ' ' A' ' 6' ' ' GLU . . . 95.44 -31.52 7.04 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.526 ' CG ' ' O ' ' A' ' 5' ' ' GLY . 9.0 pt-20 38.32 35.89 0.11 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.671 -0.899 . . . . 0.0 110.522 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' A' ' 143' ' ' ASP . . . -136.16 -160.92 8.97 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.81 HG22 ' HB2' ' A' ' 143' ' ' ASP . 40.4 p -105.53 51.53 0.75 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.294 -1.121 . . . . 0.0 110.322 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.485 ' CE1' ' CD1' ' A' ' 16' ' ' TRP . 16.5 m-85 42.71 28.87 0.14 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.306 -0.871 . . . . 0.0 110.228 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.554 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 4.5 p-10 -86.22 52.25 2.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.271 -0.893 . . . . 0.0 110.062 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.554 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 1.0 OUTLIER 161.7 37.05 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.68 -0.637 . . . . 0.0 109.901 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.99 148.43 12.11 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.568 ' HB3' HD12 ' A' ' 32' ' ' LEU . 49.6 Cg_endo -76.12 6.6 3.76 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 124.035 1.545 . . . . 0.0 110.902 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.501 ' HB3' ' O ' ' A' ' 13' ' ' PRO . 2.6 tm-20 59.26 -89.27 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.206 -0.934 . . . . 0.0 110.406 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.513 ' O ' HD12 ' A' ' 49' ' ' LEU . . . -144.22 30.66 1.87 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 1.002 ' CE2' HD22 ' A' ' 49' ' ' LEU . 52.7 m95 -85.93 124.72 32.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.215 -1.168 . . . . 0.0 110.554 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.854 ' O ' HG13 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -114.2 160.94 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.309 -0.87 . . . . 0.0 108.884 179.44 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.469 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . . . -147.12 126.1 12.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.112 -0.993 . . . . 0.0 110.297 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.626 ' HE2' HG13 ' A' ' 48' ' ' VAL . 17.5 p90 -104.94 170.59 7.78 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.486 -0.759 . . . . 0.0 110.26 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 1.064 ' HA3' HG13 ' A' ' 45' ' ' VAL . . . 115.44 35.09 1.34 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.1 p 51.13 17.75 0.5 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.682 -0.893 . . . . 0.0 111.005 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.702 ' HB3' ' HB3' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -152.68 77.6 1.18 Allowed 'General case' 0 C--N 1.306 -1.291 0 O-C-N 120.975 -1.078 . . . . 0.0 109.049 179.265 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.593 ' N ' ' CD ' ' A' ' 24' ' ' PRO . . . -118.54 43.97 1.5 Allowed Glycine 0 N--CA 1.489 2.171 0 C-N-CA 119.451 -1.357 . . . . 0.0 110.72 -179.108 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 23' ' ' GLY . 50.5 Cg_endo -75.39 76.62 3.49 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.668 1.352 . . . . 0.0 109.649 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 1.036 ' CD2' HG12 ' A' ' 34' ' ' VAL . 14.8 mt -68.16 84.6 0.24 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.182 -0.949 . . . . 0.0 110.46 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.469 ' O ' ' O ' ' A' ' 31' ' ' ALA . 0.2 OUTLIER -74.81 113.12 11.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.165 -0.959 . . . . 0.0 109.085 179.314 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.417 ' O ' ' C ' ' A' ' 28' ' ' SER . 1.4 p -119.6 -29.08 5.15 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.061 -1.024 . . . . 0.0 111.196 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 27' ' ' THR . 33.2 p -45.04 -27.92 0.63 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.948 -1.095 . . . . 0.0 108.619 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.613 HG23 ' H ' ' A' ' 31' ' ' ALA . 5.5 t -70.4 -45.78 65.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.868 -0.52 . . . . 0.0 110.751 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.574 ' N ' HG23 ' A' ' 29' ' ' THR . . . 138.04 3.42 1.97 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.613 ' H ' HG23 ' A' ' 29' ' ' THR . . . -150.38 130.91 13.89 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.98 -1.306 . . . . 0.0 110.021 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.797 HD11 HD13 ' A' ' 25' ' ' LEU . 0.9 OUTLIER -67.23 110.33 3.45 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.996 -1.065 . . . . 0.0 109.543 179.754 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.452 ' O ' ' O ' ' A' ' 24' ' ' PRO . 2.9 m -109.39 106.59 16.43 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.091 -1.006 . . . . 0.0 111.164 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 1.036 HG12 ' CD2' ' A' ' 25' ' ' LEU . 36.0 m -89.81 173.6 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.702 ' HB3' ' HB3' ' A' ' 22' ' ' ASP . . . -122.75 152.78 40.28 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.574 -1.329 . . . . 0.0 111.685 -178.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.886 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 10.6 t -137.88 111.28 8.74 Favored Pre-proline 0 C--N 1.303 -1.446 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.579 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.437 ' O ' ' O ' ' A' ' 38' ' ' ALA . 44.3 Cg_endo -73.75 141.99 31.47 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.011 1.532 . . . . 0.0 111.185 -178.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.83 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -42.35 164.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.504 -0.747 . . . . 0.0 109.834 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 51.22 50.12 41.34 Favored Glycine 0 N--CA 1.485 1.949 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.652 ' OG ' HG23 ' A' ' 45' ' ' VAL . 1.6 t -86.88 35.92 0.7 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.228 -1.16 . . . . 0.0 109.803 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.529 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . -87.44 -139.87 0.1 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.475 -0.766 . . . . 0.0 109.414 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.542 ' HG2' ' N ' ' A' ' 43' ' ' TYR . 0.0 OUTLIER 42.03 -142.29 0.09 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.476 -0.765 . . . . 0.0 110.066 -179.491 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.583 ' CE1' ' O ' ' A' ' 44' ' ' GLY . 5.8 p90 -31.39 -39.27 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.198 0 CA-C-O 121.354 0.597 . . . . 0.0 110.292 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.583 ' O ' ' CE1' ' A' ' 43' ' ' TYR . . . 88.82 137.32 6.01 Favored Glycine 0 N--CA 1.49 2.283 0 C-N-CA 120.227 -0.987 . . . . 0.0 111.128 177.66 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 1.064 HG13 ' HA3' ' A' ' 20' ' ' GLY . 4.0 t -89.75 167.91 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.511 ' C ' ' CZ ' ' A' ' 19' ' ' TYR . . . 168.11 162.19 19.54 Favored Glycine 0 N--CA 1.49 2.298 0 C-N-CA 118.51 -1.805 . . . . 0.0 111.056 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.854 HG13 ' O ' ' A' ' 17' ' ' VAL . 44.6 t -114.54 157.69 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.74 -0.859 . . . . 0.0 109.793 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.626 HG13 ' HE2' ' A' ' 19' ' ' TYR . 3.7 m -143.5 150.55 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.076 -1.015 . . . . 0.0 110.08 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 1.002 HD22 ' CE2' ' A' ' 16' ' ' TRP . 19.4 tp -138.47 89.89 2.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.199 -0.938 . . . . 0.0 110.417 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.526 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 40.9 t30 -73.04 132.79 43.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.294 -0.879 . . . . 0.0 110.151 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 124.0 60.52 0.19 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.576 HG12 ' N ' ' A' ' 53' ' ' ALA . 40.3 t -119.94 172.07 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.233 -1.157 . . . . 0.0 110.101 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.576 ' N ' HG12 ' A' ' 52' ' ' VAL . . . -137.88 102.01 4.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.235 -0.915 . . . . 0.0 110.389 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.909 HD11 HD21 ' A' ' 146' ' ' LEU . 42.3 mm -131.65 49.59 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.291 -0.881 . . . . 0.0 109.936 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.557 ' O ' ' HB3' ' A' ' 56' ' ' GLU . 0.3 OUTLIER -72.16 139.95 48.54 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.408 -0.807 . . . . 0.0 111.072 -179.571 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.557 ' HB3' ' O ' ' A' ' 55' ' ' GLU . 6.6 tm-20 73.12 178.12 0.24 Allowed 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 121.968 0.89 . . . . 0.0 111.907 178.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.565 ' HA2' ' HA ' ' A' ' 109' ' ' SER . . . -103.04 89.54 0.72 Allowed Glycine 0 N--CA 1.487 2.047 0 N-CA-C 107.764 -2.135 . . . . 0.0 107.764 178.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . 1.027 HG22 ' CE1' ' A' ' 60' ' ' TYR . 0.4 OUTLIER -120.19 -165.53 1.2 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.41 -1.053 . . . . 0.0 110.641 -178.486 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.768 ' N ' HG23 ' A' ' 58' ' ' THR . 8.2 m -103.49 86.3 2.62 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.413 -0.804 . . . . 0.0 110.372 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 1.027 ' CE1' HG22 ' A' ' 58' ' ' THR . 96.1 m-85 -85.84 116.19 23.93 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.147 -0.971 . . . . 0.0 109.905 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 38.9 m -89.89 114.76 26.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.211 -0.931 . . . . 0.0 110.154 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.446 HD22 ' CD2' ' A' ' 89' ' ' LEU . 18.2 tp -89.71 121.47 31.9 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.185 -0.947 . . . . 0.0 110.002 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.631 ' HG2' HG22 ' A' ' 103' ' ' THR . 48.3 mtp180 -122.67 121.73 37.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.297 -0.877 . . . . 0.0 110.142 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.538 ' CE2' HG11 ' A' ' 102' ' ' VAL . 0.7 OUTLIER -159.57 141.57 13.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.285 -0.884 . . . . 0.0 109.906 179.784 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.501 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 89.9 m -119.18 97.04 5.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.279 -0.888 . . . . 0.0 109.674 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.8 ' CB ' HD21 ' A' ' 95' ' ' LEU . . . -97.14 154.02 17.62 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.476 -0.765 . . . . 0.0 110.554 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.83 HG23 ' O ' ' A' ' 98' ' ' GLU . 96.9 m -150.34 122.02 8.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.369 -0.832 . . . . 0.0 110.101 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -108.3 142.9 37.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.244 -0.91 . . . . 0.0 109.945 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.12 -22.01 2.26 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.154 -0.966 . . . . 0.0 109.138 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.599 HG22 ' HB2' ' A' ' 137' ' ' TRP . 3.4 t -119.27 166.92 12.39 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.563 -0.71 . . . . 0.0 109.835 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.439 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 0.9 OUTLIER -82.38 73.54 9.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.047 -1.033 . . . . 0.0 109.114 178.925 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.714 HG23 ' HB2' ' A' ' 133' ' ' SER . 5.4 p -98.06 145.04 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.303 -0.873 . . . . 0.0 111.348 -178.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.534 HG22 ' HB3' ' A' ' 92' ' ' SER . 19.8 m -128.69 91.12 3.17 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 178.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.969 HG21 ' CD2' ' A' ' 129' ' ' LEU . 3.3 m -89.67 -148.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.203 -0.935 . . . . 0.0 110.766 -178.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.586 ' N ' HG23 ' A' ' 74' ' ' VAL . 0.1 OUTLIER -121.97 118.3 28.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.194 -0.941 . . . . 0.0 110.82 -179.437 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.686 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -122.98 147.92 46.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.204 -0.935 . . . . 0.0 109.681 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.728 HD12 ' N ' ' A' ' 78' ' ' VAL . 3.5 pp 178.92 -148.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.296 -0.878 . . . . 0.0 110.08 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.829 HG23 HD22 ' A' ' 89' ' ' LEU . 2.5 t -147.85 171.07 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.194 -0.941 . . . . 0.0 108.902 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.489 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . -172.24 -178.5 42.48 Favored Glycine 0 N--CA 1.489 2.183 0 C-N-CA 119.169 -1.491 . . . . 0.0 110.183 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.422 ' O ' ' OD1' ' A' ' 81' ' ' ASN . 8.1 tt0 -92.28 -148.99 0.24 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.49 -1.006 . . . . 0.0 110.192 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.481 ' HB3' ' OE2' ' A' ' 122' ' ' GLU . 5.8 m120 -164.38 64.22 0.14 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.523 -0.736 . . . . 0.0 109.574 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.469 ' HA3' ' HB3' ' A' ' 121' ' ' PRO . . . 134.91 147.25 5.5 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.629 ' N ' ' CE1' ' A' ' 85' ' ' TYR . . . -41.25 151.62 0.28 Allowed Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.33 -1.1 . . . . 0.0 110.375 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.46 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.3 Cg_endo -80.16 12.48 23.23 Favored 'Cis proline' 0 C--N 1.312 -1.353 0 C-N-CA 121.659 -2.226 . . . . 0.0 110.884 -0.07 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.629 ' CE1' ' N ' ' A' ' 83' ' ' ALA . 26.4 m-85 63.2 150.63 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.16 -0.963 . . . . 0.0 110.194 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 175.97 131.49 1.47 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.59 155.15 21.79 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.299 -1.118 . . . . 0.0 110.104 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.982 HG23 HD12 ' A' ' 89' ' ' LEU . 33.2 m -125.4 -22.0 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.257 -0.902 . . . . 0.0 110.447 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.982 HD12 HG23 ' A' ' 88' ' ' VAL . 3.7 mp -111.72 144.16 41.46 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.111 -0.993 . . . . 0.0 111.023 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.57 ' O ' HG23 ' A' ' 91' ' ' THR . 29.5 t0 -150.98 85.83 1.36 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.434 -0.791 . . . . 0.0 110.206 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.57 HG23 ' O ' ' A' ' 90' ' ' ASP . 2.6 p -155.04 -177.31 6.44 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.053 -1.029 . . . . 0.0 110.581 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.534 ' HB3' HG22 ' A' ' 73' ' ' THR . 3.7 m -123.64 134.16 25.1 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.346 -0.847 . . . . 0.0 109.978 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.789 ' HG2' HG22 ' A' ' 74' ' ' VAL . 51.6 Cg_endo -78.31 79.81 3.19 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.871 1.458 . . . . 0.0 110.877 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.527 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -49.26 134.51 18.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.939 -1.101 . . . . 0.0 109.159 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.8 HD21 ' CB ' ' A' ' 66' ' ' ALA . 27.6 mt -131.44 170.64 14.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.052 -1.03 . . . . 0.0 110.89 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.487 ' CG2' ' HG3' ' A' ' 100' ' ' ARG . 0.2 OUTLIER -170.99 -178.69 2.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.445 -0.784 . . . . 0.0 109.942 179.972 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.84 -6.37 26.58 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.278 -0.888 . . . . 0.0 110.244 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.83 ' O ' HG23 ' A' ' 67' ' ' THR . 0.6 OUTLIER -110.52 174.58 2.3 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.243 -0.911 . . . . 0.0 110.1 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.51 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 45.0 Cg_endo -72.31 128.02 13.28 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.026 1.54 . . . . 0.0 110.294 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.527 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 1.2 mtt-85 -119.76 92.17 3.72 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.152 -0.968 . . . . 0.0 110.4 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.455 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 38.9 tt0 -75.1 154.11 37.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.364 -0.835 . . . . 0.0 109.978 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.538 HG11 ' CE2' ' A' ' 64' ' ' TYR . 74.4 t -139.5 133.72 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.166 -0.958 . . . . 0.0 110.354 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.631 HG22 ' HG2' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -150.15 118.99 6.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.283 -0.886 . . . . 0.0 110.083 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -140.6 153.13 45.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.204 -0.935 . . . . 0.0 110.361 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.548 HG22 ' CG2' ' A' ' 59' ' ' THR . 8.4 m -109.5 70.79 0.74 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.289 -0.882 . . . . 0.0 110.116 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.879 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 40.0 p90 -84.82 146.62 27.24 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.306 -0.871 . . . . 0.0 110.144 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 58' ' ' THR . 5.6 m -89.94 102.65 15.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -0.93 . . . . 0.0 109.987 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 1.002 ' HB3' ' CD1' ' A' ' 60' ' ' TYR . . . -70.04 95.78 0.99 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.155 -0.966 . . . . 0.0 110.388 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.565 ' HA ' ' HA2' ' A' ' 57' ' ' GLY . 8.2 p -85.88 59.63 5.75 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.675 -0.64 . . . . 0.0 109.512 179.321 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.461 ' HB3' HG11 ' A' ' 88' ' ' VAL . . . -155.27 -156.24 0.64 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.12 -0.987 . . . . 0.0 110.835 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.974 HG22 ' HD3' ' A' ' 113' ' ' PRO . 46.6 m -147.42 108.05 4.14 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.373 -0.829 . . . . 0.0 110.87 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.584 ' CE2' HG12 ' A' ' 78' ' ' VAL . 16.4 m-30 -110.04 74.17 0.77 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.396 -0.815 . . . . 0.0 109.642 179.24 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.974 ' HD3' HG22 ' A' ' 111' ' ' THR . 43.7 Cg_endo -71.65 -159.08 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.908 1.478 . . . . 0.0 110.41 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.488 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -145.79 36.56 1.06 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.271 -0.893 . . . . 0.0 110.247 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.528 ' O ' ' CB ' ' A' ' 120' ' ' ASP . 20.1 m -107.53 88.26 4.04 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.286 -0.883 . . . . 0.0 110.188 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 45.9 Cg_endo -72.9 110.35 3.01 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.97 1.51 . . . . 0.0 110.404 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.647 ' HB3' ' HB2' ' A' ' 120' ' ' ASP . . . -149.47 -170.17 3.57 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.236 -0.915 . . . . 0.0 110.219 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -75.16 -8.49 56.73 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.316 -0.865 . . . . 0.0 110.174 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -151.83 16.79 0.68 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.187 -0.946 . . . . 0.0 110.225 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.647 ' HB2' ' HB3' ' A' ' 117' ' ' ALA . 2.3 m-20 -114.72 90.33 21.73 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.227 -0.921 . . . . 0.0 110.131 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.482 ' O ' ' HG2' ' A' ' 113' ' ' PRO . 46.5 Cg_endo -73.9 147.1 38.6 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.025 1.539 . . . . 0.0 110.478 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.481 ' OE2' ' HB3' ' A' ' 81' ' ' ASN . 22.5 pm0 -124.12 -154.75 0.63 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.172 -0.955 . . . . 0.0 110.219 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.514 ' HA3' ' CB ' ' A' ' 112' ' ' TYR . . . -151.36 150.8 22.79 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.569 ' HA ' ' CG2' ' A' ' 52' ' ' VAL . 3.0 pt20 -150.35 -153.34 0.48 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.269 -1.136 . . . . 0.0 110.394 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.449 ' HB ' ' HB3' ' A' ' 49' ' ' LEU . 7.5 mt -118.45 144.86 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.419 -0.801 . . . . 0.0 109.379 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.409 ' HB3' HD11 ' A' ' 77' ' ' LEU . . . -122.11 121.1 36.14 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.228 -0.92 . . . . 0.0 111.04 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.48 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 5.1 m-85 -119.42 97.19 5.53 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.49 ' O ' ' HB ' ' A' ' 74' ' ' VAL . 2.5 mt-30 -88.95 89.1 7.84 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.245 -0.91 . . . . 0.0 111.149 -178.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.986 HD13 HD13 ' A' ' 139' ' ' LEU . 16.0 mt -87.61 51.55 2.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.571 -0.705 . . . . 0.0 109.274 178.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.53 ' O ' ' CD2' ' A' ' 132' ' ' PHE . . . -127.68 151.0 18.42 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 51.81 63.55 4.65 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.622 ' CE1' ' HA ' ' A' ' 74' ' ' VAL . 15.5 m-85 -148.06 -78.79 0.15 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.243 -1.151 . . . . 0.0 110.25 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.714 ' HB2' HG23 ' A' ' 72' ' ' VAL . 2.3 t -89.59 144.58 25.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.058 -1.026 . . . . 0.0 110.055 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -81.87 -84.45 0.11 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.289 -0.882 . . . . 0.0 110.357 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -42.54 154.92 0.05 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.247 -0.908 . . . . 0.0 110.293 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.83 ' HB2' ' HB2' ' A' ' 38' ' ' ALA . . . -57.59 124.28 18.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.279 -0.888 . . . . 0.0 110.214 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.886 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 6.0 p90 -131.23 -167.49 1.86 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.279 -0.888 . . . . 0.0 110.236 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.542 ' CG2' ' N ' ' A' ' 139' ' ' LEU . 0.8 OUTLIER -160.81 178.75 9.12 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.31 -0.956 . . . . 0.0 110.532 -178.255 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.986 HD13 HD13 ' A' ' 129' ' ' LEU . 2.2 mp -133.96 155.6 49.65 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.388 -0.82 . . . . 0.0 110.062 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' CYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 33' ' ' CYS . 11.1 m -150.12 97.88 2.62 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.173 -0.954 . . . . 0.0 110.724 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.518 HD23 ' HB2' ' A' ' 66' ' ' ALA . 1.1 mt -89.62 -177.09 5.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.299 -0.876 . . . . 0.0 109.518 179.288 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.567 ' HB3' ' CB ' ' A' ' 31' ' ' ALA . 0.6 OUTLIER 172.33 44.21 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.186 -0.946 . . . . 0.0 110.999 179.926 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.81 ' HB2' HG22 ' A' ' 8' ' ' THR . 5.8 t0 171.85 69.81 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.309 -0.87 . . . . 0.0 109.592 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.828 HG11 ' HZ2' ' A' ' 16' ' ' TRP . 1.9 t -106.64 122.28 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.129 -0.982 . . . . 0.0 110.412 -179.412 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -151.81 150.93 30.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.344 -0.847 . . . . 0.0 110.067 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.966 HD11 ' HB3' ' A' ' 60' ' ' TYR . 22.3 tp -138.49 158.83 43.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.288 -0.882 . . . . 0.0 110.29 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.512 ' N ' ' HG ' ' A' ' 146' ' ' LEU . 0.4 OUTLIER -163.25 -157.33 0.42 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.213 -0.929 . . . . 0.0 110.278 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.686 ' HB2' HG21 ' A' ' 58' ' ' THR . 0.1 OUTLIER -150.35 113.18 4.78 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.215 -0.928 . . . . 0.0 110.136 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 148' ' ' SER . 0.4 OUTLIER 42.97 71.94 0.2 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.267 -0.895 . . . . 0.0 110.226 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.426 HG11 ' CG ' ' A' ' 147' ' ' ASP . 33.9 m -117.56 40.99 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.256 -0.903 . . . . 0.0 110.236 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.424 ' O ' ' C ' ' A' ' 152' ' ' LEU . 92.0 mt-10 -120.63 -172.6 2.41 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.91 . . . . 0.0 110.218 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.448 HD13 ' HA ' ' A' ' 152' ' ' LEU . 1.7 mm? . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.229 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.518 ' HB3' ' HB1' ' A' ' 53' ' ' ALA . . . . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.273 0.559 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.438 ' HB2' ' O ' ' A' ' 1' ' ' ALA . 0.9 OUTLIER -179.77 58.74 0.1 OUTLIER Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.219 -0.925 . . . . 0.0 110.229 179.997 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.426 ' HD3' ' N ' ' A' ' 2' ' ' SER . 49.2 Cg_endo -76.24 -156.32 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.008 1.53 . . . . 0.0 110.01 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.0 pt -94.5 -8.78 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.197 -0.939 . . . . 0.0 110.167 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 69.75 156.24 1.39 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -72.23 83.12 1.02 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.223 -1.163 . . . . 0.0 110.152 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -86.76 127.41 8.38 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.457 ' O ' ' HB2' ' A' ' 9' ' ' PHE . 2.1 p -77.31 2.87 14.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.222 -1.164 . . . . 0.0 110.236 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.59 ' CD2' ' HB2' ' A' ' 32' ' ' LEU . 3.3 m-85 56.41 16.7 2.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.253 -0.904 . . . . 0.0 110.204 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.547 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 18.3 p-10 -98.41 14.03 29.53 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.234 -0.916 . . . . 0.0 110.391 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.547 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 2.2 t70 161.68 80.63 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.79 -0.569 . . . . 0.0 109.544 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.22 82.49 1.65 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.916 ' HG3' HG21 ' A' ' 27' ' ' THR . 51.2 Cg_endo -81.31 43.14 1.47 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.073 1.565 . . . . 0.0 110.668 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.455 ' HB3' ' O ' ' A' ' 13' ' ' PRO . 36.2 tp10 56.9 -91.27 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.137 -0.977 . . . . 0.0 110.206 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.502 ' C ' HD13 ' A' ' 49' ' ' LEU . . . -152.75 32.63 0.82 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.888 ' CE2' HD22 ' A' ' 49' ' ' LEU . 59.5 m95 -71.19 86.71 0.78 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.23 -1.159 . . . . 0.0 110.267 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.838 ' O ' HG13 ' A' ' 47' ' ' VAL . 1.4 m -82.26 147.92 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.224 -0.922 . . . . 0.0 109.781 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.589 ' CB ' ' CG1' ' A' ' 34' ' ' VAL . . . -134.12 119.51 18.97 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.178 -0.951 . . . . 0.0 109.978 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.668 ' HE2' HG13 ' A' ' 48' ' ' VAL . 16.9 p90 -108.56 138.03 45.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.469 -0.77 . . . . 0.0 110.411 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.92 ' HA3' HG13 ' A' ' 45' ' ' VAL . . . 160.82 45.48 0.02 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.515 HG23 ' OH ' ' A' ' 43' ' ' TYR . 9.6 p 50.84 19.16 0.59 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.442 -1.034 . . . . 0.0 110.733 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.925 ' HB2' ' HB3' ' A' ' 35' ' ' ALA . 3.0 p30 -97.88 38.51 1.29 Allowed 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.069 -1.019 . . . . 0.0 110.031 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 45.94 -156.54 0.45 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.436 ' O ' ' C ' ' A' ' 25' ' ' LEU . 46.5 Cg_endo -73.72 125.63 10.16 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 123.939 1.494 . . . . 0.0 110.35 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.718 HD23 ' H ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -42.26 133.02 3.26 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.277 -0.889 . . . . 0.0 110.015 179.887 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.07 116.23 28.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.144 -0.972 . . . . 0.0 110.054 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.916 HG21 ' HG3' ' A' ' 13' ' ' PRO . 0.9 OUTLIER -119.88 -28.71 5.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.167 -0.958 . . . . 0.0 110.34 -179.76 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.45 ' O ' ' HB ' ' A' ' 29' ' ' THR . 0.3 OUTLIER -48.91 83.13 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.838 -0.539 . . . . 0.0 111.254 -179.957 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.62 HG22 ' O ' ' A' ' 27' ' ' THR . 0.8 OUTLIER 175.97 -28.93 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.017 -1.052 . . . . 0.0 110.309 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.526 ' HA2' ' CB ' ' A' ' 10' ' ' ASP . . . 133.73 -7.05 4.87 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.706 -1.357 . . . . 0.0 109.706 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.548 ' HA ' ' HB3' ' A' ' 9' ' ' PHE . . . -150.3 172.46 15.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.149 -1.207 . . . . 0.0 110.329 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.684 HD12 ' CG2' ' A' ' 27' ' ' THR . 0.6 OUTLIER -103.97 94.73 5.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.274 -0.891 . . . . 0.0 109.769 179.736 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 65.5 m -100.09 115.61 30.17 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.295 -0.878 . . . . 0.0 111.002 -179.288 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.589 ' CG1' ' CB ' ' A' ' 18' ' ' ALA . 15.1 m -96.11 157.17 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.319 -0.863 . . . . 0.0 109.231 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.925 ' HB3' ' HB2' ' A' ' 22' ' ' ASP . . . -102.26 89.23 3.51 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.269 -0.894 . . . . 0.0 111.635 -178.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.037 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 76.3 t -74.71 119.21 75.58 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 120.976 -1.077 . . . . 0.0 109.192 178.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.426 ' O ' ' C ' ' A' ' 38' ' ' ALA . 42.7 Cg_endo -69.17 144.79 58.4 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.865 1.455 . . . . 0.0 111.226 -179.095 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.519 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -42.11 147.83 0.22 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.462 -0.774 . . . . 0.0 110.109 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.459 ' O ' ' OE1' ' A' ' 42' ' ' GLN . . . 44.52 70.64 0.56 Allowed Glycine 0 N--CA 1.488 2.132 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.987 ' OG ' HG21 ' A' ' 45' ' ' VAL . 0.5 OUTLIER -87.01 29.72 0.8 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.31 -1.112 . . . . 0.0 110.44 -179.636 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.501 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . . . -91.38 19.99 5.61 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.926 0.869 . . . . 0.0 109.739 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.614 ' HG3' ' CD2' ' A' ' 43' ' ' TYR . 0.5 OUTLIER -84.44 -135.65 0.05 Allowed 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.527 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.646 ' CD1' ' N ' ' A' ' 44' ' ' GLY . 8.3 p90 -38.9 -27.39 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.379 -0.826 . . . . 0.0 110.417 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.646 ' N ' ' CD1' ' A' ' 43' ' ' TYR . . . 111.04 106.92 2.96 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.987 HG21 ' OG ' ' A' ' 40' ' ' SER . 2.9 t -90.09 153.83 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.231 -1.159 . . . . 0.0 108.73 179.175 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.542 ' C ' ' CZ ' ' A' ' 19' ' ' TYR . . . 176.75 169.51 38.16 Favored Glycine 0 N--CA 1.49 2.26 0 C-N-CA 119.221 -1.466 . . . . 0.0 110.218 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.838 HG13 ' O ' ' A' ' 17' ' ' VAL . 48.8 t -128.19 144.03 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.412 -1.052 . . . . 0.0 109.901 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.674 ' O ' HG22 ' A' ' 17' ' ' VAL . 34.0 m -135.55 147.69 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.039 -1.038 . . . . 0.0 110.419 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.888 HD22 ' CE2' ' A' ' 16' ' ' TRP . 22.8 tp -135.82 109.85 8.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.251 -0.906 . . . . 0.0 110.308 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.509 ' HA ' ' HB3' ' A' ' 124' ' ' GLN . 2.4 p-10 -84.33 121.71 27.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.224 -0.922 . . . . 0.0 110.269 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 139.92 79.43 0.06 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.574 HG12 HG12 ' A' ' 54' ' ' ILE . 54.0 t -131.36 150.44 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.197 -1.178 . . . . 0.0 110.198 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.518 ' HB1' ' HB3' ' A' ' 1' ' ' ALA . . . -117.34 92.58 3.89 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.224 -0.922 . . . . 0.0 110.238 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.817 HD11 HD21 ' A' ' 146' ' ' LEU . 14.6 mm -136.37 169.33 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.237 -0.914 . . . . 0.0 110.065 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.513 ' O ' ' HB3' ' A' ' 56' ' ' GLU . 2.2 pt-20 179.05 139.54 0.1 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.24 -0.912 . . . . 0.0 110.361 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.513 ' HB3' ' O ' ' A' ' 55' ' ' GLU . 3.9 tt0 64.23 -179.67 0.17 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.512 -0.742 . . . . 0.0 110.759 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' A' ' 109' ' ' SER . . . -92.42 70.98 1.63 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.624 -1.791 . . . . 0.0 108.624 179.397 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.711 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.0 OUTLIER -105.9 176.81 5.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.532 -0.981 . . . . 0.0 110.087 -179.281 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.577 ' N ' ' CG2' ' A' ' 58' ' ' THR . 0.7 OUTLIER -89.57 156.4 18.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.304 -0.872 . . . . 0.0 110.436 -179.69 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.903 ' HB3' HD11 ' A' ' 146' ' ' LEU . 68.2 m-85 -156.45 118.08 3.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.448 -0.782 . . . . 0.0 109.625 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 104' ' ' GLU . 10.0 m -89.94 112.03 23.29 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.209 -0.932 . . . . 0.0 110.646 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 21.7 tp -90.21 140.0 30.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.346 -0.846 . . . . 0.0 109.66 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.771 ' HG2' HG23 ' A' ' 103' ' ' THR . 27.1 mtt180 -136.92 105.68 5.87 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.146 -0.971 . . . . 0.0 110.722 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.528 ' C ' ' CD1' ' A' ' 64' ' ' TYR . 3.5 p90 -140.18 151.67 45.42 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.33 -0.856 . . . . 0.0 109.676 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.523 HG22 ' O ' ' A' ' 65' ' ' THR . 4.2 m -119.62 92.04 3.69 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.095 -1.003 . . . . 0.0 110.114 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.883 ' HB1' HD21 ' A' ' 95' ' ' LEU . . . -89.44 145.51 25.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.302 -0.874 . . . . 0.0 110.17 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.653 HG23 ' O ' ' A' ' 98' ' ' GLU . 53.4 m -150.72 104.87 3.23 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.316 -0.865 . . . . 0.0 110.492 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.528 ' HB2' HD13 ' A' ' 95' ' ' LEU . . . -95.93 132.38 41.29 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.165 -0.96 . . . . 0.0 109.854 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 68' ' ' ALA . 20.0 m -43.54 -26.78 0.24 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.219 -0.926 . . . . 0.0 109.435 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.631 HG22 ' HB2' ' A' ' 137' ' ' TRP . 3.0 t -112.74 167.63 10.33 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.563 -0.711 . . . . 0.0 109.838 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.505 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 32.9 t0 -84.29 69.36 10.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.104 -0.997 . . . . 0.0 109.224 178.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.795 HG23 ' CB ' ' A' ' 133' ' ' SER . 3.8 p -92.0 140.08 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.331 -0.856 . . . . 0.0 111.318 -178.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.474 ' O ' ' CD1' ' A' ' 132' ' ' PHE . 98.3 m -126.46 91.94 3.46 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 1.021 HG21 ' CD2' ' A' ' 129' ' ' LEU . 3.2 m -89.79 -159.34 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.18 -0.95 . . . . 0.0 110.715 -178.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.437 ' N ' HG23 ' A' ' 74' ' ' VAL . 0.3 OUTLIER -119.16 106.61 12.54 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.284 -0.885 . . . . 0.0 110.394 -179.519 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.492 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -113.08 165.14 12.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.906 . . . . 0.0 110.194 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.556 ' HA ' ' HB3' ' A' ' 89' ' ' LEU . 3.1 pp 176.93 -159.7 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.363 -0.836 . . . . 0.0 110.12 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.784 ' CG2' HD22 ' A' ' 89' ' ' LEU . 3.4 t -149.26 155.61 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.26 -0.9 . . . . 0.0 109.718 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.575 ' O ' ' CE2' ' A' ' 112' ' ' TYR . . . -172.43 -178.2 42.41 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.429 -1.367 . . . . 0.0 110.258 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.484 ' HG2' ' O ' ' A' ' 111' ' ' THR . 0.0 OUTLIER -93.42 128.34 39.44 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.434 -1.039 . . . . 0.0 110.697 -179.726 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.499 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 1.4 m-80 -96.64 75.49 2.8 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.192 -0.943 . . . . 0.0 109.557 179.082 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.586 ' O ' ' HB2' ' A' ' 83' ' ' ALA . . . -166.07 -90.48 0.08 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.586 ' HB2' ' O ' ' A' ' 82' ' ' GLY . . . 175.84 136.49 0.19 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.345 -1.091 . . . . 0.0 109.923 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.535 ' C ' ' CD2' ' A' ' 85' ' ' TYR . 52.3 Cg_endo -83.84 33.2 3.61 Favored 'Cis proline' 0 C--N 1.314 -1.271 0 C-N-CA 122.096 -2.044 . . . . 0.0 110.84 -0.158 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.579 ' CE1' ' O ' ' A' ' 82' ' ' GLY . 18.7 m-85 65.24 166.03 0.17 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.229 -0.919 . . . . 0.0 110.449 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.496 ' O ' ' CA ' ' A' ' 79' ' ' GLY . . . -163.4 171.11 39.02 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.57 133.67 21.52 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.099 -1.236 . . . . 0.0 110.507 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 1.088 HG23 HD12 ' A' ' 89' ' ' LEU . 12.4 m -119.8 -10.49 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.326 -0.859 . . . . 0.0 109.732 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 1.088 HD12 HG23 ' A' ' 88' ' ' VAL . 4.5 mp -123.5 143.49 50.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.418 -0.801 . . . . 0.0 110.816 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.715 ' O ' HG23 ' A' ' 91' ' ' THR . 0.7 OUTLIER -150.62 83.69 1.35 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.283 -0.886 . . . . 0.0 110.223 179.713 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.715 HG23 ' O ' ' A' ' 90' ' ' ASP . 1.1 p -160.06 -176.71 5.82 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.125 -0.984 . . . . 0.0 110.509 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.431 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 0.1 OUTLIER -119.93 131.24 24.48 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.321 -0.862 . . . . 0.0 110.079 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.831 ' HG2' HG22 ' A' ' 74' ' ' VAL . 48.6 Cg_endo -73.11 77.6 2.37 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.97 1.511 . . . . 0.0 110.912 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.532 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -48.63 135.26 14.91 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.975 -1.078 . . . . 0.0 109.148 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.883 HD21 ' HB1' ' A' ' 66' ' ' ALA . 36.4 mt -130.85 176.79 7.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.997 -1.064 . . . . 0.0 110.872 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 68' ' ' ALA . 0.2 OUTLIER -177.89 -178.8 0.72 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.49 -0.756 . . . . 0.0 109.918 -179.955 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.63 -22.44 63.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.226 -0.921 . . . . 0.0 110.287 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.653 ' O ' HG23 ' A' ' 67' ' ' THR . 2.6 mt-10 -90.07 169.86 11.5 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.29 -0.881 . . . . 0.0 110.078 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.495 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 45.0 Cg_endo -72.55 130.44 16.02 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 123.956 1.503 . . . . 0.0 110.276 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.532 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.69 92.2 3.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.154 -0.966 . . . . 0.0 110.35 -179.865 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.453 ' HG3' ' OG1' ' A' ' 65' ' ' THR . 38.3 tt0 -85.76 99.3 11.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.289 -0.882 . . . . 0.0 110.104 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.426 ' HB ' ' CZ ' ' A' ' 64' ' ' TYR . 72.6 t -89.62 133.77 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 0.0 110.256 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.771 HG23 ' HG2' ' A' ' 63' ' ' ARG . 49.5 m -147.51 135.72 21.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.357 -0.839 . . . . 0.0 110.084 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.507 ' CG ' ' O ' ' A' ' 103' ' ' THR . 17.9 mt-10 -160.16 -177.33 6.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.169 -0.957 . . . . 0.0 110.267 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.491 HG23 HG23 ' A' ' 61' ' ' THR . 0.0 OUTLIER -133.62 91.54 2.86 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.285 -0.885 . . . . 0.0 110.162 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -92.44 155.48 17.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.286 -0.884 . . . . 0.0 110.254 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 109' ' ' SER . 38.7 m -89.56 92.78 9.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.178 -0.951 . . . . 0.0 109.777 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.618 ' CB ' ' CD2' ' A' ' 60' ' ' TYR . . . -47.39 91.67 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.27 -0.894 . . . . 0.0 110.455 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.523 ' HA ' ' HA2' ' A' ' 57' ' ' GLY . 8.9 p -85.78 57.28 4.38 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.349 -0.844 . . . . 0.0 109.621 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.645 ' HB3' ' HE1' ' A' ' 112' ' ' TYR . . . -166.98 -156.34 0.22 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.115 -0.991 . . . . 0.0 110.868 -179.561 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.497 ' O ' ' HD3' ' A' ' 113' ' ' PRO . 35.5 m -148.0 111.57 5.01 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.539 -0.726 . . . . 0.0 110.024 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.767 ' CE2' HG12 ' A' ' 78' ' ' VAL . 4.2 m-85 -104.87 92.3 5.08 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.361 -0.837 . . . . 0.0 109.943 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 111' ' ' THR . 43.4 Cg_endo -71.73 160.9 46.79 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.798 1.42 . . . . 0.0 110.389 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -113.84 68.52 0.69 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.144 -0.972 . . . . 0.0 110.376 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.47 ' O ' ' O ' ' A' ' 120' ' ' ASP . 0.1 OUTLIER -149.1 113.6 3.6 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.263 -0.898 . . . . 0.0 110.215 179.9 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -75.85 76.61 3.66 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.838 1.441 . . . . 0.0 110.353 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -147.76 158.13 43.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.192 -0.943 . . . . 0.0 110.281 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.25 -67.93 0.37 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.316 -0.865 . . . . 0.0 110.132 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -56.12 -36.34 68.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.277 -0.889 . . . . 0.0 109.974 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.47 ' O ' ' O ' ' A' ' 115' ' ' THR . 0.5 OUTLIER -117.14 87.99 25.43 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.324 -0.86 . . . . 0.0 109.969 179.821 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.572 ' CB ' ' HA3' ' A' ' 82' ' ' GLY . 47.7 Cg_endo -74.02 -159.17 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.09 1.574 . . . . 0.0 110.547 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.499 ' O ' ' HB2' ' A' ' 81' ' ' ASN . 0.1 OUTLIER -154.86 152.14 29.43 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.153 -0.967 . . . . 0.0 110.455 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.59 ' HA3' ' CD2' ' A' ' 112' ' ' TYR . . . -89.5 149.0 20.32 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.537 ' HA ' ' CG2' ' A' ' 52' ' ' VAL . 2.8 pt20 -150.37 -163.84 1.87 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.094 -1.239 . . . . 0.0 110.948 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.604 HG21 ' HE2' ' A' ' 127' ' ' PHE . 9.5 mt -118.57 144.37 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.579 -0.7 . . . . 0.0 109.186 179.471 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -121.25 129.14 53.01 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.315 -0.866 . . . . 0.0 110.67 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.604 ' HE2' HG21 ' A' ' 125' ' ' ILE . 14.3 m-85 -118.78 105.0 11.1 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -89.03 85.37 6.68 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.376 -0.828 . . . . 0.0 111.923 -177.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 1.021 ' CD2' HG21 ' A' ' 74' ' ' VAL . 14.6 mt -91.13 45.11 1.22 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.047 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -98.37 89.45 0.95 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 -179.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.579 ' O ' ' CG ' ' A' ' 132' ' ' PHE . . . 81.08 107.87 0.32 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 110.029 -1.229 . . . . 0.0 110.029 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.63 ' CZ ' ' HA ' ' A' ' 74' ' ' VAL . 8.4 m-85 -167.78 -67.1 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.366 -1.079 . . . . 0.0 109.849 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.795 ' CB ' HG23 ' A' ' 72' ' ' VAL . 1.3 t -89.68 160.79 16.42 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.143 -0.973 . . . . 0.0 109.893 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.405 ' O ' ' C ' ' A' ' 135' ' ' ASP . . . -88.3 -94.1 0.1 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.179 -0.95 . . . . 0.0 110.606 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 134' ' ' ALA . 9.5 m-20 -43.99 153.4 0.14 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.16 -0.963 . . . . 0.0 110.511 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.519 ' HB2' ' HB2' ' A' ' 38' ' ' ALA . . . -52.97 126.33 20.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.309 -0.869 . . . . 0.0 110.149 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 1.037 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 9.7 p90 -131.07 -161.15 1.1 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.257 -0.902 . . . . 0.0 110.181 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.584 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 0.8 OUTLIER -160.42 177.74 10.27 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.157 -0.964 . . . . 0.0 110.427 -178.084 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.867 HD13 HD13 ' A' ' 129' ' ' LEU . 2.2 mp -134.02 125.85 28.99 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.365 -0.834 . . . . 0.0 109.892 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' CYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 59.9 m -120.12 104.13 9.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.16 -0.963 . . . . 0.0 110.993 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.508 ' HA ' ' O ' ' A' ' 65' ' ' THR . 1.0 OUTLIER -102.11 -178.63 3.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.259 -0.9 . . . . 0.0 109.805 179.301 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.484 ' HB3' ' O ' ' A' ' 141' ' ' LEU . 4.5 p-10 173.59 167.35 0.18 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.458 -0.776 . . . . 0.0 110.316 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.465 ' O ' ' O ' ' A' ' 63' ' ' ARG . 13.9 t70 41.74 64.54 1.04 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.341 -0.849 . . . . 0.0 110.364 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.622 HG11 ' HZ2' ' A' ' 16' ' ' TRP . 4.9 t -99.1 113.2 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.252 -0.905 . . . . 0.0 110.053 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -129.8 171.33 12.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -0.934 . . . . 0.0 110.404 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.903 HD11 ' HB3' ' A' ' 60' ' ' TYR . 60.8 tp -162.49 120.75 2.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.275 -0.891 . . . . 0.0 110.159 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.532 ' O ' ' CD1' ' A' ' 60' ' ' TYR . 0.5 OUTLIER -125.24 -152.42 0.52 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.274 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 72.5 p -149.31 95.32 2.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.303 -0.873 . . . . 0.0 110.158 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.05 -174.82 1.32 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.245 -0.91 . . . . 0.0 110.252 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.511 HG22 ' N ' ' A' ' 151' ' ' GLU . 12.1 p -130.2 171.2 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.26 -0.9 . . . . 0.0 110.243 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.511 ' N ' HG22 ' A' ' 150' ' ' VAL . 4.3 tm-20 -103.04 115.18 30.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.267 -0.896 . . . . 0.0 110.21 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.219 -179.967 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.686 ' HB1' ' HB3' ' A' ' 53' ' ' ALA . . . . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.273 0.558 . . . . 0.0 110.237 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.5 t -106.66 90.25 4.9 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 0.0 110.179 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.492 ' HD3' ' O ' ' A' ' 1' ' ' ALA . 46.8 Cg_endo -73.3 79.25 2.14 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.023 1.539 . . . . 0.0 110.515 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.94 ' HB ' HD21 ' A' ' 49' ' ' LEU . 10.7 pt -117.72 32.67 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.227 -0.921 . . . . 0.0 110.113 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 7' ' ' GLY . . . 81.49 44.45 7.92 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.859 ' HG2' ' HB1' ' A' ' 145' ' ' ALA . 4.1 mt-10 -41.93 94.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.337 -1.096 . . . . 0.0 110.337 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 5' ' ' GLY . . . 152.48 -149.9 21.63 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.447 HG22 ' O ' ' A' ' 142' ' ' ASP . 70.4 p -92.71 163.49 13.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.27 -1.136 . . . . 0.0 110.233 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.459 ' CZ ' HG21 ' A' ' 144' ' ' VAL . 24.4 m-85 -87.61 35.47 0.72 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.256 -0.903 . . . . 0.0 110.189 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.543 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 13.8 t0 -86.22 57.13 4.31 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.275 -0.891 . . . . 0.0 110.133 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.543 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.9 OUTLIER 161.69 36.84 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.628 -0.67 . . . . 0.0 110.073 -179.999 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.26 140.28 9.2 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.7 ' HB3' HD12 ' A' ' 32' ' ' LEU . 49.8 Cg_endo -77.13 6.6 4.18 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.104 1.581 . . . . 0.0 110.637 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 0.7 OUTLIER 65.57 -85.79 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.205 -0.934 . . . . 0.0 110.413 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.52 ' C ' HD12 ' A' ' 49' ' ' LEU . . . -147.88 13.88 1.33 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 1.042 ' NE1' HD22 ' A' ' 49' ' ' LEU . 30.5 m95 -66.68 135.0 53.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.163 -1.198 . . . . 0.0 110.367 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.688 ' O ' HG13 ' A' ' 47' ' ' VAL . 1.2 m -129.76 156.54 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.0 110.052 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.413 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . . . -139.1 130.87 27.54 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.474 -0.767 . . . . 0.0 108.959 179.284 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.578 ' CE2' ' O ' ' A' ' 46' ' ' GLY . 9.3 p90 -121.62 158.8 27.83 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.098 -1.001 . . . . 0.0 111.73 -178.2 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.605 ' HA2' ' CE1' ' A' ' 43' ' ' TYR . . . 75.27 36.38 45.36 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . 1.078 HG22 HG13 ' A' ' 45' ' ' VAL . 15.0 p -128.29 -160.69 1.04 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.089 -1.242 . . . . 0.0 110.5 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -98.42 39.19 1.26 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.37 -0.831 . . . . 0.0 110.249 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 133.89 175.31 13.86 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.455 ' O ' ' O ' ' A' ' 25' ' ' LEU . 46.8 Cg_endo -73.34 138.45 27.41 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.018 1.536 . . . . 0.0 110.563 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.923 HD12 HD11 ' A' ' 32' ' ' LEU . 0.8 OUTLIER -42.2 165.09 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.416 -0.802 . . . . 0.0 110.142 179.844 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -150.62 150.45 31.18 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.19 -0.944 . . . . 0.0 110.297 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.499 HG22 ' HA ' ' A' ' 32' ' ' LEU . 0.8 OUTLIER -119.94 -76.98 0.57 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.272 -0.893 . . . . 0.0 110.058 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.446 ' O ' ' N ' ' A' ' 30' ' ' GLY . 25.6 t 55.53 -88.28 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.252 -0.905 . . . . 0.0 110.605 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.553 HG23 ' H ' ' A' ' 31' ' ' ALA . 9.6 t -40.5 -27.62 0.05 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.398 -0.814 . . . . 0.0 110.573 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 28' ' ' SER . . . 132.13 -42.75 1.35 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.553 ' H ' HG23 ' A' ' 29' ' ' THR . . . -89.82 144.75 25.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.297 -1.119 . . . . 0.0 109.876 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.923 HD11 HD12 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -79.33 95.37 5.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.226 -0.921 . . . . 0.0 110.469 -179.786 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 0.8 OUTLIER -93.99 115.83 28.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.28 -0.887 . . . . 0.0 111.093 179.563 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.42 ' H ' HG22 ' A' ' 34' ' ' VAL . 15.9 m -89.31 142.12 13.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.51 76.63 8.18 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.379 -0.826 . . . . 0.0 110.777 -178.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.058 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 95.6 t -68.97 125.11 91.66 Favored Pre-proline 0 C--N 1.302 -1.463 0 O-C-N 121.443 -0.785 . . . . 0.0 109.08 179.173 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.517 ' HD3' ' HA ' ' A' ' 21' ' ' THR . 38.7 Cg_endo -65.82 175.64 4.35 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.966 1.508 . . . . 0.0 112.107 -178.51 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.531 ' HA ' ' CA ' ' A' ' 136' ' ' ALA . . . -53.94 121.64 8.43 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.566 -0.709 . . . . 0.0 111.412 -178.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 134' ' ' ALA . . . 37.73 27.86 0.03 OUTLIER Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 38' ' ' ALA . 22.4 m 33.16 61.34 0.42 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.74 -0.859 . . . . 0.0 110.103 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.546 ' O ' ' CG ' ' A' ' 42' ' ' GLN . . . -88.54 133.94 34.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.45 -0.781 . . . . 0.0 110.444 -178.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.546 ' CG ' ' O ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER 59.49 30.03 19.66 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.192 0.52 . . . . 0.0 109.766 -179.454 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.61 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.1 OUTLIER -161.94 82.37 0.57 Allowed 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 118.776 -1.17 . . . . 0.0 111.707 -178.587 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.553 ' HA2' ' CA ' ' A' ' 130' ' ' GLY . . . -50.33 99.26 0.03 OUTLIER Glycine 0 N--CA 1.482 1.761 0 N-CA-C 107.091 -2.404 . . . . 0.0 107.091 178.119 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 1.078 HG13 HG22 ' A' ' 21' ' ' THR . 3.1 t -87.2 111.8 22.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 120.976 -1.308 . . . . 0.0 108.812 -178.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.578 ' O ' ' CE2' ' A' ' 19' ' ' TYR . . . -136.78 141.78 12.82 Favored Glycine 0 N--CA 1.486 1.98 0 C-N-CA 118.959 -1.591 . . . . 0.0 110.507 -178.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.688 HG13 ' O ' ' A' ' 17' ' ' VAL . 17.0 t -106.21 125.49 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.39 -1.065 . . . . 0.0 109.433 179.419 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.575 ' CG2' ' CG2' ' A' ' 17' ' ' VAL . 35.6 m -119.94 145.22 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.001 -1.062 . . . . 0.0 110.83 -179.225 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 1.042 HD22 ' NE1' ' A' ' 16' ' ' TRP . 10.4 tp -135.23 97.19 3.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.412 -0.805 . . . . 0.0 109.955 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.514 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 3.1 m120 -73.94 129.65 38.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.226 -0.921 . . . . 0.0 110.355 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 146.69 58.23 0.02 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.565 ' CG2' ' HA ' ' A' ' 124' ' ' GLN . 71.3 t -123.2 170.79 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.092 -1.24 . . . . 0.0 110.148 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.686 ' HB3' ' HB1' ' A' ' 1' ' ' ALA . . . -146.91 92.31 2.12 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.198 -0.939 . . . . 0.0 110.572 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.86 HG21 ' HB1' ' A' ' 108' ' ' ALA . 48.6 mm -124.3 156.68 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.244 -0.91 . . . . 0.0 109.793 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.522 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 1.1 tt0 -145.19 130.43 18.56 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.034 -1.041 . . . . 0.0 110.572 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.522 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 10.4 pt-20 38.11 -154.72 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.691 -0.631 . . . . 0.0 110.758 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.461 ' HA2' ' HA ' ' A' ' 109' ' ' SER . . . -83.44 85.91 1.52 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.637 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.2 m -110.59 173.68 6.22 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.248 -1.148 . . . . 0.0 109.821 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.567 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 0.6 OUTLIER -89.88 151.29 21.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.196 -0.94 . . . . 0.0 110.354 -179.881 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.715 ' CE2' HG23 ' A' ' 54' ' ' ILE . 56.9 m-85 -160.2 178.17 9.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.265 -0.897 . . . . 0.0 110.287 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 75.5 m -150.19 119.81 6.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.437 -0.789 . . . . 0.0 109.746 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.685 HD22 ' CD2' ' A' ' 89' ' ' LEU . 17.7 tp -89.48 119.97 30.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.13 -0.981 . . . . 0.0 110.12 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.535 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 10.2 ttp180 -124.4 138.68 54.34 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.373 -0.829 . . . . 0.0 109.806 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.537 ' CE2' ' HB ' ' A' ' 102' ' ' VAL . 0.8 OUTLIER -178.74 142.2 0.21 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.37 -0.831 . . . . 0.0 109.677 179.892 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.517 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 4.3 m -119.22 94.5 4.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.066 -1.021 . . . . 0.0 110.009 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.72 ' CB ' HD21 ' A' ' 95' ' ' LEU . . . -97.12 156.16 16.51 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.377 -0.827 . . . . 0.0 110.412 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 54.9 m -149.63 119.98 7.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.316 -0.865 . . . . 0.0 110.126 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.453 ' CB ' HG12 ' A' ' 72' ' ' VAL . . . -108.2 131.3 54.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.246 -0.909 . . . . 0.0 110.043 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 11.3 t -65.62 -9.23 25.21 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.212 -0.93 . . . . 0.0 110.104 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.644 HG21 ' CB ' ' A' ' 137' ' ' TRP . 6.0 t -116.0 19.54 14.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -0.895 . . . . 0.0 110.266 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.509 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 9.6 t0 42.76 66.49 0.76 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.291 -0.88 . . . . 0.0 109.69 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.853 HG23 ' HB2' ' A' ' 133' ' ' SER . 5.8 p -97.84 141.87 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.407 -0.808 . . . . 0.0 110.826 -179.31 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.496 HG22 ' O ' ' A' ' 73' ' ' THR . 19.5 m -119.76 82.56 1.9 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.377 -0.827 . . . . 0.0 109.163 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.591 ' HA ' ' CD2' ' A' ' 132' ' ' PHE . 17.7 m -90.0 -140.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.243 -0.911 . . . . 0.0 110.739 -179.124 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.525 ' N ' HG23 ' A' ' 74' ' ' VAL . 7.5 mtm180 -130.43 145.01 51.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.19 -0.944 . . . . 0.0 110.828 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.577 ' N ' ' HD3' ' A' ' 93' ' ' PRO . . . -150.5 153.42 35.82 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.417 -0.802 . . . . 0.0 109.479 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.9 HD12 ' N ' ' A' ' 78' ' ' VAL . 3.9 pp 179.86 -147.59 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.136 -0.977 . . . . 0.0 110.4 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.9 ' N ' HD12 ' A' ' 77' ' ' LEU . 5.0 t -149.92 164.97 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.359 -0.838 . . . . 0.0 109.114 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.488 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . -171.81 -175.56 40.15 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 118.958 -1.591 . . . . 0.0 110.693 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.49 ' HA ' ' O ' ' A' ' 122' ' ' GLU . 1.3 tt0 -90.88 -151.63 0.26 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.639 -0.918 . . . . 0.0 110.272 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.519 ' HB2' ' HG2' ' A' ' 122' ' ' GLU . 14.5 m120 -161.81 83.57 0.59 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.434 -0.791 . . . . 0.0 109.582 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.536 ' CA ' ' HB3' ' A' ' 121' ' ' PRO . . . 122.54 136.67 4.93 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.63 ' N ' ' CE1' ' A' ' 85' ' ' TYR . . . -40.45 150.82 0.26 Allowed Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.333 -1.098 . . . . 0.0 110.447 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.467 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.6 Cg_endo -80.07 12.07 23.64 Favored 'Cis proline' 0 C--N 1.313 -1.334 0 C-N-CA 121.711 -2.204 . . . . 0.0 110.938 -0.013 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.63 ' CE1' ' N ' ' A' ' 83' ' ' ALA . 27.2 m-85 63.6 163.65 0.12 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.187 -0.946 . . . . 0.0 110.282 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 176.4 131.9 1.55 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.471 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 0.7 OUTLIER -117.73 153.31 33.6 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.227 -1.161 . . . . 0.0 110.282 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 1.015 HG23 HD12 ' A' ' 89' ' ' LEU . 31.3 m -124.88 -24.45 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.32 -0.863 . . . . 0.0 110.305 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 1.015 HD12 HG23 ' A' ' 88' ' ' VAL . 3.8 mp -104.79 144.29 31.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.204 -0.935 . . . . 0.0 110.952 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -151.5 76.66 1.22 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.348 -0.845 . . . . 0.0 109.974 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 67.1 p -142.71 -178.72 5.93 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.978 -1.076 . . . . 0.0 110.756 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.94 128.03 26.07 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.457 -0.777 . . . . 0.0 110.07 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.577 ' HD3' ' N ' ' A' ' 76' ' ' ALA . 46.4 Cg_endo -72.5 78.2 2.03 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.95 1.5 . . . . 0.0 111.038 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.535 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -56.43 139.64 48.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.057 -1.027 . . . . 0.0 109.223 179.255 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.829 ' CD1' HD21 ' A' ' 139' ' ' LEU . 44.4 mt -135.61 160.15 39.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.007 -1.058 . . . . 0.0 110.907 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.698 HG22 ' HG3' ' A' ' 100' ' ' ARG . 0.2 OUTLIER -158.59 -179.02 7.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.476 -0.765 . . . . 0.0 109.926 179.949 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.81 -27.65 69.32 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -0.933 . . . . 0.0 110.118 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.465 ' CB ' ' HD2' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -90.51 176.65 2.8 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.184 -0.948 . . . . 0.0 110.018 179.824 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.465 ' HD2' ' CB ' ' A' ' 98' ' ' GLU . 44.9 Cg_endo -72.08 135.61 25.5 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.928 1.488 . . . . 0.0 110.381 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.698 ' HG3' HG22 ' A' ' 96' ' ' THR . 0.0 OUTLIER -119.84 93.49 4.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.228 -0.92 . . . . 0.0 110.208 179.985 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -87.61 97.25 10.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.371 -0.831 . . . . 0.0 110.359 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.537 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 40.2 t -89.55 134.03 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.347 -0.846 . . . . 0.0 110.216 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -150.25 133.81 16.58 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.219 -0.925 . . . . 0.0 110.211 179.902 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -160.26 135.62 8.09 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.909 . . . . 0.0 110.245 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.486 HG23 ' O ' ' A' ' 60' ' ' TYR . 85.3 m -90.03 125.87 35.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.224 -0.922 . . . . 0.0 110.053 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.953 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 28.2 p90 -132.31 156.03 47.3 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.185 -0.947 . . . . 0.0 110.354 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.2 m -90.06 94.92 9.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.224 -0.923 . . . . 0.0 109.897 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.86 ' HB1' HG21 ' A' ' 54' ' ' ILE . . . -53.02 107.5 0.23 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.252 -0.905 . . . . 0.0 110.329 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.461 ' HA ' ' HA2' ' A' ' 57' ' ' GLY . 24.6 p -94.06 53.26 1.74 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.264 -0.898 . . . . 0.0 110.017 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -162.09 -153.55 0.28 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.297 -0.877 . . . . 0.0 110.278 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.494 HG23 ' HA ' ' A' ' 55' ' ' GLU . 5.2 m -147.27 118.38 7.74 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.283 -0.886 . . . . 0.0 110.172 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.63 ' OH ' HG22 ' A' ' 88' ' ' VAL . 20.3 m-30 -113.23 70.21 1.36 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.303 -0.873 . . . . 0.0 109.971 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.493 ' HD3' HG22 ' A' ' 111' ' ' THR . 46.3 Cg_endo -72.39 -159.06 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.035 1.545 . . . . 0.0 110.436 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -147.37 27.29 1.03 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.228 -0.92 . . . . 0.0 110.206 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.79 100.85 11.94 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.231 -0.918 . . . . 0.0 110.25 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' ' 120' ' ' ASP . 47.6 Cg_endo -73.9 118.22 5.34 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.029 1.542 . . . . 0.0 110.444 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.724 ' HB3' ' HB2' ' A' ' 120' ' ' ASP . . . -123.59 -160.06 0.89 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.231 -0.918 . . . . 0.0 110.138 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.12 -16.98 5.92 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.26 -0.9 . . . . 0.0 110.191 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.406 ' O ' ' HD3' ' A' ' 121' ' ' PRO . 10.0 t0 -169.87 28.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.3 -0.875 . . . . 0.0 110.146 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.724 ' HB2' ' HB3' ' A' ' 117' ' ' ALA . 0.7 OUTLIER -109.72 88.34 6.44 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.246 -0.909 . . . . 0.0 110.244 -179.957 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.536 ' HB3' ' CA ' ' A' ' 82' ' ' GLY . 46.2 Cg_endo -73.1 156.31 51.74 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.074 1.565 . . . . 0.0 110.266 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.519 ' HG2' ' HB2' ' A' ' 81' ' ' ASN . 0.8 OUTLIER -106.27 -163.02 0.89 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.131 -0.98 . . . . 0.0 109.878 179.802 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.576 ' HA3' ' CG ' ' A' ' 112' ' ' TYR . . . -144.37 149.09 21.13 Favored Glycine 0 N--CA 1.491 2.321 0 C-N-CA 119.56 -1.305 . . . . 0.0 109.889 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.653 ' O ' HG13 ' A' ' 78' ' ' VAL . 19.4 pt20 -150.51 -153.11 0.47 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.314 -1.11 . . . . 0.0 110.085 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.78 HG21 ' CH2' ' A' ' 16' ' ' TRP . 14.2 mt -118.18 139.23 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.487 -0.758 . . . . 0.0 109.359 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -117.12 123.62 47.2 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.291 -0.88 . . . . 0.0 110.933 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.475 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 4.5 m-85 -118.84 103.18 9.39 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 1.058 ' O ' HD23 ' A' ' 129' ' ' LEU . 2.0 mt-30 -89.11 129.87 35.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.203 -0.935 . . . . 0.0 111.714 -177.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 1.058 HD23 ' O ' ' A' ' 128' ' ' GLN . 0.8 OUTLIER -141.53 34.08 1.64 Allowed 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.441 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.553 ' CA ' ' HA2' ' A' ' 44' ' ' GLY . . . -82.23 118.96 4.74 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 39' ' ' GLY . . . 42.56 69.99 0.54 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.591 ' CD2' ' HA ' ' A' ' 74' ' ' VAL . 11.2 m-85 -117.35 -61.81 1.65 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.109 -1.23 . . . . 0.0 111.006 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.853 ' HB2' HG23 ' A' ' 72' ' ' VAL . 1.3 t -88.36 -176.46 5.35 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.02 -1.05 . . . . 0.0 110.693 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -92.53 -82.03 0.33 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.276 -0.89 . . . . 0.0 110.225 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -70.25 177.77 3.15 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.147 -0.971 . . . . 0.0 109.765 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.531 ' CA ' ' HA ' ' A' ' 38' ' ' ALA . . . -75.2 138.81 42.21 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.297 -0.877 . . . . 0.0 110.736 -179.507 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 1.058 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 9.0 p90 -140.99 -171.41 3.25 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.263 -0.898 . . . . 0.0 110.682 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.516 ' C ' HD12 ' A' ' 139' ' ' LEU 0.251 0.8 OUTLIER -149.25 171.34 16.65 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.536 -0.727 . . . . 0.0 109.702 -177.986 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.829 HD21 ' CD1' ' A' ' 95' ' ' LEU . 1.7 mp -139.47 117.91 12.11 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.998 -1.064 . . . . 0.0 112.11 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' CYS . . . . . 0.471 ' SG ' ' HB3' ' A' ' 31' ' ' ALA . 0.8 OUTLIER -103.4 110.11 22.0 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.646 -0.659 . . . . 0.0 110.64 178.186 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.569 HD23 ' HB2' ' A' ' 66' ' ' ALA . 1.3 mt -97.28 -178.5 4.19 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.277 -0.89 . . . . 0.0 108.974 178.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 143' ' ' ASP . 0.5 OUTLIER 169.31 61.12 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.145 -0.972 . . . . 0.0 110.407 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.53 ' CB ' ' O ' ' A' ' 142' ' ' ASP . 0.5 OUTLIER 166.35 43.26 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.388 -0.82 . . . . 0.0 109.344 179.852 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.795 HG11 ' HZ2' ' A' ' 16' ' ' TRP . 1.5 t -89.45 114.33 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.373 -0.83 . . . . 0.0 110.281 -179.244 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.859 ' HB1' ' HG2' ' A' ' 6' ' ' GLU . . . -151.84 148.45 27.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.413 -0.804 . . . . 0.0 110.081 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.835 HD21 HD11 ' A' ' 54' ' ' ILE . 38.8 tp -146.54 123.57 11.41 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.341 -0.849 . . . . 0.0 110.099 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.479 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -140.66 157.57 45.25 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.235 -0.916 . . . . 0.0 110.373 -179.938 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 59' ' ' THR . 24.4 p -98.66 115.5 28.83 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.282 -0.886 . . . . 0.0 110.136 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.67 162.17 27.94 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.208 -0.933 . . . . 0.0 110.215 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 16.6 m -89.25 31.43 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.221 -0.924 . . . . 0.0 110.185 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -97.39 113.21 24.83 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.288 -0.882 . . . . 0.0 110.21 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.4 tp . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.199 -179.974 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.265 0.555 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.8 t 179.06 66.9 0.12 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 0.0 110.184 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -75.94 -156.34 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.013 1.533 . . . . 0.0 110.09 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.0 pt -96.38 -28.93 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.183 -0.948 . . . . 0.0 110.181 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.51 ' O ' ' N ' ' A' ' 7' ' ' GLY . . . 99.4 106.47 2.71 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.617 ' HA ' ' HB2' ' A' ' 145' ' ' ALA . 0.6 OUTLIER -45.01 93.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.231 -1.158 . . . . 0.0 110.069 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 5' ' ' GLY . . . -139.55 177.84 20.12 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.671 HG22 ' HA ' ' A' ' 143' ' ' ASP . 29.4 p -129.52 20.35 5.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.386 -1.067 . . . . 0.0 109.818 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.643 ' HB3' HG21 ' A' ' 27' ' ' THR . 3.2 m-30 70.71 -78.96 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.812 -0.555 . . . . 0.0 110.671 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.555 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 1.4 p30 40.02 27.87 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.095 -1.003 . . . . 0.0 110.505 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.555 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 1.9 t70 161.13 -57.84 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.54 0.686 . . . . 0.0 109.235 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 9' ' ' PHE . . . -133.67 127.13 4.53 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.583 ' HA ' ' CD1' ' A' ' 9' ' ' PHE . 52.4 Cg_endo -81.82 29.85 0.53 Allowed 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.819 1.431 . . . . 0.0 111.16 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 0.2 OUTLIER 62.23 -89.35 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.997 -1.065 . . . . 0.0 110.326 179.923 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -149.73 22.19 1.16 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.84 ' HZ2' HG11 ' A' ' 144' ' ' VAL . 40.0 m95 -61.69 142.56 57.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.276 -1.132 . . . . 0.0 110.381 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.732 ' O ' HG13 ' A' ' 47' ' ' VAL . 0.8 OUTLIER -132.87 140.87 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.232 -0.918 . . . . 0.0 109.222 179.15 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.5 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . . . -125.15 114.75 19.43 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.97 -1.081 . . . . 0.0 110.235 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.887 ' HE2' HG13 ' A' ' 48' ' ' VAL . 40.0 p90 -100.93 150.53 22.77 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.691 -0.631 . . . . 0.0 109.924 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.777 ' C ' HG23 ' A' ' 21' ' ' THR . . . 112.58 87.2 1.64 Allowed Glycine 0 N--CA 1.483 1.802 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.777 HG23 ' C ' ' A' ' 20' ' ' GLY . 1.4 p 75.24 -139.81 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.116 0 O-C-N 122.064 -0.668 . . . . 0.0 110.333 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.96 ' O ' ' HB3' ' A' ' 35' ' ' ALA . 2.5 m-20 -88.72 116.84 27.27 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.884 -1.135 . . . . 0.0 110.075 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.557 ' N ' ' CD ' ' A' ' 24' ' ' PRO . . . -119.61 49.24 0.88 Allowed Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.557 ' CD ' ' N ' ' A' ' 23' ' ' GLY . 43.4 Cg_endo -69.89 82.17 0.8 Allowed 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 124.024 1.539 . . . . 0.0 109.677 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.784 HD13 HD11 ' A' ' 32' ' ' LEU . 40.8 mt -50.93 88.52 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.44 -0.787 . . . . 0.0 110.422 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 24' ' ' PRO . 0.3 OUTLIER -91.22 120.95 32.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -0.885 . . . . 0.0 109.442 179.626 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.643 HG21 ' HB3' ' A' ' 9' ' ' PHE . 1.2 p -119.54 -27.39 5.54 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.076 -1.015 . . . . 0.0 110.889 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 27' ' ' THR . 74.4 m -43.46 -28.08 0.33 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.186 -0.946 . . . . 0.0 109.192 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.606 HG23 ' N ' ' A' ' 30' ' ' GLY . 6.3 t -67.78 -47.89 67.87 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.629 -0.669 . . . . 0.0 110.482 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.606 ' N ' HG23 ' A' ' 29' ' ' THR . . . 164.93 -25.94 0.18 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.661 ' HB1' ' O ' ' A' ' 141' ' ' LEU . . . -150.54 159.67 44.33 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.295 -1.121 . . . . 0.0 110.218 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.784 HD11 HD13 ' A' ' 25' ' ' LEU . 0.6 OUTLIER -72.71 102.0 3.22 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.314 -0.866 . . . . 0.0 110.328 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.58 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 0.8 OUTLIER -98.84 119.76 38.14 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.167 -0.958 . . . . 0.0 111.913 -179.915 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.659 HG12 ' CD2' ' A' ' 25' ' ' LEU . 17.2 m -96.92 150.11 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.96 ' HB3' ' O ' ' A' ' 22' ' ' ASP . . . -89.95 121.75 32.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.054 -1.029 . . . . 0.0 111.781 -178.264 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.081 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 66.5 t -119.56 125.8 27.29 Favored Pre-proline 0 C--N 1.303 -1.452 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 178.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 38' ' ' ALA . 44.8 Cg_endo -71.59 147.39 51.42 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 123.811 1.427 . . . . 0.0 110.929 -178.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.489 ' HA ' ' N ' ' A' ' 136' ' ' ALA . . . -43.03 123.97 3.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.364 -0.835 . . . . 0.0 109.277 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 134' ' ' ALA . . . 61.39 78.8 0.15 Allowed Glycine 0 N--CA 1.486 1.968 0 N-CA-C 108.0 -2.04 . . . . 0.0 108.0 -178.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.667 ' HB2' HG21 ' A' ' 45' ' ' VAL . 2.4 p -85.28 53.63 2.82 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.542 -0.975 . . . . 0.0 110.076 -179.215 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.566 ' O ' ' O ' ' A' ' 42' ' ' GLN . . . -88.83 -147.49 0.16 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.69 -0.631 . . . . 0.0 110.024 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.701 ' O ' ' CD2' ' A' ' 43' ' ' TYR . 5.8 pt20 38.94 102.98 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 CA-C-O 121.761 0.791 . . . . 0.0 110.522 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.701 ' CD2' ' O ' ' A' ' 42' ' ' GLN . 0.0 OUTLIER 77.7 -20.95 0.35 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.729 -1.232 . . . . 0.0 110.275 -178.797 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.584 ' O ' ' CD1' ' A' ' 43' ' ' TYR . . . 57.71 141.95 0.01 OUTLIER Glycine 0 N--CA 1.492 2.398 0 O-C-N 120.952 -1.092 . . . . 0.0 111.196 178.155 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.76 HG13 ' HA3' ' A' ' 20' ' ' GLY . 2.5 t -93.35 -172.66 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.306 -1.114 . . . . 0.0 108.762 179.013 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.604 ' H ' HG12 ' A' ' 45' ' ' VAL . . . 172.13 -175.4 45.41 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 118.635 -1.745 . . . . 0.0 111.464 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.732 HG13 ' O ' ' A' ' 17' ' ' VAL . 35.5 t -150.6 133.75 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.887 HG13 ' HE2' ' A' ' 19' ' ' TYR . 22.5 m -123.66 138.5 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 120.81 -1.181 . . . . 0.0 110.99 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.643 ' CD2' ' CE2' ' A' ' 16' ' ' TRP . 5.2 tp -132.03 98.87 4.55 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.326 -0.859 . . . . 0.0 110.202 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.518 ' O ' ' ND2' ' A' ' 50' ' ' ASN . 3.4 p-10 -73.46 98.88 2.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 0.0 110.091 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 172.7 77.57 0.05 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.672 HG23 ' HA ' ' A' ' 124' ' ' GLN . 12.4 t -134.93 169.17 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.215 -1.168 . . . . 0.0 109.937 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.412 ' O ' HD13 ' A' ' 54' ' ' ILE . . . -136.46 79.7 1.78 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.107 -0.995 . . . . 0.0 110.671 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.836 HD11 HD21 ' A' ' 146' ' ' LEU . 36.0 mm -115.63 158.91 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.209 -0.932 . . . . 0.0 109.934 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.578 ' HA ' HG23 ' A' ' 111' ' ' THR . 3.8 tt0 -152.04 124.25 8.18 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.116 -0.99 . . . . 0.0 110.438 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.53 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 11.5 pt-20 37.73 -152.93 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.669 -0.645 . . . . 0.0 110.789 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.455 ' N ' ' HG3' ' A' ' 56' ' ' GLU . . . -82.03 99.95 2.07 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.651 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.2 m -132.46 174.16 10.55 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.33 -1.1 . . . . 0.0 109.855 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.568 ' N ' ' CG2' ' A' ' 58' ' ' THR . 1.3 m -89.72 152.97 21.06 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.226 -0.921 . . . . 0.0 110.191 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.651 ' CE2' HG22 ' A' ' 58' ' ' THR . 57.9 m-85 -158.6 158.61 34.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.255 -0.903 . . . . 0.0 110.28 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 87.8 m -132.37 117.3 17.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.317 -0.865 . . . . 0.0 109.971 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 20.1 tp -89.73 121.49 31.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.188 -0.945 . . . . 0.0 110.156 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.5 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 9.5 ttp180 -125.78 131.84 52.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 110.12 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 1.196 ' CZ ' HG21 ' A' ' 102' ' ' VAL . 2.7 p90 -169.8 146.64 3.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.221 -0.924 . . . . 0.0 109.975 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.503 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 3.4 m -119.49 101.33 7.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.199 -0.938 . . . . 0.0 109.745 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.659 ' CB ' HD21 ' A' ' 95' ' ' LEU . . . -104.83 150.79 24.52 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.356 -0.84 . . . . 0.0 110.497 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.756 HG23 ' O ' ' A' ' 98' ' ' GLU . 86.0 m -150.43 106.48 3.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.32 -0.863 . . . . 0.0 110.161 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.472 ' O ' ' O ' ' A' ' 96' ' ' THR . . . -95.73 127.04 41.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.206 -0.934 . . . . 0.0 109.951 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 68' ' ' ALA . 39.9 t -42.56 -26.95 0.14 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.284 -0.885 . . . . 0.0 109.843 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.557 ' CG2' ' CB ' ' A' ' 137' ' ' TRP . 2.6 t -108.5 159.95 16.28 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.356 -0.84 . . . . 0.0 110.056 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 60.4 t0 -78.31 78.63 4.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.121 -0.987 . . . . 0.0 109.215 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.702 HG23 ' CB ' ' A' ' 133' ' ' SER . 4.4 p -106.64 145.72 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.186 -0.946 . . . . 0.0 111.239 -178.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.476 ' O ' ' CD1' ' A' ' 132' ' ' PHE . 98.2 m -126.02 91.35 3.36 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.785 HG12 ' CD2' ' A' ' 132' ' ' PHE . 15.4 m -89.77 -152.11 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.196 -0.94 . . . . 0.0 110.833 -178.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.529 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 8.2 mtm180 -129.21 136.34 50.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.332 -0.855 . . . . 0.0 110.647 -179.173 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.691 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -135.67 153.56 51.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.388 -0.82 . . . . 0.0 109.648 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.891 HD12 ' N ' ' A' ' 78' ' ' VAL . 4.0 pp -179.74 -150.02 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.243 -0.911 . . . . 0.0 110.377 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.891 ' N ' HD12 ' A' ' 77' ' ' LEU . 3.5 t -150.87 170.54 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.29 -0.881 . . . . 0.0 109.616 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.575 ' O ' ' CE1' ' A' ' 112' ' ' TYR . . . -174.83 -162.43 26.3 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.404 -1.379 . . . . 0.0 110.256 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.544 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 3.5 tm0? -120.9 128.21 52.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.448 -1.031 . . . . 0.0 110.655 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.514 ' OD1' ' CG ' ' A' ' 124' ' ' GLN . 4.5 m120 -83.46 67.64 9.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.4 -0.812 . . . . 0.0 109.813 179.37 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.543 ' HA3' ' CB ' ' A' ' 121' ' ' PRO . . . 166.7 141.36 3.13 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.618 ' N ' ' CE1' ' A' ' 85' ' ' TYR . . . -61.97 156.06 59.63 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.245 -1.15 . . . . 0.0 110.134 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.52 ' C ' ' CD2' ' A' ' 85' ' ' TYR . 49.9 Cg_endo -77.22 8.15 17.63 Favored 'Cis proline' 0 C--N 1.312 -1.377 0 C-N-CA 121.692 -2.212 . . . . 0.0 110.904 0.103 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.618 ' CE1' ' N ' ' A' ' 83' ' ' ALA . 11.7 m-85 70.15 158.19 0.17 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.26 -0.9 . . . . 0.0 110.196 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -177.68 114.27 0.46 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.471 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 1.6 p -89.92 147.15 23.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.243 -1.151 . . . . 0.0 110.329 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.794 HG23 HD12 ' A' ' 89' ' ' LEU . 16.4 m -119.96 -24.0 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.29 -0.881 . . . . 0.0 110.016 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.832 HD22 HG23 ' A' ' 78' ' ' VAL . 4.2 mp -105.74 145.22 31.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 110.792 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -151.19 78.23 1.28 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.326 -0.859 . . . . 0.0 109.996 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.0 p -140.22 170.63 15.48 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.028 -1.045 . . . . 0.0 110.686 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.403 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 1.2 m -120.09 115.62 33.02 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.383 -0.823 . . . . 0.0 110.087 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.691 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 45.2 Cg_endo -70.68 128.76 15.61 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.901 1.474 . . . . 0.0 111.057 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.511 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -94.25 148.12 22.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.32 -0.862 . . . . 0.0 109.407 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.792 ' CD1' HD21 ' A' ' 139' ' ' LEU . 77.1 mt -141.15 157.39 45.33 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.019 -1.051 . . . . 0.0 110.807 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.515 HG23 ' N ' ' A' ' 97' ' ' SER . 6.0 t -164.47 -156.58 0.33 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.407 -0.808 . . . . 0.0 109.902 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.515 ' N ' HG23 ' A' ' 96' ' ' THR . 0.1 OUTLIER -89.11 34.05 0.79 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.177 -0.952 . . . . 0.0 110.244 179.91 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.756 ' O ' HG23 ' A' ' 67' ' ' THR . 0.1 OUTLIER -150.16 168.02 11.83 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.304 -0.872 . . . . 0.0 110.068 179.899 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.476 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 45.5 Cg_endo -72.41 127.74 12.9 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.005 1.529 . . . . 0.0 110.313 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.511 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 1.2 ttm180 -119.46 91.83 3.64 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.179 -0.951 . . . . 0.0 110.152 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.479 ' HG3' ' OG1' ' A' ' 65' ' ' THR . 0.0 OUTLIER -73.89 147.12 43.49 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.341 -0.85 . . . . 0.0 109.963 179.93 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 1.196 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 19.6 t -124.03 135.17 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.227 -0.92 . . . . 0.0 110.296 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.408 ' C ' ' HG3' ' A' ' 104' ' ' GLU . 0.2 OUTLIER -150.18 96.66 2.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.283 -0.886 . . . . 0.0 110.196 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.408 ' HG3' ' C ' ' A' ' 103' ' ' THR . 43.0 mt-10 -142.39 160.09 40.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.216 -0.927 . . . . 0.0 110.256 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 1.2 t -114.97 170.74 8.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.251 -0.906 . . . . 0.0 110.164 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.788 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 41.7 p90 -173.06 153.89 2.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.248 -0.907 . . . . 0.0 110.289 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 58' ' ' THR . 16.4 m -89.92 90.37 8.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.884 . . . . 0.0 109.993 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.632 ' HB3' ' CE2' ' A' ' 60' ' ' TYR . . . -54.15 113.49 1.26 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.296 -0.878 . . . . 0.0 110.393 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 68.7 p -97.33 54.79 1.23 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.224 -0.922 . . . . 0.0 109.993 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.439 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -165.14 -159.0 0.41 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.3 -0.875 . . . . 0.0 110.236 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.578 HG23 ' HA ' ' A' ' 55' ' ' GLU . 13.6 m -147.77 117.9 7.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.223 -0.923 . . . . 0.0 110.342 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.577 ' CD2' HG13 ' A' ' 54' ' ' ILE . 17.4 m-30 -115.9 80.39 8.82 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.29 -0.881 . . . . 0.0 109.841 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.475 ' O ' ' HB2' ' A' ' 122' ' ' GLU . 44.5 Cg_endo -72.32 -164.56 0.18 Allowed 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.92 1.484 . . . . 0.0 110.51 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -141.48 47.46 1.68 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.209 -0.932 . . . . 0.0 110.25 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.465 ' O ' ' O ' ' A' ' 120' ' ' ASP . 0.3 OUTLIER -128.17 72.24 79.55 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 0.0 110.184 -179.972 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' A' ' 120' ' ' ASP . 45.8 Cg_endo -72.89 121.57 7.44 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.071 1.563 . . . . 0.0 110.458 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.63 ' HB3' ' HB2' ' A' ' 120' ' ' ASP . . . -144.78 -160.07 1.08 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.244 -0.91 . . . . 0.0 110.189 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -75.1 -9.45 58.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.301 -0.874 . . . . 0.0 110.237 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.433 ' OD1' ' OD1' ' A' ' 120' ' ' ASP . 4.7 p30 -155.19 18.84 0.42 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.219 -0.925 . . . . 0.0 110.181 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.63 ' HB2' ' HB3' ' A' ' 117' ' ' ALA . 3.5 m-20 -132.71 90.15 33.42 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.251 -0.906 . . . . 0.0 110.23 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.543 ' CB ' ' HA3' ' A' ' 82' ' ' GLY . 45.7 Cg_endo -72.89 -159.07 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.018 1.536 . . . . 0.0 110.391 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.521 ' HG2' ' N ' ' A' ' 123' ' ' GLY . 4.9 pm0 -163.42 -137.78 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.179 -0.951 . . . . 0.0 110.408 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.544 ' HA2' ' HA ' ' A' ' 80' ' ' GLN . . . -145.82 158.26 27.62 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.672 ' HA ' HG23 ' A' ' 52' ' ' VAL . 9.7 pt20 -150.23 -161.0 1.25 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.071 -1.252 . . . . 0.0 110.748 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.693 HG21 ' HH2' ' A' ' 16' ' ' TRP . 30.4 mt -118.97 148.63 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.49 -0.756 . . . . 0.0 109.413 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.471 ' HB3' ' HG ' ' A' ' 77' ' ' LEU . . . -117.36 120.13 37.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.35 -0.844 . . . . 0.0 111.426 -179.108 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.544 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 5.3 m-85 -125.14 77.47 1.63 Allowed 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.503 ' HA ' ' CA ' ' A' ' 46' ' ' GLY . 8.4 mt-30 -87.47 121.19 29.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.135 -0.978 . . . . 0.0 111.706 -177.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.833 HD13 HD13 ' A' ' 139' ' ' LEU . 6.4 mt -105.24 49.19 0.81 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.534 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -91.34 137.71 13.95 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.579 ' O ' ' CD1' ' A' ' 132' ' ' PHE . . . 41.96 93.23 0.01 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.785 ' CD2' HG12 ' A' ' 74' ' ' VAL . 13.0 m-85 -154.86 -74.97 0.11 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -1.168 . . . . 0.0 110.353 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.702 ' CB ' HG23 ' A' ' 72' ' ' VAL . 1.4 t -89.5 166.49 13.64 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.026 -1.046 . . . . 0.0 110.26 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -101.85 -59.41 1.71 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.18 -0.95 . . . . 0.0 110.552 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.422 ' C ' ' HA ' ' A' ' 38' ' ' ALA . 15.8 m-20 -73.09 152.45 41.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.189 -0.944 . . . . 0.0 110.261 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.489 ' N ' ' HA ' ' A' ' 38' ' ' ALA . . . -49.2 133.58 18.92 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.19 -0.944 . . . . 0.0 109.925 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 1.081 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 6.2 p90 -147.25 -173.6 4.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.123 -0.985 . . . . 0.0 110.944 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.53 ' CG2' ' N ' ' A' ' 139' ' ' LEU 0.25 0.8 OUTLIER -154.09 178.75 9.61 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.538 -0.726 . . . . 0.0 109.369 -178.372 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.833 HD13 HD13 ' A' ' 129' ' ' LEU . 1.6 mp -138.16 115.93 11.47 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.846 -1.159 . . . . 0.0 112.195 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' CYS . . . . . 0.632 ' HB3' ' HB3' ' A' ' 31' ' ' ALA . 0.8 OUTLIER -103.51 107.44 18.29 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.71 -0.619 . . . . 0.0 110.929 178.351 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.661 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 3.9 mt -94.42 179.92 5.12 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.246 -0.909 . . . . 0.0 108.961 178.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 142' ' ' ASP . 2.0 p30 168.31 61.15 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.044 -1.035 . . . . 0.0 110.578 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.671 ' HA ' HG22 ' A' ' 8' ' ' THR . 0.5 OUTLIER 164.92 45.63 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.444 -0.785 . . . . 0.0 109.355 179.773 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.84 HG11 ' HZ2' ' A' ' 16' ' ' TRP . 1.1 t -89.46 115.66 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.309 -0.87 . . . . 0.0 110.316 -179.122 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.617 ' HB2' ' HA ' ' A' ' 6' ' ' GLU . . . -144.45 155.37 43.7 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.431 -0.793 . . . . 0.0 110.151 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.836 HD21 HD11 ' A' ' 54' ' ' ILE . 39.4 tp -148.98 141.71 24.53 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.332 -0.855 . . . . 0.0 110.177 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.478 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 0.5 OUTLIER -151.4 176.85 10.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.237 -0.915 . . . . 0.0 110.246 -179.914 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.583 ' HB3' ' CE1' ' A' ' 60' ' ' TYR . 6.2 p -135.13 177.88 7.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.153 -0.967 . . . . 0.0 110.249 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -106.98 142.55 36.42 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.332 -0.855 . . . . 0.0 110.185 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.477 HG22 ' O ' ' A' ' 150' ' ' VAL . 7.9 p -125.68 30.02 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.266 -0.896 . . . . 0.0 110.205 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 61.03 -162.86 0.27 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.286 -0.884 . . . . 0.0 110.2 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.2 mt . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 117.999 -1.0 . . . . 0.0 110.199 -179.988 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.751 ' HB3' ' HB3' ' A' ' 114' ' ' ALA . . . . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.241 0.544 . . . . 0.0 110.238 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -165.09 137.41 3.49 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.281 -0.887 . . . . 0.0 110.216 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -75.7 -155.73 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.984 1.518 . . . . 0.0 110.06 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.666 HG22 ' O ' ' A' ' 51' ' ' GLY . 27.7 pt -89.8 -34.36 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.195 -0.94 . . . . 0.0 110.09 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.528 ' N ' HG13 ' A' ' 4' ' ' ILE . . . -172.31 -119.93 0.54 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 5' ' ' GLY . 1.9 tt0 178.47 31.58 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.217 -1.166 . . . . 0.0 110.242 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.492 ' O ' ' HA ' ' A' ' 143' ' ' ASP . . . 156.32 -116.74 0.74 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.631 HG22 ' O ' ' A' ' 142' ' ' ASP . 3.8 p -108.03 168.28 9.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -1.151 . . . . 0.0 110.034 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.518 ' O ' ' N ' ' A' ' 11' ' ' ASP . 14.7 m-85 -70.05 -33.92 72.57 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.239 -0.913 . . . . 0.0 109.199 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.57 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 20.0 t70 37.01 27.7 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.734 -0.604 . . . . 0.0 111.384 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.57 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.9 OUTLIER 161.31 -66.55 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.313 -0.867 . . . . 0.0 110.184 179.728 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.47 ' O ' ' HB3' ' A' ' 9' ' ' PHE . . . -122.46 145.67 16.52 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.838 ' HB3' HD12 ' A' ' 32' ' ' LEU . 49.5 Cg_endo -76.02 4.95 4.82 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 O-C-N 124.093 1.575 . . . . 0.0 110.814 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.461 ' CB ' ' O ' ' A' ' 13' ' ' PRO . 1.5 mm-40 67.39 -84.77 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.199 -0.938 . . . . 0.0 110.378 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.803 ' O ' HG13 ' A' ' 17' ' ' VAL . . . -137.84 4.35 3.26 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.905 ' NE1' HD22 ' A' ' 49' ' ' LEU . 51.8 m95 -61.75 87.97 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.133 -1.216 . . . . 0.0 110.095 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.803 HG13 ' O ' ' A' ' 15' ' ' GLY . 1.2 m -93.01 162.88 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.228 -0.92 . . . . 0.0 109.976 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . . . -142.67 129.79 20.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.391 -0.818 . . . . 0.0 109.286 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.57 ' CE2' ' O ' ' A' ' 46' ' ' GLY . 10.6 p90 -118.26 157.14 27.59 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.141 -0.974 . . . . 0.0 111.363 -178.412 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.649 ' O ' HG22 ' A' ' 45' ' ' VAL . . . 74.97 41.44 32.7 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . 1.078 HG22 ' CG1' ' A' ' 45' ' ' VAL . 17.2 p -128.11 -154.09 0.61 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.147 -1.208 . . . . 0.0 110.469 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -100.76 38.11 1.59 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.389 -0.819 . . . . 0.0 110.127 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 124.93 -174.89 17.26 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.465 ' O ' ' O ' ' A' ' 25' ' ' LEU . 46.9 Cg_endo -73.47 134.7 21.03 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.046 1.551 . . . . 0.0 110.615 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.826 ' CB ' HG12 ' A' ' 34' ' ' VAL . 0.8 OUTLIER -49.14 -179.98 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.236 -0.915 . . . . 0.0 110.168 179.899 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -155.67 158.51 38.42 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.138 -0.976 . . . . 0.0 110.233 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.965 ' O ' HG22 ' A' ' 29' ' ' THR . 0.9 OUTLIER -119.92 -75.12 0.59 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.328 -0.857 . . . . 0.0 110.039 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 27' ' ' THR . 1.0 OUTLIER 40.53 27.53 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.445 -0.784 . . . . 0.0 110.624 179.843 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.965 HG22 ' O ' ' A' ' 27' ' ' THR . 9.4 t -164.48 23.75 0.06 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.17 -0.956 . . . . 0.0 110.357 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.525 ' CA ' ' HA ' ' A' ' 10' ' ' ASP . . . 60.36 17.93 48.42 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.595 ' O ' HG22 ' A' ' 27' ' ' THR . . . -142.57 153.93 43.98 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.369 -1.077 . . . . 0.0 110.088 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.838 HD12 ' HB3' ' A' ' 13' ' ' PRO . 0.4 OUTLIER -91.89 95.37 9.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.92 . . . . 0.0 110.162 179.996 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 7.4 m -101.27 99.48 9.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.302 -0.874 . . . . 0.0 110.428 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.826 HG12 ' CB ' ' A' ' 25' ' ' LEU . 20.3 m -89.82 145.67 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.257 -0.902 . . . . 0.0 109.624 179.488 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.527 ' HA ' ' OG1' ' A' ' 138' ' ' THR . . . -91.43 99.2 12.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.164 -0.96 . . . . 0.0 110.751 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.995 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 62.9 t -84.94 129.35 56.67 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.263 -0.898 . . . . 0.0 109.46 179.311 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.509 ' HD3' ' HA ' ' A' ' 21' ' ' THR . 38.5 Cg_endo -65.56 178.48 2.14 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 121.704 1.602 . . . . 0.0 112.508 -178.376 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.528 ' HA ' ' CA ' ' A' ' 136' ' ' ALA . . . -61.27 117.16 5.25 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.519 0.676 . . . . 0.0 111.51 -178.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 134' ' ' ALA . . . 37.22 26.93 0.02 OUTLIER Glycine 0 N--CA 1.493 2.494 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.52 ' OG ' HG23 ' A' ' 45' ' ' VAL . 12.6 t 36.84 73.86 0.09 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.405 -1.056 . . . . 0.0 109.859 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.579 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . -87.77 115.0 24.92 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.669 -0.812 . . . . 0.0 109.977 -179.284 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.579 ' HG2' ' O ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER 67.37 10.51 7.79 Favored 'General case' 0 N--CA 1.504 2.26 0 CA-C-O 121.399 0.619 . . . . 0.0 109.965 -179.247 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.601 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.1 OUTLIER -132.32 76.02 1.67 Allowed 'General case' 0 C--N 1.289 -2.044 0 C-N-CA 119.551 -0.86 . . . . 0.0 111.719 -178.162 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.475 ' HA2' ' HA3' ' A' ' 130' ' ' GLY . . . -48.8 98.52 0.02 OUTLIER Glycine 0 N--CA 1.484 1.843 0 N-CA-C 107.362 -2.295 . . . . 0.0 107.362 178.295 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 1.078 ' CG1' HG22 ' A' ' 21' ' ' THR . 2.7 t -86.89 113.7 24.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.185 -1.185 . . . . 0.0 108.693 -178.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.57 ' O ' ' CE2' ' A' ' 19' ' ' TYR . . . -133.35 141.2 12.54 Favored Glycine 0 N--CA 1.487 2.095 0 C-N-CA 119.299 -1.429 . . . . 0.0 110.491 -178.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.709 HG13 ' O ' ' A' ' 17' ' ' VAL . 15.8 t -105.79 123.39 60.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 121.519 -0.989 . . . . 0.0 109.483 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.534 HG13 ' HE2' ' A' ' 19' ' ' TYR . 35.1 m -119.69 140.28 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.003 -1.061 . . . . 0.0 110.72 -179.224 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.905 HD22 ' NE1' ' A' ' 16' ' ' TRP . 20.7 tp -130.91 98.67 4.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.338 -0.851 . . . . 0.0 110.191 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.503 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 19.4 p30 -77.02 138.22 39.46 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.206 -0.934 . . . . 0.0 110.223 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.666 ' O ' HG22 ' A' ' 4' ' ' ILE . . . 134.15 76.08 0.09 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.582 HG12 ' N ' ' A' ' 53' ' ' ALA . 41.5 t -135.51 171.57 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.192 -1.181 . . . . 0.0 110.148 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.582 ' N ' HG12 ' A' ' 52' ' ' VAL . . . -139.59 81.84 1.85 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.105 -0.997 . . . . 0.0 110.665 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.634 HG21 ' HB1' ' A' ' 108' ' ' ALA . 30.1 mm -119.48 159.86 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.301 -0.874 . . . . 0.0 109.774 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.527 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 6.3 tt0 -152.8 131.75 12.54 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.006 -1.059 . . . . 0.0 110.762 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 19.5 pt-20 37.8 -154.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.64 -0.662 . . . . 0.0 111.022 179.556 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.473 ' HA2' ' HA ' ' A' ' 109' ' ' SER . . . -84.58 83.47 1.63 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.636 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.2 m -112.05 170.58 8.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -1.166 . . . . 0.0 109.781 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.567 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 0.7 OUTLIER -89.88 154.12 20.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.234 -0.916 . . . . 0.0 110.311 -179.902 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.636 ' CE2' HG22 ' A' ' 58' ' ' THR . 61.8 m-85 -158.95 -179.62 8.21 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.257 -0.902 . . . . 0.0 110.112 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.519 ' O ' HD12 ' A' ' 146' ' ' LEU . 94.6 m -150.01 111.28 4.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.276 -0.89 . . . . 0.0 110.065 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.643 HD22 ' CD2' ' A' ' 89' ' ' LEU . 20.4 tp -89.7 121.3 31.74 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.183 -0.948 . . . . 0.0 110.201 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.514 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 26.5 ttp180 -127.67 138.11 52.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.324 -0.86 . . . . 0.0 109.894 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.519 ' CE2' ' HB ' ' A' ' 102' ' ' VAL . 6.3 p90 -174.9 151.29 1.35 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.278 -0.889 . . . . 0.0 109.821 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.514 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 78.1 m -119.39 91.03 3.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.149 -0.969 . . . . 0.0 110.092 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.566 ' HB1' HD21 ' A' ' 95' ' ' LEU . . . -89.79 143.1 27.08 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.387 -0.821 . . . . 0.0 110.423 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.468 ' OG1' ' HA ' ' A' ' 99' ' ' PRO . 99.4 m -143.84 116.2 8.53 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.281 -0.887 . . . . 0.0 110.205 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.631 ' HB3' ' HB3' ' A' ' 95' ' ' LEU . . . -109.14 126.48 53.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.3 -0.875 . . . . 0.0 109.874 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.433 ' C ' ' O ' ' A' ' 68' ' ' ALA . 0.4 OUTLIER -43.98 -26.41 0.28 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.234 -0.916 . . . . 0.0 109.573 179.709 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.565 HG22 ' HB2' ' A' ' 137' ' ' TRP . 2.7 t -110.41 169.87 8.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.543 -0.723 . . . . 0.0 110.01 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.488 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 12.5 t70 -87.16 51.85 2.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.177 -0.952 . . . . 0.0 108.988 178.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.999 HG23 ' HB2' ' A' ' 133' ' ' SER . 4.0 p -66.62 135.33 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.519 -0.738 . . . . 0.0 111.353 -178.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 92.2 m -119.86 79.89 1.51 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.728 HG21 HD22 ' A' ' 129' ' ' LEU . 7.5 m -89.68 -142.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.317 -0.864 . . . . 0.0 110.443 -178.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.583 ' N ' HG23 ' A' ' 74' ' ' VAL . 0.7 OUTLIER -130.27 145.88 51.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.164 -0.96 . . . . 0.0 110.718 -179.453 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.87 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -146.19 150.42 35.81 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.333 -0.854 . . . . 0.0 109.594 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.015 HD11 ' HB3' ' A' ' 126' ' ' ALA . 1.3 pp 175.6 -158.81 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.258 -0.901 . . . . 0.0 110.489 -179.536 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.742 HG23 HD22 ' A' ' 89' ' ' LEU . 5.4 t -145.65 167.63 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.415 -0.803 . . . . 0.0 109.299 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.492 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . -178.02 -171.41 41.37 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.168 -1.491 . . . . 0.0 110.444 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.505 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 26.6 tp60 -114.22 102.14 9.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.493 -1.004 . . . . 0.0 110.212 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 6.6 m-20 -63.08 95.57 0.08 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.152 -0.968 . . . . 0.0 110.234 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.536 ' C ' ' CE1' ' A' ' 85' ' ' TYR . . . 119.87 130.43 4.0 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.627 ' N ' ' CE1' ' A' ' 85' ' ' TYR . . . -42.99 153.46 0.34 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.294 -1.121 . . . . 0.0 110.196 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.457 ' C ' ' HA ' ' A' ' 83' ' ' ALA . 51.1 Cg_endo -78.09 11.85 16.16 Favored 'Cis proline' 0 C--N 1.312 -1.352 0 C-N-CA 121.648 -2.23 . . . . 0.0 111.066 0.053 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.627 ' CE1' ' N ' ' A' ' 83' ' ' ALA . 37.1 m-85 61.24 -158.87 0.33 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.098 -1.001 . . . . 0.0 110.197 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 135.9 101.53 0.64 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.8 p -89.84 139.69 30.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.276 -1.131 . . . . 0.0 110.236 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 1.033 HG23 HD12 ' A' ' 89' ' ' LEU . 22.9 m -120.08 -16.77 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.252 -0.905 . . . . 0.0 110.148 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 1.033 HD12 HG23 ' A' ' 88' ' ' VAL . 4.2 mp -118.85 139.59 51.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.296 -0.878 . . . . 0.0 110.978 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -151.12 85.17 1.33 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.425 -0.797 . . . . 0.0 109.969 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.8 p -142.76 -175.59 4.55 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.997 -1.064 . . . . 0.0 110.854 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.53 112.35 35.66 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.444 -0.785 . . . . 0.0 109.905 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.87 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 43.4 Cg_endo -70.77 92.62 0.61 Allowed 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 124.023 1.539 . . . . 0.0 111.109 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.597 ' C ' HD12 ' A' ' 95' ' ' LEU . . . -84.64 129.45 34.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.229 -0.919 . . . . 0.0 109.373 179.113 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.631 ' HB3' ' HB3' ' A' ' 68' ' ' ALA . 7.5 mp -119.69 -178.53 3.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.046 -1.034 . . . . 0.0 111.083 -179.314 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -179.99 -178.59 0.43 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.561 -0.712 . . . . 0.0 109.846 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.93 -12.3 17.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.206 -0.934 . . . . 0.0 110.148 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -99.99 158.83 31.34 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.263 -0.898 . . . . 0.0 110.11 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.468 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 44.3 Cg_endo -72.65 140.12 32.11 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.962 1.506 . . . . 0.0 110.348 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.522 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 32.0 ttm-85 -119.91 94.11 4.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.215 -0.928 . . . . 0.0 110.38 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.481 ' HG2' ' OG1' ' A' ' 65' ' ' THR . 17.0 mt-30 -84.98 92.98 8.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.398 -0.813 . . . . 0.0 109.666 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.519 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 38.9 t -89.12 133.6 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.289 -0.882 . . . . 0.0 110.434 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -150.39 130.26 13.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.404 -0.81 . . . . 0.0 110.028 179.96 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -159.19 139.39 12.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.168 -0.957 . . . . 0.0 110.416 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.489 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 88.0 m -94.7 106.65 18.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.305 -0.872 . . . . 0.0 110.123 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.666 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 38.7 p90 -113.24 157.18 22.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.275 -0.891 . . . . 0.0 110.324 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 58' ' ' THR . 26.2 m -89.97 90.17 8.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.292 -0.88 . . . . 0.0 110.016 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.634 ' HB1' HG21 ' A' ' 54' ' ' ILE . . . -45.88 105.44 0.06 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.258 -0.901 . . . . 0.0 110.348 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.473 ' HA ' ' HA2' ' A' ' 57' ' ' GLY . 79.4 p -91.84 51.4 1.83 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.232 -0.917 . . . . 0.0 110.237 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.43 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -159.46 -155.26 0.45 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.259 -0.901 . . . . 0.0 110.242 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 18.7 m -144.91 113.4 6.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.273 -0.892 . . . . 0.0 110.215 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.568 ' CG ' ' HA3' ' A' ' 123' ' ' GLY . 18.0 m-30 -111.2 86.25 6.15 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.288 -0.882 . . . . 0.0 110.101 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.487 ' HD2' ' OE1' ' A' ' 80' ' ' GLN . 44.6 Cg_endo -72.28 140.16 33.33 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.938 1.494 . . . . 0.0 110.333 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.751 ' HB3' ' HB3' ' A' ' 1' ' ' ALA . . . -85.65 55.95 3.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.21 -0.931 . . . . 0.0 110.266 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.454 ' O ' ' O ' ' A' ' 120' ' ' ASP . 90.6 m -134.47 102.55 11.6 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.278 -0.889 . . . . 0.0 110.207 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -81.35 43.04 1.45 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 124.056 1.556 . . . . 0.0 110.749 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.73 ' HB3' ' HB2' ' A' ' 120' ' ' ASP . . . -100.9 157.2 16.91 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.108 -0.995 . . . . 0.0 110.229 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.22 -54.53 45.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.225 -0.922 . . . . 0.0 110.181 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -72.6 -4.23 29.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.274 -0.891 . . . . 0.0 110.191 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.73 ' HB2' ' HB3' ' A' ' 117' ' ' ALA . 4.3 m-20 -137.52 106.49 8.43 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.313 -0.867 . . . . 0.0 110.172 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.478 ' HB3' ' HA3' ' A' ' 82' ' ' GLY . 46.7 Cg_endo -73.4 -167.41 0.36 Allowed 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.061 1.558 . . . . 0.0 110.456 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.483 ' N ' ' CD ' ' A' ' 122' ' ' GLU . 3.2 pm0 -166.83 149.53 6.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.234 -0.916 . . . . 0.0 110.177 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.568 ' HA3' ' CG ' ' A' ' 112' ' ' TYR . . . -89.48 150.55 21.31 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.524 ' O ' HG13 ' A' ' 78' ' ' VAL . 1.2 pp0? -150.31 -157.75 0.85 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.315 -1.109 . . . . 0.0 110.399 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.881 HG21 ' CH2' ' A' ' 16' ' ' TRP . 17.0 mt -118.43 141.55 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.526 -0.734 . . . . 0.0 109.309 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 1.015 ' HB3' HD11 ' A' ' 77' ' ' LEU . . . -117.62 122.8 44.57 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.302 -0.874 . . . . 0.0 111.098 -179.28 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.479 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 4.1 m-85 -118.73 101.51 8.15 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.597 ' O ' ' CE2' ' A' ' 132' ' ' PHE . 0.4 OUTLIER -89.17 85.41 6.64 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.101 -0.999 . . . . 0.0 112.09 -177.738 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 1.086 HD13 HD13 ' A' ' 139' ' ' LEU . 0.6 OUTLIER -93.38 48.23 1.3 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.325 -0.86 . . . . 0.0 108.887 178.053 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.475 ' HA3' ' HA2' ' A' ' 44' ' ' GLY . . . -108.27 135.63 12.96 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.864 -1.16 . . . . 0.0 110.753 -178.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 130' ' ' GLY . . . 39.14 55.22 2.43 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 179.382 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.602 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 8.0 m-85 -118.46 -58.02 2.01 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.089 -1.242 . . . . 0.0 110.719 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.999 ' HB2' HG23 ' A' ' 72' ' ' VAL . 1.3 t -88.74 -179.71 6.06 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.921 -1.112 . . . . 0.0 110.283 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -100.69 -74.25 0.62 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.245 -0.909 . . . . 0.0 110.249 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -72.65 174.42 7.6 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.209 -0.932 . . . . 0.0 110.07 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.528 ' CA ' ' HA ' ' A' ' 38' ' ' ALA . . . -70.38 127.94 34.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.274 -0.891 . . . . 0.0 110.286 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.995 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 6.1 p90 -132.27 -161.97 1.19 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.267 -0.895 . . . . 0.0 110.138 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.527 ' OG1' ' HA ' ' A' ' 35' ' ' ALA . 0.8 OUTLIER -160.26 166.18 30.04 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.138 -1.025 . . . . 0.0 110.57 -177.775 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 1.086 HD13 HD13 ' A' ' 129' ' ' LEU . 2.2 mp -124.15 127.51 47.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.461 -0.775 . . . . 0.0 109.282 179.168 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' CYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 52.9 m -125.27 95.75 4.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.072 -1.017 . . . . 0.0 110.9 -179.388 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.764 HD12 HD23 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -89.86 -177.69 5.29 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.21 -0.931 . . . . 0.0 109.218 179.033 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.631 ' O ' HG22 ' A' ' 8' ' ' THR . 0.6 OUTLIER 169.37 48.15 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.252 -0.905 . . . . 0.0 110.235 -179.96 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.492 ' HA ' ' O ' ' A' ' 7' ' ' GLY . 11.3 t0 177.05 46.3 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.441 -0.787 . . . . 0.0 109.148 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.663 HG11 ' HZ2' ' A' ' 16' ' ' TRP . 1.0 OUTLIER -89.21 124.74 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.478 -0.764 . . . . 0.0 110.305 -178.981 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -158.52 152.71 24.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.386 -0.821 . . . . 0.0 110.075 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.519 HD12 ' O ' ' A' ' 61' ' ' THR . 23.1 tp -149.93 153.36 36.5 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.267 -0.895 . . . . 0.0 110.218 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.456 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 34.0 t70 -176.5 152.56 1.07 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.241 -0.912 . . . . 0.0 110.273 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 59' ' ' THR . 78.7 p -91.67 130.98 37.38 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.268 -0.895 . . . . 0.0 110.205 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.7 141.34 56.95 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.202 -0.936 . . . . 0.0 110.186 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.687 HG23 ' O ' ' A' ' 150' ' ' VAL . 20.2 m -111.37 67.57 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.231 -0.918 . . . . 0.0 110.207 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 52.15 -165.16 0.06 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.275 -0.891 . . . . 0.0 110.153 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.8 mp . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.25 -180.0 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.458 ' O ' ' HD3' ' A' ' 3' ' ' PRO . . . . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.179 0.514 . . . . 0.0 110.207 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.563 ' CB ' ' HA ' ' A' ' 52' ' ' VAL . 58.2 p -109.27 74.86 0.67 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.211 -0.93 . . . . 0.0 110.312 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.458 ' HD3' ' O ' ' A' ' 1' ' ' ALA . 46.2 Cg_endo -73.44 78.59 2.31 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.952 1.501 . . . . 0.0 110.486 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.579 ' HB ' HD21 ' A' ' 49' ' ' LEU . 6.4 pt -107.71 31.0 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -0.901 . . . . 0.0 110.068 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.436 ' O ' ' HB3' ' A' ' 6' ' ' GLU . . . 81.08 -169.52 51.88 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' A' ' 144' ' ' VAL . 9.0 pt-20 176.29 65.54 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.102 -1.234 . . . . 0.0 110.358 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.595 ' C ' HG23 ' A' ' 8' ' ' THR . . . 164.52 -64.55 0.23 Allowed Glycine 0 N--CA 1.488 2.164 0 C-N-CA 119.689 -1.243 . . . . 0.0 110.002 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.595 HG23 ' C ' ' A' ' 7' ' ' GLY . 73.6 p -156.41 -154.44 0.48 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.216 -1.167 . . . . 0.0 110.302 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.602 ' HZ ' HG21 ' A' ' 144' ' ' VAL . 33.0 m-85 -135.29 42.58 2.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -0.874 . . . . 0.0 110.263 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.55 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 26.7 t0 -88.14 49.01 1.72 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.202 -0.936 . . . . 0.0 110.247 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.55 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.5 OUTLIER 161.66 80.43 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.675 -0.641 . . . . 0.0 109.735 -179.963 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 11' ' ' ASP . . . 62.83 127.3 0.01 OUTLIER Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.52 ' O ' ' N ' ' A' ' 15' ' ' GLY . 50.2 Cg_endo -80.89 42.09 1.27 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 O-C-N 123.839 1.442 . . . . 0.0 110.987 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.441 ' HA ' ' OE1' ' A' ' 14' ' ' GLU . 4.7 mm-40 46.72 -92.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.003 -1.061 . . . . 0.0 110.288 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.705 ' O ' HG13 ' A' ' 17' ' ' VAL . . . -140.61 -0.06 1.85 Allowed Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.818 -1.182 . . . . 0.0 110.469 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.954 ' CH2' HG21 ' A' ' 125' ' ' ILE . 46.6 m95 -53.54 88.63 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.004 -1.292 . . . . 0.0 110.402 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.747 ' O ' HG13 ' A' ' 47' ' ' VAL . 1.0 OUTLIER -87.81 150.67 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.035 -1.04 . . . . 0.0 109.627 179.558 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.721 ' CB ' HG12 ' A' ' 34' ' ' VAL . . . -131.29 158.38 40.79 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.174 -0.954 . . . . 0.0 109.831 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.639 ' CD1' ' N ' ' A' ' 19' ' ' TYR . 3.5 p90 -150.5 166.21 30.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.31 -0.869 . . . . 0.0 110.5 -178.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.516 ' C ' ' CG2' ' A' ' 21' ' ' THR . . . 161.04 -96.78 0.15 Allowed Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.014 -1.634 . . . . 0.0 109.014 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.516 ' CG2' ' C ' ' A' ' 20' ' ' GLY . 6.5 p -153.91 18.39 0.51 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.115 -1.227 . . . . 0.0 111.224 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.699 ' CB ' ' HB1' ' A' ' 35' ' ' ALA . 0.8 OUTLIER -137.36 -179.95 6.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.664 -1.272 . . . . 0.0 110.607 179.743 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 22' ' ' ASP . . . -42.22 164.59 0.02 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 25' ' ' LEU . 45.5 Cg_endo -72.48 160.87 45.71 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.102 1.58 . . . . 0.0 110.409 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.719 HD23 ' H ' ' A' ' 25' ' ' LEU . 0.7 OUTLIER -41.8 151.2 0.09 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.306 -0.871 . . . . 0.0 110.394 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.508 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 79.7 m-20 -124.43 137.11 54.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.317 -0.864 . . . . 0.0 109.829 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.537 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.8 OUTLIER -119.95 -26.76 5.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.099 -1.001 . . . . 0.0 110.55 -179.705 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.684 ' C ' HG22 ' A' ' 29' ' ' THR . 12.0 m -49.75 82.96 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.788 -0.57 . . . . 0.0 111.248 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.684 HG22 ' C ' ' A' ' 28' ' ' SER . 0.0 OUTLIER 166.62 -31.77 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.229 -0.919 . . . . 0.0 109.948 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 128.37 0.32 6.32 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -150.46 161.17 43.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.137 -1.214 . . . . 0.0 110.214 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.544 HD23 ' O ' ' A' ' 32' ' ' LEU . 0.3 OUTLIER -104.08 99.37 9.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.178 -0.951 . . . . 0.0 110.134 179.911 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.585 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 0.8 OUTLIER -96.09 117.0 29.84 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.197 -0.94 . . . . 0.0 111.61 -179.773 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.721 HG12 ' CB ' ' A' ' 18' ' ' ALA . 30.2 m -89.43 149.97 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.122 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.699 ' HB1' ' CB ' ' A' ' 22' ' ' ASP . . . -89.83 126.32 35.65 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.016 -1.052 . . . . 0.0 111.529 -178.333 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.038 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 48.7 t -126.73 119.63 22.78 Favored Pre-proline 0 C--N 1.303 -1.455 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.239 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.496 ' HG2' ' HA ' ' A' ' 40' ' ' SER . 39.7 Cg_endo -66.23 -177.74 0.93 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.753 1.397 . . . . 0.0 111.324 -179.005 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.536 ' HA ' ' N ' ' A' ' 136' ' ' ALA . . . -56.14 126.66 27.05 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.436 -0.79 . . . . 0.0 111.157 -179.061 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.501 ' O ' ' C ' ' A' ' 40' ' ' SER . . . 40.33 28.05 0.17 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.948 ' OG ' HG23 ' A' ' 45' ' ' VAL . 15.0 t 31.68 60.01 0.3 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.819 -0.812 . . . . 0.0 110.593 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.478 ' O ' ' HB3' ' A' ' 42' ' ' GLN . . . -88.72 95.21 10.18 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.278 -0.889 . . . . 0.0 109.864 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.807 ' NE2' HG22 ' A' ' 45' ' ' VAL . 2.0 pt20 179.83 -150.27 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 121.308 0.575 . . . . 0.0 109.822 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.531 ' CD1' ' HG3' ' A' ' 42' ' ' GLN . 16.0 p90 -61.41 -12.72 15.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.331 -0.856 . . . . 0.0 109.898 179.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.417 ' O ' ' CE2' ' A' ' 43' ' ' TYR . . . 109.75 129.14 5.69 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.948 HG23 ' OG ' ' A' ' 40' ' ' SER . 9.4 t -89.29 170.45 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.173 -1.193 . . . . 0.0 108.572 179.362 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.519 ' CA ' ' O ' ' A' ' 127' ' ' PHE . . . 169.76 -174.02 43.97 Favored Glycine 0 N--CA 1.487 2.052 0 C-N-CA 118.997 -1.573 . . . . 0.0 110.559 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.747 HG13 ' O ' ' A' ' 17' ' ' VAL . 41.4 t -150.39 129.08 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.602 -0.94 . . . . 0.0 108.781 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.642 ' O ' HG22 ' A' ' 17' ' ' VAL . 32.9 m -119.97 135.68 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.081 -1.012 . . . . 0.0 110.987 -179.038 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.846 HD22 ' NE1' ' A' ' 16' ' ' TRP . 21.3 tp -128.67 96.71 4.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.393 -0.817 . . . . 0.0 110.24 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.512 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 12.9 p30 -75.13 134.94 41.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.909 . . . . 0.0 110.186 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 136.38 76.85 0.08 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.563 ' HA ' ' CB ' ' A' ' 2' ' ' SER . 18.1 t -139.37 167.26 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -1.173 . . . . 0.0 110.023 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.413 ' N ' HG12 ' A' ' 52' ' ' VAL . . . -137.75 83.82 2.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.195 -0.941 . . . . 0.0 110.488 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.732 HG21 ' HB1' ' A' ' 108' ' ' ALA . 43.2 mm -115.92 158.78 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.227 -0.92 . . . . 0.0 109.918 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.493 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 7.9 tp10 -151.78 134.34 15.43 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.208 -0.933 . . . . 0.0 110.366 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.565 ' CG ' ' N ' ' A' ' 57' ' ' GLY . 1.1 pt-20 37.03 -157.01 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.698 -0.626 . . . . 0.0 110.73 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.565 ' N ' ' CG ' ' A' ' 56' ' ' GLU . . . -84.04 90.68 1.61 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.633 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.2 m -118.73 173.86 6.62 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.306 -1.114 . . . . 0.0 109.79 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.572 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 0.6 OUTLIER -89.82 153.85 20.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.268 -0.895 . . . . 0.0 110.494 -179.758 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.633 ' CE2' HG22 ' A' ' 58' ' ' THR . 59.2 m-85 -159.88 121.79 3.29 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.271 -0.893 . . . . 0.0 110.218 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 89.2 m -90.87 114.74 27.25 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.213 -0.929 . . . . 0.0 109.983 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.0 tp -89.55 120.85 31.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.209 -0.932 . . . . 0.0 109.945 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.522 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 12.7 ttp180 -125.59 130.17 51.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.309 -0.87 . . . . 0.0 110.227 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 1.122 ' CZ ' HG21 ' A' ' 102' ' ' VAL . 0.8 OUTLIER -170.33 142.98 2.26 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.294 -0.879 . . . . 0.0 109.821 179.756 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.496 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 16.9 m -119.16 97.63 5.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.289 -0.882 . . . . 0.0 110.079 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.697 ' CB ' HD21 ' A' ' 95' ' ' LEU . . . -98.98 149.38 23.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.382 -0.824 . . . . 0.0 110.328 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.749 HG23 ' O ' ' A' ' 98' ' ' GLU . 90.3 m -150.52 102.22 3.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -0.884 . . . . 0.0 110.198 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.47 ' O ' ' O ' ' A' ' 96' ' ' THR . . . -89.82 131.24 35.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.233 -0.917 . . . . 0.0 109.977 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.45 ' C ' ' O ' ' A' ' 68' ' ' ALA . 1.2 p -42.72 -27.17 0.16 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.298 -0.876 . . . . 0.0 109.522 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.599 ' CG2' ' CB ' ' A' ' 137' ' ' TRP . 1.7 t -109.87 161.34 15.56 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.559 -0.713 . . . . 0.0 109.836 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.19 76.69 6.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.056 -1.027 . . . . 0.0 109.25 179.05 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.791 HG23 ' CB ' ' A' ' 133' ' ' SER . 4.3 p -99.75 135.62 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.27 -0.894 . . . . 0.0 111.292 -178.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 89.6 m -121.09 87.13 2.7 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 1.113 HG21 HD23 ' A' ' 129' ' ' LEU . 5.1 m -89.7 -149.18 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.246 -0.909 . . . . 0.0 110.764 -178.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.482 ' N ' HG23 ' A' ' 74' ' ' VAL . 0.3 OUTLIER -128.43 121.32 28.73 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.262 -0.898 . . . . 0.0 110.656 -179.479 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.508 ' N ' ' HD3' ' A' ' 93' ' ' PRO . . . -119.03 161.36 20.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.217 -0.927 . . . . 0.0 109.643 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.75 ' CD1' ' HB3' ' A' ' 126' ' ' ALA . 3.5 pp 177.15 -158.83 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.128 -0.982 . . . . 0.0 110.463 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.898 HG23 HD22 ' A' ' 89' ' ' LEU . 19.5 t -149.54 165.0 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.433 -0.792 . . . . 0.0 109.266 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.542 ' C ' ' CE1' ' A' ' 112' ' ' TYR . . . -172.81 -166.75 31.79 Favored Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.056 -1.545 . . . . 0.0 110.587 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.54 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 4.7 tp60 -114.34 85.93 2.33 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.508 -0.995 . . . . 0.0 110.391 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 2.1 m-80 -66.0 100.13 0.56 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.066 -1.022 . . . . 0.0 109.308 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.636 ' O ' ' HB2' ' A' ' 83' ' ' ALA . . . 152.0 -87.67 0.14 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.466 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.636 ' HB2' ' O ' ' A' ' 82' ' ' GLY . . . 173.24 145.68 0.19 Allowed Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.189 -1.183 . . . . 0.0 110.192 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.511 ' C ' ' CD2' ' A' ' 85' ' ' TYR . 51.0 Cg_endo -84.56 32.8 4.41 Favored 'Cis proline' 0 C--N 1.313 -1.314 0 C-N-CA 121.9 -2.125 . . . . 0.0 110.663 -0.245 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.575 ' CZ ' ' O ' ' A' ' 82' ' ' GLY . 17.6 m-85 64.47 -172.67 0.18 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.165 -0.959 . . . . 0.0 110.402 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 140.03 99.38 0.41 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.483 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 1.4 p -89.8 143.59 26.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.25 -1.147 . . . . 0.0 110.367 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 1.037 HG23 HD12 ' A' ' 89' ' ' LEU . 27.0 m -123.93 -16.95 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.313 -0.867 . . . . 0.0 110.332 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 1.037 HD12 HG23 ' A' ' 88' ' ' VAL . 4.1 mp -105.36 139.87 39.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.204 -0.935 . . . . 0.0 110.924 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.733 ' O ' HG23 ' A' ' 91' ' ' THR . 1.6 m-20 -150.68 94.29 2.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.379 -0.826 . . . . 0.0 110.194 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.733 HG23 ' O ' ' A' ' 90' ' ' ASP . 3.9 p -160.07 -175.09 4.88 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.162 -0.962 . . . . 0.0 110.44 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.4 p -125.35 128.87 24.63 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.285 -0.885 . . . . 0.0 110.143 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.79 ' HG2' HG22 ' A' ' 74' ' ' VAL . 50.2 Cg_endo -74.14 77.02 2.89 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.883 1.465 . . . . 0.0 110.983 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.683 ' HB3' ' NH1' ' A' ' 100' ' ' ARG . . . -50.47 136.45 20.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.996 -1.065 . . . . 0.0 109.348 179.351 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.814 ' CD1' HD21 ' A' ' 139' ' ' LEU . 35.4 mt -135.63 168.12 19.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.991 -1.068 . . . . 0.0 110.891 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.762 HG23 ' H ' ' A' ' 98' ' ' GLU . 6.7 t -165.8 -153.18 0.17 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.444 -0.785 . . . . 0.0 109.914 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.529 ' N ' HG23 ' A' ' 96' ' ' THR . 0.1 OUTLIER -85.94 -28.19 24.45 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.103 -0.998 . . . . 0.0 110.391 -179.816 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.762 ' H ' HG23 ' A' ' 96' ' ' THR . 0.6 OUTLIER -89.77 176.5 3.04 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.238 -0.914 . . . . 0.0 110.06 179.974 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.507 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 45.4 Cg_endo -72.09 134.03 22.48 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 123.979 1.515 . . . . 0.0 110.327 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.683 ' NH1' ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.53 84.03 2.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.18 -0.95 . . . . 0.0 110.22 -179.87 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.455 ' HG2' ' OG1' ' A' ' 65' ' ' THR . 56.1 mt-30 -69.02 155.98 39.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.32 -0.862 . . . . 0.0 110.124 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 1.122 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 58.6 t -133.43 133.71 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.25 -0.906 . . . . 0.0 110.111 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.33 111.51 4.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.25 -0.906 . . . . 0.0 110.109 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -153.59 151.59 29.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.159 -0.963 . . . . 0.0 110.356 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -108.39 122.09 46.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.283 -0.886 . . . . 0.0 110.063 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.858 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 41.4 p90 -127.93 153.32 46.82 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.236 -0.915 . . . . 0.0 110.299 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 58' ' ' THR . 3.6 m -89.93 94.24 9.73 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.276 -0.89 . . . . 0.0 110.063 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.732 ' HB1' HG21 ' A' ' 54' ' ' ILE . . . -53.64 99.42 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.244 -0.91 . . . . 0.0 110.309 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.524 ' N ' ' CG1' ' A' ' 88' ' ' VAL . 54.3 p -85.93 55.66 3.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.18 -0.95 . . . . 0.0 109.945 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -160.29 -151.31 0.24 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.315 -0.866 . . . . 0.0 110.298 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.432 HG23 ' HA ' ' A' ' 55' ' ' GLU . 46.2 m -158.14 116.42 3.05 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.323 -0.861 . . . . 0.0 110.414 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.652 ' CE2' HG12 ' A' ' 78' ' ' VAL . 12.7 m-30 -112.22 109.87 53.97 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.302 -0.874 . . . . 0.0 109.784 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.516 ' HD2' ' OE1' ' A' ' 80' ' ' GLN . 47.7 Cg_endo -75.48 96.2 1.03 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.849 1.447 . . . . 0.0 110.539 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -46.75 -24.06 0.51 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.245 -0.91 . . . . 0.0 110.127 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 58.5 p -98.38 117.91 64.11 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.279 -0.888 . . . . 0.0 110.183 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.4 ' N ' ' OE1' ' A' ' 122' ' ' GLU . 45.7 Cg_endo -72.97 -161.59 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.9 1.474 . . . . 0.0 110.413 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.417 ' HB3' ' HB2' ' A' ' 120' ' ' ASP . . . -147.88 -172.29 4.02 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.255 -0.903 . . . . 0.0 110.211 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -82.24 -9.36 59.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.26 -0.9 . . . . 0.0 110.188 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -155.02 18.82 0.44 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.282 -0.886 . . . . 0.0 110.137 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.449 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 6.7 m-20 -147.78 132.86 9.08 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.315 -0.866 . . . . 0.0 110.137 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.542 ' HG2' ' CA ' ' A' ' 82' ' ' GLY . 42.2 Cg_endo -85.82 -154.76 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.928 1.488 . . . . 0.0 110.258 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.487 ' O ' ' HB2' ' A' ' 81' ' ' ASN . 5.0 pt-20 -149.21 -156.35 0.71 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.987 -1.07 . . . . 0.0 110.357 -179.534 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.582 ' HA3' ' CG ' ' A' ' 112' ' ' TYR . . . -90.59 148.09 19.38 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.592 ' O ' HG13 ' A' ' 78' ' ' VAL . 15.6 pt20 -150.31 -155.66 0.65 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.289 -1.124 . . . . 0.0 110.491 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.954 HG21 ' CH2' ' A' ' 16' ' ' TRP . 7.6 mt -118.22 141.26 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.538 -0.726 . . . . 0.0 109.256 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.75 ' HB3' ' CD1' ' A' ' 77' ' ' LEU . . . -117.6 121.75 41.77 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.36 -0.837 . . . . 0.0 111.291 -179.081 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.519 ' O ' ' CA ' ' A' ' 46' ' ' GLY . 4.4 m-85 -118.99 91.2 3.5 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 178.405 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -88.57 93.92 9.71 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.944 -1.097 . . . . 0.0 112.449 -177.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 1.113 HD23 HG21 ' A' ' 74' ' ' VAL . 12.9 mt -90.87 44.16 1.18 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 177.587 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 131' ' ' GLY . . . -82.29 115.54 4.04 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 -179.048 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.482 ' HA2' ' O ' ' A' ' 39' ' ' GLY . . . 40.36 93.1 0.01 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.586 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 8.9 m-85 -143.55 -52.59 0.35 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.099 -1.236 . . . . 0.0 110.704 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.791 ' CB ' HG23 ' A' ' 72' ' ' VAL . 1.3 t -89.26 175.3 7.4 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.973 -1.079 . . . . 0.0 110.399 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -80.93 -88.13 0.08 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.257 -0.902 . . . . 0.0 110.033 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 135' ' ' ASP . 3.9 m-20 -67.27 -173.41 0.28 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -0.909 . . . . 0.0 109.774 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.536 ' N ' ' HA ' ' A' ' 38' ' ' ALA . . . -78.94 149.33 32.37 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.229 -0.919 . . . . 0.0 110.248 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 1.038 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 15.1 p90 -151.8 -160.0 1.09 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.152 -0.967 . . . . 0.0 111.162 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.544 ' C ' HD12 ' A' ' 139' ' ' LEU . 0.8 OUTLIER -159.65 178.53 9.74 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -178.596 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.814 HD21 ' CD1' ' A' ' 95' ' ' LEU . 1.7 mp -139.91 115.54 10.09 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.766 -1.209 . . . . 0.0 112.082 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' CYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 0.8 OUTLIER -103.34 104.35 14.45 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.727 -0.608 . . . . 0.0 110.662 178.492 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.535 HD23 ' HB2' ' A' ' 66' ' ' ALA . 1.4 mt -90.22 -178.67 5.45 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.217 -0.927 . . . . 0.0 109.305 179.028 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.545 ' O ' ' CB ' ' A' ' 143' ' ' ASP . 2.3 p30 166.9 68.24 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.263 -0.898 . . . . 0.0 110.172 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.545 ' CB ' ' O ' ' A' ' 142' ' ' ASP . 0.4 OUTLIER 161.89 42.79 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.879 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.64 HG11 ' CZ2' ' A' ' 16' ' ' TRP . 1.5 t -89.4 115.93 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.418 -0.801 . . . . 0.0 110.684 -178.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.428 ' HB2' ' HA ' ' A' ' 6' ' ' GLU . . . -148.26 139.84 23.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.463 -0.773 . . . . 0.0 109.912 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.579 HD21 HD11 ' A' ' 54' ' ' ILE . 28.6 tp -129.93 152.7 49.12 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.305 -0.872 . . . . 0.0 110.332 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.464 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -161.83 -175.78 4.87 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.248 -0.907 . . . . 0.0 110.149 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.429 ' O ' ' OG ' ' A' ' 148' ' ' SER . 9.3 p -128.48 108.39 10.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.2 -0.937 . . . . 0.0 110.174 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.445 ' OE1' ' HB2' ' A' ' 151' ' ' GLU . 0.2 OUTLIER -93.3 165.43 12.8 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.292 -0.88 . . . . 0.0 110.173 179.94 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.759 HG13 ' O ' ' A' ' 150' ' ' VAL . 13.9 p -125.62 81.3 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.215 -0.928 . . . . 0.0 110.254 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.445 ' HB2' ' OE1' ' A' ' 149' ' ' GLU . 2.2 tt0 -112.1 135.07 53.22 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.265 -0.897 . . . . 0.0 110.165 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 117.969 -1.015 . . . . 0.0 110.184 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.449 ' C ' ' HD3' ' A' ' 3' ' ' PRO . . . . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.172 0.51 . . . . 0.0 110.195 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.511 ' OG ' ' HA ' ' A' ' 52' ' ' VAL . 0.5 OUTLIER -111.53 74.0 1.14 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.287 -0.883 . . . . 0.0 110.164 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.449 ' HD3' ' C ' ' A' ' 1' ' ' ALA . 47.2 Cg_endo -73.9 77.8 2.63 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.025 1.539 . . . . 0.0 110.616 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.517 ' CD1' HG12 ' A' ' 144' ' ' VAL . 32.7 pt -107.36 40.41 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.183 -0.948 . . . . 0.0 109.979 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' A' ' 7' ' ' GLY . . . 103.78 -45.48 1.32 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.454 ' HA ' ' HB2' ' A' ' 145' ' ' ALA . 44.4 mt-10 41.67 28.08 0.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.354 -1.086 . . . . 0.0 110.306 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' A' ' 143' ' ' ASP . . . -158.85 -166.28 17.58 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 34.0 p -72.59 165.81 23.96 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.307 -1.113 . . . . 0.0 110.377 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.603 ' CZ ' HG21 ' A' ' 144' ' ' VAL . 3.1 m-30 -93.7 56.57 2.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.336 -0.852 . . . . 0.0 110.135 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.537 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 16.0 t0 -114.39 52.35 0.84 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.183 -0.948 . . . . 0.0 110.202 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.537 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 2.2 t70 161.76 78.14 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.753 -0.592 . . . . 0.0 109.657 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.02 133.51 0.33 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.611 ' HB3' HD12 ' A' ' 32' ' ' LEU . 50.2 Cg_endo -77.3 5.82 4.81 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.943 1.496 . . . . 0.0 110.635 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 0.8 OUTLIER 66.44 -85.72 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.158 -0.964 . . . . 0.0 110.184 -179.853 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.781 ' C ' HD13 ' A' ' 49' ' ' LEU . . . -142.71 8.3 2.26 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.857 ' CD1' HD22 ' A' ' 49' ' ' LEU . 45.9 m95 -72.92 93.03 1.68 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.127 -1.22 . . . . 0.0 110.343 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.821 ' O ' HG13 ' A' ' 47' ' ' VAL . 1.5 m -95.49 152.23 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.148 -0.97 . . . . 0.0 109.895 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.759 ' CB ' HG11 ' A' ' 34' ' ' VAL . . . -129.96 127.54 40.27 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.164 -0.96 . . . . 0.0 109.725 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.585 ' HE2' HG13 ' A' ' 48' ' ' VAL . 10.9 p90 -121.17 158.34 28.19 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.291 -0.881 . . . . 0.0 110.739 -178.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.516 ' CA ' ' OH ' ' A' ' 43' ' ' TYR . . . 90.57 35.01 7.55 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 179.383 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.5 ' CG2' ' C ' ' A' ' 20' ' ' GLY . 5.4 p -150.89 -154.94 0.58 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.98 -1.306 . . . . 0.0 110.499 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.46 ' O ' ' O ' ' A' ' 23' ' ' GLY . 8.2 t0 -94.87 132.01 40.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.353 -0.842 . . . . 0.0 110.363 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 22' ' ' ASP . . . 44.41 -168.1 0.02 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.58 -159.85 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.062 1.559 . . . . 0.0 110.484 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.933 HD13 HD11 ' A' ' 32' ' ' LEU . 0.4 OUTLIER -101.21 161.39 13.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.258 -0.901 . . . . 0.0 110.222 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -116.86 140.04 49.91 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.205 -0.935 . . . . 0.0 110.008 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.509 ' HA ' ' O ' ' A' ' 31' ' ' ALA . 0.7 OUTLIER -128.24 -22.69 3.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.144 -0.973 . . . . 0.0 111.212 -179.55 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.2 -17.87 0.28 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.26 -0.9 . . . . 0.0 111.173 -179.459 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.544 HG23 ' H ' ' A' ' 31' ' ' ALA . 2.6 t -72.1 6.37 2.21 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.049 -1.032 . . . . 0.0 111.519 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.55 -12.28 67.81 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.644 ' HB3' ' SG ' ' A' ' 140' ' ' CYS . . . -150.97 167.99 25.92 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.481 -1.011 . . . . 0.0 109.503 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.933 HD11 HD13 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -87.04 90.92 8.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.967 -1.083 . . . . 0.0 110.163 179.906 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.555 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 0.8 OUTLIER -99.45 111.78 24.09 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.387 -0.821 . . . . 0.0 111.507 179.987 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.759 HG11 ' CB ' ' A' ' 18' ' ' ALA . 15.7 m -89.86 146.11 6.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.153 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.496 ' O ' ' HB ' ' A' ' 21' ' ' THR . . . -88.55 72.44 8.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.541 -0.725 . . . . 0.0 110.982 -178.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.095 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 56.3 t -58.66 134.07 86.15 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.322 -0.861 . . . . 0.0 109.564 179.325 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.487 ' HG2' ' HA ' ' A' ' 40' ' ' SER . 39.5 Cg_endo -67.48 176.47 4.88 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.951 1.501 . . . . 0.0 111.501 -179.17 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.511 ' HA ' ' N ' ' A' ' 136' ' ' ALA . . . -60.9 126.23 26.6 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.509 -0.744 . . . . 0.0 111.463 -178.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.534 ' O ' ' C ' ' A' ' 40' ' ' SER . . . 39.0 26.83 0.05 OUTLIER Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.901 ' OG ' HG23 ' A' ' 45' ' ' VAL . 9.6 t 27.08 59.21 0.09 Allowed 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.886 -0.773 . . . . 0.0 110.9 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.485 ' O ' ' HB3' ' A' ' 42' ' ' GLN . . . -88.36 100.8 13.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.231 -0.918 . . . . 0.0 110.201 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.485 ' HB3' ' O ' ' A' ' 41' ' ' ALA . 2.2 pt20 174.41 -158.78 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.516 ' OH ' ' CA ' ' A' ' 20' ' ' GLY . 8.9 p90 -50.32 -24.0 2.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.096 -1.002 . . . . 0.0 109.726 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.516 ' O ' ' CE2' ' A' ' 43' ' ' TYR . . . 119.82 129.29 3.82 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.901 HG23 ' OG ' ' A' ' 40' ' ' SER . 6.2 t -89.58 177.05 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.265 -1.138 . . . . 0.0 109.001 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.57 ' O ' ' CZ ' ' A' ' 19' ' ' TYR . . . 166.15 149.32 5.88 Favored Glycine 0 N--CA 1.488 2.153 0 C-N-CA 119.166 -1.492 . . . . 0.0 110.552 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.821 HG13 ' O ' ' A' ' 17' ' ' VAL . 43.8 t -116.24 144.18 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.552 -0.969 . . . . 0.0 109.449 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.585 HG13 ' HE2' ' A' ' 19' ' ' TYR . 29.0 m -138.56 153.96 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.834 -1.166 . . . . 0.0 111.004 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.857 HD22 ' CD1' ' A' ' 16' ' ' TRP . 14.8 tp -140.89 99.66 3.65 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.446 -0.784 . . . . 0.0 109.929 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.513 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 8.6 t30 -78.11 133.34 37.87 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.248 -0.907 . . . . 0.0 110.542 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 139.34 55.32 0.05 OUTLIER Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.639 HG11 ' HD2' ' A' ' 112' ' ' TYR . 53.3 t -120.04 161.11 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.092 -1.24 . . . . 0.0 110.278 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 112' ' ' TYR . . . -130.83 96.8 4.16 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.186 -0.946 . . . . 0.0 110.65 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.758 HG21 ' HB1' ' A' ' 108' ' ' ALA . 50.6 mm -131.65 160.51 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.268 -0.895 . . . . 0.0 109.786 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.528 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 13.2 pt-20 -149.02 130.58 14.88 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.087 -1.008 . . . . 0.0 110.432 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.528 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 10.8 pt-20 38.14 -152.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.646 -0.659 . . . . 0.0 110.85 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.467 ' HA2' ' HA ' ' A' ' 109' ' ' SER . . . -85.28 108.43 3.2 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.671 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.1 m -136.75 174.63 10.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.238 -1.154 . . . . 0.0 109.714 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.574 ' N ' ' CG2' ' A' ' 58' ' ' THR . 0.5 OUTLIER -89.83 145.44 25.16 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.256 -0.903 . . . . 0.0 110.261 -179.922 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.819 ' HB3' HD11 ' A' ' 146' ' ' LEU . 58.5 m-85 -154.41 154.67 33.64 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.313 -0.867 . . . . 0.0 110.271 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 85.3 m -124.1 114.0 19.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.354 -0.841 . . . . 0.0 110.066 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.536 HD22 ' CD2' ' A' ' 89' ' ' LEU . 18.2 tp -89.69 121.81 32.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -0.914 . . . . 0.0 110.105 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.569 ' HD3' HG23 ' A' ' 103' ' ' THR . 8.1 mtt85 -127.33 138.25 52.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.318 -0.864 . . . . 0.0 110.287 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 1.163 ' CZ ' HG21 ' A' ' 102' ' ' VAL . 2.8 p90 -177.92 152.69 0.77 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.395 -0.816 . . . . 0.0 109.796 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.812 HG23 ' HG2' ' A' ' 101' ' ' GLN . 0.2 OUTLIER -119.28 102.8 8.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.121 -0.987 . . . . 0.0 110.105 -179.947 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.697 ' CB ' HD21 ' A' ' 95' ' ' LEU . . . -102.3 141.66 34.78 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.308 -0.87 . . . . 0.0 110.05 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.618 HG23 ' O ' ' A' ' 98' ' ' GLU . 35.0 m -150.14 107.41 3.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.294 -0.879 . . . . 0.0 110.18 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.518 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -98.3 131.68 44.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.281 -0.887 . . . . 0.0 110.169 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 68' ' ' ALA . 0.9 OUTLIER -44.47 -26.23 0.33 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.188 -0.945 . . . . 0.0 109.467 179.528 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.581 ' CG2' ' CB ' ' A' ' 137' ' ' TRP . 1.9 t -110.28 165.27 11.9 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.453 -0.78 . . . . 0.0 109.856 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.489 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 4.8 t0 -84.15 68.97 10.31 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.146 -0.971 . . . . 0.0 109.321 179.187 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.67 HG23 ' CB ' ' A' ' 133' ' ' SER . 6.1 p -86.89 134.36 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.327 -0.858 . . . . 0.0 111.248 -179.041 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 23.3 m -120.58 85.26 2.36 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.775 HG22 ' HG2' ' A' ' 93' ' ' PRO . 3.0 m -89.63 -157.95 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.25 -0.906 . . . . 0.0 110.72 -178.675 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.462 ' N ' HG23 ' A' ' 74' ' ' VAL . 0.4 OUTLIER -120.23 104.06 9.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.357 -0.839 . . . . 0.0 110.278 -179.629 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.67 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -99.9 163.75 12.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.21 -0.931 . . . . 0.0 109.851 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.076 ' CD1' ' HB3' ' A' ' 126' ' ' ALA . 2.0 pp 173.32 -161.1 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.285 -0.884 . . . . 0.0 110.132 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.906 ' CG2' HD22 ' A' ' 89' ' ' LEU . 3.6 t -146.31 168.91 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.275 -0.89 . . . . 0.0 109.58 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.54 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . 175.09 -160.45 29.3 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.416 -1.373 . . . . 0.0 109.934 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.535 ' HG3' ' HA ' ' A' ' 85' ' ' TYR . 4.7 pt20 -125.08 137.12 54.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.275 -1.132 . . . . 0.0 110.642 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -86.62 93.82 9.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.366 -0.834 . . . . 0.0 109.964 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.58 ' O ' ' CD2' ' A' ' 85' ' ' TYR . . . 148.18 -177.39 26.46 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.271 -1.531 . . . . 0.0 109.271 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.542 ' HA ' ' CD1' ' A' ' 85' ' ' TYR . . . -99.61 152.18 37.71 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.275 -1.133 . . . . 0.0 110.231 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.468 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.7 Cg_endo -83.02 30.09 4.69 Favored 'Cis proline' 0 C--N 1.312 -1.349 0 C-N-CA 121.795 -2.169 . . . . 0.0 111.021 -0.123 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.58 ' CD2' ' O ' ' A' ' 82' ' ' GLY . 57.2 m-85 60.37 -175.6 0.11 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.138 -0.976 . . . . 0.0 110.26 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.468 ' O ' ' HG2' ' A' ' 80' ' ' GLN . . . 161.95 126.67 0.83 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.0 p -120.16 146.2 46.22 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.21 -1.17 . . . . 0.0 110.099 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 1.061 HG23 HD12 ' A' ' 89' ' ' LEU . 28.9 m -125.65 -16.41 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.259 -0.901 . . . . 0.0 110.559 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 1.061 HD12 HG23 ' A' ' 88' ' ' VAL . 4.3 mp -110.88 140.93 44.93 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.118 -0.989 . . . . 0.0 111.18 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.693 ' O ' HG23 ' A' ' 91' ' ' THR . 38.9 p30 -150.9 93.4 1.94 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.411 -0.806 . . . . 0.0 110.161 179.579 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.693 HG23 ' O ' ' A' ' 90' ' ' ASP . 16.3 p -159.02 -175.96 5.58 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.026 -1.046 . . . . 0.0 110.67 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.476 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 29.0 m -120.0 135.04 24.07 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.312 -0.868 . . . . 0.0 110.075 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.775 ' HG2' HG22 ' A' ' 74' ' ' VAL . 49.5 Cg_endo -87.46 67.91 3.82 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.968 1.509 . . . . 0.0 111.063 -179.531 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.513 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -45.59 121.91 3.33 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.95 -1.094 . . . . 0.0 109.271 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.697 HD21 ' CB ' ' A' ' 66' ' ' ALA . 15.1 mt -119.87 175.32 5.95 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.086 -1.009 . . . . 0.0 110.901 -179.192 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.41 HG22 ' C ' ' A' ' 95' ' ' LEU . 0.2 OUTLIER 179.26 -178.87 0.37 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.499 -0.751 . . . . 0.0 109.953 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.94 -14.07 20.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.21 -0.931 . . . . 0.0 110.197 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.618 ' O ' HG23 ' A' ' 67' ' ' THR . 1.7 mt-10 -96.66 157.46 35.24 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.283 -0.886 . . . . 0.0 110.145 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.491 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 45.5 Cg_endo -72.51 137.42 27.84 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.971 1.511 . . . . 0.0 110.367 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.513 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.82 93.05 3.93 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.201 -0.937 . . . . 0.0 110.351 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.812 ' HG2' HG23 ' A' ' 65' ' ' THR . 0.0 OUTLIER -74.04 143.39 45.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.912 . . . . 0.0 109.818 179.633 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 1.163 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 47.5 t -121.16 132.35 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.137 -0.977 . . . . 0.0 110.407 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.569 HG23 ' HD3' ' A' ' 63' ' ' ARG . 0.2 OUTLIER -150.86 94.11 2.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.412 -0.805 . . . . 0.0 110.098 179.919 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -139.95 157.99 44.79 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.132 -0.98 . . . . 0.0 110.447 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -114.8 97.0 6.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.305 -0.872 . . . . 0.0 110.048 179.944 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.596 ' CE1' HD11 ' A' ' 89' ' ' LEU . 36.0 p90 -96.58 155.9 16.57 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.264 -0.898 . . . . 0.0 110.334 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.7 m -90.6 101.92 14.66 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.334 -0.854 . . . . 0.0 110.004 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.758 ' HB1' HG21 ' A' ' 54' ' ' ILE . . . -64.89 102.48 0.6 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.233 -0.917 . . . . 0.0 110.355 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.467 ' HA ' ' HA2' ' A' ' 57' ' ' GLY . 2.9 p -93.95 52.37 1.64 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.258 -0.901 . . . . 0.0 110.023 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -156.91 -158.4 0.77 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.207 -0.933 . . . . 0.0 110.417 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.542 HG22 ' HD3' ' A' ' 113' ' ' PRO . 69.9 m -137.74 111.22 8.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.238 -0.914 . . . . 0.0 110.261 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.639 ' HD2' HG11 ' A' ' 52' ' ' VAL . 15.1 m-30 -106.9 78.03 0.55 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.322 -0.862 . . . . 0.0 110.001 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.542 ' HD3' HG22 ' A' ' 111' ' ' THR . 44.3 Cg_endo -71.36 124.95 10.84 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.836 1.44 . . . . 0.0 110.418 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.486 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -63.61 -10.29 17.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.276 -0.89 . . . . 0.0 110.33 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.33 106.56 23.93 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.211 -0.93 . . . . 0.0 110.208 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.486 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 46.4 Cg_endo -73.07 82.47 1.55 Allowed 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.969 1.51 . . . . 0.0 110.41 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.986 ' HB3' ' HB2' ' A' ' 120' ' ' ASP . . . -96.36 138.32 34.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.267 -0.895 . . . . 0.0 110.149 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -50.1 -43.39 51.53 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.192 -0.942 . . . . 0.0 110.222 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -82.92 -19.3 37.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.18 -0.95 . . . . 0.0 110.282 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.986 ' HB2' ' HB3' ' A' ' 117' ' ' ALA . 30.5 m-20 -116.7 120.58 34.13 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.198 -0.939 . . . . 0.0 110.241 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.513 ' HB3' ' CA ' ' A' ' 82' ' ' GLY . 46.4 Cg_endo -73.32 139.46 29.07 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.888 1.467 . . . . 0.0 110.418 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.499 ' O ' ' HA ' ' A' ' 80' ' ' GLN . 0.5 OUTLIER -90.96 -175.33 4.3 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.22 -0.925 . . . . 0.0 109.728 179.609 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.56 ' HA3' ' CB ' ' A' ' 112' ' ' TYR . . . -125.11 139.14 11.44 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.513 ' CB ' ' HA ' ' A' ' 50' ' ' ASN . 9.6 pt20 -150.39 -160.63 1.2 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.298 -1.119 . . . . 0.0 110.419 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.603 HG21 ' CH2' ' A' ' 16' ' ' TRP . 15.4 mt -118.5 135.06 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.506 -0.746 . . . . 0.0 109.131 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 1.076 ' HB3' ' CD1' ' A' ' 77' ' ' LEU . . . -112.6 123.46 50.35 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.285 -0.884 . . . . 0.0 111.082 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.504 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 4.4 m-85 -119.18 107.16 13.1 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.598 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.48 ' O ' ' HB ' ' A' ' 74' ' ' VAL . 14.2 mm100 -89.48 97.25 11.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.155 -0.966 . . . . 0.0 111.431 -178.148 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.681 HD22 HG11 ' A' ' 74' ' ' VAL . 24.1 mt -97.13 41.92 1.1 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.355 -0.84 . . . . 0.0 109.191 178.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 131' ' ' GLY . . . -88.65 116.56 4.66 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -179.522 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 39' ' ' GLY . . . 39.74 92.59 0.01 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.581 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 7.2 m-85 -143.96 -54.42 0.36 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.112 -1.228 . . . . 0.0 110.516 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.67 ' CB ' HG23 ' A' ' 72' ' ' VAL . 1.3 t -89.05 175.15 7.51 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.967 -1.083 . . . . 0.0 110.157 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.2 -91.96 0.08 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.209 -0.932 . . . . 0.0 110.348 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.38 170.32 13.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.162 -0.961 . . . . 0.0 110.122 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.511 ' N ' ' HA ' ' A' ' 38' ' ' ALA . . . -55.55 133.04 50.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.237 -0.914 . . . . 0.0 110.144 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 1.095 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 16.5 p90 -136.23 -161.67 1.19 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.197 -0.939 . . . . 0.0 110.65 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.637 ' C ' HD12 ' A' ' 139' ' ' LEU 0.258 0.9 OUTLIER -156.86 176.76 12.32 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.405 -0.809 . . . . 0.0 110.028 -177.78 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.691 HD21 ' CD1' ' A' ' 95' ' ' LEU . 1.8 mp -145.43 119.42 9.37 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.097 -1.002 . . . . 0.0 112.04 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' CYS . . . . . 0.644 ' SG ' ' HB3' ' A' ' 31' ' ' ALA . 0.8 OUTLIER -99.71 111.68 23.99 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.577 -0.702 . . . . 0.0 110.387 178.349 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.495 ' O ' ' HB3' ' A' ' 142' ' ' ASP . 5.5 mt -103.57 173.89 6.11 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.233 -0.917 . . . . 0.0 109.687 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.563 ' HA ' ' CG ' ' A' ' 9' ' ' PHE . 3.0 p-10 172.09 -177.81 0.06 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.426 -0.796 . . . . 0.0 110.166 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.45 ' HA ' ' O ' ' A' ' 7' ' ' GLY . 19.3 t0 42.07 59.62 2.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.339 -0.85 . . . . 0.0 109.856 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.603 HG21 ' CZ ' ' A' ' 9' ' ' PHE . 1.9 t -100.89 114.45 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.32 -0.863 . . . . 0.0 110.113 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.454 ' HB2' ' HA ' ' A' ' 6' ' ' GLU . . . -144.6 156.25 44.04 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.317 -0.864 . . . . 0.0 110.447 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.819 HD11 ' HB3' ' A' ' 60' ' ' TYR . 35.5 tp -154.58 125.55 7.18 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.321 -0.862 . . . . 0.0 110.094 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.482 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 6.9 m-20 -125.26 179.12 5.22 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.265 -0.897 . . . . 0.0 110.302 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.502 ' HB3' ' CE1' ' A' ' 60' ' ' TYR . 10.9 p -141.24 102.17 4.17 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.268 -0.895 . . . . 0.0 110.209 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 148' ' ' SER . 7.2 tm-20 42.84 90.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.24 -0.913 . . . . 0.0 110.208 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.511 HG22 ' O ' ' A' ' 150' ' ' VAL . 12.9 p -87.1 48.96 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.217 -0.927 . . . . 0.0 110.283 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.45 ' O ' ' O ' ' A' ' 150' ' ' VAL . 3.8 tt0 57.38 112.57 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.233 -0.917 . . . . 0.0 110.259 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.745 ' O ' HD12 ' A' ' 152' ' ' LEU . 2.7 pp . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.167 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.255 0.55 . . . . 0.0 110.181 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.457 ' HB2' ' O ' ' A' ' 1' ' ' ALA . 26.9 t 178.67 107.61 0.15 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.281 -0.887 . . . . 0.0 110.192 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -75.98 -156.47 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.961 1.506 . . . . 0.0 110.089 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.843 HD11 ' O ' ' A' ' 144' ' ' VAL . 9.4 pt -90.19 -42.78 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.17 -0.956 . . . . 0.0 110.2 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.499 ' O ' ' N ' ' A' ' 7' ' ' GLY . . . 137.38 74.42 0.06 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.623 ' CB ' ' HB2' ' A' ' 145' ' ' ALA . 5.8 pt-20 -42.75 94.95 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.3 -1.118 . . . . 0.0 110.247 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 5' ' ' GLY . . . -172.55 143.94 7.65 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.524 ' CG2' ' HB3' ' A' ' 143' ' ' ASP . 76.8 p -54.79 167.2 0.39 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.344 -1.092 . . . . 0.0 110.161 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.596 ' CD2' ' HA ' ' A' ' 142' ' ' ASP . 22.9 m-85 -91.28 55.54 2.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.243 -0.91 . . . . 0.0 110.131 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.561 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 3.3 p-10 -101.77 38.59 1.6 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.164 -0.96 . . . . 0.0 110.316 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.561 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 1.5 m-20 161.42 79.19 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.637 -0.664 . . . . 0.0 109.723 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 63.69 94.86 0.02 OUTLIER Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.536 ' O ' ' N ' ' A' ' 15' ' ' GLY . 45.1 Cg_endo -72.65 78.6 2.02 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.071 1.564 . . . . 0.0 110.627 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.46 ' HG3' ' HB ' ' A' ' 4' ' ' ILE . 6.9 mm-40 42.25 -91.4 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.35 -0.844 . . . . 0.0 110.627 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.753 ' O ' HG13 ' A' ' 17' ' ' VAL . . . -158.96 24.63 0.34 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.967 ' CE2' HD22 ' A' ' 49' ' ' LEU . 41.5 m95 -56.12 87.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.283 -1.128 . . . . 0.0 110.255 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.753 HG13 ' O ' ' A' ' 15' ' ' GLY . 0.9 OUTLIER -91.28 146.91 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.049 -1.032 . . . . 0.0 109.647 179.743 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.455 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . . . -130.14 135.58 48.36 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.125 -0.985 . . . . 0.0 109.781 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.709 ' HE1' HG13 ' A' ' 48' ' ' VAL . 19.7 p90 -124.3 167.69 13.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.424 -0.797 . . . . 0.0 110.668 -178.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.527 ' CA ' ' OH ' ' A' ' 43' ' ' TYR . . . 75.28 43.79 24.44 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.517 HG22 ' CG1' ' A' ' 45' ' ' VAL . 6.0 p -150.69 -157.23 0.79 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.125 -1.22 . . . . 0.0 110.367 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -93.87 75.92 4.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.32 -0.863 . . . . 0.0 110.23 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.74 -172.09 43.93 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.22 163.62 37.52 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.989 1.521 . . . . 0.0 110.465 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.713 HD23 ' H ' ' A' ' 25' ' ' LEU . 0.7 OUTLIER -68.17 -169.73 0.15 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.283 -0.885 . . . . 0.0 110.24 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -162.4 150.93 14.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.232 -0.918 . . . . 0.0 110.293 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' THR . . . . . 1.0 HG22 ' O ' ' A' ' 31' ' ' ALA . 0.8 OUTLIER -119.81 -77.48 0.58 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.327 -0.858 . . . . 0.0 110.046 179.933 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 27' ' ' THR . 1.3 m 40.64 27.77 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.431 -0.793 . . . . 0.0 110.476 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.93 HG22 ' O ' ' A' ' 27' ' ' THR . 9.2 t -164.52 30.76 0.07 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.153 -0.967 . . . . 0.0 110.279 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.541 ' HA2' ' CA ' ' A' ' 10' ' ' ASP . . . 53.1 28.38 33.36 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 1.0 ' O ' HG22 ' A' ' 27' ' ' THR . . . -150.13 161.46 42.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.309 -1.113 . . . . 0.0 110.313 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.773 HD23 HD12 ' A' ' 141' ' ' LEU . 0.8 OUTLIER -105.4 98.04 7.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.89 . . . . 0.0 109.562 179.817 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.515 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 64.9 m -107.59 116.35 31.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.244 -0.91 . . . . 0.0 111.01 -179.231 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.523 HG12 ' CB ' ' A' ' 25' ' ' LEU . 20.3 m -104.03 140.92 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.42 -0.8 . . . . 0.0 109.175 179.213 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.49 ' O ' ' HB ' ' A' ' 21' ' ' THR . . . -88.96 89.5 8.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.064 -1.023 . . . . 0.0 110.69 -179.223 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.055 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 43.8 t -71.62 135.79 83.54 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.263 -0.898 . . . . 0.0 109.775 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.516 ' HG3' ' OE1' ' A' ' 42' ' ' GLN . 40.0 Cg_endo -67.74 -174.06 0.55 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.091 1.574 . . . . 0.0 111.652 -179.173 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.541 ' HA ' ' CA ' ' A' ' 136' ' ' ALA . . . -72.45 118.77 15.76 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.537 -0.727 . . . . 0.0 111.874 -178.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.565 ' O ' ' C ' ' A' ' 40' ' ' SER . . . 52.98 15.25 3.25 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 178.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.565 ' C ' ' O ' ' A' ' 39' ' ' GLY . 49.3 m 25.16 46.73 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.278 0 CA-C-N 118.268 1.034 . . . . 0.0 110.831 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.508 ' N ' ' O ' ' A' ' 39' ' ' GLY . . . -89.09 26.66 1.54 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.475 -0.766 . . . . 0.0 111.167 -178.476 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.516 ' OE1' ' HG3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -91.98 -153.1 0.32 Allowed 'General case' 0 C--N 1.29 -1.992 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.461 179.183 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.563 ' CE1' ' O ' ' A' ' 44' ' ' GLY . 25.0 p90 -56.57 -16.25 5.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.035 -1.041 . . . . 0.0 109.931 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.563 ' O ' ' CE1' ' A' ' 43' ' ' TYR . . . 123.67 122.64 2.73 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.532 HG12 ' H ' ' A' ' 46' ' ' GLY . 5.2 t -90.04 179.23 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.144 -1.209 . . . . 0.0 109.21 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.532 ' H ' HG12 ' A' ' 45' ' ' VAL . . . 164.0 -175.29 40.15 Favored Glycine 0 N--CA 1.489 2.225 0 C-N-CA 119.097 -1.525 . . . . 0.0 110.772 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.73 HG13 ' O ' ' A' ' 17' ' ' VAL . 21.8 t -151.04 131.47 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.722 -0.869 . . . . 0.0 108.701 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.709 HG13 ' HE1' ' A' ' 19' ' ' TYR . 29.3 m -119.83 131.51 72.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.948 -1.095 . . . . 0.0 110.797 -179.412 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.967 HD22 ' CE2' ' A' ' 16' ' ' TRP . 21.0 tp -131.91 103.91 6.57 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.377 -0.827 . . . . 0.0 110.365 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.513 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 35.7 p30 -78.73 152.41 31.55 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.253 -0.904 . . . . 0.0 110.285 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 125.33 64.45 0.18 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.589 HG12 ' N ' ' A' ' 53' ' ' ALA . 89.2 t -131.0 172.62 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.155 -1.203 . . . . 0.0 110.134 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.589 ' N ' HG12 ' A' ' 52' ' ' VAL . . . -150.28 85.78 1.4 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.18 -0.95 . . . . 0.0 110.567 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.637 ' CG1' ' CD2' ' A' ' 112' ' ' TYR . 42.4 mm -111.11 159.97 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.244 -0.91 . . . . 0.0 109.912 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.583 ' HA ' HG23 ' A' ' 111' ' ' THR . 72.5 mt-10 -149.52 120.54 7.7 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.119 -0.988 . . . . 0.0 110.471 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.523 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 11.7 pt-20 37.52 -152.0 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.618 -0.676 . . . . 0.0 110.779 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.461 ' N ' ' HG3' ' A' ' 56' ' ' GLU . . . -79.4 114.27 3.84 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.671 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.2 m -144.22 171.76 13.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.267 -1.137 . . . . 0.0 109.772 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.574 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 0.5 OUTLIER -89.8 158.17 17.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.278 -0.889 . . . . 0.0 110.106 179.866 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.867 ' O ' HG22 ' A' ' 105' ' ' THR . 68.4 m-85 -159.2 171.22 20.29 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.249 -0.907 . . . . 0.0 110.244 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.589 ' OG1' HG22 ' A' ' 105' ' ' THR . 25.7 m -150.11 117.28 6.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.317 -0.864 . . . . 0.0 110.211 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 27.5 tp -89.74 122.49 32.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.205 -0.934 . . . . 0.0 110.022 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.51 ' NH2' ' OD2' ' A' ' 143' ' ' ASP . 1.0 OUTLIER -124.92 104.06 8.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.226 -0.921 . . . . 0.0 110.349 -179.757 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 1.16 ' CZ ' HG21 ' A' ' 102' ' ' VAL . 3.0 p90 -150.54 151.78 33.16 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.281 -0.887 . . . . 0.0 110.012 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.508 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 29.4 m -119.88 97.62 5.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.221 -0.925 . . . . 0.0 110.251 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.758 ' CB ' HD21 ' A' ' 95' ' ' LEU . . . -99.65 145.96 27.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 0.0 110.403 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.685 HG23 ' O ' ' A' ' 98' ' ' GLU . 98.9 m -150.32 117.32 5.93 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.302 -0.874 . . . . 0.0 110.08 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.522 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -107.53 133.41 52.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.184 -0.948 . . . . 0.0 110.115 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 68' ' ' ALA . 1.5 m -45.79 -25.71 0.55 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.167 -0.958 . . . . 0.0 109.399 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.558 ' CG2' ' CB ' ' A' ' 137' ' ' TRP . 1.8 t -110.27 169.26 8.85 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.484 -0.76 . . . . 0.0 109.86 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.496 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 2.2 m-20 -86.15 62.34 7.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.179 -0.951 . . . . 0.0 109.181 179.064 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.947 HG21 ' CE2' ' A' ' 137' ' ' TRP . 3.3 p -86.16 136.58 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.35 -0.844 . . . . 0.0 111.203 -179.003 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 67.0 m -122.95 92.08 3.63 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.71 HG21 HD22 ' A' ' 129' ' ' LEU . 4.3 m -89.97 -153.07 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.158 -0.964 . . . . 0.0 110.628 -178.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.464 ' N ' HG23 ' A' ' 74' ' ' VAL . 5.0 mtm180 -127.7 128.73 45.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.313 -0.867 . . . . 0.0 110.577 -179.472 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.613 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -131.22 155.41 47.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.335 -0.853 . . . . 0.0 109.786 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.669 HD12 ' C ' ' A' ' 77' ' ' LEU . 3.8 pp 178.55 -154.46 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.272 -0.892 . . . . 0.0 110.281 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.732 HG23 HD22 ' A' ' 89' ' ' LEU . 4.3 t -146.87 171.92 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.289 -0.882 . . . . 0.0 109.357 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.494 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . 178.78 -176.3 47.89 Favored Glycine 0 N--CA 1.49 2.258 0 C-N-CA 119.363 -1.399 . . . . 0.0 110.056 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.625 ' NE2' ' HD2' ' A' ' 113' ' ' PRO . 1.8 tp-100 -112.64 86.85 2.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.393 -1.063 . . . . 0.0 110.21 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.475 ' O ' ' HG2' ' A' ' 121' ' ' PRO . 3.6 m-80 -64.68 97.39 0.21 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.135 -0.978 . . . . 0.0 109.681 179.458 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.585 ' O ' ' CZ ' ' A' ' 85' ' ' TYR . . . 149.13 -88.69 0.14 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.513 ' HB2' ' O ' ' A' ' 82' ' ' GLY . . . 178.83 146.67 0.37 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.187 -1.184 . . . . 0.0 110.054 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.488 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.5 Cg_endo -85.44 36.06 3.21 Favored 'Cis proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.921 -2.116 . . . . 0.0 110.616 -0.303 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.585 ' CZ ' ' O ' ' A' ' 82' ' ' GLY . 98.9 m-85 59.17 -168.91 0.14 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.263 -0.898 . . . . 0.0 110.399 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 135.77 110.54 1.07 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -89.76 140.5 29.53 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.22 -1.165 . . . . 0.0 110.389 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.796 HG23 ' CD1' ' A' ' 89' ' ' LEU . 30.6 m -119.78 -17.98 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.409 -0.807 . . . . 0.0 109.746 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.866 HD11 ' CZ ' ' A' ' 106' ' ' PHE . 4.4 mp -121.55 143.26 49.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.401 -0.812 . . . . 0.0 110.784 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -151.15 78.88 1.3 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.886 . . . . 0.0 110.074 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 36.3 p -147.04 174.05 11.9 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.039 -1.038 . . . . 0.0 110.708 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.416 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 1.3 m -119.81 120.31 30.56 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.395 -0.815 . . . . 0.0 109.848 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.626 ' HG2' HG22 ' A' ' 74' ' ' VAL . 43.6 Cg_endo -70.61 117.49 5.17 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.928 1.489 . . . . 0.0 111.125 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.526 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -86.18 138.96 31.49 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.896 . . . . 0.0 109.339 179.173 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.826 HD13 ' HG ' ' A' ' 139' ' ' LEU . 72.4 mt -130.66 169.46 15.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.033 -1.042 . . . . 0.0 110.883 -179.405 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -178.34 -178.75 0.64 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.488 -0.757 . . . . 0.0 109.938 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.61 -23.72 67.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.887 . . . . 0.0 110.17 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.685 ' O ' HG23 ' A' ' 67' ' ' THR . 4.3 mt-10 -89.8 165.17 25.95 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.292 -0.88 . . . . 0.0 110.178 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.492 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 45.1 Cg_endo -72.45 133.18 20.31 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.946 1.498 . . . . 0.0 110.29 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.526 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.79 81.05 1.67 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.206 -0.934 . . . . 0.0 110.289 -179.927 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.45 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 0.0 OUTLIER -68.12 158.22 33.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.25 -0.906 . . . . 0.0 110.015 179.827 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 1.16 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 65.3 t -133.67 132.38 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.174 -0.954 . . . . 0.0 110.434 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -150.57 89.21 1.54 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.405 -0.809 . . . . 0.0 110.035 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' A' ' 61' ' ' THR . 1.2 mm-40 -141.38 168.78 18.97 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.155 -0.966 . . . . 0.0 110.273 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.867 HG22 ' O ' ' A' ' 60' ' ' TYR . 0.6 OUTLIER -121.98 -179.51 4.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.309 -0.869 . . . . 0.0 110.172 -179.992 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.866 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 53.7 p90 -177.96 155.47 0.98 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.217 -0.927 . . . . 0.0 110.259 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 58' ' ' THR . 99.3 m -91.25 95.79 10.22 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.223 -0.923 . . . . 0.0 110.132 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.776 ' HB3' ' CE2' ' A' ' 60' ' ' TYR . . . -65.72 113.67 4.44 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -0.918 . . . . 0.0 110.44 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.412 ' O ' ' OG ' ' A' ' 109' ' ' SER . 5.8 p -98.42 55.87 1.12 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.208 -0.933 . . . . 0.0 109.958 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.433 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -158.19 -160.62 0.92 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.256 -0.902 . . . . 0.0 110.455 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.583 HG23 ' HA ' ' A' ' 55' ' ' GLU . 10.5 m -152.54 118.17 5.35 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.347 -0.845 . . . . 0.0 110.34 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.637 ' CD2' ' CG1' ' A' ' 54' ' ' ILE . 11.2 m-30 -113.08 94.17 28.94 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.256 -0.903 . . . . 0.0 109.85 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.625 ' HD2' ' NE2' ' A' ' 80' ' ' GLN . 45.7 Cg_endo -72.94 139.72 30.55 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.022 1.538 . . . . 0.0 110.51 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.98 0.47 21.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.242 -0.911 . . . . 0.0 110.246 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -122.0 136.27 26.1 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.245 -0.909 . . . . 0.0 110.2 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.02 171.16 18.12 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.967 1.509 . . . . 0.0 110.406 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.785 ' HB3' ' HB2' ' A' ' 120' ' ' ASP . . . -90.57 49.37 1.66 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.272 -0.893 . . . . 0.0 110.281 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.583 ' HB3' ' O ' ' A' ' 117' ' ' ALA . . . 61.64 12.3 4.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.199 -0.938 . . . . 0.0 110.209 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 118' ' ' ALA . 2.1 t70 177.3 -28.61 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.35 -0.844 . . . . 0.0 110.312 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.785 ' HB2' ' HB3' ' A' ' 117' ' ' ALA . 7.6 m-20 -89.77 174.56 4.66 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.182 -0.949 . . . . 0.0 110.235 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.541 ' HG2' ' CA ' ' A' ' 82' ' ' GLY . 42.4 Cg_endo -88.7 -155.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 124.126 1.593 . . . . 0.0 110.331 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' A' ' 113' ' ' PRO . 14.7 pt-20 -145.92 -156.37 0.7 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.052 -1.03 . . . . 0.0 110.405 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.542 ' HA2' ' HA ' ' A' ' 80' ' ' GLN . . . -99.69 144.85 17.21 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.513 ' CB ' ' HA ' ' A' ' 50' ' ' ASN . 10.2 pt20 -150.49 -153.82 0.51 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.208 -1.172 . . . . 0.0 110.597 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.751 HG21 ' HH2' ' A' ' 16' ' ' TRP . 21.6 mt -118.63 142.2 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.515 -0.74 . . . . 0.0 109.297 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.639 ' HB3' ' CD1' ' A' ' 77' ' ' LEU . . . -113.64 115.87 28.58 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.395 -0.816 . . . . 0.0 111.774 -178.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.539 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 4.5 m-85 -119.75 74.28 1.01 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.135 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.928 ' C ' HD23 ' A' ' 129' ' ' LEU . 2.3 mt-30 -87.26 126.54 34.89 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.207 -0.933 . . . . 0.0 112.146 -177.305 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.928 HD23 ' C ' ' A' ' 128' ' ' GLN . 1.4 mt -112.77 55.38 0.69 Allowed 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.593 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 131' ' ' GLY . . . -73.28 85.3 0.6 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.499 ' HA2' ' O ' ' A' ' 39' ' ' GLY . . . 58.44 114.61 0.01 OUTLIER Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.639 ' CD2' HG12 ' A' ' 74' ' ' VAL . 10.3 m-85 -147.4 -57.16 0.25 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -1.148 . . . . 0.0 110.206 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.673 ' CB ' HG23 ' A' ' 72' ' ' VAL . 5.9 t -89.69 173.79 8.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.149 -0.969 . . . . 0.0 110.187 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -74.84 -93.73 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.213 -0.93 . . . . 0.0 110.208 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.33 -167.84 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.081 -1.012 . . . . 0.0 109.937 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.541 ' CA ' ' HA ' ' A' ' 38' ' ' ALA . . . -77.58 150.07 34.76 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.214 -0.929 . . . . 0.0 110.375 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 1.055 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 24.3 p90 -148.49 -154.81 0.58 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.315 -0.866 . . . . 0.0 110.11 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.522 ' O ' ' CB ' ' A' ' 68' ' ' ALA . 1.0 OUTLIER -160.43 163.17 33.26 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.922 -1.111 . . . . 0.0 111.296 -178.21 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.826 ' HG ' HD13 ' A' ' 95' ' ' LEU . 2.1 mp -126.52 125.74 42.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.429 -0.794 . . . . 0.0 109.56 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' CYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 41.1 m -121.01 99.45 6.5 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.107 -0.995 . . . . 0.0 110.713 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.773 HD12 HD23 ' A' ' 32' ' ' LEU . 2.2 mt -89.64 -154.67 0.33 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.317 -0.864 . . . . 0.0 109.479 179.366 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.92 ' O ' HG23 ' A' ' 144' ' ' VAL . 39.7 p-10 -177.78 -151.49 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.187 -0.946 . . . . 0.0 110.03 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.524 ' HB3' ' CG2' ' A' ' 8' ' ' THR . 23.6 p-10 -40.56 115.05 0.52 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.526 -0.734 . . . . 0.0 109.785 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.92 HG23 ' O ' ' A' ' 142' ' ' ASP . 43.0 t -128.85 125.09 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.284 -0.885 . . . . 0.0 110.244 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.623 ' HB2' ' CB ' ' A' ' 6' ' ' GLU . . . -136.89 178.82 6.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.292 -0.88 . . . . 0.0 110.658 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.553 HD12 ' O ' ' A' ' 61' ' ' THR . 14.4 tp -158.93 118.7 3.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.384 -0.823 . . . . 0.0 109.947 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.505 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 49.3 m-20 -113.15 141.05 47.38 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.228 -0.92 . . . . 0.0 110.415 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.573 ' HB3' ' CE1' ' A' ' 60' ' ' TYR . 0.8 OUTLIER -114.7 -160.54 0.74 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.321 -0.862 . . . . 0.0 110.224 179.935 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -114.4 101.67 9.37 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.307 -0.87 . . . . 0.0 110.2 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.533 HG13 ' O ' ' A' ' 150' ' ' VAL . 14.7 p -124.74 126.46 71.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.225 -0.922 . . . . 0.0 110.264 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -104.28 29.94 5.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -0.933 . . . . 0.0 110.269 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.491 ' H ' HG22 ' A' ' 150' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.209 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.261 0.553 . . . . 0.0 110.195 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.3 m -144.98 140.83 16.58 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.266 -0.896 . . . . 0.0 110.178 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -76.28 -156.35 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.002 1.528 . . . . 0.0 110.053 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.554 HG22 ' O ' ' A' ' 51' ' ' GLY . 9.5 pt -89.88 34.91 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.151 -0.968 . . . . 0.0 110.166 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.42 ' O ' ' C ' ' A' ' 6' ' ' GLU . . . 89.62 -34.14 4.14 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.59 ' HG3' ' HB2' ' A' ' 145' ' ' ALA . 30.4 tt0 42.86 41.47 2.57 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.34 -1.094 . . . . 0.0 110.172 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 143' ' ' ASP . . . -126.26 169.93 18.15 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 142' ' ' ASP . 12.7 p -83.7 42.51 0.85 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.275 -1.132 . . . . 0.0 110.522 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.77 ' HB3' HG21 ' A' ' 27' ' ' THR . 15.7 m-30 41.29 32.54 0.21 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.27 -0.894 . . . . 0.0 110.381 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.539 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 35.4 p-10 -89.35 46.4 1.37 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.167 -0.958 . . . . 0.0 110.316 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.539 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.3 OUTLIER 161.52 -22.56 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.798 -0.564 . . . . 0.0 109.75 179.962 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 167.58 110.74 0.23 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.81 ' HG3' HD12 ' A' ' 32' ' ' LEU . 49.9 Cg_endo -76.59 72.75 5.48 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.984 1.518 . . . . 0.0 110.778 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.519 ' HG3' HD11 ' A' ' 49' ' ' LEU . 12.8 tp10 41.32 -92.1 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.293 -0.879 . . . . 0.0 110.509 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.573 ' C ' HD13 ' A' ' 49' ' ' LEU . . . -157.71 43.24 0.51 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.945 ' NE1' HD22 ' A' ' 49' ' ' LEU . 37.9 m95 -66.47 127.88 34.01 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.32 -1.106 . . . . 0.0 110.288 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.724 HG22 ' O ' ' A' ' 48' ' ' VAL . 1.3 m -122.32 154.73 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.135 -0.978 . . . . 0.0 109.689 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.459 ' HB2' HG11 ' A' ' 34' ' ' VAL . . . -137.1 154.83 50.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.303 -0.873 . . . . 0.0 109.526 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.743 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.6 OUTLIER -139.47 138.67 36.62 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.06 -1.025 . . . . 0.0 111.13 -178.752 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.589 ' HA2' ' CE1' ' A' ' 43' ' ' TYR . . . 121.26 84.3 0.77 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.655 HG21 ' HB3' ' A' ' 37' ' ' PRO . 1.7 p 53.15 17.6 1.0 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.508 -0.995 . . . . 0.0 110.955 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 1.031 ' HA ' ' HB3' ' A' ' 35' ' ' ALA . 5.9 p30 -101.89 111.36 23.59 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.083 -1.011 . . . . 0.0 110.284 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 22' ' ' ASP . . . -59.94 -152.91 0.02 OUTLIER Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.022 -1.631 . . . . 0.0 109.022 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.455 ' O ' ' C ' ' A' ' 25' ' ' LEU . 47.0 Cg_endo -74.4 95.63 0.94 Allowed 'Trans proline' 0 C--N 1.303 -1.86 0 O-C-N 123.814 1.429 . . . . 0.0 110.307 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.716 HD23 ' H ' ' A' ' 25' ' ' LEU . 0.8 OUTLIER -40.65 150.39 0.07 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.354 -0.841 . . . . 0.0 109.771 179.808 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -146.6 159.77 43.03 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.98 -1.075 . . . . 0.0 110.757 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.77 HG21 ' HB3' ' A' ' 9' ' ' PHE . 3.7 p -119.63 -55.86 2.08 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.321 -0.862 . . . . 0.0 110.161 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 50.57 -89.58 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.275 -0.891 . . . . 0.0 110.228 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.514 ' N ' ' O ' ' A' ' 27' ' ' THR . 15.2 t -55.71 -17.19 5.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.243 -0.911 . . . . 0.0 110.161 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 9' ' ' PHE . . . 111.65 32.55 2.46 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.503 ' HA ' ' O ' ' A' ' 141' ' ' LEU . . . -140.52 109.97 6.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.272 -1.134 . . . . 0.0 110.274 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.81 HD12 ' HG3' ' A' ' 13' ' ' PRO . 0.6 OUTLIER -67.17 94.31 0.35 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.266 -0.896 . . . . 0.0 109.991 179.912 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.518 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 59.0 m -99.4 133.09 44.2 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.31 -0.869 . . . . 0.0 110.574 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.625 HG12 ' HB3' ' A' ' 25' ' ' LEU . 6.2 m -121.62 167.28 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.571 -0.705 . . . . 0.0 109.4 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 1.031 ' HB3' ' HA ' ' A' ' 22' ' ' ASP . . . -103.15 128.46 50.08 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.126 -0.984 . . . . 0.0 111.887 -178.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.999 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 90.3 t -117.5 121.47 32.01 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.163 -0.961 . . . . 0.0 108.991 178.627 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.655 ' HB3' HG21 ' A' ' 21' ' ' THR . 38.2 Cg_endo -64.25 173.99 4.6 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.856 1.45 . . . . 0.0 112.196 -178.505 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.54 ' HA ' ' CA ' ' A' ' 136' ' ' ALA . . . -53.31 122.28 9.27 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.514 0.673 . . . . 0.0 111.456 -178.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.513 ' O ' ' C ' ' A' ' 40' ' ' SER . . . 37.89 27.17 0.03 OUTLIER Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.972 ' OG ' HG23 ' A' ' 45' ' ' VAL . 31.3 t 32.77 46.39 0.08 Allowed 'General case' 0 N--CA 1.498 1.934 0 CA-C-N 118.045 0.923 . . . . 0.0 110.15 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.644 ' O ' ' CG ' ' A' ' 42' ' ' GLN . . . -89.51 119.02 29.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.594 -0.692 . . . . 0.0 110.127 -179.218 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.644 ' CG ' ' O ' ' A' ' 41' ' ' ALA . 0.5 OUTLIER 84.1 28.64 0.08 Allowed 'General case' 0 N--CA 1.508 2.433 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -179.492 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.641 ' CE2' ' CG2' ' A' ' 21' ' ' THR . 0.1 OUTLIER -146.4 -33.27 0.32 Allowed 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 118.757 -1.177 . . . . 0.0 112.335 -177.878 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 43' ' ' TYR . . . 52.26 75.28 0.23 Allowed Glycine 0 N--CA 1.482 1.758 0 N-CA-C 105.849 -2.9 . . . . 0.0 105.849 -177.011 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.972 HG23 ' OG ' ' A' ' 40' ' ' SER . 2.6 t -85.68 160.76 3.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.513 -0.992 . . . . 0.0 109.186 -177.409 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.577 ' O ' ' CE1' ' A' ' 19' ' ' TYR . . . 176.68 164.66 30.98 Favored Glycine 0 N--CA 1.488 2.102 0 C-N-CA 119.357 -1.402 . . . . 0.0 110.08 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.681 HG13 ' O ' ' A' ' 17' ' ' VAL . 17.8 t -124.59 125.53 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.473 -1.016 . . . . 0.0 109.626 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.724 ' O ' HG22 ' A' ' 17' ' ' VAL . 33.8 m -119.73 139.89 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.007 -1.058 . . . . 0.0 110.842 -179.233 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.945 HD22 ' NE1' ' A' ' 16' ' ' TRP . 18.4 tp -132.08 99.25 4.66 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.318 -0.864 . . . . 0.0 110.086 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.531 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 10.6 p30 -73.38 121.52 20.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.245 -0.909 . . . . 0.0 110.429 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.554 ' O ' HG22 ' A' ' 4' ' ' ILE . . . 150.54 65.85 0.01 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.864 -1.295 . . . . 0.0 109.864 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.656 HG23 ' HA ' ' A' ' 124' ' ' GLN . 53.1 t -122.61 169.68 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.137 -1.213 . . . . 0.0 110.073 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.562 ' N ' HG12 ' A' ' 52' ' ' VAL . . . -141.41 88.63 2.16 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.151 -0.968 . . . . 0.0 110.613 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.669 HG21 ' HB1' ' A' ' 108' ' ' ALA . 36.1 mm -122.14 163.0 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.292 -0.88 . . . . 0.0 109.718 179.572 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.524 ' HA ' HG23 ' A' ' 111' ' ' THR . 2.0 tt0 -150.25 127.05 11.02 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.044 -1.035 . . . . 0.0 110.778 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.52 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 13.6 pt-20 37.56 -157.86 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.642 -0.661 . . . . 0.0 111.093 179.576 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' A' ' 109' ' ' SER . . . -79.04 82.84 1.32 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.639 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.3 m -110.16 170.46 8.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.266 -1.137 . . . . 0.0 109.779 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.576 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 6.5 m -89.87 154.58 19.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.175 -0.953 . . . . 0.0 110.33 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.639 ' CE2' HG22 ' A' ' 58' ' ' THR . 60.3 m-85 -159.77 173.06 16.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.332 -0.855 . . . . 0.0 110.225 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 27.4 m -150.14 116.01 5.6 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.3 -0.875 . . . . 0.0 110.036 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 103' ' ' THR . 38.3 tp -89.78 122.6 33.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.265 -0.897 . . . . 0.0 110.057 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.584 ' HG2' HG23 ' A' ' 103' ' ' THR . 16.1 mtt180 -131.81 106.46 8.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.332 -0.855 . . . . 0.0 110.233 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.496 ' C ' ' CD1' ' A' ' 64' ' ' TYR . 10.0 p90 -143.04 159.62 41.92 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.246 -0.908 . . . . 0.0 110.236 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.504 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 1.3 m -119.96 102.35 8.49 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.179 -0.951 . . . . 0.0 109.866 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.708 ' CB ' HD21 ' A' ' 95' ' ' LEU . . . -104.83 149.47 25.63 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.273 -0.892 . . . . 0.0 110.699 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.498 HG23 ' O ' ' A' ' 98' ' ' GLU . 93.5 m -150.22 126.01 10.4 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.444 -0.785 . . . . 0.0 110.025 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -114.32 136.96 52.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.211 -0.931 . . . . 0.0 109.999 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' ' 68' ' ' ALA . 0.4 OUTLIER -44.03 -26.57 0.3 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.189 -0.944 . . . . 0.0 109.344 179.528 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.567 ' CG2' ' CB ' ' A' ' 137' ' ' TRP . 2.7 t -114.07 169.39 9.04 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.51 -0.744 . . . . 0.0 109.824 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.506 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 33.7 p-10 -85.07 66.02 9.53 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.137 -0.977 . . . . 0.0 109.201 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.964 HG23 ' HB2' ' A' ' 133' ' ' SER . 4.0 p -89.39 140.36 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -0.885 . . . . 0.0 111.483 -178.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.44 HG22 ' O ' ' A' ' 73' ' ' THR . 16.8 m -127.72 87.21 2.58 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.629 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 1.085 HG21 ' CD2' ' A' ' 129' ' ' LEU . 2.8 m -89.78 -140.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.238 -0.914 . . . . 0.0 110.483 -178.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.764 ' N ' HG23 ' A' ' 74' ' ' VAL . 7.0 mtm180 -127.74 149.07 50.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.169 -0.957 . . . . 0.0 110.767 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.592 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -150.11 152.47 34.81 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.399 -0.813 . . . . 0.0 109.421 179.465 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.909 HD12 ' N ' ' A' ' 78' ' ' VAL . 3.9 pp 179.87 -147.15 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.181 -0.949 . . . . 0.0 110.294 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.925 HG23 HD22 ' A' ' 89' ' ' LEU . 6.8 t -151.29 169.59 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.215 -0.928 . . . . 0.0 109.431 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.543 ' C ' ' CE1' ' A' ' 112' ' ' TYR . . . -172.42 -173.59 39.14 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.236 -1.459 . . . . 0.0 110.252 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.543 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 4.3 pt20 -115.88 108.0 15.73 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.466 -1.02 . . . . 0.0 110.163 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.477 ' HB2' ' HG2' ' A' ' 122' ' ' GLU . 6.2 m-20 -66.61 92.97 0.22 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.193 -0.942 . . . . 0.0 110.236 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.538 ' C ' ' CE1' ' A' ' 85' ' ' TYR . . . 142.8 144.23 4.27 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.654 -1.379 . . . . 0.0 109.654 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.618 ' N ' ' CE1' ' A' ' 85' ' ' TYR . . . -62.7 157.02 61.45 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.226 -1.161 . . . . 0.0 110.27 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.517 ' C ' ' CD2' ' A' ' 85' ' ' TYR . 50.6 Cg_endo -77.38 8.54 17.89 Favored 'Cis proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.647 -2.23 . . . . 0.0 110.876 -0.064 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.618 ' CE1' ' N ' ' A' ' 83' ' ' ALA . 11.6 m-85 69.83 161.34 0.21 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.241 -0.912 . . . . 0.0 110.262 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.498 ' N ' ' CG ' ' A' ' 80' ' ' GLN . . . 166.76 106.6 0.19 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.484 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 1.0 OUTLIER -89.55 152.38 21.45 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.121 -1.223 . . . . 0.0 110.464 -179.787 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 1.125 HG23 HD12 ' A' ' 89' ' ' LEU . 33.2 m -119.72 -24.92 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.35 -0.844 . . . . 0.0 109.8 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 1.125 HD12 HG23 ' A' ' 88' ' ' VAL . 3.6 mp -99.16 141.8 31.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.285 -0.884 . . . . 0.0 110.73 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 45.5 p-10 -151.34 73.92 1.11 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.393 -0.817 . . . . 0.0 110.032 179.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 41.5 p -135.35 176.03 9.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.051 -1.031 . . . . 0.0 110.643 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 1.4 m -122.01 121.33 28.05 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.385 -0.822 . . . . 0.0 109.949 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.592 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 44.7 Cg_endo -70.92 155.38 62.2 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.919 1.484 . . . . 0.0 110.898 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.519 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -122.26 137.47 54.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.449 -0.782 . . . . 0.0 109.463 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.708 HD21 ' CB ' ' A' ' 66' ' ' ALA . 93.0 mt -131.96 169.03 16.88 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.104 -0.997 . . . . 0.0 110.625 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.589 HG23 ' H ' ' A' ' 98' ' ' GLU . 5.9 t -174.65 -155.08 0.06 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.428 -0.795 . . . . 0.0 110.0 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.536 ' N ' HG23 ' A' ' 96' ' ' THR . 0.9 OUTLIER -89.7 24.33 2.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.261 -0.899 . . . . 0.0 110.128 179.956 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.589 ' H ' HG23 ' A' ' 96' ' ' THR . 0.0 OUTLIER -147.57 172.03 5.65 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.35 -0.844 . . . . 0.0 110.012 179.882 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.51 ' HD2' ' CG ' ' A' ' 98' ' ' GLU . 45.2 Cg_endo -72.82 127.45 12.28 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.979 1.515 . . . . 0.0 110.443 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.519 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 6.6 mtt-85 -119.51 93.1 3.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.261 -0.9 . . . . 0.0 109.867 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -78.06 102.71 7.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.448 -0.783 . . . . 0.0 110.569 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 50.2 t -89.41 134.13 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.241 -0.912 . . . . 0.0 109.805 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.584 HG23 ' HG2' ' A' ' 63' ' ' ARG . 0.2 OUTLIER -147.05 133.09 19.22 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.16 -0.963 . . . . 0.0 110.247 -179.884 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 103' ' ' THR . 1.8 mt-10 -160.25 134.72 7.5 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.259 -0.901 . . . . 0.0 110.333 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 25.2 m -90.68 143.82 26.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.281 -0.887 . . . . 0.0 110.125 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.913 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 41.7 p90 -154.48 159.85 41.25 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.234 -0.916 . . . . 0.0 110.259 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.489 ' HA ' ' O ' ' A' ' 58' ' ' THR . 80.2 m -97.02 89.04 4.68 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.201 -0.937 . . . . 0.0 110.054 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.669 ' HB1' HG21 ' A' ' 54' ' ' ILE . . . -45.63 106.39 0.08 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -0.892 . . . . 0.0 110.296 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.475 ' HA ' ' HA2' ' A' ' 57' ' ' GLY . 5.2 p -90.29 54.29 2.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.282 -0.886 . . . . 0.0 110.278 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.411 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -164.67 -158.39 0.41 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.895 . . . . 0.0 110.229 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.977 HG22 ' HD3' ' A' ' 113' ' ' PRO . 19.9 m -145.04 118.94 9.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.246 -0.909 . . . . 0.0 110.264 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.594 ' CG ' ' HA3' ' A' ' 123' ' ' GLY . 19.2 m-30 -115.79 63.62 2.2 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.361 -0.837 . . . . 0.0 110.073 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.977 ' HD3' HG22 ' A' ' 111' ' ' THR . 45.3 Cg_endo -71.67 147.44 51.05 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.852 1.448 . . . . 0.0 110.608 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.47 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -78.17 4.04 13.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.197 -0.94 . . . . 0.0 110.246 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 70.7 p -92.46 107.95 27.57 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.232 -0.917 . . . . 0.0 110.201 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.47 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 46.7 Cg_endo -73.33 106.49 2.18 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.965 1.508 . . . . 0.0 110.526 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.911 ' HB3' ' HB2' ' A' ' 120' ' ' ASP . . . -150.49 157.15 42.69 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.269 -0.894 . . . . 0.0 110.214 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -52.91 -68.22 0.19 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.206 -0.934 . . . . 0.0 110.262 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -76.79 -2.61 34.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.187 -0.946 . . . . 0.0 110.337 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.911 ' HB2' ' HB3' ' A' ' 117' ' ' ALA . 6.4 m-20 -128.12 72.58 79.5 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.195 -0.94 . . . . 0.0 110.202 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.518 ' HB3' ' HA3' ' A' ' 82' ' ' GLY . 47.7 Cg_endo -73.15 161.68 42.57 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.091 1.574 . . . . 0.0 110.331 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.529 ' O ' ' HA ' ' A' ' 80' ' ' GLN . 0.4 OUTLIER -104.48 -166.83 1.28 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.154 -0.966 . . . . 0.0 110.039 179.811 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.594 ' HA3' ' CG ' ' A' ' 112' ' ' TYR . . . -145.02 158.67 27.71 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.859 -1.297 . . . . 0.0 109.859 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.656 ' HA ' HG23 ' A' ' 52' ' ' VAL . 1.1 pp0? -150.38 -158.12 0.88 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.415 -1.05 . . . . 0.0 110.262 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.882 HG21 ' CH2' ' A' ' 16' ' ' TRP . 6.2 mt -118.18 139.49 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.523 -0.736 . . . . 0.0 109.208 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -117.6 122.56 43.95 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.243 -0.911 . . . . 0.0 110.886 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.487 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 3.0 m-30 -116.76 103.39 10.29 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.659 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.583 ' O ' ' CE2' ' A' ' 132' ' ' PHE . 11.0 mm100 -89.08 89.12 7.83 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.323 -0.861 . . . . 0.0 112.511 -177.283 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 1.085 ' CD2' HG21 ' A' ' 74' ' ' VAL . 27.0 mt -94.73 44.98 1.11 Allowed 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 177.387 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.552 ' O ' ' CD2' ' A' ' 132' ' ' PHE . . . -99.06 127.89 9.39 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 120.117 -1.04 . . . . 0.0 110.737 -178.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 39' ' ' GLY . . . 37.14 68.8 0.32 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.596 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 9.4 m-85 -123.29 -57.52 1.67 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.028 -1.278 . . . . 0.0 110.82 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.964 ' HB2' HG23 ' A' ' 72' ' ' VAL . 1.3 t -88.54 -177.52 5.61 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.904 -1.122 . . . . 0.0 110.415 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -93.69 -84.76 0.3 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.248 -0.908 . . . . 0.0 110.246 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.08 179.49 1.51 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.165 -0.959 . . . . 0.0 109.999 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.54 ' CA ' ' HA ' ' A' ' 38' ' ' ALA . . . -75.0 129.9 38.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.299 -0.876 . . . . 0.0 110.656 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.999 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 6.8 p90 -133.32 -158.93 0.92 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.336 -0.853 . . . . 0.0 109.859 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.524 ' O ' ' CB ' ' A' ' 68' ' ' ALA . 0.3 OUTLIER -160.37 171.68 18.67 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.048 -1.033 . . . . 0.0 110.48 -178.638 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.941 HD13 HD13 ' A' ' 129' ' ' LEU . 2.4 mp -122.26 157.39 31.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.405 -0.809 . . . . 0.0 109.639 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' CYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 67' ' ' THR . 8.5 m -150.27 91.14 1.73 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.081 -1.012 . . . . 0.0 110.657 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.504 ' HA ' ' O ' ' A' ' 65' ' ' THR . 1.0 OUTLIER -90.0 -156.33 0.41 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.926 . . . . 0.0 109.259 179.275 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.599 ' HA ' ' CD2' ' A' ' 9' ' ' PHE . 1.9 p-10 175.94 -48.53 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.007 -1.058 . . . . 0.0 110.522 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.492 ' O ' ' HA ' ' A' ' 64' ' ' TYR . 22.6 t70 -119.25 137.73 53.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -0.937 . . . . 0.0 110.208 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.492 ' O ' HD11 ' A' ' 4' ' ' ILE . 3.0 t -150.39 113.18 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.213 -0.93 . . . . 0.0 110.115 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.59 ' HB2' ' HG3' ' A' ' 6' ' ' GLU . . . -126.46 153.55 44.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.302 -0.874 . . . . 0.0 110.282 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.566 HD11 ' HB3' ' A' ' 60' ' ' TYR . 29.7 tp -159.71 96.65 1.27 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.34 -0.85 . . . . 0.0 110.03 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.492 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 32.3 t70 -121.95 164.36 17.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.228 -0.92 . . . . 0.0 110.259 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.56 ' HB3' ' CE1' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -111.39 111.36 22.34 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.226 -0.921 . . . . 0.0 110.255 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.447 ' O ' ' O ' ' A' ' 148' ' ' SER . 1.0 OUTLIER 54.52 107.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.315 -0.866 . . . . 0.0 110.236 179.96 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.42 HG22 ' H ' ' A' ' 150' ' ' VAL . 23.9 m -66.09 -175.84 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.261 -0.899 . . . . 0.0 110.245 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 61.51 34.49 17.94 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.304 -0.872 . . . . 0.0 110.213 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.152 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.416 ' C ' ' HD3' ' A' ' 3' ' ' PRO . . . . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.246 0.546 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.555 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 4.2 t 44.87 49.53 6.11 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.265 -0.897 . . . . 0.0 110.192 -179.998 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 2' ' ' SER . 45.6 Cg_endo -72.79 81.05 1.67 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.993 1.523 . . . . 0.0 110.427 179.985 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.606 HD11 HG12 ' A' ' 144' ' ' VAL . 9.1 pt -107.92 42.8 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 110.254 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.543 ' N ' ' HG3' ' A' ' 14' ' ' GLU . . . 73.93 40.54 43.63 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' ' 144' ' ' VAL . 22.0 tt0 -42.03 94.03 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.33 -1.1 . . . . 0.0 110.434 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 5' ' ' GLY . . . 163.48 -154.76 25.82 Favored Glycine 0 N--CA 1.49 2.27 0 C-N-CA 119.647 -1.264 . . . . 0.0 110.164 179.77 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.732 HG22 ' O ' ' A' ' 142' ' ' ASP . 62.0 p -105.99 38.15 2.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.416 -1.049 . . . . 0.0 110.604 -179.594 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.551 ' HZ ' HG21 ' A' ' 144' ' ' VAL . 25.4 m-85 42.75 80.78 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.209 -0.932 . . . . 0.0 110.179 179.779 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.548 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 2.6 p30 -108.48 23.23 14.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.202 -0.936 . . . . 0.0 110.415 -179.843 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.548 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.8 OUTLIER 161.51 80.48 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.601 -0.687 . . . . 0.0 109.822 179.991 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.41 101.54 0.08 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.864 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.686 ' HG3' HD12 ' A' ' 32' ' ' LEU . 45.0 Cg_endo -73.27 78.46 2.27 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.038 1.547 . . . . 0.0 110.667 -179.801 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.543 ' HG3' ' N ' ' A' ' 5' ' ' GLY . 5.0 mm-40 39.45 -91.21 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.467 -0.77 . . . . 0.0 111.066 179.675 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.585 ' C ' HD13 ' A' ' 49' ' ' LEU . . . -148.24 12.56 1.23 Allowed Glycine 0 N--CA 1.493 2.478 0 C-N-CA 119.618 -1.277 . . . . 0.0 110.386 -179.535 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.913 ' N ' HD13 ' A' ' 49' ' ' LEU . 36.8 m95 -40.62 128.82 2.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.23 -1.159 . . . . 0.0 110.786 179.832 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.836 HG22 ' O ' ' A' ' 48' ' ' VAL . 1.4 m -128.08 148.03 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.16 -0.962 . . . . 0.0 109.696 179.305 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . . . -130.32 117.27 19.53 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.027 -1.045 . . . . 0.0 109.821 179.552 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.611 ' HE2' HG13 ' A' ' 48' ' ' VAL . 29.3 p90 -106.76 172.8 6.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.471 -0.768 . . . . 0.0 110.709 -179.241 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.859 ' O ' HG13 ' A' ' 45' ' ' VAL . . . 68.07 27.17 73.77 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 179.589 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.759 HG22 ' CG1' ' A' ' 45' ' ' VAL . 30.9 p -132.32 -164.17 1.43 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.066 -1.255 . . . . 0.0 110.514 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -89.99 39.46 0.96 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.275 -0.891 . . . . 0.0 110.42 -179.75 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 126.26 -168.01 18.51 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 179.827 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.48 -159.09 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.112 1.585 . . . . 0.0 110.579 -179.877 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 1.047 ' CD1' HD11 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -115.81 156.86 25.3 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.339 -0.851 . . . . 0.0 110.104 -179.998 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -121.21 141.14 51.14 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.203 -0.935 . . . . 0.0 110.137 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.482 ' CG2' ' HA ' ' A' ' 32' ' ' LEU . 0.7 OUTLIER -126.36 -24.3 3.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.114 -0.991 . . . . 0.0 110.874 -179.694 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.435 ' C ' ' O ' ' A' ' 27' ' ' THR . 3.5 t -41.06 -36.69 0.73 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.263 -0.898 . . . . 0.0 110.538 -179.618 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.568 HG23 ' H ' ' A' ' 30' ' ' GLY . 2.7 t -53.2 -49.78 66.01 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.259 -0.9 . . . . 0.0 110.706 -179.843 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.568 ' H ' HG23 ' A' ' 29' ' ' THR . . . 166.99 -25.46 0.14 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.925 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.64 ' HB3' ' SG ' ' A' ' 140' ' ' CYS . . . -146.92 169.01 20.06 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -1.128 . . . . 0.0 109.593 179.838 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.047 HD11 ' CD1' ' A' ' 25' ' ' LEU . 0.6 OUTLIER -78.42 92.26 4.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.011 -1.056 . . . . 0.0 110.502 -179.837 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.551 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 0.8 OUTLIER -100.22 110.78 23.04 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.417 -0.802 . . . . 0.0 111.447 179.517 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.864 HG12 ' HB3' ' A' ' 25' ' ' LEU . 15.6 m -89.53 143.71 10.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.001 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.477 ' HA ' ' OG1' ' A' ' 138' ' ' THR . . . -88.63 83.13 6.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.472 -0.767 . . . . 0.0 110.916 -178.59 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.057 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 40.9 t -69.34 128.59 92.32 Favored Pre-proline 0 N--CA 1.487 1.421 0 O-C-N 121.307 -0.87 . . . . 0.0 109.112 179.064 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 21' ' ' THR . 42.8 Cg_endo -70.26 146.77 58.01 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.936 1.493 . . . . 0.0 111.157 -178.951 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.472 ' HA ' ' N ' ' A' ' 136' ' ' ALA . . . -41.57 136.42 1.85 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.512 -0.742 . . . . 0.0 110.229 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 38' ' ' ALA . . . 45.51 92.99 0.01 OUTLIER Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.845 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.559 ' HB3' ' CG2' ' A' ' 45' ' ' VAL . 25.9 m -87.36 33.76 0.69 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.164 -1.198 . . . . 0.0 110.108 179.991 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -91.58 19.95 5.84 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.933 0.873 . . . . 0.0 110.155 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.725 ' NE2' ' CE2' ' A' ' 43' ' ' TYR . 7.9 pt20 -85.69 -143.46 0.1 Allowed 'General case' 0 C--N 1.292 -1.898 0 O-C-N 121.804 -0.56 . . . . 0.0 109.721 179.49 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.725 ' CE2' ' NE2' ' A' ' 42' ' ' GLN . 5.5 p90 -41.54 -27.15 0.09 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.463 -0.773 . . . . 0.0 109.97 179.838 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.571 ' N ' ' CD1' ' A' ' 43' ' ' TYR . . . 115.14 113.49 2.93 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.448 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.859 HG13 ' O ' ' A' ' 20' ' ' GLY . 2.0 t -96.37 160.5 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.183 -1.187 . . . . 0.0 108.841 179.384 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.576 ' O ' ' CE2' ' A' ' 19' ' ' TYR . . . 177.56 152.66 10.24 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.271 -1.442 . . . . 0.0 110.329 -179.74 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.757 HG13 ' O ' ' A' ' 17' ' ' VAL . 22.9 t -113.46 134.79 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.374 -1.074 . . . . 0.0 109.796 179.479 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.836 ' O ' HG22 ' A' ' 17' ' ' VAL . 8.6 m -130.13 151.16 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.035 -1.041 . . . . 0.0 110.46 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.913 HD13 ' N ' ' A' ' 16' ' ' TRP . 19.9 tp -149.71 114.5 5.34 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.275 -0.89 . . . . 0.0 110.388 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.523 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 21.4 t30 -79.72 124.63 28.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.269 -0.894 . . . . 0.0 110.306 179.749 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.509 ' O ' ' CG2' ' A' ' 4' ' ' ILE . . . 155.23 67.99 0.01 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.686 HG23 ' HA ' ' A' ' 124' ' ' GLN . 43.0 t -130.44 171.89 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.216 -1.167 . . . . 0.0 110.106 179.844 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.537 ' HB2' ' H ' ' A' ' 2' ' ' SER . . . -145.04 87.47 1.83 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.102 -0.999 . . . . 0.0 110.718 -179.76 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.985 HD11 HD21 ' A' ' 146' ' ' LEU . 36.7 mm -120.51 159.55 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.226 -0.921 . . . . 0.0 109.893 179.418 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.521 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 0.4 OUTLIER -147.68 121.54 9.34 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.161 -0.962 . . . . 0.0 110.437 -179.868 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.521 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 9.4 pt-20 37.57 -151.65 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.654 -0.654 . . . . 0.0 110.797 179.705 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.459 ' N ' ' HG3' ' A' ' 56' ' ' GLU . . . -81.15 94.41 1.59 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.648 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.2 m -124.74 174.29 7.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.257 -1.143 . . . . 0.0 109.824 179.968 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.572 ' N ' ' CG2' ' A' ' 58' ' ' THR . 0.6 OUTLIER -89.63 151.66 21.78 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.269 -0.894 . . . . 0.0 110.137 -179.969 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.648 ' CE2' HG22 ' A' ' 58' ' ' THR . 54.6 m-85 -159.29 174.4 14.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.223 -0.923 . . . . 0.0 110.575 -179.987 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 94.8 m -149.98 121.23 7.82 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.439 -0.788 . . . . 0.0 109.685 179.69 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.544 ' HB2' HD21 ' A' ' 89' ' ' LEU . 18.7 tp -89.56 120.44 30.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.208 -0.932 . . . . 0.0 110.279 -179.691 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.539 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 3.3 ttt180 -121.03 138.24 54.26 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.326 -0.859 . . . . 0.0 109.803 179.673 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.843 ' CZ ' HG21 ' A' ' 102' ' ' VAL . 0.6 OUTLIER -178.52 142.2 0.23 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.228 -0.92 . . . . 0.0 110.033 179.922 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.504 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 5.8 m -119.37 94.36 4.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.225 -0.922 . . . . 0.0 110.06 -179.839 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.661 ' CB ' HD21 ' A' ' 95' ' ' LEU . . . -95.91 155.95 16.54 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.345 -0.847 . . . . 0.0 110.153 -179.829 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 44.3 m -148.38 117.59 6.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.261 -0.9 . . . . 0.0 110.27 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.677 ' CB ' HG12 ' A' ' 72' ' ' VAL . . . -102.87 129.8 49.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.297 -0.877 . . . . 0.0 109.942 179.783 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 82.7 p -65.5 -9.05 22.75 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.175 -0.953 . . . . 0.0 110.092 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.625 HG21 ' CB ' ' A' ' 137' ' ' TRP . 7.4 t -116.97 19.9 14.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.871 . . . . 0.0 110.166 -179.912 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.465 ' O ' ' O ' ' A' ' 70' ' ' THR . 4.7 t70 43.05 92.35 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.3 -0.875 . . . . 0.0 109.851 -179.754 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.759 HG13 HD12 ' A' ' 95' ' ' LEU . 12.1 p -131.36 161.31 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -0.918 . . . . 0.0 110.953 -179.337 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.4 ' N ' HG22 ' A' ' 72' ' ' VAL . 23.2 m -128.68 89.11 2.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.37 -0.831 . . . . 0.0 109.219 179.248 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.695 HG12 ' CB ' ' A' ' 132' ' ' PHE . 17.4 m -89.74 -140.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.911 . . . . 0.0 110.655 -179.199 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.542 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 19.3 mtm-85 -133.1 146.55 51.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.902 . . . . 0.0 110.597 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.829 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -150.02 152.21 34.51 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.348 -0.845 . . . . 0.0 109.712 179.731 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.889 HD12 ' N ' ' A' ' 78' ' ' VAL . 3.7 pp 179.49 -146.97 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.241 -0.912 . . . . 0.0 110.218 -179.587 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.889 ' N ' HD12 ' A' ' 77' ' ' LEU . 3.5 t -148.22 177.59 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.921 . . . . 0.0 109.544 179.904 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.523 ' H ' HG12 ' A' ' 78' ' ' VAL . . . -179.49 -175.87 46.67 Favored Glycine 0 N--CA 1.489 2.204 0 C-N-CA 119.384 -1.389 . . . . 0.0 110.14 179.988 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.552 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 3.0 tt0 -93.98 -153.76 0.38 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.422 -1.046 . . . . 0.0 110.107 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.532 ' O ' ' CB ' ' A' ' 121' ' ' PRO . 9.7 m120 -154.44 72.46 0.87 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.361 -0.837 . . . . 0.0 109.702 179.894 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.487 ' HA3' ' HB3' ' A' ' 121' ' ' PRO . . . 131.57 144.08 5.33 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -179.688 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.628 ' N ' ' CE1' ' A' ' 85' ' ' TYR . . . -41.93 152.27 0.31 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.28 -1.13 . . . . 0.0 110.321 -179.868 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.46 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.6 Cg_endo -80.04 12.57 22.55 Favored 'Cis proline' 0 C--N 1.312 -1.343 0 C-N-CA 121.651 -2.229 . . . . 0.0 110.896 -0.067 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.628 ' CE1' ' N ' ' A' ' 83' ' ' ALA . 29.1 m-85 62.53 146.8 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.139 -0.975 . . . . 0.0 110.233 -179.816 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -172.5 128.13 1.5 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.899 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.487 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 0.8 OUTLIER -105.55 153.76 21.31 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.236 -1.155 . . . . 0.0 110.208 179.984 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.72 HG23 HD12 ' A' ' 89' ' ' LEU . 15.5 m -124.98 -24.69 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.302 -0.873 . . . . 0.0 110.331 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.843 HD22 HG23 ' A' ' 78' ' ' VAL . 3.8 mp -105.72 145.29 31.29 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.17 -0.957 . . . . 0.0 111.082 179.883 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -151.76 76.09 1.18 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.371 -0.831 . . . . 0.0 109.947 179.474 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 82.1 p -135.62 178.52 6.98 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.98 -1.075 . . . . 0.0 110.869 -179.504 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.97 117.8 32.04 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.435 -0.791 . . . . 0.0 110.079 179.941 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.829 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 47.4 Cg_endo -73.74 105.56 2.03 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.93 1.49 . . . . 0.0 110.981 -179.697 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.53 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -77.83 151.32 33.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.156 -0.965 . . . . 0.0 109.428 179.171 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.864 ' CD1' HD21 ' A' ' 139' ' ' LEU . 64.2 mt -138.99 162.83 33.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.994 -1.067 . . . . 0.0 110.817 -179.548 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.49 HG22 ' HG3' ' A' ' 100' ' ' ARG . 0.2 OUTLIER -161.9 -178.93 6.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.455 -0.778 . . . . 0.0 109.907 179.894 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.7 p -64.64 -30.79 71.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.272 -0.892 . . . . 0.0 110.126 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.535 ' CB ' ' HD2' ' A' ' 99' ' ' PRO . 0.1 OUTLIER -90.1 179.94 1.38 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.333 -0.854 . . . . 0.0 109.978 179.822 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.535 ' HD2' ' CB ' ' A' ' 98' ' ' GLU . 44.6 Cg_endo -71.88 132.07 19.37 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.925 1.487 . . . . 0.0 110.313 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.53 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.84 92.43 3.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.234 -0.916 . . . . 0.0 110.402 -179.841 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.443 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 0.6 OUTLIER -76.99 156.76 31.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.296 -0.878 . . . . 0.0 110.113 179.861 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.843 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 52.5 t -138.71 134.15 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.205 -0.935 . . . . 0.0 110.219 -179.992 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 21.6 m -150.06 113.46 4.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.319 -0.863 . . . . 0.0 110.181 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -146.48 138.3 24.75 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.295 -0.878 . . . . 0.0 110.244 -179.949 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.03 159.28 16.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.27 -0.894 . . . . 0.0 110.085 179.952 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.803 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 48.8 p90 -167.77 151.27 6.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.23 -0.919 . . . . 0.0 110.279 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 58' ' ' THR . 3.1 m -89.89 90.71 8.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.209 -0.932 . . . . 0.0 110.012 179.787 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.7 ' HB1' HG21 ' A' ' 54' ' ' ILE . . . -52.41 116.26 2.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.244 -0.91 . . . . 0.0 110.314 -179.828 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.445 ' H ' HG12 ' A' ' 88' ' ' VAL . 55.4 p -99.4 54.83 0.97 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.262 -0.899 . . . . 0.0 110.082 179.836 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -165.06 -160.15 0.47 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.261 -0.9 . . . . 0.0 110.37 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.906 HG22 ' HD3' ' A' ' 113' ' ' PRO . 85.1 m -144.0 116.69 8.7 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.267 -0.896 . . . . 0.0 110.264 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.604 ' CD2' HG13 ' A' ' 54' ' ' ILE . 20.4 m-30 -114.49 73.43 2.8 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.251 -0.905 . . . . 0.0 110.043 179.92 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.906 ' HD3' HG22 ' A' ' 111' ' ' THR . 43.9 Cg_endo -70.47 -163.18 0.11 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.998 1.525 . . . . 0.0 110.465 -179.962 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.487 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -131.95 21.39 4.54 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.237 -0.914 . . . . 0.0 110.223 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 20.2 p -100.97 100.82 13.85 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.208 -0.933 . . . . 0.0 110.124 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.487 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 45.8 Cg_endo -72.92 79.21 2.02 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.985 1.518 . . . . 0.0 110.381 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.808 ' HB3' ' HB2' ' A' ' 120' ' ' ASP . . . -117.64 176.43 5.18 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.259 -0.901 . . . . 0.0 110.178 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -74.41 -58.75 3.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.215 -0.928 . . . . 0.0 110.222 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -85.02 -0.26 53.81 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 110.311 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.808 ' HB2' ' HB3' ' A' ' 117' ' ' ALA . 1.8 m-20 -130.71 86.7 51.84 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.268 -0.895 . . . . 0.0 110.248 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.532 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 48.6 Cg_endo -75.21 -167.47 0.43 Allowed 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.981 1.516 . . . . 0.0 110.32 179.959 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.519 ' OE1' ' N ' ' A' ' 122' ' ' GLU . 22.5 pm0 -140.63 -145.78 0.18 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.144 -0.973 . . . . 0.0 110.264 179.768 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.552 ' HA2' ' HA ' ' A' ' 80' ' ' GLN . . . -147.45 157.84 27.52 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.686 ' HA ' HG23 ' A' ' 52' ' ' VAL . 2.4 pt20 -150.43 -157.55 0.83 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.276 -1.132 . . . . 0.0 110.6 -179.58 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.606 HG21 ' CH2' ' A' ' 16' ' ' TRP . 12.4 mt -118.45 142.92 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.464 -0.773 . . . . 0.0 109.068 179.382 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.47 ' HB3' HD11 ' A' ' 77' ' ' LEU . . . -121.32 123.56 42.46 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.258 -0.901 . . . . 0.0 111.032 -179.351 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.481 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 4.9 m-85 -118.59 109.38 16.09 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 178.446 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.501 ' HB2' ' HB2' ' A' ' 75' ' ' ARG . 1.3 mm100 -88.65 102.53 15.06 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.231 -0.918 . . . . 0.0 111.901 -177.497 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.495 ' HG ' ' HA2' ' A' ' 46' ' ' GLY . 13.9 mt -107.42 45.06 1.02 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 178.289 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -95.57 78.1 0.82 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.453 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.576 ' O ' ' CG ' ' A' ' 132' ' ' PHE . . . 78.61 110.3 0.2 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.747 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.695 ' CB ' HG12 ' A' ' 74' ' ' VAL . 26.0 m-85 -161.57 -49.02 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.22 -1.165 . . . . 0.0 110.355 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.624 ' HB2' HG21 ' A' ' 72' ' ' VAL . 1.0 OUTLIER -89.43 -140.13 0.14 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.046 -1.034 . . . . 0.0 110.1 179.888 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -133.95 -83.37 0.45 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.17 -0.956 . . . . 0.0 110.364 -179.917 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.434 ' O ' ' C ' ' A' ' 136' ' ' ALA . 1.1 m-20 -81.53 162.87 23.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.192 -0.942 . . . . 0.0 110.283 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.472 ' N ' ' HA ' ' A' ' 38' ' ' ALA . . . -41.21 123.35 2.04 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.333 -0.854 . . . . 0.0 110.263 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 1.057 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 11.4 p90 -137.22 -173.15 3.38 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.174 -0.953 . . . . 0.0 110.619 -179.93 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.521 ' C ' HD12 ' A' ' 139' ' ' LEU . 0.8 OUTLIER -151.07 174.19 13.48 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.432 -0.792 . . . . 0.0 110.073 -178.024 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.864 HD21 ' CD1' ' A' ' 95' ' ' LEU . 1.7 mp -139.82 119.38 13.12 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.153 -0.967 . . . . 0.0 112.059 -179.679 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 140' ' ' CYS . . . . . 0.64 ' SG ' ' HB3' ' A' ' 31' ' ' ALA . 0.8 OUTLIER -103.27 108.37 19.56 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.618 -0.676 . . . . 0.0 110.878 178.132 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.545 HD23 ' HB2' ' A' ' 66' ' ' ALA . 1.4 mt -94.55 -178.93 4.72 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.285 -0.885 . . . . 0.0 108.792 178.513 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.732 ' O ' HG22 ' A' ' 8' ' ' THR . 0.4 OUTLIER 168.29 55.38 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.063 -1.023 . . . . 0.0 110.98 -179.963 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.535 ' HB2' ' O ' ' A' ' 142' ' ' ASP . 10.9 t70 172.91 46.81 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.469 -0.769 . . . . 0.0 109.132 179.56 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.883 HG11 ' HZ2' ' A' ' 16' ' ' TRP . 1.3 t -91.71 112.93 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.16 -0.962 . . . . 0.0 110.646 -179.043 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.469 ' HB2' ' HG3' ' A' ' 6' ' ' GLU . . . -149.43 147.17 27.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.488 -0.758 . . . . 0.0 110.041 179.85 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.985 HD21 HD11 ' A' ' 54' ' ' ILE . 10.8 tp -141.49 125.2 16.9 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.388 -0.82 . . . . 0.0 110.237 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.49 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -133.81 174.33 10.57 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.197 -0.94 . . . . 0.0 110.207 179.977 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 149' ' ' GLU . 57.5 p -119.98 141.72 49.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.207 -0.933 . . . . 0.0 110.32 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 148' ' ' SER . 15.1 tt0 42.64 93.87 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.238 -0.914 . . . . 0.0 110.306 179.964 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 150' ' ' VAL . 7.3 p -141.79 22.01 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.267 -0.896 . . . . 0.0 110.165 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -109.83 91.26 3.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.913 . . . . 0.0 110.283 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.543 HD22 ' N ' ' A' ' 152' ' ' LEU . 4.2 mm? . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.189 -179.984 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.458 ' HA ' ' CG ' ' A' ' 147' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.277 0.561 . . . . 0.0 110.213 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.444 ' HB2' ' O ' ' A' ' 1' ' ' ALA . 7.8 t -177.81 109.5 0.22 Allowed Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.32 -0.862 . . . . 0.0 110.068 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.455 ' HB2' ' O ' ' A' ' 51' ' ' GLY . 51.1 Cg_endo -80.97 19.58 1.12 Allowed 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.986 1.519 . . . . 0.0 111.115 -179.832 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.477 HD12 ' CG1' ' A' ' 144' ' ' VAL . 6.1 pt -138.78 -37.01 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.997 -1.065 . . . . 0.0 110.118 179.906 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.451 ' N ' ' CG1' ' A' ' 4' ' ' ILE . . . 161.36 126.59 0.83 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -73.52 81.99 1.48 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.258 -1.142 . . . . 0.0 110.192 179.991 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 144' ' ' VAL . . . 114.59 -123.37 5.99 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.798 HG22 ' O ' ' A' ' 142' ' ' ASP . 15.6 p -80.5 179.04 7.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.29 -1.123 . . . . 0.0 110.136 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.687 ' CE1' HG21 ' A' ' 144' ' ' VAL . 23.0 m-85 -68.57 -35.78 77.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.306 -0.871 . . . . 0.0 109.579 179.735 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.552 ' O ' ' HB2' ' A' ' 11' ' ' ASP . 23.2 t0 38.09 42.74 0.5 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.645 -0.659 . . . . 0.0 110.705 179.308 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.552 ' HB2' ' O ' ' A' ' 10' ' ' ASP . 4.3 t0 161.9 71.07 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 121.508 0.671 . . . . 0.0 109.545 179.871 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.47 ' HA2' ' HB ' ' A' ' 27' ' ' THR . . . 43.95 -168.5 0.02 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.723 ' HB3' HD12 ' A' ' 32' ' ' LEU . 51.1 Cg_endo -74.43 81.47 2.05 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.121 1.59 . . . . 0.0 110.337 179.947 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.485 ' C ' ' O ' ' A' ' 13' ' ' PRO . 0.2 OUTLIER -31.77 -67.51 0.1 Allowed 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.292 0.568 . . . . 0.0 111.183 -179.614 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.5 ' C ' ' CD1' ' A' ' 49' ' ' LEU . . . -145.75 10.24 1.64 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.946 ' CE2' HD22 ' A' ' 49' ' ' LEU . 66.4 m95 -78.06 88.95 4.18 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.149 -1.207 . . . . 0.0 110.257 -179.863 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.719 ' O ' HG13 ' A' ' 47' ' ' VAL . 0.8 OUTLIER -85.18 144.88 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.093 -1.004 . . . . 0.0 109.44 179.802 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.454 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . . . -128.64 128.81 44.88 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.025 -1.047 . . . . 0.0 109.93 179.554 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.798 ' HE2' HG13 ' A' ' 48' ' ' VAL . 23.4 p90 -113.24 145.49 40.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.451 -0.781 . . . . 0.0 110.397 -179.302 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.615 ' HA3' HG13 ' A' ' 45' ' ' VAL . . . 156.77 -91.03 0.12 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.539 ' CG2' ' HG3' ' A' ' 37' ' ' PRO . 5.5 p -151.96 18.92 0.68 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.254 -1.145 . . . . 0.0 110.051 179.675 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.476 ' HB3' ' O ' ' A' ' 35' ' ' ALA . 2.0 p30 -102.76 147.72 26.5 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.28 -0.887 . . . . 0.0 110.197 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.68 -138.13 0.15 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.801 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.417 ' O ' ' C ' ' A' ' 25' ' ' LEU . 46.2 Cg_endo -73.62 133.46 18.82 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.044 1.549 . . . . 0.0 110.346 179.865 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.858 HD22 HD11 ' A' ' 32' ' ' LEU . 7.8 mt -42.53 113.52 0.47 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.254 -0.904 . . . . 0.0 110.083 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.487 ' HB3' ' HB2' ' A' ' 33' ' ' CYS . 29.5 t70 -66.4 101.37 0.74 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.23 -0.919 . . . . 0.0 110.188 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.694 ' O ' HG22 ' A' ' 29' ' ' THR . 1.5 p -119.23 -81.32 0.63 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.296 -0.877 . . . . 0.0 109.955 -179.911 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.462 ' O ' ' HB ' ' A' ' 29' ' ' THR . 22.5 p 42.16 36.23 0.68 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.254 -0.903 . . . . 0.0 110.442 179.811 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.694 HG22 ' O ' ' A' ' 27' ' ' THR . 12.2 t -177.97 -31.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.3 -0.875 . . . . 0.0 110.194 179.914 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 9' ' ' PHE . . . 126.35 2.19 7.04 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.946 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 141' ' ' LEU . . . -111.29 109.83 20.03 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.212 -1.169 . . . . 0.0 110.24 179.992 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.858 HD11 HD22 ' A' ' 25' ' ' LEU . 1.0 OUTLIER -68.51 102.37 1.44 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.281 -0.887 . . . . 0.0 109.966 179.943 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.51 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 34.2 m -108.19 103.61 12.84 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.319 -0.863 . . . . 0.0 110.514 -179.687 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.807 HG12 HD23 ' A' ' 25' ' ' LEU . 19.5 m -89.71 155.51 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.262 -0.899 . . . . 0.0 109.762 179.621 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.514 ' HA ' ' OG1' ' A' ' 138' ' ' THR . . . -103.87 101.26 11.06 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.249 -0.907 . . . . 0.0 111.346 -179.111 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.031 HG11 ' CE2' ' A' ' 137' ' ' TRP . 91.4 t -84.41 123.07 75.25 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.168 -0.958 . . . . 0.0 109.009 178.794 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.539 ' HG3' ' CG2' ' A' ' 21' ' ' THR . 43.2 Cg_endo -67.85 147.33 74.62 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.87 1.458 . . . . 0.0 111.347 -178.866 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.581 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -47.37 116.47 1.43 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.312 -0.868 . . . . 0.0 109.817 179.659 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.1 71.91 1.16 Allowed Glycine 0 N--CA 1.486 1.99 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 -179.51 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.755 ' HB2' HG21 ' A' ' 45' ' ' VAL . 0.4 OUTLIER -84.89 43.96 1.03 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.324 -1.103 . . . . 0.0 109.807 -179.987 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.522 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . -88.5 -139.46 0.12 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.491 -0.755 . . . . 0.0 110.029 179.871 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.561 ' HG2' ' N ' ' A' ' 43' ' ' TYR . 0.0 OUTLIER 42.79 -140.98 0.14 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.543 -0.723 . . . . 0.0 110.346 -179.479 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.73 ' OH ' HG22 ' A' ' 45' ' ' VAL . 8.3 p90 -28.96 -39.51 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.175 0 CA-C-O 121.143 0.497 . . . . 0.0 110.929 -179.136 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.599 ' O ' ' CD1' ' A' ' 43' ' ' TYR . . . 89.76 132.96 4.93 Favored Glycine 0 N--CA 1.493 2.441 0 C-N-CA 120.041 -1.076 . . . . 0.0 110.674 178.22 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.755 HG21 ' HB2' ' A' ' 40' ' ' SER . 2.6 t -89.85 179.52 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.364 -1.08 . . . . 0.0 108.908 179.238 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.532 ' HA2' ' HA ' ' A' ' 128' ' ' GLN . . . 173.57 -177.58 45.86 Favored Glycine 0 N--CA 1.488 2.118 0 C-N-CA 119.024 -1.56 . . . . 0.0 110.668 -179.886 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.719 HG13 ' O ' ' A' ' 17' ' ' VAL . 21.6 t -150.65 132.43 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.737 -0.861 . . . . 0.0 108.768 179.779 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.798 HG13 ' HE2' ' A' ' 19' ' ' TYR . 31.1 m -119.66 131.7 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.976 -1.077 . . . . 0.0 110.69 -179.383 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.946 HD22 ' CE2' ' A' ' 16' ' ' TRP . 30.0 tp -124.06 90.76 3.32 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.439 -0.788 . . . . 0.0 110.353 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.522 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 22.0 p30 -75.2 145.84 41.71 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.271 -0.893 . . . . 0.0 110.237 179.881 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.455 ' O ' ' HB2' ' A' ' 3' ' ' PRO . . . 122.19 63.48 0.22 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.969 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.594 HG12 ' N ' ' A' ' 53' ' ' ALA . 53.5 t -121.96 171.9 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.235 -1.156 . . . . 0.0 109.968 179.807 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.594 ' N ' HG12 ' A' ' 52' ' ' VAL . . . -141.88 77.91 1.61 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.072 -1.017 . . . . 0.0 110.804 -179.742 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.595 HG13 ' CD2' ' A' ' 112' ' ' TYR . 35.6 mm -112.34 159.24 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.177 -0.952 . . . . 0.0 109.622 179.343 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.534 ' HA ' HG23 ' A' ' 111' ' ' THR . 0.6 OUTLIER -153.48 132.25 12.34 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.04 -1.037 . . . . 0.0 110.836 -179.634 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 19.4 pt-20 37.72 -155.49 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.67 -0.644 . . . . 0.0 110.994 179.488 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' A' ' 109' ' ' SER . . . -85.95 80.92 1.75 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.776 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.569 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.2 m -105.72 173.88 6.12 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.268 -1.137 . . . . 0.0 109.73 179.76 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.559 ' N ' ' CG2' ' A' ' 58' ' ' THR . 0.6 OUTLIER -89.7 154.78 19.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.144 -0.972 . . . . 0.0 110.411 -179.731 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.608 ' CE2' ' HB3' ' A' ' 108' ' ' ALA . 55.8 m-85 -159.87 178.5 9.69 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.32 -0.862 . . . . 0.0 110.3 179.905 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 104' ' ' GLU . 32.8 m -150.13 123.61 9.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.337 -0.852 . . . . 0.0 109.925 179.8 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.6 tp -89.44 118.63 29.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.186 -0.946 . . . . 0.0 110.067 -179.948 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.524 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 2.1 tpt180 -127.97 114.47 17.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.31 -0.869 . . . . 0.0 110.204 -179.761 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 1.163 ' CZ ' HG21 ' A' ' 102' ' ' VAL . 0.4 OUTLIER -157.99 141.19 15.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.155 -0.966 . . . . 0.0 110.037 179.591 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.537 ' CG2' ' HG2' ' A' ' 101' ' ' GLN . 18.7 m -119.42 98.91 6.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.916 . . . . 0.0 109.976 -179.834 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.759 ' HB2' HD23 ' A' ' 141' ' ' LEU . . . -103.51 152.35 21.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.335 -0.853 . . . . 0.0 110.368 -179.669 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.71 HG23 ' O ' ' A' ' 98' ' ' GLU . 98.1 m -150.2 108.32 3.74 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.235 -0.915 . . . . 0.0 110.289 179.922 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -92.84 136.05 33.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.238 -0.914 . . . . 0.0 109.975 179.836 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 68' ' ' ALA . 12.2 t -44.93 -26.14 0.39 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.082 -1.011 . . . . 0.0 109.343 179.57 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.669 HG22 ' HB2' ' A' ' 137' ' ' TRP . 3.2 t -113.71 -179.69 3.71 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.527 -0.733 . . . . 0.0 109.806 179.708 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.499 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 37.5 t0 -94.4 69.48 3.63 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.16 -0.962 . . . . 0.0 109.545 179.253 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.828 HG23 ' CB ' ' A' ' 133' ' ' SER . 4.7 p -92.1 147.34 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.259 -0.901 . . . . 0.0 111.045 -179.278 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.54 HG22 ' O ' ' A' ' 73' ' ' THR . 3.5 m -128.6 89.45 2.89 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.078 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.779 HG21 HD22 ' A' ' 129' ' ' LEU . 10.7 m -89.64 -151.2 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.228 -0.92 . . . . 0.0 110.49 -179.116 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.527 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 34.9 mtm-85 -128.05 137.6 52.24 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.206 -0.934 . . . . 0.0 110.761 -179.295 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.805 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -139.28 155.38 47.77 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.356 -0.84 . . . . 0.0 109.881 179.455 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.922 ' CD1' ' HB3' ' A' ' 126' ' ' ALA . 1.3 pp 175.23 -157.4 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.327 -0.858 . . . . 0.0 109.982 -179.601 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.928 HG23 HD22 ' A' ' 89' ' ' LEU . 4.9 t -147.85 168.54 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.204 -0.935 . . . . 0.0 109.41 179.762 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.485 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . -177.8 176.78 48.2 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.339 -1.41 . . . . 0.0 109.906 -179.882 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.486 ' NE2' ' C ' ' A' ' 81' ' ' ASN . 13.6 tp60 -107.31 135.43 48.83 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.31 -1.112 . . . . 0.0 110.534 179.931 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.552 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 2.4 m120 -123.26 96.77 5.12 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 122.072 0.939 . . . . 0.0 108.894 178.644 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.646 ' CA ' ' HD2' ' A' ' 121' ' ' PRO . . . 132.9 34.21 0.35 Allowed Glycine 0 N--CA 1.484 1.861 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.214 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 82' ' ' GLY . . . 60.15 143.94 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.264 -1.139 . . . . 0.0 110.235 -179.861 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.46 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.5 Cg_endo -82.22 18.45 17.86 Favored 'Cis proline' 0 C--N 1.313 -1.303 0 C-N-CA 121.868 -2.138 . . . . 0.0 110.869 -0.139 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.502 ' CD2' ' HA ' ' A' ' 83' ' ' ALA . 94.1 m-85 57.28 170.26 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.152 -0.967 . . . . 0.0 110.439 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 136.6 117.93 1.7 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.442 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 0.8 OUTLIER -97.78 145.69 26.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.195 -1.179 . . . . 0.0 110.185 179.863 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.96 HG23 HD12 ' A' ' 89' ' ' LEU . 29.4 m -123.98 -17.45 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.265 -0.897 . . . . 0.0 110.359 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.96 HD12 HG23 ' A' ' 88' ' ' VAL . 4.0 mp -108.5 136.96 47.25 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.189 -0.945 . . . . 0.0 111.009 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -150.97 82.2 1.33 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.457 -0.777 . . . . 0.0 109.836 179.601 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.2 p -140.06 178.5 7.23 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.033 -1.042 . . . . 0.0 110.741 -179.598 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.7 m -119.81 111.97 35.51 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.456 -0.777 . . . . 0.0 109.863 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.805 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 43.6 Cg_endo -70.1 99.57 0.79 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.957 1.503 . . . . 0.0 110.866 -179.764 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.518 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -76.23 153.21 36.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 0.0 109.687 179.504 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.712 HD21 ' CB ' ' A' ' 66' ' ' ALA . 72.7 mt -142.54 168.83 18.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.118 -0.989 . . . . 0.0 110.492 -179.751 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 70' ' ' THR . 0.3 OUTLIER -177.22 -178.82 0.82 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.411 -0.805 . . . . 0.0 110.038 -179.966 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.7 -8.23 26.38 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.228 -0.92 . . . . 0.0 110.148 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.71 ' O ' HG23 ' A' ' 67' ' ' THR . 11.3 mt-10 -106.17 168.22 8.51 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.907 . . . . 0.0 110.097 179.87 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.491 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 46.4 Cg_endo -72.83 130.26 15.46 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.046 1.55 . . . . 0.0 110.363 179.993 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.518 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 3.1 ttm-85 -119.91 92.42 3.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.176 -0.953 . . . . 0.0 110.251 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.537 ' HG2' ' CG2' ' A' ' 65' ' ' THR . 1.7 mt-30 -75.11 153.23 38.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.33 -0.856 . . . . 0.0 109.975 179.845 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 1.163 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 39.4 t -130.35 133.56 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.18 -0.95 . . . . 0.0 110.387 -179.945 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.526 ' O ' ' CG ' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -150.35 124.35 9.33 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.356 -0.84 . . . . 0.0 110.065 -179.987 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.526 ' CG ' ' O ' ' A' ' 103' ' ' THR . 35.3 mt-10 -157.56 154.53 28.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.256 -0.902 . . . . 0.0 110.315 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.2 m -117.39 114.67 23.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.261 -0.899 . . . . 0.0 110.042 179.898 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.959 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 35.4 p90 -127.27 155.42 43.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.195 -0.94 . . . . 0.0 110.342 -179.782 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.422 ' O ' HG22 ' A' ' 107' ' ' THR . 21.0 m -93.12 89.04 6.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.296 -0.878 . . . . 0.0 109.977 179.7 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.608 ' HB3' ' CE2' ' A' ' 60' ' ' TYR . . . -42.61 100.06 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.245 -0.909 . . . . 0.0 110.346 -179.855 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.47 ' H ' HG12 ' A' ' 88' ' ' VAL . 43.2 p -88.81 51.87 2.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.262 -0.899 . . . . 0.0 110.144 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.424 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -159.18 -152.81 0.33 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.264 -0.898 . . . . 0.0 110.301 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.534 HG23 ' HA ' ' A' ' 55' ' ' GLU . 25.1 m -153.5 119.07 5.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.886 . . . . 0.0 110.204 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.595 ' CD2' HG13 ' A' ' 54' ' ' ILE . 17.8 m-30 -113.95 89.7 17.28 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.303 -0.873 . . . . 0.0 109.942 179.829 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.484 ' HD2' ' OE1' ' A' ' 80' ' ' GLN . 44.9 Cg_endo -71.84 -158.69 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.028 1.541 . . . . 0.0 110.406 -179.928 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.432 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -153.94 36.89 0.44 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.221 -0.925 . . . . 0.0 110.244 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.451 HG22 ' O ' ' A' ' 115' ' ' THR . 7.2 m -106.6 95.0 11.03 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.307 -0.87 . . . . 0.0 110.203 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.49 ' HA ' ' O ' ' A' ' 120' ' ' ASP . 46.4 Cg_endo -73.16 128.37 12.93 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.014 1.534 . . . . 0.0 110.465 -179.945 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.72 ' HB3' ' HB2' ' A' ' 120' ' ' ASP . . . -150.05 -163.55 1.81 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.272 -0.892 . . . . 0.0 110.193 179.895 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.73 -11.75 48.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.229 -0.919 . . . . 0.0 110.194 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -160.3 21.98 0.16 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.201 -0.937 . . . . 0.0 110.148 179.941 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.72 ' HB2' ' HB3' ' A' ' 117' ' ' ALA . 79.9 m-20 -122.82 69.83 37.01 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.272 -0.893 . . . . 0.0 110.206 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.646 ' HD2' ' CA ' ' A' ' 82' ' ' GLY . 44.0 Cg_endo -76.48 18.06 0.73 Allowed 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 124.067 1.561 . . . . 0.0 112.505 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.552 ' O ' ' HB2' ' A' ' 81' ' ' ASN . 6.6 pt-20 40.72 -170.33 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.623 -0.673 . . . . 0.0 111.133 178.922 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -106.01 158.94 15.4 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 -179.429 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.522 ' CB ' ' HA ' ' A' ' 50' ' ' ASN . 17.1 pt20 -150.63 -151.76 0.41 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.366 -1.079 . . . . 0.0 110.621 -179.806 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.877 HG21 ' CH2' ' A' ' 16' ' ' TRP . 23.9 mt -118.56 146.51 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.616 -0.677 . . . . 0.0 109.425 179.665 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.922 ' HB3' ' CD1' ' A' ' 77' ' ' LEU . . . -116.15 114.87 25.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.336 -0.853 . . . . 0.0 111.744 -178.879 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.548 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 4.0 m-85 -119.81 75.69 1.1 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.247 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.741 ' C ' HD23 ' A' ' 129' ' ' LEU . 12.9 mt-30 -88.42 123.27 32.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.196 -0.94 . . . . 0.0 111.902 -177.754 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.993 HD13 HD13 ' A' ' 139' ' ' LEU . 3.6 mt -107.76 51.77 0.73 Allowed 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.746 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -96.1 130.75 10.38 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.627 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.577 ' O ' ' CD1' ' A' ' 132' ' ' PHE . . . 51.14 93.81 0.01 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.686 ' CD2' HG12 ' A' ' 74' ' ' VAL . 9.5 m-85 -158.86 -78.23 0.07 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.281 -1.129 . . . . 0.0 110.419 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.828 ' CB ' HG23 ' A' ' 72' ' ' VAL . 1.3 t -89.66 168.39 12.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.096 -1.003 . . . . 0.0 110.339 -179.812 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -98.26 -91.56 0.26 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.274 -0.892 . . . . 0.0 110.316 -179.917 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -46.65 158.05 0.13 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.081 -1.012 . . . . 0.0 110.35 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.581 ' HB2' ' HB2' ' A' ' 38' ' ' ALA . . . -54.48 128.66 32.93 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.313 -0.867 . . . . 0.0 110.333 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 1.031 ' CE2' HG11 ' A' ' 36' ' ' VAL . 8.9 p90 -135.24 -163.35 1.37 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.306 -0.871 . . . . 0.0 110.009 179.674 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.589 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 0.8 OUTLIER -160.95 176.5 11.34 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.195 -1.002 . . . . 0.0 110.696 -178.382 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.993 HD13 HD13 ' A' ' 129' ' ' LEU . 2.1 mp -133.52 126.04 30.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.464 -0.773 . . . . 0.0 109.605 179.172 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 140' ' ' CYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 33.4 m -121.94 98.77 6.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.032 -1.043 . . . . 0.0 110.91 -179.536 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.759 HD23 ' HB2' ' A' ' 66' ' ' ALA . 2.2 mt -89.8 -179.91 5.85 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -0.927 . . . . 0.0 109.318 179.067 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.798 ' O ' HG22 ' A' ' 8' ' ' THR . 2.7 p30 168.03 41.08 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.289 -0.882 . . . . 0.0 110.104 179.908 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.471 ' HA ' ' C ' ' A' ' 7' ' ' GLY . 0.3 OUTLIER -174.98 52.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.289 -0.882 . . . . 0.0 109.659 -179.877 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.687 HG21 ' CE1' ' A' ' 9' ' ' PHE . 1.4 t -89.2 121.27 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.349 -0.845 . . . . 0.0 109.917 -179.44 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.457 ' HB3' ' HB3' ' A' ' 63' ' ' ARG . . . -144.41 140.87 29.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.329 -0.857 . . . . 0.0 110.293 -179.631 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.482 HD21 HD11 ' A' ' 54' ' ' ILE . 13.6 tp -148.08 123.82 10.54 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.376 -0.828 . . . . 0.0 110.072 179.839 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.477 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 7.3 t0 -136.15 -177.31 4.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.179 -0.951 . . . . 0.0 110.295 -179.893 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.3 p -134.53 173.7 11.37 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.253 -0.904 . . . . 0.0 110.129 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.461 ' O ' ' HB ' ' A' ' 150' ' ' VAL . 0.0 OUTLIER -104.44 45.81 0.94 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.215 -0.928 . . . . 0.0 110.237 179.995 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.461 ' HB ' ' O ' ' A' ' 149' ' ' GLU . 6.2 p -179.6 139.81 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.247 -0.908 . . . . 0.0 110.222 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 150' ' ' VAL . 78.1 mt-10 -43.97 161.8 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.244 -0.91 . . . . 0.0 110.214 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.841 HD13 ' OXT' ' A' ' 152' ' ' LEU . 2.9 tm? . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.231 -179.986 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.232 0.539 . . . . 0.0 110.208 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.6 m -113.31 85.5 8.65 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.275 -0.89 . . . . 0.0 110.223 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -76.48 -156.59 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.987 1.52 . . . . 0.0 110.115 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.53 HG22 ' O ' ' A' ' 51' ' ' GLY . 9.1 pt -95.51 19.49 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.278 -0.889 . . . . 0.0 110.097 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' A' ' 7' ' ' GLY . . . 79.94 70.39 1.33 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.965 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.583 ' HG2' ' HB1' ' A' ' 145' ' ' ALA . 82.6 mt-10 -42.42 94.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.31 -1.112 . . . . 0.0 110.198 -179.945 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 5' ' ' GLY . . . 173.99 -159.1 28.36 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.987 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.739 HG22 ' O ' ' A' ' 142' ' ' ASP . 11.9 p -98.34 -154.91 0.47 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.367 -1.078 . . . . 0.0 110.268 -179.851 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.523 ' CE1' ' CD1' ' A' ' 16' ' ' TRP . 64.6 m-85 -120.56 44.21 2.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.305 -0.872 . . . . 0.0 110.176 179.959 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.559 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 49.5 t0 -97.84 61.7 1.57 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.234 -0.916 . . . . 0.0 110.126 -179.973 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.559 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 2.5 t0 161.83 -23.72 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.745 -0.597 . . . . 0.0 109.652 -179.973 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 176.21 133.98 1.87 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.724 ' HB3' HD12 ' A' ' 32' ' ' LEU . 48.9 Cg_endo -78.02 6.15 4.83 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.906 1.477 . . . . 0.0 110.533 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.512 ' HB3' ' O ' ' A' ' 13' ' ' PRO . 5.6 tp10 60.66 -89.03 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.356 -0.84 . . . . 0.0 110.386 -179.793 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.833 ' C ' HD13 ' A' ' 49' ' ' LEU . . . -148.09 25.44 1.43 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -179.859 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.834 ' HZ2' HG11 ' A' ' 144' ' ' VAL . 57.1 m95 -72.12 86.39 1.05 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.166 -1.197 . . . . 0.0 110.354 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.716 ' O ' HG13 ' A' ' 47' ' ' VAL . 1.1 m -87.42 153.32 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.205 -0.934 . . . . 0.0 109.92 179.942 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.403 ' CB ' HG22 ' A' ' 47' ' ' VAL . . . -136.84 133.63 36.06 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.268 -0.895 . . . . 0.0 109.456 179.437 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.6 ' HE2' HG13 ' A' ' 48' ' ' VAL . 6.1 p90 -120.38 161.11 21.74 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.283 -0.886 . . . . 0.0 111.122 -178.635 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.589 ' HA2' ' CE1' ' A' ' 43' ' ' TYR . . . 72.96 49.15 17.82 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.88 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.544 HG22 ' CG1' ' A' ' 45' ' ' VAL . 11.5 p -148.12 -153.52 0.5 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.254 -1.145 . . . . 0.0 110.404 -179.956 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -89.87 44.02 1.18 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.326 -0.859 . . . . 0.0 110.079 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.56 -144.28 16.29 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.889 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.99 -159.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.973 1.512 . . . . 0.0 110.367 179.944 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.638 ' CD1' HD11 ' A' ' 32' ' ' LEU . 0.3 OUTLIER -111.51 -173.12 2.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.184 -0.947 . . . . 0.0 110.037 179.809 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -132.03 159.9 37.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.163 -0.96 . . . . 0.0 110.19 -179.88 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.462 HG21 ' HD3' ' A' ' 13' ' ' PRO . 0.7 OUTLIER -133.62 -34.57 1.03 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.254 -0.904 . . . . 0.0 110.258 -179.911 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.44 ' O ' ' OG1' ' A' ' 29' ' ' THR . 73.6 m 51.28 30.41 5.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.23 -0.919 . . . . 0.0 110.221 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.453 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 5.4 p 42.8 55.04 4.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.28 -0.888 . . . . 0.0 110.2 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.508 ' N ' ' HA ' ' A' ' 10' ' ' ASP . . . -169.55 -54.86 0.03 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.611 ' HB1' ' O ' ' A' ' 141' ' ' LEU . . . -149.88 149.91 31.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.211 -1.17 . . . . 0.0 110.32 -179.902 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.724 HD12 ' HB3' ' A' ' 13' ' ' PRO . 1.1 tp -79.97 103.15 9.66 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.243 -0.911 . . . . 0.0 109.822 179.739 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.486 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 23.2 m -109.6 105.85 15.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.212 -0.93 . . . . 0.0 110.778 -179.503 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.545 HG12 ' HB3' ' A' ' 25' ' ' LEU . 18.0 m -91.09 140.12 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.241 -0.912 . . . . 0.0 109.122 179.08 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.483 ' O ' ' HB ' ' A' ' 21' ' ' THR . . . -89.18 98.33 11.71 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.102 -0.999 . . . . 0.0 111.032 -179.052 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.073 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 48.3 t -83.72 130.09 56.98 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.267 -0.896 . . . . 0.0 109.617 179.168 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 21' ' ' THR . 43.6 Cg_endo -70.73 -179.25 3.2 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.815 1.429 . . . . 0.0 110.538 -179.742 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.573 ' HA ' ' N ' ' A' ' 136' ' ' ALA . . . -42.79 166.67 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.25 -0.906 . . . . 0.0 110.137 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.595 ' O ' ' N ' ' A' ' 41' ' ' ALA . . . -35.68 108.12 0.05 OUTLIER Glycine 0 N--CA 1.495 2.62 0 N-CA-C 109.169 -1.573 . . . . 0.0 109.169 179.798 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.919 ' HB2' HG23 ' A' ' 45' ' ' VAL . 0.4 OUTLIER -39.36 89.9 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.979 0.895 . . . . 0.0 110.263 -178.899 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.595 ' N ' ' O ' ' A' ' 39' ' ' GLY . . . -114.79 23.84 12.28 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 121.952 0.882 . . . . 0.0 109.673 -179.465 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.543 ' O ' ' CG ' ' A' ' 42' ' ' GLN . 0.9 OUTLIER 177.04 34.3 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.241 -179.891 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.589 ' CE1' ' HA2' ' A' ' 20' ' ' GLY . 0.1 OUTLIER -158.79 -28.19 0.07 Allowed 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 118.548 -1.261 . . . . 0.0 112.389 -177.806 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 43' ' ' TYR . . . 53.43 84.47 0.03 OUTLIER Glycine 0 N--CA 1.483 1.829 0 N-CA-C 105.285 -3.126 . . . . 0.0 105.285 -176.766 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.919 HG23 ' HB2' ' A' ' 40' ' ' SER . 3.0 t -86.61 143.08 12.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.301 -1.117 . . . . 0.0 109.665 -176.751 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.572 ' O ' ' CZ ' ' A' ' 19' ' ' TYR . . . -166.26 147.35 12.01 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.289 -1.434 . . . . 0.0 110.785 -179.058 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.716 HG13 ' O ' ' A' ' 17' ' ' VAL . 19.7 t -111.7 129.69 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.576 -0.955 . . . . 0.0 109.668 179.659 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.6 HG13 ' HE2' ' A' ' 19' ' ' TYR . 27.3 m -120.69 145.02 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.743 -1.223 . . . . 0.0 110.656 -179.624 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.833 HD13 ' C ' ' A' ' 15' ' ' GLY . 15.9 tp -144.45 117.38 8.81 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.262 -0.899 . . . . 0.0 110.34 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.515 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 5.2 p-10 -90.44 148.19 22.94 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.208 -0.932 . . . . 0.0 110.49 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.53 ' O ' HG22 ' A' ' 4' ' ' ILE . . . 126.44 78.62 0.29 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.837 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.689 HG12 HG12 ' A' ' 54' ' ' ILE . 3.7 t -132.79 158.45 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.181 -1.188 . . . . 0.0 110.135 179.781 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -105.71 61.21 0.66 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.167 -0.958 . . . . 0.0 110.472 -179.885 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.928 HD11 HD21 ' A' ' 146' ' ' LEU . 6.3 mm -123.63 151.42 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.194 -0.941 . . . . 0.0 109.846 179.731 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.739 ' HA ' HG23 ' A' ' 111' ' ' THR . 4.4 pt-20 -174.97 34.07 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.106 -0.996 . . . . 0.0 110.376 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' A' ' 55' ' ' GLU . 1.3 tt0 179.88 -174.66 0.26 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.426 -0.796 . . . . 0.0 110.256 -179.797 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.494 ' HA2' ' HA ' ' A' ' 109' ' ' SER . . . -94.27 68.01 1.4 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 108.239 -1.944 . . . . 0.0 108.239 178.956 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.685 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.0 OUTLIER -109.02 176.17 5.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.503 -0.998 . . . . 0.0 110.367 -178.963 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.582 ' O ' ' CD2' ' A' ' 60' ' ' TYR . 0.4 OUTLIER -89.73 158.62 17.46 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.415 -0.803 . . . . 0.0 110.23 -179.941 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.685 ' CE2' HG22 ' A' ' 58' ' ' THR . 68.2 m-85 -156.14 -176.75 6.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.443 -0.786 . . . . 0.0 109.834 179.906 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 26.6 m -150.11 113.42 4.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.196 -0.94 . . . . 0.0 110.187 179.889 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.962 HD22 ' CD2' ' A' ' 89' ' ' LEU . 18.0 tp -89.71 120.86 31.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 110.032 179.821 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.799 ' HG2' HG23 ' A' ' 103' ' ' THR . 19.5 mtp-105 -128.4 130.73 48.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.282 -0.887 . . . . 0.0 110.099 179.961 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.548 ' CE2' ' HB ' ' A' ' 102' ' ' VAL . 8.7 p90 -165.48 152.77 10.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.262 -0.899 . . . . 0.0 109.923 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.504 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 25.6 m -119.67 93.95 4.24 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.097 -1.002 . . . . 0.0 109.968 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.551 ' HB2' HD23 ' A' ' 141' ' ' LEU . . . -96.33 154.54 17.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.274 -0.891 . . . . 0.0 110.939 -179.482 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.569 HG23 ' O ' ' A' ' 98' ' ' GLU . 50.9 m -149.69 134.94 18.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.562 -0.711 . . . . 0.0 109.39 179.263 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.534 ' N ' ' HB3' ' A' ' 95' ' ' LEU . . . -120.86 133.94 55.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.064 -1.023 . . . . 0.0 110.282 -179.685 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 68' ' ' ALA . 11.6 t -43.83 -26.17 0.24 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.27 -0.894 . . . . 0.0 109.547 179.546 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.73 HG22 ' HB2' ' A' ' 137' ' ' TRP . 5.7 t -115.21 -167.15 1.2 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.436 -0.79 . . . . 0.0 109.824 179.703 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.474 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 34.4 t0 -102.93 47.0 0.9 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.274 -0.891 . . . . 0.0 109.371 179.125 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.829 HG23 ' HB2' ' A' ' 133' ' ' SER . 1.9 p -63.46 171.53 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.429 -0.794 . . . . 0.0 110.824 -179.227 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.513 HG22 ' O ' ' A' ' 73' ' ' THR . 11.9 m -160.33 83.81 0.7 Allowed 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.67 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.997 HG21 ' CD2' ' A' ' 129' ' ' LEU . 2.4 m -89.9 -160.05 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.265 -0.897 . . . . 0.0 110.547 -178.616 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.465 ' N ' HG23 ' A' ' 74' ' ' VAL . 20.8 mtm-85 -121.28 112.97 19.27 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.256 -0.902 . . . . 0.0 110.328 -179.613 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.518 ' CB ' ' HD3' ' A' ' 93' ' ' PRO . . . -115.7 157.15 24.7 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.145 -0.972 . . . . 0.0 110.097 179.849 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.908 HD12 ' N ' ' A' ' 78' ' ' VAL . 3.8 pp 178.73 -147.3 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.409 -0.807 . . . . 0.0 109.851 -179.828 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.908 ' N ' HD12 ' A' ' 77' ' ' LEU . 3.1 t -151.92 172.57 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.115 -0.991 . . . . 0.0 109.563 179.773 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.494 ' HA2' ' HA ' ' A' ' 87' ' ' THR . . . 176.07 172.7 41.08 Favored Glycine 0 N--CA 1.49 2.276 0 C-N-CA 119.36 -1.4 . . . . 0.0 110.138 179.892 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.491 ' OE1' ' HD2' ' A' ' 113' ' ' PRO . 15.1 tp60 -93.04 137.72 32.14 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.4 -1.059 . . . . 0.0 110.355 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.532 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 3.6 m120 -123.3 96.4 4.98 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.839 0.828 . . . . 0.0 109.02 178.943 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.646 ' CA ' ' HD2' ' A' ' 121' ' ' PRO . . . 132.31 34.4 0.37 Allowed Glycine 0 N--CA 1.484 1.878 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.523 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 82' ' ' GLY . . . 60.41 142.95 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.282 -1.128 . . . . 0.0 110.14 -179.86 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.463 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.3 Cg_endo -82.28 18.6 17.7 Favored 'Cis proline' 0 C--N 1.314 -1.255 0 C-N-CA 121.938 -2.109 . . . . 0.0 110.813 -0.159 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.541 ' CD2' ' HA ' ' A' ' 83' ' ' ALA . 75.7 m-85 58.91 170.02 0.06 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.153 -0.967 . . . . 0.0 110.342 -179.911 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 142.33 114.64 1.06 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.494 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 1.1 p -91.26 147.83 22.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.188 -1.183 . . . . 0.0 110.299 -179.963 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 1.032 HG23 HD12 ' A' ' 89' ' ' LEU . 15.6 m -123.12 -21.81 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.299 -0.876 . . . . 0.0 110.266 179.98 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 1.032 HD12 HG23 ' A' ' 88' ' ' VAL . 3.9 mp -104.94 146.76 28.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.239 -0.913 . . . . 0.0 110.7 179.735 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.733 ' O ' HG23 ' A' ' 91' ' ' THR . 8.9 t0 -151.03 89.04 1.49 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.324 -0.86 . . . . 0.0 110.142 179.727 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.733 HG23 ' O ' ' A' ' 90' ' ' ASP . 6.5 p -160.0 -178.98 7.4 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.123 -0.986 . . . . 0.0 110.584 -179.862 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.529 ' CB ' ' O ' ' A' ' 74' ' ' VAL . 3.5 m -129.08 129.49 23.38 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.329 -0.857 . . . . 0.0 110.07 179.927 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.844 ' HG2' HG22 ' A' ' 74' ' ' VAL . 46.9 Cg_endo -72.28 91.44 0.76 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.935 1.492 . . . . 0.0 110.994 -179.719 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.522 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -70.48 125.14 25.96 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.073 -1.017 . . . . 0.0 109.002 178.972 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.542 ' CD1' ' HG ' ' A' ' 139' ' ' LEU . 29.4 mt -119.83 170.48 9.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.113 -0.992 . . . . 0.0 110.846 -179.023 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.601 HG23 ' N ' ' A' ' 97' ' ' SER . 6.1 t -169.36 -151.18 0.09 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.394 -0.816 . . . . 0.0 109.735 179.886 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.601 ' N ' HG23 ' A' ' 96' ' ' THR . 0.5 OUTLIER -93.41 25.51 3.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.046 -1.034 . . . . 0.0 110.043 179.8 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.569 ' O ' HG23 ' A' ' 67' ' ' THR . 2.0 mt-10 -145.84 171.99 5.83 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.34 -0.85 . . . . 0.0 109.959 179.847 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.57 130.83 16.51 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 124.005 1.529 . . . . 0.0 110.379 -179.968 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.522 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 1.7 mtt180 -119.7 93.2 3.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.254 -0.904 . . . . 0.0 110.006 179.915 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -82.99 95.24 7.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.448 -0.783 . . . . 0.0 110.45 -179.767 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.548 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 73.6 t -89.47 133.51 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.277 -0.89 . . . . 0.0 110.013 179.836 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.799 HG23 ' HG2' ' A' ' 63' ' ' ARG . 53.5 m -150.21 139.54 21.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.227 -0.921 . . . . 0.0 110.328 -179.948 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.456 ' CG ' ' O ' ' A' ' 103' ' ' THR . 21.3 mt-10 -160.2 160.94 33.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.244 -0.91 . . . . 0.0 110.257 179.881 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.41 HG22 ' H ' ' A' ' 105' ' ' THR . 3.1 t -111.5 128.06 55.9 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.229 -0.919 . . . . 0.0 110.114 179.894 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.924 ' CE2' HD11 ' A' ' 89' ' ' LEU . 22.4 p90 -136.38 157.27 47.19 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.246 -0.909 . . . . 0.0 110.269 -179.916 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.534 ' O ' ' N ' ' A' ' 109' ' ' SER . 3.6 m -89.49 93.9 9.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.163 -0.96 . . . . 0.0 109.732 179.603 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.613 ' HB3' ' CE2' ' A' ' 60' ' ' TYR . . . -49.68 89.99 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.353 -0.842 . . . . 0.0 110.084 -179.932 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.534 ' N ' ' O ' ' A' ' 107' ' ' THR . 79.8 p -85.99 53.96 2.97 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.315 -0.866 . . . . 0.0 109.76 179.888 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -159.28 -156.75 0.54 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.244 -0.91 . . . . 0.0 110.393 -179.769 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.739 HG23 ' HA ' ' A' ' 55' ' ' GLU . 3.4 m -149.8 113.45 5.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.256 -0.902 . . . . 0.0 110.457 -179.896 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.751 ' OH ' HG13 ' A' ' 88' ' ' VAL . 11.9 m-30 -109.85 85.91 4.39 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.366 -0.834 . . . . 0.0 109.571 179.535 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.638 ' HD3' HG22 ' A' ' 111' ' ' THR . 45.4 Cg_endo -72.19 -165.83 0.23 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.892 1.469 . . . . 0.0 110.517 -179.757 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -147.63 50.27 1.07 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.307 -0.871 . . . . 0.0 110.24 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 6.8 m -121.66 96.11 47.56 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 0.0 110.143 -179.968 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.498 ' HA ' ' O ' ' A' ' 120' ' ' ASP . 46.3 Cg_endo -73.3 123.81 9.01 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.052 1.554 . . . . 0.0 110.477 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.814 ' HB3' ' HB2' ' A' ' 120' ' ' ASP . . . -132.75 -163.35 1.33 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.201 -0.937 . . . . 0.0 110.189 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.64 -15.72 8.44 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.259 -0.901 . . . . 0.0 110.234 179.932 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.421 ' O ' ' HD3' ' A' ' 121' ' ' PRO . 32.3 t0 -166.91 26.97 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.247 -0.908 . . . . 0.0 110.123 179.959 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.814 ' HB2' ' HB3' ' A' ' 117' ' ' ALA . 1.2 m-20 -114.41 83.72 8.86 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.259 -0.901 . . . . 0.0 110.276 -179.931 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.646 ' HD2' ' CA ' ' A' ' 82' ' ' GLY . 43.2 Cg_endo -78.44 17.58 1.06 Allowed 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.96 1.505 . . . . 0.0 112.372 179.929 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.532 ' O ' ' HB2' ' A' ' 81' ' ' ASN . 0.5 OUTLIER 38.29 -168.95 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.325 0.583 . . . . 0.0 111.903 178.625 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.484 ' HA3' ' CB ' ' A' ' 112' ' ' TYR . . . -85.54 149.21 23.39 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -179.378 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.515 ' CB ' ' HA ' ' A' ' 50' ' ' ASN . 6.8 pt20 -150.78 -157.59 0.83 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.358 -1.084 . . . . 0.0 110.651 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.453 HG21 ' CH2' ' A' ' 16' ' ' TRP . 5.5 mt -118.54 146.97 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 179.294 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -121.5 122.62 40.12 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.325 -179.183 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.518 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 5.0 m-85 -118.59 98.54 6.29 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.185 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.489 ' O ' ' HB ' ' A' ' 74' ' ' VAL . 10.5 mm-40 -88.75 84.13 6.69 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.262 -0.899 . . . . 0.0 112.368 -177.154 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 1.055 HD13 HD13 ' A' ' 139' ' ' LEU . 7.0 mt -85.2 45.99 1.24 Allowed 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.515 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' A' ' 132' ' ' PHE . . . -64.2 -170.5 2.02 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 -179.396 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.554 ' CA ' ' O ' ' A' ' 40' ' ' SER . . . -51.81 89.49 0.01 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.905 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.567 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 9.7 m-85 -118.35 -49.53 2.47 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.113 -1.228 . . . . 0.0 110.693 -179.361 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.829 ' HB2' HG23 ' A' ' 72' ' ' VAL . 1.3 t -88.53 175.83 7.41 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.997 -1.065 . . . . 0.0 110.233 -179.71 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -97.25 -52.94 3.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.322 -0.862 . . . . 0.0 110.309 -179.744 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -98.82 174.11 6.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.228 -0.92 . . . . 0.0 109.984 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.573 ' N ' ' HA ' ' A' ' 38' ' ' ALA . . . -57.59 125.6 23.63 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.151 -0.968 . . . . 0.0 110.047 -179.756 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 1.073 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 6.6 p90 -132.18 -168.48 2.05 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.063 -1.023 . . . . 0.0 109.803 179.659 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 68' ' ' ALA . 0.5 OUTLIER -155.76 172.46 18.28 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.805 -1.185 . . . . 0.0 111.331 -177.819 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 1.055 HD13 HD13 ' A' ' 129' ' ' LEU . 2.4 mp -130.47 128.81 42.0 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.548 -0.72 . . . . 0.0 109.506 179.497 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 140' ' ' CYS . . . . . . . . . . . . . 15.9 m -127.63 100.7 6.09 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.091 -1.006 . . . . 0.0 110.771 -179.535 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.611 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 0.7 OUTLIER -95.96 -177.93 4.18 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.29 -0.881 . . . . 0.0 109.325 179.189 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.739 ' O ' HG22 ' A' ' 8' ' ' THR . 0.6 OUTLIER 171.11 49.89 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.184 -0.947 . . . . 0.0 110.411 -179.996 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.677 ' CG ' HG22 ' A' ' 8' ' ' THR . 0.4 OUTLIER 166.23 55.43 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.37 -0.831 . . . . 0.0 109.614 179.849 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.834 HG11 ' HZ2' ' A' ' 16' ' ' TRP . 2.1 t -96.32 118.72 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.303 -0.873 . . . . 0.0 110.274 -179.474 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.583 ' HB1' ' HG2' ' A' ' 6' ' ' GLU . . . -145.2 155.55 43.33 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.318 -0.864 . . . . 0.0 110.189 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.928 HD21 HD11 ' A' ' 54' ' ' ILE . 14.1 tp -147.9 143.39 27.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.922 . . . . 0.0 110.188 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.493 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 5.0 t0 -172.3 151.15 2.49 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.2 -0.937 . . . . 0.0 110.311 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.433 ' HA ' ' O ' ' A' ' 59' ' ' THR . 9.7 p -94.11 153.12 18.29 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.281 -0.887 . . . . 0.0 110.197 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -115.98 -144.77 0.39 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.243 -0.91 . . . . 0.0 110.28 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.538 HG22 ' O ' ' A' ' 150' ' ' VAL . 12.2 p -155.55 43.89 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.281 -0.887 . . . . 0.0 110.168 -179.994 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -140.76 26.03 2.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.306 -0.872 . . . . 0.0 110.192 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 1.013 HD22 ' O ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.361 -179.981 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.427 ' O ' ' HD3' ' A' ' 3' ' ' PRO . . . . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.234 0.54 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.3 m -51.76 107.8 0.91 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.267 -0.896 . . . . 0.0 110.217 179.961 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 1' ' ' ALA . 48.8 Cg_endo -75.97 -156.44 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.027 1.541 . . . . 0.0 110.072 -179.985 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.633 HG22 ' O ' ' A' ' 51' ' ' GLY . 13.8 pt -95.39 23.97 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.195 -0.941 . . . . 0.0 110.17 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 94.23 -23.8 29.99 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.917 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.76 ' HG2' ' HB1' ' A' ' 145' ' ' ALA . 1.4 tt0 44.7 74.07 0.14 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.273 -1.134 . . . . 0.0 110.212 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -163.26 -164.01 17.31 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.961 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.572 HG22 ' O ' ' A' ' 142' ' ' ASP . 26.1 p -117.57 33.92 5.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.259 -1.142 . . . . 0.0 110.323 -179.975 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.552 ' HZ ' HG21 ' A' ' 144' ' ' VAL . 13.6 m-85 60.25 48.24 8.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -0.934 . . . . 0.0 110.146 179.938 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.557 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 32.2 t70 -90.13 32.21 0.94 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.223 -0.923 . . . . 0.0 110.333 -179.911 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.557 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.4 OUTLIER 161.55 37.77 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.572 -0.705 . . . . 0.0 109.974 179.983 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.24 136.07 4.36 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.774 ' HB3' HD12 ' A' ' 32' ' ' LEU . 48.3 Cg_endo -74.69 1.66 7.31 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.962 1.506 . . . . 0.0 110.609 179.955 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 0.1 OUTLIER 68.15 -84.04 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.265 -0.897 . . . . 0.0 110.274 -179.872 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.66 ' O ' HG13 ' A' ' 17' ' ' VAL . . . -137.39 5.54 3.52 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.921 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.884 ' CE2' HD22 ' A' ' 49' ' ' LEU . 56.0 m95 -65.5 105.25 1.15 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.188 -1.183 . . . . 0.0 110.249 -179.898 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.696 ' O ' HG13 ' A' ' 47' ' ' VAL . 1.0 OUTLIER -113.41 151.72 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.173 -0.955 . . . . 0.0 109.783 179.784 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 1.018 ' HB3' HD21 ' A' ' 25' ' ' LEU . . . -133.73 136.97 44.96 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.192 -0.942 . . . . 0.0 109.679 179.359 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.635 ' HE2' HG13 ' A' ' 48' ' ' VAL . 26.8 p90 -128.17 148.64 50.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.417 -0.802 . . . . 0.0 110.665 -178.902 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.3 24.61 18.58 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 179.464 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.704 HG22 HG11 ' A' ' 45' ' ' VAL . 28.1 p -134.88 -148.6 0.32 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.033 -1.275 . . . . 0.0 110.494 179.904 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.454 ' O ' ' O ' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -116.84 136.43 52.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.342 -0.849 . . . . 0.0 110.383 -179.806 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 22' ' ' ASP . . . 52.07 174.46 0.03 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.766 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.52 -159.32 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.08 1.569 . . . . 0.0 110.42 179.966 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 1.018 HD21 ' HB3' ' A' ' 18' ' ' ALA . 17.3 mt -93.05 145.3 24.49 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.215 -0.928 . . . . 0.0 110.237 179.987 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -97.59 119.41 36.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.243 -0.911 . . . . 0.0 109.827 179.709 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' A' ' 31' ' ' ALA . 0.8 OUTLIER -119.65 -44.56 2.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.127 -0.983 . . . . 0.0 110.503 -179.58 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.43 ' C ' ' O ' ' A' ' 27' ' ' THR . 8.1 t 43.76 36.04 1.21 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.186 -0.946 . . . . 0.0 109.874 -179.831 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 28' ' ' SER . 4.3 p 54.11 59.94 3.92 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.457 -0.777 . . . . 0.0 110.057 -179.731 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 8' ' ' THR . . . -159.24 -71.12 0.02 OUTLIER Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.624 ' HB1' ' O ' ' A' ' 141' ' ' LEU . . . -150.74 160.17 44.03 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.25 -1.147 . . . . 0.0 110.451 -179.899 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.774 HD12 ' HB3' ' A' ' 13' ' ' PRO . 0.6 OUTLIER -88.71 111.8 22.39 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.276 -0.89 . . . . 0.0 109.842 179.568 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 53.4 m -119.58 106.36 12.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.221 -0.924 . . . . 0.0 110.61 -179.642 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 1.006 HG12 HD22 ' A' ' 25' ' ' LEU . 18.2 m -89.87 145.58 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.207 -0.933 . . . . 0.0 109.715 179.535 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.527 ' HA ' ' OG1' ' A' ' 138' ' ' THR . . . -95.52 91.69 6.29 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.338 -0.851 . . . . 0.0 111.113 -179.268 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.126 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 58.8 t -71.54 130.85 86.86 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.168 -0.958 . . . . 0.0 109.307 179.076 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 21' ' ' THR . 43.1 Cg_endo -71.24 155.12 61.29 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.933 1.491 . . . . 0.0 111.164 -178.945 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.549 ' HA ' ' CA ' ' A' ' 136' ' ' ALA . . . -43.05 111.1 0.23 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.37 -0.832 . . . . 0.0 110.345 -179.839 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 134' ' ' ALA . . . 58.67 117.6 0.01 OUTLIER Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.981 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.597 ' HB3' HG23 ' A' ' 45' ' ' VAL . 58.6 m -85.55 49.0 1.67 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.27 -1.135 . . . . 0.0 109.553 179.668 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.513 ' O ' ' HB3' ' A' ' 42' ' ' GLN . . . -89.72 103.89 16.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.497 -0.752 . . . . 0.0 110.217 -179.741 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.513 ' HB3' ' O ' ' A' ' 41' ' ' ALA . 0.8 OUTLIER 168.18 -152.17 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -179.757 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.409 ' C ' ' O ' ' A' ' 42' ' ' GLN . 7.4 p90 -43.13 -26.43 0.16 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.091 -1.006 . . . . 0.0 109.564 179.174 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 42' ' ' GLN . . . 107.59 129.39 6.1 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.35 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.704 HG11 HG22 ' A' ' 21' ' ' THR . 3.0 t -89.88 177.89 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.132 -1.217 . . . . 0.0 108.46 179.144 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.556 ' HA2' ' HA ' ' A' ' 128' ' ' GLN . . . 169.4 -177.29 43.09 Favored Glycine 0 N--CA 1.489 2.182 0 C-N-CA 118.748 -1.692 . . . . 0.0 111.075 -179.894 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.696 HG13 ' O ' ' A' ' 17' ' ' VAL . 18.3 t -150.95 126.84 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.803 -0.822 . . . . 0.0 108.83 179.862 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.635 HG13 ' HE2' ' A' ' 19' ' ' TYR . 29.0 m -119.82 133.67 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.027 -1.046 . . . . 0.0 110.907 -179.159 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.884 HD22 ' CE2' ' A' ' 16' ' ' TRP . 30.7 tp -122.97 90.64 3.33 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.397 -0.815 . . . . 0.0 110.074 179.787 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.481 ' HA ' ' HB3' ' A' ' 124' ' ' GLN . 8.1 p30 -73.57 113.5 10.75 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.236 -0.915 . . . . 0.0 110.247 -179.909 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.633 ' O ' HG22 ' A' ' 4' ' ' ILE . . . 153.95 65.86 0.01 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.908 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.725 HG23 ' HA ' ' A' ' 124' ' ' GLN . 97.2 t -120.04 173.07 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.164 -1.197 . . . . 0.0 109.982 179.787 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.599 ' N ' HG12 ' A' ' 52' ' ' VAL . . . -143.43 97.74 3.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.072 -1.017 . . . . 0.0 110.652 -179.786 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.863 HG21 ' HB1' ' A' ' 108' ' ' ALA . 11.6 mm -137.79 159.87 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.292 -0.88 . . . . 0.0 109.818 179.603 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.475 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -147.82 135.34 20.76 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.108 -0.995 . . . . 0.0 110.683 -179.774 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.565 ' CG ' ' N ' ' A' ' 57' ' ' GLY . 0.9 OUTLIER 34.23 -155.08 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.342 0.592 . . . . 0.0 111.243 179.759 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.565 ' N ' ' CG ' ' A' ' 56' ' ' GLU . . . -83.39 81.39 1.75 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.837 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.681 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.2 m -109.13 171.26 7.54 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.305 -1.115 . . . . 0.0 109.826 179.876 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.519 ' N ' ' CG2' ' A' ' 58' ' ' THR . 1.0 OUTLIER -89.91 150.21 22.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.257 -0.902 . . . . 0.0 110.181 -179.941 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.823 ' CE2' HG23 ' A' ' 54' ' ' ILE . 64.9 m-85 -154.69 171.74 19.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.233 -0.917 . . . . 0.0 110.225 179.895 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.514 ' OG1' HG23 ' A' ' 105' ' ' THR . 17.9 m -142.73 114.51 8.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.304 -0.872 . . . . 0.0 110.086 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.1 tp -89.71 121.19 31.64 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.177 -0.952 . . . . 0.0 109.965 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.504 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 2.2 ttt180 -129.29 127.8 41.89 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -0.878 . . . . 0.0 110.314 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.964 ' CZ ' HG21 ' A' ' 102' ' ' VAL . 2.1 p90 -165.12 149.6 8.94 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.336 -0.853 . . . . 0.0 109.888 179.807 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 51.6 m -119.44 95.7 4.9 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.183 -0.948 . . . . 0.0 110.117 -179.965 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.501 ' HB2' HD23 ' A' ' 141' ' ' LEU . . . -93.92 151.93 19.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.358 -0.839 . . . . 0.0 110.339 -179.801 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.86 HG23 ' O ' ' A' ' 98' ' ' GLU . 57.1 m -149.76 121.16 7.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.278 -0.889 . . . . 0.0 110.261 179.97 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.469 ' O ' ' O ' ' A' ' 96' ' ' THR . . . -114.89 132.01 56.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.314 -0.866 . . . . 0.0 109.852 179.752 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.9 p -47.69 -23.99 0.83 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.074 -1.016 . . . . 0.0 109.343 179.497 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.592 HG22 ' HB2' ' A' ' 137' ' ' TRP . 2.5 t -113.84 170.2 8.44 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.49 -0.756 . . . . 0.0 110.067 179.904 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.43 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 15.7 t70 -86.75 66.02 9.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.179 -0.951 . . . . 0.0 109.119 178.86 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.776 HG23 ' CB ' ' A' ' 133' ' ' SER . 3.5 p -85.23 137.25 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.319 -0.863 . . . . 0.0 111.341 -178.871 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.409 ' O ' ' CD1' ' A' ' 132' ' ' PHE . 89.6 m -122.81 86.02 2.51 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.85 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.66 HG22 ' HG2' ' A' ' 93' ' ' PRO . 4.8 m -89.33 -153.28 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.287 -0.883 . . . . 0.0 110.444 -179.068 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.44 ' N ' HG23 ' A' ' 74' ' ' VAL . 2.4 mtp180 -125.94 133.16 51.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.207 -0.933 . . . . 0.0 110.627 -179.431 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.511 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -137.32 155.72 49.09 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.346 -0.846 . . . . 0.0 110.079 179.691 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.894 HD12 ' N ' ' A' ' 78' ' ' VAL . 3.9 pp 179.18 -147.77 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.354 -0.841 . . . . 0.0 110.033 -179.724 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.894 ' N ' HD12 ' A' ' 77' ' ' LEU . 3.8 t -151.65 166.43 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.147 -0.971 . . . . 0.0 109.321 179.77 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.507 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . -171.67 -174.53 39.33 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.11 -1.519 . . . . 0.0 110.631 -179.81 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.561 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 4.0 pt20 -114.78 150.8 34.84 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.545 -0.973 . . . . 0.0 110.065 179.793 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.487 ' OD1' ' HG2' ' A' ' 122' ' ' GLU . 18.6 m120 -106.31 92.47 4.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.207 -0.933 . . . . 0.0 110.396 -179.952 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.538 ' C ' ' CE1' ' A' ' 85' ' ' TYR . . . 135.54 130.18 2.92 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.869 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.581 ' N ' ' CZ ' ' A' ' 85' ' ' TYR . . . -42.12 155.32 0.25 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.38 -1.071 . . . . 0.0 110.317 -179.951 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.464 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 50.8 Cg_endo -78.78 11.75 18.72 Favored 'Cis proline' 0 C--N 1.312 -1.352 0 C-N-CA 121.636 -2.235 . . . . 0.0 110.93 -0.049 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.581 ' CZ ' ' N ' ' A' ' 83' ' ' ALA . 39.3 m-85 60.88 157.71 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.125 -0.985 . . . . 0.0 110.17 -179.739 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.47 ' O ' ' HG2' ' A' ' 80' ' ' GLN . . . 167.78 113.46 0.28 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.479 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 1.2 p -89.84 155.52 19.1 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.232 -1.158 . . . . 0.0 110.299 -179.853 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 1.068 HG23 HD12 ' A' ' 89' ' ' LEU . 35.3 m -119.82 -24.22 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.886 . . . . 0.0 109.899 179.837 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 1.068 HD12 HG23 ' A' ' 88' ' ' VAL . 4.0 mp -104.59 144.39 31.76 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.351 -0.843 . . . . 0.0 110.667 179.684 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -151.04 76.33 1.23 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.324 -0.86 . . . . 0.0 110.195 179.805 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -144.85 176.38 9.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.052 -1.03 . . . . 0.0 110.508 -179.832 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 66.2 m -124.39 126.08 25.54 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.318 -0.864 . . . . 0.0 110.045 179.907 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.66 ' HG2' HG22 ' A' ' 74' ' ' VAL . 45.4 Cg_endo -71.73 127.66 13.34 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.876 1.461 . . . . 0.0 110.749 -179.805 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.515 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -105.19 128.49 53.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.321 -0.862 . . . . 0.0 109.838 179.58 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.664 HD12 ' CG1' ' A' ' 72' ' ' VAL . 57.4 mt -119.91 178.95 4.41 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.186 -0.946 . . . . 0.0 110.467 -179.711 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.628 HG23 ' H ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -159.24 -79.64 0.06 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.265 -0.897 . . . . 0.0 110.335 -179.848 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.628 ' H ' HG23 ' A' ' 96' ' ' THR . 0.1 OUTLIER -158.75 -37.66 0.06 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.271 -0.893 . . . . 0.0 110.061 179.952 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.86 ' O ' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -89.88 -177.72 0.85 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.341 -0.849 . . . . 0.0 109.786 179.748 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.554 ' HD2' ' CG ' ' A' ' 98' ' ' GLU . 44.2 Cg_endo -71.61 128.63 14.58 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.748 1.394 . . . . 0.0 110.272 179.915 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.515 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 8.0 ttm-85 -119.68 92.03 3.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.185 -0.947 . . . . 0.0 110.36 -179.803 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 4.4 pt20 -70.23 159.03 34.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.327 -0.858 . . . . 0.0 110.045 179.796 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.964 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 98.7 t -135.12 139.34 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.208 -0.932 . . . . 0.0 110.165 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.447 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 0.2 OUTLIER -150.21 117.1 5.89 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.238 -0.914 . . . . 0.0 110.154 179.976 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.447 ' HG2' ' O ' ' A' ' 103' ' ' THR . 17.7 mm-40 -155.28 134.86 12.6 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.206 -0.934 . . . . 0.0 110.288 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.514 HG23 ' OG1' ' A' ' 61' ' ' THR . 0.7 OUTLIER -102.18 119.24 38.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.271 -0.893 . . . . 0.0 110.106 179.939 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.896 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 35.0 p90 -125.91 157.91 36.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.233 -0.917 . . . . 0.0 110.285 -179.943 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 19.3 m -89.93 98.57 11.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.3 -0.875 . . . . 0.0 109.997 179.786 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.863 ' HB1' HG21 ' A' ' 54' ' ' ILE . . . -59.3 107.78 0.61 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.253 -0.905 . . . . 0.0 110.411 -179.726 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.463 ' HA ' ' HA2' ' A' ' 57' ' ' GLY . 3.3 p -94.8 54.27 1.72 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.258 -0.901 . . . . 0.0 110.005 179.67 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.401 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -160.57 -152.38 0.28 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.214 -0.929 . . . . 0.0 110.431 -179.81 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 111' ' ' THR . . . . . 1.054 HG22 ' HD3' ' A' ' 113' ' ' PRO . 84.1 m -151.89 111.46 3.97 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.325 -0.859 . . . . 0.0 110.312 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.673 ' CE2' HG12 ' A' ' 78' ' ' VAL . 17.3 m-30 -111.02 69.66 0.66 Allowed Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.265 -0.897 . . . . 0.0 110.16 179.791 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 1.054 ' HD3' HG22 ' A' ' 111' ' ' THR . 45.8 Cg_endo -71.3 117.21 5.04 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.889 1.468 . . . . 0.0 110.361 179.949 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.481 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -60.33 -13.41 12.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.261 -0.899 . . . . 0.0 110.231 -179.951 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.732 ' O ' HG23 ' A' ' 115' ' ' THR . 9.7 t -96.93 105.18 22.03 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.216 -0.928 . . . . 0.0 110.211 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 46.7 Cg_endo -73.32 113.6 3.82 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.006 1.53 . . . . 0.0 110.39 179.935 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 1.034 ' HB3' ' HB2' ' A' ' 120' ' ' ASP . . . -120.42 47.4 1.78 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.264 -0.898 . . . . 0.0 110.194 -179.998 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 117' ' ' ALA . . . 55.87 -89.02 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.291 -0.881 . . . . 0.0 110.202 -179.989 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.453 ' N ' ' O ' ' A' ' 117' ' ' ALA . 2.6 p30 -62.22 -11.98 17.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.241 -0.912 . . . . 0.0 110.213 -179.954 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 1.034 ' HB2' ' HB3' ' A' ' 117' ' ' ALA . 5.8 m-20 -108.77 103.99 53.29 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 110.243 179.954 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.527 ' O ' ' CG ' ' A' ' 113' ' ' PRO . 47.6 Cg_endo -73.46 146.8 40.15 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.983 1.517 . . . . 0.0 110.409 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.543 ' CG ' ' N ' ' A' ' 123' ' ' GLY . 0.7 OUTLIER -97.2 -142.75 0.29 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.256 -0.902 . . . . 0.0 109.999 179.843 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.561 ' HA2' ' HA ' ' A' ' 80' ' ' GLN . . . -166.44 156.31 28.11 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.814 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.725 ' HA ' HG23 ' A' ' 52' ' ' VAL . 3.6 pt20 -150.08 -161.23 1.3 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.38 -1.07 . . . . 0.0 110.313 -179.727 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.862 HG21 ' CH2' ' A' ' 16' ' ' TRP . 17.5 mt -118.49 149.83 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.528 -0.732 . . . . 0.0 109.552 179.772 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.761 ' HB3' ' HG ' ' A' ' 77' ' ' LEU . . . -114.97 133.92 55.62 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.78 0.8 . . . . 0.0 111.179 -179.228 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.533 ' CD1' ' O ' ' A' ' 126' ' ' ALA . 8.5 m-85 -146.8 73.9 1.33 Allowed 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.062 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.893 ' C ' HD23 ' A' ' 129' ' ' LEU . 40.2 mt-30 -87.55 125.44 34.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.303 -0.873 . . . . 0.0 111.841 -177.773 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.893 HD23 ' C ' ' A' ' 128' ' ' GLN . 2.9 mt -113.95 54.34 0.76 Allowed 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.871 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -106.54 104.33 2.18 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 -179.36 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 77.21 74.46 0.98 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.781 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.611 ' CE1' ' HA ' ' A' ' 74' ' ' VAL . 6.5 m-85 -143.93 -71.77 0.29 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.196 -1.179 . . . . 0.0 110.243 179.859 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.776 ' CB ' HG23 ' A' ' 72' ' ' VAL . 1.3 t -89.13 156.45 18.8 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.055 -1.028 . . . . 0.0 110.103 179.825 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -80.23 -92.31 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.225 -0.922 . . . . 0.0 110.874 -179.34 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.448 ' O ' ' O ' ' A' ' 134' ' ' ALA . 12.6 m-20 -52.28 -172.35 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.165 -0.959 . . . . 0.0 110.679 -179.494 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.549 ' CA ' ' HA ' ' A' ' 38' ' ' ALA . . . -76.55 139.44 40.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.363 -0.835 . . . . 0.0 110.386 -179.799 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 1.126 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 9.1 p90 -145.82 -166.34 2.43 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.296 -0.877 . . . . 0.0 110.058 179.672 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.527 ' OG1' ' HA ' ' A' ' 35' ' ' ALA . 0.8 OUTLIER -160.38 170.47 20.96 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.034 -1.041 . . . . 0.0 110.735 -178.068 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.818 HD13 HD13 ' A' ' 129' ' ' LEU . 2.2 mp -129.28 126.26 38.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.469 -0.769 . . . . 0.0 109.444 179.14 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 140' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 27.9 m -121.81 102.73 8.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.141 -0.974 . . . . 0.0 110.892 -179.443 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.624 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 1.2 mt -95.26 -177.94 4.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.301 -0.875 . . . . 0.0 109.355 179.093 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.572 ' O ' HG22 ' A' ' 8' ' ' THR . 2.8 p30 168.5 52.96 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.244 -0.91 . . . . 0.0 110.301 179.954 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.523 ' CG ' HG22 ' A' ' 8' ' ' THR . 0.3 OUTLIER 167.27 53.06 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.223 -0.923 . . . . 0.0 109.71 179.947 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.864 HG11 ' HZ2' ' A' ' 16' ' ' TRP . 2.2 t -95.71 114.17 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.28 -0.887 . . . . 0.0 110.189 -179.599 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.76 ' HB1' ' HG2' ' A' ' 6' ' ' GLU . . . -146.11 164.75 31.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.897 . . . . 0.0 110.262 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.758 HD11 ' HB3' ' A' ' 60' ' ' TYR . 6.7 tp -145.21 148.23 33.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.323 -0.861 . . . . 0.0 110.234 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.517 ' HB3' ' CG1' ' A' ' 150' ' ' VAL . 0.5 OUTLIER -134.22 -173.97 3.42 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.196 -0.94 . . . . 0.0 110.23 -179.982 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 78.5 p -137.5 102.72 4.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.237 -0.915 . . . . 0.0 110.224 -179.974 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 48.97 65.2 1.44 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.241 -0.912 . . . . 0.0 110.221 179.981 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.531 HG13 ' O ' ' A' ' 150' ' ' VAL . 14.5 p -160.63 52.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.184 -0.947 . . . . 0.0 110.173 179.905 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -54.68 173.31 0.08 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.295 -0.878 . . . . 0.0 110.207 -179.98 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.432 ' HA ' HD13 ' A' ' 152' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.214 -179.972 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.271 0.558 . . . . 0.0 110.233 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.6 t 47.86 90.86 0.07 OUTLIER Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.232 -0.918 . . . . 0.0 110.224 179.982 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.563 ' CG ' ' HA ' ' A' ' 52' ' ' VAL . 53.8 Cg_endo -80.43 19.1 1.12 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.998 1.525 . . . . 0.0 111.134 179.982 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.505 HG13 ' N ' ' A' ' 5' ' ' GLY . 7.8 pt -146.15 -37.52 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.989 -1.07 . . . . 0.0 109.811 179.715 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.511 ' O ' ' N ' ' A' ' 7' ' ' GLY . . . 55.71 163.18 0.02 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 179.574 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.68 ' CG ' ' HB2' ' A' ' 145' ' ' ALA . 63.3 mt-10 -51.69 88.75 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.302 -1.116 . . . . 0.0 110.11 179.85 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 5' ' ' GLY . . . -78.63 -32.41 41.71 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.953 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.456 ' HA ' ' C ' ' A' ' 142' ' ' ASP . 11.2 p 50.57 18.93 0.51 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.427 -1.043 . . . . 0.0 110.467 -179.794 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.604 ' CG ' ' HB2' ' A' ' 32' ' ' LEU . 24.3 m-85 36.85 46.64 0.51 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.56 -0.712 . . . . 0.0 110.813 179.563 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.558 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 3.2 p-10 -100.25 43.46 1.06 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.244 -0.91 . . . . 0.0 110.281 -179.998 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.558 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.6 OUTLIER 161.57 -24.97 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.722 -0.612 . . . . 0.0 109.52 179.951 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -177.64 151.12 10.54 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.74 ' HB3' HD12 ' A' ' 32' ' ' LEU . 46.3 Cg_endo -73.64 0.01 8.74 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.014 1.534 . . . . 0.0 110.552 -179.987 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 0.5 OUTLIER 62.07 -89.55 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.255 -0.903 . . . . 0.0 110.135 -179.791 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.595 ' O ' HG13 ' A' ' 17' ' ' VAL . . . -122.68 -15.89 3.87 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.944 ' CH2' HG21 ' A' ' 125' ' ' ILE . 82.4 m95 -54.05 140.68 30.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.254 -1.145 . . . . 0.0 110.782 -179.758 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.938 ' HA ' HD11 ' A' ' 25' ' ' LEU . 1.2 m -146.08 157.95 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.324 -0.86 . . . . 0.0 109.455 179.425 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.452 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . . . -134.26 163.2 30.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.235 -0.916 . . . . 0.0 109.49 179.303 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.53 ' HE2' HG13 ' A' ' 48' ' ' VAL . 3.5 p90 -150.04 147.9 28.38 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.93 -1.106 . . . . 0.0 111.625 -178.519 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.587 ' HA2' ' CD1' ' A' ' 43' ' ' TYR . . . 132.09 -81.75 0.32 Allowed Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.763 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.617 HG22 ' CE2' ' A' ' 43' ' ' TYR . 12.1 p -149.69 23.95 0.88 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.171 -1.194 . . . . 0.0 110.319 -179.899 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.579 ' HA ' ' HB3' ' A' ' 35' ' ' ALA . 0.5 OUTLIER -107.63 27.43 9.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 110.35 179.845 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.48 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 36.87 -137.43 0.53 Allowed Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.749 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.78 -158.88 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.974 1.513 . . . . 0.0 110.106 179.514 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.938 HD11 ' HA ' ' A' ' 17' ' ' VAL . 61.1 mt -111.26 123.69 50.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.122 -0.986 . . . . 0.0 110.263 179.923 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.02 105.63 12.39 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.196 -0.94 . . . . 0.0 109.911 179.871 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.58 HG22 ' HB3' ' A' ' 9' ' ' PHE . 0.8 OUTLIER -119.56 -27.4 5.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.185 -0.947 . . . . 0.0 110.488 -179.653 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.645 ' C ' HG22 ' A' ' 29' ' ' THR . 8.0 t -48.48 82.91 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.758 -0.589 . . . . 0.0 111.233 -179.863 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.645 HG22 ' C ' ' A' ' 28' ' ' SER . 0.0 OUTLIER 167.91 -31.71 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.254 -0.904 . . . . 0.0 109.856 -179.918 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.434 ' HA2' ' HA ' ' A' ' 10' ' ' ASP . . . 127.17 -0.07 7.0 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.907 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.549 ' CB ' ' HB3' ' A' ' 142' ' ' ASP . . . -150.75 134.98 16.93 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.15 -1.206 . . . . 0.0 110.535 -179.907 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.74 HD12 ' HB3' ' A' ' 13' ' ' PRO . 3.2 tt -76.27 138.6 40.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.181 -0.949 . . . . 0.0 109.293 179.205 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 66.6 m -141.82 118.43 10.99 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.069 -1.02 . . . . 0.0 110.838 -179.552 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.544 HG12 ' CD2' ' A' ' 25' ' ' LEU . 17.2 m -102.1 142.06 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.485 -0.759 . . . . 0.0 109.274 179.306 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.579 ' HB3' ' HA ' ' A' ' 22' ' ' ASP . . . -88.44 102.79 15.24 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.129 -0.982 . . . . 0.0 110.781 -179.211 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.025 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 49.1 t -83.91 125.23 73.48 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.417 -0.802 . . . . 0.0 109.596 179.471 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.663 ' HD2' HG21 ' A' ' 45' ' ' VAL . 40.4 Cg_endo -66.42 -178.57 1.21 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.878 1.462 . . . . 0.0 111.741 -178.965 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.528 ' HA ' ' N ' ' A' ' 136' ' ' ALA . . . -60.5 120.92 10.87 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.452 -0.78 . . . . 0.0 111.296 -178.983 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.519 ' O ' ' C ' ' A' ' 40' ' ' SER . . . 39.22 26.73 0.06 OUTLIER Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 179.588 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.751 ' HB3' HG23 ' A' ' 45' ' ' VAL . 45.6 m 28.43 44.68 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 CA-C-N 117.863 0.831 . . . . 0.0 110.65 -179.998 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.631 ' O ' ' CG ' ' A' ' 42' ' ' GLN . . . -89.07 126.58 35.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.474 -0.766 . . . . 0.0 110.158 -179.278 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.631 ' CG ' ' O ' ' A' ' 41' ' ' ALA . 0.4 OUTLIER 83.17 28.54 0.1 Allowed 'General case' 0 N--CA 1.508 2.443 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -179.365 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.617 ' CE2' HG22 ' A' ' 21' ' ' THR . 0.1 OUTLIER -156.31 -31.05 0.09 Allowed 'General case' 0 C--N 1.293 -1.865 0 C-N-CA 118.648 -1.221 . . . . 0.0 112.314 -177.767 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.54 ' HA2' ' CA ' ' A' ' 130' ' ' GLY . . . 53.2 80.01 0.08 OUTLIER Glycine 0 N--CA 1.479 1.556 0 N-CA-C 105.922 -2.871 . . . . 0.0 105.922 -177.015 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.751 HG23 ' HB3' ' A' ' 40' ' ' SER . 4.2 t -86.95 133.9 28.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.358 -1.084 . . . . 0.0 108.893 -177.955 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.511 ' C ' ' CZ ' ' A' ' 19' ' ' TYR . . . -157.13 163.74 32.5 Favored Glycine 0 N--CA 1.487 2.089 0 C-N-CA 118.755 -1.688 . . . . 0.0 110.65 -178.973 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.652 HG13 ' O ' ' A' ' 17' ' ' VAL . 15.3 t -123.87 123.31 66.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.648 -0.913 . . . . 0.0 109.536 179.639 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.642 ' O ' HG22 ' A' ' 17' ' ' VAL . 32.7 m -119.79 140.48 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.916 -1.115 . . . . 0.0 111.018 -179.002 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.874 HD22 ' NE1' ' A' ' 16' ' ' TRP . 15.0 tp -118.98 97.7 5.82 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.46 -0.775 . . . . 0.0 109.743 179.449 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.526 ' HA ' ' HB3' ' A' ' 124' ' ' GLN . 38.9 t30 -78.16 113.73 16.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.28 -0.887 . . . . 0.0 110.405 -179.782 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.488 ' O ' ' HG2' ' A' ' 3' ' ' PRO . . . 146.22 73.98 0.02 OUTLIER Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 179.748 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.563 ' HA ' ' CG ' ' A' ' 3' ' ' PRO . 96.5 t -133.81 154.45 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.216 -1.167 . . . . 0.0 110.067 179.653 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.52 ' O ' HD13 ' A' ' 54' ' ' ILE . . . -128.73 105.19 8.09 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.218 -0.926 . . . . 0.0 110.501 -179.744 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.721 HD11 HD21 ' A' ' 146' ' ' LEU . 50.7 mm -131.78 166.45 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.318 -0.864 . . . . 0.0 109.74 179.58 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.526 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 0.2 OUTLIER -154.22 130.01 10.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.054 -1.029 . . . . 0.0 110.795 -179.726 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.526 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 11.0 pt-20 37.55 -156.5 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.773 -0.579 . . . . 0.0 110.915 179.525 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' A' ' 109' ' ' SER . . . -86.63 73.59 2.47 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.915 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.569 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.2 m -95.65 173.62 7.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.312 -1.11 . . . . 0.0 109.854 179.875 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.573 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 0.8 OUTLIER -89.63 155.9 18.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.205 -0.935 . . . . 0.0 110.391 -179.74 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.621 ' CE2' ' HB3' ' A' ' 108' ' ' ALA . 56.9 m-85 -160.41 -175.21 4.89 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.333 -0.854 . . . . 0.0 110.194 179.902 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 26.9 m -150.16 114.43 5.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.341 -0.85 . . . . 0.0 109.945 179.737 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.548 HD22 ' CD2' ' A' ' 89' ' ' LEU . 14.0 tp -89.53 119.69 30.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.208 -0.932 . . . . 0.0 110.065 -179.937 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.889 ' HD2' HG23 ' A' ' 103' ' ' THR . 0.0 OUTLIER -128.23 128.92 45.59 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.352 -0.842 . . . . 0.0 110.206 -179.8 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 1.073 ' CZ ' HG21 ' A' ' 102' ' ' VAL . 0.8 OUTLIER -172.61 144.38 1.43 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.22 -0.925 . . . . 0.0 109.849 179.731 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.542 HG23 ' CA ' ' A' ' 101' ' ' GLN . 4.6 m -119.22 92.93 3.92 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.225 -0.922 . . . . 0.0 109.957 -179.815 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.908 ' HB1' HD21 ' A' ' 95' ' ' LEU . . . -90.8 149.29 22.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.38 -0.825 . . . . 0.0 110.373 -179.747 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.644 HG23 ' O ' ' A' ' 98' ' ' GLU . 99.7 m -150.25 107.15 3.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.34 -0.85 . . . . 0.0 110.265 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -97.11 133.36 41.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.246 -0.909 . . . . 0.0 110.032 179.738 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.407 ' C ' ' O ' ' A' ' 68' ' ' ALA . 19.2 t -45.35 -26.18 0.5 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.131 -0.981 . . . . 0.0 109.234 179.557 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.561 HG22 ' HB2' ' A' ' 137' ' ' TRP . 2.1 t -112.43 171.15 7.69 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.592 -0.693 . . . . 0.0 109.858 179.723 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.507 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 49.0 t0 -86.58 61.13 6.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.106 -0.996 . . . . 0.0 109.115 178.937 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 1.047 HG23 ' HB2' ' A' ' 133' ' ' SER . 2.7 p -84.78 136.76 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.381 -0.824 . . . . 0.0 111.357 -178.912 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 19.9 m -125.78 86.91 2.6 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.711 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 1.115 HG21 ' CD2' ' A' ' 129' ' ' LEU . 3.0 m -90.5 -140.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.134 -0.979 . . . . 0.0 110.663 -178.73 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.793 ' N ' HG23 ' A' ' 74' ' ' VAL . 9.4 mtm180 -123.44 144.96 49.17 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.194 -0.941 . . . . 0.0 110.81 -179.633 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.541 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -150.34 148.49 28.88 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.388 -0.82 . . . . 0.0 109.365 179.421 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.862 HD11 ' HB3' ' A' ' 126' ' ' ALA . 1.3 pp 175.37 -159.39 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.123 -0.986 . . . . 0.0 110.674 -179.551 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.526 ' HB ' ' CG2' ' A' ' 88' ' ' VAL . 6.3 t -143.7 170.44 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.375 -0.828 . . . . 0.0 109.39 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.529 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . 176.02 -173.45 46.27 Favored Glycine 0 N--CA 1.491 2.325 0 C-N-CA 119.18 -1.486 . . . . 0.0 110.534 -179.92 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.537 ' HB3' ' HA ' ' A' ' 85' ' ' TYR . 31.5 tt0 -105.39 159.39 15.95 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.58 -0.953 . . . . 0.0 110.129 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.482 ' OD1' ' HG2' ' A' ' 124' ' ' GLN . 4.2 m120 -112.18 94.13 4.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.26 -0.9 . . . . 0.0 109.984 179.761 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.542 ' C ' ' CE1' ' A' ' 85' ' ' TYR . . . 120.3 131.83 4.19 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.815 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.596 ' N ' ' CE1' ' A' ' 85' ' ' TYR . . . -42.08 152.71 0.31 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.327 -1.102 . . . . 0.0 110.232 -179.903 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.455 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.6 Cg_endo -79.1 12.43 18.8 Favored 'Cis proline' 0 C--N 1.313 -1.332 0 C-N-CA 121.657 -2.226 . . . . 0.0 111.017 -0.021 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.596 ' CE1' ' N ' ' A' ' 83' ' ' ALA . 37.9 m-85 60.85 170.54 0.1 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.099 -1.0 . . . . 0.0 110.273 -179.81 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.421 ' O ' ' HA2' ' A' ' 79' ' ' GLY . . . 176.63 108.28 0.22 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.491 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 2.5 p -98.17 147.83 24.2 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.214 -1.168 . . . . 0.0 110.346 -179.934 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.794 HG12 ' N ' ' A' ' 109' ' ' SER . 7.8 m -122.64 -22.82 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.329 -0.857 . . . . 0.0 110.168 179.874 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.573 HD11 ' CZ ' ' A' ' 106' ' ' PHE . 4.5 mp -115.51 143.74 44.87 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.288 -0.882 . . . . 0.0 110.74 179.94 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.452 ' O ' HG23 ' A' ' 91' ' ' THR . 30.9 m-20 -151.08 79.24 1.31 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.329 -0.857 . . . . 0.0 110.187 179.56 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 90' ' ' ASP . 1.9 p -151.59 -173.56 4.55 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.007 -1.058 . . . . 0.0 110.544 -179.865 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.98 134.18 23.97 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.361 -0.837 . . . . 0.0 110.037 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.695 ' HG2' HG22 ' A' ' 74' ' ' VAL . 50.0 Cg_endo -75.14 75.83 3.64 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.962 1.506 . . . . 0.0 110.808 -179.697 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.531 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -49.55 134.66 19.34 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.971 -1.081 . . . . 0.0 109.265 179.416 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.908 HD21 ' HB1' ' A' ' 66' ' ' ALA . 34.6 mt -131.91 164.65 25.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.032 -1.042 . . . . 0.0 110.819 -179.396 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -165.35 -178.71 5.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.488 -0.758 . . . . 0.0 109.933 179.864 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.8 p -67.58 -22.21 65.39 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.224 -0.923 . . . . 0.0 110.257 -179.981 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.644 ' O ' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -93.28 170.56 8.5 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.216 -0.927 . . . . 0.0 110.116 179.906 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.497 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 45.8 Cg_endo -72.34 132.38 19.18 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.993 1.523 . . . . 0.0 110.39 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.531 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -119.83 92.61 3.82 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.206 -0.934 . . . . 0.0 110.36 -179.967 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.542 ' CA ' HG23 ' A' ' 65' ' ' THR . 0.1 OUTLIER -75.75 152.37 37.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.392 -0.817 . . . . 0.0 110.083 179.962 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 1.073 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 91.6 t -132.04 133.19 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.22 -0.925 . . . . 0.0 110.246 179.942 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.889 HG23 ' HD2' ' A' ' 63' ' ' ARG . 0.2 OUTLIER -150.38 116.77 5.73 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.317 -0.864 . . . . 0.0 110.158 -179.962 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.523 ' CG ' ' O ' ' A' ' 103' ' ' THR . 23.7 mt-10 -160.33 129.97 5.15 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.16 -0.963 . . . . 0.0 110.348 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.511 HG23 ' O ' ' A' ' 60' ' ' TYR . 47.5 m -89.91 107.47 19.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.21 -0.931 . . . . 0.0 110.108 179.766 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.573 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 36.7 p90 -110.2 155.9 21.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.242 -0.911 . . . . 0.0 110.4 -179.78 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.551 HG22 ' O ' ' A' ' 107' ' ' THR . 5.2 m -90.01 89.07 7.54 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.287 -0.883 . . . . 0.0 109.953 179.735 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.621 ' HB3' ' CE2' ' A' ' 60' ' ' TYR . . . -42.71 98.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.28 -0.888 . . . . 0.0 110.278 -179.747 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.794 ' N ' HG12 ' A' ' 88' ' ' VAL . 14.2 p -87.22 53.99 3.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.239 -0.913 . . . . 0.0 110.088 179.883 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.447 ' CB ' HG13 ' A' ' 88' ' ' VAL . . . -154.19 -155.33 0.58 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.261 -0.899 . . . . 0.0 110.333 -179.943 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.52 HG23 ' HA ' ' A' ' 55' ' ' GLU . 27.5 m -159.52 110.58 2.0 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.895 . . . . 0.0 110.531 -179.9 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.633 ' CD2' ' CG1' ' A' ' 54' ' ' ILE . 5.8 m-30 -113.71 94.73 34.16 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.298 -0.877 . . . . 0.0 109.66 179.401 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.765 ' O ' HG23 ' A' ' 115' ' ' THR . 51.3 Cg_endo -80.66 33.04 0.51 Allowed 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.825 1.434 . . . . 0.0 111.717 -179.697 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 113' ' ' PRO . . . 33.55 48.86 0.21 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.606 -0.684 . . . . 0.0 111.156 179.432 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.765 HG23 ' O ' ' A' ' 113' ' ' PRO . 3.0 p -119.02 98.33 50.94 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.171 -0.956 . . . . 0.0 110.38 -179.859 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -75.58 76.15 3.72 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.06 1.558 . . . . 0.0 110.39 179.911 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.744 ' HB3' ' HB2' ' A' ' 120' ' ' ASP . . . -150.12 169.64 20.8 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.216 -0.928 . . . . 0.0 110.334 -179.995 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.67 -62.35 1.45 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.253 -0.904 . . . . 0.0 110.095 179.955 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.486 ' O ' ' HD3' ' A' ' 121' ' ' PRO . 14.4 p-10 -67.78 -29.13 68.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.301 -0.874 . . . . 0.0 110.09 179.922 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.744 ' HB2' ' HB3' ' A' ' 117' ' ' ALA . 77.5 m-20 -105.17 95.72 9.98 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.285 -0.884 . . . . 0.0 110.11 179.824 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.529 ' HG2' ' NE2' ' A' ' 80' ' ' GLN . 48.5 Cg_endo -74.26 152.94 45.36 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.957 1.504 . . . . 0.0 110.684 -179.837 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.535 ' HG2' ' N ' ' A' ' 123' ' ' GLY . 23.9 pm0 -121.26 -135.52 0.31 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.26 -0.9 . . . . 0.0 109.923 179.645 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.584 ' HA3' ' CG ' ' A' ' 112' ' ' TYR . . . -168.57 143.29 7.99 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.758 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.542 ' HA ' ' CG2' ' A' ' 52' ' ' VAL . 1.7 pt20 -150.56 -159.5 1.04 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.336 -1.096 . . . . 0.0 110.248 -179.808 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.944 HG21 ' CH2' ' A' ' 16' ' ' TRP . 10.4 mt -118.32 146.35 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.45 -0.781 . . . . 0.0 109.114 179.246 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.862 ' HB3' HD11 ' A' ' 77' ' ' LEU . . . -121.98 120.5 34.58 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.281 -0.887 . . . . 0.0 111.144 -179.302 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.51 ' CE1' ' HB1' ' A' ' 76' ' ' ALA . 3.4 m-30 -116.79 97.98 6.27 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 178.266 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.574 ' O ' ' CE2' ' A' ' 132' ' ' PHE . 2.3 mm-40 -88.37 92.56 9.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.332 -0.855 . . . . 0.0 112.702 -176.783 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 1.115 ' CD2' HG21 ' A' ' 74' ' ' VAL . 5.2 mt -99.61 42.65 1.09 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.447 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.54 ' CA ' ' HA2' ' A' ' 44' ' ' GLY . . . -97.56 125.7 8.6 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 110.509 -1.037 . . . . 0.0 110.509 -178.775 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 39' ' ' GLY . . . 39.79 64.03 1.13 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 179.304 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.597 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 9.2 m-85 -117.98 -61.65 1.65 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.048 -1.266 . . . . 0.0 110.75 179.813 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 133' ' ' SER . . . . . 1.047 ' HB2' HG23 ' A' ' 72' ' ' VAL . 1.3 t -88.4 178.78 6.47 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.043 -1.036 . . . . 0.0 110.376 -179.661 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -86.71 -89.05 0.12 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.338 -0.851 . . . . 0.0 110.278 -179.763 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -63.61 179.99 0.42 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.246 -0.909 . . . . 0.0 110.078 179.903 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.528 ' N ' ' HA ' ' A' ' 38' ' ' ALA . . . -77.16 136.18 38.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.282 -0.886 . . . . 0.0 110.47 -179.656 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 1.025 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 8.4 p90 -135.56 -156.09 0.69 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.372 -0.83 . . . . 0.0 109.756 179.38 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.529 ' O ' ' CB ' ' A' ' 68' ' ' ALA . 0.6 OUTLIER -160.34 172.2 17.75 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.875 -1.13 . . . . 0.0 111.039 -178.548 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.901 HD13 HD13 ' A' ' 129' ' ' LEU . 2.3 mp -132.23 127.99 36.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.498 -0.751 . . . . 0.0 109.253 179.272 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 140' ' ' CYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 4.9 m -123.96 96.51 4.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.067 -1.021 . . . . 0.0 111.134 -179.35 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.5 ' HA ' ' O ' ' A' ' 65' ' ' THR . 0.9 OUTLIER -89.74 -176.14 4.87 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.267 -0.895 . . . . 0.0 108.88 178.774 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.549 ' HB3' ' CB ' ' A' ' 31' ' ' ALA . 0.5 OUTLIER 170.6 43.96 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.929 -1.107 . . . . 0.0 111.003 179.98 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.504 ' HB2' ' O ' ' A' ' 142' ' ' ASP . 11.3 t70 174.01 61.47 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.36 -0.838 . . . . 0.0 109.505 179.63 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.807 HG11 ' CZ2' ' A' ' 16' ' ' TRP . 1.1 t -95.17 114.68 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.096 -1.003 . . . . 0.0 110.308 -179.399 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.68 ' HB2' ' CG ' ' A' ' 6' ' ' GLU . . . -138.27 145.29 41.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.339 -0.851 . . . . 0.0 110.229 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.721 HD21 HD11 ' A' ' 54' ' ' ILE . 6.7 tp -153.47 129.57 10.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.238 -0.914 . . . . 0.0 110.219 179.969 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.496 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 1.5 t0 -160.04 155.06 24.68 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.24 -0.912 . . . . 0.0 110.267 179.963 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.778 ' OG ' HG12 ' A' ' 150' ' ' VAL . 1.7 t -91.28 151.4 20.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.258 -0.901 . . . . 0.0 110.248 179.966 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.23 46.42 0.99 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.278 -0.889 . . . . 0.0 110.202 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.778 HG12 ' OG ' ' A' ' 148' ' ' SER . 11.8 p -142.03 21.72 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.285 -0.884 . . . . 0.0 110.194 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -169.46 -170.72 1.12 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.258 -0.901 . . . . 0.0 110.173 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.1 mp . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.187 -179.955 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo . . . . . 0 N--CA 1.48 0.706 0 N-CA-C 110.068 -0.782 . . . . 0.0 110.068 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 1.006 HD11 ' O ' ' A' ' 144' ' ' VAL . 9.4 pt -93.64 -22.93 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.241 -0.912 . . . . 0.0 110.165 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 123.11 119.3 2.5 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -57.46 94.58 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.246 -1.149 . . . . 0.0 110.03 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.481 ' HA2' ' HA ' ' A' ' 143' ' ' ASP . . . 100.03 78.74 1.39 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.426 ' O ' ' HB2' ' A' ' 9' ' ' PHE . 7.2 p -95.12 -170.53 2.21 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.286 -1.126 . . . . 0.0 110.336 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.592 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 5.5 m-30 58.62 14.52 3.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.396 -0.815 . . . . 0.0 110.322 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.562 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 26.8 p-10 -88.86 23.88 2.21 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.178 -0.951 . . . . 0.0 109.967 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.562 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.6 OUTLIER 161.36 -24.24 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.422 0.629 . . . . 0.0 109.444 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -158.51 153.56 24.7 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.703 ' HB3' HD12 ' A' ' 32' ' ' LEU . 45.6 Cg_endo -72.37 -3.13 12.81 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.96 1.505 . . . . 0.0 110.458 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 0.3 OUTLIER 60.13 -88.62 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.28 -0.887 . . . . 0.0 110.353 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.436 ' O ' ' C ' ' A' ' 16' ' ' TRP . . . -132.14 -21.33 0.97 Allowed Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.886 -1.15 . . . . 0.0 110.381 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.969 ' CE2' HD22 ' A' ' 49' ' ' LEU . 56.1 m95 -41.51 121.87 1.79 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.09 -1.241 . . . . 0.0 110.565 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.73 ' O ' HG13 ' A' ' 47' ' ' VAL . 1.2 m -115.5 150.82 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.276 -0.89 . . . . 0.0 109.611 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.893 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . . . -130.21 123.0 29.18 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.061 -1.025 . . . . 0.0 109.818 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.777 ' HE2' HG13 ' A' ' 48' ' ' VAL . 23.4 p90 -108.68 157.26 18.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.51 -0.744 . . . . 0.0 110.486 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.648 ' O ' HG13 ' A' ' 45' ' ' VAL . . . 78.81 29.37 52.09 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.716 HG22 HG11 ' A' ' 45' ' ' VAL . 24.0 p -136.29 -160.96 1.11 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.219 -1.165 . . . . 0.0 110.466 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.455 ' O ' ' O ' ' A' ' 23' ' ' GLY . 15.0 t0 -99.46 131.96 45.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.368 -0.832 . . . . 0.0 110.318 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 22' ' ' ASP . . . 43.46 -166.18 0.02 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.3 -159.58 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.039 1.547 . . . . 0.0 110.46 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.893 ' CD2' ' HB3' ' A' ' 18' ' ' ALA . 7.9 mt -87.41 160.36 18.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.221 -0.925 . . . . 0.0 110.184 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -126.66 122.88 36.22 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.26 -0.9 . . . . 0.0 110.174 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.629 HG22 ' HA ' ' A' ' 32' ' ' LEU . 2.2 p -119.51 -84.39 0.66 Allowed 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.373 -0.829 . . . . 0.0 109.801 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.461 ' O ' ' HB ' ' A' ' 29' ' ' THR . 36.5 m 37.09 55.84 1.27 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.644 -0.66 . . . . 0.0 110.972 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.461 ' HB ' ' O ' ' A' ' 28' ' ' SER . 13.0 t -177.56 -32.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.115 -0.99 . . . . 0.0 110.411 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 9' ' ' PHE . . . 121.46 13.64 5.16 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -150.15 123.05 8.73 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -1.159 . . . . 0.0 110.14 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.703 HD12 ' HB3' ' A' ' 13' ' ' PRO . 0.9 OUTLIER -62.25 103.85 0.43 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -0.922 . . . . 0.0 109.841 179.788 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.51 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 36.6 m -107.99 103.5 12.74 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.14 -0.975 . . . . 0.0 110.864 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.77 HG12 HD22 ' A' ' 25' ' ' LEU . 17.5 m -89.87 141.74 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.234 -0.916 . . . . 0.0 109.218 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.487 ' HA ' ' OG1' ' A' ' 138' ' ' THR . . . -89.63 106.05 18.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.158 -0.964 . . . . 0.0 111.137 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.045 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 94.2 t -84.48 121.22 74.98 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.235 -0.916 . . . . 0.0 109.191 178.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 21' ' ' THR . 46.9 Cg_endo -74.71 137.27 22.2 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.937 1.493 . . . . 0.0 111.043 -178.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.932 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -45.52 170.59 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.337 -0.852 . . . . 0.0 109.766 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 45.86 48.33 13.66 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.825 ' OG ' HG21 ' A' ' 45' ' ' VAL . 0.6 OUTLIER -86.97 36.12 0.71 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.27 -1.136 . . . . 0.0 109.886 179.675 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.531 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . -89.08 -141.16 0.14 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.643 -0.661 . . . . 0.0 109.859 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.55 ' HG2' ' N ' ' A' ' 43' ' ' TYR . 14.7 pm0 39.88 -140.16 0.07 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.692 -0.63 . . . . 0.0 110.247 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.659 ' OH ' HG22 ' A' ' 45' ' ' VAL . 5.3 p90 -27.59 -42.55 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.236 0 CA-C-O 121.278 0.561 . . . . 0.0 110.612 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.601 ' O ' ' CD1' ' A' ' 43' ' ' TYR . . . 88.48 136.42 5.5 Favored Glycine 0 N--CA 1.492 2.39 0 C-N-CA 120.257 -0.973 . . . . 0.0 110.998 177.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.825 HG21 ' OG ' ' A' ' 40' ' ' SER . 2.3 t -88.95 -177.2 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.426 -1.043 . . . . 0.0 108.489 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.52 ' H ' HG12 ' A' ' 45' ' ' VAL . . . 167.67 175.88 37.88 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 118.819 -1.658 . . . . 0.0 110.838 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.73 HG13 ' O ' ' A' ' 17' ' ' VAL . 23.9 t -139.45 132.1 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.717 -0.872 . . . . 0.0 109.552 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.777 HG13 ' HE2' ' A' ' 19' ' ' TYR . 17.3 m -124.63 141.28 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.967 -1.083 . . . . 0.0 110.856 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.969 HD22 ' CE2' ' A' ' 16' ' ' TRP . 10.3 tp -128.23 100.6 5.9 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.374 -0.829 . . . . 0.0 110.131 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.516 ' ND2' ' HB3' ' A' ' 124' ' ' GLN . 0.1 OUTLIER -78.22 136.02 37.71 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.261 -0.9 . . . . 0.0 110.259 179.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 126.02 72.19 0.2 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.524 HG12 HG12 ' A' ' 54' ' ' ILE . 3.5 t -126.28 161.7 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.221 -1.164 . . . . 0.0 109.97 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -122.53 77.42 1.42 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.2 -0.938 . . . . 0.0 110.373 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.605 HG13 ' CD2' ' A' ' 112' ' ' TYR . 41.2 mm -119.13 151.08 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.248 -0.908 . . . . 0.0 110.07 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.664 ' HA ' HG23 ' A' ' 111' ' ' THR . 1.6 pt-20 -150.22 133.19 16.1 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.182 -0.949 . . . . 0.0 110.461 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.524 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 11.7 pt-20 38.28 -153.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.69 -0.631 . . . . 0.0 110.842 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' A' ' 109' ' ' SER . . . -86.56 86.12 1.55 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.556 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.3 m -110.65 171.04 7.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.177 -1.19 . . . . 0.0 109.864 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.583 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 1.6 m -89.88 155.59 19.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 0.0 110.154 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.605 ' HB3' HD11 ' A' ' 146' ' ' LEU . 56.3 m-85 -159.91 177.04 11.19 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.355 -0.84 . . . . 0.0 110.132 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 62.8 m -149.91 112.22 4.68 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.312 -0.867 . . . . 0.0 110.126 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.6 tp -89.84 124.49 34.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.243 -0.911 . . . . 0.0 110.095 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.495 ' HA ' ' O ' ' A' ' 102' ' ' VAL . 10.3 mtt180 -131.47 107.45 8.9 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.194 -0.941 . . . . 0.0 110.427 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.997 ' CZ ' HG21 ' A' ' 102' ' ' VAL . 4.6 p90 -147.07 151.61 37.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.288 -0.882 . . . . 0.0 110.125 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.879 HG23 ' CA ' ' A' ' 101' ' ' GLN . 0.2 OUTLIER -119.78 92.45 3.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.184 -0.948 . . . . 0.0 109.936 179.86 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.793 ' HB1' HD21 ' A' ' 95' ' ' LEU . . . -89.59 144.85 25.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 110.507 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.601 HG23 ' O ' ' A' ' 98' ' ' GLU . 99.9 m -150.33 116.74 5.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.403 -0.811 . . . . 0.0 110.215 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -103.24 138.73 39.64 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.23 -0.919 . . . . 0.0 110.028 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.1 p -47.65 -24.29 0.88 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.149 -0.969 . . . . 0.0 109.431 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.692 HG22 ' HB2' ' A' ' 137' ' ' TRP . 3.6 t -115.38 171.78 7.49 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.496 -0.752 . . . . 0.0 109.979 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.507 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 1.0 OUTLIER -86.16 69.69 10.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.158 -0.963 . . . . 0.0 109.445 179.192 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.605 HG23 ' CB ' ' A' ' 133' ' ' SER . 5.1 p -96.2 138.94 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.279 -0.888 . . . . 0.0 111.117 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 97.1 m -120.86 89.47 3.14 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.436 -0.79 . . . . 0.0 108.921 178.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.594 ' HA ' ' CD1' ' A' ' 132' ' ' PHE . 10.7 m -89.64 -147.88 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.22 -0.925 . . . . 0.0 110.587 -179.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.542 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 4.2 mtp180 -128.98 144.37 51.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 0.0 110.697 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.855 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -142.91 150.83 40.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.286 -0.884 . . . . 0.0 109.818 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.858 HD11 ' HB3' ' A' ' 126' ' ' ALA . 2.7 pp 177.58 -159.59 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.237 -0.914 . . . . 0.0 110.479 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.903 HG23 HD22 ' A' ' 89' ' ' LEU . 6.1 t -149.36 168.64 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.396 -0.815 . . . . 0.0 109.335 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.489 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . -177.6 -178.94 47.57 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.265 -1.445 . . . . 0.0 110.088 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.489 ' OE1' ' HD2' ' A' ' 113' ' ' PRO . 14.5 tp60 -107.93 138.12 44.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.415 -1.05 . . . . 0.0 110.302 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.541 ' ND2' ' NE2' ' A' ' 124' ' ' GLN . 1.2 m-80 -123.94 97.31 5.3 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.556 ' O ' ' HB3' ' A' ' 83' ' ' ALA . . . 132.23 33.71 0.4 Allowed Glycine 0 N--CA 1.484 1.866 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 82' ' ' GLY . . . 60.41 143.58 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.191 -1.182 . . . . 0.0 110.124 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.457 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.9 Cg_endo -82.67 18.96 17.96 Favored 'Cis proline' 0 C--N 1.314 -1.261 0 C-N-CA 121.872 -2.136 . . . . 0.0 110.807 -0.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.545 ' CD2' ' HA ' ' A' ' 83' ' ' ALA . 89.3 m-85 57.53 -179.95 0.06 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.136 -0.978 . . . . 0.0 110.203 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 127.96 113.57 1.76 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.514 HG22 ' O ' ' A' ' 78' ' ' VAL . 0.8 OUTLIER -97.51 145.89 25.78 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.283 -1.128 . . . . 0.0 110.034 179.779 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 1.028 HG23 HD12 ' A' ' 89' ' ' LEU . 35.9 m -123.73 -17.98 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.193 -0.942 . . . . 0.0 110.384 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 1.028 HD12 HG23 ' A' ' 88' ' ' VAL . 3.9 mp -103.38 135.27 45.31 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.205 -0.934 . . . . 0.0 111.046 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -150.97 83.55 1.33 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.451 -0.781 . . . . 0.0 109.951 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.5 p -137.9 -179.62 5.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.035 -1.041 . . . . 0.0 110.772 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.404 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 1.7 m -119.71 110.83 36.56 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.403 -0.811 . . . . 0.0 110.063 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.855 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 44.3 Cg_endo -71.58 94.0 0.68 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.04 1.548 . . . . 0.0 110.813 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.794 ' HB3' ' HD2' ' A' ' 100' ' ' ARG . . . -71.75 151.86 43.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.234 -0.916 . . . . 0.0 109.625 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.793 HD21 ' HB1' ' A' ' 66' ' ' ALA . 97.6 mt -143.77 162.82 35.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.05 -1.031 . . . . 0.0 110.493 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 70' ' ' THR . 0.3 OUTLIER 179.75 -179.08 0.43 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.39 -0.818 . . . . 0.0 110.018 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.95 -24.5 64.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.256 -0.902 . . . . 0.0 110.07 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.601 ' O ' HG23 ' A' ' 67' ' ' THR . 1.5 mt-10 -89.92 164.48 28.31 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.281 -0.887 . . . . 0.0 110.06 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.482 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 46.1 Cg_endo -73.0 136.77 25.43 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.008 1.53 . . . . 0.0 110.366 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.794 ' HD2' ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.6 80.42 1.57 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.17 -0.956 . . . . 0.0 110.188 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.879 ' CA ' HG23 ' A' ' 65' ' ' THR . 16.3 tt0 -68.73 154.73 41.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.299 -0.876 . . . . 0.0 110.195 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.997 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 95.6 t -135.5 135.52 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.284 -0.885 . . . . 0.0 110.135 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.06 111.0 4.33 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.26 -0.9 . . . . 0.0 110.19 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -158.25 134.74 9.52 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.164 -0.96 . . . . 0.0 110.361 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.667 HG23 ' O ' ' A' ' 105' ' ' THR . 10.1 t -95.77 113.73 25.39 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.245 -0.909 . . . . 0.0 110.091 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.967 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 30.6 p90 -111.72 154.79 24.48 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.909 . . . . 0.0 110.286 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.476 HG22 ' O ' ' A' ' 107' ' ' THR . 6.6 m -91.7 91.87 8.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.286 -0.884 . . . . 0.0 110.044 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.593 ' HB1' ' CG2' ' A' ' 54' ' ' ILE . . . -48.54 96.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.235 -0.915 . . . . 0.0 110.303 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.521 ' N ' ' CG1' ' A' ' 88' ' ' VAL . 16.1 p -85.99 49.96 1.88 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.256 -0.902 . . . . 0.0 110.124 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -156.23 -154.43 0.48 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.297 -0.877 . . . . 0.0 110.136 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.664 HG23 ' HA ' ' A' ' 55' ' ' GLU . 14.2 m -152.4 112.5 4.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.209 -0.932 . . . . 0.0 110.304 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.605 ' CD2' HG13 ' A' ' 54' ' ' ILE . 13.5 m-30 -107.03 93.16 8.65 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.277 -0.889 . . . . 0.0 109.9 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.489 ' HD2' ' OE1' ' A' ' 80' ' ' GLN . 45.3 Cg_endo -72.26 179.61 4.85 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.942 1.496 . . . . 0.0 110.41 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.245 -0.909 . . . . 0.0 110.206 -179.937 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.507 ' O ' ' HB2' ' A' ' 81' ' ' ASN . 2.2 pm0 . . . . . 0 N--CA 1.5 2.06 0 CA-C-O 121.515 0.674 . . . . 0.0 111.794 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -100.99 155.56 19.22 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.976 -1.249 . . . . 0.0 109.976 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.541 ' NE2' ' ND2' ' A' ' 81' ' ' ASN . 1.4 pt20 -150.55 -149.9 0.32 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.398 -1.06 . . . . 0.0 110.395 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.739 HG21 ' CH2' ' A' ' 16' ' ' TRP . 9.6 mt -118.37 138.62 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.588 -0.695 . . . . 0.0 109.136 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.858 ' HB3' HD11 ' A' ' 77' ' ' LEU . . . -115.42 122.24 45.21 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.205 -0.934 . . . . 0.0 111.169 -179.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.477 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 4.6 m-85 -119.15 109.05 15.42 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 178.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.485 ' O ' ' HB ' ' A' ' 74' ' ' VAL . 2.0 mt-30 -88.85 91.84 8.98 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.105 -0.997 . . . . 0.0 111.141 -178.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.958 HD13 HD13 ' A' ' 139' ' ' LEU . 15.5 mt -93.23 41.89 1.09 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.451 -0.78 . . . . 0.0 109.286 178.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.548 ' HA3' ' CA ' ' A' ' 44' ' ' GLY . . . -130.49 140.16 11.53 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.475 ' O ' ' CG ' ' A' ' 132' ' ' PHE . . . 71.4 61.7 3.79 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.594 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 38.4 m-85 -154.67 -78.32 0.1 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.243 -1.151 . . . . 0.0 110.182 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.605 ' CB ' HG23 ' A' ' 72' ' ' VAL . 1.3 t -89.67 119.57 30.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.123 -0.986 . . . . 0.0 110.116 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.401 ' O ' ' O ' ' A' ' 135' ' ' ASP . . . -62.44 -71.67 0.15 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.228 -0.92 . . . . 0.0 110.274 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.401 ' O ' ' O ' ' A' ' 134' ' ' ALA . 0.8 OUTLIER -53.82 -173.29 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.292 -0.88 . . . . 0.0 110.343 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.932 ' HB2' ' HB2' ' A' ' 38' ' ' ALA . . . -83.51 141.08 31.89 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.269 -0.894 . . . . 0.0 110.302 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 1.045 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 7.3 p90 -151.5 -164.19 1.93 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.323 -0.861 . . . . 0.0 109.964 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.527 ' O ' ' CB ' ' A' ' 68' ' ' ALA . 0.5 OUTLIER -160.4 173.47 15.57 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.0 -1.08 . . . . 0.0 111.106 -178.493 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.958 HD13 HD13 ' A' ' 129' ' ' LEU . 2.6 mp -129.64 129.37 44.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.447 -0.783 . . . . 0.0 109.576 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' CYS . . . . . . . . . . . . . 6.6 m -124.37 93.26 3.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.129 -0.982 . . . . 0.0 110.938 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.644 HD23 ' HB2' ' A' ' 66' ' ' ALA . 0.7 OUTLIER -89.86 -175.42 4.61 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.179 -0.951 . . . . 0.0 109.414 179.147 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.513 ' O ' ' CB ' ' A' ' 143' ' ' ASP . 1.1 p30 176.76 124.27 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.054 -1.029 . . . . 0.0 110.842 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.513 ' CB ' ' O ' ' A' ' 142' ' ' ASP . 0.3 OUTLIER 70.94 61.29 0.18 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.288 -0.882 . . . . 0.0 110.654 179.479 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 1.006 ' O ' HD11 ' A' ' 4' ' ' ILE . 42.0 t -94.46 111.4 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -0.914 . . . . 0.0 109.73 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -120.46 163.56 17.74 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.233 -0.917 . . . . 0.0 110.47 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.605 HD11 ' HB3' ' A' ' 60' ' ' TYR . 14.0 tp -167.3 88.18 0.29 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.409 -0.807 . . . . 0.0 110.085 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.495 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 7.6 t70 -123.37 165.17 17.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.269 -0.895 . . . . 0.0 110.289 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.513 ' HB3' ' CE1' ' A' ' 60' ' ' TYR . 12.7 p . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 0.0 110.317 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo . . . . . 0 N--CA 1.479 0.673 0 N-CA-C 110.123 -0.76 . . . . 0.0 110.123 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.627 HG22 ' O ' ' A' ' 51' ' ' GLY . 13.1 pt -95.98 31.16 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.234 -0.916 . . . . 0.0 110.251 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 91.58 -29.32 7.38 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.723 ' OE1' ' HB1' ' A' ' 145' ' ' ALA . 3.9 mt-10 51.67 66.98 1.04 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.252 -1.146 . . . . 0.0 110.24 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 143' ' ' ASP . . . -148.36 -179.99 24.75 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.862 HG22 ' HB2' ' A' ' 143' ' ' ASP . 0.8 OUTLIER -98.31 51.64 1.02 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.201 -1.176 . . . . 0.0 110.151 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.559 ' CE2' ' CG2' ' A' ' 144' ' ' VAL . 69.3 m-85 43.16 36.31 0.97 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.274 -0.891 . . . . 0.0 110.095 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.556 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 5.1 p30 -84.68 44.48 1.06 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.316 -0.865 . . . . 0.0 110.299 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.556 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 2.4 t70 161.58 78.42 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.336 0.589 . . . . 0.0 109.433 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.66 159.58 7.0 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.894 ' HB3' HD12 ' A' ' 32' ' ' LEU . 50.0 Cg_endo -75.75 4.71 4.89 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.016 1.535 . . . . 0.0 110.713 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 2.8 mm-40 65.12 -89.01 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.259 -0.901 . . . . 0.0 110.516 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.592 ' C ' HD12 ' A' ' 49' ' ' LEU . . . -139.63 6.99 3.01 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.95 ' CE2' HD22 ' A' ' 49' ' ' LEU . 46.0 m95 -69.52 126.0 28.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.108 -1.23 . . . . 0.0 110.179 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.719 ' HA ' HD11 ' A' ' 25' ' ' LEU . 0.9 OUTLIER -126.9 148.6 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.206 -0.934 . . . . 0.0 109.669 179.806 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.626 ' CB ' HD21 ' A' ' 25' ' ' LEU . . . -130.32 142.16 50.55 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.101 -0.999 . . . . 0.0 109.648 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.558 ' HE1' HG13 ' A' ' 48' ' ' VAL . 23.2 p90 -131.71 164.01 26.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.292 -0.88 . . . . 0.0 110.766 -178.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.483 ' HA2' ' OH ' ' A' ' 43' ' ' TYR . . . 77.19 40.21 24.96 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.553 HG22 ' CG1' ' A' ' 45' ' ' VAL . 7.9 p -149.88 -143.79 0.14 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.129 -1.218 . . . . 0.0 110.489 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.465 ' O ' ' O ' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -117.29 129.94 56.22 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.244 -0.91 . . . . 0.0 110.355 -179.792 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 22' ' ' ASP . . . 52.21 174.48 0.03 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.38 -159.54 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.064 1.56 . . . . 0.0 110.518 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.983 ' CD2' HG12 ' A' ' 34' ' ' VAL . 24.4 mt -78.27 178.52 7.58 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.272 -0.893 . . . . 0.0 110.331 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -145.46 115.0 7.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.318 -0.864 . . . . 0.0 110.102 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.479 ' O ' ' N ' ' A' ' 29' ' ' THR . 1.1 p -119.65 -83.59 0.65 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.308 -0.87 . . . . 0.0 109.921 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 27' ' ' THR . 5.4 p 39.2 28.36 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.498 -0.751 . . . . 0.0 110.637 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.479 ' N ' ' O ' ' A' ' 27' ' ' THR . 8.5 t -153.43 -37.0 0.1 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.149 -0.969 . . . . 0.0 110.385 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.493 ' O ' ' HB2' ' A' ' 9' ' ' PHE . . . 133.97 -2.29 4.36 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.598 ' HB1' ' O ' ' A' ' 141' ' ' LEU . . . -133.15 143.97 49.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.138 -1.213 . . . . 0.0 110.125 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.894 HD12 ' HB3' ' A' ' 13' ' ' PRO . 0.6 OUTLIER -83.96 112.31 20.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.24 -0.912 . . . . 0.0 110.055 179.87 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.51 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 34.1 m -114.86 116.55 28.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 110.554 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.983 HG12 ' CD2' ' A' ' 25' ' ' LEU . 33.2 m -101.1 144.63 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.324 -0.86 . . . . 0.0 109.812 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.532 ' HA ' ' OG1' ' A' ' 138' ' ' THR . . . -93.05 94.02 8.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.189 -0.944 . . . . 0.0 110.547 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.087 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 41.9 t -86.23 132.49 43.14 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.377 -0.827 . . . . 0.0 110.099 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.415 ' C ' ' HA ' ' A' ' 136' ' ' ALA . 40.0 Cg_endo -66.85 168.95 15.71 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.809 1.426 . . . . 0.0 110.586 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.499 ' O ' ' O ' ' A' ' 39' ' ' GLY . . . -62.01 121.04 12.02 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.305 -0.872 . . . . 0.0 110.912 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.553 ' O ' ' N ' ' A' ' 41' ' ' ALA . . . 41.6 96.03 0.01 OUTLIER Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.666 ' HB2' HG23 ' A' ' 45' ' ' VAL . 0.4 OUTLIER -42.12 93.75 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.428 -1.043 . . . . 0.0 109.786 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' A' ' 39' ' ' GLY . . . -89.38 28.91 1.17 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.695 0.759 . . . . 0.0 110.565 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -128.92 -166.95 1.71 Allowed 'General case' 0 C--N 1.292 -1.904 0 O-C-N 121.773 -0.579 . . . . 0.0 109.779 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.483 ' OH ' ' HA2' ' A' ' 20' ' ' GLY . 11.1 p90 -46.54 -24.13 0.48 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.16 -0.962 . . . . 0.0 109.797 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.473 ' O ' ' CD1' ' A' ' 43' ' ' TYR . . . 126.45 140.58 5.29 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.666 HG23 ' HB2' ' A' ' 40' ' ' SER . 19.9 t -89.39 173.65 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.124 -1.221 . . . . 0.0 109.205 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.562 ' HA2' ' HA ' ' A' ' 128' ' ' GLN . . . -178.22 -179.42 48.19 Favored Glycine 0 N--CA 1.487 2.098 0 C-N-CA 118.92 -1.61 . . . . 0.0 110.851 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.701 HG13 ' O ' ' A' ' 17' ' ' VAL . 21.4 t -150.39 128.48 2.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.594 ' CG2' HG22 ' A' ' 17' ' ' VAL . 30.5 m -119.38 132.68 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.018 -1.051 . . . . 0.0 111.106 -178.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 1.065 HD23 HD12 ' A' ' 125' ' ' ILE . 13.8 tp -124.22 91.27 3.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.559 -0.713 . . . . 0.0 110.01 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.44 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 0.1 OUTLIER -66.86 113.88 5.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 110.209 -179.908 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.627 ' O ' HG22 ' A' ' 4' ' ' ILE . . . 154.14 83.04 0.04 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.579 HG11 ' HD2' ' A' ' 112' ' ' TYR . 38.8 t -140.53 160.43 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.197 -1.178 . . . . 0.0 110.207 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.434 ' O ' HD13 ' A' ' 54' ' ' ILE . . . -129.85 90.78 3.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.203 -0.936 . . . . 0.0 110.396 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.743 HD11 HD21 ' A' ' 146' ' ' LEU . 33.5 mm -124.01 168.7 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.261 -0.899 . . . . 0.0 109.931 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.574 ' HA ' HG23 ' A' ' 111' ' ' THR . 1.7 tt0 -162.71 127.72 3.2 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.122 -0.986 . . . . 0.0 110.653 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.522 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 13.1 pt-20 37.74 -152.89 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.635 -0.666 . . . . 0.0 110.984 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 108' ' ' ALA . . . -86.76 79.57 1.81 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.625 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.2 m -108.85 173.71 6.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.253 -1.145 . . . . 0.0 109.804 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.574 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 0.4 OUTLIER -89.8 156.23 18.64 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.287 -0.883 . . . . 0.0 110.281 -179.82 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.829 ' HB3' HD11 ' A' ' 146' ' ' LEU . 67.9 m-85 -158.94 167.83 28.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 110.323 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 85.5 m -143.19 115.49 8.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -0.893 . . . . 0.0 110.072 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 28.4 tp -89.76 122.55 32.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.261 -0.899 . . . . 0.0 110.05 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.475 ' HA ' ' O ' ' A' ' 102' ' ' VAL . 6.1 mtm180 -126.38 125.8 42.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.253 -0.904 . . . . 0.0 110.356 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 1.184 ' CZ ' HG21 ' A' ' 102' ' ' VAL . 5.3 p90 -167.89 151.71 6.2 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.248 -0.908 . . . . 0.0 110.145 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.5 ' CG2' ' HG2' ' A' ' 101' ' ' GLN . 93.6 m -119.65 99.58 6.74 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.242 -0.911 . . . . 0.0 110.063 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.621 ' CB ' HD21 ' A' ' 95' ' ' LEU . . . -100.34 145.59 27.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.327 -0.858 . . . . 0.0 110.364 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.483 ' OG1' ' HA ' ' A' ' 99' ' ' PRO . 43.8 m -148.09 115.92 6.39 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.255 -0.903 . . . . 0.0 110.303 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.443 ' HB2' HD13 ' A' ' 95' ' ' LEU . . . -101.66 141.02 35.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 109.971 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.11 -23.05 1.09 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.129 -0.982 . . . . 0.0 109.41 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.684 HG22 ' HB2' ' A' ' 137' ' ' TRP . 2.9 t -116.96 169.69 9.21 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.51 -0.743 . . . . 0.0 110.034 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.509 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 77.0 m-20 -84.57 69.75 10.64 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.13 -0.981 . . . . 0.0 109.289 179.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.624 HG23 ' CB ' ' A' ' 133' ' ' SER . 4.8 p -94.47 140.05 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.874 . . . . 0.0 111.273 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 21.4 m -121.72 91.87 3.61 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.417 -0.802 . . . . 0.0 108.916 178.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.588 HG12 ' CD2' ' A' ' 132' ' ' PHE . 12.3 m -89.8 -147.56 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.21 -0.931 . . . . 0.0 110.774 -178.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.519 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 6.9 mtm180 -131.03 139.01 49.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.38 -0.825 . . . . 0.0 110.52 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.694 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -138.63 154.52 48.66 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.336 -0.853 . . . . 0.0 109.687 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.901 HD12 ' N ' ' A' ' 78' ' ' VAL . 3.9 pp -179.84 -148.36 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.207 -0.933 . . . . 0.0 110.326 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.901 ' N ' HD12 ' A' ' 77' ' ' LEU . 3.0 t -150.76 167.68 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.269 -0.894 . . . . 0.0 109.495 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.517 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . -170.69 -171.27 35.86 Favored Glycine 0 N--CA 1.491 2.33 0 C-N-CA 119.277 -1.44 . . . . 0.0 110.338 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.534 ' HA ' ' O ' ' A' ' 122' ' ' GLU . 3.7 tt0 -100.25 -160.96 0.83 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.473 -1.016 . . . . 0.0 110.262 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 80' ' ' GLN . 25.8 m120 -158.18 80.31 0.83 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.235 -0.915 . . . . 0.0 110.229 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.638 ' O ' ' HB2' ' A' ' 83' ' ' ALA . . . 167.52 -83.8 0.1 OUTLIER Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.638 ' HB2' ' O ' ' A' ' 82' ' ' GLY . . . 173.88 146.89 0.21 Allowed Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.176 -1.191 . . . . 0.0 110.205 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.456 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.4 Cg_endo -84.81 33.68 4.03 Favored 'Cis proline' 0 C--N 1.312 -1.355 0 C-N-CA 121.887 -2.131 . . . . 0.0 110.619 -0.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.571 ' CZ ' ' O ' ' A' ' 82' ' ' GLY . 21.2 m-85 64.14 137.17 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.187 -0.946 . . . . 0.0 110.2 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -153.02 121.4 1.16 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.462 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 2.0 p -96.83 147.78 23.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.203 -1.175 . . . . 0.0 110.261 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.986 HG23 HD12 ' A' ' 89' ' ' LEU . 33.5 m -119.79 -24.22 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.304 -0.873 . . . . 0.0 109.989 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.986 HD12 HG23 ' A' ' 88' ' ' VAL . 3.9 mp -105.76 146.39 29.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.313 -0.867 . . . . 0.0 110.729 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -151.17 81.74 1.31 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.23 -0.919 . . . . 0.0 110.13 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.2 p -145.4 173.55 11.89 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.071 -1.018 . . . . 0.0 110.578 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.463 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 43.3 m -121.78 118.77 29.32 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.348 -0.845 . . . . 0.0 110.093 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.694 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 46.1 Cg_endo -71.96 146.82 48.1 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.884 1.465 . . . . 0.0 110.966 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 1.032 ' HB3' ' NE ' ' A' ' 100' ' ' ARG . . . -109.62 148.99 30.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.396 -0.815 . . . . 0.0 109.543 179.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.622 ' C ' HG22 ' A' ' 96' ' ' THR . 70.9 mt -140.13 172.43 12.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.085 -1.009 . . . . 0.0 110.609 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.622 HG22 ' C ' ' A' ' 95' ' ' LEU . 0.1 OUTLIER 169.16 -179.15 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.467 -0.771 . . . . 0.0 109.888 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.4 ' N ' ' OG1' ' A' ' 96' ' ' THR . 0.1 OUTLIER -62.88 -12.7 26.74 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.223 -0.923 . . . . 0.0 109.734 179.765 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.526 ' CG ' ' HD2' ' A' ' 99' ' ' PRO . 33.9 tt0 -100.2 149.21 35.83 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.433 -0.792 . . . . 0.0 109.89 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.526 ' HD2' ' CG ' ' A' ' 98' ' ' GLU . 41.8 Cg_endo -68.71 131.25 22.32 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.877 1.462 . . . . 0.0 110.248 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 1.032 ' NE ' ' HB3' ' A' ' 94' ' ' ALA . 11.6 ttt-85 -119.66 92.22 3.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.243 -0.91 . . . . 0.0 110.5 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.5 ' HG2' ' CG2' ' A' ' 65' ' ' THR . 0.0 OUTLIER -71.49 160.84 32.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.329 -0.857 . . . . 0.0 109.771 179.629 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 1.184 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 38.9 t -131.05 133.91 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.135 -0.978 . . . . 0.0 110.444 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.39 88.34 1.5 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.341 -0.85 . . . . 0.0 110.105 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -139.72 151.77 46.12 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.162 -0.962 . . . . 0.0 110.387 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.816 HG23 ' O ' ' A' ' 60' ' ' TYR . 90.6 m -111.3 137.23 49.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.325 -0.859 . . . . 0.0 110.15 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.944 ' CE1' HD11 ' A' ' 89' ' ' LEU . 51.3 p90 -132.5 156.61 46.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.271 -0.893 . . . . 0.0 110.217 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.542 HG22 ' O ' ' A' ' 107' ' ' THR . 7.6 m -90.29 88.29 7.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.292 -0.88 . . . . 0.0 110.102 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.603 ' HB3' ' CE2' ' A' ' 60' ' ' TYR . . . -47.26 104.22 0.05 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.894 . . . . 0.0 110.347 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 84.9 p -91.54 53.63 2.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.247 -0.908 . . . . 0.0 110.162 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.726 ' HB3' ' CG1' ' A' ' 88' ' ' VAL . . . -166.13 -156.34 0.25 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.239 -0.913 . . . . 0.0 110.316 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.574 HG23 ' HA ' ' A' ' 55' ' ' GLU . 12.3 m -146.18 117.1 7.72 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.305 -0.872 . . . . 0.0 110.287 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.594 ' CG ' ' HA3' ' A' ' 123' ' ' GLY . 20.7 m-30 -113.31 75.48 2.31 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.887 . . . . 0.0 109.994 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.481 ' O ' ' CB ' ' A' ' 122' ' ' GLU . 45.8 Cg_endo -72.39 136.93 27.28 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.932 1.491 . . . . 0.0 110.422 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.667 0 O-C-N 121.315 -0.866 . . . . 0.0 110.293 -179.954 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.534 ' O ' ' HA ' ' A' ' 80' ' ' GLN . 15.2 pm0 . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.594 ' HA3' ' CG ' ' A' ' 112' ' ' TYR . . . -140.21 159.02 26.08 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.545 ' O ' HG13 ' A' ' 78' ' ' VAL . 2.1 pm0 -150.5 -160.01 1.11 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.342 -1.093 . . . . 0.0 110.213 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 1.065 HD12 HD23 ' A' ' 49' ' ' LEU . 33.2 mt -118.38 142.45 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.37 -0.831 . . . . 0.0 109.522 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.524 ' HB3' ' HG ' ' A' ' 77' ' ' LEU . . . -113.88 115.22 27.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.304 -0.872 . . . . 0.0 111.541 -178.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.572 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 4.5 m-85 -120.58 80.8 1.67 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.562 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 2.9 mt-30 -87.96 115.06 25.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.112 -0.993 . . . . 0.0 111.636 -178.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 1.063 ' CD1' HD13 ' A' ' 139' ' ' LEU . 9.0 mt -98.77 49.66 0.97 Allowed 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 121.835 0.826 . . . . 0.0 108.856 178.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 132' ' ' PHE . . . -53.11 -173.45 0.04 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.434 ' HA2' ' HB3' ' A' ' 40' ' ' SER . . . -52.95 90.24 0.01 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.588 ' CD2' HG12 ' A' ' 74' ' ' VAL . 20.1 m-85 -114.87 -56.93 2.33 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.235 -1.156 . . . . 0.0 110.647 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.624 ' CB ' HG23 ' A' ' 72' ' ' VAL . 1.4 t -89.42 -177.36 5.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.259 -0.9 . . . . 0.0 110.373 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.455 ' N ' ' OG ' ' A' ' 133' ' ' SER . . . -106.59 -73.74 0.68 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.294 -0.879 . . . . 0.0 110.073 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.425 ' O ' ' C ' ' A' ' 136' ' ' ALA . 17.3 m-20 -70.09 152.99 43.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.233 -0.917 . . . . 0.0 110.076 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.484 ' HA ' ' N ' ' A' ' 38' ' ' ALA . . . -43.29 120.79 1.99 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.281 -0.887 . . . . 0.0 110.134 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 1.087 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 5.0 p90 -125.27 -169.59 2.02 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.176 -0.952 . . . . 0.0 110.258 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.532 ' OG1' ' HA ' ' A' ' 35' ' ' ALA 0.255 0.9 OUTLIER -159.33 168.65 25.85 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.384 -0.927 . . . . 0.0 110.41 -177.528 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 1.063 HD13 ' CD1' ' A' ' 129' ' ' LEU . 2.2 mp -124.85 125.84 44.61 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.378 -0.826 . . . . 0.0 109.629 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' CYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 22.2 m -122.98 99.5 6.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.117 -0.989 . . . . 0.0 110.76 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.598 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 1.5 mt -92.09 -177.17 4.61 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.302 -0.874 . . . . 0.0 109.308 179.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.669 ' O ' HG22 ' A' ' 8' ' ' THR . 2.8 p-10 -169.77 26.09 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.107 -0.996 . . . . 0.0 110.438 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.862 ' HB2' HG22 ' A' ' 8' ' ' THR . 0.7 OUTLIER 172.54 130.75 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.317 -0.864 . . . . 0.0 109.87 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.82 HG11 ' HZ2' ' A' ' 16' ' ' TRP . 1.3 t -150.48 115.9 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.117 -0.989 . . . . 0.0 109.761 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.723 ' HB1' ' OE1' ' A' ' 6' ' ' GLU . . . -140.35 154.44 46.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.252 -0.905 . . . . 0.0 110.495 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.829 HD11 ' HB3' ' A' ' 60' ' ' TYR . 61.0 tp -148.07 99.6 3.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.39 -0.819 . . . . 0.0 110.113 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.481 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 1.3 m-20 -102.69 -166.58 1.29 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.238 -0.914 . . . . 0.0 110.243 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.493 1.69 0 O-C-N 121.278 -0.889 . . . . 0.0 110.154 -179.929 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo . . . . . 0 N--CA 1.484 0.926 0 N-CA-C 110.645 -0.559 . . . . 0.0 110.645 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.489 HD11 HG12 ' A' ' 144' ' ' VAL . 27.9 pt -97.11 42.78 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.16 -0.962 . . . . 0.0 109.928 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 6' ' ' GLU . . . 97.98 -16.84 59.64 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' A' ' 5' ' ' GLY . 3.3 tt0 42.5 30.73 0.23 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.316 -1.109 . . . . 0.0 110.193 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 143' ' ' ASP . . . -159.86 -130.73 1.16 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.953 HG22 ' CA ' ' A' ' 143' ' ' ASP . 40.1 p -126.83 -172.39 2.63 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.273 -1.133 . . . . 0.0 110.443 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.597 ' CD2' ' HB2' ' A' ' 32' ' ' LEU . 5.8 m-30 -94.4 47.68 1.2 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.326 -0.859 . . . . 0.0 110.097 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.555 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 32.6 p30 -87.78 36.89 0.77 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.247 -0.908 . . . . 0.0 110.2 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.555 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.7 OUTLIER 161.46 37.47 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.678 -0.639 . . . . 0.0 109.686 -179.891 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 124.87 133.18 3.95 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.773 ' HB3' HD12 ' A' ' 32' ' ' LEU . 50.4 Cg_endo -80.43 41.14 1.08 Allowed 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.909 1.479 . . . . 0.0 111.136 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.46 ' OE1' ' O ' ' A' ' 4' ' ' ILE . 0.9 OUTLIER 45.88 -91.99 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.996 -1.065 . . . . 0.0 110.431 179.867 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 13' ' ' PRO . . . -149.07 10.35 1.01 Allowed Glycine 0 N--CA 1.493 2.459 0 C-N-CA 119.779 -1.2 . . . . 0.0 110.331 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.591 ' CH2' HG21 ' A' ' 125' ' ' ILE . 53.5 m95 -53.25 120.35 5.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.006 -1.291 . . . . 0.0 110.154 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.671 ' O ' HG13 ' A' ' 47' ' ' VAL . 0.9 OUTLIER -116.36 154.48 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.106 -0.996 . . . . 0.0 109.763 179.77 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.423 ' HB3' ' OD1' ' A' ' 22' ' ' ASP . . . -137.53 139.77 40.69 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.433 -0.792 . . . . 0.0 109.008 179.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.601 ' HE2' HG13 ' A' ' 48' ' ' VAL . 6.1 p90 -123.24 151.4 42.33 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.022 -1.049 . . . . 0.0 111.729 -178.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.577 ' HA2' ' CE1' ' A' ' 43' ' ' TYR . . . 133.59 -77.05 0.39 Allowed Glycine 0 N--CA 1.495 2.629 0 N-CA-C 108.899 -1.681 . . . . 0.0 108.899 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.583 HG22 ' CE2' ' A' ' 43' ' ' TYR . 5.5 p -150.81 19.57 0.8 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.213 -1.169 . . . . 0.0 110.08 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.601 ' HA ' ' HB3' ' A' ' 35' ' ' ALA . 1.3 p30 -107.44 112.3 25.02 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.301 -0.874 . . . . 0.0 110.09 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 22' ' ' ASP . . . -61.88 -132.49 0.01 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.455 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 46.1 Cg_endo -72.94 122.17 7.91 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.874 1.46 . . . . 0.0 110.215 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 1.102 ' CD1' HD11 ' A' ' 32' ' ' LEU . 8.1 mt -42.23 126.4 3.35 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.254 -0.904 . . . . 0.0 109.911 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 24' ' ' PRO . 11.8 m-20 -88.45 121.97 31.42 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.226 -0.921 . . . . 0.0 110.603 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.966 HG22 ' O ' ' A' ' 31' ' ' ALA . 3.0 p -119.96 -82.74 0.65 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.339 -0.851 . . . . 0.0 109.964 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.692 ' C ' HG22 ' A' ' 29' ' ' THR . 0.2 OUTLIER 58.28 46.38 15.7 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.247 -0.908 . . . . 0.0 110.662 179.581 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.832 HG22 ' O ' ' A' ' 27' ' ' THR . 0.0 OUTLIER 169.78 -95.37 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.153 -0.967 . . . . 0.0 110.261 179.738 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.516 ' H ' HG23 ' A' ' 29' ' ' THR . . . -158.39 21.93 0.35 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.966 ' O ' HG22 ' A' ' 27' ' ' THR . . . -135.02 162.06 33.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.306 -1.114 . . . . 0.0 110.157 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.102 HD11 ' CD1' ' A' ' 25' ' ' LEU . 0.5 OUTLIER -119.17 98.3 6.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.262 -0.899 . . . . 0.0 110.146 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.556 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 0.8 OUTLIER -98.09 113.21 25.03 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.287 -0.883 . . . . 0.0 111.594 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.95 HG12 HD22 ' A' ' 25' ' ' LEU . 16.6 m -89.55 147.83 4.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 178.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.601 ' HB3' ' HA ' ' A' ' 22' ' ' ASP . . . -89.18 91.09 8.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.361 -0.837 . . . . 0.0 111.409 -178.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.079 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 66.6 t -79.67 133.67 58.73 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.376 -0.828 . . . . 0.0 108.888 178.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.819 ' HD2' HG21 ' A' ' 45' ' ' VAL . 38.4 Cg_endo -66.66 168.34 16.92 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.881 1.464 . . . . 0.0 111.573 -178.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.523 ' HA ' ' N ' ' A' ' 136' ' ' ALA . . . -55.34 124.39 16.94 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.526 -0.734 . . . . 0.0 111.367 -178.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.532 ' O ' ' C ' ' A' ' 40' ' ' SER . . . 39.73 26.08 0.08 OUTLIER Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.943 ' OG ' HG23 ' A' ' 45' ' ' VAL . 24.1 t 30.06 66.61 0.12 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.844 -0.797 . . . . 0.0 110.565 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.575 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . -89.06 145.05 25.72 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.659 -0.651 . . . . 0.0 109.661 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.575 ' HG2' ' O ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER 45.77 27.61 0.48 Allowed 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -178.893 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.583 ' CE2' HG22 ' A' ' 21' ' ' THR . 0.1 OUTLIER -151.83 124.65 8.52 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 119.034 -1.066 . . . . 0.0 111.881 -178.19 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.536 ' HA2' ' CA ' ' A' ' 130' ' ' GLY . . . -90.32 95.63 2.11 Favored Glycine 0 C--N 1.296 -1.681 0 N-CA-C 106.615 -2.594 . . . . 0.0 106.615 177.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.943 HG23 ' OG ' ' A' ' 40' ' ' SER . 3.2 t -86.55 111.95 22.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 O-C-N 120.968 -1.313 . . . . 0.0 108.127 -178.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.576 ' O ' ' CE2' ' A' ' 19' ' ' TYR . . . -141.88 147.71 19.28 Favored Glycine 0 N--CA 1.484 1.895 0 C-N-CA 118.886 -1.626 . . . . 0.0 109.876 -178.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.671 HG13 ' O ' ' A' ' 17' ' ' VAL . 9.3 t -109.92 126.65 67.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.315 -1.109 . . . . 0.0 109.887 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.601 HG13 ' HE2' ' A' ' 19' ' ' TYR . 27.6 m -119.73 142.36 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.962 -1.086 . . . . 0.0 110.567 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.555 HD13 ' CD1' ' A' ' 16' ' ' TRP . 6.7 tp -126.04 95.17 4.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.369 -0.832 . . . . 0.0 109.918 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.518 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 0.7 OUTLIER -76.47 144.36 39.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.295 -0.878 . . . . 0.0 110.469 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 123.23 54.9 0.2 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.615 HG11 ' HD2' ' A' ' 112' ' ' TYR . 75.2 t -119.8 164.54 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.148 -1.207 . . . . 0.0 110.218 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.491 ' HA ' ' O ' ' A' ' 112' ' ' TYR . . . -140.15 84.54 1.97 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.248 -0.908 . . . . 0.0 110.516 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.623 HG23 ' CE2' ' A' ' 60' ' ' TYR . 47.5 mm -111.75 155.21 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.243 -0.911 . . . . 0.0 109.702 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.541 ' HG3' HG23 ' A' ' 111' ' ' THR . 0.7 OUTLIER -145.24 132.07 20.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.097 -1.002 . . . . 0.0 110.56 -179.766 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 7.9 pt-20 38.39 -152.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.743 -0.598 . . . . 0.0 110.695 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.494 ' N ' ' HG3' ' A' ' 56' ' ' GLU . . . -88.98 116.99 4.78 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.523 ' CG2' ' CE2' ' A' ' 60' ' ' TYR . 0.9 OUTLIER -136.35 168.27 19.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.279 -1.13 . . . . 0.0 109.769 179.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.498 ' O ' ' HA ' ' A' ' 148' ' ' SER . 1.6 m -90.25 99.48 12.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.284 -0.885 . . . . 0.0 110.578 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.907 ' HB3' HD11 ' A' ' 146' ' ' LEU . 59.9 m-85 -106.33 151.96 24.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.228 -0.92 . . . . 0.0 110.21 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.431 ' C ' HD12 ' A' ' 146' ' ' LEU . 92.9 m -125.3 109.77 13.2 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 110.028 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 103' ' ' THR . 14.2 tp -89.94 120.14 30.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.22 -0.925 . . . . 0.0 110.008 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.596 ' HB2' HG23 ' A' ' 103' ' ' THR . 20.9 ttp180 -129.45 110.84 12.21 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.896 . . . . 0.0 110.257 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.496 ' C ' ' CD1' ' A' ' 64' ' ' TYR . 8.3 p90 -143.41 155.44 44.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.375 -0.828 . . . . 0.0 109.911 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.504 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 4.5 m -119.69 97.72 5.77 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.108 -0.995 . . . . 0.0 109.921 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.58 ' CB ' HD21 ' A' ' 95' ' ' LEU . . . -97.9 150.17 21.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.223 -0.923 . . . . 0.0 110.479 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.43 HG23 ' O ' ' A' ' 96' ' ' THR . 99.9 m -149.96 130.71 14.12 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.291 -0.88 . . . . 0.0 110.017 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.511 ' CB ' HG12 ' A' ' 72' ' ' VAL . . . -119.32 128.92 54.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.235 -0.915 . . . . 0.0 110.205 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.79 -9.23 26.62 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.257 -0.902 . . . . 0.0 110.102 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.674 HG21 ' CB ' ' A' ' 137' ' ' TRP . 6.0 t -114.33 19.53 16.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.238 -0.914 . . . . 0.0 110.095 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.501 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 4.9 t70 43.35 73.56 0.14 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.32 -0.862 . . . . 0.0 109.772 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.682 ' CG1' HD12 ' A' ' 95' ' ' LEU . 5.6 p -109.59 140.48 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.385 -0.822 . . . . 0.0 110.768 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 54.4 m -119.87 83.88 2.12 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.447 -0.783 . . . . 0.0 109.036 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.728 HG21 ' CD2' ' A' ' 129' ' ' LEU . 14.2 m -89.83 -139.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.221 -0.925 . . . . 0.0 110.759 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.567 ' N ' HG23 ' A' ' 74' ' ' VAL . 0.4 OUTLIER -131.58 142.93 50.01 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.185 -0.947 . . . . 0.0 111.12 -179.075 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.85 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -143.91 154.37 43.27 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.472 -0.768 . . . . 0.0 109.44 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.804 HD12 ' N ' ' A' ' 78' ' ' VAL . 4.2 pp -179.86 -152.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.116 -0.99 . . . . 0.0 110.5 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.867 HG23 HD22 ' A' ' 89' ' ' LEU . 66.8 t -155.14 168.94 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.392 -0.818 . . . . 0.0 109.251 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.515 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . 173.37 179.37 43.99 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.205 -1.474 . . . . 0.0 110.312 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.472 ' HG2' ' O ' ' A' ' 122' ' ' GLU . 1.0 OUTLIER -72.74 -152.9 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.571 -0.958 . . . . 0.0 110.265 179.932 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.48 ' N ' ' O ' ' A' ' 122' ' ' GLU . 15.2 m120 -160.57 60.55 0.32 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.541 -0.725 . . . . 0.0 109.317 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.578 ' O ' ' CZ ' ' A' ' 85' ' ' TYR . . . 158.28 -125.97 1.62 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.457 ' HA ' ' N ' ' A' ' 85' ' ' TYR . . . -125.2 153.2 71.73 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.174 -1.192 . . . . 0.0 110.122 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.472 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.5 Cg_endo -86.07 35.69 3.73 Favored 'Cis proline' 0 C--N 1.311 -1.418 0 C-N-CA 121.854 -2.144 . . . . 0.0 110.614 -0.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.578 ' CZ ' ' O ' ' A' ' 82' ' ' GLY . 76.6 m-85 58.98 148.89 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.178 -0.951 . . . . 0.0 110.226 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -173.19 115.57 0.57 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -110.65 143.63 40.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.238 -1.154 . . . . 0.0 110.376 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 1.046 HG23 HD12 ' A' ' 89' ' ' LEU . 34.6 m -124.43 -15.14 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.265 -0.897 . . . . 0.0 110.38 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 1.046 HD12 HG23 ' A' ' 88' ' ' VAL . 4.2 mp -108.33 137.39 46.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.209 -0.932 . . . . 0.0 111.002 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -151.15 81.27 1.32 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.4 -0.812 . . . . 0.0 109.901 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.5 p -137.76 179.52 6.38 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.994 -1.066 . . . . 0.0 110.699 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.7 m -119.89 115.28 33.48 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.378 -0.826 . . . . 0.0 110.059 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.85 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 44.1 Cg_endo -72.18 92.81 0.73 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.93 1.489 . . . . 0.0 110.919 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.524 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -75.15 147.89 40.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.904 . . . . 0.0 109.568 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.682 HD12 ' CG1' ' A' ' 72' ' ' VAL . 71.1 mt -138.99 162.36 35.09 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.04 -1.038 . . . . 0.0 110.778 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.43 ' O ' HG23 ' A' ' 67' ' ' THR . 0.3 OUTLIER -174.68 -179.22 1.44 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.438 -0.789 . . . . 0.0 110.088 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.56 -29.19 58.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.285 -0.884 . . . . 0.0 110.068 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.94 161.09 39.3 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.294 -0.879 . . . . 0.0 110.007 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.87 145.11 39.9 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.96 1.505 . . . . 0.0 110.487 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.524 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.85 94.34 4.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.29 -0.881 . . . . 0.0 110.037 179.811 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.425 ' HG3' ' OG1' ' A' ' 65' ' ' THR . 0.0 OUTLIER -84.23 95.07 8.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.385 -0.822 . . . . 0.0 110.198 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 25.2 t -89.54 134.4 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.348 -0.845 . . . . 0.0 110.066 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.596 HG23 ' HB2' ' A' ' 63' ' ' ARG . 0.2 OUTLIER -150.15 130.72 13.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.327 -0.858 . . . . 0.0 110.163 -179.945 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.52 ' CG ' ' O ' ' A' ' 103' ' ' THR . 21.1 mt-10 -160.1 138.23 10.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.19 -0.944 . . . . 0.0 110.378 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 105' ' ' THR . 4.1 t -90.05 76.14 7.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.233 -0.917 . . . . 0.0 110.047 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.845 ' CE1' HD11 ' A' ' 89' ' ' LEU . 30.4 p90 -77.64 153.01 33.56 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.261 -0.9 . . . . 0.0 110.422 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 58' ' ' THR . 78.8 m -93.57 98.57 11.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.267 -0.895 . . . . 0.0 109.919 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.643 ' HB3' ' CE2' ' A' ' 60' ' ' TYR . . . -58.47 99.19 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -0.933 . . . . 0.0 110.239 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.416 ' N ' ' CG1' ' A' ' 88' ' ' VAL . 81.6 p -87.05 55.15 3.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.222 -0.924 . . . . 0.0 109.927 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -161.96 -151.42 0.21 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.268 -0.895 . . . . 0.0 110.353 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.541 HG23 ' HG3' ' A' ' 55' ' ' GLU . 31.6 m -157.13 122.43 4.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.319 -0.863 . . . . 0.0 110.398 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.615 ' HD2' HG11 ' A' ' 52' ' ' VAL . 14.3 m-30 -112.73 86.52 8.78 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.312 -0.867 . . . . 0.0 109.766 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.472 ' HG2' ' HA ' ' A' ' 122' ' ' GLU . 43.1 Cg_endo -70.5 163.84 37.4 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.941 1.495 . . . . 0.0 110.4 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.222 -0.924 . . . . 0.0 110.295 -179.775 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.48 ' O ' ' N ' ' A' ' 81' ' ' ASN . 0.4 OUTLIER . . . . . 0 N--CA 1.494 1.742 0 CA-C-O 121.198 0.523 . . . . 0.0 110.485 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.514 ' HA3' ' CB ' ' A' ' 112' ' ' TYR . . . -148.38 140.79 8.56 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.083 -1.607 . . . . 0.0 109.083 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.526 ' O ' HG13 ' A' ' 78' ' ' VAL . 1.0 OUTLIER -150.34 -149.83 0.32 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.134 -1.215 . . . . 0.0 110.731 -179.325 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.591 HG21 ' CH2' ' A' ' 16' ' ' TRP . 11.4 mt -118.22 150.98 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.481 -0.762 . . . . 0.0 109.409 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.413 ' HB3' HD11 ' A' ' 77' ' ' LEU . . . -130.13 124.19 32.13 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.271 -0.893 . . . . 0.0 110.801 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.501 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 5.4 m-85 -118.61 106.02 12.2 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 1.049 ' O ' HD23 ' A' ' 129' ' ' LEU . 0.5 OUTLIER -89.58 129.19 36.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.187 -0.945 . . . . 0.0 112.109 -177.711 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 1.049 HD23 ' O ' ' A' ' 128' ' ' GLN . 0.4 OUTLIER -143.73 34.79 1.27 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 178.047 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.536 ' CA ' ' HA2' ' A' ' 44' ' ' GLY . . . -83.8 123.67 6.28 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.301 -1.519 . . . . 0.0 109.301 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 44.91 63.42 2.57 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.594 ' CD2' ' HA ' ' A' ' 74' ' ' VAL . 10.5 m-85 -115.61 -61.8 1.69 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.088 -1.242 . . . . 0.0 111.155 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.592 ' HB3' ' CE3' ' A' ' 137' ' ' TRP . 3.3 t -87.73 -161.25 0.69 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.949 -1.094 . . . . 0.0 110.527 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -119.79 -62.97 1.43 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.169 -0.957 . . . . 0.0 110.557 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -84.54 151.69 24.39 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.107 -0.996 . . . . 0.0 110.042 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.523 ' N ' ' HA ' ' A' ' 38' ' ' ALA . . . -48.59 127.91 14.2 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.331 -0.856 . . . . 0.0 110.543 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 1.079 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 10.5 p90 -139.38 -173.18 3.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.204 -0.935 . . . . 0.0 110.489 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.528 ' C ' HD12 ' A' ' 139' ' ' LEU 0.254 0.8 OUTLIER -150.16 176.64 10.66 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.404 -0.81 . . . . 0.0 109.922 -177.799 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.556 ' O ' ' HA ' ' A' ' 33' ' ' CYS . 1.9 mp -139.0 117.98 12.48 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.069 -1.019 . . . . 0.0 111.76 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' CYS . . . . . 0.511 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 0.8 OUTLIER -101.45 116.25 32.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.653 -0.655 . . . . 0.0 110.834 178.7 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.504 ' HA ' ' O ' ' A' ' 65' ' ' THR . 1.6 mt -110.42 178.85 4.25 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.258 -0.901 . . . . 0.0 109.508 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.477 ' HB3' ' O ' ' A' ' 141' ' ' LEU . 4.7 p-10 174.18 175.96 0.15 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.399 -0.813 . . . . 0.0 110.239 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.953 ' CA ' HG22 ' A' ' 8' ' ' THR . 5.1 t0 41.24 59.33 2.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.541 -0.725 . . . . 0.0 110.076 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.535 HG21 ' HZ ' ' A' ' 9' ' ' PHE . 2.8 t -100.57 113.23 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.3 -0.875 . . . . 0.0 110.04 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -136.95 158.87 43.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.24 -0.913 . . . . 0.0 110.377 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.907 HD11 ' HB3' ' A' ' 60' ' ' TYR . 13.0 tp -167.39 122.09 1.03 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.36 -0.837 . . . . 0.0 110.06 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.463 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 1.5 t70 -139.22 -158.51 0.86 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.229 -0.919 . . . . 0.0 110.312 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' A' ' 59' ' ' THR . 75.0 p . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.27 -0.894 . . . . 0.0 110.196 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo . . . . . 0 N--CA 1.48 0.7 0 N-CA-C 110.104 -0.768 . . . . 0.0 110.104 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.41 HG13 ' N ' ' A' ' 5' ' ' GLY . 14.3 pt -90.24 -32.45 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.238 -0.913 . . . . 0.0 110.163 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.41 ' N ' HG13 ' A' ' 4' ' ' ILE . . . 169.16 147.82 5.57 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.42 19.57 2.74 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.277 -1.131 . . . . 0.0 110.194 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 143' ' ' ASP . . . 161.75 -97.74 0.16 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.657 HG22 ' O ' ' A' ' 142' ' ' ASP . 17.1 p -92.07 147.31 23.05 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.23 -1.159 . . . . 0.0 109.95 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.603 ' CE2' ' HB2' ' A' ' 32' ' ' LEU . 21.8 m-85 -44.04 -40.77 5.02 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.312 -0.868 . . . . 0.0 109.408 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.553 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 12.0 t70 31.28 42.27 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.074 0.464 . . . . 0.0 111.299 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.553 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 1.7 t70 161.66 80.87 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.559 -0.713 . . . . 0.0 109.58 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 55.23 173.38 0.1 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.861 ' HB3' HD12 ' A' ' 32' ' ' LEU . 47.6 Cg_endo -73.56 -5.42 17.07 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 124.048 1.551 . . . . 0.0 110.519 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 0.5 OUTLIER 65.29 -87.1 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.215 -0.928 . . . . 0.0 110.282 -179.92 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.74 ' C ' HD13 ' A' ' 49' ' ' LEU . . . -140.92 6.23 2.58 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.808 ' HH2' HG21 ' A' ' 125' ' ' ILE . 55.0 m95 -71.34 82.6 0.77 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.178 -1.189 . . . . 0.0 110.406 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.744 ' O ' HG13 ' A' ' 47' ' ' VAL . 1.0 OUTLIER -78.53 149.35 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.011 -1.055 . . . . 0.0 109.287 179.559 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.611 ' CB ' HG12 ' A' ' 34' ' ' VAL . . . -135.33 132.74 38.03 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.049 -1.032 . . . . 0.0 110.461 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.602 ' HE1' HG13 ' A' ' 48' ' ' VAL . 11.8 p90 -122.07 115.46 22.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.526 -0.734 . . . . 0.0 110.006 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.917 ' CA ' HG13 ' A' ' 45' ' ' VAL . . . -152.96 27.55 0.81 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.9 p 47.87 21.32 0.28 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.304 -1.115 . . . . 0.0 110.862 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.559 ' HB3' ' CB ' ' A' ' 35' ' ' ALA . 3.2 m-20 -125.15 43.12 3.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.898 -1.126 . . . . 0.0 110.261 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.41 152.07 17.32 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.415 ' O ' ' C ' ' A' ' 25' ' ' LEU . 46.6 Cg_endo -73.09 140.76 31.68 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.989 1.521 . . . . 0.0 110.428 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.743 HD13 HD11 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -42.41 156.64 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.316 -0.865 . . . . 0.0 110.219 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -145.12 148.76 33.98 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.262 -0.899 . . . . 0.0 110.261 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.646 ' O ' HG22 ' A' ' 29' ' ' THR . 0.8 OUTLIER -119.89 -74.14 0.62 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.266 -0.896 . . . . 0.0 110.236 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 27' ' ' THR . 2.5 t 43.14 36.05 0.91 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.229 -0.919 . . . . 0.0 110.232 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.646 HG22 ' O ' ' A' ' 27' ' ' THR . 14.9 t -172.65 -34.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.317 -0.864 . . . . 0.0 110.21 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.44 ' N ' HG23 ' A' ' 29' ' ' THR . . . 123.73 7.88 6.53 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.453 ' H ' HG23 ' A' ' 29' ' ' THR . . . -130.95 132.21 44.92 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.164 -1.197 . . . . 0.0 110.222 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.861 HD12 ' HB3' ' A' ' 13' ' ' PRO . 2.2 tp -74.03 109.06 7.23 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.233 -0.917 . . . . 0.0 110.066 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 9.5 m -111.12 103.36 11.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.151 -0.968 . . . . 0.0 110.774 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.611 HG12 ' CB ' ' A' ' 18' ' ' ALA . 25.4 m -89.7 169.44 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.894 . . . . 0.0 109.13 179.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.559 ' CB ' ' HB3' ' A' ' 22' ' ' ASP . . . -122.46 129.22 51.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.904 -1.122 . . . . 0.0 111.317 -179.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.139 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 4.5 t -117.1 122.58 31.06 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.508 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 45.4 Cg_endo -74.5 152.65 43.7 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.804 1.423 . . . . 0.0 111.625 -178.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.484 ' HA ' ' CA ' ' A' ' 136' ' ' ALA . . . -42.07 131.39 3.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.32 -0.862 . . . . 0.0 109.892 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 38' ' ' ALA . . . 46.18 71.98 0.45 Allowed Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.558 -1.817 . . . . 0.0 108.558 -179.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.926 ' OG ' HG12 ' A' ' 36' ' ' VAL . 0.9 OUTLIER -84.6 34.92 0.54 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.319 -1.106 . . . . 0.0 110.778 -179.354 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.95 ' HB2' ' HA3' ' A' ' 131' ' ' GLY . . . -98.87 20.73 12.63 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.308 -0.87 . . . . 0.0 109.708 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.58 ' HG3' ' CD2' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -95.02 20.25 9.25 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.747 0.785 . . . . 0.0 109.882 179.771 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.702 ' CZ ' HG22 ' A' ' 45' ' ' VAL . 24.4 p90 176.86 -29.35 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.497 ' N ' ' CD1' ' A' ' 43' ' ' TYR . . . 99.24 108.91 2.93 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 110.241 -1.143 . . . . 0.0 110.241 179.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.917 HG13 ' CA ' ' A' ' 20' ' ' GLY . 1.9 t -89.99 178.28 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.215 -1.167 . . . . 0.0 108.74 179.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.509 ' CA ' ' HA ' ' A' ' 128' ' ' GLN . . . 162.81 -173.96 39.1 Favored Glycine 0 N--CA 1.487 2.051 0 C-N-CA 118.867 -1.635 . . . . 0.0 110.823 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.744 HG13 ' O ' ' A' ' 17' ' ' VAL . 38.9 t -151.06 128.2 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.625 ' O ' HG22 ' A' ' 17' ' ' VAL . 27.6 m -120.55 128.37 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.842 -1.161 . . . . 0.0 110.749 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.787 HD22 ' NE1' ' A' ' 16' ' ' TRP . 19.7 tp -119.29 105.2 11.09 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.367 -0.833 . . . . 0.0 110.3 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.512 ' HA ' ' HB3' ' A' ' 124' ' ' GLN . 0.2 OUTLIER -82.29 103.29 11.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.265 -0.897 . . . . 0.0 110.161 179.826 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.71 69.48 0.02 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.587 HG12 ' N ' ' A' ' 53' ' ' ALA . 38.3 t -119.9 171.78 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.196 -1.179 . . . . 0.0 109.979 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.587 ' N ' HG12 ' A' ' 52' ' ' VAL . . . -137.6 78.46 1.69 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.122 -0.987 . . . . 0.0 110.783 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.719 HD11 HD21 ' A' ' 146' ' ' LEU . 28.2 mm -118.31 160.41 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.21 -0.931 . . . . 0.0 109.712 179.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.527 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 1.2 tt0 -154.46 131.77 11.15 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.026 -1.046 . . . . 0.0 110.82 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 10.8 pt-20 37.58 -154.4 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.726 -0.609 . . . . 0.0 110.981 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 108' ' ' ALA . . . -86.77 91.91 1.76 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.555 ' CG2' ' N ' ' A' ' 59' ' ' THR . 1.2 m -121.36 173.74 7.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.274 -1.133 . . . . 0.0 109.83 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.555 ' N ' ' CG2' ' A' ' 58' ' ' THR . 0.5 OUTLIER -89.72 152.66 21.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.278 -0.889 . . . . 0.0 110.28 -179.913 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.629 ' CE1' ' CD1' ' A' ' 54' ' ' ILE . 54.1 m-85 -156.79 165.33 36.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.286 -0.884 . . . . 0.0 110.344 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 96.2 m -142.78 112.95 7.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.314 -0.866 . . . . 0.0 109.982 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.3 tp -89.76 120.76 31.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 110.148 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.491 ' HA ' ' O ' ' A' ' 102' ' ' VAL . 32.5 ttp180 -130.12 119.48 23.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.339 -0.851 . . . . 0.0 110.119 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.983 ' CZ ' HG21 ' A' ' 102' ' ' VAL . 14.6 p90 -150.91 153.26 34.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.237 -0.915 . . . . 0.0 110.252 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.492 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 5.6 m -119.73 94.86 4.55 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.26 -0.9 . . . . 0.0 109.968 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.832 ' HB2' HD23 ' A' ' 141' ' ' LEU . . . -99.72 153.33 19.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.324 -0.86 . . . . 0.0 110.401 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.691 HG23 ' O ' ' A' ' 98' ' ' GLU . 67.9 m -150.1 117.08 5.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.243 -0.911 . . . . 0.0 110.161 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -99.48 140.35 33.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.268 -0.895 . . . . 0.0 109.872 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.409 ' C ' ' O ' ' A' ' 68' ' ' ALA . 22.9 t -44.72 -26.27 0.37 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.185 -0.947 . . . . 0.0 109.282 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.738 HG22 ' HB2' ' A' ' 137' ' ' TRP . 5.0 t -116.99 -152.63 0.51 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.574 -0.704 . . . . 0.0 109.764 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.622 ' N ' HG23 ' A' ' 70' ' ' THR . 0.1 OUTLIER -116.03 62.17 0.71 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.276 -0.89 . . . . 0.0 109.324 179.043 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.818 HG23 ' HB2' ' A' ' 133' ' ' SER . 4.5 p -82.95 136.63 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.329 -0.857 . . . . 0.0 111.187 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.465 HG22 ' O ' ' A' ' 73' ' ' THR . 8.3 m -119.79 89.96 3.23 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.878 HG21 HD22 ' A' ' 129' ' ' LEU . 12.8 m -89.81 -150.39 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.279 -0.888 . . . . 0.0 110.811 -178.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.522 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 6.4 mtm180 -129.83 137.04 50.25 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.319 -0.863 . . . . 0.0 110.63 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.718 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -134.24 157.67 45.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.408 -0.808 . . . . 0.0 109.746 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.669 HD12 ' N ' ' A' ' 78' ' ' VAL . 3.8 pp 178.66 -156.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.195 -0.94 . . . . 0.0 110.373 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.86 ' CG2' HD22 ' A' ' 89' ' ' LEU . 3.4 t -148.39 167.55 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.296 -0.877 . . . . 0.0 109.565 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.49 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . -178.78 -170.23 40.5 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.343 -1.408 . . . . 0.0 110.202 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.52 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 28.2 tt0 -111.15 118.5 36.13 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.441 -1.035 . . . . 0.0 110.297 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.501 ' CB ' ' OE2' ' A' ' 122' ' ' GLU . 2.5 m120 -85.49 94.51 9.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.221 -0.924 . . . . 0.0 110.166 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.661 ' O ' ' HB2' ' A' ' 83' ' ' ALA . . . 164.69 -89.53 0.1 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.661 ' HB2' ' O ' ' A' ' 82' ' ' GLY . . . 173.04 144.19 0.17 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.229 -1.159 . . . . 0.0 110.15 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.467 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.6 Cg_endo -84.23 32.87 4.1 Favored 'Cis proline' 0 C--N 1.314 -1.28 0 C-N-CA 121.929 -2.113 . . . . 0.0 110.681 -0.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.581 ' CZ ' ' O ' ' A' ' 82' ' ' GLY . 19.4 m-85 64.76 157.47 0.09 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.16 -0.963 . . . . 0.0 110.246 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.472 ' O ' ' HA2' ' A' ' 79' ' ' GLY . . . -171.74 103.48 0.19 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.487 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 1.7 p -89.87 139.25 30.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.19 -1.182 . . . . 0.0 110.359 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 1.032 HG23 HD12 ' A' ' 89' ' ' LEU . 34.4 m -119.92 -16.79 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.337 -0.852 . . . . 0.0 109.979 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 1.032 HD12 HG23 ' A' ' 88' ' ' VAL . 4.2 mp -108.82 143.34 38.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.292 -0.88 . . . . 0.0 110.775 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -150.78 83.51 1.34 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.34 -0.85 . . . . 0.0 110.125 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.0 p -145.3 174.9 10.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.082 -1.011 . . . . 0.0 110.534 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.5 m -121.38 116.33 30.88 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.33 -0.856 . . . . 0.0 110.145 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.718 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 43.9 Cg_endo -71.15 124.77 10.79 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.898 1.473 . . . . 0.0 110.962 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 1.011 ' HB3' ' NH1' ' A' ' 100' ' ' ARG . . . -96.62 148.11 23.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.32 -0.862 . . . . 0.0 109.438 179.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.797 HD21 ' CB ' ' A' ' 66' ' ' ALA . 32.2 mt -136.2 166.51 23.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.001 -1.062 . . . . 0.0 110.726 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' A' ' 70' ' ' THR . 0.2 OUTLIER -164.35 -178.81 5.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.482 -0.761 . . . . 0.0 109.975 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.42 -6.47 30.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.225 -0.922 . . . . 0.0 110.183 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.691 ' O ' HG23 ' A' ' 67' ' ' THR . 1.5 mt-10 -113.11 178.34 0.99 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.292 -0.88 . . . . 0.0 110.074 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.495 ' HD2' ' CB ' ' A' ' 98' ' ' GLU . 45.6 Cg_endo -72.68 128.03 12.99 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.0 1.527 . . . . 0.0 110.359 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 1.011 ' NH1' ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.77 91.56 3.58 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.26 -0.9 . . . . 0.0 110.217 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.437 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 0.5 OUTLIER -75.78 157.19 33.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.302 -0.874 . . . . 0.0 110.138 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.983 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 41.0 t -135.09 139.26 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.221 -0.924 . . . . 0.0 110.129 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.96 102.43 3.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.263 -0.898 . . . . 0.0 110.194 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -142.01 165.78 26.51 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.239 -0.913 . . . . 0.0 110.171 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.5 t -122.08 167.15 13.48 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.22 -0.925 . . . . 0.0 110.163 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.881 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 34.4 p90 -173.3 151.37 2.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.245 -0.909 . . . . 0.0 110.274 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 66.9 m -89.98 96.14 10.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.225 -0.922 . . . . 0.0 110.029 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.598 ' HB3' ' CE2' ' A' ' 60' ' ' TYR . . . -55.17 100.07 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.289 -0.882 . . . . 0.0 110.251 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 54.5 p -89.08 52.45 2.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.258 -0.901 . . . . 0.0 110.179 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.43 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -159.22 -155.85 0.49 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.253 -0.904 . . . . 0.0 110.191 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.679 HG22 ' HD3' ' A' ' 113' ' ' PRO . 88.6 m -147.05 111.1 5.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.262 -0.899 . . . . 0.0 110.283 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.605 ' CE2' HG12 ' A' ' 78' ' ' VAL . 15.0 m-30 -111.43 77.04 1.58 Allowed Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.361 -0.837 . . . . 0.0 109.994 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.679 ' HD3' HG22 ' A' ' 111' ' ' THR . 44.8 Cg_endo -72.46 177.56 7.24 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.975 1.513 . . . . 0.0 110.419 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.243 -0.911 . . . . 0.0 110.264 -179.909 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.515 ' OE1' ' N ' ' A' ' 122' ' ' GLU . 6.4 pm0 . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.218 0.532 . . . . 0.0 110.187 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.526 ' HA3' ' CB ' ' A' ' 112' ' ' TYR . . . -138.12 154.6 22.91 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.574 ' HA ' ' CG2' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -150.25 -162.14 1.49 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -1.176 . . . . 0.0 110.518 -179.716 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.808 HG21 ' HH2' ' A' ' 16' ' ' TRP . 10.1 mt -118.86 144.25 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.486 -0.759 . . . . 0.0 109.503 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.51 ' O ' ' HA ' ' A' ' 76' ' ' ALA . . . -116.28 115.29 25.67 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.453 -0.779 . . . . 0.0 111.41 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.546 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 2.7 m-30 -118.09 75.52 1.01 Allowed 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.861 ' C ' HD23 ' A' ' 129' ' ' LEU . 25.6 mt-30 -88.21 122.72 32.08 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.278 -0.888 . . . . 0.0 112.512 -177.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.878 HD22 HG21 ' A' ' 74' ' ' VAL . 0.6 OUTLIER -108.38 55.6 0.64 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.008 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.495 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -66.04 89.38 0.13 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 -178.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.95 ' HA3' ' HB2' ' A' ' 41' ' ' ALA . . . 39.7 86.04 0.01 OUTLIER Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.999 -1.241 . . . . 0.0 109.999 179.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.694 ' CD2' HG12 ' A' ' 74' ' ' VAL . 12.9 m-85 -111.94 -47.95 3.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.191 -1.182 . . . . 0.0 110.348 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.818 ' HB2' HG23 ' A' ' 72' ' ' VAL . 37.2 t -89.84 -174.47 4.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.214 -0.929 . . . . 0.0 110.235 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -98.11 -80.6 0.45 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -0.892 . . . . 0.0 110.391 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -63.17 155.81 27.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.211 -0.931 . . . . 0.0 110.425 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.484 ' CA ' ' HA ' ' A' ' 38' ' ' ALA . . . -50.4 128.42 19.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.246 -0.909 . . . . 0.0 110.193 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 1.139 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 11.2 p90 -132.04 -165.03 1.53 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.287 -0.883 . . . . 0.0 110.216 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.604 ' C ' HD12 ' A' ' 139' ' ' LEU . 0.5 OUTLIER -160.38 -178.44 6.93 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.683 -178.831 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.847 HD13 HD13 ' A' ' 129' ' ' LEU . 2.3 mp -141.08 141.22 34.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.348 -0.845 . . . . 0.0 110.129 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' CYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 22.3 m -140.59 103.35 4.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.185 -0.947 . . . . 0.0 110.459 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.832 HD23 ' HB2' ' A' ' 66' ' ' ALA . 1.0 OUTLIER -96.29 -177.95 4.14 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.2 -0.938 . . . . 0.0 109.926 179.58 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.657 ' O ' HG22 ' A' ' 8' ' ' THR . 3.2 p30 168.87 35.68 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.439 -0.788 . . . . 0.0 110.004 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.503 ' HA ' ' O ' ' A' ' 7' ' ' GLY . 3.3 t0 -169.69 43.29 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.32 -0.862 . . . . 0.0 109.676 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.639 HG11 ' HZ2' ' A' ' 16' ' ' TRP . 3.5 t -89.7 126.46 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.39 -0.819 . . . . 0.0 110.353 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -149.11 148.32 29.53 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.336 -0.853 . . . . 0.0 110.094 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.719 HD21 HD11 ' A' ' 54' ' ' ILE . 47.5 tp -140.41 139.92 35.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.259 -0.901 . . . . 0.0 110.303 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.483 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -151.3 -177.83 6.29 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.281 -0.887 . . . . 0.0 110.031 179.9 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.666 0 O-C-N 121.224 -0.922 . . . . 0.0 110.205 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo . . . . . 0 N--CA 1.48 0.714 0 N-CA-C 110.043 -0.791 . . . . 0.0 110.043 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.563 ' CD1' HG12 ' A' ' 144' ' ' VAL . 8.2 pt -89.97 4.49 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.189 -0.944 . . . . 0.0 110.215 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 133.07 -166.43 23.7 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -137.14 76.84 1.61 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.23 -1.159 . . . . 0.0 110.203 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.43 ' C ' ' HA ' ' A' ' 143' ' ' ASP . . . 110.89 -133.13 11.36 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 1.048 HG22 ' O ' ' A' ' 142' ' ' ASP . 80.7 p -76.19 146.42 39.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.256 -1.143 . . . . 0.0 110.252 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.53 ' CE1' ' CD1' ' A' ' 16' ' ' TRP . 43.3 m-85 -42.95 -36.0 1.4 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.343 -0.848 . . . . 0.0 109.968 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.56 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 3.3 p-10 35.53 59.36 0.81 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.653 -0.654 . . . . 0.0 111.417 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.56 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 4.0 t0 162.03 -67.34 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.514 -0.742 . . . . 0.0 109.764 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.469 ' HA2' ' HB ' ' A' ' 27' ' ' THR . . . -174.56 -172.06 39.32 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.761 ' HD3' HG21 ' A' ' 27' ' ' THR . 47.3 Cg_endo -74.35 80.91 2.14 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 124.124 1.591 . . . . 0.0 110.384 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -35.8 -65.61 0.24 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.666 -0.646 . . . . 0.0 110.567 -179.853 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.69 ' C ' HD13 ' A' ' 49' ' ' LEU . . . -144.73 12.15 1.94 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.86 ' NE1' HD22 ' A' ' 49' ' ' LEU . 51.3 m95 -73.27 108.18 6.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.294 -1.121 . . . . 0.0 110.851 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.773 ' O ' HG13 ' A' ' 47' ' ' VAL . 1.4 m -109.0 151.38 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.317 -0.864 . . . . 0.0 109.133 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.431 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . . . -130.77 118.14 20.41 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.862 -1.149 . . . . 0.0 109.757 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.571 ' CE2' ' O ' ' A' ' 46' ' ' GLY . 7.4 p90 -107.02 173.63 6.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.513 -0.742 . . . . 0.0 110.861 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.566 ' HA2' ' CE1' ' A' ' 43' ' ' TYR . . . 90.69 -13.94 64.36 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.783 HG23 HG13 ' A' ' 45' ' ' VAL . 17.8 p -149.93 -141.44 0.11 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.27 -1.135 . . . . 0.0 110.236 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.561 ' CB ' ' HD3' ' A' ' 24' ' ' PRO . 19.4 t0 -89.29 174.47 7.81 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.357 -0.839 . . . . 0.0 109.658 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.614 ' N ' ' HD3' ' A' ' 24' ' ' PRO . . . -122.08 43.82 1.43 Allowed Glycine 0 N--CA 1.488 2.165 0 C-N-CA 119.513 -1.327 . . . . 0.0 110.765 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.614 ' HD3' ' N ' ' A' ' 23' ' ' GLY . 55.8 Cg_endo -80.19 41.12 1.07 Allowed 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 123.458 1.241 . . . . 0.0 110.685 179.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 1.015 ' CD2' HG12 ' A' ' 34' ' ' VAL . 17.4 mt -44.33 93.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.978 -1.076 . . . . 0.0 110.273 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 24' ' ' PRO . 36.0 t0 -74.67 115.82 14.67 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.278 -0.888 . . . . 0.0 109.333 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.761 HG21 ' HD3' ' A' ' 13' ' ' PRO . 2.1 p -119.38 -30.97 4.76 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.158 -0.964 . . . . 0.0 110.779 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.7 ' C ' HG22 ' A' ' 29' ' ' THR . 3.4 m -53.42 82.75 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.615 -0.678 . . . . 0.0 110.59 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.7 HG22 ' C ' ' A' ' 28' ' ' SER . 0.0 OUTLIER 165.6 -33.14 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.215 -0.928 . . . . 0.0 109.806 -179.542 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.455 ' O ' ' HB3' ' A' ' 142' ' ' ASP . . . 127.51 7.36 4.83 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.497 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -150.57 154.95 38.49 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.039 -1.271 . . . . 0.0 110.662 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.78 HD11 HD13 ' A' ' 25' ' ' LEU . 2.0 tt -105.4 104.65 14.42 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.369 -0.832 . . . . 0.0 110.239 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.569 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 0.8 OUTLIER -97.65 113.86 25.69 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.223 -0.923 . . . . 0.0 111.449 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 1.015 HG12 ' CD2' ' A' ' 25' ' ' LEU . 18.7 m -89.76 148.8 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 178.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.423 ' HB2' ' HG2' ' A' ' 24' ' ' PRO . . . -89.29 111.0 21.72 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.39 -0.819 . . . . 0.0 111.309 -178.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.094 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 55.7 t -105.29 133.36 20.2 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.477 -0.765 . . . . 0.0 109.303 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.577 ' HD3' ' CG2' ' A' ' 21' ' ' THR . 40.2 Cg_endo -67.2 171.84 10.88 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.81 1.426 . . . . 0.0 111.0 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.509 ' HA ' ' N ' ' A' ' 136' ' ' ALA . . . -57.86 129.26 41.08 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.441 -0.787 . . . . 0.0 111.06 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.574 ' O ' ' C ' ' A' ' 40' ' ' SER . . . 40.31 38.95 1.49 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.574 ' C ' ' O ' ' A' ' 39' ' ' GLY . 74.6 p 17.45 59.91 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 117.524 0.662 . . . . 0.0 111.733 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.465 ' O ' ' HB3' ' A' ' 42' ' ' GLN . . . -89.5 104.98 17.49 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.66 0.743 . . . . 0.0 110.52 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.466 ' OE1' ' HG3' ' A' ' 37' ' ' PRO . 2.8 pt20 171.32 -169.47 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.842 -0.536 . . . . 0.0 109.709 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.566 ' CE1' ' HA2' ' A' ' 20' ' ' GLY . 3.1 p90 -44.2 -26.14 0.29 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.162 -0.961 . . . . 0.0 109.73 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.511 ' N ' ' CD1' ' A' ' 43' ' ' TYR . . . 123.68 127.73 3.25 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.783 HG13 HG23 ' A' ' 21' ' ' THR . 4.0 t -89.45 177.08 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.198 -1.178 . . . . 0.0 109.153 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.571 ' O ' ' CE2' ' A' ' 19' ' ' TYR . . . 165.45 137.63 2.24 Favored Glycine 0 N--CA 1.49 2.275 0 C-N-CA 119.047 -1.549 . . . . 0.0 110.849 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.773 HG13 ' O ' ' A' ' 17' ' ' VAL . 21.5 t -104.58 141.55 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.534 -0.98 . . . . 0.0 109.487 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.603 HG23 HG22 ' A' ' 17' ' ' VAL . 4.9 m -132.44 143.91 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 120.799 -1.188 . . . . 0.0 110.474 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.86 HD22 ' NE1' ' A' ' 16' ' ' TRP . 25.5 tp -136.72 113.05 9.9 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.313 -0.867 . . . . 0.0 110.09 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.519 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 4.4 t30 -88.9 132.33 34.73 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.204 -0.935 . . . . 0.0 110.561 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 141.21 72.31 0.04 OUTLIER Glycine 0 N--CA 1.49 2.258 0 C-N-CA 119.826 -1.178 . . . . 0.0 110.204 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 123' ' ' GLY . 5.7 t -119.9 173.28 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.025 -1.28 . . . . 0.0 110.009 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.971 ' O ' HD13 ' A' ' 54' ' ' ILE . . . -124.4 80.12 1.81 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.06 -1.025 . . . . 0.0 110.806 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.971 HD13 ' O ' ' A' ' 53' ' ' ALA . 4.9 mm -142.52 163.63 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.256 -0.902 . . . . 0.0 109.603 179.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.881 ' HA ' HG23 ' A' ' 111' ' ' THR . 36.8 tt0 -172.12 27.62 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.02 -1.05 . . . . 0.0 110.557 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.522 ' HB3' ' O ' ' A' ' 55' ' ' GLU . 3.3 pt-20 177.62 -165.52 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.649 -0.657 . . . . 0.0 110.111 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.497 ' N ' ' HG3' ' A' ' 56' ' ' GLU . . . -94.08 68.75 1.4 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.58 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.2 m -104.4 173.02 6.48 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.463 -1.022 . . . . 0.0 110.393 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.574 ' O ' ' CD2' ' A' ' 60' ' ' TYR . 0.4 OUTLIER -89.79 159.57 16.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.437 -0.789 . . . . 0.0 109.79 179.636 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.812 ' HB3' HD11 ' A' ' 146' ' ' LEU . 66.4 m-85 -159.5 -175.51 5.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.29 -0.881 . . . . 0.0 110.23 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.712 HG23 ' O ' ' A' ' 104' ' ' GLU . 91.5 m -147.68 121.62 9.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.326 -0.859 . . . . 0.0 109.894 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.635 HD22 HD23 ' A' ' 89' ' ' LEU . 18.9 tp -89.56 120.43 30.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.205 -0.935 . . . . 0.0 110.15 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.522 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 2.6 ttt180 -124.26 137.57 54.49 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.338 -0.851 . . . . 0.0 109.97 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 1.18 ' CZ ' HG21 ' A' ' 102' ' ' VAL . 0.9 OUTLIER -178.46 142.94 0.25 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.302 -0.874 . . . . 0.0 109.732 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.511 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 96.0 m -119.19 97.86 5.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.187 -0.946 . . . . 0.0 109.892 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.793 ' CB ' HD21 ' A' ' 95' ' ' LEU . . . -99.62 149.22 23.5 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.425 -0.797 . . . . 0.0 110.32 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.487 ' OG1' ' HA ' ' A' ' 99' ' ' PRO . 95.4 m -149.79 102.28 3.13 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.321 -0.862 . . . . 0.0 110.197 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -90.01 133.1 35.01 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.289 -0.882 . . . . 0.0 110.008 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.421 ' C ' ' O ' ' A' ' 68' ' ' ALA . 19.2 p -43.99 -26.49 0.29 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.251 -0.906 . . . . 0.0 109.521 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.598 ' CG2' ' CB ' ' A' ' 137' ' ' TRP . 2.4 t -111.23 159.7 17.65 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.457 -0.777 . . . . 0.0 109.987 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.501 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 3.1 m-20 -78.75 79.52 5.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.142 -0.974 . . . . 0.0 109.424 179.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.592 HG23 ' CB ' ' A' ' 133' ' ' SER . 9.9 p -102.73 139.43 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.18 -0.95 . . . . 0.0 111.27 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.418 HG22 ' O ' ' A' ' 73' ' ' THR . 17.8 m -119.86 86.73 2.61 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.691 HG11 HD22 ' A' ' 129' ' ' LEU . 11.1 m -89.55 -142.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.273 -0.892 . . . . 0.0 110.674 -178.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.548 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 30.1 mtm-85 -132.56 148.68 52.38 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.281 -0.887 . . . . 0.0 110.456 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.791 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -148.25 154.75 40.47 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.238 -0.914 . . . . 0.0 109.826 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.866 ' CD1' ' HB3' ' A' ' 126' ' ' ALA . 3.9 pp 179.0 -156.42 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.253 -0.904 . . . . 0.0 110.467 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.833 HG23 HD22 ' A' ' 89' ' ' LEU . 3.9 t -149.41 165.48 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.352 -0.842 . . . . 0.0 109.535 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.544 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . -174.83 -163.64 28.33 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.408 -1.377 . . . . 0.0 110.255 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.526 ' HG3' ' HA ' ' A' ' 85' ' ' TYR . 3.3 pt20 -119.84 143.38 47.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.383 -1.069 . . . . 0.0 110.461 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.482 ' HB2' ' HG2' ' A' ' 122' ' ' GLU . 3.6 m-20 -96.22 94.71 7.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.365 -0.834 . . . . 0.0 109.991 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.544 ' C ' ' CE1' ' A' ' 85' ' ' TYR . . . 137.49 149.43 5.57 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.622 ' N ' ' CE1' ' A' ' 85' ' ' TYR . . . -62.44 155.12 69.33 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.303 -1.116 . . . . 0.0 110.298 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.52 ' C ' ' CD2' ' A' ' 85' ' ' TYR . 50.5 Cg_endo -77.41 7.91 18.71 Favored 'Cis proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.636 -2.235 . . . . 0.0 110.803 -0.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.622 ' CE1' ' N ' ' A' ' 83' ' ' ALA . 11.4 m-85 69.94 166.0 0.28 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.306 -0.871 . . . . 0.0 110.161 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.518 ' N ' ' CG ' ' A' ' 80' ' ' GLN . . . 172.69 165.94 30.48 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.444 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 0.8 OUTLIER -143.31 149.1 37.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.274 -1.133 . . . . 0.0 110.239 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.951 HG23 HD12 ' A' ' 89' ' ' LEU . 30.3 m -122.14 -18.43 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.25 -0.906 . . . . 0.0 110.285 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.951 HD12 HG23 ' A' ' 88' ' ' VAL . 4.3 mp -111.93 143.02 43.6 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.178 -0.951 . . . . 0.0 110.984 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.507 ' O ' HG23 ' A' ' 91' ' ' THR . 11.2 m-20 -151.11 88.59 1.46 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.339 -0.85 . . . . 0.0 110.183 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.507 HG23 ' O ' ' A' ' 90' ' ' ASP . 6.4 p -153.29 176.96 11.39 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.049 -1.032 . . . . 0.0 110.656 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.2 m -119.89 120.05 30.66 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.348 -0.845 . . . . 0.0 110.072 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.791 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 46.1 Cg_endo -74.05 127.88 11.77 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.928 1.488 . . . . 0.0 111.076 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.593 ' HB3' ' NE ' ' A' ' 100' ' ' ARG . . . -95.11 149.68 21.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.318 -0.864 . . . . 0.0 109.3 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.793 HD21 ' CB ' ' A' ' 66' ' ' ALA . 43.5 mt -145.21 173.5 11.89 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.973 -1.079 . . . . 0.0 110.997 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.607 HG22 ' C ' ' A' ' 95' ' ' LEU . 0.1 OUTLIER 169.15 -178.59 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.633 -0.667 . . . . 0.0 109.716 -179.874 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.32 -13.75 21.66 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.126 -0.984 . . . . 0.0 109.806 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.541 ' CG ' ' HD2' ' A' ' 99' ' ' PRO . 33.7 tt0 -95.74 149.56 36.22 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.444 -0.785 . . . . 0.0 109.866 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.541 ' HD2' ' CG ' ' A' ' 98' ' ' GLU . 41.5 Cg_endo -68.11 130.09 20.75 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.807 1.425 . . . . 0.0 110.169 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.593 ' NE ' ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.83 91.92 3.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.267 -0.896 . . . . 0.0 110.624 -179.537 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.462 ' HG2' ' OG1' ' A' ' 65' ' ' THR . 31.8 mt-30 -73.54 157.94 35.78 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.273 -0.892 . . . . 0.0 109.632 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 1.18 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 60.4 t -131.29 133.03 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.143 -0.973 . . . . 0.0 110.518 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.49 87.73 1.46 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.406 -0.809 . . . . 0.0 110.009 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.712 ' O ' HG23 ' A' ' 61' ' ' THR . 56.8 mt-10 -125.83 -176.14 3.54 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.203 -0.935 . . . . 0.0 110.377 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 1.8 t -135.64 166.93 22.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.3 -0.875 . . . . 0.0 110.204 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.707 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 31.8 p90 -174.74 152.8 1.66 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.22 -0.925 . . . . 0.0 110.196 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.521 ' O ' ' N ' ' A' ' 109' ' ' SER . 4.8 m -89.7 94.95 10.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.192 -0.943 . . . . 0.0 109.97 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.685 ' HB1' HG21 ' A' ' 54' ' ' ILE . . . -50.76 89.54 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.301 -0.874 . . . . 0.0 110.014 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 107' ' ' THR . 10.3 p -85.65 53.27 2.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.27 -0.894 . . . . 0.0 109.996 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -157.79 -163.35 1.32 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.178 -0.951 . . . . 0.0 110.392 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.951 HG22 ' HD3' ' A' ' 113' ' ' PRO . 97.0 m -136.0 110.63 8.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.272 -0.892 . . . . 0.0 110.286 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.59 ' CG ' ' HA3' ' A' ' 123' ' ' GLY . 15.4 m-30 -109.07 70.75 0.43 Allowed Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.341 -0.849 . . . . 0.0 110.047 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.951 ' HD3' HG22 ' A' ' 111' ' ' THR . 46.4 Cg_endo -71.38 120.42 6.95 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 123.802 1.422 . . . . 0.0 110.401 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.275 -0.89 . . . . 0.0 110.218 -179.98 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.534 ' CG ' ' N ' ' A' ' 123' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 121.036 0.446 . . . . 0.0 110.06 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.6 ' O ' HG23 ' A' ' 52' ' ' VAL . . . -149.86 147.3 17.41 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.591 ' O ' HG13 ' A' ' 78' ' ' VAL . 1.8 pt20 -150.32 -162.56 1.58 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.328 -1.101 . . . . 0.0 110.421 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.543 HG21 ' CH2' ' A' ' 16' ' ' TRP . 13.0 mt -119.12 143.83 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.481 -0.762 . . . . 0.0 109.278 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.866 ' HB3' ' CD1' ' A' ' 77' ' ' LEU . . . -117.04 117.44 29.66 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.178 -0.951 . . . . 0.0 111.048 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.519 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 3.0 m-30 -116.97 102.75 9.62 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.5 ' HB2' ' HB2' ' A' ' 75' ' ' ARG . 6.6 mt-30 -88.98 107.77 19.21 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.108 -0.995 . . . . 0.0 111.132 -178.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.691 HD22 HG11 ' A' ' 74' ' ' VAL . 16.8 mt -106.35 43.53 1.14 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.5 -0.75 . . . . 0.0 109.035 178.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 131' ' ' GLY . . . -91.68 116.65 5.04 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.546 ' N ' ' OG ' ' A' ' 40' ' ' SER . . . 41.95 90.07 0.01 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.613 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 6.8 m-85 -139.98 -55.73 0.55 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.167 -1.196 . . . . 0.0 110.492 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.592 ' CB ' HG23 ' A' ' 72' ' ' VAL . 1.2 t -88.95 -177.24 5.42 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.945 -1.097 . . . . 0.0 110.29 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.454 ' N ' ' OG ' ' A' ' 133' ' ' SER . . . -100.08 -75.22 0.58 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.226 -0.921 . . . . 0.0 110.393 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' A' ' 136' ' ' ALA . 83.9 m-20 -83.24 153.75 24.54 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.218 -0.927 . . . . 0.0 110.156 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.509 ' N ' ' HA ' ' A' ' 38' ' ' ALA . . . -40.95 142.3 0.5 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.363 -0.836 . . . . 0.0 110.452 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 1.094 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 18.8 p90 -153.46 -159.9 1.05 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.281 -0.887 . . . . 0.0 110.654 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.523 ' O ' ' CB ' ' A' ' 68' ' ' ALA . 0.8 OUTLIER -160.1 176.12 12.16 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.371 -0.83 . . . . 0.0 109.63 -178.4 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.569 ' O ' ' HA ' ' A' ' 33' ' ' CYS . 1.8 mp -136.66 117.33 13.95 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.905 -1.122 . . . . 0.0 111.89 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' CYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 0.8 OUTLIER -105.37 111.03 23.6 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.662 -0.649 . . . . 0.0 111.176 178.683 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.723 HD23 ' HB2' ' A' ' 66' ' ' ALA . 1.4 mt -100.78 -179.73 4.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.914 . . . . 0.0 109.08 178.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 1.048 ' O ' HG22 ' A' ' 8' ' ' THR . 0.5 OUTLIER 166.19 64.88 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.327 -0.858 . . . . 0.0 110.073 179.912 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.513 ' CB ' ' O ' ' A' ' 142' ' ' ASP . 0.3 OUTLIER 165.79 42.8 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.374 -0.829 . . . . 0.0 108.962 -179.906 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.692 HG11 ' HZ2' ' A' ' 16' ' ' TRP . 1.0 OUTLIER -89.15 120.02 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.542 -0.724 . . . . 0.0 110.593 -178.811 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -157.53 147.35 20.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.471 -0.768 . . . . 0.0 109.778 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.812 HD11 ' HB3' ' A' ' 60' ' ' TYR . 42.9 tp -144.07 146.83 33.08 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.254 -0.903 . . . . 0.0 110.342 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.482 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 7.1 t0 -177.88 152.12 0.74 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.214 -0.929 . . . . 0.0 110.296 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.527 ' HB2' ' CG2' ' A' ' 58' ' ' THR . 22.5 p . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.286 -0.884 . . . . 0.0 110.174 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.46 ' HG2' ' O ' ' A' ' 51' ' ' GLY . 51.4 Cg_endo . . . . . 0 N--CA 1.482 0.824 0 N-CA-C 111.072 -0.395 . . . . 0.0 111.072 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.639 ' CG2' HD21 ' A' ' 49' ' ' LEU . 6.7 pt -145.09 11.74 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.968 -1.082 . . . . 0.0 110.221 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 115.07 148.47 9.47 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -89.73 20.8 3.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.234 -1.157 . . . . 0.0 110.24 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.469 ' C ' ' HA ' ' A' ' 143' ' ' ASP . . . 153.86 -125.41 1.74 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.783 HG22 ' O ' ' A' ' 142' ' ' ASP . 0.8 OUTLIER -57.62 132.91 54.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.229 -1.159 . . . . 0.0 110.154 -179.92 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.569 ' O ' ' CB ' ' A' ' 10' ' ' ASP . 11.8 m-85 -43.86 -27.24 0.33 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.32 -0.862 . . . . 0.0 109.527 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.595 ' O ' ' HB2' ' A' ' 11' ' ' ASP . 0.0 OUTLIER 80.34 -43.43 0.24 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 122.038 -0.413 . . . . 0.0 111.062 179.303 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.595 ' HB2' ' O ' ' A' ' 10' ' ' ASP . 9.4 t70 161.93 39.22 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.083 0 CA-C-O 121.904 0.859 . . . . 0.0 109.085 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -176.81 134.74 2.62 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.618 ' HB3' HD12 ' A' ' 32' ' ' LEU . 45.9 Cg_endo -72.86 -15.39 26.53 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.932 1.491 . . . . 0.0 110.43 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 0.3 OUTLIER 63.77 -87.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.237 -0.914 . . . . 0.0 110.184 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.643 ' O ' HG13 ' A' ' 17' ' ' VAL . . . -124.35 -14.8 3.52 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 1.062 ' CE2' HD22 ' A' ' 49' ' ' LEU . 80.6 m95 -51.82 111.36 0.59 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.263 -1.139 . . . . 0.0 110.593 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.746 ' O ' HG13 ' A' ' 47' ' ' VAL . 1.0 OUTLIER -112.56 148.01 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.142 -0.974 . . . . 0.0 109.528 179.433 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.698 ' HB3' ' HB3' ' A' ' 25' ' ' LEU . . . -129.76 154.02 47.62 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.052 -1.03 . . . . 0.0 109.817 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.742 ' HE2' HG13 ' A' ' 48' ' ' VAL . 9.4 p90 -145.91 155.58 42.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.915 . . . . 0.0 110.936 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.649 ' HA3' HG13 ' A' ' 45' ' ' VAL . . . 161.83 -93.89 0.12 Allowed Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.016 -1.633 . . . . 0.0 109.016 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.569 HG22 ' HH ' ' A' ' 43' ' ' TYR . 11.6 p -151.21 18.19 0.75 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.183 -1.187 . . . . 0.0 110.715 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.941 ' CB ' ' HB3' ' A' ' 35' ' ' ALA . 0.4 OUTLIER -123.87 60.6 1.11 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.037 -1.039 . . . . 0.0 110.229 179.479 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 43.53 -161.7 0.06 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.431 ' O ' ' C ' ' A' ' 25' ' ' LEU . 46.0 Cg_endo -72.86 145.12 39.99 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.973 1.512 . . . . 0.0 110.378 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.729 HD13 HD11 ' A' ' 32' ' ' LEU . 0.8 OUTLIER -42.66 163.43 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.311 -0.868 . . . . 0.0 110.194 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.28 138.55 45.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.264 -0.898 . . . . 0.0 110.109 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.614 ' O ' HG22 ' A' ' 29' ' ' THR . 0.7 OUTLIER -119.85 -78.97 0.6 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.182 -0.949 . . . . 0.0 110.232 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.46 ' HB2' ' O ' ' A' ' 27' ' ' THR . 0.4 OUTLIER 61.43 -87.68 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.257 -0.902 . . . . 0.0 110.227 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.676 HG23 ' H ' ' A' ' 31' ' ' ALA . 5.1 t -42.18 -29.99 0.27 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.275 -0.891 . . . . 0.0 110.276 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' A' ' 11' ' ' ASP . . . 125.39 -26.41 5.49 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.676 ' H ' HG23 ' A' ' 29' ' ' THR . . . -91.8 136.08 33.42 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.211 -1.17 . . . . 0.0 110.188 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.729 HD11 HD13 ' A' ' 25' ' ' LEU . 1.9 tp -68.05 106.25 2.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.163 -0.96 . . . . 0.0 109.806 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 8.9 m -113.86 102.75 10.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.219 -0.925 . . . . 0.0 110.97 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.617 ' CG1' ' HB2' ' A' ' 18' ' ' ALA . 24.0 m -89.76 164.19 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.244 -0.91 . . . . 0.0 108.997 178.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.941 ' HB3' ' CB ' ' A' ' 22' ' ' ASP . . . -112.07 132.14 55.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.942 -1.099 . . . . 0.0 111.139 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.12 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 37.2 t -119.66 117.37 32.71 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.543 -0.723 . . . . 0.0 109.325 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.558 ' HG3' ' CG2' ' A' ' 21' ' ' THR . 44.2 Cg_endo -70.38 144.22 50.1 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.885 1.466 . . . . 0.0 111.236 -179.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.583 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -45.34 153.94 0.2 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.375 -0.828 . . . . 0.0 109.83 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 38' ' ' ALA . . . 45.22 59.39 4.61 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.724 ' OG ' HG21 ' A' ' 45' ' ' VAL . 0.6 OUTLIER -84.14 36.99 0.59 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.314 -1.109 . . . . 0.0 110.589 -179.625 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -92.44 19.73 6.92 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.96 0.886 . . . . 0.0 109.664 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.575 ' HG3' ' CD2' ' A' ' 43' ' ' TYR . 16.2 pt20 -73.23 -143.19 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.635 ' CD1' ' N ' ' A' ' 44' ' ' GLY . 6.8 p90 -42.05 -27.52 0.13 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.502 -0.749 . . . . 0.0 109.375 179.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.635 ' N ' ' CD1' ' A' ' 43' ' ' TYR . . . 117.66 113.51 2.64 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.724 HG21 ' OG ' ' A' ' 40' ' ' SER . 2.6 t -89.55 149.99 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.137 -1.214 . . . . 0.0 108.191 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.571 ' O ' ' CE2' ' A' ' 19' ' ' TYR . . . 179.3 166.97 35.99 Favored Glycine 0 N--CA 1.489 2.178 0 C-N-CA 118.582 -1.771 . . . . 0.0 111.083 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.746 HG13 ' O ' ' A' ' 17' ' ' VAL . 38.4 t -122.22 131.41 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.754 -0.851 . . . . 0.0 109.457 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.742 HG13 ' HE2' ' A' ' 19' ' ' TYR . 33.0 m -120.14 139.01 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.886 -1.134 . . . . 0.0 110.683 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 1.062 HD22 ' CE2' ' A' ' 16' ' ' TRP . 7.7 tp -130.66 87.33 2.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.325 -0.859 . . . . 0.0 110.211 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.552 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 3.5 m120 -69.15 103.3 1.87 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.926 . . . . 0.0 110.276 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.46 ' O ' ' HG2' ' A' ' 3' ' ' PRO . . . 157.02 79.72 0.03 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.66 HG23 ' HA ' ' A' ' 124' ' ' GLN . 6.8 t -124.92 160.16 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.167 -1.196 . . . . 0.0 109.933 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.616 ' O ' HD13 ' A' ' 54' ' ' ILE . . . -119.63 89.94 3.23 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.173 -0.955 . . . . 0.0 110.855 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.742 HD11 HD21 ' A' ' 146' ' ' LEU . 27.4 mm -130.06 172.79 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.28 -0.887 . . . . 0.0 109.507 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.585 ' N ' HG22 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -177.79 131.51 0.15 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.913 -1.117 . . . . 0.0 111.354 -179.749 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.464 ' O ' ' O ' ' A' ' 108' ' ' ALA . 7.8 mm-40 52.96 -168.45 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.667 -0.646 . . . . 0.0 110.85 178.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.502 ' HA2' ' HA ' ' A' ' 109' ' ' SER . . . -87.24 61.57 4.24 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.357 -1.897 . . . . 0.0 108.357 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.732 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.0 OUTLIER -96.41 174.43 6.87 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.625 -0.927 . . . . 0.0 110.078 -179.323 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.571 ' O ' ' CD2' ' A' ' 60' ' ' TYR . 7.5 m -89.89 158.8 17.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.331 -0.856 . . . . 0.0 110.487 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.732 ' CE2' HG22 ' A' ' 58' ' ' THR . 66.4 m-85 -159.31 119.81 3.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.381 -0.824 . . . . 0.0 109.917 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 68.9 m -89.91 110.65 21.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.175 -0.953 . . . . 0.0 110.29 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.417 HD22 ' CD2' ' A' ' 89' ' ' LEU . 17.5 tp -89.76 126.0 35.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.257 -0.902 . . . . 0.0 109.775 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.501 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 19.8 mtm105 -132.81 130.46 39.88 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.251 -0.906 . . . . 0.0 110.395 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 1.129 ' CZ ' HG21 ' A' ' 102' ' ' VAL . 5.7 p90 -166.0 149.61 7.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.398 -0.814 . . . . 0.0 109.809 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.688 HG23 ' HG2' ' A' ' 101' ' ' GLN . 28.9 m -119.58 89.69 3.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.208 -0.932 . . . . 0.0 110.245 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.734 ' CB ' HD21 ' A' ' 95' ' ' LEU . . . -89.9 149.26 22.7 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.355 -0.84 . . . . 0.0 110.18 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.768 HG23 ' O ' ' A' ' 98' ' ' GLU . 98.8 m -150.19 129.77 13.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.364 -0.835 . . . . 0.0 110.217 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -114.36 142.32 46.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.312 -0.868 . . . . 0.0 109.915 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 68' ' ' ALA . 17.3 m -45.6 -25.64 0.49 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.064 -1.023 . . . . 0.0 109.102 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.78 HG22 ' HB2' ' A' ' 137' ' ' TRP . 4.8 t -119.03 -160.55 0.81 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.589 -0.695 . . . . 0.0 109.835 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.503 ' N ' HG23 ' A' ' 70' ' ' THR . 4.9 m-20 -107.77 67.98 0.7 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.336 -0.853 . . . . 0.0 109.179 178.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.79 HG23 ' CB ' ' A' ' 133' ' ' SER . 3.8 p -88.04 135.64 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.33 -0.856 . . . . 0.0 111.374 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.432 HG22 ' O ' ' A' ' 73' ' ' THR . 7.4 m -121.92 91.42 3.51 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.918 HG11 HD22 ' A' ' 129' ' ' LEU . 5.3 m -89.56 -158.93 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.172 -0.955 . . . . 0.0 110.88 -178.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 14.4 mtm-85 -119.15 107.51 13.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.264 -0.897 . . . . 0.0 110.886 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.494 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -112.1 160.59 17.39 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.156 -0.965 . . . . 0.0 109.797 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.609 HD12 ' N ' ' A' ' 78' ' ' VAL . 3.3 pp 177.71 -156.65 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.295 -0.878 . . . . 0.0 110.201 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.826 HG23 HD22 ' A' ' 89' ' ' LEU . 3.9 t -147.81 168.03 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.217 -0.927 . . . . 0.0 109.527 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.488 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . 177.39 -176.18 47.94 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.39 -1.386 . . . . 0.0 110.174 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.496 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 1.5 tt0 -89.27 -159.16 0.55 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.423 -1.045 . . . . 0.0 110.222 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.501 ' HB2' ' HG2' ' A' ' 122' ' ' GLU . 4.7 m120 -168.12 83.95 0.19 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.352 -0.843 . . . . 0.0 110.166 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.534 ' O ' ' HB3' ' A' ' 83' ' ' ALA . . . 140.55 36.75 0.11 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.537 ' HA ' ' CD2' ' A' ' 85' ' ' TYR . . . 59.49 145.99 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.254 -1.145 . . . . 0.0 110.315 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.461 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.6 Cg_endo -81.79 21.27 11.78 Favored 'Cis proline' 0 C--N 1.314 -1.288 0 C-N-CA 121.755 -2.185 . . . . 0.0 110.869 -0.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.537 ' CD2' ' HA ' ' A' ' 83' ' ' ALA . 50.0 m-85 60.39 124.16 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.095 -1.003 . . . . 0.0 110.282 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -152.86 112.91 0.55 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.568 HG22 ' O ' ' A' ' 78' ' ' VAL . 0.8 OUTLIER -98.09 147.21 24.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.247 -1.149 . . . . 0.0 110.396 -179.891 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 1.063 HG23 HD12 ' A' ' 89' ' ' LEU . 33.2 m -119.97 -20.73 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.299 -0.876 . . . . 0.0 109.966 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 1.063 HD12 HG23 ' A' ' 88' ' ' VAL . 4.5 mp -105.36 143.86 32.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.312 -0.868 . . . . 0.0 110.764 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.732 ' O ' HG23 ' A' ' 91' ' ' THR . 10.1 m-20 -150.63 86.21 1.39 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.294 -0.879 . . . . 0.0 110.245 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.732 HG23 ' O ' ' A' ' 90' ' ' ASP . 1.8 p -159.98 177.98 10.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.167 -0.958 . . . . 0.0 110.476 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.507 ' CB ' ' O ' ' A' ' 74' ' ' VAL . 4.8 m -120.0 129.78 25.18 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.305 -0.872 . . . . 0.0 110.066 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.775 ' HG2' HG22 ' A' ' 74' ' ' VAL . 48.0 Cg_endo -72.19 78.61 1.85 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.906 1.477 . . . . 0.0 110.879 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.533 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -50.84 138.67 18.35 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.059 -1.026 . . . . 0.0 109.313 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.734 HD21 ' CB ' ' A' ' 66' ' ' ALA . 42.7 mt -130.12 176.3 8.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.93 -1.106 . . . . 0.0 110.862 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' A' ' 70' ' ' THR . 0.2 OUTLIER -171.73 -178.66 2.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.493 -0.754 . . . . 0.0 109.786 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 9.8 p -70.25 -7.84 45.39 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.2 -0.938 . . . . 0.0 110.12 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.768 ' O ' HG23 ' A' ' 67' ' ' THR . 4.4 mt-10 -109.18 177.34 1.27 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.238 -0.914 . . . . 0.0 110.077 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.504 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 46.4 Cg_endo -72.6 132.99 19.7 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 124.035 1.545 . . . . 0.0 110.357 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.533 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.59 86.55 2.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.222 -0.924 . . . . 0.0 110.16 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.688 ' HG2' HG23 ' A' ' 65' ' ' THR . 1.8 mt-30 -73.49 155.8 38.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.283 -0.885 . . . . 0.0 110.258 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 1.129 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 23.0 t -134.76 138.34 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -0.906 . . . . 0.0 110.105 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.3 m -150.11 112.51 4.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.931 . . . . 0.0 110.245 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -156.91 133.03 9.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.233 -0.917 . . . . 0.0 110.306 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.548 HG22 ' CG2' ' A' ' 59' ' ' THR . 11.2 m -95.53 94.18 7.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.283 -0.886 . . . . 0.0 110.164 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.585 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 33.8 p90 -94.23 153.57 17.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.27 -0.894 . . . . 0.0 110.281 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 97.3 m -89.72 99.36 12.38 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.175 -0.953 . . . . 0.0 109.811 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.648 ' CB ' ' CD2' ' A' ' 60' ' ' TYR . . . -58.72 104.58 0.23 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.28 -0.888 . . . . 0.0 110.497 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.502 ' HA ' ' HA2' ' A' ' 57' ' ' GLY . 11.1 p -91.11 53.7 2.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.393 -0.817 . . . . 0.0 110.047 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -164.28 -153.43 0.21 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.292 -0.88 . . . . 0.0 110.217 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.545 HG23 ' HA ' ' A' ' 55' ' ' GLU . 14.4 m -150.85 112.55 4.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -0.898 . . . . 0.0 110.341 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.611 ' CE2' HG12 ' A' ' 78' ' ' VAL . 14.4 m-30 -110.81 78.2 1.53 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.289 -0.882 . . . . 0.0 110.171 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.502 ' HD2' ' HA ' ' A' ' 122' ' ' GLU . 44.2 Cg_endo -70.99 -174.0 1.03 Allowed 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.956 1.503 . . . . 0.0 110.347 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 0.0 110.239 -179.931 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.502 ' HA ' ' HD2' ' A' ' 113' ' ' PRO . 1.2 pt-20 . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.237 0.541 . . . . 0.0 110.133 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.582 ' HA3' ' CG ' ' A' ' 112' ' ' TYR . . . -137.28 154.76 22.54 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.66 ' HA ' HG23 ' A' ' 52' ' ' VAL . 1.7 pp0? -150.51 -160.55 1.18 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.151 -1.205 . . . . 0.0 110.623 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.805 HG21 ' HH2' ' A' ' 16' ' ' TRP . 13.8 mt -118.21 143.34 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 76' ' ' ALA . . . -119.31 123.59 44.58 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.234 -0.916 . . . . 0.0 111.198 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.581 ' HE2' HG21 ' A' ' 125' ' ' ILE . 11.3 m-85 -118.51 97.11 5.59 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 178.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.449 ' O ' ' HB ' ' A' ' 74' ' ' VAL . 12.4 mm-40 -88.65 93.23 9.49 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.302 -0.874 . . . . 0.0 111.841 -177.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 1.062 HD13 HD13 ' A' ' 139' ' ' LEU . 15.1 mt -93.94 47.17 1.2 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -84.42 83.1 1.64 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -179.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 55.61 100.13 0.01 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.594 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 9.8 m-85 -139.39 -40.44 0.46 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.312 -1.111 . . . . 0.0 109.943 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.79 ' CB ' HG23 ' A' ' 72' ' ' VAL . 1.3 t -90.86 -176.98 4.83 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.276 -0.89 . . . . 0.0 110.152 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.46 ' N ' ' OG ' ' A' ' 133' ' ' SER . . . -89.05 -88.07 0.16 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.207 -0.933 . . . . 0.0 110.402 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.8 176.49 6.27 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.274 -0.891 . . . . 0.0 110.452 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.583 ' HB2' ' HB2' ' A' ' 38' ' ' ALA . . . -50.12 128.98 20.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.326 -0.859 . . . . 0.0 110.286 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 1.12 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 4.4 p90 -134.92 -170.07 2.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.25 -0.906 . . . . 0.0 110.027 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.526 ' O ' ' CB ' ' A' ' 68' ' ' ALA . 0.5 OUTLIER -160.55 175.18 13.0 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.255 -0.978 . . . . 0.0 110.7 -178.759 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 1.062 HD13 HD13 ' A' ' 129' ' ' LEU . 2.4 mp -127.78 146.46 50.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.312 -0.867 . . . . 0.0 109.731 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' CYS . . . . . 0.517 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 11.8 m -147.56 97.74 2.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.062 -1.024 . . . . 0.0 110.949 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.584 HD12 HD23 ' A' ' 32' ' ' LEU . 0.5 OUTLIER -93.2 -177.07 4.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.168 -0.958 . . . . 0.0 109.222 179.012 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.783 ' O ' HG22 ' A' ' 8' ' ' THR . 0.8 OUTLIER 175.57 38.23 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.058 -1.027 . . . . 0.0 110.624 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.522 ' OD2' ' N ' ' A' ' 65' ' ' THR . 3.8 p-10 175.31 51.45 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.364 -0.835 . . . . 0.0 109.698 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.803 HG11 ' CZ2' ' A' ' 16' ' ' TRP . 3.5 t -90.13 114.88 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.389 -0.819 . . . . 0.0 110.32 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -137.75 133.39 34.05 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.319 -0.863 . . . . 0.0 110.077 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.742 HD21 HD11 ' A' ' 54' ' ' ILE . 39.4 tp -129.17 137.92 51.45 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.276 -0.89 . . . . 0.0 110.182 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.467 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 1.3 t70 -179.07 156.25 0.78 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.229 -0.919 . . . . 0.0 110.253 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.429 ' HB3' ' CG2' ' A' ' 58' ' ' THR . 2.3 p . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.263 -0.898 . . . . 0.0 110.196 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo . . . . . 0 N--CA 1.48 0.699 0 N-CA-C 110.133 -0.757 . . . . 0.0 110.133 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.427 ' O ' ' CD ' ' A' ' 14' ' ' GLU . 8.2 pt -94.76 -13.03 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.203 -0.936 . . . . 0.0 110.139 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 144.09 -25.96 2.05 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.558 ' HA ' ' CB ' ' A' ' 145' ' ' ALA . 6.1 mt-10 54.52 68.77 0.81 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.274 -1.133 . . . . 0.0 110.26 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 170.11 -161.82 35.02 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.781 HG22 ' O ' ' A' ' 142' ' ' ASP . 15.2 p -90.54 -168.06 2.0 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.213 -1.169 . . . . 0.0 110.218 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.521 ' CE1' ' CD1' ' A' ' 16' ' ' TRP . 44.7 m-85 -103.29 49.67 0.82 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.9 . . . . 0.0 110.122 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.546 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 4.8 p30 -84.98 44.63 1.09 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.263 -0.898 . . . . 0.0 110.248 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.546 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 4.5 t0 161.75 78.66 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.264 0.554 . . . . 0.0 109.597 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 70.14 142.49 0.19 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.482 ' O ' ' HB2' ' A' ' 14' ' ' GLU . 48.7 Cg_endo -75.83 3.82 5.7 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.059 1.557 . . . . 0.0 110.666 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 0.1 OUTLIER 67.41 -84.78 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.262 -0.899 . . . . 0.0 110.301 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.463 ' O ' HG13 ' A' ' 17' ' ' VAL . . . -141.46 8.39 2.6 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.92 ' CE2' HD22 ' A' ' 49' ' ' LEU . 38.0 m95 -64.23 131.94 48.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.173 -1.192 . . . . 0.0 110.391 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.702 ' O ' HG13 ' A' ' 47' ' ' VAL . 1.0 OUTLIER -133.5 153.9 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.255 -0.903 . . . . 0.0 109.82 179.692 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.422 ' HB3' HD21 ' A' ' 25' ' ' LEU . . . -139.13 139.41 37.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.333 -0.854 . . . . 0.0 109.348 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.565 ' CE2' ' O ' ' A' ' 46' ' ' GLY . 1.7 p90 -121.52 144.04 48.94 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.165 -0.959 . . . . 0.0 111.093 -178.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.595 ' HA2' ' CE1' ' A' ' 43' ' ' TYR . . . 116.24 82.97 1.0 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.642 ' CG2' ' CE2' ' A' ' 43' ' ' TYR . 1.6 p 52.04 18.26 0.8 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.495 -1.003 . . . . 0.0 110.688 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 1.015 ' HA ' ' HB3' ' A' ' 35' ' ' ALA . 5.4 p30 -114.91 93.07 4.15 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.113 -0.992 . . . . 0.0 109.939 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 22' ' ' ASP . . . -60.31 -121.67 0.01 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.85 145.85 41.34 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.826 1.435 . . . . 0.0 110.488 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 1.081 HD22 HG12 ' A' ' 34' ' ' VAL . 14.3 mt -76.32 102.87 6.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.255 -0.903 . . . . 0.0 110.069 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.503 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 24.4 t0 -43.53 110.24 0.19 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.207 -0.933 . . . . 0.0 109.933 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.831 HG23 ' O ' ' A' ' 25' ' ' LEU . 12.7 p -119.41 -61.15 1.66 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.073 -1.017 . . . . 0.0 110.563 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.43 ' O ' ' OG1' ' A' ' 29' ' ' THR . 68.9 m 43.75 38.61 2.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.156 -0.965 . . . . 0.0 109.921 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 28' ' ' SER . 13.9 p 48.75 80.01 0.07 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.374 -0.829 . . . . 0.0 110.314 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 175.54 -65.5 0.1 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -150.17 151.72 33.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.308 -1.113 . . . . 0.0 110.069 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.72 HD11 ' CD1' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -104.82 94.41 5.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.158 -0.964 . . . . 0.0 110.393 -179.908 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.565 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 0.8 OUTLIER -94.71 115.81 27.98 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.215 -0.928 . . . . 0.0 111.176 179.759 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 1.081 HG12 HD22 ' A' ' 25' ' ' LEU . 16.6 m -89.4 149.43 4.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 1.015 ' HB3' ' HA ' ' A' ' 22' ' ' ASP . . . -88.95 92.99 9.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.314 -0.866 . . . . 0.0 111.093 -178.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.973 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 96.7 t -89.89 123.43 66.23 Favored Pre-proline 0 C--N 1.301 -1.508 0 O-C-N 121.489 -0.757 . . . . 0.0 109.373 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.91 ' HD2' HG21 ' A' ' 45' ' ' VAL . 40.0 Cg_endo -66.1 179.28 1.97 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.845 1.445 . . . . 0.0 112.048 -178.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.545 ' HA ' ' CA ' ' A' ' 136' ' ' ALA . . . -62.99 125.26 23.4 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.542 -0.724 . . . . 0.0 111.285 -179.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.531 ' O ' ' C ' ' A' ' 40' ' ' SER . . . 37.62 28.42 0.04 OUTLIER Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.712 ' OG ' HG23 ' A' ' 45' ' ' VAL . 11.0 t 28.64 53.88 0.08 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.984 -0.715 . . . . 0.0 110.435 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.641 ' O ' ' CG ' ' A' ' 42' ' ' GLN . . . -88.19 114.43 24.8 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.541 -0.725 . . . . 0.0 110.156 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.641 ' CG ' ' O ' ' A' ' 41' ' ' ALA . 1.1 pt20 84.19 30.4 0.06 Allowed 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.642 ' CE2' ' CG2' ' A' ' 21' ' ' THR . 0.1 OUTLIER -149.45 -33.37 0.2 Allowed 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 118.564 -1.254 . . . . 0.0 112.677 -177.888 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.535 ' HA2' ' CA ' ' A' ' 130' ' ' GLY . . . 52.81 79.88 0.08 OUTLIER Glycine 0 N--CA 1.483 1.794 0 N-CA-C 105.733 -2.947 . . . . 0.0 105.733 -176.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.91 HG21 ' HD2' ' A' ' 37' ' ' PRO . 3.8 t -87.64 129.31 39.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.422 -1.046 . . . . 0.0 109.001 -177.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.565 ' O ' ' CE2' ' A' ' 19' ' ' TYR . . . -155.44 156.46 27.0 Favored Glycine 0 N--CA 1.487 2.094 0 C-N-CA 119.018 -1.563 . . . . 0.0 110.172 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.702 HG13 ' O ' ' A' ' 17' ' ' VAL . 11.3 t -112.9 128.46 69.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.419 -1.048 . . . . 0.0 109.791 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.584 ' CG2' ' CG2' ' A' ' 17' ' ' VAL . 27.3 m -119.86 137.06 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.031 -1.043 . . . . 0.0 110.62 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.92 HD22 ' CE2' ' A' ' 16' ' ' TRP . 14.1 tp -131.27 97.4 4.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.341 -0.849 . . . . 0.0 110.197 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.518 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 45.2 m-80 -75.46 147.07 40.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.256 -0.903 . . . . 0.0 110.445 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 124.5 63.2 0.19 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.66 HG11 ' HD2' ' A' ' 112' ' ' TYR . 43.1 t -119.92 158.42 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.163 -1.198 . . . . 0.0 110.177 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -128.12 80.74 1.98 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.224 -0.923 . . . . 0.0 110.695 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 1.082 HD11 HD21 ' A' ' 146' ' ' LEU . 34.7 mm -117.44 173.03 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.244 -0.91 . . . . 0.0 109.72 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.589 ' N ' HG22 ' A' ' 54' ' ' ILE . 1.8 tp10 -166.92 131.58 2.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.966 -1.083 . . . . 0.0 110.785 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.522 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 8.1 pt-20 37.85 -153.9 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.664 -0.647 . . . . 0.0 110.922 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' A' ' 109' ' ' SER . . . -87.77 87.21 1.52 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.561 ' CG2' ' N ' ' A' ' 59' ' ' THR . 1.3 m -113.78 173.6 6.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.269 -1.136 . . . . 0.0 109.843 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.576 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 3.5 m -89.66 153.21 20.91 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.163 -0.961 . . . . 0.0 110.376 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.61 ' HB3' HD11 ' A' ' 146' ' ' LEU . 56.9 m-85 -160.29 179.37 8.73 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.339 -0.85 . . . . 0.0 110.211 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 36.7 m -150.31 115.35 5.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.344 -0.848 . . . . 0.0 109.876 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.917 HD22 ' CD2' ' A' ' 89' ' ' LEU . 13.7 tp -89.45 119.68 30.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.162 -0.961 . . . . 0.0 110.18 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.517 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 6.4 mtm180 -126.37 137.8 53.49 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.45 -0.781 . . . . 0.0 109.693 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.721 ' CZ ' HG21 ' A' ' 102' ' ' VAL . 0.7 OUTLIER -178.3 143.63 0.29 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.288 -0.883 . . . . 0.0 109.676 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.542 HG23 ' N ' ' A' ' 101' ' ' GLN . 69.9 m -119.14 99.49 6.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.244 -0.91 . . . . 0.0 109.962 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.807 ' CB ' HD21 ' A' ' 95' ' ' LEU . . . -99.78 156.77 16.93 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.432 -0.793 . . . . 0.0 110.225 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.647 HG23 ' O ' ' A' ' 98' ' ' GLU . 64.6 m -150.38 121.7 7.85 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.301 -0.875 . . . . 0.0 110.266 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.456 ' CB ' HG12 ' A' ' 72' ' ' VAL . . . -110.07 135.2 51.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.214 -0.928 . . . . 0.0 109.998 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.76 -9.12 25.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.206 -0.934 . . . . 0.0 109.972 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.6 ' CG2' ' CB ' ' A' ' 137' ' ' TRP . 5.0 t -118.37 19.39 13.42 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.326 -0.859 . . . . 0.0 110.214 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.498 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 8.4 t70 43.01 61.1 2.25 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.321 -0.862 . . . . 0.0 109.611 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.901 HG23 ' HB2' ' A' ' 133' ' ' SER . 6.5 p -89.97 139.3 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.387 -0.821 . . . . 0.0 110.95 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.8 m -120.58 85.95 2.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.393 -0.817 . . . . 0.0 109.283 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 1.1 HG21 ' CD2' ' A' ' 129' ' ' LEU . 4.6 m -89.94 -141.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.298 -0.877 . . . . 0.0 110.508 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.688 ' N ' HG23 ' A' ' 74' ' ' VAL . 0.3 OUTLIER -132.32 119.42 20.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.254 -0.904 . . . . 0.0 110.617 -179.574 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.542 ' N ' ' HD3' ' A' ' 93' ' ' PRO . . . -122.63 163.64 19.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.217 -0.927 . . . . 0.0 109.663 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.681 ' CD1' ' HB3' ' A' ' 126' ' ' ALA . 1.8 pp 174.69 -157.62 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.22 -0.925 . . . . 0.0 110.283 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.742 HG23 HD22 ' A' ' 89' ' ' LEU . 4.0 t -144.2 169.45 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.344 -0.847 . . . . 0.0 109.181 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.498 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . 172.2 179.22 42.95 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 118.993 -1.575 . . . . 0.0 110.465 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.5 ' NE2' ' O ' ' A' ' 82' ' ' GLY . 11.6 tt0 -98.15 142.16 30.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.537 -0.978 . . . . 0.0 110.119 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.473 ' OD1' ' HG2' ' A' ' 124' ' ' GLN . 5.7 m120 -95.58 86.0 4.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.276 -0.89 . . . . 0.0 109.968 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.505 ' C ' ' CE1' ' A' ' 85' ' ' TYR . . . 124.68 142.85 6.0 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.619 ' N ' ' CE1' ' A' ' 85' ' ' TYR . . . -42.67 154.12 0.3 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.211 -1.17 . . . . 0.0 110.291 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.457 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.7 Cg_endo -79.38 12.25 20.34 Favored 'Cis proline' 0 C--N 1.312 -1.356 0 C-N-CA 121.673 -2.22 . . . . 0.0 110.896 -0.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.619 ' CE1' ' N ' ' A' ' 83' ' ' ALA . 31.9 m-85 61.79 150.4 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.105 -0.997 . . . . 0.0 110.261 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.457 ' O ' ' HA2' ' A' ' 79' ' ' GLY . . . -171.95 106.9 0.24 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.7 p -96.6 140.52 31.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.195 -1.179 . . . . 0.0 110.261 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 1.088 HG23 HD12 ' A' ' 89' ' ' LEU . 17.3 m -121.71 -15.91 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.274 -0.891 . . . . 0.0 110.177 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 1.088 HD12 HG23 ' A' ' 88' ' ' VAL . 4.4 mp -118.74 142.36 47.76 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.285 -0.884 . . . . 0.0 110.857 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.726 ' O ' HG23 ' A' ' 91' ' ' THR . 2.7 m-20 -150.62 85.65 1.38 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.342 -0.849 . . . . 0.0 110.203 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.726 HG23 ' O ' ' A' ' 90' ' ' ASP . 3.3 p -159.55 -172.32 3.66 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.16 -0.963 . . . . 0.0 110.412 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.436 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 72.1 m -121.75 138.34 28.41 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.324 -0.86 . . . . 0.0 110.207 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.713 ' HG2' HG22 ' A' ' 74' ' ' VAL . 49.4 Cg_endo -76.75 74.29 4.94 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.977 1.514 . . . . 0.0 110.623 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.523 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -49.62 127.37 15.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.121 -0.987 . . . . 0.0 109.557 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.807 HD21 ' CB ' ' A' ' 66' ' ' ALA . 20.8 mt -125.08 165.62 17.86 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.065 -1.022 . . . . 0.0 110.808 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.431 ' CG2' ' HG3' ' A' ' 100' ' ' ARG . 0.1 OUTLIER -157.93 -178.44 7.31 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.45 -0.781 . . . . 0.0 109.923 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.6 p -67.2 -29.17 68.76 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.151 -0.968 . . . . 0.0 110.38 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.647 ' O ' HG23 ' A' ' 67' ' ' THR . 2.6 mt-10 -91.41 179.78 1.33 Allowed Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.19 -0.944 . . . . 0.0 110.12 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.503 ' HD2' ' CB ' ' A' ' 98' ' ' GLU . 46.2 Cg_endo -73.75 130.47 14.69 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.896 1.472 . . . . 0.0 110.276 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.523 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 1.3 mtt-85 -119.83 92.65 3.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.145 -0.972 . . . . 0.0 110.498 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.542 ' N ' HG23 ' A' ' 65' ' ' THR . 1.0 OUTLIER -73.16 156.59 38.47 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.339 -0.851 . . . . 0.0 109.997 179.725 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.721 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 49.8 t -137.02 134.32 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.202 -0.936 . . . . 0.0 110.267 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.443 ' O ' ' CG ' ' A' ' 104' ' ' GLU . 0.2 OUTLIER -150.06 120.5 7.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.231 -0.918 . . . . 0.0 110.249 -179.891 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.443 ' CG ' ' O ' ' A' ' 103' ' ' THR . 14.3 mp0 -160.01 133.73 7.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.213 -0.93 . . . . 0.0 110.222 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.562 HG23 ' O ' ' A' ' 60' ' ' TYR . 24.2 m -92.22 145.05 24.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.168 -0.957 . . . . 0.0 110.228 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.415 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 34.0 p90 -150.21 153.33 36.07 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.312 -0.867 . . . . 0.0 110.315 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.425 ' O ' ' N ' ' A' ' 109' ' ' SER . 22.6 m -90.03 92.62 9.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.247 -0.908 . . . . 0.0 109.917 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.581 ' CB ' ' CD2' ' A' ' 60' ' ' TYR . . . -48.23 96.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.296 -0.878 . . . . 0.0 110.354 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.475 ' HA ' ' HA2' ' A' ' 57' ' ' GLY . 70.0 p -85.24 49.48 1.76 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.268 -0.895 . . . . 0.0 110.145 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.464 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -154.05 -154.16 0.5 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.268 -0.895 . . . . 0.0 110.224 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.524 HG23 ' HA ' ' A' ' 55' ' ' GLU . 18.8 m -150.95 112.66 4.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.268 -0.895 . . . . 0.0 110.277 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.713 ' OH ' HG13 ' A' ' 88' ' ' VAL . 14.7 m-30 -109.91 101.52 47.34 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.32 -0.863 . . . . 0.0 110.152 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.475 ' HG2' ' HA ' ' A' ' 122' ' ' GLU . 42.4 Cg_endo -71.75 136.86 28.76 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.747 1.393 . . . . 0.0 110.019 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.301 -0.874 . . . . 0.0 110.916 -179.158 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.475 ' HA ' ' HG2' ' A' ' 113' ' ' PRO . 5.8 pm0 . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 121.238 0.542 . . . . 0.0 110.056 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.495 ' HA2' ' HA ' ' A' ' 80' ' ' GLN . . . -82.76 146.66 24.54 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.562 ' HA ' ' CG2' ' A' ' 52' ' ' VAL . 7.9 pt20 -150.72 -156.22 0.7 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.206 -1.173 . . . . 0.0 110.696 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.461 ' CG2' ' CE1' ' A' ' 127' ' ' PHE . 10.7 mt -117.82 137.7 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.681 ' HB3' ' CD1' ' A' ' 77' ' ' LEU . . . -114.41 124.95 53.21 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.296 -0.878 . . . . 0.0 111.26 -179.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.493 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 4.4 m-85 -118.39 95.4 4.86 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.561 ' O ' ' CE2' ' A' ' 132' ' ' PHE . 3.0 mp0 -88.38 90.91 8.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.512 -0.743 . . . . 0.0 112.39 -177.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 1.1 ' CD2' HG21 ' A' ' 74' ' ' VAL . 5.4 mt -100.95 45.65 0.97 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 177.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.57 ' O ' ' CD2' ' A' ' 132' ' ' PHE . . . -96.47 136.18 12.67 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' A' ' 39' ' ' GLY . . . 38.25 73.33 0.15 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.604 ' CE1' ' HA ' ' A' ' 74' ' ' VAL . 9.8 m-85 -129.41 -80.27 0.56 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.073 -1.251 . . . . 0.0 110.967 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.901 ' HB2' HG23 ' A' ' 72' ' ' VAL . 14.0 t -89.06 100.31 13.11 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.061 -1.024 . . . . 0.0 110.462 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -30.26 -50.45 0.12 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.967 -0.458 . . . . 0.0 111.75 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.466 ' O ' ' O ' ' A' ' 133' ' ' SER . 6.7 m-20 -73.04 159.6 33.38 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.004 -1.06 . . . . 0.0 110.038 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.545 ' CA ' ' HA ' ' A' ' 38' ' ' ALA . . . -80.57 146.88 31.04 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.358 -0.838 . . . . 0.0 110.355 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.973 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 4.6 p90 -155.58 -166.8 2.33 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.222 -0.924 . . . . 0.0 111.012 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.505 ' CG2' ' SG ' ' A' ' 33' ' ' CYS 0.254 0.7 OUTLIER -149.5 169.07 21.76 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -178.236 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.644 HD21 ' CD1' ' A' ' 95' ' ' LEU . 1.8 mp -133.02 116.91 16.97 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.826 -1.171 . . . . 0.0 111.82 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' CYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 0.8 OUTLIER -102.06 109.53 21.27 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.747 -0.596 . . . . 0.0 111.081 178.895 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.504 HD23 ' HB2' ' A' ' 66' ' ' ALA . 1.5 mt -100.42 -179.0 3.98 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.294 -0.879 . . . . 0.0 108.679 178.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.781 ' O ' HG22 ' A' ' 8' ' ' THR . 1.8 p30 167.14 57.9 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.167 -0.958 . . . . 0.0 110.486 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.521 ' CG ' HG22 ' A' ' 8' ' ' THR . 0.4 OUTLIER 167.35 44.62 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.263 -0.898 . . . . 0.0 109.664 179.838 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.865 HG11 ' HZ2' ' A' ' 16' ' ' TRP . 1.9 t -89.92 114.09 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.434 -0.791 . . . . 0.0 110.205 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.558 ' CB ' ' HA ' ' A' ' 6' ' ' GLU . . . -145.8 155.17 42.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.315 -0.866 . . . . 0.0 110.168 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 1.082 HD21 HD11 ' A' ' 54' ' ' ILE . 10.2 tp -153.83 123.55 6.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.317 -0.864 . . . . 0.0 110.169 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.486 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 11.1 t0 -136.02 147.52 47.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.256 -0.903 . . . . 0.0 110.281 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.59 ' HB3' ' CE1' ' A' ' 60' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.333 -0.854 . . . . 0.0 110.205 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.529 ' N ' ' HB2' ' A' ' 53' ' ' ALA . 49.3 Cg_endo . . . . . 0 N--CA 1.48 0.707 0 N-CA-C 110.03 -0.796 . . . . 0.0 110.03 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 1.049 HD11 ' O ' ' A' ' 144' ' ' VAL . 13.3 pt -92.04 -1.57 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.209 -0.932 . . . . 0.0 110.13 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 6' ' ' GLU . . . 75.82 43.54 22.53 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.512 ' HG3' ' HB1' ' A' ' 145' ' ' ALA . 0.8 OUTLIER 42.54 66.23 0.79 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.295 -1.121 . . . . 0.0 110.189 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.449 ' O ' ' CE1' ' A' ' 9' ' ' PHE . . . -67.82 89.69 0.2 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.454 ' O ' ' HB2' ' A' ' 9' ' ' PHE . 1.9 p -76.14 -1.29 25.41 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.238 -1.154 . . . . 0.0 110.101 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.597 ' CD1' ' HB3' ' A' ' 13' ' ' PRO . 6.3 m-30 60.32 81.42 0.18 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.33 -0.857 . . . . 0.0 110.321 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.543 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 21.0 t70 -142.26 12.22 1.97 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.225 -0.922 . . . . 0.0 110.168 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.543 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.8 OUTLIER 161.47 -24.26 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.678 -0.639 . . . . 0.0 109.609 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -161.23 86.66 0.11 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.597 ' HB3' ' CD1' ' A' ' 9' ' ' PHE . 49.6 Cg_endo -76.0 72.94 5.06 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.153 1.607 . . . . 0.0 110.963 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.452 ' HG3' ' HB ' ' A' ' 4' ' ' ILE . 25.6 mm-40 38.33 -92.0 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.491 -0.756 . . . . 0.0 110.782 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.561 ' O ' HG13 ' A' ' 17' ' ' VAL . . . -153.42 17.87 0.68 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.932 ' NE1' HD22 ' A' ' 49' ' ' LEU . 41.3 m95 -42.93 122.52 2.44 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -1.135 . . . . 0.0 110.4 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.737 ' O ' HG13 ' A' ' 47' ' ' VAL . 1.9 m -119.28 153.2 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.177 -0.952 . . . . 0.0 109.865 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.433 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . . . -137.58 122.47 18.89 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.165 -0.959 . . . . 0.0 109.96 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.563 ' CZ ' ' O ' ' A' ' 46' ' ' GLY . 3.7 p90 -115.24 154.78 28.44 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.39 -0.819 . . . . 0.0 110.498 -179.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.632 ' O ' HG22 ' A' ' 45' ' ' VAL . . . 90.77 29.11 13.96 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.484 ' HB ' ' O ' ' A' ' 35' ' ' ALA . 14.2 p -146.15 -160.38 1.14 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.127 -1.219 . . . . 0.0 110.303 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.45 ' O ' ' O ' ' A' ' 23' ' ' GLY . 12.4 t0 -89.93 123.47 33.88 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 0.0 110.196 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 22' ' ' ASP . . . 43.94 -166.1 0.03 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.416 ' O ' ' O ' ' A' ' 25' ' ' LEU . 45.5 Cg_endo -73.18 162.74 39.86 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.066 1.561 . . . . 0.0 110.405 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.828 HD13 HD11 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -59.37 -154.43 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.265 -0.897 . . . . 0.0 110.185 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -152.48 161.35 42.71 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.269 -0.894 . . . . 0.0 110.145 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.597 HG21 ' HD3' ' A' ' 13' ' ' PRO . 0.7 OUTLIER -125.22 -28.2 3.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.27 -0.894 . . . . 0.0 110.235 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.454 ' O ' ' OG1' ' A' ' 29' ' ' THR . 0.5 OUTLIER 48.48 23.48 0.61 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.216 -0.927 . . . . 0.0 110.152 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.454 ' OG1' ' O ' ' A' ' 28' ' ' SER . 17.9 p 47.19 65.83 1.15 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.297 -0.877 . . . . 0.0 110.268 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.526 ' N ' ' HA ' ' A' ' 10' ' ' ASP . . . 169.85 -50.17 0.21 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.451 ' HB1' ' O ' ' A' ' 141' ' ' LEU . . . -150.04 141.51 23.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -1.117 . . . . 0.0 110.292 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.828 HD11 HD13 ' A' ' 25' ' ' LEU . 5.8 tt -79.96 110.87 15.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.215 -0.928 . . . . 0.0 109.921 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 88.7 m -118.43 129.2 55.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.141 -0.975 . . . . 0.0 110.708 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.532 ' CG2' ' HB2' ' A' ' 139' ' ' LEU . 17.9 m -98.83 153.06 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.301 -0.874 . . . . 0.0 109.692 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.498 ' HA ' ' OG1' ' A' ' 138' ' ' THR . . . -102.76 87.65 3.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.249 -0.907 . . . . 0.0 110.898 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.101 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 57.5 t -75.98 132.14 74.67 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.161 -0.962 . . . . 0.0 109.386 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.524 ' CG ' ' OH ' ' A' ' 43' ' ' TYR . 47.8 Cg_endo -78.89 158.24 27.49 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.87 1.458 . . . . 0.0 111.114 -179.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.502 ' HA ' ' CA ' ' A' ' 136' ' ' ALA . . . -42.94 126.79 3.95 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.291 -0.881 . . . . 0.0 109.775 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 38' ' ' ALA . . . 47.92 86.67 0.01 OUTLIER Glycine 0 N--CA 1.485 1.963 0 N-CA-C 108.385 -1.886 . . . . 0.0 108.385 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.835 ' HB2' HG21 ' A' ' 45' ' ' VAL . 0.8 OUTLIER -82.2 39.04 0.56 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.353 -1.086 . . . . 0.0 110.636 -179.453 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.953 ' HB2' ' HA3' ' A' ' 131' ' ' GLY . . . -105.25 20.23 19.24 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.17 -0.957 . . . . 0.0 109.756 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.589 ' HG3' ' CD2' ' A' ' 43' ' ' TYR . 17.6 pt20 -93.04 27.02 2.58 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 121.581 0.705 . . . . 0.0 109.5 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.628 ' CD1' ' N ' ' A' ' 43' ' ' TYR . 0.0 OUTLIER 159.55 6.24 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.203 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.725 179.357 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.479 ' HA2' ' HA2' ' A' ' 130' ' ' GLY . . . 67.6 100.77 0.03 OUTLIER Glycine 0 N--CA 1.487 2.042 0 O-C-N 120.502 -1.374 . . . . 0.0 109.83 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.835 HG21 ' HB2' ' A' ' 40' ' ' SER . 48.8 t -89.19 170.37 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.119 -1.224 . . . . 0.0 108.431 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.563 ' O ' ' CZ ' ' A' ' 19' ' ' TYR . . . 167.33 140.45 2.91 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 118.943 -1.598 . . . . 0.0 110.721 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.737 HG13 ' O ' ' A' ' 17' ' ' VAL . 21.3 t -105.94 132.2 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.505 -0.997 . . . . 0.0 109.605 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.732 ' O ' HG22 ' A' ' 17' ' ' VAL . 35.6 m -126.9 141.03 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.923 -1.111 . . . . 0.0 110.572 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.932 HD22 ' NE1' ' A' ' 16' ' ' TRP . 14.2 tp -132.12 102.26 5.73 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.329 -0.857 . . . . 0.0 110.207 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.53 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 1.4 m-80 -80.08 122.79 27.22 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.289 -0.882 . . . . 0.0 110.424 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.549 ' O ' HG22 ' A' ' 4' ' ' ILE . . . 146.04 74.47 0.02 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.627 HG12 ' H ' ' A' ' 53' ' ' ALA . 6.3 t -119.81 178.84 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.185 -1.185 . . . . 0.0 110.086 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.887 ' O ' HD13 ' A' ' 54' ' ' ILE . . . -132.84 84.01 2.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.174 -0.954 . . . . 0.0 110.441 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.887 HD13 ' O ' ' A' ' 53' ' ' ALA . 5.6 mm -143.08 163.48 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.227 -0.92 . . . . 0.0 109.625 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.687 ' HG3' HG23 ' A' ' 111' ' ' THR . 8.1 tt0 -178.88 32.44 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.101 -0.999 . . . . 0.0 110.28 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 55' ' ' GLU . 2.0 tt0 179.78 -176.44 0.32 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.529 -0.732 . . . . 0.0 110.07 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.487 ' HA2' ' HA ' ' A' ' 109' ' ' SER . . . -93.41 67.07 1.7 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.255 -1.938 . . . . 0.0 108.255 178.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.716 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.0 OUTLIER -105.08 177.68 4.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.585 -0.95 . . . . 0.0 110.265 -179.036 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.584 ' N ' ' CG2' ' A' ' 58' ' ' THR . 0.6 OUTLIER -88.95 154.62 20.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.302 -0.874 . . . . 0.0 110.016 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.957 ' HB3' HD11 ' A' ' 146' ' ' LEU . 59.3 m-85 -155.98 124.37 5.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.346 -0.847 . . . . 0.0 110.061 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 28.9 m -94.1 115.23 27.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.204 -0.935 . . . . 0.0 110.108 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.668 HD22 ' CD2' ' A' ' 89' ' ' LEU . 19.4 tp -89.39 122.53 32.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.173 -0.954 . . . . 0.0 109.816 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.502 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 6.3 mtt180 -123.4 140.58 52.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.311 -0.868 . . . . 0.0 110.263 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.992 ' CZ ' HG21 ' A' ' 102' ' ' VAL . 1.6 p90 -178.28 147.53 0.43 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.41 -0.806 . . . . 0.0 109.629 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 47.6 m -119.37 91.04 3.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.115 -0.99 . . . . 0.0 110.407 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.603 ' CB ' HD21 ' A' ' 95' ' ' LEU . . . -90.06 147.65 23.52 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.366 -0.833 . . . . 0.0 110.069 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.5 ' OG1' ' HA ' ' A' ' 99' ' ' PRO . 40.7 m -146.84 131.9 18.26 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.27 -0.894 . . . . 0.0 110.442 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.598 ' CB ' HG12 ' A' ' 72' ' ' VAL . . . -123.85 136.57 54.46 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.35 -0.844 . . . . 0.0 109.906 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 64.5 m -65.17 -9.06 20.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.177 -0.952 . . . . 0.0 110.314 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.565 ' CG2' ' HB2' ' A' ' 137' ' ' TRP . 6.4 t -119.77 19.79 12.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.25 -0.906 . . . . 0.0 110.237 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.484 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 13.2 t70 43.57 49.94 6.42 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.295 -0.878 . . . . 0.0 109.678 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.762 ' CG1' HD12 ' A' ' 95' ' ' LEU . 8.8 p -75.47 145.64 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.429 -0.794 . . . . 0.0 110.662 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 89.7 m -119.94 86.06 2.49 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.39 -0.819 . . . . 0.0 109.339 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.711 HG12 ' HB2' ' A' ' 132' ' ' PHE . 15.0 m -89.5 -141.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.258 -0.901 . . . . 0.0 110.312 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.535 ' N ' HG23 ' A' ' 74' ' ' VAL . 16.0 mtm-85 -131.94 148.05 52.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.129 -0.982 . . . . 0.0 110.851 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.758 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -148.34 155.35 41.17 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.336 -0.853 . . . . 0.0 109.998 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.057 ' CD1' ' HB3' ' A' ' 126' ' ' ALA . 2.1 pp 175.82 -160.52 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 0.0 110.294 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.904 ' CG2' HD22 ' A' ' 89' ' ' LEU . 4.3 t -147.78 167.98 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.303 -0.873 . . . . 0.0 109.597 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.505 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . 174.08 -175.76 46.54 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.33 -1.414 . . . . 0.0 110.314 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.527 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 3.5 tm0? -94.37 178.25 5.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.458 -1.025 . . . . 0.0 110.142 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.536 ' ND2' ' HG2' ' A' ' 124' ' ' GLN . 3.8 m-80 -146.53 87.75 1.73 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.248 -0.907 . . . . 0.0 110.155 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.512 ' O ' ' HB3' ' A' ' 83' ' ' ALA . . . 137.07 34.27 0.21 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.544 ' HA ' ' CD2' ' A' ' 85' ' ' TYR . . . 59.07 148.31 0.07 OUTLIER Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.133 -1.216 . . . . 0.0 110.407 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.453 ' O ' ' O ' ' A' ' 85' ' ' TYR . 52.4 Cg_endo -80.37 21.03 9.08 Favored 'Cis proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.761 -2.183 . . . . 0.0 111.103 -0.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.544 ' CD2' ' HA ' ' A' ' 83' ' ' ALA . 35.6 m-85 60.93 130.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.057 -1.027 . . . . 0.0 110.239 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.465 ' O ' ' HA2' ' A' ' 79' ' ' GLY . . . -151.44 99.05 0.19 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.3 p -91.16 134.15 34.78 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.287 -1.125 . . . . 0.0 110.187 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 1.109 HG23 HD12 ' A' ' 89' ' ' LEU . 32.1 m -120.24 -9.2 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.233 -0.917 . . . . 0.0 110.092 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 1.109 HD12 HG23 ' A' ' 88' ' ' VAL . 4.2 mp -118.63 137.63 53.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.275 -0.89 . . . . 0.0 111.006 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.405 ' C ' HG23 ' A' ' 91' ' ' THR . 12.0 p-10 -150.71 85.13 1.36 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.486 -0.759 . . . . 0.0 109.951 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.405 HG23 ' C ' ' A' ' 90' ' ' ASP . 65.6 p -144.08 -174.28 4.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.053 -1.029 . . . . 0.0 110.698 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.2 m -119.69 116.88 32.96 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.364 -0.835 . . . . 0.0 109.947 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.758 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 44.6 Cg_endo -71.84 79.61 1.59 Allowed 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.923 1.486 . . . . 0.0 110.642 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.805 ' HB3' HH11 ' A' ' 100' ' ' ARG . . . -67.03 148.17 52.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.208 -0.932 . . . . 0.0 109.833 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.762 HD12 ' CG1' ' A' ' 72' ' ' VAL . 73.3 mt -134.08 176.97 8.11 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.187 -0.946 . . . . 0.0 110.475 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.404 ' O ' HG23 ' A' ' 67' ' ' THR . 0.3 OUTLIER -170.66 -179.14 2.81 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.275 -0.891 . . . . 0.0 110.14 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.63 -30.27 71.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.257 -0.902 . . . . 0.0 110.039 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.525 ' CB ' ' HD2' ' A' ' 99' ' ' PRO . 0.1 OUTLIER -93.1 179.72 1.23 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.278 -0.889 . . . . 0.0 110.042 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.525 ' HD2' ' CB ' ' A' ' 98' ' ' GLU . 44.3 Cg_endo -72.06 134.99 24.33 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.9 1.474 . . . . 0.0 110.287 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.805 HH11 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.73 85.81 2.45 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.283 -0.885 . . . . 0.0 110.25 -179.893 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.413 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 8.7 mt-30 -71.7 156.33 39.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.27 -0.894 . . . . 0.0 110.216 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.992 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 40.7 t -139.66 138.92 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.24 -0.913 . . . . 0.0 110.166 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.07 116.34 6.53 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.252 -0.905 . . . . 0.0 110.131 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -140.88 131.87 26.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.253 -0.904 . . . . 0.0 110.245 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.527 HG22 HG22 ' A' ' 59' ' ' THR . 4.4 m -89.82 65.42 6.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.181 -0.949 . . . . 0.0 110.225 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.61 ' CZ ' ' CB ' ' A' ' 60' ' ' TYR . 26.1 p90 -71.29 144.95 49.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 0.0 110.099 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.531 ' O ' ' N ' ' A' ' 109' ' ' SER . 3.5 m -89.35 92.76 9.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.17 -0.956 . . . . 0.0 109.699 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.634 ' CB ' ' CD2' ' A' ' 60' ' ' TYR . . . -45.23 92.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.37 -0.831 . . . . 0.0 110.156 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 107' ' ' THR . 81.2 p -89.45 54.68 2.99 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.332 -0.855 . . . . 0.0 109.61 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -163.34 -155.2 0.31 Allowed 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.465 -0.894 . . . . 0.0 110.678 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.687 HG23 ' HG3' ' A' ' 55' ' ' GLU . 4.5 m -148.14 118.58 7.4 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.294 -0.879 . . . . 0.0 110.587 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.598 ' CD2' HG13 ' A' ' 54' ' ' ILE . 15.8 m-30 -112.61 85.52 7.48 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.497 -0.752 . . . . 0.0 109.542 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.677 ' HD3' HG22 ' A' ' 111' ' ' THR . 43.4 Cg_endo -69.97 127.77 14.9 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 123.86 1.453 . . . . 0.0 110.49 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.318 -0.864 . . . . 0.0 110.395 -179.796 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.487 ' HB2' ' O ' ' A' ' 113' ' ' PRO . 0.9 OUTLIER . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 121.298 0.57 . . . . 0.0 110.663 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.613 ' O ' HG23 ' A' ' 52' ' ' VAL . . . -106.51 155.55 16.51 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.552 ' HA ' ' CG2' ' A' ' 52' ' ' VAL . 1.1 pt20 -150.4 -160.15 1.13 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.168 -1.195 . . . . 0.0 110.719 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.819 HG21 ' HH2' ' A' ' 16' ' ' TRP . 18.3 mt -118.34 142.65 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 1.057 ' HB3' ' CD1' ' A' ' 77' ' ' LEU . . . -118.03 120.98 39.43 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.249 -0.907 . . . . 0.0 111.439 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.498 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 4.9 m-85 -118.79 100.79 7.62 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.543 ' O ' ' CE2' ' A' ' 132' ' ' PHE . 32.1 mm-40 -89.47 103.15 15.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.127 -0.983 . . . . 0.0 112.313 -177.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.624 ' CD2' HG21 ' A' ' 74' ' ' VAL . 11.5 mt -100.68 41.04 1.2 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 177.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.479 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -67.61 85.68 0.15 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 -179.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.953 ' HA3' ' HB2' ' A' ' 41' ' ' ALA . . . 40.57 79.23 0.05 OUTLIER Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.711 ' HB2' HG12 ' A' ' 74' ' ' VAL . 10.5 m-85 -107.28 -42.64 4.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.171 -1.194 . . . . 0.0 110.183 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.703 ' HB2' HG23 ' A' ' 72' ' ' VAL . 1.2 t -89.81 -176.5 4.97 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.198 -0.938 . . . . 0.0 110.238 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.46 ' N ' ' OG ' ' A' ' 133' ' ' SER . . . -96.69 -92.23 0.23 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.122 -0.986 . . . . 0.0 110.855 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -63.63 170.75 3.03 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.187 -0.946 . . . . 0.0 110.637 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.502 ' CA ' ' HA ' ' A' ' 38' ' ' ALA . . . -52.92 136.53 34.37 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.392 -0.817 . . . . 0.0 110.397 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 1.101 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 8.1 p90 -145.17 -167.55 2.71 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.314 -0.866 . . . . 0.0 110.336 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.538 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 0.5 OUTLIER -160.35 165.96 30.27 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.214 -0.929 . . . . 0.0 110.398 -178.729 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.543 ' HG ' HD13 ' A' ' 95' ' ' LEU . 2.4 mp -119.52 161.32 20.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.434 -0.791 . . . . 0.0 109.209 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' CYS . . . . . . . . . . . . . 1.9 m -150.58 94.44 2.1 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.069 -1.019 . . . . 0.0 111.209 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.493 ' HA ' ' O ' ' A' ' 65' ' ' THR . 0.9 OUTLIER -95.14 -176.03 3.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.229 -0.919 . . . . 0.0 108.903 178.754 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.486 ' CB ' ' O ' ' A' ' 141' ' ' LEU . 0.5 OUTLIER 170.2 37.25 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.051 -1.031 . . . . 0.0 110.631 179.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.467 ' O ' ' O ' ' A' ' 63' ' ' ARG . 34.5 t0 179.35 48.75 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.184 -0.948 . . . . 0.0 110.056 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 1.049 ' O ' HD11 ' A' ' 4' ' ' ILE . 2.8 t -89.77 113.51 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.369 -0.832 . . . . 0.0 110.08 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.512 ' HB1' ' HG3' ' A' ' 6' ' ' GLU . . . -144.4 163.19 34.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.263 -0.898 . . . . 0.0 110.219 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.957 HD11 ' HB3' ' A' ' 60' ' ' TYR . 16.3 tp -145.99 128.87 16.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.27 -0.894 . . . . 0.0 110.218 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.581 ' O ' ' CD1' ' A' ' 60' ' ' TYR . 0.3 OUTLIER -135.75 -154.15 0.55 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.302 -0.874 . . . . 0.0 110.238 179.988 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 48.3 p . . . . . 0 N--CA 1.492 1.665 0 O-C-N 121.273 -0.892 . . . . 0.0 110.116 179.991 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo . . . . . 0 N--CA 1.48 0.69 0 N-CA-C 110.097 -0.77 . . . . 0.0 110.097 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.731 HD11 ' O ' ' A' ' 144' ' ' VAL . 7.8 pt -120.52 -3.62 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.181 -0.95 . . . . 0.0 110.128 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 6' ' ' GLU . . . 97.52 139.17 10.54 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 5' ' ' GLY . 0.4 OUTLIER -42.76 -85.5 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.241 -1.152 . . . . 0.0 110.126 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.5 ' HA2' ' HA ' ' A' ' 143' ' ' ASP . . . -80.85 127.66 8.03 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.69 HG21 ' HB ' ' A' ' 144' ' ' VAL . 16.3 p -107.0 163.89 12.6 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.147 -1.208 . . . . 0.0 110.64 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.604 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.1 m-30 65.89 9.79 6.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.452 -0.78 . . . . 0.0 110.229 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.552 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 4.0 p-10 -86.12 41.66 0.94 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.159 -0.963 . . . . 0.0 109.885 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.552 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 2.1 t70 161.3 -24.17 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 172.91 164.21 27.95 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.635 ' CB ' HD11 ' A' ' 25' ' ' LEU . 44.1 Cg_endo -71.17 81.56 1.16 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.011 1.532 . . . . 0.0 110.442 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.48 ' C ' ' O ' ' A' ' 13' ' ' PRO . 1.0 OUTLIER -31.42 -68.2 0.09 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.275 0.559 . . . . 0.0 111.163 -179.636 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.495 ' C ' ' CD1' ' A' ' 49' ' ' LEU . . . -152.47 14.05 0.71 Allowed Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.765 -1.207 . . . . 0.0 110.218 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 1.103 ' NE1' HD22 ' A' ' 49' ' ' LEU . 24.2 m95 -77.77 110.08 12.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.028 -1.278 . . . . 0.0 110.244 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.541 HG22 HG23 ' A' ' 48' ' ' VAL . 2.2 m -100.64 125.67 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.238 -0.914 . . . . 0.0 110.068 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.575 ' HB2' HG11 ' A' ' 34' ' ' VAL . . . -104.17 119.32 38.69 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.156 -0.965 . . . . 0.0 110.093 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.588 ' CZ ' ' O ' ' A' ' 46' ' ' GLY . 6.2 p90 -112.42 148.05 35.16 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.298 -0.876 . . . . 0.0 110.458 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.537 ' CA ' ' OH ' ' A' ' 43' ' ' TYR . . . 96.82 34.62 5.66 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.481 ' CG2' ' C ' ' A' ' 20' ' ' GLY . 7.3 p -150.21 -147.31 0.22 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.137 -1.214 . . . . 0.0 110.407 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 23' ' ' GLY . 62.2 t0 -89.96 114.77 26.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.334 -0.854 . . . . 0.0 110.33 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 43.16 -155.52 0.16 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.32 157.32 49.94 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 124.031 1.543 . . . . 0.0 110.493 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.639 HD23 ' H ' ' A' ' 25' ' ' LEU . 0.6 OUTLIER -53.63 179.8 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.254 -0.904 . . . . 0.0 110.201 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -152.58 142.33 21.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.27 -0.894 . . . . 0.0 110.196 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.78 HG22 ' HA ' ' A' ' 32' ' ' LEU . 2.2 p -119.64 -79.97 0.61 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.295 -0.878 . . . . 0.0 110.031 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.42 ' OG ' ' C ' ' A' ' 27' ' ' THR . 1.6 p 40.44 27.46 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.384 -0.822 . . . . 0.0 110.645 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.482 HG22 ' O ' ' A' ' 27' ' ' THR . 12.8 t -148.7 13.93 0.93 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.139 -0.976 . . . . 0.0 110.364 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 9' ' ' PHE . . . 75.48 7.86 83.3 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.643 ' HB1' ' O ' ' A' ' 141' ' ' LEU . . . -150.35 151.38 32.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.256 -1.144 . . . . 0.0 110.118 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.78 ' HA ' HG22 ' A' ' 27' ' ' THR . 0.5 OUTLIER -79.85 114.56 18.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.123 -0.986 . . . . 0.0 109.822 179.829 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 67.0 m -120.93 118.27 29.46 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.184 -0.947 . . . . 0.0 110.745 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.575 HG11 ' HB2' ' A' ' 18' ' ' ALA . 15.3 m -99.52 135.38 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.35 -0.844 . . . . 0.0 109.494 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.476 ' O ' ' HB ' ' A' ' 21' ' ' THR . . . -89.47 89.74 7.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.207 -0.933 . . . . 0.0 111.089 -179.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.141 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 53.1 t -69.87 134.53 87.89 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.245 -0.91 . . . . 0.0 109.416 179.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 21' ' ' THR . 47.2 Cg_endo -76.68 152.85 33.53 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.944 1.497 . . . . 0.0 111.325 -178.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.503 ' HA ' ' N ' ' A' ' 136' ' ' ALA . . . -43.89 130.99 5.74 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.373 -0.83 . . . . 0.0 109.884 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 38' ' ' ALA . . . 45.24 78.18 0.08 OUTLIER Glycine 0 N--CA 1.487 2.041 0 N-CA-C 108.724 -1.75 . . . . 0.0 108.724 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.883 ' HB2' HG21 ' A' ' 45' ' ' VAL . 1.1 p -82.76 40.33 0.67 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.304 -1.115 . . . . 0.0 110.473 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.966 ' HB2' ' HA3' ' A' ' 131' ' ' GLY . . . -109.1 25.13 12.17 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.361 -0.837 . . . . 0.0 109.767 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.51 ' O ' ' HB3' ' A' ' 43' ' ' TYR . 16.3 pt20 -78.14 2.7 17.19 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.637 0.732 . . . . 0.0 110.542 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.537 ' OH ' ' CA ' ' A' ' 20' ' ' GLY . 2.5 p90 177.26 -32.52 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.508 ' O ' ' CE2' ' A' ' 43' ' ' TYR . . . 123.48 104.47 1.68 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 110.266 -1.133 . . . . 0.0 110.266 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.883 HG21 ' HB2' ' A' ' 40' ' ' SER . 39.8 t -89.7 177.27 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.066 -1.255 . . . . 0.0 108.502 178.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.588 ' O ' ' CZ ' ' A' ' 19' ' ' TYR . . . 160.55 140.11 2.81 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 118.491 -1.814 . . . . 0.0 111.66 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.608 ' O ' HG13 ' A' ' 48' ' ' VAL . 21.5 t -100.53 162.17 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.644 -0.915 . . . . 0.0 108.693 178.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.608 HG13 ' O ' ' A' ' 47' ' ' VAL . 15.6 m -157.25 157.61 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.841 -1.162 . . . . 0.0 110.71 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 1.103 HD22 ' NE1' ' A' ' 16' ' ' TRP . 13.8 tp -151.33 120.28 6.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.327 -0.858 . . . . 0.0 110.351 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.483 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 23.7 p30 -96.26 158.24 15.53 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.216 -0.927 . . . . 0.0 110.234 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.11 74.4 0.62 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.594 HG12 ' N ' ' A' ' 53' ' ' ALA . 87.2 t -138.83 172.43 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.173 -1.193 . . . . 0.0 110.177 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.594 ' N ' HG12 ' A' ' 52' ' ' VAL . . . -139.5 101.19 4.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.173 -0.955 . . . . 0.0 110.409 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.65 ' CG1' ' CD2' ' A' ' 112' ' ' TYR . 45.0 mm -126.34 173.13 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.248 -0.907 . . . . 0.0 109.987 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.676 ' HA ' HG23 ' A' ' 111' ' ' THR . 0.0 OUTLIER -164.74 128.59 2.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.118 -0.989 . . . . 0.0 110.814 -179.923 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 8.3 pt-20 37.74 -153.31 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.673 -0.642 . . . . 0.0 110.999 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 108' ' ' ALA . . . -87.03 75.67 2.16 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.582 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.3 m -101.67 173.61 6.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.334 -1.098 . . . . 0.0 109.807 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.575 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 0.7 OUTLIER -89.96 153.27 20.73 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.235 -0.916 . . . . 0.0 110.559 -179.577 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.636 ' CD2' ' HB2' ' A' ' 108' ' ' ALA . 64.3 m-85 -159.96 123.12 3.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.311 -0.868 . . . . 0.0 110.01 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 30.6 m -89.88 115.35 27.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.161 -0.962 . . . . 0.0 110.167 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.423 HD22 ' CD2' ' A' ' 89' ' ' LEU . 15.2 tp -89.5 126.27 35.52 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.232 -0.918 . . . . 0.0 109.907 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.523 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 14.3 ttp85 -131.16 136.49 48.36 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.385 -0.822 . . . . 0.0 110.107 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 1.165 ' CZ ' HG21 ' A' ' 102' ' ' VAL . 0.6 OUTLIER -178.46 143.2 0.26 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.383 -0.823 . . . . 0.0 109.57 179.678 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.85 HG23 ' CA ' ' A' ' 101' ' ' GLN . 0.2 OUTLIER -119.26 93.35 4.05 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.149 -0.969 . . . . 0.0 110.434 -179.466 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.688 ' HB2' HD23 ' A' ' 141' ' ' LEU . . . -94.81 153.95 17.49 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.293 -0.879 . . . . 0.0 110.119 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.535 HG23 ' O ' ' A' ' 98' ' ' GLU . 51.9 m -150.14 135.65 18.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.22 -0.925 . . . . 0.0 110.363 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 138' ' ' THR . . . -126.14 140.06 52.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.282 -0.886 . . . . 0.0 110.013 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.9 m -71.2 -3.71 21.67 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.22 -0.925 . . . . 0.0 110.113 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.569 ' CG2' ' HB2' ' A' ' 137' ' ' TRP . 6.3 t -124.62 19.84 8.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 110.096 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.487 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 14.9 t0 43.51 60.77 2.48 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.272 -0.892 . . . . 0.0 109.558 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.742 HG23 ' HB2' ' A' ' 133' ' ' SER . 5.5 p -87.07 140.96 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.463 -0.773 . . . . 0.0 110.87 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 23.2 m -119.86 87.88 2.83 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.483 -0.761 . . . . 0.0 109.107 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.819 HG11 HD22 ' A' ' 129' ' ' LEU . 19.2 m -89.73 -146.15 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -0.906 . . . . 0.0 110.382 -179.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.414 ' N ' HG23 ' A' ' 74' ' ' VAL . 0.4 OUTLIER -127.16 124.14 38.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.244 -0.91 . . . . 0.0 110.434 -179.67 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.655 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -126.99 158.67 36.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.309 -0.869 . . . . 0.0 109.666 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.912 HD11 ' HB3' ' A' ' 126' ' ' ALA . 3.4 pp 177.87 -157.33 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.19 -0.944 . . . . 0.0 110.475 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.715 HG23 HD22 ' A' ' 89' ' ' LEU . 9.8 t -143.56 -178.21 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.339 -0.851 . . . . 0.0 109.558 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.631 ' H ' HG12 ' A' ' 78' ' ' VAL . . . 161.56 -154.93 26.03 Favored Glycine 0 N--CA 1.49 2.274 0 C-N-CA 119.303 -1.427 . . . . 0.0 110.053 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.571 ' HB3' ' CD1' ' A' ' 112' ' ' TYR . 6.2 pt20 -135.21 158.36 44.56 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.469 -1.018 . . . . 0.0 110.356 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.466 ' HB2' ' HG2' ' A' ' 122' ' ' GLU . 2.4 m120 -107.23 97.22 7.01 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.315 -0.866 . . . . 0.0 110.038 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.542 ' C ' ' CE1' ' A' ' 85' ' ' TYR . . . 138.44 143.01 4.4 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.593 ' N ' ' CE1' ' A' ' 85' ' ' TYR . . . -65.95 155.7 86.08 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.262 -1.14 . . . . 0.0 110.222 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.533 ' C ' ' CD2' ' A' ' 85' ' ' TYR . 50.6 Cg_endo -77.48 8.94 17.83 Favored 'Cis proline' 0 C--N 1.313 -1.322 0 C-N-CA 121.637 -2.235 . . . . 0.0 110.905 0.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.593 ' CE1' ' N ' ' A' ' 83' ' ' ALA . 10.5 m-85 69.33 -171.23 0.18 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.231 -0.918 . . . . 0.0 110.214 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 153.46 107.27 0.31 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.504 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 4.1 p -96.05 167.84 10.98 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.211 -1.17 . . . . 0.0 110.391 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.812 HG12 ' N ' ' A' ' 109' ' ' SER . 5.4 m -135.5 -32.76 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.364 -0.835 . . . . 0.0 110.324 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.715 HD22 HG23 ' A' ' 78' ' ' VAL . 4.3 mp -98.3 144.24 27.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -0.909 . . . . 0.0 110.859 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.651 ' O ' HG23 ' A' ' 91' ' ' THR . 17.4 p-10 -151.08 86.11 1.36 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.324 -0.86 . . . . 0.0 110.172 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.651 HG23 ' O ' ' A' ' 90' ' ' ASP . 2.4 p -157.52 -175.03 5.16 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.024 -1.047 . . . . 0.0 110.531 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.49 130.47 24.78 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.326 -0.858 . . . . 0.0 110.172 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.655 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 49.7 Cg_endo -75.44 80.58 2.49 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.961 1.506 . . . . 0.0 110.87 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.69 ' HB3' HH11 ' A' ' 100' ' ' ARG . . . -56.55 135.63 54.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.059 -1.025 . . . . 0.0 109.479 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.71 HD12 ' CG1' ' A' ' 72' ' ' VAL . 93.4 mt -125.16 176.22 6.87 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.032 -1.043 . . . . 0.0 110.691 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.52 HG22 ' HG3' ' A' ' 100' ' ' ARG . 0.3 OUTLIER -167.9 -178.92 3.97 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.43 -0.794 . . . . 0.0 110.039 179.922 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.4 -29.87 70.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.196 -0.94 . . . . 0.0 110.281 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.535 ' O ' HG23 ' A' ' 67' ' ' THR . 3.7 mt-10 -90.28 176.7 2.8 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.172 -0.955 . . . . 0.0 110.14 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.499 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 45.4 Cg_endo -72.19 134.44 23.05 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.956 1.503 . . . . 0.0 110.334 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.69 HH11 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.9 92.94 3.9 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.191 -0.943 . . . . 0.0 110.368 -179.868 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.85 ' CA ' HG23 ' A' ' 65' ' ' THR . 6.4 tp-100 -76.71 154.92 33.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.292 -0.88 . . . . 0.0 110.085 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 1.165 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 32.2 t -131.72 134.47 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.232 -0.917 . . . . 0.0 110.194 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.25 115.61 5.45 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.275 -0.891 . . . . 0.0 110.138 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -159.88 131.19 5.95 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.207 -0.933 . . . . 0.0 110.32 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.6 m -89.97 105.25 17.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.261 -0.899 . . . . 0.0 110.06 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.628 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 34.4 p90 -106.83 154.28 21.25 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.275 -0.89 . . . . 0.0 110.447 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 58' ' ' THR . 33.0 m -91.29 89.8 7.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.28 -0.888 . . . . 0.0 109.691 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.636 ' HB2' ' CD2' ' A' ' 60' ' ' TYR . . . -41.94 101.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.329 -0.857 . . . . 0.0 110.452 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.812 ' N ' HG12 ' A' ' 88' ' ' VAL . 88.8 p -85.89 55.55 3.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.3 -0.875 . . . . 0.0 110.063 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.457 ' CB ' HG13 ' A' ' 88' ' ' VAL . . . -159.55 -154.96 0.43 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.282 -0.886 . . . . 0.0 110.131 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.676 HG23 ' HA ' ' A' ' 55' ' ' GLU . 19.7 m -159.99 110.89 1.92 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.111 -0.993 . . . . 0.0 110.591 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.65 ' CD2' ' CG1' ' A' ' 54' ' ' ILE . 3.3 m-30 -112.99 106.72 54.92 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.188 -0.945 . . . . 0.0 109.84 179.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.63 -159.02 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.785 1.413 . . . . 0.0 110.094 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.106 -0.996 . . . . 0.0 110.322 -179.969 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.478 ' O ' ' HA ' ' A' ' 80' ' ' GLN . 1.4 pt-20 . . . . . 0 N--CA 1.494 1.769 0 CA-C-O 121.163 0.506 . . . . 0.0 110.303 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.546 ' CA ' ' HB3' ' A' ' 112' ' ' TYR . . . -130.15 131.81 6.73 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.483 ' CB ' ' HA ' ' A' ' 50' ' ' ASN . 1.5 pt20 -150.43 -174.23 4.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.145 -1.209 . . . . 0.0 110.78 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.764 HG21 ' HH2' ' A' ' 16' ' ' TRP . 8.8 mt -118.74 143.87 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.912 ' HB3' HD11 ' A' ' 77' ' ' LEU . . . -115.15 119.65 37.11 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.286 -0.884 . . . . 0.0 111.275 -179.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.446 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 2.6 m-30 -117.34 94.08 4.42 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -89.25 105.08 17.55 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.084 -1.01 . . . . 0.0 111.524 -178.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.819 HD22 HG11 ' A' ' 74' ' ' VAL . 14.8 mt -100.13 50.09 0.91 Allowed 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.497 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -69.51 84.12 0.27 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.019 -1.233 . . . . 0.0 110.019 -179.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.966 ' HA3' ' HB2' ' A' ' 41' ' ' ALA . . . 39.02 72.47 0.2 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.743 ' HB2' HG12 ' A' ' 74' ' ' VAL . 10.5 m-85 -97.89 -39.64 8.89 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.136 -1.214 . . . . 0.0 110.124 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.742 ' HB2' HG23 ' A' ' 72' ' ' VAL . 1.2 t -89.69 -176.08 4.86 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.239 -0.913 . . . . 0.0 109.915 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.451 ' N ' ' OG ' ' A' ' 133' ' ' SER . . . -93.9 -99.48 0.14 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.033 -1.042 . . . . 0.0 110.982 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -61.17 177.51 0.34 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.993 -1.067 . . . . 0.0 110.853 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.503 ' N ' ' HA ' ' A' ' 38' ' ' ALA . . . -53.52 136.5 38.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.472 -0.767 . . . . 0.0 110.342 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 1.141 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 5.7 p90 -145.5 -170.16 3.38 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.372 -0.83 . . . . 0.0 110.157 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.537 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 0.5 OUTLIER -160.34 159.91 31.76 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.244 -0.983 . . . . 0.0 110.812 -178.789 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.675 ' CD2' HD11 ' A' ' 95' ' ' LEU . 2.2 mp -119.34 160.37 22.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.423 -0.798 . . . . 0.0 109.303 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' CYS . . . . . . . . . . . . . 13.6 m -150.53 100.55 2.87 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.128 -0.982 . . . . 0.0 110.598 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.688 HD23 ' HB2' ' A' ' 66' ' ' ALA . 0.9 OUTLIER -96.44 -176.75 3.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.3 -0.875 . . . . 0.0 109.446 179.321 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.573 ' O ' ' CB ' ' A' ' 143' ' ' ASP . 2.4 p30 166.72 61.52 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.324 -0.86 . . . . 0.0 110.042 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.573 ' CB ' ' O ' ' A' ' 142' ' ' ASP . 1.4 m-20 159.85 46.52 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.839 HG11 ' HZ2' ' A' ' 16' ' ' TRP . 3.5 t -89.64 112.04 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.329 -0.857 . . . . 0.0 110.466 -179.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -135.3 151.93 51.01 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.223 -0.923 . . . . 0.0 110.187 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.507 HD23 HG13 ' A' ' 52' ' ' VAL . 58.8 tp -151.61 124.67 8.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.335 -0.853 . . . . 0.0 110.194 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.469 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 3.5 t0 -161.07 156.43 24.53 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.278 -0.889 . . . . 0.0 110.326 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 59' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.259 -0.901 . . . . 0.0 110.167 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo . . . . . 0 N--CA 1.48 0.695 0 N-CA-C 110.159 -0.746 . . . . 0.0 110.159 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.516 ' CD1' ' HB ' ' A' ' 144' ' ' VAL . 6.1 pt -89.9 -0.05 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.234 -0.916 . . . . 0.0 110.18 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 6' ' ' GLU . . . 119.69 -24.42 8.0 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.548 ' HG3' ' CB ' ' A' ' 145' ' ' ALA . 4.3 tt0 43.06 48.68 5.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.308 -1.113 . . . . 0.0 110.153 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 143' ' ' ASP . . . -134.81 159.17 23.83 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.444 ' HA ' ' HB2' ' A' ' 143' ' ' ASP . 1.2 p -51.29 -179.0 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.291 -1.123 . . . . 0.0 110.345 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.606 ' CD2' ' HA ' ' A' ' 142' ' ' ASP . 3.2 m-30 -110.78 24.83 12.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.292 -0.88 . . . . 0.0 110.283 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.565 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 29.6 t70 -110.74 50.91 0.79 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.172 -0.955 . . . . 0.0 110.209 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.565 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.3 OUTLIER 161.61 66.49 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.572 -0.705 . . . . 0.0 109.927 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.08 94.39 0.67 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.691 ' HG3' HG21 ' A' ' 27' ' ' THR . 51.1 Cg_endo -81.8 46.19 2.16 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.113 1.586 . . . . 0.0 110.63 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.477 ' HG3' ' N ' ' A' ' 15' ' ' GLY . 12.7 tp10 56.85 -90.97 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.155 -0.966 . . . . 0.0 110.187 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.725 ' C ' HD13 ' A' ' 49' ' ' LEU . . . -154.61 31.73 0.69 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.866 ' CE2' HD22 ' A' ' 49' ' ' LEU . 61.3 m95 -69.3 84.45 0.38 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.283 -1.127 . . . . 0.0 110.297 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.728 ' O ' HG13 ' A' ' 47' ' ' VAL . 1.3 m -89.64 148.05 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.149 -0.97 . . . . 0.0 109.804 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.534 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . . . -124.58 135.75 53.39 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.095 -1.003 . . . . 0.0 109.893 179.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.945 ' CE1' HG13 ' A' ' 48' ' ' VAL . 20.1 p90 -124.69 168.51 13.08 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.385 -0.822 . . . . 0.0 110.753 -178.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.602 ' O ' HG13 ' A' ' 45' ' ' VAL . . . 68.71 42.68 78.9 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.501 HG22 ' CG1' ' A' ' 45' ' ' VAL . 1.8 p -151.35 -147.55 0.23 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.088 -1.242 . . . . 0.0 110.245 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.419 ' O ' ' O ' ' A' ' 23' ' ' GLY . 1.1 t70 -108.86 117.31 33.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.308 -0.87 . . . . 0.0 110.165 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 22' ' ' ASP . . . 52.83 177.15 0.06 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.02 151.12 49.69 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.965 1.508 . . . . 0.0 110.447 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.701 HD23 ' H ' ' A' ' 25' ' ' LEU . 0.8 OUTLIER -49.02 161.86 0.13 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.333 -0.855 . . . . 0.0 110.228 179.945 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -121.34 132.29 54.69 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.241 -0.912 . . . . 0.0 110.046 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.691 HG21 ' HG3' ' A' ' 13' ' ' PRO . 0.7 OUTLIER -120.33 -24.93 5.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.216 -0.927 . . . . 0.0 110.61 -179.797 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 27' ' ' THR . 0.6 OUTLIER -43.93 -25.81 0.23 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.134 -0.978 . . . . 0.0 110.176 -179.828 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.592 HG23 ' N ' ' A' ' 30' ' ' GLY . 6.2 t -62.97 -47.51 82.83 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.271 -0.893 . . . . 0.0 110.686 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.592 ' N ' HG23 ' A' ' 29' ' ' THR . . . 161.03 -20.64 0.21 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.856 -1.297 . . . . 0.0 109.856 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.663 ' HB1' ' O ' ' A' ' 141' ' ' LEU . . . -150.12 -176.08 5.31 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.167 -1.196 . . . . 0.0 109.965 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.615 HD11 HD13 ' A' ' 25' ' ' LEU . 0.7 OUTLIER -87.51 94.9 9.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.108 -0.995 . . . . 0.0 109.949 179.801 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 89.4 m -110.54 106.68 16.05 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.149 -0.969 . . . . 0.0 110.748 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.537 HG12 ' HB3' ' A' ' 25' ' ' LEU . 22.4 m -89.72 138.79 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.292 -0.88 . . . . 0.0 109.178 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.475 ' O ' ' HB ' ' A' ' 21' ' ' THR . . . -89.0 93.15 9.5 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.141 -0.975 . . . . 0.0 111.337 -178.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.132 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 75.3 t -70.53 135.3 86.26 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.341 -0.849 . . . . 0.0 109.372 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.454 ' O ' ' OG ' ' A' ' 40' ' ' SER . 41.4 Cg_endo -68.56 172.28 11.7 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.727 1.383 . . . . 0.0 111.542 -178.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.504 ' HA ' ' N ' ' A' ' 136' ' ' ALA . . . -70.47 115.32 9.51 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.39 -0.819 . . . . 0.0 110.447 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.476 ' O ' ' N ' ' A' ' 41' ' ' ALA . . . 83.79 -40.63 2.9 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.753 ' HB3' HG21 ' A' ' 45' ' ' VAL . 1.5 m 38.3 30.48 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.542 -0.975 . . . . 0.0 110.146 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 39' ' ' GLY . . . -89.6 23.22 2.7 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.973 0.892 . . . . 0.0 110.08 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.589 ' O ' ' CG ' ' A' ' 43' ' ' TYR . 9.7 pm0 -108.67 126.9 53.49 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.589 ' CG ' ' O ' ' A' ' 42' ' ' GLN . 43.9 p90 39.45 27.88 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.515 -0.741 . . . . 0.0 109.927 -178.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 42' ' ' GLN . . . 51.17 173.84 0.02 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.753 HG21 ' HB3' ' A' ' 40' ' ' SER . 43.5 t -142.0 -179.07 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 179.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.578 ' H ' HG12 ' A' ' 45' ' ' VAL . . . 164.22 -163.39 36.0 Favored Glycine 0 N--CA 1.484 1.852 0 C-N-CA 117.345 -2.36 . . . . 0.0 112.734 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.728 HG13 ' O ' ' A' ' 17' ' ' VAL . 38.5 t -150.98 132.09 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.945 HG13 ' CE1' ' A' ' 19' ' ' TYR . 35.7 m -119.51 138.93 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.917 -1.115 . . . . 0.0 110.833 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.866 HD22 ' CE2' ' A' ' 16' ' ' TRP . 20.1 tp -133.69 97.68 3.99 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.373 -0.829 . . . . 0.0 110.236 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.51 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 8.6 p30 -81.11 113.61 19.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.218 -0.926 . . . . 0.0 110.239 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.413 ' O ' HG22 ' A' ' 4' ' ' ILE . . . 154.89 64.25 0.01 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.684 HG12 ' H ' ' A' ' 53' ' ' ALA . 3.2 t -119.95 -176.18 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.237 -1.155 . . . . 0.0 109.881 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.684 ' H ' HG12 ' A' ' 52' ' ' VAL . . . -142.49 75.14 1.48 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.074 -1.016 . . . . 0.0 110.634 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.638 ' CG2' ' HB1' ' A' ' 108' ' ' ALA . 32.5 mm -113.78 162.29 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.098 -1.001 . . . . 0.0 109.971 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.526 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 18.4 tt0 -162.25 132.31 4.68 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.176 -0.952 . . . . 0.0 110.605 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.526 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 15.2 pt-20 38.13 -160.25 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.67 -0.644 . . . . 0.0 110.916 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' A' ' 109' ' ' SER . . . -80.63 74.88 2.32 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.679 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.3 m -104.17 168.2 9.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.351 -1.087 . . . . 0.0 109.868 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.571 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 3.1 m -89.99 157.98 17.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.177 -0.952 . . . . 0.0 110.264 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.78 ' HB3' HD11 ' A' ' 146' ' ' LEU . 66.5 m-85 -158.95 173.79 15.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.225 -0.922 . . . . 0.0 110.37 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.839 ' OG1' HG22 ' A' ' 105' ' ' THR . 22.1 m -150.16 113.98 5.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.355 -0.841 . . . . 0.0 110.034 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.468 HD12 ' N ' ' A' ' 63' ' ' ARG . 10.3 tp -89.66 121.96 32.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.16 -0.963 . . . . 0.0 110.077 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.485 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 9.5 ttt-85 -127.63 107.16 9.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 110.489 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.603 ' OH ' HG21 ' A' ' 102' ' ' VAL . 7.8 p90 -143.34 172.33 12.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.333 -0.854 . . . . 0.0 109.915 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 5.0 m -131.27 94.91 3.66 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.171 -0.956 . . . . 0.0 110.226 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.689 ' CB ' HD21 ' A' ' 95' ' ' LEU . . . -99.6 142.1 31.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -0.898 . . . . 0.0 110.398 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.782 HG23 ' O ' ' A' ' 98' ' ' GLU . 93.3 m -150.37 101.86 3.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.403 -0.811 . . . . 0.0 110.048 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -89.81 144.07 26.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.192 -0.942 . . . . 0.0 110.105 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.4 m -60.59 -15.01 23.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.147 -0.971 . . . . 0.0 109.225 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.555 ' CG2' ' HB2' ' A' ' 137' ' ' TRP . 3.0 t -121.71 160.18 25.05 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.592 -0.693 . . . . 0.0 109.809 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -77.94 79.7 4.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.044 -1.035 . . . . 0.0 108.927 178.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.738 HG23 ' HB2' ' A' ' 133' ' ' SER . 3.7 p -99.56 135.31 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.199 -0.938 . . . . 0.0 111.654 -178.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 23.3 m -121.61 86.86 2.65 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.962 HG21 ' CD2' ' A' ' 129' ' ' LEU . 10.8 m -89.84 -149.71 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.283 -0.886 . . . . 0.0 111.172 -178.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.474 ' N ' HG23 ' A' ' 74' ' ' VAL . 0.4 OUTLIER -130.68 106.38 8.44 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.534 -0.729 . . . . 0.0 110.524 -179.583 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.48 ' O ' ' HB3' ' A' ' 77' ' ' LEU . . . -110.39 158.22 18.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.378 -0.827 . . . . 0.0 109.586 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.595 HD12 ' N ' ' A' ' 78' ' ' VAL . 3.7 pp 177.79 -158.04 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.279 -0.888 . . . . 0.0 110.376 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.85 ' CG2' HD22 ' A' ' 89' ' ' LEU . 4.3 t -147.19 171.6 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.39 -0.819 . . . . 0.0 109.488 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.489 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . 175.36 -171.66 44.76 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.353 -1.403 . . . . 0.0 110.242 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.426 ' O ' ' CG ' ' A' ' 81' ' ' ASN . 2.5 tt0 -94.08 -169.63 2.12 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.429 -1.042 . . . . 0.0 110.171 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 23.2 m120 -157.21 75.2 0.8 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.308 -0.87 . . . . 0.0 109.831 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.513 ' O ' ' HB3' ' A' ' 83' ' ' ALA . . . 144.5 38.57 0.06 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.513 ' HB3' ' O ' ' A' ' 82' ' ' GLY . . . 58.96 150.91 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.232 -1.158 . . . . 0.0 110.305 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.461 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 52.1 Cg_endo -80.49 21.99 8.32 Favored 'Cis proline' 0 C--N 1.312 -1.343 0 C-N-CA 121.696 -2.21 . . . . 0.0 111.113 0.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.464 ' N ' ' HA ' ' A' ' 83' ' ' ALA . 43.5 m-85 60.49 123.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.01 -1.056 . . . . 0.0 110.317 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -154.86 110.77 0.46 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.8 p -89.89 142.53 27.61 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.208 -1.172 . . . . 0.0 110.333 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 1.081 HG23 HD12 ' A' ' 89' ' ' LEU . 28.8 m -119.97 -20.11 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.345 -0.847 . . . . 0.0 109.973 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 1.081 HD12 HG23 ' A' ' 88' ' ' VAL . 4.7 mp -111.97 142.18 44.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.855 . . . . 0.0 110.652 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.634 ' O ' HG23 ' A' ' 91' ' ' THR . 1.7 p30 -151.18 87.84 1.42 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.252 -0.905 . . . . 0.0 110.159 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.634 HG23 ' O ' ' A' ' 90' ' ' ASP . 1.7 p -156.74 178.66 10.09 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.933 -1.104 . . . . 0.0 110.797 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 81.5 p -119.79 127.81 26.2 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.377 -0.827 . . . . 0.0 109.886 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.805 ' HG2' HG22 ' A' ' 74' ' ' VAL . 48.9 Cg_endo -75.08 75.08 3.84 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.887 1.467 . . . . 0.0 111.192 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.521 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -52.45 124.83 14.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.922 -1.111 . . . . 0.0 109.094 179.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.689 HD21 ' CB ' ' A' ' 66' ' ' ALA . 38.2 mt -119.91 175.51 5.87 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.992 -1.068 . . . . 0.0 111.0 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -168.78 -178.54 3.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.521 -0.737 . . . . 0.0 109.806 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.2 p -70.26 -7.38 41.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.221 -0.924 . . . . 0.0 110.293 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.782 ' O ' HG23 ' A' ' 67' ' ' THR . 1.1 mt-10 -102.35 172.34 4.44 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.212 -0.93 . . . . 0.0 110.094 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.5 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 44.8 Cg_endo -72.5 129.0 14.16 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.014 1.534 . . . . 0.0 110.304 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.521 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.79 92.03 3.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.205 -0.934 . . . . 0.0 110.333 -179.81 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.432 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 0.0 OUTLIER -88.61 106.14 18.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.254 -0.904 . . . . 0.0 110.081 179.842 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.603 HG21 ' OH ' ' A' ' 64' ' ' TYR . 37.5 t -89.98 133.82 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.231 -0.918 . . . . 0.0 110.316 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.465 ' C ' ' CG ' ' A' ' 104' ' ' GLU . 8.3 m -150.24 112.03 4.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.286 -0.884 . . . . 0.0 110.042 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.465 ' CG ' ' C ' ' A' ' 103' ' ' THR . 32.0 mt-10 -150.7 156.13 40.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.184 -0.947 . . . . 0.0 110.354 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.839 HG22 ' OG1' ' A' ' 61' ' ' THR . 0.8 OUTLIER -106.33 134.78 48.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.331 -0.856 . . . . 0.0 110.095 179.863 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.6 ' CE1' HD11 ' A' ' 89' ' ' LEU . 55.4 p90 -136.65 157.63 46.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.215 -0.928 . . . . 0.0 110.305 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 86.4 m -89.98 91.36 8.54 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.278 -0.889 . . . . 0.0 110.041 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.68 ' HB3' ' CE2' ' A' ' 60' ' ' TYR . . . -57.36 117.08 3.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.253 -0.904 . . . . 0.0 110.381 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.45 ' HA ' ' HA2' ' A' ' 57' ' ' GLY . 11.0 p -100.21 54.93 0.9 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.227 -0.921 . . . . 0.0 110.099 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -166.38 -162.42 0.52 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.215 -0.928 . . . . 0.0 110.417 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.497 HG22 ' HD3' ' A' ' 113' ' ' PRO . 61.9 m -143.39 115.27 8.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.237 -0.914 . . . . 0.0 110.297 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.633 ' OH ' HG13 ' A' ' 88' ' ' VAL . 11.8 m-30 -114.84 80.97 6.97 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.266 -0.896 . . . . 0.0 110.08 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.497 ' HD3' HG22 ' A' ' 111' ' ' THR . 45.7 Cg_endo -73.04 -162.37 0.13 Allowed 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 124.015 1.534 . . . . 0.0 110.446 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.275 -0.891 . . . . 0.0 110.29 -179.954 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.485 ' HA ' ' HD2' ' A' ' 113' ' ' PRO . 3.7 pm0 . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 121.197 0.522 . . . . 0.0 110.465 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.564 ' HA3' ' CD1' ' A' ' 112' ' ' TYR . . . -123.62 159.08 18.28 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.336 -1.505 . . . . 0.0 109.336 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.562 ' HA ' ' CG2' ' A' ' 52' ' ' VAL . 19.6 pt20 -150.34 -159.07 0.98 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.161 -1.199 . . . . 0.0 110.687 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.748 HG21 ' HH2' ' A' ' 16' ' ' TRP . 9.8 mt -118.95 147.08 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.529 -0.732 . . . . 0.0 109.388 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.507 ' HB3' ' CD1' ' A' ' 77' ' ' LEU . . . -120.35 118.85 31.46 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.322 -0.861 . . . . 0.0 111.314 -179.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.548 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 4.6 m-85 -119.57 73.35 0.95 Allowed 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.547 ' HA ' ' HA3' ' A' ' 46' ' ' GLY . 34.1 mt-30 -87.9 106.01 17.82 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 122.52 1.152 . . . . 0.0 112.104 -177.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.962 ' CD2' HG21 ' A' ' 74' ' ' VAL . 10.3 mt -93.47 -111.22 0.11 Allowed 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.62 ' HA3' ' N ' ' A' ' 45' ' ' VAL . . . 50.75 111.81 0.01 OUTLIER Glycine 0 N--CA 1.493 2.442 0 O-C-N 120.743 -1.223 . . . . 0.0 111.138 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 40' ' ' SER . . . 72.91 66.88 1.94 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.588 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 5.0 m-85 -148.03 -52.01 0.18 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.234 -1.157 . . . . 0.0 110.182 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.738 ' HB2' HG23 ' A' ' 72' ' ' VAL . 1.6 t -89.36 -151.78 0.23 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.086 -1.009 . . . . 0.0 110.15 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -112.09 -88.82 0.52 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.147 -0.97 . . . . 0.0 110.321 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.407 ' O ' ' C ' ' A' ' 136' ' ' ALA . 6.1 m-20 -84.07 172.65 11.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.222 -0.924 . . . . 0.0 110.273 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.504 ' N ' ' HA ' ' A' ' 38' ' ' ALA . . . -42.35 130.33 3.81 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.297 -0.877 . . . . 0.0 110.293 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 1.132 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 9.7 p90 -142.97 -165.21 2.01 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.325 -0.859 . . . . 0.0 109.648 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.526 ' O ' ' CB ' ' A' ' 68' ' ' ALA . 0.5 OUTLIER -160.04 172.72 17.0 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.834 -1.166 . . . . 0.0 111.231 -178.284 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.609 HD13 HD13 ' A' ' 129' ' ' LEU . 2.2 mp -134.35 126.58 29.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.582 -0.699 . . . . 0.0 109.326 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' CYS . . . . . . . . . . . . . 7.2 m -114.07 96.09 5.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.154 -0.966 . . . . 0.0 110.807 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.663 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 2.1 mt -89.75 -166.65 1.64 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.357 -0.839 . . . . 0.0 109.357 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.606 ' HA ' ' CD2' ' A' ' 9' ' ' PHE . 22.0 p-10 -167.93 -151.31 0.11 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.964 -1.085 . . . . 0.0 110.626 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.476 ' C ' ' CG2' ' A' ' 144' ' ' VAL . 6.5 t0 -38.82 150.89 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.641 -0.662 . . . . 0.0 110.662 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 142' ' ' ASP . 3.0 t -150.15 132.47 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.357 -0.839 . . . . 0.0 109.955 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.548 ' CB ' ' HG3' ' A' ' 6' ' ' GLU . . . -127.91 146.35 50.66 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.187 -0.946 . . . . 0.0 110.413 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.78 HD11 ' HB3' ' A' ' 60' ' ' TYR . 22.8 tp -153.81 90.72 1.4 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.323 -0.861 . . . . 0.0 110.085 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.462 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 0.4 OUTLIER -107.07 -167.02 1.22 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.249 -0.907 . . . . 0.0 110.258 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.43 ' HB3' ' CE1' ' A' ' 60' ' ' TYR . 1.2 p . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.207 -0.933 . . . . 0.0 110.25 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo . . . . . 0 N--CA 1.48 0.69 0 N-CA-C 110.085 -0.775 . . . . 0.0 110.085 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.631 HG22 ' O ' ' A' ' 51' ' ' GLY . 20.7 pt -89.96 43.63 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.19 -0.944 . . . . 0.0 110.113 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 6' ' ' GLU . . . 56.83 61.28 7.68 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 5' ' ' GLY . 1.7 mp0 57.16 -88.62 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.292 -1.122 . . . . 0.0 110.193 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 8' ' ' THR . . . 159.22 -115.34 0.65 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 7' ' ' GLY . 4.1 p 45.46 97.49 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.39 -1.065 . . . . 0.0 110.165 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.603 ' CD2' ' HB2' ' A' ' 32' ' ' LEU . 78.2 m-85 -77.62 7.62 5.41 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.479 -0.763 . . . . 0.0 109.7 179.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.551 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 34.4 t0 -84.15 45.06 1.06 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.419 -0.801 . . . . 0.0 110.122 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.551 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.3 OUTLIER 161.6 36.83 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.572 -0.705 . . . . 0.0 109.879 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 118.29 112.01 2.52 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.906 ' HG3' HG21 ' A' ' 27' ' ' THR . 51.0 Cg_endo -77.07 8.91 2.97 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 O-C-N 123.834 1.439 . . . . 0.0 110.93 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.509 ' HB3' ' O ' ' A' ' 13' ' ' PRO . 30.1 tp10 61.34 -89.47 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.237 -0.914 . . . . 0.0 110.464 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -149.02 19.15 1.22 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.97 ' CE2' HD22 ' A' ' 49' ' ' LEU . 23.5 m95 -62.53 125.31 23.48 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.211 -1.17 . . . . 0.0 110.324 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.855 ' O ' HG13 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -115.44 161.93 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.234 -0.916 . . . . 0.0 109.234 179.635 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.474 ' HB1' HG11 ' A' ' 34' ' ' VAL . . . -146.9 152.24 38.35 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.323 -0.861 . . . . 0.0 110.209 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.638 ' HE2' HG13 ' A' ' 48' ' ' VAL . 11.8 p90 -138.61 114.02 9.62 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.296 -0.877 . . . . 0.0 110.274 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.854 ' HA3' HG13 ' A' ' 45' ' ' VAL . . . -173.0 49.97 0.16 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.445 ' OG1' ' HG3' ' A' ' 37' ' ' PRO . 8.2 p 50.9 19.22 0.61 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.366 -1.079 . . . . 0.0 110.479 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.634 ' CB ' ' HB3' ' A' ' 35' ' ' ALA . 1.8 p30 -102.59 38.01 1.8 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.133 -0.98 . . . . 0.0 110.197 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 44.46 -153.27 0.47 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.457 ' O ' ' O ' ' A' ' 25' ' ' LEU . 46.3 Cg_endo -73.54 125.92 10.48 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.933 1.491 . . . . 0.0 110.361 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.708 HD23 ' H ' ' A' ' 25' ' ' LEU . 0.8 OUTLIER -42.87 166.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.227 -0.921 . . . . 0.0 110.11 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.486 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 0.5 OUTLIER -125.83 149.92 48.25 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.163 -0.96 . . . . 0.0 110.275 -179.815 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.906 HG21 ' HG3' ' A' ' 13' ' ' PRO . 0.7 OUTLIER -129.78 -43.78 1.22 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.249 -0.907 . . . . 0.0 110.251 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.451 ' HB3' ' O ' ' A' ' 27' ' ' THR . 4.5 t 56.35 36.28 27.26 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.31 -0.869 . . . . 0.0 110.303 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.451 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 33.2 p 42.53 33.21 0.42 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.299 -0.876 . . . . 0.0 110.3 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.516 ' CA ' ' HA ' ' A' ' 10' ' ' ASP . . . -140.51 -63.58 0.03 OUTLIER Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.432 ' HB1' ' O ' ' A' ' 141' ' ' LEU . . . -150.11 148.78 29.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.308 -1.113 . . . . 0.0 110.101 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.701 HD12 ' HB3' ' A' ' 13' ' ' PRO . 1.8 tt -88.36 115.46 25.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.116 -0.99 . . . . 0.0 109.861 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 72.8 m -121.56 137.74 54.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.193 -0.942 . . . . 0.0 110.765 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.496 ' CG2' ' HB2' ' A' ' 139' ' ' LEU . 2.7 m -110.98 143.47 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.408 -0.807 . . . . 0.0 109.215 179.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.634 ' HB3' ' CB ' ' A' ' 22' ' ' ASP . . . -89.43 90.04 8.13 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.167 -0.958 . . . . 0.0 111.46 -178.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.154 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 87.2 t -72.52 119.14 73.39 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.043 -1.036 . . . . 0.0 109.182 178.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.445 ' HG3' ' OG1' ' A' ' 21' ' ' THR . 42.7 Cg_endo -68.12 151.1 77.51 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.951 1.501 . . . . 0.0 111.415 -178.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.577 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -43.11 144.24 0.67 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.498 -0.751 . . . . 0.0 110.042 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 38' ' ' ALA . . . 44.46 77.73 0.09 OUTLIER Glycine 0 N--CA 1.488 2.133 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.856 ' HB2' HG21 ' A' ' 45' ' ' VAL . 0.3 OUTLIER -87.33 25.98 1.3 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.223 -1.163 . . . . 0.0 110.386 -179.703 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.559 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . . . -92.85 19.89 7.17 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 122.048 0.928 . . . . 0.0 109.606 179.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.569 ' HG3' ' CD2' ' A' ' 43' ' ' TYR . 25.7 pt20 -89.87 -131.34 0.09 Allowed 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.417 179.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.638 ' CD1' ' N ' ' A' ' 44' ' ' GLY . 12.4 p90 -37.51 -28.94 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.589 -0.695 . . . . 0.0 110.218 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.638 ' N ' ' CD1' ' A' ' 43' ' ' TYR . . . 105.45 111.3 3.59 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 179.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.856 HG21 ' HB2' ' A' ' 40' ' ' SER . 2.1 t -89.91 171.18 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.176 -1.19 . . . . 0.0 108.541 178.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.574 ' O ' ' CE2' ' A' ' 19' ' ' TYR . . . 160.72 155.61 7.87 Favored Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.029 -1.557 . . . . 0.0 110.478 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.855 HG13 ' O ' ' A' ' 17' ' ' VAL . 48.6 t -120.5 133.48 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.473 -1.016 . . . . 0.0 109.656 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.638 HG13 ' HE2' ' A' ' 19' ' ' TYR . 30.4 m -120.02 153.46 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.079 -1.013 . . . . 0.0 110.523 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.97 HD22 ' CE2' ' A' ' 16' ' ' TRP . 13.5 tp -140.51 87.64 2.14 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.304 -0.872 . . . . 0.0 110.197 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.509 ' HA ' ' HB3' ' A' ' 124' ' ' GLN . 23.6 m-20 -68.1 104.13 1.7 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.291 -0.881 . . . . 0.0 110.241 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.631 ' O ' HG22 ' A' ' 4' ' ' ILE . . . 154.39 74.22 0.01 OUTLIER Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.735 HG23 ' HA ' ' A' ' 124' ' ' GLN . 24.7 t -120.74 172.44 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.277 -1.131 . . . . 0.0 109.939 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.578 ' N ' HG12 ' A' ' 52' ' ' VAL . . . -134.27 77.57 1.71 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.09 -1.006 . . . . 0.0 110.941 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 1.028 HD11 HD21 ' A' ' 146' ' ' LEU . 24.9 mm -118.82 165.2 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.191 -0.943 . . . . 0.0 109.599 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.52 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 0.3 OUTLIER -158.88 126.79 5.07 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.989 -1.07 . . . . 0.0 110.888 -179.722 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.52 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 17.2 pt-20 37.29 -154.98 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.65 -0.656 . . . . 0.0 110.99 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.467 ' HA2' ' O ' ' A' ' 108' ' ' ALA . . . -81.4 81.67 1.62 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.626 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.2 m -112.44 172.34 6.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.209 -1.171 . . . . 0.0 109.943 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.57 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 0.4 OUTLIER -89.98 154.3 19.94 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.316 -0.865 . . . . 0.0 110.213 -179.894 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.626 ' CE2' HG22 ' A' ' 58' ' ' THR . 59.9 m-85 -159.69 173.47 16.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.293 -0.879 . . . . 0.0 110.238 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 27.4 m -150.11 114.52 5.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.282 -0.886 . . . . 0.0 110.081 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 14.1 tp -89.62 120.83 31.25 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.211 -0.931 . . . . 0.0 109.902 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.498 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 6.5 ttt180 -131.49 128.5 39.5 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.228 -0.92 . . . . 0.0 110.405 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.962 ' HB2' HG22 ' A' ' 144' ' ' VAL . 6.9 p90 -165.09 156.02 14.32 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.409 -0.807 . . . . 0.0 109.964 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.48 ' HB ' ' OD1' ' A' ' 142' ' ' ASP . 32.2 m -119.76 99.79 6.85 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.17 -0.956 . . . . 0.0 109.919 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.515 ' HB2' HD23 ' A' ' 141' ' ' LEU . . . -100.79 154.51 18.57 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.264 -0.897 . . . . 0.0 110.473 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.647 HG23 ' O ' ' A' ' 98' ' ' GLU . 90.6 m -150.34 136.84 18.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.362 -0.836 . . . . 0.0 110.145 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.536 ' N ' ' HB3' ' A' ' 95' ' ' LEU . . . -129.39 127.33 40.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.234 -0.916 . . . . 0.0 109.993 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 68' ' ' ALA . 0.6 OUTLIER -43.13 -26.84 0.18 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.246 -0.909 . . . . 0.0 109.66 179.809 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.583 ' CG2' ' CB ' ' A' ' 137' ' ' TRP . 3.5 t -110.5 164.08 13.06 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.482 -0.761 . . . . 0.0 109.928 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -82.79 72.04 9.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.168 -0.958 . . . . 0.0 109.038 178.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.778 HG23 ' CB ' ' A' ' 133' ' ' SER . 4.0 p -93.54 136.38 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.326 -0.859 . . . . 0.0 111.384 -178.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.541 ' O ' ' CD1' ' A' ' 132' ' ' PHE . 13.5 m -119.98 87.85 2.82 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.701 HG11 HD22 ' A' ' 129' ' ' LEU . 11.5 m -89.5 -153.18 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.249 -0.907 . . . . 0.0 110.761 -178.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.528 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 0.3 OUTLIER -127.99 135.29 49.72 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.369 -0.832 . . . . 0.0 110.476 -179.207 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.685 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -136.83 154.89 50.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.299 -0.875 . . . . 0.0 109.979 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.892 HD12 ' N ' ' A' ' 78' ' ' VAL . 4.0 pp 179.2 -149.22 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.363 -0.836 . . . . 0.0 110.099 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.892 ' N ' HD12 ' A' ' 77' ' ' LEU . 4.7 t -147.86 177.67 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.28 -0.887 . . . . 0.0 109.365 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.533 ' C ' ' CZ ' ' A' ' 112' ' ' TYR . . . -177.69 -176.55 45.81 Favored Glycine 0 N--CA 1.489 2.186 0 C-N-CA 119.22 -1.466 . . . . 0.0 110.16 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' A' ' 122' ' ' GLU . 5.0 tt0 -98.0 -151.93 0.39 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.404 -1.056 . . . . 0.0 110.193 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.489 ' HB2' ' HG2' ' A' ' 122' ' ' GLU . 10.0 m120 -161.15 61.6 0.28 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.411 -0.806 . . . . 0.0 109.681 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 83' ' ' ALA . . . 159.97 128.4 0.97 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.196 -1.561 . . . . 0.0 109.196 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.628 ' N ' ' CE1' ' A' ' 85' ' ' TYR . . . -41.73 151.34 0.32 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.319 -1.106 . . . . 0.0 110.377 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.488 ' C ' ' CD2' ' A' ' 85' ' ' TYR . 50.9 Cg_endo -79.14 10.04 22.91 Favored 'Cis proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.632 -2.237 . . . . 0.0 110.775 -0.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.628 ' CE1' ' N ' ' A' ' 83' ' ' ALA . 12.5 m-85 68.0 156.53 0.12 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.241 -0.912 . . . . 0.0 110.169 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -171.6 125.84 1.23 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.98 152.44 19.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.242 -1.152 . . . . 0.0 110.209 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.678 HG23 HD12 ' A' ' 89' ' ' LEU . 16.0 m -123.23 -24.94 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.287 -0.883 . . . . 0.0 110.2 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.864 HD22 HG23 ' A' ' 78' ' ' VAL . 4.2 mp -108.96 144.79 36.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.232 -0.917 . . . . 0.0 110.911 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.424 ' O ' ' CG ' ' A' ' 90' ' ' ASP . 40.2 p-10 -151.45 80.91 1.3 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.352 -0.843 . . . . 0.0 110.063 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.403 HG23 ' C ' ' A' ' 90' ' ' ASP . 44.3 p -144.01 171.74 13.84 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.959 -1.088 . . . . 0.0 110.742 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.405 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 0.7 OUTLIER -119.96 115.02 33.51 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.385 -0.822 . . . . 0.0 110.021 179.879 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.685 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 43.7 Cg_endo -70.16 155.19 65.19 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.951 1.501 . . . . 0.0 110.998 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.777 ' O ' HD23 ' A' ' 95' ' ' LEU . . . -129.92 145.39 51.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.407 -0.808 . . . . 0.0 109.573 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.777 HD23 ' O ' ' A' ' 94' ' ' ALA . 39.6 mt -134.19 173.0 12.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.07 -1.019 . . . . 0.0 110.673 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.546 HG23 ' N ' ' A' ' 97' ' ' SER . 6.0 t -171.85 -154.87 0.09 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.401 -0.812 . . . . 0.0 109.918 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.546 ' N ' HG23 ' A' ' 96' ' ' THR . 0.3 OUTLIER -90.44 28.41 1.48 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.206 -0.934 . . . . 0.0 110.143 179.893 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.647 ' O ' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -149.95 173.81 3.99 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.315 -0.866 . . . . 0.0 109.968 179.873 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.56 130.62 16.25 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.953 1.501 . . . . 0.0 110.364 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.519 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.61 87.43 2.74 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.226 -0.921 . . . . 0.0 110.042 -179.98 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.444 ' HG2' ' OG1' ' A' ' 65' ' ' THR . 0.9 OUTLIER -68.31 151.68 46.55 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.359 -0.838 . . . . 0.0 110.245 -179.903 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.925 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 65.1 t -131.49 136.31 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.228 -0.92 . . . . 0.0 110.009 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.463 ' O ' ' HG3' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -150.13 104.04 3.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.271 -0.893 . . . . 0.0 110.173 -179.937 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.463 ' HG3' ' O ' ' A' ' 103' ' ' THR . 6.7 mt-10 -145.53 132.9 20.64 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.286 -0.884 . . . . 0.0 110.166 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.441 ' O ' ' HB3' ' A' ' 106' ' ' PHE . 0.2 OUTLIER -89.92 169.82 10.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.287 -0.883 . . . . 0.0 110.12 179.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.649 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 42.1 p90 -177.38 150.49 0.71 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -0.923 . . . . 0.0 110.288 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.5 m -91.47 92.39 8.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.234 -0.917 . . . . 0.0 110.061 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.611 ' HB3' ' CE2' ' A' ' 60' ' ' TYR . . . -50.86 113.83 1.01 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.887 . . . . 0.0 110.227 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.59 ' H ' HG12 ' A' ' 88' ' ' VAL . 17.1 p -96.52 51.4 1.17 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.213 -0.93 . . . . 0.0 110.191 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.402 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -162.99 -166.57 1.31 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.218 -0.926 . . . . 0.0 110.18 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.606 HG22 ' HD3' ' A' ' 113' ' ' PRO . 11.2 m -134.39 112.27 10.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.218 -0.926 . . . . 0.0 110.307 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.533 ' CZ ' ' C ' ' A' ' 79' ' ' GLY . 17.9 m-30 -113.02 71.42 1.34 Allowed Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.339 -0.85 . . . . 0.0 110.001 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.606 ' HD3' HG22 ' A' ' 111' ' ' THR . 44.0 Cg_endo -72.13 -167.6 0.33 Allowed 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.932 1.49 . . . . 0.0 110.374 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.202 -0.936 . . . . 0.0 110.279 -179.895 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.494 ' HA ' ' HD2' ' A' ' 113' ' ' PRO . 5.4 pt-20 . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 121.244 0.545 . . . . 0.0 110.484 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.531 ' HA3' ' CB ' ' A' ' 112' ' ' TYR . . . -148.21 156.1 26.74 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.351 -1.499 . . . . 0.0 109.351 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.735 ' HA ' HG23 ' A' ' 52' ' ' VAL . 1.0 OUTLIER -150.52 -158.68 0.94 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.171 -1.193 . . . . 0.0 110.72 -179.644 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.692 HG21 ' HH2' ' A' ' 16' ' ' TRP . 11.4 mt -118.24 150.37 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.473 -0.767 . . . . 0.0 109.132 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -127.89 122.63 33.0 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.292 -0.88 . . . . 0.0 111.033 -179.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.472 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 4.9 m-85 -118.73 101.77 8.34 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.454 ' C ' HD23 ' A' ' 129' ' ' LEU . 0.0 OUTLIER -88.97 101.51 14.15 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.252 -0.905 . . . . 0.0 111.956 -177.596 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.701 HD22 HG11 ' A' ' 74' ' ' VAL . 8.8 mt -104.6 42.65 1.18 Allowed 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 178.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -97.45 87.3 0.87 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.575 ' O ' ' CG ' ' A' ' 132' ' ' PHE . . . 84.53 107.95 0.61 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.586 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 7.0 m-85 -167.31 -62.19 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.331 -1.099 . . . . 0.0 110.102 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.778 ' CB ' HG23 ' A' ' 72' ' ' VAL . 1.3 t -89.52 -178.84 5.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.076 -1.015 . . . . 0.0 109.912 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.426 ' N ' ' OG ' ' A' ' 133' ' ' SER . . . -100.62 -95.31 0.27 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.127 -0.983 . . . . 0.0 110.7 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -55.68 153.74 7.69 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.094 -1.004 . . . . 0.0 110.574 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.577 ' HB2' ' HB2' ' A' ' 38' ' ' ALA . . . -47.7 121.94 4.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.372 -0.83 . . . . 0.0 110.167 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 1.154 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 22.2 p90 -125.7 -157.58 0.8 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.287 -0.883 . . . . 0.0 110.044 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.543 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 0.5 OUTLIER -160.33 169.53 22.95 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.104 -0.997 . . . . 0.0 110.62 -178.844 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.6 HD13 HD13 ' A' ' 129' ' ' LEU . 2.4 mp -121.8 159.5 26.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.334 -0.854 . . . . 0.0 109.322 179.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' CYS . . . . . . . . . . . . . 2.0 m -150.61 92.22 1.82 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.041 -1.037 . . . . 0.0 110.931 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.515 HD23 ' HB2' ' A' ' 66' ' ' ALA . 1.2 mt -90.01 -178.36 5.43 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.227 -0.92 . . . . 0.0 109.316 179.068 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.52 ' O ' ' CB ' ' A' ' 143' ' ' ASP . 2.0 p30 167.19 47.88 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.276 -0.89 . . . . 0.0 110.423 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.52 ' CB ' ' O ' ' A' ' 142' ' ' ASP . 0.4 OUTLIER 166.64 40.41 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.26 -0.9 . . . . 0.0 109.84 179.961 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.962 HG22 ' HB2' ' A' ' 64' ' ' TYR . 25.9 t -89.26 111.55 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.302 -0.874 . . . . 0.0 110.259 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.414 ' HA ' ' O ' ' A' ' 6' ' ' GLU . . . -137.33 165.47 26.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.337 -0.852 . . . . 0.0 110.237 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 1.028 HD21 HD11 ' A' ' 54' ' ' ILE . 10.5 tp -151.8 139.58 19.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.249 -0.907 . . . . 0.0 110.181 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.489 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -155.06 152.89 30.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.188 -0.945 . . . . 0.0 110.268 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.489 ' HB3' ' CE1' ' A' ' 60' ' ' TYR . 3.0 p . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.291 -0.881 . . . . 0.0 110.191 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo . . . . . 0 N--CA 1.483 0.897 0 N-CA-C 110.579 -0.585 . . . . 0.0 110.579 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.418 ' O ' HG13 ' A' ' 4' ' ' ILE . 11.4 pt -113.46 32.33 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.223 -0.923 . . . . 0.0 110.096 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.526 ' O ' ' CG ' ' A' ' 6' ' ' GLU . . . 95.44 -31.52 7.04 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.526 ' CG ' ' O ' ' A' ' 5' ' ' GLY . 9.0 pt-20 38.32 35.89 0.11 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.671 -0.899 . . . . 0.0 110.522 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' A' ' 143' ' ' ASP . . . -136.16 -160.92 8.97 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.81 HG22 ' HB2' ' A' ' 143' ' ' ASP . 40.4 p -105.53 51.53 0.75 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.294 -1.121 . . . . 0.0 110.322 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.485 ' CE1' ' CD1' ' A' ' 16' ' ' TRP . 16.5 m-85 42.71 28.87 0.14 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.306 -0.871 . . . . 0.0 110.228 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.554 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 4.5 p-10 -86.22 52.25 2.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.271 -0.893 . . . . 0.0 110.062 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.554 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 1.0 OUTLIER 161.7 37.05 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.68 -0.637 . . . . 0.0 109.901 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.99 148.43 12.11 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.568 ' HB3' HD12 ' A' ' 32' ' ' LEU . 49.6 Cg_endo -76.12 6.6 3.76 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 124.035 1.545 . . . . 0.0 110.902 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.501 ' HB3' ' O ' ' A' ' 13' ' ' PRO . 2.6 tm-20 59.26 -89.27 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.206 -0.934 . . . . 0.0 110.406 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.513 ' O ' HD12 ' A' ' 49' ' ' LEU . . . -144.22 30.66 1.87 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 1.002 ' CE2' HD22 ' A' ' 49' ' ' LEU . 52.7 m95 -85.93 124.72 32.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.215 -1.168 . . . . 0.0 110.554 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.854 ' O ' HG13 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -114.2 160.94 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.309 -0.87 . . . . 0.0 108.884 179.44 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.469 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . . . -147.12 126.1 12.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.112 -0.993 . . . . 0.0 110.297 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.626 ' HE2' HG13 ' A' ' 48' ' ' VAL . 17.5 p90 -104.94 170.59 7.78 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.486 -0.759 . . . . 0.0 110.26 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 1.064 ' HA3' HG13 ' A' ' 45' ' ' VAL . . . 115.44 35.09 1.34 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.1 p 51.13 17.75 0.5 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.682 -0.893 . . . . 0.0 111.005 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.702 ' HB3' ' HB3' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -152.68 77.6 1.18 Allowed 'General case' 0 C--N 1.306 -1.291 0 O-C-N 120.975 -1.078 . . . . 0.0 109.049 179.265 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.593 ' N ' ' CD ' ' A' ' 24' ' ' PRO . . . -118.54 43.97 1.5 Allowed Glycine 0 N--CA 1.489 2.171 0 C-N-CA 119.451 -1.357 . . . . 0.0 110.72 -179.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 23' ' ' GLY . 50.5 Cg_endo -75.39 76.62 3.49 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.668 1.352 . . . . 0.0 109.649 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 1.036 ' CD2' HG12 ' A' ' 34' ' ' VAL . 14.8 mt -68.16 84.6 0.24 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.182 -0.949 . . . . 0.0 110.46 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.469 ' O ' ' O ' ' A' ' 31' ' ' ALA . 0.2 OUTLIER -74.81 113.12 11.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.165 -0.959 . . . . 0.0 109.085 179.314 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.417 ' O ' ' C ' ' A' ' 28' ' ' SER . 1.4 p -119.6 -29.08 5.15 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.061 -1.024 . . . . 0.0 111.196 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 27' ' ' THR . 33.2 p -45.04 -27.92 0.63 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.948 -1.095 . . . . 0.0 108.619 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.613 HG23 ' H ' ' A' ' 31' ' ' ALA . 5.5 t -70.4 -45.78 65.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.868 -0.52 . . . . 0.0 110.751 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.574 ' N ' HG23 ' A' ' 29' ' ' THR . . . 138.04 3.42 1.97 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.613 ' H ' HG23 ' A' ' 29' ' ' THR . . . -150.38 130.91 13.89 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.98 -1.306 . . . . 0.0 110.021 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.797 HD11 HD13 ' A' ' 25' ' ' LEU . 0.9 OUTLIER -67.23 110.33 3.45 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.996 -1.065 . . . . 0.0 109.543 179.754 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.452 ' O ' ' O ' ' A' ' 24' ' ' PRO . 2.9 m -109.39 106.59 16.43 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.091 -1.006 . . . . 0.0 111.164 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 1.036 HG12 ' CD2' ' A' ' 25' ' ' LEU . 36.0 m -89.81 173.6 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.702 ' HB3' ' HB3' ' A' ' 22' ' ' ASP . . . -122.75 152.78 40.28 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.574 -1.329 . . . . 0.0 111.685 -178.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.886 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 10.6 t -137.88 111.28 8.74 Favored Pre-proline 0 C--N 1.303 -1.446 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.437 ' O ' ' O ' ' A' ' 38' ' ' ALA . 44.3 Cg_endo -73.75 141.99 31.47 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.011 1.532 . . . . 0.0 111.185 -178.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.83 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -42.35 164.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.504 -0.747 . . . . 0.0 109.834 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 51.22 50.12 41.34 Favored Glycine 0 N--CA 1.485 1.949 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.652 ' OG ' HG23 ' A' ' 45' ' ' VAL . 1.6 t -86.88 35.92 0.7 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.228 -1.16 . . . . 0.0 109.803 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.529 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . -87.44 -139.87 0.1 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.475 -0.766 . . . . 0.0 109.414 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.542 ' HG2' ' N ' ' A' ' 43' ' ' TYR . 0.0 OUTLIER 42.03 -142.29 0.09 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.476 -0.765 . . . . 0.0 110.066 -179.491 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.583 ' CE1' ' O ' ' A' ' 44' ' ' GLY . 5.8 p90 -31.39 -39.27 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.198 0 CA-C-O 121.354 0.597 . . . . 0.0 110.292 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.583 ' O ' ' CE1' ' A' ' 43' ' ' TYR . . . 88.82 137.32 6.01 Favored Glycine 0 N--CA 1.49 2.283 0 C-N-CA 120.227 -0.987 . . . . 0.0 111.128 177.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 1.064 HG13 ' HA3' ' A' ' 20' ' ' GLY . 4.0 t -89.75 167.91 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.511 ' C ' ' CZ ' ' A' ' 19' ' ' TYR . . . 168.11 162.19 19.54 Favored Glycine 0 N--CA 1.49 2.298 0 C-N-CA 118.51 -1.805 . . . . 0.0 111.056 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.854 HG13 ' O ' ' A' ' 17' ' ' VAL . 44.6 t -114.54 157.69 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.74 -0.859 . . . . 0.0 109.793 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.626 HG13 ' HE2' ' A' ' 19' ' ' TYR . 3.7 m -143.5 150.55 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.076 -1.015 . . . . 0.0 110.08 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 1.002 HD22 ' CE2' ' A' ' 16' ' ' TRP . 19.4 tp -138.47 89.89 2.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.199 -0.938 . . . . 0.0 110.417 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.526 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 40.9 t30 -73.04 132.79 43.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.294 -0.879 . . . . 0.0 110.151 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 124.0 60.52 0.19 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.576 HG12 ' N ' ' A' ' 53' ' ' ALA . 40.3 t -119.94 172.07 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.233 -1.157 . . . . 0.0 110.101 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.576 ' N ' HG12 ' A' ' 52' ' ' VAL . . . -137.88 102.01 4.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.235 -0.915 . . . . 0.0 110.389 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.909 HD11 HD21 ' A' ' 146' ' ' LEU . 42.3 mm -131.65 49.59 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.291 -0.881 . . . . 0.0 109.936 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.557 ' O ' ' HB3' ' A' ' 56' ' ' GLU . 0.3 OUTLIER -72.16 139.95 48.54 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.408 -0.807 . . . . 0.0 111.072 -179.571 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.557 ' HB3' ' O ' ' A' ' 55' ' ' GLU . 6.6 tm-20 73.12 178.12 0.24 Allowed 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 121.968 0.89 . . . . 0.0 111.907 178.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.565 ' HA2' ' HA ' ' A' ' 109' ' ' SER . . . -103.04 89.54 0.72 Allowed Glycine 0 N--CA 1.487 2.047 0 N-CA-C 107.764 -2.135 . . . . 0.0 107.764 178.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 1.027 HG22 ' CE1' ' A' ' 60' ' ' TYR . 0.4 OUTLIER -120.19 -165.53 1.2 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.41 -1.053 . . . . 0.0 110.641 -178.486 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.768 ' N ' HG23 ' A' ' 58' ' ' THR . 8.2 m -103.49 86.3 2.62 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.413 -0.804 . . . . 0.0 110.372 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 1.027 ' CE1' HG22 ' A' ' 58' ' ' THR . 96.1 m-85 -85.84 116.19 23.93 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.147 -0.971 . . . . 0.0 109.905 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 38.9 m -89.89 114.76 26.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.211 -0.931 . . . . 0.0 110.154 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.446 HD22 ' CD2' ' A' ' 89' ' ' LEU . 18.2 tp -89.71 121.47 31.9 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.185 -0.947 . . . . 0.0 110.002 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.631 ' HG2' HG22 ' A' ' 103' ' ' THR . 48.3 mtp180 -122.67 121.73 37.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.297 -0.877 . . . . 0.0 110.142 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.538 ' CE2' HG11 ' A' ' 102' ' ' VAL . 0.7 OUTLIER -159.57 141.57 13.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.285 -0.884 . . . . 0.0 109.906 179.784 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.501 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 89.9 m -119.18 97.04 5.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.279 -0.888 . . . . 0.0 109.674 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.8 ' CB ' HD21 ' A' ' 95' ' ' LEU . . . -97.14 154.02 17.62 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.476 -0.765 . . . . 0.0 110.554 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.83 HG23 ' O ' ' A' ' 98' ' ' GLU . 96.9 m -150.34 122.02 8.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.369 -0.832 . . . . 0.0 110.101 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -108.3 142.9 37.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.244 -0.91 . . . . 0.0 109.945 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.12 -22.01 2.26 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.154 -0.966 . . . . 0.0 109.138 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.599 HG22 ' HB2' ' A' ' 137' ' ' TRP . 3.4 t -119.27 166.92 12.39 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.563 -0.71 . . . . 0.0 109.835 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.439 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 0.9 OUTLIER -82.38 73.54 9.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.047 -1.033 . . . . 0.0 109.114 178.925 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.714 HG23 ' HB2' ' A' ' 133' ' ' SER . 5.4 p -98.06 145.04 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.303 -0.873 . . . . 0.0 111.348 -178.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.534 HG22 ' HB3' ' A' ' 92' ' ' SER . 19.8 m -128.69 91.12 3.17 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 178.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.969 HG21 ' CD2' ' A' ' 129' ' ' LEU . 3.3 m -89.67 -148.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.203 -0.935 . . . . 0.0 110.766 -178.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.586 ' N ' HG23 ' A' ' 74' ' ' VAL . 0.1 OUTLIER -121.97 118.3 28.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.194 -0.941 . . . . 0.0 110.82 -179.437 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.686 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -122.98 147.92 46.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.204 -0.935 . . . . 0.0 109.681 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.728 HD12 ' N ' ' A' ' 78' ' ' VAL . 3.5 pp 178.92 -148.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.296 -0.878 . . . . 0.0 110.08 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.829 HG23 HD22 ' A' ' 89' ' ' LEU . 2.5 t -147.85 171.07 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.194 -0.941 . . . . 0.0 108.902 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.489 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . -172.24 -178.5 42.48 Favored Glycine 0 N--CA 1.489 2.183 0 C-N-CA 119.169 -1.491 . . . . 0.0 110.183 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.422 ' O ' ' OD1' ' A' ' 81' ' ' ASN . 8.1 tt0 -92.28 -148.99 0.24 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.49 -1.006 . . . . 0.0 110.192 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.481 ' HB3' ' OE2' ' A' ' 122' ' ' GLU . 5.8 m120 -164.38 64.22 0.14 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.523 -0.736 . . . . 0.0 109.574 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.433 ' O ' ' C ' ' A' ' 83' ' ' ALA . . . 134.91 147.25 5.5 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.629 ' N ' ' CE1' ' A' ' 85' ' ' TYR . . . -41.25 151.62 0.28 Allowed Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.33 -1.1 . . . . 0.0 110.375 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.46 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.3 Cg_endo -80.16 12.48 23.23 Favored 'Cis proline' 0 C--N 1.312 -1.353 0 C-N-CA 121.659 -2.226 . . . . 0.0 110.884 -0.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.629 ' CE1' ' N ' ' A' ' 83' ' ' ALA . 26.4 m-85 63.2 150.63 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.16 -0.963 . . . . 0.0 110.194 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 175.97 131.49 1.47 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.59 155.15 21.79 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.299 -1.118 . . . . 0.0 110.104 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.982 HG23 HD12 ' A' ' 89' ' ' LEU . 33.2 m -125.4 -22.0 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.257 -0.902 . . . . 0.0 110.447 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.982 HD12 HG23 ' A' ' 88' ' ' VAL . 3.7 mp -111.72 144.16 41.46 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.111 -0.993 . . . . 0.0 111.023 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.57 ' O ' HG23 ' A' ' 91' ' ' THR . 29.5 t0 -150.98 85.83 1.36 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.434 -0.791 . . . . 0.0 110.206 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.57 HG23 ' O ' ' A' ' 90' ' ' ASP . 2.6 p -155.04 -177.31 6.44 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.053 -1.029 . . . . 0.0 110.581 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.534 ' HB3' HG22 ' A' ' 73' ' ' THR . 3.7 m -123.64 134.16 25.1 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.346 -0.847 . . . . 0.0 109.978 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.789 ' HG2' HG22 ' A' ' 74' ' ' VAL . 51.6 Cg_endo -78.31 79.81 3.19 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.871 1.458 . . . . 0.0 110.877 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.527 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -49.26 134.51 18.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.939 -1.101 . . . . 0.0 109.159 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.8 HD21 ' CB ' ' A' ' 66' ' ' ALA . 27.6 mt -131.44 170.64 14.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.052 -1.03 . . . . 0.0 110.89 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.487 ' CG2' ' HG3' ' A' ' 100' ' ' ARG . 0.2 OUTLIER -170.99 -178.69 2.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.445 -0.784 . . . . 0.0 109.942 179.972 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.84 -6.37 26.58 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.278 -0.888 . . . . 0.0 110.244 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.83 ' O ' HG23 ' A' ' 67' ' ' THR . 0.6 OUTLIER -110.52 174.58 2.3 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.243 -0.911 . . . . 0.0 110.1 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.51 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 45.0 Cg_endo -72.31 128.02 13.28 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.026 1.54 . . . . 0.0 110.294 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.527 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 1.2 mtt-85 -119.76 92.17 3.72 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.152 -0.968 . . . . 0.0 110.4 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.455 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 38.9 tt0 -75.1 154.11 37.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.364 -0.835 . . . . 0.0 109.978 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.538 HG11 ' CE2' ' A' ' 64' ' ' TYR . 74.4 t -139.5 133.72 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.166 -0.958 . . . . 0.0 110.354 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.631 HG22 ' HG2' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -150.15 118.99 6.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.283 -0.886 . . . . 0.0 110.083 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -140.6 153.13 45.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.204 -0.935 . . . . 0.0 110.361 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.548 HG22 ' CG2' ' A' ' 59' ' ' THR . 8.4 m -109.5 70.79 0.74 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.289 -0.882 . . . . 0.0 110.116 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.879 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 40.0 p90 -84.82 146.62 27.24 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.306 -0.871 . . . . 0.0 110.144 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 58' ' ' THR . 5.6 m -89.94 102.65 15.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -0.93 . . . . 0.0 109.987 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 1.002 ' HB3' ' CD1' ' A' ' 60' ' ' TYR . . . -70.04 95.78 0.99 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.155 -0.966 . . . . 0.0 110.388 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.565 ' HA ' ' HA2' ' A' ' 57' ' ' GLY . 8.2 p -85.88 59.63 5.75 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.675 -0.64 . . . . 0.0 109.512 179.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.461 ' HB3' HG11 ' A' ' 88' ' ' VAL . . . -155.27 -156.24 0.64 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.12 -0.987 . . . . 0.0 110.835 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.974 HG22 ' HD3' ' A' ' 113' ' ' PRO . 46.6 m -147.42 108.05 4.14 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.373 -0.829 . . . . 0.0 110.87 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.584 ' CE2' HG12 ' A' ' 78' ' ' VAL . 16.4 m-30 -110.04 74.17 0.77 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.396 -0.815 . . . . 0.0 109.642 179.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.974 ' HD3' HG22 ' A' ' 111' ' ' THR . 43.7 Cg_endo -71.65 -159.08 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.908 1.478 . . . . 0.0 110.41 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.271 -0.893 . . . . 0.0 110.247 -179.824 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.481 ' OE2' ' HB3' ' A' ' 81' ' ' ASN . 22.5 pm0 . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 121.107 0.479 . . . . 0.0 110.219 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.514 ' HA3' ' CB ' ' A' ' 112' ' ' TYR . . . -151.36 150.8 22.79 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.569 ' HA ' ' CG2' ' A' ' 52' ' ' VAL . 3.0 pt20 -150.35 -153.34 0.48 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.269 -1.136 . . . . 0.0 110.394 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.449 ' HB ' ' HB3' ' A' ' 49' ' ' LEU . 7.5 mt -118.45 144.86 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.419 -0.801 . . . . 0.0 109.379 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.409 ' HB3' HD11 ' A' ' 77' ' ' LEU . . . -122.11 121.1 36.14 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.228 -0.92 . . . . 0.0 111.04 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.48 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 5.1 m-85 -119.42 97.19 5.53 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.49 ' O ' ' HB ' ' A' ' 74' ' ' VAL . 2.5 mt-30 -88.95 89.1 7.84 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.245 -0.91 . . . . 0.0 111.149 -178.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.986 HD13 HD13 ' A' ' 139' ' ' LEU . 16.0 mt -87.61 51.55 2.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.571 -0.705 . . . . 0.0 109.274 178.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.53 ' O ' ' CD2' ' A' ' 132' ' ' PHE . . . -127.68 151.0 18.42 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 51.81 63.55 4.65 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.622 ' CE1' ' HA ' ' A' ' 74' ' ' VAL . 15.5 m-85 -148.06 -78.79 0.15 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.243 -1.151 . . . . 0.0 110.25 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.714 ' HB2' HG23 ' A' ' 72' ' ' VAL . 2.3 t -89.59 144.58 25.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.058 -1.026 . . . . 0.0 110.055 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -81.87 -84.45 0.11 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.289 -0.882 . . . . 0.0 110.357 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -42.54 154.92 0.05 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.247 -0.908 . . . . 0.0 110.293 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.83 ' HB2' ' HB2' ' A' ' 38' ' ' ALA . . . -57.59 124.28 18.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.279 -0.888 . . . . 0.0 110.214 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.886 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 6.0 p90 -131.23 -167.49 1.86 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.279 -0.888 . . . . 0.0 110.236 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.542 ' CG2' ' N ' ' A' ' 139' ' ' LEU . 0.8 OUTLIER -160.81 178.75 9.12 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.31 -0.956 . . . . 0.0 110.532 -178.255 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.986 HD13 HD13 ' A' ' 129' ' ' LEU . 2.2 mp -133.96 155.6 49.65 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.388 -0.82 . . . . 0.0 110.062 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' CYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 33' ' ' CYS . 11.1 m -150.12 97.88 2.62 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.173 -0.954 . . . . 0.0 110.724 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.518 HD23 ' HB2' ' A' ' 66' ' ' ALA . 1.1 mt -89.62 -177.09 5.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.299 -0.876 . . . . 0.0 109.518 179.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.567 ' HB3' ' CB ' ' A' ' 31' ' ' ALA . 0.6 OUTLIER 172.33 44.21 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.186 -0.946 . . . . 0.0 110.999 179.926 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.81 ' HB2' HG22 ' A' ' 8' ' ' THR . 5.8 t0 171.85 69.81 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.309 -0.87 . . . . 0.0 109.592 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.828 HG11 ' HZ2' ' A' ' 16' ' ' TRP . 1.9 t -106.64 122.28 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.129 -0.982 . . . . 0.0 110.412 -179.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -151.81 150.93 30.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.344 -0.847 . . . . 0.0 110.067 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.966 HD11 ' HB3' ' A' ' 60' ' ' TYR . 22.3 tp -138.49 158.83 43.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.288 -0.882 . . . . 0.0 110.29 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.512 ' N ' ' HG ' ' A' ' 146' ' ' LEU . 0.4 OUTLIER -163.25 -157.33 0.42 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.213 -0.929 . . . . 0.0 110.278 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.686 ' HB2' HG21 ' A' ' 58' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.679 0 O-C-N 121.215 -0.928 . . . . 0.0 110.136 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo . . . . . 0 N--CA 1.48 0.712 0 N-CA-C 110.01 -0.804 . . . . 0.0 110.01 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.0 pt -94.5 -8.78 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.197 -0.939 . . . . 0.0 110.167 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 69.75 156.24 1.39 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -72.23 83.12 1.02 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.223 -1.163 . . . . 0.0 110.152 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -86.76 127.41 8.38 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.457 ' O ' ' HB2' ' A' ' 9' ' ' PHE . 2.1 p -77.31 2.87 14.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.222 -1.164 . . . . 0.0 110.236 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.59 ' CD2' ' HB2' ' A' ' 32' ' ' LEU . 3.3 m-85 56.41 16.7 2.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.253 -0.904 . . . . 0.0 110.204 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.547 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 18.3 p-10 -98.41 14.03 29.53 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.234 -0.916 . . . . 0.0 110.391 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.547 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 2.2 t70 161.68 80.63 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.79 -0.569 . . . . 0.0 109.544 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.22 82.49 1.65 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.916 ' HG3' HG21 ' A' ' 27' ' ' THR . 51.2 Cg_endo -81.31 43.14 1.47 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.073 1.565 . . . . 0.0 110.668 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.455 ' HB3' ' O ' ' A' ' 13' ' ' PRO . 36.2 tp10 56.9 -91.27 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.137 -0.977 . . . . 0.0 110.206 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.502 ' C ' HD13 ' A' ' 49' ' ' LEU . . . -152.75 32.63 0.82 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.888 ' CE2' HD22 ' A' ' 49' ' ' LEU . 59.5 m95 -71.19 86.71 0.78 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.23 -1.159 . . . . 0.0 110.267 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.838 ' O ' HG13 ' A' ' 47' ' ' VAL . 1.4 m -82.26 147.92 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.224 -0.922 . . . . 0.0 109.781 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.589 ' CB ' ' CG1' ' A' ' 34' ' ' VAL . . . -134.12 119.51 18.97 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.178 -0.951 . . . . 0.0 109.978 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.668 ' HE2' HG13 ' A' ' 48' ' ' VAL . 16.9 p90 -108.56 138.03 45.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.469 -0.77 . . . . 0.0 110.411 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.92 ' HA3' HG13 ' A' ' 45' ' ' VAL . . . 160.82 45.48 0.02 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.515 HG23 ' OH ' ' A' ' 43' ' ' TYR . 9.6 p 50.84 19.16 0.59 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.442 -1.034 . . . . 0.0 110.733 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.925 ' HB2' ' HB3' ' A' ' 35' ' ' ALA . 3.0 p30 -97.88 38.51 1.29 Allowed 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.069 -1.019 . . . . 0.0 110.031 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 45.94 -156.54 0.45 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.436 ' O ' ' C ' ' A' ' 25' ' ' LEU . 46.5 Cg_endo -73.72 125.63 10.16 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 123.939 1.494 . . . . 0.0 110.35 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.718 HD23 ' H ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -42.26 133.02 3.26 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.277 -0.889 . . . . 0.0 110.015 179.887 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.07 116.23 28.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.144 -0.972 . . . . 0.0 110.054 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.916 HG21 ' HG3' ' A' ' 13' ' ' PRO . 0.9 OUTLIER -119.88 -28.71 5.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.167 -0.958 . . . . 0.0 110.34 -179.76 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.45 ' O ' ' HB ' ' A' ' 29' ' ' THR . 0.3 OUTLIER -48.91 83.13 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.838 -0.539 . . . . 0.0 111.254 -179.957 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.62 HG22 ' O ' ' A' ' 27' ' ' THR . 0.8 OUTLIER 175.97 -28.93 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.017 -1.052 . . . . 0.0 110.309 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.526 ' HA2' ' CB ' ' A' ' 10' ' ' ASP . . . 133.73 -7.05 4.87 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.706 -1.357 . . . . 0.0 109.706 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.548 ' HA ' ' HB3' ' A' ' 9' ' ' PHE . . . -150.3 172.46 15.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.149 -1.207 . . . . 0.0 110.329 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.684 HD12 ' CG2' ' A' ' 27' ' ' THR . 0.6 OUTLIER -103.97 94.73 5.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.274 -0.891 . . . . 0.0 109.769 179.736 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 65.5 m -100.09 115.61 30.17 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.295 -0.878 . . . . 0.0 111.002 -179.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.589 ' CG1' ' CB ' ' A' ' 18' ' ' ALA . 15.1 m -96.11 157.17 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.319 -0.863 . . . . 0.0 109.231 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.925 ' HB3' ' HB2' ' A' ' 22' ' ' ASP . . . -102.26 89.23 3.51 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.269 -0.894 . . . . 0.0 111.635 -178.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.037 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 76.3 t -74.71 119.21 75.58 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 120.976 -1.077 . . . . 0.0 109.192 178.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.426 ' O ' ' C ' ' A' ' 38' ' ' ALA . 42.7 Cg_endo -69.17 144.79 58.4 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.865 1.455 . . . . 0.0 111.226 -179.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.519 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -42.11 147.83 0.22 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.462 -0.774 . . . . 0.0 110.109 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.459 ' O ' ' OE1' ' A' ' 42' ' ' GLN . . . 44.52 70.64 0.56 Allowed Glycine 0 N--CA 1.488 2.132 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.987 ' OG ' HG21 ' A' ' 45' ' ' VAL . 0.5 OUTLIER -87.01 29.72 0.8 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.31 -1.112 . . . . 0.0 110.44 -179.636 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.501 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . . . -91.38 19.99 5.61 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.926 0.869 . . . . 0.0 109.739 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.614 ' HG3' ' CD2' ' A' ' 43' ' ' TYR . 0.5 OUTLIER -84.44 -135.65 0.05 Allowed 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.527 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.646 ' CD1' ' N ' ' A' ' 44' ' ' GLY . 8.3 p90 -38.9 -27.39 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.379 -0.826 . . . . 0.0 110.417 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.646 ' N ' ' CD1' ' A' ' 43' ' ' TYR . . . 111.04 106.92 2.96 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.987 HG21 ' OG ' ' A' ' 40' ' ' SER . 2.9 t -90.09 153.83 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.231 -1.159 . . . . 0.0 108.73 179.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.542 ' C ' ' CZ ' ' A' ' 19' ' ' TYR . . . 176.75 169.51 38.16 Favored Glycine 0 N--CA 1.49 2.26 0 C-N-CA 119.221 -1.466 . . . . 0.0 110.218 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.838 HG13 ' O ' ' A' ' 17' ' ' VAL . 48.8 t -128.19 144.03 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.412 -1.052 . . . . 0.0 109.901 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.674 ' O ' HG22 ' A' ' 17' ' ' VAL . 34.0 m -135.55 147.69 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.039 -1.038 . . . . 0.0 110.419 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.888 HD22 ' CE2' ' A' ' 16' ' ' TRP . 22.8 tp -135.82 109.85 8.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.251 -0.906 . . . . 0.0 110.308 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.509 ' HA ' ' HB3' ' A' ' 124' ' ' GLN . 2.4 p-10 -84.33 121.71 27.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.224 -0.922 . . . . 0.0 110.269 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 139.92 79.43 0.06 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.574 HG12 HG12 ' A' ' 54' ' ' ILE . 54.0 t -131.36 150.44 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.197 -1.178 . . . . 0.0 110.198 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -117.34 92.58 3.89 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.224 -0.922 . . . . 0.0 110.238 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.817 HD11 HD21 ' A' ' 146' ' ' LEU . 14.6 mm -136.37 169.33 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.237 -0.914 . . . . 0.0 110.065 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.513 ' O ' ' HB3' ' A' ' 56' ' ' GLU . 2.2 pt-20 179.05 139.54 0.1 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.24 -0.912 . . . . 0.0 110.361 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.513 ' HB3' ' O ' ' A' ' 55' ' ' GLU . 3.9 tt0 64.23 -179.67 0.17 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.512 -0.742 . . . . 0.0 110.759 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' A' ' 109' ' ' SER . . . -92.42 70.98 1.63 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.624 -1.791 . . . . 0.0 108.624 179.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.711 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.0 OUTLIER -105.9 176.81 5.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.532 -0.981 . . . . 0.0 110.087 -179.281 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.577 ' N ' ' CG2' ' A' ' 58' ' ' THR . 0.7 OUTLIER -89.57 156.4 18.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.304 -0.872 . . . . 0.0 110.436 -179.69 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.903 ' HB3' HD11 ' A' ' 146' ' ' LEU . 68.2 m-85 -156.45 118.08 3.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.448 -0.782 . . . . 0.0 109.625 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 104' ' ' GLU . 10.0 m -89.94 112.03 23.29 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.209 -0.932 . . . . 0.0 110.646 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 21.7 tp -90.21 140.0 30.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.346 -0.846 . . . . 0.0 109.66 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.771 ' HG2' HG23 ' A' ' 103' ' ' THR . 27.1 mtt180 -136.92 105.68 5.87 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.146 -0.971 . . . . 0.0 110.722 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.528 ' C ' ' CD1' ' A' ' 64' ' ' TYR . 3.5 p90 -140.18 151.67 45.42 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.33 -0.856 . . . . 0.0 109.676 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.523 HG22 ' O ' ' A' ' 65' ' ' THR . 4.2 m -119.62 92.04 3.69 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.095 -1.003 . . . . 0.0 110.114 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.883 ' HB1' HD21 ' A' ' 95' ' ' LEU . . . -89.44 145.51 25.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.302 -0.874 . . . . 0.0 110.17 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.653 HG23 ' O ' ' A' ' 98' ' ' GLU . 53.4 m -150.72 104.87 3.23 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.316 -0.865 . . . . 0.0 110.492 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.528 ' HB2' HD13 ' A' ' 95' ' ' LEU . . . -95.93 132.38 41.29 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.165 -0.96 . . . . 0.0 109.854 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 68' ' ' ALA . 20.0 m -43.54 -26.78 0.24 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.219 -0.926 . . . . 0.0 109.435 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.631 HG22 ' HB2' ' A' ' 137' ' ' TRP . 3.0 t -112.74 167.63 10.33 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.563 -0.711 . . . . 0.0 109.838 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.505 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 32.9 t0 -84.29 69.36 10.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.104 -0.997 . . . . 0.0 109.224 178.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.795 HG23 ' CB ' ' A' ' 133' ' ' SER . 3.8 p -92.0 140.08 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.331 -0.856 . . . . 0.0 111.318 -178.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.474 ' O ' ' CD1' ' A' ' 132' ' ' PHE . 98.3 m -126.46 91.94 3.46 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 1.021 HG21 ' CD2' ' A' ' 129' ' ' LEU . 3.2 m -89.79 -159.34 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.18 -0.95 . . . . 0.0 110.715 -178.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.437 ' N ' HG23 ' A' ' 74' ' ' VAL . 0.3 OUTLIER -119.16 106.61 12.54 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.284 -0.885 . . . . 0.0 110.394 -179.519 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.492 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -113.08 165.14 12.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.906 . . . . 0.0 110.194 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.556 ' HA ' ' HB3' ' A' ' 89' ' ' LEU . 3.1 pp 176.93 -159.7 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.363 -0.836 . . . . 0.0 110.12 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.784 ' CG2' HD22 ' A' ' 89' ' ' LEU . 3.4 t -149.26 155.61 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.26 -0.9 . . . . 0.0 109.718 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.575 ' O ' ' CE2' ' A' ' 112' ' ' TYR . . . -172.43 -178.2 42.41 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.429 -1.367 . . . . 0.0 110.258 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.484 ' HG2' ' O ' ' A' ' 111' ' ' THR . 0.0 OUTLIER -93.42 128.34 39.44 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.434 -1.039 . . . . 0.0 110.697 -179.726 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.499 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 1.4 m-80 -96.64 75.49 2.8 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.192 -0.943 . . . . 0.0 109.557 179.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.586 ' O ' ' HB2' ' A' ' 83' ' ' ALA . . . -166.07 -90.48 0.08 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.586 ' HB2' ' O ' ' A' ' 82' ' ' GLY . . . 175.84 136.49 0.19 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.345 -1.091 . . . . 0.0 109.923 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.535 ' C ' ' CD2' ' A' ' 85' ' ' TYR . 52.3 Cg_endo -83.84 33.2 3.61 Favored 'Cis proline' 0 C--N 1.314 -1.271 0 C-N-CA 122.096 -2.044 . . . . 0.0 110.84 -0.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.579 ' CE1' ' O ' ' A' ' 82' ' ' GLY . 18.7 m-85 65.24 166.03 0.17 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.229 -0.919 . . . . 0.0 110.449 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.496 ' O ' ' CA ' ' A' ' 79' ' ' GLY . . . -163.4 171.11 39.02 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.57 133.67 21.52 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.099 -1.236 . . . . 0.0 110.507 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 1.088 HG23 HD12 ' A' ' 89' ' ' LEU . 12.4 m -119.8 -10.49 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.326 -0.859 . . . . 0.0 109.732 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 1.088 HD12 HG23 ' A' ' 88' ' ' VAL . 4.5 mp -123.5 143.49 50.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.418 -0.801 . . . . 0.0 110.816 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.715 ' O ' HG23 ' A' ' 91' ' ' THR . 0.7 OUTLIER -150.62 83.69 1.35 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.283 -0.886 . . . . 0.0 110.223 179.713 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.715 HG23 ' O ' ' A' ' 90' ' ' ASP . 1.1 p -160.06 -176.71 5.82 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.125 -0.984 . . . . 0.0 110.509 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.431 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 0.1 OUTLIER -119.93 131.24 24.48 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.321 -0.862 . . . . 0.0 110.079 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.831 ' HG2' HG22 ' A' ' 74' ' ' VAL . 48.6 Cg_endo -73.11 77.6 2.37 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.97 1.511 . . . . 0.0 110.912 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.532 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -48.63 135.26 14.91 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.975 -1.078 . . . . 0.0 109.148 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.883 HD21 ' HB1' ' A' ' 66' ' ' ALA . 36.4 mt -130.85 176.79 7.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.997 -1.064 . . . . 0.0 110.872 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 68' ' ' ALA . 0.2 OUTLIER -177.89 -178.8 0.72 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.49 -0.756 . . . . 0.0 109.918 -179.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.63 -22.44 63.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.226 -0.921 . . . . 0.0 110.287 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.653 ' O ' HG23 ' A' ' 67' ' ' THR . 2.6 mt-10 -90.07 169.86 11.5 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.29 -0.881 . . . . 0.0 110.078 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.495 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 45.0 Cg_endo -72.55 130.44 16.02 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 123.956 1.503 . . . . 0.0 110.276 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.532 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.69 92.2 3.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.154 -0.966 . . . . 0.0 110.35 -179.865 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.453 ' HG3' ' OG1' ' A' ' 65' ' ' THR . 38.3 tt0 -85.76 99.3 11.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.289 -0.882 . . . . 0.0 110.104 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.426 ' HB ' ' CZ ' ' A' ' 64' ' ' TYR . 72.6 t -89.62 133.77 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 0.0 110.256 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.771 HG23 ' HG2' ' A' ' 63' ' ' ARG . 49.5 m -147.51 135.72 21.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.357 -0.839 . . . . 0.0 110.084 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.507 ' CG ' ' O ' ' A' ' 103' ' ' THR . 17.9 mt-10 -160.16 -177.33 6.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.169 -0.957 . . . . 0.0 110.267 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.491 HG23 HG23 ' A' ' 61' ' ' THR . 0.0 OUTLIER -133.62 91.54 2.86 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.285 -0.885 . . . . 0.0 110.162 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -92.44 155.48 17.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.286 -0.884 . . . . 0.0 110.254 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 109' ' ' SER . 38.7 m -89.56 92.78 9.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.178 -0.951 . . . . 0.0 109.777 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.618 ' CB ' ' CD2' ' A' ' 60' ' ' TYR . . . -47.39 91.67 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.27 -0.894 . . . . 0.0 110.455 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.523 ' HA ' ' HA2' ' A' ' 57' ' ' GLY . 8.9 p -85.78 57.28 4.38 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.349 -0.844 . . . . 0.0 109.621 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.645 ' HB3' ' HE1' ' A' ' 112' ' ' TYR . . . -166.98 -156.34 0.22 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.115 -0.991 . . . . 0.0 110.868 -179.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.497 ' O ' ' HD3' ' A' ' 113' ' ' PRO . 35.5 m -148.0 111.57 5.01 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.539 -0.726 . . . . 0.0 110.024 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.767 ' CE2' HG12 ' A' ' 78' ' ' VAL . 4.2 m-85 -104.87 92.3 5.08 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.361 -0.837 . . . . 0.0 109.943 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 111' ' ' THR . 43.4 Cg_endo -71.73 160.9 46.79 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.798 1.42 . . . . 0.0 110.389 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.67 0 O-C-N 121.144 -0.972 . . . . 0.0 110.376 -179.695 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.499 ' O ' ' HB2' ' A' ' 81' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.229 0.537 . . . . 0.0 110.455 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.59 ' HA3' ' CD2' ' A' ' 112' ' ' TYR . . . -89.5 149.0 20.32 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.537 ' HA ' ' CG2' ' A' ' 52' ' ' VAL . 2.8 pt20 -150.37 -163.84 1.87 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.094 -1.239 . . . . 0.0 110.948 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.604 HG21 ' HE2' ' A' ' 127' ' ' PHE . 9.5 mt -118.57 144.37 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.579 -0.7 . . . . 0.0 109.186 179.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -121.25 129.14 53.01 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.315 -0.866 . . . . 0.0 110.67 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.604 ' HE2' HG21 ' A' ' 125' ' ' ILE . 14.3 m-85 -118.78 105.0 11.1 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -89.03 85.37 6.68 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.376 -0.828 . . . . 0.0 111.923 -177.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 1.021 ' CD2' HG21 ' A' ' 74' ' ' VAL . 14.6 mt -91.13 45.11 1.22 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -98.37 89.45 0.95 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 -179.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.579 ' O ' ' CG ' ' A' ' 132' ' ' PHE . . . 81.08 107.87 0.32 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 110.029 -1.229 . . . . 0.0 110.029 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.63 ' CZ ' ' HA ' ' A' ' 74' ' ' VAL . 8.4 m-85 -167.78 -67.1 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.366 -1.079 . . . . 0.0 109.849 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.795 ' CB ' HG23 ' A' ' 72' ' ' VAL . 1.3 t -89.68 160.79 16.42 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.143 -0.973 . . . . 0.0 109.893 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.405 ' O ' ' C ' ' A' ' 135' ' ' ASP . . . -88.3 -94.1 0.1 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.179 -0.95 . . . . 0.0 110.606 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 134' ' ' ALA . 9.5 m-20 -43.99 153.4 0.14 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.16 -0.963 . . . . 0.0 110.511 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.519 ' HB2' ' HB2' ' A' ' 38' ' ' ALA . . . -52.97 126.33 20.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.309 -0.869 . . . . 0.0 110.149 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 1.037 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 9.7 p90 -131.07 -161.15 1.1 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.257 -0.902 . . . . 0.0 110.181 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.584 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 0.8 OUTLIER -160.42 177.74 10.27 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.157 -0.964 . . . . 0.0 110.427 -178.084 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.867 HD13 HD13 ' A' ' 129' ' ' LEU . 2.2 mp -134.02 125.85 28.99 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.365 -0.834 . . . . 0.0 109.892 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' CYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 59.9 m -120.12 104.13 9.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.16 -0.963 . . . . 0.0 110.993 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.508 ' HA ' ' O ' ' A' ' 65' ' ' THR . 1.0 OUTLIER -102.11 -178.63 3.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.259 -0.9 . . . . 0.0 109.805 179.301 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.484 ' HB3' ' O ' ' A' ' 141' ' ' LEU . 4.5 p-10 173.59 167.35 0.18 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.458 -0.776 . . . . 0.0 110.316 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.465 ' O ' ' O ' ' A' ' 63' ' ' ARG . 13.9 t70 41.74 64.54 1.04 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.341 -0.849 . . . . 0.0 110.364 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.622 HG11 ' HZ2' ' A' ' 16' ' ' TRP . 4.9 t -99.1 113.2 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.252 -0.905 . . . . 0.0 110.053 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -129.8 171.33 12.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -0.934 . . . . 0.0 110.404 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.903 HD11 ' HB3' ' A' ' 60' ' ' TYR . 60.8 tp -162.49 120.75 2.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.275 -0.891 . . . . 0.0 110.159 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.532 ' O ' ' CD1' ' A' ' 60' ' ' TYR . 0.5 OUTLIER -125.24 -152.42 0.52 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.274 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 72.5 p . . . . . 0 N--CA 1.492 1.647 0 O-C-N 121.303 -0.873 . . . . 0.0 110.158 -179.951 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo . . . . . 0 N--CA 1.483 0.859 0 N-CA-C 110.515 -0.61 . . . . 0.0 110.515 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.94 ' HB ' HD21 ' A' ' 49' ' ' LEU . 10.7 pt -117.72 32.67 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.227 -0.921 . . . . 0.0 110.113 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 7' ' ' GLY . . . 81.49 44.45 7.92 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.859 ' HG2' ' HB1' ' A' ' 145' ' ' ALA . 4.1 mt-10 -41.93 94.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.337 -1.096 . . . . 0.0 110.337 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 5' ' ' GLY . . . 152.48 -149.9 21.63 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.447 HG22 ' O ' ' A' ' 142' ' ' ASP . 70.4 p -92.71 163.49 13.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.27 -1.136 . . . . 0.0 110.233 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.459 ' CZ ' HG21 ' A' ' 144' ' ' VAL . 24.4 m-85 -87.61 35.47 0.72 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.256 -0.903 . . . . 0.0 110.189 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.543 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 13.8 t0 -86.22 57.13 4.31 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.275 -0.891 . . . . 0.0 110.133 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.543 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.9 OUTLIER 161.69 36.84 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.628 -0.67 . . . . 0.0 110.073 -179.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.26 140.28 9.2 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.7 ' HB3' HD12 ' A' ' 32' ' ' LEU . 49.8 Cg_endo -77.13 6.6 4.18 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.104 1.581 . . . . 0.0 110.637 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 0.7 OUTLIER 65.57 -85.79 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.205 -0.934 . . . . 0.0 110.413 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.52 ' C ' HD12 ' A' ' 49' ' ' LEU . . . -147.88 13.88 1.33 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 1.042 ' NE1' HD22 ' A' ' 49' ' ' LEU . 30.5 m95 -66.68 135.0 53.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.163 -1.198 . . . . 0.0 110.367 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.688 ' O ' HG13 ' A' ' 47' ' ' VAL . 1.2 m -129.76 156.54 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.0 110.052 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.413 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . . . -139.1 130.87 27.54 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.474 -0.767 . . . . 0.0 108.959 179.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.578 ' CE2' ' O ' ' A' ' 46' ' ' GLY . 9.3 p90 -121.62 158.8 27.83 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.098 -1.001 . . . . 0.0 111.73 -178.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.605 ' HA2' ' CE1' ' A' ' 43' ' ' TYR . . . 75.27 36.38 45.36 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 1.078 HG22 HG13 ' A' ' 45' ' ' VAL . 15.0 p -128.29 -160.69 1.04 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.089 -1.242 . . . . 0.0 110.5 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -98.42 39.19 1.26 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.37 -0.831 . . . . 0.0 110.249 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 133.89 175.31 13.86 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.455 ' O ' ' O ' ' A' ' 25' ' ' LEU . 46.8 Cg_endo -73.34 138.45 27.41 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.018 1.536 . . . . 0.0 110.563 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.923 HD12 HD11 ' A' ' 32' ' ' LEU . 0.8 OUTLIER -42.2 165.09 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.416 -0.802 . . . . 0.0 110.142 179.844 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -150.62 150.45 31.18 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.19 -0.944 . . . . 0.0 110.297 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.499 HG22 ' HA ' ' A' ' 32' ' ' LEU . 0.8 OUTLIER -119.94 -76.98 0.57 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.272 -0.893 . . . . 0.0 110.058 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.446 ' O ' ' N ' ' A' ' 30' ' ' GLY . 25.6 t 55.53 -88.28 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.252 -0.905 . . . . 0.0 110.605 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.553 HG23 ' H ' ' A' ' 31' ' ' ALA . 9.6 t -40.5 -27.62 0.05 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.398 -0.814 . . . . 0.0 110.573 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 28' ' ' SER . . . 132.13 -42.75 1.35 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.553 ' H ' HG23 ' A' ' 29' ' ' THR . . . -89.82 144.75 25.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.297 -1.119 . . . . 0.0 109.876 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.923 HD11 HD12 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -79.33 95.37 5.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.226 -0.921 . . . . 0.0 110.469 -179.786 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 0.8 OUTLIER -93.99 115.83 28.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.28 -0.887 . . . . 0.0 111.093 179.563 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.42 ' H ' HG22 ' A' ' 34' ' ' VAL . 15.9 m -89.31 142.12 13.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.51 76.63 8.18 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.379 -0.826 . . . . 0.0 110.777 -178.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.058 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 95.6 t -68.97 125.11 91.66 Favored Pre-proline 0 C--N 1.302 -1.463 0 O-C-N 121.443 -0.785 . . . . 0.0 109.08 179.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.517 ' HD3' ' HA ' ' A' ' 21' ' ' THR . 38.7 Cg_endo -65.82 175.64 4.35 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.966 1.508 . . . . 0.0 112.107 -178.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.531 ' HA ' ' CA ' ' A' ' 136' ' ' ALA . . . -53.94 121.64 8.43 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.566 -0.709 . . . . 0.0 111.412 -178.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 134' ' ' ALA . . . 37.73 27.86 0.03 OUTLIER Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 38' ' ' ALA . 22.4 m 33.16 61.34 0.42 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.74 -0.859 . . . . 0.0 110.103 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.546 ' O ' ' CG ' ' A' ' 42' ' ' GLN . . . -88.54 133.94 34.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.45 -0.781 . . . . 0.0 110.444 -178.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.546 ' CG ' ' O ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER 59.49 30.03 19.66 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.192 0.52 . . . . 0.0 109.766 -179.454 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.61 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.1 OUTLIER -161.94 82.37 0.57 Allowed 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 118.776 -1.17 . . . . 0.0 111.707 -178.587 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.553 ' HA2' ' CA ' ' A' ' 130' ' ' GLY . . . -50.33 99.26 0.03 OUTLIER Glycine 0 N--CA 1.482 1.761 0 N-CA-C 107.091 -2.404 . . . . 0.0 107.091 178.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 1.078 HG13 HG22 ' A' ' 21' ' ' THR . 3.1 t -87.2 111.8 22.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 120.976 -1.308 . . . . 0.0 108.812 -178.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.578 ' O ' ' CE2' ' A' ' 19' ' ' TYR . . . -136.78 141.78 12.82 Favored Glycine 0 N--CA 1.486 1.98 0 C-N-CA 118.959 -1.591 . . . . 0.0 110.507 -178.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.688 HG13 ' O ' ' A' ' 17' ' ' VAL . 17.0 t -106.21 125.49 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.39 -1.065 . . . . 0.0 109.433 179.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.575 ' CG2' ' CG2' ' A' ' 17' ' ' VAL . 35.6 m -119.94 145.22 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.001 -1.062 . . . . 0.0 110.83 -179.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 1.042 HD22 ' NE1' ' A' ' 16' ' ' TRP . 10.4 tp -135.23 97.19 3.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.412 -0.805 . . . . 0.0 109.955 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.514 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 3.1 m120 -73.94 129.65 38.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.226 -0.921 . . . . 0.0 110.355 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 146.69 58.23 0.02 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.565 ' CG2' ' HA ' ' A' ' 124' ' ' GLN . 71.3 t -123.2 170.79 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.092 -1.24 . . . . 0.0 110.148 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.562 ' N ' HG12 ' A' ' 52' ' ' VAL . . . -146.91 92.31 2.12 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.198 -0.939 . . . . 0.0 110.572 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.86 HG21 ' HB1' ' A' ' 108' ' ' ALA . 48.6 mm -124.3 156.68 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.244 -0.91 . . . . 0.0 109.793 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.522 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 1.1 tt0 -145.19 130.43 18.56 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.034 -1.041 . . . . 0.0 110.572 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.522 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 10.4 pt-20 38.11 -154.72 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.691 -0.631 . . . . 0.0 110.758 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.461 ' HA2' ' HA ' ' A' ' 109' ' ' SER . . . -83.44 85.91 1.52 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.637 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.2 m -110.59 173.68 6.22 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.248 -1.148 . . . . 0.0 109.821 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.567 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 0.6 OUTLIER -89.88 151.29 21.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.196 -0.94 . . . . 0.0 110.354 -179.881 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.715 ' CE2' HG23 ' A' ' 54' ' ' ILE . 56.9 m-85 -160.2 178.17 9.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.265 -0.897 . . . . 0.0 110.287 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 75.5 m -150.19 119.81 6.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.437 -0.789 . . . . 0.0 109.746 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.685 HD22 ' CD2' ' A' ' 89' ' ' LEU . 17.7 tp -89.48 119.97 30.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.13 -0.981 . . . . 0.0 110.12 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.535 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 10.2 ttp180 -124.4 138.68 54.34 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.373 -0.829 . . . . 0.0 109.806 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.537 ' CE2' ' HB ' ' A' ' 102' ' ' VAL . 0.8 OUTLIER -178.74 142.2 0.21 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.37 -0.831 . . . . 0.0 109.677 179.892 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.517 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 4.3 m -119.22 94.5 4.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.066 -1.021 . . . . 0.0 110.009 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.72 ' CB ' HD21 ' A' ' 95' ' ' LEU . . . -97.12 156.16 16.51 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.377 -0.827 . . . . 0.0 110.412 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 54.9 m -149.63 119.98 7.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.316 -0.865 . . . . 0.0 110.126 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.453 ' CB ' HG12 ' A' ' 72' ' ' VAL . . . -108.2 131.3 54.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.246 -0.909 . . . . 0.0 110.043 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 11.3 t -65.62 -9.23 25.21 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.212 -0.93 . . . . 0.0 110.104 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.644 HG21 ' CB ' ' A' ' 137' ' ' TRP . 6.0 t -116.0 19.54 14.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -0.895 . . . . 0.0 110.266 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.509 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 9.6 t0 42.76 66.49 0.76 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.291 -0.88 . . . . 0.0 109.69 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.853 HG23 ' HB2' ' A' ' 133' ' ' SER . 5.8 p -97.84 141.87 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.407 -0.808 . . . . 0.0 110.826 -179.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.496 HG22 ' O ' ' A' ' 73' ' ' THR . 19.5 m -119.76 82.56 1.9 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.377 -0.827 . . . . 0.0 109.163 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.591 ' HA ' ' CD2' ' A' ' 132' ' ' PHE . 17.7 m -90.0 -140.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.243 -0.911 . . . . 0.0 110.739 -179.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.525 ' N ' HG23 ' A' ' 74' ' ' VAL . 7.5 mtm180 -130.43 145.01 51.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.19 -0.944 . . . . 0.0 110.828 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.577 ' N ' ' HD3' ' A' ' 93' ' ' PRO . . . -150.5 153.42 35.82 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.417 -0.802 . . . . 0.0 109.479 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.9 HD12 ' N ' ' A' ' 78' ' ' VAL . 3.9 pp 179.86 -147.59 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.136 -0.977 . . . . 0.0 110.4 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.9 ' N ' HD12 ' A' ' 77' ' ' LEU . 5.0 t -149.92 164.97 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.359 -0.838 . . . . 0.0 109.114 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.488 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . -171.81 -175.56 40.15 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 118.958 -1.591 . . . . 0.0 110.693 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.49 ' HA ' ' O ' ' A' ' 122' ' ' GLU . 1.3 tt0 -90.88 -151.63 0.26 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.639 -0.918 . . . . 0.0 110.272 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.519 ' HB2' ' HG2' ' A' ' 122' ' ' GLU . 47.9 m-80 -161.81 83.57 0.59 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.434 -0.791 . . . . 0.0 109.582 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 83' ' ' ALA . . . 122.54 136.67 4.93 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.63 ' N ' ' CE1' ' A' ' 85' ' ' TYR . . . -40.45 150.82 0.26 Allowed Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.333 -1.098 . . . . 0.0 110.447 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.467 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.6 Cg_endo -80.07 12.07 23.64 Favored 'Cis proline' 0 C--N 1.313 -1.334 0 C-N-CA 121.711 -2.204 . . . . 0.0 110.938 -0.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.63 ' CE1' ' N ' ' A' ' 83' ' ' ALA . 27.2 m-85 63.6 163.65 0.12 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.187 -0.946 . . . . 0.0 110.282 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 176.4 131.9 1.55 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.471 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 0.7 OUTLIER -117.73 153.31 33.6 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.227 -1.161 . . . . 0.0 110.282 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 1.015 HG23 HD12 ' A' ' 89' ' ' LEU . 31.3 m -124.88 -24.45 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.32 -0.863 . . . . 0.0 110.305 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 1.015 HD12 HG23 ' A' ' 88' ' ' VAL . 3.8 mp -104.79 144.29 31.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.204 -0.935 . . . . 0.0 110.952 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -151.5 76.66 1.22 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.348 -0.845 . . . . 0.0 109.974 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 67.1 p -142.71 -178.72 5.93 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.978 -1.076 . . . . 0.0 110.756 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.94 128.03 26.07 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.457 -0.777 . . . . 0.0 110.07 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.577 ' HD3' ' N ' ' A' ' 76' ' ' ALA . 46.4 Cg_endo -72.5 78.2 2.03 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.95 1.5 . . . . 0.0 111.038 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.535 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -56.43 139.64 48.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.057 -1.027 . . . . 0.0 109.223 179.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.829 ' CD1' HD21 ' A' ' 139' ' ' LEU . 44.4 mt -135.61 160.15 39.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.007 -1.058 . . . . 0.0 110.907 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.698 HG22 ' HG3' ' A' ' 100' ' ' ARG . 0.2 OUTLIER -158.59 -179.02 7.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.476 -0.765 . . . . 0.0 109.926 179.949 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.81 -27.65 69.32 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -0.933 . . . . 0.0 110.118 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.465 ' CB ' ' HD2' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -90.51 176.65 2.8 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.184 -0.948 . . . . 0.0 110.018 179.824 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.465 ' HD2' ' CB ' ' A' ' 98' ' ' GLU . 44.9 Cg_endo -72.08 135.61 25.5 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.928 1.488 . . . . 0.0 110.381 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.698 ' HG3' HG22 ' A' ' 96' ' ' THR . 0.0 OUTLIER -119.84 93.49 4.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.228 -0.92 . . . . 0.0 110.208 179.985 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -87.61 97.25 10.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.371 -0.831 . . . . 0.0 110.359 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.537 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 40.2 t -89.55 134.03 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.347 -0.846 . . . . 0.0 110.216 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -150.25 133.81 16.58 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.219 -0.925 . . . . 0.0 110.211 179.902 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -160.26 135.62 8.09 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.909 . . . . 0.0 110.245 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.486 HG23 ' O ' ' A' ' 60' ' ' TYR . 85.3 m -90.03 125.87 35.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.224 -0.922 . . . . 0.0 110.053 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.953 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 28.2 p90 -132.31 156.03 47.3 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.185 -0.947 . . . . 0.0 110.354 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.2 m -90.06 94.92 9.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.224 -0.923 . . . . 0.0 109.897 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.86 ' HB1' HG21 ' A' ' 54' ' ' ILE . . . -53.02 107.5 0.23 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.252 -0.905 . . . . 0.0 110.329 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.461 ' HA ' ' HA2' ' A' ' 57' ' ' GLY . 24.6 p -94.06 53.26 1.74 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.264 -0.898 . . . . 0.0 110.017 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -162.09 -153.55 0.28 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.297 -0.877 . . . . 0.0 110.278 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.494 HG23 ' HA ' ' A' ' 55' ' ' GLU . 5.2 m -147.27 118.38 7.74 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.283 -0.886 . . . . 0.0 110.172 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.63 ' OH ' HG22 ' A' ' 88' ' ' VAL . 20.3 m-30 -113.23 70.21 1.36 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.303 -0.873 . . . . 0.0 109.971 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.493 ' HD3' HG22 ' A' ' 111' ' ' THR . 46.3 Cg_endo -72.39 -159.06 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.035 1.545 . . . . 0.0 110.436 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.228 -0.92 . . . . 0.0 110.206 -179.944 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.519 ' HG2' ' HB2' ' A' ' 81' ' ' ASN . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 121.012 0.434 . . . . 0.0 109.878 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.576 ' HA3' ' CG ' ' A' ' 112' ' ' TYR . . . -144.37 149.09 21.13 Favored Glycine 0 N--CA 1.491 2.321 0 C-N-CA 119.56 -1.305 . . . . 0.0 109.889 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.653 ' O ' HG13 ' A' ' 78' ' ' VAL . 19.4 pt20 -150.51 -153.11 0.47 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.314 -1.11 . . . . 0.0 110.085 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.78 HG21 ' CH2' ' A' ' 16' ' ' TRP . 14.2 mt -118.18 139.23 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.487 -0.758 . . . . 0.0 109.359 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -117.12 123.62 47.2 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.291 -0.88 . . . . 0.0 110.933 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.475 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 4.5 m-85 -118.84 103.18 9.39 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 1.058 ' O ' HD23 ' A' ' 129' ' ' LEU . 2.0 mt-30 -89.11 129.87 35.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.203 -0.935 . . . . 0.0 111.714 -177.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 1.058 HD23 ' O ' ' A' ' 128' ' ' GLN . 0.8 OUTLIER -141.53 34.08 1.64 Allowed 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.441 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.553 ' CA ' ' HA2' ' A' ' 44' ' ' GLY . . . -82.23 118.96 4.74 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 39' ' ' GLY . . . 42.56 69.99 0.54 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.591 ' CD2' ' HA ' ' A' ' 74' ' ' VAL . 11.2 m-85 -117.35 -61.81 1.65 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.109 -1.23 . . . . 0.0 111.006 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.853 ' HB2' HG23 ' A' ' 72' ' ' VAL . 1.3 t -88.36 -176.46 5.35 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.02 -1.05 . . . . 0.0 110.693 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -92.53 -82.03 0.33 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.276 -0.89 . . . . 0.0 110.225 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -70.25 177.77 3.15 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.147 -0.971 . . . . 0.0 109.765 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.531 ' CA ' ' HA ' ' A' ' 38' ' ' ALA . . . -75.2 138.81 42.21 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.297 -0.877 . . . . 0.0 110.736 -179.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 1.058 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 9.0 p90 -140.99 -171.41 3.25 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.263 -0.898 . . . . 0.0 110.682 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.516 ' C ' HD12 ' A' ' 139' ' ' LEU 0.251 0.8 OUTLIER -149.25 171.34 16.65 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.536 -0.727 . . . . 0.0 109.702 -177.986 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.829 HD21 ' CD1' ' A' ' 95' ' ' LEU . 1.7 mp -139.47 117.91 12.11 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.998 -1.064 . . . . 0.0 112.11 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' CYS . . . . . 0.471 ' SG ' ' HB3' ' A' ' 31' ' ' ALA . 0.8 OUTLIER -103.4 110.11 22.0 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.646 -0.659 . . . . 0.0 110.64 178.186 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.569 HD23 ' HB2' ' A' ' 66' ' ' ALA . 1.3 mt -97.28 -178.5 4.19 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.277 -0.89 . . . . 0.0 108.974 178.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 143' ' ' ASP . 0.5 OUTLIER 169.31 61.12 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.145 -0.972 . . . . 0.0 110.407 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.53 ' CB ' ' O ' ' A' ' 142' ' ' ASP . 0.5 OUTLIER 166.35 43.26 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.388 -0.82 . . . . 0.0 109.344 179.852 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.795 HG11 ' HZ2' ' A' ' 16' ' ' TRP . 1.5 t -89.45 114.33 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.373 -0.83 . . . . 0.0 110.281 -179.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.859 ' HB1' ' HG2' ' A' ' 6' ' ' GLU . . . -151.84 148.45 27.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.413 -0.804 . . . . 0.0 110.081 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.835 HD21 HD11 ' A' ' 54' ' ' ILE . 38.8 tp -146.54 123.57 11.41 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.341 -0.849 . . . . 0.0 110.099 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.479 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -140.66 157.57 45.25 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.235 -0.916 . . . . 0.0 110.373 -179.938 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 59' ' ' THR . 24.4 p . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.282 -0.886 . . . . 0.0 110.136 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo . . . . . 0 N--CA 1.479 0.649 0 N-CA-C 110.09 -0.773 . . . . 0.0 110.09 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.0 pt -96.38 -28.93 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.183 -0.948 . . . . 0.0 110.181 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.51 ' O ' ' N ' ' A' ' 7' ' ' GLY . . . 99.4 106.47 2.71 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.617 ' HA ' ' HB2' ' A' ' 145' ' ' ALA . 0.6 OUTLIER -45.01 93.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.231 -1.158 . . . . 0.0 110.069 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 5' ' ' GLY . . . -139.55 177.84 20.12 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.671 HG22 ' HA ' ' A' ' 143' ' ' ASP . 29.4 p -129.52 20.35 5.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.386 -1.067 . . . . 0.0 109.818 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.643 ' HB3' HG21 ' A' ' 27' ' ' THR . 3.2 m-30 70.71 -78.96 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.812 -0.555 . . . . 0.0 110.671 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.555 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 1.4 p30 40.02 27.87 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.095 -1.003 . . . . 0.0 110.505 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.555 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 1.9 t70 161.13 -57.84 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.54 0.686 . . . . 0.0 109.235 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 9' ' ' PHE . . . -133.67 127.13 4.53 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.583 ' HA ' ' CD1' ' A' ' 9' ' ' PHE . 52.4 Cg_endo -81.82 29.85 0.53 Allowed 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.819 1.431 . . . . 0.0 111.16 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 0.2 OUTLIER 62.23 -89.35 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.997 -1.065 . . . . 0.0 110.326 179.923 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -149.73 22.19 1.16 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.84 ' HZ2' HG11 ' A' ' 144' ' ' VAL . 40.0 m95 -61.69 142.56 57.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.276 -1.132 . . . . 0.0 110.381 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.732 ' O ' HG13 ' A' ' 47' ' ' VAL . 0.8 OUTLIER -132.87 140.87 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.232 -0.918 . . . . 0.0 109.222 179.15 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.5 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . . . -125.15 114.75 19.43 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.97 -1.081 . . . . 0.0 110.235 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.887 ' HE2' HG13 ' A' ' 48' ' ' VAL . 40.0 p90 -100.93 150.53 22.77 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.691 -0.631 . . . . 0.0 109.924 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.777 ' C ' HG23 ' A' ' 21' ' ' THR . . . 112.58 87.2 1.64 Allowed Glycine 0 N--CA 1.483 1.802 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.777 HG23 ' C ' ' A' ' 20' ' ' GLY . 1.4 p 75.24 -139.81 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.116 0 O-C-N 122.064 -0.668 . . . . 0.0 110.333 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.96 ' O ' ' HB3' ' A' ' 35' ' ' ALA . 2.5 m-20 -88.72 116.84 27.27 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.884 -1.135 . . . . 0.0 110.075 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.557 ' N ' ' CD ' ' A' ' 24' ' ' PRO . . . -119.61 49.24 0.88 Allowed Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.557 ' CD ' ' N ' ' A' ' 23' ' ' GLY . 43.4 Cg_endo -69.89 82.17 0.8 Allowed 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 124.024 1.539 . . . . 0.0 109.677 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.784 HD13 HD11 ' A' ' 32' ' ' LEU . 40.8 mt -50.93 88.52 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.44 -0.787 . . . . 0.0 110.422 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 24' ' ' PRO . 0.3 OUTLIER -91.22 120.95 32.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -0.885 . . . . 0.0 109.442 179.626 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.643 HG21 ' HB3' ' A' ' 9' ' ' PHE . 1.2 p -119.54 -27.39 5.54 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.076 -1.015 . . . . 0.0 110.889 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 27' ' ' THR . 74.4 m -43.46 -28.08 0.33 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.186 -0.946 . . . . 0.0 109.192 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.606 HG23 ' N ' ' A' ' 30' ' ' GLY . 6.3 t -67.78 -47.89 67.87 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.629 -0.669 . . . . 0.0 110.482 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.606 ' N ' HG23 ' A' ' 29' ' ' THR . . . 164.93 -25.94 0.18 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.661 ' HB1' ' O ' ' A' ' 141' ' ' LEU . . . -150.54 159.67 44.33 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.295 -1.121 . . . . 0.0 110.218 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.784 HD11 HD13 ' A' ' 25' ' ' LEU . 0.6 OUTLIER -72.71 102.0 3.22 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.314 -0.866 . . . . 0.0 110.328 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.58 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 0.8 OUTLIER -98.84 119.76 38.14 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.167 -0.958 . . . . 0.0 111.913 -179.915 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.659 HG12 ' CD2' ' A' ' 25' ' ' LEU . 17.2 m -96.92 150.11 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.96 ' HB3' ' O ' ' A' ' 22' ' ' ASP . . . -89.95 121.75 32.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.054 -1.029 . . . . 0.0 111.781 -178.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.081 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 66.5 t -119.56 125.8 27.29 Favored Pre-proline 0 C--N 1.303 -1.452 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 178.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 38' ' ' ALA . 44.8 Cg_endo -71.59 147.39 51.42 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 123.811 1.427 . . . . 0.0 110.929 -178.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.489 ' HA ' ' N ' ' A' ' 136' ' ' ALA . . . -43.03 123.97 3.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.364 -0.835 . . . . 0.0 109.277 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 134' ' ' ALA . . . 61.39 78.8 0.15 Allowed Glycine 0 N--CA 1.486 1.968 0 N-CA-C 108.0 -2.04 . . . . 0.0 108.0 -178.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.667 ' HB2' HG21 ' A' ' 45' ' ' VAL . 2.4 p -85.28 53.63 2.82 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.542 -0.975 . . . . 0.0 110.076 -179.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.566 ' O ' ' O ' ' A' ' 42' ' ' GLN . . . -88.83 -147.49 0.16 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.69 -0.631 . . . . 0.0 110.024 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.701 ' O ' ' CD2' ' A' ' 43' ' ' TYR . 5.8 pt20 38.94 102.98 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 CA-C-O 121.761 0.791 . . . . 0.0 110.522 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.701 ' CD2' ' O ' ' A' ' 42' ' ' GLN . 0.0 OUTLIER 77.7 -20.95 0.35 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.729 -1.232 . . . . 0.0 110.275 -178.797 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.584 ' O ' ' CD1' ' A' ' 43' ' ' TYR . . . 57.71 141.95 0.01 OUTLIER Glycine 0 N--CA 1.492 2.398 0 O-C-N 120.952 -1.092 . . . . 0.0 111.196 178.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.76 HG13 ' HA3' ' A' ' 20' ' ' GLY . 2.5 t -93.35 -172.66 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.306 -1.114 . . . . 0.0 108.762 179.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.604 ' H ' HG12 ' A' ' 45' ' ' VAL . . . 172.13 -175.4 45.41 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 118.635 -1.745 . . . . 0.0 111.464 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.732 HG13 ' O ' ' A' ' 17' ' ' VAL . 35.5 t -150.6 133.75 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.887 HG13 ' HE2' ' A' ' 19' ' ' TYR . 22.5 m -123.66 138.5 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 120.81 -1.181 . . . . 0.0 110.99 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.643 ' CD2' ' CE2' ' A' ' 16' ' ' TRP . 5.2 tp -132.03 98.87 4.55 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.326 -0.859 . . . . 0.0 110.202 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.518 ' O ' ' ND2' ' A' ' 50' ' ' ASN . 3.4 p-10 -73.46 98.88 2.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 0.0 110.091 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 172.7 77.57 0.05 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.672 HG23 ' HA ' ' A' ' 124' ' ' GLN . 12.4 t -134.93 169.17 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.215 -1.168 . . . . 0.0 109.937 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.412 ' O ' HD13 ' A' ' 54' ' ' ILE . . . -136.46 79.7 1.78 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.107 -0.995 . . . . 0.0 110.671 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.836 HD11 HD21 ' A' ' 146' ' ' LEU . 36.0 mm -115.63 158.91 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.209 -0.932 . . . . 0.0 109.934 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.578 ' HA ' HG23 ' A' ' 111' ' ' THR . 3.8 tt0 -152.04 124.25 8.18 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.116 -0.99 . . . . 0.0 110.438 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.53 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 11.5 pt-20 37.73 -152.93 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.669 -0.645 . . . . 0.0 110.789 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.455 ' N ' ' HG3' ' A' ' 56' ' ' GLU . . . -82.03 99.95 2.07 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.651 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.2 m -132.46 174.16 10.55 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.33 -1.1 . . . . 0.0 109.855 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.568 ' N ' ' CG2' ' A' ' 58' ' ' THR . 1.3 m -89.72 152.97 21.06 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.226 -0.921 . . . . 0.0 110.191 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.651 ' CE2' HG22 ' A' ' 58' ' ' THR . 57.9 m-85 -158.6 158.61 34.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.255 -0.903 . . . . 0.0 110.28 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 87.8 m -132.37 117.3 17.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.317 -0.865 . . . . 0.0 109.971 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 20.1 tp -89.73 121.49 31.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.188 -0.945 . . . . 0.0 110.156 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.5 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 9.5 ttp180 -125.78 131.84 52.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 110.12 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 1.196 ' CZ ' HG21 ' A' ' 102' ' ' VAL . 2.7 p90 -169.8 146.64 3.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.221 -0.924 . . . . 0.0 109.975 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.503 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 3.4 m -119.49 101.33 7.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.199 -0.938 . . . . 0.0 109.745 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.659 ' CB ' HD21 ' A' ' 95' ' ' LEU . . . -104.83 150.79 24.52 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.356 -0.84 . . . . 0.0 110.497 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.756 HG23 ' O ' ' A' ' 98' ' ' GLU . 86.0 m -150.43 106.48 3.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.32 -0.863 . . . . 0.0 110.161 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.472 ' O ' ' O ' ' A' ' 96' ' ' THR . . . -95.73 127.04 41.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.206 -0.934 . . . . 0.0 109.951 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 68' ' ' ALA . 39.9 t -42.56 -26.95 0.14 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.284 -0.885 . . . . 0.0 109.843 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.557 ' CG2' ' CB ' ' A' ' 137' ' ' TRP . 2.6 t -108.5 159.95 16.28 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.356 -0.84 . . . . 0.0 110.056 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 60.4 t0 -78.31 78.63 4.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.121 -0.987 . . . . 0.0 109.215 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.702 HG23 ' CB ' ' A' ' 133' ' ' SER . 4.4 p -106.64 145.72 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.186 -0.946 . . . . 0.0 111.239 -178.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.476 ' O ' ' CD1' ' A' ' 132' ' ' PHE . 98.2 m -126.02 91.35 3.36 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.785 HG12 ' CD2' ' A' ' 132' ' ' PHE . 15.4 m -89.77 -152.11 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.196 -0.94 . . . . 0.0 110.833 -178.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.529 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 8.2 mtm180 -129.21 136.34 50.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.332 -0.855 . . . . 0.0 110.647 -179.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.691 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -135.67 153.56 51.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.388 -0.82 . . . . 0.0 109.648 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.891 HD12 ' N ' ' A' ' 78' ' ' VAL . 4.0 pp -179.74 -150.02 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.243 -0.911 . . . . 0.0 110.377 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.891 ' N ' HD12 ' A' ' 77' ' ' LEU . 3.5 t -150.87 170.54 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.29 -0.881 . . . . 0.0 109.616 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.575 ' O ' ' CE1' ' A' ' 112' ' ' TYR . . . -174.83 -162.43 26.3 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.404 -1.379 . . . . 0.0 110.256 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.544 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 3.5 tm0? -120.9 128.21 52.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.448 -1.031 . . . . 0.0 110.655 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.518 ' OD1' ' NE2' ' A' ' 124' ' ' GLN . 4.5 m120 -83.46 67.64 9.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.4 -0.812 . . . . 0.0 109.813 179.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.514 ' N ' ' OE1' ' A' ' 80' ' ' GLN . . . 166.7 141.36 3.13 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.618 ' N ' ' CE1' ' A' ' 85' ' ' TYR . . . -61.97 156.06 59.63 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.245 -1.15 . . . . 0.0 110.134 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.52 ' C ' ' CD2' ' A' ' 85' ' ' TYR . 49.9 Cg_endo -77.22 8.15 17.63 Favored 'Cis proline' 0 C--N 1.312 -1.377 0 C-N-CA 121.692 -2.212 . . . . 0.0 110.904 0.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.618 ' CE1' ' N ' ' A' ' 83' ' ' ALA . 11.7 m-85 70.15 158.19 0.17 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.26 -0.9 . . . . 0.0 110.196 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -177.68 114.27 0.46 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.471 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 1.6 p -89.92 147.15 23.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.243 -1.151 . . . . 0.0 110.329 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.794 HG23 HD12 ' A' ' 89' ' ' LEU . 16.4 m -119.96 -24.0 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.29 -0.881 . . . . 0.0 110.016 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.832 HD22 HG23 ' A' ' 78' ' ' VAL . 4.2 mp -105.74 145.22 31.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 110.792 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -151.19 78.23 1.28 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.326 -0.859 . . . . 0.0 109.996 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.0 p -140.22 170.63 15.48 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.028 -1.045 . . . . 0.0 110.686 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.403 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 1.2 m -120.09 115.62 33.02 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.383 -0.823 . . . . 0.0 110.087 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.691 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 45.2 Cg_endo -70.68 128.76 15.61 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.901 1.474 . . . . 0.0 111.057 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.511 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -94.25 148.12 22.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.32 -0.862 . . . . 0.0 109.407 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.792 ' CD1' HD21 ' A' ' 139' ' ' LEU . 77.1 mt -141.15 157.39 45.33 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.019 -1.051 . . . . 0.0 110.807 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.515 HG23 ' N ' ' A' ' 97' ' ' SER . 6.0 t -164.47 -156.58 0.33 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.407 -0.808 . . . . 0.0 109.902 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.515 ' N ' HG23 ' A' ' 96' ' ' THR . 0.1 OUTLIER -89.11 34.05 0.79 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.177 -0.952 . . . . 0.0 110.244 179.91 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.756 ' O ' HG23 ' A' ' 67' ' ' THR . 0.1 OUTLIER -150.16 168.02 11.83 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.304 -0.872 . . . . 0.0 110.068 179.899 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.476 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 45.5 Cg_endo -72.41 127.74 12.9 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.005 1.529 . . . . 0.0 110.313 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.511 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 1.2 ttm180 -119.46 91.83 3.64 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.179 -0.951 . . . . 0.0 110.152 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.479 ' HG3' ' OG1' ' A' ' 65' ' ' THR . 0.0 OUTLIER -73.89 147.12 43.49 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.341 -0.85 . . . . 0.0 109.963 179.93 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 1.196 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 19.6 t -124.03 135.17 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.227 -0.92 . . . . 0.0 110.296 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.408 ' C ' ' HG3' ' A' ' 104' ' ' GLU . 0.2 OUTLIER -150.18 96.66 2.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.283 -0.886 . . . . 0.0 110.196 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.408 ' HG3' ' C ' ' A' ' 103' ' ' THR . 43.0 mt-10 -142.39 160.09 40.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.216 -0.927 . . . . 0.0 110.256 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 1.2 t -114.97 170.74 8.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.251 -0.906 . . . . 0.0 110.164 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.788 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 41.7 p90 -173.06 153.89 2.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.248 -0.907 . . . . 0.0 110.289 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 58' ' ' THR . 16.4 m -89.92 90.37 8.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.884 . . . . 0.0 109.993 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.632 ' HB3' ' CE2' ' A' ' 60' ' ' TYR . . . -54.15 113.49 1.26 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.296 -0.878 . . . . 0.0 110.393 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 68.7 p -97.33 54.79 1.23 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.224 -0.922 . . . . 0.0 109.993 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.439 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -165.14 -159.0 0.41 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.3 -0.875 . . . . 0.0 110.236 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.578 HG23 ' HA ' ' A' ' 55' ' ' GLU . 13.6 m -147.77 117.9 7.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.223 -0.923 . . . . 0.0 110.342 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.577 ' CD2' HG13 ' A' ' 54' ' ' ILE . 17.4 m-30 -115.9 80.39 8.82 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.29 -0.881 . . . . 0.0 109.841 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.475 ' O ' ' HB2' ' A' ' 122' ' ' GLU . 44.5 Cg_endo -72.32 -164.56 0.18 Allowed 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.92 1.484 . . . . 0.0 110.51 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.209 -0.932 . . . . 0.0 110.25 -179.956 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.521 ' HG2' ' N ' ' A' ' 123' ' ' GLY . 4.9 pm0 . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.017 0.437 . . . . 0.0 110.408 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.544 ' HA2' ' HA ' ' A' ' 80' ' ' GLN . . . -145.82 158.26 27.62 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.672 ' HA ' HG23 ' A' ' 52' ' ' VAL . 3.3 pt20 -150.23 -161.0 1.25 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.071 -1.252 . . . . 0.0 110.748 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.693 HG21 ' HH2' ' A' ' 16' ' ' TRP . 30.4 mt -118.97 148.63 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.49 -0.756 . . . . 0.0 109.413 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.471 ' HB3' ' HG ' ' A' ' 77' ' ' LEU . . . -117.36 120.13 37.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.35 -0.844 . . . . 0.0 111.426 -179.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.544 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 5.3 m-85 -125.14 77.47 1.63 Allowed 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.503 ' HA ' ' CA ' ' A' ' 46' ' ' GLY . 8.4 mt-30 -87.47 121.19 29.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.135 -0.978 . . . . 0.0 111.706 -177.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.833 HD13 HD13 ' A' ' 139' ' ' LEU . 6.4 mt -105.24 49.19 0.81 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.534 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -91.34 137.71 13.95 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.579 ' O ' ' CD1' ' A' ' 132' ' ' PHE . . . 41.96 93.23 0.01 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.785 ' CD2' HG12 ' A' ' 74' ' ' VAL . 13.0 m-85 -154.86 -74.97 0.11 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -1.168 . . . . 0.0 110.353 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.702 ' CB ' HG23 ' A' ' 72' ' ' VAL . 1.4 t -89.5 166.49 13.64 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.026 -1.046 . . . . 0.0 110.26 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -101.85 -59.41 1.71 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.18 -0.95 . . . . 0.0 110.552 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.422 ' C ' ' HA ' ' A' ' 38' ' ' ALA . 15.8 m-20 -73.09 152.45 41.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.189 -0.944 . . . . 0.0 110.261 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.489 ' N ' ' HA ' ' A' ' 38' ' ' ALA . . . -49.2 133.58 18.92 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.19 -0.944 . . . . 0.0 109.925 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 1.081 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 6.2 p90 -147.25 -173.6 4.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.123 -0.985 . . . . 0.0 110.944 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.53 ' CG2' ' N ' ' A' ' 139' ' ' LEU 0.25 0.8 OUTLIER -154.09 178.75 9.61 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.538 -0.726 . . . . 0.0 109.369 -178.372 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.833 HD13 HD13 ' A' ' 129' ' ' LEU . 1.6 mp -138.16 115.93 11.47 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.846 -1.159 . . . . 0.0 112.195 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' CYS . . . . . 0.632 ' HB3' ' HB3' ' A' ' 31' ' ' ALA . 0.8 OUTLIER -103.51 107.44 18.29 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.71 -0.619 . . . . 0.0 110.929 178.351 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.661 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 3.9 mt -94.42 179.92 5.12 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.246 -0.909 . . . . 0.0 108.961 178.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 142' ' ' ASP . 2.0 p30 168.31 61.15 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.044 -1.035 . . . . 0.0 110.578 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.671 ' HA ' HG22 ' A' ' 8' ' ' THR . 0.5 OUTLIER 164.92 45.63 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.444 -0.785 . . . . 0.0 109.355 179.773 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.84 HG11 ' HZ2' ' A' ' 16' ' ' TRP . 1.1 t -89.46 115.66 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.309 -0.87 . . . . 0.0 110.316 -179.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.617 ' HB2' ' HA ' ' A' ' 6' ' ' GLU . . . -144.45 155.37 43.7 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.431 -0.793 . . . . 0.0 110.151 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.836 HD21 HD11 ' A' ' 54' ' ' ILE . 39.4 tp -148.98 141.71 24.53 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.332 -0.855 . . . . 0.0 110.177 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.478 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 0.5 OUTLIER -151.4 176.85 10.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.237 -0.915 . . . . 0.0 110.246 -179.914 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.583 ' HB3' ' CE1' ' A' ' 60' ' ' TYR . 6.2 p . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.153 -0.967 . . . . 0.0 110.249 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo . . . . . 0 N--CA 1.481 0.76 0 N-CA-C 110.06 -0.785 . . . . 0.0 110.06 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.666 HG22 ' O ' ' A' ' 51' ' ' GLY . 27.7 pt -89.8 -34.36 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.195 -0.94 . . . . 0.0 110.09 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.528 ' N ' HG13 ' A' ' 4' ' ' ILE . . . -172.31 -119.93 0.54 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 5' ' ' GLY . 1.9 tt0 178.47 31.58 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.217 -1.166 . . . . 0.0 110.242 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.492 ' O ' ' HA ' ' A' ' 143' ' ' ASP . . . 156.32 -116.74 0.74 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.631 HG22 ' O ' ' A' ' 142' ' ' ASP . 3.8 p -108.03 168.28 9.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -1.151 . . . . 0.0 110.034 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.518 ' O ' ' N ' ' A' ' 11' ' ' ASP . 14.7 m-85 -70.05 -33.92 72.57 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.239 -0.913 . . . . 0.0 109.199 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.57 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 20.0 t70 37.01 27.7 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.734 -0.604 . . . . 0.0 111.384 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.57 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.9 OUTLIER 161.31 -66.55 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.313 -0.867 . . . . 0.0 110.184 179.728 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.47 ' O ' ' HB3' ' A' ' 9' ' ' PHE . . . -122.46 145.67 16.52 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.838 ' HB3' HD12 ' A' ' 32' ' ' LEU . 49.5 Cg_endo -76.02 4.95 4.82 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 O-C-N 124.093 1.575 . . . . 0.0 110.814 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.461 ' CB ' ' O ' ' A' ' 13' ' ' PRO . 1.5 mm-40 67.39 -84.77 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.199 -0.938 . . . . 0.0 110.378 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.803 ' O ' HG13 ' A' ' 17' ' ' VAL . . . -137.84 4.35 3.26 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.905 ' NE1' HD22 ' A' ' 49' ' ' LEU . 51.8 m95 -61.75 87.97 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.133 -1.216 . . . . 0.0 110.095 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.803 HG13 ' O ' ' A' ' 15' ' ' GLY . 1.2 m -93.01 162.88 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.228 -0.92 . . . . 0.0 109.976 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . . . -142.67 129.79 20.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.391 -0.818 . . . . 0.0 109.286 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.57 ' CE2' ' O ' ' A' ' 46' ' ' GLY . 10.6 p90 -118.26 157.14 27.59 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.141 -0.974 . . . . 0.0 111.363 -178.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.649 ' O ' HG22 ' A' ' 45' ' ' VAL . . . 74.97 41.44 32.7 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 1.078 HG22 ' CG1' ' A' ' 45' ' ' VAL . 17.2 p -128.11 -154.09 0.61 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.147 -1.208 . . . . 0.0 110.469 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -100.76 38.11 1.59 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.389 -0.819 . . . . 0.0 110.127 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 124.93 -174.89 17.26 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.465 ' O ' ' O ' ' A' ' 25' ' ' LEU . 46.9 Cg_endo -73.47 134.7 21.03 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.046 1.551 . . . . 0.0 110.615 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.826 ' CB ' HG12 ' A' ' 34' ' ' VAL . 0.8 OUTLIER -49.14 -179.98 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.236 -0.915 . . . . 0.0 110.168 179.899 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -155.67 158.51 38.42 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.138 -0.976 . . . . 0.0 110.233 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.965 ' O ' HG22 ' A' ' 29' ' ' THR . 0.9 OUTLIER -119.92 -75.12 0.59 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.328 -0.857 . . . . 0.0 110.039 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 27' ' ' THR . 1.0 OUTLIER 40.53 27.53 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.445 -0.784 . . . . 0.0 110.624 179.843 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.965 HG22 ' O ' ' A' ' 27' ' ' THR . 9.4 t -164.48 23.75 0.06 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.17 -0.956 . . . . 0.0 110.357 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.525 ' CA ' ' HA ' ' A' ' 10' ' ' ASP . . . 60.36 17.93 48.42 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.595 ' O ' HG22 ' A' ' 27' ' ' THR . . . -142.57 153.93 43.98 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.369 -1.077 . . . . 0.0 110.088 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.838 HD12 ' HB3' ' A' ' 13' ' ' PRO . 0.4 OUTLIER -91.89 95.37 9.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.92 . . . . 0.0 110.162 179.996 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 7.4 m -101.27 99.48 9.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.302 -0.874 . . . . 0.0 110.428 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.826 HG12 ' CB ' ' A' ' 25' ' ' LEU . 20.3 m -89.82 145.67 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.257 -0.902 . . . . 0.0 109.624 179.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.527 ' HA ' ' OG1' ' A' ' 138' ' ' THR . . . -91.43 99.2 12.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.164 -0.96 . . . . 0.0 110.751 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.995 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 62.9 t -84.94 129.35 56.67 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.263 -0.898 . . . . 0.0 109.46 179.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.509 ' HD3' ' HA ' ' A' ' 21' ' ' THR . 38.5 Cg_endo -65.56 178.48 2.14 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 121.704 1.602 . . . . 0.0 112.508 -178.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.528 ' HA ' ' CA ' ' A' ' 136' ' ' ALA . . . -61.27 117.16 5.25 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.519 0.676 . . . . 0.0 111.51 -178.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 134' ' ' ALA . . . 37.22 26.93 0.02 OUTLIER Glycine 0 N--CA 1.493 2.494 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.52 ' OG ' HG23 ' A' ' 45' ' ' VAL . 12.6 t 36.84 73.86 0.09 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.405 -1.056 . . . . 0.0 109.859 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.579 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . -87.77 115.0 24.92 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.669 -0.812 . . . . 0.0 109.977 -179.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.579 ' HG2' ' O ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER 67.37 10.51 7.79 Favored 'General case' 0 N--CA 1.504 2.26 0 CA-C-O 121.399 0.619 . . . . 0.0 109.965 -179.247 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.601 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.1 OUTLIER -132.32 76.02 1.67 Allowed 'General case' 0 C--N 1.289 -2.044 0 C-N-CA 119.551 -0.86 . . . . 0.0 111.719 -178.162 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.475 ' HA2' ' HA3' ' A' ' 130' ' ' GLY . . . -48.8 98.52 0.02 OUTLIER Glycine 0 N--CA 1.484 1.843 0 N-CA-C 107.362 -2.295 . . . . 0.0 107.362 178.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 1.078 ' CG1' HG22 ' A' ' 21' ' ' THR . 2.7 t -86.89 113.7 24.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.185 -1.185 . . . . 0.0 108.693 -178.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.57 ' O ' ' CE2' ' A' ' 19' ' ' TYR . . . -133.35 141.2 12.54 Favored Glycine 0 N--CA 1.487 2.095 0 C-N-CA 119.299 -1.429 . . . . 0.0 110.491 -178.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.709 HG13 ' O ' ' A' ' 17' ' ' VAL . 15.8 t -105.79 123.39 60.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 121.519 -0.989 . . . . 0.0 109.483 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.534 HG13 ' HE2' ' A' ' 19' ' ' TYR . 35.1 m -119.69 140.28 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.003 -1.061 . . . . 0.0 110.72 -179.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.905 HD22 ' NE1' ' A' ' 16' ' ' TRP . 20.7 tp -130.91 98.67 4.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.338 -0.851 . . . . 0.0 110.191 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.503 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 19.4 p30 -77.02 138.22 39.46 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.206 -0.934 . . . . 0.0 110.223 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.666 ' O ' HG22 ' A' ' 4' ' ' ILE . . . 134.15 76.08 0.09 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.582 HG12 ' N ' ' A' ' 53' ' ' ALA . 41.5 t -135.51 171.57 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.192 -1.181 . . . . 0.0 110.148 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.582 ' N ' HG12 ' A' ' 52' ' ' VAL . . . -139.59 81.84 1.85 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.105 -0.997 . . . . 0.0 110.665 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.634 HG21 ' HB1' ' A' ' 108' ' ' ALA . 30.1 mm -119.48 159.86 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.301 -0.874 . . . . 0.0 109.774 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.527 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 6.3 tt0 -152.8 131.75 12.54 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.006 -1.059 . . . . 0.0 110.762 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 19.5 pt-20 37.8 -154.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.64 -0.662 . . . . 0.0 111.022 179.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.473 ' HA2' ' HA ' ' A' ' 109' ' ' SER . . . -84.58 83.47 1.63 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.636 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.2 m -112.05 170.58 8.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -1.166 . . . . 0.0 109.781 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.567 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 0.7 OUTLIER -89.88 154.12 20.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.234 -0.916 . . . . 0.0 110.311 -179.902 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.636 ' CE2' HG22 ' A' ' 58' ' ' THR . 61.8 m-85 -158.95 -179.62 8.21 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.257 -0.902 . . . . 0.0 110.112 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.519 ' O ' HD12 ' A' ' 146' ' ' LEU . 94.6 m -150.01 111.28 4.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.276 -0.89 . . . . 0.0 110.065 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.643 HD22 ' CD2' ' A' ' 89' ' ' LEU . 20.4 tp -89.7 121.3 31.74 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.183 -0.948 . . . . 0.0 110.201 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.514 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 26.5 ttp180 -127.67 138.11 52.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.324 -0.86 . . . . 0.0 109.894 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.519 ' CE2' ' HB ' ' A' ' 102' ' ' VAL . 6.3 p90 -174.9 151.29 1.35 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.278 -0.889 . . . . 0.0 109.821 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.514 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 78.1 m -119.39 91.03 3.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.149 -0.969 . . . . 0.0 110.092 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.566 ' HB1' HD21 ' A' ' 95' ' ' LEU . . . -89.79 143.1 27.08 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.387 -0.821 . . . . 0.0 110.423 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.468 ' OG1' ' HA ' ' A' ' 99' ' ' PRO . 99.4 m -143.84 116.2 8.53 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.281 -0.887 . . . . 0.0 110.205 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.631 ' HB3' ' HB3' ' A' ' 95' ' ' LEU . . . -109.14 126.48 53.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.3 -0.875 . . . . 0.0 109.874 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.433 ' C ' ' O ' ' A' ' 68' ' ' ALA . 0.4 OUTLIER -43.98 -26.41 0.28 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.234 -0.916 . . . . 0.0 109.573 179.709 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.565 HG22 ' HB2' ' A' ' 137' ' ' TRP . 2.7 t -110.41 169.87 8.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.543 -0.723 . . . . 0.0 110.01 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.488 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 12.5 t70 -87.16 51.85 2.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.177 -0.952 . . . . 0.0 108.988 178.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.999 HG23 ' HB2' ' A' ' 133' ' ' SER . 4.0 p -66.62 135.33 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.519 -0.738 . . . . 0.0 111.353 -178.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 92.2 m -119.86 79.89 1.51 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.728 HG21 HD22 ' A' ' 129' ' ' LEU . 7.5 m -89.68 -142.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.317 -0.864 . . . . 0.0 110.443 -178.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.583 ' N ' HG23 ' A' ' 74' ' ' VAL . 0.7 OUTLIER -130.27 145.88 51.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.164 -0.96 . . . . 0.0 110.718 -179.453 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.87 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -146.19 150.42 35.81 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.333 -0.854 . . . . 0.0 109.594 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.015 HD11 ' HB3' ' A' ' 126' ' ' ALA . 1.3 pp 175.6 -158.81 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.258 -0.901 . . . . 0.0 110.489 -179.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.742 HG23 HD22 ' A' ' 89' ' ' LEU . 5.4 t -145.65 167.63 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.415 -0.803 . . . . 0.0 109.299 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.492 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . -178.02 -171.41 41.37 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.168 -1.491 . . . . 0.0 110.444 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.505 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 26.6 tp60 -114.22 102.14 9.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.493 -1.004 . . . . 0.0 110.212 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 0.8 OUTLIER -63.08 95.57 0.08 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.152 -0.968 . . . . 0.0 110.234 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.536 ' C ' ' CE1' ' A' ' 85' ' ' TYR . . . 119.87 130.43 4.0 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.627 ' N ' ' CE1' ' A' ' 85' ' ' TYR . . . -42.99 153.46 0.34 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.294 -1.121 . . . . 0.0 110.196 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.457 ' C ' ' HA ' ' A' ' 83' ' ' ALA . 51.1 Cg_endo -78.09 11.85 16.16 Favored 'Cis proline' 0 C--N 1.312 -1.352 0 C-N-CA 121.648 -2.23 . . . . 0.0 111.066 0.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.627 ' CE1' ' N ' ' A' ' 83' ' ' ALA . 37.1 m-85 61.24 -158.87 0.33 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.098 -1.001 . . . . 0.0 110.197 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 135.9 101.53 0.64 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.8 p -89.84 139.69 30.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.276 -1.131 . . . . 0.0 110.236 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 1.033 HG23 HD12 ' A' ' 89' ' ' LEU . 22.9 m -120.08 -16.77 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.252 -0.905 . . . . 0.0 110.148 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 1.033 HD12 HG23 ' A' ' 88' ' ' VAL . 4.2 mp -118.85 139.59 51.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.296 -0.878 . . . . 0.0 110.978 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -151.12 85.17 1.33 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.425 -0.797 . . . . 0.0 109.969 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.8 p -142.76 -175.59 4.55 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.997 -1.064 . . . . 0.0 110.854 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.53 112.35 35.66 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.444 -0.785 . . . . 0.0 109.905 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.87 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 43.4 Cg_endo -70.77 92.62 0.61 Allowed 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 124.023 1.539 . . . . 0.0 111.109 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.597 ' C ' HD12 ' A' ' 95' ' ' LEU . . . -84.64 129.45 34.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.229 -0.919 . . . . 0.0 109.373 179.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.631 ' HB3' ' HB3' ' A' ' 68' ' ' ALA . 7.5 mp -119.69 -178.53 3.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.046 -1.034 . . . . 0.0 111.083 -179.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -179.99 -178.59 0.43 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.561 -0.712 . . . . 0.0 109.846 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.93 -12.3 17.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.206 -0.934 . . . . 0.0 110.148 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -99.99 158.83 31.34 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.263 -0.898 . . . . 0.0 110.11 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.468 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 44.3 Cg_endo -72.65 140.12 32.11 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.962 1.506 . . . . 0.0 110.348 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.522 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 32.0 ttm-85 -119.91 94.11 4.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.215 -0.928 . . . . 0.0 110.38 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.481 ' HG2' ' OG1' ' A' ' 65' ' ' THR . 17.0 mt-30 -84.98 92.98 8.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.398 -0.813 . . . . 0.0 109.666 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.519 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 38.9 t -89.12 133.6 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.289 -0.882 . . . . 0.0 110.434 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -150.39 130.26 13.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.404 -0.81 . . . . 0.0 110.028 179.96 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -159.19 139.39 12.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.168 -0.957 . . . . 0.0 110.416 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.489 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 88.0 m -94.7 106.65 18.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.305 -0.872 . . . . 0.0 110.123 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.666 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 38.7 p90 -113.24 157.18 22.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.275 -0.891 . . . . 0.0 110.324 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 58' ' ' THR . 26.2 m -89.97 90.17 8.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.292 -0.88 . . . . 0.0 110.016 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.634 ' HB1' HG21 ' A' ' 54' ' ' ILE . . . -45.88 105.44 0.06 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.258 -0.901 . . . . 0.0 110.348 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.473 ' HA ' ' HA2' ' A' ' 57' ' ' GLY . 79.4 p -91.84 51.4 1.83 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.232 -0.917 . . . . 0.0 110.237 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.43 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -159.46 -155.26 0.45 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.259 -0.901 . . . . 0.0 110.242 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 18.7 m -144.91 113.4 6.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.273 -0.892 . . . . 0.0 110.215 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.568 ' CG ' ' HA3' ' A' ' 123' ' ' GLY . 18.0 m-30 -111.2 86.25 6.15 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.288 -0.882 . . . . 0.0 110.101 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.487 ' HD2' ' OE1' ' A' ' 80' ' ' GLN . 44.6 Cg_endo -72.28 140.16 33.33 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.938 1.494 . . . . 0.0 110.333 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.21 -0.931 . . . . 0.0 110.266 -179.911 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.483 ' N ' ' CD ' ' A' ' 122' ' ' GLU . 3.2 pm0 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.23 0.538 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.568 ' HA3' ' CG ' ' A' ' 112' ' ' TYR . . . -89.48 150.55 21.31 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.524 ' O ' HG13 ' A' ' 78' ' ' VAL . 1.2 pp0? -150.31 -157.75 0.85 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.315 -1.109 . . . . 0.0 110.399 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.881 HG21 ' CH2' ' A' ' 16' ' ' TRP . 17.0 mt -118.43 141.55 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.526 -0.734 . . . . 0.0 109.309 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 1.015 ' HB3' HD11 ' A' ' 77' ' ' LEU . . . -117.62 122.8 44.57 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.302 -0.874 . . . . 0.0 111.098 -179.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.479 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 4.1 m-85 -118.73 101.51 8.15 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.597 ' O ' ' CE2' ' A' ' 132' ' ' PHE . 0.4 OUTLIER -89.17 85.41 6.64 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.101 -0.999 . . . . 0.0 112.09 -177.738 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 1.086 HD13 HD13 ' A' ' 139' ' ' LEU . 0.6 OUTLIER -93.38 48.23 1.3 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.325 -0.86 . . . . 0.0 108.887 178.053 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.475 ' HA3' ' HA2' ' A' ' 44' ' ' GLY . . . -108.27 135.63 12.96 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.864 -1.16 . . . . 0.0 110.753 -178.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 130' ' ' GLY . . . 39.14 55.22 2.43 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 179.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.602 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 8.0 m-85 -118.46 -58.02 2.01 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.089 -1.242 . . . . 0.0 110.719 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.999 ' HB2' HG23 ' A' ' 72' ' ' VAL . 1.3 t -88.74 -179.71 6.06 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.921 -1.112 . . . . 0.0 110.283 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -100.69 -74.25 0.62 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.245 -0.909 . . . . 0.0 110.249 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -72.65 174.42 7.6 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.209 -0.932 . . . . 0.0 110.07 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.528 ' CA ' ' HA ' ' A' ' 38' ' ' ALA . . . -70.38 127.94 34.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.274 -0.891 . . . . 0.0 110.286 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.995 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 6.1 p90 -132.27 -161.97 1.19 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.267 -0.895 . . . . 0.0 110.138 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.527 ' OG1' ' HA ' ' A' ' 35' ' ' ALA . 0.8 OUTLIER -160.26 166.18 30.04 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.138 -1.025 . . . . 0.0 110.57 -177.775 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 1.086 HD13 HD13 ' A' ' 129' ' ' LEU . 2.2 mp -124.15 127.51 47.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.461 -0.775 . . . . 0.0 109.282 179.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' CYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 52.9 m -125.27 95.75 4.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.072 -1.017 . . . . 0.0 110.9 -179.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.764 HD12 HD23 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -89.86 -177.69 5.29 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.21 -0.931 . . . . 0.0 109.218 179.033 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.631 ' O ' HG22 ' A' ' 8' ' ' THR . 0.6 OUTLIER 169.37 48.15 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.252 -0.905 . . . . 0.0 110.235 -179.96 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.492 ' HA ' ' O ' ' A' ' 7' ' ' GLY . 11.3 t0 177.05 46.3 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.441 -0.787 . . . . 0.0 109.148 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.663 HG11 ' HZ2' ' A' ' 16' ' ' TRP . 1.0 OUTLIER -89.21 124.74 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.478 -0.764 . . . . 0.0 110.305 -178.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -158.52 152.71 24.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.386 -0.821 . . . . 0.0 110.075 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.519 HD12 ' O ' ' A' ' 61' ' ' THR . 23.1 tp -149.93 153.36 36.5 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.267 -0.895 . . . . 0.0 110.218 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.456 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 34.0 t70 -176.5 152.56 1.07 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.241 -0.912 . . . . 0.0 110.273 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 59' ' ' THR . 78.7 p . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.268 -0.895 . . . . 0.0 110.205 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo . . . . . 0 N--CA 1.484 0.914 0 N-CA-C 110.486 -0.621 . . . . 0.0 110.486 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.579 ' HB ' HD21 ' A' ' 49' ' ' LEU . 6.4 pt -107.71 31.0 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -0.901 . . . . 0.0 110.068 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.436 ' O ' ' HB3' ' A' ' 6' ' ' GLU . . . 81.08 -169.52 51.88 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' A' ' 144' ' ' VAL . 9.0 pt-20 176.29 65.54 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.102 -1.234 . . . . 0.0 110.358 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.595 ' C ' HG23 ' A' ' 8' ' ' THR . . . 164.52 -64.55 0.23 Allowed Glycine 0 N--CA 1.488 2.164 0 C-N-CA 119.689 -1.243 . . . . 0.0 110.002 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.595 HG23 ' C ' ' A' ' 7' ' ' GLY . 73.6 p -156.41 -154.44 0.48 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.216 -1.167 . . . . 0.0 110.302 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.602 ' HZ ' HG21 ' A' ' 144' ' ' VAL . 33.0 m-85 -135.29 42.58 2.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -0.874 . . . . 0.0 110.263 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.55 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 26.7 t0 -88.14 49.01 1.72 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.202 -0.936 . . . . 0.0 110.247 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.55 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.5 OUTLIER 161.66 80.43 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.675 -0.641 . . . . 0.0 109.735 -179.963 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 11' ' ' ASP . . . 62.83 127.3 0.01 OUTLIER Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.52 ' O ' ' N ' ' A' ' 15' ' ' GLY . 50.2 Cg_endo -80.89 42.09 1.27 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 O-C-N 123.839 1.442 . . . . 0.0 110.987 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.441 ' HA ' ' OE1' ' A' ' 14' ' ' GLU . 4.7 mm-40 46.72 -92.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.003 -1.061 . . . . 0.0 110.288 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.705 ' O ' HG13 ' A' ' 17' ' ' VAL . . . -140.61 -0.06 1.85 Allowed Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.818 -1.182 . . . . 0.0 110.469 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.954 ' CH2' HG21 ' A' ' 125' ' ' ILE . 46.6 m95 -53.54 88.63 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.004 -1.292 . . . . 0.0 110.402 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.747 ' O ' HG13 ' A' ' 47' ' ' VAL . 1.0 OUTLIER -87.81 150.67 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.035 -1.04 . . . . 0.0 109.627 179.558 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.721 ' CB ' HG12 ' A' ' 34' ' ' VAL . . . -131.29 158.38 40.79 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.174 -0.954 . . . . 0.0 109.831 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.639 ' CD1' ' N ' ' A' ' 19' ' ' TYR . 3.5 p90 -150.5 166.21 30.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.31 -0.869 . . . . 0.0 110.5 -178.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.516 ' C ' ' CG2' ' A' ' 21' ' ' THR . . . 161.04 -96.78 0.15 Allowed Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.014 -1.634 . . . . 0.0 109.014 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.516 ' CG2' ' C ' ' A' ' 20' ' ' GLY . 6.5 p -153.91 18.39 0.51 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.115 -1.227 . . . . 0.0 111.224 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.699 ' CB ' ' HB1' ' A' ' 35' ' ' ALA . 0.8 OUTLIER -137.36 -179.95 6.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.664 -1.272 . . . . 0.0 110.607 179.743 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 22' ' ' ASP . . . -42.22 164.59 0.02 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 25' ' ' LEU . 45.5 Cg_endo -72.48 160.87 45.71 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.102 1.58 . . . . 0.0 110.409 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.719 HD23 ' H ' ' A' ' 25' ' ' LEU . 0.7 OUTLIER -41.8 151.2 0.09 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.306 -0.871 . . . . 0.0 110.394 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.508 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 79.7 m-20 -124.43 137.11 54.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.317 -0.864 . . . . 0.0 109.829 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.537 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.8 OUTLIER -119.95 -26.76 5.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.099 -1.001 . . . . 0.0 110.55 -179.705 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.684 ' C ' HG22 ' A' ' 29' ' ' THR . 12.0 m -49.75 82.96 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.788 -0.57 . . . . 0.0 111.248 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.684 HG22 ' C ' ' A' ' 28' ' ' SER . 0.0 OUTLIER 166.62 -31.77 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.229 -0.919 . . . . 0.0 109.948 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 128.37 0.32 6.32 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -150.46 161.17 43.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.137 -1.214 . . . . 0.0 110.214 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.544 HD23 ' O ' ' A' ' 32' ' ' LEU . 0.3 OUTLIER -104.08 99.37 9.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.178 -0.951 . . . . 0.0 110.134 179.911 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.585 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 0.8 OUTLIER -96.09 117.0 29.84 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.197 -0.94 . . . . 0.0 111.61 -179.773 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.721 HG12 ' CB ' ' A' ' 18' ' ' ALA . 30.2 m -89.43 149.97 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.699 ' HB1' ' CB ' ' A' ' 22' ' ' ASP . . . -89.83 126.32 35.65 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.016 -1.052 . . . . 0.0 111.529 -178.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.038 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 48.7 t -126.73 119.63 22.78 Favored Pre-proline 0 C--N 1.303 -1.455 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.496 ' HG2' ' HA ' ' A' ' 40' ' ' SER . 39.7 Cg_endo -66.23 -177.74 0.93 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.753 1.397 . . . . 0.0 111.324 -179.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.536 ' HA ' ' N ' ' A' ' 136' ' ' ALA . . . -56.14 126.66 27.05 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.436 -0.79 . . . . 0.0 111.157 -179.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.501 ' O ' ' C ' ' A' ' 40' ' ' SER . . . 40.33 28.05 0.17 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.948 ' OG ' HG23 ' A' ' 45' ' ' VAL . 15.0 t 31.68 60.01 0.3 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.819 -0.812 . . . . 0.0 110.593 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.478 ' O ' ' HB3' ' A' ' 42' ' ' GLN . . . -88.72 95.21 10.18 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.278 -0.889 . . . . 0.0 109.864 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.807 ' NE2' HG22 ' A' ' 45' ' ' VAL . 2.0 pt20 179.83 -150.27 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 121.308 0.575 . . . . 0.0 109.822 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.531 ' CD1' ' HG3' ' A' ' 42' ' ' GLN . 16.0 p90 -61.41 -12.72 15.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.331 -0.856 . . . . 0.0 109.898 179.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.417 ' O ' ' CE2' ' A' ' 43' ' ' TYR . . . 109.75 129.14 5.69 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.948 HG23 ' OG ' ' A' ' 40' ' ' SER . 9.4 t -89.29 170.45 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.173 -1.193 . . . . 0.0 108.572 179.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.519 ' CA ' ' O ' ' A' ' 127' ' ' PHE . . . 169.76 -174.02 43.97 Favored Glycine 0 N--CA 1.487 2.052 0 C-N-CA 118.997 -1.573 . . . . 0.0 110.559 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.747 HG13 ' O ' ' A' ' 17' ' ' VAL . 41.4 t -150.39 129.08 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.602 -0.94 . . . . 0.0 108.781 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.642 ' O ' HG22 ' A' ' 17' ' ' VAL . 32.9 m -119.97 135.68 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.081 -1.012 . . . . 0.0 110.987 -179.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.846 HD22 ' NE1' ' A' ' 16' ' ' TRP . 21.3 tp -128.67 96.71 4.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.393 -0.817 . . . . 0.0 110.24 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.512 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 12.9 p30 -75.13 134.94 41.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.909 . . . . 0.0 110.186 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 136.38 76.85 0.08 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.556 ' CG2' ' HA ' ' A' ' 124' ' ' GLN . 18.1 t -139.37 167.26 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -1.173 . . . . 0.0 110.023 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.413 ' N ' HG12 ' A' ' 52' ' ' VAL . . . -137.75 83.82 2.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.195 -0.941 . . . . 0.0 110.488 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.732 HG21 ' HB1' ' A' ' 108' ' ' ALA . 43.2 mm -115.92 158.78 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.227 -0.92 . . . . 0.0 109.918 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.493 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 7.9 tp10 -151.78 134.34 15.43 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.208 -0.933 . . . . 0.0 110.366 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.565 ' CG ' ' N ' ' A' ' 57' ' ' GLY . 1.1 pt-20 37.03 -157.01 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.698 -0.626 . . . . 0.0 110.73 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.565 ' N ' ' CG ' ' A' ' 56' ' ' GLU . . . -84.04 90.68 1.61 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.633 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.2 m -118.73 173.86 6.62 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.306 -1.114 . . . . 0.0 109.79 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.572 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 0.6 OUTLIER -89.82 153.85 20.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.268 -0.895 . . . . 0.0 110.494 -179.758 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.633 ' CE2' HG22 ' A' ' 58' ' ' THR . 59.2 m-85 -159.88 121.79 3.29 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.271 -0.893 . . . . 0.0 110.218 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 89.2 m -90.87 114.74 27.25 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.213 -0.929 . . . . 0.0 109.983 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.0 tp -89.55 120.85 31.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.209 -0.932 . . . . 0.0 109.945 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.522 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 12.7 ttp180 -125.59 130.17 51.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.309 -0.87 . . . . 0.0 110.227 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 1.122 ' CZ ' HG21 ' A' ' 102' ' ' VAL . 0.8 OUTLIER -170.33 142.98 2.26 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.294 -0.879 . . . . 0.0 109.821 179.756 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.496 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 16.9 m -119.16 97.63 5.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.289 -0.882 . . . . 0.0 110.079 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.697 ' CB ' HD21 ' A' ' 95' ' ' LEU . . . -98.98 149.38 23.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.382 -0.824 . . . . 0.0 110.328 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.749 HG23 ' O ' ' A' ' 98' ' ' GLU . 90.3 m -150.52 102.22 3.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -0.884 . . . . 0.0 110.198 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.47 ' O ' ' O ' ' A' ' 96' ' ' THR . . . -89.82 131.24 35.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.233 -0.917 . . . . 0.0 109.977 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.45 ' C ' ' O ' ' A' ' 68' ' ' ALA . 1.2 p -42.72 -27.17 0.16 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.298 -0.876 . . . . 0.0 109.522 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.599 ' CG2' ' CB ' ' A' ' 137' ' ' TRP . 1.7 t -109.87 161.34 15.56 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.559 -0.713 . . . . 0.0 109.836 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.19 76.69 6.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.056 -1.027 . . . . 0.0 109.25 179.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.791 HG23 ' CB ' ' A' ' 133' ' ' SER . 4.3 p -99.75 135.62 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.27 -0.894 . . . . 0.0 111.292 -178.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 89.6 m -121.09 87.13 2.7 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 1.113 HG21 HD23 ' A' ' 129' ' ' LEU . 5.1 m -89.7 -149.18 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.246 -0.909 . . . . 0.0 110.764 -178.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.482 ' N ' HG23 ' A' ' 74' ' ' VAL . 0.3 OUTLIER -128.43 121.32 28.73 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.262 -0.898 . . . . 0.0 110.656 -179.479 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.508 ' N ' ' HD3' ' A' ' 93' ' ' PRO . . . -119.03 161.36 20.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.217 -0.927 . . . . 0.0 109.643 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.75 ' CD1' ' HB3' ' A' ' 126' ' ' ALA . 3.5 pp 177.15 -158.83 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.128 -0.982 . . . . 0.0 110.463 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.898 HG23 HD22 ' A' ' 89' ' ' LEU . 19.5 t -149.54 165.0 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.433 -0.792 . . . . 0.0 109.266 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.542 ' C ' ' CE1' ' A' ' 112' ' ' TYR . . . -172.81 -166.75 31.79 Favored Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.056 -1.545 . . . . 0.0 110.587 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.54 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 4.7 tp60 -114.34 85.93 2.33 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.508 -0.995 . . . . 0.0 110.391 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 2.1 m-80 -66.0 100.13 0.56 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.066 -1.022 . . . . 0.0 109.308 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.636 ' O ' ' HB2' ' A' ' 83' ' ' ALA . . . 152.0 -87.67 0.14 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.636 ' HB2' ' O ' ' A' ' 82' ' ' GLY . . . 173.24 145.68 0.19 Allowed Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.189 -1.183 . . . . 0.0 110.192 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.511 ' C ' ' CD2' ' A' ' 85' ' ' TYR . 51.0 Cg_endo -84.56 32.8 4.41 Favored 'Cis proline' 0 C--N 1.313 -1.314 0 C-N-CA 121.9 -2.125 . . . . 0.0 110.663 -0.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.575 ' CZ ' ' O ' ' A' ' 82' ' ' GLY . 17.6 m-85 64.47 -172.67 0.18 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.165 -0.959 . . . . 0.0 110.402 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 140.03 99.38 0.41 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.483 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 1.4 p -89.8 143.59 26.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.25 -1.147 . . . . 0.0 110.367 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 1.037 HG23 HD12 ' A' ' 89' ' ' LEU . 27.0 m -123.93 -16.95 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.313 -0.867 . . . . 0.0 110.332 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 1.037 HD12 HG23 ' A' ' 88' ' ' VAL . 4.1 mp -105.36 139.87 39.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.204 -0.935 . . . . 0.0 110.924 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.733 ' O ' HG23 ' A' ' 91' ' ' THR . 1.6 m-20 -150.68 94.29 2.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.379 -0.826 . . . . 0.0 110.194 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.733 HG23 ' O ' ' A' ' 90' ' ' ASP . 3.9 p -160.07 -175.09 4.88 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.162 -0.962 . . . . 0.0 110.44 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.4 p -125.35 128.87 24.63 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.285 -0.885 . . . . 0.0 110.143 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.79 ' HG2' HG22 ' A' ' 74' ' ' VAL . 50.2 Cg_endo -74.14 77.02 2.89 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.883 1.465 . . . . 0.0 110.983 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.683 ' HB3' ' NH1' ' A' ' 100' ' ' ARG . . . -50.47 136.45 20.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.996 -1.065 . . . . 0.0 109.348 179.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.814 ' CD1' HD21 ' A' ' 139' ' ' LEU . 35.4 mt -135.63 168.12 19.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.991 -1.068 . . . . 0.0 110.891 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.762 HG23 ' H ' ' A' ' 98' ' ' GLU . 6.7 t -165.8 -153.18 0.17 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.444 -0.785 . . . . 0.0 109.914 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.529 ' N ' HG23 ' A' ' 96' ' ' THR . 0.1 OUTLIER -85.94 -28.19 24.45 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.103 -0.998 . . . . 0.0 110.391 -179.816 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.762 ' H ' HG23 ' A' ' 96' ' ' THR . 0.6 OUTLIER -89.77 176.5 3.04 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.238 -0.914 . . . . 0.0 110.06 179.974 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.507 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 45.4 Cg_endo -72.09 134.03 22.48 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 123.979 1.515 . . . . 0.0 110.327 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.683 ' NH1' ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.53 84.03 2.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.18 -0.95 . . . . 0.0 110.22 -179.87 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.455 ' HG2' ' OG1' ' A' ' 65' ' ' THR . 17.6 mt-30 -69.02 155.98 39.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.32 -0.862 . . . . 0.0 110.124 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 1.122 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 58.6 t -133.43 133.71 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.25 -0.906 . . . . 0.0 110.111 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.33 111.51 4.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.25 -0.906 . . . . 0.0 110.109 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -153.59 151.59 29.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.159 -0.963 . . . . 0.0 110.356 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -108.39 122.09 46.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.283 -0.886 . . . . 0.0 110.063 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.858 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 41.4 p90 -127.93 153.32 46.82 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.236 -0.915 . . . . 0.0 110.299 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 58' ' ' THR . 3.6 m -89.93 94.24 9.73 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.276 -0.89 . . . . 0.0 110.063 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.732 ' HB1' HG21 ' A' ' 54' ' ' ILE . . . -53.64 99.42 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.244 -0.91 . . . . 0.0 110.309 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.524 ' N ' ' CG1' ' A' ' 88' ' ' VAL . 54.3 p -85.93 55.66 3.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.18 -0.95 . . . . 0.0 109.945 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -160.29 -151.31 0.24 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.315 -0.866 . . . . 0.0 110.298 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.432 HG23 ' HA ' ' A' ' 55' ' ' GLU . 46.2 m -158.14 116.42 3.05 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.323 -0.861 . . . . 0.0 110.414 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.652 ' CE2' HG12 ' A' ' 78' ' ' VAL . 12.7 m-30 -112.22 109.87 53.97 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.302 -0.874 . . . . 0.0 109.784 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.516 ' HD2' ' OE1' ' A' ' 80' ' ' GLN . 47.7 Cg_endo -75.48 96.2 1.03 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.849 1.447 . . . . 0.0 110.539 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.245 -0.91 . . . . 0.0 110.127 179.935 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.487 ' O ' ' HB2' ' A' ' 81' ' ' ASN . 5.0 pt-20 . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 121.177 0.513 . . . . 0.0 110.357 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.582 ' HA3' ' CG ' ' A' ' 112' ' ' TYR . . . -90.59 148.09 19.38 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.592 ' O ' HG13 ' A' ' 78' ' ' VAL . 3.3 pt20 -150.31 -155.66 0.65 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.289 -1.124 . . . . 0.0 110.491 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.954 HG21 ' CH2' ' A' ' 16' ' ' TRP . 7.6 mt -118.22 141.26 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.538 -0.726 . . . . 0.0 109.256 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.75 ' HB3' ' CD1' ' A' ' 77' ' ' LEU . . . -117.6 121.75 41.77 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.36 -0.837 . . . . 0.0 111.291 -179.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.519 ' O ' ' CA ' ' A' ' 46' ' ' GLY . 4.4 m-85 -118.99 91.2 3.5 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 178.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -88.57 93.92 9.71 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.944 -1.097 . . . . 0.0 112.449 -177.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 1.113 HD23 HG21 ' A' ' 74' ' ' VAL . 12.9 mt -90.87 44.16 1.18 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 177.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 131' ' ' GLY . . . -82.29 115.54 4.04 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 -179.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.482 ' HA2' ' O ' ' A' ' 39' ' ' GLY . . . 40.36 93.1 0.01 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.586 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 8.9 m-85 -143.55 -52.59 0.35 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.099 -1.236 . . . . 0.0 110.704 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.791 ' CB ' HG23 ' A' ' 72' ' ' VAL . 1.3 t -89.26 175.3 7.4 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.973 -1.079 . . . . 0.0 110.399 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -80.93 -88.13 0.08 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.257 -0.902 . . . . 0.0 110.033 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 135' ' ' ASP . 3.9 m-20 -67.27 -173.41 0.28 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -0.909 . . . . 0.0 109.774 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.536 ' N ' ' HA ' ' A' ' 38' ' ' ALA . . . -78.94 149.33 32.37 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.229 -0.919 . . . . 0.0 110.248 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 1.038 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 15.1 p90 -151.8 -160.0 1.09 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.152 -0.967 . . . . 0.0 111.162 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.544 ' C ' HD12 ' A' ' 139' ' ' LEU . 0.8 OUTLIER -159.65 178.53 9.74 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -178.596 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.814 HD21 ' CD1' ' A' ' 95' ' ' LEU . 1.7 mp -139.91 115.54 10.09 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.766 -1.209 . . . . 0.0 112.082 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' CYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 0.8 OUTLIER -103.34 104.35 14.45 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.727 -0.608 . . . . 0.0 110.662 178.492 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.535 HD23 ' HB2' ' A' ' 66' ' ' ALA . 1.4 mt -90.22 -178.67 5.45 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.217 -0.927 . . . . 0.0 109.305 179.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.545 ' O ' ' CB ' ' A' ' 143' ' ' ASP . 2.3 p30 166.9 68.24 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.263 -0.898 . . . . 0.0 110.172 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.545 ' CB ' ' O ' ' A' ' 142' ' ' ASP . 0.4 OUTLIER 161.89 42.79 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.879 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.64 HG11 ' CZ2' ' A' ' 16' ' ' TRP . 1.5 t -89.4 115.93 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.418 -0.801 . . . . 0.0 110.684 -178.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.428 ' HB2' ' HA ' ' A' ' 6' ' ' GLU . . . -148.26 139.84 23.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.463 -0.773 . . . . 0.0 109.912 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.579 HD21 HD11 ' A' ' 54' ' ' ILE . 28.6 tp -129.93 152.7 49.12 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.305 -0.872 . . . . 0.0 110.332 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.464 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -161.83 -175.78 4.87 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.248 -0.907 . . . . 0.0 110.149 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.429 ' O ' ' OG ' ' A' ' 148' ' ' SER . 9.3 p . . . . . 0 N--CA 1.493 1.676 0 O-C-N 121.2 -0.937 . . . . 0.0 110.174 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo . . . . . 0 N--CA 1.483 0.873 0 N-CA-C 110.616 -0.571 . . . . 0.0 110.616 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.517 ' CD1' HG12 ' A' ' 144' ' ' VAL . 32.7 pt -107.36 40.41 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.183 -0.948 . . . . 0.0 109.979 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' A' ' 7' ' ' GLY . . . 103.78 -45.48 1.32 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.454 ' HA ' ' HB2' ' A' ' 145' ' ' ALA . 44.4 mt-10 41.67 28.08 0.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.354 -1.086 . . . . 0.0 110.306 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' A' ' 143' ' ' ASP . . . -158.85 -166.28 17.58 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 34.0 p -72.59 165.81 23.96 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.307 -1.113 . . . . 0.0 110.377 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.603 ' CZ ' HG21 ' A' ' 144' ' ' VAL . 3.1 m-30 -93.7 56.57 2.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.336 -0.852 . . . . 0.0 110.135 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.537 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 16.0 t0 -114.39 52.35 0.84 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.183 -0.948 . . . . 0.0 110.202 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.537 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 2.2 t70 161.76 78.14 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.753 -0.592 . . . . 0.0 109.657 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.02 133.51 0.33 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.611 ' HB3' HD12 ' A' ' 32' ' ' LEU . 50.2 Cg_endo -77.3 5.82 4.81 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.943 1.496 . . . . 0.0 110.635 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 0.8 OUTLIER 66.44 -85.72 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.158 -0.964 . . . . 0.0 110.184 -179.853 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.781 ' C ' HD13 ' A' ' 49' ' ' LEU . . . -142.71 8.3 2.26 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.857 ' CD1' HD22 ' A' ' 49' ' ' LEU . 45.9 m95 -72.92 93.03 1.68 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.127 -1.22 . . . . 0.0 110.343 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.821 ' O ' HG13 ' A' ' 47' ' ' VAL . 1.5 m -95.49 152.23 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.148 -0.97 . . . . 0.0 109.895 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.759 ' CB ' HG11 ' A' ' 34' ' ' VAL . . . -129.96 127.54 40.27 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.164 -0.96 . . . . 0.0 109.725 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.585 ' HE2' HG13 ' A' ' 48' ' ' VAL . 10.9 p90 -121.17 158.34 28.19 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.291 -0.881 . . . . 0.0 110.739 -178.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.516 ' CA ' ' OH ' ' A' ' 43' ' ' TYR . . . 90.57 35.01 7.55 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 179.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.5 ' CG2' ' C ' ' A' ' 20' ' ' GLY . 5.4 p -150.89 -154.94 0.58 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.98 -1.306 . . . . 0.0 110.499 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.46 ' O ' ' O ' ' A' ' 23' ' ' GLY . 8.2 t0 -94.87 132.01 40.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.353 -0.842 . . . . 0.0 110.363 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 22' ' ' ASP . . . 44.41 -168.1 0.02 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.58 -159.85 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.062 1.559 . . . . 0.0 110.484 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.933 HD13 HD11 ' A' ' 32' ' ' LEU . 0.4 OUTLIER -101.21 161.39 13.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.258 -0.901 . . . . 0.0 110.222 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -116.86 140.04 49.91 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.205 -0.935 . . . . 0.0 110.008 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.509 ' HA ' ' O ' ' A' ' 31' ' ' ALA . 0.7 OUTLIER -128.24 -22.69 3.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.144 -0.973 . . . . 0.0 111.212 -179.55 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.2 -17.87 0.28 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.26 -0.9 . . . . 0.0 111.173 -179.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.544 HG23 ' H ' ' A' ' 31' ' ' ALA . 2.6 t -72.1 6.37 2.21 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.049 -1.032 . . . . 0.0 111.519 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.55 -12.28 67.81 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.644 ' HB3' ' SG ' ' A' ' 140' ' ' CYS . . . -150.97 167.99 25.92 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.481 -1.011 . . . . 0.0 109.503 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.933 HD11 HD13 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -87.04 90.92 8.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.967 -1.083 . . . . 0.0 110.163 179.906 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.555 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 0.8 OUTLIER -99.45 111.78 24.09 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.387 -0.821 . . . . 0.0 111.507 179.987 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.759 HG11 ' CB ' ' A' ' 18' ' ' ALA . 15.7 m -89.86 146.11 6.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.496 ' O ' ' HB ' ' A' ' 21' ' ' THR . . . -88.55 72.44 8.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.541 -0.725 . . . . 0.0 110.982 -178.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.095 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 56.3 t -58.66 134.07 86.15 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.322 -0.861 . . . . 0.0 109.564 179.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.487 ' HG2' ' HA ' ' A' ' 40' ' ' SER . 39.5 Cg_endo -67.48 176.47 4.88 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.951 1.501 . . . . 0.0 111.501 -179.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.511 ' HA ' ' N ' ' A' ' 136' ' ' ALA . . . -60.9 126.23 26.6 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.509 -0.744 . . . . 0.0 111.463 -178.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.534 ' O ' ' C ' ' A' ' 40' ' ' SER . . . 39.0 26.83 0.05 OUTLIER Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.901 ' OG ' HG23 ' A' ' 45' ' ' VAL . 9.6 t 27.08 59.21 0.09 Allowed 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.886 -0.773 . . . . 0.0 110.9 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.485 ' O ' ' HB3' ' A' ' 42' ' ' GLN . . . -88.36 100.8 13.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.231 -0.918 . . . . 0.0 110.201 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.485 ' HB3' ' O ' ' A' ' 41' ' ' ALA . 0.9 OUTLIER 174.41 -158.78 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.912 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.516 ' OH ' ' CA ' ' A' ' 20' ' ' GLY . 8.9 p90 -50.32 -24.0 2.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.096 -1.002 . . . . 0.0 109.726 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.516 ' O ' ' CE2' ' A' ' 43' ' ' TYR . . . 119.82 129.29 3.82 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.901 HG23 ' OG ' ' A' ' 40' ' ' SER . 6.2 t -89.58 177.05 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.265 -1.138 . . . . 0.0 109.001 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.57 ' O ' ' CZ ' ' A' ' 19' ' ' TYR . . . 166.15 149.32 5.88 Favored Glycine 0 N--CA 1.488 2.153 0 C-N-CA 119.166 -1.492 . . . . 0.0 110.552 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.821 HG13 ' O ' ' A' ' 17' ' ' VAL . 43.8 t -116.24 144.18 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.552 -0.969 . . . . 0.0 109.449 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.585 HG13 ' HE2' ' A' ' 19' ' ' TYR . 29.0 m -138.56 153.96 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.834 -1.166 . . . . 0.0 111.004 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.857 HD22 ' CD1' ' A' ' 16' ' ' TRP . 14.8 tp -140.89 99.66 3.65 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.446 -0.784 . . . . 0.0 109.929 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.513 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 8.6 t30 -78.11 133.34 37.87 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.248 -0.907 . . . . 0.0 110.542 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 139.34 55.32 0.05 OUTLIER Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.639 HG11 ' HD2' ' A' ' 112' ' ' TYR . 53.3 t -120.04 161.11 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.092 -1.24 . . . . 0.0 110.278 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 112' ' ' TYR . . . -130.83 96.8 4.16 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.186 -0.946 . . . . 0.0 110.65 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.758 HG21 ' HB1' ' A' ' 108' ' ' ALA . 50.6 mm -131.65 160.51 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.268 -0.895 . . . . 0.0 109.786 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.528 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 13.2 pt-20 -149.02 130.58 14.88 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.087 -1.008 . . . . 0.0 110.432 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.528 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 10.8 pt-20 38.14 -152.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.646 -0.659 . . . . 0.0 110.85 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.467 ' HA2' ' HA ' ' A' ' 109' ' ' SER . . . -85.28 108.43 3.2 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.671 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.1 m -136.75 174.63 10.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.238 -1.154 . . . . 0.0 109.714 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.574 ' N ' ' CG2' ' A' ' 58' ' ' THR . 0.5 OUTLIER -89.83 145.44 25.16 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.256 -0.903 . . . . 0.0 110.261 -179.922 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.819 ' HB3' HD11 ' A' ' 146' ' ' LEU . 58.5 m-85 -154.41 154.67 33.64 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.313 -0.867 . . . . 0.0 110.271 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 85.3 m -124.1 114.0 19.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.354 -0.841 . . . . 0.0 110.066 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.536 HD22 ' CD2' ' A' ' 89' ' ' LEU . 18.2 tp -89.69 121.81 32.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -0.914 . . . . 0.0 110.105 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.569 ' HD3' HG23 ' A' ' 103' ' ' THR . 8.1 mtt85 -127.33 138.25 52.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.318 -0.864 . . . . 0.0 110.287 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 1.163 ' CZ ' HG21 ' A' ' 102' ' ' VAL . 2.8 p90 -177.92 152.69 0.77 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.395 -0.816 . . . . 0.0 109.796 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.812 HG23 ' HG2' ' A' ' 101' ' ' GLN . 0.2 OUTLIER -119.28 102.8 8.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.121 -0.987 . . . . 0.0 110.105 -179.947 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.697 ' CB ' HD21 ' A' ' 95' ' ' LEU . . . -102.3 141.66 34.78 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.308 -0.87 . . . . 0.0 110.05 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.618 HG23 ' O ' ' A' ' 98' ' ' GLU . 35.0 m -150.14 107.41 3.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.294 -0.879 . . . . 0.0 110.18 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.518 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -98.3 131.68 44.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.281 -0.887 . . . . 0.0 110.169 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 68' ' ' ALA . 0.9 OUTLIER -44.47 -26.23 0.33 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.188 -0.945 . . . . 0.0 109.467 179.528 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.581 ' CG2' ' CB ' ' A' ' 137' ' ' TRP . 1.9 t -110.28 165.27 11.9 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.453 -0.78 . . . . 0.0 109.856 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.489 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 4.8 t0 -84.15 68.97 10.31 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.146 -0.971 . . . . 0.0 109.321 179.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.67 HG23 ' CB ' ' A' ' 133' ' ' SER . 6.1 p -86.89 134.36 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.327 -0.858 . . . . 0.0 111.248 -179.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 23.3 m -120.58 85.26 2.36 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.775 HG22 ' HG2' ' A' ' 93' ' ' PRO . 3.0 m -89.63 -157.95 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.25 -0.906 . . . . 0.0 110.72 -178.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.462 ' N ' HG23 ' A' ' 74' ' ' VAL . 0.4 OUTLIER -120.23 104.06 9.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.357 -0.839 . . . . 0.0 110.278 -179.629 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.67 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -99.9 163.75 12.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.21 -0.931 . . . . 0.0 109.851 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.076 ' CD1' ' HB3' ' A' ' 126' ' ' ALA . 2.0 pp 173.32 -161.1 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.285 -0.884 . . . . 0.0 110.132 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.906 ' CG2' HD22 ' A' ' 89' ' ' LEU . 3.6 t -146.31 168.91 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.275 -0.89 . . . . 0.0 109.58 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.54 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . 175.09 -160.45 29.3 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.416 -1.373 . . . . 0.0 109.934 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.535 ' HG3' ' HA ' ' A' ' 85' ' ' TYR . 4.7 pt20 -125.08 137.12 54.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.275 -1.132 . . . . 0.0 110.642 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -86.62 93.82 9.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.366 -0.834 . . . . 0.0 109.964 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.58 ' O ' ' CD2' ' A' ' 85' ' ' TYR . . . 148.18 -177.39 26.46 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.271 -1.531 . . . . 0.0 109.271 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.542 ' HA ' ' CD1' ' A' ' 85' ' ' TYR . . . -99.61 152.18 37.71 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.275 -1.133 . . . . 0.0 110.231 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.468 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.7 Cg_endo -83.02 30.09 4.69 Favored 'Cis proline' 0 C--N 1.312 -1.349 0 C-N-CA 121.795 -2.169 . . . . 0.0 111.021 -0.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.58 ' CD2' ' O ' ' A' ' 82' ' ' GLY . 57.2 m-85 60.37 -175.6 0.11 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.138 -0.976 . . . . 0.0 110.26 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.468 ' O ' ' HG2' ' A' ' 80' ' ' GLN . . . 161.95 126.67 0.83 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.0 p -120.16 146.2 46.22 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.21 -1.17 . . . . 0.0 110.099 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 1.061 HG23 HD12 ' A' ' 89' ' ' LEU . 28.9 m -125.65 -16.41 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.259 -0.901 . . . . 0.0 110.559 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 1.061 HD12 HG23 ' A' ' 88' ' ' VAL . 4.3 mp -110.88 140.93 44.93 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.118 -0.989 . . . . 0.0 111.18 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.693 ' O ' HG23 ' A' ' 91' ' ' THR . 38.9 p30 -150.9 93.4 1.94 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.411 -0.806 . . . . 0.0 110.161 179.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.693 HG23 ' O ' ' A' ' 90' ' ' ASP . 16.3 p -159.02 -175.96 5.58 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.026 -1.046 . . . . 0.0 110.67 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.476 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 29.0 m -120.0 135.04 24.07 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.312 -0.868 . . . . 0.0 110.075 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.775 ' HG2' HG22 ' A' ' 74' ' ' VAL . 49.5 Cg_endo -87.46 67.91 3.82 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.968 1.509 . . . . 0.0 111.063 -179.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.513 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -45.59 121.91 3.33 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.95 -1.094 . . . . 0.0 109.271 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.697 HD21 ' CB ' ' A' ' 66' ' ' ALA . 15.1 mt -119.87 175.32 5.95 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.086 -1.009 . . . . 0.0 110.901 -179.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.41 HG22 ' C ' ' A' ' 95' ' ' LEU . 0.2 OUTLIER 179.26 -178.87 0.37 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.499 -0.751 . . . . 0.0 109.953 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.94 -14.07 20.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.21 -0.931 . . . . 0.0 110.197 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.618 ' O ' HG23 ' A' ' 67' ' ' THR . 1.7 mt-10 -96.66 157.46 35.24 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.283 -0.886 . . . . 0.0 110.145 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.491 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 45.5 Cg_endo -72.51 137.42 27.84 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.971 1.511 . . . . 0.0 110.367 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.513 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.82 93.05 3.93 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.201 -0.937 . . . . 0.0 110.351 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.812 ' HG2' HG23 ' A' ' 65' ' ' THR . 0.0 OUTLIER -74.04 143.39 45.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.912 . . . . 0.0 109.818 179.633 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 1.163 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 47.5 t -121.16 132.35 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.137 -0.977 . . . . 0.0 110.407 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.569 HG23 ' HD3' ' A' ' 63' ' ' ARG . 0.2 OUTLIER -150.86 94.11 2.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.412 -0.805 . . . . 0.0 110.098 179.919 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -139.95 157.99 44.79 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.132 -0.98 . . . . 0.0 110.447 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -114.8 97.0 6.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.305 -0.872 . . . . 0.0 110.048 179.944 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.596 ' CE1' HD11 ' A' ' 89' ' ' LEU . 36.0 p90 -96.58 155.9 16.57 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.264 -0.898 . . . . 0.0 110.334 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.7 m -90.6 101.92 14.66 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.334 -0.854 . . . . 0.0 110.004 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.758 ' HB1' HG21 ' A' ' 54' ' ' ILE . . . -64.89 102.48 0.6 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.233 -0.917 . . . . 0.0 110.355 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.467 ' HA ' ' HA2' ' A' ' 57' ' ' GLY . 2.9 p -93.95 52.37 1.64 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.258 -0.901 . . . . 0.0 110.023 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -156.91 -158.4 0.77 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.207 -0.933 . . . . 0.0 110.417 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.542 HG22 ' HD3' ' A' ' 113' ' ' PRO . 69.9 m -137.74 111.22 8.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.238 -0.914 . . . . 0.0 110.261 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.639 ' HD2' HG11 ' A' ' 52' ' ' VAL . 15.1 m-30 -106.9 78.03 0.55 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.322 -0.862 . . . . 0.0 110.001 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.542 ' HD3' HG22 ' A' ' 111' ' ' THR . 44.3 Cg_endo -71.36 124.95 10.84 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.836 1.44 . . . . 0.0 110.418 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.276 -0.89 . . . . 0.0 110.33 -179.85 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.499 ' O ' ' HA ' ' A' ' 80' ' ' GLN . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.56 ' HA3' ' CB ' ' A' ' 112' ' ' TYR . . . -125.11 139.14 11.44 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.513 ' CB ' ' HA ' ' A' ' 50' ' ' ASN . 3.2 pt20 -150.39 -160.63 1.2 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.298 -1.119 . . . . 0.0 110.419 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.603 HG21 ' CH2' ' A' ' 16' ' ' TRP . 15.4 mt -118.5 135.06 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.506 -0.746 . . . . 0.0 109.131 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 1.076 ' HB3' ' CD1' ' A' ' 77' ' ' LEU . . . -112.6 123.46 50.35 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.285 -0.884 . . . . 0.0 111.082 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.504 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 4.4 m-85 -119.18 107.16 13.1 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.48 ' O ' ' HB ' ' A' ' 74' ' ' VAL . 10.5 mm-40 -89.48 97.25 11.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.155 -0.966 . . . . 0.0 111.431 -178.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.681 HD22 HG11 ' A' ' 74' ' ' VAL . 24.1 mt -97.13 41.92 1.1 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.355 -0.84 . . . . 0.0 109.191 178.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 131' ' ' GLY . . . -88.65 116.56 4.66 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -179.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 39' ' ' GLY . . . 39.74 92.59 0.01 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.581 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 7.2 m-85 -143.96 -54.42 0.36 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.112 -1.228 . . . . 0.0 110.516 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.67 ' CB ' HG23 ' A' ' 72' ' ' VAL . 1.3 t -89.05 175.15 7.51 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.967 -1.083 . . . . 0.0 110.157 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.2 -91.96 0.08 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.209 -0.932 . . . . 0.0 110.348 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.38 170.32 13.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.162 -0.961 . . . . 0.0 110.122 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.511 ' N ' ' HA ' ' A' ' 38' ' ' ALA . . . -55.55 133.04 50.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.237 -0.914 . . . . 0.0 110.144 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 1.095 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 16.5 p90 -136.23 -161.67 1.19 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.197 -0.939 . . . . 0.0 110.65 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.637 ' C ' HD12 ' A' ' 139' ' ' LEU 0.258 0.9 OUTLIER -156.86 176.76 12.32 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.405 -0.809 . . . . 0.0 110.028 -177.78 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.691 HD21 ' CD1' ' A' ' 95' ' ' LEU . 1.8 mp -145.43 119.42 9.37 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.097 -1.002 . . . . 0.0 112.04 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' CYS . . . . . 0.644 ' SG ' ' HB3' ' A' ' 31' ' ' ALA . 0.8 OUTLIER -99.71 111.68 23.99 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.577 -0.702 . . . . 0.0 110.387 178.349 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.495 ' O ' ' HB3' ' A' ' 142' ' ' ASP . 5.5 mt -103.57 173.89 6.11 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.233 -0.917 . . . . 0.0 109.687 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.563 ' HA ' ' CG ' ' A' ' 9' ' ' PHE . 3.0 p-10 172.09 -177.81 0.06 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.426 -0.796 . . . . 0.0 110.166 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.45 ' HA ' ' O ' ' A' ' 7' ' ' GLY . 19.3 t0 42.07 59.62 2.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.339 -0.85 . . . . 0.0 109.856 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.603 HG21 ' CZ ' ' A' ' 9' ' ' PHE . 1.9 t -100.89 114.45 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.32 -0.863 . . . . 0.0 110.113 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.454 ' HB2' ' HA ' ' A' ' 6' ' ' GLU . . . -144.6 156.25 44.04 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.317 -0.864 . . . . 0.0 110.447 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.819 HD11 ' HB3' ' A' ' 60' ' ' TYR . 35.5 tp -154.58 125.55 7.18 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.321 -0.862 . . . . 0.0 110.094 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.482 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 6.9 m-20 -125.26 179.12 5.22 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.265 -0.897 . . . . 0.0 110.302 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.502 ' HB3' ' CE1' ' A' ' 60' ' ' TYR . 10.9 p . . . . . 0 N--CA 1.493 1.689 0 O-C-N 121.268 -0.895 . . . . 0.0 110.209 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo . . . . . 0 N--CA 1.48 0.679 0 N-CA-C 110.089 -0.774 . . . . 0.0 110.089 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.843 HD11 ' O ' ' A' ' 144' ' ' VAL . 9.4 pt -90.19 -42.78 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.17 -0.956 . . . . 0.0 110.2 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.499 ' O ' ' N ' ' A' ' 7' ' ' GLY . . . 137.38 74.42 0.06 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.623 ' CB ' ' HB2' ' A' ' 145' ' ' ALA . 5.8 pt-20 -42.75 94.95 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.3 -1.118 . . . . 0.0 110.247 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 5' ' ' GLY . . . -172.55 143.94 7.65 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.524 ' CG2' ' HB3' ' A' ' 143' ' ' ASP . 76.8 p -54.79 167.2 0.39 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.344 -1.092 . . . . 0.0 110.161 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.596 ' CD2' ' HA ' ' A' ' 142' ' ' ASP . 22.9 m-85 -91.28 55.54 2.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.243 -0.91 . . . . 0.0 110.131 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.561 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 3.3 p-10 -101.77 38.59 1.6 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.164 -0.96 . . . . 0.0 110.316 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.561 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 1.5 m-20 161.42 79.19 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.637 -0.664 . . . . 0.0 109.723 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 63.69 94.86 0.02 OUTLIER Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.536 ' O ' ' N ' ' A' ' 15' ' ' GLY . 45.1 Cg_endo -72.65 78.6 2.02 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.071 1.564 . . . . 0.0 110.627 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.46 ' HG3' ' HB ' ' A' ' 4' ' ' ILE . 6.9 mm-40 42.25 -91.4 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.35 -0.844 . . . . 0.0 110.627 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.753 ' O ' HG13 ' A' ' 17' ' ' VAL . . . -158.96 24.63 0.34 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.967 ' CE2' HD22 ' A' ' 49' ' ' LEU . 41.5 m95 -56.12 87.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.283 -1.128 . . . . 0.0 110.255 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.753 HG13 ' O ' ' A' ' 15' ' ' GLY . 0.9 OUTLIER -91.28 146.91 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.049 -1.032 . . . . 0.0 109.647 179.743 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.455 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . . . -130.14 135.58 48.36 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.125 -0.985 . . . . 0.0 109.781 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.709 ' HE1' HG13 ' A' ' 48' ' ' VAL . 19.7 p90 -124.3 167.69 13.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.424 -0.797 . . . . 0.0 110.668 -178.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.527 ' CA ' ' OH ' ' A' ' 43' ' ' TYR . . . 75.28 43.79 24.44 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.517 HG22 ' CG1' ' A' ' 45' ' ' VAL . 6.0 p -150.69 -157.23 0.79 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.125 -1.22 . . . . 0.0 110.367 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -93.87 75.92 4.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.32 -0.863 . . . . 0.0 110.23 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.74 -172.09 43.93 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.22 163.62 37.52 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.989 1.521 . . . . 0.0 110.465 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.713 HD23 ' H ' ' A' ' 25' ' ' LEU . 0.7 OUTLIER -68.17 -169.73 0.15 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.283 -0.885 . . . . 0.0 110.24 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -162.4 150.93 14.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.232 -0.918 . . . . 0.0 110.293 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 1.0 HG22 ' O ' ' A' ' 31' ' ' ALA . 0.8 OUTLIER -119.81 -77.48 0.58 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.327 -0.858 . . . . 0.0 110.046 179.933 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 27' ' ' THR . 1.3 m 40.64 27.77 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.431 -0.793 . . . . 0.0 110.476 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.93 HG22 ' O ' ' A' ' 27' ' ' THR . 9.2 t -164.52 30.76 0.07 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.153 -0.967 . . . . 0.0 110.279 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.541 ' HA2' ' CA ' ' A' ' 10' ' ' ASP . . . 53.1 28.38 33.36 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 1.0 ' O ' HG22 ' A' ' 27' ' ' THR . . . -150.13 161.46 42.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.309 -1.113 . . . . 0.0 110.313 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.773 HD23 HD12 ' A' ' 141' ' ' LEU . 0.8 OUTLIER -105.4 98.04 7.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.89 . . . . 0.0 109.562 179.817 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.515 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 64.9 m -107.59 116.35 31.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.244 -0.91 . . . . 0.0 111.01 -179.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.523 HG12 ' CB ' ' A' ' 25' ' ' LEU . 20.3 m -104.03 140.92 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.42 -0.8 . . . . 0.0 109.175 179.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.49 ' O ' ' HB ' ' A' ' 21' ' ' THR . . . -88.96 89.5 8.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.064 -1.023 . . . . 0.0 110.69 -179.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.055 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 43.8 t -71.62 135.79 83.54 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.263 -0.898 . . . . 0.0 109.775 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.516 ' HG3' ' OE1' ' A' ' 42' ' ' GLN . 40.0 Cg_endo -67.74 -174.06 0.55 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.091 1.574 . . . . 0.0 111.652 -179.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.541 ' HA ' ' CA ' ' A' ' 136' ' ' ALA . . . -72.45 118.77 15.76 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.537 -0.727 . . . . 0.0 111.874 -178.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.565 ' O ' ' C ' ' A' ' 40' ' ' SER . . . 52.98 15.25 3.25 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 178.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.565 ' C ' ' O ' ' A' ' 39' ' ' GLY . 49.3 m 25.16 46.73 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.278 0 CA-C-N 118.268 1.034 . . . . 0.0 110.831 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.508 ' N ' ' O ' ' A' ' 39' ' ' GLY . . . -89.09 26.66 1.54 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.475 -0.766 . . . . 0.0 111.167 -178.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.516 ' OE1' ' HG3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -91.98 -153.1 0.32 Allowed 'General case' 0 C--N 1.29 -1.992 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.461 179.183 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.563 ' CE1' ' O ' ' A' ' 44' ' ' GLY . 25.0 p90 -56.57 -16.25 5.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.035 -1.041 . . . . 0.0 109.931 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.563 ' O ' ' CE1' ' A' ' 43' ' ' TYR . . . 123.67 122.64 2.73 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.532 HG12 ' H ' ' A' ' 46' ' ' GLY . 5.2 t -90.04 179.23 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.144 -1.209 . . . . 0.0 109.21 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.532 ' H ' HG12 ' A' ' 45' ' ' VAL . . . 164.0 -175.29 40.15 Favored Glycine 0 N--CA 1.489 2.225 0 C-N-CA 119.097 -1.525 . . . . 0.0 110.772 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.73 HG13 ' O ' ' A' ' 17' ' ' VAL . 21.8 t -151.04 131.47 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.722 -0.869 . . . . 0.0 108.701 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.709 HG13 ' HE1' ' A' ' 19' ' ' TYR . 29.3 m -119.83 131.51 72.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.948 -1.095 . . . . 0.0 110.797 -179.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.967 HD22 ' CE2' ' A' ' 16' ' ' TRP . 21.0 tp -131.91 103.91 6.57 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.377 -0.827 . . . . 0.0 110.365 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.513 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 35.7 p30 -78.73 152.41 31.55 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.253 -0.904 . . . . 0.0 110.285 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 125.33 64.45 0.18 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.589 HG12 ' N ' ' A' ' 53' ' ' ALA . 89.2 t -131.0 172.62 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.155 -1.203 . . . . 0.0 110.134 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.589 ' N ' HG12 ' A' ' 52' ' ' VAL . . . -150.28 85.78 1.4 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.18 -0.95 . . . . 0.0 110.567 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.637 ' CG1' ' CD2' ' A' ' 112' ' ' TYR . 42.4 mm -111.11 159.97 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.244 -0.91 . . . . 0.0 109.912 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.583 ' HA ' HG23 ' A' ' 111' ' ' THR . 72.5 mt-10 -149.52 120.54 7.7 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.119 -0.988 . . . . 0.0 110.471 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.523 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 11.7 pt-20 37.52 -152.0 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.618 -0.676 . . . . 0.0 110.779 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.461 ' N ' ' HG3' ' A' ' 56' ' ' GLU . . . -79.4 114.27 3.84 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.671 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.2 m -144.22 171.76 13.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.267 -1.137 . . . . 0.0 109.772 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.574 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 0.5 OUTLIER -89.8 158.17 17.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.278 -0.889 . . . . 0.0 110.106 179.866 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.867 ' O ' HG22 ' A' ' 105' ' ' THR . 68.4 m-85 -159.2 171.22 20.29 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.249 -0.907 . . . . 0.0 110.244 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.589 ' OG1' HG22 ' A' ' 105' ' ' THR . 25.7 m -150.11 117.28 6.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.317 -0.864 . . . . 0.0 110.211 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 27.5 tp -89.74 122.49 32.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.205 -0.934 . . . . 0.0 110.022 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.51 ' NH2' ' OD2' ' A' ' 143' ' ' ASP . 1.0 OUTLIER -124.92 104.06 8.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.226 -0.921 . . . . 0.0 110.349 -179.757 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 1.16 ' CZ ' HG21 ' A' ' 102' ' ' VAL . 3.0 p90 -150.54 151.78 33.16 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.281 -0.887 . . . . 0.0 110.012 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.508 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 29.4 m -119.88 97.62 5.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.221 -0.925 . . . . 0.0 110.251 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.758 ' CB ' HD21 ' A' ' 95' ' ' LEU . . . -99.65 145.96 27.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 0.0 110.403 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.685 HG23 ' O ' ' A' ' 98' ' ' GLU . 98.9 m -150.32 117.32 5.93 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.302 -0.874 . . . . 0.0 110.08 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.522 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -107.53 133.41 52.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.184 -0.948 . . . . 0.0 110.115 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 68' ' ' ALA . 1.5 m -45.79 -25.71 0.55 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.167 -0.958 . . . . 0.0 109.399 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.558 ' CG2' ' CB ' ' A' ' 137' ' ' TRP . 1.8 t -110.27 169.26 8.85 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.484 -0.76 . . . . 0.0 109.86 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.496 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 2.2 m-20 -86.15 62.34 7.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.179 -0.951 . . . . 0.0 109.181 179.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.947 HG21 ' CE2' ' A' ' 137' ' ' TRP . 3.3 p -86.16 136.58 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.35 -0.844 . . . . 0.0 111.203 -179.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 67.0 m -122.95 92.08 3.63 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.71 HG21 HD22 ' A' ' 129' ' ' LEU . 4.3 m -89.97 -153.07 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.158 -0.964 . . . . 0.0 110.628 -178.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.464 ' N ' HG23 ' A' ' 74' ' ' VAL . 5.0 mtm180 -127.7 128.73 45.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.313 -0.867 . . . . 0.0 110.577 -179.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.613 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -131.22 155.41 47.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.335 -0.853 . . . . 0.0 109.786 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.669 HD12 ' C ' ' A' ' 77' ' ' LEU . 3.8 pp 178.55 -154.46 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.272 -0.892 . . . . 0.0 110.281 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.732 HG23 HD22 ' A' ' 89' ' ' LEU . 4.3 t -146.87 171.92 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.289 -0.882 . . . . 0.0 109.357 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.494 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . 178.78 -176.3 47.89 Favored Glycine 0 N--CA 1.49 2.258 0 C-N-CA 119.363 -1.399 . . . . 0.0 110.056 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.542 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 5.1 tp60 -112.64 86.85 2.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.393 -1.063 . . . . 0.0 110.21 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.472 ' N ' ' O ' ' A' ' 122' ' ' GLU . 3.6 m-80 -64.68 97.39 0.21 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.135 -0.978 . . . . 0.0 109.681 179.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.585 ' O ' ' CZ ' ' A' ' 85' ' ' TYR . . . 149.13 -88.69 0.14 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.513 ' HB2' ' O ' ' A' ' 82' ' ' GLY . . . 178.83 146.67 0.37 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.187 -1.184 . . . . 0.0 110.054 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.488 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.5 Cg_endo -85.44 36.06 3.21 Favored 'Cis proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.921 -2.116 . . . . 0.0 110.616 -0.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.585 ' CZ ' ' O ' ' A' ' 82' ' ' GLY . 98.9 m-85 59.17 -168.91 0.14 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.263 -0.898 . . . . 0.0 110.399 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 135.77 110.54 1.07 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -89.76 140.5 29.53 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.22 -1.165 . . . . 0.0 110.389 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.796 HG23 ' CD1' ' A' ' 89' ' ' LEU . 30.6 m -119.78 -17.98 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.409 -0.807 . . . . 0.0 109.746 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.866 HD11 ' CZ ' ' A' ' 106' ' ' PHE . 4.4 mp -121.55 143.26 49.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.401 -0.812 . . . . 0.0 110.784 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -151.15 78.88 1.3 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.886 . . . . 0.0 110.074 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 36.3 p -147.04 174.05 11.9 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.039 -1.038 . . . . 0.0 110.708 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.416 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 1.3 m -119.81 120.31 30.56 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.395 -0.815 . . . . 0.0 109.848 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.626 ' HG2' HG22 ' A' ' 74' ' ' VAL . 43.6 Cg_endo -70.61 117.49 5.17 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.928 1.489 . . . . 0.0 111.125 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.526 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -86.18 138.96 31.49 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.896 . . . . 0.0 109.339 179.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.826 HD13 ' HG ' ' A' ' 139' ' ' LEU . 72.4 mt -130.66 169.46 15.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.033 -1.042 . . . . 0.0 110.883 -179.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -178.34 -178.75 0.64 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.488 -0.757 . . . . 0.0 109.938 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.61 -23.72 67.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.887 . . . . 0.0 110.17 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.685 ' O ' HG23 ' A' ' 67' ' ' THR . 4.3 mt-10 -89.8 165.17 25.95 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.292 -0.88 . . . . 0.0 110.178 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.492 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 45.1 Cg_endo -72.45 133.18 20.31 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.946 1.498 . . . . 0.0 110.29 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.526 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.79 81.05 1.67 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.206 -0.934 . . . . 0.0 110.289 -179.927 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.45 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 0.0 OUTLIER -68.12 158.22 33.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.25 -0.906 . . . . 0.0 110.015 179.827 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 1.16 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 65.3 t -133.67 132.38 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.174 -0.954 . . . . 0.0 110.434 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -150.57 89.21 1.54 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.405 -0.809 . . . . 0.0 110.035 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' A' ' 61' ' ' THR . 1.2 mm-40 -141.38 168.78 18.97 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.155 -0.966 . . . . 0.0 110.273 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.867 HG22 ' O ' ' A' ' 60' ' ' TYR . 0.6 OUTLIER -121.98 -179.51 4.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.309 -0.869 . . . . 0.0 110.172 -179.992 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.866 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 53.7 p90 -177.96 155.47 0.98 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.217 -0.927 . . . . 0.0 110.259 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 58' ' ' THR . 99.3 m -91.25 95.79 10.22 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.223 -0.923 . . . . 0.0 110.132 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.776 ' HB3' ' CE2' ' A' ' 60' ' ' TYR . . . -65.72 113.67 4.44 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -0.918 . . . . 0.0 110.44 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.412 ' O ' ' OG ' ' A' ' 109' ' ' SER . 5.8 p -98.42 55.87 1.12 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.208 -0.933 . . . . 0.0 109.958 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.433 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -158.19 -160.62 0.92 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.256 -0.902 . . . . 0.0 110.455 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.583 HG23 ' HA ' ' A' ' 55' ' ' GLU . 10.5 m -152.54 118.17 5.35 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.347 -0.845 . . . . 0.0 110.34 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.637 ' CD2' ' CG1' ' A' ' 54' ' ' ILE . 11.2 m-30 -113.08 94.17 28.94 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.256 -0.903 . . . . 0.0 109.85 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.476 ' O ' ' HB2' ' A' ' 122' ' ' GLU . 45.7 Cg_endo -72.94 139.72 30.55 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.022 1.538 . . . . 0.0 110.51 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.242 -0.911 . . . . 0.0 110.246 179.95 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' A' ' 113' ' ' PRO . 14.7 pt-20 . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 121.201 0.524 . . . . 0.0 110.405 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.542 ' HA2' ' HA ' ' A' ' 80' ' ' GLN . . . -99.69 144.85 17.21 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.513 ' CB ' ' HA ' ' A' ' 50' ' ' ASN . 2.1 pt20 -150.49 -153.82 0.51 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.208 -1.172 . . . . 0.0 110.597 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.751 HG21 ' HH2' ' A' ' 16' ' ' TRP . 21.6 mt -118.63 142.2 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.515 -0.74 . . . . 0.0 109.297 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.639 ' HB3' ' CD1' ' A' ' 77' ' ' LEU . . . -113.64 115.87 28.58 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.395 -0.816 . . . . 0.0 111.774 -178.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.539 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 4.5 m-85 -119.75 74.28 1.01 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.135 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.928 ' C ' HD23 ' A' ' 129' ' ' LEU . 2.3 mt-30 -87.26 126.54 34.89 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.207 -0.933 . . . . 0.0 112.146 -177.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.928 HD23 ' C ' ' A' ' 128' ' ' GLN . 1.4 mt -112.77 55.38 0.69 Allowed 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 131' ' ' GLY . . . -73.28 85.3 0.6 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.499 ' HA2' ' O ' ' A' ' 39' ' ' GLY . . . 58.44 114.61 0.01 OUTLIER Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.639 ' CD2' HG12 ' A' ' 74' ' ' VAL . 10.3 m-85 -147.4 -57.16 0.25 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -1.148 . . . . 0.0 110.206 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.673 ' CB ' HG23 ' A' ' 72' ' ' VAL . 5.9 t -89.69 173.79 8.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.149 -0.969 . . . . 0.0 110.187 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -74.84 -93.73 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.213 -0.93 . . . . 0.0 110.208 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.33 -167.84 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.081 -1.012 . . . . 0.0 109.937 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.541 ' CA ' ' HA ' ' A' ' 38' ' ' ALA . . . -77.58 150.07 34.76 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.214 -0.929 . . . . 0.0 110.375 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 1.055 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 24.3 p90 -148.49 -154.81 0.58 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.315 -0.866 . . . . 0.0 110.11 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.522 ' O ' ' CB ' ' A' ' 68' ' ' ALA . 1.0 OUTLIER -160.43 163.17 33.26 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.922 -1.111 . . . . 0.0 111.296 -178.21 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.826 ' HG ' HD13 ' A' ' 95' ' ' LEU . 2.1 mp -126.52 125.74 42.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.429 -0.794 . . . . 0.0 109.56 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' CYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 41.1 m -121.01 99.45 6.5 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.107 -0.995 . . . . 0.0 110.713 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.773 HD12 HD23 ' A' ' 32' ' ' LEU . 2.2 mt -89.64 -154.67 0.33 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.317 -0.864 . . . . 0.0 109.479 179.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.92 ' O ' HG23 ' A' ' 144' ' ' VAL . 39.7 p-10 -177.78 -151.49 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.187 -0.946 . . . . 0.0 110.03 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.524 ' HB3' ' CG2' ' A' ' 8' ' ' THR . 23.6 p-10 -40.56 115.05 0.52 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.526 -0.734 . . . . 0.0 109.785 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.92 HG23 ' O ' ' A' ' 142' ' ' ASP . 43.0 t -128.85 125.09 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.284 -0.885 . . . . 0.0 110.244 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.623 ' HB2' ' CB ' ' A' ' 6' ' ' GLU . . . -136.89 178.82 6.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.292 -0.88 . . . . 0.0 110.658 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.553 HD12 ' O ' ' A' ' 61' ' ' THR . 14.4 tp -158.93 118.7 3.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.384 -0.823 . . . . 0.0 109.947 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.505 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 49.3 m-20 -113.15 141.05 47.38 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.228 -0.92 . . . . 0.0 110.415 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.573 ' HB3' ' CE1' ' A' ' 60' ' ' TYR . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.321 -0.862 . . . . 0.0 110.224 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo . . . . . 0 N--CA 1.48 0.728 0 N-CA-C 110.053 -0.787 . . . . 0.0 110.053 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.554 HG22 ' O ' ' A' ' 51' ' ' GLY . 9.5 pt -89.88 34.91 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.151 -0.968 . . . . 0.0 110.166 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.42 ' O ' ' C ' ' A' ' 6' ' ' GLU . . . 89.62 -34.14 4.14 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.59 ' HG3' ' HB2' ' A' ' 145' ' ' ALA . 30.4 tt0 42.86 41.47 2.57 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.34 -1.094 . . . . 0.0 110.172 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 143' ' ' ASP . . . -126.26 169.93 18.15 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 142' ' ' ASP . 12.7 p -83.7 42.51 0.85 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.275 -1.132 . . . . 0.0 110.522 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.77 ' HB3' HG21 ' A' ' 27' ' ' THR . 15.7 m-30 41.29 32.54 0.21 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.27 -0.894 . . . . 0.0 110.381 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.539 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 35.4 p-10 -89.35 46.4 1.37 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.167 -0.958 . . . . 0.0 110.316 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.539 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.3 OUTLIER 161.52 -22.56 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.798 -0.564 . . . . 0.0 109.75 179.962 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 167.58 110.74 0.23 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.81 ' HG3' HD12 ' A' ' 32' ' ' LEU . 49.9 Cg_endo -76.59 72.75 5.48 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.984 1.518 . . . . 0.0 110.778 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.519 ' HG3' HD11 ' A' ' 49' ' ' LEU . 12.8 tp10 41.32 -92.1 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.293 -0.879 . . . . 0.0 110.509 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.573 ' C ' HD13 ' A' ' 49' ' ' LEU . . . -157.71 43.24 0.51 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.945 ' NE1' HD22 ' A' ' 49' ' ' LEU . 37.9 m95 -66.47 127.88 34.01 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.32 -1.106 . . . . 0.0 110.288 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.724 HG22 ' O ' ' A' ' 48' ' ' VAL . 1.3 m -122.32 154.73 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.135 -0.978 . . . . 0.0 109.689 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.459 ' HB2' HG11 ' A' ' 34' ' ' VAL . . . -137.1 154.83 50.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.303 -0.873 . . . . 0.0 109.526 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.743 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.6 OUTLIER -139.47 138.67 36.62 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.06 -1.025 . . . . 0.0 111.13 -178.752 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.589 ' HA2' ' CE1' ' A' ' 43' ' ' TYR . . . 121.26 84.3 0.77 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.655 HG21 ' HB3' ' A' ' 37' ' ' PRO . 1.7 p 53.15 17.6 1.0 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.508 -0.995 . . . . 0.0 110.955 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 1.031 ' HA ' ' HB3' ' A' ' 35' ' ' ALA . 5.9 p30 -101.89 111.36 23.59 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.083 -1.011 . . . . 0.0 110.284 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 22' ' ' ASP . . . -59.94 -152.91 0.02 OUTLIER Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.022 -1.631 . . . . 0.0 109.022 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.455 ' O ' ' C ' ' A' ' 25' ' ' LEU . 47.0 Cg_endo -74.4 95.63 0.94 Allowed 'Trans proline' 0 C--N 1.303 -1.86 0 O-C-N 123.814 1.429 . . . . 0.0 110.307 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.716 HD23 ' H ' ' A' ' 25' ' ' LEU . 0.8 OUTLIER -40.65 150.39 0.07 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.354 -0.841 . . . . 0.0 109.771 179.808 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -146.6 159.77 43.03 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.98 -1.075 . . . . 0.0 110.757 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.77 HG21 ' HB3' ' A' ' 9' ' ' PHE . 3.7 p -119.63 -55.86 2.08 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.321 -0.862 . . . . 0.0 110.161 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 50.57 -89.58 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.275 -0.891 . . . . 0.0 110.228 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.514 ' N ' ' O ' ' A' ' 27' ' ' THR . 15.2 t -55.71 -17.19 5.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.243 -0.911 . . . . 0.0 110.161 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 9' ' ' PHE . . . 111.65 32.55 2.46 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.503 ' HA ' ' O ' ' A' ' 141' ' ' LEU . . . -140.52 109.97 6.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.272 -1.134 . . . . 0.0 110.274 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.81 HD12 ' HG3' ' A' ' 13' ' ' PRO . 0.6 OUTLIER -67.17 94.31 0.35 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.266 -0.896 . . . . 0.0 109.991 179.912 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.518 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 59.0 m -99.4 133.09 44.2 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.31 -0.869 . . . . 0.0 110.574 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.625 HG12 ' HB3' ' A' ' 25' ' ' LEU . 6.2 m -121.62 167.28 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.571 -0.705 . . . . 0.0 109.4 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 1.031 ' HB3' ' HA ' ' A' ' 22' ' ' ASP . . . -103.15 128.46 50.08 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.126 -0.984 . . . . 0.0 111.887 -178.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.999 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 90.3 t -117.5 121.47 32.01 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.163 -0.961 . . . . 0.0 108.991 178.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.655 ' HB3' HG21 ' A' ' 21' ' ' THR . 38.2 Cg_endo -64.25 173.99 4.6 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.856 1.45 . . . . 0.0 112.196 -178.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.54 ' HA ' ' CA ' ' A' ' 136' ' ' ALA . . . -53.31 122.28 9.27 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.514 0.673 . . . . 0.0 111.456 -178.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.513 ' O ' ' C ' ' A' ' 40' ' ' SER . . . 37.89 27.17 0.03 OUTLIER Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.972 ' OG ' HG23 ' A' ' 45' ' ' VAL . 31.3 t 32.77 46.39 0.08 Allowed 'General case' 0 N--CA 1.498 1.934 0 CA-C-N 118.045 0.923 . . . . 0.0 110.15 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.644 ' O ' ' CG ' ' A' ' 42' ' ' GLN . . . -89.51 119.02 29.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.594 -0.692 . . . . 0.0 110.127 -179.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.644 ' CG ' ' O ' ' A' ' 41' ' ' ALA . 0.5 OUTLIER 84.1 28.64 0.08 Allowed 'General case' 0 N--CA 1.508 2.433 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -179.492 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.641 ' CE2' ' CG2' ' A' ' 21' ' ' THR . 0.1 OUTLIER -146.4 -33.27 0.32 Allowed 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 118.757 -1.177 . . . . 0.0 112.335 -177.878 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 43' ' ' TYR . . . 52.26 75.28 0.23 Allowed Glycine 0 N--CA 1.482 1.758 0 N-CA-C 105.849 -2.9 . . . . 0.0 105.849 -177.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.972 HG23 ' OG ' ' A' ' 40' ' ' SER . 2.6 t -85.68 160.76 3.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.513 -0.992 . . . . 0.0 109.186 -177.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.577 ' O ' ' CE1' ' A' ' 19' ' ' TYR . . . 176.68 164.66 30.98 Favored Glycine 0 N--CA 1.488 2.102 0 C-N-CA 119.357 -1.402 . . . . 0.0 110.08 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.681 HG13 ' O ' ' A' ' 17' ' ' VAL . 17.8 t -124.59 125.53 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.473 -1.016 . . . . 0.0 109.626 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.724 ' O ' HG22 ' A' ' 17' ' ' VAL . 33.8 m -119.73 139.89 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.007 -1.058 . . . . 0.0 110.842 -179.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.945 HD22 ' NE1' ' A' ' 16' ' ' TRP . 18.4 tp -132.08 99.25 4.66 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.318 -0.864 . . . . 0.0 110.086 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.531 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 10.6 p30 -73.38 121.52 20.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.245 -0.909 . . . . 0.0 110.429 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.554 ' O ' HG22 ' A' ' 4' ' ' ILE . . . 150.54 65.85 0.01 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.864 -1.295 . . . . 0.0 109.864 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.656 HG23 ' HA ' ' A' ' 124' ' ' GLN . 53.1 t -122.61 169.68 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.137 -1.213 . . . . 0.0 110.073 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.562 ' N ' HG12 ' A' ' 52' ' ' VAL . . . -141.41 88.63 2.16 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.151 -0.968 . . . . 0.0 110.613 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.669 HG21 ' HB1' ' A' ' 108' ' ' ALA . 36.1 mm -122.14 163.0 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.292 -0.88 . . . . 0.0 109.718 179.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.524 ' HA ' HG23 ' A' ' 111' ' ' THR . 2.0 tt0 -150.25 127.05 11.02 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.044 -1.035 . . . . 0.0 110.778 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.52 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 13.6 pt-20 37.56 -157.86 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.642 -0.661 . . . . 0.0 111.093 179.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' A' ' 109' ' ' SER . . . -79.04 82.84 1.32 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.639 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.3 m -110.16 170.46 8.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.266 -1.137 . . . . 0.0 109.779 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.576 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 6.5 m -89.87 154.58 19.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.175 -0.953 . . . . 0.0 110.33 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.639 ' CE2' HG22 ' A' ' 58' ' ' THR . 60.3 m-85 -159.77 173.06 16.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.332 -0.855 . . . . 0.0 110.225 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 27.4 m -150.14 116.01 5.6 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.3 -0.875 . . . . 0.0 110.036 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 103' ' ' THR . 38.3 tp -89.78 122.6 33.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.265 -0.897 . . . . 0.0 110.057 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.584 ' HG2' HG23 ' A' ' 103' ' ' THR . 16.1 mtt180 -131.81 106.46 8.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.332 -0.855 . . . . 0.0 110.233 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.496 ' C ' ' CD1' ' A' ' 64' ' ' TYR . 10.0 p90 -143.04 159.62 41.92 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.246 -0.908 . . . . 0.0 110.236 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.504 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 1.3 m -119.96 102.35 8.49 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.179 -0.951 . . . . 0.0 109.866 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.708 ' CB ' HD21 ' A' ' 95' ' ' LEU . . . -104.83 149.47 25.63 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.273 -0.892 . . . . 0.0 110.699 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.498 HG23 ' O ' ' A' ' 98' ' ' GLU . 93.5 m -150.22 126.01 10.4 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.444 -0.785 . . . . 0.0 110.025 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -114.32 136.96 52.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.211 -0.931 . . . . 0.0 109.999 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' ' 68' ' ' ALA . 0.4 OUTLIER -44.03 -26.57 0.3 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.189 -0.944 . . . . 0.0 109.344 179.528 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.567 ' CG2' ' CB ' ' A' ' 137' ' ' TRP . 2.7 t -114.07 169.39 9.04 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.51 -0.744 . . . . 0.0 109.824 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.506 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 33.7 p-10 -85.07 66.02 9.53 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.137 -0.977 . . . . 0.0 109.201 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.964 HG23 ' HB2' ' A' ' 133' ' ' SER . 4.0 p -89.39 140.36 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -0.885 . . . . 0.0 111.483 -178.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.44 HG22 ' O ' ' A' ' 73' ' ' THR . 16.8 m -127.72 87.21 2.58 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 1.085 HG21 ' CD2' ' A' ' 129' ' ' LEU . 2.8 m -89.78 -140.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.238 -0.914 . . . . 0.0 110.483 -178.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.764 ' N ' HG23 ' A' ' 74' ' ' VAL . 7.0 mtm180 -127.74 149.07 50.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.169 -0.957 . . . . 0.0 110.767 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.592 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -150.11 152.47 34.81 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.399 -0.813 . . . . 0.0 109.421 179.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.909 HD12 ' N ' ' A' ' 78' ' ' VAL . 3.9 pp 179.87 -147.15 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.181 -0.949 . . . . 0.0 110.294 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.925 HG23 HD22 ' A' ' 89' ' ' LEU . 6.8 t -151.29 169.59 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.215 -0.928 . . . . 0.0 109.431 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.543 ' C ' ' CE1' ' A' ' 112' ' ' TYR . . . -172.42 -173.59 39.14 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.236 -1.459 . . . . 0.0 110.252 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.543 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 4.3 pt20 -115.88 108.0 15.73 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.466 -1.02 . . . . 0.0 110.163 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.477 ' HB2' ' HG2' ' A' ' 122' ' ' GLU . 6.2 m-20 -66.61 92.97 0.22 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.193 -0.942 . . . . 0.0 110.236 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.538 ' C ' ' CE1' ' A' ' 85' ' ' TYR . . . 142.8 144.23 4.27 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.654 -1.379 . . . . 0.0 109.654 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.618 ' N ' ' CE1' ' A' ' 85' ' ' TYR . . . -62.7 157.02 61.45 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.226 -1.161 . . . . 0.0 110.27 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.517 ' C ' ' CD2' ' A' ' 85' ' ' TYR . 50.6 Cg_endo -77.38 8.54 17.89 Favored 'Cis proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.647 -2.23 . . . . 0.0 110.876 -0.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.618 ' CE1' ' N ' ' A' ' 83' ' ' ALA . 11.6 m-85 69.83 161.34 0.21 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.241 -0.912 . . . . 0.0 110.262 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.498 ' N ' ' CG ' ' A' ' 80' ' ' GLN . . . 166.76 106.6 0.19 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.484 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 1.0 OUTLIER -89.55 152.38 21.45 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.121 -1.223 . . . . 0.0 110.464 -179.787 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 1.125 HG23 HD12 ' A' ' 89' ' ' LEU . 33.2 m -119.72 -24.92 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.35 -0.844 . . . . 0.0 109.8 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 1.125 HD12 HG23 ' A' ' 88' ' ' VAL . 3.6 mp -99.16 141.8 31.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.285 -0.884 . . . . 0.0 110.73 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 45.5 p-10 -151.34 73.92 1.11 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.393 -0.817 . . . . 0.0 110.032 179.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 41.5 p -135.35 176.03 9.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.051 -1.031 . . . . 0.0 110.643 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 1.4 m -122.01 121.33 28.05 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.385 -0.822 . . . . 0.0 109.949 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.592 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 44.7 Cg_endo -70.92 155.38 62.2 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.919 1.484 . . . . 0.0 110.898 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.519 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -122.26 137.47 54.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.449 -0.782 . . . . 0.0 109.463 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.708 HD21 ' CB ' ' A' ' 66' ' ' ALA . 93.0 mt -131.96 169.03 16.88 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.104 -0.997 . . . . 0.0 110.625 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.589 HG23 ' H ' ' A' ' 98' ' ' GLU . 5.9 t -174.65 -155.08 0.06 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.428 -0.795 . . . . 0.0 110.0 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.536 ' N ' HG23 ' A' ' 96' ' ' THR . 0.9 OUTLIER -89.7 24.33 2.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.261 -0.899 . . . . 0.0 110.128 179.956 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.589 ' H ' HG23 ' A' ' 96' ' ' THR . 0.0 OUTLIER -147.57 172.03 5.65 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.35 -0.844 . . . . 0.0 110.012 179.882 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.51 ' HD2' ' CG ' ' A' ' 98' ' ' GLU . 45.2 Cg_endo -72.82 127.45 12.28 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.979 1.515 . . . . 0.0 110.443 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.519 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 6.6 mtt-85 -119.51 93.1 3.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.261 -0.9 . . . . 0.0 109.867 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -78.06 102.71 7.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.448 -0.783 . . . . 0.0 110.569 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 50.2 t -89.41 134.13 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.241 -0.912 . . . . 0.0 109.805 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.584 HG23 ' HG2' ' A' ' 63' ' ' ARG . 0.2 OUTLIER -147.05 133.09 19.22 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.16 -0.963 . . . . 0.0 110.247 -179.884 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 103' ' ' THR . 1.8 mt-10 -160.25 134.72 7.5 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.259 -0.901 . . . . 0.0 110.333 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 25.2 m -90.68 143.82 26.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.281 -0.887 . . . . 0.0 110.125 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.913 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 41.7 p90 -154.48 159.85 41.25 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.234 -0.916 . . . . 0.0 110.259 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.489 ' HA ' ' O ' ' A' ' 58' ' ' THR . 80.2 m -97.02 89.04 4.68 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.201 -0.937 . . . . 0.0 110.054 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.669 ' HB1' HG21 ' A' ' 54' ' ' ILE . . . -45.63 106.39 0.08 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -0.892 . . . . 0.0 110.296 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.475 ' HA ' ' HA2' ' A' ' 57' ' ' GLY . 5.2 p -90.29 54.29 2.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.282 -0.886 . . . . 0.0 110.278 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.411 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -164.67 -158.39 0.41 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.895 . . . . 0.0 110.229 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.977 HG22 ' HD3' ' A' ' 113' ' ' PRO . 19.9 m -145.04 118.94 9.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.246 -0.909 . . . . 0.0 110.264 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.594 ' CG ' ' HA3' ' A' ' 123' ' ' GLY . 19.2 m-30 -115.79 63.62 2.2 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.361 -0.837 . . . . 0.0 110.073 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.977 ' HD3' HG22 ' A' ' 111' ' ' THR . 45.3 Cg_endo -71.67 147.44 51.05 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.852 1.448 . . . . 0.0 110.608 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.197 -0.94 . . . . 0.0 110.246 179.952 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.529 ' O ' ' HA ' ' A' ' 80' ' ' GLN . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.024 0.44 . . . . 0.0 110.039 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.594 ' HA3' ' CG ' ' A' ' 112' ' ' TYR . . . -145.02 158.67 27.71 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.859 -1.297 . . . . 0.0 109.859 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.656 ' HA ' HG23 ' A' ' 52' ' ' VAL . 1.1 pp0? -150.38 -158.12 0.88 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.415 -1.05 . . . . 0.0 110.262 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.882 HG21 ' CH2' ' A' ' 16' ' ' TRP . 6.2 mt -118.18 139.49 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.523 -0.736 . . . . 0.0 109.208 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -117.6 122.56 43.95 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.243 -0.911 . . . . 0.0 110.886 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.487 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 3.0 m-30 -116.76 103.39 10.29 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.583 ' O ' ' CE2' ' A' ' 132' ' ' PHE . 11.0 mm100 -89.08 89.12 7.83 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.323 -0.861 . . . . 0.0 112.511 -177.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 1.085 ' CD2' HG21 ' A' ' 74' ' ' VAL . 27.0 mt -94.73 44.98 1.11 Allowed 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 177.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.552 ' O ' ' CD2' ' A' ' 132' ' ' PHE . . . -99.06 127.89 9.39 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 120.117 -1.04 . . . . 0.0 110.737 -178.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 39' ' ' GLY . . . 37.14 68.8 0.32 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.596 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 9.4 m-85 -123.29 -57.52 1.67 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.028 -1.278 . . . . 0.0 110.82 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.964 ' HB2' HG23 ' A' ' 72' ' ' VAL . 1.3 t -88.54 -177.52 5.61 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.904 -1.122 . . . . 0.0 110.415 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -93.69 -84.76 0.3 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.248 -0.908 . . . . 0.0 110.246 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.08 179.49 1.51 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.165 -0.959 . . . . 0.0 109.999 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.54 ' CA ' ' HA ' ' A' ' 38' ' ' ALA . . . -75.0 129.9 38.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.299 -0.876 . . . . 0.0 110.656 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.999 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 6.8 p90 -133.32 -158.93 0.92 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.336 -0.853 . . . . 0.0 109.859 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.524 ' O ' ' CB ' ' A' ' 68' ' ' ALA . 0.3 OUTLIER -160.37 171.68 18.67 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.048 -1.033 . . . . 0.0 110.48 -178.638 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.941 HD13 HD13 ' A' ' 129' ' ' LEU . 2.4 mp -122.26 157.39 31.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.405 -0.809 . . . . 0.0 109.639 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' CYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 67' ' ' THR . 8.5 m -150.27 91.14 1.73 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.081 -1.012 . . . . 0.0 110.657 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.504 ' HA ' ' O ' ' A' ' 65' ' ' THR . 1.0 OUTLIER -90.0 -156.33 0.41 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.926 . . . . 0.0 109.259 179.275 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.599 ' HA ' ' CD2' ' A' ' 9' ' ' PHE . 1.9 p-10 175.94 -48.53 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.007 -1.058 . . . . 0.0 110.522 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.492 ' O ' ' HA ' ' A' ' 64' ' ' TYR . 22.6 t70 -119.25 137.73 53.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -0.937 . . . . 0.0 110.208 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.492 ' O ' HD11 ' A' ' 4' ' ' ILE . 3.0 t -150.39 113.18 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.213 -0.93 . . . . 0.0 110.115 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.59 ' HB2' ' HG3' ' A' ' 6' ' ' GLU . . . -126.46 153.55 44.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.302 -0.874 . . . . 0.0 110.282 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.566 HD11 ' HB3' ' A' ' 60' ' ' TYR . 29.7 tp -159.71 96.65 1.27 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.34 -0.85 . . . . 0.0 110.03 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.492 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 32.3 t70 -121.95 164.36 17.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.228 -0.92 . . . . 0.0 110.259 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.56 ' HB3' ' CE1' ' A' ' 60' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.226 -0.921 . . . . 0.0 110.255 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo . . . . . 0 N--CA 1.483 0.875 0 N-CA-C 110.427 -0.643 . . . . 0.0 110.427 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.606 HD11 HG12 ' A' ' 144' ' ' VAL . 9.1 pt -107.92 42.8 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 110.254 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.543 ' N ' ' HG3' ' A' ' 14' ' ' GLU . . . 73.93 40.54 43.63 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' ' 144' ' ' VAL . 22.0 tt0 -42.03 94.03 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.33 -1.1 . . . . 0.0 110.434 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 5' ' ' GLY . . . 163.48 -154.76 25.82 Favored Glycine 0 N--CA 1.49 2.27 0 C-N-CA 119.647 -1.264 . . . . 0.0 110.164 179.77 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.732 HG22 ' O ' ' A' ' 142' ' ' ASP . 62.0 p -105.99 38.15 2.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.416 -1.049 . . . . 0.0 110.604 -179.594 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.551 ' HZ ' HG21 ' A' ' 144' ' ' VAL . 25.4 m-85 42.75 80.78 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.209 -0.932 . . . . 0.0 110.179 179.779 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.548 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 2.6 p30 -108.48 23.23 14.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.202 -0.936 . . . . 0.0 110.415 -179.843 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.548 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.8 OUTLIER 161.51 80.48 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.601 -0.687 . . . . 0.0 109.822 179.991 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.41 101.54 0.08 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.864 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.686 ' HG3' HD12 ' A' ' 32' ' ' LEU . 45.0 Cg_endo -73.27 78.46 2.27 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.038 1.547 . . . . 0.0 110.667 -179.801 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.543 ' HG3' ' N ' ' A' ' 5' ' ' GLY . 5.0 mm-40 39.45 -91.21 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.467 -0.77 . . . . 0.0 111.066 179.675 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.585 ' C ' HD13 ' A' ' 49' ' ' LEU . . . -148.24 12.56 1.23 Allowed Glycine 0 N--CA 1.493 2.478 0 C-N-CA 119.618 -1.277 . . . . 0.0 110.386 -179.535 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.913 ' N ' HD13 ' A' ' 49' ' ' LEU . 36.8 m95 -40.62 128.82 2.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.23 -1.159 . . . . 0.0 110.786 179.832 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.836 HG22 ' O ' ' A' ' 48' ' ' VAL . 1.4 m -128.08 148.03 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.16 -0.962 . . . . 0.0 109.696 179.305 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . . . -130.32 117.27 19.53 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.027 -1.045 . . . . 0.0 109.821 179.552 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.611 ' HE2' HG13 ' A' ' 48' ' ' VAL . 29.3 p90 -106.76 172.8 6.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.471 -0.768 . . . . 0.0 110.709 -179.241 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.859 ' O ' HG13 ' A' ' 45' ' ' VAL . . . 68.07 27.17 73.77 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 179.589 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.759 HG22 ' CG1' ' A' ' 45' ' ' VAL . 30.9 p -132.32 -164.17 1.43 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.066 -1.255 . . . . 0.0 110.514 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -89.99 39.46 0.96 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.275 -0.891 . . . . 0.0 110.42 -179.75 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 126.26 -168.01 18.51 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 179.827 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.48 -159.09 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.112 1.585 . . . . 0.0 110.579 -179.877 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 1.047 ' CD1' HD11 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -115.81 156.86 25.3 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.339 -0.851 . . . . 0.0 110.104 -179.998 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -121.21 141.14 51.14 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.203 -0.935 . . . . 0.0 110.137 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.482 ' CG2' ' HA ' ' A' ' 32' ' ' LEU . 0.7 OUTLIER -126.36 -24.3 3.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.114 -0.991 . . . . 0.0 110.874 -179.694 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.435 ' C ' ' O ' ' A' ' 27' ' ' THR . 3.5 t -41.06 -36.69 0.73 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.263 -0.898 . . . . 0.0 110.538 -179.618 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.568 HG23 ' H ' ' A' ' 30' ' ' GLY . 2.7 t -53.2 -49.78 66.01 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.259 -0.9 . . . . 0.0 110.706 -179.843 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.568 ' H ' HG23 ' A' ' 29' ' ' THR . . . 166.99 -25.46 0.14 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.925 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.64 ' HB3' ' SG ' ' A' ' 140' ' ' CYS . . . -146.92 169.01 20.06 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -1.128 . . . . 0.0 109.593 179.838 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.047 HD11 ' CD1' ' A' ' 25' ' ' LEU . 0.6 OUTLIER -78.42 92.26 4.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.011 -1.056 . . . . 0.0 110.502 -179.837 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.551 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 0.8 OUTLIER -100.22 110.78 23.04 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.417 -0.802 . . . . 0.0 111.447 179.517 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.864 HG12 ' HB3' ' A' ' 25' ' ' LEU . 15.6 m -89.53 143.71 10.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.001 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.477 ' HA ' ' OG1' ' A' ' 138' ' ' THR . . . -88.63 83.13 6.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.472 -0.767 . . . . 0.0 110.916 -178.59 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.057 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 40.9 t -69.34 128.59 92.32 Favored Pre-proline 0 N--CA 1.487 1.421 0 O-C-N 121.307 -0.87 . . . . 0.0 109.112 179.064 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 21' ' ' THR . 42.8 Cg_endo -70.26 146.77 58.01 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.936 1.493 . . . . 0.0 111.157 -178.951 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.472 ' HA ' ' N ' ' A' ' 136' ' ' ALA . . . -41.57 136.42 1.85 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.512 -0.742 . . . . 0.0 110.229 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 38' ' ' ALA . . . 45.51 92.99 0.01 OUTLIER Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.845 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.559 ' HB3' ' CG2' ' A' ' 45' ' ' VAL . 25.9 m -87.36 33.76 0.69 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.164 -1.198 . . . . 0.0 110.108 179.991 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -91.58 19.95 5.84 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.933 0.873 . . . . 0.0 110.155 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.581 ' HG3' ' CG ' ' A' ' 43' ' ' TYR . 17.8 pt20 -85.69 -143.46 0.1 Allowed 'General case' 0 C--N 1.292 -1.898 0 O-C-N 121.804 -0.56 . . . . 0.0 109.721 179.49 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.581 ' CG ' ' HG3' ' A' ' 42' ' ' GLN . 5.5 p90 -41.54 -27.15 0.09 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.463 -0.773 . . . . 0.0 109.97 179.838 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.571 ' N ' ' CD1' ' A' ' 43' ' ' TYR . . . 115.14 113.49 2.93 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.448 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.859 HG13 ' O ' ' A' ' 20' ' ' GLY . 2.0 t -96.37 160.5 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.183 -1.187 . . . . 0.0 108.841 179.384 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.576 ' O ' ' CE2' ' A' ' 19' ' ' TYR . . . 177.56 152.66 10.24 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.271 -1.442 . . . . 0.0 110.329 -179.74 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.757 HG13 ' O ' ' A' ' 17' ' ' VAL . 22.9 t -113.46 134.79 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.374 -1.074 . . . . 0.0 109.796 179.479 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.836 ' O ' HG22 ' A' ' 17' ' ' VAL . 8.6 m -130.13 151.16 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.035 -1.041 . . . . 0.0 110.46 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.913 HD13 ' N ' ' A' ' 16' ' ' TRP . 19.9 tp -149.71 114.5 5.34 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.275 -0.89 . . . . 0.0 110.388 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.523 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 21.4 t30 -79.72 124.63 28.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.269 -0.894 . . . . 0.0 110.306 179.749 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.509 ' O ' ' CG2' ' A' ' 4' ' ' ILE . . . 155.23 67.99 0.01 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.686 HG23 ' HA ' ' A' ' 124' ' ' GLN . 43.0 t -130.44 171.89 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.216 -1.167 . . . . 0.0 110.106 179.844 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.533 ' O ' HD13 ' A' ' 54' ' ' ILE . . . -145.04 87.47 1.83 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.102 -0.999 . . . . 0.0 110.718 -179.76 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.985 HD11 HD21 ' A' ' 146' ' ' LEU . 36.7 mm -120.51 159.55 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.226 -0.921 . . . . 0.0 109.893 179.418 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.521 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 0.4 OUTLIER -147.68 121.54 9.34 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.161 -0.962 . . . . 0.0 110.437 -179.868 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.521 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 9.4 pt-20 37.57 -151.65 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.654 -0.654 . . . . 0.0 110.797 179.705 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.459 ' N ' ' HG3' ' A' ' 56' ' ' GLU . . . -81.15 94.41 1.59 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.648 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.2 m -124.74 174.29 7.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.257 -1.143 . . . . 0.0 109.824 179.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.572 ' N ' ' CG2' ' A' ' 58' ' ' THR . 0.6 OUTLIER -89.63 151.66 21.78 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.269 -0.894 . . . . 0.0 110.137 -179.969 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.648 ' CE2' HG22 ' A' ' 58' ' ' THR . 54.6 m-85 -159.29 174.4 14.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.223 -0.923 . . . . 0.0 110.575 -179.987 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 94.8 m -149.98 121.23 7.82 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.439 -0.788 . . . . 0.0 109.685 179.69 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.544 ' HB2' HD21 ' A' ' 89' ' ' LEU . 18.7 tp -89.56 120.44 30.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.208 -0.932 . . . . 0.0 110.279 -179.691 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.539 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 3.3 ttt180 -121.03 138.24 54.26 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.326 -0.859 . . . . 0.0 109.803 179.673 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.843 ' CZ ' HG21 ' A' ' 102' ' ' VAL . 0.6 OUTLIER -178.52 142.2 0.23 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.228 -0.92 . . . . 0.0 110.033 179.922 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.504 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 5.8 m -119.37 94.36 4.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.225 -0.922 . . . . 0.0 110.06 -179.839 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.661 ' CB ' HD21 ' A' ' 95' ' ' LEU . . . -95.91 155.95 16.54 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.345 -0.847 . . . . 0.0 110.153 -179.829 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 44.3 m -148.38 117.59 6.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.261 -0.9 . . . . 0.0 110.27 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.677 ' CB ' HG12 ' A' ' 72' ' ' VAL . . . -102.87 129.8 49.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.297 -0.877 . . . . 0.0 109.942 179.783 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 82.7 p -65.5 -9.05 22.75 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.175 -0.953 . . . . 0.0 110.092 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.625 HG21 ' CB ' ' A' ' 137' ' ' TRP . 7.4 t -116.97 19.9 14.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.871 . . . . 0.0 110.166 -179.912 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.465 ' O ' ' O ' ' A' ' 70' ' ' THR . 4.7 t70 43.05 92.35 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.3 -0.875 . . . . 0.0 109.851 -179.754 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.759 HG13 HD12 ' A' ' 95' ' ' LEU . 12.1 p -131.36 161.31 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -0.918 . . . . 0.0 110.953 -179.337 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.4 ' N ' HG22 ' A' ' 72' ' ' VAL . 23.2 m -128.68 89.11 2.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.37 -0.831 . . . . 0.0 109.219 179.248 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.695 HG12 ' CB ' ' A' ' 132' ' ' PHE . 17.4 m -89.74 -140.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.911 . . . . 0.0 110.655 -179.199 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.542 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 19.3 mtm-85 -133.1 146.55 51.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.902 . . . . 0.0 110.597 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.829 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -150.02 152.21 34.51 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.348 -0.845 . . . . 0.0 109.712 179.731 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.889 HD12 ' N ' ' A' ' 78' ' ' VAL . 3.7 pp 179.49 -146.97 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.241 -0.912 . . . . 0.0 110.218 -179.587 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.889 ' N ' HD12 ' A' ' 77' ' ' LEU . 3.5 t -148.22 177.59 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.921 . . . . 0.0 109.544 179.904 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.523 ' H ' HG12 ' A' ' 78' ' ' VAL . . . -179.49 -175.87 46.67 Favored Glycine 0 N--CA 1.489 2.204 0 C-N-CA 119.384 -1.389 . . . . 0.0 110.14 179.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.552 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 3.0 tt0 -93.98 -153.76 0.38 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.422 -1.046 . . . . 0.0 110.107 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.479 ' HB3' ' OE2' ' A' ' 122' ' ' GLU . 9.7 m120 -154.44 72.46 0.87 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.361 -0.837 . . . . 0.0 109.702 179.894 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.478 ' C ' ' CE1' ' A' ' 85' ' ' TYR . . . 131.57 144.08 5.33 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -179.688 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.628 ' N ' ' CE1' ' A' ' 85' ' ' TYR . . . -41.93 152.27 0.31 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.28 -1.13 . . . . 0.0 110.321 -179.868 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.46 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.6 Cg_endo -80.04 12.57 22.55 Favored 'Cis proline' 0 C--N 1.312 -1.343 0 C-N-CA 121.651 -2.229 . . . . 0.0 110.896 -0.067 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.628 ' CE1' ' N ' ' A' ' 83' ' ' ALA . 29.1 m-85 62.53 146.8 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.139 -0.975 . . . . 0.0 110.233 -179.816 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -172.5 128.13 1.5 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.899 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.487 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 0.8 OUTLIER -105.55 153.76 21.31 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.236 -1.155 . . . . 0.0 110.208 179.984 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.72 HG23 HD12 ' A' ' 89' ' ' LEU . 15.5 m -124.98 -24.69 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.302 -0.873 . . . . 0.0 110.331 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.843 HD22 HG23 ' A' ' 78' ' ' VAL . 3.8 mp -105.72 145.29 31.29 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.17 -0.957 . . . . 0.0 111.082 179.883 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -151.76 76.09 1.18 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.371 -0.831 . . . . 0.0 109.947 179.474 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 82.1 p -135.62 178.52 6.98 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.98 -1.075 . . . . 0.0 110.869 -179.504 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.97 117.8 32.04 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.435 -0.791 . . . . 0.0 110.079 179.941 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.829 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 47.4 Cg_endo -73.74 105.56 2.03 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.93 1.49 . . . . 0.0 110.981 -179.697 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.53 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -77.83 151.32 33.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.156 -0.965 . . . . 0.0 109.428 179.171 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.864 ' CD1' HD21 ' A' ' 139' ' ' LEU . 64.2 mt -138.99 162.83 33.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.994 -1.067 . . . . 0.0 110.817 -179.548 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.49 HG22 ' HG3' ' A' ' 100' ' ' ARG . 0.2 OUTLIER -161.9 -178.93 6.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.455 -0.778 . . . . 0.0 109.907 179.894 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.7 p -64.64 -30.79 71.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.272 -0.892 . . . . 0.0 110.126 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.535 ' CB ' ' HD2' ' A' ' 99' ' ' PRO . 0.1 OUTLIER -90.1 179.94 1.38 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.333 -0.854 . . . . 0.0 109.978 179.822 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.535 ' HD2' ' CB ' ' A' ' 98' ' ' GLU . 44.6 Cg_endo -71.88 132.07 19.37 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.925 1.487 . . . . 0.0 110.313 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.53 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.84 92.43 3.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.234 -0.916 . . . . 0.0 110.402 -179.841 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.443 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 1.5 tt0 -76.99 156.76 31.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.296 -0.878 . . . . 0.0 110.113 179.861 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.843 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 52.5 t -138.71 134.15 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.205 -0.935 . . . . 0.0 110.219 -179.992 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 21.6 m -150.06 113.46 4.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.319 -0.863 . . . . 0.0 110.181 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -146.48 138.3 24.75 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.295 -0.878 . . . . 0.0 110.244 -179.949 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.03 159.28 16.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.27 -0.894 . . . . 0.0 110.085 179.952 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.803 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 48.8 p90 -167.77 151.27 6.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.23 -0.919 . . . . 0.0 110.279 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 58' ' ' THR . 3.1 m -89.89 90.71 8.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.209 -0.932 . . . . 0.0 110.012 179.787 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.7 ' HB1' HG21 ' A' ' 54' ' ' ILE . . . -52.41 116.26 2.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.244 -0.91 . . . . 0.0 110.314 -179.828 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.445 ' H ' HG12 ' A' ' 88' ' ' VAL . 55.4 p -99.4 54.83 0.97 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.262 -0.899 . . . . 0.0 110.082 179.836 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -165.06 -160.15 0.47 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.261 -0.9 . . . . 0.0 110.37 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.906 HG22 ' HD3' ' A' ' 113' ' ' PRO . 85.1 m -144.0 116.69 8.7 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.267 -0.896 . . . . 0.0 110.264 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.604 ' CD2' HG13 ' A' ' 54' ' ' ILE . 20.4 m-30 -114.49 73.43 2.8 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.251 -0.905 . . . . 0.0 110.043 179.92 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.906 ' HD3' HG22 ' A' ' 111' ' ' THR . 43.9 Cg_endo -70.47 -163.18 0.11 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.998 1.525 . . . . 0.0 110.465 -179.962 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.669 0 O-C-N 121.237 -0.914 . . . . 0.0 110.223 -179.873 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.519 ' OE1' ' N ' ' A' ' 122' ' ' GLU . 22.5 pm0 . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 121.215 0.531 . . . . 0.0 110.264 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.552 ' HA2' ' HA ' ' A' ' 80' ' ' GLN . . . -147.45 157.84 27.52 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.686 ' HA ' HG23 ' A' ' 52' ' ' VAL . 2.4 pt20 -150.43 -157.55 0.83 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.276 -1.132 . . . . 0.0 110.6 -179.58 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.606 HG21 ' CH2' ' A' ' 16' ' ' TRP . 12.4 mt -118.45 142.92 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.464 -0.773 . . . . 0.0 109.068 179.382 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.47 ' HB3' HD11 ' A' ' 77' ' ' LEU . . . -121.32 123.56 42.46 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.258 -0.901 . . . . 0.0 111.032 -179.351 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.481 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 4.9 m-85 -118.59 109.38 16.09 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 178.446 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.501 ' HB2' ' HB2' ' A' ' 75' ' ' ARG . 1.3 mm100 -88.65 102.53 15.06 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.231 -0.918 . . . . 0.0 111.901 -177.497 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.495 ' HG ' ' HA2' ' A' ' 46' ' ' GLY . 13.9 mt -107.42 45.06 1.02 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 178.289 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -95.57 78.1 0.82 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.453 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.576 ' O ' ' CG ' ' A' ' 132' ' ' PHE . . . 78.61 110.3 0.2 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.747 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.695 ' CB ' HG12 ' A' ' 74' ' ' VAL . 26.0 m-85 -161.57 -49.02 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.22 -1.165 . . . . 0.0 110.355 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.624 ' HB2' HG21 ' A' ' 72' ' ' VAL . 1.0 OUTLIER -89.43 -140.13 0.14 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.046 -1.034 . . . . 0.0 110.1 179.888 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -133.95 -83.37 0.45 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.17 -0.956 . . . . 0.0 110.364 -179.917 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.434 ' O ' ' C ' ' A' ' 136' ' ' ALA . 1.1 m-20 -81.53 162.87 23.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.192 -0.942 . . . . 0.0 110.283 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.472 ' N ' ' HA ' ' A' ' 38' ' ' ALA . . . -41.21 123.35 2.04 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.333 -0.854 . . . . 0.0 110.263 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 1.057 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 11.4 p90 -137.22 -173.15 3.38 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.174 -0.953 . . . . 0.0 110.619 -179.93 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.521 ' C ' HD12 ' A' ' 139' ' ' LEU . 0.8 OUTLIER -151.07 174.19 13.48 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.432 -0.792 . . . . 0.0 110.073 -178.024 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.864 HD21 ' CD1' ' A' ' 95' ' ' LEU . 1.7 mp -139.82 119.38 13.12 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.153 -0.967 . . . . 0.0 112.059 -179.679 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' CYS . . . . . 0.64 ' SG ' ' HB3' ' A' ' 31' ' ' ALA . 0.8 OUTLIER -103.27 108.37 19.56 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.618 -0.676 . . . . 0.0 110.878 178.132 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.545 HD23 ' HB2' ' A' ' 66' ' ' ALA . 1.4 mt -94.55 -178.93 4.72 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.285 -0.885 . . . . 0.0 108.792 178.513 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.732 ' O ' HG22 ' A' ' 8' ' ' THR . 0.4 OUTLIER 168.29 55.38 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.063 -1.023 . . . . 0.0 110.98 -179.963 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.535 ' HB2' ' O ' ' A' ' 142' ' ' ASP . 10.9 t70 172.91 46.81 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.469 -0.769 . . . . 0.0 109.132 179.56 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.883 HG11 ' HZ2' ' A' ' 16' ' ' TRP . 1.3 t -91.71 112.93 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.16 -0.962 . . . . 0.0 110.646 -179.043 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.469 ' HB2' ' HG3' ' A' ' 6' ' ' GLU . . . -149.43 147.17 27.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.488 -0.758 . . . . 0.0 110.041 179.85 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.985 HD21 HD11 ' A' ' 54' ' ' ILE . 10.8 tp -141.49 125.2 16.9 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.388 -0.82 . . . . 0.0 110.237 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.49 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -133.81 174.33 10.57 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.197 -0.94 . . . . 0.0 110.207 179.977 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 57.5 p . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.207 -0.933 . . . . 0.0 110.32 -179.989 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.455 ' HB2' ' O ' ' A' ' 51' ' ' GLY . 51.1 Cg_endo . . . . . 0 N--CA 1.481 0.755 0 N-CA-C 111.115 -0.379 . . . . 0.0 111.115 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.477 HD12 ' CG1' ' A' ' 144' ' ' VAL . 6.1 pt -138.78 -37.01 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.997 -1.065 . . . . 0.0 110.118 179.906 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.451 ' N ' ' CG1' ' A' ' 4' ' ' ILE . . . 161.36 126.59 0.83 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -73.52 81.99 1.48 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.258 -1.142 . . . . 0.0 110.192 179.991 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 144' ' ' VAL . . . 114.59 -123.37 5.99 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.798 HG22 ' O ' ' A' ' 142' ' ' ASP . 15.6 p -80.5 179.04 7.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.29 -1.123 . . . . 0.0 110.136 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.687 ' CE1' HG21 ' A' ' 144' ' ' VAL . 23.0 m-85 -68.57 -35.78 77.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.306 -0.871 . . . . 0.0 109.579 179.735 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.552 ' O ' ' HB2' ' A' ' 11' ' ' ASP . 23.2 t0 38.09 42.74 0.5 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.645 -0.659 . . . . 0.0 110.705 179.308 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.552 ' HB2' ' O ' ' A' ' 10' ' ' ASP . 4.3 t0 161.9 71.07 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 121.508 0.671 . . . . 0.0 109.545 179.871 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.47 ' HA2' ' HB ' ' A' ' 27' ' ' THR . . . 43.95 -168.5 0.02 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.723 ' HB3' HD12 ' A' ' 32' ' ' LEU . 51.1 Cg_endo -74.43 81.47 2.05 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.121 1.59 . . . . 0.0 110.337 179.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.485 ' C ' ' O ' ' A' ' 13' ' ' PRO . 0.2 OUTLIER -31.77 -67.51 0.1 Allowed 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.292 0.568 . . . . 0.0 111.183 -179.614 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.5 ' C ' ' CD1' ' A' ' 49' ' ' LEU . . . -145.75 10.24 1.64 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.946 ' CE2' HD22 ' A' ' 49' ' ' LEU . 66.4 m95 -78.06 88.95 4.18 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.149 -1.207 . . . . 0.0 110.257 -179.863 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.719 ' O ' HG13 ' A' ' 47' ' ' VAL . 0.8 OUTLIER -85.18 144.88 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.093 -1.004 . . . . 0.0 109.44 179.802 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.454 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . . . -128.64 128.81 44.88 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.025 -1.047 . . . . 0.0 109.93 179.554 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.798 ' HE2' HG13 ' A' ' 48' ' ' VAL . 23.4 p90 -113.24 145.49 40.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.451 -0.781 . . . . 0.0 110.397 -179.302 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.615 ' HA3' HG13 ' A' ' 45' ' ' VAL . . . 156.77 -91.03 0.12 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.539 ' CG2' ' HG3' ' A' ' 37' ' ' PRO . 5.5 p -151.96 18.92 0.68 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.254 -1.145 . . . . 0.0 110.051 179.675 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.476 ' HB3' ' O ' ' A' ' 35' ' ' ALA . 2.0 p30 -102.76 147.72 26.5 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.28 -0.887 . . . . 0.0 110.197 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.68 -138.13 0.15 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.801 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.417 ' O ' ' C ' ' A' ' 25' ' ' LEU . 46.2 Cg_endo -73.62 133.46 18.82 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.044 1.549 . . . . 0.0 110.346 179.865 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.858 HD22 HD11 ' A' ' 32' ' ' LEU . 7.8 mt -42.53 113.52 0.47 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.254 -0.904 . . . . 0.0 110.083 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.487 ' HB3' ' HB2' ' A' ' 33' ' ' CYS . 29.5 t70 -66.4 101.37 0.74 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.23 -0.919 . . . . 0.0 110.188 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.694 ' O ' HG22 ' A' ' 29' ' ' THR . 1.5 p -119.23 -81.32 0.63 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.296 -0.877 . . . . 0.0 109.955 -179.911 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.462 ' O ' ' HB ' ' A' ' 29' ' ' THR . 22.5 p 42.16 36.23 0.68 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.254 -0.903 . . . . 0.0 110.442 179.811 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.694 HG22 ' O ' ' A' ' 27' ' ' THR . 12.2 t -177.97 -31.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.3 -0.875 . . . . 0.0 110.194 179.914 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 9' ' ' PHE . . . 126.35 2.19 7.04 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.946 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 141' ' ' LEU . . . -111.29 109.83 20.03 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.212 -1.169 . . . . 0.0 110.24 179.992 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.858 HD11 HD22 ' A' ' 25' ' ' LEU . 1.0 OUTLIER -68.51 102.37 1.44 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.281 -0.887 . . . . 0.0 109.966 179.943 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.51 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 34.2 m -108.19 103.61 12.84 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.319 -0.863 . . . . 0.0 110.514 -179.687 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.807 HG12 HD23 ' A' ' 25' ' ' LEU . 19.5 m -89.71 155.51 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.262 -0.899 . . . . 0.0 109.762 179.621 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.514 ' HA ' ' OG1' ' A' ' 138' ' ' THR . . . -103.87 101.26 11.06 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.249 -0.907 . . . . 0.0 111.346 -179.111 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.031 HG11 ' CE2' ' A' ' 137' ' ' TRP . 91.4 t -84.41 123.07 75.25 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.168 -0.958 . . . . 0.0 109.009 178.794 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.539 ' HG3' ' CG2' ' A' ' 21' ' ' THR . 43.2 Cg_endo -67.85 147.33 74.62 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.87 1.458 . . . . 0.0 111.347 -178.866 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.581 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -47.37 116.47 1.43 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.312 -0.868 . . . . 0.0 109.817 179.659 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.1 71.91 1.16 Allowed Glycine 0 N--CA 1.486 1.99 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 -179.51 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.755 ' HB2' HG21 ' A' ' 45' ' ' VAL . 0.4 OUTLIER -84.89 43.96 1.03 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.324 -1.103 . . . . 0.0 109.807 -179.987 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.522 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . -88.5 -139.46 0.12 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.491 -0.755 . . . . 0.0 110.029 179.871 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.561 ' HG2' ' N ' ' A' ' 43' ' ' TYR . 0.0 OUTLIER 42.79 -140.98 0.14 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.543 -0.723 . . . . 0.0 110.346 -179.479 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.73 ' OH ' HG22 ' A' ' 45' ' ' VAL . 8.3 p90 -28.96 -39.51 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.175 0 CA-C-O 121.143 0.497 . . . . 0.0 110.929 -179.136 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.599 ' O ' ' CD1' ' A' ' 43' ' ' TYR . . . 89.76 132.96 4.93 Favored Glycine 0 N--CA 1.493 2.441 0 C-N-CA 120.041 -1.076 . . . . 0.0 110.674 178.22 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.755 HG21 ' HB2' ' A' ' 40' ' ' SER . 2.6 t -89.85 179.52 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.364 -1.08 . . . . 0.0 108.908 179.238 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.532 ' HA2' ' HA ' ' A' ' 128' ' ' GLN . . . 173.57 -177.58 45.86 Favored Glycine 0 N--CA 1.488 2.118 0 C-N-CA 119.024 -1.56 . . . . 0.0 110.668 -179.886 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.719 HG13 ' O ' ' A' ' 17' ' ' VAL . 21.6 t -150.65 132.43 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.737 -0.861 . . . . 0.0 108.768 179.779 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.798 HG13 ' HE2' ' A' ' 19' ' ' TYR . 31.1 m -119.66 131.7 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.976 -1.077 . . . . 0.0 110.69 -179.383 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.946 HD22 ' CE2' ' A' ' 16' ' ' TRP . 30.0 tp -124.06 90.76 3.32 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.439 -0.788 . . . . 0.0 110.353 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.522 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 22.0 p30 -75.2 145.84 41.71 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.271 -0.893 . . . . 0.0 110.237 179.881 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.455 ' O ' ' HB2' ' A' ' 3' ' ' PRO . . . 122.19 63.48 0.22 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.969 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.594 HG12 ' N ' ' A' ' 53' ' ' ALA . 53.5 t -121.96 171.9 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.235 -1.156 . . . . 0.0 109.968 179.807 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.594 ' N ' HG12 ' A' ' 52' ' ' VAL . . . -141.88 77.91 1.61 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.072 -1.017 . . . . 0.0 110.804 -179.742 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.595 HG13 ' CD2' ' A' ' 112' ' ' TYR . 35.6 mm -112.34 159.24 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.177 -0.952 . . . . 0.0 109.622 179.343 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.534 ' HA ' HG23 ' A' ' 111' ' ' THR . 0.6 OUTLIER -153.48 132.25 12.34 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.04 -1.037 . . . . 0.0 110.836 -179.634 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 19.4 pt-20 37.72 -155.49 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.67 -0.644 . . . . 0.0 110.994 179.488 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' A' ' 109' ' ' SER . . . -85.95 80.92 1.75 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.776 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.569 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.2 m -105.72 173.88 6.12 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.268 -1.137 . . . . 0.0 109.73 179.76 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.559 ' N ' ' CG2' ' A' ' 58' ' ' THR . 0.6 OUTLIER -89.7 154.78 19.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.144 -0.972 . . . . 0.0 110.411 -179.731 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.608 ' CE2' ' HB3' ' A' ' 108' ' ' ALA . 55.8 m-85 -159.87 178.5 9.69 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.32 -0.862 . . . . 0.0 110.3 179.905 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 104' ' ' GLU . 32.8 m -150.13 123.61 9.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.337 -0.852 . . . . 0.0 109.925 179.8 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.6 tp -89.44 118.63 29.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.186 -0.946 . . . . 0.0 110.067 -179.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.524 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 2.1 tpt180 -127.97 114.47 17.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.31 -0.869 . . . . 0.0 110.204 -179.761 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 1.163 ' CZ ' HG21 ' A' ' 102' ' ' VAL . 0.4 OUTLIER -157.99 141.19 15.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.155 -0.966 . . . . 0.0 110.037 179.591 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.537 ' CG2' ' HG2' ' A' ' 101' ' ' GLN . 18.7 m -119.42 98.91 6.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.916 . . . . 0.0 109.976 -179.834 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.759 ' HB2' HD23 ' A' ' 141' ' ' LEU . . . -103.51 152.35 21.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.335 -0.853 . . . . 0.0 110.368 -179.669 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.71 HG23 ' O ' ' A' ' 98' ' ' GLU . 98.1 m -150.2 108.32 3.74 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.235 -0.915 . . . . 0.0 110.289 179.922 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -92.84 136.05 33.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.238 -0.914 . . . . 0.0 109.975 179.836 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 68' ' ' ALA . 12.2 t -44.93 -26.14 0.39 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.082 -1.011 . . . . 0.0 109.343 179.57 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.669 HG22 ' HB2' ' A' ' 137' ' ' TRP . 3.2 t -113.71 -179.69 3.71 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.527 -0.733 . . . . 0.0 109.806 179.708 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.499 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 37.5 t0 -94.4 69.48 3.63 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.16 -0.962 . . . . 0.0 109.545 179.253 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.828 HG23 ' CB ' ' A' ' 133' ' ' SER . 4.7 p -92.1 147.34 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.259 -0.901 . . . . 0.0 111.045 -179.278 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.54 HG22 ' O ' ' A' ' 73' ' ' THR . 3.5 m -128.6 89.45 2.89 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.078 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.779 HG21 HD22 ' A' ' 129' ' ' LEU . 10.7 m -89.64 -151.2 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.228 -0.92 . . . . 0.0 110.49 -179.116 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.527 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 34.9 mtm-85 -128.05 137.6 52.24 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.206 -0.934 . . . . 0.0 110.761 -179.295 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.805 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -139.28 155.38 47.77 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.356 -0.84 . . . . 0.0 109.881 179.455 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.922 ' CD1' ' HB3' ' A' ' 126' ' ' ALA . 1.3 pp 175.23 -157.4 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.327 -0.858 . . . . 0.0 109.982 -179.601 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.928 HG23 HD22 ' A' ' 89' ' ' LEU . 4.9 t -147.85 168.54 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.204 -0.935 . . . . 0.0 109.41 179.762 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.485 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . -177.8 176.78 48.2 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.339 -1.41 . . . . 0.0 109.906 -179.882 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.486 ' NE2' ' C ' ' A' ' 81' ' ' ASN . 13.6 tp60 -107.31 135.43 48.83 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.31 -1.112 . . . . 0.0 110.534 179.931 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.552 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 2.4 m120 -123.26 96.77 5.12 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 122.072 0.939 . . . . 0.0 108.894 178.644 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.528 ' O ' ' HB3' ' A' ' 83' ' ' ALA . . . 132.9 34.21 0.35 Allowed Glycine 0 N--CA 1.484 1.861 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.214 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 82' ' ' GLY . . . 60.15 143.94 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.264 -1.139 . . . . 0.0 110.235 -179.861 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.46 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.5 Cg_endo -82.22 18.45 17.86 Favored 'Cis proline' 0 C--N 1.313 -1.303 0 C-N-CA 121.868 -2.138 . . . . 0.0 110.869 -0.139 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.502 ' CD2' ' HA ' ' A' ' 83' ' ' ALA . 94.1 m-85 57.28 170.26 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.152 -0.967 . . . . 0.0 110.439 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 136.6 117.93 1.7 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.442 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 0.8 OUTLIER -97.78 145.69 26.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.195 -1.179 . . . . 0.0 110.185 179.863 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.96 HG23 HD12 ' A' ' 89' ' ' LEU . 29.4 m -123.98 -17.45 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.265 -0.897 . . . . 0.0 110.359 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.96 HD12 HG23 ' A' ' 88' ' ' VAL . 4.0 mp -108.5 136.96 47.25 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.189 -0.945 . . . . 0.0 111.009 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -150.97 82.2 1.33 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.457 -0.777 . . . . 0.0 109.836 179.601 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.2 p -140.06 178.5 7.23 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.033 -1.042 . . . . 0.0 110.741 -179.598 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.7 m -119.81 111.97 35.51 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.456 -0.777 . . . . 0.0 109.863 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.805 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 43.6 Cg_endo -70.1 99.57 0.79 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.957 1.503 . . . . 0.0 110.866 -179.764 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.518 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -76.23 153.21 36.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 0.0 109.687 179.504 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.712 HD21 ' CB ' ' A' ' 66' ' ' ALA . 72.7 mt -142.54 168.83 18.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.118 -0.989 . . . . 0.0 110.492 -179.751 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 70' ' ' THR . 0.3 OUTLIER -177.22 -178.82 0.82 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.411 -0.805 . . . . 0.0 110.038 -179.966 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.7 -8.23 26.38 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.228 -0.92 . . . . 0.0 110.148 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.71 ' O ' HG23 ' A' ' 67' ' ' THR . 11.3 mt-10 -106.17 168.22 8.51 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.907 . . . . 0.0 110.097 179.87 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.491 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 46.4 Cg_endo -72.83 130.26 15.46 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.046 1.55 . . . . 0.0 110.363 179.993 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.518 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 3.1 ttm-85 -119.91 92.42 3.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.176 -0.953 . . . . 0.0 110.251 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.537 ' HG2' ' CG2' ' A' ' 65' ' ' THR . 1.7 mt-30 -75.11 153.23 38.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.33 -0.856 . . . . 0.0 109.975 179.845 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 1.163 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 39.4 t -130.35 133.56 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.18 -0.95 . . . . 0.0 110.387 -179.945 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.526 ' O ' ' CG ' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -150.35 124.35 9.33 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.356 -0.84 . . . . 0.0 110.065 -179.987 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.526 ' CG ' ' O ' ' A' ' 103' ' ' THR . 35.3 mt-10 -157.56 154.53 28.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.256 -0.902 . . . . 0.0 110.315 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.2 m -117.39 114.67 23.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.261 -0.899 . . . . 0.0 110.042 179.898 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.959 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 35.4 p90 -127.27 155.42 43.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.195 -0.94 . . . . 0.0 110.342 -179.782 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.422 ' O ' HG22 ' A' ' 107' ' ' THR . 21.0 m -93.12 89.04 6.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.296 -0.878 . . . . 0.0 109.977 179.7 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.608 ' HB3' ' CE2' ' A' ' 60' ' ' TYR . . . -42.61 100.06 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.245 -0.909 . . . . 0.0 110.346 -179.855 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.47 ' H ' HG12 ' A' ' 88' ' ' VAL . 43.2 p -88.81 51.87 2.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.262 -0.899 . . . . 0.0 110.144 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.424 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -159.18 -152.81 0.33 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.264 -0.898 . . . . 0.0 110.301 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.534 HG23 ' HA ' ' A' ' 55' ' ' GLU . 25.1 m -153.5 119.07 5.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.886 . . . . 0.0 110.204 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.595 ' CD2' HG13 ' A' ' 54' ' ' ILE . 17.8 m-30 -113.95 89.7 17.28 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.303 -0.873 . . . . 0.0 109.942 179.829 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.484 ' HD2' ' OE1' ' A' ' 80' ' ' GLN . 44.9 Cg_endo -71.84 -158.69 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.028 1.541 . . . . 0.0 110.406 -179.928 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.431 ' HA ' ' CD ' ' A' ' 122' ' ' GLU . . . . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.221 -0.925 . . . . 0.0 110.244 -179.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.552 ' O ' ' HB2' ' A' ' 81' ' ' ASN . 6.6 pt-20 . . . . . 0 N--CA 1.497 1.907 0 CA-C-O 121.108 0.48 . . . . 0.0 111.133 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -106.01 158.94 15.4 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 -179.429 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.522 ' CB ' ' HA ' ' A' ' 50' ' ' ASN . 17.1 pt20 -150.63 -151.76 0.41 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.366 -1.079 . . . . 0.0 110.621 -179.806 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.877 HG21 ' CH2' ' A' ' 16' ' ' TRP . 23.9 mt -118.56 146.51 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.616 -0.677 . . . . 0.0 109.425 179.665 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.922 ' HB3' ' CD1' ' A' ' 77' ' ' LEU . . . -116.15 114.87 25.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.336 -0.853 . . . . 0.0 111.744 -178.879 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.548 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 4.0 m-85 -119.81 75.69 1.1 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.247 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.741 ' C ' HD23 ' A' ' 129' ' ' LEU . 12.9 mt-30 -88.42 123.27 32.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.196 -0.94 . . . . 0.0 111.902 -177.754 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.993 HD13 HD13 ' A' ' 139' ' ' LEU . 3.6 mt -107.76 51.77 0.73 Allowed 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.746 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -96.1 130.75 10.38 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.627 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.577 ' O ' ' CD1' ' A' ' 132' ' ' PHE . . . 51.14 93.81 0.01 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.686 ' CD2' HG12 ' A' ' 74' ' ' VAL . 9.5 m-85 -158.86 -78.23 0.07 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.281 -1.129 . . . . 0.0 110.419 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.828 ' CB ' HG23 ' A' ' 72' ' ' VAL . 1.3 t -89.66 168.39 12.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.096 -1.003 . . . . 0.0 110.339 -179.812 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -98.26 -91.56 0.26 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.274 -0.892 . . . . 0.0 110.316 -179.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -46.65 158.05 0.13 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.081 -1.012 . . . . 0.0 110.35 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.581 ' HB2' ' HB2' ' A' ' 38' ' ' ALA . . . -54.48 128.66 32.93 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.313 -0.867 . . . . 0.0 110.333 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 1.031 ' CE2' HG11 ' A' ' 36' ' ' VAL . 8.9 p90 -135.24 -163.35 1.37 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.306 -0.871 . . . . 0.0 110.009 179.674 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.589 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 0.8 OUTLIER -160.95 176.5 11.34 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.195 -1.002 . . . . 0.0 110.696 -178.382 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.993 HD13 HD13 ' A' ' 129' ' ' LEU . 2.1 mp -133.52 126.04 30.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.464 -0.773 . . . . 0.0 109.605 179.172 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 140' ' ' CYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 33.4 m -121.94 98.77 6.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.032 -1.043 . . . . 0.0 110.91 -179.536 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.759 HD23 ' HB2' ' A' ' 66' ' ' ALA . 2.2 mt -89.8 -179.91 5.85 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -0.927 . . . . 0.0 109.318 179.067 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.798 ' O ' HG22 ' A' ' 8' ' ' THR . 2.7 p30 168.03 41.08 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.289 -0.882 . . . . 0.0 110.104 179.908 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.471 ' HA ' ' C ' ' A' ' 7' ' ' GLY . 0.3 OUTLIER -174.98 52.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.289 -0.882 . . . . 0.0 109.659 -179.877 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.687 HG21 ' CE1' ' A' ' 9' ' ' PHE . 1.4 t -89.2 121.27 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.349 -0.845 . . . . 0.0 109.917 -179.44 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.457 ' HB3' ' HB3' ' A' ' 63' ' ' ARG . . . -144.41 140.87 29.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.329 -0.857 . . . . 0.0 110.293 -179.631 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.482 HD21 HD11 ' A' ' 54' ' ' ILE . 13.6 tp -148.08 123.82 10.54 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.376 -0.828 . . . . 0.0 110.072 179.839 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.477 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 7.3 t0 -136.15 -177.31 4.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.179 -0.951 . . . . 0.0 110.295 -179.893 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.3 p . . . . . 0 N--CA 1.492 1.666 0 O-C-N 121.253 -0.904 . . . . 0.0 110.129 179.958 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo . . . . . 0 N--CA 1.479 0.675 0 N-CA-C 110.115 -0.763 . . . . 0.0 110.115 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.53 HG22 ' O ' ' A' ' 51' ' ' GLY . 9.1 pt -95.51 19.49 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.278 -0.889 . . . . 0.0 110.097 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' A' ' 7' ' ' GLY . . . 79.94 70.39 1.33 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.965 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.583 ' HG2' ' HB1' ' A' ' 145' ' ' ALA . 82.6 mt-10 -42.42 94.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.31 -1.112 . . . . 0.0 110.198 -179.945 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 5' ' ' GLY . . . 173.99 -159.1 28.36 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.987 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.739 HG22 ' O ' ' A' ' 142' ' ' ASP . 11.9 p -98.34 -154.91 0.47 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.367 -1.078 . . . . 0.0 110.268 -179.851 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.523 ' CE1' ' CD1' ' A' ' 16' ' ' TRP . 64.6 m-85 -120.56 44.21 2.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.305 -0.872 . . . . 0.0 110.176 179.959 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.559 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 49.5 t0 -97.84 61.7 1.57 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.234 -0.916 . . . . 0.0 110.126 -179.973 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.559 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 2.5 t0 161.83 -23.72 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.745 -0.597 . . . . 0.0 109.652 -179.973 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 176.21 133.98 1.87 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.724 ' HB3' HD12 ' A' ' 32' ' ' LEU . 48.9 Cg_endo -78.02 6.15 4.83 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.906 1.477 . . . . 0.0 110.533 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.512 ' HB3' ' O ' ' A' ' 13' ' ' PRO . 5.6 tp10 60.66 -89.03 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.356 -0.84 . . . . 0.0 110.386 -179.793 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.833 ' C ' HD13 ' A' ' 49' ' ' LEU . . . -148.09 25.44 1.43 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -179.859 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.834 ' HZ2' HG11 ' A' ' 144' ' ' VAL . 57.1 m95 -72.12 86.39 1.05 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.166 -1.197 . . . . 0.0 110.354 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.716 ' O ' HG13 ' A' ' 47' ' ' VAL . 1.1 m -87.42 153.32 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.205 -0.934 . . . . 0.0 109.92 179.942 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.403 ' CB ' HG22 ' A' ' 47' ' ' VAL . . . -136.84 133.63 36.06 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.268 -0.895 . . . . 0.0 109.456 179.437 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.6 ' HE2' HG13 ' A' ' 48' ' ' VAL . 6.1 p90 -120.38 161.11 21.74 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.283 -0.886 . . . . 0.0 111.122 -178.635 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.589 ' HA2' ' CE1' ' A' ' 43' ' ' TYR . . . 72.96 49.15 17.82 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.88 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.544 HG22 ' CG1' ' A' ' 45' ' ' VAL . 11.5 p -148.12 -153.52 0.5 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.254 -1.145 . . . . 0.0 110.404 -179.956 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -89.87 44.02 1.18 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.326 -0.859 . . . . 0.0 110.079 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.56 -144.28 16.29 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.889 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.99 -159.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.973 1.512 . . . . 0.0 110.367 179.944 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.638 ' CD1' HD11 ' A' ' 32' ' ' LEU . 0.3 OUTLIER -111.51 -173.12 2.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.184 -0.947 . . . . 0.0 110.037 179.809 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -132.03 159.9 37.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.163 -0.96 . . . . 0.0 110.19 -179.88 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.462 HG21 ' HD3' ' A' ' 13' ' ' PRO . 0.7 OUTLIER -133.62 -34.57 1.03 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.254 -0.904 . . . . 0.0 110.258 -179.911 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.44 ' O ' ' OG1' ' A' ' 29' ' ' THR . 73.6 m 51.28 30.41 5.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.23 -0.919 . . . . 0.0 110.221 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.453 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 5.4 p 42.8 55.04 4.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.28 -0.888 . . . . 0.0 110.2 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.508 ' N ' ' HA ' ' A' ' 10' ' ' ASP . . . -169.55 -54.86 0.03 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.611 ' HB1' ' O ' ' A' ' 141' ' ' LEU . . . -149.88 149.91 31.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.211 -1.17 . . . . 0.0 110.32 -179.902 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.724 HD12 ' HB3' ' A' ' 13' ' ' PRO . 1.1 tp -79.97 103.15 9.66 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.243 -0.911 . . . . 0.0 109.822 179.739 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.486 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 23.2 m -109.6 105.85 15.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.212 -0.93 . . . . 0.0 110.778 -179.503 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.545 HG12 ' HB3' ' A' ' 25' ' ' LEU . 18.0 m -91.09 140.12 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.241 -0.912 . . . . 0.0 109.122 179.08 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.483 ' O ' ' HB ' ' A' ' 21' ' ' THR . . . -89.18 98.33 11.71 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.102 -0.999 . . . . 0.0 111.032 -179.052 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.073 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 48.3 t -83.72 130.09 56.98 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.267 -0.896 . . . . 0.0 109.617 179.168 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 21' ' ' THR . 43.6 Cg_endo -70.73 -179.25 3.2 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.815 1.429 . . . . 0.0 110.538 -179.742 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.573 ' HA ' ' N ' ' A' ' 136' ' ' ALA . . . -42.79 166.67 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.25 -0.906 . . . . 0.0 110.137 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.595 ' O ' ' N ' ' A' ' 41' ' ' ALA . . . -35.68 108.12 0.05 OUTLIER Glycine 0 N--CA 1.495 2.62 0 N-CA-C 109.169 -1.573 . . . . 0.0 109.169 179.798 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.919 ' HB2' HG23 ' A' ' 45' ' ' VAL . 0.4 OUTLIER -39.36 89.9 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.979 0.895 . . . . 0.0 110.263 -178.899 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.595 ' N ' ' O ' ' A' ' 39' ' ' GLY . . . -114.79 23.84 12.28 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 121.952 0.882 . . . . 0.0 109.673 -179.465 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.543 ' O ' ' CG ' ' A' ' 42' ' ' GLN . 0.9 OUTLIER 177.04 34.3 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.241 -179.891 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.589 ' CE1' ' HA2' ' A' ' 20' ' ' GLY . 0.1 OUTLIER -158.79 -28.19 0.07 Allowed 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 118.548 -1.261 . . . . 0.0 112.389 -177.806 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 43' ' ' TYR . . . 53.43 84.47 0.03 OUTLIER Glycine 0 N--CA 1.483 1.829 0 N-CA-C 105.285 -3.126 . . . . 0.0 105.285 -176.766 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.919 HG23 ' HB2' ' A' ' 40' ' ' SER . 3.0 t -86.61 143.08 12.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.301 -1.117 . . . . 0.0 109.665 -176.751 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.572 ' O ' ' CZ ' ' A' ' 19' ' ' TYR . . . -166.26 147.35 12.01 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.289 -1.434 . . . . 0.0 110.785 -179.058 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.716 HG13 ' O ' ' A' ' 17' ' ' VAL . 19.7 t -111.7 129.69 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.576 -0.955 . . . . 0.0 109.668 179.659 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.6 HG13 ' HE2' ' A' ' 19' ' ' TYR . 27.3 m -120.69 145.02 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.743 -1.223 . . . . 0.0 110.656 -179.624 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.833 HD13 ' C ' ' A' ' 15' ' ' GLY . 15.9 tp -144.45 117.38 8.81 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.262 -0.899 . . . . 0.0 110.34 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.515 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 5.2 p-10 -90.44 148.19 22.94 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.208 -0.932 . . . . 0.0 110.49 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.53 ' O ' HG22 ' A' ' 4' ' ' ILE . . . 126.44 78.62 0.29 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.837 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.689 HG12 HG12 ' A' ' 54' ' ' ILE . 3.7 t -132.79 158.45 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.181 -1.188 . . . . 0.0 110.135 179.781 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -105.71 61.21 0.66 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.167 -0.958 . . . . 0.0 110.472 -179.885 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.928 HD11 HD21 ' A' ' 146' ' ' LEU . 6.3 mm -123.63 151.42 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.194 -0.941 . . . . 0.0 109.846 179.731 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.739 ' HA ' HG23 ' A' ' 111' ' ' THR . 4.4 pt-20 -174.97 34.07 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.106 -0.996 . . . . 0.0 110.376 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' A' ' 55' ' ' GLU . 1.3 tt0 179.88 -174.66 0.26 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.426 -0.796 . . . . 0.0 110.256 -179.797 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.494 ' HA2' ' HA ' ' A' ' 109' ' ' SER . . . -94.27 68.01 1.4 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 108.239 -1.944 . . . . 0.0 108.239 178.956 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.685 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.0 OUTLIER -109.02 176.17 5.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.503 -0.998 . . . . 0.0 110.367 -178.963 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.582 ' O ' ' CD2' ' A' ' 60' ' ' TYR . 0.4 OUTLIER -89.73 158.62 17.46 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.415 -0.803 . . . . 0.0 110.23 -179.941 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.685 ' CE2' HG22 ' A' ' 58' ' ' THR . 68.2 m-85 -156.14 -176.75 6.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.443 -0.786 . . . . 0.0 109.834 179.906 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 26.6 m -150.11 113.42 4.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.196 -0.94 . . . . 0.0 110.187 179.889 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.962 HD22 ' CD2' ' A' ' 89' ' ' LEU . 18.0 tp -89.71 120.86 31.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 110.032 179.821 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.799 ' HG2' HG23 ' A' ' 103' ' ' THR . 19.5 mtp-105 -128.4 130.73 48.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.282 -0.887 . . . . 0.0 110.099 179.961 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.548 ' CE2' ' HB ' ' A' ' 102' ' ' VAL . 8.7 p90 -165.48 152.77 10.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.262 -0.899 . . . . 0.0 109.923 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.504 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 25.6 m -119.67 93.95 4.24 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.097 -1.002 . . . . 0.0 109.968 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.551 ' HB2' HD23 ' A' ' 141' ' ' LEU . . . -96.33 154.54 17.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.274 -0.891 . . . . 0.0 110.939 -179.482 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.569 HG23 ' O ' ' A' ' 98' ' ' GLU . 50.9 m -149.69 134.94 18.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.562 -0.711 . . . . 0.0 109.39 179.263 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.534 ' N ' ' HB3' ' A' ' 95' ' ' LEU . . . -120.86 133.94 55.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.064 -1.023 . . . . 0.0 110.282 -179.685 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 68' ' ' ALA . 11.6 t -43.83 -26.17 0.24 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.27 -0.894 . . . . 0.0 109.547 179.546 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.73 HG22 ' HB2' ' A' ' 137' ' ' TRP . 5.7 t -115.21 -167.15 1.2 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.436 -0.79 . . . . 0.0 109.824 179.703 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.474 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 34.4 t0 -102.93 47.0 0.9 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.274 -0.891 . . . . 0.0 109.371 179.125 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.829 HG23 ' HB2' ' A' ' 133' ' ' SER . 1.9 p -63.46 171.53 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.429 -0.794 . . . . 0.0 110.824 -179.227 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.513 HG22 ' O ' ' A' ' 73' ' ' THR . 11.9 m -160.33 83.81 0.7 Allowed 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.67 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.997 HG21 ' CD2' ' A' ' 129' ' ' LEU . 2.4 m -89.9 -160.05 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.265 -0.897 . . . . 0.0 110.547 -178.616 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.465 ' N ' HG23 ' A' ' 74' ' ' VAL . 20.8 mtm-85 -121.28 112.97 19.27 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.256 -0.902 . . . . 0.0 110.328 -179.613 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.518 ' CB ' ' HD3' ' A' ' 93' ' ' PRO . . . -115.7 157.15 24.7 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.145 -0.972 . . . . 0.0 110.097 179.849 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.908 HD12 ' N ' ' A' ' 78' ' ' VAL . 3.8 pp 178.73 -147.3 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.409 -0.807 . . . . 0.0 109.851 -179.828 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.908 ' N ' HD12 ' A' ' 77' ' ' LEU . 3.1 t -151.92 172.57 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.115 -0.991 . . . . 0.0 109.563 179.773 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.494 ' HA2' ' HA ' ' A' ' 87' ' ' THR . . . 176.07 172.7 41.08 Favored Glycine 0 N--CA 1.49 2.276 0 C-N-CA 119.36 -1.4 . . . . 0.0 110.138 179.892 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.491 ' OE1' ' HD2' ' A' ' 113' ' ' PRO . 15.1 tp60 -93.04 137.72 32.14 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.4 -1.059 . . . . 0.0 110.355 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.532 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 3.6 m120 -123.3 96.4 4.98 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.839 0.828 . . . . 0.0 109.02 178.943 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.543 ' O ' ' HB3' ' A' ' 83' ' ' ALA . . . 132.31 34.4 0.37 Allowed Glycine 0 N--CA 1.484 1.878 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.523 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 82' ' ' GLY . . . 60.41 142.95 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.282 -1.128 . . . . 0.0 110.14 -179.86 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.463 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.3 Cg_endo -82.28 18.6 17.7 Favored 'Cis proline' 0 C--N 1.314 -1.255 0 C-N-CA 121.938 -2.109 . . . . 0.0 110.813 -0.159 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.541 ' CD2' ' HA ' ' A' ' 83' ' ' ALA . 75.7 m-85 58.91 170.02 0.06 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.153 -0.967 . . . . 0.0 110.342 -179.911 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 142.33 114.64 1.06 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.494 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 1.1 p -91.26 147.83 22.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.188 -1.183 . . . . 0.0 110.299 -179.963 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 1.032 HG23 HD12 ' A' ' 89' ' ' LEU . 15.6 m -123.12 -21.81 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.299 -0.876 . . . . 0.0 110.266 179.98 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 1.032 HD12 HG23 ' A' ' 88' ' ' VAL . 3.9 mp -104.94 146.76 28.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.239 -0.913 . . . . 0.0 110.7 179.735 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.733 ' O ' HG23 ' A' ' 91' ' ' THR . 8.9 t0 -151.03 89.04 1.49 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.324 -0.86 . . . . 0.0 110.142 179.727 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.733 HG23 ' O ' ' A' ' 90' ' ' ASP . 6.5 p -160.0 -178.98 7.4 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.123 -0.986 . . . . 0.0 110.584 -179.862 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.529 ' CB ' ' O ' ' A' ' 74' ' ' VAL . 3.5 m -129.08 129.49 23.38 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.329 -0.857 . . . . 0.0 110.07 179.927 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.844 ' HG2' HG22 ' A' ' 74' ' ' VAL . 46.9 Cg_endo -72.28 91.44 0.76 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.935 1.492 . . . . 0.0 110.994 -179.719 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.522 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -70.48 125.14 25.96 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.073 -1.017 . . . . 0.0 109.002 178.972 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.542 ' CD1' ' HG ' ' A' ' 139' ' ' LEU . 29.4 mt -119.83 170.48 9.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.113 -0.992 . . . . 0.0 110.846 -179.023 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.601 HG23 ' N ' ' A' ' 97' ' ' SER . 6.1 t -169.36 -151.18 0.09 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.394 -0.816 . . . . 0.0 109.735 179.886 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.601 ' N ' HG23 ' A' ' 96' ' ' THR . 0.5 OUTLIER -93.41 25.51 3.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.046 -1.034 . . . . 0.0 110.043 179.8 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.569 ' O ' HG23 ' A' ' 67' ' ' THR . 2.0 mt-10 -145.84 171.99 5.83 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.34 -0.85 . . . . 0.0 109.959 179.847 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.57 130.83 16.51 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 124.005 1.529 . . . . 0.0 110.379 -179.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.522 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 1.7 mtt180 -119.7 93.2 3.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.254 -0.904 . . . . 0.0 110.006 179.915 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -82.99 95.24 7.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.448 -0.783 . . . . 0.0 110.45 -179.767 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.548 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 73.6 t -89.47 133.51 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.277 -0.89 . . . . 0.0 110.013 179.836 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.799 HG23 ' HG2' ' A' ' 63' ' ' ARG . 53.5 m -150.21 139.54 21.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.227 -0.921 . . . . 0.0 110.328 -179.948 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.456 ' CG ' ' O ' ' A' ' 103' ' ' THR . 21.3 mt-10 -160.2 160.94 33.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.244 -0.91 . . . . 0.0 110.257 179.881 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.41 HG22 ' H ' ' A' ' 105' ' ' THR . 3.1 t -111.5 128.06 55.9 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.229 -0.919 . . . . 0.0 110.114 179.894 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.924 ' CE2' HD11 ' A' ' 89' ' ' LEU . 22.4 p90 -136.38 157.27 47.19 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.246 -0.909 . . . . 0.0 110.269 -179.916 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.534 ' O ' ' N ' ' A' ' 109' ' ' SER . 3.6 m -89.49 93.9 9.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.163 -0.96 . . . . 0.0 109.732 179.603 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.613 ' HB3' ' CE2' ' A' ' 60' ' ' TYR . . . -49.68 89.99 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.353 -0.842 . . . . 0.0 110.084 -179.932 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.534 ' N ' ' O ' ' A' ' 107' ' ' THR . 79.8 p -85.99 53.96 2.97 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.315 -0.866 . . . . 0.0 109.76 179.888 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -159.28 -156.75 0.54 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.244 -0.91 . . . . 0.0 110.393 -179.769 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.739 HG23 ' HA ' ' A' ' 55' ' ' GLU . 3.4 m -149.8 113.45 5.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.256 -0.902 . . . . 0.0 110.457 -179.896 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.751 ' OH ' HG13 ' A' ' 88' ' ' VAL . 11.9 m-30 -109.85 85.91 4.39 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.366 -0.834 . . . . 0.0 109.571 179.535 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.638 ' HD3' HG22 ' A' ' 111' ' ' THR . 45.4 Cg_endo -72.19 -165.83 0.23 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.892 1.469 . . . . 0.0 110.517 -179.757 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.307 -0.871 . . . . 0.0 110.24 -179.993 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.532 ' O ' ' HB2' ' A' ' 81' ' ' ASN . 0.5 OUTLIER . . . . . 0 N--CA 1.5 2.033 0 CA-C-O 121.325 0.583 . . . . 0.0 111.903 . . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.484 ' HA3' ' CB ' ' A' ' 112' ' ' TYR . . . -85.54 149.21 23.39 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -179.378 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.515 ' CB ' ' HA ' ' A' ' 50' ' ' ASN . 6.8 pt20 -150.78 -157.59 0.83 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.358 -1.084 . . . . 0.0 110.651 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.453 HG21 ' CH2' ' A' ' 16' ' ' TRP . 5.5 mt -118.54 146.97 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 179.294 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -121.5 122.62 40.12 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.325 -179.183 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.518 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 5.0 m-85 -118.59 98.54 6.29 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.185 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.489 ' O ' ' HB ' ' A' ' 74' ' ' VAL . 10.5 mm-40 -88.75 84.13 6.69 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.262 -0.899 . . . . 0.0 112.368 -177.154 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 1.055 HD13 HD13 ' A' ' 139' ' ' LEU . 7.0 mt -85.2 45.99 1.24 Allowed 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.515 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' A' ' 132' ' ' PHE . . . -64.2 -170.5 2.02 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 -179.396 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.554 ' CA ' ' O ' ' A' ' 40' ' ' SER . . . -51.81 89.49 0.01 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.905 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.567 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 9.7 m-85 -118.35 -49.53 2.47 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.113 -1.228 . . . . 0.0 110.693 -179.361 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.829 ' HB2' HG23 ' A' ' 72' ' ' VAL . 1.3 t -88.53 175.83 7.41 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.997 -1.065 . . . . 0.0 110.233 -179.71 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -97.25 -52.94 3.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.322 -0.862 . . . . 0.0 110.309 -179.744 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -98.82 174.11 6.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.228 -0.92 . . . . 0.0 109.984 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.573 ' N ' ' HA ' ' A' ' 38' ' ' ALA . . . -57.59 125.6 23.63 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.151 -0.968 . . . . 0.0 110.047 -179.756 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 1.073 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 6.6 p90 -132.18 -168.48 2.05 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.063 -1.023 . . . . 0.0 109.803 179.659 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 68' ' ' ALA . 0.5 OUTLIER -155.76 172.46 18.28 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.805 -1.185 . . . . 0.0 111.331 -177.819 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 1.055 HD13 HD13 ' A' ' 129' ' ' LEU . 2.4 mp -130.47 128.81 42.0 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.548 -0.72 . . . . 0.0 109.506 179.497 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 140' ' ' CYS . . . . . . . . . . . . . 15.9 m -127.63 100.7 6.09 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.091 -1.006 . . . . 0.0 110.771 -179.535 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.611 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 0.7 OUTLIER -95.96 -177.93 4.18 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.29 -0.881 . . . . 0.0 109.325 179.189 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.739 ' O ' HG22 ' A' ' 8' ' ' THR . 0.6 OUTLIER 171.11 49.89 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.184 -0.947 . . . . 0.0 110.411 -179.996 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.677 ' CG ' HG22 ' A' ' 8' ' ' THR . 0.4 OUTLIER 166.23 55.43 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.37 -0.831 . . . . 0.0 109.614 179.849 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.834 HG11 ' HZ2' ' A' ' 16' ' ' TRP . 2.1 t -96.32 118.72 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.303 -0.873 . . . . 0.0 110.274 -179.474 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.583 ' HB1' ' HG2' ' A' ' 6' ' ' GLU . . . -145.2 155.55 43.33 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.318 -0.864 . . . . 0.0 110.189 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.928 HD21 HD11 ' A' ' 54' ' ' ILE . 14.1 tp -147.9 143.39 27.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.922 . . . . 0.0 110.188 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.493 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 5.0 t0 -172.3 151.15 2.49 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.2 -0.937 . . . . 0.0 110.311 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.433 ' HA ' ' O ' ' A' ' 59' ' ' THR . 9.7 p . . . . . 0 N--CA 1.492 1.653 0 O-C-N 121.281 -0.887 . . . . 0.0 110.197 179.998 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo . . . . . 0 N--CA 1.48 0.72 0 N-CA-C 110.072 -0.78 . . . . 0.0 110.072 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.633 HG22 ' O ' ' A' ' 51' ' ' GLY . 13.8 pt -95.39 23.97 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.195 -0.941 . . . . 0.0 110.17 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 94.23 -23.8 29.99 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.917 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.76 ' HG2' ' HB1' ' A' ' 145' ' ' ALA . 1.4 tt0 44.7 74.07 0.14 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.273 -1.134 . . . . 0.0 110.212 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -163.26 -164.01 17.31 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.961 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.572 HG22 ' O ' ' A' ' 142' ' ' ASP . 26.1 p -117.57 33.92 5.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.259 -1.142 . . . . 0.0 110.323 -179.975 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.552 ' HZ ' HG21 ' A' ' 144' ' ' VAL . 13.6 m-85 60.25 48.24 8.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -0.934 . . . . 0.0 110.146 179.938 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.557 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 32.2 t70 -90.13 32.21 0.94 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.223 -0.923 . . . . 0.0 110.333 -179.911 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.557 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.4 OUTLIER 161.55 37.77 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.572 -0.705 . . . . 0.0 109.974 179.983 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.24 136.07 4.36 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.774 ' HB3' HD12 ' A' ' 32' ' ' LEU . 48.3 Cg_endo -74.69 1.66 7.31 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.962 1.506 . . . . 0.0 110.609 179.955 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 0.1 OUTLIER 68.15 -84.04 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.265 -0.897 . . . . 0.0 110.274 -179.872 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.66 ' O ' HG13 ' A' ' 17' ' ' VAL . . . -137.39 5.54 3.52 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.921 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.884 ' CE2' HD22 ' A' ' 49' ' ' LEU . 56.0 m95 -65.5 105.25 1.15 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.188 -1.183 . . . . 0.0 110.249 -179.898 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.696 ' O ' HG13 ' A' ' 47' ' ' VAL . 1.0 OUTLIER -113.41 151.72 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.173 -0.955 . . . . 0.0 109.783 179.784 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 1.018 ' HB3' HD21 ' A' ' 25' ' ' LEU . . . -133.73 136.97 44.96 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.192 -0.942 . . . . 0.0 109.679 179.359 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.635 ' HE2' HG13 ' A' ' 48' ' ' VAL . 26.8 p90 -128.17 148.64 50.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.417 -0.802 . . . . 0.0 110.665 -178.902 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.3 24.61 18.58 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 179.464 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.704 HG22 HG11 ' A' ' 45' ' ' VAL . 28.1 p -134.88 -148.6 0.32 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.033 -1.275 . . . . 0.0 110.494 179.904 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.454 ' O ' ' O ' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -116.84 136.43 52.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.342 -0.849 . . . . 0.0 110.383 -179.806 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 22' ' ' ASP . . . 52.07 174.46 0.03 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.766 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.52 -159.32 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.08 1.569 . . . . 0.0 110.42 179.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 1.018 HD21 ' HB3' ' A' ' 18' ' ' ALA . 17.3 mt -93.05 145.3 24.49 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.215 -0.928 . . . . 0.0 110.237 179.987 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -97.59 119.41 36.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.243 -0.911 . . . . 0.0 109.827 179.709 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' A' ' 31' ' ' ALA . 0.8 OUTLIER -119.65 -44.56 2.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.127 -0.983 . . . . 0.0 110.503 -179.58 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.43 ' C ' ' O ' ' A' ' 27' ' ' THR . 8.1 t 43.76 36.04 1.21 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.186 -0.946 . . . . 0.0 109.874 -179.831 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 28' ' ' SER . 4.3 p 54.11 59.94 3.92 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.457 -0.777 . . . . 0.0 110.057 -179.731 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 8' ' ' THR . . . -159.24 -71.12 0.02 OUTLIER Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.624 ' HB1' ' O ' ' A' ' 141' ' ' LEU . . . -150.74 160.17 44.03 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.25 -1.147 . . . . 0.0 110.451 -179.899 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.774 HD12 ' HB3' ' A' ' 13' ' ' PRO . 0.6 OUTLIER -88.71 111.8 22.39 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.276 -0.89 . . . . 0.0 109.842 179.568 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 53.4 m -119.58 106.36 12.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.221 -0.924 . . . . 0.0 110.61 -179.642 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 1.006 HG12 HD22 ' A' ' 25' ' ' LEU . 18.2 m -89.87 145.58 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.207 -0.933 . . . . 0.0 109.715 179.535 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.527 ' HA ' ' OG1' ' A' ' 138' ' ' THR . . . -95.52 91.69 6.29 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.338 -0.851 . . . . 0.0 111.113 -179.268 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.126 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 58.8 t -71.54 130.85 86.86 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.168 -0.958 . . . . 0.0 109.307 179.076 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 21' ' ' THR . 43.1 Cg_endo -71.24 155.12 61.29 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.933 1.491 . . . . 0.0 111.164 -178.945 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.549 ' HA ' ' CA ' ' A' ' 136' ' ' ALA . . . -43.05 111.1 0.23 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.37 -0.832 . . . . 0.0 110.345 -179.839 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 134' ' ' ALA . . . 58.67 117.6 0.01 OUTLIER Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.981 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.597 ' HB3' HG23 ' A' ' 45' ' ' VAL . 58.6 m -85.55 49.0 1.67 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.27 -1.135 . . . . 0.0 109.553 179.668 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.513 ' O ' ' HB3' ' A' ' 42' ' ' GLN . . . -89.72 103.89 16.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.497 -0.752 . . . . 0.0 110.217 -179.741 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.513 ' HB3' ' O ' ' A' ' 41' ' ' ALA . 0.8 OUTLIER 168.18 -152.17 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -179.757 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.409 ' C ' ' O ' ' A' ' 42' ' ' GLN . 7.4 p90 -43.13 -26.43 0.16 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.091 -1.006 . . . . 0.0 109.564 179.174 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 42' ' ' GLN . . . 107.59 129.39 6.1 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.35 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.704 HG11 HG22 ' A' ' 21' ' ' THR . 3.0 t -89.88 177.89 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.132 -1.217 . . . . 0.0 108.46 179.144 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.556 ' HA2' ' HA ' ' A' ' 128' ' ' GLN . . . 169.4 -177.29 43.09 Favored Glycine 0 N--CA 1.489 2.182 0 C-N-CA 118.748 -1.692 . . . . 0.0 111.075 -179.894 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.696 HG13 ' O ' ' A' ' 17' ' ' VAL . 18.3 t -150.95 126.84 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.803 -0.822 . . . . 0.0 108.83 179.862 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.635 HG13 ' HE2' ' A' ' 19' ' ' TYR . 29.0 m -119.82 133.67 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.027 -1.046 . . . . 0.0 110.907 -179.159 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.884 HD22 ' CE2' ' A' ' 16' ' ' TRP . 30.7 tp -122.97 90.64 3.33 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.397 -0.815 . . . . 0.0 110.074 179.787 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.481 ' HA ' ' HB3' ' A' ' 124' ' ' GLN . 8.1 p30 -73.57 113.5 10.75 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.236 -0.915 . . . . 0.0 110.247 -179.909 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.633 ' O ' HG22 ' A' ' 4' ' ' ILE . . . 153.95 65.86 0.01 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.908 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.725 HG23 ' HA ' ' A' ' 124' ' ' GLN . 97.2 t -120.04 173.07 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.164 -1.197 . . . . 0.0 109.982 179.787 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.599 ' N ' HG12 ' A' ' 52' ' ' VAL . . . -143.43 97.74 3.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.072 -1.017 . . . . 0.0 110.652 -179.786 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.863 HG21 ' HB1' ' A' ' 108' ' ' ALA . 11.6 mm -137.79 159.87 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.292 -0.88 . . . . 0.0 109.818 179.603 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.475 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -147.82 135.34 20.76 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.108 -0.995 . . . . 0.0 110.683 -179.774 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.565 ' CG ' ' N ' ' A' ' 57' ' ' GLY . 0.9 OUTLIER 34.23 -155.08 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.342 0.592 . . . . 0.0 111.243 179.759 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.565 ' N ' ' CG ' ' A' ' 56' ' ' GLU . . . -83.39 81.39 1.75 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.837 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.681 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.2 m -109.13 171.26 7.54 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.305 -1.115 . . . . 0.0 109.826 179.876 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.519 ' N ' ' CG2' ' A' ' 58' ' ' THR . 1.0 OUTLIER -89.91 150.21 22.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.257 -0.902 . . . . 0.0 110.181 -179.941 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.823 ' CE2' HG23 ' A' ' 54' ' ' ILE . 64.9 m-85 -154.69 171.74 19.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.233 -0.917 . . . . 0.0 110.225 179.895 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.514 ' OG1' HG23 ' A' ' 105' ' ' THR . 17.9 m -142.73 114.51 8.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.304 -0.872 . . . . 0.0 110.086 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.1 tp -89.71 121.19 31.64 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.177 -0.952 . . . . 0.0 109.965 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.504 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 2.2 ttt180 -129.29 127.8 41.89 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -0.878 . . . . 0.0 110.314 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.964 ' CZ ' HG21 ' A' ' 102' ' ' VAL . 2.1 p90 -165.12 149.6 8.94 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.336 -0.853 . . . . 0.0 109.888 179.807 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 51.6 m -119.44 95.7 4.9 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.183 -0.948 . . . . 0.0 110.117 -179.965 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.501 ' HB2' HD23 ' A' ' 141' ' ' LEU . . . -93.92 151.93 19.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.358 -0.839 . . . . 0.0 110.339 -179.801 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.86 HG23 ' O ' ' A' ' 98' ' ' GLU . 57.1 m -149.76 121.16 7.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.278 -0.889 . . . . 0.0 110.261 179.97 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.469 ' O ' ' O ' ' A' ' 96' ' ' THR . . . -114.89 132.01 56.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.314 -0.866 . . . . 0.0 109.852 179.752 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.9 p -47.69 -23.99 0.83 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.074 -1.016 . . . . 0.0 109.343 179.497 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.592 HG22 ' HB2' ' A' ' 137' ' ' TRP . 2.5 t -113.84 170.2 8.44 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.49 -0.756 . . . . 0.0 110.067 179.904 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.43 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 15.7 t70 -86.75 66.02 9.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.179 -0.951 . . . . 0.0 109.119 178.86 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.776 HG23 ' CB ' ' A' ' 133' ' ' SER . 3.5 p -85.23 137.25 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.319 -0.863 . . . . 0.0 111.341 -178.871 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.409 ' O ' ' CD1' ' A' ' 132' ' ' PHE . 89.6 m -122.81 86.02 2.51 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.85 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.66 HG22 ' HG2' ' A' ' 93' ' ' PRO . 4.8 m -89.33 -153.28 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.287 -0.883 . . . . 0.0 110.444 -179.068 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.44 ' N ' HG23 ' A' ' 74' ' ' VAL . 2.4 mtp180 -125.94 133.16 51.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.207 -0.933 . . . . 0.0 110.627 -179.431 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.511 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -137.32 155.72 49.09 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.346 -0.846 . . . . 0.0 110.079 179.691 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.894 HD12 ' N ' ' A' ' 78' ' ' VAL . 3.9 pp 179.18 -147.77 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.354 -0.841 . . . . 0.0 110.033 -179.724 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.894 ' N ' HD12 ' A' ' 77' ' ' LEU . 3.8 t -151.65 166.43 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.147 -0.971 . . . . 0.0 109.321 179.77 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.507 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . -171.67 -174.53 39.33 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.11 -1.519 . . . . 0.0 110.631 -179.81 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.561 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 4.0 pt20 -114.78 150.8 34.84 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.545 -0.973 . . . . 0.0 110.065 179.793 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.487 ' OD1' ' HG2' ' A' ' 122' ' ' GLU . 18.6 m120 -106.31 92.47 4.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.207 -0.933 . . . . 0.0 110.396 -179.952 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.538 ' C ' ' CE1' ' A' ' 85' ' ' TYR . . . 135.54 130.18 2.92 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.869 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.581 ' N ' ' CZ ' ' A' ' 85' ' ' TYR . . . -42.12 155.32 0.25 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.38 -1.071 . . . . 0.0 110.317 -179.951 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.464 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 50.8 Cg_endo -78.78 11.75 18.72 Favored 'Cis proline' 0 C--N 1.312 -1.352 0 C-N-CA 121.636 -2.235 . . . . 0.0 110.93 -0.049 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.581 ' CZ ' ' N ' ' A' ' 83' ' ' ALA . 39.3 m-85 60.88 157.71 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.125 -0.985 . . . . 0.0 110.17 -179.739 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.47 ' O ' ' HG2' ' A' ' 80' ' ' GLN . . . 167.78 113.46 0.28 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.479 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 1.2 p -89.84 155.52 19.1 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.232 -1.158 . . . . 0.0 110.299 -179.853 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 1.068 HG23 HD12 ' A' ' 89' ' ' LEU . 35.3 m -119.82 -24.22 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.886 . . . . 0.0 109.899 179.837 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 1.068 HD12 HG23 ' A' ' 88' ' ' VAL . 4.0 mp -104.59 144.39 31.76 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.351 -0.843 . . . . 0.0 110.667 179.684 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -151.04 76.33 1.23 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.324 -0.86 . . . . 0.0 110.195 179.805 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -144.85 176.38 9.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.052 -1.03 . . . . 0.0 110.508 -179.832 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 66.2 m -124.39 126.08 25.54 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.318 -0.864 . . . . 0.0 110.045 179.907 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.66 ' HG2' HG22 ' A' ' 74' ' ' VAL . 45.4 Cg_endo -71.73 127.66 13.34 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.876 1.461 . . . . 0.0 110.749 -179.805 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.515 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -105.19 128.49 53.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.321 -0.862 . . . . 0.0 109.838 179.58 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.664 HD12 ' CG1' ' A' ' 72' ' ' VAL . 57.4 mt -119.91 178.95 4.41 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.186 -0.946 . . . . 0.0 110.467 -179.711 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.628 HG23 ' H ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -159.24 -79.64 0.06 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.265 -0.897 . . . . 0.0 110.335 -179.848 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.628 ' H ' HG23 ' A' ' 96' ' ' THR . 0.1 OUTLIER -158.75 -37.66 0.06 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.271 -0.893 . . . . 0.0 110.061 179.952 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.86 ' O ' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -89.88 -177.72 0.85 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.341 -0.849 . . . . 0.0 109.786 179.748 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.554 ' HD2' ' CG ' ' A' ' 98' ' ' GLU . 44.2 Cg_endo -71.61 128.63 14.58 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.748 1.394 . . . . 0.0 110.272 179.915 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.515 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 8.0 ttm-85 -119.68 92.03 3.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.185 -0.947 . . . . 0.0 110.36 -179.803 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 1.9 pt20 -70.23 159.03 34.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.327 -0.858 . . . . 0.0 110.045 179.796 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.964 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 98.7 t -135.12 139.34 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.208 -0.932 . . . . 0.0 110.165 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.447 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 0.2 OUTLIER -150.21 117.1 5.89 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.238 -0.914 . . . . 0.0 110.154 179.976 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.447 ' HG2' ' O ' ' A' ' 103' ' ' THR . 17.7 mm-40 -155.28 134.86 12.6 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.206 -0.934 . . . . 0.0 110.288 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.514 HG23 ' OG1' ' A' ' 61' ' ' THR . 0.7 OUTLIER -102.18 119.24 38.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.271 -0.893 . . . . 0.0 110.106 179.939 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.896 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 35.0 p90 -125.91 157.91 36.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.233 -0.917 . . . . 0.0 110.285 -179.943 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 19.3 m -89.93 98.57 11.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.3 -0.875 . . . . 0.0 109.997 179.786 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.863 ' HB1' HG21 ' A' ' 54' ' ' ILE . . . -59.3 107.78 0.61 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.253 -0.905 . . . . 0.0 110.411 -179.726 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.463 ' HA ' ' HA2' ' A' ' 57' ' ' GLY . 3.3 p -94.8 54.27 1.72 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.258 -0.901 . . . . 0.0 110.005 179.67 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.401 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -160.57 -152.38 0.28 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.214 -0.929 . . . . 0.0 110.431 -179.81 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 1.054 HG22 ' HD3' ' A' ' 113' ' ' PRO . 84.1 m -151.89 111.46 3.97 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.325 -0.859 . . . . 0.0 110.312 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.673 ' CE2' HG12 ' A' ' 78' ' ' VAL . 17.3 m-30 -111.02 69.66 0.66 Allowed Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.265 -0.897 . . . . 0.0 110.16 179.791 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 1.054 ' HD3' HG22 ' A' ' 111' ' ' THR . 45.8 Cg_endo -71.3 117.21 5.04 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.889 1.468 . . . . 0.0 110.361 179.949 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.261 -0.899 . . . . 0.0 110.231 -179.951 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.543 ' CG ' ' N ' ' A' ' 123' ' ' GLY . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.117 0.485 . . . . 0.0 109.999 . . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.561 ' HA2' ' HA ' ' A' ' 80' ' ' GLN . . . -166.44 156.31 28.11 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.814 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.725 ' HA ' HG23 ' A' ' 52' ' ' VAL . 3.6 pt20 -150.08 -161.23 1.3 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.38 -1.07 . . . . 0.0 110.313 -179.727 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.862 HG21 ' CH2' ' A' ' 16' ' ' TRP . 17.5 mt -118.49 149.83 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.528 -0.732 . . . . 0.0 109.552 179.772 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.761 ' HB3' ' HG ' ' A' ' 77' ' ' LEU . . . -114.97 133.92 55.62 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.78 0.8 . . . . 0.0 111.179 -179.228 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.533 ' CD1' ' O ' ' A' ' 126' ' ' ALA . 8.5 m-85 -146.8 73.9 1.33 Allowed 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.062 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.893 ' C ' HD23 ' A' ' 129' ' ' LEU . 40.2 mt-30 -87.55 125.44 34.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.303 -0.873 . . . . 0.0 111.841 -177.773 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.893 HD23 ' C ' ' A' ' 128' ' ' GLN . 2.9 mt -113.95 54.34 0.76 Allowed 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.871 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -106.54 104.33 2.18 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 -179.36 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 77.21 74.46 0.98 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.781 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.611 ' CE1' ' HA ' ' A' ' 74' ' ' VAL . 6.5 m-85 -143.93 -71.77 0.29 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.196 -1.179 . . . . 0.0 110.243 179.859 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.776 ' CB ' HG23 ' A' ' 72' ' ' VAL . 1.3 t -89.13 156.45 18.8 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.055 -1.028 . . . . 0.0 110.103 179.825 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -80.23 -92.31 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.225 -0.922 . . . . 0.0 110.874 -179.34 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.448 ' O ' ' O ' ' A' ' 134' ' ' ALA . 12.6 m-20 -52.28 -172.35 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.165 -0.959 . . . . 0.0 110.679 -179.494 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.549 ' CA ' ' HA ' ' A' ' 38' ' ' ALA . . . -76.55 139.44 40.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.363 -0.835 . . . . 0.0 110.386 -179.799 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 1.126 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 9.1 p90 -145.82 -166.34 2.43 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.296 -0.877 . . . . 0.0 110.058 179.672 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.527 ' OG1' ' HA ' ' A' ' 35' ' ' ALA . 0.8 OUTLIER -160.38 170.47 20.96 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.034 -1.041 . . . . 0.0 110.735 -178.068 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.818 HD13 HD13 ' A' ' 129' ' ' LEU . 2.2 mp -129.28 126.26 38.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.469 -0.769 . . . . 0.0 109.444 179.14 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 140' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 27.9 m -121.81 102.73 8.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.141 -0.974 . . . . 0.0 110.892 -179.443 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.624 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 1.2 mt -95.26 -177.94 4.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.301 -0.875 . . . . 0.0 109.355 179.093 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.572 ' O ' HG22 ' A' ' 8' ' ' THR . 2.8 p30 168.5 52.96 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.244 -0.91 . . . . 0.0 110.301 179.954 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.523 ' CG ' HG22 ' A' ' 8' ' ' THR . 0.3 OUTLIER 167.27 53.06 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.223 -0.923 . . . . 0.0 109.71 179.947 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.864 HG11 ' HZ2' ' A' ' 16' ' ' TRP . 2.2 t -95.71 114.17 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.28 -0.887 . . . . 0.0 110.189 -179.599 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.76 ' HB1' ' HG2' ' A' ' 6' ' ' GLU . . . -146.11 164.75 31.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.897 . . . . 0.0 110.262 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.758 HD11 ' HB3' ' A' ' 60' ' ' TYR . 6.7 tp -145.21 148.23 33.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.323 -0.861 . . . . 0.0 110.234 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.477 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 0.5 OUTLIER -134.22 -173.97 3.42 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.196 -0.94 . . . . 0.0 110.23 -179.982 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 78.5 p . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.237 -0.915 . . . . 0.0 110.224 -179.974 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.563 ' CG ' ' HA ' ' A' ' 52' ' ' VAL . 53.8 Cg_endo . . . . . 0 N--CA 1.483 0.869 0 N-CA-C 111.134 -0.372 . . . . 0.0 111.134 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.505 HG13 ' N ' ' A' ' 5' ' ' GLY . 7.8 pt -146.15 -37.52 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.989 -1.07 . . . . 0.0 109.811 179.715 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.511 ' O ' ' N ' ' A' ' 7' ' ' GLY . . . 55.71 163.18 0.02 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 179.574 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.68 ' CG ' ' HB2' ' A' ' 145' ' ' ALA . 63.3 mt-10 -51.69 88.75 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.302 -1.116 . . . . 0.0 110.11 179.85 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 5' ' ' GLY . . . -78.63 -32.41 41.71 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.953 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.456 ' HA ' ' C ' ' A' ' 142' ' ' ASP . 11.2 p 50.57 18.93 0.51 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.427 -1.043 . . . . 0.0 110.467 -179.794 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.604 ' CG ' ' HB2' ' A' ' 32' ' ' LEU . 24.3 m-85 36.85 46.64 0.51 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.56 -0.712 . . . . 0.0 110.813 179.563 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.558 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 3.2 p-10 -100.25 43.46 1.06 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.244 -0.91 . . . . 0.0 110.281 -179.998 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.558 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.6 OUTLIER 161.57 -24.97 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.722 -0.612 . . . . 0.0 109.52 179.951 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -177.64 151.12 10.54 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.74 ' HB3' HD12 ' A' ' 32' ' ' LEU . 46.3 Cg_endo -73.64 0.01 8.74 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.014 1.534 . . . . 0.0 110.552 -179.987 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 0.5 OUTLIER 62.07 -89.55 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.255 -0.903 . . . . 0.0 110.135 -179.791 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.595 ' O ' HG13 ' A' ' 17' ' ' VAL . . . -122.68 -15.89 3.87 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.944 ' CH2' HG21 ' A' ' 125' ' ' ILE . 82.4 m95 -54.05 140.68 30.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.254 -1.145 . . . . 0.0 110.782 -179.758 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.938 ' HA ' HD11 ' A' ' 25' ' ' LEU . 1.2 m -146.08 157.95 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.324 -0.86 . . . . 0.0 109.455 179.425 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.452 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . . . -134.26 163.2 30.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.235 -0.916 . . . . 0.0 109.49 179.303 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.53 ' HE2' HG13 ' A' ' 48' ' ' VAL . 3.5 p90 -150.04 147.9 28.38 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.93 -1.106 . . . . 0.0 111.625 -178.519 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.587 ' HA2' ' CD1' ' A' ' 43' ' ' TYR . . . 132.09 -81.75 0.32 Allowed Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.763 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.617 HG22 ' CE2' ' A' ' 43' ' ' TYR . 12.1 p -149.69 23.95 0.88 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.171 -1.194 . . . . 0.0 110.319 -179.899 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.579 ' HA ' ' HB3' ' A' ' 35' ' ' ALA . 0.5 OUTLIER -107.63 27.43 9.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 110.35 179.845 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.48 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 36.87 -137.43 0.53 Allowed Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.749 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.78 -158.88 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.974 1.513 . . . . 0.0 110.106 179.514 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.938 HD11 ' HA ' ' A' ' 17' ' ' VAL . 61.1 mt -111.26 123.69 50.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.122 -0.986 . . . . 0.0 110.263 179.923 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.02 105.63 12.39 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.196 -0.94 . . . . 0.0 109.911 179.871 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.58 HG22 ' HB3' ' A' ' 9' ' ' PHE . 0.8 OUTLIER -119.56 -27.4 5.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.185 -0.947 . . . . 0.0 110.488 -179.653 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.645 ' C ' HG22 ' A' ' 29' ' ' THR . 8.0 t -48.48 82.91 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.758 -0.589 . . . . 0.0 111.233 -179.863 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.645 HG22 ' C ' ' A' ' 28' ' ' SER . 0.0 OUTLIER 167.91 -31.71 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.254 -0.904 . . . . 0.0 109.856 -179.918 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.434 ' HA2' ' HA ' ' A' ' 10' ' ' ASP . . . 127.17 -0.07 7.0 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.907 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.549 ' CB ' ' HB3' ' A' ' 142' ' ' ASP . . . -150.75 134.98 16.93 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.15 -1.206 . . . . 0.0 110.535 -179.907 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.74 HD12 ' HB3' ' A' ' 13' ' ' PRO . 3.2 tt -76.27 138.6 40.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.181 -0.949 . . . . 0.0 109.293 179.205 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 66.6 m -141.82 118.43 10.99 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.069 -1.02 . . . . 0.0 110.838 -179.552 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.544 HG12 ' CD2' ' A' ' 25' ' ' LEU . 17.2 m -102.1 142.06 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.485 -0.759 . . . . 0.0 109.274 179.306 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.579 ' HB3' ' HA ' ' A' ' 22' ' ' ASP . . . -88.44 102.79 15.24 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.129 -0.982 . . . . 0.0 110.781 -179.211 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.025 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 49.1 t -83.91 125.23 73.48 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.417 -0.802 . . . . 0.0 109.596 179.471 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.663 ' HD2' HG21 ' A' ' 45' ' ' VAL . 40.4 Cg_endo -66.42 -178.57 1.21 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.878 1.462 . . . . 0.0 111.741 -178.965 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.528 ' HA ' ' N ' ' A' ' 136' ' ' ALA . . . -60.5 120.92 10.87 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.452 -0.78 . . . . 0.0 111.296 -178.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.519 ' O ' ' C ' ' A' ' 40' ' ' SER . . . 39.22 26.73 0.06 OUTLIER Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 179.588 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.751 ' HB3' HG23 ' A' ' 45' ' ' VAL . 45.6 m 28.43 44.68 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 CA-C-N 117.863 0.831 . . . . 0.0 110.65 -179.998 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.631 ' O ' ' CG ' ' A' ' 42' ' ' GLN . . . -89.07 126.58 35.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.474 -0.766 . . . . 0.0 110.158 -179.278 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.631 ' CG ' ' O ' ' A' ' 41' ' ' ALA . 0.4 OUTLIER 83.17 28.54 0.1 Allowed 'General case' 0 N--CA 1.508 2.443 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -179.365 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.617 ' CE2' HG22 ' A' ' 21' ' ' THR . 0.1 OUTLIER -156.31 -31.05 0.09 Allowed 'General case' 0 C--N 1.293 -1.865 0 C-N-CA 118.648 -1.221 . . . . 0.0 112.314 -177.767 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.54 ' HA2' ' CA ' ' A' ' 130' ' ' GLY . . . 53.2 80.01 0.08 OUTLIER Glycine 0 N--CA 1.479 1.556 0 N-CA-C 105.922 -2.871 . . . . 0.0 105.922 -177.015 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.751 HG23 ' HB3' ' A' ' 40' ' ' SER . 4.2 t -86.95 133.9 28.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.358 -1.084 . . . . 0.0 108.893 -177.955 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.511 ' C ' ' CZ ' ' A' ' 19' ' ' TYR . . . -157.13 163.74 32.5 Favored Glycine 0 N--CA 1.487 2.089 0 C-N-CA 118.755 -1.688 . . . . 0.0 110.65 -178.973 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.652 HG13 ' O ' ' A' ' 17' ' ' VAL . 15.3 t -123.87 123.31 66.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.648 -0.913 . . . . 0.0 109.536 179.639 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.642 ' O ' HG22 ' A' ' 17' ' ' VAL . 32.7 m -119.79 140.48 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.916 -1.115 . . . . 0.0 111.018 -179.002 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.874 HD22 ' NE1' ' A' ' 16' ' ' TRP . 15.0 tp -118.98 97.7 5.82 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.46 -0.775 . . . . 0.0 109.743 179.449 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.526 ' HA ' ' HB3' ' A' ' 124' ' ' GLN . 2.3 t-20 -78.16 113.73 16.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.28 -0.887 . . . . 0.0 110.405 -179.782 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.488 ' O ' ' HG2' ' A' ' 3' ' ' PRO . . . 146.22 73.98 0.02 OUTLIER Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 179.748 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.563 ' HA ' ' CG ' ' A' ' 3' ' ' PRO . 96.5 t -133.81 154.45 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.216 -1.167 . . . . 0.0 110.067 179.653 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.52 ' O ' HD13 ' A' ' 54' ' ' ILE . . . -128.73 105.19 8.09 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.218 -0.926 . . . . 0.0 110.501 -179.744 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.721 HD11 HD21 ' A' ' 146' ' ' LEU . 50.7 mm -131.78 166.45 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.318 -0.864 . . . . 0.0 109.74 179.58 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.526 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 0.2 OUTLIER -154.22 130.01 10.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.054 -1.029 . . . . 0.0 110.795 -179.726 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.526 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 11.0 pt-20 37.55 -156.5 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.773 -0.579 . . . . 0.0 110.915 179.525 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' A' ' 109' ' ' SER . . . -86.63 73.59 2.47 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.915 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.569 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.2 m -95.65 173.62 7.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.312 -1.11 . . . . 0.0 109.854 179.875 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.573 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 0.8 OUTLIER -89.63 155.9 18.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.205 -0.935 . . . . 0.0 110.391 -179.74 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.621 ' CE2' ' HB3' ' A' ' 108' ' ' ALA . 56.9 m-85 -160.41 -175.21 4.89 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.333 -0.854 . . . . 0.0 110.194 179.902 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 26.9 m -150.16 114.43 5.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.341 -0.85 . . . . 0.0 109.945 179.737 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.548 HD22 ' CD2' ' A' ' 89' ' ' LEU . 14.0 tp -89.53 119.69 30.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.208 -0.932 . . . . 0.0 110.065 -179.937 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.889 ' HD2' HG23 ' A' ' 103' ' ' THR . 0.0 OUTLIER -128.23 128.92 45.59 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.352 -0.842 . . . . 0.0 110.206 -179.8 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 1.073 ' CZ ' HG21 ' A' ' 102' ' ' VAL . 0.8 OUTLIER -172.61 144.38 1.43 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.22 -0.925 . . . . 0.0 109.849 179.731 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.542 HG23 ' CA ' ' A' ' 101' ' ' GLN . 4.6 m -119.22 92.93 3.92 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.225 -0.922 . . . . 0.0 109.957 -179.815 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.908 ' HB1' HD21 ' A' ' 95' ' ' LEU . . . -90.8 149.29 22.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.38 -0.825 . . . . 0.0 110.373 -179.747 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.644 HG23 ' O ' ' A' ' 98' ' ' GLU . 99.7 m -150.25 107.15 3.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.34 -0.85 . . . . 0.0 110.265 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -97.11 133.36 41.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.246 -0.909 . . . . 0.0 110.032 179.738 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.407 ' C ' ' O ' ' A' ' 68' ' ' ALA . 19.2 t -45.35 -26.18 0.5 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.131 -0.981 . . . . 0.0 109.234 179.557 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.561 HG22 ' HB2' ' A' ' 137' ' ' TRP . 2.1 t -112.43 171.15 7.69 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.592 -0.693 . . . . 0.0 109.858 179.723 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.507 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 49.0 t0 -86.58 61.13 6.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.106 -0.996 . . . . 0.0 109.115 178.937 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 1.047 HG23 ' HB2' ' A' ' 133' ' ' SER . 2.7 p -84.78 136.76 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.381 -0.824 . . . . 0.0 111.357 -178.912 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 19.9 m -125.78 86.91 2.6 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.711 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 1.115 HG21 ' CD2' ' A' ' 129' ' ' LEU . 3.0 m -90.5 -140.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.134 -0.979 . . . . 0.0 110.663 -178.73 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.793 ' N ' HG23 ' A' ' 74' ' ' VAL . 9.4 mtm180 -123.44 144.96 49.17 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.194 -0.941 . . . . 0.0 110.81 -179.633 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.541 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -150.34 148.49 28.88 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.388 -0.82 . . . . 0.0 109.365 179.421 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.862 HD11 ' HB3' ' A' ' 126' ' ' ALA . 1.3 pp 175.37 -159.39 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.123 -0.986 . . . . 0.0 110.674 -179.551 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.526 ' HB ' ' CG2' ' A' ' 88' ' ' VAL . 6.3 t -143.7 170.44 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.375 -0.828 . . . . 0.0 109.39 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.529 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . 176.02 -173.45 46.27 Favored Glycine 0 N--CA 1.491 2.325 0 C-N-CA 119.18 -1.486 . . . . 0.0 110.534 -179.92 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.537 ' HB3' ' HA ' ' A' ' 85' ' ' TYR . 31.5 tt0 -105.39 159.39 15.95 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.58 -0.953 . . . . 0.0 110.129 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.482 ' OD1' ' HG2' ' A' ' 124' ' ' GLN . 4.2 m120 -112.18 94.13 4.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.26 -0.9 . . . . 0.0 109.984 179.761 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.542 ' C ' ' CE1' ' A' ' 85' ' ' TYR . . . 120.3 131.83 4.19 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.815 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.596 ' N ' ' CE1' ' A' ' 85' ' ' TYR . . . -42.08 152.71 0.31 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.327 -1.102 . . . . 0.0 110.232 -179.903 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.455 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.6 Cg_endo -79.1 12.43 18.8 Favored 'Cis proline' 0 C--N 1.313 -1.332 0 C-N-CA 121.657 -2.226 . . . . 0.0 111.017 -0.021 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.596 ' CE1' ' N ' ' A' ' 83' ' ' ALA . 37.9 m-85 60.85 170.54 0.1 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.099 -1.0 . . . . 0.0 110.273 -179.81 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.421 ' O ' ' HA2' ' A' ' 79' ' ' GLY . . . 176.63 108.28 0.22 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.491 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 2.5 p -98.17 147.83 24.2 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.214 -1.168 . . . . 0.0 110.346 -179.934 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.794 HG12 ' N ' ' A' ' 109' ' ' SER . 7.8 m -122.64 -22.82 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.329 -0.857 . . . . 0.0 110.168 179.874 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.573 HD11 ' CZ ' ' A' ' 106' ' ' PHE . 4.5 mp -115.51 143.74 44.87 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.288 -0.882 . . . . 0.0 110.74 179.94 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.452 ' O ' HG23 ' A' ' 91' ' ' THR . 30.9 m-20 -151.08 79.24 1.31 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.329 -0.857 . . . . 0.0 110.187 179.56 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 90' ' ' ASP . 1.9 p -151.59 -173.56 4.55 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.007 -1.058 . . . . 0.0 110.544 -179.865 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.98 134.18 23.97 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.361 -0.837 . . . . 0.0 110.037 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.695 ' HG2' HG22 ' A' ' 74' ' ' VAL . 50.0 Cg_endo -75.14 75.83 3.64 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.962 1.506 . . . . 0.0 110.808 -179.697 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.531 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -49.55 134.66 19.34 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.971 -1.081 . . . . 0.0 109.265 179.416 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.908 HD21 ' HB1' ' A' ' 66' ' ' ALA . 34.6 mt -131.91 164.65 25.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.032 -1.042 . . . . 0.0 110.819 -179.396 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -165.35 -178.71 5.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.488 -0.758 . . . . 0.0 109.933 179.864 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.8 p -67.58 -22.21 65.39 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.224 -0.923 . . . . 0.0 110.257 -179.981 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.644 ' O ' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -93.28 170.56 8.5 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.216 -0.927 . . . . 0.0 110.116 179.906 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.497 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 45.8 Cg_endo -72.34 132.38 19.18 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.993 1.523 . . . . 0.0 110.39 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.531 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -119.83 92.61 3.82 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.206 -0.934 . . . . 0.0 110.36 -179.967 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.542 ' CA ' HG23 ' A' ' 65' ' ' THR . 0.1 OUTLIER -75.75 152.37 37.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.392 -0.817 . . . . 0.0 110.083 179.962 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 1.073 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 91.6 t -132.04 133.19 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.22 -0.925 . . . . 0.0 110.246 179.942 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.889 HG23 ' HD2' ' A' ' 63' ' ' ARG . 0.2 OUTLIER -150.38 116.77 5.73 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.317 -0.864 . . . . 0.0 110.158 -179.962 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.523 ' CG ' ' O ' ' A' ' 103' ' ' THR . 23.7 mt-10 -160.33 129.97 5.15 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.16 -0.963 . . . . 0.0 110.348 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.511 HG23 ' O ' ' A' ' 60' ' ' TYR . 47.5 m -89.91 107.47 19.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.21 -0.931 . . . . 0.0 110.108 179.766 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.573 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 36.7 p90 -110.2 155.9 21.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.242 -0.911 . . . . 0.0 110.4 -179.78 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.551 HG22 ' O ' ' A' ' 107' ' ' THR . 5.2 m -90.01 89.07 7.54 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.287 -0.883 . . . . 0.0 109.953 179.735 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.621 ' HB3' ' CE2' ' A' ' 60' ' ' TYR . . . -42.71 98.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.28 -0.888 . . . . 0.0 110.278 -179.747 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.794 ' N ' HG12 ' A' ' 88' ' ' VAL . 14.2 p -87.22 53.99 3.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.239 -0.913 . . . . 0.0 110.088 179.883 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.447 ' CB ' HG13 ' A' ' 88' ' ' VAL . . . -154.19 -155.33 0.58 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.261 -0.899 . . . . 0.0 110.333 -179.943 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.52 HG23 ' HA ' ' A' ' 55' ' ' GLU . 27.5 m -159.52 110.58 2.0 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.895 . . . . 0.0 110.531 -179.9 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.633 ' CD2' ' CG1' ' A' ' 54' ' ' ILE . 5.8 m-30 -113.71 94.73 34.16 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.298 -0.877 . . . . 0.0 109.66 179.401 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.493 ' HD2' ' HA ' ' A' ' 122' ' ' GLU . 51.3 Cg_endo -80.66 33.04 0.51 Allowed 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.825 1.434 . . . . 0.0 111.717 -179.697 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 113' ' ' PRO . . . . . . . . 0 N--CA 1.498 1.953 0 O-C-N 121.606 -0.684 . . . . 0.0 111.156 179.432 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.535 ' HG2' ' N ' ' A' ' 123' ' ' GLY . 23.9 pm0 . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 120.994 0.426 . . . . 0.0 109.923 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.584 ' HA3' ' CG ' ' A' ' 112' ' ' TYR . . . -168.57 143.29 7.99 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.758 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.542 ' HA ' ' CG2' ' A' ' 52' ' ' VAL . 1.7 pt20 -150.56 -159.5 1.04 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.336 -1.096 . . . . 0.0 110.248 -179.808 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.944 HG21 ' CH2' ' A' ' 16' ' ' TRP . 10.4 mt -118.32 146.35 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.45 -0.781 . . . . 0.0 109.114 179.246 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.862 ' HB3' HD11 ' A' ' 77' ' ' LEU . . . -121.98 120.5 34.58 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.281 -0.887 . . . . 0.0 111.144 -179.302 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.51 ' CE1' ' HB1' ' A' ' 76' ' ' ALA . 3.4 m-30 -116.79 97.98 6.27 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 178.266 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.574 ' O ' ' CE2' ' A' ' 132' ' ' PHE . 2.3 mm-40 -88.37 92.56 9.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.332 -0.855 . . . . 0.0 112.702 -176.783 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 1.115 ' CD2' HG21 ' A' ' 74' ' ' VAL . 5.2 mt -99.61 42.65 1.09 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.447 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.54 ' CA ' ' HA2' ' A' ' 44' ' ' GLY . . . -97.56 125.7 8.6 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 110.509 -1.037 . . . . 0.0 110.509 -178.775 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 39' ' ' GLY . . . 39.79 64.03 1.13 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 179.304 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.597 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 9.2 m-85 -117.98 -61.65 1.65 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.048 -1.266 . . . . 0.0 110.75 179.813 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 1.047 ' HB2' HG23 ' A' ' 72' ' ' VAL . 1.3 t -88.4 178.78 6.47 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.043 -1.036 . . . . 0.0 110.376 -179.661 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -86.71 -89.05 0.12 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.338 -0.851 . . . . 0.0 110.278 -179.763 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -63.61 179.99 0.42 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.246 -0.909 . . . . 0.0 110.078 179.903 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.528 ' N ' ' HA ' ' A' ' 38' ' ' ALA . . . -77.16 136.18 38.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.282 -0.886 . . . . 0.0 110.47 -179.656 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 1.025 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 8.4 p90 -135.56 -156.09 0.69 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.372 -0.83 . . . . 0.0 109.756 179.38 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.529 ' O ' ' CB ' ' A' ' 68' ' ' ALA . 0.6 OUTLIER -160.34 172.2 17.75 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.875 -1.13 . . . . 0.0 111.039 -178.548 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.901 HD13 HD13 ' A' ' 129' ' ' LEU . 2.3 mp -132.23 127.99 36.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.498 -0.751 . . . . 0.0 109.253 179.272 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 140' ' ' CYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 4.9 m -123.96 96.51 4.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.067 -1.021 . . . . 0.0 111.134 -179.35 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.5 ' HA ' ' O ' ' A' ' 65' ' ' THR . 0.9 OUTLIER -89.74 -176.14 4.87 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.267 -0.895 . . . . 0.0 108.88 178.774 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.549 ' HB3' ' CB ' ' A' ' 31' ' ' ALA . 0.5 OUTLIER 170.6 43.96 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.929 -1.107 . . . . 0.0 111.003 179.98 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.504 ' HB2' ' O ' ' A' ' 142' ' ' ASP . 11.3 t70 174.01 61.47 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.36 -0.838 . . . . 0.0 109.505 179.63 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.807 HG11 ' CZ2' ' A' ' 16' ' ' TRP . 1.1 t -95.17 114.68 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.096 -1.003 . . . . 0.0 110.308 -179.399 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.68 ' HB2' ' CG ' ' A' ' 6' ' ' GLU . . . -138.27 145.29 41.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.339 -0.851 . . . . 0.0 110.229 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.721 HD21 HD11 ' A' ' 54' ' ' ILE . 6.7 tp -153.47 129.57 10.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.238 -0.914 . . . . 0.0 110.219 179.969 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.496 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 1.5 t0 -160.04 155.06 24.68 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.24 -0.912 . . . . 0.0 110.267 179.963 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.446 ' HA ' ' O ' ' A' ' 59' ' ' THR . 1.7 t . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.258 -0.901 . . . . 0.0 110.248 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.226 0.536 . . . . 0.0 110.184 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 p -116.63 133.24 23.05 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.254 -0.903 . . . . 0.0 110.244 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -76.41 -156.45 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.938 1.494 . . . . 0.0 110.068 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 1.006 HD11 ' O ' ' A' ' 144' ' ' VAL . 9.4 pt -93.64 -22.93 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.241 -0.912 . . . . 0.0 110.165 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 123.11 119.3 2.5 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -57.46 94.58 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.246 -1.149 . . . . 0.0 110.03 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.481 ' HA2' ' HA ' ' A' ' 143' ' ' ASP . . . 100.03 78.74 1.39 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.426 ' O ' ' HB2' ' A' ' 9' ' ' PHE . 7.2 p -95.12 -170.53 2.21 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.286 -1.126 . . . . 0.0 110.336 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.592 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 5.5 m-30 58.62 14.52 3.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.396 -0.815 . . . . 0.0 110.322 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.562 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 26.8 p-10 -88.86 23.88 2.21 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.178 -0.951 . . . . 0.0 109.967 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.562 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.6 OUTLIER 161.36 -24.24 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.422 0.629 . . . . 0.0 109.444 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -158.51 153.56 24.7 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.703 ' HB3' HD12 ' A' ' 32' ' ' LEU . 45.6 Cg_endo -72.37 -3.13 12.81 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.96 1.505 . . . . 0.0 110.458 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 0.3 OUTLIER 60.13 -88.62 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.28 -0.887 . . . . 0.0 110.353 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.436 ' O ' ' C ' ' A' ' 16' ' ' TRP . . . -132.14 -21.33 0.97 Allowed Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.886 -1.15 . . . . 0.0 110.381 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.969 ' CE2' HD22 ' A' ' 49' ' ' LEU . 56.1 m95 -41.51 121.87 1.79 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.09 -1.241 . . . . 0.0 110.565 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.73 ' O ' HG13 ' A' ' 47' ' ' VAL . 1.2 m -115.5 150.82 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.276 -0.89 . . . . 0.0 109.611 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.893 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . . . -130.21 123.0 29.18 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.061 -1.025 . . . . 0.0 109.818 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.777 ' HE2' HG13 ' A' ' 48' ' ' VAL . 23.4 p90 -108.68 157.26 18.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.51 -0.744 . . . . 0.0 110.486 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.648 ' O ' HG13 ' A' ' 45' ' ' VAL . . . 78.81 29.37 52.09 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.716 HG22 HG11 ' A' ' 45' ' ' VAL . 24.0 p -136.29 -160.96 1.11 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.219 -1.165 . . . . 0.0 110.466 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.455 ' O ' ' O ' ' A' ' 23' ' ' GLY . 15.0 t0 -99.46 131.96 45.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.368 -0.832 . . . . 0.0 110.318 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 22' ' ' ASP . . . 43.46 -166.18 0.02 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.3 -159.58 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.039 1.547 . . . . 0.0 110.46 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.893 ' CD2' ' HB3' ' A' ' 18' ' ' ALA . 7.9 mt -87.41 160.36 18.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.221 -0.925 . . . . 0.0 110.184 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -126.66 122.88 36.22 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.26 -0.9 . . . . 0.0 110.174 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.629 HG22 ' HA ' ' A' ' 32' ' ' LEU . 2.2 p -119.51 -84.39 0.66 Allowed 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.373 -0.829 . . . . 0.0 109.801 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.461 ' O ' ' HB ' ' A' ' 29' ' ' THR . 36.5 m 37.09 55.84 1.27 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.644 -0.66 . . . . 0.0 110.972 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.461 ' HB ' ' O ' ' A' ' 28' ' ' SER . 13.0 t -177.56 -32.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.115 -0.99 . . . . 0.0 110.411 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 9' ' ' PHE . . . 121.46 13.64 5.16 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -150.15 123.05 8.73 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -1.159 . . . . 0.0 110.14 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.703 HD12 ' HB3' ' A' ' 13' ' ' PRO . 0.9 OUTLIER -62.25 103.85 0.43 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -0.922 . . . . 0.0 109.841 179.788 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.51 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 36.6 m -107.99 103.5 12.74 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.14 -0.975 . . . . 0.0 110.864 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.77 HG12 HD22 ' A' ' 25' ' ' LEU . 17.5 m -89.87 141.74 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.234 -0.916 . . . . 0.0 109.218 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.487 ' HA ' ' OG1' ' A' ' 138' ' ' THR . . . -89.63 106.05 18.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.158 -0.964 . . . . 0.0 111.137 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.045 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 94.2 t -84.48 121.22 74.98 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.235 -0.916 . . . . 0.0 109.191 178.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 21' ' ' THR . 46.9 Cg_endo -74.71 137.27 22.2 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.937 1.493 . . . . 0.0 111.043 -178.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.932 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -45.52 170.59 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.337 -0.852 . . . . 0.0 109.766 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 45.86 48.33 13.66 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.825 ' OG ' HG21 ' A' ' 45' ' ' VAL . 0.6 OUTLIER -86.97 36.12 0.71 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.27 -1.136 . . . . 0.0 109.886 179.675 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.531 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . -89.08 -141.16 0.14 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.643 -0.661 . . . . 0.0 109.859 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.55 ' HG2' ' N ' ' A' ' 43' ' ' TYR . 14.7 pm0 39.88 -140.16 0.07 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.692 -0.63 . . . . 0.0 110.247 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.659 ' OH ' HG22 ' A' ' 45' ' ' VAL . 5.3 p90 -27.59 -42.55 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.236 0 CA-C-O 121.278 0.561 . . . . 0.0 110.612 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.601 ' O ' ' CD1' ' A' ' 43' ' ' TYR . . . 88.48 136.42 5.5 Favored Glycine 0 N--CA 1.492 2.39 0 C-N-CA 120.257 -0.973 . . . . 0.0 110.998 177.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.825 HG21 ' OG ' ' A' ' 40' ' ' SER . 2.3 t -88.95 -177.2 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.426 -1.043 . . . . 0.0 108.489 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.52 ' H ' HG12 ' A' ' 45' ' ' VAL . . . 167.67 175.88 37.88 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 118.819 -1.658 . . . . 0.0 110.838 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.73 HG13 ' O ' ' A' ' 17' ' ' VAL . 23.9 t -139.45 132.1 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.717 -0.872 . . . . 0.0 109.552 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.777 HG13 ' HE2' ' A' ' 19' ' ' TYR . 17.3 m -124.63 141.28 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.967 -1.083 . . . . 0.0 110.856 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.969 HD22 ' CE2' ' A' ' 16' ' ' TRP . 10.3 tp -128.23 100.6 5.9 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.374 -0.829 . . . . 0.0 110.131 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.516 ' ND2' ' HB3' ' A' ' 124' ' ' GLN . 0.1 OUTLIER -78.22 136.02 37.71 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.261 -0.9 . . . . 0.0 110.259 179.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 126.02 72.19 0.2 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.524 HG12 HG12 ' A' ' 54' ' ' ILE . 3.5 t -126.28 161.7 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.221 -1.164 . . . . 0.0 109.97 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -122.53 77.42 1.42 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.2 -0.938 . . . . 0.0 110.373 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.605 HG13 ' CD2' ' A' ' 112' ' ' TYR . 41.2 mm -119.13 151.08 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.248 -0.908 . . . . 0.0 110.07 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.664 ' HA ' HG23 ' A' ' 111' ' ' THR . 1.6 pt-20 -150.22 133.19 16.1 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.182 -0.949 . . . . 0.0 110.461 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.524 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 11.7 pt-20 38.28 -153.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.69 -0.631 . . . . 0.0 110.842 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' A' ' 109' ' ' SER . . . -86.56 86.12 1.55 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.556 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.3 m -110.65 171.04 7.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.177 -1.19 . . . . 0.0 109.864 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.583 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 1.6 m -89.88 155.59 19.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 0.0 110.154 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.605 ' HB3' HD11 ' A' ' 146' ' ' LEU . 56.3 m-85 -159.91 177.04 11.19 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.355 -0.84 . . . . 0.0 110.132 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 62.8 m -149.91 112.22 4.68 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.312 -0.867 . . . . 0.0 110.126 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.6 tp -89.84 124.49 34.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.243 -0.911 . . . . 0.0 110.095 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.495 ' HA ' ' O ' ' A' ' 102' ' ' VAL . 10.3 mtt180 -131.47 107.45 8.9 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.194 -0.941 . . . . 0.0 110.427 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.997 ' CZ ' HG21 ' A' ' 102' ' ' VAL . 4.6 p90 -147.07 151.61 37.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.288 -0.882 . . . . 0.0 110.125 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.879 HG23 ' CA ' ' A' ' 101' ' ' GLN . 0.2 OUTLIER -119.78 92.45 3.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.184 -0.948 . . . . 0.0 109.936 179.86 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.793 ' HB1' HD21 ' A' ' 95' ' ' LEU . . . -89.59 144.85 25.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 110.507 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.601 HG23 ' O ' ' A' ' 98' ' ' GLU . 99.9 m -150.33 116.74 5.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.403 -0.811 . . . . 0.0 110.215 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -103.24 138.73 39.64 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.23 -0.919 . . . . 0.0 110.028 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.1 p -47.65 -24.29 0.88 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.149 -0.969 . . . . 0.0 109.431 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.692 HG22 ' HB2' ' A' ' 137' ' ' TRP . 3.6 t -115.38 171.78 7.49 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.496 -0.752 . . . . 0.0 109.979 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.507 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 1.0 OUTLIER -86.16 69.69 10.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.158 -0.963 . . . . 0.0 109.445 179.192 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.605 HG23 ' CB ' ' A' ' 133' ' ' SER . 5.1 p -96.2 138.94 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.279 -0.888 . . . . 0.0 111.117 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 97.1 m -120.86 89.47 3.14 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.436 -0.79 . . . . 0.0 108.921 178.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.594 ' HA ' ' CD1' ' A' ' 132' ' ' PHE . 10.7 m -89.64 -147.88 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.22 -0.925 . . . . 0.0 110.587 -179.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.542 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 4.2 mtp180 -128.98 144.37 51.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 0.0 110.697 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.855 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -142.91 150.83 40.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.286 -0.884 . . . . 0.0 109.818 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.858 HD11 ' HB3' ' A' ' 126' ' ' ALA . 2.7 pp 177.58 -159.59 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.237 -0.914 . . . . 0.0 110.479 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.903 HG23 HD22 ' A' ' 89' ' ' LEU . 6.1 t -149.36 168.64 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.396 -0.815 . . . . 0.0 109.335 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.489 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . -177.6 -178.94 47.57 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.265 -1.445 . . . . 0.0 110.088 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.489 ' OE1' ' HD2' ' A' ' 113' ' ' PRO . 14.5 tp60 -107.93 138.12 44.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.415 -1.05 . . . . 0.0 110.302 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.541 ' ND2' ' NE2' ' A' ' 124' ' ' GLN . 1.2 m-80 -123.94 97.31 5.3 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.639 ' CA ' ' HD2' ' A' ' 121' ' ' PRO . . . 132.23 33.71 0.4 Allowed Glycine 0 N--CA 1.484 1.866 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 82' ' ' GLY . . . 60.41 143.58 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.191 -1.182 . . . . 0.0 110.124 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.457 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.9 Cg_endo -82.67 18.96 17.96 Favored 'Cis proline' 0 C--N 1.314 -1.261 0 C-N-CA 121.872 -2.136 . . . . 0.0 110.807 -0.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.545 ' CD2' ' HA ' ' A' ' 83' ' ' ALA . 89.3 m-85 57.53 -179.95 0.06 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.136 -0.978 . . . . 0.0 110.203 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 127.96 113.57 1.76 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.514 HG22 ' O ' ' A' ' 78' ' ' VAL . 0.8 OUTLIER -97.51 145.89 25.78 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.283 -1.128 . . . . 0.0 110.034 179.779 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 1.028 HG23 HD12 ' A' ' 89' ' ' LEU . 35.9 m -123.73 -17.98 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.193 -0.942 . . . . 0.0 110.384 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 1.028 HD12 HG23 ' A' ' 88' ' ' VAL . 3.9 mp -103.38 135.27 45.31 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.205 -0.934 . . . . 0.0 111.046 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -150.97 83.55 1.33 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.451 -0.781 . . . . 0.0 109.951 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.5 p -137.9 -179.62 5.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.035 -1.041 . . . . 0.0 110.772 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.404 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 1.7 m -119.71 110.83 36.56 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.403 -0.811 . . . . 0.0 110.063 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.855 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 44.3 Cg_endo -71.58 94.0 0.68 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.04 1.548 . . . . 0.0 110.813 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.794 ' HB3' ' HD2' ' A' ' 100' ' ' ARG . . . -71.75 151.86 43.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.234 -0.916 . . . . 0.0 109.625 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.793 HD21 ' HB1' ' A' ' 66' ' ' ALA . 97.6 mt -143.77 162.82 35.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.05 -1.031 . . . . 0.0 110.493 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 70' ' ' THR . 0.3 OUTLIER 179.75 -179.08 0.43 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.39 -0.818 . . . . 0.0 110.018 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.95 -24.5 64.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.256 -0.902 . . . . 0.0 110.07 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.601 ' O ' HG23 ' A' ' 67' ' ' THR . 1.5 mt-10 -89.92 164.48 28.31 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.281 -0.887 . . . . 0.0 110.06 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.482 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 46.1 Cg_endo -73.0 136.77 25.43 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.008 1.53 . . . . 0.0 110.366 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.794 ' HD2' ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.6 80.42 1.57 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.17 -0.956 . . . . 0.0 110.188 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.879 ' CA ' HG23 ' A' ' 65' ' ' THR . 16.3 tt0 -68.73 154.73 41.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.299 -0.876 . . . . 0.0 110.195 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.997 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 95.6 t -135.5 135.52 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.284 -0.885 . . . . 0.0 110.135 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.06 111.0 4.33 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.26 -0.9 . . . . 0.0 110.19 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -158.25 134.74 9.52 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.164 -0.96 . . . . 0.0 110.361 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.667 HG23 ' O ' ' A' ' 105' ' ' THR . 10.1 t -95.77 113.73 25.39 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.245 -0.909 . . . . 0.0 110.091 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.967 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 30.6 p90 -111.72 154.79 24.48 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.909 . . . . 0.0 110.286 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.476 HG22 ' O ' ' A' ' 107' ' ' THR . 6.6 m -91.7 91.87 8.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.286 -0.884 . . . . 0.0 110.044 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.593 ' HB1' ' CG2' ' A' ' 54' ' ' ILE . . . -48.54 96.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.235 -0.915 . . . . 0.0 110.303 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.521 ' N ' ' CG1' ' A' ' 88' ' ' VAL . 16.1 p -85.99 49.96 1.88 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.256 -0.902 . . . . 0.0 110.124 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -156.23 -154.43 0.48 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.297 -0.877 . . . . 0.0 110.136 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.664 HG23 ' HA ' ' A' ' 55' ' ' GLU . 14.2 m -152.4 112.5 4.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.209 -0.932 . . . . 0.0 110.304 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.605 ' CD2' HG13 ' A' ' 54' ' ' ILE . 13.5 m-30 -107.03 93.16 8.65 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.277 -0.889 . . . . 0.0 109.9 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.489 ' HD2' ' OE1' ' A' ' 80' ' ' GLN . 45.3 Cg_endo -72.26 179.61 4.85 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.942 1.496 . . . . 0.0 110.41 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -129.62 63.62 1.51 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.245 -0.909 . . . . 0.0 110.206 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.571 ' O ' HG23 ' A' ' 115' ' ' THR . 2.8 t -121.93 100.48 43.13 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.279 -0.888 . . . . 0.0 110.155 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.92 81.7 1.62 Allowed 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.036 1.545 . . . . 0.0 110.449 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.987 ' HB3' ' HB2' ' A' ' 120' ' ' ASP . . . -122.7 166.51 14.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.27 -0.894 . . . . 0.0 110.213 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.47 -63.49 1.21 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.238 -0.914 . . . . 0.0 110.205 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -87.65 26.9 1.2 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.275 -0.891 . . . . 0.0 110.326 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.987 ' HB2' ' HB3' ' A' ' 117' ' ' ALA . 1.4 m-20 -150.04 72.52 9.44 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.177 -0.952 . . . . 0.0 110.255 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.639 ' HD2' ' CA ' ' A' ' 82' ' ' GLY . 44.5 Cg_endo -76.14 17.95 0.69 Allowed 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 124.032 1.543 . . . . 0.0 112.598 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.525 ' O ' ' O ' ' A' ' 121' ' ' PRO . 2.2 pm0 40.5 -173.31 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 CA-C-O 121.515 0.674 . . . . 0.0 111.794 178.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -100.99 155.56 19.22 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.976 -1.249 . . . . 0.0 109.976 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.541 ' NE2' ' ND2' ' A' ' 81' ' ' ASN . 1.4 pt20 -150.55 -149.9 0.32 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.398 -1.06 . . . . 0.0 110.395 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.739 HG21 ' CH2' ' A' ' 16' ' ' TRP . 9.6 mt -118.37 138.62 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.588 -0.695 . . . . 0.0 109.136 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.858 ' HB3' HD11 ' A' ' 77' ' ' LEU . . . -115.42 122.24 45.21 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.205 -0.934 . . . . 0.0 111.169 -179.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.477 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 4.6 m-85 -119.15 109.05 15.42 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 178.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.485 ' O ' ' HB ' ' A' ' 74' ' ' VAL . 2.0 mt-30 -88.85 91.84 8.98 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.105 -0.997 . . . . 0.0 111.141 -178.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.958 HD13 HD13 ' A' ' 139' ' ' LEU . 15.5 mt -93.23 41.89 1.09 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.451 -0.78 . . . . 0.0 109.286 178.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.548 ' HA3' ' CA ' ' A' ' 44' ' ' GLY . . . -130.49 140.16 11.53 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.475 ' O ' ' CG ' ' A' ' 132' ' ' PHE . . . 71.4 61.7 3.79 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.594 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 38.4 m-85 -154.67 -78.32 0.1 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.243 -1.151 . . . . 0.0 110.182 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.605 ' CB ' HG23 ' A' ' 72' ' ' VAL . 1.3 t -89.67 119.57 30.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.123 -0.986 . . . . 0.0 110.116 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.401 ' O ' ' O ' ' A' ' 135' ' ' ASP . . . -62.44 -71.67 0.15 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.228 -0.92 . . . . 0.0 110.274 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.401 ' O ' ' O ' ' A' ' 134' ' ' ALA . 0.8 OUTLIER -53.82 -173.29 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.292 -0.88 . . . . 0.0 110.343 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.932 ' HB2' ' HB2' ' A' ' 38' ' ' ALA . . . -83.51 141.08 31.89 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.269 -0.894 . . . . 0.0 110.302 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 1.045 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 7.3 p90 -151.5 -164.19 1.93 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.323 -0.861 . . . . 0.0 109.964 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.527 ' O ' ' CB ' ' A' ' 68' ' ' ALA . 0.5 OUTLIER -160.4 173.47 15.57 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.0 -1.08 . . . . 0.0 111.106 -178.493 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.958 HD13 HD13 ' A' ' 129' ' ' LEU . 2.6 mp -129.64 129.37 44.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.447 -0.783 . . . . 0.0 109.576 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' CYS . . . . . . . . . . . . . 6.6 m -124.37 93.26 3.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.129 -0.982 . . . . 0.0 110.938 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.644 HD23 ' HB2' ' A' ' 66' ' ' ALA . 0.7 OUTLIER -89.86 -175.42 4.61 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.179 -0.951 . . . . 0.0 109.414 179.147 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.513 ' O ' ' CB ' ' A' ' 143' ' ' ASP . 1.1 p30 176.76 124.27 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.054 -1.029 . . . . 0.0 110.842 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.513 ' CB ' ' O ' ' A' ' 142' ' ' ASP . 0.3 OUTLIER 70.94 61.29 0.18 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.288 -0.882 . . . . 0.0 110.654 179.479 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 1.006 ' O ' HD11 ' A' ' 4' ' ' ILE . 42.0 t -94.46 111.4 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -0.914 . . . . 0.0 109.73 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -120.46 163.56 17.74 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.233 -0.917 . . . . 0.0 110.47 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.605 HD11 ' HB3' ' A' ' 60' ' ' TYR . 14.0 tp -167.3 88.18 0.29 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.409 -0.807 . . . . 0.0 110.085 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.495 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 7.6 t70 -123.37 165.17 17.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.269 -0.895 . . . . 0.0 110.289 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.513 ' HB3' ' CE1' ' A' ' 60' ' ' TYR . 12.7 p -95.43 119.9 34.73 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 0.0 110.317 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.46 ' HB3' ' O ' ' A' ' 148' ' ' SER . 2.4 tp10 58.44 118.91 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.321 -0.862 . . . . 0.0 110.331 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 9.4 p -149.03 166.16 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.262 -0.899 . . . . 0.0 110.127 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -48.41 165.95 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.26 -0.9 . . . . 0.0 110.225 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.3 pp . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.197 -179.983 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.836 ' HB3' ' HB1' ' A' ' 53' ' ' ALA . . . . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.266 0.555 . . . . 0.0 110.227 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.409 ' N ' ' HD3' ' A' ' 3' ' ' PRO . 0.4 OUTLIER 55.21 59.26 10.4 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.267 -0.896 . . . . 0.0 110.217 -179.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.409 ' HD3' ' N ' ' A' ' 2' ' ' SER . 49.4 Cg_endo -75.78 -156.44 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.991 1.522 . . . . 0.0 110.123 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.627 HG22 ' O ' ' A' ' 51' ' ' GLY . 13.1 pt -95.98 31.16 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.234 -0.916 . . . . 0.0 110.251 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 91.58 -29.32 7.38 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.723 ' OE1' ' HB1' ' A' ' 145' ' ' ALA . 3.9 mt-10 51.67 66.98 1.04 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.252 -1.146 . . . . 0.0 110.24 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 143' ' ' ASP . . . -148.36 -179.99 24.75 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.862 HG22 ' HB2' ' A' ' 143' ' ' ASP . 0.8 OUTLIER -98.31 51.64 1.02 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.201 -1.176 . . . . 0.0 110.151 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.559 ' CE2' ' CG2' ' A' ' 144' ' ' VAL . 69.3 m-85 43.16 36.31 0.97 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.274 -0.891 . . . . 0.0 110.095 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.556 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 5.1 p30 -84.68 44.48 1.06 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.316 -0.865 . . . . 0.0 110.299 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.556 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 2.4 t70 161.58 78.42 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.336 0.589 . . . . 0.0 109.433 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.66 159.58 7.0 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.894 ' HB3' HD12 ' A' ' 32' ' ' LEU . 50.0 Cg_endo -75.75 4.71 4.89 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.016 1.535 . . . . 0.0 110.713 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 2.8 mm-40 65.12 -89.01 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.259 -0.901 . . . . 0.0 110.516 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.592 ' C ' HD12 ' A' ' 49' ' ' LEU . . . -139.63 6.99 3.01 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.95 ' CE2' HD22 ' A' ' 49' ' ' LEU . 46.0 m95 -69.52 126.0 28.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.108 -1.23 . . . . 0.0 110.179 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.719 ' HA ' HD11 ' A' ' 25' ' ' LEU . 0.9 OUTLIER -126.9 148.6 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.206 -0.934 . . . . 0.0 109.669 179.806 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.626 ' CB ' HD21 ' A' ' 25' ' ' LEU . . . -130.32 142.16 50.55 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.101 -0.999 . . . . 0.0 109.648 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.558 ' HE1' HG13 ' A' ' 48' ' ' VAL . 23.2 p90 -131.71 164.01 26.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.292 -0.88 . . . . 0.0 110.766 -178.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.483 ' HA2' ' OH ' ' A' ' 43' ' ' TYR . . . 77.19 40.21 24.96 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.553 HG22 ' CG1' ' A' ' 45' ' ' VAL . 7.9 p -149.88 -143.79 0.14 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.129 -1.218 . . . . 0.0 110.489 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.465 ' O ' ' O ' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -117.29 129.94 56.22 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.244 -0.91 . . . . 0.0 110.355 -179.792 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 22' ' ' ASP . . . 52.21 174.48 0.03 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.38 -159.54 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.064 1.56 . . . . 0.0 110.518 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.983 ' CD2' HG12 ' A' ' 34' ' ' VAL . 24.4 mt -78.27 178.52 7.58 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.272 -0.893 . . . . 0.0 110.331 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -145.46 115.0 7.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.318 -0.864 . . . . 0.0 110.102 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.479 ' O ' ' N ' ' A' ' 29' ' ' THR . 1.1 p -119.65 -83.59 0.65 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.308 -0.87 . . . . 0.0 109.921 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 27' ' ' THR . 5.4 p 39.2 28.36 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.498 -0.751 . . . . 0.0 110.637 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.479 ' N ' ' O ' ' A' ' 27' ' ' THR . 8.5 t -153.43 -37.0 0.1 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.149 -0.969 . . . . 0.0 110.385 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.493 ' O ' ' HB2' ' A' ' 9' ' ' PHE . . . 133.97 -2.29 4.36 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.598 ' HB1' ' O ' ' A' ' 141' ' ' LEU . . . -133.15 143.97 49.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.138 -1.213 . . . . 0.0 110.125 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.894 HD12 ' HB3' ' A' ' 13' ' ' PRO . 0.6 OUTLIER -83.96 112.31 20.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.24 -0.912 . . . . 0.0 110.055 179.87 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.51 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 34.1 m -114.86 116.55 28.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 110.554 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.983 HG12 ' CD2' ' A' ' 25' ' ' LEU . 33.2 m -101.1 144.63 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.324 -0.86 . . . . 0.0 109.812 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.532 ' HA ' ' OG1' ' A' ' 138' ' ' THR . . . -93.05 94.02 8.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.189 -0.944 . . . . 0.0 110.547 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.087 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 41.9 t -86.23 132.49 43.14 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.377 -0.827 . . . . 0.0 110.099 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.415 ' C ' ' HA ' ' A' ' 136' ' ' ALA . 40.0 Cg_endo -66.85 168.95 15.71 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.809 1.426 . . . . 0.0 110.586 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.499 ' O ' ' O ' ' A' ' 39' ' ' GLY . . . -62.01 121.04 12.02 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.305 -0.872 . . . . 0.0 110.912 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.553 ' O ' ' N ' ' A' ' 41' ' ' ALA . . . 41.6 96.03 0.01 OUTLIER Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.666 ' HB2' HG23 ' A' ' 45' ' ' VAL . 0.4 OUTLIER -42.12 93.75 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.428 -1.043 . . . . 0.0 109.786 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' A' ' 39' ' ' GLY . . . -89.38 28.91 1.17 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.695 0.759 . . . . 0.0 110.565 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -128.92 -166.95 1.71 Allowed 'General case' 0 C--N 1.292 -1.904 0 O-C-N 121.773 -0.579 . . . . 0.0 109.779 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.483 ' OH ' ' HA2' ' A' ' 20' ' ' GLY . 11.1 p90 -46.54 -24.13 0.48 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.16 -0.962 . . . . 0.0 109.797 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.473 ' O ' ' CD1' ' A' ' 43' ' ' TYR . . . 126.45 140.58 5.29 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.666 HG23 ' HB2' ' A' ' 40' ' ' SER . 19.9 t -89.39 173.65 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.124 -1.221 . . . . 0.0 109.205 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.562 ' HA2' ' HA ' ' A' ' 128' ' ' GLN . . . -178.22 -179.42 48.19 Favored Glycine 0 N--CA 1.487 2.098 0 C-N-CA 118.92 -1.61 . . . . 0.0 110.851 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.701 HG13 ' O ' ' A' ' 17' ' ' VAL . 21.4 t -150.39 128.48 2.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.594 ' CG2' HG22 ' A' ' 17' ' ' VAL . 30.5 m -119.38 132.68 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.018 -1.051 . . . . 0.0 111.106 -178.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 1.065 HD23 HD12 ' A' ' 125' ' ' ILE . 13.8 tp -124.22 91.27 3.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.559 -0.713 . . . . 0.0 110.01 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.44 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 0.1 OUTLIER -66.86 113.88 5.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 110.209 -179.908 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.627 ' O ' HG22 ' A' ' 4' ' ' ILE . . . 154.14 83.04 0.04 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.579 HG11 ' HD2' ' A' ' 112' ' ' TYR . 38.8 t -140.53 160.43 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.197 -1.178 . . . . 0.0 110.207 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.836 ' HB1' ' HB3' ' A' ' 1' ' ' ALA . . . -129.85 90.78 3.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.203 -0.936 . . . . 0.0 110.396 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.743 HD11 HD21 ' A' ' 146' ' ' LEU . 33.5 mm -124.01 168.7 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.261 -0.899 . . . . 0.0 109.931 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.574 ' HA ' HG23 ' A' ' 111' ' ' THR . 1.7 tt0 -162.71 127.72 3.2 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.122 -0.986 . . . . 0.0 110.653 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.522 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 13.1 pt-20 37.74 -152.89 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.635 -0.666 . . . . 0.0 110.984 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 108' ' ' ALA . . . -86.76 79.57 1.81 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.625 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.2 m -108.85 173.71 6.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.253 -1.145 . . . . 0.0 109.804 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.574 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 0.4 OUTLIER -89.8 156.23 18.64 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.287 -0.883 . . . . 0.0 110.281 -179.82 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.829 ' HB3' HD11 ' A' ' 146' ' ' LEU . 67.9 m-85 -158.94 167.83 28.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 110.323 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 85.5 m -143.19 115.49 8.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -0.893 . . . . 0.0 110.072 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 28.4 tp -89.76 122.55 32.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.261 -0.899 . . . . 0.0 110.05 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.475 ' HA ' ' O ' ' A' ' 102' ' ' VAL . 6.1 mtm180 -126.38 125.8 42.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.253 -0.904 . . . . 0.0 110.356 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 1.184 ' CZ ' HG21 ' A' ' 102' ' ' VAL . 5.3 p90 -167.89 151.71 6.2 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.248 -0.908 . . . . 0.0 110.145 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.5 ' CG2' ' HG2' ' A' ' 101' ' ' GLN . 93.6 m -119.65 99.58 6.74 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.242 -0.911 . . . . 0.0 110.063 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.621 ' CB ' HD21 ' A' ' 95' ' ' LEU . . . -100.34 145.59 27.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.327 -0.858 . . . . 0.0 110.364 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.483 ' OG1' ' HA ' ' A' ' 99' ' ' PRO . 43.8 m -148.09 115.92 6.39 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.255 -0.903 . . . . 0.0 110.303 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.443 ' HB2' HD13 ' A' ' 95' ' ' LEU . . . -101.66 141.02 35.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 109.971 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.11 -23.05 1.09 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.129 -0.982 . . . . 0.0 109.41 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.684 HG22 ' HB2' ' A' ' 137' ' ' TRP . 2.9 t -116.96 169.69 9.21 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.51 -0.743 . . . . 0.0 110.034 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.509 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 77.0 m-20 -84.57 69.75 10.64 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.13 -0.981 . . . . 0.0 109.289 179.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.624 HG23 ' CB ' ' A' ' 133' ' ' SER . 4.8 p -94.47 140.05 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.874 . . . . 0.0 111.273 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 21.4 m -121.72 91.87 3.61 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.417 -0.802 . . . . 0.0 108.916 178.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.588 HG12 ' CD2' ' A' ' 132' ' ' PHE . 12.3 m -89.8 -147.56 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.21 -0.931 . . . . 0.0 110.774 -178.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.519 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 6.9 mtm180 -131.03 139.01 49.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.38 -0.825 . . . . 0.0 110.52 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.694 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -138.63 154.52 48.66 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.336 -0.853 . . . . 0.0 109.687 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.901 HD12 ' N ' ' A' ' 78' ' ' VAL . 3.9 pp -179.84 -148.36 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.207 -0.933 . . . . 0.0 110.326 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.901 ' N ' HD12 ' A' ' 77' ' ' LEU . 3.0 t -150.76 167.68 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.269 -0.894 . . . . 0.0 109.495 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.517 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . -170.69 -171.27 35.86 Favored Glycine 0 N--CA 1.491 2.33 0 C-N-CA 119.277 -1.44 . . . . 0.0 110.338 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.534 ' HA ' ' O ' ' A' ' 122' ' ' GLU . 3.7 tt0 -100.25 -160.96 0.83 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.473 -1.016 . . . . 0.0 110.262 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 80' ' ' GLN . 25.8 m120 -158.18 80.31 0.83 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.235 -0.915 . . . . 0.0 110.229 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.638 ' O ' ' HB2' ' A' ' 83' ' ' ALA . . . 167.52 -83.8 0.1 OUTLIER Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.638 ' HB2' ' O ' ' A' ' 82' ' ' GLY . . . 173.88 146.89 0.21 Allowed Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.176 -1.191 . . . . 0.0 110.205 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.456 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.4 Cg_endo -84.81 33.68 4.03 Favored 'Cis proline' 0 C--N 1.312 -1.355 0 C-N-CA 121.887 -2.131 . . . . 0.0 110.619 -0.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.571 ' CZ ' ' O ' ' A' ' 82' ' ' GLY . 21.2 m-85 64.14 137.17 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.187 -0.946 . . . . 0.0 110.2 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -153.02 121.4 1.16 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.462 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 2.0 p -96.83 147.78 23.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.203 -1.175 . . . . 0.0 110.261 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.986 HG23 HD12 ' A' ' 89' ' ' LEU . 33.5 m -119.79 -24.22 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.304 -0.873 . . . . 0.0 109.989 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.986 HD12 HG23 ' A' ' 88' ' ' VAL . 3.9 mp -105.76 146.39 29.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.313 -0.867 . . . . 0.0 110.729 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -151.17 81.74 1.31 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.23 -0.919 . . . . 0.0 110.13 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.2 p -145.4 173.55 11.89 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.071 -1.018 . . . . 0.0 110.578 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.463 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 43.3 m -121.78 118.77 29.32 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.348 -0.845 . . . . 0.0 110.093 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.694 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 46.1 Cg_endo -71.96 146.82 48.1 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.884 1.465 . . . . 0.0 110.966 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 1.032 ' HB3' ' NE ' ' A' ' 100' ' ' ARG . . . -109.62 148.99 30.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.396 -0.815 . . . . 0.0 109.543 179.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.622 ' C ' HG22 ' A' ' 96' ' ' THR . 70.9 mt -140.13 172.43 12.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.085 -1.009 . . . . 0.0 110.609 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.622 HG22 ' C ' ' A' ' 95' ' ' LEU . 0.1 OUTLIER 169.16 -179.15 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.467 -0.771 . . . . 0.0 109.888 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.4 ' N ' ' OG1' ' A' ' 96' ' ' THR . 0.1 OUTLIER -62.88 -12.7 26.74 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.223 -0.923 . . . . 0.0 109.734 179.765 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.526 ' CG ' ' HD2' ' A' ' 99' ' ' PRO . 33.9 tt0 -100.2 149.21 35.83 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.433 -0.792 . . . . 0.0 109.89 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.526 ' HD2' ' CG ' ' A' ' 98' ' ' GLU . 41.8 Cg_endo -68.71 131.25 22.32 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.877 1.462 . . . . 0.0 110.248 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 1.032 ' NE ' ' HB3' ' A' ' 94' ' ' ALA . 11.6 ttt-85 -119.66 92.22 3.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.243 -0.91 . . . . 0.0 110.5 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.5 ' HG2' ' CG2' ' A' ' 65' ' ' THR . 0.0 OUTLIER -71.49 160.84 32.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.329 -0.857 . . . . 0.0 109.771 179.629 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 1.184 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 38.9 t -131.05 133.91 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.135 -0.978 . . . . 0.0 110.444 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.39 88.34 1.5 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.341 -0.85 . . . . 0.0 110.105 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -139.72 151.77 46.12 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.162 -0.962 . . . . 0.0 110.387 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.816 HG23 ' O ' ' A' ' 60' ' ' TYR . 90.6 m -111.3 137.23 49.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.325 -0.859 . . . . 0.0 110.15 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.944 ' CE1' HD11 ' A' ' 89' ' ' LEU . 51.3 p90 -132.5 156.61 46.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.271 -0.893 . . . . 0.0 110.217 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.542 HG22 ' O ' ' A' ' 107' ' ' THR . 7.6 m -90.29 88.29 7.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.292 -0.88 . . . . 0.0 110.102 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.603 ' HB3' ' CE2' ' A' ' 60' ' ' TYR . . . -47.26 104.22 0.05 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.894 . . . . 0.0 110.347 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 84.9 p -91.54 53.63 2.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.247 -0.908 . . . . 0.0 110.162 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.726 ' HB3' ' CG1' ' A' ' 88' ' ' VAL . . . -166.13 -156.34 0.25 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.239 -0.913 . . . . 0.0 110.316 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.574 HG23 ' HA ' ' A' ' 55' ' ' GLU . 12.3 m -146.18 117.1 7.72 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.305 -0.872 . . . . 0.0 110.287 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.594 ' CG ' ' HA3' ' A' ' 123' ' ' GLY . 20.7 m-30 -113.31 75.48 2.31 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.887 . . . . 0.0 109.994 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.665 ' HB2' HG22 ' A' ' 115' ' ' THR . 45.8 Cg_endo -72.39 136.93 27.28 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.932 1.491 . . . . 0.0 110.422 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -84.4 45.39 1.12 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.315 -0.866 . . . . 0.0 110.293 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.703 ' O ' HG23 ' A' ' 115' ' ' THR . 7.5 t -123.65 85.46 53.13 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.218 -0.926 . . . . 0.0 110.148 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.0 118.19 5.45 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.002 1.527 . . . . 0.0 110.41 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.754 ' HB3' ' CG ' ' A' ' 120' ' ' ASP . . . -147.81 -175.21 4.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.224 -0.922 . . . . 0.0 110.248 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.38 -8.94 36.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.255 -0.903 . . . . 0.0 110.249 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -152.99 17.23 0.57 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.255 -0.903 . . . . 0.0 110.257 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.754 ' CG ' ' HB3' ' A' ' 117' ' ' ALA . 0.8 OUTLIER -109.01 96.75 21.68 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.244 -0.91 . . . . 0.0 110.119 179.913 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.548 ' HB3' ' HA3' ' A' ' 82' ' ' GLY . 44.0 Cg_endo -74.82 126.61 10.2 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.045 1.55 . . . . 0.0 110.736 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.534 ' O ' ' HA ' ' A' ' 80' ' ' GLN . 15.2 pm0 -105.74 -157.42 0.61 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.261 -0.899 . . . . 0.0 109.565 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.594 ' HA3' ' CG ' ' A' ' 112' ' ' TYR . . . -140.21 159.02 26.08 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.545 ' O ' HG13 ' A' ' 78' ' ' VAL . 2.1 pm0 -150.5 -160.01 1.11 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.342 -1.093 . . . . 0.0 110.213 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 1.065 HD12 HD23 ' A' ' 49' ' ' LEU . 33.2 mt -118.38 142.45 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.37 -0.831 . . . . 0.0 109.522 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.524 ' HB3' ' HG ' ' A' ' 77' ' ' LEU . . . -113.88 115.22 27.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.304 -0.872 . . . . 0.0 111.541 -178.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.572 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 4.5 m-85 -120.58 80.8 1.67 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.562 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 2.9 mt-30 -87.96 115.06 25.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.112 -0.993 . . . . 0.0 111.636 -178.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 1.063 ' CD1' HD13 ' A' ' 139' ' ' LEU . 9.0 mt -98.77 49.66 0.97 Allowed 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 121.835 0.826 . . . . 0.0 108.856 178.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 132' ' ' PHE . . . -53.11 -173.45 0.04 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.434 ' HA2' ' HB3' ' A' ' 40' ' ' SER . . . -52.95 90.24 0.01 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.588 ' CD2' HG12 ' A' ' 74' ' ' VAL . 20.1 m-85 -114.87 -56.93 2.33 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.235 -1.156 . . . . 0.0 110.647 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.624 ' CB ' HG23 ' A' ' 72' ' ' VAL . 1.4 t -89.42 -177.36 5.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.259 -0.9 . . . . 0.0 110.373 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.455 ' N ' ' OG ' ' A' ' 133' ' ' SER . . . -106.59 -73.74 0.68 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.294 -0.879 . . . . 0.0 110.073 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.425 ' O ' ' C ' ' A' ' 136' ' ' ALA . 17.3 m-20 -70.09 152.99 43.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.233 -0.917 . . . . 0.0 110.076 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.484 ' HA ' ' N ' ' A' ' 38' ' ' ALA . . . -43.29 120.79 1.99 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.281 -0.887 . . . . 0.0 110.134 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 1.087 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 5.0 p90 -125.27 -169.59 2.02 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.176 -0.952 . . . . 0.0 110.258 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.532 ' OG1' ' HA ' ' A' ' 35' ' ' ALA 0.255 0.9 OUTLIER -159.33 168.65 25.85 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.384 -0.927 . . . . 0.0 110.41 -177.528 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 1.063 HD13 ' CD1' ' A' ' 129' ' ' LEU . 2.2 mp -124.85 125.84 44.61 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.378 -0.826 . . . . 0.0 109.629 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' CYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 22.2 m -122.98 99.5 6.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.117 -0.989 . . . . 0.0 110.76 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.598 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 1.5 mt -92.09 -177.17 4.61 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.302 -0.874 . . . . 0.0 109.308 179.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.669 ' O ' HG22 ' A' ' 8' ' ' THR . 2.8 p-10 -169.77 26.09 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.107 -0.996 . . . . 0.0 110.438 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.862 ' HB2' HG22 ' A' ' 8' ' ' THR . 0.7 OUTLIER 172.54 130.75 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.317 -0.864 . . . . 0.0 109.87 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.82 HG11 ' HZ2' ' A' ' 16' ' ' TRP . 1.3 t -150.48 115.9 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.117 -0.989 . . . . 0.0 109.761 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.723 ' HB1' ' OE1' ' A' ' 6' ' ' GLU . . . -140.35 154.44 46.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.252 -0.905 . . . . 0.0 110.495 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.829 HD11 ' HB3' ' A' ' 60' ' ' TYR . 61.0 tp -148.07 99.6 3.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.39 -0.819 . . . . 0.0 110.113 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.481 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 1.3 m-20 -102.69 -166.58 1.29 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.238 -0.914 . . . . 0.0 110.243 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.936 ' O ' HG13 ' A' ' 150' ' ' VAL . 1.5 p -128.21 -177.52 4.18 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.278 -0.889 . . . . 0.0 110.154 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -53.79 96.43 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.288 -0.883 . . . . 0.0 110.214 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.936 HG13 ' O ' ' A' ' 148' ' ' SER . 12.4 m -123.62 19.99 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.276 -0.89 . . . . 0.0 110.202 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 7.4 pt-20 -65.34 157.62 28.69 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.205 -0.934 . . . . 0.0 110.238 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.457 ' HB2' ' O ' ' A' ' 151' ' ' GLU . 1.2 tt . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.217 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.768 ' HB1' ' O ' ' A' ' 53' ' ' ALA . . . . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.232 0.539 . . . . 0.0 110.157 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.41 ' HB3' HG13 ' A' ' 52' ' ' VAL . 91.2 p -107.26 88.86 4.23 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.191 -0.943 . . . . 0.0 110.191 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.493 ' HD3' ' O ' ' A' ' 1' ' ' ALA . 47.0 Cg_endo -73.52 77.97 2.46 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.022 1.538 . . . . 0.0 110.645 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.489 HD11 HG12 ' A' ' 144' ' ' VAL . 27.9 pt -97.11 42.78 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.16 -0.962 . . . . 0.0 109.928 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 6' ' ' GLU . . . 97.98 -16.84 59.64 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' A' ' 5' ' ' GLY . 3.3 tt0 42.5 30.73 0.23 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.316 -1.109 . . . . 0.0 110.193 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 143' ' ' ASP . . . -159.86 -130.73 1.16 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.953 HG22 ' CA ' ' A' ' 143' ' ' ASP . 40.1 p -126.83 -172.39 2.63 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.273 -1.133 . . . . 0.0 110.443 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.597 ' CD2' ' HB2' ' A' ' 32' ' ' LEU . 5.8 m-30 -94.4 47.68 1.2 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.326 -0.859 . . . . 0.0 110.097 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.555 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 32.6 p30 -87.78 36.89 0.77 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.247 -0.908 . . . . 0.0 110.2 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.555 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.7 OUTLIER 161.46 37.47 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.678 -0.639 . . . . 0.0 109.686 -179.891 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 124.87 133.18 3.95 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.773 ' HB3' HD12 ' A' ' 32' ' ' LEU . 50.4 Cg_endo -80.43 41.14 1.08 Allowed 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.909 1.479 . . . . 0.0 111.136 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.46 ' OE1' ' O ' ' A' ' 4' ' ' ILE . 0.9 OUTLIER 45.88 -91.99 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.996 -1.065 . . . . 0.0 110.431 179.867 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 13' ' ' PRO . . . -149.07 10.35 1.01 Allowed Glycine 0 N--CA 1.493 2.459 0 C-N-CA 119.779 -1.2 . . . . 0.0 110.331 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.591 ' CH2' HG21 ' A' ' 125' ' ' ILE . 53.5 m95 -53.25 120.35 5.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.006 -1.291 . . . . 0.0 110.154 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.671 ' O ' HG13 ' A' ' 47' ' ' VAL . 0.9 OUTLIER -116.36 154.48 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.106 -0.996 . . . . 0.0 109.763 179.77 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.423 ' HB3' ' OD1' ' A' ' 22' ' ' ASP . . . -137.53 139.77 40.69 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.433 -0.792 . . . . 0.0 109.008 179.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.601 ' HE2' HG13 ' A' ' 48' ' ' VAL . 6.1 p90 -123.24 151.4 42.33 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.022 -1.049 . . . . 0.0 111.729 -178.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.577 ' HA2' ' CE1' ' A' ' 43' ' ' TYR . . . 133.59 -77.05 0.39 Allowed Glycine 0 N--CA 1.495 2.629 0 N-CA-C 108.899 -1.681 . . . . 0.0 108.899 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.583 HG22 ' CE2' ' A' ' 43' ' ' TYR . 5.5 p -150.81 19.57 0.8 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.213 -1.169 . . . . 0.0 110.08 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.601 ' HA ' ' HB3' ' A' ' 35' ' ' ALA . 1.3 p30 -107.44 112.3 25.02 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.301 -0.874 . . . . 0.0 110.09 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 22' ' ' ASP . . . -61.88 -132.49 0.01 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.455 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 46.1 Cg_endo -72.94 122.17 7.91 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.874 1.46 . . . . 0.0 110.215 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 1.102 ' CD1' HD11 ' A' ' 32' ' ' LEU . 8.1 mt -42.23 126.4 3.35 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.254 -0.904 . . . . 0.0 109.911 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 24' ' ' PRO . 11.8 m-20 -88.45 121.97 31.42 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.226 -0.921 . . . . 0.0 110.603 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.966 HG22 ' O ' ' A' ' 31' ' ' ALA . 3.0 p -119.96 -82.74 0.65 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.339 -0.851 . . . . 0.0 109.964 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.692 ' C ' HG22 ' A' ' 29' ' ' THR . 0.2 OUTLIER 58.28 46.38 15.7 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.247 -0.908 . . . . 0.0 110.662 179.581 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.832 HG22 ' O ' ' A' ' 27' ' ' THR . 0.0 OUTLIER 169.78 -95.37 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.153 -0.967 . . . . 0.0 110.261 179.738 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.516 ' H ' HG23 ' A' ' 29' ' ' THR . . . -158.39 21.93 0.35 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.966 ' O ' HG22 ' A' ' 27' ' ' THR . . . -135.02 162.06 33.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.306 -1.114 . . . . 0.0 110.157 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.102 HD11 ' CD1' ' A' ' 25' ' ' LEU . 0.5 OUTLIER -119.17 98.3 6.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.262 -0.899 . . . . 0.0 110.146 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.556 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 0.8 OUTLIER -98.09 113.21 25.03 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.287 -0.883 . . . . 0.0 111.594 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.95 HG12 HD22 ' A' ' 25' ' ' LEU . 16.6 m -89.55 147.83 4.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 178.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.601 ' HB3' ' HA ' ' A' ' 22' ' ' ASP . . . -89.18 91.09 8.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.361 -0.837 . . . . 0.0 111.409 -178.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.079 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 66.6 t -79.67 133.67 58.73 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.376 -0.828 . . . . 0.0 108.888 178.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.819 ' HD2' HG21 ' A' ' 45' ' ' VAL . 38.4 Cg_endo -66.66 168.34 16.92 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.881 1.464 . . . . 0.0 111.573 -178.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.523 ' HA ' ' N ' ' A' ' 136' ' ' ALA . . . -55.34 124.39 16.94 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.526 -0.734 . . . . 0.0 111.367 -178.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.532 ' O ' ' C ' ' A' ' 40' ' ' SER . . . 39.73 26.08 0.08 OUTLIER Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.943 ' OG ' HG23 ' A' ' 45' ' ' VAL . 24.1 t 30.06 66.61 0.12 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.844 -0.797 . . . . 0.0 110.565 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.575 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . -89.06 145.05 25.72 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.659 -0.651 . . . . 0.0 109.661 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.575 ' HG2' ' O ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER 45.77 27.61 0.48 Allowed 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -178.893 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.583 ' CE2' HG22 ' A' ' 21' ' ' THR . 0.1 OUTLIER -151.83 124.65 8.52 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 119.034 -1.066 . . . . 0.0 111.881 -178.19 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.536 ' HA2' ' CA ' ' A' ' 130' ' ' GLY . . . -90.32 95.63 2.11 Favored Glycine 0 C--N 1.296 -1.681 0 N-CA-C 106.615 -2.594 . . . . 0.0 106.615 177.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.943 HG23 ' OG ' ' A' ' 40' ' ' SER . 3.2 t -86.55 111.95 22.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 O-C-N 120.968 -1.313 . . . . 0.0 108.127 -178.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.576 ' O ' ' CE2' ' A' ' 19' ' ' TYR . . . -141.88 147.71 19.28 Favored Glycine 0 N--CA 1.484 1.895 0 C-N-CA 118.886 -1.626 . . . . 0.0 109.876 -178.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.671 HG13 ' O ' ' A' ' 17' ' ' VAL . 9.3 t -109.92 126.65 67.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.315 -1.109 . . . . 0.0 109.887 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.601 HG13 ' HE2' ' A' ' 19' ' ' TYR . 27.6 m -119.73 142.36 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.962 -1.086 . . . . 0.0 110.567 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.555 HD13 ' CD1' ' A' ' 16' ' ' TRP . 6.7 tp -126.04 95.17 4.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.369 -0.832 . . . . 0.0 109.918 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.518 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 0.7 OUTLIER -76.47 144.36 39.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.295 -0.878 . . . . 0.0 110.469 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 123.23 54.9 0.2 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.615 HG11 ' HD2' ' A' ' 112' ' ' TYR . 75.2 t -119.8 164.54 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.148 -1.207 . . . . 0.0 110.218 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.768 ' O ' ' HB1' ' A' ' 1' ' ' ALA . . . -140.15 84.54 1.97 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.248 -0.908 . . . . 0.0 110.516 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.623 HG23 ' CE2' ' A' ' 60' ' ' TYR . 47.5 mm -111.75 155.21 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.243 -0.911 . . . . 0.0 109.702 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.541 ' HG3' HG23 ' A' ' 111' ' ' THR . 0.7 OUTLIER -145.24 132.07 20.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.097 -1.002 . . . . 0.0 110.56 -179.766 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 7.9 pt-20 38.39 -152.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.743 -0.598 . . . . 0.0 110.695 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.494 ' N ' ' HG3' ' A' ' 56' ' ' GLU . . . -88.98 116.99 4.78 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.523 ' CG2' ' CE2' ' A' ' 60' ' ' TYR . 0.9 OUTLIER -136.35 168.27 19.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.279 -1.13 . . . . 0.0 109.769 179.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.498 ' O ' ' HA ' ' A' ' 148' ' ' SER . 1.6 m -90.25 99.48 12.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.284 -0.885 . . . . 0.0 110.578 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.907 ' HB3' HD11 ' A' ' 146' ' ' LEU . 59.9 m-85 -106.33 151.96 24.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.228 -0.92 . . . . 0.0 110.21 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.431 ' C ' HD12 ' A' ' 146' ' ' LEU . 92.9 m -125.3 109.77 13.2 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 110.028 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 103' ' ' THR . 14.2 tp -89.94 120.14 30.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.22 -0.925 . . . . 0.0 110.008 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.596 ' HB2' HG23 ' A' ' 103' ' ' THR . 20.9 ttp180 -129.45 110.84 12.21 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.896 . . . . 0.0 110.257 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.496 ' C ' ' CD1' ' A' ' 64' ' ' TYR . 8.3 p90 -143.41 155.44 44.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.375 -0.828 . . . . 0.0 109.911 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.504 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 4.5 m -119.69 97.72 5.77 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.108 -0.995 . . . . 0.0 109.921 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.58 ' CB ' HD21 ' A' ' 95' ' ' LEU . . . -97.9 150.17 21.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.223 -0.923 . . . . 0.0 110.479 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.43 HG23 ' O ' ' A' ' 96' ' ' THR . 99.9 m -149.96 130.71 14.12 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.291 -0.88 . . . . 0.0 110.017 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.511 ' CB ' HG12 ' A' ' 72' ' ' VAL . . . -119.32 128.92 54.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.235 -0.915 . . . . 0.0 110.205 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.79 -9.23 26.62 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.257 -0.902 . . . . 0.0 110.102 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.674 HG21 ' CB ' ' A' ' 137' ' ' TRP . 6.0 t -114.33 19.53 16.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.238 -0.914 . . . . 0.0 110.095 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.501 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 4.9 t70 43.35 73.56 0.14 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.32 -0.862 . . . . 0.0 109.772 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.682 ' CG1' HD12 ' A' ' 95' ' ' LEU . 5.6 p -109.59 140.48 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.385 -0.822 . . . . 0.0 110.768 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 54.4 m -119.87 83.88 2.12 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.447 -0.783 . . . . 0.0 109.036 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.728 HG21 ' CD2' ' A' ' 129' ' ' LEU . 14.2 m -89.83 -139.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.221 -0.925 . . . . 0.0 110.759 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.567 ' N ' HG23 ' A' ' 74' ' ' VAL . 0.4 OUTLIER -131.58 142.93 50.01 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.185 -0.947 . . . . 0.0 111.12 -179.075 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.85 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -143.91 154.37 43.27 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.472 -0.768 . . . . 0.0 109.44 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.804 HD12 ' N ' ' A' ' 78' ' ' VAL . 4.2 pp -179.86 -152.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.116 -0.99 . . . . 0.0 110.5 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.867 HG23 HD22 ' A' ' 89' ' ' LEU . 66.8 t -155.14 168.94 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.392 -0.818 . . . . 0.0 109.251 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.515 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . 173.37 179.37 43.99 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.205 -1.474 . . . . 0.0 110.312 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.472 ' HG2' ' O ' ' A' ' 122' ' ' GLU . 1.0 OUTLIER -72.74 -152.9 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.571 -0.958 . . . . 0.0 110.265 179.932 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.529 ' O ' ' CB ' ' A' ' 121' ' ' PRO . 15.2 m120 -160.57 60.55 0.32 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.541 -0.725 . . . . 0.0 109.317 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.578 ' O ' ' CZ ' ' A' ' 85' ' ' TYR . . . 158.28 -125.97 1.62 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.457 ' HA ' ' N ' ' A' ' 85' ' ' TYR . . . -125.2 153.2 71.73 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.174 -1.192 . . . . 0.0 110.122 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.472 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.5 Cg_endo -86.07 35.69 3.73 Favored 'Cis proline' 0 C--N 1.311 -1.418 0 C-N-CA 121.854 -2.144 . . . . 0.0 110.614 -0.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.578 ' CZ ' ' O ' ' A' ' 82' ' ' GLY . 76.6 m-85 58.98 148.89 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.178 -0.951 . . . . 0.0 110.226 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -173.19 115.57 0.57 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -110.65 143.63 40.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.238 -1.154 . . . . 0.0 110.376 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 1.046 HG23 HD12 ' A' ' 89' ' ' LEU . 34.6 m -124.43 -15.14 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.265 -0.897 . . . . 0.0 110.38 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 1.046 HD12 HG23 ' A' ' 88' ' ' VAL . 4.2 mp -108.33 137.39 46.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.209 -0.932 . . . . 0.0 111.002 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -151.15 81.27 1.32 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.4 -0.812 . . . . 0.0 109.901 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.5 p -137.76 179.52 6.38 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.994 -1.066 . . . . 0.0 110.699 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.7 m -119.89 115.28 33.48 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.378 -0.826 . . . . 0.0 110.059 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.85 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 44.1 Cg_endo -72.18 92.81 0.73 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.93 1.489 . . . . 0.0 110.919 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.524 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -75.15 147.89 40.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.904 . . . . 0.0 109.568 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.682 HD12 ' CG1' ' A' ' 72' ' ' VAL . 71.1 mt -138.99 162.36 35.09 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.04 -1.038 . . . . 0.0 110.778 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.43 ' O ' HG23 ' A' ' 67' ' ' THR . 0.3 OUTLIER -174.68 -179.22 1.44 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.438 -0.789 . . . . 0.0 110.088 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.56 -29.19 58.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.285 -0.884 . . . . 0.0 110.068 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.94 161.09 39.3 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.294 -0.879 . . . . 0.0 110.007 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.87 145.11 39.9 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.96 1.505 . . . . 0.0 110.487 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.524 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.85 94.34 4.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.29 -0.881 . . . . 0.0 110.037 179.811 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.425 ' HG3' ' OG1' ' A' ' 65' ' ' THR . 0.0 OUTLIER -84.23 95.07 8.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.385 -0.822 . . . . 0.0 110.198 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 25.2 t -89.54 134.4 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.348 -0.845 . . . . 0.0 110.066 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.596 HG23 ' HB2' ' A' ' 63' ' ' ARG . 0.2 OUTLIER -150.15 130.72 13.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.327 -0.858 . . . . 0.0 110.163 -179.945 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.52 ' CG ' ' O ' ' A' ' 103' ' ' THR . 21.1 mt-10 -160.1 138.23 10.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.19 -0.944 . . . . 0.0 110.378 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 105' ' ' THR . 4.1 t -90.05 76.14 7.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.233 -0.917 . . . . 0.0 110.047 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.845 ' CE1' HD11 ' A' ' 89' ' ' LEU . 30.4 p90 -77.64 153.01 33.56 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.261 -0.9 . . . . 0.0 110.422 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 58' ' ' THR . 78.8 m -93.57 98.57 11.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.267 -0.895 . . . . 0.0 109.919 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.643 ' HB3' ' CE2' ' A' ' 60' ' ' TYR . . . -58.47 99.19 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -0.933 . . . . 0.0 110.239 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.416 ' N ' ' CG1' ' A' ' 88' ' ' VAL . 81.6 p -87.05 55.15 3.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.222 -0.924 . . . . 0.0 109.927 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -161.96 -151.42 0.21 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.268 -0.895 . . . . 0.0 110.353 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.541 HG23 ' HG3' ' A' ' 55' ' ' GLU . 31.6 m -157.13 122.43 4.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.319 -0.863 . . . . 0.0 110.398 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.615 ' HD2' HG11 ' A' ' 52' ' ' VAL . 14.3 m-30 -112.73 86.52 8.78 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.312 -0.867 . . . . 0.0 109.766 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.472 ' HG2' ' HA ' ' A' ' 122' ' ' GLU . 43.1 Cg_endo -70.5 163.84 37.4 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.941 1.495 . . . . 0.0 110.4 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -102.97 63.14 0.82 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.222 -0.924 . . . . 0.0 110.295 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.468 ' O ' ' O ' ' A' ' 120' ' ' ASP . 27.2 m -134.27 88.15 31.36 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.268 -0.895 . . . . 0.0 110.14 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.73 91.56 0.89 Allowed 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.965 1.508 . . . . 0.0 110.37 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.445 ' HB3' ' HB2' ' A' ' 120' ' ' ASP . . . -149.97 165.25 33.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.268 -0.895 . . . . 0.0 110.247 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.66 -64.3 0.94 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.248 -0.907 . . . . 0.0 110.208 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.445 ' O ' ' HD3' ' A' ' 121' ' ' PRO . 8.9 t0 -69.09 -31.46 70.22 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.305 -0.872 . . . . 0.0 110.09 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.468 ' O ' ' O ' ' A' ' 115' ' ' THR . 0.6 OUTLIER -107.24 95.32 12.97 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.283 -0.886 . . . . 0.0 110.206 179.96 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.529 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 48.2 Cg_endo -74.9 -164.44 0.23 Allowed 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.037 1.546 . . . . 0.0 110.496 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.48 ' O ' ' N ' ' A' ' 81' ' ' ASN . 0.4 OUTLIER -155.73 -151.11 0.33 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.171 -0.955 . . . . 0.0 110.485 179.899 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.514 ' HA3' ' CB ' ' A' ' 112' ' ' TYR . . . -148.38 140.79 8.56 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.083 -1.607 . . . . 0.0 109.083 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.526 ' O ' HG13 ' A' ' 78' ' ' VAL . 1.0 OUTLIER -150.34 -149.83 0.32 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.134 -1.215 . . . . 0.0 110.731 -179.325 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.591 HG21 ' CH2' ' A' ' 16' ' ' TRP . 11.4 mt -118.22 150.98 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.481 -0.762 . . . . 0.0 109.409 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.413 ' HB3' HD11 ' A' ' 77' ' ' LEU . . . -130.13 124.19 32.13 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.271 -0.893 . . . . 0.0 110.801 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.501 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 5.4 m-85 -118.61 106.02 12.2 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 1.049 ' O ' HD23 ' A' ' 129' ' ' LEU . 0.5 OUTLIER -89.58 129.19 36.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.187 -0.945 . . . . 0.0 112.109 -177.711 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 1.049 HD23 ' O ' ' A' ' 128' ' ' GLN . 0.4 OUTLIER -143.73 34.79 1.27 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 178.047 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.536 ' CA ' ' HA2' ' A' ' 44' ' ' GLY . . . -83.8 123.67 6.28 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.301 -1.519 . . . . 0.0 109.301 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 44.91 63.42 2.57 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.594 ' CD2' ' HA ' ' A' ' 74' ' ' VAL . 10.5 m-85 -115.61 -61.8 1.69 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.088 -1.242 . . . . 0.0 111.155 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.592 ' HB3' ' CE3' ' A' ' 137' ' ' TRP . 3.3 t -87.73 -161.25 0.69 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.949 -1.094 . . . . 0.0 110.527 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -119.79 -62.97 1.43 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.169 -0.957 . . . . 0.0 110.557 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -84.54 151.69 24.39 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.107 -0.996 . . . . 0.0 110.042 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.523 ' N ' ' HA ' ' A' ' 38' ' ' ALA . . . -48.59 127.91 14.2 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.331 -0.856 . . . . 0.0 110.543 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 1.079 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 10.5 p90 -139.38 -173.18 3.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.204 -0.935 . . . . 0.0 110.489 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.528 ' C ' HD12 ' A' ' 139' ' ' LEU 0.254 0.8 OUTLIER -150.16 176.64 10.66 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.404 -0.81 . . . . 0.0 109.922 -177.799 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.556 ' O ' ' HA ' ' A' ' 33' ' ' CYS . 1.9 mp -139.0 117.98 12.48 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.069 -1.019 . . . . 0.0 111.76 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' CYS . . . . . 0.511 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 0.8 OUTLIER -101.45 116.25 32.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.653 -0.655 . . . . 0.0 110.834 178.7 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.504 ' HA ' ' O ' ' A' ' 65' ' ' THR . 1.6 mt -110.42 178.85 4.25 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.258 -0.901 . . . . 0.0 109.508 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.477 ' HB3' ' O ' ' A' ' 141' ' ' LEU . 4.7 p-10 174.18 175.96 0.15 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.399 -0.813 . . . . 0.0 110.239 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.953 ' CA ' HG22 ' A' ' 8' ' ' THR . 5.1 t0 41.24 59.33 2.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.541 -0.725 . . . . 0.0 110.076 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.535 HG21 ' HZ ' ' A' ' 9' ' ' PHE . 2.8 t -100.57 113.23 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.3 -0.875 . . . . 0.0 110.04 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -136.95 158.87 43.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.24 -0.913 . . . . 0.0 110.377 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.907 HD11 ' HB3' ' A' ' 60' ' ' TYR . 13.0 tp -167.39 122.09 1.03 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.36 -0.837 . . . . 0.0 110.06 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.463 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 1.5 t70 -139.22 -158.51 0.86 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.229 -0.919 . . . . 0.0 110.312 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' A' ' 59' ' ' THR . 75.0 p -136.05 128.96 31.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.27 -0.894 . . . . 0.0 110.196 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -68.93 174.11 4.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.279 -0.888 . . . . 0.0 110.206 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.764 HG22 ' O ' ' A' ' 150' ' ' VAL . 6.3 p -168.92 30.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.223 -0.923 . . . . 0.0 110.194 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.449 ' HB2' ' O ' ' A' ' 150' ' ' VAL . 1.0 OUTLIER -177.46 125.73 0.14 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.297 -0.877 . . . . 0.0 110.192 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.215 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.41 ' O ' ' CB ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.217 0.532 . . . . 0.0 110.197 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.41 ' CB ' ' O ' ' A' ' 1' ' ' ALA . 0.2 OUTLIER 174.89 85.79 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.241 -0.912 . . . . 0.0 110.224 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -76.02 -156.14 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.07 1.563 . . . . 0.0 110.104 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.41 HG13 ' N ' ' A' ' 5' ' ' GLY . 14.3 pt -90.24 -32.45 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.238 -0.913 . . . . 0.0 110.163 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.41 ' N ' HG13 ' A' ' 4' ' ' ILE . . . 169.16 147.82 5.57 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.42 19.57 2.74 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.277 -1.131 . . . . 0.0 110.194 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 143' ' ' ASP . . . 161.75 -97.74 0.16 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.657 HG22 ' O ' ' A' ' 142' ' ' ASP . 17.1 p -92.07 147.31 23.05 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.23 -1.159 . . . . 0.0 109.95 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.603 ' CE2' ' HB2' ' A' ' 32' ' ' LEU . 21.8 m-85 -44.04 -40.77 5.02 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.312 -0.868 . . . . 0.0 109.408 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.553 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 12.0 t70 31.28 42.27 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.074 0.464 . . . . 0.0 111.299 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.553 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 1.7 t70 161.66 80.87 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.559 -0.713 . . . . 0.0 109.58 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 55.23 173.38 0.1 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.861 ' HB3' HD12 ' A' ' 32' ' ' LEU . 47.6 Cg_endo -73.56 -5.42 17.07 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 124.048 1.551 . . . . 0.0 110.519 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 0.5 OUTLIER 65.29 -87.1 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.215 -0.928 . . . . 0.0 110.282 -179.92 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.74 ' C ' HD13 ' A' ' 49' ' ' LEU . . . -140.92 6.23 2.58 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.808 ' HH2' HG21 ' A' ' 125' ' ' ILE . 55.0 m95 -71.34 82.6 0.77 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.178 -1.189 . . . . 0.0 110.406 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.744 ' O ' HG13 ' A' ' 47' ' ' VAL . 1.0 OUTLIER -78.53 149.35 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.011 -1.055 . . . . 0.0 109.287 179.559 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.611 ' CB ' HG12 ' A' ' 34' ' ' VAL . . . -135.33 132.74 38.03 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.049 -1.032 . . . . 0.0 110.461 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.602 ' HE1' HG13 ' A' ' 48' ' ' VAL . 11.8 p90 -122.07 115.46 22.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.526 -0.734 . . . . 0.0 110.006 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.917 ' CA ' HG13 ' A' ' 45' ' ' VAL . . . -152.96 27.55 0.81 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.9 p 47.87 21.32 0.28 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.304 -1.115 . . . . 0.0 110.862 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.559 ' HB3' ' CB ' ' A' ' 35' ' ' ALA . 3.2 m-20 -125.15 43.12 3.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.898 -1.126 . . . . 0.0 110.261 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.41 152.07 17.32 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.415 ' O ' ' C ' ' A' ' 25' ' ' LEU . 46.6 Cg_endo -73.09 140.76 31.68 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.989 1.521 . . . . 0.0 110.428 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.743 HD13 HD11 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -42.41 156.64 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.316 -0.865 . . . . 0.0 110.219 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -145.12 148.76 33.98 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.262 -0.899 . . . . 0.0 110.261 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.646 ' O ' HG22 ' A' ' 29' ' ' THR . 0.8 OUTLIER -119.89 -74.14 0.62 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.266 -0.896 . . . . 0.0 110.236 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 27' ' ' THR . 2.5 t 43.14 36.05 0.91 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.229 -0.919 . . . . 0.0 110.232 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.646 HG22 ' O ' ' A' ' 27' ' ' THR . 14.9 t -172.65 -34.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.317 -0.864 . . . . 0.0 110.21 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.44 ' N ' HG23 ' A' ' 29' ' ' THR . . . 123.73 7.88 6.53 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.453 ' H ' HG23 ' A' ' 29' ' ' THR . . . -130.95 132.21 44.92 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.164 -1.197 . . . . 0.0 110.222 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.861 HD12 ' HB3' ' A' ' 13' ' ' PRO . 2.2 tp -74.03 109.06 7.23 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.233 -0.917 . . . . 0.0 110.066 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 9.5 m -111.12 103.36 11.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.151 -0.968 . . . . 0.0 110.774 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.611 HG12 ' CB ' ' A' ' 18' ' ' ALA . 25.4 m -89.7 169.44 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.894 . . . . 0.0 109.13 179.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.559 ' CB ' ' HB3' ' A' ' 22' ' ' ASP . . . -122.46 129.22 51.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.904 -1.122 . . . . 0.0 111.317 -179.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.139 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 4.5 t -117.1 122.58 31.06 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.508 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 45.4 Cg_endo -74.5 152.65 43.7 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.804 1.423 . . . . 0.0 111.625 -178.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.484 ' HA ' ' CA ' ' A' ' 136' ' ' ALA . . . -42.07 131.39 3.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.32 -0.862 . . . . 0.0 109.892 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 38' ' ' ALA . . . 46.18 71.98 0.45 Allowed Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.558 -1.817 . . . . 0.0 108.558 -179.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.926 ' OG ' HG12 ' A' ' 36' ' ' VAL . 0.9 OUTLIER -84.6 34.92 0.54 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.319 -1.106 . . . . 0.0 110.778 -179.354 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.95 ' HB2' ' HA3' ' A' ' 131' ' ' GLY . . . -98.87 20.73 12.63 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.308 -0.87 . . . . 0.0 109.708 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.58 ' HG3' ' CD2' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -95.02 20.25 9.25 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.747 0.785 . . . . 0.0 109.882 179.771 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.702 ' CZ ' HG22 ' A' ' 45' ' ' VAL . 24.4 p90 176.86 -29.35 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.497 ' N ' ' CD1' ' A' ' 43' ' ' TYR . . . 99.24 108.91 2.93 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 110.241 -1.143 . . . . 0.0 110.241 179.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.917 HG13 ' CA ' ' A' ' 20' ' ' GLY . 1.9 t -89.99 178.28 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.215 -1.167 . . . . 0.0 108.74 179.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.509 ' CA ' ' HA ' ' A' ' 128' ' ' GLN . . . 162.81 -173.96 39.1 Favored Glycine 0 N--CA 1.487 2.051 0 C-N-CA 118.867 -1.635 . . . . 0.0 110.823 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.744 HG13 ' O ' ' A' ' 17' ' ' VAL . 38.9 t -151.06 128.2 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.625 ' O ' HG22 ' A' ' 17' ' ' VAL . 27.6 m -120.55 128.37 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.842 -1.161 . . . . 0.0 110.749 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.787 HD22 ' NE1' ' A' ' 16' ' ' TRP . 19.7 tp -119.29 105.2 11.09 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.367 -0.833 . . . . 0.0 110.3 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.512 ' HA ' ' HB3' ' A' ' 124' ' ' GLN . 0.2 OUTLIER -82.29 103.29 11.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.265 -0.897 . . . . 0.0 110.161 179.826 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.71 69.48 0.02 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.587 HG12 ' N ' ' A' ' 53' ' ' ALA . 38.3 t -119.9 171.78 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.196 -1.179 . . . . 0.0 109.979 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.587 ' N ' HG12 ' A' ' 52' ' ' VAL . . . -137.6 78.46 1.69 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.122 -0.987 . . . . 0.0 110.783 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.719 HD11 HD21 ' A' ' 146' ' ' LEU . 28.2 mm -118.31 160.41 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.21 -0.931 . . . . 0.0 109.712 179.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.527 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 1.2 tt0 -154.46 131.77 11.15 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.026 -1.046 . . . . 0.0 110.82 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 10.8 pt-20 37.58 -154.4 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.726 -0.609 . . . . 0.0 110.981 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 108' ' ' ALA . . . -86.77 91.91 1.76 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.555 ' CG2' ' N ' ' A' ' 59' ' ' THR . 1.2 m -121.36 173.74 7.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.274 -1.133 . . . . 0.0 109.83 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.555 ' N ' ' CG2' ' A' ' 58' ' ' THR . 0.5 OUTLIER -89.72 152.66 21.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.278 -0.889 . . . . 0.0 110.28 -179.913 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.629 ' CE1' ' CD1' ' A' ' 54' ' ' ILE . 54.1 m-85 -156.79 165.33 36.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.286 -0.884 . . . . 0.0 110.344 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 96.2 m -142.78 112.95 7.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.314 -0.866 . . . . 0.0 109.982 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.3 tp -89.76 120.76 31.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 110.148 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.491 ' HA ' ' O ' ' A' ' 102' ' ' VAL . 32.5 ttp180 -130.12 119.48 23.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.339 -0.851 . . . . 0.0 110.119 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.983 ' CZ ' HG21 ' A' ' 102' ' ' VAL . 14.6 p90 -150.91 153.26 34.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.237 -0.915 . . . . 0.0 110.252 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.492 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 5.6 m -119.73 94.86 4.55 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.26 -0.9 . . . . 0.0 109.968 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.832 ' HB2' HD23 ' A' ' 141' ' ' LEU . . . -99.72 153.33 19.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.324 -0.86 . . . . 0.0 110.401 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.691 HG23 ' O ' ' A' ' 98' ' ' GLU . 67.9 m -150.1 117.08 5.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.243 -0.911 . . . . 0.0 110.161 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -99.48 140.35 33.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.268 -0.895 . . . . 0.0 109.872 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.409 ' C ' ' O ' ' A' ' 68' ' ' ALA . 22.9 t -44.72 -26.27 0.37 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.185 -0.947 . . . . 0.0 109.282 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.738 HG22 ' HB2' ' A' ' 137' ' ' TRP . 5.0 t -116.99 -152.63 0.51 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.574 -0.704 . . . . 0.0 109.764 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.622 ' N ' HG23 ' A' ' 70' ' ' THR . 0.1 OUTLIER -116.03 62.17 0.71 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.276 -0.89 . . . . 0.0 109.324 179.043 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.818 HG23 ' HB2' ' A' ' 133' ' ' SER . 4.5 p -82.95 136.63 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.329 -0.857 . . . . 0.0 111.187 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.465 HG22 ' O ' ' A' ' 73' ' ' THR . 8.3 m -119.79 89.96 3.23 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.878 HG21 HD22 ' A' ' 129' ' ' LEU . 12.8 m -89.81 -150.39 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.279 -0.888 . . . . 0.0 110.811 -178.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.522 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 6.4 mtm180 -129.83 137.04 50.25 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.319 -0.863 . . . . 0.0 110.63 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.718 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -134.24 157.67 45.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.408 -0.808 . . . . 0.0 109.746 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.669 HD12 ' N ' ' A' ' 78' ' ' VAL . 3.8 pp 178.66 -156.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.195 -0.94 . . . . 0.0 110.373 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.86 ' CG2' HD22 ' A' ' 89' ' ' LEU . 3.4 t -148.39 167.55 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.296 -0.877 . . . . 0.0 109.565 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.49 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . -178.78 -170.23 40.5 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.343 -1.408 . . . . 0.0 110.202 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.52 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 28.2 tt0 -111.15 118.5 36.13 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.441 -1.035 . . . . 0.0 110.297 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.501 ' CB ' ' OE2' ' A' ' 122' ' ' GLU . 2.5 m120 -85.49 94.51 9.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.221 -0.924 . . . . 0.0 110.166 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.661 ' O ' ' HB2' ' A' ' 83' ' ' ALA . . . 164.69 -89.53 0.1 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.661 ' HB2' ' O ' ' A' ' 82' ' ' GLY . . . 173.04 144.19 0.17 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.229 -1.159 . . . . 0.0 110.15 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.467 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.6 Cg_endo -84.23 32.87 4.1 Favored 'Cis proline' 0 C--N 1.314 -1.28 0 C-N-CA 121.929 -2.113 . . . . 0.0 110.681 -0.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.581 ' CZ ' ' O ' ' A' ' 82' ' ' GLY . 19.4 m-85 64.76 157.47 0.09 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.16 -0.963 . . . . 0.0 110.246 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.472 ' O ' ' HA2' ' A' ' 79' ' ' GLY . . . -171.74 103.48 0.19 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.487 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 1.7 p -89.87 139.25 30.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.19 -1.182 . . . . 0.0 110.359 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 1.032 HG23 HD12 ' A' ' 89' ' ' LEU . 34.4 m -119.92 -16.79 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.337 -0.852 . . . . 0.0 109.979 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 1.032 HD12 HG23 ' A' ' 88' ' ' VAL . 4.2 mp -108.82 143.34 38.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.292 -0.88 . . . . 0.0 110.775 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -150.78 83.51 1.34 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.34 -0.85 . . . . 0.0 110.125 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.0 p -145.3 174.9 10.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.082 -1.011 . . . . 0.0 110.534 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.5 m -121.38 116.33 30.88 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.33 -0.856 . . . . 0.0 110.145 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.718 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 43.9 Cg_endo -71.15 124.77 10.79 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.898 1.473 . . . . 0.0 110.962 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 1.011 ' HB3' ' NH1' ' A' ' 100' ' ' ARG . . . -96.62 148.11 23.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.32 -0.862 . . . . 0.0 109.438 179.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.797 HD21 ' CB ' ' A' ' 66' ' ' ALA . 32.2 mt -136.2 166.51 23.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.001 -1.062 . . . . 0.0 110.726 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' A' ' 70' ' ' THR . 0.2 OUTLIER -164.35 -178.81 5.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.482 -0.761 . . . . 0.0 109.975 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.42 -6.47 30.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.225 -0.922 . . . . 0.0 110.183 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.691 ' O ' HG23 ' A' ' 67' ' ' THR . 1.5 mt-10 -113.11 178.34 0.99 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.292 -0.88 . . . . 0.0 110.074 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.495 ' HD2' ' CB ' ' A' ' 98' ' ' GLU . 45.6 Cg_endo -72.68 128.03 12.99 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.0 1.527 . . . . 0.0 110.359 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 1.011 ' NH1' ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.77 91.56 3.58 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.26 -0.9 . . . . 0.0 110.217 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.437 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 0.5 OUTLIER -75.78 157.19 33.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.302 -0.874 . . . . 0.0 110.138 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.983 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 41.0 t -135.09 139.26 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.221 -0.924 . . . . 0.0 110.129 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.96 102.43 3.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.263 -0.898 . . . . 0.0 110.194 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -142.01 165.78 26.51 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.239 -0.913 . . . . 0.0 110.171 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.5 t -122.08 167.15 13.48 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.22 -0.925 . . . . 0.0 110.163 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.881 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 34.4 p90 -173.3 151.37 2.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.245 -0.909 . . . . 0.0 110.274 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 66.9 m -89.98 96.14 10.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.225 -0.922 . . . . 0.0 110.029 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.598 ' HB3' ' CE2' ' A' ' 60' ' ' TYR . . . -55.17 100.07 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.289 -0.882 . . . . 0.0 110.251 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 54.5 p -89.08 52.45 2.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.258 -0.901 . . . . 0.0 110.179 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.43 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -159.22 -155.85 0.49 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.253 -0.904 . . . . 0.0 110.191 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.679 HG22 ' HD3' ' A' ' 113' ' ' PRO . 88.6 m -147.05 111.1 5.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.262 -0.899 . . . . 0.0 110.283 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.605 ' CE2' HG12 ' A' ' 78' ' ' VAL . 15.0 m-30 -111.43 77.04 1.58 Allowed Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.361 -0.837 . . . . 0.0 109.994 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.679 ' HD3' HG22 ' A' ' 111' ' ' THR . 44.8 Cg_endo -72.46 177.56 7.24 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.975 1.513 . . . . 0.0 110.419 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.444 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -115.95 34.4 4.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.243 -0.911 . . . . 0.0 110.264 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 120' ' ' ASP . 1.4 m -108.24 89.49 5.85 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.21 -0.931 . . . . 0.0 110.168 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 46.2 Cg_endo -72.87 80.19 1.83 Allowed 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.968 1.51 . . . . 0.0 110.434 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 1.02 ' HB3' ' HB2' ' A' ' 120' ' ' ASP . . . -132.25 175.02 9.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.253 -0.904 . . . . 0.0 110.132 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.73 -59.8 3.04 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.245 -0.91 . . . . 0.0 110.186 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.88 12.6 5.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.255 -0.903 . . . . 0.0 110.288 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 1.02 ' HB2' ' HB3' ' A' ' 117' ' ' ALA . 41.0 m-20 -135.55 91.89 17.9 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.28 -0.887 . . . . 0.0 110.239 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.501 ' HB3' ' HA3' ' A' ' 82' ' ' GLY . 47.5 Cg_endo -73.64 172.12 16.4 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.999 1.526 . . . . 0.0 110.416 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.515 ' OE1' ' N ' ' A' ' 122' ' ' GLU . 6.4 pm0 -141.02 -163.88 1.63 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.233 -0.917 . . . . 0.0 110.187 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.526 ' HA3' ' CB ' ' A' ' 112' ' ' TYR . . . -138.12 154.6 22.91 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.574 ' HA ' ' CG2' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -150.25 -162.14 1.49 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -1.176 . . . . 0.0 110.518 -179.716 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.808 HG21 ' HH2' ' A' ' 16' ' ' TRP . 10.1 mt -118.86 144.25 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.486 -0.759 . . . . 0.0 109.503 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.51 ' O ' ' HA ' ' A' ' 76' ' ' ALA . . . -116.28 115.29 25.67 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.453 -0.779 . . . . 0.0 111.41 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.546 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 2.7 m-30 -118.09 75.52 1.01 Allowed 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.861 ' C ' HD23 ' A' ' 129' ' ' LEU . 25.6 mt-30 -88.21 122.72 32.08 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.278 -0.888 . . . . 0.0 112.512 -177.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.878 HD22 HG21 ' A' ' 74' ' ' VAL . 0.6 OUTLIER -108.38 55.6 0.64 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.008 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.495 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -66.04 89.38 0.13 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 -178.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.95 ' HA3' ' HB2' ' A' ' 41' ' ' ALA . . . 39.7 86.04 0.01 OUTLIER Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.999 -1.241 . . . . 0.0 109.999 179.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.694 ' CD2' HG12 ' A' ' 74' ' ' VAL . 12.9 m-85 -111.94 -47.95 3.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.191 -1.182 . . . . 0.0 110.348 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.818 ' HB2' HG23 ' A' ' 72' ' ' VAL . 37.2 t -89.84 -174.47 4.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.214 -0.929 . . . . 0.0 110.235 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -98.11 -80.6 0.45 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -0.892 . . . . 0.0 110.391 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -63.17 155.81 27.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.211 -0.931 . . . . 0.0 110.425 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.484 ' CA ' ' HA ' ' A' ' 38' ' ' ALA . . . -50.4 128.42 19.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.246 -0.909 . . . . 0.0 110.193 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 1.139 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 11.2 p90 -132.04 -165.03 1.53 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.287 -0.883 . . . . 0.0 110.216 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.604 ' C ' HD12 ' A' ' 139' ' ' LEU . 0.5 OUTLIER -160.38 -178.44 6.93 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.683 -178.831 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.847 HD13 HD13 ' A' ' 129' ' ' LEU . 2.3 mp -141.08 141.22 34.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.348 -0.845 . . . . 0.0 110.129 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' CYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 22.3 m -140.59 103.35 4.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.185 -0.947 . . . . 0.0 110.459 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.832 HD23 ' HB2' ' A' ' 66' ' ' ALA . 1.0 OUTLIER -96.29 -177.95 4.14 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.2 -0.938 . . . . 0.0 109.926 179.58 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.657 ' O ' HG22 ' A' ' 8' ' ' THR . 3.2 p30 168.87 35.68 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.439 -0.788 . . . . 0.0 110.004 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.503 ' HA ' ' O ' ' A' ' 7' ' ' GLY . 3.3 t0 -169.69 43.29 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.32 -0.862 . . . . 0.0 109.676 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.639 HG11 ' HZ2' ' A' ' 16' ' ' TRP . 3.5 t -89.7 126.46 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.39 -0.819 . . . . 0.0 110.353 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -149.11 148.32 29.53 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.336 -0.853 . . . . 0.0 110.094 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.719 HD21 HD11 ' A' ' 54' ' ' ILE . 47.5 tp -140.41 139.92 35.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.259 -0.901 . . . . 0.0 110.303 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.483 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -151.3 -177.83 6.29 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.281 -0.887 . . . . 0.0 110.031 179.9 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -129.61 175.25 8.95 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.224 -0.922 . . . . 0.0 110.205 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.469 ' O ' ' HB ' ' A' ' 150' ' ' VAL . 0.0 OUTLIER -64.74 86.75 0.05 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.894 . . . . 0.0 110.266 -179.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.525 HG13 ' O ' ' A' ' 150' ' ' VAL . 14.2 p -178.28 127.66 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.237 -0.914 . . . . 0.0 110.218 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 150' ' ' VAL . 4.7 mm-40 55.62 -172.91 0.06 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.283 -0.885 . . . . 0.0 110.243 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 7.8 mt . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.191 -179.993 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.263 0.554 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.455 ' HB2' ' HD2' ' A' ' 3' ' ' PRO . 9.7 p -165.98 169.01 7.16 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.22 -0.925 . . . . 0.0 110.26 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' A' ' 2' ' ' SER . 49.5 Cg_endo -75.99 -156.17 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.043 1.549 . . . . 0.0 110.043 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.563 ' CD1' HG12 ' A' ' 144' ' ' VAL . 8.2 pt -89.97 4.49 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.189 -0.944 . . . . 0.0 110.215 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 133.07 -166.43 23.7 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -137.14 76.84 1.61 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.23 -1.159 . . . . 0.0 110.203 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.43 ' C ' ' HA ' ' A' ' 143' ' ' ASP . . . 110.89 -133.13 11.36 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 1.048 HG22 ' O ' ' A' ' 142' ' ' ASP . 80.7 p -76.19 146.42 39.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.256 -1.143 . . . . 0.0 110.252 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.53 ' CE1' ' CD1' ' A' ' 16' ' ' TRP . 43.3 m-85 -42.95 -36.0 1.4 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.343 -0.848 . . . . 0.0 109.968 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.56 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 3.3 p-10 35.53 59.36 0.81 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.653 -0.654 . . . . 0.0 111.417 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.56 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 4.0 t0 162.03 -67.34 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.514 -0.742 . . . . 0.0 109.764 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.469 ' HA2' ' HB ' ' A' ' 27' ' ' THR . . . -174.56 -172.06 39.32 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.761 ' HD3' HG21 ' A' ' 27' ' ' THR . 47.3 Cg_endo -74.35 80.91 2.14 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 124.124 1.591 . . . . 0.0 110.384 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -35.8 -65.61 0.24 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.666 -0.646 . . . . 0.0 110.567 -179.853 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.69 ' C ' HD13 ' A' ' 49' ' ' LEU . . . -144.73 12.15 1.94 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.86 ' NE1' HD22 ' A' ' 49' ' ' LEU . 51.3 m95 -73.27 108.18 6.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.294 -1.121 . . . . 0.0 110.851 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.773 ' O ' HG13 ' A' ' 47' ' ' VAL . 1.4 m -109.0 151.38 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.317 -0.864 . . . . 0.0 109.133 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.431 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . . . -130.77 118.14 20.41 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.862 -1.149 . . . . 0.0 109.757 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.571 ' CE2' ' O ' ' A' ' 46' ' ' GLY . 7.4 p90 -107.02 173.63 6.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.513 -0.742 . . . . 0.0 110.861 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.566 ' HA2' ' CE1' ' A' ' 43' ' ' TYR . . . 90.69 -13.94 64.36 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.783 HG23 HG13 ' A' ' 45' ' ' VAL . 17.8 p -149.93 -141.44 0.11 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.27 -1.135 . . . . 0.0 110.236 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.561 ' CB ' ' HD3' ' A' ' 24' ' ' PRO . 19.4 t0 -89.29 174.47 7.81 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.357 -0.839 . . . . 0.0 109.658 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.614 ' N ' ' HD3' ' A' ' 24' ' ' PRO . . . -122.08 43.82 1.43 Allowed Glycine 0 N--CA 1.488 2.165 0 C-N-CA 119.513 -1.327 . . . . 0.0 110.765 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.614 ' HD3' ' N ' ' A' ' 23' ' ' GLY . 55.8 Cg_endo -80.19 41.12 1.07 Allowed 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 123.458 1.241 . . . . 0.0 110.685 179.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 1.015 ' CD2' HG12 ' A' ' 34' ' ' VAL . 17.4 mt -44.33 93.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.978 -1.076 . . . . 0.0 110.273 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 24' ' ' PRO . 36.0 t0 -74.67 115.82 14.67 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.278 -0.888 . . . . 0.0 109.333 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.761 HG21 ' HD3' ' A' ' 13' ' ' PRO . 2.1 p -119.38 -30.97 4.76 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.158 -0.964 . . . . 0.0 110.779 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.7 ' C ' HG22 ' A' ' 29' ' ' THR . 3.4 m -53.42 82.75 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.615 -0.678 . . . . 0.0 110.59 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.7 HG22 ' C ' ' A' ' 28' ' ' SER . 0.0 OUTLIER 165.6 -33.14 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.215 -0.928 . . . . 0.0 109.806 -179.542 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.455 ' O ' ' HB3' ' A' ' 142' ' ' ASP . . . 127.51 7.36 4.83 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.497 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -150.57 154.95 38.49 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.039 -1.271 . . . . 0.0 110.662 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.78 HD11 HD13 ' A' ' 25' ' ' LEU . 2.0 tt -105.4 104.65 14.42 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.369 -0.832 . . . . 0.0 110.239 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.569 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 0.8 OUTLIER -97.65 113.86 25.69 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.223 -0.923 . . . . 0.0 111.449 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 1.015 HG12 ' CD2' ' A' ' 25' ' ' LEU . 18.7 m -89.76 148.8 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 178.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.423 ' HB2' ' HG2' ' A' ' 24' ' ' PRO . . . -89.29 111.0 21.72 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.39 -0.819 . . . . 0.0 111.309 -178.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.094 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 55.7 t -105.29 133.36 20.2 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.477 -0.765 . . . . 0.0 109.303 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.577 ' HD3' ' CG2' ' A' ' 21' ' ' THR . 40.2 Cg_endo -67.2 171.84 10.88 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.81 1.426 . . . . 0.0 111.0 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.509 ' HA ' ' N ' ' A' ' 136' ' ' ALA . . . -57.86 129.26 41.08 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.441 -0.787 . . . . 0.0 111.06 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.574 ' O ' ' C ' ' A' ' 40' ' ' SER . . . 40.31 38.95 1.49 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.574 ' C ' ' O ' ' A' ' 39' ' ' GLY . 74.6 p 17.45 59.91 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 117.524 0.662 . . . . 0.0 111.733 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.465 ' O ' ' HB3' ' A' ' 42' ' ' GLN . . . -89.5 104.98 17.49 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.66 0.743 . . . . 0.0 110.52 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.466 ' OE1' ' HG3' ' A' ' 37' ' ' PRO . 2.8 pt20 171.32 -169.47 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.842 -0.536 . . . . 0.0 109.709 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.566 ' CE1' ' HA2' ' A' ' 20' ' ' GLY . 3.1 p90 -44.2 -26.14 0.29 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.162 -0.961 . . . . 0.0 109.73 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.511 ' N ' ' CD1' ' A' ' 43' ' ' TYR . . . 123.68 127.73 3.25 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.783 HG13 HG23 ' A' ' 21' ' ' THR . 4.0 t -89.45 177.08 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.198 -1.178 . . . . 0.0 109.153 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.571 ' O ' ' CE2' ' A' ' 19' ' ' TYR . . . 165.45 137.63 2.24 Favored Glycine 0 N--CA 1.49 2.275 0 C-N-CA 119.047 -1.549 . . . . 0.0 110.849 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.773 HG13 ' O ' ' A' ' 17' ' ' VAL . 21.5 t -104.58 141.55 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.534 -0.98 . . . . 0.0 109.487 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.603 HG23 HG22 ' A' ' 17' ' ' VAL . 4.9 m -132.44 143.91 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 120.799 -1.188 . . . . 0.0 110.474 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.86 HD22 ' NE1' ' A' ' 16' ' ' TRP . 25.5 tp -136.72 113.05 9.9 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.313 -0.867 . . . . 0.0 110.09 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.519 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 4.4 t30 -88.9 132.33 34.73 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.204 -0.935 . . . . 0.0 110.561 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 141.21 72.31 0.04 OUTLIER Glycine 0 N--CA 1.49 2.258 0 C-N-CA 119.826 -1.178 . . . . 0.0 110.204 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 123' ' ' GLY . 5.7 t -119.9 173.28 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.025 -1.28 . . . . 0.0 110.009 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.971 ' O ' HD13 ' A' ' 54' ' ' ILE . . . -124.4 80.12 1.81 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.06 -1.025 . . . . 0.0 110.806 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.971 HD13 ' O ' ' A' ' 53' ' ' ALA . 4.9 mm -142.52 163.63 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.256 -0.902 . . . . 0.0 109.603 179.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.881 ' HA ' HG23 ' A' ' 111' ' ' THR . 36.8 tt0 -172.12 27.62 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.02 -1.05 . . . . 0.0 110.557 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.522 ' HB3' ' O ' ' A' ' 55' ' ' GLU . 3.3 pt-20 177.62 -165.52 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.649 -0.657 . . . . 0.0 110.111 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.497 ' N ' ' HG3' ' A' ' 56' ' ' GLU . . . -94.08 68.75 1.4 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.58 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.2 m -104.4 173.02 6.48 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.463 -1.022 . . . . 0.0 110.393 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.574 ' O ' ' CD2' ' A' ' 60' ' ' TYR . 0.4 OUTLIER -89.79 159.57 16.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.437 -0.789 . . . . 0.0 109.79 179.636 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.812 ' HB3' HD11 ' A' ' 146' ' ' LEU . 66.4 m-85 -159.5 -175.51 5.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.29 -0.881 . . . . 0.0 110.23 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.712 HG23 ' O ' ' A' ' 104' ' ' GLU . 91.5 m -147.68 121.62 9.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.326 -0.859 . . . . 0.0 109.894 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.635 HD22 HD23 ' A' ' 89' ' ' LEU . 18.9 tp -89.56 120.43 30.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.205 -0.935 . . . . 0.0 110.15 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.522 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 2.6 ttt180 -124.26 137.57 54.49 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.338 -0.851 . . . . 0.0 109.97 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 1.18 ' CZ ' HG21 ' A' ' 102' ' ' VAL . 0.9 OUTLIER -178.46 142.94 0.25 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.302 -0.874 . . . . 0.0 109.732 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.511 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 96.0 m -119.19 97.86 5.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.187 -0.946 . . . . 0.0 109.892 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.793 ' CB ' HD21 ' A' ' 95' ' ' LEU . . . -99.62 149.22 23.5 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.425 -0.797 . . . . 0.0 110.32 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.487 ' OG1' ' HA ' ' A' ' 99' ' ' PRO . 95.4 m -149.79 102.28 3.13 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.321 -0.862 . . . . 0.0 110.197 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -90.01 133.1 35.01 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.289 -0.882 . . . . 0.0 110.008 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.421 ' C ' ' O ' ' A' ' 68' ' ' ALA . 19.2 p -43.99 -26.49 0.29 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.251 -0.906 . . . . 0.0 109.521 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.598 ' CG2' ' CB ' ' A' ' 137' ' ' TRP . 2.4 t -111.23 159.7 17.65 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.457 -0.777 . . . . 0.0 109.987 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.501 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 3.1 m-20 -78.75 79.52 5.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.142 -0.974 . . . . 0.0 109.424 179.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.592 HG23 ' CB ' ' A' ' 133' ' ' SER . 9.9 p -102.73 139.43 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.18 -0.95 . . . . 0.0 111.27 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.418 HG22 ' O ' ' A' ' 73' ' ' THR . 17.8 m -119.86 86.73 2.61 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.691 HG11 HD22 ' A' ' 129' ' ' LEU . 11.1 m -89.55 -142.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.273 -0.892 . . . . 0.0 110.674 -178.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.548 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 30.1 mtm-85 -132.56 148.68 52.38 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.281 -0.887 . . . . 0.0 110.456 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.791 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -148.25 154.75 40.47 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.238 -0.914 . . . . 0.0 109.826 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.866 ' CD1' ' HB3' ' A' ' 126' ' ' ALA . 3.9 pp 179.0 -156.42 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.253 -0.904 . . . . 0.0 110.467 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.833 HG23 HD22 ' A' ' 89' ' ' LEU . 3.9 t -149.41 165.48 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.352 -0.842 . . . . 0.0 109.535 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.544 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . -174.83 -163.64 28.33 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.408 -1.377 . . . . 0.0 110.255 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.526 ' HG3' ' HA ' ' A' ' 85' ' ' TYR . 3.3 pt20 -119.84 143.38 47.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.383 -1.069 . . . . 0.0 110.461 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.482 ' HB2' ' HG2' ' A' ' 122' ' ' GLU . 3.6 m-20 -96.22 94.71 7.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.365 -0.834 . . . . 0.0 109.991 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.544 ' C ' ' CE1' ' A' ' 85' ' ' TYR . . . 137.49 149.43 5.57 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.622 ' N ' ' CE1' ' A' ' 85' ' ' TYR . . . -62.44 155.12 69.33 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.303 -1.116 . . . . 0.0 110.298 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.52 ' C ' ' CD2' ' A' ' 85' ' ' TYR . 50.5 Cg_endo -77.41 7.91 18.71 Favored 'Cis proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.636 -2.235 . . . . 0.0 110.803 -0.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.622 ' CE1' ' N ' ' A' ' 83' ' ' ALA . 11.4 m-85 69.94 166.0 0.28 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.306 -0.871 . . . . 0.0 110.161 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.518 ' N ' ' CG ' ' A' ' 80' ' ' GLN . . . 172.69 165.94 30.48 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.444 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 0.8 OUTLIER -143.31 149.1 37.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.274 -1.133 . . . . 0.0 110.239 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.951 HG23 HD12 ' A' ' 89' ' ' LEU . 30.3 m -122.14 -18.43 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.25 -0.906 . . . . 0.0 110.285 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.951 HD12 HG23 ' A' ' 88' ' ' VAL . 4.3 mp -111.93 143.02 43.6 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.178 -0.951 . . . . 0.0 110.984 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.507 ' O ' HG23 ' A' ' 91' ' ' THR . 11.2 m-20 -151.11 88.59 1.46 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.339 -0.85 . . . . 0.0 110.183 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.507 HG23 ' O ' ' A' ' 90' ' ' ASP . 6.4 p -153.29 176.96 11.39 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.049 -1.032 . . . . 0.0 110.656 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.2 m -119.89 120.05 30.66 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.348 -0.845 . . . . 0.0 110.072 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.791 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 46.1 Cg_endo -74.05 127.88 11.77 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.928 1.488 . . . . 0.0 111.076 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.593 ' HB3' ' NE ' ' A' ' 100' ' ' ARG . . . -95.11 149.68 21.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.318 -0.864 . . . . 0.0 109.3 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.793 HD21 ' CB ' ' A' ' 66' ' ' ALA . 43.5 mt -145.21 173.5 11.89 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.973 -1.079 . . . . 0.0 110.997 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.607 HG22 ' C ' ' A' ' 95' ' ' LEU . 0.1 OUTLIER 169.15 -178.59 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.633 -0.667 . . . . 0.0 109.716 -179.874 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.32 -13.75 21.66 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.126 -0.984 . . . . 0.0 109.806 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.541 ' CG ' ' HD2' ' A' ' 99' ' ' PRO . 33.7 tt0 -95.74 149.56 36.22 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.444 -0.785 . . . . 0.0 109.866 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.541 ' HD2' ' CG ' ' A' ' 98' ' ' GLU . 41.5 Cg_endo -68.11 130.09 20.75 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.807 1.425 . . . . 0.0 110.169 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.593 ' NE ' ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.83 91.92 3.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.267 -0.896 . . . . 0.0 110.624 -179.537 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.462 ' HG2' ' OG1' ' A' ' 65' ' ' THR . 31.8 mt-30 -73.54 157.94 35.78 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.273 -0.892 . . . . 0.0 109.632 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 1.18 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 60.4 t -131.29 133.03 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.143 -0.973 . . . . 0.0 110.518 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.49 87.73 1.46 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.406 -0.809 . . . . 0.0 110.009 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.712 ' O ' HG23 ' A' ' 61' ' ' THR . 56.8 mt-10 -125.83 -176.14 3.54 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.203 -0.935 . . . . 0.0 110.377 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 61' ' ' THR . 1.8 t -135.64 166.93 22.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.3 -0.875 . . . . 0.0 110.204 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.707 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 31.8 p90 -174.74 152.8 1.66 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.22 -0.925 . . . . 0.0 110.196 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.521 ' O ' ' N ' ' A' ' 109' ' ' SER . 4.8 m -89.7 94.95 10.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.192 -0.943 . . . . 0.0 109.97 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.685 ' HB1' HG21 ' A' ' 54' ' ' ILE . . . -50.76 89.54 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.301 -0.874 . . . . 0.0 110.014 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 107' ' ' THR . 10.3 p -85.65 53.27 2.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.27 -0.894 . . . . 0.0 109.996 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -157.79 -163.35 1.32 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.178 -0.951 . . . . 0.0 110.392 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.951 HG22 ' HD3' ' A' ' 113' ' ' PRO . 97.0 m -136.0 110.63 8.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.272 -0.892 . . . . 0.0 110.286 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.59 ' CG ' ' HA3' ' A' ' 123' ' ' GLY . 15.4 m-30 -109.07 70.75 0.43 Allowed Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.341 -0.849 . . . . 0.0 110.047 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.951 ' HD3' HG22 ' A' ' 111' ' ' THR . 46.4 Cg_endo -71.38 120.42 6.95 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 123.802 1.422 . . . . 0.0 110.401 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.491 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -66.39 -8.07 23.33 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.275 -0.89 . . . . 0.0 110.218 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.6 m -107.46 86.56 2.81 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.216 -0.928 . . . . 0.0 110.286 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.491 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 45.5 Cg_endo -72.65 151.69 52.55 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.001 1.527 . . . . 0.0 110.441 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.703 ' HB3' ' HB2' ' A' ' 120' ' ' ASP . . . -142.45 -165.88 2.14 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.267 -0.896 . . . . 0.0 110.289 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.58 -11.46 16.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.21 -0.931 . . . . 0.0 110.263 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -156.66 21.46 0.34 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.242 -0.911 . . . . 0.0 110.124 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.703 ' HB2' ' HB3' ' A' ' 117' ' ' ALA . 26.2 m-20 -112.86 102.53 54.79 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.25 -0.906 . . . . 0.0 110.251 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.534 ' HB3' ' CA ' ' A' ' 82' ' ' GLY . 47.1 Cg_endo -73.28 135.04 21.92 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.022 1.538 . . . . 0.0 110.271 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.534 ' CG ' ' N ' ' A' ' 123' ' ' GLY . 0.2 OUTLIER -95.58 -143.25 0.26 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.21 -0.931 . . . . 0.0 110.06 179.904 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.6 ' O ' HG23 ' A' ' 52' ' ' VAL . . . -149.86 147.3 17.41 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.591 ' O ' HG13 ' A' ' 78' ' ' VAL . 1.8 pt20 -150.32 -162.56 1.58 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.328 -1.101 . . . . 0.0 110.421 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.543 HG21 ' CH2' ' A' ' 16' ' ' TRP . 13.0 mt -119.12 143.83 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.481 -0.762 . . . . 0.0 109.278 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.866 ' HB3' ' CD1' ' A' ' 77' ' ' LEU . . . -117.04 117.44 29.66 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.178 -0.951 . . . . 0.0 111.048 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.519 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 3.0 m-30 -116.97 102.75 9.62 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.5 ' HB2' ' HB2' ' A' ' 75' ' ' ARG . 6.6 mt-30 -88.98 107.77 19.21 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.108 -0.995 . . . . 0.0 111.132 -178.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.691 HD22 HG11 ' A' ' 74' ' ' VAL . 16.8 mt -106.35 43.53 1.14 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.5 -0.75 . . . . 0.0 109.035 178.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 131' ' ' GLY . . . -91.68 116.65 5.04 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.546 ' N ' ' OG ' ' A' ' 40' ' ' SER . . . 41.95 90.07 0.01 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.613 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 6.8 m-85 -139.98 -55.73 0.55 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.167 -1.196 . . . . 0.0 110.492 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.592 ' CB ' HG23 ' A' ' 72' ' ' VAL . 1.2 t -88.95 -177.24 5.42 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.945 -1.097 . . . . 0.0 110.29 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.454 ' N ' ' OG ' ' A' ' 133' ' ' SER . . . -100.08 -75.22 0.58 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.226 -0.921 . . . . 0.0 110.393 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' A' ' 136' ' ' ALA . 83.9 m-20 -83.24 153.75 24.54 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.218 -0.927 . . . . 0.0 110.156 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.509 ' N ' ' HA ' ' A' ' 38' ' ' ALA . . . -40.95 142.3 0.5 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.363 -0.836 . . . . 0.0 110.452 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 1.094 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 18.8 p90 -153.46 -159.9 1.05 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.281 -0.887 . . . . 0.0 110.654 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.523 ' O ' ' CB ' ' A' ' 68' ' ' ALA . 0.8 OUTLIER -160.1 176.12 12.16 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.371 -0.83 . . . . 0.0 109.63 -178.4 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.569 ' O ' ' HA ' ' A' ' 33' ' ' CYS . 1.8 mp -136.66 117.33 13.95 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.905 -1.122 . . . . 0.0 111.89 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' CYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 0.8 OUTLIER -105.37 111.03 23.6 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.662 -0.649 . . . . 0.0 111.176 178.683 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.723 HD23 ' HB2' ' A' ' 66' ' ' ALA . 1.4 mt -100.78 -179.73 4.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.914 . . . . 0.0 109.08 178.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 1.048 ' O ' HG22 ' A' ' 8' ' ' THR . 0.5 OUTLIER 166.19 64.88 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.327 -0.858 . . . . 0.0 110.073 179.912 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.513 ' CB ' ' O ' ' A' ' 142' ' ' ASP . 0.3 OUTLIER 165.79 42.8 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.374 -0.829 . . . . 0.0 108.962 -179.906 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.692 HG11 ' HZ2' ' A' ' 16' ' ' TRP . 1.0 OUTLIER -89.15 120.02 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.542 -0.724 . . . . 0.0 110.593 -178.811 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -157.53 147.35 20.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.471 -0.768 . . . . 0.0 109.778 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.812 HD11 ' HB3' ' A' ' 60' ' ' TYR . 42.9 tp -144.07 146.83 33.08 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.254 -0.903 . . . . 0.0 110.342 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.482 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 7.1 t0 -177.88 152.12 0.74 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.214 -0.929 . . . . 0.0 110.296 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.527 ' HB2' ' CG2' ' A' ' 58' ' ' THR . 22.5 p -91.95 -176.02 4.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.286 -0.884 . . . . 0.0 110.174 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -52.91 169.51 0.09 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.226 -0.921 . . . . 0.0 110.143 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 11.4 p -47.48 146.04 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.229 -0.92 . . . . 0.0 110.218 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -168.71 61.15 0.06 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.286 -0.884 . . . . 0.0 110.218 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.207 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.425 ' O ' ' C ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.293 0.568 . . . . 0.0 110.175 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 1' ' ' ALA . 1.6 t -42.95 107.82 0.59 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.193 -0.942 . . . . 0.0 110.138 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.46 ' HG2' ' O ' ' A' ' 51' ' ' GLY . 51.4 Cg_endo -80.82 19.58 1.11 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.998 1.525 . . . . 0.0 111.072 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.639 ' CG2' HD21 ' A' ' 49' ' ' LEU . 6.7 pt -145.09 11.74 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.968 -1.082 . . . . 0.0 110.221 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 115.07 148.47 9.47 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -89.73 20.8 3.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.234 -1.157 . . . . 0.0 110.24 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.469 ' C ' ' HA ' ' A' ' 143' ' ' ASP . . . 153.86 -125.41 1.74 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.783 HG22 ' O ' ' A' ' 142' ' ' ASP . 0.8 OUTLIER -57.62 132.91 54.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.229 -1.159 . . . . 0.0 110.154 -179.92 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.569 ' O ' ' CB ' ' A' ' 10' ' ' ASP . 11.8 m-85 -43.86 -27.24 0.33 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.32 -0.862 . . . . 0.0 109.527 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.595 ' O ' ' HB2' ' A' ' 11' ' ' ASP . 0.0 OUTLIER 80.34 -43.43 0.24 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 122.038 -0.413 . . . . 0.0 111.062 179.303 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.595 ' HB2' ' O ' ' A' ' 10' ' ' ASP . 9.4 t70 161.93 39.22 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.083 0 CA-C-O 121.904 0.859 . . . . 0.0 109.085 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -176.81 134.74 2.62 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.618 ' HB3' HD12 ' A' ' 32' ' ' LEU . 45.9 Cg_endo -72.86 -15.39 26.53 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.932 1.491 . . . . 0.0 110.43 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 0.3 OUTLIER 63.77 -87.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.237 -0.914 . . . . 0.0 110.184 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.643 ' O ' HG13 ' A' ' 17' ' ' VAL . . . -124.35 -14.8 3.52 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 1.062 ' CE2' HD22 ' A' ' 49' ' ' LEU . 80.6 m95 -51.82 111.36 0.59 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.263 -1.139 . . . . 0.0 110.593 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.746 ' O ' HG13 ' A' ' 47' ' ' VAL . 1.0 OUTLIER -112.56 148.01 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.142 -0.974 . . . . 0.0 109.528 179.433 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.698 ' HB3' ' HB3' ' A' ' 25' ' ' LEU . . . -129.76 154.02 47.62 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.052 -1.03 . . . . 0.0 109.817 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.742 ' HE2' HG13 ' A' ' 48' ' ' VAL . 9.4 p90 -145.91 155.58 42.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.915 . . . . 0.0 110.936 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.649 ' HA3' HG13 ' A' ' 45' ' ' VAL . . . 161.83 -93.89 0.12 Allowed Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.016 -1.633 . . . . 0.0 109.016 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.569 HG22 ' HH ' ' A' ' 43' ' ' TYR . 11.6 p -151.21 18.19 0.75 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.183 -1.187 . . . . 0.0 110.715 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.941 ' CB ' ' HB3' ' A' ' 35' ' ' ALA . 0.4 OUTLIER -123.87 60.6 1.11 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.037 -1.039 . . . . 0.0 110.229 179.479 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 43.53 -161.7 0.06 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.431 ' O ' ' C ' ' A' ' 25' ' ' LEU . 46.0 Cg_endo -72.86 145.12 39.99 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.973 1.512 . . . . 0.0 110.378 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.729 HD13 HD11 ' A' ' 32' ' ' LEU . 0.8 OUTLIER -42.66 163.43 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.311 -0.868 . . . . 0.0 110.194 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.28 138.55 45.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.264 -0.898 . . . . 0.0 110.109 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.614 ' O ' HG22 ' A' ' 29' ' ' THR . 0.7 OUTLIER -119.85 -78.97 0.6 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.182 -0.949 . . . . 0.0 110.232 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.46 ' HB2' ' O ' ' A' ' 27' ' ' THR . 0.4 OUTLIER 61.43 -87.68 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.257 -0.902 . . . . 0.0 110.227 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.676 HG23 ' H ' ' A' ' 31' ' ' ALA . 5.1 t -42.18 -29.99 0.27 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.275 -0.891 . . . . 0.0 110.276 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' A' ' 11' ' ' ASP . . . 125.39 -26.41 5.49 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.676 ' H ' HG23 ' A' ' 29' ' ' THR . . . -91.8 136.08 33.42 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.211 -1.17 . . . . 0.0 110.188 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.729 HD11 HD13 ' A' ' 25' ' ' LEU . 1.9 tp -68.05 106.25 2.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.163 -0.96 . . . . 0.0 109.806 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 8.9 m -113.86 102.75 10.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.219 -0.925 . . . . 0.0 110.97 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.617 ' CG1' ' HB2' ' A' ' 18' ' ' ALA . 24.0 m -89.76 164.19 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.244 -0.91 . . . . 0.0 108.997 178.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.941 ' HB3' ' CB ' ' A' ' 22' ' ' ASP . . . -112.07 132.14 55.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.942 -1.099 . . . . 0.0 111.139 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.12 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 37.2 t -119.66 117.37 32.71 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.543 -0.723 . . . . 0.0 109.325 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.558 ' HG3' ' CG2' ' A' ' 21' ' ' THR . 44.2 Cg_endo -70.38 144.22 50.1 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.885 1.466 . . . . 0.0 111.236 -179.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.583 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -45.34 153.94 0.2 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.375 -0.828 . . . . 0.0 109.83 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 38' ' ' ALA . . . 45.22 59.39 4.61 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.724 ' OG ' HG21 ' A' ' 45' ' ' VAL . 0.6 OUTLIER -84.14 36.99 0.59 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.314 -1.109 . . . . 0.0 110.589 -179.625 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -92.44 19.73 6.92 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.96 0.886 . . . . 0.0 109.664 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.575 ' HG3' ' CD2' ' A' ' 43' ' ' TYR . 16.2 pt20 -73.23 -143.19 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.635 ' CD1' ' N ' ' A' ' 44' ' ' GLY . 6.8 p90 -42.05 -27.52 0.13 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.502 -0.749 . . . . 0.0 109.375 179.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.635 ' N ' ' CD1' ' A' ' 43' ' ' TYR . . . 117.66 113.51 2.64 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.724 HG21 ' OG ' ' A' ' 40' ' ' SER . 2.6 t -89.55 149.99 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.137 -1.214 . . . . 0.0 108.191 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.571 ' O ' ' CE2' ' A' ' 19' ' ' TYR . . . 179.3 166.97 35.99 Favored Glycine 0 N--CA 1.489 2.178 0 C-N-CA 118.582 -1.771 . . . . 0.0 111.083 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.746 HG13 ' O ' ' A' ' 17' ' ' VAL . 38.4 t -122.22 131.41 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.754 -0.851 . . . . 0.0 109.457 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.742 HG13 ' HE2' ' A' ' 19' ' ' TYR . 33.0 m -120.14 139.01 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.886 -1.134 . . . . 0.0 110.683 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 1.062 HD22 ' CE2' ' A' ' 16' ' ' TRP . 7.7 tp -130.66 87.33 2.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.325 -0.859 . . . . 0.0 110.211 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.552 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 3.5 m120 -69.15 103.3 1.87 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.926 . . . . 0.0 110.276 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.46 ' O ' ' HG2' ' A' ' 3' ' ' PRO . . . 157.02 79.72 0.03 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.66 HG23 ' HA ' ' A' ' 124' ' ' GLN . 6.8 t -124.92 160.16 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.167 -1.196 . . . . 0.0 109.933 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.616 ' O ' HD13 ' A' ' 54' ' ' ILE . . . -119.63 89.94 3.23 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.173 -0.955 . . . . 0.0 110.855 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.742 HD11 HD21 ' A' ' 146' ' ' LEU . 27.4 mm -130.06 172.79 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.28 -0.887 . . . . 0.0 109.507 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.585 ' N ' HG22 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -177.79 131.51 0.15 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.913 -1.117 . . . . 0.0 111.354 -179.749 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.464 ' O ' ' O ' ' A' ' 108' ' ' ALA . 7.8 mm-40 52.96 -168.45 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.667 -0.646 . . . . 0.0 110.85 178.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.502 ' HA2' ' HA ' ' A' ' 109' ' ' SER . . . -87.24 61.57 4.24 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.357 -1.897 . . . . 0.0 108.357 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.732 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.0 OUTLIER -96.41 174.43 6.87 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.625 -0.927 . . . . 0.0 110.078 -179.323 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.571 ' O ' ' CD2' ' A' ' 60' ' ' TYR . 7.5 m -89.89 158.8 17.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.331 -0.856 . . . . 0.0 110.487 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.732 ' CE2' HG22 ' A' ' 58' ' ' THR . 66.4 m-85 -159.31 119.81 3.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.381 -0.824 . . . . 0.0 109.917 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 68.9 m -89.91 110.65 21.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.175 -0.953 . . . . 0.0 110.29 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.417 HD22 ' CD2' ' A' ' 89' ' ' LEU . 17.5 tp -89.76 126.0 35.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.257 -0.902 . . . . 0.0 109.775 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.501 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 19.8 mtm105 -132.81 130.46 39.88 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.251 -0.906 . . . . 0.0 110.395 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 1.129 ' CZ ' HG21 ' A' ' 102' ' ' VAL . 5.7 p90 -166.0 149.61 7.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.398 -0.814 . . . . 0.0 109.809 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.688 HG23 ' HG2' ' A' ' 101' ' ' GLN . 28.9 m -119.58 89.69 3.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.208 -0.932 . . . . 0.0 110.245 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.734 ' CB ' HD21 ' A' ' 95' ' ' LEU . . . -89.9 149.26 22.7 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.355 -0.84 . . . . 0.0 110.18 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.768 HG23 ' O ' ' A' ' 98' ' ' GLU . 98.8 m -150.19 129.77 13.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.364 -0.835 . . . . 0.0 110.217 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -114.36 142.32 46.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.312 -0.868 . . . . 0.0 109.915 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 68' ' ' ALA . 17.3 m -45.6 -25.64 0.49 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.064 -1.023 . . . . 0.0 109.102 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.78 HG22 ' HB2' ' A' ' 137' ' ' TRP . 4.8 t -119.03 -160.55 0.81 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.589 -0.695 . . . . 0.0 109.835 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.503 ' N ' HG23 ' A' ' 70' ' ' THR . 4.9 m-20 -107.77 67.98 0.7 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.336 -0.853 . . . . 0.0 109.179 178.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.79 HG23 ' CB ' ' A' ' 133' ' ' SER . 3.8 p -88.04 135.64 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.33 -0.856 . . . . 0.0 111.374 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.432 HG22 ' O ' ' A' ' 73' ' ' THR . 7.4 m -121.92 91.42 3.51 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.918 HG11 HD22 ' A' ' 129' ' ' LEU . 5.3 m -89.56 -158.93 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.172 -0.955 . . . . 0.0 110.88 -178.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 14.4 mtm-85 -119.15 107.51 13.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.264 -0.897 . . . . 0.0 110.886 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.494 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -112.1 160.59 17.39 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.156 -0.965 . . . . 0.0 109.797 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.609 HD12 ' N ' ' A' ' 78' ' ' VAL . 3.3 pp 177.71 -156.65 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.295 -0.878 . . . . 0.0 110.201 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.826 HG23 HD22 ' A' ' 89' ' ' LEU . 3.9 t -147.81 168.03 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.217 -0.927 . . . . 0.0 109.527 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.488 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . 177.39 -176.18 47.94 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.39 -1.386 . . . . 0.0 110.174 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.496 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 1.5 tt0 -89.27 -159.16 0.55 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.423 -1.045 . . . . 0.0 110.222 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.501 ' HB2' ' HG2' ' A' ' 122' ' ' GLU . 4.7 m120 -168.12 83.95 0.19 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.352 -0.843 . . . . 0.0 110.166 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.534 ' O ' ' HB3' ' A' ' 83' ' ' ALA . . . 140.55 36.75 0.11 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.537 ' HA ' ' CD2' ' A' ' 85' ' ' TYR . . . 59.49 145.99 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.254 -1.145 . . . . 0.0 110.315 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.461 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.6 Cg_endo -81.79 21.27 11.78 Favored 'Cis proline' 0 C--N 1.314 -1.288 0 C-N-CA 121.755 -2.185 . . . . 0.0 110.869 -0.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.537 ' CD2' ' HA ' ' A' ' 83' ' ' ALA . 50.0 m-85 60.39 124.16 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.095 -1.003 . . . . 0.0 110.282 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -152.86 112.91 0.55 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.568 HG22 ' O ' ' A' ' 78' ' ' VAL . 0.8 OUTLIER -98.09 147.21 24.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.247 -1.149 . . . . 0.0 110.396 -179.891 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 1.063 HG23 HD12 ' A' ' 89' ' ' LEU . 33.2 m -119.97 -20.73 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.299 -0.876 . . . . 0.0 109.966 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 1.063 HD12 HG23 ' A' ' 88' ' ' VAL . 4.5 mp -105.36 143.86 32.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.312 -0.868 . . . . 0.0 110.764 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.732 ' O ' HG23 ' A' ' 91' ' ' THR . 10.1 m-20 -150.63 86.21 1.39 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.294 -0.879 . . . . 0.0 110.245 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.732 HG23 ' O ' ' A' ' 90' ' ' ASP . 1.8 p -159.98 177.98 10.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.167 -0.958 . . . . 0.0 110.476 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.507 ' CB ' ' O ' ' A' ' 74' ' ' VAL . 4.8 m -120.0 129.78 25.18 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.305 -0.872 . . . . 0.0 110.066 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.775 ' HG2' HG22 ' A' ' 74' ' ' VAL . 48.0 Cg_endo -72.19 78.61 1.85 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.906 1.477 . . . . 0.0 110.879 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.533 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -50.84 138.67 18.35 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.059 -1.026 . . . . 0.0 109.313 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.734 HD21 ' CB ' ' A' ' 66' ' ' ALA . 42.7 mt -130.12 176.3 8.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.93 -1.106 . . . . 0.0 110.862 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' A' ' 70' ' ' THR . 0.2 OUTLIER -171.73 -178.66 2.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.493 -0.754 . . . . 0.0 109.786 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 9.8 p -70.25 -7.84 45.39 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.2 -0.938 . . . . 0.0 110.12 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.768 ' O ' HG23 ' A' ' 67' ' ' THR . 4.4 mt-10 -109.18 177.34 1.27 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.238 -0.914 . . . . 0.0 110.077 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.504 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 46.4 Cg_endo -72.6 132.99 19.7 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 124.035 1.545 . . . . 0.0 110.357 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.533 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.59 86.55 2.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.222 -0.924 . . . . 0.0 110.16 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.688 ' HG2' HG23 ' A' ' 65' ' ' THR . 1.8 mt-30 -73.49 155.8 38.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.283 -0.885 . . . . 0.0 110.258 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 1.129 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 23.0 t -134.76 138.34 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -0.906 . . . . 0.0 110.105 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.3 m -150.11 112.51 4.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.931 . . . . 0.0 110.245 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -156.91 133.03 9.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.233 -0.917 . . . . 0.0 110.306 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.548 HG22 ' CG2' ' A' ' 59' ' ' THR . 11.2 m -95.53 94.18 7.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.283 -0.886 . . . . 0.0 110.164 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.585 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 33.8 p90 -94.23 153.57 17.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.27 -0.894 . . . . 0.0 110.281 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 97.3 m -89.72 99.36 12.38 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.175 -0.953 . . . . 0.0 109.811 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.648 ' CB ' ' CD2' ' A' ' 60' ' ' TYR . . . -58.72 104.58 0.23 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.28 -0.888 . . . . 0.0 110.497 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.502 ' HA ' ' HA2' ' A' ' 57' ' ' GLY . 11.1 p -91.11 53.7 2.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.393 -0.817 . . . . 0.0 110.047 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -164.28 -153.43 0.21 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.292 -0.88 . . . . 0.0 110.217 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.545 HG23 ' HA ' ' A' ' 55' ' ' GLU . 14.4 m -150.85 112.55 4.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -0.898 . . . . 0.0 110.341 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.611 ' CE2' HG12 ' A' ' 78' ' ' VAL . 14.4 m-30 -110.81 78.2 1.53 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.289 -0.882 . . . . 0.0 110.171 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.502 ' HD2' ' HA ' ' A' ' 122' ' ' GLU . 44.2 Cg_endo -70.99 -174.0 1.03 Allowed 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.956 1.503 . . . . 0.0 110.347 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -133.75 43.88 2.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 0.0 110.239 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.726 ' O ' HG23 ' A' ' 115' ' ' THR . 8.5 t -139.87 93.74 9.34 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.286 -0.884 . . . . 0.0 110.162 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.99 117.44 5.12 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.059 1.557 . . . . 0.0 110.443 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.679 ' HB3' ' HB2' ' A' ' 120' ' ' ASP . . . -135.38 -174.6 3.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.241 -0.912 . . . . 0.0 110.143 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.02 -10.6 22.81 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.21 -0.931 . . . . 0.0 110.198 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.435 ' OD1' ' OD1' ' A' ' 120' ' ' ASP . 5.4 p30 -156.46 20.08 0.34 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.291 -0.88 . . . . 0.0 110.155 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.679 ' HB2' ' HB3' ' A' ' 117' ' ' ALA . 80.0 m-20 -116.51 89.01 26.04 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.213 -0.929 . . . . 0.0 110.246 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.479 ' HB3' ' HA3' ' A' ' 82' ' ' GLY . 46.7 Cg_endo -73.71 155.11 49.42 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.997 1.525 . . . . 0.0 110.401 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.502 ' HA ' ' HD2' ' A' ' 113' ' ' PRO . 1.2 pt-20 -122.09 -164.11 1.13 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.23 -0.919 . . . . 0.0 110.133 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.582 ' HA3' ' CG ' ' A' ' 112' ' ' TYR . . . -137.28 154.76 22.54 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.66 ' HA ' HG23 ' A' ' 52' ' ' VAL . 1.7 pp0? -150.51 -160.55 1.18 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.151 -1.205 . . . . 0.0 110.623 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.805 HG21 ' HH2' ' A' ' 16' ' ' TRP . 13.8 mt -118.21 143.34 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 76' ' ' ALA . . . -119.31 123.59 44.58 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.234 -0.916 . . . . 0.0 111.198 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.581 ' HE2' HG21 ' A' ' 125' ' ' ILE . 11.3 m-85 -118.51 97.11 5.59 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 178.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.449 ' O ' ' HB ' ' A' ' 74' ' ' VAL . 12.4 mm-40 -88.65 93.23 9.49 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.302 -0.874 . . . . 0.0 111.841 -177.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 1.062 HD13 HD13 ' A' ' 139' ' ' LEU . 15.1 mt -93.94 47.17 1.2 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -84.42 83.1 1.64 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -179.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 55.61 100.13 0.01 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.594 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 9.8 m-85 -139.39 -40.44 0.46 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.312 -1.111 . . . . 0.0 109.943 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.79 ' CB ' HG23 ' A' ' 72' ' ' VAL . 1.3 t -90.86 -176.98 4.83 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.276 -0.89 . . . . 0.0 110.152 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.46 ' N ' ' OG ' ' A' ' 133' ' ' SER . . . -89.05 -88.07 0.16 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.207 -0.933 . . . . 0.0 110.402 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.8 176.49 6.27 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.274 -0.891 . . . . 0.0 110.452 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.583 ' HB2' ' HB2' ' A' ' 38' ' ' ALA . . . -50.12 128.98 20.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.326 -0.859 . . . . 0.0 110.286 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 1.12 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 4.4 p90 -134.92 -170.07 2.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.25 -0.906 . . . . 0.0 110.027 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.526 ' O ' ' CB ' ' A' ' 68' ' ' ALA . 0.5 OUTLIER -160.55 175.18 13.0 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.255 -0.978 . . . . 0.0 110.7 -178.759 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 1.062 HD13 HD13 ' A' ' 129' ' ' LEU . 2.4 mp -127.78 146.46 50.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.312 -0.867 . . . . 0.0 109.731 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' CYS . . . . . 0.517 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 11.8 m -147.56 97.74 2.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.062 -1.024 . . . . 0.0 110.949 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.584 HD12 HD23 ' A' ' 32' ' ' LEU . 0.5 OUTLIER -93.2 -177.07 4.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.168 -0.958 . . . . 0.0 109.222 179.012 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.783 ' O ' HG22 ' A' ' 8' ' ' THR . 0.8 OUTLIER 175.57 38.23 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.058 -1.027 . . . . 0.0 110.624 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.522 ' OD2' ' N ' ' A' ' 65' ' ' THR . 3.8 p-10 175.31 51.45 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.364 -0.835 . . . . 0.0 109.698 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.803 HG11 ' CZ2' ' A' ' 16' ' ' TRP . 3.5 t -90.13 114.88 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.389 -0.819 . . . . 0.0 110.32 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -137.75 133.39 34.05 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.319 -0.863 . . . . 0.0 110.077 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.742 HD21 HD11 ' A' ' 54' ' ' ILE . 39.4 tp -129.17 137.92 51.45 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.276 -0.89 . . . . 0.0 110.182 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.467 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 1.3 t70 -179.07 156.25 0.78 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.229 -0.919 . . . . 0.0 110.253 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.429 ' HB3' ' CG2' ' A' ' 58' ' ' THR . 2.3 p -90.72 -171.91 3.2 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.263 -0.898 . . . . 0.0 110.196 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.516 ' OE1' HG12 ' A' ' 150' ' ' VAL . 0.9 OUTLIER -46.82 169.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.206 -0.934 . . . . 0.0 110.209 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.516 HG12 ' OE1' ' A' ' 149' ' ' GLU . 9.9 p -43.04 161.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -0.894 . . . . 0.0 110.263 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -117.24 166.03 12.75 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.233 -0.917 . . . . 0.0 110.187 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.4 tp . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.204 -179.987 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.414 ' O ' ' CB ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.246 0.546 . . . . 0.0 110.241 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.414 ' CB ' ' O ' ' A' ' 1' ' ' ALA . 0.5 OUTLIER 63.72 61.2 1.72 Allowed Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.278 -0.889 . . . . 0.0 110.228 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -76.22 -156.36 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.009 1.531 . . . . 0.0 110.133 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.427 ' O ' ' CD ' ' A' ' 14' ' ' GLU . 8.2 pt -94.76 -13.03 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.203 -0.936 . . . . 0.0 110.139 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 144.09 -25.96 2.05 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.558 ' HA ' ' CB ' ' A' ' 145' ' ' ALA . 6.1 mt-10 54.52 68.77 0.81 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.274 -1.133 . . . . 0.0 110.26 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 170.11 -161.82 35.02 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.781 HG22 ' O ' ' A' ' 142' ' ' ASP . 15.2 p -90.54 -168.06 2.0 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.213 -1.169 . . . . 0.0 110.218 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.521 ' CE1' ' CD1' ' A' ' 16' ' ' TRP . 44.7 m-85 -103.29 49.67 0.82 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.9 . . . . 0.0 110.122 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.546 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 4.8 p30 -84.98 44.63 1.09 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.263 -0.898 . . . . 0.0 110.248 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.546 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 4.5 t0 161.75 78.66 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.264 0.554 . . . . 0.0 109.597 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 70.14 142.49 0.19 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.482 ' O ' ' HB2' ' A' ' 14' ' ' GLU . 48.7 Cg_endo -75.83 3.82 5.7 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.059 1.557 . . . . 0.0 110.666 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 0.1 OUTLIER 67.41 -84.78 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.262 -0.899 . . . . 0.0 110.301 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.463 ' O ' HG13 ' A' ' 17' ' ' VAL . . . -141.46 8.39 2.6 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.92 ' CE2' HD22 ' A' ' 49' ' ' LEU . 38.0 m95 -64.23 131.94 48.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.173 -1.192 . . . . 0.0 110.391 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.702 ' O ' HG13 ' A' ' 47' ' ' VAL . 1.0 OUTLIER -133.5 153.9 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.255 -0.903 . . . . 0.0 109.82 179.692 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.422 ' HB3' HD21 ' A' ' 25' ' ' LEU . . . -139.13 139.41 37.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.333 -0.854 . . . . 0.0 109.348 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.565 ' CE2' ' O ' ' A' ' 46' ' ' GLY . 1.7 p90 -121.52 144.04 48.94 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.165 -0.959 . . . . 0.0 111.093 -178.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.595 ' HA2' ' CE1' ' A' ' 43' ' ' TYR . . . 116.24 82.97 1.0 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.642 ' CG2' ' CE2' ' A' ' 43' ' ' TYR . 1.6 p 52.04 18.26 0.8 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.495 -1.003 . . . . 0.0 110.688 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 1.015 ' HA ' ' HB3' ' A' ' 35' ' ' ALA . 5.4 p30 -114.91 93.07 4.15 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.113 -0.992 . . . . 0.0 109.939 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 22' ' ' ASP . . . -60.31 -121.67 0.01 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.85 145.85 41.34 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.826 1.435 . . . . 0.0 110.488 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 1.081 HD22 HG12 ' A' ' 34' ' ' VAL . 14.3 mt -76.32 102.87 6.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.255 -0.903 . . . . 0.0 110.069 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.503 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 24.4 t0 -43.53 110.24 0.19 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.207 -0.933 . . . . 0.0 109.933 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.831 HG23 ' O ' ' A' ' 25' ' ' LEU . 12.7 p -119.41 -61.15 1.66 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.073 -1.017 . . . . 0.0 110.563 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.43 ' O ' ' OG1' ' A' ' 29' ' ' THR . 68.9 m 43.75 38.61 2.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.156 -0.965 . . . . 0.0 109.921 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 28' ' ' SER . 13.9 p 48.75 80.01 0.07 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.374 -0.829 . . . . 0.0 110.314 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 175.54 -65.5 0.1 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -150.17 151.72 33.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.308 -1.113 . . . . 0.0 110.069 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.72 HD11 ' CD1' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -104.82 94.41 5.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.158 -0.964 . . . . 0.0 110.393 -179.908 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.565 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 0.8 OUTLIER -94.71 115.81 27.98 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.215 -0.928 . . . . 0.0 111.176 179.759 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 1.081 HG12 HD22 ' A' ' 25' ' ' LEU . 16.6 m -89.4 149.43 4.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 1.015 ' HB3' ' HA ' ' A' ' 22' ' ' ASP . . . -88.95 92.99 9.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.314 -0.866 . . . . 0.0 111.093 -178.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.973 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 96.7 t -89.89 123.43 66.23 Favored Pre-proline 0 C--N 1.301 -1.508 0 O-C-N 121.489 -0.757 . . . . 0.0 109.373 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.91 ' HD2' HG21 ' A' ' 45' ' ' VAL . 40.0 Cg_endo -66.1 179.28 1.97 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.845 1.445 . . . . 0.0 112.048 -178.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.545 ' HA ' ' CA ' ' A' ' 136' ' ' ALA . . . -62.99 125.26 23.4 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.542 -0.724 . . . . 0.0 111.285 -179.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.531 ' O ' ' C ' ' A' ' 40' ' ' SER . . . 37.62 28.42 0.04 OUTLIER Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.712 ' OG ' HG23 ' A' ' 45' ' ' VAL . 11.0 t 28.64 53.88 0.08 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.984 -0.715 . . . . 0.0 110.435 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.641 ' O ' ' CG ' ' A' ' 42' ' ' GLN . . . -88.19 114.43 24.8 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.541 -0.725 . . . . 0.0 110.156 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.641 ' CG ' ' O ' ' A' ' 41' ' ' ALA . 1.1 pt20 84.19 30.4 0.06 Allowed 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.642 ' CE2' ' CG2' ' A' ' 21' ' ' THR . 0.1 OUTLIER -149.45 -33.37 0.2 Allowed 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 118.564 -1.254 . . . . 0.0 112.677 -177.888 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.535 ' HA2' ' CA ' ' A' ' 130' ' ' GLY . . . 52.81 79.88 0.08 OUTLIER Glycine 0 N--CA 1.483 1.794 0 N-CA-C 105.733 -2.947 . . . . 0.0 105.733 -176.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.91 HG21 ' HD2' ' A' ' 37' ' ' PRO . 3.8 t -87.64 129.31 39.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.422 -1.046 . . . . 0.0 109.001 -177.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.565 ' O ' ' CE2' ' A' ' 19' ' ' TYR . . . -155.44 156.46 27.0 Favored Glycine 0 N--CA 1.487 2.094 0 C-N-CA 119.018 -1.563 . . . . 0.0 110.172 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.702 HG13 ' O ' ' A' ' 17' ' ' VAL . 11.3 t -112.9 128.46 69.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.419 -1.048 . . . . 0.0 109.791 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.584 ' CG2' ' CG2' ' A' ' 17' ' ' VAL . 27.3 m -119.86 137.06 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.031 -1.043 . . . . 0.0 110.62 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.92 HD22 ' CE2' ' A' ' 16' ' ' TRP . 14.1 tp -131.27 97.4 4.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.341 -0.849 . . . . 0.0 110.197 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.518 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 45.2 m-80 -75.46 147.07 40.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.256 -0.903 . . . . 0.0 110.445 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 124.5 63.2 0.19 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.66 HG11 ' HD2' ' A' ' 112' ' ' TYR . 43.1 t -119.92 158.42 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.163 -1.198 . . . . 0.0 110.177 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -128.12 80.74 1.98 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.224 -0.923 . . . . 0.0 110.695 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 1.082 HD11 HD21 ' A' ' 146' ' ' LEU . 34.7 mm -117.44 173.03 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.244 -0.91 . . . . 0.0 109.72 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.589 ' N ' HG22 ' A' ' 54' ' ' ILE . 1.8 tp10 -166.92 131.58 2.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.966 -1.083 . . . . 0.0 110.785 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.522 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 8.1 pt-20 37.85 -153.9 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.664 -0.647 . . . . 0.0 110.922 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' A' ' 109' ' ' SER . . . -87.77 87.21 1.52 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.561 ' CG2' ' N ' ' A' ' 59' ' ' THR . 1.3 m -113.78 173.6 6.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.269 -1.136 . . . . 0.0 109.843 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.576 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 3.5 m -89.66 153.21 20.91 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.163 -0.961 . . . . 0.0 110.376 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.61 ' HB3' HD11 ' A' ' 146' ' ' LEU . 56.9 m-85 -160.29 179.37 8.73 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.339 -0.85 . . . . 0.0 110.211 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 36.7 m -150.31 115.35 5.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.344 -0.848 . . . . 0.0 109.876 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.917 HD22 ' CD2' ' A' ' 89' ' ' LEU . 13.7 tp -89.45 119.68 30.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.162 -0.961 . . . . 0.0 110.18 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.517 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 6.4 mtm180 -126.37 137.8 53.49 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.45 -0.781 . . . . 0.0 109.693 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.721 ' CZ ' HG21 ' A' ' 102' ' ' VAL . 0.7 OUTLIER -178.3 143.63 0.29 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.288 -0.883 . . . . 0.0 109.676 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.542 HG23 ' N ' ' A' ' 101' ' ' GLN . 69.9 m -119.14 99.49 6.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.244 -0.91 . . . . 0.0 109.962 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.807 ' CB ' HD21 ' A' ' 95' ' ' LEU . . . -99.78 156.77 16.93 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.432 -0.793 . . . . 0.0 110.225 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.647 HG23 ' O ' ' A' ' 98' ' ' GLU . 64.6 m -150.38 121.7 7.85 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.301 -0.875 . . . . 0.0 110.266 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.456 ' CB ' HG12 ' A' ' 72' ' ' VAL . . . -110.07 135.2 51.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.214 -0.928 . . . . 0.0 109.998 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.76 -9.12 25.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.206 -0.934 . . . . 0.0 109.972 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.6 ' CG2' ' CB ' ' A' ' 137' ' ' TRP . 5.0 t -118.37 19.39 13.42 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.326 -0.859 . . . . 0.0 110.214 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.498 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 8.4 t70 43.01 61.1 2.25 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.321 -0.862 . . . . 0.0 109.611 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.901 HG23 ' HB2' ' A' ' 133' ' ' SER . 6.5 p -89.97 139.3 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.387 -0.821 . . . . 0.0 110.95 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.8 m -120.58 85.95 2.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.393 -0.817 . . . . 0.0 109.283 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 1.1 HG21 ' CD2' ' A' ' 129' ' ' LEU . 4.6 m -89.94 -141.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.298 -0.877 . . . . 0.0 110.508 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.688 ' N ' HG23 ' A' ' 74' ' ' VAL . 0.3 OUTLIER -132.32 119.42 20.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.254 -0.904 . . . . 0.0 110.617 -179.574 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.542 ' N ' ' HD3' ' A' ' 93' ' ' PRO . . . -122.63 163.64 19.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.217 -0.927 . . . . 0.0 109.663 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.681 ' CD1' ' HB3' ' A' ' 126' ' ' ALA . 1.8 pp 174.69 -157.62 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.22 -0.925 . . . . 0.0 110.283 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.742 HG23 HD22 ' A' ' 89' ' ' LEU . 4.0 t -144.2 169.45 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.344 -0.847 . . . . 0.0 109.181 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.498 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . 172.2 179.22 42.95 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 118.993 -1.575 . . . . 0.0 110.465 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.5 ' NE2' ' O ' ' A' ' 82' ' ' GLY . 11.6 tt0 -98.15 142.16 30.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.537 -0.978 . . . . 0.0 110.119 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.533 ' O ' ' CB ' ' A' ' 121' ' ' PRO . 5.7 m120 -95.58 86.0 4.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.276 -0.89 . . . . 0.0 109.968 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.505 ' C ' ' CE1' ' A' ' 85' ' ' TYR . . . 124.68 142.85 6.0 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.619 ' N ' ' CE1' ' A' ' 85' ' ' TYR . . . -42.67 154.12 0.3 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.211 -1.17 . . . . 0.0 110.291 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.457 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.7 Cg_endo -79.38 12.25 20.34 Favored 'Cis proline' 0 C--N 1.312 -1.356 0 C-N-CA 121.673 -2.22 . . . . 0.0 110.896 -0.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.619 ' CE1' ' N ' ' A' ' 83' ' ' ALA . 31.9 m-85 61.79 150.4 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.105 -0.997 . . . . 0.0 110.261 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.457 ' O ' ' HA2' ' A' ' 79' ' ' GLY . . . -171.95 106.9 0.24 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.7 p -96.6 140.52 31.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.195 -1.179 . . . . 0.0 110.261 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 1.088 HG23 HD12 ' A' ' 89' ' ' LEU . 17.3 m -121.71 -15.91 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.274 -0.891 . . . . 0.0 110.177 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 1.088 HD12 HG23 ' A' ' 88' ' ' VAL . 4.4 mp -118.74 142.36 47.76 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.285 -0.884 . . . . 0.0 110.857 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.726 ' O ' HG23 ' A' ' 91' ' ' THR . 2.7 m-20 -150.62 85.65 1.38 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.342 -0.849 . . . . 0.0 110.203 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.726 HG23 ' O ' ' A' ' 90' ' ' ASP . 3.3 p -159.55 -172.32 3.66 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.16 -0.963 . . . . 0.0 110.412 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.436 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 72.1 m -121.75 138.34 28.41 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.324 -0.86 . . . . 0.0 110.207 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.713 ' HG2' HG22 ' A' ' 74' ' ' VAL . 49.4 Cg_endo -76.75 74.29 4.94 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.977 1.514 . . . . 0.0 110.623 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.523 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -49.62 127.37 15.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.121 -0.987 . . . . 0.0 109.557 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.807 HD21 ' CB ' ' A' ' 66' ' ' ALA . 20.8 mt -125.08 165.62 17.86 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.065 -1.022 . . . . 0.0 110.808 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.431 ' CG2' ' HG3' ' A' ' 100' ' ' ARG . 0.1 OUTLIER -157.93 -178.44 7.31 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.45 -0.781 . . . . 0.0 109.923 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.6 p -67.2 -29.17 68.76 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.151 -0.968 . . . . 0.0 110.38 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.647 ' O ' HG23 ' A' ' 67' ' ' THR . 2.6 mt-10 -91.41 179.78 1.33 Allowed Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.19 -0.944 . . . . 0.0 110.12 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.503 ' HD2' ' CB ' ' A' ' 98' ' ' GLU . 46.2 Cg_endo -73.75 130.47 14.69 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.896 1.472 . . . . 0.0 110.276 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.523 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 1.3 mtt-85 -119.83 92.65 3.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.145 -0.972 . . . . 0.0 110.498 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.542 ' N ' HG23 ' A' ' 65' ' ' THR . 1.0 OUTLIER -73.16 156.59 38.47 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.339 -0.851 . . . . 0.0 109.997 179.725 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.721 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 49.8 t -137.02 134.32 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.202 -0.936 . . . . 0.0 110.267 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.443 ' O ' ' CG ' ' A' ' 104' ' ' GLU . 0.2 OUTLIER -150.06 120.5 7.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.231 -0.918 . . . . 0.0 110.249 -179.891 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.443 ' CG ' ' O ' ' A' ' 103' ' ' THR . 14.3 mp0 -160.01 133.73 7.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.213 -0.93 . . . . 0.0 110.222 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.562 HG23 ' O ' ' A' ' 60' ' ' TYR . 24.2 m -92.22 145.05 24.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.168 -0.957 . . . . 0.0 110.228 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.415 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 34.0 p90 -150.21 153.33 36.07 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.312 -0.867 . . . . 0.0 110.315 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.425 ' O ' ' N ' ' A' ' 109' ' ' SER . 22.6 m -90.03 92.62 9.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.247 -0.908 . . . . 0.0 109.917 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.581 ' CB ' ' CD2' ' A' ' 60' ' ' TYR . . . -48.23 96.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.296 -0.878 . . . . 0.0 110.354 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.475 ' HA ' ' HA2' ' A' ' 57' ' ' GLY . 70.0 p -85.24 49.48 1.76 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.268 -0.895 . . . . 0.0 110.145 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.464 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -154.05 -154.16 0.5 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.268 -0.895 . . . . 0.0 110.224 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.524 HG23 ' HA ' ' A' ' 55' ' ' GLU . 18.8 m -150.95 112.66 4.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.268 -0.895 . . . . 0.0 110.277 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.713 ' OH ' HG13 ' A' ' 88' ' ' VAL . 14.7 m-30 -109.91 101.52 47.34 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.32 -0.863 . . . . 0.0 110.152 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.479 ' HG2' ' O ' ' A' ' 121' ' ' PRO . 42.4 Cg_endo -71.75 136.86 28.76 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.747 1.393 . . . . 0.0 110.019 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -43.84 -84.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.301 -0.874 . . . . 0.0 110.916 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.91 153.86 42.91 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.217 -0.927 . . . . 0.0 110.671 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.532 ' CB ' ' O ' ' A' ' 120' ' ' ASP . 48.0 Cg_endo -74.57 178.96 6.42 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.131 1.595 . . . . 0.0 110.427 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.551 ' HB3' ' HB2' ' A' ' 120' ' ' ASP . . . -150.15 -161.36 1.32 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.243 -0.911 . . . . 0.0 110.028 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -46.58 -24.41 0.53 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.17 -0.956 . . . . 0.0 109.952 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -161.95 23.02 0.11 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.344 -0.847 . . . . 0.0 110.066 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.551 ' HB2' ' HB3' ' A' ' 117' ' ' ALA . 1.1 m-20 -105.76 128.38 26.59 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.297 -0.877 . . . . 0.0 110.113 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.533 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 50.7 Cg_endo -76.56 -170.05 0.82 Allowed 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.896 1.471 . . . . 0.0 110.66 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.475 ' HA ' ' HG2' ' A' ' 113' ' ' PRO . 5.8 pm0 -153.08 132.8 13.12 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.341 -0.849 . . . . 0.0 110.056 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.495 ' HA2' ' HA ' ' A' ' 80' ' ' GLN . . . -82.76 146.66 24.54 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.562 ' HA ' ' CG2' ' A' ' 52' ' ' VAL . 7.9 pt20 -150.72 -156.22 0.7 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.206 -1.173 . . . . 0.0 110.696 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.461 ' CG2' ' CE1' ' A' ' 127' ' ' PHE . 10.7 mt -117.82 137.7 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.681 ' HB3' ' CD1' ' A' ' 77' ' ' LEU . . . -114.41 124.95 53.21 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.296 -0.878 . . . . 0.0 111.26 -179.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.493 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 4.4 m-85 -118.39 95.4 4.86 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.561 ' O ' ' CE2' ' A' ' 132' ' ' PHE . 3.0 mp0 -88.38 90.91 8.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.512 -0.743 . . . . 0.0 112.39 -177.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 1.1 ' CD2' HG21 ' A' ' 74' ' ' VAL . 5.4 mt -100.95 45.65 0.97 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 177.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.57 ' O ' ' CD2' ' A' ' 132' ' ' PHE . . . -96.47 136.18 12.67 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' A' ' 39' ' ' GLY . . . 38.25 73.33 0.15 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.604 ' CE1' ' HA ' ' A' ' 74' ' ' VAL . 9.8 m-85 -129.41 -80.27 0.56 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.073 -1.251 . . . . 0.0 110.967 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.901 ' HB2' HG23 ' A' ' 72' ' ' VAL . 14.0 t -89.06 100.31 13.11 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.061 -1.024 . . . . 0.0 110.462 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -30.26 -50.45 0.12 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.967 -0.458 . . . . 0.0 111.75 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.466 ' O ' ' O ' ' A' ' 133' ' ' SER . 6.7 m-20 -73.04 159.6 33.38 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.004 -1.06 . . . . 0.0 110.038 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.545 ' CA ' ' HA ' ' A' ' 38' ' ' ALA . . . -80.57 146.88 31.04 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.358 -0.838 . . . . 0.0 110.355 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.973 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 4.6 p90 -155.58 -166.8 2.33 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.222 -0.924 . . . . 0.0 111.012 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.505 ' CG2' ' SG ' ' A' ' 33' ' ' CYS 0.254 0.7 OUTLIER -149.5 169.07 21.76 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -178.236 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.644 HD21 ' CD1' ' A' ' 95' ' ' LEU . 1.8 mp -133.02 116.91 16.97 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.826 -1.171 . . . . 0.0 111.82 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' CYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 0.8 OUTLIER -102.06 109.53 21.27 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.747 -0.596 . . . . 0.0 111.081 178.895 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.504 HD23 ' HB2' ' A' ' 66' ' ' ALA . 1.5 mt -100.42 -179.0 3.98 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.294 -0.879 . . . . 0.0 108.679 178.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.781 ' O ' HG22 ' A' ' 8' ' ' THR . 1.8 p30 167.14 57.9 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.167 -0.958 . . . . 0.0 110.486 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.521 ' CG ' HG22 ' A' ' 8' ' ' THR . 0.4 OUTLIER 167.35 44.62 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.263 -0.898 . . . . 0.0 109.664 179.838 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.865 HG11 ' HZ2' ' A' ' 16' ' ' TRP . 1.9 t -89.92 114.09 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.434 -0.791 . . . . 0.0 110.205 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.558 ' CB ' ' HA ' ' A' ' 6' ' ' GLU . . . -145.8 155.17 42.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.315 -0.866 . . . . 0.0 110.168 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 1.082 HD21 HD11 ' A' ' 54' ' ' ILE . 10.2 tp -153.83 123.55 6.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.317 -0.864 . . . . 0.0 110.169 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.486 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 11.1 t0 -136.02 147.52 47.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.256 -0.903 . . . . 0.0 110.281 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.628 ' OG ' HG12 ' A' ' 150' ' ' VAL . 0.2 OUTLIER -107.1 112.95 26.11 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.333 -0.854 . . . . 0.0 110.205 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.468 ' HG3' ' HB ' ' A' ' 59' ' ' THR . 0.4 OUTLIER -73.93 87.38 1.81 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -0.896 . . . . 0.0 110.201 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.628 HG12 ' OG ' ' A' ' 148' ' ' SER . 3.9 p -159.37 170.42 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.255 -0.903 . . . . 0.0 110.275 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.577 ' N ' HG22 ' A' ' 150' ' ' VAL . 38.3 tt0 -87.25 74.97 9.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.276 -0.89 . . . . 0.0 110.218 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.744 ' O ' HD12 ' A' ' 152' ' ' LEU . 1.1 pp . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.219 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.259 0.552 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.641 ' C ' ' HB2' ' A' ' 53' ' ' ALA . 0.7 OUTLIER -128.41 136.4 29.03 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.246 -0.909 . . . . 0.0 110.142 -180.0 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.529 ' N ' ' HB2' ' A' ' 53' ' ' ALA . 49.3 Cg_endo -76.21 -156.25 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.97 1.51 . . . . 0.0 110.03 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 1.049 HD11 ' O ' ' A' ' 144' ' ' VAL . 13.3 pt -92.04 -1.57 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.209 -0.932 . . . . 0.0 110.13 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 6' ' ' GLU . . . 75.82 43.54 22.53 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.512 ' HG3' ' HB1' ' A' ' 145' ' ' ALA . 0.8 OUTLIER 42.54 66.23 0.79 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.295 -1.121 . . . . 0.0 110.189 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.449 ' O ' ' CE1' ' A' ' 9' ' ' PHE . . . -67.82 89.69 0.2 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.454 ' O ' ' HB2' ' A' ' 9' ' ' PHE . 1.9 p -76.14 -1.29 25.41 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.238 -1.154 . . . . 0.0 110.101 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.597 ' CD1' ' HB3' ' A' ' 13' ' ' PRO . 6.3 m-30 60.32 81.42 0.18 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.33 -0.857 . . . . 0.0 110.321 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.543 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 21.0 t70 -142.26 12.22 1.97 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.225 -0.922 . . . . 0.0 110.168 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.543 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.8 OUTLIER 161.47 -24.26 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.678 -0.639 . . . . 0.0 109.609 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -161.23 86.66 0.11 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.597 ' HB3' ' CD1' ' A' ' 9' ' ' PHE . 49.6 Cg_endo -76.0 72.94 5.06 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.153 1.607 . . . . 0.0 110.963 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.452 ' HG3' ' HB ' ' A' ' 4' ' ' ILE . 25.6 mm-40 38.33 -92.0 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.491 -0.756 . . . . 0.0 110.782 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.561 ' O ' HG13 ' A' ' 17' ' ' VAL . . . -153.42 17.87 0.68 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.932 ' NE1' HD22 ' A' ' 49' ' ' LEU . 41.3 m95 -42.93 122.52 2.44 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -1.135 . . . . 0.0 110.4 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.737 ' O ' HG13 ' A' ' 47' ' ' VAL . 1.9 m -119.28 153.2 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.177 -0.952 . . . . 0.0 109.865 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.433 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . . . -137.58 122.47 18.89 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.165 -0.959 . . . . 0.0 109.96 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.563 ' CZ ' ' O ' ' A' ' 46' ' ' GLY . 3.7 p90 -115.24 154.78 28.44 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.39 -0.819 . . . . 0.0 110.498 -179.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.632 ' O ' HG22 ' A' ' 45' ' ' VAL . . . 90.77 29.11 13.96 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.484 ' HB ' ' O ' ' A' ' 35' ' ' ALA . 14.2 p -146.15 -160.38 1.14 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.127 -1.219 . . . . 0.0 110.303 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.45 ' O ' ' O ' ' A' ' 23' ' ' GLY . 12.4 t0 -89.93 123.47 33.88 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 0.0 110.196 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 22' ' ' ASP . . . 43.94 -166.1 0.03 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.416 ' O ' ' O ' ' A' ' 25' ' ' LEU . 45.5 Cg_endo -73.18 162.74 39.86 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.066 1.561 . . . . 0.0 110.405 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.828 HD13 HD11 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -59.37 -154.43 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.265 -0.897 . . . . 0.0 110.185 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -152.48 161.35 42.71 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.269 -0.894 . . . . 0.0 110.145 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.597 HG21 ' HD3' ' A' ' 13' ' ' PRO . 0.7 OUTLIER -125.22 -28.2 3.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.27 -0.894 . . . . 0.0 110.235 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.454 ' O ' ' OG1' ' A' ' 29' ' ' THR . 0.5 OUTLIER 48.48 23.48 0.61 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.216 -0.927 . . . . 0.0 110.152 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.454 ' OG1' ' O ' ' A' ' 28' ' ' SER . 17.9 p 47.19 65.83 1.15 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.297 -0.877 . . . . 0.0 110.268 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.526 ' N ' ' HA ' ' A' ' 10' ' ' ASP . . . 169.85 -50.17 0.21 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.451 ' HB1' ' O ' ' A' ' 141' ' ' LEU . . . -150.04 141.51 23.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -1.117 . . . . 0.0 110.292 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.828 HD11 HD13 ' A' ' 25' ' ' LEU . 5.8 tt -79.96 110.87 15.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.215 -0.928 . . . . 0.0 109.921 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 88.7 m -118.43 129.2 55.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.141 -0.975 . . . . 0.0 110.708 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.532 ' CG2' ' HB2' ' A' ' 139' ' ' LEU . 17.9 m -98.83 153.06 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.301 -0.874 . . . . 0.0 109.692 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.498 ' HA ' ' OG1' ' A' ' 138' ' ' THR . . . -102.76 87.65 3.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.249 -0.907 . . . . 0.0 110.898 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.101 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 57.5 t -75.98 132.14 74.67 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.161 -0.962 . . . . 0.0 109.386 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.524 ' CG ' ' OH ' ' A' ' 43' ' ' TYR . 47.8 Cg_endo -78.89 158.24 27.49 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.87 1.458 . . . . 0.0 111.114 -179.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.502 ' HA ' ' CA ' ' A' ' 136' ' ' ALA . . . -42.94 126.79 3.95 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.291 -0.881 . . . . 0.0 109.775 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 38' ' ' ALA . . . 47.92 86.67 0.01 OUTLIER Glycine 0 N--CA 1.485 1.963 0 N-CA-C 108.385 -1.886 . . . . 0.0 108.385 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.835 ' HB2' HG21 ' A' ' 45' ' ' VAL . 0.8 OUTLIER -82.2 39.04 0.56 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.353 -1.086 . . . . 0.0 110.636 -179.453 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.953 ' HB2' ' HA3' ' A' ' 131' ' ' GLY . . . -105.25 20.23 19.24 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.17 -0.957 . . . . 0.0 109.756 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.589 ' HG3' ' CD2' ' A' ' 43' ' ' TYR . 17.6 pt20 -93.04 27.02 2.58 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 121.581 0.705 . . . . 0.0 109.5 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.628 ' CD1' ' N ' ' A' ' 43' ' ' TYR . 0.0 OUTLIER 159.55 6.24 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.203 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.725 179.357 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.479 ' HA2' ' HA2' ' A' ' 130' ' ' GLY . . . 67.6 100.77 0.03 OUTLIER Glycine 0 N--CA 1.487 2.042 0 O-C-N 120.502 -1.374 . . . . 0.0 109.83 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.835 HG21 ' HB2' ' A' ' 40' ' ' SER . 48.8 t -89.19 170.37 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.119 -1.224 . . . . 0.0 108.431 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.563 ' O ' ' CZ ' ' A' ' 19' ' ' TYR . . . 167.33 140.45 2.91 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 118.943 -1.598 . . . . 0.0 110.721 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.737 HG13 ' O ' ' A' ' 17' ' ' VAL . 21.3 t -105.94 132.2 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.505 -0.997 . . . . 0.0 109.605 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.732 ' O ' HG22 ' A' ' 17' ' ' VAL . 35.6 m -126.9 141.03 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.923 -1.111 . . . . 0.0 110.572 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.932 HD22 ' NE1' ' A' ' 16' ' ' TRP . 14.2 tp -132.12 102.26 5.73 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.329 -0.857 . . . . 0.0 110.207 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.53 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 1.4 m-80 -80.08 122.79 27.22 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.289 -0.882 . . . . 0.0 110.424 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.549 ' O ' HG22 ' A' ' 4' ' ' ILE . . . 146.04 74.47 0.02 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.627 HG12 ' H ' ' A' ' 53' ' ' ALA . 6.3 t -119.81 178.84 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.185 -1.185 . . . . 0.0 110.086 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.887 ' O ' HD13 ' A' ' 54' ' ' ILE . . . -132.84 84.01 2.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.174 -0.954 . . . . 0.0 110.441 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.887 HD13 ' O ' ' A' ' 53' ' ' ALA . 5.6 mm -143.08 163.48 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.227 -0.92 . . . . 0.0 109.625 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.687 ' HG3' HG23 ' A' ' 111' ' ' THR . 8.1 tt0 -178.88 32.44 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.101 -0.999 . . . . 0.0 110.28 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 55' ' ' GLU . 2.0 tt0 179.78 -176.44 0.32 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.529 -0.732 . . . . 0.0 110.07 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.487 ' HA2' ' HA ' ' A' ' 109' ' ' SER . . . -93.41 67.07 1.7 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.255 -1.938 . . . . 0.0 108.255 178.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.716 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.0 OUTLIER -105.08 177.68 4.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.585 -0.95 . . . . 0.0 110.265 -179.036 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.584 ' N ' ' CG2' ' A' ' 58' ' ' THR . 0.6 OUTLIER -88.95 154.62 20.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.302 -0.874 . . . . 0.0 110.016 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.957 ' HB3' HD11 ' A' ' 146' ' ' LEU . 59.3 m-85 -155.98 124.37 5.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.346 -0.847 . . . . 0.0 110.061 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 28.9 m -94.1 115.23 27.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.204 -0.935 . . . . 0.0 110.108 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.668 HD22 ' CD2' ' A' ' 89' ' ' LEU . 19.4 tp -89.39 122.53 32.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.173 -0.954 . . . . 0.0 109.816 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.502 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 6.3 mtt180 -123.4 140.58 52.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.311 -0.868 . . . . 0.0 110.263 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.992 ' CZ ' HG21 ' A' ' 102' ' ' VAL . 1.6 p90 -178.28 147.53 0.43 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.41 -0.806 . . . . 0.0 109.629 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 47.6 m -119.37 91.04 3.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.115 -0.99 . . . . 0.0 110.407 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.603 ' CB ' HD21 ' A' ' 95' ' ' LEU . . . -90.06 147.65 23.52 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.366 -0.833 . . . . 0.0 110.069 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.5 ' OG1' ' HA ' ' A' ' 99' ' ' PRO . 40.7 m -146.84 131.9 18.26 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.27 -0.894 . . . . 0.0 110.442 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.598 ' CB ' HG12 ' A' ' 72' ' ' VAL . . . -123.85 136.57 54.46 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.35 -0.844 . . . . 0.0 109.906 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 64.5 m -65.17 -9.06 20.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.177 -0.952 . . . . 0.0 110.314 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.565 ' CG2' ' HB2' ' A' ' 137' ' ' TRP . 6.4 t -119.77 19.79 12.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.25 -0.906 . . . . 0.0 110.237 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.484 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 13.2 t70 43.57 49.94 6.42 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.295 -0.878 . . . . 0.0 109.678 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.762 ' CG1' HD12 ' A' ' 95' ' ' LEU . 8.8 p -75.47 145.64 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.429 -0.794 . . . . 0.0 110.662 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 89.7 m -119.94 86.06 2.49 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.39 -0.819 . . . . 0.0 109.339 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.711 HG12 ' HB2' ' A' ' 132' ' ' PHE . 15.0 m -89.5 -141.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.258 -0.901 . . . . 0.0 110.312 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.535 ' N ' HG23 ' A' ' 74' ' ' VAL . 16.0 mtm-85 -131.94 148.05 52.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.129 -0.982 . . . . 0.0 110.851 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.758 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -148.34 155.35 41.17 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.336 -0.853 . . . . 0.0 109.998 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.057 ' CD1' ' HB3' ' A' ' 126' ' ' ALA . 2.1 pp 175.82 -160.52 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 0.0 110.294 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.904 ' CG2' HD22 ' A' ' 89' ' ' LEU . 4.3 t -147.78 167.98 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.303 -0.873 . . . . 0.0 109.597 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.505 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . 174.08 -175.76 46.54 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.33 -1.414 . . . . 0.0 110.314 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.531 ' NE2' ' HB2' ' A' ' 121' ' ' PRO . 3.5 tm0? -94.37 178.25 5.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.458 -1.025 . . . . 0.0 110.142 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.536 ' ND2' ' HG2' ' A' ' 124' ' ' GLN . 3.8 m-80 -146.53 87.75 1.73 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.248 -0.907 . . . . 0.0 110.155 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.531 ' HA3' ' HB3' ' A' ' 121' ' ' PRO . . . 137.07 34.27 0.21 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.544 ' HA ' ' CD2' ' A' ' 85' ' ' TYR . . . 59.07 148.31 0.07 OUTLIER Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.133 -1.216 . . . . 0.0 110.407 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.453 ' O ' ' O ' ' A' ' 85' ' ' TYR . 52.4 Cg_endo -80.37 21.03 9.08 Favored 'Cis proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.761 -2.183 . . . . 0.0 111.103 -0.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.544 ' CD2' ' HA ' ' A' ' 83' ' ' ALA . 35.6 m-85 60.93 130.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.057 -1.027 . . . . 0.0 110.239 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.465 ' O ' ' HA2' ' A' ' 79' ' ' GLY . . . -151.44 99.05 0.19 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.3 p -91.16 134.15 34.78 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.287 -1.125 . . . . 0.0 110.187 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 1.109 HG23 HD12 ' A' ' 89' ' ' LEU . 32.1 m -120.24 -9.2 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.233 -0.917 . . . . 0.0 110.092 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 1.109 HD12 HG23 ' A' ' 88' ' ' VAL . 4.2 mp -118.63 137.63 53.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.275 -0.89 . . . . 0.0 111.006 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.405 ' C ' HG23 ' A' ' 91' ' ' THR . 12.0 p-10 -150.71 85.13 1.36 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.486 -0.759 . . . . 0.0 109.951 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.405 HG23 ' C ' ' A' ' 90' ' ' ASP . 65.6 p -144.08 -174.28 4.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.053 -1.029 . . . . 0.0 110.698 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.2 m -119.69 116.88 32.96 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.364 -0.835 . . . . 0.0 109.947 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.758 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 44.6 Cg_endo -71.84 79.61 1.59 Allowed 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.923 1.486 . . . . 0.0 110.642 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.805 ' HB3' HH11 ' A' ' 100' ' ' ARG . . . -67.03 148.17 52.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.208 -0.932 . . . . 0.0 109.833 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.762 HD12 ' CG1' ' A' ' 72' ' ' VAL . 73.3 mt -134.08 176.97 8.11 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.187 -0.946 . . . . 0.0 110.475 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.404 ' O ' HG23 ' A' ' 67' ' ' THR . 0.3 OUTLIER -170.66 -179.14 2.81 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.275 -0.891 . . . . 0.0 110.14 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.63 -30.27 71.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.257 -0.902 . . . . 0.0 110.039 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.525 ' CB ' ' HD2' ' A' ' 99' ' ' PRO . 0.1 OUTLIER -93.1 179.72 1.23 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.278 -0.889 . . . . 0.0 110.042 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.525 ' HD2' ' CB ' ' A' ' 98' ' ' GLU . 44.3 Cg_endo -72.06 134.99 24.33 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.9 1.474 . . . . 0.0 110.287 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.805 HH11 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.73 85.81 2.45 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.283 -0.885 . . . . 0.0 110.25 -179.893 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.413 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 8.7 mt-30 -71.7 156.33 39.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.27 -0.894 . . . . 0.0 110.216 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.992 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 40.7 t -139.66 138.92 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.24 -0.913 . . . . 0.0 110.166 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.07 116.34 6.53 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.252 -0.905 . . . . 0.0 110.131 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -140.88 131.87 26.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.253 -0.904 . . . . 0.0 110.245 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.527 HG22 HG22 ' A' ' 59' ' ' THR . 4.4 m -89.82 65.42 6.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.181 -0.949 . . . . 0.0 110.225 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.61 ' CZ ' ' CB ' ' A' ' 60' ' ' TYR . 26.1 p90 -71.29 144.95 49.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 0.0 110.099 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.531 ' O ' ' N ' ' A' ' 109' ' ' SER . 3.5 m -89.35 92.76 9.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.17 -0.956 . . . . 0.0 109.699 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.634 ' CB ' ' CD2' ' A' ' 60' ' ' TYR . . . -45.23 92.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.37 -0.831 . . . . 0.0 110.156 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 107' ' ' THR . 81.2 p -89.45 54.68 2.99 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.332 -0.855 . . . . 0.0 109.61 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -163.34 -155.2 0.31 Allowed 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.465 -0.894 . . . . 0.0 110.678 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.687 HG23 ' HG3' ' A' ' 55' ' ' GLU . 4.5 m -148.14 118.58 7.4 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.294 -0.879 . . . . 0.0 110.587 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.598 ' CD2' HG13 ' A' ' 54' ' ' ILE . 15.8 m-30 -112.61 85.52 7.48 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.497 -0.752 . . . . 0.0 109.542 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.677 ' HD3' HG22 ' A' ' 111' ' ' THR . 43.4 Cg_endo -69.97 127.77 14.9 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 123.86 1.453 . . . . 0.0 110.49 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -85.12 55.65 3.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.318 -0.864 . . . . 0.0 110.395 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.519 ' O ' ' CB ' ' A' ' 120' ' ' ASP . 5.7 m -136.21 74.7 54.83 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.212 -0.93 . . . . 0.0 110.046 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.429 ' HB3' ' CD ' ' A' ' 122' ' ' GLU . 44.8 Cg_endo -72.06 81.27 1.44 Allowed 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 124.036 1.545 . . . . 0.0 110.387 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.663 ' HB3' ' HB2' ' A' ' 120' ' ' ASP . . . -122.98 -172.69 2.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.341 -0.85 . . . . 0.0 110.116 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -53.12 -56.48 15.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.233 -0.917 . . . . 0.0 110.19 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -110.99 40.11 2.11 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.235 -0.916 . . . . 0.0 110.318 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.663 ' HB2' ' HB3' ' A' ' 117' ' ' ALA . 72.2 m-20 -139.63 99.28 7.75 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.209 -0.932 . . . . 0.0 110.15 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.531 ' HB3' ' HA3' ' A' ' 82' ' ' GLY . 48.8 Cg_endo -74.38 -176.94 2.98 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 124.001 1.527 . . . . 0.0 110.35 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.487 ' HB2' ' O ' ' A' ' 113' ' ' PRO . 0.9 OUTLIER -162.37 169.73 20.03 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.204 -0.935 . . . . 0.0 110.663 179.738 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.613 ' O ' HG23 ' A' ' 52' ' ' VAL . . . -106.51 155.55 16.51 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.552 ' HA ' ' CG2' ' A' ' 52' ' ' VAL . 1.1 pt20 -150.4 -160.15 1.13 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.168 -1.195 . . . . 0.0 110.719 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.819 HG21 ' HH2' ' A' ' 16' ' ' TRP . 18.3 mt -118.34 142.65 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 1.057 ' HB3' ' CD1' ' A' ' 77' ' ' LEU . . . -118.03 120.98 39.43 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.249 -0.907 . . . . 0.0 111.439 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.498 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 4.9 m-85 -118.79 100.79 7.62 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.543 ' O ' ' CE2' ' A' ' 132' ' ' PHE . 32.1 mm-40 -89.47 103.15 15.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.127 -0.983 . . . . 0.0 112.313 -177.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.624 ' CD2' HG21 ' A' ' 74' ' ' VAL . 11.5 mt -100.68 41.04 1.2 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 177.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.479 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -67.61 85.68 0.15 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 -179.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.953 ' HA3' ' HB2' ' A' ' 41' ' ' ALA . . . 40.57 79.23 0.05 OUTLIER Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.711 ' HB2' HG12 ' A' ' 74' ' ' VAL . 10.5 m-85 -107.28 -42.64 4.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.171 -1.194 . . . . 0.0 110.183 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.703 ' HB2' HG23 ' A' ' 72' ' ' VAL . 1.2 t -89.81 -176.5 4.97 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.198 -0.938 . . . . 0.0 110.238 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.46 ' N ' ' OG ' ' A' ' 133' ' ' SER . . . -96.69 -92.23 0.23 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.122 -0.986 . . . . 0.0 110.855 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -63.63 170.75 3.03 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.187 -0.946 . . . . 0.0 110.637 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.502 ' CA ' ' HA ' ' A' ' 38' ' ' ALA . . . -52.92 136.53 34.37 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.392 -0.817 . . . . 0.0 110.397 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 1.101 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 8.1 p90 -145.17 -167.55 2.71 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.314 -0.866 . . . . 0.0 110.336 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.538 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 0.5 OUTLIER -160.35 165.96 30.27 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.214 -0.929 . . . . 0.0 110.398 -178.729 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.543 ' HG ' HD13 ' A' ' 95' ' ' LEU . 2.4 mp -119.52 161.32 20.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.434 -0.791 . . . . 0.0 109.209 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' CYS . . . . . . . . . . . . . 1.9 m -150.58 94.44 2.1 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.069 -1.019 . . . . 0.0 111.209 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.493 ' HA ' ' O ' ' A' ' 65' ' ' THR . 0.9 OUTLIER -95.14 -176.03 3.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.229 -0.919 . . . . 0.0 108.903 178.754 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.486 ' CB ' ' O ' ' A' ' 141' ' ' LEU . 0.5 OUTLIER 170.2 37.25 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.051 -1.031 . . . . 0.0 110.631 179.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.467 ' O ' ' O ' ' A' ' 63' ' ' ARG . 34.5 t0 179.35 48.75 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.184 -0.948 . . . . 0.0 110.056 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 1.049 ' O ' HD11 ' A' ' 4' ' ' ILE . 2.8 t -89.77 113.51 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.369 -0.832 . . . . 0.0 110.08 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.512 ' HB1' ' HG3' ' A' ' 6' ' ' GLU . . . -144.4 163.19 34.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.263 -0.898 . . . . 0.0 110.219 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.957 HD11 ' HB3' ' A' ' 60' ' ' TYR . 16.3 tp -145.99 128.87 16.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.27 -0.894 . . . . 0.0 110.218 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.581 ' O ' ' CD1' ' A' ' 60' ' ' TYR . 0.3 OUTLIER -135.75 -154.15 0.55 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.302 -0.874 . . . . 0.0 110.238 179.988 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 149' ' ' GLU . 48.3 p -140.25 169.24 18.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.273 -0.892 . . . . 0.0 110.116 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.509 ' O ' ' CG ' ' A' ' 149' ' ' GLU . 21.1 pt-20 -43.28 121.36 2.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.201 -0.937 . . . . 0.0 110.175 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.581 HG22 ' H ' ' A' ' 151' ' ' GLU . 8.7 p -103.53 177.17 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.22 -0.925 . . . . 0.0 110.266 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.581 ' H ' HG22 ' A' ' 150' ' ' VAL . 1.6 mp0 -64.21 -167.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.262 -0.899 . . . . 0.0 110.263 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.426 ' HA ' HD13 ' A' ' 152' ' ' LEU . 1.7 mm? . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.179 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.459 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.242 0.544 . . . . 0.0 110.183 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 1' ' ' ALA . 0.1 OUTLIER 55.12 166.47 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.259 -0.901 . . . . 0.0 110.162 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.442 ' HD2' ' OG ' ' A' ' 2' ' ' SER . 48.9 Cg_endo -76.0 -156.38 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.016 1.535 . . . . 0.0 110.097 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.731 HD11 ' O ' ' A' ' 144' ' ' VAL . 7.8 pt -120.52 -3.62 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.181 -0.95 . . . . 0.0 110.128 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 6' ' ' GLU . . . 97.52 139.17 10.54 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 5' ' ' GLY . 0.4 OUTLIER -42.76 -85.5 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.241 -1.152 . . . . 0.0 110.126 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.5 ' HA2' ' HA ' ' A' ' 143' ' ' ASP . . . -80.85 127.66 8.03 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.69 HG21 ' HB ' ' A' ' 144' ' ' VAL . 16.3 p -107.0 163.89 12.6 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.147 -1.208 . . . . 0.0 110.64 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.604 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.1 m-30 65.89 9.79 6.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.452 -0.78 . . . . 0.0 110.229 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.552 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 4.0 p-10 -86.12 41.66 0.94 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.159 -0.963 . . . . 0.0 109.885 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.552 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 2.1 t70 161.3 -24.17 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 172.91 164.21 27.95 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.635 ' CB ' HD11 ' A' ' 25' ' ' LEU . 44.1 Cg_endo -71.17 81.56 1.16 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.011 1.532 . . . . 0.0 110.442 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.48 ' C ' ' O ' ' A' ' 13' ' ' PRO . 1.0 OUTLIER -31.42 -68.2 0.09 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.275 0.559 . . . . 0.0 111.163 -179.636 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.495 ' C ' ' CD1' ' A' ' 49' ' ' LEU . . . -152.47 14.05 0.71 Allowed Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.765 -1.207 . . . . 0.0 110.218 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 1.103 ' NE1' HD22 ' A' ' 49' ' ' LEU . 24.2 m95 -77.77 110.08 12.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.028 -1.278 . . . . 0.0 110.244 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.541 HG22 HG23 ' A' ' 48' ' ' VAL . 2.2 m -100.64 125.67 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.238 -0.914 . . . . 0.0 110.068 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.575 ' HB2' HG11 ' A' ' 34' ' ' VAL . . . -104.17 119.32 38.69 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.156 -0.965 . . . . 0.0 110.093 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.588 ' CZ ' ' O ' ' A' ' 46' ' ' GLY . 6.2 p90 -112.42 148.05 35.16 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.298 -0.876 . . . . 0.0 110.458 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.537 ' CA ' ' OH ' ' A' ' 43' ' ' TYR . . . 96.82 34.62 5.66 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.481 ' CG2' ' C ' ' A' ' 20' ' ' GLY . 7.3 p -150.21 -147.31 0.22 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.137 -1.214 . . . . 0.0 110.407 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 23' ' ' GLY . 62.2 t0 -89.96 114.77 26.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.334 -0.854 . . . . 0.0 110.33 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 43.16 -155.52 0.16 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.32 157.32 49.94 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 124.031 1.543 . . . . 0.0 110.493 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.639 HD23 ' H ' ' A' ' 25' ' ' LEU . 0.6 OUTLIER -53.63 179.8 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.254 -0.904 . . . . 0.0 110.201 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -152.58 142.33 21.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.27 -0.894 . . . . 0.0 110.196 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.78 HG22 ' HA ' ' A' ' 32' ' ' LEU . 2.2 p -119.64 -79.97 0.61 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.295 -0.878 . . . . 0.0 110.031 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.42 ' OG ' ' C ' ' A' ' 27' ' ' THR . 1.6 p 40.44 27.46 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.384 -0.822 . . . . 0.0 110.645 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.482 HG22 ' O ' ' A' ' 27' ' ' THR . 12.8 t -148.7 13.93 0.93 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.139 -0.976 . . . . 0.0 110.364 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 9' ' ' PHE . . . 75.48 7.86 83.3 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.643 ' HB1' ' O ' ' A' ' 141' ' ' LEU . . . -150.35 151.38 32.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.256 -1.144 . . . . 0.0 110.118 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.78 ' HA ' HG22 ' A' ' 27' ' ' THR . 0.5 OUTLIER -79.85 114.56 18.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.123 -0.986 . . . . 0.0 109.822 179.829 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 67.0 m -120.93 118.27 29.46 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.184 -0.947 . . . . 0.0 110.745 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.575 HG11 ' HB2' ' A' ' 18' ' ' ALA . 15.3 m -99.52 135.38 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.35 -0.844 . . . . 0.0 109.494 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.476 ' O ' ' HB ' ' A' ' 21' ' ' THR . . . -89.47 89.74 7.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.207 -0.933 . . . . 0.0 111.089 -179.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.141 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 53.1 t -69.87 134.53 87.89 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.245 -0.91 . . . . 0.0 109.416 179.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 21' ' ' THR . 47.2 Cg_endo -76.68 152.85 33.53 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.944 1.497 . . . . 0.0 111.325 -178.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.503 ' HA ' ' N ' ' A' ' 136' ' ' ALA . . . -43.89 130.99 5.74 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.373 -0.83 . . . . 0.0 109.884 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 38' ' ' ALA . . . 45.24 78.18 0.08 OUTLIER Glycine 0 N--CA 1.487 2.041 0 N-CA-C 108.724 -1.75 . . . . 0.0 108.724 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.883 ' HB2' HG21 ' A' ' 45' ' ' VAL . 1.1 p -82.76 40.33 0.67 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.304 -1.115 . . . . 0.0 110.473 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.966 ' HB2' ' HA3' ' A' ' 131' ' ' GLY . . . -109.1 25.13 12.17 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.361 -0.837 . . . . 0.0 109.767 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.51 ' O ' ' HB3' ' A' ' 43' ' ' TYR . 16.3 pt20 -78.14 2.7 17.19 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.637 0.732 . . . . 0.0 110.542 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.537 ' OH ' ' CA ' ' A' ' 20' ' ' GLY . 2.5 p90 177.26 -32.52 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.508 ' O ' ' CE2' ' A' ' 43' ' ' TYR . . . 123.48 104.47 1.68 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 110.266 -1.133 . . . . 0.0 110.266 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.883 HG21 ' HB2' ' A' ' 40' ' ' SER . 39.8 t -89.7 177.27 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.066 -1.255 . . . . 0.0 108.502 178.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.588 ' O ' ' CZ ' ' A' ' 19' ' ' TYR . . . 160.55 140.11 2.81 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 118.491 -1.814 . . . . 0.0 111.66 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.608 ' O ' HG13 ' A' ' 48' ' ' VAL . 21.5 t -100.53 162.17 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.644 -0.915 . . . . 0.0 108.693 178.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.608 HG13 ' O ' ' A' ' 47' ' ' VAL . 15.6 m -157.25 157.61 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.841 -1.162 . . . . 0.0 110.71 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 1.103 HD22 ' NE1' ' A' ' 16' ' ' TRP . 13.8 tp -151.33 120.28 6.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.327 -0.858 . . . . 0.0 110.351 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.483 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 23.7 p30 -96.26 158.24 15.53 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.216 -0.927 . . . . 0.0 110.234 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.11 74.4 0.62 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.594 HG12 ' N ' ' A' ' 53' ' ' ALA . 87.2 t -138.83 172.43 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.173 -1.193 . . . . 0.0 110.177 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.594 ' N ' HG12 ' A' ' 52' ' ' VAL . . . -139.5 101.19 4.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.173 -0.955 . . . . 0.0 110.409 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.65 ' CG1' ' CD2' ' A' ' 112' ' ' TYR . 45.0 mm -126.34 173.13 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.248 -0.907 . . . . 0.0 109.987 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.676 ' HA ' HG23 ' A' ' 111' ' ' THR . 0.0 OUTLIER -164.74 128.59 2.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.118 -0.989 . . . . 0.0 110.814 -179.923 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 8.3 pt-20 37.74 -153.31 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.673 -0.642 . . . . 0.0 110.999 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 108' ' ' ALA . . . -87.03 75.67 2.16 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.582 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.3 m -101.67 173.61 6.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.334 -1.098 . . . . 0.0 109.807 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.575 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 0.7 OUTLIER -89.96 153.27 20.73 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.235 -0.916 . . . . 0.0 110.559 -179.577 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.636 ' CD2' ' HB2' ' A' ' 108' ' ' ALA . 64.3 m-85 -159.96 123.12 3.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.311 -0.868 . . . . 0.0 110.01 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 30.6 m -89.88 115.35 27.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.161 -0.962 . . . . 0.0 110.167 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.423 HD22 ' CD2' ' A' ' 89' ' ' LEU . 15.2 tp -89.5 126.27 35.52 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.232 -0.918 . . . . 0.0 109.907 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.523 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 14.3 ttp85 -131.16 136.49 48.36 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.385 -0.822 . . . . 0.0 110.107 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 1.165 ' CZ ' HG21 ' A' ' 102' ' ' VAL . 0.6 OUTLIER -178.46 143.2 0.26 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.383 -0.823 . . . . 0.0 109.57 179.678 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.85 HG23 ' CA ' ' A' ' 101' ' ' GLN . 0.2 OUTLIER -119.26 93.35 4.05 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.149 -0.969 . . . . 0.0 110.434 -179.466 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.688 ' HB2' HD23 ' A' ' 141' ' ' LEU . . . -94.81 153.95 17.49 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.293 -0.879 . . . . 0.0 110.119 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.535 HG23 ' O ' ' A' ' 98' ' ' GLU . 51.9 m -150.14 135.65 18.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.22 -0.925 . . . . 0.0 110.363 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 138' ' ' THR . . . -126.14 140.06 52.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.282 -0.886 . . . . 0.0 110.013 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.9 m -71.2 -3.71 21.67 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.22 -0.925 . . . . 0.0 110.113 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.569 ' CG2' ' HB2' ' A' ' 137' ' ' TRP . 6.3 t -124.62 19.84 8.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 110.096 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.487 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 14.9 t0 43.51 60.77 2.48 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.272 -0.892 . . . . 0.0 109.558 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.742 HG23 ' HB2' ' A' ' 133' ' ' SER . 5.5 p -87.07 140.96 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.463 -0.773 . . . . 0.0 110.87 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 23.2 m -119.86 87.88 2.83 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.483 -0.761 . . . . 0.0 109.107 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.819 HG11 HD22 ' A' ' 129' ' ' LEU . 19.2 m -89.73 -146.15 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -0.906 . . . . 0.0 110.382 -179.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.414 ' N ' HG23 ' A' ' 74' ' ' VAL . 0.4 OUTLIER -127.16 124.14 38.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.244 -0.91 . . . . 0.0 110.434 -179.67 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.655 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -126.99 158.67 36.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.309 -0.869 . . . . 0.0 109.666 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.912 HD11 ' HB3' ' A' ' 126' ' ' ALA . 3.4 pp 177.87 -157.33 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.19 -0.944 . . . . 0.0 110.475 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.715 HG23 HD22 ' A' ' 89' ' ' LEU . 9.8 t -143.56 -178.21 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.339 -0.851 . . . . 0.0 109.558 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.631 ' H ' HG12 ' A' ' 78' ' ' VAL . . . 161.56 -154.93 26.03 Favored Glycine 0 N--CA 1.49 2.274 0 C-N-CA 119.303 -1.427 . . . . 0.0 110.053 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.571 ' HB3' ' CD1' ' A' ' 112' ' ' TYR . 6.2 pt20 -135.21 158.36 44.56 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.469 -1.018 . . . . 0.0 110.356 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.466 ' HB2' ' HG2' ' A' ' 122' ' ' GLU . 2.4 m120 -107.23 97.22 7.01 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.315 -0.866 . . . . 0.0 110.038 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.542 ' C ' ' CE1' ' A' ' 85' ' ' TYR . . . 138.44 143.01 4.4 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.593 ' N ' ' CE1' ' A' ' 85' ' ' TYR . . . -65.95 155.7 86.08 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.262 -1.14 . . . . 0.0 110.222 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.533 ' C ' ' CD2' ' A' ' 85' ' ' TYR . 50.6 Cg_endo -77.48 8.94 17.83 Favored 'Cis proline' 0 C--N 1.313 -1.322 0 C-N-CA 121.637 -2.235 . . . . 0.0 110.905 0.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.593 ' CE1' ' N ' ' A' ' 83' ' ' ALA . 10.5 m-85 69.33 -171.23 0.18 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.231 -0.918 . . . . 0.0 110.214 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 153.46 107.27 0.31 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.504 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 4.1 p -96.05 167.84 10.98 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.211 -1.17 . . . . 0.0 110.391 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.812 HG12 ' N ' ' A' ' 109' ' ' SER . 5.4 m -135.5 -32.76 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.364 -0.835 . . . . 0.0 110.324 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.715 HD22 HG23 ' A' ' 78' ' ' VAL . 4.3 mp -98.3 144.24 27.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -0.909 . . . . 0.0 110.859 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.651 ' O ' HG23 ' A' ' 91' ' ' THR . 17.4 p-10 -151.08 86.11 1.36 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.324 -0.86 . . . . 0.0 110.172 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.651 HG23 ' O ' ' A' ' 90' ' ' ASP . 2.4 p -157.52 -175.03 5.16 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.024 -1.047 . . . . 0.0 110.531 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.49 130.47 24.78 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.326 -0.858 . . . . 0.0 110.172 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.655 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 49.7 Cg_endo -75.44 80.58 2.49 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.961 1.506 . . . . 0.0 110.87 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.69 ' HB3' HH11 ' A' ' 100' ' ' ARG . . . -56.55 135.63 54.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.059 -1.025 . . . . 0.0 109.479 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.71 HD12 ' CG1' ' A' ' 72' ' ' VAL . 93.4 mt -125.16 176.22 6.87 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.032 -1.043 . . . . 0.0 110.691 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.52 HG22 ' HG3' ' A' ' 100' ' ' ARG . 0.3 OUTLIER -167.9 -178.92 3.97 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.43 -0.794 . . . . 0.0 110.039 179.922 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.4 -29.87 70.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.196 -0.94 . . . . 0.0 110.281 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.535 ' O ' HG23 ' A' ' 67' ' ' THR . 3.7 mt-10 -90.28 176.7 2.8 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.172 -0.955 . . . . 0.0 110.14 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.499 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 45.4 Cg_endo -72.19 134.44 23.05 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.956 1.503 . . . . 0.0 110.334 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.69 HH11 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.9 92.94 3.9 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.191 -0.943 . . . . 0.0 110.368 -179.868 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.85 ' CA ' HG23 ' A' ' 65' ' ' THR . 6.4 tp-100 -76.71 154.92 33.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.292 -0.88 . . . . 0.0 110.085 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 1.165 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 32.2 t -131.72 134.47 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.232 -0.917 . . . . 0.0 110.194 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.25 115.61 5.45 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.275 -0.891 . . . . 0.0 110.138 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -159.88 131.19 5.95 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.207 -0.933 . . . . 0.0 110.32 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.6 m -89.97 105.25 17.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.261 -0.899 . . . . 0.0 110.06 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.628 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 34.4 p90 -106.83 154.28 21.25 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.275 -0.89 . . . . 0.0 110.447 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 58' ' ' THR . 33.0 m -91.29 89.8 7.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.28 -0.888 . . . . 0.0 109.691 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.636 ' HB2' ' CD2' ' A' ' 60' ' ' TYR . . . -41.94 101.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.329 -0.857 . . . . 0.0 110.452 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.812 ' N ' HG12 ' A' ' 88' ' ' VAL . 88.8 p -85.89 55.55 3.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.3 -0.875 . . . . 0.0 110.063 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.457 ' CB ' HG13 ' A' ' 88' ' ' VAL . . . -159.55 -154.96 0.43 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.282 -0.886 . . . . 0.0 110.131 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.676 HG23 ' HA ' ' A' ' 55' ' ' GLU . 19.7 m -159.99 110.89 1.92 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.111 -0.993 . . . . 0.0 110.591 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.65 ' CD2' ' CG1' ' A' ' 54' ' ' ILE . 3.3 m-30 -112.99 106.72 54.92 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.188 -0.945 . . . . 0.0 109.84 179.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.48 ' HG2' ' O ' ' A' ' 121' ' ' PRO . 46.4 Cg_endo -72.63 -159.02 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.785 1.413 . . . . 0.0 110.094 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -124.96 27.14 6.82 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.106 -0.996 . . . . 0.0 110.322 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.84 102.59 3.22 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.214 -0.928 . . . . 0.0 110.096 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.523 ' HA ' ' O ' ' A' ' 120' ' ' ASP . 47.2 Cg_endo -74.1 77.53 2.76 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.045 1.55 . . . . 0.0 110.588 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.95 ' HB3' ' HB2' ' A' ' 120' ' ' ASP . . . -96.59 -178.21 4.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.227 -0.921 . . . . 0.0 110.112 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -49.84 -58.89 4.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.239 -0.913 . . . . 0.0 110.223 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -101.18 26.82 6.67 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.275 -0.891 . . . . 0.0 110.354 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.95 ' HB2' ' HB3' ' A' ' 117' ' ' ALA . 28.6 m-20 -133.81 96.4 16.45 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.235 -0.916 . . . . 0.0 110.28 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.537 ' HB3' ' CA ' ' A' ' 82' ' ' GLY . 47.0 Cg_endo -73.85 164.25 35.08 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.011 1.532 . . . . 0.0 110.406 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.478 ' O ' ' HA ' ' A' ' 80' ' ' GLN . 1.4 pt-20 -112.78 -157.5 0.62 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.176 -0.953 . . . . 0.0 110.303 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.546 ' CA ' ' HB3' ' A' ' 112' ' ' TYR . . . -130.15 131.81 6.73 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.483 ' CB ' ' HA ' ' A' ' 50' ' ' ASN . 1.5 pt20 -150.43 -174.23 4.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.145 -1.209 . . . . 0.0 110.78 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.764 HG21 ' HH2' ' A' ' 16' ' ' TRP . 8.8 mt -118.74 143.87 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.912 ' HB3' HD11 ' A' ' 77' ' ' LEU . . . -115.15 119.65 37.11 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.286 -0.884 . . . . 0.0 111.275 -179.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.446 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 2.6 m-30 -117.34 94.08 4.42 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -89.25 105.08 17.55 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.084 -1.01 . . . . 0.0 111.524 -178.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.819 HD22 HG11 ' A' ' 74' ' ' VAL . 14.8 mt -100.13 50.09 0.91 Allowed 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.497 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -69.51 84.12 0.27 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.019 -1.233 . . . . 0.0 110.019 -179.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.966 ' HA3' ' HB2' ' A' ' 41' ' ' ALA . . . 39.02 72.47 0.2 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.743 ' HB2' HG12 ' A' ' 74' ' ' VAL . 10.5 m-85 -97.89 -39.64 8.89 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.136 -1.214 . . . . 0.0 110.124 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.742 ' HB2' HG23 ' A' ' 72' ' ' VAL . 1.2 t -89.69 -176.08 4.86 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.239 -0.913 . . . . 0.0 109.915 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.451 ' N ' ' OG ' ' A' ' 133' ' ' SER . . . -93.9 -99.48 0.14 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.033 -1.042 . . . . 0.0 110.982 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -61.17 177.51 0.34 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.993 -1.067 . . . . 0.0 110.853 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.503 ' N ' ' HA ' ' A' ' 38' ' ' ALA . . . -53.52 136.5 38.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.472 -0.767 . . . . 0.0 110.342 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 1.141 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 5.7 p90 -145.5 -170.16 3.38 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.372 -0.83 . . . . 0.0 110.157 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.537 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 0.5 OUTLIER -160.34 159.91 31.76 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.244 -0.983 . . . . 0.0 110.812 -178.789 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.675 ' CD2' HD11 ' A' ' 95' ' ' LEU . 2.2 mp -119.34 160.37 22.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.423 -0.798 . . . . 0.0 109.303 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' CYS . . . . . . . . . . . . . 13.6 m -150.53 100.55 2.87 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.128 -0.982 . . . . 0.0 110.598 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.688 HD23 ' HB2' ' A' ' 66' ' ' ALA . 0.9 OUTLIER -96.44 -176.75 3.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.3 -0.875 . . . . 0.0 109.446 179.321 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.573 ' O ' ' CB ' ' A' ' 143' ' ' ASP . 2.4 p30 166.72 61.52 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.324 -0.86 . . . . 0.0 110.042 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.573 ' CB ' ' O ' ' A' ' 142' ' ' ASP . 1.4 m-20 159.85 46.52 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.839 HG11 ' HZ2' ' A' ' 16' ' ' TRP . 3.5 t -89.64 112.04 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.329 -0.857 . . . . 0.0 110.466 -179.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -135.3 151.93 51.01 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.223 -0.923 . . . . 0.0 110.187 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.507 HD23 HG13 ' A' ' 52' ' ' VAL . 58.8 tp -151.61 124.67 8.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.335 -0.853 . . . . 0.0 110.194 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.469 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 3.5 t0 -161.07 156.43 24.53 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.278 -0.889 . . . . 0.0 110.326 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.514 ' OG ' ' N ' ' A' ' 149' ' ' GLU . 0.1 OUTLIER -99.48 -172.84 2.33 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.259 -0.901 . . . . 0.0 110.167 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.514 ' N ' ' OG ' ' A' ' 148' ' ' SER . 0.9 OUTLIER -121.46 111.34 17.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.188 -0.945 . . . . 0.0 110.32 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.457 ' HB ' ' O ' ' A' ' 149' ' ' GLU . 3.1 p 178.74 154.3 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.296 -0.878 . . . . 0.0 110.209 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -105.21 -147.5 0.39 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.272 -0.892 . . . . 0.0 110.182 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.2 tp . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.266 -179.971 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.222 0.534 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.4 t -169.88 81.74 0.62 Allowed Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.294 -0.879 . . . . 0.0 110.117 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -76.13 -156.46 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.072 1.564 . . . . 0.0 110.159 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.516 ' CD1' ' HB ' ' A' ' 144' ' ' VAL . 6.1 pt -89.9 -0.05 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.234 -0.916 . . . . 0.0 110.18 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 6' ' ' GLU . . . 119.69 -24.42 8.0 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.548 ' HG3' ' CB ' ' A' ' 145' ' ' ALA . 4.3 tt0 43.06 48.68 5.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.308 -1.113 . . . . 0.0 110.153 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 143' ' ' ASP . . . -134.81 159.17 23.83 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.444 ' HA ' ' HB2' ' A' ' 143' ' ' ASP . 1.2 p -51.29 -179.0 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.291 -1.123 . . . . 0.0 110.345 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.606 ' CD2' ' HA ' ' A' ' 142' ' ' ASP . 3.2 m-30 -110.78 24.83 12.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.292 -0.88 . . . . 0.0 110.283 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.565 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 29.6 t70 -110.74 50.91 0.79 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.172 -0.955 . . . . 0.0 110.209 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.565 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.3 OUTLIER 161.61 66.49 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.572 -0.705 . . . . 0.0 109.927 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.08 94.39 0.67 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.691 ' HG3' HG21 ' A' ' 27' ' ' THR . 51.1 Cg_endo -81.8 46.19 2.16 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.113 1.586 . . . . 0.0 110.63 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.477 ' HG3' ' N ' ' A' ' 15' ' ' GLY . 12.7 tp10 56.85 -90.97 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.155 -0.966 . . . . 0.0 110.187 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.725 ' C ' HD13 ' A' ' 49' ' ' LEU . . . -154.61 31.73 0.69 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.866 ' CE2' HD22 ' A' ' 49' ' ' LEU . 61.3 m95 -69.3 84.45 0.38 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.283 -1.127 . . . . 0.0 110.297 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.728 ' O ' HG13 ' A' ' 47' ' ' VAL . 1.3 m -89.64 148.05 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.149 -0.97 . . . . 0.0 109.804 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.534 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . . . -124.58 135.75 53.39 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.095 -1.003 . . . . 0.0 109.893 179.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.945 ' CE1' HG13 ' A' ' 48' ' ' VAL . 20.1 p90 -124.69 168.51 13.08 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.385 -0.822 . . . . 0.0 110.753 -178.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.602 ' O ' HG13 ' A' ' 45' ' ' VAL . . . 68.71 42.68 78.9 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.501 HG22 ' CG1' ' A' ' 45' ' ' VAL . 1.8 p -151.35 -147.55 0.23 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.088 -1.242 . . . . 0.0 110.245 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.419 ' O ' ' O ' ' A' ' 23' ' ' GLY . 1.1 t70 -108.86 117.31 33.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.308 -0.87 . . . . 0.0 110.165 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 22' ' ' ASP . . . 52.83 177.15 0.06 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.02 151.12 49.69 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.965 1.508 . . . . 0.0 110.447 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.701 HD23 ' H ' ' A' ' 25' ' ' LEU . 0.8 OUTLIER -49.02 161.86 0.13 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.333 -0.855 . . . . 0.0 110.228 179.945 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -121.34 132.29 54.69 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.241 -0.912 . . . . 0.0 110.046 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.691 HG21 ' HG3' ' A' ' 13' ' ' PRO . 0.7 OUTLIER -120.33 -24.93 5.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.216 -0.927 . . . . 0.0 110.61 -179.797 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 27' ' ' THR . 0.6 OUTLIER -43.93 -25.81 0.23 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.134 -0.978 . . . . 0.0 110.176 -179.828 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.592 HG23 ' N ' ' A' ' 30' ' ' GLY . 6.2 t -62.97 -47.51 82.83 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.271 -0.893 . . . . 0.0 110.686 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.592 ' N ' HG23 ' A' ' 29' ' ' THR . . . 161.03 -20.64 0.21 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.856 -1.297 . . . . 0.0 109.856 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.663 ' HB1' ' O ' ' A' ' 141' ' ' LEU . . . -150.12 -176.08 5.31 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.167 -1.196 . . . . 0.0 109.965 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.615 HD11 HD13 ' A' ' 25' ' ' LEU . 0.7 OUTLIER -87.51 94.9 9.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.108 -0.995 . . . . 0.0 109.949 179.801 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 89.4 m -110.54 106.68 16.05 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.149 -0.969 . . . . 0.0 110.748 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.537 HG12 ' HB3' ' A' ' 25' ' ' LEU . 22.4 m -89.72 138.79 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.292 -0.88 . . . . 0.0 109.178 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.475 ' O ' ' HB ' ' A' ' 21' ' ' THR . . . -89.0 93.15 9.5 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.141 -0.975 . . . . 0.0 111.337 -178.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.132 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 75.3 t -70.53 135.3 86.26 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.341 -0.849 . . . . 0.0 109.372 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.454 ' O ' ' OG ' ' A' ' 40' ' ' SER . 41.4 Cg_endo -68.56 172.28 11.7 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.727 1.383 . . . . 0.0 111.542 -178.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.504 ' HA ' ' N ' ' A' ' 136' ' ' ALA . . . -70.47 115.32 9.51 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.39 -0.819 . . . . 0.0 110.447 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.476 ' O ' ' N ' ' A' ' 41' ' ' ALA . . . 83.79 -40.63 2.9 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.753 ' HB3' HG21 ' A' ' 45' ' ' VAL . 1.5 m 38.3 30.48 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.542 -0.975 . . . . 0.0 110.146 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 39' ' ' GLY . . . -89.6 23.22 2.7 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.973 0.892 . . . . 0.0 110.08 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.589 ' O ' ' CG ' ' A' ' 43' ' ' TYR . 9.7 pm0 -108.67 126.9 53.49 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.589 ' CG ' ' O ' ' A' ' 42' ' ' GLN . 43.9 p90 39.45 27.88 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.515 -0.741 . . . . 0.0 109.927 -178.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 42' ' ' GLN . . . 51.17 173.84 0.02 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.753 HG21 ' HB3' ' A' ' 40' ' ' SER . 43.5 t -142.0 -179.07 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 179.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.578 ' H ' HG12 ' A' ' 45' ' ' VAL . . . 164.22 -163.39 36.0 Favored Glycine 0 N--CA 1.484 1.852 0 C-N-CA 117.345 -2.36 . . . . 0.0 112.734 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.728 HG13 ' O ' ' A' ' 17' ' ' VAL . 38.5 t -150.98 132.09 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.945 HG13 ' CE1' ' A' ' 19' ' ' TYR . 35.7 m -119.51 138.93 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.917 -1.115 . . . . 0.0 110.833 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.866 HD22 ' CE2' ' A' ' 16' ' ' TRP . 20.1 tp -133.69 97.68 3.99 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.373 -0.829 . . . . 0.0 110.236 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.51 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 8.6 p30 -81.11 113.61 19.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.218 -0.926 . . . . 0.0 110.239 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.413 ' O ' HG22 ' A' ' 4' ' ' ILE . . . 154.89 64.25 0.01 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.684 HG12 ' H ' ' A' ' 53' ' ' ALA . 3.2 t -119.95 -176.18 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.237 -1.155 . . . . 0.0 109.881 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.684 ' H ' HG12 ' A' ' 52' ' ' VAL . . . -142.49 75.14 1.48 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.074 -1.016 . . . . 0.0 110.634 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.638 ' CG2' ' HB1' ' A' ' 108' ' ' ALA . 32.5 mm -113.78 162.29 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.098 -1.001 . . . . 0.0 109.971 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.526 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 18.4 tt0 -162.25 132.31 4.68 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.176 -0.952 . . . . 0.0 110.605 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.526 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 15.2 pt-20 38.13 -160.25 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.67 -0.644 . . . . 0.0 110.916 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' A' ' 109' ' ' SER . . . -80.63 74.88 2.32 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.679 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.3 m -104.17 168.2 9.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.351 -1.087 . . . . 0.0 109.868 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.571 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 3.1 m -89.99 157.98 17.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.177 -0.952 . . . . 0.0 110.264 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.78 ' HB3' HD11 ' A' ' 146' ' ' LEU . 66.5 m-85 -158.95 173.79 15.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.225 -0.922 . . . . 0.0 110.37 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.839 ' OG1' HG22 ' A' ' 105' ' ' THR . 22.1 m -150.16 113.98 5.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.355 -0.841 . . . . 0.0 110.034 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.468 HD12 ' N ' ' A' ' 63' ' ' ARG . 10.3 tp -89.66 121.96 32.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.16 -0.963 . . . . 0.0 110.077 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.485 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 9.5 ttt-85 -127.63 107.16 9.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 110.489 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.603 ' OH ' HG21 ' A' ' 102' ' ' VAL . 7.8 p90 -143.34 172.33 12.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.333 -0.854 . . . . 0.0 109.915 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 5.0 m -131.27 94.91 3.66 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.171 -0.956 . . . . 0.0 110.226 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.689 ' CB ' HD21 ' A' ' 95' ' ' LEU . . . -99.6 142.1 31.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -0.898 . . . . 0.0 110.398 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.782 HG23 ' O ' ' A' ' 98' ' ' GLU . 93.3 m -150.37 101.86 3.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.403 -0.811 . . . . 0.0 110.048 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -89.81 144.07 26.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.192 -0.942 . . . . 0.0 110.105 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.4 m -60.59 -15.01 23.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.147 -0.971 . . . . 0.0 109.225 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.555 ' CG2' ' HB2' ' A' ' 137' ' ' TRP . 3.0 t -121.71 160.18 25.05 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.592 -0.693 . . . . 0.0 109.809 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -77.94 79.7 4.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.044 -1.035 . . . . 0.0 108.927 178.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.738 HG23 ' HB2' ' A' ' 133' ' ' SER . 3.7 p -99.56 135.31 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.199 -0.938 . . . . 0.0 111.654 -178.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 23.3 m -121.61 86.86 2.65 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.962 HG21 ' CD2' ' A' ' 129' ' ' LEU . 10.8 m -89.84 -149.71 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.283 -0.886 . . . . 0.0 111.172 -178.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.474 ' N ' HG23 ' A' ' 74' ' ' VAL . 0.4 OUTLIER -130.68 106.38 8.44 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.534 -0.729 . . . . 0.0 110.524 -179.583 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.48 ' O ' ' HB3' ' A' ' 77' ' ' LEU . . . -110.39 158.22 18.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.378 -0.827 . . . . 0.0 109.586 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.595 HD12 ' N ' ' A' ' 78' ' ' VAL . 3.7 pp 177.79 -158.04 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.279 -0.888 . . . . 0.0 110.376 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.85 ' CG2' HD22 ' A' ' 89' ' ' LEU . 4.3 t -147.19 171.6 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.39 -0.819 . . . . 0.0 109.488 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.489 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . 175.36 -171.66 44.76 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.353 -1.403 . . . . 0.0 110.242 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.426 ' O ' ' CG ' ' A' ' 81' ' ' ASN . 2.5 tt0 -94.08 -169.63 2.12 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.429 -1.042 . . . . 0.0 110.171 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.487 ' O ' ' HB2' ' A' ' 121' ' ' PRO . 23.2 m120 -157.21 75.2 0.8 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.308 -0.87 . . . . 0.0 109.831 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.532 ' HA3' ' CB ' ' A' ' 121' ' ' PRO . . . 144.5 38.57 0.06 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.513 ' HB3' ' O ' ' A' ' 82' ' ' GLY . . . 58.96 150.91 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.232 -1.158 . . . . 0.0 110.305 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.461 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 52.1 Cg_endo -80.49 21.99 8.32 Favored 'Cis proline' 0 C--N 1.312 -1.343 0 C-N-CA 121.696 -2.21 . . . . 0.0 111.113 0.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.464 ' N ' ' HA ' ' A' ' 83' ' ' ALA . 43.5 m-85 60.49 123.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.01 -1.056 . . . . 0.0 110.317 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -154.86 110.77 0.46 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.8 p -89.89 142.53 27.61 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.208 -1.172 . . . . 0.0 110.333 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 1.081 HG23 HD12 ' A' ' 89' ' ' LEU . 28.8 m -119.97 -20.11 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.345 -0.847 . . . . 0.0 109.973 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 1.081 HD12 HG23 ' A' ' 88' ' ' VAL . 4.7 mp -111.97 142.18 44.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.855 . . . . 0.0 110.652 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.634 ' O ' HG23 ' A' ' 91' ' ' THR . 1.7 p30 -151.18 87.84 1.42 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.252 -0.905 . . . . 0.0 110.159 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.634 HG23 ' O ' ' A' ' 90' ' ' ASP . 1.7 p -156.74 178.66 10.09 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.933 -1.104 . . . . 0.0 110.797 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 81.5 p -119.79 127.81 26.2 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.377 -0.827 . . . . 0.0 109.886 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.805 ' HG2' HG22 ' A' ' 74' ' ' VAL . 48.9 Cg_endo -75.08 75.08 3.84 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.887 1.467 . . . . 0.0 111.192 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.521 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -52.45 124.83 14.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.922 -1.111 . . . . 0.0 109.094 179.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.689 HD21 ' CB ' ' A' ' 66' ' ' ALA . 38.2 mt -119.91 175.51 5.87 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.992 -1.068 . . . . 0.0 111.0 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -168.78 -178.54 3.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.521 -0.737 . . . . 0.0 109.806 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.2 p -70.26 -7.38 41.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.221 -0.924 . . . . 0.0 110.293 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.782 ' O ' HG23 ' A' ' 67' ' ' THR . 1.1 mt-10 -102.35 172.34 4.44 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.212 -0.93 . . . . 0.0 110.094 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.5 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 44.8 Cg_endo -72.5 129.0 14.16 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.014 1.534 . . . . 0.0 110.304 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.521 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.79 92.03 3.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.205 -0.934 . . . . 0.0 110.333 -179.81 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.432 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 0.0 OUTLIER -88.61 106.14 18.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.254 -0.904 . . . . 0.0 110.081 179.842 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.603 HG21 ' OH ' ' A' ' 64' ' ' TYR . 37.5 t -89.98 133.82 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.231 -0.918 . . . . 0.0 110.316 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.465 ' C ' ' CG ' ' A' ' 104' ' ' GLU . 8.3 m -150.24 112.03 4.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.286 -0.884 . . . . 0.0 110.042 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.465 ' CG ' ' C ' ' A' ' 103' ' ' THR . 32.0 mt-10 -150.7 156.13 40.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.184 -0.947 . . . . 0.0 110.354 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.839 HG22 ' OG1' ' A' ' 61' ' ' THR . 0.8 OUTLIER -106.33 134.78 48.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.331 -0.856 . . . . 0.0 110.095 179.863 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.6 ' CE1' HD11 ' A' ' 89' ' ' LEU . 55.4 p90 -136.65 157.63 46.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.215 -0.928 . . . . 0.0 110.305 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 86.4 m -89.98 91.36 8.54 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.278 -0.889 . . . . 0.0 110.041 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.68 ' HB3' ' CE2' ' A' ' 60' ' ' TYR . . . -57.36 117.08 3.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.253 -0.904 . . . . 0.0 110.381 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.45 ' HA ' ' HA2' ' A' ' 57' ' ' GLY . 11.0 p -100.21 54.93 0.9 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.227 -0.921 . . . . 0.0 110.099 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -166.38 -162.42 0.52 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.215 -0.928 . . . . 0.0 110.417 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.497 HG22 ' HD3' ' A' ' 113' ' ' PRO . 61.9 m -143.39 115.27 8.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.237 -0.914 . . . . 0.0 110.297 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.633 ' OH ' HG13 ' A' ' 88' ' ' VAL . 11.8 m-30 -114.84 80.97 6.97 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.266 -0.896 . . . . 0.0 110.08 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.497 ' HD3' HG22 ' A' ' 111' ' ' THR . 45.7 Cg_endo -73.04 -162.37 0.13 Allowed 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 124.015 1.534 . . . . 0.0 110.446 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.476 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -142.69 25.0 1.85 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.275 -0.891 . . . . 0.0 110.29 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.448 ' O ' ' O ' ' A' ' 120' ' ' ASP . 1.3 m -108.92 83.13 2.03 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.197 -0.939 . . . . 0.0 110.172 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 46.3 Cg_endo -73.2 78.88 2.17 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.994 1.523 . . . . 0.0 110.506 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.821 ' HB3' ' HB2' ' A' ' 120' ' ' ASP . . . -101.37 -167.92 1.49 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.253 -0.904 . . . . 0.0 110.179 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.7 -53.2 58.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.235 -0.916 . . . . 0.0 110.218 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.49 41.13 2.38 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.268 -0.895 . . . . 0.0 110.253 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.821 ' HB2' ' HB3' ' A' ' 117' ' ' ALA . 52.3 m-20 -148.98 86.75 5.59 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.223 -0.923 . . . . 0.0 110.229 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.532 ' CB ' ' HA3' ' A' ' 82' ' ' GLY . 45.8 Cg_endo -73.04 -158.96 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.966 1.509 . . . . 0.0 110.44 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.485 ' HA ' ' HD2' ' A' ' 113' ' ' PRO . 3.7 pm0 -160.68 -170.0 2.61 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.149 -0.97 . . . . 0.0 110.465 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.564 ' HA3' ' CD1' ' A' ' 112' ' ' TYR . . . -123.62 159.08 18.28 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.336 -1.505 . . . . 0.0 109.336 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.562 ' HA ' ' CG2' ' A' ' 52' ' ' VAL . 19.6 pt20 -150.34 -159.07 0.98 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.161 -1.199 . . . . 0.0 110.687 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.748 HG21 ' HH2' ' A' ' 16' ' ' TRP . 9.8 mt -118.95 147.08 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.529 -0.732 . . . . 0.0 109.388 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.507 ' HB3' ' CD1' ' A' ' 77' ' ' LEU . . . -120.35 118.85 31.46 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.322 -0.861 . . . . 0.0 111.314 -179.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.548 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 4.6 m-85 -119.57 73.35 0.95 Allowed 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.547 ' HA ' ' HA3' ' A' ' 46' ' ' GLY . 34.1 mt-30 -87.9 106.01 17.82 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 122.52 1.152 . . . . 0.0 112.104 -177.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.962 ' CD2' HG21 ' A' ' 74' ' ' VAL . 10.3 mt -93.47 -111.22 0.11 Allowed 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.62 ' HA3' ' N ' ' A' ' 45' ' ' VAL . . . 50.75 111.81 0.01 OUTLIER Glycine 0 N--CA 1.493 2.442 0 O-C-N 120.743 -1.223 . . . . 0.0 111.138 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 40' ' ' SER . . . 72.91 66.88 1.94 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.588 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 5.0 m-85 -148.03 -52.01 0.18 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.234 -1.157 . . . . 0.0 110.182 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.738 ' HB2' HG23 ' A' ' 72' ' ' VAL . 1.6 t -89.36 -151.78 0.23 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.086 -1.009 . . . . 0.0 110.15 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -112.09 -88.82 0.52 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.147 -0.97 . . . . 0.0 110.321 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.407 ' O ' ' C ' ' A' ' 136' ' ' ALA . 6.1 m-20 -84.07 172.65 11.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.222 -0.924 . . . . 0.0 110.273 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.504 ' N ' ' HA ' ' A' ' 38' ' ' ALA . . . -42.35 130.33 3.81 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.297 -0.877 . . . . 0.0 110.293 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 1.132 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 9.7 p90 -142.97 -165.21 2.01 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.325 -0.859 . . . . 0.0 109.648 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.526 ' O ' ' CB ' ' A' ' 68' ' ' ALA . 0.5 OUTLIER -160.04 172.72 17.0 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.834 -1.166 . . . . 0.0 111.231 -178.284 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.609 HD13 HD13 ' A' ' 129' ' ' LEU . 2.2 mp -134.35 126.58 29.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.582 -0.699 . . . . 0.0 109.326 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' CYS . . . . . . . . . . . . . 7.2 m -114.07 96.09 5.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.154 -0.966 . . . . 0.0 110.807 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.663 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 2.1 mt -89.75 -166.65 1.64 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.357 -0.839 . . . . 0.0 109.357 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.606 ' HA ' ' CD2' ' A' ' 9' ' ' PHE . 22.0 p-10 -167.93 -151.31 0.11 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.964 -1.085 . . . . 0.0 110.626 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.476 ' C ' ' CG2' ' A' ' 144' ' ' VAL . 6.5 t0 -38.82 150.89 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.641 -0.662 . . . . 0.0 110.662 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 142' ' ' ASP . 3.0 t -150.15 132.47 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.357 -0.839 . . . . 0.0 109.955 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.548 ' CB ' ' HG3' ' A' ' 6' ' ' GLU . . . -127.91 146.35 50.66 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.187 -0.946 . . . . 0.0 110.413 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.78 HD11 ' HB3' ' A' ' 60' ' ' TYR . 22.8 tp -153.81 90.72 1.4 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.323 -0.861 . . . . 0.0 110.085 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.462 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 0.4 OUTLIER -107.07 -167.02 1.22 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.249 -0.907 . . . . 0.0 110.258 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.43 ' HB3' ' CE1' ' A' ' 60' ' ' TYR . 1.2 p -138.77 105.9 5.47 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.207 -0.933 . . . . 0.0 110.25 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -114.61 155.74 25.97 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.262 -0.899 . . . . 0.0 110.226 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.673 HG22 ' O ' ' A' ' 150' ' ' VAL . 7.9 p -106.46 48.36 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.243 -0.91 . . . . 0.0 110.222 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -60.33 167.53 2.45 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.257 -0.902 . . . . 0.0 110.119 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.4 mp . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.227 179.983 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.218 0.532 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.4 m -129.66 153.65 80.8 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.226 -0.922 . . . . 0.0 110.239 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -75.88 -156.06 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.005 1.529 . . . . 0.0 110.085 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.631 HG22 ' O ' ' A' ' 51' ' ' GLY . 20.7 pt -89.96 43.63 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.19 -0.944 . . . . 0.0 110.113 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 6' ' ' GLU . . . 56.83 61.28 7.68 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 5' ' ' GLY . 1.7 mp0 57.16 -88.62 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.292 -1.122 . . . . 0.0 110.193 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 8' ' ' THR . . . 159.22 -115.34 0.65 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 7' ' ' GLY . 4.1 p 45.46 97.49 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.39 -1.065 . . . . 0.0 110.165 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.603 ' CD2' ' HB2' ' A' ' 32' ' ' LEU . 78.2 m-85 -77.62 7.62 5.41 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.479 -0.763 . . . . 0.0 109.7 179.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.551 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 34.4 t0 -84.15 45.06 1.06 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.419 -0.801 . . . . 0.0 110.122 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.551 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.3 OUTLIER 161.6 36.83 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.572 -0.705 . . . . 0.0 109.879 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 118.29 112.01 2.52 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.906 ' HG3' HG21 ' A' ' 27' ' ' THR . 51.0 Cg_endo -77.07 8.91 2.97 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 O-C-N 123.834 1.439 . . . . 0.0 110.93 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.509 ' HB3' ' O ' ' A' ' 13' ' ' PRO . 30.1 tp10 61.34 -89.47 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.237 -0.914 . . . . 0.0 110.464 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -149.02 19.15 1.22 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.97 ' CE2' HD22 ' A' ' 49' ' ' LEU . 23.5 m95 -62.53 125.31 23.48 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.211 -1.17 . . . . 0.0 110.324 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.855 ' O ' HG13 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -115.44 161.93 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.234 -0.916 . . . . 0.0 109.234 179.635 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.474 ' HB1' HG11 ' A' ' 34' ' ' VAL . . . -146.9 152.24 38.35 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.323 -0.861 . . . . 0.0 110.209 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.638 ' HE2' HG13 ' A' ' 48' ' ' VAL . 11.8 p90 -138.61 114.02 9.62 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.296 -0.877 . . . . 0.0 110.274 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.854 ' HA3' HG13 ' A' ' 45' ' ' VAL . . . -173.0 49.97 0.16 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.445 ' OG1' ' HG3' ' A' ' 37' ' ' PRO . 8.2 p 50.9 19.22 0.61 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.366 -1.079 . . . . 0.0 110.479 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.634 ' CB ' ' HB3' ' A' ' 35' ' ' ALA . 1.8 p30 -102.59 38.01 1.8 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.133 -0.98 . . . . 0.0 110.197 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 44.46 -153.27 0.47 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.457 ' O ' ' O ' ' A' ' 25' ' ' LEU . 46.3 Cg_endo -73.54 125.92 10.48 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.933 1.491 . . . . 0.0 110.361 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.708 HD23 ' H ' ' A' ' 25' ' ' LEU . 0.8 OUTLIER -42.87 166.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.227 -0.921 . . . . 0.0 110.11 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.486 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 0.5 OUTLIER -125.83 149.92 48.25 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.163 -0.96 . . . . 0.0 110.275 -179.815 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.906 HG21 ' HG3' ' A' ' 13' ' ' PRO . 0.7 OUTLIER -129.78 -43.78 1.22 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.249 -0.907 . . . . 0.0 110.251 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.451 ' HB3' ' O ' ' A' ' 27' ' ' THR . 4.5 t 56.35 36.28 27.26 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.31 -0.869 . . . . 0.0 110.303 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.451 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 33.2 p 42.53 33.21 0.42 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.299 -0.876 . . . . 0.0 110.3 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.516 ' CA ' ' HA ' ' A' ' 10' ' ' ASP . . . -140.51 -63.58 0.03 OUTLIER Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.432 ' HB1' ' O ' ' A' ' 141' ' ' LEU . . . -150.11 148.78 29.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.308 -1.113 . . . . 0.0 110.101 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.701 HD12 ' HB3' ' A' ' 13' ' ' PRO . 1.8 tt -88.36 115.46 25.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.116 -0.99 . . . . 0.0 109.861 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 72.8 m -121.56 137.74 54.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.193 -0.942 . . . . 0.0 110.765 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.496 ' CG2' ' HB2' ' A' ' 139' ' ' LEU . 2.7 m -110.98 143.47 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.408 -0.807 . . . . 0.0 109.215 179.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.634 ' HB3' ' CB ' ' A' ' 22' ' ' ASP . . . -89.43 90.04 8.13 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.167 -0.958 . . . . 0.0 111.46 -178.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.154 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 87.2 t -72.52 119.14 73.39 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.043 -1.036 . . . . 0.0 109.182 178.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.445 ' HG3' ' OG1' ' A' ' 21' ' ' THR . 42.7 Cg_endo -68.12 151.1 77.51 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.951 1.501 . . . . 0.0 111.415 -178.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.577 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -43.11 144.24 0.67 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.498 -0.751 . . . . 0.0 110.042 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 38' ' ' ALA . . . 44.46 77.73 0.09 OUTLIER Glycine 0 N--CA 1.488 2.133 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.856 ' HB2' HG21 ' A' ' 45' ' ' VAL . 0.3 OUTLIER -87.33 25.98 1.3 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.223 -1.163 . . . . 0.0 110.386 -179.703 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.559 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . . . -92.85 19.89 7.17 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 122.048 0.928 . . . . 0.0 109.606 179.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.569 ' HG3' ' CD2' ' A' ' 43' ' ' TYR . 25.7 pt20 -89.87 -131.34 0.09 Allowed 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.417 179.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.638 ' CD1' ' N ' ' A' ' 44' ' ' GLY . 12.4 p90 -37.51 -28.94 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.589 -0.695 . . . . 0.0 110.218 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.638 ' N ' ' CD1' ' A' ' 43' ' ' TYR . . . 105.45 111.3 3.59 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 179.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.856 HG21 ' HB2' ' A' ' 40' ' ' SER . 2.1 t -89.91 171.18 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.176 -1.19 . . . . 0.0 108.541 178.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.574 ' O ' ' CE2' ' A' ' 19' ' ' TYR . . . 160.72 155.61 7.87 Favored Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.029 -1.557 . . . . 0.0 110.478 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.855 HG13 ' O ' ' A' ' 17' ' ' VAL . 48.6 t -120.5 133.48 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.473 -1.016 . . . . 0.0 109.656 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.638 HG13 ' HE2' ' A' ' 19' ' ' TYR . 30.4 m -120.02 153.46 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.079 -1.013 . . . . 0.0 110.523 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.97 HD22 ' CE2' ' A' ' 16' ' ' TRP . 13.5 tp -140.51 87.64 2.14 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.304 -0.872 . . . . 0.0 110.197 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.509 ' HA ' ' HB3' ' A' ' 124' ' ' GLN . 23.6 m-20 -68.1 104.13 1.7 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.291 -0.881 . . . . 0.0 110.241 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.631 ' O ' HG22 ' A' ' 4' ' ' ILE . . . 154.39 74.22 0.01 OUTLIER Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.735 HG23 ' HA ' ' A' ' 124' ' ' GLN . 24.7 t -120.74 172.44 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.277 -1.131 . . . . 0.0 109.939 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.578 ' N ' HG12 ' A' ' 52' ' ' VAL . . . -134.27 77.57 1.71 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.09 -1.006 . . . . 0.0 110.941 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 1.028 HD11 HD21 ' A' ' 146' ' ' LEU . 24.9 mm -118.82 165.2 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.191 -0.943 . . . . 0.0 109.599 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.52 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 0.3 OUTLIER -158.88 126.79 5.07 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.989 -1.07 . . . . 0.0 110.888 -179.722 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.52 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 17.2 pt-20 37.29 -154.98 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.65 -0.656 . . . . 0.0 110.99 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.467 ' HA2' ' O ' ' A' ' 108' ' ' ALA . . . -81.4 81.67 1.62 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.626 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.2 m -112.44 172.34 6.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.209 -1.171 . . . . 0.0 109.943 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.57 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 0.4 OUTLIER -89.98 154.3 19.94 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.316 -0.865 . . . . 0.0 110.213 -179.894 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.626 ' CE2' HG22 ' A' ' 58' ' ' THR . 59.9 m-85 -159.69 173.47 16.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.293 -0.879 . . . . 0.0 110.238 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 27.4 m -150.11 114.52 5.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.282 -0.886 . . . . 0.0 110.081 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 14.1 tp -89.62 120.83 31.25 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.211 -0.931 . . . . 0.0 109.902 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.498 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 6.5 ttt180 -131.49 128.5 39.5 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.228 -0.92 . . . . 0.0 110.405 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.962 ' HB2' HG22 ' A' ' 144' ' ' VAL . 6.9 p90 -165.09 156.02 14.32 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.409 -0.807 . . . . 0.0 109.964 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.48 ' HB ' ' OD1' ' A' ' 142' ' ' ASP . 32.2 m -119.76 99.79 6.85 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.17 -0.956 . . . . 0.0 109.919 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.515 ' HB2' HD23 ' A' ' 141' ' ' LEU . . . -100.79 154.51 18.57 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.264 -0.897 . . . . 0.0 110.473 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.647 HG23 ' O ' ' A' ' 98' ' ' GLU . 90.6 m -150.34 136.84 18.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.362 -0.836 . . . . 0.0 110.145 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.536 ' N ' ' HB3' ' A' ' 95' ' ' LEU . . . -129.39 127.33 40.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.234 -0.916 . . . . 0.0 109.993 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 68' ' ' ALA . 0.6 OUTLIER -43.13 -26.84 0.18 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.246 -0.909 . . . . 0.0 109.66 179.809 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.583 ' CG2' ' CB ' ' A' ' 137' ' ' TRP . 3.5 t -110.5 164.08 13.06 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.482 -0.761 . . . . 0.0 109.928 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -82.79 72.04 9.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.168 -0.958 . . . . 0.0 109.038 178.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.778 HG23 ' CB ' ' A' ' 133' ' ' SER . 4.0 p -93.54 136.38 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.326 -0.859 . . . . 0.0 111.384 -178.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.541 ' O ' ' CD1' ' A' ' 132' ' ' PHE . 13.5 m -119.98 87.85 2.82 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.701 HG11 HD22 ' A' ' 129' ' ' LEU . 11.5 m -89.5 -153.18 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.249 -0.907 . . . . 0.0 110.761 -178.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.528 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 0.3 OUTLIER -127.99 135.29 49.72 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.369 -0.832 . . . . 0.0 110.476 -179.207 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.685 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -136.83 154.89 50.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.299 -0.875 . . . . 0.0 109.979 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.892 HD12 ' N ' ' A' ' 78' ' ' VAL . 4.0 pp 179.2 -149.22 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.363 -0.836 . . . . 0.0 110.099 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.892 ' N ' HD12 ' A' ' 77' ' ' LEU . 4.7 t -147.86 177.67 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.28 -0.887 . . . . 0.0 109.365 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.533 ' C ' ' CZ ' ' A' ' 112' ' ' TYR . . . -177.69 -176.55 45.81 Favored Glycine 0 N--CA 1.489 2.186 0 C-N-CA 119.22 -1.466 . . . . 0.0 110.16 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' A' ' 122' ' ' GLU . 5.0 tt0 -98.0 -151.93 0.39 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.404 -1.056 . . . . 0.0 110.193 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.533 ' O ' ' CB ' ' A' ' 121' ' ' PRO . 10.0 m120 -161.15 61.6 0.28 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.411 -0.806 . . . . 0.0 109.681 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.51 ' HA3' ' HB3' ' A' ' 121' ' ' PRO . . . 159.97 128.4 0.97 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.196 -1.561 . . . . 0.0 109.196 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.628 ' N ' ' CE1' ' A' ' 85' ' ' TYR . . . -41.73 151.34 0.32 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.319 -1.106 . . . . 0.0 110.377 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.488 ' C ' ' CD2' ' A' ' 85' ' ' TYR . 50.9 Cg_endo -79.14 10.04 22.91 Favored 'Cis proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.632 -2.237 . . . . 0.0 110.775 -0.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.628 ' CE1' ' N ' ' A' ' 83' ' ' ALA . 12.5 m-85 68.0 156.53 0.12 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.241 -0.912 . . . . 0.0 110.169 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -171.6 125.84 1.23 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.98 152.44 19.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.242 -1.152 . . . . 0.0 110.209 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.678 HG23 HD12 ' A' ' 89' ' ' LEU . 16.0 m -123.23 -24.94 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.287 -0.883 . . . . 0.0 110.2 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.864 HD22 HG23 ' A' ' 78' ' ' VAL . 4.2 mp -108.96 144.79 36.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.232 -0.917 . . . . 0.0 110.911 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.424 ' O ' ' CG ' ' A' ' 90' ' ' ASP . 40.2 p-10 -151.45 80.91 1.3 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.352 -0.843 . . . . 0.0 110.063 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.403 HG23 ' C ' ' A' ' 90' ' ' ASP . 44.3 p -144.01 171.74 13.84 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.959 -1.088 . . . . 0.0 110.742 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.405 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 0.7 OUTLIER -119.96 115.02 33.51 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.385 -0.822 . . . . 0.0 110.021 179.879 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.685 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 43.7 Cg_endo -70.16 155.19 65.19 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.951 1.501 . . . . 0.0 110.998 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.777 ' O ' HD23 ' A' ' 95' ' ' LEU . . . -129.92 145.39 51.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.407 -0.808 . . . . 0.0 109.573 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.777 HD23 ' O ' ' A' ' 94' ' ' ALA . 39.6 mt -134.19 173.0 12.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.07 -1.019 . . . . 0.0 110.673 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.546 HG23 ' N ' ' A' ' 97' ' ' SER . 6.0 t -171.85 -154.87 0.09 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.401 -0.812 . . . . 0.0 109.918 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.546 ' N ' HG23 ' A' ' 96' ' ' THR . 0.3 OUTLIER -90.44 28.41 1.48 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.206 -0.934 . . . . 0.0 110.143 179.893 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.647 ' O ' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -149.95 173.81 3.99 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.315 -0.866 . . . . 0.0 109.968 179.873 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.56 130.62 16.25 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.953 1.501 . . . . 0.0 110.364 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.519 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.61 87.43 2.74 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.226 -0.921 . . . . 0.0 110.042 -179.98 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.444 ' HG2' ' OG1' ' A' ' 65' ' ' THR . 0.9 OUTLIER -68.31 151.68 46.55 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.359 -0.838 . . . . 0.0 110.245 -179.903 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.925 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 65.1 t -131.49 136.31 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.228 -0.92 . . . . 0.0 110.009 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.463 ' O ' ' HG3' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -150.13 104.04 3.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.271 -0.893 . . . . 0.0 110.173 -179.937 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.463 ' HG3' ' O ' ' A' ' 103' ' ' THR . 6.7 mt-10 -145.53 132.9 20.64 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.286 -0.884 . . . . 0.0 110.166 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.441 ' O ' ' HB3' ' A' ' 106' ' ' PHE . 0.2 OUTLIER -89.92 169.82 10.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.287 -0.883 . . . . 0.0 110.12 179.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.649 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 42.1 p90 -177.38 150.49 0.71 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -0.923 . . . . 0.0 110.288 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.5 m -91.47 92.39 8.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.234 -0.917 . . . . 0.0 110.061 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.611 ' HB3' ' CE2' ' A' ' 60' ' ' TYR . . . -50.86 113.83 1.01 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.887 . . . . 0.0 110.227 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.59 ' H ' HG12 ' A' ' 88' ' ' VAL . 17.1 p -96.52 51.4 1.17 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.213 -0.93 . . . . 0.0 110.191 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.402 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -162.99 -166.57 1.31 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.218 -0.926 . . . . 0.0 110.18 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.606 HG22 ' HD3' ' A' ' 113' ' ' PRO . 11.2 m -134.39 112.27 10.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.218 -0.926 . . . . 0.0 110.307 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.533 ' CZ ' ' C ' ' A' ' 79' ' ' GLY . 17.9 m-30 -113.02 71.42 1.34 Allowed Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.339 -0.85 . . . . 0.0 110.001 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.606 ' HD3' HG22 ' A' ' 111' ' ' THR . 44.0 Cg_endo -72.13 -167.6 0.33 Allowed 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.932 1.49 . . . . 0.0 110.374 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -135.51 63.69 1.6 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.202 -0.936 . . . . 0.0 110.279 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 120' ' ' ASP . 0.8 OUTLIER -150.08 85.57 5.47 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.29 -0.881 . . . . 0.0 110.159 179.91 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.63 80.74 1.67 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.039 1.547 . . . . 0.0 110.518 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.68 ' HB3' ' HB2' ' A' ' 120' ' ' ASP . . . -118.27 46.62 1.76 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.273 -0.892 . . . . 0.0 110.163 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 117' ' ' ALA . . . 58.31 -88.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.232 -0.918 . . . . 0.0 110.247 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.417 ' N ' ' O ' ' A' ' 117' ' ' ALA . 33.2 t70 -57.62 -18.47 20.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.22 -0.925 . . . . 0.0 110.194 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.68 ' HB2' ' HB3' ' A' ' 117' ' ' ALA . 4.2 m-20 -116.13 93.21 38.13 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.252 -0.905 . . . . 0.0 110.203 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.533 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 47.3 Cg_endo -74.05 -167.5 0.39 Allowed 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 123.958 1.504 . . . . 0.0 110.449 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.494 ' HA ' ' HD2' ' A' ' 113' ' ' PRO . 5.4 pt-20 -153.45 -150.63 0.34 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.201 -0.937 . . . . 0.0 110.484 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.531 ' HA3' ' CB ' ' A' ' 112' ' ' TYR . . . -148.21 156.1 26.74 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.351 -1.499 . . . . 0.0 109.351 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.735 ' HA ' HG23 ' A' ' 52' ' ' VAL . 1.0 OUTLIER -150.52 -158.68 0.94 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.171 -1.193 . . . . 0.0 110.72 -179.644 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.692 HG21 ' HH2' ' A' ' 16' ' ' TRP . 11.4 mt -118.24 150.37 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.473 -0.767 . . . . 0.0 109.132 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -127.89 122.63 33.0 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.292 -0.88 . . . . 0.0 111.033 -179.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.472 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 4.9 m-85 -118.73 101.77 8.34 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.454 ' C ' HD23 ' A' ' 129' ' ' LEU . 0.0 OUTLIER -88.97 101.51 14.15 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.252 -0.905 . . . . 0.0 111.956 -177.596 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.701 HD22 HG11 ' A' ' 74' ' ' VAL . 8.8 mt -104.6 42.65 1.18 Allowed 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 178.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -97.45 87.3 0.87 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.575 ' O ' ' CG ' ' A' ' 132' ' ' PHE . . . 84.53 107.95 0.61 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.586 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 7.0 m-85 -167.31 -62.19 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.331 -1.099 . . . . 0.0 110.102 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.778 ' CB ' HG23 ' A' ' 72' ' ' VAL . 1.3 t -89.52 -178.84 5.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.076 -1.015 . . . . 0.0 109.912 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.426 ' N ' ' OG ' ' A' ' 133' ' ' SER . . . -100.62 -95.31 0.27 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.127 -0.983 . . . . 0.0 110.7 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -55.68 153.74 7.69 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.094 -1.004 . . . . 0.0 110.574 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.577 ' HB2' ' HB2' ' A' ' 38' ' ' ALA . . . -47.7 121.94 4.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.372 -0.83 . . . . 0.0 110.167 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 1.154 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 22.2 p90 -125.7 -157.58 0.8 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.287 -0.883 . . . . 0.0 110.044 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.543 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 0.5 OUTLIER -160.33 169.53 22.95 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.104 -0.997 . . . . 0.0 110.62 -178.844 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.6 HD13 HD13 ' A' ' 129' ' ' LEU . 2.4 mp -121.8 159.5 26.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.334 -0.854 . . . . 0.0 109.322 179.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' CYS . . . . . . . . . . . . . 2.0 m -150.61 92.22 1.82 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.041 -1.037 . . . . 0.0 110.931 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.515 HD23 ' HB2' ' A' ' 66' ' ' ALA . 1.2 mt -90.01 -178.36 5.43 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.227 -0.92 . . . . 0.0 109.316 179.068 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.52 ' O ' ' CB ' ' A' ' 143' ' ' ASP . 2.0 p30 167.19 47.88 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.276 -0.89 . . . . 0.0 110.423 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.52 ' CB ' ' O ' ' A' ' 142' ' ' ASP . 0.4 OUTLIER 166.64 40.41 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.26 -0.9 . . . . 0.0 109.84 179.961 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.962 HG22 ' HB2' ' A' ' 64' ' ' TYR . 25.9 t -89.26 111.55 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.302 -0.874 . . . . 0.0 110.259 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.414 ' HA ' ' O ' ' A' ' 6' ' ' GLU . . . -137.33 165.47 26.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.337 -0.852 . . . . 0.0 110.237 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 1.028 HD21 HD11 ' A' ' 54' ' ' ILE . 10.5 tp -151.8 139.58 19.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.249 -0.907 . . . . 0.0 110.181 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.489 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -155.06 152.89 30.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.188 -0.945 . . . . 0.0 110.268 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.489 ' HB3' ' CE1' ' A' ' 60' ' ' TYR . 3.0 p -101.65 119.94 39.55 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.291 -0.881 . . . . 0.0 110.191 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -102.96 -164.42 1.08 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.269 -0.894 . . . . 0.0 110.208 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.417 HG13 ' O ' ' A' ' 150' ' ' VAL . 9.9 p -120.44 136.33 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.243 -0.91 . . . . 0.0 110.2 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -147.51 137.58 23.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.249 -0.907 . . . . 0.0 110.232 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.162 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.224 0.535 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.577 ' HB2' HD23 ' A' ' 146' ' ' LEU . 0.2 OUTLIER 47.27 75.67 0.64 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.286 -0.883 . . . . 0.0 110.176 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.87 77.86 2.61 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.041 1.548 . . . . 0.0 110.579 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.418 ' O ' HG13 ' A' ' 4' ' ' ILE . 11.4 pt -113.46 32.33 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.223 -0.923 . . . . 0.0 110.096 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.526 ' O ' ' CG ' ' A' ' 6' ' ' GLU . . . 95.44 -31.52 7.04 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.526 ' CG ' ' O ' ' A' ' 5' ' ' GLY . 9.0 pt-20 38.32 35.89 0.11 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.671 -0.899 . . . . 0.0 110.522 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' A' ' 143' ' ' ASP . . . -136.16 -160.92 8.97 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.81 HG22 ' HB2' ' A' ' 143' ' ' ASP . 40.4 p -105.53 51.53 0.75 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.294 -1.121 . . . . 0.0 110.322 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.485 ' CE1' ' CD1' ' A' ' 16' ' ' TRP . 16.5 m-85 42.71 28.87 0.14 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.306 -0.871 . . . . 0.0 110.228 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.554 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 4.5 p-10 -86.22 52.25 2.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.271 -0.893 . . . . 0.0 110.062 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.554 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 1.0 OUTLIER 161.7 37.05 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.68 -0.637 . . . . 0.0 109.901 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.99 148.43 12.11 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.568 ' HB3' HD12 ' A' ' 32' ' ' LEU . 49.6 Cg_endo -76.12 6.6 3.76 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 124.035 1.545 . . . . 0.0 110.902 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.501 ' HB3' ' O ' ' A' ' 13' ' ' PRO . 2.6 tm-20 59.26 -89.27 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.206 -0.934 . . . . 0.0 110.406 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.513 ' O ' HD12 ' A' ' 49' ' ' LEU . . . -144.22 30.66 1.87 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 1.002 ' CE2' HD22 ' A' ' 49' ' ' LEU . 52.7 m95 -85.93 124.72 32.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.215 -1.168 . . . . 0.0 110.554 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.854 ' O ' HG13 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -114.2 160.94 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.309 -0.87 . . . . 0.0 108.884 179.44 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.469 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . . . -147.12 126.1 12.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.112 -0.993 . . . . 0.0 110.297 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.626 ' HE2' HG13 ' A' ' 48' ' ' VAL . 17.5 p90 -104.94 170.59 7.78 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.486 -0.759 . . . . 0.0 110.26 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 1.064 ' HA3' HG13 ' A' ' 45' ' ' VAL . . . 115.44 35.09 1.34 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.1 p 51.13 17.75 0.5 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.682 -0.893 . . . . 0.0 111.005 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.702 ' HB3' ' HB3' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -152.68 77.6 1.18 Allowed 'General case' 0 C--N 1.306 -1.291 0 O-C-N 120.975 -1.078 . . . . 0.0 109.049 179.265 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.593 ' N ' ' CD ' ' A' ' 24' ' ' PRO . . . -118.54 43.97 1.5 Allowed Glycine 0 N--CA 1.489 2.171 0 C-N-CA 119.451 -1.357 . . . . 0.0 110.72 -179.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 23' ' ' GLY . 50.5 Cg_endo -75.39 76.62 3.49 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.668 1.352 . . . . 0.0 109.649 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 1.036 ' CD2' HG12 ' A' ' 34' ' ' VAL . 14.8 mt -68.16 84.6 0.24 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.182 -0.949 . . . . 0.0 110.46 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.469 ' O ' ' O ' ' A' ' 31' ' ' ALA . 0.2 OUTLIER -74.81 113.12 11.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.165 -0.959 . . . . 0.0 109.085 179.314 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.417 ' O ' ' C ' ' A' ' 28' ' ' SER . 1.4 p -119.6 -29.08 5.15 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.061 -1.024 . . . . 0.0 111.196 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 27' ' ' THR . 33.2 p -45.04 -27.92 0.63 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.948 -1.095 . . . . 0.0 108.619 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.613 HG23 ' H ' ' A' ' 31' ' ' ALA . 5.5 t -70.4 -45.78 65.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.868 -0.52 . . . . 0.0 110.751 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.574 ' N ' HG23 ' A' ' 29' ' ' THR . . . 138.04 3.42 1.97 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.613 ' H ' HG23 ' A' ' 29' ' ' THR . . . -150.38 130.91 13.89 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.98 -1.306 . . . . 0.0 110.021 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.797 HD11 HD13 ' A' ' 25' ' ' LEU . 0.9 OUTLIER -67.23 110.33 3.45 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.996 -1.065 . . . . 0.0 109.543 179.754 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.452 ' O ' ' O ' ' A' ' 24' ' ' PRO . 2.9 m -109.39 106.59 16.43 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.091 -1.006 . . . . 0.0 111.164 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 1.036 HG12 ' CD2' ' A' ' 25' ' ' LEU . 36.0 m -89.81 173.6 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.702 ' HB3' ' HB3' ' A' ' 22' ' ' ASP . . . -122.75 152.78 40.28 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.574 -1.329 . . . . 0.0 111.685 -178.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.886 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 10.6 t -137.88 111.28 8.74 Favored Pre-proline 0 C--N 1.303 -1.446 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.437 ' O ' ' O ' ' A' ' 38' ' ' ALA . 44.3 Cg_endo -73.75 141.99 31.47 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.011 1.532 . . . . 0.0 111.185 -178.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.83 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -42.35 164.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.504 -0.747 . . . . 0.0 109.834 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 51.22 50.12 41.34 Favored Glycine 0 N--CA 1.485 1.949 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.652 ' OG ' HG23 ' A' ' 45' ' ' VAL . 1.6 t -86.88 35.92 0.7 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.228 -1.16 . . . . 0.0 109.803 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.529 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . -87.44 -139.87 0.1 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.475 -0.766 . . . . 0.0 109.414 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.542 ' HG2' ' N ' ' A' ' 43' ' ' TYR . 0.0 OUTLIER 42.03 -142.29 0.09 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.476 -0.765 . . . . 0.0 110.066 -179.491 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.583 ' CE1' ' O ' ' A' ' 44' ' ' GLY . 5.8 p90 -31.39 -39.27 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.198 0 CA-C-O 121.354 0.597 . . . . 0.0 110.292 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.583 ' O ' ' CE1' ' A' ' 43' ' ' TYR . . . 88.82 137.32 6.01 Favored Glycine 0 N--CA 1.49 2.283 0 C-N-CA 120.227 -0.987 . . . . 0.0 111.128 177.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 1.064 HG13 ' HA3' ' A' ' 20' ' ' GLY . 4.0 t -89.75 167.91 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.511 ' C ' ' CZ ' ' A' ' 19' ' ' TYR . . . 168.11 162.19 19.54 Favored Glycine 0 N--CA 1.49 2.298 0 C-N-CA 118.51 -1.805 . . . . 0.0 111.056 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.854 HG13 ' O ' ' A' ' 17' ' ' VAL . 44.6 t -114.54 157.69 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.74 -0.859 . . . . 0.0 109.793 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.626 HG13 ' HE2' ' A' ' 19' ' ' TYR . 3.7 m -143.5 150.55 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.076 -1.015 . . . . 0.0 110.08 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 1.002 HD22 ' CE2' ' A' ' 16' ' ' TRP . 19.4 tp -138.47 89.89 2.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.199 -0.938 . . . . 0.0 110.417 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.526 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 40.9 t30 -73.04 132.79 43.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.294 -0.879 . . . . 0.0 110.151 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 124.0 60.52 0.19 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.576 HG12 ' N ' ' A' ' 53' ' ' ALA . 40.3 t -119.94 172.07 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.233 -1.157 . . . . 0.0 110.101 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.576 ' N ' HG12 ' A' ' 52' ' ' VAL . . . -137.88 102.01 4.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.235 -0.915 . . . . 0.0 110.389 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.909 HD11 HD21 ' A' ' 146' ' ' LEU . 42.3 mm -131.65 49.59 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.291 -0.881 . . . . 0.0 109.936 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.557 ' O ' ' HB3' ' A' ' 56' ' ' GLU . 0.3 OUTLIER -72.16 139.95 48.54 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.408 -0.807 . . . . 0.0 111.072 -179.571 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.557 ' HB3' ' O ' ' A' ' 55' ' ' GLU . 6.6 tm-20 73.12 178.12 0.24 Allowed 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 121.968 0.89 . . . . 0.0 111.907 178.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.565 ' HA2' ' HA ' ' A' ' 109' ' ' SER . . . -103.04 89.54 0.72 Allowed Glycine 0 N--CA 1.487 2.047 0 N-CA-C 107.764 -2.135 . . . . 0.0 107.764 178.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 1.027 HG22 ' CE1' ' A' ' 60' ' ' TYR . 0.4 OUTLIER -120.19 -165.53 1.2 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.41 -1.053 . . . . 0.0 110.641 -178.486 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.768 ' N ' HG23 ' A' ' 58' ' ' THR . 8.2 m -103.49 86.3 2.62 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.413 -0.804 . . . . 0.0 110.372 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 1.027 ' CE1' HG22 ' A' ' 58' ' ' THR . 96.1 m-85 -85.84 116.19 23.93 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.147 -0.971 . . . . 0.0 109.905 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 38.9 m -89.89 114.76 26.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.211 -0.931 . . . . 0.0 110.154 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.446 HD22 ' CD2' ' A' ' 89' ' ' LEU . 18.2 tp -89.71 121.47 31.9 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.185 -0.947 . . . . 0.0 110.002 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.631 ' HG2' HG22 ' A' ' 103' ' ' THR . 48.3 mtp180 -122.67 121.73 37.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.297 -0.877 . . . . 0.0 110.142 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.538 ' CE2' HG11 ' A' ' 102' ' ' VAL . 0.7 OUTLIER -159.57 141.57 13.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.285 -0.884 . . . . 0.0 109.906 179.784 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.501 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 89.9 m -119.18 97.04 5.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.279 -0.888 . . . . 0.0 109.674 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.8 ' CB ' HD21 ' A' ' 95' ' ' LEU . . . -97.14 154.02 17.62 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.476 -0.765 . . . . 0.0 110.554 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.83 HG23 ' O ' ' A' ' 98' ' ' GLU . 96.9 m -150.34 122.02 8.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.369 -0.832 . . . . 0.0 110.101 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -108.3 142.9 37.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.244 -0.91 . . . . 0.0 109.945 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.12 -22.01 2.26 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.154 -0.966 . . . . 0.0 109.138 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.599 HG22 ' HB2' ' A' ' 137' ' ' TRP . 3.4 t -119.27 166.92 12.39 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.563 -0.71 . . . . 0.0 109.835 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.439 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 0.9 OUTLIER -82.38 73.54 9.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.047 -1.033 . . . . 0.0 109.114 178.925 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.714 HG23 ' HB2' ' A' ' 133' ' ' SER . 5.4 p -98.06 145.04 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.303 -0.873 . . . . 0.0 111.348 -178.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.534 HG22 ' HB3' ' A' ' 92' ' ' SER . 19.8 m -128.69 91.12 3.17 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 178.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.969 HG21 ' CD2' ' A' ' 129' ' ' LEU . 3.3 m -89.67 -148.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.203 -0.935 . . . . 0.0 110.766 -178.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.586 ' N ' HG23 ' A' ' 74' ' ' VAL . 0.1 OUTLIER -121.97 118.3 28.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.194 -0.941 . . . . 0.0 110.82 -179.437 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.686 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -122.98 147.92 46.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.204 -0.935 . . . . 0.0 109.681 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.728 HD12 ' N ' ' A' ' 78' ' ' VAL . 3.5 pp 178.92 -148.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.296 -0.878 . . . . 0.0 110.08 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.829 HG23 HD22 ' A' ' 89' ' ' LEU . 2.5 t -147.85 171.07 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.194 -0.941 . . . . 0.0 108.902 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.489 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . -172.24 -178.5 42.48 Favored Glycine 0 N--CA 1.489 2.183 0 C-N-CA 119.169 -1.491 . . . . 0.0 110.183 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.422 ' O ' ' OD1' ' A' ' 81' ' ' ASN . 8.1 tt0 -92.28 -148.99 0.24 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.49 -1.006 . . . . 0.0 110.192 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.481 ' HB3' ' OE2' ' A' ' 122' ' ' GLU . 5.8 m120 -164.38 64.22 0.14 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.523 -0.736 . . . . 0.0 109.574 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.469 ' HA3' ' HB3' ' A' ' 121' ' ' PRO . . . 134.91 147.25 5.5 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.629 ' N ' ' CE1' ' A' ' 85' ' ' TYR . . . -41.25 151.62 0.28 Allowed Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.33 -1.1 . . . . 0.0 110.375 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.46 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.3 Cg_endo -80.16 12.48 23.23 Favored 'Cis proline' 0 C--N 1.312 -1.353 0 C-N-CA 121.659 -2.226 . . . . 0.0 110.884 -0.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.629 ' CE1' ' N ' ' A' ' 83' ' ' ALA . 26.4 m-85 63.2 150.63 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.16 -0.963 . . . . 0.0 110.194 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 175.97 131.49 1.47 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.59 155.15 21.79 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.299 -1.118 . . . . 0.0 110.104 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.982 HG23 HD12 ' A' ' 89' ' ' LEU . 33.2 m -125.4 -22.0 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.257 -0.902 . . . . 0.0 110.447 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.982 HD12 HG23 ' A' ' 88' ' ' VAL . 3.7 mp -111.72 144.16 41.46 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.111 -0.993 . . . . 0.0 111.023 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.57 ' O ' HG23 ' A' ' 91' ' ' THR . 29.5 t0 -150.98 85.83 1.36 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.434 -0.791 . . . . 0.0 110.206 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.57 HG23 ' O ' ' A' ' 90' ' ' ASP . 2.6 p -155.04 -177.31 6.44 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.053 -1.029 . . . . 0.0 110.581 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.534 ' HB3' HG22 ' A' ' 73' ' ' THR . 3.7 m -123.64 134.16 25.1 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.346 -0.847 . . . . 0.0 109.978 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.789 ' HG2' HG22 ' A' ' 74' ' ' VAL . 51.6 Cg_endo -78.31 79.81 3.19 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.871 1.458 . . . . 0.0 110.877 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.527 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -49.26 134.51 18.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.939 -1.101 . . . . 0.0 109.159 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.8 HD21 ' CB ' ' A' ' 66' ' ' ALA . 27.6 mt -131.44 170.64 14.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.052 -1.03 . . . . 0.0 110.89 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.487 ' CG2' ' HG3' ' A' ' 100' ' ' ARG . 0.2 OUTLIER -170.99 -178.69 2.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.445 -0.784 . . . . 0.0 109.942 179.972 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.84 -6.37 26.58 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.278 -0.888 . . . . 0.0 110.244 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.83 ' O ' HG23 ' A' ' 67' ' ' THR . 0.6 OUTLIER -110.52 174.58 2.3 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.243 -0.911 . . . . 0.0 110.1 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.51 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 45.0 Cg_endo -72.31 128.02 13.28 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.026 1.54 . . . . 0.0 110.294 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.527 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 1.2 mtt-85 -119.76 92.17 3.72 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.152 -0.968 . . . . 0.0 110.4 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.455 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 38.9 tt0 -75.1 154.11 37.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.364 -0.835 . . . . 0.0 109.978 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.538 HG11 ' CE2' ' A' ' 64' ' ' TYR . 74.4 t -139.5 133.72 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.166 -0.958 . . . . 0.0 110.354 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.631 HG22 ' HG2' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -150.15 118.99 6.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.283 -0.886 . . . . 0.0 110.083 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -140.6 153.13 45.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.204 -0.935 . . . . 0.0 110.361 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.548 HG22 ' CG2' ' A' ' 59' ' ' THR . 8.4 m -109.5 70.79 0.74 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.289 -0.882 . . . . 0.0 110.116 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.879 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 40.0 p90 -84.82 146.62 27.24 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.306 -0.871 . . . . 0.0 110.144 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 58' ' ' THR . 5.6 m -89.94 102.65 15.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -0.93 . . . . 0.0 109.987 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 1.002 ' HB3' ' CD1' ' A' ' 60' ' ' TYR . . . -70.04 95.78 0.99 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.155 -0.966 . . . . 0.0 110.388 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.565 ' HA ' ' HA2' ' A' ' 57' ' ' GLY . 8.2 p -85.88 59.63 5.75 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.675 -0.64 . . . . 0.0 109.512 179.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.461 ' HB3' HG11 ' A' ' 88' ' ' VAL . . . -155.27 -156.24 0.64 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.12 -0.987 . . . . 0.0 110.835 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.974 HG22 ' HD3' ' A' ' 113' ' ' PRO . 46.6 m -147.42 108.05 4.14 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.373 -0.829 . . . . 0.0 110.87 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.584 ' CE2' HG12 ' A' ' 78' ' ' VAL . 16.4 m-30 -110.04 74.17 0.77 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.396 -0.815 . . . . 0.0 109.642 179.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.974 ' HD3' HG22 ' A' ' 111' ' ' THR . 43.7 Cg_endo -71.65 -159.08 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.908 1.478 . . . . 0.0 110.41 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.488 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -145.79 36.56 1.06 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.271 -0.893 . . . . 0.0 110.247 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.528 ' O ' ' CB ' ' A' ' 120' ' ' ASP . 20.1 m -107.53 88.26 4.04 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.286 -0.883 . . . . 0.0 110.188 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 45.9 Cg_endo -72.9 110.35 3.01 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.97 1.51 . . . . 0.0 110.404 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.647 ' HB3' ' HB2' ' A' ' 120' ' ' ASP . . . -149.47 -170.17 3.57 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.236 -0.915 . . . . 0.0 110.219 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -75.16 -8.49 56.73 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.316 -0.865 . . . . 0.0 110.174 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -151.83 16.79 0.68 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.187 -0.946 . . . . 0.0 110.225 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.647 ' HB2' ' HB3' ' A' ' 117' ' ' ALA . 2.3 m-20 -114.72 90.33 21.73 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.227 -0.921 . . . . 0.0 110.131 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.482 ' O ' ' HG2' ' A' ' 113' ' ' PRO . 46.5 Cg_endo -73.9 147.1 38.6 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.025 1.539 . . . . 0.0 110.478 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.481 ' OE2' ' HB3' ' A' ' 81' ' ' ASN . 22.5 pm0 -124.12 -154.75 0.63 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.172 -0.955 . . . . 0.0 110.219 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.514 ' HA3' ' CB ' ' A' ' 112' ' ' TYR . . . -151.36 150.8 22.79 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.569 ' HA ' ' CG2' ' A' ' 52' ' ' VAL . 3.0 pt20 -150.35 -153.34 0.48 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.269 -1.136 . . . . 0.0 110.394 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.449 ' HB ' ' HB3' ' A' ' 49' ' ' LEU . 7.5 mt -118.45 144.86 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.419 -0.801 . . . . 0.0 109.379 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.409 ' HB3' HD11 ' A' ' 77' ' ' LEU . . . -122.11 121.1 36.14 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.228 -0.92 . . . . 0.0 111.04 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.48 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 5.1 m-85 -119.42 97.19 5.53 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.49 ' O ' ' HB ' ' A' ' 74' ' ' VAL . 2.5 mt-30 -88.95 89.1 7.84 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.245 -0.91 . . . . 0.0 111.149 -178.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.986 HD13 HD13 ' A' ' 139' ' ' LEU . 16.0 mt -87.61 51.55 2.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.571 -0.705 . . . . 0.0 109.274 178.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.53 ' O ' ' CD2' ' A' ' 132' ' ' PHE . . . -127.68 151.0 18.42 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 51.81 63.55 4.65 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.622 ' CE1' ' HA ' ' A' ' 74' ' ' VAL . 15.5 m-85 -148.06 -78.79 0.15 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.243 -1.151 . . . . 0.0 110.25 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.714 ' HB2' HG23 ' A' ' 72' ' ' VAL . 2.3 t -89.59 144.58 25.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.058 -1.026 . . . . 0.0 110.055 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -81.87 -84.45 0.11 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.289 -0.882 . . . . 0.0 110.357 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -42.54 154.92 0.05 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.247 -0.908 . . . . 0.0 110.293 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.83 ' HB2' ' HB2' ' A' ' 38' ' ' ALA . . . -57.59 124.28 18.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.279 -0.888 . . . . 0.0 110.214 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.886 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 6.0 p90 -131.23 -167.49 1.86 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.279 -0.888 . . . . 0.0 110.236 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.542 ' CG2' ' N ' ' A' ' 139' ' ' LEU . 0.8 OUTLIER -160.81 178.75 9.12 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.31 -0.956 . . . . 0.0 110.532 -178.255 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.986 HD13 HD13 ' A' ' 129' ' ' LEU . 2.2 mp -133.96 155.6 49.65 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.388 -0.82 . . . . 0.0 110.062 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' CYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 33' ' ' CYS . 11.1 m -150.12 97.88 2.62 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.173 -0.954 . . . . 0.0 110.724 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.518 HD23 ' HB2' ' A' ' 66' ' ' ALA . 1.1 mt -89.62 -177.09 5.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.299 -0.876 . . . . 0.0 109.518 179.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.567 ' HB3' ' CB ' ' A' ' 31' ' ' ALA . 0.6 OUTLIER 172.33 44.21 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.186 -0.946 . . . . 0.0 110.999 179.926 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.81 ' HB2' HG22 ' A' ' 8' ' ' THR . 5.8 t0 171.85 69.81 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.309 -0.87 . . . . 0.0 109.592 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.828 HG11 ' HZ2' ' A' ' 16' ' ' TRP . 1.9 t -106.64 122.28 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.129 -0.982 . . . . 0.0 110.412 -179.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -151.81 150.93 30.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.344 -0.847 . . . . 0.0 110.067 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.966 HD11 ' HB3' ' A' ' 60' ' ' TYR . 22.3 tp -138.49 158.83 43.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.288 -0.882 . . . . 0.0 110.29 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.512 ' N ' ' HG ' ' A' ' 146' ' ' LEU . 0.4 OUTLIER -163.25 -157.33 0.42 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.213 -0.929 . . . . 0.0 110.278 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.686 ' HB2' HG21 ' A' ' 58' ' ' THR . 0.1 OUTLIER -150.35 113.18 4.78 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.215 -0.928 . . . . 0.0 110.136 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 148' ' ' SER . 0.4 OUTLIER 42.97 71.94 0.2 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.267 -0.895 . . . . 0.0 110.226 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.426 HG11 ' CG ' ' A' ' 147' ' ' ASP . 33.9 m -117.56 40.99 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.256 -0.903 . . . . 0.0 110.236 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.424 ' O ' ' C ' ' A' ' 152' ' ' LEU . 92.0 mt-10 -120.63 -172.6 2.41 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.91 . . . . 0.0 110.218 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.448 HD13 ' HA ' ' A' ' 152' ' ' LEU . 1.7 mm? . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.229 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.518 ' HB3' ' HB1' ' A' ' 53' ' ' ALA . . . . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.273 0.559 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.438 ' HB2' ' O ' ' A' ' 1' ' ' ALA . 0.9 OUTLIER -179.77 58.74 0.1 OUTLIER Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.219 -0.925 . . . . 0.0 110.229 179.997 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.426 ' HD3' ' N ' ' A' ' 2' ' ' SER . 49.2 Cg_endo -76.24 -156.32 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.008 1.53 . . . . 0.0 110.01 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.0 pt -94.5 -8.78 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.197 -0.939 . . . . 0.0 110.167 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 69.75 156.24 1.39 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -72.23 83.12 1.02 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.223 -1.163 . . . . 0.0 110.152 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -86.76 127.41 8.38 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.457 ' O ' ' HB2' ' A' ' 9' ' ' PHE . 2.1 p -77.31 2.87 14.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.222 -1.164 . . . . 0.0 110.236 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.59 ' CD2' ' HB2' ' A' ' 32' ' ' LEU . 3.3 m-85 56.41 16.7 2.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.253 -0.904 . . . . 0.0 110.204 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.547 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 18.3 p-10 -98.41 14.03 29.53 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.234 -0.916 . . . . 0.0 110.391 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.547 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 2.2 t70 161.68 80.63 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.79 -0.569 . . . . 0.0 109.544 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.22 82.49 1.65 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.916 ' HG3' HG21 ' A' ' 27' ' ' THR . 51.2 Cg_endo -81.31 43.14 1.47 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.073 1.565 . . . . 0.0 110.668 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.455 ' HB3' ' O ' ' A' ' 13' ' ' PRO . 36.2 tp10 56.9 -91.27 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.137 -0.977 . . . . 0.0 110.206 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.502 ' C ' HD13 ' A' ' 49' ' ' LEU . . . -152.75 32.63 0.82 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.888 ' CE2' HD22 ' A' ' 49' ' ' LEU . 59.5 m95 -71.19 86.71 0.78 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.23 -1.159 . . . . 0.0 110.267 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.838 ' O ' HG13 ' A' ' 47' ' ' VAL . 1.4 m -82.26 147.92 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.224 -0.922 . . . . 0.0 109.781 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.589 ' CB ' ' CG1' ' A' ' 34' ' ' VAL . . . -134.12 119.51 18.97 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.178 -0.951 . . . . 0.0 109.978 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.668 ' HE2' HG13 ' A' ' 48' ' ' VAL . 16.9 p90 -108.56 138.03 45.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.469 -0.77 . . . . 0.0 110.411 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.92 ' HA3' HG13 ' A' ' 45' ' ' VAL . . . 160.82 45.48 0.02 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.515 HG23 ' OH ' ' A' ' 43' ' ' TYR . 9.6 p 50.84 19.16 0.59 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.442 -1.034 . . . . 0.0 110.733 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.925 ' HB2' ' HB3' ' A' ' 35' ' ' ALA . 3.0 p30 -97.88 38.51 1.29 Allowed 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.069 -1.019 . . . . 0.0 110.031 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 45.94 -156.54 0.45 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.436 ' O ' ' C ' ' A' ' 25' ' ' LEU . 46.5 Cg_endo -73.72 125.63 10.16 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 123.939 1.494 . . . . 0.0 110.35 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.718 HD23 ' H ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -42.26 133.02 3.26 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.277 -0.889 . . . . 0.0 110.015 179.887 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.07 116.23 28.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.144 -0.972 . . . . 0.0 110.054 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.916 HG21 ' HG3' ' A' ' 13' ' ' PRO . 0.9 OUTLIER -119.88 -28.71 5.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.167 -0.958 . . . . 0.0 110.34 -179.76 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.45 ' O ' ' HB ' ' A' ' 29' ' ' THR . 0.3 OUTLIER -48.91 83.13 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.838 -0.539 . . . . 0.0 111.254 -179.957 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.62 HG22 ' O ' ' A' ' 27' ' ' THR . 0.8 OUTLIER 175.97 -28.93 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.017 -1.052 . . . . 0.0 110.309 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.526 ' HA2' ' CB ' ' A' ' 10' ' ' ASP . . . 133.73 -7.05 4.87 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.706 -1.357 . . . . 0.0 109.706 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.548 ' HA ' ' HB3' ' A' ' 9' ' ' PHE . . . -150.3 172.46 15.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.149 -1.207 . . . . 0.0 110.329 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.684 HD12 ' CG2' ' A' ' 27' ' ' THR . 0.6 OUTLIER -103.97 94.73 5.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.274 -0.891 . . . . 0.0 109.769 179.736 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 65.5 m -100.09 115.61 30.17 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.295 -0.878 . . . . 0.0 111.002 -179.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.589 ' CG1' ' CB ' ' A' ' 18' ' ' ALA . 15.1 m -96.11 157.17 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.319 -0.863 . . . . 0.0 109.231 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.925 ' HB3' ' HB2' ' A' ' 22' ' ' ASP . . . -102.26 89.23 3.51 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.269 -0.894 . . . . 0.0 111.635 -178.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.037 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 76.3 t -74.71 119.21 75.58 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 120.976 -1.077 . . . . 0.0 109.192 178.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.426 ' O ' ' C ' ' A' ' 38' ' ' ALA . 42.7 Cg_endo -69.17 144.79 58.4 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.865 1.455 . . . . 0.0 111.226 -179.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.519 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -42.11 147.83 0.22 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.462 -0.774 . . . . 0.0 110.109 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.459 ' O ' ' OE1' ' A' ' 42' ' ' GLN . . . 44.52 70.64 0.56 Allowed Glycine 0 N--CA 1.488 2.132 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.987 ' OG ' HG21 ' A' ' 45' ' ' VAL . 0.5 OUTLIER -87.01 29.72 0.8 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.31 -1.112 . . . . 0.0 110.44 -179.636 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.501 ' HB2' ' HA2' ' A' ' 131' ' ' GLY . . . -91.38 19.99 5.61 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.926 0.869 . . . . 0.0 109.739 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.614 ' HG3' ' CD2' ' A' ' 43' ' ' TYR . 0.5 OUTLIER -84.44 -135.65 0.05 Allowed 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.527 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.646 ' CD1' ' N ' ' A' ' 44' ' ' GLY . 8.3 p90 -38.9 -27.39 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.379 -0.826 . . . . 0.0 110.417 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.646 ' N ' ' CD1' ' A' ' 43' ' ' TYR . . . 111.04 106.92 2.96 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.987 HG21 ' OG ' ' A' ' 40' ' ' SER . 2.9 t -90.09 153.83 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.231 -1.159 . . . . 0.0 108.73 179.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.542 ' C ' ' CZ ' ' A' ' 19' ' ' TYR . . . 176.75 169.51 38.16 Favored Glycine 0 N--CA 1.49 2.26 0 C-N-CA 119.221 -1.466 . . . . 0.0 110.218 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.838 HG13 ' O ' ' A' ' 17' ' ' VAL . 48.8 t -128.19 144.03 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.412 -1.052 . . . . 0.0 109.901 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.674 ' O ' HG22 ' A' ' 17' ' ' VAL . 34.0 m -135.55 147.69 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.039 -1.038 . . . . 0.0 110.419 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.888 HD22 ' CE2' ' A' ' 16' ' ' TRP . 22.8 tp -135.82 109.85 8.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.251 -0.906 . . . . 0.0 110.308 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.509 ' HA ' ' HB3' ' A' ' 124' ' ' GLN . 2.4 p-10 -84.33 121.71 27.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.224 -0.922 . . . . 0.0 110.269 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 139.92 79.43 0.06 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.574 HG12 HG12 ' A' ' 54' ' ' ILE . 54.0 t -131.36 150.44 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.197 -1.178 . . . . 0.0 110.198 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.518 ' HB1' ' HB3' ' A' ' 1' ' ' ALA . . . -117.34 92.58 3.89 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.224 -0.922 . . . . 0.0 110.238 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.817 HD11 HD21 ' A' ' 146' ' ' LEU . 14.6 mm -136.37 169.33 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.237 -0.914 . . . . 0.0 110.065 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.513 ' O ' ' HB3' ' A' ' 56' ' ' GLU . 2.2 pt-20 179.05 139.54 0.1 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.24 -0.912 . . . . 0.0 110.361 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.513 ' HB3' ' O ' ' A' ' 55' ' ' GLU . 3.9 tt0 64.23 -179.67 0.17 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.512 -0.742 . . . . 0.0 110.759 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' A' ' 109' ' ' SER . . . -92.42 70.98 1.63 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.624 -1.791 . . . . 0.0 108.624 179.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.711 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.0 OUTLIER -105.9 176.81 5.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.532 -0.981 . . . . 0.0 110.087 -179.281 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.577 ' N ' ' CG2' ' A' ' 58' ' ' THR . 0.7 OUTLIER -89.57 156.4 18.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.304 -0.872 . . . . 0.0 110.436 -179.69 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.903 ' HB3' HD11 ' A' ' 146' ' ' LEU . 68.2 m-85 -156.45 118.08 3.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.448 -0.782 . . . . 0.0 109.625 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 104' ' ' GLU . 10.0 m -89.94 112.03 23.29 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.209 -0.932 . . . . 0.0 110.646 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 21.7 tp -90.21 140.0 30.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.346 -0.846 . . . . 0.0 109.66 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.771 ' HG2' HG23 ' A' ' 103' ' ' THR . 27.1 mtt180 -136.92 105.68 5.87 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.146 -0.971 . . . . 0.0 110.722 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.528 ' C ' ' CD1' ' A' ' 64' ' ' TYR . 3.5 p90 -140.18 151.67 45.42 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.33 -0.856 . . . . 0.0 109.676 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.523 HG22 ' O ' ' A' ' 65' ' ' THR . 4.2 m -119.62 92.04 3.69 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.095 -1.003 . . . . 0.0 110.114 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.883 ' HB1' HD21 ' A' ' 95' ' ' LEU . . . -89.44 145.51 25.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.302 -0.874 . . . . 0.0 110.17 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.653 HG23 ' O ' ' A' ' 98' ' ' GLU . 53.4 m -150.72 104.87 3.23 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.316 -0.865 . . . . 0.0 110.492 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.528 ' HB2' HD13 ' A' ' 95' ' ' LEU . . . -95.93 132.38 41.29 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.165 -0.96 . . . . 0.0 109.854 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 68' ' ' ALA . 20.0 m -43.54 -26.78 0.24 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.219 -0.926 . . . . 0.0 109.435 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.631 HG22 ' HB2' ' A' ' 137' ' ' TRP . 3.0 t -112.74 167.63 10.33 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.563 -0.711 . . . . 0.0 109.838 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.505 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 32.9 t0 -84.29 69.36 10.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.104 -0.997 . . . . 0.0 109.224 178.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.795 HG23 ' CB ' ' A' ' 133' ' ' SER . 3.8 p -92.0 140.08 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.331 -0.856 . . . . 0.0 111.318 -178.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.474 ' O ' ' CD1' ' A' ' 132' ' ' PHE . 98.3 m -126.46 91.94 3.46 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 1.021 HG21 ' CD2' ' A' ' 129' ' ' LEU . 3.2 m -89.79 -159.34 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.18 -0.95 . . . . 0.0 110.715 -178.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.437 ' N ' HG23 ' A' ' 74' ' ' VAL . 0.3 OUTLIER -119.16 106.61 12.54 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.284 -0.885 . . . . 0.0 110.394 -179.519 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.492 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -113.08 165.14 12.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.906 . . . . 0.0 110.194 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.556 ' HA ' ' HB3' ' A' ' 89' ' ' LEU . 3.1 pp 176.93 -159.7 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.363 -0.836 . . . . 0.0 110.12 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.784 ' CG2' HD22 ' A' ' 89' ' ' LEU . 3.4 t -149.26 155.61 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.26 -0.9 . . . . 0.0 109.718 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.575 ' O ' ' CE2' ' A' ' 112' ' ' TYR . . . -172.43 -178.2 42.41 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.429 -1.367 . . . . 0.0 110.258 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.484 ' HG2' ' O ' ' A' ' 111' ' ' THR . 0.0 OUTLIER -93.42 128.34 39.44 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.434 -1.039 . . . . 0.0 110.697 -179.726 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.499 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 1.4 m-80 -96.64 75.49 2.8 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.192 -0.943 . . . . 0.0 109.557 179.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.586 ' O ' ' HB2' ' A' ' 83' ' ' ALA . . . -166.07 -90.48 0.08 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.586 ' HB2' ' O ' ' A' ' 82' ' ' GLY . . . 175.84 136.49 0.19 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.345 -1.091 . . . . 0.0 109.923 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.535 ' C ' ' CD2' ' A' ' 85' ' ' TYR . 52.3 Cg_endo -83.84 33.2 3.61 Favored 'Cis proline' 0 C--N 1.314 -1.271 0 C-N-CA 122.096 -2.044 . . . . 0.0 110.84 -0.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.579 ' CE1' ' O ' ' A' ' 82' ' ' GLY . 18.7 m-85 65.24 166.03 0.17 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.229 -0.919 . . . . 0.0 110.449 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.496 ' O ' ' CA ' ' A' ' 79' ' ' GLY . . . -163.4 171.11 39.02 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.57 133.67 21.52 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.099 -1.236 . . . . 0.0 110.507 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 1.088 HG23 HD12 ' A' ' 89' ' ' LEU . 12.4 m -119.8 -10.49 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.326 -0.859 . . . . 0.0 109.732 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 1.088 HD12 HG23 ' A' ' 88' ' ' VAL . 4.5 mp -123.5 143.49 50.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.418 -0.801 . . . . 0.0 110.816 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.715 ' O ' HG23 ' A' ' 91' ' ' THR . 0.7 OUTLIER -150.62 83.69 1.35 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.283 -0.886 . . . . 0.0 110.223 179.713 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.715 HG23 ' O ' ' A' ' 90' ' ' ASP . 1.1 p -160.06 -176.71 5.82 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.125 -0.984 . . . . 0.0 110.509 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.431 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 0.1 OUTLIER -119.93 131.24 24.48 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.321 -0.862 . . . . 0.0 110.079 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.831 ' HG2' HG22 ' A' ' 74' ' ' VAL . 48.6 Cg_endo -73.11 77.6 2.37 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.97 1.511 . . . . 0.0 110.912 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.532 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -48.63 135.26 14.91 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.975 -1.078 . . . . 0.0 109.148 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.883 HD21 ' HB1' ' A' ' 66' ' ' ALA . 36.4 mt -130.85 176.79 7.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.997 -1.064 . . . . 0.0 110.872 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 68' ' ' ALA . 0.2 OUTLIER -177.89 -178.8 0.72 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.49 -0.756 . . . . 0.0 109.918 -179.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.63 -22.44 63.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.226 -0.921 . . . . 0.0 110.287 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.653 ' O ' HG23 ' A' ' 67' ' ' THR . 2.6 mt-10 -90.07 169.86 11.5 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.29 -0.881 . . . . 0.0 110.078 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.495 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 45.0 Cg_endo -72.55 130.44 16.02 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 123.956 1.503 . . . . 0.0 110.276 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.532 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.69 92.2 3.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.154 -0.966 . . . . 0.0 110.35 -179.865 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.453 ' HG3' ' OG1' ' A' ' 65' ' ' THR . 38.3 tt0 -85.76 99.3 11.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.289 -0.882 . . . . 0.0 110.104 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.426 ' HB ' ' CZ ' ' A' ' 64' ' ' TYR . 72.6 t -89.62 133.77 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 0.0 110.256 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.771 HG23 ' HG2' ' A' ' 63' ' ' ARG . 49.5 m -147.51 135.72 21.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.357 -0.839 . . . . 0.0 110.084 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.507 ' CG ' ' O ' ' A' ' 103' ' ' THR . 17.9 mt-10 -160.16 -177.33 6.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.169 -0.957 . . . . 0.0 110.267 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.491 HG23 HG23 ' A' ' 61' ' ' THR . 0.0 OUTLIER -133.62 91.54 2.86 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.285 -0.885 . . . . 0.0 110.162 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -92.44 155.48 17.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.286 -0.884 . . . . 0.0 110.254 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 109' ' ' SER . 38.7 m -89.56 92.78 9.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.178 -0.951 . . . . 0.0 109.777 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.618 ' CB ' ' CD2' ' A' ' 60' ' ' TYR . . . -47.39 91.67 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.27 -0.894 . . . . 0.0 110.455 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.523 ' HA ' ' HA2' ' A' ' 57' ' ' GLY . 8.9 p -85.78 57.28 4.38 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.349 -0.844 . . . . 0.0 109.621 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.645 ' HB3' ' HE1' ' A' ' 112' ' ' TYR . . . -166.98 -156.34 0.22 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.115 -0.991 . . . . 0.0 110.868 -179.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.497 ' O ' ' HD3' ' A' ' 113' ' ' PRO . 35.5 m -148.0 111.57 5.01 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.539 -0.726 . . . . 0.0 110.024 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.767 ' CE2' HG12 ' A' ' 78' ' ' VAL . 4.2 m-85 -104.87 92.3 5.08 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.361 -0.837 . . . . 0.0 109.943 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 111' ' ' THR . 43.4 Cg_endo -71.73 160.9 46.79 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.798 1.42 . . . . 0.0 110.389 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -113.84 68.52 0.69 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.144 -0.972 . . . . 0.0 110.376 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.47 ' O ' ' O ' ' A' ' 120' ' ' ASP . 0.1 OUTLIER -149.1 113.6 3.6 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.263 -0.898 . . . . 0.0 110.215 179.9 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -75.85 76.61 3.66 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.838 1.441 . . . . 0.0 110.353 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -147.76 158.13 43.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.192 -0.943 . . . . 0.0 110.281 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.25 -67.93 0.37 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.316 -0.865 . . . . 0.0 110.132 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -56.12 -36.34 68.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.277 -0.889 . . . . 0.0 109.974 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.47 ' O ' ' O ' ' A' ' 115' ' ' THR . 0.5 OUTLIER -117.14 87.99 25.43 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.324 -0.86 . . . . 0.0 109.969 179.821 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.572 ' CB ' ' HA3' ' A' ' 82' ' ' GLY . 47.7 Cg_endo -74.02 -159.17 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.09 1.574 . . . . 0.0 110.547 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.499 ' O ' ' HB2' ' A' ' 81' ' ' ASN . 0.1 OUTLIER -154.86 152.14 29.43 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.153 -0.967 . . . . 0.0 110.455 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.59 ' HA3' ' CD2' ' A' ' 112' ' ' TYR . . . -89.5 149.0 20.32 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.537 ' HA ' ' CG2' ' A' ' 52' ' ' VAL . 2.8 pt20 -150.37 -163.84 1.87 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.094 -1.239 . . . . 0.0 110.948 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.604 HG21 ' HE2' ' A' ' 127' ' ' PHE . 9.5 mt -118.57 144.37 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.579 -0.7 . . . . 0.0 109.186 179.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -121.25 129.14 53.01 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.315 -0.866 . . . . 0.0 110.67 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.604 ' HE2' HG21 ' A' ' 125' ' ' ILE . 14.3 m-85 -118.78 105.0 11.1 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -89.03 85.37 6.68 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.376 -0.828 . . . . 0.0 111.923 -177.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 1.021 ' CD2' HG21 ' A' ' 74' ' ' VAL . 14.6 mt -91.13 45.11 1.22 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -98.37 89.45 0.95 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 -179.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.579 ' O ' ' CG ' ' A' ' 132' ' ' PHE . . . 81.08 107.87 0.32 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 110.029 -1.229 . . . . 0.0 110.029 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.63 ' CZ ' ' HA ' ' A' ' 74' ' ' VAL . 8.4 m-85 -167.78 -67.1 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.366 -1.079 . . . . 0.0 109.849 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.795 ' CB ' HG23 ' A' ' 72' ' ' VAL . 1.3 t -89.68 160.79 16.42 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.143 -0.973 . . . . 0.0 109.893 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.405 ' O ' ' C ' ' A' ' 135' ' ' ASP . . . -88.3 -94.1 0.1 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.179 -0.95 . . . . 0.0 110.606 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 134' ' ' ALA . 9.5 m-20 -43.99 153.4 0.14 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.16 -0.963 . . . . 0.0 110.511 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.519 ' HB2' ' HB2' ' A' ' 38' ' ' ALA . . . -52.97 126.33 20.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.309 -0.869 . . . . 0.0 110.149 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 1.037 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 9.7 p90 -131.07 -161.15 1.1 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.257 -0.902 . . . . 0.0 110.181 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.584 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 0.8 OUTLIER -160.42 177.74 10.27 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.157 -0.964 . . . . 0.0 110.427 -178.084 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.867 HD13 HD13 ' A' ' 129' ' ' LEU . 2.2 mp -134.02 125.85 28.99 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.365 -0.834 . . . . 0.0 109.892 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' CYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 59.9 m -120.12 104.13 9.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.16 -0.963 . . . . 0.0 110.993 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.508 ' HA ' ' O ' ' A' ' 65' ' ' THR . 1.0 OUTLIER -102.11 -178.63 3.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.259 -0.9 . . . . 0.0 109.805 179.301 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.484 ' HB3' ' O ' ' A' ' 141' ' ' LEU . 4.5 p-10 173.59 167.35 0.18 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.458 -0.776 . . . . 0.0 110.316 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.465 ' O ' ' O ' ' A' ' 63' ' ' ARG . 13.9 t70 41.74 64.54 1.04 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.341 -0.849 . . . . 0.0 110.364 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.622 HG11 ' HZ2' ' A' ' 16' ' ' TRP . 4.9 t -99.1 113.2 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.252 -0.905 . . . . 0.0 110.053 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -129.8 171.33 12.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -0.934 . . . . 0.0 110.404 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.903 HD11 ' HB3' ' A' ' 60' ' ' TYR . 60.8 tp -162.49 120.75 2.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.275 -0.891 . . . . 0.0 110.159 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.532 ' O ' ' CD1' ' A' ' 60' ' ' TYR . 0.5 OUTLIER -125.24 -152.42 0.52 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.274 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 72.5 p -149.31 95.32 2.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.303 -0.873 . . . . 0.0 110.158 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.05 -174.82 1.32 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.245 -0.91 . . . . 0.0 110.252 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.511 HG22 ' N ' ' A' ' 151' ' ' GLU . 12.1 p -130.2 171.2 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.26 -0.9 . . . . 0.0 110.243 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.511 ' N ' HG22 ' A' ' 150' ' ' VAL . 4.3 tm-20 -103.04 115.18 30.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.267 -0.896 . . . . 0.0 110.21 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.219 -179.967 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.686 ' HB1' ' HB3' ' A' ' 53' ' ' ALA . . . . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.273 0.558 . . . . 0.0 110.237 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.5 t -106.66 90.25 4.9 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 0.0 110.179 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.492 ' HD3' ' O ' ' A' ' 1' ' ' ALA . 46.8 Cg_endo -73.3 79.25 2.14 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.023 1.539 . . . . 0.0 110.515 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.94 ' HB ' HD21 ' A' ' 49' ' ' LEU . 10.7 pt -117.72 32.67 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.227 -0.921 . . . . 0.0 110.113 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 7' ' ' GLY . . . 81.49 44.45 7.92 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.859 ' HG2' ' HB1' ' A' ' 145' ' ' ALA . 4.1 mt-10 -41.93 94.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.337 -1.096 . . . . 0.0 110.337 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 5' ' ' GLY . . . 152.48 -149.9 21.63 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.447 HG22 ' O ' ' A' ' 142' ' ' ASP . 70.4 p -92.71 163.49 13.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.27 -1.136 . . . . 0.0 110.233 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.459 ' CZ ' HG21 ' A' ' 144' ' ' VAL . 24.4 m-85 -87.61 35.47 0.72 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.256 -0.903 . . . . 0.0 110.189 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.543 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 13.8 t0 -86.22 57.13 4.31 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.275 -0.891 . . . . 0.0 110.133 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.543 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.9 OUTLIER 161.69 36.84 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.628 -0.67 . . . . 0.0 110.073 -179.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.26 140.28 9.2 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.7 ' HB3' HD12 ' A' ' 32' ' ' LEU . 49.8 Cg_endo -77.13 6.6 4.18 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.104 1.581 . . . . 0.0 110.637 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 0.7 OUTLIER 65.57 -85.79 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.205 -0.934 . . . . 0.0 110.413 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.52 ' C ' HD12 ' A' ' 49' ' ' LEU . . . -147.88 13.88 1.33 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 1.042 ' NE1' HD22 ' A' ' 49' ' ' LEU . 30.5 m95 -66.68 135.0 53.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.163 -1.198 . . . . 0.0 110.367 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.688 ' O ' HG13 ' A' ' 47' ' ' VAL . 1.2 m -129.76 156.54 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.0 110.052 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.413 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . . . -139.1 130.87 27.54 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.474 -0.767 . . . . 0.0 108.959 179.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.578 ' CE2' ' O ' ' A' ' 46' ' ' GLY . 9.3 p90 -121.62 158.8 27.83 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.098 -1.001 . . . . 0.0 111.73 -178.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.605 ' HA2' ' CE1' ' A' ' 43' ' ' TYR . . . 75.27 36.38 45.36 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 1.078 HG22 HG13 ' A' ' 45' ' ' VAL . 15.0 p -128.29 -160.69 1.04 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.089 -1.242 . . . . 0.0 110.5 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -98.42 39.19 1.26 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.37 -0.831 . . . . 0.0 110.249 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 133.89 175.31 13.86 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.455 ' O ' ' O ' ' A' ' 25' ' ' LEU . 46.8 Cg_endo -73.34 138.45 27.41 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.018 1.536 . . . . 0.0 110.563 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.923 HD12 HD11 ' A' ' 32' ' ' LEU . 0.8 OUTLIER -42.2 165.09 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.416 -0.802 . . . . 0.0 110.142 179.844 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -150.62 150.45 31.18 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.19 -0.944 . . . . 0.0 110.297 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.499 HG22 ' HA ' ' A' ' 32' ' ' LEU . 0.8 OUTLIER -119.94 -76.98 0.57 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.272 -0.893 . . . . 0.0 110.058 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.446 ' O ' ' N ' ' A' ' 30' ' ' GLY . 25.6 t 55.53 -88.28 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.252 -0.905 . . . . 0.0 110.605 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.553 HG23 ' H ' ' A' ' 31' ' ' ALA . 9.6 t -40.5 -27.62 0.05 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.398 -0.814 . . . . 0.0 110.573 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 28' ' ' SER . . . 132.13 -42.75 1.35 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.553 ' H ' HG23 ' A' ' 29' ' ' THR . . . -89.82 144.75 25.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.297 -1.119 . . . . 0.0 109.876 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.923 HD11 HD12 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -79.33 95.37 5.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.226 -0.921 . . . . 0.0 110.469 -179.786 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 0.8 OUTLIER -93.99 115.83 28.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.28 -0.887 . . . . 0.0 111.093 179.563 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.42 ' H ' HG22 ' A' ' 34' ' ' VAL . 15.9 m -89.31 142.12 13.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.51 76.63 8.18 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.379 -0.826 . . . . 0.0 110.777 -178.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.058 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 95.6 t -68.97 125.11 91.66 Favored Pre-proline 0 C--N 1.302 -1.463 0 O-C-N 121.443 -0.785 . . . . 0.0 109.08 179.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.517 ' HD3' ' HA ' ' A' ' 21' ' ' THR . 38.7 Cg_endo -65.82 175.64 4.35 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.966 1.508 . . . . 0.0 112.107 -178.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.531 ' HA ' ' CA ' ' A' ' 136' ' ' ALA . . . -53.94 121.64 8.43 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.566 -0.709 . . . . 0.0 111.412 -178.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 134' ' ' ALA . . . 37.73 27.86 0.03 OUTLIER Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 38' ' ' ALA . 22.4 m 33.16 61.34 0.42 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.74 -0.859 . . . . 0.0 110.103 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.546 ' O ' ' CG ' ' A' ' 42' ' ' GLN . . . -88.54 133.94 34.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.45 -0.781 . . . . 0.0 110.444 -178.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.546 ' CG ' ' O ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER 59.49 30.03 19.66 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.192 0.52 . . . . 0.0 109.766 -179.454 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.61 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.1 OUTLIER -161.94 82.37 0.57 Allowed 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 118.776 -1.17 . . . . 0.0 111.707 -178.587 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.553 ' HA2' ' CA ' ' A' ' 130' ' ' GLY . . . -50.33 99.26 0.03 OUTLIER Glycine 0 N--CA 1.482 1.761 0 N-CA-C 107.091 -2.404 . . . . 0.0 107.091 178.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 1.078 HG13 HG22 ' A' ' 21' ' ' THR . 3.1 t -87.2 111.8 22.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 120.976 -1.308 . . . . 0.0 108.812 -178.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.578 ' O ' ' CE2' ' A' ' 19' ' ' TYR . . . -136.78 141.78 12.82 Favored Glycine 0 N--CA 1.486 1.98 0 C-N-CA 118.959 -1.591 . . . . 0.0 110.507 -178.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.688 HG13 ' O ' ' A' ' 17' ' ' VAL . 17.0 t -106.21 125.49 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.39 -1.065 . . . . 0.0 109.433 179.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.575 ' CG2' ' CG2' ' A' ' 17' ' ' VAL . 35.6 m -119.94 145.22 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.001 -1.062 . . . . 0.0 110.83 -179.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 1.042 HD22 ' NE1' ' A' ' 16' ' ' TRP . 10.4 tp -135.23 97.19 3.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.412 -0.805 . . . . 0.0 109.955 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.514 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 3.1 m120 -73.94 129.65 38.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.226 -0.921 . . . . 0.0 110.355 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 146.69 58.23 0.02 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.565 ' CG2' ' HA ' ' A' ' 124' ' ' GLN . 71.3 t -123.2 170.79 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.092 -1.24 . . . . 0.0 110.148 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.686 ' HB3' ' HB1' ' A' ' 1' ' ' ALA . . . -146.91 92.31 2.12 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.198 -0.939 . . . . 0.0 110.572 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.86 HG21 ' HB1' ' A' ' 108' ' ' ALA . 48.6 mm -124.3 156.68 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.244 -0.91 . . . . 0.0 109.793 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.522 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 1.1 tt0 -145.19 130.43 18.56 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.034 -1.041 . . . . 0.0 110.572 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.522 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 10.4 pt-20 38.11 -154.72 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.691 -0.631 . . . . 0.0 110.758 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.461 ' HA2' ' HA ' ' A' ' 109' ' ' SER . . . -83.44 85.91 1.52 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.637 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.2 m -110.59 173.68 6.22 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.248 -1.148 . . . . 0.0 109.821 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.567 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 0.6 OUTLIER -89.88 151.29 21.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.196 -0.94 . . . . 0.0 110.354 -179.881 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.715 ' CE2' HG23 ' A' ' 54' ' ' ILE . 56.9 m-85 -160.2 178.17 9.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.265 -0.897 . . . . 0.0 110.287 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 75.5 m -150.19 119.81 6.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.437 -0.789 . . . . 0.0 109.746 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.685 HD22 ' CD2' ' A' ' 89' ' ' LEU . 17.7 tp -89.48 119.97 30.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.13 -0.981 . . . . 0.0 110.12 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.535 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 10.2 ttp180 -124.4 138.68 54.34 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.373 -0.829 . . . . 0.0 109.806 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.537 ' CE2' ' HB ' ' A' ' 102' ' ' VAL . 0.8 OUTLIER -178.74 142.2 0.21 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.37 -0.831 . . . . 0.0 109.677 179.892 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.517 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 4.3 m -119.22 94.5 4.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.066 -1.021 . . . . 0.0 110.009 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.72 ' CB ' HD21 ' A' ' 95' ' ' LEU . . . -97.12 156.16 16.51 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.377 -0.827 . . . . 0.0 110.412 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 54.9 m -149.63 119.98 7.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.316 -0.865 . . . . 0.0 110.126 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.453 ' CB ' HG12 ' A' ' 72' ' ' VAL . . . -108.2 131.3 54.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.246 -0.909 . . . . 0.0 110.043 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 11.3 t -65.62 -9.23 25.21 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.212 -0.93 . . . . 0.0 110.104 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.644 HG21 ' CB ' ' A' ' 137' ' ' TRP . 6.0 t -116.0 19.54 14.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -0.895 . . . . 0.0 110.266 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.509 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 9.6 t0 42.76 66.49 0.76 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.291 -0.88 . . . . 0.0 109.69 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.853 HG23 ' HB2' ' A' ' 133' ' ' SER . 5.8 p -97.84 141.87 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.407 -0.808 . . . . 0.0 110.826 -179.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.496 HG22 ' O ' ' A' ' 73' ' ' THR . 19.5 m -119.76 82.56 1.9 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.377 -0.827 . . . . 0.0 109.163 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.591 ' HA ' ' CD2' ' A' ' 132' ' ' PHE . 17.7 m -90.0 -140.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.243 -0.911 . . . . 0.0 110.739 -179.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.525 ' N ' HG23 ' A' ' 74' ' ' VAL . 7.5 mtm180 -130.43 145.01 51.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.19 -0.944 . . . . 0.0 110.828 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.577 ' N ' ' HD3' ' A' ' 93' ' ' PRO . . . -150.5 153.42 35.82 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.417 -0.802 . . . . 0.0 109.479 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.9 HD12 ' N ' ' A' ' 78' ' ' VAL . 3.9 pp 179.86 -147.59 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.136 -0.977 . . . . 0.0 110.4 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.9 ' N ' HD12 ' A' ' 77' ' ' LEU . 5.0 t -149.92 164.97 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.359 -0.838 . . . . 0.0 109.114 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.488 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . -171.81 -175.56 40.15 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 118.958 -1.591 . . . . 0.0 110.693 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.49 ' HA ' ' O ' ' A' ' 122' ' ' GLU . 1.3 tt0 -90.88 -151.63 0.26 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.639 -0.918 . . . . 0.0 110.272 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.519 ' HB2' ' HG2' ' A' ' 122' ' ' GLU . 47.9 m-80 -161.81 83.57 0.59 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.434 -0.791 . . . . 0.0 109.582 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.536 ' CA ' ' HB3' ' A' ' 121' ' ' PRO . . . 122.54 136.67 4.93 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.63 ' N ' ' CE1' ' A' ' 85' ' ' TYR . . . -40.45 150.82 0.26 Allowed Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.333 -1.098 . . . . 0.0 110.447 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.467 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.6 Cg_endo -80.07 12.07 23.64 Favored 'Cis proline' 0 C--N 1.313 -1.334 0 C-N-CA 121.711 -2.204 . . . . 0.0 110.938 -0.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.63 ' CE1' ' N ' ' A' ' 83' ' ' ALA . 27.2 m-85 63.6 163.65 0.12 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.187 -0.946 . . . . 0.0 110.282 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 176.4 131.9 1.55 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.471 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 0.7 OUTLIER -117.73 153.31 33.6 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.227 -1.161 . . . . 0.0 110.282 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 1.015 HG23 HD12 ' A' ' 89' ' ' LEU . 31.3 m -124.88 -24.45 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.32 -0.863 . . . . 0.0 110.305 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 1.015 HD12 HG23 ' A' ' 88' ' ' VAL . 3.8 mp -104.79 144.29 31.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.204 -0.935 . . . . 0.0 110.952 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -151.5 76.66 1.22 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.348 -0.845 . . . . 0.0 109.974 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 67.1 p -142.71 -178.72 5.93 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.978 -1.076 . . . . 0.0 110.756 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.94 128.03 26.07 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.457 -0.777 . . . . 0.0 110.07 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.577 ' HD3' ' N ' ' A' ' 76' ' ' ALA . 46.4 Cg_endo -72.5 78.2 2.03 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.95 1.5 . . . . 0.0 111.038 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.535 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -56.43 139.64 48.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.057 -1.027 . . . . 0.0 109.223 179.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.829 ' CD1' HD21 ' A' ' 139' ' ' LEU . 44.4 mt -135.61 160.15 39.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.007 -1.058 . . . . 0.0 110.907 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.698 HG22 ' HG3' ' A' ' 100' ' ' ARG . 0.2 OUTLIER -158.59 -179.02 7.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.476 -0.765 . . . . 0.0 109.926 179.949 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.81 -27.65 69.32 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -0.933 . . . . 0.0 110.118 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.465 ' CB ' ' HD2' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -90.51 176.65 2.8 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.184 -0.948 . . . . 0.0 110.018 179.824 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.465 ' HD2' ' CB ' ' A' ' 98' ' ' GLU . 44.9 Cg_endo -72.08 135.61 25.5 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.928 1.488 . . . . 0.0 110.381 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.698 ' HG3' HG22 ' A' ' 96' ' ' THR . 0.0 OUTLIER -119.84 93.49 4.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.228 -0.92 . . . . 0.0 110.208 179.985 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -87.61 97.25 10.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.371 -0.831 . . . . 0.0 110.359 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.537 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 40.2 t -89.55 134.03 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.347 -0.846 . . . . 0.0 110.216 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -150.25 133.81 16.58 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.219 -0.925 . . . . 0.0 110.211 179.902 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -160.26 135.62 8.09 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.909 . . . . 0.0 110.245 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.486 HG23 ' O ' ' A' ' 60' ' ' TYR . 85.3 m -90.03 125.87 35.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.224 -0.922 . . . . 0.0 110.053 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.953 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 28.2 p90 -132.31 156.03 47.3 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.185 -0.947 . . . . 0.0 110.354 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.2 m -90.06 94.92 9.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.224 -0.923 . . . . 0.0 109.897 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.86 ' HB1' HG21 ' A' ' 54' ' ' ILE . . . -53.02 107.5 0.23 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.252 -0.905 . . . . 0.0 110.329 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.461 ' HA ' ' HA2' ' A' ' 57' ' ' GLY . 24.6 p -94.06 53.26 1.74 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.264 -0.898 . . . . 0.0 110.017 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -162.09 -153.55 0.28 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.297 -0.877 . . . . 0.0 110.278 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.494 HG23 ' HA ' ' A' ' 55' ' ' GLU . 5.2 m -147.27 118.38 7.74 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.283 -0.886 . . . . 0.0 110.172 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.63 ' OH ' HG22 ' A' ' 88' ' ' VAL . 20.3 m-30 -113.23 70.21 1.36 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.303 -0.873 . . . . 0.0 109.971 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.493 ' HD3' HG22 ' A' ' 111' ' ' THR . 46.3 Cg_endo -72.39 -159.06 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.035 1.545 . . . . 0.0 110.436 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -147.37 27.29 1.03 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.228 -0.92 . . . . 0.0 110.206 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.79 100.85 11.94 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.231 -0.918 . . . . 0.0 110.25 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' ' 120' ' ' ASP . 47.6 Cg_endo -73.9 118.22 5.34 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.029 1.542 . . . . 0.0 110.444 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.724 ' HB3' ' HB2' ' A' ' 120' ' ' ASP . . . -123.59 -160.06 0.89 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.231 -0.918 . . . . 0.0 110.138 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.12 -16.98 5.92 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.26 -0.9 . . . . 0.0 110.191 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.406 ' O ' ' HD3' ' A' ' 121' ' ' PRO . 10.0 t0 -169.87 28.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.3 -0.875 . . . . 0.0 110.146 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.724 ' HB2' ' HB3' ' A' ' 117' ' ' ALA . 0.7 OUTLIER -109.72 88.34 6.44 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.246 -0.909 . . . . 0.0 110.244 -179.957 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.536 ' HB3' ' CA ' ' A' ' 82' ' ' GLY . 46.2 Cg_endo -73.1 156.31 51.74 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.074 1.565 . . . . 0.0 110.266 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.519 ' HG2' ' HB2' ' A' ' 81' ' ' ASN . 0.8 OUTLIER -106.27 -163.02 0.89 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.131 -0.98 . . . . 0.0 109.878 179.802 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.576 ' HA3' ' CG ' ' A' ' 112' ' ' TYR . . . -144.37 149.09 21.13 Favored Glycine 0 N--CA 1.491 2.321 0 C-N-CA 119.56 -1.305 . . . . 0.0 109.889 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.653 ' O ' HG13 ' A' ' 78' ' ' VAL . 19.4 pt20 -150.51 -153.11 0.47 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.314 -1.11 . . . . 0.0 110.085 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.78 HG21 ' CH2' ' A' ' 16' ' ' TRP . 14.2 mt -118.18 139.23 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.487 -0.758 . . . . 0.0 109.359 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -117.12 123.62 47.2 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.291 -0.88 . . . . 0.0 110.933 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.475 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 4.5 m-85 -118.84 103.18 9.39 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 1.058 ' O ' HD23 ' A' ' 129' ' ' LEU . 2.0 mt-30 -89.11 129.87 35.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.203 -0.935 . . . . 0.0 111.714 -177.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 1.058 HD23 ' O ' ' A' ' 128' ' ' GLN . 0.8 OUTLIER -141.53 34.08 1.64 Allowed 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.441 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.553 ' CA ' ' HA2' ' A' ' 44' ' ' GLY . . . -82.23 118.96 4.74 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 39' ' ' GLY . . . 42.56 69.99 0.54 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.591 ' CD2' ' HA ' ' A' ' 74' ' ' VAL . 11.2 m-85 -117.35 -61.81 1.65 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.109 -1.23 . . . . 0.0 111.006 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.853 ' HB2' HG23 ' A' ' 72' ' ' VAL . 1.3 t -88.36 -176.46 5.35 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.02 -1.05 . . . . 0.0 110.693 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -92.53 -82.03 0.33 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.276 -0.89 . . . . 0.0 110.225 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -70.25 177.77 3.15 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.147 -0.971 . . . . 0.0 109.765 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.531 ' CA ' ' HA ' ' A' ' 38' ' ' ALA . . . -75.2 138.81 42.21 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.297 -0.877 . . . . 0.0 110.736 -179.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 1.058 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 9.0 p90 -140.99 -171.41 3.25 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.263 -0.898 . . . . 0.0 110.682 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.516 ' C ' HD12 ' A' ' 139' ' ' LEU 0.251 0.8 OUTLIER -149.25 171.34 16.65 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.536 -0.727 . . . . 0.0 109.702 -177.986 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.829 HD21 ' CD1' ' A' ' 95' ' ' LEU . 1.7 mp -139.47 117.91 12.11 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.998 -1.064 . . . . 0.0 112.11 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' CYS . . . . . 0.471 ' SG ' ' HB3' ' A' ' 31' ' ' ALA . 0.8 OUTLIER -103.4 110.11 22.0 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.646 -0.659 . . . . 0.0 110.64 178.186 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.569 HD23 ' HB2' ' A' ' 66' ' ' ALA . 1.3 mt -97.28 -178.5 4.19 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.277 -0.89 . . . . 0.0 108.974 178.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 143' ' ' ASP . 0.5 OUTLIER 169.31 61.12 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.145 -0.972 . . . . 0.0 110.407 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.53 ' CB ' ' O ' ' A' ' 142' ' ' ASP . 0.5 OUTLIER 166.35 43.26 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.388 -0.82 . . . . 0.0 109.344 179.852 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.795 HG11 ' HZ2' ' A' ' 16' ' ' TRP . 1.5 t -89.45 114.33 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.373 -0.83 . . . . 0.0 110.281 -179.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.859 ' HB1' ' HG2' ' A' ' 6' ' ' GLU . . . -151.84 148.45 27.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.413 -0.804 . . . . 0.0 110.081 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.835 HD21 HD11 ' A' ' 54' ' ' ILE . 38.8 tp -146.54 123.57 11.41 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.341 -0.849 . . . . 0.0 110.099 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.479 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -140.66 157.57 45.25 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.235 -0.916 . . . . 0.0 110.373 -179.938 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 59' ' ' THR . 24.4 p -98.66 115.5 28.83 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.282 -0.886 . . . . 0.0 110.136 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.67 162.17 27.94 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.208 -0.933 . . . . 0.0 110.215 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 16.6 m -89.25 31.43 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.221 -0.924 . . . . 0.0 110.185 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -97.39 113.21 24.83 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.288 -0.882 . . . . 0.0 110.21 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.4 tp . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.199 -179.974 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.265 0.555 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.8 t 179.06 66.9 0.12 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 0.0 110.184 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -75.94 -156.34 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.013 1.533 . . . . 0.0 110.09 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.0 pt -96.38 -28.93 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.183 -0.948 . . . . 0.0 110.181 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.51 ' O ' ' N ' ' A' ' 7' ' ' GLY . . . 99.4 106.47 2.71 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.617 ' HA ' ' HB2' ' A' ' 145' ' ' ALA . 0.6 OUTLIER -45.01 93.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.231 -1.158 . . . . 0.0 110.069 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 5' ' ' GLY . . . -139.55 177.84 20.12 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.671 HG22 ' HA ' ' A' ' 143' ' ' ASP . 29.4 p -129.52 20.35 5.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.386 -1.067 . . . . 0.0 109.818 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.643 ' HB3' HG21 ' A' ' 27' ' ' THR . 3.2 m-30 70.71 -78.96 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.812 -0.555 . . . . 0.0 110.671 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.555 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 1.4 p30 40.02 27.87 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.095 -1.003 . . . . 0.0 110.505 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.555 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 1.9 t70 161.13 -57.84 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.54 0.686 . . . . 0.0 109.235 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 9' ' ' PHE . . . -133.67 127.13 4.53 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.583 ' HA ' ' CD1' ' A' ' 9' ' ' PHE . 52.4 Cg_endo -81.82 29.85 0.53 Allowed 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.819 1.431 . . . . 0.0 111.16 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 0.2 OUTLIER 62.23 -89.35 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.997 -1.065 . . . . 0.0 110.326 179.923 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -149.73 22.19 1.16 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.84 ' HZ2' HG11 ' A' ' 144' ' ' VAL . 40.0 m95 -61.69 142.56 57.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.276 -1.132 . . . . 0.0 110.381 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.732 ' O ' HG13 ' A' ' 47' ' ' VAL . 0.8 OUTLIER -132.87 140.87 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.232 -0.918 . . . . 0.0 109.222 179.15 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.5 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . . . -125.15 114.75 19.43 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.97 -1.081 . . . . 0.0 110.235 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.887 ' HE2' HG13 ' A' ' 48' ' ' VAL . 40.0 p90 -100.93 150.53 22.77 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.691 -0.631 . . . . 0.0 109.924 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.777 ' C ' HG23 ' A' ' 21' ' ' THR . . . 112.58 87.2 1.64 Allowed Glycine 0 N--CA 1.483 1.802 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.777 HG23 ' C ' ' A' ' 20' ' ' GLY . 1.4 p 75.24 -139.81 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.116 0 O-C-N 122.064 -0.668 . . . . 0.0 110.333 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.96 ' O ' ' HB3' ' A' ' 35' ' ' ALA . 2.5 m-20 -88.72 116.84 27.27 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.884 -1.135 . . . . 0.0 110.075 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.557 ' N ' ' CD ' ' A' ' 24' ' ' PRO . . . -119.61 49.24 0.88 Allowed Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.557 ' CD ' ' N ' ' A' ' 23' ' ' GLY . 43.4 Cg_endo -69.89 82.17 0.8 Allowed 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 124.024 1.539 . . . . 0.0 109.677 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.784 HD13 HD11 ' A' ' 32' ' ' LEU . 40.8 mt -50.93 88.52 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.44 -0.787 . . . . 0.0 110.422 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 24' ' ' PRO . 0.3 OUTLIER -91.22 120.95 32.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -0.885 . . . . 0.0 109.442 179.626 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.643 HG21 ' HB3' ' A' ' 9' ' ' PHE . 1.2 p -119.54 -27.39 5.54 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.076 -1.015 . . . . 0.0 110.889 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 27' ' ' THR . 74.4 m -43.46 -28.08 0.33 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.186 -0.946 . . . . 0.0 109.192 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.606 HG23 ' N ' ' A' ' 30' ' ' GLY . 6.3 t -67.78 -47.89 67.87 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.629 -0.669 . . . . 0.0 110.482 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.606 ' N ' HG23 ' A' ' 29' ' ' THR . . . 164.93 -25.94 0.18 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.661 ' HB1' ' O ' ' A' ' 141' ' ' LEU . . . -150.54 159.67 44.33 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.295 -1.121 . . . . 0.0 110.218 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.784 HD11 HD13 ' A' ' 25' ' ' LEU . 0.6 OUTLIER -72.71 102.0 3.22 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.314 -0.866 . . . . 0.0 110.328 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.58 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 0.8 OUTLIER -98.84 119.76 38.14 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.167 -0.958 . . . . 0.0 111.913 -179.915 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.659 HG12 ' CD2' ' A' ' 25' ' ' LEU . 17.2 m -96.92 150.11 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.96 ' HB3' ' O ' ' A' ' 22' ' ' ASP . . . -89.95 121.75 32.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.054 -1.029 . . . . 0.0 111.781 -178.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.081 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 66.5 t -119.56 125.8 27.29 Favored Pre-proline 0 C--N 1.303 -1.452 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 178.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 38' ' ' ALA . 44.8 Cg_endo -71.59 147.39 51.42 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 123.811 1.427 . . . . 0.0 110.929 -178.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.489 ' HA ' ' N ' ' A' ' 136' ' ' ALA . . . -43.03 123.97 3.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.364 -0.835 . . . . 0.0 109.277 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 134' ' ' ALA . . . 61.39 78.8 0.15 Allowed Glycine 0 N--CA 1.486 1.968 0 N-CA-C 108.0 -2.04 . . . . 0.0 108.0 -178.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.667 ' HB2' HG21 ' A' ' 45' ' ' VAL . 2.4 p -85.28 53.63 2.82 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.542 -0.975 . . . . 0.0 110.076 -179.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.566 ' O ' ' O ' ' A' ' 42' ' ' GLN . . . -88.83 -147.49 0.16 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.69 -0.631 . . . . 0.0 110.024 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.701 ' O ' ' CD2' ' A' ' 43' ' ' TYR . 5.8 pt20 38.94 102.98 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 CA-C-O 121.761 0.791 . . . . 0.0 110.522 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.701 ' CD2' ' O ' ' A' ' 42' ' ' GLN . 0.0 OUTLIER 77.7 -20.95 0.35 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.729 -1.232 . . . . 0.0 110.275 -178.797 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.584 ' O ' ' CD1' ' A' ' 43' ' ' TYR . . . 57.71 141.95 0.01 OUTLIER Glycine 0 N--CA 1.492 2.398 0 O-C-N 120.952 -1.092 . . . . 0.0 111.196 178.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.76 HG13 ' HA3' ' A' ' 20' ' ' GLY . 2.5 t -93.35 -172.66 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.306 -1.114 . . . . 0.0 108.762 179.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.604 ' H ' HG12 ' A' ' 45' ' ' VAL . . . 172.13 -175.4 45.41 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 118.635 -1.745 . . . . 0.0 111.464 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.732 HG13 ' O ' ' A' ' 17' ' ' VAL . 35.5 t -150.6 133.75 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.887 HG13 ' HE2' ' A' ' 19' ' ' TYR . 22.5 m -123.66 138.5 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 120.81 -1.181 . . . . 0.0 110.99 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.643 ' CD2' ' CE2' ' A' ' 16' ' ' TRP . 5.2 tp -132.03 98.87 4.55 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.326 -0.859 . . . . 0.0 110.202 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.518 ' O ' ' ND2' ' A' ' 50' ' ' ASN . 3.4 p-10 -73.46 98.88 2.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 0.0 110.091 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 172.7 77.57 0.05 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.672 HG23 ' HA ' ' A' ' 124' ' ' GLN . 12.4 t -134.93 169.17 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.215 -1.168 . . . . 0.0 109.937 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.412 ' O ' HD13 ' A' ' 54' ' ' ILE . . . -136.46 79.7 1.78 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.107 -0.995 . . . . 0.0 110.671 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.836 HD11 HD21 ' A' ' 146' ' ' LEU . 36.0 mm -115.63 158.91 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.209 -0.932 . . . . 0.0 109.934 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.578 ' HA ' HG23 ' A' ' 111' ' ' THR . 3.8 tt0 -152.04 124.25 8.18 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.116 -0.99 . . . . 0.0 110.438 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.53 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 11.5 pt-20 37.73 -152.93 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.669 -0.645 . . . . 0.0 110.789 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.455 ' N ' ' HG3' ' A' ' 56' ' ' GLU . . . -82.03 99.95 2.07 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.651 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.2 m -132.46 174.16 10.55 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.33 -1.1 . . . . 0.0 109.855 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.568 ' N ' ' CG2' ' A' ' 58' ' ' THR . 1.3 m -89.72 152.97 21.06 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.226 -0.921 . . . . 0.0 110.191 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.651 ' CE2' HG22 ' A' ' 58' ' ' THR . 57.9 m-85 -158.6 158.61 34.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.255 -0.903 . . . . 0.0 110.28 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 87.8 m -132.37 117.3 17.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.317 -0.865 . . . . 0.0 109.971 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 20.1 tp -89.73 121.49 31.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.188 -0.945 . . . . 0.0 110.156 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.5 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 9.5 ttp180 -125.78 131.84 52.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 110.12 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 1.196 ' CZ ' HG21 ' A' ' 102' ' ' VAL . 2.7 p90 -169.8 146.64 3.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.221 -0.924 . . . . 0.0 109.975 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.503 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 3.4 m -119.49 101.33 7.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.199 -0.938 . . . . 0.0 109.745 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.659 ' CB ' HD21 ' A' ' 95' ' ' LEU . . . -104.83 150.79 24.52 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.356 -0.84 . . . . 0.0 110.497 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.756 HG23 ' O ' ' A' ' 98' ' ' GLU . 86.0 m -150.43 106.48 3.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.32 -0.863 . . . . 0.0 110.161 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.472 ' O ' ' O ' ' A' ' 96' ' ' THR . . . -95.73 127.04 41.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.206 -0.934 . . . . 0.0 109.951 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 68' ' ' ALA . 39.9 t -42.56 -26.95 0.14 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.284 -0.885 . . . . 0.0 109.843 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.557 ' CG2' ' CB ' ' A' ' 137' ' ' TRP . 2.6 t -108.5 159.95 16.28 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.356 -0.84 . . . . 0.0 110.056 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 60.4 t0 -78.31 78.63 4.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.121 -0.987 . . . . 0.0 109.215 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.702 HG23 ' CB ' ' A' ' 133' ' ' SER . 4.4 p -106.64 145.72 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.186 -0.946 . . . . 0.0 111.239 -178.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.476 ' O ' ' CD1' ' A' ' 132' ' ' PHE . 98.2 m -126.02 91.35 3.36 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.785 HG12 ' CD2' ' A' ' 132' ' ' PHE . 15.4 m -89.77 -152.11 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.196 -0.94 . . . . 0.0 110.833 -178.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.529 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 8.2 mtm180 -129.21 136.34 50.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.332 -0.855 . . . . 0.0 110.647 -179.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.691 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -135.67 153.56 51.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.388 -0.82 . . . . 0.0 109.648 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.891 HD12 ' N ' ' A' ' 78' ' ' VAL . 4.0 pp -179.74 -150.02 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.243 -0.911 . . . . 0.0 110.377 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.891 ' N ' HD12 ' A' ' 77' ' ' LEU . 3.5 t -150.87 170.54 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.29 -0.881 . . . . 0.0 109.616 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.575 ' O ' ' CE1' ' A' ' 112' ' ' TYR . . . -174.83 -162.43 26.3 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.404 -1.379 . . . . 0.0 110.256 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.544 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 3.5 tm0? -120.9 128.21 52.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.448 -1.031 . . . . 0.0 110.655 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.518 ' OD1' ' NE2' ' A' ' 124' ' ' GLN . 4.5 m120 -83.46 67.64 9.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.4 -0.812 . . . . 0.0 109.813 179.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.543 ' HA3' ' CB ' ' A' ' 121' ' ' PRO . . . 166.7 141.36 3.13 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.618 ' N ' ' CE1' ' A' ' 85' ' ' TYR . . . -61.97 156.06 59.63 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.245 -1.15 . . . . 0.0 110.134 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.52 ' C ' ' CD2' ' A' ' 85' ' ' TYR . 49.9 Cg_endo -77.22 8.15 17.63 Favored 'Cis proline' 0 C--N 1.312 -1.377 0 C-N-CA 121.692 -2.212 . . . . 0.0 110.904 0.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.618 ' CE1' ' N ' ' A' ' 83' ' ' ALA . 11.7 m-85 70.15 158.19 0.17 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.26 -0.9 . . . . 0.0 110.196 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -177.68 114.27 0.46 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.471 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 1.6 p -89.92 147.15 23.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.243 -1.151 . . . . 0.0 110.329 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.794 HG23 HD12 ' A' ' 89' ' ' LEU . 16.4 m -119.96 -24.0 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.29 -0.881 . . . . 0.0 110.016 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.832 HD22 HG23 ' A' ' 78' ' ' VAL . 4.2 mp -105.74 145.22 31.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 110.792 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -151.19 78.23 1.28 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.326 -0.859 . . . . 0.0 109.996 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.0 p -140.22 170.63 15.48 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.028 -1.045 . . . . 0.0 110.686 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.403 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 1.2 m -120.09 115.62 33.02 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.383 -0.823 . . . . 0.0 110.087 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.691 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 45.2 Cg_endo -70.68 128.76 15.61 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.901 1.474 . . . . 0.0 111.057 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.511 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -94.25 148.12 22.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.32 -0.862 . . . . 0.0 109.407 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.792 ' CD1' HD21 ' A' ' 139' ' ' LEU . 77.1 mt -141.15 157.39 45.33 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.019 -1.051 . . . . 0.0 110.807 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.515 HG23 ' N ' ' A' ' 97' ' ' SER . 6.0 t -164.47 -156.58 0.33 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.407 -0.808 . . . . 0.0 109.902 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.515 ' N ' HG23 ' A' ' 96' ' ' THR . 0.1 OUTLIER -89.11 34.05 0.79 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.177 -0.952 . . . . 0.0 110.244 179.91 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.756 ' O ' HG23 ' A' ' 67' ' ' THR . 0.1 OUTLIER -150.16 168.02 11.83 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.304 -0.872 . . . . 0.0 110.068 179.899 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.476 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 45.5 Cg_endo -72.41 127.74 12.9 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.005 1.529 . . . . 0.0 110.313 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.511 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 1.2 ttm180 -119.46 91.83 3.64 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.179 -0.951 . . . . 0.0 110.152 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.479 ' HG3' ' OG1' ' A' ' 65' ' ' THR . 0.0 OUTLIER -73.89 147.12 43.49 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.341 -0.85 . . . . 0.0 109.963 179.93 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 1.196 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 19.6 t -124.03 135.17 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.227 -0.92 . . . . 0.0 110.296 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.408 ' C ' ' HG3' ' A' ' 104' ' ' GLU . 0.2 OUTLIER -150.18 96.66 2.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.283 -0.886 . . . . 0.0 110.196 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.408 ' HG3' ' C ' ' A' ' 103' ' ' THR . 43.0 mt-10 -142.39 160.09 40.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.216 -0.927 . . . . 0.0 110.256 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 1.2 t -114.97 170.74 8.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.251 -0.906 . . . . 0.0 110.164 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.788 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 41.7 p90 -173.06 153.89 2.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.248 -0.907 . . . . 0.0 110.289 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 58' ' ' THR . 16.4 m -89.92 90.37 8.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.884 . . . . 0.0 109.993 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.632 ' HB3' ' CE2' ' A' ' 60' ' ' TYR . . . -54.15 113.49 1.26 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.296 -0.878 . . . . 0.0 110.393 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 68.7 p -97.33 54.79 1.23 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.224 -0.922 . . . . 0.0 109.993 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.439 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -165.14 -159.0 0.41 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.3 -0.875 . . . . 0.0 110.236 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.578 HG23 ' HA ' ' A' ' 55' ' ' GLU . 13.6 m -147.77 117.9 7.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.223 -0.923 . . . . 0.0 110.342 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.577 ' CD2' HG13 ' A' ' 54' ' ' ILE . 17.4 m-30 -115.9 80.39 8.82 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.29 -0.881 . . . . 0.0 109.841 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.475 ' O ' ' HB2' ' A' ' 122' ' ' GLU . 44.5 Cg_endo -72.32 -164.56 0.18 Allowed 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.92 1.484 . . . . 0.0 110.51 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -141.48 47.46 1.68 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.209 -0.932 . . . . 0.0 110.25 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.465 ' O ' ' O ' ' A' ' 120' ' ' ASP . 0.3 OUTLIER -128.17 72.24 79.55 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 0.0 110.184 -179.972 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' A' ' 120' ' ' ASP . 45.8 Cg_endo -72.89 121.57 7.44 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.071 1.563 . . . . 0.0 110.458 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.63 ' HB3' ' HB2' ' A' ' 120' ' ' ASP . . . -144.78 -160.07 1.08 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.244 -0.91 . . . . 0.0 110.189 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -75.1 -9.45 58.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.301 -0.874 . . . . 0.0 110.237 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.433 ' OD1' ' OD1' ' A' ' 120' ' ' ASP . 4.7 p30 -155.19 18.84 0.42 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.219 -0.925 . . . . 0.0 110.181 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.63 ' HB2' ' HB3' ' A' ' 117' ' ' ALA . 3.5 m-20 -132.71 90.15 33.42 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.251 -0.906 . . . . 0.0 110.23 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.543 ' CB ' ' HA3' ' A' ' 82' ' ' GLY . 45.7 Cg_endo -72.89 -159.07 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.018 1.536 . . . . 0.0 110.391 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.521 ' HG2' ' N ' ' A' ' 123' ' ' GLY . 4.9 pm0 -163.42 -137.78 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.179 -0.951 . . . . 0.0 110.408 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.544 ' HA2' ' HA ' ' A' ' 80' ' ' GLN . . . -145.82 158.26 27.62 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.672 ' HA ' HG23 ' A' ' 52' ' ' VAL . 3.3 pt20 -150.23 -161.0 1.25 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.071 -1.252 . . . . 0.0 110.748 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.693 HG21 ' HH2' ' A' ' 16' ' ' TRP . 30.4 mt -118.97 148.63 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.49 -0.756 . . . . 0.0 109.413 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.471 ' HB3' ' HG ' ' A' ' 77' ' ' LEU . . . -117.36 120.13 37.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.35 -0.844 . . . . 0.0 111.426 -179.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.544 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 5.3 m-85 -125.14 77.47 1.63 Allowed 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.503 ' HA ' ' CA ' ' A' ' 46' ' ' GLY . 8.4 mt-30 -87.47 121.19 29.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.135 -0.978 . . . . 0.0 111.706 -177.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.833 HD13 HD13 ' A' ' 139' ' ' LEU . 6.4 mt -105.24 49.19 0.81 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.534 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . -91.34 137.71 13.95 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.579 ' O ' ' CD1' ' A' ' 132' ' ' PHE . . . 41.96 93.23 0.01 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.785 ' CD2' HG12 ' A' ' 74' ' ' VAL . 13.0 m-85 -154.86 -74.97 0.11 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -1.168 . . . . 0.0 110.353 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.702 ' CB ' HG23 ' A' ' 72' ' ' VAL . 1.4 t -89.5 166.49 13.64 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.026 -1.046 . . . . 0.0 110.26 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -101.85 -59.41 1.71 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.18 -0.95 . . . . 0.0 110.552 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.422 ' C ' ' HA ' ' A' ' 38' ' ' ALA . 15.8 m-20 -73.09 152.45 41.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.189 -0.944 . . . . 0.0 110.261 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.489 ' N ' ' HA ' ' A' ' 38' ' ' ALA . . . -49.2 133.58 18.92 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.19 -0.944 . . . . 0.0 109.925 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 1.081 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 6.2 p90 -147.25 -173.6 4.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.123 -0.985 . . . . 0.0 110.944 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.53 ' CG2' ' N ' ' A' ' 139' ' ' LEU 0.25 0.8 OUTLIER -154.09 178.75 9.61 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.538 -0.726 . . . . 0.0 109.369 -178.372 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.833 HD13 HD13 ' A' ' 129' ' ' LEU . 1.6 mp -138.16 115.93 11.47 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.846 -1.159 . . . . 0.0 112.195 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' CYS . . . . . 0.632 ' HB3' ' HB3' ' A' ' 31' ' ' ALA . 0.8 OUTLIER -103.51 107.44 18.29 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.71 -0.619 . . . . 0.0 110.929 178.351 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.661 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 3.9 mt -94.42 179.92 5.12 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.246 -0.909 . . . . 0.0 108.961 178.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 142' ' ' ASP . 2.0 p30 168.31 61.15 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.044 -1.035 . . . . 0.0 110.578 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.671 ' HA ' HG22 ' A' ' 8' ' ' THR . 0.5 OUTLIER 164.92 45.63 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.444 -0.785 . . . . 0.0 109.355 179.773 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.84 HG11 ' HZ2' ' A' ' 16' ' ' TRP . 1.1 t -89.46 115.66 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.309 -0.87 . . . . 0.0 110.316 -179.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.617 ' HB2' ' HA ' ' A' ' 6' ' ' GLU . . . -144.45 155.37 43.7 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.431 -0.793 . . . . 0.0 110.151 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.836 HD21 HD11 ' A' ' 54' ' ' ILE . 39.4 tp -148.98 141.71 24.53 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.332 -0.855 . . . . 0.0 110.177 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.478 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 0.5 OUTLIER -151.4 176.85 10.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.237 -0.915 . . . . 0.0 110.246 -179.914 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.583 ' HB3' ' CE1' ' A' ' 60' ' ' TYR . 6.2 p -135.13 177.88 7.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.153 -0.967 . . . . 0.0 110.249 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -106.98 142.55 36.42 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.332 -0.855 . . . . 0.0 110.185 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.477 HG22 ' O ' ' A' ' 150' ' ' VAL . 7.9 p -125.68 30.02 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.266 -0.896 . . . . 0.0 110.205 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 61.03 -162.86 0.27 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.286 -0.884 . . . . 0.0 110.2 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.2 mt . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 117.999 -1.0 . . . . 0.0 110.199 -179.988 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.751 ' HB3' ' HB3' ' A' ' 114' ' ' ALA . . . . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.241 0.544 . . . . 0.0 110.238 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -165.09 137.41 3.49 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.281 -0.887 . . . . 0.0 110.216 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -75.7 -155.73 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.984 1.518 . . . . 0.0 110.06 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.666 HG22 ' O ' ' A' ' 51' ' ' GLY . 27.7 pt -89.8 -34.36 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.195 -0.94 . . . . 0.0 110.09 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.528 ' N ' HG13 ' A' ' 4' ' ' ILE . . . -172.31 -119.93 0.54 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 5' ' ' GLY . 1.9 tt0 178.47 31.58 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.217 -1.166 . . . . 0.0 110.242 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.492 ' O ' ' HA ' ' A' ' 143' ' ' ASP . . . 156.32 -116.74 0.74 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.631 HG22 ' O ' ' A' ' 142' ' ' ASP . 3.8 p -108.03 168.28 9.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -1.151 . . . . 0.0 110.034 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.518 ' O ' ' N ' ' A' ' 11' ' ' ASP . 14.7 m-85 -70.05 -33.92 72.57 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.239 -0.913 . . . . 0.0 109.199 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.57 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 20.0 t70 37.01 27.7 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.734 -0.604 . . . . 0.0 111.384 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.57 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.9 OUTLIER 161.31 -66.55 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.313 -0.867 . . . . 0.0 110.184 179.728 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.47 ' O ' ' HB3' ' A' ' 9' ' ' PHE . . . -122.46 145.67 16.52 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.838 ' HB3' HD12 ' A' ' 32' ' ' LEU . 49.5 Cg_endo -76.02 4.95 4.82 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 O-C-N 124.093 1.575 . . . . 0.0 110.814 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.461 ' CB ' ' O ' ' A' ' 13' ' ' PRO . 1.5 mm-40 67.39 -84.77 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.199 -0.938 . . . . 0.0 110.378 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.803 ' O ' HG13 ' A' ' 17' ' ' VAL . . . -137.84 4.35 3.26 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.905 ' NE1' HD22 ' A' ' 49' ' ' LEU . 51.8 m95 -61.75 87.97 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.133 -1.216 . . . . 0.0 110.095 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.803 HG13 ' O ' ' A' ' 15' ' ' GLY . 1.2 m -93.01 162.88 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.228 -0.92 . . . . 0.0 109.976 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . . . -142.67 129.79 20.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.391 -0.818 . . . . 0.0 109.286 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.57 ' CE2' ' O ' ' A' ' 46' ' ' GLY . 10.6 p90 -118.26 157.14 27.59 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.141 -0.974 . . . . 0.0 111.363 -178.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.649 ' O ' HG22 ' A' ' 45' ' ' VAL . . . 74.97 41.44 32.7 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 1.078 HG22 ' CG1' ' A' ' 45' ' ' VAL . 17.2 p -128.11 -154.09 0.61 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.147 -1.208 . . . . 0.0 110.469 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -100.76 38.11 1.59 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.389 -0.819 . . . . 0.0 110.127 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 124.93 -174.89 17.26 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.465 ' O ' ' O ' ' A' ' 25' ' ' LEU . 46.9 Cg_endo -73.47 134.7 21.03 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.046 1.551 . . . . 0.0 110.615 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.826 ' CB ' HG12 ' A' ' 34' ' ' VAL . 0.8 OUTLIER -49.14 -179.98 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.236 -0.915 . . . . 0.0 110.168 179.899 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -155.67 158.51 38.42 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.138 -0.976 . . . . 0.0 110.233 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.965 ' O ' HG22 ' A' ' 29' ' ' THR . 0.9 OUTLIER -119.92 -75.12 0.59 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.328 -0.857 . . . . 0.0 110.039 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 27' ' ' THR . 1.0 OUTLIER 40.53 27.53 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.445 -0.784 . . . . 0.0 110.624 179.843 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.965 HG22 ' O ' ' A' ' 27' ' ' THR . 9.4 t -164.48 23.75 0.06 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.17 -0.956 . . . . 0.0 110.357 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.525 ' CA ' ' HA ' ' A' ' 10' ' ' ASP . . . 60.36 17.93 48.42 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.595 ' O ' HG22 ' A' ' 27' ' ' THR . . . -142.57 153.93 43.98 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.369 -1.077 . . . . 0.0 110.088 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.838 HD12 ' HB3' ' A' ' 13' ' ' PRO . 0.4 OUTLIER -91.89 95.37 9.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.92 . . . . 0.0 110.162 179.996 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 7.4 m -101.27 99.48 9.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.302 -0.874 . . . . 0.0 110.428 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.826 HG12 ' CB ' ' A' ' 25' ' ' LEU . 20.3 m -89.82 145.67 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.257 -0.902 . . . . 0.0 109.624 179.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.527 ' HA ' ' OG1' ' A' ' 138' ' ' THR . . . -91.43 99.2 12.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.164 -0.96 . . . . 0.0 110.751 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.995 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 62.9 t -84.94 129.35 56.67 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.263 -0.898 . . . . 0.0 109.46 179.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.509 ' HD3' ' HA ' ' A' ' 21' ' ' THR . 38.5 Cg_endo -65.56 178.48 2.14 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 121.704 1.602 . . . . 0.0 112.508 -178.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.528 ' HA ' ' CA ' ' A' ' 136' ' ' ALA . . . -61.27 117.16 5.25 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.519 0.676 . . . . 0.0 111.51 -178.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 134' ' ' ALA . . . 37.22 26.93 0.02 OUTLIER Glycine 0 N--CA 1.493 2.494 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.52 ' OG ' HG23 ' A' ' 45' ' ' VAL . 12.6 t 36.84 73.86 0.09 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.405 -1.056 . . . . 0.0 109.859 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.579 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . -87.77 115.0 24.92 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.669 -0.812 . . . . 0.0 109.977 -179.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.579 ' HG2' ' O ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER 67.37 10.51 7.79 Favored 'General case' 0 N--CA 1.504 2.26 0 CA-C-O 121.399 0.619 . . . . 0.0 109.965 -179.247 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.601 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.1 OUTLIER -132.32 76.02 1.67 Allowed 'General case' 0 C--N 1.289 -2.044 0 C-N-CA 119.551 -0.86 . . . . 0.0 111.719 -178.162 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.475 ' HA2' ' HA3' ' A' ' 130' ' ' GLY . . . -48.8 98.52 0.02 OUTLIER Glycine 0 N--CA 1.484 1.843 0 N-CA-C 107.362 -2.295 . . . . 0.0 107.362 178.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 1.078 ' CG1' HG22 ' A' ' 21' ' ' THR . 2.7 t -86.89 113.7 24.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.185 -1.185 . . . . 0.0 108.693 -178.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.57 ' O ' ' CE2' ' A' ' 19' ' ' TYR . . . -133.35 141.2 12.54 Favored Glycine 0 N--CA 1.487 2.095 0 C-N-CA 119.299 -1.429 . . . . 0.0 110.491 -178.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.709 HG13 ' O ' ' A' ' 17' ' ' VAL . 15.8 t -105.79 123.39 60.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 121.519 -0.989 . . . . 0.0 109.483 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.534 HG13 ' HE2' ' A' ' 19' ' ' TYR . 35.1 m -119.69 140.28 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.003 -1.061 . . . . 0.0 110.72 -179.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.905 HD22 ' NE1' ' A' ' 16' ' ' TRP . 20.7 tp -130.91 98.67 4.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.338 -0.851 . . . . 0.0 110.191 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.503 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 19.4 p30 -77.02 138.22 39.46 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.206 -0.934 . . . . 0.0 110.223 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.666 ' O ' HG22 ' A' ' 4' ' ' ILE . . . 134.15 76.08 0.09 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.582 HG12 ' N ' ' A' ' 53' ' ' ALA . 41.5 t -135.51 171.57 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.192 -1.181 . . . . 0.0 110.148 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.582 ' N ' HG12 ' A' ' 52' ' ' VAL . . . -139.59 81.84 1.85 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.105 -0.997 . . . . 0.0 110.665 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.634 HG21 ' HB1' ' A' ' 108' ' ' ALA . 30.1 mm -119.48 159.86 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.301 -0.874 . . . . 0.0 109.774 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.527 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 6.3 tt0 -152.8 131.75 12.54 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.006 -1.059 . . . . 0.0 110.762 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 19.5 pt-20 37.8 -154.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.64 -0.662 . . . . 0.0 111.022 179.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.473 ' HA2' ' HA ' ' A' ' 109' ' ' SER . . . -84.58 83.47 1.63 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.636 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.2 m -112.05 170.58 8.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -1.166 . . . . 0.0 109.781 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.567 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 0.7 OUTLIER -89.88 154.12 20.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.234 -0.916 . . . . 0.0 110.311 -179.902 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.636 ' CE2' HG22 ' A' ' 58' ' ' THR . 61.8 m-85 -158.95 -179.62 8.21 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.257 -0.902 . . . . 0.0 110.112 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.519 ' O ' HD12 ' A' ' 146' ' ' LEU . 94.6 m -150.01 111.28 4.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.276 -0.89 . . . . 0.0 110.065 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.643 HD22 ' CD2' ' A' ' 89' ' ' LEU . 20.4 tp -89.7 121.3 31.74 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.183 -0.948 . . . . 0.0 110.201 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.514 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 26.5 ttp180 -127.67 138.11 52.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.324 -0.86 . . . . 0.0 109.894 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.519 ' CE2' ' HB ' ' A' ' 102' ' ' VAL . 6.3 p90 -174.9 151.29 1.35 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.278 -0.889 . . . . 0.0 109.821 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.514 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 78.1 m -119.39 91.03 3.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.149 -0.969 . . . . 0.0 110.092 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.566 ' HB1' HD21 ' A' ' 95' ' ' LEU . . . -89.79 143.1 27.08 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.387 -0.821 . . . . 0.0 110.423 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.468 ' OG1' ' HA ' ' A' ' 99' ' ' PRO . 99.4 m -143.84 116.2 8.53 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.281 -0.887 . . . . 0.0 110.205 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.631 ' HB3' ' HB3' ' A' ' 95' ' ' LEU . . . -109.14 126.48 53.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.3 -0.875 . . . . 0.0 109.874 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.433 ' C ' ' O ' ' A' ' 68' ' ' ALA . 0.4 OUTLIER -43.98 -26.41 0.28 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.234 -0.916 . . . . 0.0 109.573 179.709 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.565 HG22 ' HB2' ' A' ' 137' ' ' TRP . 2.7 t -110.41 169.87 8.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.543 -0.723 . . . . 0.0 110.01 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.488 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 12.5 t70 -87.16 51.85 2.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.177 -0.952 . . . . 0.0 108.988 178.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.999 HG23 ' HB2' ' A' ' 133' ' ' SER . 4.0 p -66.62 135.33 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.519 -0.738 . . . . 0.0 111.353 -178.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 92.2 m -119.86 79.89 1.51 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.728 HG21 HD22 ' A' ' 129' ' ' LEU . 7.5 m -89.68 -142.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.317 -0.864 . . . . 0.0 110.443 -178.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.583 ' N ' HG23 ' A' ' 74' ' ' VAL . 0.7 OUTLIER -130.27 145.88 51.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.164 -0.96 . . . . 0.0 110.718 -179.453 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.87 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -146.19 150.42 35.81 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.333 -0.854 . . . . 0.0 109.594 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.015 HD11 ' HB3' ' A' ' 126' ' ' ALA . 1.3 pp 175.6 -158.81 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.258 -0.901 . . . . 0.0 110.489 -179.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.742 HG23 HD22 ' A' ' 89' ' ' LEU . 5.4 t -145.65 167.63 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.415 -0.803 . . . . 0.0 109.299 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.492 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . -178.02 -171.41 41.37 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.168 -1.491 . . . . 0.0 110.444 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.505 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 26.6 tp60 -114.22 102.14 9.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.493 -1.004 . . . . 0.0 110.212 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 0.8 OUTLIER -63.08 95.57 0.08 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.152 -0.968 . . . . 0.0 110.234 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.536 ' C ' ' CE1' ' A' ' 85' ' ' TYR . . . 119.87 130.43 4.0 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.627 ' N ' ' CE1' ' A' ' 85' ' ' TYR . . . -42.99 153.46 0.34 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.294 -1.121 . . . . 0.0 110.196 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.457 ' C ' ' HA ' ' A' ' 83' ' ' ALA . 51.1 Cg_endo -78.09 11.85 16.16 Favored 'Cis proline' 0 C--N 1.312 -1.352 0 C-N-CA 121.648 -2.23 . . . . 0.0 111.066 0.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.627 ' CE1' ' N ' ' A' ' 83' ' ' ALA . 37.1 m-85 61.24 -158.87 0.33 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.098 -1.001 . . . . 0.0 110.197 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 135.9 101.53 0.64 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.8 p -89.84 139.69 30.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.276 -1.131 . . . . 0.0 110.236 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 1.033 HG23 HD12 ' A' ' 89' ' ' LEU . 22.9 m -120.08 -16.77 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.252 -0.905 . . . . 0.0 110.148 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 1.033 HD12 HG23 ' A' ' 88' ' ' VAL . 4.2 mp -118.85 139.59 51.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.296 -0.878 . . . . 0.0 110.978 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -151.12 85.17 1.33 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.425 -0.797 . . . . 0.0 109.969 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.8 p -142.76 -175.59 4.55 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.997 -1.064 . . . . 0.0 110.854 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.53 112.35 35.66 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.444 -0.785 . . . . 0.0 109.905 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.87 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 43.4 Cg_endo -70.77 92.62 0.61 Allowed 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 124.023 1.539 . . . . 0.0 111.109 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.597 ' C ' HD12 ' A' ' 95' ' ' LEU . . . -84.64 129.45 34.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.229 -0.919 . . . . 0.0 109.373 179.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.631 ' HB3' ' HB3' ' A' ' 68' ' ' ALA . 7.5 mp -119.69 -178.53 3.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.046 -1.034 . . . . 0.0 111.083 -179.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -179.99 -178.59 0.43 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.561 -0.712 . . . . 0.0 109.846 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.93 -12.3 17.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.206 -0.934 . . . . 0.0 110.148 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -99.99 158.83 31.34 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.263 -0.898 . . . . 0.0 110.11 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.468 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 44.3 Cg_endo -72.65 140.12 32.11 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.962 1.506 . . . . 0.0 110.348 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.522 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 32.0 ttm-85 -119.91 94.11 4.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.215 -0.928 . . . . 0.0 110.38 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.481 ' HG2' ' OG1' ' A' ' 65' ' ' THR . 17.0 mt-30 -84.98 92.98 8.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.398 -0.813 . . . . 0.0 109.666 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.519 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 38.9 t -89.12 133.6 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.289 -0.882 . . . . 0.0 110.434 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -150.39 130.26 13.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.404 -0.81 . . . . 0.0 110.028 179.96 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -159.19 139.39 12.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.168 -0.957 . . . . 0.0 110.416 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.489 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 88.0 m -94.7 106.65 18.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.305 -0.872 . . . . 0.0 110.123 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.666 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 38.7 p90 -113.24 157.18 22.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.275 -0.891 . . . . 0.0 110.324 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 58' ' ' THR . 26.2 m -89.97 90.17 8.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.292 -0.88 . . . . 0.0 110.016 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.634 ' HB1' HG21 ' A' ' 54' ' ' ILE . . . -45.88 105.44 0.06 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.258 -0.901 . . . . 0.0 110.348 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.473 ' HA ' ' HA2' ' A' ' 57' ' ' GLY . 79.4 p -91.84 51.4 1.83 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.232 -0.917 . . . . 0.0 110.237 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.43 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -159.46 -155.26 0.45 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.259 -0.901 . . . . 0.0 110.242 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 18.7 m -144.91 113.4 6.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.273 -0.892 . . . . 0.0 110.215 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.568 ' CG ' ' HA3' ' A' ' 123' ' ' GLY . 18.0 m-30 -111.2 86.25 6.15 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.288 -0.882 . . . . 0.0 110.101 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.487 ' HD2' ' OE1' ' A' ' 80' ' ' GLN . 44.6 Cg_endo -72.28 140.16 33.33 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.938 1.494 . . . . 0.0 110.333 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.751 ' HB3' ' HB3' ' A' ' 1' ' ' ALA . . . -85.65 55.95 3.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.21 -0.931 . . . . 0.0 110.266 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.454 ' O ' ' O ' ' A' ' 120' ' ' ASP . 90.6 m -134.47 102.55 11.6 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.278 -0.889 . . . . 0.0 110.207 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -81.35 43.04 1.45 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 124.056 1.556 . . . . 0.0 110.749 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.73 ' HB3' ' HB2' ' A' ' 120' ' ' ASP . . . -100.9 157.2 16.91 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.108 -0.995 . . . . 0.0 110.229 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.22 -54.53 45.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.225 -0.922 . . . . 0.0 110.181 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -72.6 -4.23 29.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.274 -0.891 . . . . 0.0 110.191 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.73 ' HB2' ' HB3' ' A' ' 117' ' ' ALA . 4.3 m-20 -137.52 106.49 8.43 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.313 -0.867 . . . . 0.0 110.172 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.478 ' HB3' ' HA3' ' A' ' 82' ' ' GLY . 46.7 Cg_endo -73.4 -167.41 0.36 Allowed 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.061 1.558 . . . . 0.0 110.456 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.483 ' N ' ' CD ' ' A' ' 122' ' ' GLU . 3.2 pm0 -166.83 149.53 6.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.234 -0.916 . . . . 0.0 110.177 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.568 ' HA3' ' CG ' ' A' ' 112' ' ' TYR . . . -89.48 150.55 21.31 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.524 ' O ' HG13 ' A' ' 78' ' ' VAL . 1.2 pp0? -150.31 -157.75 0.85 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.315 -1.109 . . . . 0.0 110.399 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.881 HG21 ' CH2' ' A' ' 16' ' ' TRP . 17.0 mt -118.43 141.55 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.526 -0.734 . . . . 0.0 109.309 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 1.015 ' HB3' HD11 ' A' ' 77' ' ' LEU . . . -117.62 122.8 44.57 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.302 -0.874 . . . . 0.0 111.098 -179.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.479 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 4.1 m-85 -118.73 101.51 8.15 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.597 ' O ' ' CE2' ' A' ' 132' ' ' PHE . 0.4 OUTLIER -89.17 85.41 6.64 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.101 -0.999 . . . . 0.0 112.09 -177.738 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 1.086 HD13 HD13 ' A' ' 139' ' ' LEU . 0.6 OUTLIER -93.38 48.23 1.3 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.325 -0.86 . . . . 0.0 108.887 178.053 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.475 ' HA3' ' HA2' ' A' ' 44' ' ' GLY . . . -108.27 135.63 12.96 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.864 -1.16 . . . . 0.0 110.753 -178.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 130' ' ' GLY . . . 39.14 55.22 2.43 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 179.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.602 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 8.0 m-85 -118.46 -58.02 2.01 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.089 -1.242 . . . . 0.0 110.719 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.999 ' HB2' HG23 ' A' ' 72' ' ' VAL . 1.3 t -88.74 -179.71 6.06 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.921 -1.112 . . . . 0.0 110.283 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -100.69 -74.25 0.62 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.245 -0.909 . . . . 0.0 110.249 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -72.65 174.42 7.6 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.209 -0.932 . . . . 0.0 110.07 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.528 ' CA ' ' HA ' ' A' ' 38' ' ' ALA . . . -70.38 127.94 34.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.274 -0.891 . . . . 0.0 110.286 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.995 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 6.1 p90 -132.27 -161.97 1.19 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.267 -0.895 . . . . 0.0 110.138 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.527 ' OG1' ' HA ' ' A' ' 35' ' ' ALA . 0.8 OUTLIER -160.26 166.18 30.04 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.138 -1.025 . . . . 0.0 110.57 -177.775 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 1.086 HD13 HD13 ' A' ' 129' ' ' LEU . 2.2 mp -124.15 127.51 47.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.461 -0.775 . . . . 0.0 109.282 179.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' CYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 52.9 m -125.27 95.75 4.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.072 -1.017 . . . . 0.0 110.9 -179.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.764 HD12 HD23 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -89.86 -177.69 5.29 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.21 -0.931 . . . . 0.0 109.218 179.033 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.631 ' O ' HG22 ' A' ' 8' ' ' THR . 0.6 OUTLIER 169.37 48.15 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.252 -0.905 . . . . 0.0 110.235 -179.96 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.492 ' HA ' ' O ' ' A' ' 7' ' ' GLY . 11.3 t0 177.05 46.3 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.441 -0.787 . . . . 0.0 109.148 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.663 HG11 ' HZ2' ' A' ' 16' ' ' TRP . 1.0 OUTLIER -89.21 124.74 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.478 -0.764 . . . . 0.0 110.305 -178.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -158.52 152.71 24.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.386 -0.821 . . . . 0.0 110.075 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.519 HD12 ' O ' ' A' ' 61' ' ' THR . 23.1 tp -149.93 153.36 36.5 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.267 -0.895 . . . . 0.0 110.218 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.456 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 34.0 t70 -176.5 152.56 1.07 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.241 -0.912 . . . . 0.0 110.273 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 59' ' ' THR . 78.7 p -91.67 130.98 37.38 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.268 -0.895 . . . . 0.0 110.205 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.7 141.34 56.95 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.202 -0.936 . . . . 0.0 110.186 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.687 HG23 ' O ' ' A' ' 150' ' ' VAL . 20.2 m -111.37 67.57 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.231 -0.918 . . . . 0.0 110.207 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 52.15 -165.16 0.06 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.275 -0.891 . . . . 0.0 110.153 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.8 mp . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.25 -180.0 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.458 ' O ' ' HD3' ' A' ' 3' ' ' PRO . . . . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.179 0.514 . . . . 0.0 110.207 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.563 ' CB ' ' HA ' ' A' ' 52' ' ' VAL . 58.2 p -109.27 74.86 0.67 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.211 -0.93 . . . . 0.0 110.312 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.458 ' HD3' ' O ' ' A' ' 1' ' ' ALA . 46.2 Cg_endo -73.44 78.59 2.31 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.952 1.501 . . . . 0.0 110.486 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.579 ' HB ' HD21 ' A' ' 49' ' ' LEU . 6.4 pt -107.71 31.0 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -0.901 . . . . 0.0 110.068 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.436 ' O ' ' HB3' ' A' ' 6' ' ' GLU . . . 81.08 -169.52 51.88 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' A' ' 144' ' ' VAL . 9.0 pt-20 176.29 65.54 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.102 -1.234 . . . . 0.0 110.358 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.595 ' C ' HG23 ' A' ' 8' ' ' THR . . . 164.52 -64.55 0.23 Allowed Glycine 0 N--CA 1.488 2.164 0 C-N-CA 119.689 -1.243 . . . . 0.0 110.002 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.595 HG23 ' C ' ' A' ' 7' ' ' GLY . 73.6 p -156.41 -154.44 0.48 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.216 -1.167 . . . . 0.0 110.302 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.602 ' HZ ' HG21 ' A' ' 144' ' ' VAL . 33.0 m-85 -135.29 42.58 2.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -0.874 . . . . 0.0 110.263 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.55 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 26.7 t0 -88.14 49.01 1.72 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.202 -0.936 . . . . 0.0 110.247 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.55 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.5 OUTLIER 161.66 80.43 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.675 -0.641 . . . . 0.0 109.735 -179.963 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 11' ' ' ASP . . . 62.83 127.3 0.01 OUTLIER Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.52 ' O ' ' N ' ' A' ' 15' ' ' GLY . 50.2 Cg_endo -80.89 42.09 1.27 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 O-C-N 123.839 1.442 . . . . 0.0 110.987 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.441 ' HA ' ' OE1' ' A' ' 14' ' ' GLU . 4.7 mm-40 46.72 -92.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.003 -1.061 . . . . 0.0 110.288 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.705 ' O ' HG13 ' A' ' 17' ' ' VAL . . . -140.61 -0.06 1.85 Allowed Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.818 -1.182 . . . . 0.0 110.469 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.954 ' CH2' HG21 ' A' ' 125' ' ' ILE . 46.6 m95 -53.54 88.63 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.004 -1.292 . . . . 0.0 110.402 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.747 ' O ' HG13 ' A' ' 47' ' ' VAL . 1.0 OUTLIER -87.81 150.67 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.035 -1.04 . . . . 0.0 109.627 179.558 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.721 ' CB ' HG12 ' A' ' 34' ' ' VAL . . . -131.29 158.38 40.79 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.174 -0.954 . . . . 0.0 109.831 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.639 ' CD1' ' N ' ' A' ' 19' ' ' TYR . 3.5 p90 -150.5 166.21 30.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.31 -0.869 . . . . 0.0 110.5 -178.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.516 ' C ' ' CG2' ' A' ' 21' ' ' THR . . . 161.04 -96.78 0.15 Allowed Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.014 -1.634 . . . . 0.0 109.014 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.516 ' CG2' ' C ' ' A' ' 20' ' ' GLY . 6.5 p -153.91 18.39 0.51 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.115 -1.227 . . . . 0.0 111.224 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.699 ' CB ' ' HB1' ' A' ' 35' ' ' ALA . 0.8 OUTLIER -137.36 -179.95 6.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.664 -1.272 . . . . 0.0 110.607 179.743 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 22' ' ' ASP . . . -42.22 164.59 0.02 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 25' ' ' LEU . 45.5 Cg_endo -72.48 160.87 45.71 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.102 1.58 . . . . 0.0 110.409 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.719 HD23 ' H ' ' A' ' 25' ' ' LEU . 0.7 OUTLIER -41.8 151.2 0.09 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.306 -0.871 . . . . 0.0 110.394 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.508 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 79.7 m-20 -124.43 137.11 54.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.317 -0.864 . . . . 0.0 109.829 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.537 ' O ' ' N ' ' A' ' 29' ' ' THR . 0.8 OUTLIER -119.95 -26.76 5.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.099 -1.001 . . . . 0.0 110.55 -179.705 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.684 ' C ' HG22 ' A' ' 29' ' ' THR . 12.0 m -49.75 82.96 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.788 -0.57 . . . . 0.0 111.248 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.684 HG22 ' C ' ' A' ' 28' ' ' SER . 0.0 OUTLIER 166.62 -31.77 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.229 -0.919 . . . . 0.0 109.948 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 128.37 0.32 6.32 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 27' ' ' THR . . . -150.46 161.17 43.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.137 -1.214 . . . . 0.0 110.214 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.544 HD23 ' O ' ' A' ' 32' ' ' LEU . 0.3 OUTLIER -104.08 99.37 9.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.178 -0.951 . . . . 0.0 110.134 179.911 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.585 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 0.8 OUTLIER -96.09 117.0 29.84 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.197 -0.94 . . . . 0.0 111.61 -179.773 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.721 HG12 ' CB ' ' A' ' 18' ' ' ALA . 30.2 m -89.43 149.97 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.699 ' HB1' ' CB ' ' A' ' 22' ' ' ASP . . . -89.83 126.32 35.65 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.016 -1.052 . . . . 0.0 111.529 -178.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.038 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 48.7 t -126.73 119.63 22.78 Favored Pre-proline 0 C--N 1.303 -1.455 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.496 ' HG2' ' HA ' ' A' ' 40' ' ' SER . 39.7 Cg_endo -66.23 -177.74 0.93 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.753 1.397 . . . . 0.0 111.324 -179.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.536 ' HA ' ' N ' ' A' ' 136' ' ' ALA . . . -56.14 126.66 27.05 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.436 -0.79 . . . . 0.0 111.157 -179.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.501 ' O ' ' C ' ' A' ' 40' ' ' SER . . . 40.33 28.05 0.17 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.948 ' OG ' HG23 ' A' ' 45' ' ' VAL . 15.0 t 31.68 60.01 0.3 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.819 -0.812 . . . . 0.0 110.593 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.478 ' O ' ' HB3' ' A' ' 42' ' ' GLN . . . -88.72 95.21 10.18 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.278 -0.889 . . . . 0.0 109.864 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.807 ' NE2' HG22 ' A' ' 45' ' ' VAL . 2.0 pt20 179.83 -150.27 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 121.308 0.575 . . . . 0.0 109.822 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.531 ' CD1' ' HG3' ' A' ' 42' ' ' GLN . 16.0 p90 -61.41 -12.72 15.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.331 -0.856 . . . . 0.0 109.898 179.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.417 ' O ' ' CE2' ' A' ' 43' ' ' TYR . . . 109.75 129.14 5.69 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.948 HG23 ' OG ' ' A' ' 40' ' ' SER . 9.4 t -89.29 170.45 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.173 -1.193 . . . . 0.0 108.572 179.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.519 ' CA ' ' O ' ' A' ' 127' ' ' PHE . . . 169.76 -174.02 43.97 Favored Glycine 0 N--CA 1.487 2.052 0 C-N-CA 118.997 -1.573 . . . . 0.0 110.559 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.747 HG13 ' O ' ' A' ' 17' ' ' VAL . 41.4 t -150.39 129.08 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.602 -0.94 . . . . 0.0 108.781 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.642 ' O ' HG22 ' A' ' 17' ' ' VAL . 32.9 m -119.97 135.68 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.081 -1.012 . . . . 0.0 110.987 -179.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.846 HD22 ' NE1' ' A' ' 16' ' ' TRP . 21.3 tp -128.67 96.71 4.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.393 -0.817 . . . . 0.0 110.24 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.512 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 12.9 p30 -75.13 134.94 41.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.909 . . . . 0.0 110.186 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 136.38 76.85 0.08 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.563 ' HA ' ' CB ' ' A' ' 2' ' ' SER . 18.1 t -139.37 167.26 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -1.173 . . . . 0.0 110.023 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.413 ' N ' HG12 ' A' ' 52' ' ' VAL . . . -137.75 83.82 2.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.195 -0.941 . . . . 0.0 110.488 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.732 HG21 ' HB1' ' A' ' 108' ' ' ALA . 43.2 mm -115.92 158.78 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.227 -0.92 . . . . 0.0 109.918 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.493 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 7.9 tp10 -151.78 134.34 15.43 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.208 -0.933 . . . . 0.0 110.366 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.565 ' CG ' ' N ' ' A' ' 57' ' ' GLY . 1.1 pt-20 37.03 -157.01 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.698 -0.626 . . . . 0.0 110.73 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.565 ' N ' ' CG ' ' A' ' 56' ' ' GLU . . . -84.04 90.68 1.61 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.633 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.2 m -118.73 173.86 6.62 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.306 -1.114 . . . . 0.0 109.79 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.572 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 0.6 OUTLIER -89.82 153.85 20.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.268 -0.895 . . . . 0.0 110.494 -179.758 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.633 ' CE2' HG22 ' A' ' 58' ' ' THR . 59.2 m-85 -159.88 121.79 3.29 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.271 -0.893 . . . . 0.0 110.218 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 89.2 m -90.87 114.74 27.25 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.213 -0.929 . . . . 0.0 109.983 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.0 tp -89.55 120.85 31.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.209 -0.932 . . . . 0.0 109.945 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.522 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 12.7 ttp180 -125.59 130.17 51.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.309 -0.87 . . . . 0.0 110.227 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 1.122 ' CZ ' HG21 ' A' ' 102' ' ' VAL . 0.8 OUTLIER -170.33 142.98 2.26 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.294 -0.879 . . . . 0.0 109.821 179.756 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.496 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 16.9 m -119.16 97.63 5.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.289 -0.882 . . . . 0.0 110.079 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.697 ' CB ' HD21 ' A' ' 95' ' ' LEU . . . -98.98 149.38 23.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.382 -0.824 . . . . 0.0 110.328 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.749 HG23 ' O ' ' A' ' 98' ' ' GLU . 90.3 m -150.52 102.22 3.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -0.884 . . . . 0.0 110.198 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.47 ' O ' ' O ' ' A' ' 96' ' ' THR . . . -89.82 131.24 35.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.233 -0.917 . . . . 0.0 109.977 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.45 ' C ' ' O ' ' A' ' 68' ' ' ALA . 1.2 p -42.72 -27.17 0.16 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.298 -0.876 . . . . 0.0 109.522 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.599 ' CG2' ' CB ' ' A' ' 137' ' ' TRP . 1.7 t -109.87 161.34 15.56 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.559 -0.713 . . . . 0.0 109.836 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.19 76.69 6.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.056 -1.027 . . . . 0.0 109.25 179.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.791 HG23 ' CB ' ' A' ' 133' ' ' SER . 4.3 p -99.75 135.62 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.27 -0.894 . . . . 0.0 111.292 -178.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 89.6 m -121.09 87.13 2.7 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 1.113 HG21 HD23 ' A' ' 129' ' ' LEU . 5.1 m -89.7 -149.18 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.246 -0.909 . . . . 0.0 110.764 -178.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.482 ' N ' HG23 ' A' ' 74' ' ' VAL . 0.3 OUTLIER -128.43 121.32 28.73 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.262 -0.898 . . . . 0.0 110.656 -179.479 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.508 ' N ' ' HD3' ' A' ' 93' ' ' PRO . . . -119.03 161.36 20.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.217 -0.927 . . . . 0.0 109.643 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.75 ' CD1' ' HB3' ' A' ' 126' ' ' ALA . 3.5 pp 177.15 -158.83 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.128 -0.982 . . . . 0.0 110.463 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.898 HG23 HD22 ' A' ' 89' ' ' LEU . 19.5 t -149.54 165.0 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.433 -0.792 . . . . 0.0 109.266 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.542 ' C ' ' CE1' ' A' ' 112' ' ' TYR . . . -172.81 -166.75 31.79 Favored Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.056 -1.545 . . . . 0.0 110.587 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.54 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 4.7 tp60 -114.34 85.93 2.33 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.508 -0.995 . . . . 0.0 110.391 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 2.1 m-80 -66.0 100.13 0.56 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.066 -1.022 . . . . 0.0 109.308 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.636 ' O ' ' HB2' ' A' ' 83' ' ' ALA . . . 152.0 -87.67 0.14 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.636 ' HB2' ' O ' ' A' ' 82' ' ' GLY . . . 173.24 145.68 0.19 Allowed Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.189 -1.183 . . . . 0.0 110.192 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.511 ' C ' ' CD2' ' A' ' 85' ' ' TYR . 51.0 Cg_endo -84.56 32.8 4.41 Favored 'Cis proline' 0 C--N 1.313 -1.314 0 C-N-CA 121.9 -2.125 . . . . 0.0 110.663 -0.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.575 ' CZ ' ' O ' ' A' ' 82' ' ' GLY . 17.6 m-85 64.47 -172.67 0.18 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.165 -0.959 . . . . 0.0 110.402 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 140.03 99.38 0.41 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.483 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 1.4 p -89.8 143.59 26.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.25 -1.147 . . . . 0.0 110.367 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 1.037 HG23 HD12 ' A' ' 89' ' ' LEU . 27.0 m -123.93 -16.95 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.313 -0.867 . . . . 0.0 110.332 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 1.037 HD12 HG23 ' A' ' 88' ' ' VAL . 4.1 mp -105.36 139.87 39.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.204 -0.935 . . . . 0.0 110.924 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.733 ' O ' HG23 ' A' ' 91' ' ' THR . 1.6 m-20 -150.68 94.29 2.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.379 -0.826 . . . . 0.0 110.194 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.733 HG23 ' O ' ' A' ' 90' ' ' ASP . 3.9 p -160.07 -175.09 4.88 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.162 -0.962 . . . . 0.0 110.44 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.4 p -125.35 128.87 24.63 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.285 -0.885 . . . . 0.0 110.143 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.79 ' HG2' HG22 ' A' ' 74' ' ' VAL . 50.2 Cg_endo -74.14 77.02 2.89 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.883 1.465 . . . . 0.0 110.983 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.683 ' HB3' ' NH1' ' A' ' 100' ' ' ARG . . . -50.47 136.45 20.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.996 -1.065 . . . . 0.0 109.348 179.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.814 ' CD1' HD21 ' A' ' 139' ' ' LEU . 35.4 mt -135.63 168.12 19.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.991 -1.068 . . . . 0.0 110.891 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.762 HG23 ' H ' ' A' ' 98' ' ' GLU . 6.7 t -165.8 -153.18 0.17 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.444 -0.785 . . . . 0.0 109.914 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.529 ' N ' HG23 ' A' ' 96' ' ' THR . 0.1 OUTLIER -85.94 -28.19 24.45 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.103 -0.998 . . . . 0.0 110.391 -179.816 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.762 ' H ' HG23 ' A' ' 96' ' ' THR . 0.6 OUTLIER -89.77 176.5 3.04 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.238 -0.914 . . . . 0.0 110.06 179.974 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.507 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 45.4 Cg_endo -72.09 134.03 22.48 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 123.979 1.515 . . . . 0.0 110.327 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.683 ' NH1' ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.53 84.03 2.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.18 -0.95 . . . . 0.0 110.22 -179.87 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.455 ' HG2' ' OG1' ' A' ' 65' ' ' THR . 17.6 mt-30 -69.02 155.98 39.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.32 -0.862 . . . . 0.0 110.124 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 1.122 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 58.6 t -133.43 133.71 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.25 -0.906 . . . . 0.0 110.111 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.33 111.51 4.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.25 -0.906 . . . . 0.0 110.109 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -153.59 151.59 29.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.159 -0.963 . . . . 0.0 110.356 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -108.39 122.09 46.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.283 -0.886 . . . . 0.0 110.063 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.858 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 41.4 p90 -127.93 153.32 46.82 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.236 -0.915 . . . . 0.0 110.299 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 58' ' ' THR . 3.6 m -89.93 94.24 9.73 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.276 -0.89 . . . . 0.0 110.063 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.732 ' HB1' HG21 ' A' ' 54' ' ' ILE . . . -53.64 99.42 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.244 -0.91 . . . . 0.0 110.309 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.524 ' N ' ' CG1' ' A' ' 88' ' ' VAL . 54.3 p -85.93 55.66 3.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.18 -0.95 . . . . 0.0 109.945 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -160.29 -151.31 0.24 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.315 -0.866 . . . . 0.0 110.298 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.432 HG23 ' HA ' ' A' ' 55' ' ' GLU . 46.2 m -158.14 116.42 3.05 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.323 -0.861 . . . . 0.0 110.414 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.652 ' CE2' HG12 ' A' ' 78' ' ' VAL . 12.7 m-30 -112.22 109.87 53.97 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.302 -0.874 . . . . 0.0 109.784 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.516 ' HD2' ' OE1' ' A' ' 80' ' ' GLN . 47.7 Cg_endo -75.48 96.2 1.03 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.849 1.447 . . . . 0.0 110.539 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -46.75 -24.06 0.51 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.245 -0.91 . . . . 0.0 110.127 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 58.5 p -98.38 117.91 64.11 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.279 -0.888 . . . . 0.0 110.183 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.4 ' N ' ' OE1' ' A' ' 122' ' ' GLU . 45.7 Cg_endo -72.97 -161.59 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.9 1.474 . . . . 0.0 110.413 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.417 ' HB3' ' HB2' ' A' ' 120' ' ' ASP . . . -147.88 -172.29 4.02 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.255 -0.903 . . . . 0.0 110.211 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -82.24 -9.36 59.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.26 -0.9 . . . . 0.0 110.188 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -155.02 18.82 0.44 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.282 -0.886 . . . . 0.0 110.137 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.449 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 6.7 m-20 -147.78 132.86 9.08 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.315 -0.866 . . . . 0.0 110.137 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.542 ' HG2' ' CA ' ' A' ' 82' ' ' GLY . 42.2 Cg_endo -85.82 -154.76 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.928 1.488 . . . . 0.0 110.258 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.487 ' O ' ' HB2' ' A' ' 81' ' ' ASN . 5.0 pt-20 -149.21 -156.35 0.71 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.987 -1.07 . . . . 0.0 110.357 -179.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.582 ' HA3' ' CG ' ' A' ' 112' ' ' TYR . . . -90.59 148.09 19.38 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.592 ' O ' HG13 ' A' ' 78' ' ' VAL . 3.3 pt20 -150.31 -155.66 0.65 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.289 -1.124 . . . . 0.0 110.491 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.954 HG21 ' CH2' ' A' ' 16' ' ' TRP . 7.6 mt -118.22 141.26 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.538 -0.726 . . . . 0.0 109.256 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.75 ' HB3' ' CD1' ' A' ' 77' ' ' LEU . . . -117.6 121.75 41.77 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.36 -0.837 . . . . 0.0 111.291 -179.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.519 ' O ' ' CA ' ' A' ' 46' ' ' GLY . 4.4 m-85 -118.99 91.2 3.5 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 178.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -88.57 93.92 9.71 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.944 -1.097 . . . . 0.0 112.449 -177.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 1.113 HD23 HG21 ' A' ' 74' ' ' VAL . 12.9 mt -90.87 44.16 1.18 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 177.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 131' ' ' GLY . . . -82.29 115.54 4.04 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 -179.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.482 ' HA2' ' O ' ' A' ' 39' ' ' GLY . . . 40.36 93.1 0.01 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.586 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 8.9 m-85 -143.55 -52.59 0.35 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.099 -1.236 . . . . 0.0 110.704 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.791 ' CB ' HG23 ' A' ' 72' ' ' VAL . 1.3 t -89.26 175.3 7.4 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.973 -1.079 . . . . 0.0 110.399 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -80.93 -88.13 0.08 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.257 -0.902 . . . . 0.0 110.033 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 135' ' ' ASP . 3.9 m-20 -67.27 -173.41 0.28 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -0.909 . . . . 0.0 109.774 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.536 ' N ' ' HA ' ' A' ' 38' ' ' ALA . . . -78.94 149.33 32.37 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.229 -0.919 . . . . 0.0 110.248 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 1.038 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 15.1 p90 -151.8 -160.0 1.09 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.152 -0.967 . . . . 0.0 111.162 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.544 ' C ' HD12 ' A' ' 139' ' ' LEU . 0.8 OUTLIER -159.65 178.53 9.74 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -178.596 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.814 HD21 ' CD1' ' A' ' 95' ' ' LEU . 1.7 mp -139.91 115.54 10.09 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.766 -1.209 . . . . 0.0 112.082 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' CYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 0.8 OUTLIER -103.34 104.35 14.45 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.727 -0.608 . . . . 0.0 110.662 178.492 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.535 HD23 ' HB2' ' A' ' 66' ' ' ALA . 1.4 mt -90.22 -178.67 5.45 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.217 -0.927 . . . . 0.0 109.305 179.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.545 ' O ' ' CB ' ' A' ' 143' ' ' ASP . 2.3 p30 166.9 68.24 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.263 -0.898 . . . . 0.0 110.172 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.545 ' CB ' ' O ' ' A' ' 142' ' ' ASP . 0.4 OUTLIER 161.89 42.79 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.879 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.64 HG11 ' CZ2' ' A' ' 16' ' ' TRP . 1.5 t -89.4 115.93 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.418 -0.801 . . . . 0.0 110.684 -178.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.428 ' HB2' ' HA ' ' A' ' 6' ' ' GLU . . . -148.26 139.84 23.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.463 -0.773 . . . . 0.0 109.912 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.579 HD21 HD11 ' A' ' 54' ' ' ILE . 28.6 tp -129.93 152.7 49.12 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.305 -0.872 . . . . 0.0 110.332 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.464 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -161.83 -175.78 4.87 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.248 -0.907 . . . . 0.0 110.149 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.429 ' O ' ' OG ' ' A' ' 148' ' ' SER . 9.3 p -128.48 108.39 10.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.2 -0.937 . . . . 0.0 110.174 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.445 ' OE1' ' HB2' ' A' ' 151' ' ' GLU . 0.2 OUTLIER -93.3 165.43 12.8 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.292 -0.88 . . . . 0.0 110.173 179.94 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.759 HG13 ' O ' ' A' ' 150' ' ' VAL . 13.9 p -125.62 81.3 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.215 -0.928 . . . . 0.0 110.254 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.445 ' HB2' ' OE1' ' A' ' 149' ' ' GLU . 2.2 tt0 -112.1 135.07 53.22 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.265 -0.897 . . . . 0.0 110.165 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 117.969 -1.015 . . . . 0.0 110.184 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.449 ' C ' ' HD3' ' A' ' 3' ' ' PRO . . . . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.172 0.51 . . . . 0.0 110.195 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.511 ' OG ' ' HA ' ' A' ' 52' ' ' VAL . 0.5 OUTLIER -111.53 74.0 1.14 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.287 -0.883 . . . . 0.0 110.164 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.449 ' HD3' ' C ' ' A' ' 1' ' ' ALA . 47.2 Cg_endo -73.9 77.8 2.63 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.025 1.539 . . . . 0.0 110.616 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.517 ' CD1' HG12 ' A' ' 144' ' ' VAL . 32.7 pt -107.36 40.41 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.183 -0.948 . . . . 0.0 109.979 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' A' ' 7' ' ' GLY . . . 103.78 -45.48 1.32 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.454 ' HA ' ' HB2' ' A' ' 145' ' ' ALA . 44.4 mt-10 41.67 28.08 0.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.354 -1.086 . . . . 0.0 110.306 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' A' ' 143' ' ' ASP . . . -158.85 -166.28 17.58 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 34.0 p -72.59 165.81 23.96 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.307 -1.113 . . . . 0.0 110.377 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.603 ' CZ ' HG21 ' A' ' 144' ' ' VAL . 3.1 m-30 -93.7 56.57 2.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.336 -0.852 . . . . 0.0 110.135 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.537 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 16.0 t0 -114.39 52.35 0.84 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.183 -0.948 . . . . 0.0 110.202 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.537 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 2.2 t70 161.76 78.14 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.753 -0.592 . . . . 0.0 109.657 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.02 133.51 0.33 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.611 ' HB3' HD12 ' A' ' 32' ' ' LEU . 50.2 Cg_endo -77.3 5.82 4.81 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.943 1.496 . . . . 0.0 110.635 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 0.8 OUTLIER 66.44 -85.72 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.158 -0.964 . . . . 0.0 110.184 -179.853 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.781 ' C ' HD13 ' A' ' 49' ' ' LEU . . . -142.71 8.3 2.26 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.857 ' CD1' HD22 ' A' ' 49' ' ' LEU . 45.9 m95 -72.92 93.03 1.68 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.127 -1.22 . . . . 0.0 110.343 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.821 ' O ' HG13 ' A' ' 47' ' ' VAL . 1.5 m -95.49 152.23 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.148 -0.97 . . . . 0.0 109.895 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.759 ' CB ' HG11 ' A' ' 34' ' ' VAL . . . -129.96 127.54 40.27 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.164 -0.96 . . . . 0.0 109.725 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.585 ' HE2' HG13 ' A' ' 48' ' ' VAL . 10.9 p90 -121.17 158.34 28.19 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.291 -0.881 . . . . 0.0 110.739 -178.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.516 ' CA ' ' OH ' ' A' ' 43' ' ' TYR . . . 90.57 35.01 7.55 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 179.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.5 ' CG2' ' C ' ' A' ' 20' ' ' GLY . 5.4 p -150.89 -154.94 0.58 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.98 -1.306 . . . . 0.0 110.499 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.46 ' O ' ' O ' ' A' ' 23' ' ' GLY . 8.2 t0 -94.87 132.01 40.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.353 -0.842 . . . . 0.0 110.363 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 22' ' ' ASP . . . 44.41 -168.1 0.02 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.58 -159.85 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.062 1.559 . . . . 0.0 110.484 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.933 HD13 HD11 ' A' ' 32' ' ' LEU . 0.4 OUTLIER -101.21 161.39 13.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.258 -0.901 . . . . 0.0 110.222 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -116.86 140.04 49.91 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.205 -0.935 . . . . 0.0 110.008 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.509 ' HA ' ' O ' ' A' ' 31' ' ' ALA . 0.7 OUTLIER -128.24 -22.69 3.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.144 -0.973 . . . . 0.0 111.212 -179.55 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.2 -17.87 0.28 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.26 -0.9 . . . . 0.0 111.173 -179.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.544 HG23 ' H ' ' A' ' 31' ' ' ALA . 2.6 t -72.1 6.37 2.21 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.049 -1.032 . . . . 0.0 111.519 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.55 -12.28 67.81 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.644 ' HB3' ' SG ' ' A' ' 140' ' ' CYS . . . -150.97 167.99 25.92 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.481 -1.011 . . . . 0.0 109.503 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.933 HD11 HD13 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -87.04 90.92 8.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.967 -1.083 . . . . 0.0 110.163 179.906 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.555 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 0.8 OUTLIER -99.45 111.78 24.09 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.387 -0.821 . . . . 0.0 111.507 179.987 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.759 HG11 ' CB ' ' A' ' 18' ' ' ALA . 15.7 m -89.86 146.11 6.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.496 ' O ' ' HB ' ' A' ' 21' ' ' THR . . . -88.55 72.44 8.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.541 -0.725 . . . . 0.0 110.982 -178.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.095 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 56.3 t -58.66 134.07 86.15 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.322 -0.861 . . . . 0.0 109.564 179.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.487 ' HG2' ' HA ' ' A' ' 40' ' ' SER . 39.5 Cg_endo -67.48 176.47 4.88 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.951 1.501 . . . . 0.0 111.501 -179.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.511 ' HA ' ' N ' ' A' ' 136' ' ' ALA . . . -60.9 126.23 26.6 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.509 -0.744 . . . . 0.0 111.463 -178.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.534 ' O ' ' C ' ' A' ' 40' ' ' SER . . . 39.0 26.83 0.05 OUTLIER Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.901 ' OG ' HG23 ' A' ' 45' ' ' VAL . 9.6 t 27.08 59.21 0.09 Allowed 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.886 -0.773 . . . . 0.0 110.9 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.485 ' O ' ' HB3' ' A' ' 42' ' ' GLN . . . -88.36 100.8 13.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.231 -0.918 . . . . 0.0 110.201 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.485 ' HB3' ' O ' ' A' ' 41' ' ' ALA . 0.9 OUTLIER 174.41 -158.78 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.912 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.516 ' OH ' ' CA ' ' A' ' 20' ' ' GLY . 8.9 p90 -50.32 -24.0 2.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.096 -1.002 . . . . 0.0 109.726 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.516 ' O ' ' CE2' ' A' ' 43' ' ' TYR . . . 119.82 129.29 3.82 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.901 HG23 ' OG ' ' A' ' 40' ' ' SER . 6.2 t -89.58 177.05 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.265 -1.138 . . . . 0.0 109.001 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.57 ' O ' ' CZ ' ' A' ' 19' ' ' TYR . . . 166.15 149.32 5.88 Favored Glycine 0 N--CA 1.488 2.153 0 C-N-CA 119.166 -1.492 . . . . 0.0 110.552 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.821 HG13 ' O ' ' A' ' 17' ' ' VAL . 43.8 t -116.24 144.18 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.552 -0.969 . . . . 0.0 109.449 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.585 HG13 ' HE2' ' A' ' 19' ' ' TYR . 29.0 m -138.56 153.96 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.834 -1.166 . . . . 0.0 111.004 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.857 HD22 ' CD1' ' A' ' 16' ' ' TRP . 14.8 tp -140.89 99.66 3.65 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.446 -0.784 . . . . 0.0 109.929 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.513 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 8.6 t30 -78.11 133.34 37.87 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.248 -0.907 . . . . 0.0 110.542 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 139.34 55.32 0.05 OUTLIER Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.639 HG11 ' HD2' ' A' ' 112' ' ' TYR . 53.3 t -120.04 161.11 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.092 -1.24 . . . . 0.0 110.278 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 112' ' ' TYR . . . -130.83 96.8 4.16 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.186 -0.946 . . . . 0.0 110.65 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.758 HG21 ' HB1' ' A' ' 108' ' ' ALA . 50.6 mm -131.65 160.51 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.268 -0.895 . . . . 0.0 109.786 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.528 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 13.2 pt-20 -149.02 130.58 14.88 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.087 -1.008 . . . . 0.0 110.432 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.528 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 10.8 pt-20 38.14 -152.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.646 -0.659 . . . . 0.0 110.85 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.467 ' HA2' ' HA ' ' A' ' 109' ' ' SER . . . -85.28 108.43 3.2 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.671 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.1 m -136.75 174.63 10.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.238 -1.154 . . . . 0.0 109.714 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.574 ' N ' ' CG2' ' A' ' 58' ' ' THR . 0.5 OUTLIER -89.83 145.44 25.16 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.256 -0.903 . . . . 0.0 110.261 -179.922 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.819 ' HB3' HD11 ' A' ' 146' ' ' LEU . 58.5 m-85 -154.41 154.67 33.64 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.313 -0.867 . . . . 0.0 110.271 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 85.3 m -124.1 114.0 19.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.354 -0.841 . . . . 0.0 110.066 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.536 HD22 ' CD2' ' A' ' 89' ' ' LEU . 18.2 tp -89.69 121.81 32.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -0.914 . . . . 0.0 110.105 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.569 ' HD3' HG23 ' A' ' 103' ' ' THR . 8.1 mtt85 -127.33 138.25 52.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.318 -0.864 . . . . 0.0 110.287 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 1.163 ' CZ ' HG21 ' A' ' 102' ' ' VAL . 2.8 p90 -177.92 152.69 0.77 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.395 -0.816 . . . . 0.0 109.796 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.812 HG23 ' HG2' ' A' ' 101' ' ' GLN . 0.2 OUTLIER -119.28 102.8 8.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.121 -0.987 . . . . 0.0 110.105 -179.947 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.697 ' CB ' HD21 ' A' ' 95' ' ' LEU . . . -102.3 141.66 34.78 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.308 -0.87 . . . . 0.0 110.05 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.618 HG23 ' O ' ' A' ' 98' ' ' GLU . 35.0 m -150.14 107.41 3.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.294 -0.879 . . . . 0.0 110.18 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.518 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -98.3 131.68 44.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.281 -0.887 . . . . 0.0 110.169 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 68' ' ' ALA . 0.9 OUTLIER -44.47 -26.23 0.33 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.188 -0.945 . . . . 0.0 109.467 179.528 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.581 ' CG2' ' CB ' ' A' ' 137' ' ' TRP . 1.9 t -110.28 165.27 11.9 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.453 -0.78 . . . . 0.0 109.856 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.489 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 4.8 t0 -84.15 68.97 10.31 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.146 -0.971 . . . . 0.0 109.321 179.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.67 HG23 ' CB ' ' A' ' 133' ' ' SER . 6.1 p -86.89 134.36 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.327 -0.858 . . . . 0.0 111.248 -179.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 23.3 m -120.58 85.26 2.36 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.775 HG22 ' HG2' ' A' ' 93' ' ' PRO . 3.0 m -89.63 -157.95 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.25 -0.906 . . . . 0.0 110.72 -178.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.462 ' N ' HG23 ' A' ' 74' ' ' VAL . 0.4 OUTLIER -120.23 104.06 9.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.357 -0.839 . . . . 0.0 110.278 -179.629 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.67 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -99.9 163.75 12.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.21 -0.931 . . . . 0.0 109.851 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.076 ' CD1' ' HB3' ' A' ' 126' ' ' ALA . 2.0 pp 173.32 -161.1 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.285 -0.884 . . . . 0.0 110.132 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.906 ' CG2' HD22 ' A' ' 89' ' ' LEU . 3.6 t -146.31 168.91 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.275 -0.89 . . . . 0.0 109.58 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.54 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . 175.09 -160.45 29.3 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.416 -1.373 . . . . 0.0 109.934 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.535 ' HG3' ' HA ' ' A' ' 85' ' ' TYR . 4.7 pt20 -125.08 137.12 54.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.275 -1.132 . . . . 0.0 110.642 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -86.62 93.82 9.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.366 -0.834 . . . . 0.0 109.964 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.58 ' O ' ' CD2' ' A' ' 85' ' ' TYR . . . 148.18 -177.39 26.46 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.271 -1.531 . . . . 0.0 109.271 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.542 ' HA ' ' CD1' ' A' ' 85' ' ' TYR . . . -99.61 152.18 37.71 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.275 -1.133 . . . . 0.0 110.231 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.468 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.7 Cg_endo -83.02 30.09 4.69 Favored 'Cis proline' 0 C--N 1.312 -1.349 0 C-N-CA 121.795 -2.169 . . . . 0.0 111.021 -0.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.58 ' CD2' ' O ' ' A' ' 82' ' ' GLY . 57.2 m-85 60.37 -175.6 0.11 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.138 -0.976 . . . . 0.0 110.26 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.468 ' O ' ' HG2' ' A' ' 80' ' ' GLN . . . 161.95 126.67 0.83 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.0 p -120.16 146.2 46.22 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.21 -1.17 . . . . 0.0 110.099 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 1.061 HG23 HD12 ' A' ' 89' ' ' LEU . 28.9 m -125.65 -16.41 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.259 -0.901 . . . . 0.0 110.559 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 1.061 HD12 HG23 ' A' ' 88' ' ' VAL . 4.3 mp -110.88 140.93 44.93 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.118 -0.989 . . . . 0.0 111.18 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.693 ' O ' HG23 ' A' ' 91' ' ' THR . 38.9 p30 -150.9 93.4 1.94 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.411 -0.806 . . . . 0.0 110.161 179.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.693 HG23 ' O ' ' A' ' 90' ' ' ASP . 16.3 p -159.02 -175.96 5.58 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.026 -1.046 . . . . 0.0 110.67 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.476 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 29.0 m -120.0 135.04 24.07 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.312 -0.868 . . . . 0.0 110.075 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.775 ' HG2' HG22 ' A' ' 74' ' ' VAL . 49.5 Cg_endo -87.46 67.91 3.82 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.968 1.509 . . . . 0.0 111.063 -179.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.513 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -45.59 121.91 3.33 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.95 -1.094 . . . . 0.0 109.271 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.697 HD21 ' CB ' ' A' ' 66' ' ' ALA . 15.1 mt -119.87 175.32 5.95 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.086 -1.009 . . . . 0.0 110.901 -179.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.41 HG22 ' C ' ' A' ' 95' ' ' LEU . 0.2 OUTLIER 179.26 -178.87 0.37 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.499 -0.751 . . . . 0.0 109.953 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.94 -14.07 20.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.21 -0.931 . . . . 0.0 110.197 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.618 ' O ' HG23 ' A' ' 67' ' ' THR . 1.7 mt-10 -96.66 157.46 35.24 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.283 -0.886 . . . . 0.0 110.145 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.491 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 45.5 Cg_endo -72.51 137.42 27.84 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.971 1.511 . . . . 0.0 110.367 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.513 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.82 93.05 3.93 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.201 -0.937 . . . . 0.0 110.351 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.812 ' HG2' HG23 ' A' ' 65' ' ' THR . 0.0 OUTLIER -74.04 143.39 45.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.912 . . . . 0.0 109.818 179.633 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 1.163 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 47.5 t -121.16 132.35 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.137 -0.977 . . . . 0.0 110.407 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.569 HG23 ' HD3' ' A' ' 63' ' ' ARG . 0.2 OUTLIER -150.86 94.11 2.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.412 -0.805 . . . . 0.0 110.098 179.919 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -139.95 157.99 44.79 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.132 -0.98 . . . . 0.0 110.447 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -114.8 97.0 6.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.305 -0.872 . . . . 0.0 110.048 179.944 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.596 ' CE1' HD11 ' A' ' 89' ' ' LEU . 36.0 p90 -96.58 155.9 16.57 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.264 -0.898 . . . . 0.0 110.334 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.7 m -90.6 101.92 14.66 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.334 -0.854 . . . . 0.0 110.004 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.758 ' HB1' HG21 ' A' ' 54' ' ' ILE . . . -64.89 102.48 0.6 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.233 -0.917 . . . . 0.0 110.355 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.467 ' HA ' ' HA2' ' A' ' 57' ' ' GLY . 2.9 p -93.95 52.37 1.64 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.258 -0.901 . . . . 0.0 110.023 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -156.91 -158.4 0.77 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.207 -0.933 . . . . 0.0 110.417 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.542 HG22 ' HD3' ' A' ' 113' ' ' PRO . 69.9 m -137.74 111.22 8.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.238 -0.914 . . . . 0.0 110.261 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.639 ' HD2' HG11 ' A' ' 52' ' ' VAL . 15.1 m-30 -106.9 78.03 0.55 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.322 -0.862 . . . . 0.0 110.001 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.542 ' HD3' HG22 ' A' ' 111' ' ' THR . 44.3 Cg_endo -71.36 124.95 10.84 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.836 1.44 . . . . 0.0 110.418 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.486 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -63.61 -10.29 17.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.276 -0.89 . . . . 0.0 110.33 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.33 106.56 23.93 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.211 -0.93 . . . . 0.0 110.208 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.486 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 46.4 Cg_endo -73.07 82.47 1.55 Allowed 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.969 1.51 . . . . 0.0 110.41 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.986 ' HB3' ' HB2' ' A' ' 120' ' ' ASP . . . -96.36 138.32 34.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.267 -0.895 . . . . 0.0 110.149 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -50.1 -43.39 51.53 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.192 -0.942 . . . . 0.0 110.222 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -82.92 -19.3 37.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.18 -0.95 . . . . 0.0 110.282 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.986 ' HB2' ' HB3' ' A' ' 117' ' ' ALA . 30.5 m-20 -116.7 120.58 34.13 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.198 -0.939 . . . . 0.0 110.241 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.513 ' HB3' ' CA ' ' A' ' 82' ' ' GLY . 46.4 Cg_endo -73.32 139.46 29.07 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.888 1.467 . . . . 0.0 110.418 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.499 ' O ' ' HA ' ' A' ' 80' ' ' GLN . 0.5 OUTLIER -90.96 -175.33 4.3 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.22 -0.925 . . . . 0.0 109.728 179.609 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.56 ' HA3' ' CB ' ' A' ' 112' ' ' TYR . . . -125.11 139.14 11.44 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.513 ' CB ' ' HA ' ' A' ' 50' ' ' ASN . 3.2 pt20 -150.39 -160.63 1.2 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.298 -1.119 . . . . 0.0 110.419 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.603 HG21 ' CH2' ' A' ' 16' ' ' TRP . 15.4 mt -118.5 135.06 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.506 -0.746 . . . . 0.0 109.131 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 1.076 ' HB3' ' CD1' ' A' ' 77' ' ' LEU . . . -112.6 123.46 50.35 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.285 -0.884 . . . . 0.0 111.082 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.504 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 4.4 m-85 -119.18 107.16 13.1 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.48 ' O ' ' HB ' ' A' ' 74' ' ' VAL . 10.5 mm-40 -89.48 97.25 11.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.155 -0.966 . . . . 0.0 111.431 -178.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.681 HD22 HG11 ' A' ' 74' ' ' VAL . 24.1 mt -97.13 41.92 1.1 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.355 -0.84 . . . . 0.0 109.191 178.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 131' ' ' GLY . . . -88.65 116.56 4.66 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -179.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 39' ' ' GLY . . . 39.74 92.59 0.01 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.581 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 7.2 m-85 -143.96 -54.42 0.36 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.112 -1.228 . . . . 0.0 110.516 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.67 ' CB ' HG23 ' A' ' 72' ' ' VAL . 1.3 t -89.05 175.15 7.51 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.967 -1.083 . . . . 0.0 110.157 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.2 -91.96 0.08 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.209 -0.932 . . . . 0.0 110.348 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.38 170.32 13.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.162 -0.961 . . . . 0.0 110.122 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.511 ' N ' ' HA ' ' A' ' 38' ' ' ALA . . . -55.55 133.04 50.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.237 -0.914 . . . . 0.0 110.144 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 1.095 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 16.5 p90 -136.23 -161.67 1.19 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.197 -0.939 . . . . 0.0 110.65 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.637 ' C ' HD12 ' A' ' 139' ' ' LEU 0.258 0.9 OUTLIER -156.86 176.76 12.32 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.405 -0.809 . . . . 0.0 110.028 -177.78 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.691 HD21 ' CD1' ' A' ' 95' ' ' LEU . 1.8 mp -145.43 119.42 9.37 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.097 -1.002 . . . . 0.0 112.04 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' CYS . . . . . 0.644 ' SG ' ' HB3' ' A' ' 31' ' ' ALA . 0.8 OUTLIER -99.71 111.68 23.99 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.577 -0.702 . . . . 0.0 110.387 178.349 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.495 ' O ' ' HB3' ' A' ' 142' ' ' ASP . 5.5 mt -103.57 173.89 6.11 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.233 -0.917 . . . . 0.0 109.687 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.563 ' HA ' ' CG ' ' A' ' 9' ' ' PHE . 3.0 p-10 172.09 -177.81 0.06 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.426 -0.796 . . . . 0.0 110.166 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.45 ' HA ' ' O ' ' A' ' 7' ' ' GLY . 19.3 t0 42.07 59.62 2.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.339 -0.85 . . . . 0.0 109.856 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.603 HG21 ' CZ ' ' A' ' 9' ' ' PHE . 1.9 t -100.89 114.45 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.32 -0.863 . . . . 0.0 110.113 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.454 ' HB2' ' HA ' ' A' ' 6' ' ' GLU . . . -144.6 156.25 44.04 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.317 -0.864 . . . . 0.0 110.447 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.819 HD11 ' HB3' ' A' ' 60' ' ' TYR . 35.5 tp -154.58 125.55 7.18 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.321 -0.862 . . . . 0.0 110.094 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.482 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 6.9 m-20 -125.26 179.12 5.22 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.265 -0.897 . . . . 0.0 110.302 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.502 ' HB3' ' CE1' ' A' ' 60' ' ' TYR . 10.9 p -141.24 102.17 4.17 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.268 -0.895 . . . . 0.0 110.209 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 148' ' ' SER . 7.2 tm-20 42.84 90.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.24 -0.913 . . . . 0.0 110.208 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.511 HG22 ' O ' ' A' ' 150' ' ' VAL . 12.9 p -87.1 48.96 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.217 -0.927 . . . . 0.0 110.283 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.45 ' O ' ' O ' ' A' ' 150' ' ' VAL . 3.8 tt0 57.38 112.57 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.233 -0.917 . . . . 0.0 110.259 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.745 ' O ' HD12 ' A' ' 152' ' ' LEU . 2.7 pp . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.167 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.255 0.55 . . . . 0.0 110.181 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.457 ' HB2' ' O ' ' A' ' 1' ' ' ALA . 26.9 t 178.67 107.61 0.15 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.281 -0.887 . . . . 0.0 110.192 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -75.98 -156.47 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.961 1.506 . . . . 0.0 110.089 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.843 HD11 ' O ' ' A' ' 144' ' ' VAL . 9.4 pt -90.19 -42.78 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.17 -0.956 . . . . 0.0 110.2 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.499 ' O ' ' N ' ' A' ' 7' ' ' GLY . . . 137.38 74.42 0.06 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.623 ' CB ' ' HB2' ' A' ' 145' ' ' ALA . 5.8 pt-20 -42.75 94.95 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.3 -1.118 . . . . 0.0 110.247 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 5' ' ' GLY . . . -172.55 143.94 7.65 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.524 ' CG2' ' HB3' ' A' ' 143' ' ' ASP . 76.8 p -54.79 167.2 0.39 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.344 -1.092 . . . . 0.0 110.161 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.596 ' CD2' ' HA ' ' A' ' 142' ' ' ASP . 22.9 m-85 -91.28 55.54 2.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.243 -0.91 . . . . 0.0 110.131 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.561 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 3.3 p-10 -101.77 38.59 1.6 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.164 -0.96 . . . . 0.0 110.316 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.561 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 1.5 m-20 161.42 79.19 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.637 -0.664 . . . . 0.0 109.723 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 63.69 94.86 0.02 OUTLIER Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.536 ' O ' ' N ' ' A' ' 15' ' ' GLY . 45.1 Cg_endo -72.65 78.6 2.02 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.071 1.564 . . . . 0.0 110.627 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.46 ' HG3' ' HB ' ' A' ' 4' ' ' ILE . 6.9 mm-40 42.25 -91.4 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.35 -0.844 . . . . 0.0 110.627 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.753 ' O ' HG13 ' A' ' 17' ' ' VAL . . . -158.96 24.63 0.34 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.967 ' CE2' HD22 ' A' ' 49' ' ' LEU . 41.5 m95 -56.12 87.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.283 -1.128 . . . . 0.0 110.255 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.753 HG13 ' O ' ' A' ' 15' ' ' GLY . 0.9 OUTLIER -91.28 146.91 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.049 -1.032 . . . . 0.0 109.647 179.743 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.455 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . . . -130.14 135.58 48.36 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.125 -0.985 . . . . 0.0 109.781 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.709 ' HE1' HG13 ' A' ' 48' ' ' VAL . 19.7 p90 -124.3 167.69 13.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.424 -0.797 . . . . 0.0 110.668 -178.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.527 ' CA ' ' OH ' ' A' ' 43' ' ' TYR . . . 75.28 43.79 24.44 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.517 HG22 ' CG1' ' A' ' 45' ' ' VAL . 6.0 p -150.69 -157.23 0.79 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.125 -1.22 . . . . 0.0 110.367 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -93.87 75.92 4.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.32 -0.863 . . . . 0.0 110.23 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.74 -172.09 43.93 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.22 163.62 37.52 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.989 1.521 . . . . 0.0 110.465 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.713 HD23 ' H ' ' A' ' 25' ' ' LEU . 0.7 OUTLIER -68.17 -169.73 0.15 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.283 -0.885 . . . . 0.0 110.24 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -162.4 150.93 14.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.232 -0.918 . . . . 0.0 110.293 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 1.0 HG22 ' O ' ' A' ' 31' ' ' ALA . 0.8 OUTLIER -119.81 -77.48 0.58 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.327 -0.858 . . . . 0.0 110.046 179.933 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 27' ' ' THR . 1.3 m 40.64 27.77 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.431 -0.793 . . . . 0.0 110.476 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.93 HG22 ' O ' ' A' ' 27' ' ' THR . 9.2 t -164.52 30.76 0.07 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.153 -0.967 . . . . 0.0 110.279 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.541 ' HA2' ' CA ' ' A' ' 10' ' ' ASP . . . 53.1 28.38 33.36 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 1.0 ' O ' HG22 ' A' ' 27' ' ' THR . . . -150.13 161.46 42.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.309 -1.113 . . . . 0.0 110.313 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.773 HD23 HD12 ' A' ' 141' ' ' LEU . 0.8 OUTLIER -105.4 98.04 7.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.89 . . . . 0.0 109.562 179.817 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.515 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 64.9 m -107.59 116.35 31.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.244 -0.91 . . . . 0.0 111.01 -179.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.523 HG12 ' CB ' ' A' ' 25' ' ' LEU . 20.3 m -104.03 140.92 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.42 -0.8 . . . . 0.0 109.175 179.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.49 ' O ' ' HB ' ' A' ' 21' ' ' THR . . . -88.96 89.5 8.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.064 -1.023 . . . . 0.0 110.69 -179.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.055 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 43.8 t -71.62 135.79 83.54 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.263 -0.898 . . . . 0.0 109.775 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.516 ' HG3' ' OE1' ' A' ' 42' ' ' GLN . 40.0 Cg_endo -67.74 -174.06 0.55 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.091 1.574 . . . . 0.0 111.652 -179.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.541 ' HA ' ' CA ' ' A' ' 136' ' ' ALA . . . -72.45 118.77 15.76 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.537 -0.727 . . . . 0.0 111.874 -178.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.565 ' O ' ' C ' ' A' ' 40' ' ' SER . . . 52.98 15.25 3.25 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 178.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.565 ' C ' ' O ' ' A' ' 39' ' ' GLY . 49.3 m 25.16 46.73 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.278 0 CA-C-N 118.268 1.034 . . . . 0.0 110.831 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.508 ' N ' ' O ' ' A' ' 39' ' ' GLY . . . -89.09 26.66 1.54 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.475 -0.766 . . . . 0.0 111.167 -178.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.516 ' OE1' ' HG3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -91.98 -153.1 0.32 Allowed 'General case' 0 C--N 1.29 -1.992 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.461 179.183 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.563 ' CE1' ' O ' ' A' ' 44' ' ' GLY . 25.0 p90 -56.57 -16.25 5.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.035 -1.041 . . . . 0.0 109.931 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.563 ' O ' ' CE1' ' A' ' 43' ' ' TYR . . . 123.67 122.64 2.73 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.532 HG12 ' H ' ' A' ' 46' ' ' GLY . 5.2 t -90.04 179.23 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.144 -1.209 . . . . 0.0 109.21 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.532 ' H ' HG12 ' A' ' 45' ' ' VAL . . . 164.0 -175.29 40.15 Favored Glycine 0 N--CA 1.489 2.225 0 C-N-CA 119.097 -1.525 . . . . 0.0 110.772 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.73 HG13 ' O ' ' A' ' 17' ' ' VAL . 21.8 t -151.04 131.47 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.722 -0.869 . . . . 0.0 108.701 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.709 HG13 ' HE1' ' A' ' 19' ' ' TYR . 29.3 m -119.83 131.51 72.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.948 -1.095 . . . . 0.0 110.797 -179.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.967 HD22 ' CE2' ' A' ' 16' ' ' TRP . 21.0 tp -131.91 103.91 6.57 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.377 -0.827 . . . . 0.0 110.365 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.513 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 35.7 p30 -78.73 152.41 31.55 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.253 -0.904 . . . . 0.0 110.285 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 125.33 64.45 0.18 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.589 HG12 ' N ' ' A' ' 53' ' ' ALA . 89.2 t -131.0 172.62 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.155 -1.203 . . . . 0.0 110.134 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.589 ' N ' HG12 ' A' ' 52' ' ' VAL . . . -150.28 85.78 1.4 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.18 -0.95 . . . . 0.0 110.567 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.637 ' CG1' ' CD2' ' A' ' 112' ' ' TYR . 42.4 mm -111.11 159.97 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.244 -0.91 . . . . 0.0 109.912 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.583 ' HA ' HG23 ' A' ' 111' ' ' THR . 72.5 mt-10 -149.52 120.54 7.7 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.119 -0.988 . . . . 0.0 110.471 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.523 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 11.7 pt-20 37.52 -152.0 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.618 -0.676 . . . . 0.0 110.779 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.461 ' N ' ' HG3' ' A' ' 56' ' ' GLU . . . -79.4 114.27 3.84 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.671 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.2 m -144.22 171.76 13.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.267 -1.137 . . . . 0.0 109.772 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.574 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 0.5 OUTLIER -89.8 158.17 17.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.278 -0.889 . . . . 0.0 110.106 179.866 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.867 ' O ' HG22 ' A' ' 105' ' ' THR . 68.4 m-85 -159.2 171.22 20.29 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.249 -0.907 . . . . 0.0 110.244 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.589 ' OG1' HG22 ' A' ' 105' ' ' THR . 25.7 m -150.11 117.28 6.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.317 -0.864 . . . . 0.0 110.211 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 27.5 tp -89.74 122.49 32.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.205 -0.934 . . . . 0.0 110.022 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.51 ' NH2' ' OD2' ' A' ' 143' ' ' ASP . 1.0 OUTLIER -124.92 104.06 8.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.226 -0.921 . . . . 0.0 110.349 -179.757 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 1.16 ' CZ ' HG21 ' A' ' 102' ' ' VAL . 3.0 p90 -150.54 151.78 33.16 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.281 -0.887 . . . . 0.0 110.012 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.508 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 29.4 m -119.88 97.62 5.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.221 -0.925 . . . . 0.0 110.251 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.758 ' CB ' HD21 ' A' ' 95' ' ' LEU . . . -99.65 145.96 27.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 0.0 110.403 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.685 HG23 ' O ' ' A' ' 98' ' ' GLU . 98.9 m -150.32 117.32 5.93 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.302 -0.874 . . . . 0.0 110.08 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.522 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -107.53 133.41 52.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.184 -0.948 . . . . 0.0 110.115 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 68' ' ' ALA . 1.5 m -45.79 -25.71 0.55 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.167 -0.958 . . . . 0.0 109.399 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.558 ' CG2' ' CB ' ' A' ' 137' ' ' TRP . 1.8 t -110.27 169.26 8.85 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.484 -0.76 . . . . 0.0 109.86 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.496 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 2.2 m-20 -86.15 62.34 7.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.179 -0.951 . . . . 0.0 109.181 179.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.947 HG21 ' CE2' ' A' ' 137' ' ' TRP . 3.3 p -86.16 136.58 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.35 -0.844 . . . . 0.0 111.203 -179.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 67.0 m -122.95 92.08 3.63 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.71 HG21 HD22 ' A' ' 129' ' ' LEU . 4.3 m -89.97 -153.07 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.158 -0.964 . . . . 0.0 110.628 -178.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.464 ' N ' HG23 ' A' ' 74' ' ' VAL . 5.0 mtm180 -127.7 128.73 45.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.313 -0.867 . . . . 0.0 110.577 -179.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.613 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -131.22 155.41 47.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.335 -0.853 . . . . 0.0 109.786 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.669 HD12 ' C ' ' A' ' 77' ' ' LEU . 3.8 pp 178.55 -154.46 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.272 -0.892 . . . . 0.0 110.281 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.732 HG23 HD22 ' A' ' 89' ' ' LEU . 4.3 t -146.87 171.92 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.289 -0.882 . . . . 0.0 109.357 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.494 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . 178.78 -176.3 47.89 Favored Glycine 0 N--CA 1.49 2.258 0 C-N-CA 119.363 -1.399 . . . . 0.0 110.056 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.542 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 5.1 tp60 -112.64 86.85 2.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.393 -1.063 . . . . 0.0 110.21 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.475 ' O ' ' HG2' ' A' ' 121' ' ' PRO . 3.6 m-80 -64.68 97.39 0.21 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.135 -0.978 . . . . 0.0 109.681 179.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.585 ' O ' ' CZ ' ' A' ' 85' ' ' TYR . . . 149.13 -88.69 0.14 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.513 ' HB2' ' O ' ' A' ' 82' ' ' GLY . . . 178.83 146.67 0.37 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.187 -1.184 . . . . 0.0 110.054 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.488 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.5 Cg_endo -85.44 36.06 3.21 Favored 'Cis proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.921 -2.116 . . . . 0.0 110.616 -0.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.585 ' CZ ' ' O ' ' A' ' 82' ' ' GLY . 98.9 m-85 59.17 -168.91 0.14 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.263 -0.898 . . . . 0.0 110.399 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 135.77 110.54 1.07 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -89.76 140.5 29.53 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.22 -1.165 . . . . 0.0 110.389 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.796 HG23 ' CD1' ' A' ' 89' ' ' LEU . 30.6 m -119.78 -17.98 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.409 -0.807 . . . . 0.0 109.746 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.866 HD11 ' CZ ' ' A' ' 106' ' ' PHE . 4.4 mp -121.55 143.26 49.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.401 -0.812 . . . . 0.0 110.784 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -151.15 78.88 1.3 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.886 . . . . 0.0 110.074 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 36.3 p -147.04 174.05 11.9 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.039 -1.038 . . . . 0.0 110.708 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.416 ' HB3' ' O ' ' A' ' 74' ' ' VAL . 1.3 m -119.81 120.31 30.56 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.395 -0.815 . . . . 0.0 109.848 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.626 ' HG2' HG22 ' A' ' 74' ' ' VAL . 43.6 Cg_endo -70.61 117.49 5.17 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.928 1.489 . . . . 0.0 111.125 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.526 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -86.18 138.96 31.49 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.896 . . . . 0.0 109.339 179.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.826 HD13 ' HG ' ' A' ' 139' ' ' LEU . 72.4 mt -130.66 169.46 15.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.033 -1.042 . . . . 0.0 110.883 -179.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -178.34 -178.75 0.64 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.488 -0.757 . . . . 0.0 109.938 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.61 -23.72 67.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.887 . . . . 0.0 110.17 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.685 ' O ' HG23 ' A' ' 67' ' ' THR . 4.3 mt-10 -89.8 165.17 25.95 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.292 -0.88 . . . . 0.0 110.178 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.492 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 45.1 Cg_endo -72.45 133.18 20.31 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.946 1.498 . . . . 0.0 110.29 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.526 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.79 81.05 1.67 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.206 -0.934 . . . . 0.0 110.289 -179.927 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.45 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 0.0 OUTLIER -68.12 158.22 33.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.25 -0.906 . . . . 0.0 110.015 179.827 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 1.16 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 65.3 t -133.67 132.38 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.174 -0.954 . . . . 0.0 110.434 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -150.57 89.21 1.54 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.405 -0.809 . . . . 0.0 110.035 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' A' ' 61' ' ' THR . 1.2 mm-40 -141.38 168.78 18.97 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.155 -0.966 . . . . 0.0 110.273 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.867 HG22 ' O ' ' A' ' 60' ' ' TYR . 0.6 OUTLIER -121.98 -179.51 4.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.309 -0.869 . . . . 0.0 110.172 -179.992 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.866 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 53.7 p90 -177.96 155.47 0.98 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.217 -0.927 . . . . 0.0 110.259 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 58' ' ' THR . 99.3 m -91.25 95.79 10.22 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.223 -0.923 . . . . 0.0 110.132 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.776 ' HB3' ' CE2' ' A' ' 60' ' ' TYR . . . -65.72 113.67 4.44 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -0.918 . . . . 0.0 110.44 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.412 ' O ' ' OG ' ' A' ' 109' ' ' SER . 5.8 p -98.42 55.87 1.12 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.208 -0.933 . . . . 0.0 109.958 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.433 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -158.19 -160.62 0.92 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.256 -0.902 . . . . 0.0 110.455 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.583 HG23 ' HA ' ' A' ' 55' ' ' GLU . 10.5 m -152.54 118.17 5.35 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.347 -0.845 . . . . 0.0 110.34 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.637 ' CD2' ' CG1' ' A' ' 54' ' ' ILE . 11.2 m-30 -113.08 94.17 28.94 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.256 -0.903 . . . . 0.0 109.85 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.476 ' O ' ' HB2' ' A' ' 122' ' ' GLU . 45.7 Cg_endo -72.94 139.72 30.55 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.022 1.538 . . . . 0.0 110.51 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.98 0.47 21.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.242 -0.911 . . . . 0.0 110.246 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -122.0 136.27 26.1 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.245 -0.909 . . . . 0.0 110.2 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.02 171.16 18.12 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.967 1.509 . . . . 0.0 110.406 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.785 ' HB3' ' HB2' ' A' ' 120' ' ' ASP . . . -90.57 49.37 1.66 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.272 -0.893 . . . . 0.0 110.281 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.583 ' HB3' ' O ' ' A' ' 117' ' ' ALA . . . 61.64 12.3 4.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.199 -0.938 . . . . 0.0 110.209 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 118' ' ' ALA . 2.1 t70 177.3 -28.61 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.35 -0.844 . . . . 0.0 110.312 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.785 ' HB2' ' HB3' ' A' ' 117' ' ' ALA . 7.6 m-20 -89.77 174.56 4.66 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.182 -0.949 . . . . 0.0 110.235 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.541 ' HG2' ' CA ' ' A' ' 82' ' ' GLY . 42.4 Cg_endo -88.7 -155.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 124.126 1.593 . . . . 0.0 110.331 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' A' ' 113' ' ' PRO . 14.7 pt-20 -145.92 -156.37 0.7 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.052 -1.03 . . . . 0.0 110.405 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.542 ' HA2' ' HA ' ' A' ' 80' ' ' GLN . . . -99.69 144.85 17.21 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.513 ' CB ' ' HA ' ' A' ' 50' ' ' ASN . 2.1 pt20 -150.49 -153.82 0.51 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.208 -1.172 . . . . 0.0 110.597 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.751 HG21 ' HH2' ' A' ' 16' ' ' TRP . 21.6 mt -118.63 142.2 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.515 -0.74 . . . . 0.0 109.297 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.639 ' HB3' ' CD1' ' A' ' 77' ' ' LEU . . . -113.64 115.87 28.58 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.395 -0.816 . . . . 0.0 111.774 -178.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.539 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 4.5 m-85 -119.75 74.28 1.01 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.135 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.928 ' C ' HD23 ' A' ' 129' ' ' LEU . 2.3 mt-30 -87.26 126.54 34.89 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.207 -0.933 . . . . 0.0 112.146 -177.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.928 HD23 ' C ' ' A' ' 128' ' ' GLN . 1.4 mt -112.77 55.38 0.69 Allowed 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 131' ' ' GLY . . . -73.28 85.3 0.6 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.499 ' HA2' ' O ' ' A' ' 39' ' ' GLY . . . 58.44 114.61 0.01 OUTLIER Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.639 ' CD2' HG12 ' A' ' 74' ' ' VAL . 10.3 m-85 -147.4 -57.16 0.25 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -1.148 . . . . 0.0 110.206 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.673 ' CB ' HG23 ' A' ' 72' ' ' VAL . 5.9 t -89.69 173.79 8.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.149 -0.969 . . . . 0.0 110.187 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -74.84 -93.73 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.213 -0.93 . . . . 0.0 110.208 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.33 -167.84 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.081 -1.012 . . . . 0.0 109.937 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.541 ' CA ' ' HA ' ' A' ' 38' ' ' ALA . . . -77.58 150.07 34.76 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.214 -0.929 . . . . 0.0 110.375 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 1.055 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 24.3 p90 -148.49 -154.81 0.58 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.315 -0.866 . . . . 0.0 110.11 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.522 ' O ' ' CB ' ' A' ' 68' ' ' ALA . 1.0 OUTLIER -160.43 163.17 33.26 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.922 -1.111 . . . . 0.0 111.296 -178.21 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.826 ' HG ' HD13 ' A' ' 95' ' ' LEU . 2.1 mp -126.52 125.74 42.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.429 -0.794 . . . . 0.0 109.56 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' CYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 41.1 m -121.01 99.45 6.5 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.107 -0.995 . . . . 0.0 110.713 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.773 HD12 HD23 ' A' ' 32' ' ' LEU . 2.2 mt -89.64 -154.67 0.33 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.317 -0.864 . . . . 0.0 109.479 179.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.92 ' O ' HG23 ' A' ' 144' ' ' VAL . 39.7 p-10 -177.78 -151.49 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.187 -0.946 . . . . 0.0 110.03 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.524 ' HB3' ' CG2' ' A' ' 8' ' ' THR . 23.6 p-10 -40.56 115.05 0.52 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.526 -0.734 . . . . 0.0 109.785 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.92 HG23 ' O ' ' A' ' 142' ' ' ASP . 43.0 t -128.85 125.09 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.284 -0.885 . . . . 0.0 110.244 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.623 ' HB2' ' CB ' ' A' ' 6' ' ' GLU . . . -136.89 178.82 6.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.292 -0.88 . . . . 0.0 110.658 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.553 HD12 ' O ' ' A' ' 61' ' ' THR . 14.4 tp -158.93 118.7 3.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.384 -0.823 . . . . 0.0 109.947 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.505 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 49.3 m-20 -113.15 141.05 47.38 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.228 -0.92 . . . . 0.0 110.415 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.573 ' HB3' ' CE1' ' A' ' 60' ' ' TYR . 0.8 OUTLIER -114.7 -160.54 0.74 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.321 -0.862 . . . . 0.0 110.224 179.935 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -114.4 101.67 9.37 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.307 -0.87 . . . . 0.0 110.2 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.533 HG13 ' O ' ' A' ' 150' ' ' VAL . 14.7 p -124.74 126.46 71.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.225 -0.922 . . . . 0.0 110.264 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -104.28 29.94 5.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -0.933 . . . . 0.0 110.269 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.491 ' H ' HG22 ' A' ' 150' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.209 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.261 0.553 . . . . 0.0 110.195 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.3 m -144.98 140.83 16.58 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.266 -0.896 . . . . 0.0 110.178 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -76.28 -156.35 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.002 1.528 . . . . 0.0 110.053 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.554 HG22 ' O ' ' A' ' 51' ' ' GLY . 9.5 pt -89.88 34.91 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.151 -0.968 . . . . 0.0 110.166 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.42 ' O ' ' C ' ' A' ' 6' ' ' GLU . . . 89.62 -34.14 4.14 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.59 ' HG3' ' HB2' ' A' ' 145' ' ' ALA . 30.4 tt0 42.86 41.47 2.57 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.34 -1.094 . . . . 0.0 110.172 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 143' ' ' ASP . . . -126.26 169.93 18.15 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 142' ' ' ASP . 12.7 p -83.7 42.51 0.85 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.275 -1.132 . . . . 0.0 110.522 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.77 ' HB3' HG21 ' A' ' 27' ' ' THR . 15.7 m-30 41.29 32.54 0.21 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.27 -0.894 . . . . 0.0 110.381 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.539 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 35.4 p-10 -89.35 46.4 1.37 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.167 -0.958 . . . . 0.0 110.316 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.539 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.3 OUTLIER 161.52 -22.56 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.798 -0.564 . . . . 0.0 109.75 179.962 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 167.58 110.74 0.23 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.81 ' HG3' HD12 ' A' ' 32' ' ' LEU . 49.9 Cg_endo -76.59 72.75 5.48 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.984 1.518 . . . . 0.0 110.778 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.519 ' HG3' HD11 ' A' ' 49' ' ' LEU . 12.8 tp10 41.32 -92.1 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.293 -0.879 . . . . 0.0 110.509 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.573 ' C ' HD13 ' A' ' 49' ' ' LEU . . . -157.71 43.24 0.51 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.945 ' NE1' HD22 ' A' ' 49' ' ' LEU . 37.9 m95 -66.47 127.88 34.01 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.32 -1.106 . . . . 0.0 110.288 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.724 HG22 ' O ' ' A' ' 48' ' ' VAL . 1.3 m -122.32 154.73 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.135 -0.978 . . . . 0.0 109.689 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.459 ' HB2' HG11 ' A' ' 34' ' ' VAL . . . -137.1 154.83 50.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.303 -0.873 . . . . 0.0 109.526 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.743 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.6 OUTLIER -139.47 138.67 36.62 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.06 -1.025 . . . . 0.0 111.13 -178.752 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.589 ' HA2' ' CE1' ' A' ' 43' ' ' TYR . . . 121.26 84.3 0.77 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.655 HG21 ' HB3' ' A' ' 37' ' ' PRO . 1.7 p 53.15 17.6 1.0 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.508 -0.995 . . . . 0.0 110.955 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 1.031 ' HA ' ' HB3' ' A' ' 35' ' ' ALA . 5.9 p30 -101.89 111.36 23.59 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.083 -1.011 . . . . 0.0 110.284 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 22' ' ' ASP . . . -59.94 -152.91 0.02 OUTLIER Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.022 -1.631 . . . . 0.0 109.022 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.455 ' O ' ' C ' ' A' ' 25' ' ' LEU . 47.0 Cg_endo -74.4 95.63 0.94 Allowed 'Trans proline' 0 C--N 1.303 -1.86 0 O-C-N 123.814 1.429 . . . . 0.0 110.307 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.716 HD23 ' H ' ' A' ' 25' ' ' LEU . 0.8 OUTLIER -40.65 150.39 0.07 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.354 -0.841 . . . . 0.0 109.771 179.808 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -146.6 159.77 43.03 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.98 -1.075 . . . . 0.0 110.757 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.77 HG21 ' HB3' ' A' ' 9' ' ' PHE . 3.7 p -119.63 -55.86 2.08 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.321 -0.862 . . . . 0.0 110.161 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 50.57 -89.58 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.275 -0.891 . . . . 0.0 110.228 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.514 ' N ' ' O ' ' A' ' 27' ' ' THR . 15.2 t -55.71 -17.19 5.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.243 -0.911 . . . . 0.0 110.161 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 9' ' ' PHE . . . 111.65 32.55 2.46 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.503 ' HA ' ' O ' ' A' ' 141' ' ' LEU . . . -140.52 109.97 6.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.272 -1.134 . . . . 0.0 110.274 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.81 HD12 ' HG3' ' A' ' 13' ' ' PRO . 0.6 OUTLIER -67.17 94.31 0.35 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.266 -0.896 . . . . 0.0 109.991 179.912 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.518 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 59.0 m -99.4 133.09 44.2 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.31 -0.869 . . . . 0.0 110.574 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.625 HG12 ' HB3' ' A' ' 25' ' ' LEU . 6.2 m -121.62 167.28 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.571 -0.705 . . . . 0.0 109.4 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 1.031 ' HB3' ' HA ' ' A' ' 22' ' ' ASP . . . -103.15 128.46 50.08 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.126 -0.984 . . . . 0.0 111.887 -178.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.999 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 90.3 t -117.5 121.47 32.01 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.163 -0.961 . . . . 0.0 108.991 178.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.655 ' HB3' HG21 ' A' ' 21' ' ' THR . 38.2 Cg_endo -64.25 173.99 4.6 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.856 1.45 . . . . 0.0 112.196 -178.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.54 ' HA ' ' CA ' ' A' ' 136' ' ' ALA . . . -53.31 122.28 9.27 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.514 0.673 . . . . 0.0 111.456 -178.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.513 ' O ' ' C ' ' A' ' 40' ' ' SER . . . 37.89 27.17 0.03 OUTLIER Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.972 ' OG ' HG23 ' A' ' 45' ' ' VAL . 31.3 t 32.77 46.39 0.08 Allowed 'General case' 0 N--CA 1.498 1.934 0 CA-C-N 118.045 0.923 . . . . 0.0 110.15 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.644 ' O ' ' CG ' ' A' ' 42' ' ' GLN . . . -89.51 119.02 29.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.594 -0.692 . . . . 0.0 110.127 -179.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.644 ' CG ' ' O ' ' A' ' 41' ' ' ALA . 0.5 OUTLIER 84.1 28.64 0.08 Allowed 'General case' 0 N--CA 1.508 2.433 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -179.492 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.641 ' CE2' ' CG2' ' A' ' 21' ' ' THR . 0.1 OUTLIER -146.4 -33.27 0.32 Allowed 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 118.757 -1.177 . . . . 0.0 112.335 -177.878 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 43' ' ' TYR . . . 52.26 75.28 0.23 Allowed Glycine 0 N--CA 1.482 1.758 0 N-CA-C 105.849 -2.9 . . . . 0.0 105.849 -177.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.972 HG23 ' OG ' ' A' ' 40' ' ' SER . 2.6 t -85.68 160.76 3.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.513 -0.992 . . . . 0.0 109.186 -177.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.577 ' O ' ' CE1' ' A' ' 19' ' ' TYR . . . 176.68 164.66 30.98 Favored Glycine 0 N--CA 1.488 2.102 0 C-N-CA 119.357 -1.402 . . . . 0.0 110.08 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.681 HG13 ' O ' ' A' ' 17' ' ' VAL . 17.8 t -124.59 125.53 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.473 -1.016 . . . . 0.0 109.626 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.724 ' O ' HG22 ' A' ' 17' ' ' VAL . 33.8 m -119.73 139.89 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.007 -1.058 . . . . 0.0 110.842 -179.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.945 HD22 ' NE1' ' A' ' 16' ' ' TRP . 18.4 tp -132.08 99.25 4.66 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.318 -0.864 . . . . 0.0 110.086 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.531 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 10.6 p30 -73.38 121.52 20.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.245 -0.909 . . . . 0.0 110.429 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.554 ' O ' HG22 ' A' ' 4' ' ' ILE . . . 150.54 65.85 0.01 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.864 -1.295 . . . . 0.0 109.864 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.656 HG23 ' HA ' ' A' ' 124' ' ' GLN . 53.1 t -122.61 169.68 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.137 -1.213 . . . . 0.0 110.073 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.562 ' N ' HG12 ' A' ' 52' ' ' VAL . . . -141.41 88.63 2.16 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.151 -0.968 . . . . 0.0 110.613 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.669 HG21 ' HB1' ' A' ' 108' ' ' ALA . 36.1 mm -122.14 163.0 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.292 -0.88 . . . . 0.0 109.718 179.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.524 ' HA ' HG23 ' A' ' 111' ' ' THR . 2.0 tt0 -150.25 127.05 11.02 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.044 -1.035 . . . . 0.0 110.778 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.52 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 13.6 pt-20 37.56 -157.86 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.642 -0.661 . . . . 0.0 111.093 179.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' A' ' 109' ' ' SER . . . -79.04 82.84 1.32 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.639 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.3 m -110.16 170.46 8.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.266 -1.137 . . . . 0.0 109.779 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.576 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 6.5 m -89.87 154.58 19.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.175 -0.953 . . . . 0.0 110.33 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.639 ' CE2' HG22 ' A' ' 58' ' ' THR . 60.3 m-85 -159.77 173.06 16.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.332 -0.855 . . . . 0.0 110.225 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 27.4 m -150.14 116.01 5.6 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.3 -0.875 . . . . 0.0 110.036 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 103' ' ' THR . 38.3 tp -89.78 122.6 33.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.265 -0.897 . . . . 0.0 110.057 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.584 ' HG2' HG23 ' A' ' 103' ' ' THR . 16.1 mtt180 -131.81 106.46 8.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.332 -0.855 . . . . 0.0 110.233 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.496 ' C ' ' CD1' ' A' ' 64' ' ' TYR . 10.0 p90 -143.04 159.62 41.92 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.246 -0.908 . . . . 0.0 110.236 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.504 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 1.3 m -119.96 102.35 8.49 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.179 -0.951 . . . . 0.0 109.866 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.708 ' CB ' HD21 ' A' ' 95' ' ' LEU . . . -104.83 149.47 25.63 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.273 -0.892 . . . . 0.0 110.699 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.498 HG23 ' O ' ' A' ' 98' ' ' GLU . 93.5 m -150.22 126.01 10.4 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.444 -0.785 . . . . 0.0 110.025 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -114.32 136.96 52.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.211 -0.931 . . . . 0.0 109.999 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' ' 68' ' ' ALA . 0.4 OUTLIER -44.03 -26.57 0.3 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.189 -0.944 . . . . 0.0 109.344 179.528 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.567 ' CG2' ' CB ' ' A' ' 137' ' ' TRP . 2.7 t -114.07 169.39 9.04 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.51 -0.744 . . . . 0.0 109.824 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.506 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 33.7 p-10 -85.07 66.02 9.53 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.137 -0.977 . . . . 0.0 109.201 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.964 HG23 ' HB2' ' A' ' 133' ' ' SER . 4.0 p -89.39 140.36 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -0.885 . . . . 0.0 111.483 -178.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.44 HG22 ' O ' ' A' ' 73' ' ' THR . 16.8 m -127.72 87.21 2.58 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 1.085 HG21 ' CD2' ' A' ' 129' ' ' LEU . 2.8 m -89.78 -140.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.238 -0.914 . . . . 0.0 110.483 -178.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.764 ' N ' HG23 ' A' ' 74' ' ' VAL . 7.0 mtm180 -127.74 149.07 50.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.169 -0.957 . . . . 0.0 110.767 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.592 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -150.11 152.47 34.81 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.399 -0.813 . . . . 0.0 109.421 179.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.909 HD12 ' N ' ' A' ' 78' ' ' VAL . 3.9 pp 179.87 -147.15 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.181 -0.949 . . . . 0.0 110.294 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.925 HG23 HD22 ' A' ' 89' ' ' LEU . 6.8 t -151.29 169.59 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.215 -0.928 . . . . 0.0 109.431 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.543 ' C ' ' CE1' ' A' ' 112' ' ' TYR . . . -172.42 -173.59 39.14 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.236 -1.459 . . . . 0.0 110.252 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.543 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 4.3 pt20 -115.88 108.0 15.73 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.466 -1.02 . . . . 0.0 110.163 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.477 ' HB2' ' HG2' ' A' ' 122' ' ' GLU . 6.2 m-20 -66.61 92.97 0.22 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.193 -0.942 . . . . 0.0 110.236 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.538 ' C ' ' CE1' ' A' ' 85' ' ' TYR . . . 142.8 144.23 4.27 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.654 -1.379 . . . . 0.0 109.654 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.618 ' N ' ' CE1' ' A' ' 85' ' ' TYR . . . -62.7 157.02 61.45 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.226 -1.161 . . . . 0.0 110.27 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.517 ' C ' ' CD2' ' A' ' 85' ' ' TYR . 50.6 Cg_endo -77.38 8.54 17.89 Favored 'Cis proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.647 -2.23 . . . . 0.0 110.876 -0.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.618 ' CE1' ' N ' ' A' ' 83' ' ' ALA . 11.6 m-85 69.83 161.34 0.21 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.241 -0.912 . . . . 0.0 110.262 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.498 ' N ' ' CG ' ' A' ' 80' ' ' GLN . . . 166.76 106.6 0.19 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.484 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 1.0 OUTLIER -89.55 152.38 21.45 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.121 -1.223 . . . . 0.0 110.464 -179.787 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 1.125 HG23 HD12 ' A' ' 89' ' ' LEU . 33.2 m -119.72 -24.92 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.35 -0.844 . . . . 0.0 109.8 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 1.125 HD12 HG23 ' A' ' 88' ' ' VAL . 3.6 mp -99.16 141.8 31.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.285 -0.884 . . . . 0.0 110.73 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 45.5 p-10 -151.34 73.92 1.11 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.393 -0.817 . . . . 0.0 110.032 179.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 41.5 p -135.35 176.03 9.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.051 -1.031 . . . . 0.0 110.643 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 1.4 m -122.01 121.33 28.05 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.385 -0.822 . . . . 0.0 109.949 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.592 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 44.7 Cg_endo -70.92 155.38 62.2 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.919 1.484 . . . . 0.0 110.898 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.519 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -122.26 137.47 54.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.449 -0.782 . . . . 0.0 109.463 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.708 HD21 ' CB ' ' A' ' 66' ' ' ALA . 93.0 mt -131.96 169.03 16.88 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.104 -0.997 . . . . 0.0 110.625 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.589 HG23 ' H ' ' A' ' 98' ' ' GLU . 5.9 t -174.65 -155.08 0.06 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.428 -0.795 . . . . 0.0 110.0 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.536 ' N ' HG23 ' A' ' 96' ' ' THR . 0.9 OUTLIER -89.7 24.33 2.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.261 -0.899 . . . . 0.0 110.128 179.956 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.589 ' H ' HG23 ' A' ' 96' ' ' THR . 0.0 OUTLIER -147.57 172.03 5.65 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.35 -0.844 . . . . 0.0 110.012 179.882 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.51 ' HD2' ' CG ' ' A' ' 98' ' ' GLU . 45.2 Cg_endo -72.82 127.45 12.28 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.979 1.515 . . . . 0.0 110.443 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.519 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 6.6 mtt-85 -119.51 93.1 3.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.261 -0.9 . . . . 0.0 109.867 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -78.06 102.71 7.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.448 -0.783 . . . . 0.0 110.569 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 50.2 t -89.41 134.13 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.241 -0.912 . . . . 0.0 109.805 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.584 HG23 ' HG2' ' A' ' 63' ' ' ARG . 0.2 OUTLIER -147.05 133.09 19.22 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.16 -0.963 . . . . 0.0 110.247 -179.884 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 103' ' ' THR . 1.8 mt-10 -160.25 134.72 7.5 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.259 -0.901 . . . . 0.0 110.333 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 25.2 m -90.68 143.82 26.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.281 -0.887 . . . . 0.0 110.125 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.913 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 41.7 p90 -154.48 159.85 41.25 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.234 -0.916 . . . . 0.0 110.259 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.489 ' HA ' ' O ' ' A' ' 58' ' ' THR . 80.2 m -97.02 89.04 4.68 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.201 -0.937 . . . . 0.0 110.054 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.669 ' HB1' HG21 ' A' ' 54' ' ' ILE . . . -45.63 106.39 0.08 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -0.892 . . . . 0.0 110.296 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.475 ' HA ' ' HA2' ' A' ' 57' ' ' GLY . 5.2 p -90.29 54.29 2.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.282 -0.886 . . . . 0.0 110.278 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.411 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -164.67 -158.39 0.41 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.895 . . . . 0.0 110.229 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.977 HG22 ' HD3' ' A' ' 113' ' ' PRO . 19.9 m -145.04 118.94 9.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.246 -0.909 . . . . 0.0 110.264 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.594 ' CG ' ' HA3' ' A' ' 123' ' ' GLY . 19.2 m-30 -115.79 63.62 2.2 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.361 -0.837 . . . . 0.0 110.073 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.977 ' HD3' HG22 ' A' ' 111' ' ' THR . 45.3 Cg_endo -71.67 147.44 51.05 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.852 1.448 . . . . 0.0 110.608 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.47 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -78.17 4.04 13.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.197 -0.94 . . . . 0.0 110.246 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 70.7 p -92.46 107.95 27.57 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.232 -0.917 . . . . 0.0 110.201 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.47 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 46.7 Cg_endo -73.33 106.49 2.18 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.965 1.508 . . . . 0.0 110.526 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.911 ' HB3' ' HB2' ' A' ' 120' ' ' ASP . . . -150.49 157.15 42.69 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.269 -0.894 . . . . 0.0 110.214 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -52.91 -68.22 0.19 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.206 -0.934 . . . . 0.0 110.262 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -76.79 -2.61 34.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.187 -0.946 . . . . 0.0 110.337 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.911 ' HB2' ' HB3' ' A' ' 117' ' ' ALA . 6.4 m-20 -128.12 72.58 79.5 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.195 -0.94 . . . . 0.0 110.202 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.518 ' HB3' ' HA3' ' A' ' 82' ' ' GLY . 47.7 Cg_endo -73.15 161.68 42.57 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.091 1.574 . . . . 0.0 110.331 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.529 ' O ' ' HA ' ' A' ' 80' ' ' GLN . 0.4 OUTLIER -104.48 -166.83 1.28 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.154 -0.966 . . . . 0.0 110.039 179.811 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.594 ' HA3' ' CG ' ' A' ' 112' ' ' TYR . . . -145.02 158.67 27.71 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.859 -1.297 . . . . 0.0 109.859 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.656 ' HA ' HG23 ' A' ' 52' ' ' VAL . 1.1 pp0? -150.38 -158.12 0.88 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.415 -1.05 . . . . 0.0 110.262 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.882 HG21 ' CH2' ' A' ' 16' ' ' TRP . 6.2 mt -118.18 139.49 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.523 -0.736 . . . . 0.0 109.208 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -117.6 122.56 43.95 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.243 -0.911 . . . . 0.0 110.886 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.487 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 3.0 m-30 -116.76 103.39 10.29 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.583 ' O ' ' CE2' ' A' ' 132' ' ' PHE . 11.0 mm100 -89.08 89.12 7.83 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.323 -0.861 . . . . 0.0 112.511 -177.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 1.085 ' CD2' HG21 ' A' ' 74' ' ' VAL . 27.0 mt -94.73 44.98 1.11 Allowed 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 177.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.552 ' O ' ' CD2' ' A' ' 132' ' ' PHE . . . -99.06 127.89 9.39 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 120.117 -1.04 . . . . 0.0 110.737 -178.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 39' ' ' GLY . . . 37.14 68.8 0.32 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.596 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 9.4 m-85 -123.29 -57.52 1.67 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.028 -1.278 . . . . 0.0 110.82 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.964 ' HB2' HG23 ' A' ' 72' ' ' VAL . 1.3 t -88.54 -177.52 5.61 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.904 -1.122 . . . . 0.0 110.415 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -93.69 -84.76 0.3 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.248 -0.908 . . . . 0.0 110.246 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.08 179.49 1.51 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.165 -0.959 . . . . 0.0 109.999 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.54 ' CA ' ' HA ' ' A' ' 38' ' ' ALA . . . -75.0 129.9 38.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.299 -0.876 . . . . 0.0 110.656 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.999 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 6.8 p90 -133.32 -158.93 0.92 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.336 -0.853 . . . . 0.0 109.859 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.524 ' O ' ' CB ' ' A' ' 68' ' ' ALA . 0.3 OUTLIER -160.37 171.68 18.67 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.048 -1.033 . . . . 0.0 110.48 -178.638 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.941 HD13 HD13 ' A' ' 129' ' ' LEU . 2.4 mp -122.26 157.39 31.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.405 -0.809 . . . . 0.0 109.639 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' CYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 67' ' ' THR . 8.5 m -150.27 91.14 1.73 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.081 -1.012 . . . . 0.0 110.657 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.504 ' HA ' ' O ' ' A' ' 65' ' ' THR . 1.0 OUTLIER -90.0 -156.33 0.41 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.926 . . . . 0.0 109.259 179.275 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.599 ' HA ' ' CD2' ' A' ' 9' ' ' PHE . 1.9 p-10 175.94 -48.53 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.007 -1.058 . . . . 0.0 110.522 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.492 ' O ' ' HA ' ' A' ' 64' ' ' TYR . 22.6 t70 -119.25 137.73 53.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -0.937 . . . . 0.0 110.208 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.492 ' O ' HD11 ' A' ' 4' ' ' ILE . 3.0 t -150.39 113.18 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.213 -0.93 . . . . 0.0 110.115 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.59 ' HB2' ' HG3' ' A' ' 6' ' ' GLU . . . -126.46 153.55 44.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.302 -0.874 . . . . 0.0 110.282 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.566 HD11 ' HB3' ' A' ' 60' ' ' TYR . 29.7 tp -159.71 96.65 1.27 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.34 -0.85 . . . . 0.0 110.03 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.492 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 32.3 t70 -121.95 164.36 17.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.228 -0.92 . . . . 0.0 110.259 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.56 ' HB3' ' CE1' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -111.39 111.36 22.34 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.226 -0.921 . . . . 0.0 110.255 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.447 ' O ' ' O ' ' A' ' 148' ' ' SER . 1.0 OUTLIER 54.52 107.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.315 -0.866 . . . . 0.0 110.236 179.96 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.42 HG22 ' H ' ' A' ' 150' ' ' VAL . 23.9 m -66.09 -175.84 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.261 -0.899 . . . . 0.0 110.245 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 61.51 34.49 17.94 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.304 -0.872 . . . . 0.0 110.213 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.152 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.416 ' C ' ' HD3' ' A' ' 3' ' ' PRO . . . . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.246 0.546 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.555 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 4.2 t 44.87 49.53 6.11 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.265 -0.897 . . . . 0.0 110.192 -179.998 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 2' ' ' SER . 45.6 Cg_endo -72.79 81.05 1.67 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.993 1.523 . . . . 0.0 110.427 179.985 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.606 HD11 HG12 ' A' ' 144' ' ' VAL . 9.1 pt -107.92 42.8 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 110.254 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.543 ' N ' ' HG3' ' A' ' 14' ' ' GLU . . . 73.93 40.54 43.63 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' ' 144' ' ' VAL . 22.0 tt0 -42.03 94.03 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.33 -1.1 . . . . 0.0 110.434 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 5' ' ' GLY . . . 163.48 -154.76 25.82 Favored Glycine 0 N--CA 1.49 2.27 0 C-N-CA 119.647 -1.264 . . . . 0.0 110.164 179.77 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.732 HG22 ' O ' ' A' ' 142' ' ' ASP . 62.0 p -105.99 38.15 2.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.416 -1.049 . . . . 0.0 110.604 -179.594 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.551 ' HZ ' HG21 ' A' ' 144' ' ' VAL . 25.4 m-85 42.75 80.78 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.209 -0.932 . . . . 0.0 110.179 179.779 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.548 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 2.6 p30 -108.48 23.23 14.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.202 -0.936 . . . . 0.0 110.415 -179.843 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.548 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.8 OUTLIER 161.51 80.48 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.601 -0.687 . . . . 0.0 109.822 179.991 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.41 101.54 0.08 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.864 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.686 ' HG3' HD12 ' A' ' 32' ' ' LEU . 45.0 Cg_endo -73.27 78.46 2.27 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.038 1.547 . . . . 0.0 110.667 -179.801 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.543 ' HG3' ' N ' ' A' ' 5' ' ' GLY . 5.0 mm-40 39.45 -91.21 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.467 -0.77 . . . . 0.0 111.066 179.675 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.585 ' C ' HD13 ' A' ' 49' ' ' LEU . . . -148.24 12.56 1.23 Allowed Glycine 0 N--CA 1.493 2.478 0 C-N-CA 119.618 -1.277 . . . . 0.0 110.386 -179.535 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.913 ' N ' HD13 ' A' ' 49' ' ' LEU . 36.8 m95 -40.62 128.82 2.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.23 -1.159 . . . . 0.0 110.786 179.832 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.836 HG22 ' O ' ' A' ' 48' ' ' VAL . 1.4 m -128.08 148.03 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.16 -0.962 . . . . 0.0 109.696 179.305 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . . . -130.32 117.27 19.53 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.027 -1.045 . . . . 0.0 109.821 179.552 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.611 ' HE2' HG13 ' A' ' 48' ' ' VAL . 29.3 p90 -106.76 172.8 6.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.471 -0.768 . . . . 0.0 110.709 -179.241 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.859 ' O ' HG13 ' A' ' 45' ' ' VAL . . . 68.07 27.17 73.77 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 179.589 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.759 HG22 ' CG1' ' A' ' 45' ' ' VAL . 30.9 p -132.32 -164.17 1.43 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.066 -1.255 . . . . 0.0 110.514 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -89.99 39.46 0.96 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.275 -0.891 . . . . 0.0 110.42 -179.75 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 126.26 -168.01 18.51 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 179.827 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.48 -159.09 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.112 1.585 . . . . 0.0 110.579 -179.877 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 1.047 ' CD1' HD11 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -115.81 156.86 25.3 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.339 -0.851 . . . . 0.0 110.104 -179.998 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -121.21 141.14 51.14 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.203 -0.935 . . . . 0.0 110.137 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.482 ' CG2' ' HA ' ' A' ' 32' ' ' LEU . 0.7 OUTLIER -126.36 -24.3 3.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.114 -0.991 . . . . 0.0 110.874 -179.694 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.435 ' C ' ' O ' ' A' ' 27' ' ' THR . 3.5 t -41.06 -36.69 0.73 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.263 -0.898 . . . . 0.0 110.538 -179.618 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.568 HG23 ' H ' ' A' ' 30' ' ' GLY . 2.7 t -53.2 -49.78 66.01 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.259 -0.9 . . . . 0.0 110.706 -179.843 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.568 ' H ' HG23 ' A' ' 29' ' ' THR . . . 166.99 -25.46 0.14 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.925 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.64 ' HB3' ' SG ' ' A' ' 140' ' ' CYS . . . -146.92 169.01 20.06 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -1.128 . . . . 0.0 109.593 179.838 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.047 HD11 ' CD1' ' A' ' 25' ' ' LEU . 0.6 OUTLIER -78.42 92.26 4.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.011 -1.056 . . . . 0.0 110.502 -179.837 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.551 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 0.8 OUTLIER -100.22 110.78 23.04 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.417 -0.802 . . . . 0.0 111.447 179.517 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.864 HG12 ' HB3' ' A' ' 25' ' ' LEU . 15.6 m -89.53 143.71 10.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.001 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.477 ' HA ' ' OG1' ' A' ' 138' ' ' THR . . . -88.63 83.13 6.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.472 -0.767 . . . . 0.0 110.916 -178.59 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.057 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 40.9 t -69.34 128.59 92.32 Favored Pre-proline 0 N--CA 1.487 1.421 0 O-C-N 121.307 -0.87 . . . . 0.0 109.112 179.064 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 21' ' ' THR . 42.8 Cg_endo -70.26 146.77 58.01 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.936 1.493 . . . . 0.0 111.157 -178.951 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.472 ' HA ' ' N ' ' A' ' 136' ' ' ALA . . . -41.57 136.42 1.85 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.512 -0.742 . . . . 0.0 110.229 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 38' ' ' ALA . . . 45.51 92.99 0.01 OUTLIER Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.845 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.559 ' HB3' ' CG2' ' A' ' 45' ' ' VAL . 25.9 m -87.36 33.76 0.69 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.164 -1.198 . . . . 0.0 110.108 179.991 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -91.58 19.95 5.84 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.933 0.873 . . . . 0.0 110.155 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.581 ' HG3' ' CG ' ' A' ' 43' ' ' TYR . 17.8 pt20 -85.69 -143.46 0.1 Allowed 'General case' 0 C--N 1.292 -1.898 0 O-C-N 121.804 -0.56 . . . . 0.0 109.721 179.49 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.581 ' CG ' ' HG3' ' A' ' 42' ' ' GLN . 5.5 p90 -41.54 -27.15 0.09 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.463 -0.773 . . . . 0.0 109.97 179.838 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.571 ' N ' ' CD1' ' A' ' 43' ' ' TYR . . . 115.14 113.49 2.93 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.448 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.859 HG13 ' O ' ' A' ' 20' ' ' GLY . 2.0 t -96.37 160.5 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.183 -1.187 . . . . 0.0 108.841 179.384 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.576 ' O ' ' CE2' ' A' ' 19' ' ' TYR . . . 177.56 152.66 10.24 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.271 -1.442 . . . . 0.0 110.329 -179.74 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.757 HG13 ' O ' ' A' ' 17' ' ' VAL . 22.9 t -113.46 134.79 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.374 -1.074 . . . . 0.0 109.796 179.479 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.836 ' O ' HG22 ' A' ' 17' ' ' VAL . 8.6 m -130.13 151.16 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.035 -1.041 . . . . 0.0 110.46 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.913 HD13 ' N ' ' A' ' 16' ' ' TRP . 19.9 tp -149.71 114.5 5.34 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.275 -0.89 . . . . 0.0 110.388 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.523 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 21.4 t30 -79.72 124.63 28.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.269 -0.894 . . . . 0.0 110.306 179.749 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.509 ' O ' ' CG2' ' A' ' 4' ' ' ILE . . . 155.23 67.99 0.01 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.686 HG23 ' HA ' ' A' ' 124' ' ' GLN . 43.0 t -130.44 171.89 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.216 -1.167 . . . . 0.0 110.106 179.844 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.537 ' HB2' ' H ' ' A' ' 2' ' ' SER . . . -145.04 87.47 1.83 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.102 -0.999 . . . . 0.0 110.718 -179.76 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.985 HD11 HD21 ' A' ' 146' ' ' LEU . 36.7 mm -120.51 159.55 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.226 -0.921 . . . . 0.0 109.893 179.418 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.521 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 0.4 OUTLIER -147.68 121.54 9.34 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.161 -0.962 . . . . 0.0 110.437 -179.868 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.521 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 9.4 pt-20 37.57 -151.65 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.654 -0.654 . . . . 0.0 110.797 179.705 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.459 ' N ' ' HG3' ' A' ' 56' ' ' GLU . . . -81.15 94.41 1.59 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.648 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.2 m -124.74 174.29 7.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.257 -1.143 . . . . 0.0 109.824 179.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.572 ' N ' ' CG2' ' A' ' 58' ' ' THR . 0.6 OUTLIER -89.63 151.66 21.78 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.269 -0.894 . . . . 0.0 110.137 -179.969 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.648 ' CE2' HG22 ' A' ' 58' ' ' THR . 54.6 m-85 -159.29 174.4 14.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.223 -0.923 . . . . 0.0 110.575 -179.987 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 94.8 m -149.98 121.23 7.82 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.439 -0.788 . . . . 0.0 109.685 179.69 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.544 ' HB2' HD21 ' A' ' 89' ' ' LEU . 18.7 tp -89.56 120.44 30.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.208 -0.932 . . . . 0.0 110.279 -179.691 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.539 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 3.3 ttt180 -121.03 138.24 54.26 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.326 -0.859 . . . . 0.0 109.803 179.673 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.843 ' CZ ' HG21 ' A' ' 102' ' ' VAL . 0.6 OUTLIER -178.52 142.2 0.23 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.228 -0.92 . . . . 0.0 110.033 179.922 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.504 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 5.8 m -119.37 94.36 4.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.225 -0.922 . . . . 0.0 110.06 -179.839 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.661 ' CB ' HD21 ' A' ' 95' ' ' LEU . . . -95.91 155.95 16.54 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.345 -0.847 . . . . 0.0 110.153 -179.829 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 44.3 m -148.38 117.59 6.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.261 -0.9 . . . . 0.0 110.27 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.677 ' CB ' HG12 ' A' ' 72' ' ' VAL . . . -102.87 129.8 49.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.297 -0.877 . . . . 0.0 109.942 179.783 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 82.7 p -65.5 -9.05 22.75 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.175 -0.953 . . . . 0.0 110.092 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.625 HG21 ' CB ' ' A' ' 137' ' ' TRP . 7.4 t -116.97 19.9 14.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.871 . . . . 0.0 110.166 -179.912 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.465 ' O ' ' O ' ' A' ' 70' ' ' THR . 4.7 t70 43.05 92.35 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.3 -0.875 . . . . 0.0 109.851 -179.754 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.759 HG13 HD12 ' A' ' 95' ' ' LEU . 12.1 p -131.36 161.31 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -0.918 . . . . 0.0 110.953 -179.337 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.4 ' N ' HG22 ' A' ' 72' ' ' VAL . 23.2 m -128.68 89.11 2.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.37 -0.831 . . . . 0.0 109.219 179.248 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.695 HG12 ' CB ' ' A' ' 132' ' ' PHE . 17.4 m -89.74 -140.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.911 . . . . 0.0 110.655 -179.199 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.542 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 19.3 mtm-85 -133.1 146.55 51.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.902 . . . . 0.0 110.597 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.829 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -150.02 152.21 34.51 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.348 -0.845 . . . . 0.0 109.712 179.731 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.889 HD12 ' N ' ' A' ' 78' ' ' VAL . 3.7 pp 179.49 -146.97 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.241 -0.912 . . . . 0.0 110.218 -179.587 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.889 ' N ' HD12 ' A' ' 77' ' ' LEU . 3.5 t -148.22 177.59 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.921 . . . . 0.0 109.544 179.904 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.523 ' H ' HG12 ' A' ' 78' ' ' VAL . . . -179.49 -175.87 46.67 Favored Glycine 0 N--CA 1.489 2.204 0 C-N-CA 119.384 -1.389 . . . . 0.0 110.14 179.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.552 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 3.0 tt0 -93.98 -153.76 0.38 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.422 -1.046 . . . . 0.0 110.107 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.532 ' O ' ' CB ' ' A' ' 121' ' ' PRO . 9.7 m120 -154.44 72.46 0.87 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.361 -0.837 . . . . 0.0 109.702 179.894 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.487 ' HA3' ' HB3' ' A' ' 121' ' ' PRO . . . 131.57 144.08 5.33 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -179.688 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.628 ' N ' ' CE1' ' A' ' 85' ' ' TYR . . . -41.93 152.27 0.31 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.28 -1.13 . . . . 0.0 110.321 -179.868 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.46 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.6 Cg_endo -80.04 12.57 22.55 Favored 'Cis proline' 0 C--N 1.312 -1.343 0 C-N-CA 121.651 -2.229 . . . . 0.0 110.896 -0.067 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.628 ' CE1' ' N ' ' A' ' 83' ' ' ALA . 29.1 m-85 62.53 146.8 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.139 -0.975 . . . . 0.0 110.233 -179.816 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -172.5 128.13 1.5 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.899 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.487 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 0.8 OUTLIER -105.55 153.76 21.31 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.236 -1.155 . . . . 0.0 110.208 179.984 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.72 HG23 HD12 ' A' ' 89' ' ' LEU . 15.5 m -124.98 -24.69 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.302 -0.873 . . . . 0.0 110.331 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.843 HD22 HG23 ' A' ' 78' ' ' VAL . 3.8 mp -105.72 145.29 31.29 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.17 -0.957 . . . . 0.0 111.082 179.883 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -151.76 76.09 1.18 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.371 -0.831 . . . . 0.0 109.947 179.474 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 82.1 p -135.62 178.52 6.98 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.98 -1.075 . . . . 0.0 110.869 -179.504 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.97 117.8 32.04 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.435 -0.791 . . . . 0.0 110.079 179.941 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.829 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 47.4 Cg_endo -73.74 105.56 2.03 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.93 1.49 . . . . 0.0 110.981 -179.697 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.53 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -77.83 151.32 33.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.156 -0.965 . . . . 0.0 109.428 179.171 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.864 ' CD1' HD21 ' A' ' 139' ' ' LEU . 64.2 mt -138.99 162.83 33.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.994 -1.067 . . . . 0.0 110.817 -179.548 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.49 HG22 ' HG3' ' A' ' 100' ' ' ARG . 0.2 OUTLIER -161.9 -178.93 6.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.455 -0.778 . . . . 0.0 109.907 179.894 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.7 p -64.64 -30.79 71.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.272 -0.892 . . . . 0.0 110.126 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.535 ' CB ' ' HD2' ' A' ' 99' ' ' PRO . 0.1 OUTLIER -90.1 179.94 1.38 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.333 -0.854 . . . . 0.0 109.978 179.822 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.535 ' HD2' ' CB ' ' A' ' 98' ' ' GLU . 44.6 Cg_endo -71.88 132.07 19.37 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.925 1.487 . . . . 0.0 110.313 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.53 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -119.84 92.43 3.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.234 -0.916 . . . . 0.0 110.402 -179.841 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.443 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 1.5 tt0 -76.99 156.76 31.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.296 -0.878 . . . . 0.0 110.113 179.861 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.843 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 52.5 t -138.71 134.15 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.205 -0.935 . . . . 0.0 110.219 -179.992 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 21.6 m -150.06 113.46 4.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.319 -0.863 . . . . 0.0 110.181 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -146.48 138.3 24.75 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.295 -0.878 . . . . 0.0 110.244 -179.949 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.03 159.28 16.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.27 -0.894 . . . . 0.0 110.085 179.952 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.803 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 48.8 p90 -167.77 151.27 6.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.23 -0.919 . . . . 0.0 110.279 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 58' ' ' THR . 3.1 m -89.89 90.71 8.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.209 -0.932 . . . . 0.0 110.012 179.787 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.7 ' HB1' HG21 ' A' ' 54' ' ' ILE . . . -52.41 116.26 2.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.244 -0.91 . . . . 0.0 110.314 -179.828 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.445 ' H ' HG12 ' A' ' 88' ' ' VAL . 55.4 p -99.4 54.83 0.97 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.262 -0.899 . . . . 0.0 110.082 179.836 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -165.06 -160.15 0.47 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.261 -0.9 . . . . 0.0 110.37 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.906 HG22 ' HD3' ' A' ' 113' ' ' PRO . 85.1 m -144.0 116.69 8.7 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.267 -0.896 . . . . 0.0 110.264 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.604 ' CD2' HG13 ' A' ' 54' ' ' ILE . 20.4 m-30 -114.49 73.43 2.8 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.251 -0.905 . . . . 0.0 110.043 179.92 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.906 ' HD3' HG22 ' A' ' 111' ' ' THR . 43.9 Cg_endo -70.47 -163.18 0.11 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.998 1.525 . . . . 0.0 110.465 -179.962 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.487 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -131.95 21.39 4.54 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.237 -0.914 . . . . 0.0 110.223 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 20.2 p -100.97 100.82 13.85 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.208 -0.933 . . . . 0.0 110.124 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.487 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 45.8 Cg_endo -72.92 79.21 2.02 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.985 1.518 . . . . 0.0 110.381 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.808 ' HB3' ' HB2' ' A' ' 120' ' ' ASP . . . -117.64 176.43 5.18 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.259 -0.901 . . . . 0.0 110.178 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -74.41 -58.75 3.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.215 -0.928 . . . . 0.0 110.222 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -85.02 -0.26 53.81 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 110.311 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.808 ' HB2' ' HB3' ' A' ' 117' ' ' ALA . 1.8 m-20 -130.71 86.7 51.84 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.268 -0.895 . . . . 0.0 110.248 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.532 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 48.6 Cg_endo -75.21 -167.47 0.43 Allowed 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.981 1.516 . . . . 0.0 110.32 179.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.519 ' OE1' ' N ' ' A' ' 122' ' ' GLU . 22.5 pm0 -140.63 -145.78 0.18 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.144 -0.973 . . . . 0.0 110.264 179.768 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.552 ' HA2' ' HA ' ' A' ' 80' ' ' GLN . . . -147.45 157.84 27.52 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.686 ' HA ' HG23 ' A' ' 52' ' ' VAL . 2.4 pt20 -150.43 -157.55 0.83 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.276 -1.132 . . . . 0.0 110.6 -179.58 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.606 HG21 ' CH2' ' A' ' 16' ' ' TRP . 12.4 mt -118.45 142.92 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.464 -0.773 . . . . 0.0 109.068 179.382 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.47 ' HB3' HD11 ' A' ' 77' ' ' LEU . . . -121.32 123.56 42.46 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.258 -0.901 . . . . 0.0 111.032 -179.351 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.481 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 4.9 m-85 -118.59 109.38 16.09 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 178.446 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.501 ' HB2' ' HB2' ' A' ' 75' ' ' ARG . 1.3 mm100 -88.65 102.53 15.06 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.231 -0.918 . . . . 0.0 111.901 -177.497 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.495 ' HG ' ' HA2' ' A' ' 46' ' ' GLY . 13.9 mt -107.42 45.06 1.02 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 178.289 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -95.57 78.1 0.82 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.453 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.576 ' O ' ' CG ' ' A' ' 132' ' ' PHE . . . 78.61 110.3 0.2 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.747 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.695 ' CB ' HG12 ' A' ' 74' ' ' VAL . 26.0 m-85 -161.57 -49.02 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.22 -1.165 . . . . 0.0 110.355 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.624 ' HB2' HG21 ' A' ' 72' ' ' VAL . 1.0 OUTLIER -89.43 -140.13 0.14 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.046 -1.034 . . . . 0.0 110.1 179.888 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -133.95 -83.37 0.45 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.17 -0.956 . . . . 0.0 110.364 -179.917 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.434 ' O ' ' C ' ' A' ' 136' ' ' ALA . 1.1 m-20 -81.53 162.87 23.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.192 -0.942 . . . . 0.0 110.283 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.472 ' N ' ' HA ' ' A' ' 38' ' ' ALA . . . -41.21 123.35 2.04 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.333 -0.854 . . . . 0.0 110.263 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 1.057 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 11.4 p90 -137.22 -173.15 3.38 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.174 -0.953 . . . . 0.0 110.619 -179.93 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.521 ' C ' HD12 ' A' ' 139' ' ' LEU . 0.8 OUTLIER -151.07 174.19 13.48 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.432 -0.792 . . . . 0.0 110.073 -178.024 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.864 HD21 ' CD1' ' A' ' 95' ' ' LEU . 1.7 mp -139.82 119.38 13.12 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.153 -0.967 . . . . 0.0 112.059 -179.679 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' CYS . . . . . 0.64 ' SG ' ' HB3' ' A' ' 31' ' ' ALA . 0.8 OUTLIER -103.27 108.37 19.56 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.618 -0.676 . . . . 0.0 110.878 178.132 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.545 HD23 ' HB2' ' A' ' 66' ' ' ALA . 1.4 mt -94.55 -178.93 4.72 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.285 -0.885 . . . . 0.0 108.792 178.513 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.732 ' O ' HG22 ' A' ' 8' ' ' THR . 0.4 OUTLIER 168.29 55.38 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.063 -1.023 . . . . 0.0 110.98 -179.963 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.535 ' HB2' ' O ' ' A' ' 142' ' ' ASP . 10.9 t70 172.91 46.81 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.469 -0.769 . . . . 0.0 109.132 179.56 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.883 HG11 ' HZ2' ' A' ' 16' ' ' TRP . 1.3 t -91.71 112.93 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.16 -0.962 . . . . 0.0 110.646 -179.043 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.469 ' HB2' ' HG3' ' A' ' 6' ' ' GLU . . . -149.43 147.17 27.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.488 -0.758 . . . . 0.0 110.041 179.85 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.985 HD21 HD11 ' A' ' 54' ' ' ILE . 10.8 tp -141.49 125.2 16.9 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.388 -0.82 . . . . 0.0 110.237 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.49 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -133.81 174.33 10.57 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.197 -0.94 . . . . 0.0 110.207 179.977 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 149' ' ' GLU . 57.5 p -119.98 141.72 49.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.207 -0.933 . . . . 0.0 110.32 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 148' ' ' SER . 15.1 tt0 42.64 93.87 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.238 -0.914 . . . . 0.0 110.306 179.964 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 150' ' ' VAL . 7.3 p -141.79 22.01 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.267 -0.896 . . . . 0.0 110.165 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -109.83 91.26 3.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.913 . . . . 0.0 110.283 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.543 HD22 ' N ' ' A' ' 152' ' ' LEU . 4.2 mm? . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.189 -179.984 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.458 ' HA ' ' CG ' ' A' ' 147' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.277 0.561 . . . . 0.0 110.213 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.444 ' HB2' ' O ' ' A' ' 1' ' ' ALA . 7.8 t -177.81 109.5 0.22 Allowed Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.32 -0.862 . . . . 0.0 110.068 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.455 ' HB2' ' O ' ' A' ' 51' ' ' GLY . 51.1 Cg_endo -80.97 19.58 1.12 Allowed 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.986 1.519 . . . . 0.0 111.115 -179.832 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.477 HD12 ' CG1' ' A' ' 144' ' ' VAL . 6.1 pt -138.78 -37.01 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.997 -1.065 . . . . 0.0 110.118 179.906 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.451 ' N ' ' CG1' ' A' ' 4' ' ' ILE . . . 161.36 126.59 0.83 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -73.52 81.99 1.48 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.258 -1.142 . . . . 0.0 110.192 179.991 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 144' ' ' VAL . . . 114.59 -123.37 5.99 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.798 HG22 ' O ' ' A' ' 142' ' ' ASP . 15.6 p -80.5 179.04 7.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.29 -1.123 . . . . 0.0 110.136 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.687 ' CE1' HG21 ' A' ' 144' ' ' VAL . 23.0 m-85 -68.57 -35.78 77.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.306 -0.871 . . . . 0.0 109.579 179.735 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.552 ' O ' ' HB2' ' A' ' 11' ' ' ASP . 23.2 t0 38.09 42.74 0.5 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.645 -0.659 . . . . 0.0 110.705 179.308 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.552 ' HB2' ' O ' ' A' ' 10' ' ' ASP . 4.3 t0 161.9 71.07 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 121.508 0.671 . . . . 0.0 109.545 179.871 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.47 ' HA2' ' HB ' ' A' ' 27' ' ' THR . . . 43.95 -168.5 0.02 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.723 ' HB3' HD12 ' A' ' 32' ' ' LEU . 51.1 Cg_endo -74.43 81.47 2.05 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.121 1.59 . . . . 0.0 110.337 179.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.485 ' C ' ' O ' ' A' ' 13' ' ' PRO . 0.2 OUTLIER -31.77 -67.51 0.1 Allowed 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.292 0.568 . . . . 0.0 111.183 -179.614 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.5 ' C ' ' CD1' ' A' ' 49' ' ' LEU . . . -145.75 10.24 1.64 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.946 ' CE2' HD22 ' A' ' 49' ' ' LEU . 66.4 m95 -78.06 88.95 4.18 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.149 -1.207 . . . . 0.0 110.257 -179.863 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.719 ' O ' HG13 ' A' ' 47' ' ' VAL . 0.8 OUTLIER -85.18 144.88 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.093 -1.004 . . . . 0.0 109.44 179.802 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.454 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . . . -128.64 128.81 44.88 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.025 -1.047 . . . . 0.0 109.93 179.554 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.798 ' HE2' HG13 ' A' ' 48' ' ' VAL . 23.4 p90 -113.24 145.49 40.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.451 -0.781 . . . . 0.0 110.397 -179.302 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.615 ' HA3' HG13 ' A' ' 45' ' ' VAL . . . 156.77 -91.03 0.12 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.539 ' CG2' ' HG3' ' A' ' 37' ' ' PRO . 5.5 p -151.96 18.92 0.68 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.254 -1.145 . . . . 0.0 110.051 179.675 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.476 ' HB3' ' O ' ' A' ' 35' ' ' ALA . 2.0 p30 -102.76 147.72 26.5 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.28 -0.887 . . . . 0.0 110.197 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.68 -138.13 0.15 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.801 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.417 ' O ' ' C ' ' A' ' 25' ' ' LEU . 46.2 Cg_endo -73.62 133.46 18.82 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.044 1.549 . . . . 0.0 110.346 179.865 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.858 HD22 HD11 ' A' ' 32' ' ' LEU . 7.8 mt -42.53 113.52 0.47 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.254 -0.904 . . . . 0.0 110.083 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.487 ' HB3' ' HB2' ' A' ' 33' ' ' CYS . 29.5 t70 -66.4 101.37 0.74 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.23 -0.919 . . . . 0.0 110.188 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.694 ' O ' HG22 ' A' ' 29' ' ' THR . 1.5 p -119.23 -81.32 0.63 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.296 -0.877 . . . . 0.0 109.955 -179.911 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.462 ' O ' ' HB ' ' A' ' 29' ' ' THR . 22.5 p 42.16 36.23 0.68 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.254 -0.903 . . . . 0.0 110.442 179.811 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.694 HG22 ' O ' ' A' ' 27' ' ' THR . 12.2 t -177.97 -31.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.3 -0.875 . . . . 0.0 110.194 179.914 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 9' ' ' PHE . . . 126.35 2.19 7.04 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.946 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 141' ' ' LEU . . . -111.29 109.83 20.03 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.212 -1.169 . . . . 0.0 110.24 179.992 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.858 HD11 HD22 ' A' ' 25' ' ' LEU . 1.0 OUTLIER -68.51 102.37 1.44 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.281 -0.887 . . . . 0.0 109.966 179.943 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.51 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 34.2 m -108.19 103.61 12.84 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.319 -0.863 . . . . 0.0 110.514 -179.687 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.807 HG12 HD23 ' A' ' 25' ' ' LEU . 19.5 m -89.71 155.51 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.262 -0.899 . . . . 0.0 109.762 179.621 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.514 ' HA ' ' OG1' ' A' ' 138' ' ' THR . . . -103.87 101.26 11.06 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.249 -0.907 . . . . 0.0 111.346 -179.111 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.031 HG11 ' CE2' ' A' ' 137' ' ' TRP . 91.4 t -84.41 123.07 75.25 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.168 -0.958 . . . . 0.0 109.009 178.794 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.539 ' HG3' ' CG2' ' A' ' 21' ' ' THR . 43.2 Cg_endo -67.85 147.33 74.62 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.87 1.458 . . . . 0.0 111.347 -178.866 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.581 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -47.37 116.47 1.43 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.312 -0.868 . . . . 0.0 109.817 179.659 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.1 71.91 1.16 Allowed Glycine 0 N--CA 1.486 1.99 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 -179.51 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.755 ' HB2' HG21 ' A' ' 45' ' ' VAL . 0.4 OUTLIER -84.89 43.96 1.03 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.324 -1.103 . . . . 0.0 109.807 -179.987 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.522 ' O ' ' HG2' ' A' ' 42' ' ' GLN . . . -88.5 -139.46 0.12 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.491 -0.755 . . . . 0.0 110.029 179.871 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.561 ' HG2' ' N ' ' A' ' 43' ' ' TYR . 0.0 OUTLIER 42.79 -140.98 0.14 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.543 -0.723 . . . . 0.0 110.346 -179.479 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.73 ' OH ' HG22 ' A' ' 45' ' ' VAL . 8.3 p90 -28.96 -39.51 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.175 0 CA-C-O 121.143 0.497 . . . . 0.0 110.929 -179.136 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.599 ' O ' ' CD1' ' A' ' 43' ' ' TYR . . . 89.76 132.96 4.93 Favored Glycine 0 N--CA 1.493 2.441 0 C-N-CA 120.041 -1.076 . . . . 0.0 110.674 178.22 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.755 HG21 ' HB2' ' A' ' 40' ' ' SER . 2.6 t -89.85 179.52 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.364 -1.08 . . . . 0.0 108.908 179.238 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.532 ' HA2' ' HA ' ' A' ' 128' ' ' GLN . . . 173.57 -177.58 45.86 Favored Glycine 0 N--CA 1.488 2.118 0 C-N-CA 119.024 -1.56 . . . . 0.0 110.668 -179.886 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.719 HG13 ' O ' ' A' ' 17' ' ' VAL . 21.6 t -150.65 132.43 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.737 -0.861 . . . . 0.0 108.768 179.779 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.798 HG13 ' HE2' ' A' ' 19' ' ' TYR . 31.1 m -119.66 131.7 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.976 -1.077 . . . . 0.0 110.69 -179.383 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.946 HD22 ' CE2' ' A' ' 16' ' ' TRP . 30.0 tp -124.06 90.76 3.32 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.439 -0.788 . . . . 0.0 110.353 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.522 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 22.0 p30 -75.2 145.84 41.71 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.271 -0.893 . . . . 0.0 110.237 179.881 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.455 ' O ' ' HB2' ' A' ' 3' ' ' PRO . . . 122.19 63.48 0.22 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.969 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.594 HG12 ' N ' ' A' ' 53' ' ' ALA . 53.5 t -121.96 171.9 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.235 -1.156 . . . . 0.0 109.968 179.807 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.594 ' N ' HG12 ' A' ' 52' ' ' VAL . . . -141.88 77.91 1.61 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.072 -1.017 . . . . 0.0 110.804 -179.742 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.595 HG13 ' CD2' ' A' ' 112' ' ' TYR . 35.6 mm -112.34 159.24 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.177 -0.952 . . . . 0.0 109.622 179.343 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.534 ' HA ' HG23 ' A' ' 111' ' ' THR . 0.6 OUTLIER -153.48 132.25 12.34 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.04 -1.037 . . . . 0.0 110.836 -179.634 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 19.4 pt-20 37.72 -155.49 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.67 -0.644 . . . . 0.0 110.994 179.488 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' A' ' 109' ' ' SER . . . -85.95 80.92 1.75 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.776 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.569 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.2 m -105.72 173.88 6.12 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.268 -1.137 . . . . 0.0 109.73 179.76 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.559 ' N ' ' CG2' ' A' ' 58' ' ' THR . 0.6 OUTLIER -89.7 154.78 19.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.144 -0.972 . . . . 0.0 110.411 -179.731 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.608 ' CE2' ' HB3' ' A' ' 108' ' ' ALA . 55.8 m-85 -159.87 178.5 9.69 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.32 -0.862 . . . . 0.0 110.3 179.905 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 104' ' ' GLU . 32.8 m -150.13 123.61 9.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.337 -0.852 . . . . 0.0 109.925 179.8 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.6 tp -89.44 118.63 29.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.186 -0.946 . . . . 0.0 110.067 -179.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.524 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 2.1 tpt180 -127.97 114.47 17.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.31 -0.869 . . . . 0.0 110.204 -179.761 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 1.163 ' CZ ' HG21 ' A' ' 102' ' ' VAL . 0.4 OUTLIER -157.99 141.19 15.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.155 -0.966 . . . . 0.0 110.037 179.591 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.537 ' CG2' ' HG2' ' A' ' 101' ' ' GLN . 18.7 m -119.42 98.91 6.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.916 . . . . 0.0 109.976 -179.834 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.759 ' HB2' HD23 ' A' ' 141' ' ' LEU . . . -103.51 152.35 21.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.335 -0.853 . . . . 0.0 110.368 -179.669 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.71 HG23 ' O ' ' A' ' 98' ' ' GLU . 98.1 m -150.2 108.32 3.74 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.235 -0.915 . . . . 0.0 110.289 179.922 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -92.84 136.05 33.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.238 -0.914 . . . . 0.0 109.975 179.836 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 68' ' ' ALA . 12.2 t -44.93 -26.14 0.39 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.082 -1.011 . . . . 0.0 109.343 179.57 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.669 HG22 ' HB2' ' A' ' 137' ' ' TRP . 3.2 t -113.71 -179.69 3.71 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.527 -0.733 . . . . 0.0 109.806 179.708 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.499 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 37.5 t0 -94.4 69.48 3.63 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.16 -0.962 . . . . 0.0 109.545 179.253 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.828 HG23 ' CB ' ' A' ' 133' ' ' SER . 4.7 p -92.1 147.34 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.259 -0.901 . . . . 0.0 111.045 -179.278 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.54 HG22 ' O ' ' A' ' 73' ' ' THR . 3.5 m -128.6 89.45 2.89 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.078 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.779 HG21 HD22 ' A' ' 129' ' ' LEU . 10.7 m -89.64 -151.2 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.228 -0.92 . . . . 0.0 110.49 -179.116 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.527 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 34.9 mtm-85 -128.05 137.6 52.24 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.206 -0.934 . . . . 0.0 110.761 -179.295 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.805 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -139.28 155.38 47.77 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.356 -0.84 . . . . 0.0 109.881 179.455 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.922 ' CD1' ' HB3' ' A' ' 126' ' ' ALA . 1.3 pp 175.23 -157.4 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.327 -0.858 . . . . 0.0 109.982 -179.601 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.928 HG23 HD22 ' A' ' 89' ' ' LEU . 4.9 t -147.85 168.54 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.204 -0.935 . . . . 0.0 109.41 179.762 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.485 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . -177.8 176.78 48.2 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.339 -1.41 . . . . 0.0 109.906 -179.882 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.486 ' NE2' ' C ' ' A' ' 81' ' ' ASN . 13.6 tp60 -107.31 135.43 48.83 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.31 -1.112 . . . . 0.0 110.534 179.931 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.552 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 2.4 m120 -123.26 96.77 5.12 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 122.072 0.939 . . . . 0.0 108.894 178.644 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.646 ' CA ' ' HD2' ' A' ' 121' ' ' PRO . . . 132.9 34.21 0.35 Allowed Glycine 0 N--CA 1.484 1.861 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.214 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 82' ' ' GLY . . . 60.15 143.94 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.264 -1.139 . . . . 0.0 110.235 -179.861 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.46 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.5 Cg_endo -82.22 18.45 17.86 Favored 'Cis proline' 0 C--N 1.313 -1.303 0 C-N-CA 121.868 -2.138 . . . . 0.0 110.869 -0.139 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.502 ' CD2' ' HA ' ' A' ' 83' ' ' ALA . 94.1 m-85 57.28 170.26 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.152 -0.967 . . . . 0.0 110.439 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 136.6 117.93 1.7 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.442 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 0.8 OUTLIER -97.78 145.69 26.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.195 -1.179 . . . . 0.0 110.185 179.863 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.96 HG23 HD12 ' A' ' 89' ' ' LEU . 29.4 m -123.98 -17.45 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.265 -0.897 . . . . 0.0 110.359 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.96 HD12 HG23 ' A' ' 88' ' ' VAL . 4.0 mp -108.5 136.96 47.25 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.189 -0.945 . . . . 0.0 111.009 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -150.97 82.2 1.33 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.457 -0.777 . . . . 0.0 109.836 179.601 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.2 p -140.06 178.5 7.23 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.033 -1.042 . . . . 0.0 110.741 -179.598 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.7 m -119.81 111.97 35.51 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.456 -0.777 . . . . 0.0 109.863 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.805 ' HG3' ' HB2' ' A' ' 76' ' ' ALA . 43.6 Cg_endo -70.1 99.57 0.79 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.957 1.503 . . . . 0.0 110.866 -179.764 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.518 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -76.23 153.21 36.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 0.0 109.687 179.504 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.712 HD21 ' CB ' ' A' ' 66' ' ' ALA . 72.7 mt -142.54 168.83 18.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.118 -0.989 . . . . 0.0 110.492 -179.751 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 70' ' ' THR . 0.3 OUTLIER -177.22 -178.82 0.82 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.411 -0.805 . . . . 0.0 110.038 -179.966 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.7 -8.23 26.38 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.228 -0.92 . . . . 0.0 110.148 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.71 ' O ' HG23 ' A' ' 67' ' ' THR . 11.3 mt-10 -106.17 168.22 8.51 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.907 . . . . 0.0 110.097 179.87 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.491 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 46.4 Cg_endo -72.83 130.26 15.46 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.046 1.55 . . . . 0.0 110.363 179.993 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.518 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 3.1 ttm-85 -119.91 92.42 3.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.176 -0.953 . . . . 0.0 110.251 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.537 ' HG2' ' CG2' ' A' ' 65' ' ' THR . 1.7 mt-30 -75.11 153.23 38.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.33 -0.856 . . . . 0.0 109.975 179.845 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 1.163 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 39.4 t -130.35 133.56 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.18 -0.95 . . . . 0.0 110.387 -179.945 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.526 ' O ' ' CG ' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -150.35 124.35 9.33 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.356 -0.84 . . . . 0.0 110.065 -179.987 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.526 ' CG ' ' O ' ' A' ' 103' ' ' THR . 35.3 mt-10 -157.56 154.53 28.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.256 -0.902 . . . . 0.0 110.315 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.2 m -117.39 114.67 23.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.261 -0.899 . . . . 0.0 110.042 179.898 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.959 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 35.4 p90 -127.27 155.42 43.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.195 -0.94 . . . . 0.0 110.342 -179.782 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.422 ' O ' HG22 ' A' ' 107' ' ' THR . 21.0 m -93.12 89.04 6.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.296 -0.878 . . . . 0.0 109.977 179.7 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.608 ' HB3' ' CE2' ' A' ' 60' ' ' TYR . . . -42.61 100.06 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.245 -0.909 . . . . 0.0 110.346 -179.855 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.47 ' H ' HG12 ' A' ' 88' ' ' VAL . 43.2 p -88.81 51.87 2.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.262 -0.899 . . . . 0.0 110.144 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.424 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -159.18 -152.81 0.33 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.264 -0.898 . . . . 0.0 110.301 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.534 HG23 ' HA ' ' A' ' 55' ' ' GLU . 25.1 m -153.5 119.07 5.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.886 . . . . 0.0 110.204 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.595 ' CD2' HG13 ' A' ' 54' ' ' ILE . 17.8 m-30 -113.95 89.7 17.28 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.303 -0.873 . . . . 0.0 109.942 179.829 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.484 ' HD2' ' OE1' ' A' ' 80' ' ' GLN . 44.9 Cg_endo -71.84 -158.69 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.028 1.541 . . . . 0.0 110.406 -179.928 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.432 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -153.94 36.89 0.44 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.221 -0.925 . . . . 0.0 110.244 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.451 HG22 ' O ' ' A' ' 115' ' ' THR . 7.2 m -106.6 95.0 11.03 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.307 -0.87 . . . . 0.0 110.203 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.49 ' HA ' ' O ' ' A' ' 120' ' ' ASP . 46.4 Cg_endo -73.16 128.37 12.93 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.014 1.534 . . . . 0.0 110.465 -179.945 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.72 ' HB3' ' HB2' ' A' ' 120' ' ' ASP . . . -150.05 -163.55 1.81 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.272 -0.892 . . . . 0.0 110.193 179.895 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.73 -11.75 48.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.229 -0.919 . . . . 0.0 110.194 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -160.3 21.98 0.16 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.201 -0.937 . . . . 0.0 110.148 179.941 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.72 ' HB2' ' HB3' ' A' ' 117' ' ' ALA . 79.9 m-20 -122.82 69.83 37.01 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.272 -0.893 . . . . 0.0 110.206 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.646 ' HD2' ' CA ' ' A' ' 82' ' ' GLY . 44.0 Cg_endo -76.48 18.06 0.73 Allowed 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 124.067 1.561 . . . . 0.0 112.505 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.552 ' O ' ' HB2' ' A' ' 81' ' ' ASN . 6.6 pt-20 40.72 -170.33 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.623 -0.673 . . . . 0.0 111.133 178.922 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -106.01 158.94 15.4 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 -179.429 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.522 ' CB ' ' HA ' ' A' ' 50' ' ' ASN . 17.1 pt20 -150.63 -151.76 0.41 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.366 -1.079 . . . . 0.0 110.621 -179.806 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.877 HG21 ' CH2' ' A' ' 16' ' ' TRP . 23.9 mt -118.56 146.51 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.616 -0.677 . . . . 0.0 109.425 179.665 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.922 ' HB3' ' CD1' ' A' ' 77' ' ' LEU . . . -116.15 114.87 25.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.336 -0.853 . . . . 0.0 111.744 -178.879 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.548 ' HB2' ' HB ' ' A' ' 47' ' ' VAL . 4.0 m-85 -119.81 75.69 1.1 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.247 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.741 ' C ' HD23 ' A' ' 129' ' ' LEU . 12.9 mt-30 -88.42 123.27 32.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.196 -0.94 . . . . 0.0 111.902 -177.754 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.993 HD13 HD13 ' A' ' 139' ' ' LEU . 3.6 mt -107.76 51.77 0.73 Allowed 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.746 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -96.1 130.75 10.38 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.627 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.577 ' O ' ' CD1' ' A' ' 132' ' ' PHE . . . 51.14 93.81 0.01 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.686 ' CD2' HG12 ' A' ' 74' ' ' VAL . 9.5 m-85 -158.86 -78.23 0.07 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.281 -1.129 . . . . 0.0 110.419 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.828 ' CB ' HG23 ' A' ' 72' ' ' VAL . 1.3 t -89.66 168.39 12.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.096 -1.003 . . . . 0.0 110.339 -179.812 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -98.26 -91.56 0.26 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.274 -0.892 . . . . 0.0 110.316 -179.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -46.65 158.05 0.13 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.081 -1.012 . . . . 0.0 110.35 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.581 ' HB2' ' HB2' ' A' ' 38' ' ' ALA . . . -54.48 128.66 32.93 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.313 -0.867 . . . . 0.0 110.333 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 1.031 ' CE2' HG11 ' A' ' 36' ' ' VAL . 8.9 p90 -135.24 -163.35 1.37 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.306 -0.871 . . . . 0.0 110.009 179.674 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.589 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 0.8 OUTLIER -160.95 176.5 11.34 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.195 -1.002 . . . . 0.0 110.696 -178.382 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.993 HD13 HD13 ' A' ' 129' ' ' LEU . 2.1 mp -133.52 126.04 30.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.464 -0.773 . . . . 0.0 109.605 179.172 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' CYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 33.4 m -121.94 98.77 6.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.032 -1.043 . . . . 0.0 110.91 -179.536 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.759 HD23 ' HB2' ' A' ' 66' ' ' ALA . 2.2 mt -89.8 -179.91 5.85 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -0.927 . . . . 0.0 109.318 179.067 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.798 ' O ' HG22 ' A' ' 8' ' ' THR . 2.7 p30 168.03 41.08 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.289 -0.882 . . . . 0.0 110.104 179.908 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.471 ' HA ' ' C ' ' A' ' 7' ' ' GLY . 0.3 OUTLIER -174.98 52.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.289 -0.882 . . . . 0.0 109.659 -179.877 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.687 HG21 ' CE1' ' A' ' 9' ' ' PHE . 1.4 t -89.2 121.27 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.349 -0.845 . . . . 0.0 109.917 -179.44 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.457 ' HB3' ' HB3' ' A' ' 63' ' ' ARG . . . -144.41 140.87 29.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.329 -0.857 . . . . 0.0 110.293 -179.631 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.482 HD21 HD11 ' A' ' 54' ' ' ILE . 13.6 tp -148.08 123.82 10.54 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.376 -0.828 . . . . 0.0 110.072 179.839 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.477 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 7.3 t0 -136.15 -177.31 4.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.179 -0.951 . . . . 0.0 110.295 -179.893 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.3 p -134.53 173.7 11.37 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.253 -0.904 . . . . 0.0 110.129 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.461 ' O ' ' HB ' ' A' ' 150' ' ' VAL . 0.0 OUTLIER -104.44 45.81 0.94 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.215 -0.928 . . . . 0.0 110.237 179.995 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.461 ' HB ' ' O ' ' A' ' 149' ' ' GLU . 6.2 p -179.6 139.81 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.247 -0.908 . . . . 0.0 110.222 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 150' ' ' VAL . 78.1 mt-10 -43.97 161.8 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.244 -0.91 . . . . 0.0 110.214 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.841 HD13 ' OXT' ' A' ' 152' ' ' LEU . 2.9 tm? . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.231 -179.986 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.232 0.539 . . . . 0.0 110.208 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.6 m -113.31 85.5 8.65 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.275 -0.89 . . . . 0.0 110.223 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -76.48 -156.59 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.987 1.52 . . . . 0.0 110.115 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.53 HG22 ' O ' ' A' ' 51' ' ' GLY . 9.1 pt -95.51 19.49 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.278 -0.889 . . . . 0.0 110.097 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' A' ' 7' ' ' GLY . . . 79.94 70.39 1.33 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.965 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.583 ' HG2' ' HB1' ' A' ' 145' ' ' ALA . 82.6 mt-10 -42.42 94.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.31 -1.112 . . . . 0.0 110.198 -179.945 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 5' ' ' GLY . . . 173.99 -159.1 28.36 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.987 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.739 HG22 ' O ' ' A' ' 142' ' ' ASP . 11.9 p -98.34 -154.91 0.47 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.367 -1.078 . . . . 0.0 110.268 -179.851 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.523 ' CE1' ' CD1' ' A' ' 16' ' ' TRP . 64.6 m-85 -120.56 44.21 2.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.305 -0.872 . . . . 0.0 110.176 179.959 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.559 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 49.5 t0 -97.84 61.7 1.57 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.234 -0.916 . . . . 0.0 110.126 -179.973 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.559 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 2.5 t0 161.83 -23.72 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.745 -0.597 . . . . 0.0 109.652 -179.973 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 176.21 133.98 1.87 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.724 ' HB3' HD12 ' A' ' 32' ' ' LEU . 48.9 Cg_endo -78.02 6.15 4.83 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.906 1.477 . . . . 0.0 110.533 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.512 ' HB3' ' O ' ' A' ' 13' ' ' PRO . 5.6 tp10 60.66 -89.03 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.356 -0.84 . . . . 0.0 110.386 -179.793 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.833 ' C ' HD13 ' A' ' 49' ' ' LEU . . . -148.09 25.44 1.43 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -179.859 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.834 ' HZ2' HG11 ' A' ' 144' ' ' VAL . 57.1 m95 -72.12 86.39 1.05 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.166 -1.197 . . . . 0.0 110.354 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.716 ' O ' HG13 ' A' ' 47' ' ' VAL . 1.1 m -87.42 153.32 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.205 -0.934 . . . . 0.0 109.92 179.942 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.403 ' CB ' HG22 ' A' ' 47' ' ' VAL . . . -136.84 133.63 36.06 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.268 -0.895 . . . . 0.0 109.456 179.437 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.6 ' HE2' HG13 ' A' ' 48' ' ' VAL . 6.1 p90 -120.38 161.11 21.74 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.283 -0.886 . . . . 0.0 111.122 -178.635 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.589 ' HA2' ' CE1' ' A' ' 43' ' ' TYR . . . 72.96 49.15 17.82 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.88 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.544 HG22 ' CG1' ' A' ' 45' ' ' VAL . 11.5 p -148.12 -153.52 0.5 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.254 -1.145 . . . . 0.0 110.404 -179.956 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -89.87 44.02 1.18 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.326 -0.859 . . . . 0.0 110.079 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.56 -144.28 16.29 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.889 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.99 -159.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.973 1.512 . . . . 0.0 110.367 179.944 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.638 ' CD1' HD11 ' A' ' 32' ' ' LEU . 0.3 OUTLIER -111.51 -173.12 2.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.184 -0.947 . . . . 0.0 110.037 179.809 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -132.03 159.9 37.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.163 -0.96 . . . . 0.0 110.19 -179.88 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.462 HG21 ' HD3' ' A' ' 13' ' ' PRO . 0.7 OUTLIER -133.62 -34.57 1.03 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.254 -0.904 . . . . 0.0 110.258 -179.911 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.44 ' O ' ' OG1' ' A' ' 29' ' ' THR . 73.6 m 51.28 30.41 5.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.23 -0.919 . . . . 0.0 110.221 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.453 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 5.4 p 42.8 55.04 4.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.28 -0.888 . . . . 0.0 110.2 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.508 ' N ' ' HA ' ' A' ' 10' ' ' ASP . . . -169.55 -54.86 0.03 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.611 ' HB1' ' O ' ' A' ' 141' ' ' LEU . . . -149.88 149.91 31.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.211 -1.17 . . . . 0.0 110.32 -179.902 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.724 HD12 ' HB3' ' A' ' 13' ' ' PRO . 1.1 tp -79.97 103.15 9.66 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.243 -0.911 . . . . 0.0 109.822 179.739 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.486 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 23.2 m -109.6 105.85 15.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.212 -0.93 . . . . 0.0 110.778 -179.503 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.545 HG12 ' HB3' ' A' ' 25' ' ' LEU . 18.0 m -91.09 140.12 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.241 -0.912 . . . . 0.0 109.122 179.08 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.483 ' O ' ' HB ' ' A' ' 21' ' ' THR . . . -89.18 98.33 11.71 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.102 -0.999 . . . . 0.0 111.032 -179.052 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.073 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 48.3 t -83.72 130.09 56.98 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.267 -0.896 . . . . 0.0 109.617 179.168 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 21' ' ' THR . 43.6 Cg_endo -70.73 -179.25 3.2 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.815 1.429 . . . . 0.0 110.538 -179.742 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.573 ' HA ' ' N ' ' A' ' 136' ' ' ALA . . . -42.79 166.67 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.25 -0.906 . . . . 0.0 110.137 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.595 ' O ' ' N ' ' A' ' 41' ' ' ALA . . . -35.68 108.12 0.05 OUTLIER Glycine 0 N--CA 1.495 2.62 0 N-CA-C 109.169 -1.573 . . . . 0.0 109.169 179.798 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.919 ' HB2' HG23 ' A' ' 45' ' ' VAL . 0.4 OUTLIER -39.36 89.9 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.979 0.895 . . . . 0.0 110.263 -178.899 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.595 ' N ' ' O ' ' A' ' 39' ' ' GLY . . . -114.79 23.84 12.28 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 121.952 0.882 . . . . 0.0 109.673 -179.465 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.543 ' O ' ' CG ' ' A' ' 42' ' ' GLN . 0.9 OUTLIER 177.04 34.3 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.241 -179.891 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.589 ' CE1' ' HA2' ' A' ' 20' ' ' GLY . 0.1 OUTLIER -158.79 -28.19 0.07 Allowed 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 118.548 -1.261 . . . . 0.0 112.389 -177.806 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 43' ' ' TYR . . . 53.43 84.47 0.03 OUTLIER Glycine 0 N--CA 1.483 1.829 0 N-CA-C 105.285 -3.126 . . . . 0.0 105.285 -176.766 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.919 HG23 ' HB2' ' A' ' 40' ' ' SER . 3.0 t -86.61 143.08 12.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.301 -1.117 . . . . 0.0 109.665 -176.751 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.572 ' O ' ' CZ ' ' A' ' 19' ' ' TYR . . . -166.26 147.35 12.01 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.289 -1.434 . . . . 0.0 110.785 -179.058 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.716 HG13 ' O ' ' A' ' 17' ' ' VAL . 19.7 t -111.7 129.69 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.576 -0.955 . . . . 0.0 109.668 179.659 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.6 HG13 ' HE2' ' A' ' 19' ' ' TYR . 27.3 m -120.69 145.02 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.743 -1.223 . . . . 0.0 110.656 -179.624 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.833 HD13 ' C ' ' A' ' 15' ' ' GLY . 15.9 tp -144.45 117.38 8.81 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.262 -0.899 . . . . 0.0 110.34 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.515 ' HA ' ' CB ' ' A' ' 124' ' ' GLN . 5.2 p-10 -90.44 148.19 22.94 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.208 -0.932 . . . . 0.0 110.49 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.53 ' O ' HG22 ' A' ' 4' ' ' ILE . . . 126.44 78.62 0.29 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.837 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.689 HG12 HG12 ' A' ' 54' ' ' ILE . 3.7 t -132.79 158.45 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.181 -1.188 . . . . 0.0 110.135 179.781 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -105.71 61.21 0.66 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.167 -0.958 . . . . 0.0 110.472 -179.885 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.928 HD11 HD21 ' A' ' 146' ' ' LEU . 6.3 mm -123.63 151.42 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.194 -0.941 . . . . 0.0 109.846 179.731 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.739 ' HA ' HG23 ' A' ' 111' ' ' THR . 4.4 pt-20 -174.97 34.07 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.106 -0.996 . . . . 0.0 110.376 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' A' ' 55' ' ' GLU . 1.3 tt0 179.88 -174.66 0.26 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.426 -0.796 . . . . 0.0 110.256 -179.797 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.494 ' HA2' ' HA ' ' A' ' 109' ' ' SER . . . -94.27 68.01 1.4 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 108.239 -1.944 . . . . 0.0 108.239 178.956 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.685 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.0 OUTLIER -109.02 176.17 5.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.503 -0.998 . . . . 0.0 110.367 -178.963 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.582 ' O ' ' CD2' ' A' ' 60' ' ' TYR . 0.4 OUTLIER -89.73 158.62 17.46 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.415 -0.803 . . . . 0.0 110.23 -179.941 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.685 ' CE2' HG22 ' A' ' 58' ' ' THR . 68.2 m-85 -156.14 -176.75 6.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.443 -0.786 . . . . 0.0 109.834 179.906 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 26.6 m -150.11 113.42 4.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.196 -0.94 . . . . 0.0 110.187 179.889 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.962 HD22 ' CD2' ' A' ' 89' ' ' LEU . 18.0 tp -89.71 120.86 31.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 110.032 179.821 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.799 ' HG2' HG23 ' A' ' 103' ' ' THR . 19.5 mtp-105 -128.4 130.73 48.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.282 -0.887 . . . . 0.0 110.099 179.961 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.548 ' CE2' ' HB ' ' A' ' 102' ' ' VAL . 8.7 p90 -165.48 152.77 10.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.262 -0.899 . . . . 0.0 109.923 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.504 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 25.6 m -119.67 93.95 4.24 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.097 -1.002 . . . . 0.0 109.968 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.551 ' HB2' HD23 ' A' ' 141' ' ' LEU . . . -96.33 154.54 17.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.274 -0.891 . . . . 0.0 110.939 -179.482 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.569 HG23 ' O ' ' A' ' 98' ' ' GLU . 50.9 m -149.69 134.94 18.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.562 -0.711 . . . . 0.0 109.39 179.263 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.534 ' N ' ' HB3' ' A' ' 95' ' ' LEU . . . -120.86 133.94 55.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.064 -1.023 . . . . 0.0 110.282 -179.685 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 68' ' ' ALA . 11.6 t -43.83 -26.17 0.24 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.27 -0.894 . . . . 0.0 109.547 179.546 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.73 HG22 ' HB2' ' A' ' 137' ' ' TRP . 5.7 t -115.21 -167.15 1.2 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.436 -0.79 . . . . 0.0 109.824 179.703 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.474 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 34.4 t0 -102.93 47.0 0.9 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.274 -0.891 . . . . 0.0 109.371 179.125 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.829 HG23 ' HB2' ' A' ' 133' ' ' SER . 1.9 p -63.46 171.53 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.429 -0.794 . . . . 0.0 110.824 -179.227 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.513 HG22 ' O ' ' A' ' 73' ' ' THR . 11.9 m -160.33 83.81 0.7 Allowed 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.67 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.997 HG21 ' CD2' ' A' ' 129' ' ' LEU . 2.4 m -89.9 -160.05 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.265 -0.897 . . . . 0.0 110.547 -178.616 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.465 ' N ' HG23 ' A' ' 74' ' ' VAL . 20.8 mtm-85 -121.28 112.97 19.27 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.256 -0.902 . . . . 0.0 110.328 -179.613 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.518 ' CB ' ' HD3' ' A' ' 93' ' ' PRO . . . -115.7 157.15 24.7 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.145 -0.972 . . . . 0.0 110.097 179.849 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.908 HD12 ' N ' ' A' ' 78' ' ' VAL . 3.8 pp 178.73 -147.3 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.409 -0.807 . . . . 0.0 109.851 -179.828 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.908 ' N ' HD12 ' A' ' 77' ' ' LEU . 3.1 t -151.92 172.57 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.115 -0.991 . . . . 0.0 109.563 179.773 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.494 ' HA2' ' HA ' ' A' ' 87' ' ' THR . . . 176.07 172.7 41.08 Favored Glycine 0 N--CA 1.49 2.276 0 C-N-CA 119.36 -1.4 . . . . 0.0 110.138 179.892 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.491 ' OE1' ' HD2' ' A' ' 113' ' ' PRO . 15.1 tp60 -93.04 137.72 32.14 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.4 -1.059 . . . . 0.0 110.355 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.532 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 3.6 m120 -123.3 96.4 4.98 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.839 0.828 . . . . 0.0 109.02 178.943 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.646 ' CA ' ' HD2' ' A' ' 121' ' ' PRO . . . 132.31 34.4 0.37 Allowed Glycine 0 N--CA 1.484 1.878 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.523 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 82' ' ' GLY . . . 60.41 142.95 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.282 -1.128 . . . . 0.0 110.14 -179.86 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.463 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.3 Cg_endo -82.28 18.6 17.7 Favored 'Cis proline' 0 C--N 1.314 -1.255 0 C-N-CA 121.938 -2.109 . . . . 0.0 110.813 -0.159 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.541 ' CD2' ' HA ' ' A' ' 83' ' ' ALA . 75.7 m-85 58.91 170.02 0.06 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.153 -0.967 . . . . 0.0 110.342 -179.911 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 142.33 114.64 1.06 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.494 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 1.1 p -91.26 147.83 22.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.188 -1.183 . . . . 0.0 110.299 -179.963 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 1.032 HG23 HD12 ' A' ' 89' ' ' LEU . 15.6 m -123.12 -21.81 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.299 -0.876 . . . . 0.0 110.266 179.98 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 1.032 HD12 HG23 ' A' ' 88' ' ' VAL . 3.9 mp -104.94 146.76 28.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.239 -0.913 . . . . 0.0 110.7 179.735 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.733 ' O ' HG23 ' A' ' 91' ' ' THR . 8.9 t0 -151.03 89.04 1.49 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.324 -0.86 . . . . 0.0 110.142 179.727 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.733 HG23 ' O ' ' A' ' 90' ' ' ASP . 6.5 p -160.0 -178.98 7.4 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.123 -0.986 . . . . 0.0 110.584 -179.862 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.529 ' CB ' ' O ' ' A' ' 74' ' ' VAL . 3.5 m -129.08 129.49 23.38 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.329 -0.857 . . . . 0.0 110.07 179.927 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.844 ' HG2' HG22 ' A' ' 74' ' ' VAL . 46.9 Cg_endo -72.28 91.44 0.76 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.935 1.492 . . . . 0.0 110.994 -179.719 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.522 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -70.48 125.14 25.96 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.073 -1.017 . . . . 0.0 109.002 178.972 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.542 ' CD1' ' HG ' ' A' ' 139' ' ' LEU . 29.4 mt -119.83 170.48 9.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.113 -0.992 . . . . 0.0 110.846 -179.023 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.601 HG23 ' N ' ' A' ' 97' ' ' SER . 6.1 t -169.36 -151.18 0.09 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.394 -0.816 . . . . 0.0 109.735 179.886 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.601 ' N ' HG23 ' A' ' 96' ' ' THR . 0.5 OUTLIER -93.41 25.51 3.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.046 -1.034 . . . . 0.0 110.043 179.8 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.569 ' O ' HG23 ' A' ' 67' ' ' THR . 2.0 mt-10 -145.84 171.99 5.83 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.34 -0.85 . . . . 0.0 109.959 179.847 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.57 130.83 16.51 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 124.005 1.529 . . . . 0.0 110.379 -179.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.522 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 1.7 mtt180 -119.7 93.2 3.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.254 -0.904 . . . . 0.0 110.006 179.915 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -82.99 95.24 7.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.448 -0.783 . . . . 0.0 110.45 -179.767 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.548 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 73.6 t -89.47 133.51 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.277 -0.89 . . . . 0.0 110.013 179.836 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.799 HG23 ' HG2' ' A' ' 63' ' ' ARG . 53.5 m -150.21 139.54 21.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.227 -0.921 . . . . 0.0 110.328 -179.948 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.456 ' CG ' ' O ' ' A' ' 103' ' ' THR . 21.3 mt-10 -160.2 160.94 33.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.244 -0.91 . . . . 0.0 110.257 179.881 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.41 HG22 ' H ' ' A' ' 105' ' ' THR . 3.1 t -111.5 128.06 55.9 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.229 -0.919 . . . . 0.0 110.114 179.894 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.924 ' CE2' HD11 ' A' ' 89' ' ' LEU . 22.4 p90 -136.38 157.27 47.19 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.246 -0.909 . . . . 0.0 110.269 -179.916 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.534 ' O ' ' N ' ' A' ' 109' ' ' SER . 3.6 m -89.49 93.9 9.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.163 -0.96 . . . . 0.0 109.732 179.603 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.613 ' HB3' ' CE2' ' A' ' 60' ' ' TYR . . . -49.68 89.99 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.353 -0.842 . . . . 0.0 110.084 -179.932 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.534 ' N ' ' O ' ' A' ' 107' ' ' THR . 79.8 p -85.99 53.96 2.97 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.315 -0.866 . . . . 0.0 109.76 179.888 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -159.28 -156.75 0.54 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.244 -0.91 . . . . 0.0 110.393 -179.769 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.739 HG23 ' HA ' ' A' ' 55' ' ' GLU . 3.4 m -149.8 113.45 5.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.256 -0.902 . . . . 0.0 110.457 -179.896 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.751 ' OH ' HG13 ' A' ' 88' ' ' VAL . 11.9 m-30 -109.85 85.91 4.39 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.366 -0.834 . . . . 0.0 109.571 179.535 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.638 ' HD3' HG22 ' A' ' 111' ' ' THR . 45.4 Cg_endo -72.19 -165.83 0.23 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.892 1.469 . . . . 0.0 110.517 -179.757 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -147.63 50.27 1.07 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.307 -0.871 . . . . 0.0 110.24 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 6.8 m -121.66 96.11 47.56 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 0.0 110.143 -179.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.498 ' HA ' ' O ' ' A' ' 120' ' ' ASP . 46.3 Cg_endo -73.3 123.81 9.01 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.052 1.554 . . . . 0.0 110.477 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.814 ' HB3' ' HB2' ' A' ' 120' ' ' ASP . . . -132.75 -163.35 1.33 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.201 -0.937 . . . . 0.0 110.189 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.64 -15.72 8.44 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.259 -0.901 . . . . 0.0 110.234 179.932 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.421 ' O ' ' HD3' ' A' ' 121' ' ' PRO . 32.3 t0 -166.91 26.97 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.247 -0.908 . . . . 0.0 110.123 179.959 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.814 ' HB2' ' HB3' ' A' ' 117' ' ' ALA . 1.2 m-20 -114.41 83.72 8.86 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.259 -0.901 . . . . 0.0 110.276 -179.931 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.646 ' HD2' ' CA ' ' A' ' 82' ' ' GLY . 43.2 Cg_endo -78.44 17.58 1.06 Allowed 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.96 1.505 . . . . 0.0 112.372 179.929 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.532 ' O ' ' HB2' ' A' ' 81' ' ' ASN . 0.5 OUTLIER 38.29 -168.95 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.325 0.583 . . . . 0.0 111.903 178.625 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.484 ' HA3' ' CB ' ' A' ' 112' ' ' TYR . . . -85.54 149.21 23.39 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -179.378 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.515 ' CB ' ' HA ' ' A' ' 50' ' ' ASN . 6.8 pt20 -150.78 -157.59 0.83 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.358 -1.084 . . . . 0.0 110.651 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.453 HG21 ' CH2' ' A' ' 16' ' ' TRP . 5.5 mt -118.54 146.97 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 179.294 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -121.5 122.62 40.12 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.325 -179.183 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.518 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 5.0 m-85 -118.59 98.54 6.29 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.185 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.489 ' O ' ' HB ' ' A' ' 74' ' ' VAL . 10.5 mm-40 -88.75 84.13 6.69 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.262 -0.899 . . . . 0.0 112.368 -177.154 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 1.055 HD13 HD13 ' A' ' 139' ' ' LEU . 7.0 mt -85.2 45.99 1.24 Allowed 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.515 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' A' ' 132' ' ' PHE . . . -64.2 -170.5 2.02 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 -179.396 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.554 ' CA ' ' O ' ' A' ' 40' ' ' SER . . . -51.81 89.49 0.01 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.905 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.567 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 9.7 m-85 -118.35 -49.53 2.47 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.113 -1.228 . . . . 0.0 110.693 -179.361 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.829 ' HB2' HG23 ' A' ' 72' ' ' VAL . 1.3 t -88.53 175.83 7.41 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.997 -1.065 . . . . 0.0 110.233 -179.71 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -97.25 -52.94 3.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.322 -0.862 . . . . 0.0 110.309 -179.744 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -98.82 174.11 6.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.228 -0.92 . . . . 0.0 109.984 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.573 ' N ' ' HA ' ' A' ' 38' ' ' ALA . . . -57.59 125.6 23.63 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.151 -0.968 . . . . 0.0 110.047 -179.756 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 1.073 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 6.6 p90 -132.18 -168.48 2.05 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.063 -1.023 . . . . 0.0 109.803 179.659 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 68' ' ' ALA . 0.5 OUTLIER -155.76 172.46 18.28 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.805 -1.185 . . . . 0.0 111.331 -177.819 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 1.055 HD13 HD13 ' A' ' 129' ' ' LEU . 2.4 mp -130.47 128.81 42.0 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.548 -0.72 . . . . 0.0 109.506 179.497 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' CYS . . . . . . . . . . . . . 15.9 m -127.63 100.7 6.09 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.091 -1.006 . . . . 0.0 110.771 -179.535 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.611 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 0.7 OUTLIER -95.96 -177.93 4.18 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.29 -0.881 . . . . 0.0 109.325 179.189 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.739 ' O ' HG22 ' A' ' 8' ' ' THR . 0.6 OUTLIER 171.11 49.89 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.184 -0.947 . . . . 0.0 110.411 -179.996 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.677 ' CG ' HG22 ' A' ' 8' ' ' THR . 0.4 OUTLIER 166.23 55.43 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.37 -0.831 . . . . 0.0 109.614 179.849 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.834 HG11 ' HZ2' ' A' ' 16' ' ' TRP . 2.1 t -96.32 118.72 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.303 -0.873 . . . . 0.0 110.274 -179.474 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.583 ' HB1' ' HG2' ' A' ' 6' ' ' GLU . . . -145.2 155.55 43.33 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.318 -0.864 . . . . 0.0 110.189 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.928 HD21 HD11 ' A' ' 54' ' ' ILE . 14.1 tp -147.9 143.39 27.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.922 . . . . 0.0 110.188 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.493 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 5.0 t0 -172.3 151.15 2.49 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.2 -0.937 . . . . 0.0 110.311 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.433 ' HA ' ' O ' ' A' ' 59' ' ' THR . 9.7 p -94.11 153.12 18.29 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.281 -0.887 . . . . 0.0 110.197 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -115.98 -144.77 0.39 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.243 -0.91 . . . . 0.0 110.28 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.538 HG22 ' O ' ' A' ' 150' ' ' VAL . 12.2 p -155.55 43.89 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.281 -0.887 . . . . 0.0 110.168 -179.994 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -140.76 26.03 2.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.306 -0.872 . . . . 0.0 110.192 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 1.013 HD22 ' O ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.361 -179.981 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.427 ' O ' ' HD3' ' A' ' 3' ' ' PRO . . . . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.234 0.54 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.3 m -51.76 107.8 0.91 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.267 -0.896 . . . . 0.0 110.217 179.961 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 1' ' ' ALA . 48.8 Cg_endo -75.97 -156.44 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.027 1.541 . . . . 0.0 110.072 -179.985 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.633 HG22 ' O ' ' A' ' 51' ' ' GLY . 13.8 pt -95.39 23.97 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.195 -0.941 . . . . 0.0 110.17 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 94.23 -23.8 29.99 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.917 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.76 ' HG2' ' HB1' ' A' ' 145' ' ' ALA . 1.4 tt0 44.7 74.07 0.14 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.273 -1.134 . . . . 0.0 110.212 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -163.26 -164.01 17.31 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.961 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.572 HG22 ' O ' ' A' ' 142' ' ' ASP . 26.1 p -117.57 33.92 5.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.259 -1.142 . . . . 0.0 110.323 -179.975 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.552 ' HZ ' HG21 ' A' ' 144' ' ' VAL . 13.6 m-85 60.25 48.24 8.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -0.934 . . . . 0.0 110.146 179.938 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.557 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 32.2 t70 -90.13 32.21 0.94 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.223 -0.923 . . . . 0.0 110.333 -179.911 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.557 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.4 OUTLIER 161.55 37.77 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.572 -0.705 . . . . 0.0 109.974 179.983 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.24 136.07 4.36 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.774 ' HB3' HD12 ' A' ' 32' ' ' LEU . 48.3 Cg_endo -74.69 1.66 7.31 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.962 1.506 . . . . 0.0 110.609 179.955 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 0.1 OUTLIER 68.15 -84.04 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.265 -0.897 . . . . 0.0 110.274 -179.872 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.66 ' O ' HG13 ' A' ' 17' ' ' VAL . . . -137.39 5.54 3.52 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.921 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.884 ' CE2' HD22 ' A' ' 49' ' ' LEU . 56.0 m95 -65.5 105.25 1.15 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.188 -1.183 . . . . 0.0 110.249 -179.898 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.696 ' O ' HG13 ' A' ' 47' ' ' VAL . 1.0 OUTLIER -113.41 151.72 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.173 -0.955 . . . . 0.0 109.783 179.784 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 1.018 ' HB3' HD21 ' A' ' 25' ' ' LEU . . . -133.73 136.97 44.96 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.192 -0.942 . . . . 0.0 109.679 179.359 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.635 ' HE2' HG13 ' A' ' 48' ' ' VAL . 26.8 p90 -128.17 148.64 50.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.417 -0.802 . . . . 0.0 110.665 -178.902 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.3 24.61 18.58 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 179.464 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.704 HG22 HG11 ' A' ' 45' ' ' VAL . 28.1 p -134.88 -148.6 0.32 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.033 -1.275 . . . . 0.0 110.494 179.904 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.454 ' O ' ' O ' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -116.84 136.43 52.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.342 -0.849 . . . . 0.0 110.383 -179.806 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 22' ' ' ASP . . . 52.07 174.46 0.03 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.766 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.52 -159.32 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.08 1.569 . . . . 0.0 110.42 179.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 1.018 HD21 ' HB3' ' A' ' 18' ' ' ALA . 17.3 mt -93.05 145.3 24.49 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.215 -0.928 . . . . 0.0 110.237 179.987 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -97.59 119.41 36.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.243 -0.911 . . . . 0.0 109.827 179.709 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' A' ' 31' ' ' ALA . 0.8 OUTLIER -119.65 -44.56 2.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.127 -0.983 . . . . 0.0 110.503 -179.58 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.43 ' C ' ' O ' ' A' ' 27' ' ' THR . 8.1 t 43.76 36.04 1.21 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.186 -0.946 . . . . 0.0 109.874 -179.831 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 28' ' ' SER . 4.3 p 54.11 59.94 3.92 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.457 -0.777 . . . . 0.0 110.057 -179.731 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 8' ' ' THR . . . -159.24 -71.12 0.02 OUTLIER Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.624 ' HB1' ' O ' ' A' ' 141' ' ' LEU . . . -150.74 160.17 44.03 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.25 -1.147 . . . . 0.0 110.451 -179.899 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.774 HD12 ' HB3' ' A' ' 13' ' ' PRO . 0.6 OUTLIER -88.71 111.8 22.39 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.276 -0.89 . . . . 0.0 109.842 179.568 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 53.4 m -119.58 106.36 12.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.221 -0.924 . . . . 0.0 110.61 -179.642 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 1.006 HG12 HD22 ' A' ' 25' ' ' LEU . 18.2 m -89.87 145.58 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.207 -0.933 . . . . 0.0 109.715 179.535 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.527 ' HA ' ' OG1' ' A' ' 138' ' ' THR . . . -95.52 91.69 6.29 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.338 -0.851 . . . . 0.0 111.113 -179.268 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.126 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 58.8 t -71.54 130.85 86.86 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.168 -0.958 . . . . 0.0 109.307 179.076 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 21' ' ' THR . 43.1 Cg_endo -71.24 155.12 61.29 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.933 1.491 . . . . 0.0 111.164 -178.945 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.549 ' HA ' ' CA ' ' A' ' 136' ' ' ALA . . . -43.05 111.1 0.23 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.37 -0.832 . . . . 0.0 110.345 -179.839 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 134' ' ' ALA . . . 58.67 117.6 0.01 OUTLIER Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.981 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.597 ' HB3' HG23 ' A' ' 45' ' ' VAL . 58.6 m -85.55 49.0 1.67 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.27 -1.135 . . . . 0.0 109.553 179.668 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.513 ' O ' ' HB3' ' A' ' 42' ' ' GLN . . . -89.72 103.89 16.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.497 -0.752 . . . . 0.0 110.217 -179.741 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.513 ' HB3' ' O ' ' A' ' 41' ' ' ALA . 0.8 OUTLIER 168.18 -152.17 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -179.757 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.409 ' C ' ' O ' ' A' ' 42' ' ' GLN . 7.4 p90 -43.13 -26.43 0.16 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.091 -1.006 . . . . 0.0 109.564 179.174 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 42' ' ' GLN . . . 107.59 129.39 6.1 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.35 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.704 HG11 HG22 ' A' ' 21' ' ' THR . 3.0 t -89.88 177.89 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.132 -1.217 . . . . 0.0 108.46 179.144 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.556 ' HA2' ' HA ' ' A' ' 128' ' ' GLN . . . 169.4 -177.29 43.09 Favored Glycine 0 N--CA 1.489 2.182 0 C-N-CA 118.748 -1.692 . . . . 0.0 111.075 -179.894 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.696 HG13 ' O ' ' A' ' 17' ' ' VAL . 18.3 t -150.95 126.84 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.803 -0.822 . . . . 0.0 108.83 179.862 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.635 HG13 ' HE2' ' A' ' 19' ' ' TYR . 29.0 m -119.82 133.67 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.027 -1.046 . . . . 0.0 110.907 -179.159 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.884 HD22 ' CE2' ' A' ' 16' ' ' TRP . 30.7 tp -122.97 90.64 3.33 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.397 -0.815 . . . . 0.0 110.074 179.787 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.481 ' HA ' ' HB3' ' A' ' 124' ' ' GLN . 8.1 p30 -73.57 113.5 10.75 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.236 -0.915 . . . . 0.0 110.247 -179.909 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.633 ' O ' HG22 ' A' ' 4' ' ' ILE . . . 153.95 65.86 0.01 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.908 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.725 HG23 ' HA ' ' A' ' 124' ' ' GLN . 97.2 t -120.04 173.07 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.164 -1.197 . . . . 0.0 109.982 179.787 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.599 ' N ' HG12 ' A' ' 52' ' ' VAL . . . -143.43 97.74 3.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.072 -1.017 . . . . 0.0 110.652 -179.786 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.863 HG21 ' HB1' ' A' ' 108' ' ' ALA . 11.6 mm -137.79 159.87 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.292 -0.88 . . . . 0.0 109.818 179.603 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.475 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -147.82 135.34 20.76 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.108 -0.995 . . . . 0.0 110.683 -179.774 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.565 ' CG ' ' N ' ' A' ' 57' ' ' GLY . 0.9 OUTLIER 34.23 -155.08 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.342 0.592 . . . . 0.0 111.243 179.759 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.565 ' N ' ' CG ' ' A' ' 56' ' ' GLU . . . -83.39 81.39 1.75 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.837 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.681 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.2 m -109.13 171.26 7.54 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.305 -1.115 . . . . 0.0 109.826 179.876 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.519 ' N ' ' CG2' ' A' ' 58' ' ' THR . 1.0 OUTLIER -89.91 150.21 22.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.257 -0.902 . . . . 0.0 110.181 -179.941 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.823 ' CE2' HG23 ' A' ' 54' ' ' ILE . 64.9 m-85 -154.69 171.74 19.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.233 -0.917 . . . . 0.0 110.225 179.895 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.514 ' OG1' HG23 ' A' ' 105' ' ' THR . 17.9 m -142.73 114.51 8.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.304 -0.872 . . . . 0.0 110.086 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.1 tp -89.71 121.19 31.64 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.177 -0.952 . . . . 0.0 109.965 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.504 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 2.2 ttt180 -129.29 127.8 41.89 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -0.878 . . . . 0.0 110.314 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.964 ' CZ ' HG21 ' A' ' 102' ' ' VAL . 2.1 p90 -165.12 149.6 8.94 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.336 -0.853 . . . . 0.0 109.888 179.807 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 141' ' ' LEU . 51.6 m -119.44 95.7 4.9 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.183 -0.948 . . . . 0.0 110.117 -179.965 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.501 ' HB2' HD23 ' A' ' 141' ' ' LEU . . . -93.92 151.93 19.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.358 -0.839 . . . . 0.0 110.339 -179.801 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.86 HG23 ' O ' ' A' ' 98' ' ' GLU . 57.1 m -149.76 121.16 7.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.278 -0.889 . . . . 0.0 110.261 179.97 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.469 ' O ' ' O ' ' A' ' 96' ' ' THR . . . -114.89 132.01 56.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.314 -0.866 . . . . 0.0 109.852 179.752 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.9 p -47.69 -23.99 0.83 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.074 -1.016 . . . . 0.0 109.343 179.497 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.592 HG22 ' HB2' ' A' ' 137' ' ' TRP . 2.5 t -113.84 170.2 8.44 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.49 -0.756 . . . . 0.0 110.067 179.904 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.43 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 15.7 t70 -86.75 66.02 9.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.179 -0.951 . . . . 0.0 109.119 178.86 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.776 HG23 ' CB ' ' A' ' 133' ' ' SER . 3.5 p -85.23 137.25 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.319 -0.863 . . . . 0.0 111.341 -178.871 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.409 ' O ' ' CD1' ' A' ' 132' ' ' PHE . 89.6 m -122.81 86.02 2.51 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.85 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.66 HG22 ' HG2' ' A' ' 93' ' ' PRO . 4.8 m -89.33 -153.28 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.287 -0.883 . . . . 0.0 110.444 -179.068 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.44 ' N ' HG23 ' A' ' 74' ' ' VAL . 2.4 mtp180 -125.94 133.16 51.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.207 -0.933 . . . . 0.0 110.627 -179.431 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.511 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -137.32 155.72 49.09 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.346 -0.846 . . . . 0.0 110.079 179.691 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.894 HD12 ' N ' ' A' ' 78' ' ' VAL . 3.9 pp 179.18 -147.77 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.354 -0.841 . . . . 0.0 110.033 -179.724 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.894 ' N ' HD12 ' A' ' 77' ' ' LEU . 3.8 t -151.65 166.43 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.147 -0.971 . . . . 0.0 109.321 179.77 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.507 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . -171.67 -174.53 39.33 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.11 -1.519 . . . . 0.0 110.631 -179.81 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.561 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 4.0 pt20 -114.78 150.8 34.84 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.545 -0.973 . . . . 0.0 110.065 179.793 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.487 ' OD1' ' HG2' ' A' ' 122' ' ' GLU . 18.6 m120 -106.31 92.47 4.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.207 -0.933 . . . . 0.0 110.396 -179.952 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.538 ' C ' ' CE1' ' A' ' 85' ' ' TYR . . . 135.54 130.18 2.92 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.869 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.581 ' N ' ' CZ ' ' A' ' 85' ' ' TYR . . . -42.12 155.32 0.25 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.38 -1.071 . . . . 0.0 110.317 -179.951 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.464 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 50.8 Cg_endo -78.78 11.75 18.72 Favored 'Cis proline' 0 C--N 1.312 -1.352 0 C-N-CA 121.636 -2.235 . . . . 0.0 110.93 -0.049 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.581 ' CZ ' ' N ' ' A' ' 83' ' ' ALA . 39.3 m-85 60.88 157.71 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.125 -0.985 . . . . 0.0 110.17 -179.739 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.47 ' O ' ' HG2' ' A' ' 80' ' ' GLN . . . 167.78 113.46 0.28 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.479 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 1.2 p -89.84 155.52 19.1 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.232 -1.158 . . . . 0.0 110.299 -179.853 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 1.068 HG23 HD12 ' A' ' 89' ' ' LEU . 35.3 m -119.82 -24.22 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.886 . . . . 0.0 109.899 179.837 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 1.068 HD12 HG23 ' A' ' 88' ' ' VAL . 4.0 mp -104.59 144.39 31.76 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.351 -0.843 . . . . 0.0 110.667 179.684 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -151.04 76.33 1.23 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.324 -0.86 . . . . 0.0 110.195 179.805 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -144.85 176.38 9.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.052 -1.03 . . . . 0.0 110.508 -179.832 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 66.2 m -124.39 126.08 25.54 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.318 -0.864 . . . . 0.0 110.045 179.907 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.66 ' HG2' HG22 ' A' ' 74' ' ' VAL . 45.4 Cg_endo -71.73 127.66 13.34 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.876 1.461 . . . . 0.0 110.749 -179.805 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.515 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -105.19 128.49 53.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.321 -0.862 . . . . 0.0 109.838 179.58 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.664 HD12 ' CG1' ' A' ' 72' ' ' VAL . 57.4 mt -119.91 178.95 4.41 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.186 -0.946 . . . . 0.0 110.467 -179.711 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.628 HG23 ' H ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -159.24 -79.64 0.06 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.265 -0.897 . . . . 0.0 110.335 -179.848 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.628 ' H ' HG23 ' A' ' 96' ' ' THR . 0.1 OUTLIER -158.75 -37.66 0.06 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.271 -0.893 . . . . 0.0 110.061 179.952 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.86 ' O ' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -89.88 -177.72 0.85 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.341 -0.849 . . . . 0.0 109.786 179.748 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.554 ' HD2' ' CG ' ' A' ' 98' ' ' GLU . 44.2 Cg_endo -71.61 128.63 14.58 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.748 1.394 . . . . 0.0 110.272 179.915 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.515 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 8.0 ttm-85 -119.68 92.03 3.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.185 -0.947 . . . . 0.0 110.36 -179.803 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 1.9 pt20 -70.23 159.03 34.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.327 -0.858 . . . . 0.0 110.045 179.796 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.964 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 98.7 t -135.12 139.34 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.208 -0.932 . . . . 0.0 110.165 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.447 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 0.2 OUTLIER -150.21 117.1 5.89 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.238 -0.914 . . . . 0.0 110.154 179.976 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.447 ' HG2' ' O ' ' A' ' 103' ' ' THR . 17.7 mm-40 -155.28 134.86 12.6 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.206 -0.934 . . . . 0.0 110.288 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.514 HG23 ' OG1' ' A' ' 61' ' ' THR . 0.7 OUTLIER -102.18 119.24 38.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.271 -0.893 . . . . 0.0 110.106 179.939 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.896 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 35.0 p90 -125.91 157.91 36.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.233 -0.917 . . . . 0.0 110.285 -179.943 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 19.3 m -89.93 98.57 11.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.3 -0.875 . . . . 0.0 109.997 179.786 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.863 ' HB1' HG21 ' A' ' 54' ' ' ILE . . . -59.3 107.78 0.61 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.253 -0.905 . . . . 0.0 110.411 -179.726 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.463 ' HA ' ' HA2' ' A' ' 57' ' ' GLY . 3.3 p -94.8 54.27 1.72 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.258 -0.901 . . . . 0.0 110.005 179.67 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.401 ' O ' ' N ' ' A' ' 56' ' ' GLU . . . -160.57 -152.38 0.28 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.214 -0.929 . . . . 0.0 110.431 -179.81 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 1.054 HG22 ' HD3' ' A' ' 113' ' ' PRO . 84.1 m -151.89 111.46 3.97 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.325 -0.859 . . . . 0.0 110.312 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.673 ' CE2' HG12 ' A' ' 78' ' ' VAL . 17.3 m-30 -111.02 69.66 0.66 Allowed Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.265 -0.897 . . . . 0.0 110.16 179.791 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 1.054 ' HD3' HG22 ' A' ' 111' ' ' THR . 45.8 Cg_endo -71.3 117.21 5.04 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.889 1.468 . . . . 0.0 110.361 179.949 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.481 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -60.33 -13.41 12.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.261 -0.899 . . . . 0.0 110.231 -179.951 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.732 ' O ' HG23 ' A' ' 115' ' ' THR . 9.7 t -96.93 105.18 22.03 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.216 -0.928 . . . . 0.0 110.211 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 46.7 Cg_endo -73.32 113.6 3.82 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.006 1.53 . . . . 0.0 110.39 179.935 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 1.034 ' HB3' ' HB2' ' A' ' 120' ' ' ASP . . . -120.42 47.4 1.78 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.264 -0.898 . . . . 0.0 110.194 -179.998 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 117' ' ' ALA . . . 55.87 -89.02 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.291 -0.881 . . . . 0.0 110.202 -179.989 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.453 ' N ' ' O ' ' A' ' 117' ' ' ALA . 2.6 p30 -62.22 -11.98 17.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.241 -0.912 . . . . 0.0 110.213 -179.954 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 1.034 ' HB2' ' HB3' ' A' ' 117' ' ' ALA . 5.8 m-20 -108.77 103.99 53.29 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 110.243 179.954 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.527 ' O ' ' CG ' ' A' ' 113' ' ' PRO . 47.6 Cg_endo -73.46 146.8 40.15 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.983 1.517 . . . . 0.0 110.409 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.543 ' CG ' ' N ' ' A' ' 123' ' ' GLY . 0.7 OUTLIER -97.2 -142.75 0.29 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.256 -0.902 . . . . 0.0 109.999 179.843 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.561 ' HA2' ' HA ' ' A' ' 80' ' ' GLN . . . -166.44 156.31 28.11 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.814 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.725 ' HA ' HG23 ' A' ' 52' ' ' VAL . 3.6 pt20 -150.08 -161.23 1.3 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.38 -1.07 . . . . 0.0 110.313 -179.727 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.862 HG21 ' CH2' ' A' ' 16' ' ' TRP . 17.5 mt -118.49 149.83 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.528 -0.732 . . . . 0.0 109.552 179.772 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.761 ' HB3' ' HG ' ' A' ' 77' ' ' LEU . . . -114.97 133.92 55.62 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.78 0.8 . . . . 0.0 111.179 -179.228 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.533 ' CD1' ' O ' ' A' ' 126' ' ' ALA . 8.5 m-85 -146.8 73.9 1.33 Allowed 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.062 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.893 ' C ' HD23 ' A' ' 129' ' ' LEU . 40.2 mt-30 -87.55 125.44 34.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.303 -0.873 . . . . 0.0 111.841 -177.773 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.893 HD23 ' C ' ' A' ' 128' ' ' GLN . 2.9 mt -113.95 54.34 0.76 Allowed 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.871 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -106.54 104.33 2.18 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 -179.36 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 77.21 74.46 0.98 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.781 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.611 ' CE1' ' HA ' ' A' ' 74' ' ' VAL . 6.5 m-85 -143.93 -71.77 0.29 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.196 -1.179 . . . . 0.0 110.243 179.859 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.776 ' CB ' HG23 ' A' ' 72' ' ' VAL . 1.3 t -89.13 156.45 18.8 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.055 -1.028 . . . . 0.0 110.103 179.825 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -80.23 -92.31 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.225 -0.922 . . . . 0.0 110.874 -179.34 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.448 ' O ' ' O ' ' A' ' 134' ' ' ALA . 12.6 m-20 -52.28 -172.35 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.165 -0.959 . . . . 0.0 110.679 -179.494 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.549 ' CA ' ' HA ' ' A' ' 38' ' ' ALA . . . -76.55 139.44 40.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.363 -0.835 . . . . 0.0 110.386 -179.799 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 1.126 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 9.1 p90 -145.82 -166.34 2.43 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.296 -0.877 . . . . 0.0 110.058 179.672 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.527 ' OG1' ' HA ' ' A' ' 35' ' ' ALA . 0.8 OUTLIER -160.38 170.47 20.96 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.034 -1.041 . . . . 0.0 110.735 -178.068 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.818 HD13 HD13 ' A' ' 129' ' ' LEU . 2.2 mp -129.28 126.26 38.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.469 -0.769 . . . . 0.0 109.444 179.14 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 27.9 m -121.81 102.73 8.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.141 -0.974 . . . . 0.0 110.892 -179.443 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.624 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 1.2 mt -95.26 -177.94 4.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.301 -0.875 . . . . 0.0 109.355 179.093 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.572 ' O ' HG22 ' A' ' 8' ' ' THR . 2.8 p30 168.5 52.96 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.244 -0.91 . . . . 0.0 110.301 179.954 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.523 ' CG ' HG22 ' A' ' 8' ' ' THR . 0.3 OUTLIER 167.27 53.06 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.223 -0.923 . . . . 0.0 109.71 179.947 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.864 HG11 ' HZ2' ' A' ' 16' ' ' TRP . 2.2 t -95.71 114.17 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.28 -0.887 . . . . 0.0 110.189 -179.599 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.76 ' HB1' ' HG2' ' A' ' 6' ' ' GLU . . . -146.11 164.75 31.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.897 . . . . 0.0 110.262 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.758 HD11 ' HB3' ' A' ' 60' ' ' TYR . 6.7 tp -145.21 148.23 33.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.323 -0.861 . . . . 0.0 110.234 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.517 ' HB3' ' CG1' ' A' ' 150' ' ' VAL . 0.5 OUTLIER -134.22 -173.97 3.42 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.196 -0.94 . . . . 0.0 110.23 -179.982 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 78.5 p -137.5 102.72 4.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.237 -0.915 . . . . 0.0 110.224 -179.974 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 48.97 65.2 1.44 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.241 -0.912 . . . . 0.0 110.221 179.981 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.531 HG13 ' O ' ' A' ' 150' ' ' VAL . 14.5 p -160.63 52.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.184 -0.947 . . . . 0.0 110.173 179.905 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -54.68 173.31 0.08 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.295 -0.878 . . . . 0.0 110.207 -179.98 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.432 ' HA ' HD13 ' A' ' 152' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.214 -179.972 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.271 0.558 . . . . 0.0 110.233 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.6 t 47.86 90.86 0.07 OUTLIER Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.232 -0.918 . . . . 0.0 110.224 179.982 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.563 ' CG ' ' HA ' ' A' ' 52' ' ' VAL . 53.8 Cg_endo -80.43 19.1 1.12 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.998 1.525 . . . . 0.0 111.134 179.982 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.505 HG13 ' N ' ' A' ' 5' ' ' GLY . 7.8 pt -146.15 -37.52 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.989 -1.07 . . . . 0.0 109.811 179.715 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.511 ' O ' ' N ' ' A' ' 7' ' ' GLY . . . 55.71 163.18 0.02 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 179.574 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.68 ' CG ' ' HB2' ' A' ' 145' ' ' ALA . 63.3 mt-10 -51.69 88.75 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.302 -1.116 . . . . 0.0 110.11 179.85 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 5' ' ' GLY . . . -78.63 -32.41 41.71 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.953 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.456 ' HA ' ' C ' ' A' ' 142' ' ' ASP . 11.2 p 50.57 18.93 0.51 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.427 -1.043 . . . . 0.0 110.467 -179.794 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.604 ' CG ' ' HB2' ' A' ' 32' ' ' LEU . 24.3 m-85 36.85 46.64 0.51 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.56 -0.712 . . . . 0.0 110.813 179.563 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.558 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 3.2 p-10 -100.25 43.46 1.06 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.244 -0.91 . . . . 0.0 110.281 -179.998 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.558 ' CB ' ' O ' ' A' ' 10' ' ' ASP . 0.6 OUTLIER 161.57 -24.97 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.722 -0.612 . . . . 0.0 109.52 179.951 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -177.64 151.12 10.54 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.74 ' HB3' HD12 ' A' ' 32' ' ' LEU . 46.3 Cg_endo -73.64 0.01 8.74 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.014 1.534 . . . . 0.0 110.552 -179.987 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 0.5 OUTLIER 62.07 -89.55 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.255 -0.903 . . . . 0.0 110.135 -179.791 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.595 ' O ' HG13 ' A' ' 17' ' ' VAL . . . -122.68 -15.89 3.87 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.944 ' CH2' HG21 ' A' ' 125' ' ' ILE . 82.4 m95 -54.05 140.68 30.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.254 -1.145 . . . . 0.0 110.782 -179.758 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.938 ' HA ' HD11 ' A' ' 25' ' ' LEU . 1.2 m -146.08 157.95 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.324 -0.86 . . . . 0.0 109.455 179.425 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.452 ' HA ' ' HA ' ' A' ' 47' ' ' VAL . . . -134.26 163.2 30.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.235 -0.916 . . . . 0.0 109.49 179.303 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.53 ' HE2' HG13 ' A' ' 48' ' ' VAL . 3.5 p90 -150.04 147.9 28.38 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.93 -1.106 . . . . 0.0 111.625 -178.519 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.587 ' HA2' ' CD1' ' A' ' 43' ' ' TYR . . . 132.09 -81.75 0.32 Allowed Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.763 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.617 HG22 ' CE2' ' A' ' 43' ' ' TYR . 12.1 p -149.69 23.95 0.88 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.171 -1.194 . . . . 0.0 110.319 -179.899 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.579 ' HA ' ' HB3' ' A' ' 35' ' ' ALA . 0.5 OUTLIER -107.63 27.43 9.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 110.35 179.845 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.48 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 36.87 -137.43 0.53 Allowed Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.749 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.78 -158.88 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.974 1.513 . . . . 0.0 110.106 179.514 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.938 HD11 ' HA ' ' A' ' 17' ' ' VAL . 61.1 mt -111.26 123.69 50.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.122 -0.986 . . . . 0.0 110.263 179.923 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.02 105.63 12.39 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.196 -0.94 . . . . 0.0 109.911 179.871 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.58 HG22 ' HB3' ' A' ' 9' ' ' PHE . 0.8 OUTLIER -119.56 -27.4 5.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.185 -0.947 . . . . 0.0 110.488 -179.653 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.645 ' C ' HG22 ' A' ' 29' ' ' THR . 8.0 t -48.48 82.91 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.758 -0.589 . . . . 0.0 111.233 -179.863 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.645 HG22 ' C ' ' A' ' 28' ' ' SER . 0.0 OUTLIER 167.91 -31.71 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.254 -0.904 . . . . 0.0 109.856 -179.918 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.434 ' HA2' ' HA ' ' A' ' 10' ' ' ASP . . . 127.17 -0.07 7.0 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.907 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.549 ' CB ' ' HB3' ' A' ' 142' ' ' ASP . . . -150.75 134.98 16.93 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.15 -1.206 . . . . 0.0 110.535 -179.907 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.74 HD12 ' HB3' ' A' ' 13' ' ' PRO . 3.2 tt -76.27 138.6 40.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.181 -0.949 . . . . 0.0 109.293 179.205 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 66.6 m -141.82 118.43 10.99 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.069 -1.02 . . . . 0.0 110.838 -179.552 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.544 HG12 ' CD2' ' A' ' 25' ' ' LEU . 17.2 m -102.1 142.06 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.485 -0.759 . . . . 0.0 109.274 179.306 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.579 ' HB3' ' HA ' ' A' ' 22' ' ' ASP . . . -88.44 102.79 15.24 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.129 -0.982 . . . . 0.0 110.781 -179.211 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.025 HG11 ' CZ2' ' A' ' 137' ' ' TRP . 49.1 t -83.91 125.23 73.48 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.417 -0.802 . . . . 0.0 109.596 179.471 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.663 ' HD2' HG21 ' A' ' 45' ' ' VAL . 40.4 Cg_endo -66.42 -178.57 1.21 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.878 1.462 . . . . 0.0 111.741 -178.965 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.528 ' HA ' ' N ' ' A' ' 136' ' ' ALA . . . -60.5 120.92 10.87 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.452 -0.78 . . . . 0.0 111.296 -178.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.519 ' O ' ' C ' ' A' ' 40' ' ' SER . . . 39.22 26.73 0.06 OUTLIER Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 179.588 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.751 ' HB3' HG23 ' A' ' 45' ' ' VAL . 45.6 m 28.43 44.68 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 CA-C-N 117.863 0.831 . . . . 0.0 110.65 -179.998 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.631 ' O ' ' CG ' ' A' ' 42' ' ' GLN . . . -89.07 126.58 35.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.474 -0.766 . . . . 0.0 110.158 -179.278 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.631 ' CG ' ' O ' ' A' ' 41' ' ' ALA . 0.4 OUTLIER 83.17 28.54 0.1 Allowed 'General case' 0 N--CA 1.508 2.443 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -179.365 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.617 ' CE2' HG22 ' A' ' 21' ' ' THR . 0.1 OUTLIER -156.31 -31.05 0.09 Allowed 'General case' 0 C--N 1.293 -1.865 0 C-N-CA 118.648 -1.221 . . . . 0.0 112.314 -177.767 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.54 ' HA2' ' CA ' ' A' ' 130' ' ' GLY . . . 53.2 80.01 0.08 OUTLIER Glycine 0 N--CA 1.479 1.556 0 N-CA-C 105.922 -2.871 . . . . 0.0 105.922 -177.015 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.751 HG23 ' HB3' ' A' ' 40' ' ' SER . 4.2 t -86.95 133.9 28.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.358 -1.084 . . . . 0.0 108.893 -177.955 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.511 ' C ' ' CZ ' ' A' ' 19' ' ' TYR . . . -157.13 163.74 32.5 Favored Glycine 0 N--CA 1.487 2.089 0 C-N-CA 118.755 -1.688 . . . . 0.0 110.65 -178.973 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.652 HG13 ' O ' ' A' ' 17' ' ' VAL . 15.3 t -123.87 123.31 66.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.648 -0.913 . . . . 0.0 109.536 179.639 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.642 ' O ' HG22 ' A' ' 17' ' ' VAL . 32.7 m -119.79 140.48 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.916 -1.115 . . . . 0.0 111.018 -179.002 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.874 HD22 ' NE1' ' A' ' 16' ' ' TRP . 15.0 tp -118.98 97.7 5.82 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.46 -0.775 . . . . 0.0 109.743 179.449 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.526 ' HA ' ' HB3' ' A' ' 124' ' ' GLN . 2.3 t-20 -78.16 113.73 16.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.28 -0.887 . . . . 0.0 110.405 -179.782 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.488 ' O ' ' HG2' ' A' ' 3' ' ' PRO . . . 146.22 73.98 0.02 OUTLIER Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 179.748 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.563 ' HA ' ' CG ' ' A' ' 3' ' ' PRO . 96.5 t -133.81 154.45 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.216 -1.167 . . . . 0.0 110.067 179.653 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.52 ' O ' HD13 ' A' ' 54' ' ' ILE . . . -128.73 105.19 8.09 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.218 -0.926 . . . . 0.0 110.501 -179.744 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.721 HD11 HD21 ' A' ' 146' ' ' LEU . 50.7 mm -131.78 166.45 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.318 -0.864 . . . . 0.0 109.74 179.58 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.526 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 0.2 OUTLIER -154.22 130.01 10.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.054 -1.029 . . . . 0.0 110.795 -179.726 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.526 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 11.0 pt-20 37.55 -156.5 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.773 -0.579 . . . . 0.0 110.915 179.525 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' A' ' 109' ' ' SER . . . -86.63 73.59 2.47 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.915 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.569 HG22 ' CE2' ' A' ' 60' ' ' TYR . 1.2 m -95.65 173.62 7.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.312 -1.11 . . . . 0.0 109.854 179.875 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.573 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 0.8 OUTLIER -89.63 155.9 18.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.205 -0.935 . . . . 0.0 110.391 -179.74 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.621 ' CE2' ' HB3' ' A' ' 108' ' ' ALA . 56.9 m-85 -160.41 -175.21 4.89 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.333 -0.854 . . . . 0.0 110.194 179.902 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 26.9 m -150.16 114.43 5.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.341 -0.85 . . . . 0.0 109.945 179.737 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.548 HD22 ' CD2' ' A' ' 89' ' ' LEU . 14.0 tp -89.53 119.69 30.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.208 -0.932 . . . . 0.0 110.065 -179.937 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.889 ' HD2' HG23 ' A' ' 103' ' ' THR . 0.0 OUTLIER -128.23 128.92 45.59 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.352 -0.842 . . . . 0.0 110.206 -179.8 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 1.073 ' CZ ' HG21 ' A' ' 102' ' ' VAL . 0.8 OUTLIER -172.61 144.38 1.43 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.22 -0.925 . . . . 0.0 109.849 179.731 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.542 HG23 ' CA ' ' A' ' 101' ' ' GLN . 4.6 m -119.22 92.93 3.92 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.225 -0.922 . . . . 0.0 109.957 -179.815 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.908 ' HB1' HD21 ' A' ' 95' ' ' LEU . . . -90.8 149.29 22.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.38 -0.825 . . . . 0.0 110.373 -179.747 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.644 HG23 ' O ' ' A' ' 98' ' ' GLU . 99.7 m -150.25 107.15 3.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.34 -0.85 . . . . 0.0 110.265 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -97.11 133.36 41.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.246 -0.909 . . . . 0.0 110.032 179.738 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.407 ' C ' ' O ' ' A' ' 68' ' ' ALA . 19.2 t -45.35 -26.18 0.5 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.131 -0.981 . . . . 0.0 109.234 179.557 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.561 HG22 ' HB2' ' A' ' 137' ' ' TRP . 2.1 t -112.43 171.15 7.69 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.592 -0.693 . . . . 0.0 109.858 179.723 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.507 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 49.0 t0 -86.58 61.13 6.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.106 -0.996 . . . . 0.0 109.115 178.937 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 1.047 HG23 ' HB2' ' A' ' 133' ' ' SER . 2.7 p -84.78 136.76 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.381 -0.824 . . . . 0.0 111.357 -178.912 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 19.9 m -125.78 86.91 2.6 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.711 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 1.115 HG21 ' CD2' ' A' ' 129' ' ' LEU . 3.0 m -90.5 -140.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.134 -0.979 . . . . 0.0 110.663 -178.73 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.793 ' N ' HG23 ' A' ' 74' ' ' VAL . 9.4 mtm180 -123.44 144.96 49.17 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.194 -0.941 . . . . 0.0 110.81 -179.633 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.541 ' HB2' ' HG3' ' A' ' 93' ' ' PRO . . . -150.34 148.49 28.88 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.388 -0.82 . . . . 0.0 109.365 179.421 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.862 HD11 ' HB3' ' A' ' 126' ' ' ALA . 1.3 pp 175.37 -159.39 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.123 -0.986 . . . . 0.0 110.674 -179.551 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.526 ' HB ' ' CG2' ' A' ' 88' ' ' VAL . 6.3 t -143.7 170.44 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.375 -0.828 . . . . 0.0 109.39 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.529 ' HA2' ' OH ' ' A' ' 112' ' ' TYR . . . 176.02 -173.45 46.27 Favored Glycine 0 N--CA 1.491 2.325 0 C-N-CA 119.18 -1.486 . . . . 0.0 110.534 -179.92 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.537 ' HB3' ' HA ' ' A' ' 85' ' ' TYR . 31.5 tt0 -105.39 159.39 15.95 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.58 -0.953 . . . . 0.0 110.129 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.482 ' OD1' ' HG2' ' A' ' 124' ' ' GLN . 4.2 m120 -112.18 94.13 4.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.26 -0.9 . . . . 0.0 109.984 179.761 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.542 ' C ' ' CE1' ' A' ' 85' ' ' TYR . . . 120.3 131.83 4.19 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.815 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.596 ' N ' ' CE1' ' A' ' 85' ' ' TYR . . . -42.08 152.71 0.31 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.327 -1.102 . . . . 0.0 110.232 -179.903 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.455 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 51.6 Cg_endo -79.1 12.43 18.8 Favored 'Cis proline' 0 C--N 1.313 -1.332 0 C-N-CA 121.657 -2.226 . . . . 0.0 111.017 -0.021 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.596 ' CE1' ' N ' ' A' ' 83' ' ' ALA . 37.9 m-85 60.85 170.54 0.1 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.099 -1.0 . . . . 0.0 110.273 -179.81 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.421 ' O ' ' HA2' ' A' ' 79' ' ' GLY . . . 176.63 108.28 0.22 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.491 ' HA ' ' HA2' ' A' ' 79' ' ' GLY . 2.5 p -98.17 147.83 24.2 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.214 -1.168 . . . . 0.0 110.346 -179.934 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.794 HG12 ' N ' ' A' ' 109' ' ' SER . 7.8 m -122.64 -22.82 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.329 -0.857 . . . . 0.0 110.168 179.874 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.573 HD11 ' CZ ' ' A' ' 106' ' ' PHE . 4.5 mp -115.51 143.74 44.87 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.288 -0.882 . . . . 0.0 110.74 179.94 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.452 ' O ' HG23 ' A' ' 91' ' ' THR . 30.9 m-20 -151.08 79.24 1.31 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.329 -0.857 . . . . 0.0 110.187 179.56 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 90' ' ' ASP . 1.9 p -151.59 -173.56 4.55 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.007 -1.058 . . . . 0.0 110.544 -179.865 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.98 134.18 23.97 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.361 -0.837 . . . . 0.0 110.037 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.695 ' HG2' HG22 ' A' ' 74' ' ' VAL . 50.0 Cg_endo -75.14 75.83 3.64 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.962 1.506 . . . . 0.0 110.808 -179.697 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.531 ' O ' ' CD ' ' A' ' 100' ' ' ARG . . . -49.55 134.66 19.34 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.971 -1.081 . . . . 0.0 109.265 179.416 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.908 HD21 ' HB1' ' A' ' 66' ' ' ALA . 34.6 mt -131.91 164.65 25.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.032 -1.042 . . . . 0.0 110.819 -179.396 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -165.35 -178.71 5.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.488 -0.758 . . . . 0.0 109.933 179.864 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.8 p -67.58 -22.21 65.39 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.224 -0.923 . . . . 0.0 110.257 -179.981 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.644 ' O ' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -93.28 170.56 8.5 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.216 -0.927 . . . . 0.0 110.116 179.906 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.497 ' HA ' ' OG1' ' A' ' 67' ' ' THR . 45.8 Cg_endo -72.34 132.38 19.18 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.993 1.523 . . . . 0.0 110.39 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.531 ' CD ' ' O ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -119.83 92.61 3.82 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.206 -0.934 . . . . 0.0 110.36 -179.967 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.542 ' CA ' HG23 ' A' ' 65' ' ' THR . 0.1 OUTLIER -75.75 152.37 37.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.392 -0.817 . . . . 0.0 110.083 179.962 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 1.073 HG21 ' CZ ' ' A' ' 64' ' ' TYR . 91.6 t -132.04 133.19 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.22 -0.925 . . . . 0.0 110.246 179.942 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.889 HG23 ' HD2' ' A' ' 63' ' ' ARG . 0.2 OUTLIER -150.38 116.77 5.73 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.317 -0.864 . . . . 0.0 110.158 -179.962 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.523 ' CG ' ' O ' ' A' ' 103' ' ' THR . 23.7 mt-10 -160.33 129.97 5.15 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.16 -0.963 . . . . 0.0 110.348 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.511 HG23 ' O ' ' A' ' 60' ' ' TYR . 47.5 m -89.91 107.47 19.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.21 -0.931 . . . . 0.0 110.108 179.766 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.573 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 36.7 p90 -110.2 155.9 21.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.242 -0.911 . . . . 0.0 110.4 -179.78 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.551 HG22 ' O ' ' A' ' 107' ' ' THR . 5.2 m -90.01 89.07 7.54 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.287 -0.883 . . . . 0.0 109.953 179.735 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.621 ' HB3' ' CE2' ' A' ' 60' ' ' TYR . . . -42.71 98.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.28 -0.888 . . . . 0.0 110.278 -179.747 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.794 ' N ' HG12 ' A' ' 88' ' ' VAL . 14.2 p -87.22 53.99 3.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.239 -0.913 . . . . 0.0 110.088 179.883 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.447 ' CB ' HG13 ' A' ' 88' ' ' VAL . . . -154.19 -155.33 0.58 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.261 -0.899 . . . . 0.0 110.333 -179.943 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.52 HG23 ' HA ' ' A' ' 55' ' ' GLU . 27.5 m -159.52 110.58 2.0 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.895 . . . . 0.0 110.531 -179.9 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.633 ' CD2' ' CG1' ' A' ' 54' ' ' ILE . 5.8 m-30 -113.71 94.73 34.16 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.298 -0.877 . . . . 0.0 109.66 179.401 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.765 ' O ' HG23 ' A' ' 115' ' ' THR . 51.3 Cg_endo -80.66 33.04 0.51 Allowed 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.825 1.434 . . . . 0.0 111.717 -179.697 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 113' ' ' PRO . . . 33.55 48.86 0.21 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.606 -0.684 . . . . 0.0 111.156 179.432 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.765 HG23 ' O ' ' A' ' 113' ' ' PRO . 3.0 p -119.02 98.33 50.94 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.171 -0.956 . . . . 0.0 110.38 -179.859 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -75.58 76.15 3.72 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.06 1.558 . . . . 0.0 110.39 179.911 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.744 ' HB3' ' HB2' ' A' ' 120' ' ' ASP . . . -150.12 169.64 20.8 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.216 -0.928 . . . . 0.0 110.334 -179.995 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.67 -62.35 1.45 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.253 -0.904 . . . . 0.0 110.095 179.955 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.486 ' O ' ' HD3' ' A' ' 121' ' ' PRO . 14.4 p-10 -67.78 -29.13 68.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.301 -0.874 . . . . 0.0 110.09 179.922 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.744 ' HB2' ' HB3' ' A' ' 117' ' ' ALA . 77.5 m-20 -105.17 95.72 9.98 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.285 -0.884 . . . . 0.0 110.11 179.824 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.529 ' HG2' ' NE2' ' A' ' 80' ' ' GLN . 48.5 Cg_endo -74.26 152.94 45.36 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.957 1.504 . . . . 0.0 110.684 -179.837 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.535 ' HG2' ' N ' ' A' ' 123' ' ' GLY . 23.9 pm0 -121.26 -135.52 0.31 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.26 -0.9 . . . . 0.0 109.923 179.645 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.584 ' HA3' ' CG ' ' A' ' 112' ' ' TYR . . . -168.57 143.29 7.99 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.758 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.542 ' HA ' ' CG2' ' A' ' 52' ' ' VAL . 1.7 pt20 -150.56 -159.5 1.04 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.336 -1.096 . . . . 0.0 110.248 -179.808 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.944 HG21 ' CH2' ' A' ' 16' ' ' TRP . 10.4 mt -118.32 146.35 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.45 -0.781 . . . . 0.0 109.114 179.246 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.862 ' HB3' HD11 ' A' ' 77' ' ' LEU . . . -121.98 120.5 34.58 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.281 -0.887 . . . . 0.0 111.144 -179.302 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.51 ' CE1' ' HB1' ' A' ' 76' ' ' ALA . 3.4 m-30 -116.79 97.98 6.27 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 178.266 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.574 ' O ' ' CE2' ' A' ' 132' ' ' PHE . 2.3 mm-40 -88.37 92.56 9.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.332 -0.855 . . . . 0.0 112.702 -176.783 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 1.115 ' CD2' HG21 ' A' ' 74' ' ' VAL . 5.2 mt -99.61 42.65 1.09 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.447 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.54 ' CA ' ' HA2' ' A' ' 44' ' ' GLY . . . -97.56 125.7 8.6 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 110.509 -1.037 . . . . 0.0 110.509 -178.775 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 39' ' ' GLY . . . 39.79 64.03 1.13 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 179.304 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.597 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 9.2 m-85 -117.98 -61.65 1.65 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.048 -1.266 . . . . 0.0 110.75 179.813 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 1.047 ' HB2' HG23 ' A' ' 72' ' ' VAL . 1.3 t -88.4 178.78 6.47 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.043 -1.036 . . . . 0.0 110.376 -179.661 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -86.71 -89.05 0.12 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.338 -0.851 . . . . 0.0 110.278 -179.763 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -63.61 179.99 0.42 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.246 -0.909 . . . . 0.0 110.078 179.903 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.528 ' N ' ' HA ' ' A' ' 38' ' ' ALA . . . -77.16 136.18 38.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.282 -0.886 . . . . 0.0 110.47 -179.656 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 1.025 ' CZ2' HG11 ' A' ' 36' ' ' VAL . 8.4 p90 -135.56 -156.09 0.69 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.372 -0.83 . . . . 0.0 109.756 179.38 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.529 ' O ' ' CB ' ' A' ' 68' ' ' ALA . 0.6 OUTLIER -160.34 172.2 17.75 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.875 -1.13 . . . . 0.0 111.039 -178.548 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.901 HD13 HD13 ' A' ' 129' ' ' LEU . 2.3 mp -132.23 127.99 36.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.498 -0.751 . . . . 0.0 109.253 179.272 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 140' ' ' CYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 4.9 m -123.96 96.51 4.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.067 -1.021 . . . . 0.0 111.134 -179.35 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.5 ' HA ' ' O ' ' A' ' 65' ' ' THR . 0.9 OUTLIER -89.74 -176.14 4.87 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.267 -0.895 . . . . 0.0 108.88 178.774 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.549 ' HB3' ' CB ' ' A' ' 31' ' ' ALA . 0.5 OUTLIER 170.6 43.96 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.929 -1.107 . . . . 0.0 111.003 179.98 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.504 ' HB2' ' O ' ' A' ' 142' ' ' ASP . 11.3 t70 174.01 61.47 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.36 -0.838 . . . . 0.0 109.505 179.63 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.807 HG11 ' CZ2' ' A' ' 16' ' ' TRP . 1.1 t -95.17 114.68 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.096 -1.003 . . . . 0.0 110.308 -179.399 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.68 ' HB2' ' CG ' ' A' ' 6' ' ' GLU . . . -138.27 145.29 41.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.339 -0.851 . . . . 0.0 110.229 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.721 HD21 HD11 ' A' ' 54' ' ' ILE . 6.7 tp -153.47 129.57 10.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.238 -0.914 . . . . 0.0 110.219 179.969 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.496 ' O ' ' HA ' ' A' ' 60' ' ' TYR . 1.5 t0 -160.04 155.06 24.68 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.24 -0.912 . . . . 0.0 110.267 179.963 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.778 ' OG ' HG12 ' A' ' 150' ' ' VAL . 1.7 t -91.28 151.4 20.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.258 -0.901 . . . . 0.0 110.248 179.966 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.23 46.42 0.99 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.278 -0.889 . . . . 0.0 110.202 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.778 HG12 ' OG ' ' A' ' 148' ' ' SER . 11.8 p -142.03 21.72 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.285 -0.884 . . . . 0.0 110.194 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -169.46 -170.72 1.12 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.258 -0.901 . . . . 0.0 110.173 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.1 mp . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.187 -179.955 . . . . . . . . 0 0 . 1 stop_ save_